PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nikiforow, S; Ritz, J				Nikiforow, Sarah; Ritz, Jerome			Dramatic Expansion of HSCs: New Possibilities for HSC Transplants?	CELL STEM CELL			English	Editorial Material							CORD BLOOD TRANSPLANTATION; PLATELET ENGRAFTMENT; NEUTROPHIL	The identification of mechanisms that regulate stem cell renewal has led to the development of innovative approaches to expand hematopoietic stem cells ex vivo. One approach reported by Wagner et al. (2016) in this issue of Cell Stem Cell has demonstrated dramatic expansion of umbilical cord blood stem cells that promote rapid engraftment while maintaining capacity for long-term hematopoiesis.	[Nikiforow, Sarah; Ritz, Jerome] Dana Farber Canc Inst, Dept Med Oncol, Div Hematol Malignancies, Boston, MA 02115 USA; [Nikiforow, Sarah; Ritz, Jerome] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Ritz, J (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Div Hematol Malignancies, Boston, MA 02115 USA.; Ritz, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	jerome_ritz@dfci.harvard.edu	Ritz, Jerome/C-7929-2009	Ritz, Jerome/0000-0001-5526-4669				Ballen KK, 2013, BLOOD, V122, P491, DOI 10.1182/blood-2013-02-453175; Cutler C, 2013, BLOOD, V122, P3074, DOI 10.1182/blood-2013-05-503177; de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979; de Lima M, 2012, NEW ENGL J MED, V367, P2305, DOI 10.1056/NEJMoa1207285; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Gluckman E, 2004, EXP HEMATOL, V32, P397, DOI 10.1016/j.exphem.2004.01.002; Horwitz ME, 2014, J CLIN INVEST, V124, P3121, DOI 10.1172/JCI74556; Page KM, 2011, BIOL BLOOD MARROW TR, V17, P1362, DOI 10.1016/j.bbmt.2011.01.011; Popat U, 2015, BLOOD, V125, P2885, DOI 10.1182/blood-2015-01-607366; Wagner JE, 2016, CELL STEM CELL, V18, P144, DOI 10.1016/j.stem.2015.10.004	10	22	22	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					10	12		10.1016/j.stem.2015.12.011	http://dx.doi.org/10.1016/j.stem.2015.12.011			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26748750	Bronze			2022-12-28	WOS:000372321300005
J	Steinbeck, JA; Jaiswal, MK; Calder, EL; Kishinevsky, S; Weishaupt, A; Toyka, KV; Goldstein, PA; Studer, L				Steinbeck, Julius A.; Jaiswal, Manoj K.; Calder, Elizabeth L.; Kishinevsky, Sarah; Weishaupt, Andreas; Toyka, Klaus V.; Goldstein, Peter A.; Studer, Lorenz			Functional Connectivity under Optogenetic Control Allows Modeling of Human Neuromuscular Disease	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; MOTOR-NEURONS; MYASTHENIA-GRAVIS; ACETYLCHOLINE-RECEPTOR; OPTICAL CONTROL; HUMAN ES; MICE; JUNCTION; TRANSPLANTATION; MECHANISMS	Capturing the full potential of human pluripotent stem cell (PSC)-derived neurons in disease modeling and regenerative medicine requires analysis in complex functional systems. Here we establish optogenetic control in human PSC-derived spinal motorneurons and show that co-culture of these cells with human myoblast-derived skeletal muscle builds a functional all-human neuromuscular junction that can be triggered to twitch upon light stimulation. To model neuromuscular disease we incubated these co-cultures with IgG from myasthenia gravis patients and active complement. Myasthenia gravis is an autoimmune disorder that selectively targets neuromuscular junctions. We saw a reversible reduction in the amplitude of muscle contractions, representing a surrogate marker for the characteristic loss of muscle strength seen in this disease. The ability to recapitulate key aspects of disease pathology and its symptomatic treatment suggests that this neuromuscular junction assay has significant potential for modeling of neuromuscular disease and regeneration.	[Steinbeck, Julius A.; Calder, Elizabeth L.; Kishinevsky, Sarah; Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA; [Steinbeck, Julius A.; Calder, Elizabeth L.; Kishinevsky, Sarah; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY 10065 USA; [Jaiswal, Manoj K.; Goldstein, Peter A.] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10065 USA; [Goldstein, Peter A.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Weishaupt, Andreas; Toyka, Klaus V.] Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; University of Wurzburg	Steinbeck, JA; Studer, L (corresponding author), Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA.; Steinbeck, JA; Studer, L (corresponding author), Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY 10065 USA.	just.msk@use.startmail.com; studerl@mskcc.org	Studer, Lorenz/ABH-1491-2021; Jaiswal, Manoj Kumar/L-9967-2019	Studer, Lorenz/0000-0003-0741-7987; Jaiswal, Manoj Kumar/0000-0003-3702-2492; Goldstein, Peter/0000-0002-5973-9104; Jaiswal, Manoj/0000-0001-9198-7450	University Medical School, Wurzburg; DFG [STE 2064/1-1]; NIH/NINDS [NS052671, C028503, P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052671] Funding Source: NIH RePORTER	University Medical School, Wurzburg; DFG(German Research Foundation (DFG)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Sanghoon Oh, Vitaly Boyoko, Sho Fujisawa, and Katia Manova (MSKCC molecular cytology core) as well as M. Tomishima (SKI stem cell core) for excellent technical support. K.V.T is the recipient of a senior professorship award funded by the University Medical School, Wurzburg. J.A.S. was supported by a DFG fellowship (STE 2064/1-1). The work was supported in part by NIH/NINDS grant NS052671, NYSTEM contract C028503 to L.S., and P30 CA008748.	Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; BARKER AT, 1985, LANCET, V1, P1106; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Calder EL, 2015, J NEUROSCI, V35, P11462, DOI 10.1523/JNEUROSCI.3046-14.2015; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan A, 2007, J NEUROL, V254, P1604, DOI 10.1007/s00415-007-0593-9; Cisterna BA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00405; Cunningham M, 2014, CELL STEM CELL, V15, P559, DOI 10.1016/j.stem.2014.10.006; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Daube JR, 2009, MUSCLE NERVE, V39, P244, DOI 10.1002/mus.21180; Davis-Dusenbery BN, 2014, DEVELOPMENT, V141, P491, DOI 10.1242/dev.097410; DRACHMAN DB, 1978, NEW ENGL J MED, V298, P1116, DOI 10.1056/NEJM197805182982004; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Gold Ralf, 2008, Ther Adv Neurol Disord, V1, P36, DOI 10.1177/1756285608093888; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Moloney EB, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00252; Plomp JJ, 2015, EXP NEUROL, V270, P41, DOI 10.1016/j.expneurol.2015.01.007; SAHASHI K, 1980, J NEUROPATH EXP NEUR, V39, P160, DOI 10.1097/00005072-198003000-00005; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sendtner M, 2014, Handb Exp Pharmacol, V220, P411, DOI 10.1007/978-3-642-45106-5_15; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Skoglund G, 2014, P NATL ACAD SCI USA, V111, P8275, DOI 10.1073/pnas.1322258111; Steinbeck JA, 2015, NEURON, V86, P187, DOI 10.1016/j.neuron.2015.03.002; Steinbeck JA, 2015, NAT BIOTECHNOL, V33, P204, DOI 10.1038/nbt.3124; Titulaer MJ, 2011, LANCET NEUROL, V10, P1098, DOI 10.1016/S1474-4422(11)70245-9; TOYKA KV, 1977, NEW ENGL J MED, V296, P125, DOI 10.1056/NEJM197701202960301; Verschuuren JJGM, 2013, AUTOIMMUN REV, V12, P918, DOI 10.1016/j.autrev.2013.03.001; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	38	79	82	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					134	143		10.1016/j.stem.2015.10.002	http://dx.doi.org/10.1016/j.stem.2015.10.002			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26549107	Bronze, Green Accepted			2022-12-28	WOS:000372321300018
J	Haas, S; Hansson, J; Klimmeck, D; Loeffler, D; Velten, L; Uckelmann, H; Wurzer, S; Prendergast, AM; Schnell, A; Hexel, K; Santarella-Mellwig, R; Blaszkiewicz, S; Kuck, A; Geiger, H; Milsom, MD; Steinmetz, LM; Schroeder, T; Trumpp, A; Krijgsveld, J; Essers, MAG				Haas, Simon; Hansson, Jenny; Klimmeck, Daniel; Loeffler, Dirk; Velten, Lars; Uckelmann, Hannah; Wurzer, Stephan; Prendergast, Aine M.; Schnell, Alexandra; Hexel, Klaus; Santarella-Mellwig, Rachel; Blaszkiewicz, Sandra; Kuck, Andrea; Geiger, Hartmut; Milsom, Michael D.; Steinmetz, Lars M.; Schroeder, Timm; Trumpp, Andreas; Krijgsveld, Jeroen; Essers, Marieke A. G.			Inflammation-Induced Emergency Megakaryopoiesis Driven by Hematopoietic Stem Cell-like Megakaryocyte Progenitors	CELL STEM CELL			English	Article							PROTEIN-SYNTHESIS; SELF-RENEWAL; IN-VIVO; EXPRESSION; THROMBOCYTOPENIA; PLATELETS; GENE; TRANSLATION; DEGRADATION; HOMEOSTASIS	Infections are associated with extensive platelet consumption, representing a high risk for health. However, the mechanism coordinating the rapid regeneration of the platelet pool during such stress conditions remains unclear. Here, we report that the phenotypic hematopoietic stem cell (HSC) compartment contains stem-like megakaryocyte-committed progenitors (SL-MkPs), a cell population that shares many features with multipotent HSCs and serves as a lineage-restricted emergency pool for inflammatory insults. During homeostasis, SL-MkPs are maintained in a primed but quiescent state, thus contributing little to steady-state megakaryopoiesis. Even though lineage-specific megakaryocyte transcripts are expressed, protein synthesis is suppressed. In response to acute inflammation, SL-MkPs become activated, resulting in megakaryocyte protein production from preexisting transcripts and a maturation of SL-MkPs and other megakaryocyte progenitors. This results in an efficient replenishment of platelets that are lost during inflammatory insult. Thus, our study reveals an emergency machinery that counteracts life-threatening platelet depletions during acute inflammation.	[Haas, Simon; Klimmeck, Daniel; Uckelmann, Hannah; Wurzer, Stephan; Prendergast, Aine M.; Schnell, Alexandra; Blaszkiewicz, Sandra; Kuck, Andrea; Milsom, Michael D.; Trumpp, Andreas; Essers, Marieke A. G.] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany; [Haas, Simon; Uckelmann, Hannah; Wurzer, Stephan; Prendergast, Aine M.; Schnell, Alexandra; Blaszkiewicz, Sandra; Kuck, Andrea; Essers, Marieke A. G.] Deutsch Krebsforschungszentrum DKFZ, Hematopoiet Stem Cells & Stress Grp, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Hansson, Jenny; Klimmeck, Daniel; Velten, Lars; Steinmetz, Lars M.; Krijgsveld, Jeroen] EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Klimmeck, Daniel; Trumpp, Andreas] Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Loeffler, Dirk; Schroeder, Timm] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn D BSSE, CH-4058 Basel, Switzerland; [Hexel, Klaus] Deutsch Krebsforschungszentrum DKFZ, Core Facil Flow Cytometry, D-69120 Heidelberg, Germany; [Santarella-Mellwig, Rachel] EMBL, Electron Microscopy Core Facil, D-69117 Heidelberg, Germany; [Geiger, Hartmut] Univ Ulm, Inst Mol Med, D-89081 Ulm, Germany; [Geiger, Hartmut] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Geiger, Hartmut] Univ Cincinnati, Cincinnati, OH 45229 USA; [Milsom, Michael D.] Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, Expt Hematol Grp, D-69120 Heidelberg, Germany; [Steinmetz, Lars M.] Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Steinmetz, Lars M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Ulm University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Helmholtz Association; German Cancer Research Center (DKFZ); Stanford University; Stanford University	Essers, MAG (corresponding author), Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany.	m.essers@dkfz.de	Trumpp, Andreas/Z-2141-2019; Velten, Lars/Z-5952-2019; Hansson, Jenny/J-5062-2014; Milsom, Michael/AAK-4600-2020; Essers, Marieke A.G./B-7758-2017	Trumpp, Andreas/0000-0002-6212-3466; Hansson, Jenny/0000-0001-9174-8089; Essers, Marieke A.G./0000-0003-3117-1809; Uckelmann, Hannah/0000-0003-2048-7357; Krijgsveld, Jeroen/0000-0001-7549-9326; Velten, Lars/0000-0002-1233-5874; Schroeder, Timm/0000-0001-9320-0252; Steinmetz, Lars/0000-0002-3962-2865; Loeffler, Dirk/0000-0001-9870-0088; /0000-0002-3567-254X; Haas, Simon/0000-0001-9227-2051; Schnell, Alexandra/0000-0003-3442-7750	BioRN Leading-Edge Cluster "Cell-Based and Molecular Medicine" - German Federal Ministry of Education and Research; Dietmar Hopp Foundation; Deutsche Forschungsgemeinschaft (DFG) [SFB873, FOR2033 NicHem]	BioRN Leading-Edge Cluster "Cell-Based and Molecular Medicine" - German Federal Ministry of Education and Research; Dietmar Hopp Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We would like to thank A. Atzberger and S. Schmitt from the Deutsches Krebsforschungszentrum (DKFZ) Flow Cytometry Facility; D. Krunic from the DKFZ Imaging Core Facility; J. Kirkpatrick, S. Leicht, and K. Dzeyk from the EMBL Proteomics Core Facility; C. Funaya, C. Antony, and Y. Schwab from the EMBL Electron Microscopy Core Facility; members from the EMBL Genomics Core Facility; and the DKFZ Animal Laboratory Services for assistance and their expertise. This work was supported by the BioRN Leading-Edge Cluster "Cell-Based and Molecular Medicine" funded by the German Federal Ministry of Education and Research, the Dietmar Hopp Foundation, and the SFB873 and FOR2033 NicHem, both funded by the Deutsche Forschungsgemeinschaft (DFG).	Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Browne EP, 2001, J VIROL, V75, P12319, DOI 10.1128/JVI.75.24.12319-12330.2001; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Cole JL, 1998, BLOOD, V91, P3239, DOI 10.1182/blood.V91.9.3239.3239_3239_3246; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Goerge T, 2008, BLOOD, V111, P4958, DOI 10.1182/blood-2007-11-123620; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Heijnen HFG, 1998, BLOOD, V91, P2313, DOI 10.1182/blood.V91.7.2313.2313_2313_2325; Huang Z, 2007, J CLIN INVEST, V117, P3890, DOI 10.1172/JCI33010; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kruiswijk F, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002718; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Martin TG, 1998, HEPATOLOGY, V28, P1430, DOI 10.1002/hep.510280536; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Platani M, 2009, MOL BIOL CELL, V20, P5260, DOI 10.1091/mbc.E09-05-0377; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rajan SK, 2005, BRIT J HAEMATOL, V129, P818, DOI 10.1111/j.1365-2141.2005.05542.x; Raslova H, 2006, BLOOD, V107, P2303, DOI 10.1182/blood-2005-07-3005; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Shin JY, 2014, J EXP MED, V211, P217, DOI 10.1084/jem.20131128; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Stohlawetz P, 1999, THROMB HAEMOSTASIS, V81, P613; Tacchini-Cottier F, 1998, J IMMUNOL, V160, P6182; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xiang BG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3657; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yeaman MR, 2014, NAT REV MICROBIOL, V12, P426, DOI 10.1038/nrmicro3269	40	249	253	2	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 1	2015	17	4					422	434		10.1016/j.stem.2015.07.007	http://dx.doi.org/10.1016/j.stem.2015.07.007			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4TS	26299573	Bronze			2022-12-28	WOS:000365693800009
J	Caputo, L; Witzel, HR; Kolovos, P; Cheedipudi, S; Looso, M; Mylona, A; van IJcken, WFJ; Laugwitz, KL; Evans, SM; Braun, T; Soler, E; Grosveld, F; Dobreva, G				Caputo, Luca; Witzel, Hagen R.; Kolovos, Petros; Cheedipudi, Sirisha; Looso, Mario; Mylona, Athina; van IJcken, Wilfred F. J.; Laugwitz, Karl-Ludwig; Evans, Sylvia M.; Braun, Thomas; Soler, Eric; Grosveld, Frank; Dobreva, Gergana			The Isl1/Ldb1 Complex Orchestrates Genome-wide Chromatin Organization to Instruct Differentiation of Multipotent Cardiac Progenitors	CELL STEM CELL			English	Article							HOMEODOMAIN TRANSCRIPTION FACTORS; CHROMOSOME CONFORMATION CAPTURE; ERYTHROID-DIFFERENTIATION; PLURIPOTENCY FACTORS; HEART FIELD; STEM-CELLS; LIM; LDB1; BINDING; PROTEIN	Cardiac stem/progenitor cells hold great potential for regenerative therapies; however, the mechanisms regulating their expansion and differentiation remain insufficiently defined. Here we show that Ldb1 is a central regulator of genome organization in cardiac progenitor cells, which is crucial for cardiac lineage differentiation and heart development. We demonstrate that Ldb1 binds to the key regulator of cardiac progenitors, Isl1, and protects it from degradation. Furthermore, the Isl1/Ldb1 complex promotes long-range enhancer-promoter interactions at the loci of the core cardiac transcription factors Mef2c and Hand2. Chromosome conformation capture followed by sequencing identified specific Ldb1-mediated interactions of the Isl1/Ldb1 responsive Mef2c anterior heart field enhancer with genes that play key roles in cardiac progenitor cell function and cardiovascular development. Importantly, the expression of these genes was downregulated upon Ldb1 depletion and Isl1/Ldb1 haplodeficiency. In conclusion, the Isl1/Ldb1 complex orchestrates a network for heart-specific transcriptional regulation and coordination in three-dimensional space during cardiogenesis.	[Caputo, Luca; Witzel, Hagen R.; Cheedipudi, Sirisha; Looso, Mario; Braun, Thomas; Dobreva, Gergana] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany; [Kolovos, Petros; Mylona, Athina; Soler, Eric; Grosveld, Frank] Erasmus MC, Dept Cell Biol, NL-3015 CN Rotterdam, Netherlands; [Mylona, Athina] Canterbury Christ Church Univ, Sch Human & Life Sci, Canterbury CT1 1QU, Kent, England; [van IJcken, Wilfred F. J.] Erasmus MC, Ctr Biom, NL-3015 CN Rotterdam, Netherlands; [Laugwitz, Karl-Ludwig] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 1, Cardiol, D-81675 Munich, Germany; [Evans, Sylvia M.] Univ Calif San Diego, Skaggs Sch Pharm, Dept Med, La Jolla, CA 92093 USA; [Soler, Eric] INSERM UMR967, CEA DSV iRCM LHM, Lab Mol Hematopoiesis, F-92265 Fontenay Aux Roses, France; [Soler, Eric] Lab Excellence GR Ex, F-75015 Paris, France; [Dobreva, Gergana] Goethe Univ Frankfurt, Fac Med, D-60590 Frankfurt, Germany	Max Planck Society; Erasmus University Rotterdam; Erasmus MC; Canterbury Christ Church University; Erasmus University Rotterdam; Erasmus MC; Technical University of Munich; University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Goethe University Frankfurt	Dobreva, G (corresponding author), Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany.	gergana.dobreva@mpi-bn.mpg.de	Soler, Eric/ABE-9723-2021; van ijcken, willem/N-9805-2018; Caputo, Luca/X-6885-2019	Soler, Eric/0000-0003-0521-7463; van ijcken, willem/0000-0002-0421-8301; Caputo, Luca/0000-0002-1697-9968; Looso, Mario/0000-0003-1495-9530; Braun, Thomas/0000-0002-6165-4804; Kolovos, Petros/0000-0002-0787-6158; Dobreva, Gergana/0000-0002-4814-9416; cheedipudi, sirisha/0000-0002-3202-3229	LOEWE Center for Cell and Gene Therapy (CGT) - Hessian Ministry of Higher Education, Research and Arts [III L 4- 518/17.004, DO 1323/1-1]; SFB [TRR 81]; DFG (Germany) [EXC 147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074066] Funding Source: NIH RePORTER	LOEWE Center for Cell and Gene Therapy (CGT) - Hessian Ministry of Higher Education, Research and Arts; SFB(Austrian Science Fund (FWF)); DFG (Germany)(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Ingrid Konrad, Susanne Kreutzer, Kerstin Richter, and Monika Muller-Boche for technical assistance. We are grateful to Boyan Garvalov for careful reading of the manuscript and the constructive comments. This work was supported by the LOEWE Center for Cell and Gene Therapy (CGT), financed by the Hessian Ministry of Higher Education, Research and Arts (III L 4- 518/17.004[2013]), an Emmy-Noether Program grant DO 1323/1-1, the SFB TRR 81, and the EXC 147 of the DFG (Germany).	Aguirre A, 2013, CELL STEM CELL, V12, P275, DOI 10.1016/j.stem.2013.02.008; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Becker T, 2002, MECH DEVELOP, V117, P75, DOI 10.1016/S0925-4773(02)00178-8; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; D'Amico L, 2007, CURR BIOL, V17, P252, DOI 10.1016/j.cub.2006.12.023; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Gungor C, 2007, P NATL ACAD SCI USA, V104, P15000, DOI 10.1073/pnas.0703738104; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Krivega I, 2014, GENE DEV, V28, P1278, DOI 10.1101/gad.239749.114; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1219, DOI 10.1038/nn.3467; McFadden DG, 2000, DEVELOPMENT, V127, P5331; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Mukhopadhyay M, 2003, DEVELOPMENT, V130, P495, DOI 10.1242/dev.00225; Mylona A, 2013, BLOOD, V121, P2902, DOI 10.1182/blood-2012-11-467654; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Thongjuea S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt373; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Witzel HR, 2012, DEV CELL, V23, P58, DOI 10.1016/j.devcel.2012.06.005	44	51	52	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					287	299		10.1016/j.stem.2015.08.007	http://dx.doi.org/10.1016/j.stem.2015.08.007			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26321200	Green Accepted, Bronze			2022-12-28	WOS:000364011000008
J	Wilson, NK; Kent, DG; Buettner, F; Shehata, M; Macaulay, IC; Calero-Nieto, FJ; Castillo, MS; Oedekoven, CA; Diamanti, E; Schulte, R; Ponting, CP; Voet, T; Caldas, C; Stingl, J; Green, AR; Theis, FJ; Gottgens, B				Wilson, Nicola K.; Kent, David G.; Buettner, Florian; Shehata, Mona; Macaulay, Iain C.; Calero-Nieto, Fernando J.; Castillo, Manuel Sanchez; Oedekoven, Caroline A.; Diamanti, Evangelia; Schulte, Reiner; Ponting, Chris P.; Voet, Thierry; Caldas, Carlos; Stingl, John; Green, Anthony R.; Theis, Fabian J.; Goettgens, Berthold			Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM; SELF-RENEWAL; RNA-SEQ; PROGENITOR CELLS; HIERARCHY	Heterogeneity within the self-renewal durability of adult hematopoietic stem cells (HSCs) challenges our understanding of the molecular framework underlying HSC function. Gene expression studies have been hampered by the presence of multiple HSC subtypes and contaminating non-HSCs in bulk HSC populations. To gain deeper insight into the gene expression program of murine HSCs, we combined single-cell functional assays with flow cytometric index sorting and single-cell gene expression assays. Through bioinformatic integration of these datasets, we designed an unbiased sorting strategy that separates non-HSCs away from HSCs, and single-cell transplantation experiments using the enriched population were combined with RNA-seq data to identify key molecules that associate with long-term durable self-renewal, producing a single-cell molecular dataset that is linked to functional stem cell activity. Finally, we demonstrated the broader applicability of this approach for linking key molecules with defined cellular functions in another stem cell system.	[Wilson, Nicola K.; Kent, David G.; Calero-Nieto, Fernando J.; Castillo, Manuel Sanchez; Oedekoven, Caroline A.; Diamanti, Evangelia; Green, Anthony R.; Goettgens, Berthold] Univ Cambridge, Wellcome Trust & MRC Cambridge Stem Cell Inst, Dept Haematol, Cambridge CB2 0XY, England; [Wilson, Nicola K.; Kent, David G.; Calero-Nieto, Fernando J.; Castillo, Manuel Sanchez; Oedekoven, Caroline A.; Diamanti, Evangelia; Green, Anthony R.; Goettgens, Berthold] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Buettner, Florian; Theis, Fabian J.] Helmholtz Zentrum Munchen, Inst Computat Biol, D-85764 Neuherberg, Germany; [Macaulay, Iain C.; Ponting, Chris P.; Voet, Thierry] Wellcome Trust Sanger Inst, Single Cell Genom Ctr, Cambridge CB10 1SA, England; [Schulte, Reiner] Univ Cambridge, Cambridge Inst Med Res, Head Flow Cytometry, Cambridge CB2 0XY, England; [Caldas, Carlos] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, MRC Computat Genom Anal & Training Programme, Oxford OX1 3PT, England; [Voet, Thierry] Katholieke Univ Leuven, Dept Human Genet, Lab Reprod Gen, B-3000 Louvain, Belgium; [Shehata, Mona; Caldas, Carlos; Stingl, John] Univ Cambridge, Li Ka Shing Ctr, Dept Oncol, Cambridge CB2 0RE, England; [Shehata, Mona; Caldas, Carlos; Stingl, John] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Theis, Fabian J.] Tech Univ Munich, Dept Math, D-85748 Garching, Germany	University of Cambridge; University of Cambridge; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Wellcome Trust Sanger Institute; University of Cambridge; University of Oxford; KU Leuven; CRUK Cambridge Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Technical University of Munich	Gottgens, B (corresponding author), Univ Cambridge, Wellcome Trust & MRC Cambridge Stem Cell Inst, Dept Haematol, Cambridge CB2 0XY, England.	bg200@cam.ac.uk	Kent, David/AAZ-4916-2021; Caldas, Carlos/U-7250-2019; Buettner, Florian/ABF-1230-2020; Ponting, Chris/AAV-2621-2021; Voet, Thierry/E-8877-2017; Theis, Fabian J/ABD-5212-2021	Kent, David/0000-0001-7871-8811; Caldas, Carlos/0000-0003-3547-1489; Buettner, Florian/0000-0001-5587-6761; Voet, Thierry/0000-0003-1204-9963; Theis, Fabian J/0000-0002-2419-1943; Green, Anthony/0000-0002-9795-0218; Schulte, Reiner/0000-0003-4928-2857; Macaulay, Iain/0000-0002-6761-757X; Oedekoven, Caroline Anna/0000-0002-2309-2097; Gottgens, Berthold/0000-0001-6302-5705; Ponting, Chris/0000-0003-0202-7816; Calero-Nieto, Fernando/0000-0003-3358-8253	Leukaemia and Lymphoma Research; Medical Research Council; Cancer Research UK; Biotechnology and Biological Sciences Research Council; Leukemia Lymphoma Society; National Institute for Health Research Cambridge Biomedical Research Centre; Wellcome Trust; Wellcome Trust-MRC Cambridge Stem Cell Institute; Canadian Institutes of Health Research; European Research Council; University of Cambridge; Cancer Research UK Institute [C14303/A17197]; Hutchison Whampoa Limited; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [MC_UU_12021/1, MC_U137761446, G0900951, MR/M008975/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [16942, 12765] Funding Source: researchfish; Medical Research Council [MC_PC_12009, G0900951, MC_UU_12021/1, MC_U137761446, MR/M008975/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	Leukaemia and Lymphoma Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leukemia Lymphoma Society(Leukemia and Lymphoma Society); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Wellcome Trust-MRC Cambridge Stem Cell Institute(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European Research Council(European Research Council (ERC)European Commission); University of Cambridge(University of Cambridge); Cancer Research UK Institute(Cancer Research UK); Hutchison Whampoa Limited; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank Chiara Cossetti and Michal Maj at the CIMR Flow Cytometry Core for their help with cell sorting, Dean Pask and Tina Hamilton for technical assistance, Vicki Moignard for advice on Fluidigm Biomark analyses, and Cheuk-Ho Tsang for helpful suggestions. Work in the author's laboratory is supported by grants from the Leukaemia and Lymphoma Research, the Medical Research Council, Cancer Research UK, Biotechnology and Biological Sciences Research Council, Leukemia Lymphoma Society, and the National Institute for Health Research Cambridge Biomedical Research Centre and core support grants by the Wellcome Trust to the Cambridge Institute for Medical Research and Wellcome Trust-MRC Cambridge Stem Cell Institute. D.G.K. is the recipient of a Canadian Institutes of Health Research Postdoctoral Fellowship. F.B. and F.J.T. are funded by the European Research Council (starting grant "LatentCauses"). For funding for the open access charge, the core support grant was provided by the Wellcome Trust-MRC Cambridge Stem Cell Institute. We acknowledge the support of the University of Cambridge, Cancer Research UK Institute (core grant C14303/A17197), and Hutchison Whampoa Limited.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Copley MR, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.98; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Eirew P, 2010, NAT PROTOC, V5, P1945, DOI 10.1038/nprot.2010.148; Ema H, 2014, EXP HEMATOL, V42, P74, DOI 10.1016/j.exphem.2013.11.004; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grinenko T, 2014, J EXP MED, V211, P209, DOI 10.1084/jem.20131115; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Kent DG, 2008, BLOOD, V112, P560, DOI 10.1182/blood-2007-10-117820; Kent DG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001576; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Moignard Victoria, 2013, Nat Cell Biol, V15, P363, DOI 10.1038/ncb2709; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Osborne GW, 2011, METHOD CELL BIOL, V102, P533, DOI 10.1016/B978-0-12-374912-3.00021-3; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Prick J, 2014, EXP HEMATOL, V42, P841, DOI 10.1016/j.exphem.2014.07.268; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Wilkinson AC, 2013, ADV EXP MED BIOL, V786, P187, DOI 10.1007/978-94-007-6621-1_11; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007	43	278	282	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					712	724		10.1016/j.stem.2015.04.004	http://dx.doi.org/10.1016/j.stem.2015.04.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26004780	Green Published, hybrid			2022-12-28	WOS:000355932300018
J	Ibrayeva, A; Bonaguidi, MA				Ibrayeva, Albina; Bonaguidi, Michael A.			Pushing and Pulling on Adult Neural Stem Cells	CELL STEM CELL			English	Editorial Material							NEUROGENESIS	How plastic is adult neurogenesis? In this issue of Cell Stem Cell, Sierra et al. (2015) use epilepsy models to probe how hippocampal neural stem cells (NSCs) respond to graded pathological conditions. They uncover changes in cell fate potential upon NSC activation, but it comes at a cost.	[Ibrayeva, Albina; Bonaguidi, Michael A.] Univ So Calif, Dept Stem Cell Biol & Regenerat Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, WM Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California	Bonaguidi, MA (corresponding author), Univ So Calif, Dept Stem Cell Biol & Regenerat Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, WM Keck Sch Med, Los Angeles, CA 90033 USA.	mbonagui@usc.edu		Ibrayeva, Albina/0000-0001-5782-5511	NINDS NIH HHS [R00 NS080913] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS080913] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Bonaguidi MA, 2012, CURR OPIN NEUROBIOL, V22, P754, DOI 10.1016/j.conb.2012.03.013; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Iyengar SS, 2015, EXP NEUROL, V264, P135, DOI 10.1016/j.expneurol.2014.11.009; Magnusson JP, 2014, SCIENCE, V346, P237, DOI 10.1126/science.346.6206.237; Sierra A, 2015, CELL STEM CELL, V16, P488, DOI 10.1016/j.stem.2015.04.003; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Yu T.S., 2014, NEUROSCIENT IN PRESS	10	3	3	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					451	452		10.1016/j.stem.2015.04.011	http://dx.doi.org/10.1016/j.stem.2015.04.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25957896	Bronze			2022-12-28	WOS:000354188600002
J	Wang, YY; He, L; Du, Y; Zhu, PP; Huang, GL; Luo, JJ; Yan, XL; Ye, BQ; Li, C; Xia, PY; Zhang, G; Tian, Y; Chen, RS; Fan, ZS				Wang, Yanying; He, Lei; Du, Ying; Zhu, Pingping; Huang, Guanling; Luo, Jianjun; Yan, Xinlong; Ye, Buqing; Li, Chong; Xia, Pengyan; Zhang, Geng; Tian, Yong; Chen, Runsheng; Fan, Zusen			The Long Noncoding RNA IncTCF7 Promotes Self-Renewal of Human Liver Cancer Stem Cells through Activation of Wnt Signaling	CELL STEM CELL			English	Article							TUMOR-INITIATING CELLS; SWI/SNF COMPLEXES; CHROMATIN; SUPPRESSION; MUTATIONS; AUTOPHAGY; TARGET; ROLES; TCF-1; ACTS	Hepatocellular carcinoma (HCC) is the most prevalent subtype of liver cancer, and it is characterized by a high rate of recurrence and heterogeneity. Liver cancer stem cells (CSCs) may well contribute to both of these pathological properties, but the mechanisms underlying their self-renewal and maintenance are poorly understood. Here, using transcriptome microarray analysis, we identified a long noncoding RNA (IncRNA) termed IncTCF7 that is highly expressed in HCC tumors and liver CSCs. LncTCF7 is required for liver CSC self-renewal and tumor propagation. Mechanistically, IncTCF7 recruits the SWI/SNF complex to the promoter of TCF7 to regulate its expression, leading to activation of Wnt signaling. Our data suggest that IncTCF7-mediated Wnt signaling primes liver CSC self-renewal and tumor propagation. In sum, therefore, we have identified an IncRNA-based Wnt signaling regulatory circuit that promotes tumorigenic activity in liver cancer stem cells, highlighting the role that IncRNAs can play in tumor growth and propagation.	[Wang, Yanying; Du, Ying; Zhu, Pingping; Huang, Guanling; Yan, Xinlong; Ye, Buqing; Li, Chong; Xia, Pengyan; Zhang, Geng; Fan, Zusen] Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Beijing 100101, Peoples R China; [He, Lei] Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing 100853, Peoples R China; [Huang, Guanling; Fan, Zusen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Luo, Jianjun; Tian, Yong; Chen, Runsheng] Chinese Acad Sci, Inst Biophys, CAS Key Lab RNA Biol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chen, RS (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Key Lab RNA Biol, Beijing 100101, Peoples R China.	crs@sun5.ibp.ac.cn; fanz@moon.ibp.ac.cn	Luo, Jianjun/L-1264-2015; Huang, Guanling/AAE-3779-2020; TIAN, YONG/ABF-4406-2021; Chen, Runsheng/S-9834-2017; TIAN, YONG/L-2414-2019	Luo, Jianjun/0000-0002-5550-9889; Chen, Runsheng/0000-0001-6049-8347; TIAN, YONG/0000-0002-8790-1148; Zhu, Pingping/0000-0002-8009-2923; Yan, Xinlong/0000-0001-9967-5654; Huang, Guanling/0000-0002-2597-6195	National Natural Science Foundation of China [81330047, 91419308, 81402459, 81272270, 81101531]; State Projects of Essential Drug Research and development [2012ZX09103301-041]; 973 Program of the MOST of China [2015CB553705, 2010CB911902]; Strategic Priority Research Programs of the Chinese Academy of Sciences [XDA01010407]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Projects of Essential Drug Research and development; 973 Program of the MOST of China(National Basic Research Program of China); Strategic Priority Research Programs of the Chinese Academy of Sciences	We thank Dr. Zeguang Han (Shanghai Jiaotong University School of Medicine, Shanghai) for providing hepatocellular carcinoma cell lines. We thank Drs. Xinlu Wang, Zhensheng Xie, Junying Jia, Yan Teng, and Jing Li (Cnkingbio Company Ltd, Beijing, China) for technical support. This work was supported by the National Natural Science Foundation of China (81330047, 91419308, 81402459, 81272270, and 81101531); the State Projects of Essential Drug Research and development (2012ZX09103301-041); 973 Program of the MOST of China (2015CB553705 and 2010CB911902); and the Strategic Priority Research Programs of the Chinese Academy of Sciences (XDA01010407).	Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Cui L, 2013, J CLIN INVEST, V123, P1647, DOI 10.1172/JCI65048; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Eroglu E, 2014, CELL, V156, P1259, DOI 10.1016/j.cell.2014.01.053; Flynn RA, 2014, CELL STEM CELL, V14, P752, DOI 10.1016/j.stem.2014.05.014; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Helming KC, 2014, CANCER CELL, V26, P309, DOI 10.1016/j.ccr.2014.07.018; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Krasteva V, 2012, BLOOD, V120, P4720, DOI 10.1182/blood-2012-04-427047; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Myant KB, 2013, CELL STEM CELL, V12, P761, DOI 10.1016/j.stem.2013.04.006; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Prensner JR, 2013, NAT GENET, V45, P1392, DOI 10.1038/ng.2771; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Tolstorukov MY, 2013, P NATL ACAD SCI USA, V110, P10165, DOI 10.1073/pnas.1302209110; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang JY, 2013, MOL CELL, V51, P211, DOI 10.1016/j.molcel.2013.05.013; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang S, 2013, CELL STEM CELL, V13, P617, DOI 10.1016/j.stem.2013.10.005; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Xia PY, 2013, EMBO J, V32, P2685, DOI 10.1038/emboj.2013.189; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; You JS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003459; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Yu Y, 2013, CELL, V152, P248, DOI 10.1016/j.cell.2012.12.006; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zeng XK, 2013, DEVELOPMENT, V140, P3532, DOI 10.1242/dev.096891; Zhao W, 2013, CANCER CELL, V23, P541, DOI 10.1016/j.ccr.2013.02.025; Zhu YY, 2013, MOL CELL, V49, P298, DOI 10.1016/j.molcel.2012.11.011	52	445	481	9	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					413	425		10.1016/j.stem.2015.03.003	http://dx.doi.org/10.1016/j.stem.2015.03.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25842979	Bronze			2022-12-28	WOS:000352228600013
J	Zunder, ER; Lujan, E; Goltsev, Y; Wernig, M; Nolan, GP				Zunder, Eli R.; Lujan, Ernesto; Goltsev, Yury; Wernig, Marius; Nolan, Garry P.			A Continuous Molecular Roadmap to iPSC Reprogramming through Progression Analysis of Single-Cell Mass Cytometry	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; SELF-RENEWAL; SURFACE MARKERS; C-MYC; EXPRESSION; MOUSE; PATHWAY; MURINE; DIFFERENTIATION	To analyze cellular reprogramming at the single-cell level, mass cytometry was used to simultaneously measure markers of pluripotency, differentiation, cell-cycle status, and cellular signaling throughout the reprogramming process. Time-resolved progression analysis of the resulting data sets was used to construct a continuous molecular roadmap for three independent reprogramming systems. Although these systems varied substantially in Oct4, Sox2, Klf4, and c-Myc stoichiometry, they presented a common set of reprogramming landmarks. Early in the reprogramming process, Oct4(high) Klf4(high) cells transitioned to a CD73(high) CD104(high) CD54(low) partially reprogrammed state. Ki67(low) cells from this intermediate population reverted to a MEF-like phenotype, but Ki67(high) cells advanced through the M-E-T and then bifurcated into two distinct populations: an ESC-like Nanog(high) Sox2(high) CD54(high) population and a mesendoderm-like Nanog low Sox2 low Lin28 high CD24(high) PDGFR-alpha(high) population. The methods developed here for time-resolved, single-cell progression analysis may be used for the study of additional complex and dynamic systems, such as cancer progression and embryonic development.	[Zunder, Eli R.; Goltsev, Yury; Nolan, Garry P.] Stanford Univ Sch Med, Baxter Lab Stem Cell Biol, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Lujan, Ernesto; Wernig, Marius] Stanford Univ Sch Med, Dept Pathol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Lujan, Ernesto] Stanford Univ Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Nolan, GP (corresponding author), Stanford Univ Sch Med, Baxter Lab Stem Cell Biol, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Nolan, Garry/AAE-7903-2019	Zunder, Eli/0000-0002-0356-1685; Nolan, Garry/0000-0002-8862-9043	NIH NRSA [F32 GM093508-01]; California Institute for Regenerative Medicine (CIRM) [TG2-01159]; National Science Foundation (NSF) Graduate Research Fellowship [DGE-114747]; NIH [U19 AI057229, U54CA149145, N01-HV-00242, 1U19AI100627, 5R01AI07372405, R01CA184968, 1 R33 CA183654, R33 CA183692]; NIH-Baylor Research Institute [41000411217]; NIH-Northrop Grumman [7500108142]; CIRM [DR1-01477, RB2-01592]; Department of Defense [OC110674, 11491122]; European Commission [Health.2010.1.2-1]; Food and Drug Administration [HHSF223201210194C]; Bill and Melinda Gates Foundation [OPP 1017093]; Alliance for Lupus Research; Entertainment Industry Foundation (NWCRA); Rachford and Carlota A. Harris Endowed Professorship; NATIONAL CANCER INSTITUTE [R01CA184968, U54CA149145, R33CA183692, R33CA183654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, U19AI100627, R01AI073724, U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093508] Funding Source: NIH RePORTER	NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-Baylor Research Institute; NIH-Northrop Grumman; CIRM(California Institute for Regenerative Medicine); Department of Defense(United States Department of Defense); European Commission(European CommissionEuropean Commission Joint Research Centre); Food and Drug Administration(United States Department of Health & Human Services); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Alliance for Lupus Research; Entertainment Industry Foundation (NWCRA); Rachford and Carlota A. Harris Endowed Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Angelica Trejo and Astraea Jager for mass cytometry quality control and instrument maintenance. We thank the Stanford Shared FACS Facility for assistance with cell sorting. We thank the Stanford PAN Facility for assistance with microarray hybridization and imaging. We thank Rob Bruggner for patiently answering our questions about the R programming language. We thank Sean Bendall and David Burns for helpful discussions. We thank Alex Chang for assistance with immunofluorescence microscopy. E.R.Z. was supported by NIH NRSA F32 GM093508-01. E.L. was supported by the California Institute for Regenerative Medicine (CIRM) Predoctoral Fellowship TG2-01159 and the National Science Foundation (NSF) Graduate Research Fellowship DGE-114747. M.W. is a New York Stem Cell Foundation-Robertson Investigator and a Tashia and John Morgridge Faculty Scholar at the Child Health Research Institute at Stanford. This work was supported by NIH (U19 AI057229, U54CA149145, N01-HV-00242, 1U19AI100627, 5R01AI07372405, R01CA184968, 1 R33 CA183654, and R33 CA183692), NIH-Baylor Research Institute (41000411217), NIH-Northrop Grumman (7500108142), CIRM (DR1-01477 and RB2-01592), Department of Defense (OC110674 and 11491122), European Commission (Health.2010.1.2-1), Food and Drug Administration (HHSF223201210194C), Bill and Melinda Gates Foundation (OPP 1017093), the Alliance for Lupus Research, the Entertainment Industry Foundation (NWCRA grant), and the Rachford and Carlota A. Harris Endowed Professorship to G.P.N. G.P.N. has personal financial interest in the company Fluidigm, the manufacturer of the mass cytometer used in this manuscript.	Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bastian M., 2009, GEPHI OPEN SOURCE SO; Behbehani GK, 2012, CYTOM PART A, V81A, P552, DOI 10.1002/cyto.a.22075; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen TT, 2011, AGING CELL, V10, P908, DOI 10.1111/j.1474-9726.2011.00722.x; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; He J, 2012, STEM CELLS DEV, V21, P2630, DOI 10.1089/scd.2012.0015; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Krutzik PO, 2005, J IMMUNOL, V175, P2357, DOI 10.4049/jimmunol.175.4.2357; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Linderman MD, 2012, BIOINFORMATICS, V28, P2400, DOI 10.1093/bioinformatics/bts425; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Roy S, 2013, P NATL ACAD SCI USA, V110, P4598, DOI 10.1073/pnas.1218682110; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wang J, 2012, STEM CELLS DEV, V21, P1524, DOI 10.1089/scd.2011.0350; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	57	124	127	0	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					323	337		10.1016/j.stem.2015.01.015	http://dx.doi.org/10.1016/j.stem.2015.01.015			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25748935	Green Accepted, Bronze			2022-12-28	WOS:000350747700014
J	Buganim, Y; Markoulaki, S; van Wietmarschen, N; Hoke, H; Wu, T; Ganz, K; Akhtar-Zaidi, B; He, YP; Abraham, BJ; Porubsky, D; Kulenkampff, E; Faddah, DA; Shi, LY; Gao, Q; Sarkar, S; Cohen, M; Goldmann, J; Nery, JR; Schultz, MD; Ecker, JR; Xiao, A; Young, RA; Lansdorp, PM; Jaenisch, R				Buganim, Yosef; Markoulaki, Styliani; van Wietmarschen, Niek; Hoke, Heather; Wu, Tao; Ganz, Kibibi; Akhtar-Zaidi, Batool; He, Yupeng; Abraham, Brian J.; Porubsky, David; Kulenkampff, Elisabeth; Faddah, Dina A.; Shi, Linyu; Gao, Qing; Sarkar, Sovan; Cohen, Malkiel; Goldmann, Johanna; Nery, Joseph R.; Schultz, Matthew D.; Ecker, Joseph R.; Xiao, Andrew; Young, Richard A.; Lansdorp, Peter M.; Jaenisch, Rudolf			The Developmental Potential of iPSCs Is Greatly Influenced by Reprogramming Factor Selection	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; ES CELLS; TETRAPLOID COMPLEMENTATION; C-MYC; EPIGENETIC MEMORY; SUPER-ENHANCERS; TRANSGENIC MICE; SINGLE-CELLS; COPY NUMBER; DNA-DAMAGE	Induced pluripotent stem cells (iPSCs) are commonly generated by transduction of Oct4, Sox2, Klf4, and Myc (OSKM) into cells. Although iPSCs are pluripotent, they frequently exhibit high variation in terms of quality, as measured in mice by chimera contribution and tetraploid complementation. Reliably high-quality iPSCs will be needed for future therapeutic applications. Here, we show that one major determinant of iPSC quality is the combination of reprogramming factors used. Based on tetraploid complementation, we found that ectopic expression of Sall4, Nanog, Esrrb, and Lin28 (SNEL) in mouse embryonic fibroblasts (MEFs) generated high-quality iPSCs more efficiently than other combinations of factors including OSKM. Although differentially methylated regions, transcript number of master regulators, establishment of specific superenhancers, and global aneuploidy were comparable between high- and low-quality lines, aberrant gene expression, trisomy of chromosome 8, and abnormal H2A. X deposition were distinguishing features that could potentially also be applicable to human.	[Markoulaki, Styliani; Hoke, Heather; Ganz, Kibibi; Akhtar-Zaidi, Batool; Abraham, Brian J.; Kulenkampff, Elisabeth; Faddah, Dina A.; Shi, Linyu; Gao, Qing; Sarkar, Sovan; Cohen, Malkiel; Goldmann, Johanna; Young, Richard A.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Buganim, Yosef] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [van Wietmarschen, Niek; Porubsky, David; Lansdorp, Peter M.] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, NL-9713 AV Groningen, Netherlands; [Hoke, Heather; Faddah, Dina A.; Young, Richard A.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Wu, Tao; Xiao, Andrew] Yale Univ, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [He, Yupeng; Nery, Joseph R.; Schultz, Matthew D.; Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, Genom Anal Lab, La Jolla, CA 92037 USA; [Young, Richard A.; Lansdorp, Peter M.; Jaenisch, Rudolf] Skolkovo Inst Sci & Technol Skoltech, Skolkovo 143025, Moscow Region, Russia	Massachusetts Institute of Technology (MIT); Whitehead Institute; Hebrew University of Jerusalem; University of Groningen; Massachusetts Institute of Technology (MIT); Yale University; Howard Hughes Medical Institute; Salk Institute; Skolkovo Institute of Science & Technology	Buganim, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel.	yossibug@ekmd.huji.ac.il; jaenisch@wi.mit.edu	Young, Richard A/F-6495-2012; Nery, Joseph/AAE-8422-2019; van Wietmarschen, Niek/ABE-8269-2020; Ecker, Joseph R/B-9144-2008; Sarkar, Sovan/F-8486-2017; Cohen, Malkiel/AAE-1115-2020; Abraham, Brian/C-2230-2019; Wu, Tao/A-1063-2013	Young, Richard A/0000-0001-8855-8647; Nery, Joseph/0000-0003-0153-5659; Ecker, Joseph R/0000-0001-5799-5895; Sarkar, Sovan/0000-0002-9456-4362; Abraham, Brian/0000-0001-8085-3027; Wu, Tao/0000-0002-9859-4534; van Wietmarschen, Niek/0000-0001-6136-5757; Porubsky, David/0000-0001-8414-8966; Lansdorp, Peter/0000-0001-7435-1071; Cohen, Malkiel/0000-0002-4187-691X	NIH [1 F32GM099153-01A1, HD 045022, R37CA084198]; National Science Foundation (NSF) Graduate Research Fellowship; Jerome and Florence Brill Graduate Student Fellowship; Gordon and Betty Moore Foundation [GMBF3034]; Chapman Foundation; Israeli Centers of Research Excellence (I-CORE) program [41/11]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014051, R37CA084198, R01CA084198] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099153] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); Jerome and Florence Brill Graduate Student Fellowship; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Chapman Foundation; Israeli Centers of Research Excellence (I-CORE) program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Biology and Research Computing (BaRC), especially Prathapan Thiru at the Whitehead Institute's Center for Microarray Technology, for computational and technical assistance. Y. B. was supported by an NIH Kirschstein National Research Service Award (1 F32GM099153-01A1). D. A. F. is a Vertex Scholar and was supported by a National Science Foundation (NSF) Graduate Research Fellowship and Jerome and Florence Brill Graduate Student Fellowship. R. J. is an adviser to Stemgent and a cofounder of Fate Therapeutics. J. R. E. is an investigator of the Howard Hughes Medical Institute. This research project was supported by NIH grants HD 045022 and R37CA084198 to R. J., the Gordon and Betty Moore Foundation (GMBF3034) and Chapman Foundation grants to J. R. E., and the Israeli Centers of Research Excellence (I-CORE) program (Center No. 41/11) grant to Y. B.	Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Esteban MA, 2012, NAT GENET, V44, P366, DOI 10.1038/ng.2222; Falconer E, 2012, NAT METHODS, V9, P1107, DOI [10.1038/NMETH.2206, 10.1038/nmeth.2206]; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Gonzalez F, 2013, CELL REP, V3, P651, DOI 10.1016/j.celrep.2013.02.005; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hills M, 2013, GENOME MED, V5, DOI 10.1186/gm486; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Jiang J, 2011, J MOL CELL BIOL, V3, P197, DOI 10.1093/jmcb/mjr012; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Klemm S, 2014, NAT METHODS, V11, P549, DOI [10.1038/nmeth.2910, 10.1038/NMETH.2910]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu X, 1997, DEV DYNAM, V209, P85; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Muller LUW, 2012, BLOOD, V119, P5449, DOI 10.1182/blood-2012-02-408674; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Pan GJ, 2012, CELL STEM CELL, V11, P445, DOI 10.1016/j.stem.2012.09.004; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Shah SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048533; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stelzer G, 2009, OMICS, V13, P477, DOI 10.1089/omi.2009.0069; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang ZD, 2004, DEV BIOL, V275, P192, DOI 10.1016/j.ydbio.2004.06.026; Weinhold B, 2000, EMBO J, V19, P5835, DOI 10.1093/emboj/19.21.5835; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu T, 2014, CELL STEM CELL, V15, P281, DOI 10.1016/j.stem.2014.06.004; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	62	110	115	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					295	309		10.1016/j.stem.2014.07.003	http://dx.doi.org/10.1016/j.stem.2014.07.003			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25192464	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000341441600010
J	Gonzalez, F; Zhu, ZR; Shi, ZD; Lelli, K; Verma, N; Li, QV; Huangfu, D				Gonzalez, Federico; Zhu, Zengrong; Shi, Zhong-Dong; Lelli, Katherine; Verma, Nipun; Li, Qing V.; Huangfu, Danwei			An iCRISPR Platform for Rapid, Multiplexable, and Inducible Genome Editing in Human Pluripotent Stem Cells	CELL STEM CELL			English	Article							ZINC-FINGER NUCLEASES; MAMMALIAN GENOME; ALZHEIMERS-DISEASE; CAS9 NUCLEASE; CRISPR; DNA; SPECIFICITY; GENES; MUTATIONS; SYSTEM	Human pluripotent stem cells (hPSCs) offer a unique platform for elucidating the genes and molecular pathways that underlie complex traits and diseases. To realize this promise, methods for rapid and controllable genetic manipulations are urgently needed. By combining two newly developed gene-editing tools, the TALEN and CRISPR/Cas systems, we have developed a genome-engineering platform in hPSCs, which we named iCRISPR. iCRISPR enabled rapid and highly efficient generation of biallelic knockout hPSCs for loss-of-function studies, as well as homozygous knockin hPSCs with specific nucleotide alterations for precise modeling of disease conditions. We further demonstrate efficient one-step generation of double-and triple-gene knockout hPSC lines, as well as stage-specific inducible gene knockout during hPSC differentiation. Thus the iCRISPR platform is uniquely suited for dissection of complex genetic interactions and pleiotropic gene functions in human disease studies and has the potential to support high-throughput genetic analysis in hPSCs.	[Gonzalez, Federico; Zhu, Zengrong; Shi, Zhong-Dong; Lelli, Katherine; Verma, Nipun; Li, Qing V.; Huangfu, Danwei] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Verma, Nipun] Rockefeller Univ, Weill Grad Sch Med Sci Cornell Univ, Sloan Kettering Inst, Tri Inst MD PhD Program, New York, NY 10065 USA; [Li, Qing V.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University; Memorial Sloan Kettering Cancer Center	Huangfu, D (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	huangfud@mskcc.org	Li, Qing/AAL-8818-2020	Gonzalez Grassi, Federico/0000-0002-7147-2246; Huangfu, Danwei/0000-0002-1145-6199; Verma, Nipun/0000-0002-9522-6699	NIH [R01DK096239]; NYSTEM [C029156]; Basil O'Connor Starter Scholar Award from March of Dimes Birth Defects Foundation; Tri-Institutional Stem Cell Initiative; Louis V. Gerstner Jr. Young Investigators Award; MSKCC Society Special Projects Committee; New York State Stem Cell Science fellowship from the Center for Stem Cell Biology of the Sloan-Kettering Institute; Howard Hughes Medical Institute (HHMI) Medical Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; Basil O'Connor Starter Scholar Award from March of Dimes Birth Defects Foundation; Tri-Institutional Stem Cell Initiative; Louis V. Gerstner Jr. Young Investigators Award; MSKCC Society Special Projects Committee; New York State Stem Cell Science fellowship from the Center for Stem Cell Biology of the Sloan-Kettering Institute; Howard Hughes Medical Institute (HHMI) Medical Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Feng Zhang and Rudolf Jaenisch for providing vectors through Addgene; Dirk Hockemeyer for the Neo-M2rtTA donor and the AAVS1 3' external probe vector; Qiurong Ding from Chad Cowan's laboratory for providing technical advice on picking hPSC colonies for identification and establishment of mutant clones; Drs. Ed Stanley and Andrew Elefanty for kindly providing MEL-1 cells; Gouri Nanjangud at the MSKCC Molecular Cytogenetics Core for performing karyotype analysis; Daniela Georgieva for technical assistance; and Lorenz Studer, Wenjun Guo, and members of the Huangfu laboratory for insightful discussions and critical reading of the manuscript. This study was funded in part by the NIH (R01DK096239), NYSTEM (C029156), the Basil O'Connor Starter Scholar Award from March of Dimes Birth Defects Foundation, the Tri-Institutional Stem Cell Initiative, a Louis V. Gerstner Jr. Young Investigators Award, and the MSKCC Society Special Projects Committee. F.G. and Z. Z. were supported by the New York State Stem Cell Science fellowship from the Center for Stem Cell Biology of the Sloan-Kettering Institute. N.V. was supported by a Howard Hughes Medical Institute (HHMI) Medical Research Fellowship.	Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hockemeyer D, 2010, COLD SH Q B, V75, P201, DOI 10.1101/sqb.2010.75.021; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MASHAL RD, 1995, NAT GENET, V9, P177, DOI 10.1038/ng0295-177; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Smith JR, 2008, STEM CELLS, V26, P496, DOI 10.1634/stemcells.2007-0039; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; THOMAS KR, 1986, COLD SPRING HARB SYM, V51, P1101, DOI 10.1101/SQB.1986.051.01.128; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Zhu ZR, 2013, DEVELOPMENT, V140, P705, DOI 10.1242/dev.086165	45	290	330	4	74	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					215	226		10.1016/j.stem.2014.05.018	http://dx.doi.org/10.1016/j.stem.2014.05.018			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	24931489	Bronze, Green Accepted			2022-12-28	WOS:000340880100013
J	Xie, Q; Flavahan, WA; Bao, SD; Rich, J				Xie, Qi; Flavahan, William A.; Bao, Shideng; Rich, Jeremy			The Tailless Root of Glioma: Cancer Stem Cells	CELL STEM CELL			English	Editorial Material							NUCLEAR RECEPTOR TLX; EXPRESSION	In this issue of Cell Stem Cell, Zhu et al. (2014) demonstrate that a genetically engineered glioma model displays a functional cellular hierarchy defined by expression of the nuclear orphan receptor Tlx. Targeting cancer stem cells through genetic deletion of TLX promotes cancer stem cell death and differentiation and extends survival.	[Xie, Qi; Flavahan, William A.; Bao, Shideng; Rich, Jeremy] Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Rich, J (corresponding author), Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA.	drjeremyrich@gmail.com	Rich, Jeremy/AAM-1445-2021	Xie, Qi/0000-0002-2370-2078	NCI NIH HHS [R01 CA171652, R01 CA154130, R01 CA169117] Funding Source: Medline; NINDS NIH HHS [R01 NS089272, R01 NS087913] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA171652, R01CA154130, R01CA169117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089272, R01NS087913] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Benod C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099440; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Park HJ, 2010, MOL CELLS, V30, P403, DOI 10.1007/s10059-010-0122-z; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Zhu Z, 2014, CELL STEM CELL, V15, P185, DOI 10.1016/j.stem.2014.04.007; Zou YH, 2012, MOL CELL BIOL, V32, P4811, DOI 10.1128/MCB.01122-12	10	12	13	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					114	116		10.1016/j.stem.2014.07.004	http://dx.doi.org/10.1016/j.stem.2014.07.004			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	25105574	Bronze, Green Accepted			2022-12-28	WOS:000340880100003
J	Mathieu, J; Zhou, WY; Xing, YL; Sperber, H; Ferreccio, A; Agoston, Z; Kuppusamy, KT; Moon, RT; Ruohola-Baker, H				Mathieu, Julie; Zhou, Wenyu; Xing, Yalan; Sperber, Henrik; Ferreccio, Amy; Agoston, Zsuzsa; Kuppusamy, Kavitha T.; Moon, Randall T.; Ruohola-Baker, Hannele			Hypoxia-Inducible Factors Have Distinct and Stage-Specific Roles during Reprogramming of Human Cells to Pluripotency	CELL STEM CELL			English	Article							CARBONYL CYANIDE PHENYLHYDRAZONES; TRAIL-MEDIATED APOPTOSIS; HEMATOPOIETIC STEM-CELLS; NF-KAPPA-B; SOMATIC-CELLS; OXIDATIVE-PHOSPHORYLATION; ENERGY-METABOLISM; CANCER-CELLS; TARGET GENE; DIFFERENTIATION	Pluripotent stem cells have distinct metabolic requirements, and reprogramming cells to pluripotency requires a shift from oxidative to glycolytic metabolism. Here, we show that this shift occurs early during reprogramming of human cells and requires hypoxia-inducible factors (HIFs) in a stage-specific manner. HIF1 alpha and HIF2 alpha are both necessary to initiate this metabolic switch and for the acquisition of pluripotency, and the stabilization of either protein during early phases of reprogramming is sufficient to induce the switch to glycolytic metabolism. In contrast, stabilization of HIF2 alpha during later stages represses reprogramming, partly because of the upregulation of TNF-related apoptosis-inducing ligand (TRAIL). TRAIL inhibits induced pluripotent stem cell (iPSC) generation by repressing apoptotic caspase 3 activity specifically in cells undergoing reprogramming but not human embryonic stem cells (hESCs), and inhibiting TRAIL activity enhances human iPSC generation. These results shed light on the mechanisms underlying the metabolic shifts associated with the acquisition of a pluripotent identity during reprogramming.	[Mathieu, Julie; Xing, Yalan; Sperber, Henrik; Ferreccio, Amy; Kuppusamy, Kavitha T.; Ruohola-Baker, Hannele] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98109 USA; [Zhou, Wenyu; Ruohola-Baker, Hannele] Univ Washington, Dept Biol, Seattle, WA 98109 USA; [Sperber, Henrik; Ruohola-Baker, Hannele] Univ Washington, Dept Chem, Seattle, WA 98109 USA; [Agoston, Zsuzsa; Moon, Randall T.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98109 USA; [Moon, Randall T.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Mathieu, Julie; Zhou, Wenyu; Xing, Yalan; Sperber, Henrik; Ferreccio, Amy; Agoston, Zsuzsa; Kuppusamy, Kavitha T.; Moon, Randall T.; Ruohola-Baker, Hannele] Univ Washington, Sch Med, Dept Biochem, ISCRM, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ruohola-Baker, H (corresponding author), Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98109 USA.	hannele@uw.edu	Zhou, Wenyu/I-1278-2014; Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Sperber, Henrik/0000-0002-3235-1396	American Heart Association; Tietze Award; National Institutes of Health [R01GM097372, R01GM083867, R01GM083867-02S2, U01HL100395, P01GM081619]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097372, R01GM083867, P01GM081619] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Tietze Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Ware, Hockenbery, and Horwitz and members of the H.R.-B. laboratory for helpful discussions throughout this work. We thank Dr. Stadler for work early in the project. We thank Michael Choi and Timothy Dosey for technical help. We thank Pamela Troisch from Institute for Systems Biology for the microarray gene expression service and Dr. Mecham from Sage Bionetworks for some of the statistical analysis on microarray data. We thank Dr. Gardner for providing the scramble shRNA and shRNA against HIF1 alpha. We also thank members of Tom & Sue Ellison Stem Cell Core for help on iPSC reprogramming procedures and cell cultures. This work was supported by fellowships from the American Heart Association (to J.M., W.Z., and Y.X.), a Tietze Award (to K. T. K.), and grants from the National Institutes of Health (R01GM097372, R01GM083867, and R01GM083867-02S2 to H.R.-B., U01HL100395 to Z.A. and R. T. M., and P01GM081619 to R. T. M. and H.R.-B.).	Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Das B, 2012, STEM CELLS, V30, P1685, DOI 10.1002/stem.1142; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; GOLDSBY RA, 1963, BIOCHEMISTRY-US, V2, P1142, DOI 10.1021/bi00905a041; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; HEYTLER PG, 1963, BIOCHEMISTRY-US, V2, P357, DOI 10.1021/bi00902a031; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Husa M, 2010, NAT MED, V16, P641, DOI 10.1038/nm0610-641; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim YS, 2002, HEPATOLOGY, V36, P1498, DOI 10.1053/jhep.2002.36942; Kruyt FAE, 2010, BIOCHEM PHARMACOL, V80, P423, DOI 10.1016/j.bcp.2010.04.010; Li F, 2010, CELL STEM CELL, V7, P508, DOI 10.1016/j.stem.2010.09.003; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu XG, 2005, CANCER RES, V65, P9169, DOI 10.1158/0008-5472.CAN-05-0939; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Mathieu J, 2013, STEM CELLS, V31, P1737, DOI 10.1002/stem.1446; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Merino D, 2007, EXPERT OPIN THER TAR, V11, P1299, DOI 10.1517/14728222.11.10.1299; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Nemetski SM, 2007, J BIOL CHEM, V282, P240, DOI 10.1074/jbc.M607275200; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Panopoulos AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019743; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Rafalski VA, 2012, J CELL SCI, V125, P5597, DOI 10.1242/jcs.114827; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sanlioglu AD, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-54; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Studer L, 2000, J NEUROSCI, V20, P7377; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takubo K, 2012, INT J HEMATOL, V95, P478, DOI 10.1007/s12185-012-1071-4; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Ware CB, 2006, STEM CELLS, V24, P2677, DOI 10.1634/stemcells.2005-0452; Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71; Zhou WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027460; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	72	164	169	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					592	605		10.1016/j.stem.2014.02.012	http://dx.doi.org/10.1016/j.stem.2014.02.012			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24656769	Green Accepted, Bronze			2022-12-28	WOS:000335659900009
J	Isasi, R; Andrews, PW; Baltz, JM; Bredenoord, AL; Burton, P; Chiu, IM; Hull, SC; Jung, JW; Kurtz, A; Lomax, G; Ludwig, T; McDonald, M; Morris, C; Ng, HH; Rooke, H; Sharma, A; Stacey, GN; Williams, C; Zeng, FY; Knoppers, BM				Isasi, Rosario; Andrews, Peter W.; Baltz, Jay M.; Bredenoord, Annelien L.; Burton, Paul; Chiu, Ing-Ming; Hull, Sara Chandros; Jung, Ji-Won; Kurtz, Andreas; Lomax, Geoffrey; Ludwig, Tenneille; McDonald, Michael; Morris, Clive; Ng, Huck Hui; Rooke, Heather; Sharma, Alka; Stacey, Glyn N.; Williams, Clare; Zeng, Fanyi; Knoppers, Bartha Maria			Identifiability and Privacy in Pluripotent Stem Cell Research	CELL STEM CELL			English	Editorial Material								Data sharing is an essential element of research; however, recent scientific and social developments have challenged conventional methods for protecting privacy. Here we provide guidance for determining data sharing thresholds for human pluripotent stem cell research aimed at a wide range of stakeholders, including research consortia, biorepositories, policy-makers, and funders.	[Isasi, Rosario; Knoppers, Bartha Maria] McGill Univ, Dept Human Genet, Ctr Genom & Policy, Fac Med, Montreal, PQ H3A 0G1, Canada; [Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Baltz, Jay M.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON K1H 8L6, Canada; [Baltz, Jay M.] Univ Ottawa, Dept Obstet & Gynecol, Fac Med, Ottawa, ON K1H 8L6, Canada; [Bredenoord, Annelien L.] Univ Med Ctr Utrecht, Dept Med Eth, Julius Ctr, NL-3584 CX Utrecht, Netherlands; [Burton, Paul] Univ Bristol, Sch Social & Community Med, Bristol BS8 1TH, Avon, England; [Chiu, Ing-Ming] Natl Hlth Res Inst, ICSM, Jhunan 35053, Miaoli, Taiwan; [Hull, Sara Chandros] NIH, NHGRI Bioeth Core, Bethesda, MD 20892 USA; [Jung, Ji-Won] Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Chungcheongbuk Do 363951, South Korea; [Jung, Ji-Won] Korea Ctr Dis Control & Prevent, Chungcheongbuk Do 363951, South Korea; [Kurtz, Andreas] Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Lomax, Geoffrey] Calif Inst Regenerat Med, San Francisco, CA 94107 USA; [Ludwig, Tenneille] WiCell Res Inst, Madison, WI 53726 USA; [McDonald, Michael] Univ British Columbia, Sch Populat & Publ Hlth, W Maurice Young Ctr Appl Eth, Vancouver, BC V6T 1Z2, Canada; [Morris, Clive] Natl Hlth & Med Res Council, Canberra, ACT 2601, Australia; [Ng, Huck Hui] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Rooke, Heather] Int Soc Stem Cell Res, Skokie, IL 60077 USA; [Sharma, Alka] Govt India, Minist Sci & Technol, Dept Biotechnol, Med Biotechnol Div, New Delhi 110003, India; [Stacey, Glyn N.] Natl Inst Biol Stand & Controls, S Mimms UB8 3PH, Herts, England; [Williams, Clare] Brunel Univ, Sch Social Sci, Dept Sociol & Commun, Uxbridge UB8 3PH, Middx, England; [Zeng, Fanyi] Shanghai Stem Cell Inst, Shanghai Inst Med Genet, Shanghai 200025, Peoples R China	McGill University; University of Sheffield; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Utrecht University; Utrecht University Medical Center; University of Bristol; National Health Research Institutes - Taiwan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea Centers for Disease Control & Prevention (KCDC); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; WiCell Research Institute; University of British Columbia; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Department of Biotechnology (DBT) India; National Institute for Biological Standards & Control; Brunel University	Isasi, R (corresponding author), McGill Univ, Dept Human Genet, Ctr Genom & Policy, Fac Med, Montreal, PQ H3A 0G1, Canada.	rosario.isasi@mcgill.ca	Chiu, Ing-Ming/B-1534-2008; Ng, Huck Hui/A-1135-2009	Morris, Clive/0000-0003-1392-7959; Williams, Clare/0000-0001-6315-5534; Baltz, Jay/0000-0002-9749-2480; Andrews, Peter/0000-0001-7215-4410; Kurtz, Andreas/0000-0003-3301-6546	Intramural NIH HHS [Z99 HG999999] Funding Source: Medline; Medical Research Council [G1001045, MR/L01324X/1] Funding Source: Medline; Wellcome Trust [086034] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIDHG200347] Funding Source: NIH RePORTER; MRC [G1001045, MR/L01324X/1] Funding Source: UKRI	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dasgupta I, 2014, CELL STEM CELL, V14, P9, DOI 10.1016/j.stem.2013.12.006; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Isasi R, 2012, REGEN MED, V7, P439, DOI [10.2217/RME.12.23, 10.2217/rme.12.23]; Knoppers BM, 2011, STEM CELL REV REP, V7, P482, DOI 10.1007/s12015-010-9226-2; Knoppers BM, 2010, EMBO REP, V11, P416, DOI 10.1038/embor.2010.69; Kreiner T, 2013, CELL STEM CELL, V12, P513, DOI 10.1016/j.stem.2013.04.024; McKernan R, 2013, NAT BIOTECHNOL, V31, P875, DOI 10.1038/nbt.2710; Rodriguez LL, 2013, SCIENCE, V339, P275, DOI 10.1126/science.1234593; Stacey GN, 2013, CELL STEM CELL, V13, P385, DOI 10.1016/j.stem.2013.09.007	10	30	30	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					427	430		10.1016/j.stem.2014.03.014	http://dx.doi.org/10.1016/j.stem.2014.03.014			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24702994	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000334766400007
J	Kim, S; Kim, N; Presson, AP; Metzger, ME; Bonifacino, AC; Sehl, M; Chow, SA; Crooks, GM; Dunbar, CE; An, DS; Donahue, RE; Chen, ISY				Kim, Sanggu; Kim, Namshin; Presson, Angela P.; Metzger, Mark E.; Bonifacino, Aylin C.; Sehl, Mary; Chow, Samson A.; Crooks, Gay M.; Dunbar, Cynthia E.; An, Dong Sung; Donahue, Robert E.; Chen, Irvin S. Y.			Dynamics of HSPC Repopulation in Nonhuman Primates Revealed by a Decade-Long Clonal-Tracking Study	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELL; SCID-X1 GENE-THERAPY; IN-VIVO; LENTIVIRAL VECTOR; SELF-RENEWAL; RETROVIRAL INTEGRATION; HIGH-THROUGHPUT; HETEROGENEITY; DIFFERENTIATION; RECONSTITUTION	In mice, clonal tracking of hematopoietic stem cells (HSCs) has revealed variations in repopulation characteristics. However, it is unclear whether similar properties apply in primates. Here, we examined this issue through tracking of thousands of hematopoietic stem and progenitor cells (HSPCs) in rhesus macaques for up to 12 years. Approximately half of the clones analyzed contributed to long-term repopulation (over 3-10 years), arising in sequential groups and likely representing self-renewing HSCs. The remainder contributed primarily for the first year. The long-lived clones could be further subdivided into functional groups contributing primarily to myeloid, lymphoid, or both myeloid and lymphoid lineages. Over time, the 4%-10% of clones with robust dual lineage contribution predominated in repopulation. HSPCs expressing a CCR5 shRNA transgene behaved similarly to controls. Our study therefore documents HSPC behavior in a clinically relevant model over a long time frame and provides a substantial system-level data set that is a reference point for future work.	[Kim, Sanggu; Chen, Irvin S. Y.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Chow, Samson A.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Presson, Angela P.] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90095 USA; [Sehl, Mary; Chen, Irvin S. Y.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Sehl, Mary] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90095 USA; [Kim, Sanggu; Presson, Angela P.; Chow, Samson A.; An, Dong Sung; Chen, Irvin S. Y.] Univ Calif Los Angeles, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [An, Dong Sung] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90095 USA; [Crooks, Gay M.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Kim, Namshin] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon 305806, South Korea; [Metzger, Mark E.; Bonifacino, Aylin C.; Dunbar, Cynthia E.; Donahue, Robert E.] NHLBI, Hematol Branch, NIH, Rockville, MD 20850 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Chen, ISY (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	syuchen@mednet.ucla.edu	Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X; Dunbar, Cynthia/0000-0002-7645-838X	NIH, Hematology Branch, National Heart, Lung and Blood Institute; NIH [AI055281-06A2, CA68859, P01 HL073104, K99 HL116234]; California Institute of Regenerative Medicine [DR1-01431]; UCLA AIDS Institute/Center for AIDS Research [AI28697]; Korean NRF [2011-0030049]; Next-Gen BioGreen21 [PJ008019, PJ008068]; Calimmune, Inc.; NATIONAL CANCER INSTITUTE [P30CA016042, R01CA068859] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000122] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073104, ZIAHL002339, ZIGHL006020, K99HL116234, R00HL116234, ZICHL002338, ZIAHL006063, ZIAHL006186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055281, P30AI028697] Funding Source: NIH RePORTER	NIH, Hematology Branch, National Heart, Lung and Blood Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); UCLA AIDS Institute/Center for AIDS Research; Korean NRF(National Research Foundation of Korea); Next-Gen BioGreen21; Calimmune, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the animal support and veterinary staff of both 5 Research Court and the Division of Veterinary Resources for maintaining these nonhuman primates for all these years; Keyvan Keyvanfar of the Hematology Branch and Ann Williams of the Core Flow Cytometry Laboratory, NHLBI, for performing cell sorting; and the UCLA Genotyping and Sequencing Core for performing DNA sequencing. This work was supported in part by the intramural program of the NIH, Hematology Branch, National Heart, Lung and Blood Institute; NIH grants AI055281-06A2 (I.S.Y.C.), CA68859 (S. A. C.), P01 HL073104 (G. M. C.), and K99 HL116234 (S. K.); the California Institute of Regenerative Medicine DR1-01431 (I.S.Y.C.); The UCLA AIDS Institute/Center for AIDS Research AI28697; and Korean NRF grants (2011-0030049) and Next-Gen BioGreen21 (PJ008019 & PJ008068). I.S.Y.C. is a founder of Calimmune, Inc., a company developing genetic therapies for HIV disease.	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; An DS, 2001, J VIROL, V75, P3547, DOI 10.1128/JVI.75.8.3547-3555.2001; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Biffi A, 2011, BLOOD, V117, P5332, DOI 10.1182/blood-2010-09-306761; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2011, BLOOD, V117, P4420, DOI 10.1182/blood-2010-09-255679; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Cornils K, 2013, EXP HEMATOL, V41, P28, DOI 10.1016/j.exphem.2012.09.003; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Heim DA, 2000, IMMUNOL REV, V178, P29, DOI 10.1034/j.1600-065X.2000.17802.x; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Kim S, 2010, J VIROL, V84, P11771, DOI 10.1128/JVI.01355-10; Kohn DB, 2009, NEW ENGL J MED, V360, P518, DOI 10.1056/NEJMe0809614; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Muller-Sieburg CE, 2012, BLOOD, V119, P3900, DOI 10.1182/blood-2011-12-376749; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Presson AP, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-367; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Sander WE, 2006, J NUCL MED, V47, P1212; Shi PA, 2002, ONCOGENE, V21, P3274, DOI 10.1038/sj.onc.1205320; Shimizu S, 2010, BLOOD, V115, P1534, DOI 10.1182/blood-2009-04-215855; Shimizu Saki, 2009, Genet Vaccines Ther, V7, P8, DOI 10.1186/1479-0556-7-8; Sieburg HB, 2011, P NATL ACAD SCI USA, V108, P4370, DOI 10.1073/pnas.1011414108; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Verovskaya E, 2013, BLOOD, V122, P523, DOI 10.1182/blood-2013-01-481135; Wang GP, 2010, BLOOD, V115, P4356, DOI 10.1182/blood-2009-12-257352; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wu CF, 2014, CELL STEM CELL, V14, P486, DOI 10.1016/j.stem.2014.01.020	46	66	69	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					473	485		10.1016/j.stem.2013.12.012	http://dx.doi.org/10.1016/j.stem.2013.12.012			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24702996	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000334766400011
J	Noh, JY; Weiss, MJ; Poncz, M				Noh, Ji-Yoon; Weiss, Mitchell J.; Poncz, Mortimer			Personalized Platelet Transfusions: One Step Closer to the Clinic	CELL STEM CELL			English	Editorial Material							IN-VITRO; CELLS; GENERATION; MEGAKARYOCYTES; MICE	In this issue of Cell Stem Cell, Nakamura et al. (2014) use human pluripotent stem cells to generate immortalized megakaryocyte progenitor cell lines that can be cryopreserved, expanded in vitro, and induced to undergo terminal maturation and platelet release. This strategy advances efforts to produce clinically relevant numbers of tissue-culture-derived platelets for transfusion therapies.	[Noh, Ji-Yoon; Weiss, Mitchell J.; Poncz, Mortimer] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Weiss, Mitchell J.; Poncz, Mortimer] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Poncz, M (corresponding author), Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA.	poncz@email.chop.edu	Weiss, Mitchell J/W-9814-2018	Weiss, Mitchell J/0000-0003-2460-3036	NHLBI NIH HHS [P01 HL064190, U01 HL099656, U01 HL099993] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099993, U01HL099656, P01HL064190] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; KAUFMAN RM, 1965, BLOOD-J HEMATOL, V26, P720, DOI 10.1182/blood.V26.6.720.720; Lu SJ, 2011, CELL RES, V21, P530, DOI 10.1038/cr.2011.8; Nakagawa Y, 2013, EXP HEMATOL, V41, P742, DOI 10.1016/j.exphem.2013.04.007; Nakamura S, 2014, CELL STEM CELL, V14, P535, DOI 10.1016/j.stem.2014.01.011; Neyman M, 2008, BLOOD, V112, P1101, DOI 10.1182/blood-2008-04-152959; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Tober J, 2007, BLOOD, V109, P1433, DOI 10.1182/blood-2006-06-031898	10	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					425	426		10.1016/j.stem.2014.03.012	http://dx.doi.org/10.1016/j.stem.2014.03.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24702993	Bronze			2022-12-28	WOS:000334766400006
J	Liang, GY; Zhang, Y				Liang, Gaoyang; Zhang, Yi			Genetic and Epigenetic Variations in iPSCs: Potential Causes and Implications for Application	CELL STEM CELL			English	Review							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; COPY NUMBER; HOMOLOGOUS RECOMBINATION; CODING MUTATIONS; DNA METHYLATION; DIFFERENTIATION; MECHANISMS; GENERATION; MEMORY	The ability to reprogram somatic cells to induced pluripotent stem cells (iPSCs) has revolutionized the field of regenerative medicine. However, recent studies on the genetic and epigenetic variations in iPSCs have raised concerns that these variations may compromise the utility of iPSCs. In this Perspective, we review the current understanding of genetic and epigenetic variations in iPSCs, trace their causes, discuss the implications of these variations for iPSC applications, and propose approaches to cope with these variations.	[Liang, Gaoyang; Zhang, Yi] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Liang, Gaoyang; Zhang, Yi] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Liang, Gaoyang; Zhang, Yi] Boston Childrens Hosp, Dept Pediat, Div Hematol Oncol, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Zhang, Y (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, 300 Longwood Ave, Boston, MA 02115 USA.	yzhang@genetics.med.harvard.edu	Liang, Gaoyang/L-2087-2013	Liang, Gaoyang/0000-0002-2157-974X	Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [U01 DK089565, U01DK089565] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Ben-David U, 2012, STEM CELLS, V30, P612, DOI 10.1002/stem.1057; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Gonzalez F., 2013, CELL REPORTS; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Hamada M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002913; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hirata T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00208; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Hussein SMI, 2013, BIOESSAYS, V35, P152, DOI 10.1002/bies.201200114; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kinoshita T, 2011, BIOCHEM BIOPH RES CO, V407, P321, DOI 10.1016/j.bbrc.2011.03.013; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Liang GY, 2013, CELL RES, V23, P49, DOI 10.1038/cr.2012.175; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Momcilovic O, 2011, RESULTS PROBL CELL D, V53, P415, DOI 10.1007/978-3-642-19065-0_18; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2011, CIRC RES, V109, P720, DOI 10.1161/RES.0b013e318232e187; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Pomp O, 2011, CELL STEM CELL, V9, P156, DOI 10.1016/j.stem.2011.06.004; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Ruiz S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2381; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Serrano L, 2011, STEM CELLS DEV, V20, P363, DOI 10.1089/scd.2010.0159; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Taylor CJ, 2012, CELL STEM CELL, V11, P147, DOI 10.1016/j.stem.2012.07.014; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; Tomoda K, 2012, CELL STEM CELL, V11, P91, DOI 10.1016/j.stem.2012.05.019; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wutz A, 2012, CELL STEM CELL, V11, P9, DOI 10.1016/j.stem.2012.06.012; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	84	245	254	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					149	159		10.1016/j.stem.2013.07.001	http://dx.doi.org/10.1016/j.stem.2013.07.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910082	Green Accepted, Bronze			2022-12-28	WOS:000329570600009
J	Franklin, RJM				Franklin, Robin J. M.			Regenerative Medicines for Remyelination: From Aspiration to Reality	CELL STEM CELL			English	Editorial Material							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; REJUVENATION; CNS	Stimulating an endogenous regenerative response is a powerful approach for potential treatment of chronic demyelinating diseases such as multiple sclerosis. Recently in Nature, Najm et al. (2015) identified two clinically relevant, FDA-approved compounds that promote oligodendrocyte progenitor cell differentiation and induce remyelination in demyelinating disease models.	Univ Cambridge, Wellcome Trust MRC Cambridge Stem Cell Inst, Cambridge CB2 0AH, England	University of Cambridge	Franklin, RJM (corresponding author), Univ Cambridge, Wellcome Trust MRC Cambridge Stem Cell Inst, Clifford Allbutt Bldg,Cambridge Biomed Campus,Hil, Cambridge CB2 0AH, England.	rjf1000@cam.ac.uk		Franklin, Robin/0000-0001-6522-2104				Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Mei F, 2014, NAT MED, V20, P954, DOI 10.1038/nm.3618; Najm F.J., 2015, NATURE IN PRESS; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; van Wijngaarden P, 2013, DEVELOPMENT, V140, P2562, DOI 10.1242/dev.092262	7	16	16	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					576	577		10.1016/j.stem.2015.05.010	http://dx.doi.org/10.1016/j.stem.2015.05.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26046755	Bronze			2022-12-28	WOS:000355932300004
J	Kfoury, Y; Scadden, DT				Kfoury, Youmna; Scadden, David T.			Mesenchymal Cell Contributions to the Stem Cell Niche	CELL STEM CELL			English	Review							HUMAN-BONE-MARROW; GROWTH-FACTOR RECEPTOR; HEMATOPOIETIC MICRO-ENVIRONMENT; COLONY-FORMING CELLS; LONG-TERM CULTURE; STROMAL CELLS; PROGENITOR CELLS; RADIATION SENSITIVITY; INTERNATIONAL-SOCIETY; MONOCLONAL-ANTIBODY	Mesenchymal stromal cells (MSCs) are heterogeneous and primitive cells discovered first in the bone marrow (BM). They have putative roles in maintaining tissue homeostasis and are increasingly recognized as components of stem cell niches, which are best defined in the blood. The absence of in vivo MSC markers has limited our ability to track their behavior in vivo and draw comparisons with in vitro observations. Here we review the historical background of BM-MSCs, advances made in their prospective isolation, their developmental origin and contribution to maintaining subsets of hematopoietic cells, and how mesenchymal cells contribute to other stem cell niches.	[Kfoury, Youmna; Scadden, David T.] Harvard Univ, Ctr Regenerat Med, Boston, MA 02114 USA; [Kfoury, Youmna; Scadden, David T.] Harvard Univ, MGH Canc Ctr, Massachusetts Gen Hosp, Dept Stem Cell & Regenerat Biol, Boston, MA 02114 USA; [Kfoury, Youmna; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University	Scadden, DT (corresponding author), Harvard Univ, Ctr Regenerat Med, Boston, MA 02114 USA.	david_scadden@harvard.edu			National Institutes of Health [U01H100402, R01EB014703, R01HL044851]; Aplastic Anemia and MDS International foundation; Dubai Harvard foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aplastic Anemia and MDS International foundation; Dubai Harvard foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	D.T.S. is Gerald and Darlene Jordan Professor of Medicine and was supported by the National Institutes of Health (U01H100402, R01EB014703, and R01HL044851). Y.K. is a recipient of the Aplastic Anemia and MDS International foundation research grant and a former recipient of the Dubai Harvard foundation for medical research post-doctoral fellowship.	Aslan H, 2006, STEM CELLS, V24, P1728, DOI 10.1634/stemcells.2005-0546; Babovic S, 2014, EXP CELL RES, V329, P185, DOI 10.1016/j.yexcr.2014.08.005; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; BENTLEY SA, 1982, EXP HEMATOL, V10, P367; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; BERESFORD JN, 1992, J CELL SCI, V102, P341; Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Boiret N, 2005, EXP HEMATOL, V33, P219, DOI 10.1016/j.exphem.2004.11.001; Boregowda SV, 2012, STEM CELLS, V30, P975, DOI 10.1002/stem.1069; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; CASTROMALASPINA H, 1980, BLOOD, V56, P289; CATTORETTI G, 1993, BLOOD, V81, P1726; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Chan CKF, 2013, P NATL ACAD SCI USA, V110, P12643, DOI 10.1073/pnas.1310212110; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; Churchman SM, 2012, ARTHRITIS RHEUM-US, V64, P2632, DOI 10.1002/art.34434; Coskun S, 2014, CELL REP, V9, P581, DOI 10.1016/j.celrep.2014.09.013; Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205; DEXTER TM, 1982, NATURE, V298, P222, DOI 10.1038/298222a0; DEXTER TM, 1977, BIOMED EXPRESS, V27, P344; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Doan PL, 2012, LEUKEMIA, V26, P54, DOI 10.1038/leu.2011.236; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Friedenstein A, 1989, Haematol Blood Transfus, V32, P159; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; FRIEDENSTEIN AJ, 1982, EXP HEMATOL, V10, P217; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; GARTNER S, 1980, P NATL ACAD SCI-BIOL, V77, P4756, DOI 10.1073/pnas.77.8.4756; GONG JK, 1978, SCIENCE, V199, P1443, DOI 10.1126/science.75570; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Gronthos S, 2007, STEM CELLS DEV, V16, P953, DOI 10.1089/scd.2007.0069; Guezguez B, 2013, CELL STEM CELL, V13, P175, DOI 10.1016/j.stem.2013.06.015; Harichandan A, 2013, ADV BIOCHEM ENG BIOT, V129, P1, DOI 10.1007/10_2012_147; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Horwitz EM, 2000, CYTOTHERAPY, V2, P387, DOI 10.1080/146532400539305; HOWLETT CR, 1986, CLIN ORTHOP RELAT R, P251; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Inlay MA, 2014, STEM CELL REP, V2, P457, DOI 10.1016/j.stemcr.2014.02.001; Isern J, 2014, ELIFE, V3, DOI 10.7554/eLife.03696; Isern J, 2013, CELL REP, V3, P1714, DOI 10.1016/j.celrep.2013.03.041; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jones E, 2010, ARTHRITIS RHEUM-US, V62, P1944, DOI 10.1002/art.27451; Jones EA, 2006, CYTOM PART B-CLIN CY, V70B, P391, DOI 10.1002/cyto.b.20118; KEATING A, 1984, BLOOD, V64, P1159; KEATING A, 1982, NATURE, V298, P280, DOI 10.1038/298280a0; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Koide Y, 2007, STEM CELLS, V25, P1213, DOI 10.1634/stemcells.2006-0325; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Li HZ, 2014, STEM CELL REP, V3, P965, DOI 10.1016/j.stemcr.2014.09.018; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; LORD BI, 1975, BLOOD, V46, P65; Mabuchi Y, 2013, STEM CELL REP, V1, P152, DOI 10.1016/j.stemcr.2013.06.001; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; MARDON HJ, 1987, CELL TISSUE RES, V250, P157, DOI 10.1007/BF00214667; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; MCCULLOCH EA, 1960, RADIAT RES, V13, P115, DOI 10.2307/3570877; Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615; Mendez-Ferrer S, 2015, ANN NY ACAD SCI, V1335, P32, DOI 10.1111/nyas.12641; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Neirinckx V, 2013, STEM CELL TRANSL MED, V2, P284, DOI 10.5966/sctm.2012-0147; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Ono N, 2014, DEV CELL, V29, P330, DOI 10.1016/j.devcel.2014.03.014; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; OWEN M, 1967, J CELL SCI, V2, P39; OWEN M, 1988, CIBA F SYMP, V136, P42; OWEN M, 1963, J CELL BIOL, V19, P19, DOI 10.1083/jcb.19.1.19; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qian H, 2012, J BIOL CHEM, V287, P25795, DOI 10.1074/jbc.M112.339622; Quirici N, 2002, EXP HEMATOL, V30, P783, DOI 10.1016/S0301-472X(02)00812-3; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Saez B, 2014, BLOOD, V124, P2937, DOI 10.1182/blood-2014-08-593426; Schepeler T, 2014, DEVELOPMENT, V141, P2559, DOI 10.1242/dev.104588; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sharma RR, 2014, TRANSFUSION, V54, P1418, DOI 10.1111/trf.12421; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; SIMMONS PJ, 1991, BLOOD, V78, P55; Sinclair K, 2013, RESPIROLOGY, V18, P397, DOI 10.1111/resp.12050; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Strecker S, 2013, GENESIS, V51, P246, DOI 10.1002/dvg.22360; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Taichman RS, 1997, BLOOD, V89, P1165, DOI 10.1182/blood.V89.4.1165; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Taichman RS, 2001, BRIT J HAEMATOL, V112, P438, DOI 10.1046/j.1365-2141.2001.02568.x; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; TAVASSOLI M, 1968, SCIENCE, V161, P54, DOI 10.1126/science.161.3836.54; THOMSON TM, 1988, EXP CELL RES, V174, P533, DOI 10.1016/0014-4827(88)90323-0; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Via Alessio Giai, 2012, Muscles Ligaments Tendons J, V2, P154; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Warr MR, 2011, WIRES SYST BIOL MED, V3, P681, DOI 10.1002/wsbm.145; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Wolber FM, 2002, EXP HEMATOL, V30, P1010, DOI 10.1016/S0301-472X(02)00881-0; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; Zhu XY, 2013, STEM CELLS, V31, P1731, DOI 10.1002/stem.1449; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	140	334	354	1	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					239	253		10.1016/j.stem.2015.02.019	http://dx.doi.org/10.1016/j.stem.2015.02.019			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25748931	Bronze			2022-12-28	WOS:000350747700007
J	Laurenti, E; Frelin, C; Xie, S; Ferrari, R; Dunant, CF; Zandi, S; Neumann, A; Plumb, I; Doulatov, S; Chen, J; April, C; Fan, JB; Iscove, N; Dick, JE				Laurenti, Elisa; Frelin, Catherine; Xie, Stephanie; Ferrari, Robin; Dunant, Cyrille F.; Zandi, Sasan; Neumann, Andrea; Plumb, Ian; Doulatov, Sergei; Chen, Jing; April, Craig; Fan, Jian-Bing; Iscove, Norman; Dick, John E.			CDK6 Levels Regulate Quiescence Exit in Human Hematopoietic Stem Cells	CELL STEM CELL			English	Article							IN-VIVO; SELF-RENEWAL; GENE-EXPRESSION; SUBPOPULATIONS; PROLIFERATION; KINETICS	Regulated blood production is achieved through the hierarchical organization of dormant hematopoietic stem cell (HSC) subsets that differ in self-renewal potential and division frequency, with long-term (LT)-HSCs dividing the least. The molecular mechanisms underlying this variability in HSC division kinetics are unknown. We report here that quiescence exit kinetics are differentially regulated within human HSC subsets through the expression level of CDK6. LT-HSCs lack CDK6 protein. Short-term (ST)-HSCs are also quiescent but contain high CDK6 protein levels that permit rapid cell cycle entry upon mitogenic stimulation. Enforced CDK6 expression in LT-HSCs shortens quiescence exit and confers competitive advantage without impacting function. Computational modeling suggests that this independent control of quiescence exit kinetics inherently limits LT-HSC divisions and preserves the HSC pool to ensure lifelong hematopoiesis. Thus, differential expression of CDK6 underlies heterogeneity in stem cell quiescence states that functionally regulates this highly regenerative system.	[Laurenti, Elisa; Frelin, Catherine; Xie, Stephanie; Ferrari, Robin; Zandi, Sasan; Neumann, Andrea; Plumb, Ian; Iscove, Norman; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Ferrari, Robin] Ecole Normale Super, Dept Biol, F-94235 Cachan, France; [Dunant, Cyrille F.] Ecole Polytech Fed Lausanne, LMC, Stn 12, CH-1015 Lausanne, Switzerland; [Doulatov, Sergei] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Doulatov, Sergei] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Chen, Jing; April, Craig; Fan, Jian-Bing] Illumina, San Diego, CA 92121 USA; [Iscove, Norman] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Illumina; University of Toronto	Laurenti, E (corresponding author), Univ Cambridge, Dept Haematol, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 0AH, England.	el422@cam.ac.uk; jdick@uhnresearch.ca		Xie, Stephanie/0000-0002-0284-494X; Dick, John/0000-0002-9527-8317; Dunant, Cyrille/0000-0001-5176-4439; Laurenti, Elisa/0000-0002-9917-9092	Swiss National Science Foundation; Roche; Fondation Suisse pour les Bourses en Medecine et Biologie; Swedish Research Council; Canadian Institutes of Health Research (CIHR); Aplastic Anemia and Myelodysplasia Association of Canada; CIHR; Canadian Cancer Society; Terry Fox Foundation; Genome Canada through Ontario Genomics Institute; Ontario Institute for Cancer Research; province of Ontario, a Canada Research Chair; Princess Margaret Hospital foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC); Wellcome Trust; MRC	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche(Roche Holding); Fondation Suisse pour les Bourses en Medecine et Biologie; Swedish Research Council(Swedish Research CouncilEuropean Commission); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Aplastic Anemia and Myelodysplasia Association of Canada; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; Genome Canada through Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; province of Ontario, a Canada Research Chair; Princess Margaret Hospital foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the obstetrics unit of Trillium Health Partners (Missisauga and Credit Valley sites) for cord blood samples; N. Simard, P.A. Penttila, A. Khandi, L. Jamieson, and S. Zhao at the UHN-SickKids Flow Cytometry Facility for cell sorting; V. Voisin and G. Bader for advice on bioinformatics; and M. Doedens for help with intrafemoral injections. This work was supported by the Swiss National Science Foundation (E.L.), Roche (E.L.), the Fondation Suisse pour les Bourses en Medecine et Biologie (E.L.), the Swedish Research Council (S.Z.); and a Canadian Institutes of Health Research (CIHR) fellowship in partnership with the Aplastic Anemia and Myelodysplasia Association of Canada (S.Z.). Work in J.E.D.'s laboratory is supported by grants from the CIHR, Canadian Cancer Society, Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research with funds from the province of Ontario, a Canada Research Chair, the Princess Margaret Hospital foundation, and the Ontario Ministry of Health and Long Term Care (OMOHLTC). Research in E.L.'s laboratory is currently supported by a recruitment support from the Wellcome Trust and a core support grant from the Wellcome Trust and MRC to the Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute.	Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Bradford GB, 1997, EXP HEMATOL, V25, P445; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gazit R, 2013, STEM CELL REP, V1, P266, DOI 10.1016/j.stemcr.2013.07.004; Glauche I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000447; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Huang XG, 2012, BLOOD, V120, P1095, DOI 10.1182/blood-2012-03-415984; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Lajtha L. G., 1963, J CELL PHYSL, V62, pL1; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Lechman ER, 2012, CELL STEM CELL, V11, P799, DOI 10.1016/j.stem.2012.09.001; Micklem H. S., 1976, STEM CELLS RENEWING, P331; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; PIETRZYK ME, 1985, BLOOD, V66, P1460; Placke T, 2014, BLOOD, V124, P13, DOI 10.1182/blood-2014-02-558114; Qiu JJ, 2014, STEM CELL REP, V2, P473, DOI 10.1016/j.stemcr.2014.01.016; Ren SJ, 2004, CELL, V117, P239, DOI 10.1016/S0092-8674(04)00300-9; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Roeder I, 2002, EXP HEMATOL, V30, P853, DOI 10.1016/S0301-472X(02)00832-9; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Scheicher R, 2015, BLOOD, V125, P90, DOI 10.1182/blood-2014-06-584417; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SUDA T, 1983, J CELL PHYSIOL, V117, P308, DOI 10.1002/jcp.1041170305; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Uchida N, 2003, EXP HEMATOL, V31, P1338, DOI 10.1016/j.exphem.2003.09.001; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; Veiga-Fernandes H, 2004, NAT IMMUNOL, V5, P31, DOI 10.1038/ni1015; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126	41	166	171	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					302	313		10.1016/j.stem.2015.01.017	http://dx.doi.org/10.1016/j.stem.2015.01.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25704240	hybrid, Green Published			2022-12-28	WOS:000350747700012
J	Beck, B; Lapouge, G; Rorive, S; Drogat, B; Desaedelaere, K; Delafaille, S; Dubois, C; Salmon, I; Willekens, K; Marine, JC; Blanpain, C				Beck, Benjamin; Lapouge, Gaelle; Rorive, Sandrine; Drogat, Benjamin; Desaedelaere, Kylie; Delafaille, Stephanie; Dubois, Christine; Salmon, Isabelle; Willekens, Karen; Marine, Jean-Christophe; Blanpain, Cedric			Different Levels of Twist1 Regulate Skin Tumor Initiation, Stemness, and Progression	CELL STEM CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SQUAMOUS-CELL CARCINOMA; CANCER-CELLS; TRANSCRIPTION FACTOR; PROMOTES INVASION; BREAST-CANCER; DNA-DAMAGE; SENESCENCE; P53; METASTASIS	Twist1 promotes epithelial-to-mesenchymal transition (EMT), invasion, metastasis, and cancer stem cell (CSC) properties. However, it remains unclear whether Twist1 is also required for tumor initiation and whether Twist1-induced cancer stemness and EMT are functionally linked. Using a conditional deletion of Twist1 at different stages of skin carcinogenesis, we show that Twist1 is required for skin tumor initiation and progression in a gene-dosage-dependent manner. Moreover, conditional ablation of Twist1 in benign tumors leads to increased apoptosis, reduced cell proliferation, and defective tumor maintenance and propagation independently of its EMT-inducing abilities. Concomitant deletion of Twist1 and p53 rescues the apoptotic response, but not the cell proliferation and propagation defects. These results reveal that Twist1 is required for tumor initiation and maintenance in a p53-dependent and -independent manner. Importantly, our findings also indicate that tumor stemness and EMT can be regulated by distinct mechanisms.	[Beck, Benjamin; Lapouge, Gaelle; Drogat, Benjamin; Desaedelaere, Kylie; Delafaille, Stephanie; Dubois, Christine; Blanpain, Cedric] ULB, IRIBHM, B-1070 Brussels, Belgium; [Rorive, Sandrine; Salmon, Isabelle] ULB, Erasme Hosp, Dept Pathol, B-1070 Brussels, Belgium; [Rorive, Sandrine; Salmon, Isabelle] CMMI, DIAPATH, B-6041 Gosselies, Belgium; [Willekens, Karen; Marine, Jean-Christophe] VIB, Ctr Biol Dis, Lab Mol Canc Biol, B-3000 Louvain, Belgium; [Willekens, Karen; Marine, Jean-Christophe] VIB, Ctr Human Genet, Lab Mol Canc Biol, B-3000 Louvain, Belgium; [Blanpain, Cedric] WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); WELBIO	Blanpain, C (corresponding author), ULB, IRIBHM, 808 Route Lennik, B-1070 Brussels, Belgium.	cedric.blanpain@ulb.ac.be	Marine, Jean-Christophe/K-3292-2016; Marine, Jean Christophe/J-2237-2015; Blanpain, Cedric/ABD-8392-2021	Marine, Jean-Christophe/0000-0003-2433-9837; Beck, Benjamin/0000-0001-8162-7566; benjamin, Drogat/0000-0002-0020-4826	Fonds national de la Recherche Scientifique (FNRS); TELEVIE fellowship; European Regional Development Fund; Wallonia; FNRS; TELEVIE; Interuniversity Attraction Pole/Pole d'Attraction Interuniversitaire program; Fondation Contre le Cancer; ULB foundation; Fonds Gaston Ithier; Fonds Yvonne Boel; Financement Le Fonds Europeen de Developpement Regional; foundation Bettencourt Schueller; Foundation Baillet Latour; European Research Council	Fonds national de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); TELEVIE fellowship; European Regional Development Fund(European Commission); Wallonia; FNRS(Fonds de la Recherche Scientifique - FNRS); TELEVIE; Interuniversity Attraction Pole/Pole d'Attraction Interuniversitaire program; Fondation Contre le Cancer; ULB foundation; Fonds Gaston Ithier; Fonds Yvonne Boel; Financement Le Fonds Europeen de Developpement Regional; foundation Bettencourt Schueller; Foundation Baillet Latour; European Research Council(European Research Council (ERC)European Commission)	We thank our colleagues who provided us with reagents, which are cited in the text. We also thank the animal house facility and the cell sorting facility of the Universite Libre de Bruxelles (ULB) (Erasme campus). We thank Sylvain Brohee for his help with the microarray analyses. We thank Christina Scheel for her helpful comments on our manuscript. C.B. is an investigator of Walloon Excellence in Lifesciences & BIOtechnology. B.B., G.L., and B.D. are supported by a Fonds national de la Recherche Scientifique (FNRS) and TELEVIE fellowship. The Centre de Microscopie et d'Imagerie Moleculaire is supported by the European Regional Development Fund and Wallonia. This work was supported by the FNRS, TELEVIE, the Interuniversity Attraction Pole/Pole d'Attraction Interuniversitaire program, a research grant from the Fondation Contre le Cancer, the ULB foundation, the Fonds Gaston Ithier, le Fonds Yvonne Boel, le Financement Le Fonds Europeen de Developpement Regional, the foundation Bettencourt Schueller, the Foundation Baillet Latour, and the European Research Council.	Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Baygi ME, 2010, CELL BIOL TOXICOL, V26, P553, DOI 10.1007/s10565-010-9163-5; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Burns TF, 2013, MOL CANCER RES, V11, P329, DOI 10.1158/1541-7786.MCR-12-0456; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chen YT, 2007, GENESIS, V45, P588, DOI 10.1002/dvg.20332; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Elias MC, 2005, NEOPLASIA, V7, P824, DOI 10.1593/neo.04352; Hamerlik P, 2012, J EXP MED, V209, P507, DOI 10.1084/jem.20111424; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hasselblatt M, 2009, CANCER RES, V69, P2219, DOI 10.1158/0008-5472.CAN-08-3176; Hildebrand DG, 2013, CELL CYCLE, V12, P1922, DOI 10.4161/cc.24944; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; Kogan-Sakin I, 2011, CELL DEATH DIFFER, V18, P271, DOI 10.1038/cdd.2010.94; Kwok WK, 2007, CARCINOGENESIS, V28, P2467, DOI 10.1093/carcin/bgm185; Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Lee KE, 2010, CANCER CELL, V18, P448, DOI 10.1016/j.ccr.2010.10.020; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Masui T, 2014, INT J ONCOL, V44, P693, DOI 10.3892/ijo.2013.2225; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Morel AP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002723; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nieto M.A., 2013, SCIENCE, V8; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Piccinin S, 2012, CANCER CELL, V22, P404, DOI 10.1016/j.ccr.2012.08.003; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Sarrio D, 2012, STEM CELLS, V30, P292, DOI 10.1002/stem.791; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Shiota M, 2008, ONCOGENE, V27, P5543, DOI 10.1038/onc.2008.176; Siegle JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5511; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tran PT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002650; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vichalkovski A, 2010, ONCOGENE, V29, P3554, DOI 10.1038/onc.2010.115; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yuen HF, 2007, J CLIN PATHOL, V60, P510, DOI 10.1136/jcp.2006.039099; Zhou W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087409	57	142	147	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					67	79		10.1016/j.stem.2014.12.002	http://dx.doi.org/10.1016/j.stem.2014.12.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25575080	Bronze			2022-12-28	WOS:000347708400012
J	Ivanovs, A; Medvinsky, A				Ivanovs, Andrejs; Medvinsky, Alexander			In Search of Human Hematopoietic Stem Cell Identity	CELL STEM CELL			English	Editorial Material							IDENTIFICATION; PERSPECTIVE	Better insight into hematopoietic stem cell (HSC) development in the human embryo and fetus is crucial for translational research. In this issue of Cell Stem Cell, Prashad et al. (2014) describe a novel surface marker for human fetal liver HSCs, glycosylphosphatidylinositol-anchored protein GPI-80, that is functionally required for their self-renewal.	[Ivanovs, Andrejs; Medvinsky, Alexander] Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland	University of Edinburgh	Medvinsky, A (corresponding author), Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland.	a.medvinsky@ed.ac.uk		Ivanovs, Andrejs/0000-0003-0808-3595				Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Gratwohl A, 2010, JAMA-J AM MED ASSOC, V303, P1617, DOI 10.1001/jama.2010.491; Huang JB, 2004, MOL IMMUNOL, V40, P1249, DOI 10.1016/j.molimm.2003.11.033; Ivanovs A, 2014, STEM CELL REP, V2, P449, DOI 10.1016/j.stemcr.2014.02.004; Ivanovs A, 2011, J EXP MED, V208, P2417, DOI 10.1084/jem.20111688; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Oberlin E, 2010, BLOOD, V116, P4444, DOI 10.1182/blood-2010-03-272625; Prashad S. L, 2014, CELL STEM CELL, V16, P80	10	1	2	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					5	6		10.1016/j.stem.2014.12.010	http://dx.doi.org/10.1016/j.stem.2014.12.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25575075	Bronze			2022-12-28	WOS:000347708400003
J	Silva, M; Daheron, L; Hurley, H; Bure, K; Barker, R; Carr, AJ; Williams, D; Kim, HW; French, A; Coffey, PJ; Cooper-White, JJ; Reeve, B; Rao, M; Snyder, EY; Ng, KS; Mead, BE; Smith, JA; Karp, JM; Brindley, DA; Wall, I				Silva, Marli; Daheron, Laurence; Hurley, Hannah; Bure, Kim; Barker, Richard; Carr, Andrew J.; Williams, David; Kim, Hae-Won; French, Anna; Coffey, Pete J.; Cooper-White, Justin J.; Reeve, Brock; Rao, Mahendra; Snyder, Evan Y.; Ng, Kelvin S.; Mead, Benjamin E.; Smith, James A.; Karp, Jeffrey M.; Brindley, David A.; Wall, Ivan			Generating iPSCs: Translating Cell Reprogramming Science into Scalable and Robust Biomanufacturing Strategies	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS	Induced pluripotent stem cells (iPSCs) have the potential to transform drug discovery and healthcare in the 21st century. However, successful commercialization will require standardized manufacturing platforms. Here we highlight the need to define standardized practices for iPSC generation and processing and discuss current challenges to the robust manufacture of iPSC products.	[Silva, Marli; French, Anna; Wall, Ivan] UCL, Dept Biochem Engn, London WC1H 0AH, England; [Daheron, Laurence; Reeve, Brock; Ng, Kelvin S.; Mead, Benjamin E.; Smith, James A.; Karp, Jeffrey M.; Brindley, David A.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Hurley, Hannah; Barker, Richard; Carr, Andrew J.; Smith, James A.; Brindley, David A.] Univ Oxford, Oxford UCL Ctr Adv Sustainable Med Innovat, Oxford OX3 9DU, England; [Bure, Kim] TAP Biosyst, Royston SG8 5WY, Herts, England; [Carr, Andrew J.; Brindley, David A.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Williams, David] Univ Loughborough, Wolfson Sch Mech & Mfg Engn, Ctr Biol Engn, Loughborough LE11 3TU, Leics, England; [Kim, Hae-Won; Wall, Ivan] Dankook Univ, Dept Nanobiomed Sci, Cheonan 330714, South Korea; [Kim, Hae-Won; Wall, Ivan] Dankook Univ, Plus NBM Global Res Ctr Regenerat Med BK21, Cheonan 330714, South Korea; [Kim, Hae-Won; Wall, Ivan] Dankook Univ, Grad Sch, Inst Tissue Regenerat Engn, Cheonan 330714, South Korea; [Kim, Hae-Won] Dankook Univ, Sch Dent, Dept Dent Biomat, Cheonan 330714, South Korea; [Coffey, Pete J.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Coffey, Pete J.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Cooper-White, Justin J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia; [Cooper-White, Justin J.] Univ Queensland, Sch Chem Engn, St Lucia, Qld 4072, Australia; [Cooper-White, Justin J.] CSIRO, Mat Sci & Engn Div, Clayton, Vic 3169, Australia; [Rao, Mahendra] New York Stem Cell Fdn, New York, NY 10023 USA; [Snyder, Evan Y.] Burnham Med Res Inst, La Jolla, CA 92037 USA; [Snyder, Evan Y.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92161 USA; [Snyder, Evan Y.] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Ng, Kelvin S.; Mead, Benjamin E.; Karp, Jeffrey M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Biomed Engn,Dept Med,Ctr Regenerat Therapeut, Boston, MA 02115 USA; [Ng, Kelvin S.; Mead, Benjamin E.; Karp, Jeffrey M.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Brindley, David A.] UCL, UCL Sch Pharm, Ctr Behav Med, London WC1H 9JP, England	University of London; University College London; Harvard University; University of Oxford; University of Oxford; Loughborough University; Dankook University; Dankook University; Dankook University; Dankook University; University of London; University College London; University of California System; University of California Santa Barbara; University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); The New York Stem Cell Foundation; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; University of London; University College London; University of London School of Pharmacy	Wall, I (corresponding author), UCL, Dept Biochem Engn, London WC1H 0AH, England.	i.wall@ucl.ac.uk	Smith, James Andrew/AAP-5497-2020	Smith, James Andrew/0000-0003-2634-0268; /0000-0003-1937-9594; Coffey, Peter/0000-0002-5427-2939; Mead, Ben/0000-0001-5855-0097; Cooper-White, Justin/0000-0002-1920-8229	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095722] Funding Source: NIH RePORTER; MRC [MR/L022842/1] Funding Source: UKRI; Medical Research Council [MR/L022842/1] Funding Source: Medline; NHLBI NIH HHS [HL095722] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Jacoby M, 2012, EPIGENETICS-US, V7, P1421, DOI 10.4161/epi.22845; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Roberts M, 2014, NAT BIOTECHNOL, V32, P742, DOI 10.1038/nbt.2975; Theunissen TW, 2014, CELL STEM CELL, V14, P720, DOI 10.1016/j.stem.2014.05.002; Titmarsh DM, 2013, BIOTECHNOL J, V8, P167, DOI 10.1002/biot.201200149; Turner M, 2013, CELL STEM CELL, V13, P382, DOI 10.1016/j.stem.2013.08.003; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Whitworth DJ, 2014, STEM CELLS DEV, V23, P3021, DOI 10.1089/scd.2013.0634; Yu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017557	10	37	39	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					13	17		10.1016/j.stem.2014.12.013	http://dx.doi.org/10.1016/j.stem.2014.12.013			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25575079	Bronze			2022-12-28	WOS:000347708400007
J	Genander, M; Cook, PJ; Ramskold, D; Keyes, BE; Mertz, AF; Sandberg, R; Fuchs, E				Genander, Maria; Cook, Peter J.; Ramskold, Daniel; Keyes, Brice E.; Mertz, Aaron F.; Sandberg, Rickard; Fuchs, Elaine			BMP Signaling and Its pSMAD1/5 Target Genes Differentially Regulate Hair Follicle Stem Cell Lineages	CELL STEM CELL			English	Article							NICHE; TRANSCRIPTION; GROWTH; ROLES; MORPHOGENESIS; ORGANIZATION; HOMEOSTASIS; EXPRESSION; APPENDAGES; PROTEIN	Hair follicle stem cells (HFSCs) and their transit amplifying cell (TAC) progeny sense BMPs at defined stages of the hair cycle to control their proliferation and differentiation. Here, we exploit the distinct spatial and temporal localizations of these cells to selectively ablate BMP signaling in each compartment and examine its functional role. We find that BMP signaling is required for HFSC quiescence and to promote TAC differentiation along different lineages as the hair cycle progresses. We also combine in vivo genome-wide chromatin immunoprecipitation and deep-sequencing, transcriptional profiling, and loss-of-function genetics to define BMP-regulated genes. We show that some pSMAD1/5 targets, like Gata3, function specifically in TAC lineage-progression. Others, like Id1 and Id3, function in both HFSCs and TACs, but in distinct ways. Our study therefore illustrates the complex differential roles that a key signaling pathway can play in regulation of closely related stem/progenitor cells within the context of their overall niche.	[Genander, Maria; Keyes, Brice E.; Mertz, Aaron F.; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Cook, Peter J.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Ramskold, Daniel; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Ramskold, Daniel; Sandberg, Rickard] Karolinska Inst, Ludwig Inst Canc Res, S-17177 Stockholm, Sweden	Howard Hughes Medical Institute; Rockefeller University; Memorial Sloan Kettering Cancer Center; Karolinska Institutet; Karolinska Institutet; Ludwig Institute for Cancer Research	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, 1230 York Ave, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Sandberg, Rickard/0000-0001-6473-1740; Ramskold, Daniel/0000-0003-2892-673X; Genander, Maria/0000-0002-2428-8040	Damon Runyon Cancer Research Foundation; Wenner-Gren Foundations;  [NIAMS R01-AR31737]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Wenner-Gren Foundations; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank RU Genomics Resource Center for Illumina sequencing; S. Mazel, L. Li, S. Semova, and S. Tadesse for FACS (RU FACS facility); and the MSKCC Genomics Core Facility for RNA-sequencing. We thank Fuchs' lab members: D. Oristian and L. Polak for assistance in mouse research; H. A. Pasolli and C. Kaufman for ultrastructural data; and W.-H. Lien, M. Kadaja, and C. P. Lu for valuable discussions. M. G. was supported by Damon Runyon Cancer Research Foundation and the Wenner-Gren Foundations. E. F. is an HHMI Investigator. This work was supported by grants to E. F. (NIAMS R01-AR31737).	Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hertveldt V, 2008, DEV DYNAM, V237, P883, DOI 10.1002/dvdy.21355; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Kandyba E, 2014, STEM CELLS, V32, P886, DOI 10.1002/stem.1599; Kandyba E, 2014, STEM CELLS, V32, P534, DOI 10.1002/stem.1548; Kandyba E, 2013, P NATL ACAD SCI USA, V110, P1351, DOI 10.1073/pnas.1121312110; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Kwan KM, 2004, GENESIS, V39, P10, DOI 10.1002/gene.20021; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langbein L, 2010, J INVEST DERMATOL, V130, P55, DOI 10.1038/jid.2009.192; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Moya IM, 2012, DEV CELL, V22, P501, DOI 10.1016/j.devcel.2012.01.007; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Sequeira I, 2012, DEVELOPMENT, V139, P3741, DOI 10.1242/dev.081091; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Walsh CM, 2007, DEVELOPMENT, V134, P3585, DOI 10.1242/dev.009522; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yuhki M, 2004, DEVELOPMENT, V131, P1825, DOI 10.1242/dev.01079; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	46	100	106	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					619	633		10.1016/j.stem.2014.09.009	http://dx.doi.org/10.1016/j.stem.2014.09.009			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25312496	Bronze, Green Accepted			2022-12-28	WOS:000345012700014
J	Tsai, SQ; Joung, JK				Tsai, Shengdar Q.; Joung, J. Keith			What's Changed with Genome Editing?	CELL STEM CELL			English	Editorial Material								Targeted genome editing using engineered nucleases can reliably generate defined genetic mutations, although the range of off-target lesions caused by these techniques is unclear. Recent papers in Cell Stem Cell perform high-coverage whole-genome sequencing to demonstrate the feasibility of obtaining correctly targeted pluripotent stem cell clones with minimal unintended modifications.	[Tsai, Shengdar Q.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Tsai, Shengdar Q.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	jjoung@mgh.harvard.edu	Tsai, Shengdar Q./G-4600-2012	Tsai, Shengdar Q./0000-0001-9161-3993				Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020	7	22	29	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					3	4		10.1016/j.stem.2014.06.017	http://dx.doi.org/10.1016/j.stem.2014.06.017			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24996161	Bronze			2022-12-28	WOS:000340878600002
J	Kiskinis, E; Sandoe, J; Williams, LA; Boulting, GL; Moccia, R; Wainger, BJ; Han, S; Peng, T; Thams, S; Mikkilineni, S; Mellin, C; Merkle, FT; Davis-Dusenbery, BN; Ziller, M; Oakley, D; Ichida, J; Di Costanzo, S; Atwater, N; Maeder, ML; Goodwin, MJ; Nemesh, J; Handsaker, RE; Paull, D; Noggle, S; McCarroll, SA; Joung, JK; Woolf, CJ; Brown, RH; Eggan, K				Kiskinis, Evangelos; Sandoe, Jackson; Williams, Luis A.; Boulting, Gabriella L.; Moccia, Rob; Wainger, Brian J.; Han, Steve; Peng, Theodore; Thams, Sebastian; Mikkilineni, Shravani; Mellin, Cassidy; Merkle, Florian T.; Davis-Dusenbery, Brandi N.; Ziller, Michael; Oakley, Derek; Ichida, Justin; Di Costanzo, Stefania; Atwater, Nick; Maeder, Morgan L.; Goodwin, Mathew J.; Nemesh, James; Handsaker, Robert E.; Paull, Daniel; Noggle, Scott; McCarroll, Steven A.; Joung, J. Keith; Woolf, Clifford J.; Brown, Robert H.; Eggan, Kevin			Pathways Disrupted in Human ALS Motor Neurons Identified through Genetic Correction of Mutant SOD1	CELL STEM CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT; C9ORF72; CELLS; EXPANSION; GENOME; TRANSLATION; MUTATIONS; INSIGHTS; DISEASE	Althoughmany distinct mutations in a variety of genes are known to cause Amyotrophic Lateral Sclerosis (ALS), it remains poorly understood how they selectively impact motor neuron biology and whether they converge on common pathways to cause neuronal degeneration. Here, we have combined reprogramming and stem cell differentiation approaches with genome engineering and RNA sequencing to define the transcriptional and functional changes that are induced in human motor neurons by mutant SOD1. Mutant SOD1 protein induced a transcriptional signature indicative of increased oxidative stress, reduced mitochondrial function, altered subcellular transport, and activation of the ER stress and unfolded protein response pathways. Functional studies demonstrated that these pathways were perturbed in a manner dependent on the SOD1 mutation. Finally, interrogation of stem-cell-derived motor neurons produced from ALS patients harboring a repeat expansion in C9orf72 indicates that at least a subset of these changes are more broadly conserved in ALS.	[Kiskinis, Evangelos; Sandoe, Jackson; Williams, Luis A.; Boulting, Gabriella L.; Moccia, Rob; Han, Steve; Peng, Theodore; Mikkilineni, Shravani; Merkle, Florian T.; Davis-Dusenbery, Brandi N.; Ichida, Justin; Di Costanzo, Stefania; Atwater, Nick; Eggan, Kevin] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Kiskinis, Evangelos; Sandoe, Jackson; Williams, Luis A.; Boulting, Gabriella L.; Moccia, Rob; Han, Steve; Peng, Theodore; Mikkilineni, Shravani; Merkle, Florian T.; Davis-Dusenbery, Brandi N.; Ziller, Michael; Ichida, Justin; Di Costanzo, Stefania; Atwater, Nick; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Kiskinis, Evangelos; Sandoe, Jackson; Williams, Luis A.; Moccia, Rob; Han, Steve; Peng, Theodore; Mikkilineni, Shravani; Merkle, Florian T.; Davis-Dusenbery, Brandi N.; Atwater, Nick; Nemesh, James; Handsaker, Robert E.; McCarroll, Steven A.; Eggan, Kevin] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02138 USA; [Wainger, Brian J.; Mellin, Cassidy; Woolf, Clifford J.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Wainger, Brian J.; Mellin, Cassidy; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Wainger, Brian J.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA; [Thams, Sebastian; Oakley, Derek] Columbia Univ, Project ALS Jenifer Estess Lab Stem Cell Res, Dept Pathol, Ctr Motor Neuron Biol & Dis MNC, New York, NY 10027 USA; [Thams, Sebastian; Oakley, Derek] Columbia Univ, Project ALS Jenifer Estess Lab Stem Cell Res, Dept Neurol, Ctr Motor Neuron Biol & Dis MNC, New York, NY 10027 USA; [Thams, Sebastian; Oakley, Derek] Columbia Univ, Project ALS Jenifer Estess Lab Stem Cell Res, Dept Neurosci, Ctr Motor Neuron Biol & Dis MNC, New York, NY 10027 USA; [Thams, Sebastian; Oakley, Derek] CSCI, New York, NY 10027 USA; [Maeder, Morgan L.; Goodwin, Mathew J.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Maeder, Morgan L.; Goodwin, Mathew J.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Nemesh, James; Handsaker, Robert E.; McCarroll, Steven A.; Brown, Robert H.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA; [Nemesh, James; Handsaker, Robert E.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Paull, Daniel; Noggle, Scott] New York Stem Cell Fdn, Res Inst, New York, NY 10023 USA	Howard Hughes Medical Institute; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Columbia University; Columbia University; Columbia University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; The New York Stem Cell Foundation	Eggan, K (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	eggan@mcb.harvard.edu	Wainger, Brian/L-7553-2017; Eggan, Kevin/P-7119-2018; Di Costanzo, Stefania/H-4703-2018; Woolf, Clifford/A-9784-2010; Oakley, Derek/ABA-4689-2020	Oakley, Derek/0000-0002-6998-9510; Merkle, Florian/0000-0002-8513-2998; Noggle, Scott/0000-0002-0374-2240; Boulting, Gabriella/0000-0003-2012-1259; Mellin, Cassidy/0000-0002-1057-0985	ALS Therapy Alliance, Project ALS, P2ALS; Angel Fund; Pierre L. de Bourgknecht ALS Research Foundation; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; NIH/NINDS [1R01NS050557]; NIH/NINDS (NINDS ARRA Award) [RC2-NS070-342]; Target ALS, Project A.L.S., P2ALS; NINDS GO grant [5RC2NS069395-02]; NINDS R24 [1U24NS078736-01]; HHMI; NIH Director's Pioneer Award DP1 [OD006862]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050557, R00NS077435, U24NS078736, RC2NS070342, RC2NS069395] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER	ALS Therapy Alliance, Project ALS, P2ALS; Angel Fund; Pierre L. de Bourgknecht ALS Research Foundation; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NINDS (NINDS ARRA Award); Target ALS, Project A.L.S., P2ALS; NINDS GO grant; NINDS R24; HHMI(Howard Hughes Medical Institute); NIH Director's Pioneer Award DP1; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Mitsumoto and D. McKenna-Yasek for performing skin biopsies; K. Koszka for maintaining mice; all members of the Eggan Lab; and C. Henderson and M. W. Amoroso for helpful comments on the manuscript. R. H. B. acknowledges generous support from the ALS Therapy Alliance, Project ALS, P2ALS, the Angel Fund, the Pierre L. de Bourgknecht ALS Research Foundation, the Al-Athel ALS Research Foundation, the ALS Family Charitable Foundation, and the NIH/NINDS (1R01NS050557 and NINDS ARRA Award RC2-NS070-342). This work was funded by Target ALS, Project A.L.S., P2ALS, NINDS GO grant (5RC2NS069395-02), NINDS R24 (1U24NS078736-01), the HHMI, and the NIH Director's Pioneer Award DP1 (OD006862). E. K. is a Charles A. King Trust Postdoctoral fellow, and K. E. is an HHMI early career scientist. J.K.J. has financial interests in Editas Medicine and Transposagen Biopharmaceuticals. J.K.J.'s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brotherton TE, 2013, NEUROBIOL DIS, V49, P49, DOI 10.1016/j.nbd.2012.08.010; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Cardoso RMF, 2002, J MOL BIOL, V324, P247, DOI 10.1016/S0022-2836(02)01090-2; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Gladman M, 2012, CURR OPIN NEUROL, V25, P735, DOI 10.1097/WCO.0b013e32835a309d; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; KIERNAN JA, 1991, BRAIN, V114, P843, DOI 10.1093/brain/114.2.843; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; MCILWAIN DL, 1991, ADV NEUROL, V56, P67; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Oh YK, 2008, J NEUROCHEM, V104, P993, DOI 10.1111/j.1471-4159.2007.05053.x; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sreedharan J, 2013, ANN NEUROL, V74, P309, DOI 10.1002/ana.24012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trusina A, 2008, P NATL ACAD SCI USA, V105, P20280, DOI 10.1073/pnas.0803476105; Wada T, 2012, STEM CELL TRANSL MED, V1, P396, DOI 10.5966/sctm.2011-0061; Wainger B., 2014, CELL REPORT IN PRESS	42	276	291	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					781	795		10.1016/j.stem.2014.03.004	http://dx.doi.org/10.1016/j.stem.2014.03.004			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24704492	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000341248500015
J	Nguyen, PK; Riegler, J; Wu, JC				Nguyen, Patricia K.; Riegler, Johannes; Wu, Joseph C.			Stem Cell Imaging: From Bench to Bedside	CELL STEM CELL			English	Review							ACUTE MYOCARDIAL-INFARCTION; MARROW MONONUCLEAR-CELLS; LEFT-VENTRICULAR FUNCTION; MAGNETIC-RESONANCE TRACKING; IN-VIVO TRACKING; INDUCED PLURIPOTENT; REPORTER GENE; ISCHEMIC CARDIOMYOPATHY; ENDOTHELIAL-CELLS; IMMUNE REJECTION	Although cellular therapies hold great promise for the treatment of human disease, results from several initial clinical trials have not shown a level of efficacy required for their use as a first line therapy. Here we discuss how in vivo molecular imaging has helped identify barriers to clinical translation and potential strategies that may contribute to successful transplantation and improved outcomes, with a focus on cardiovascular and neurological diseases. We conclude with a perspective on the future role of molecular imaging in defining safety and efficacy for clinical implementation of stem cell therapies.	[Nguyen, Patricia K.; Riegler, Johannes; Wu, Joseph C.] Stanford Univ, Dept Med, Div Cardiol, Stanford, CA 94305 USA; [Nguyen, Patricia K.; Riegler, Johannes; Wu, Joseph C.] Dept Radiol, Mol Imaging Program, Stanford, CA 94305 USA; [Nguyen, Patricia K.; Riegler, Johannes; Wu, Joseph C.] Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Wu, Joseph C.] Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University	Wu, JC (corresponding author), Stanford Univ, Dept Med, Div Cardiol, Stanford, CA 94305 USA.	joewu@stanford.edu	Wu, Joseph/H-1067-2013	Wu, Joseph/0000-0002-6068-8041	American Heart Association; Austrian Science Foundation; NIH [HL093172, EB009689, HL095571]; CIRM [TR3-05556, DR2-05394]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095571, R01HL093172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009689] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Austrian Science Foundation(Austrian Science Fund (FWF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by grants from the American Heart Association (P.K.N.), Austrian Science Foundation (J.R.), NIH HL093172, NIH EB009689, NIH HL095571, CIRM TR3-05556, and CIRM DR2-05394 (J.C.W.). We would like to give a special thanks to Christina Sicoli Design for creating the figures. We also thank Blake Wu and Ian Chen for assistance with manuscript preparation. Due to space limitation, we were unable to include all the important relevant papers in stem cell imaging. We apologize to the investigators who have made significant contributions to this field not discussed in this Review.	Abdullah Z, 2007, J IMMUNOL, V178, P3390, DOI 10.4049/jimmunol.178.6.3390; Alper J, 2009, NAT BIOTECHNOL, V27, P213, DOI 10.1038/nbt0309-213a; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Antonic A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001738; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bading JR, 2008, J NUCL MED, V49, p64S, DOI 10.2967/jnumed.107.046391; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; da Fonseca LMB, 2011, INT J CARDIOL, V149, P310, DOI 10.1016/j.ijcard.2010.02.008; da Fonseca LMB, 2010, EXP NEUROL, V221, P122, DOI 10.1016/j.expneurol.2009.10.010; Ben-David U, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2992; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Callera F, 2007, STEM CELLS DEV, V16, P461, DOI 10.1089/scd.2007.0083; Campan M, 2011, AM J PHYSIOL-HEART C, V300, pH2238, DOI 10.1152/ajpheart.00935.2010; Cao F, 2007, STEM CELLS DEV, V16, P883, DOI 10.1089/scd.2007.0160; Cao F, 2007, CLONING STEM CELLS, V9, P107, DOI 10.1089/clo.2006.0E16; Cao F, 2009, CANCER RES, V69, P2709, DOI 10.1158/0008-5472.CAN-08-4122; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Chen HSV, 2009, CIRCULATION, V120, P2496, DOI 10.1161/CIRCULATIONAHA.107.751412; Chen IY, 2011, CIRCULATION, V123, P425, DOI 10.1161/CIRCULATIONAHA.109.916338; Christen T, 2009, CIRCULATION, V119, P1925, DOI 10.1161/CIRCULATIONAHA.108.796888; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Correa PL, 2007, CLIN NUCL MED, V32, P839, DOI 10.1097/RLU.0b013e318156b980; Daadi MM, 2009, MOL THER, V17, P1282, DOI 10.1038/mt.2009.104; de Almeida PE, 2013, CIRC RES, V112, P549, DOI 10.1161/CIRCRESAHA.111.249243; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Dedobbeleer C, 2009, J CARDIOVASC PHARM, V53, P480, DOI 10.1097/FJC.0b013e3181a7b572; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Fadini GP, 2010, ATHEROSCLEROSIS, V209, P10, DOI 10.1016/j.atherosclerosis.2009.08.033; Garber K, 2013, NAT BIOTECHNOL, V31, P483, DOI 10.1038/nbt.2602; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Gyongyosi M, 2008, CIRC-CARDIOVASC IMAG, V1, P94, DOI 10.1161/CIRCIMAGING.108.797449; Gyongyosi M, 2010, JACC-CARDIOVASC IMAG, V3, P772, DOI 10.1016/j.jcmg.2010.04.012; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Hoffmann J, 2010, THORAC CARDIOV SURG, V58, P136, DOI 10.1055/s-0029-1240758; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Huang NF, 2010, ARTERIOSCL THROM VAS, V30, P984, DOI 10.1161/ATVBAHA.110.202796; Huber BC, 2013, STEM CELLS, V31, P2354, DOI 10.1002/stem.1501; Kang JH, 2005, J NUCL MED, V46, P479; Kang WJ, 2006, J NUCL MED, V47, P1295; Karow M, 2011, STEM CELLS, V29, P1696, DOI 10.1002/stem.730; Karpov RS, 2005, B EXP BIOL MED+, V140, P640, DOI 10.1007/s10517-006-0043-1; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kim DE, 2004, STROKE, V35, P952, DOI 10.1161/01.STR.0000120308.21946.5D; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Koch CA, 2008, STEM CELLS, V26, P89, DOI 10.1634/stemcells.2007-0151; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005; Kraitchman DL, 2005, CIRCULATION, V112, P1451, DOI 10.1161/CIRCULATIONAHA.105.537480; Lan F, 2012, CIRCULATION, V126, pS20, DOI 10.1161/CIRCULATIONAHA.111.084913; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Lees JS, 2012, INT J STROKE, V7, P582, DOI 10.1111/j.1747-4949.2012.00797.x; Levit RD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000367; Li ZJ, 2008, STEM CELLS, V26, P864, DOI 10.1634/stemcells.2007-0843; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Magliocca JF, 2006, STEM CELLS DEV, V15, P707, DOI 10.1089/scd.2006.15.707; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Mothe AJ, 2012, J CLIN INVEST, V122, P3824, DOI 10.1172/JCI64124; Nguyen PK, 2011, CIRC RES, V109, P962, DOI 10.1161/CIRCRESAHA.111.242909; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Ochiai H, 2012, P NATL ACAD SCI USA, V109, P10915, DOI 10.1073/pnas.1202768109; Pearl JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005090; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Pendharkar AV, 2010, STROKE, V41, P2064, DOI 10.1161/STROKEAHA.109.575993; Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418; Ponomarev V, 2007, J NUCL MED, V48, P819, DOI 10.2967/jnumed.106.036962; Poole J, 2013, JAMA-J AM MED ASSOC, V310, P2631, DOI 10.1001/jama.2013.282540; Rong ZL, 2014, CELL STEM CELL, V14, P121, DOI 10.1016/j.stem.2013.11.014; Rosenblum S, 2012, STROKE, V43, P1624, DOI 10.1161/STROKEAHA.111.637884; Rufaihah AJ, 2011, ARTERIOSCL THROM VAS, V31, pE72, DOI 10.1161/ATVBAHA.111.230938; Schachinger V, 2008, CIRCULATION, V118, P1425, DOI 10.1161/CIRCULATIONAHA.108.777102; Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503; Sheikh AY, 2007, STEM CELLS, V25, P2677, DOI 10.1634/stemcells.2007-0041; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Silva SA, 2009, CELL TRANSPLANT, V18, P343, DOI 10.3727/096368909788534951; Sommer D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4045; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Swijnenburg RJ, 2010, CIRC-CARDIOVASC IMAG, V3, P77, DOI 10.1161/CIRCIMAGING.109.872085; Swijnenburg RJ, 2008, STEM CELLS DEV, V17, P1023, DOI 10.1089/scd.2008.0091; Sykova E, 2007, PROG BRAIN RES, V161, P367, DOI 10.1016/S0079-6123(06)61026-1; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Templin C, 2012, CIRCULATION, V126, P430, DOI 10.1161/CIRCULATIONAHA.111.087684; Terrovitis J, 2008, CIRCULATION, V117, P1555, DOI 10.1161/CIRCULATIONAHA.107.732073; Toma C, 2009, CIRC RES, V104, P398, DOI 10.1161/CIRCRESAHA.108.187724; Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726; Traverse JH, 2011, JAMA-J AM MED ASSOC, V306, P2110, DOI 10.1001/jama.2011.1670; Uccelli A, 2011, LANCET NEUROL, V10, P649, DOI 10.1016/S1474-4422(11)70121-1; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; van der Spoel TIG, 2011, CARDIOVASC RES, V91, P649, DOI 10.1093/cvr/cvr113; Vrtovec B, 2013, CIRCULATION, V128, pS42, DOI 10.1161/CIRCULATIONAHA.112.000230; Wang YM, 2012, CIRC RES, V111, P1494, DOI 10.1161/CIRCRESAHA.112.274969; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Xie XY, 2009, STEM CELLS DEV, V18, P205, DOI 10.1089/scd.2008.0152; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yilmaz A, 2013, INT J CARDIOL, V163, P175, DOI 10.1016/j.ijcard.2011.06.004; Yu DX, 2013, CELL STEM CELL, V12, P678, DOI 10.1016/j.stem.2013.05.018; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	113	191	192	2	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					431	444		10.1016/j.stem.2014.03.009	http://dx.doi.org/10.1016/j.stem.2014.03.009			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24702995	Green Accepted, Bronze			2022-12-28	WOS:000334766400008
J	Metcalfe, C; Kljavin, NM; Ybarra, R; de Sauvage, FJ				Metcalfe, Ciara; Kljavin, Noelyn M.; Ybarra, Ryan; de Sauvage, Frederic J.			Lgr5(+) Stem Cells Are Indispensable for Radiation-Induced Intestinal Regeneration	CELL STEM CELL			English	Article							GROWTH-FACTOR; IN-VIVO; MICE; DIFFERENTIATION; POPULATIONS; EXPRESSION; EPITHELIUM; GENE; BMI1; R-SPONDIN1	The intestinal epithelium continually self-renews and can rapidly regenerate after damage. Lgr5 marks mitotically active intestinal stem cells (ISCs). Importantly, intestinal homeostasis can be maintained after depletion of Lgr5(+) cells due to the activation of Lgr5(-) reserve ISCs. The Lgr5(-) ISC populations are thought to play a similar role during intestinal regeneration following radiation-induced damage. We tested this regeneration hypothesis by combining depletion of Lgr5(+) ISCs with radiation exposure. In contrast to the negligible effect of Lgr5(+) ISC loss during homeostasis, depletion of Lgr5(+) cells during radiation-induced damage and subsequent repair caused catastrophic crypt loss and deterioration of crypt-villus architecture. Interestingly though, we found that crypts deficient for Lgr5(+) cells are competent to undergo hyperplasia upon loss of Apc. These data argue that Lgr5(+) reserve stem cells are radiosensitive and that Lgr5(+) cells are crucial for robust intestinal regeneration following radiation exposure but are dispensable for premalignant hyperproliferation.	[Metcalfe, Ciara; Kljavin, Noelyn M.; Ybarra, Ryan; de Sauvage, Frederic J.] Genentech Inc, Mol Oncol Dept, San Francisco, CA 94080 USA	Roche Holding; Genentech	de Sauvage, FJ (corresponding author), Genentech Inc, Mol Oncol Dept, San Francisco, CA 94080 USA.	desauvage.fred@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584				Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cordero JB, 2012, ACTA PHYSIOL, V204, P137, DOI 10.1111/j.1748-1716.2011.02288.x; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Fafilek B, 2013, GASTROENTEROLOGY, V144, P381, DOI 10.1053/j.gastro.2012.10.048; Hirata A, 2013, DEVELOPMENT, V140, P66, DOI 10.1242/dev.084103; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; MERRITT AJ, 1994, CANCER RES, V54, P614; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Zhou WJ, 2013, NATURE, V501, P107, DOI 10.1038/nature12416; Zhu YH, 2013, CELL STEM CELL, V12, P298, DOI 10.1016/j.stem.2013.01.003	40	355	364	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					149	159		10.1016/j.stem.2013.11.008	http://dx.doi.org/10.1016/j.stem.2013.11.008			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24332836	Bronze			2022-12-28	WOS:000330835800008
J	Shin, JW; Buxboim, A; Spinler, KR; Swift, J; Christian, DA; Hunter, CA; Leon, C; Gachet, C; Dingal, PCDP; Ivanovska, IL; Rehfeldt, F; Chasis, JA; Discher, DE				Shin, Jae-Won; Buxboim, Amnon; Spinler, Kyle R.; Swift, Joe; Christian, David A.; Hunter, Christopher A.; Leon, Catherine; Gachet, Christian; Dingal, P. C. Dave P.; Ivanovska, Irena L.; Rehfeldt, Florian; Chasis, Joel Anne; Discher, Dennis E.			Contractile Forces Sustain and Polarize Hematopoiesis from Stem and Progenitor Cells	CELL STEM CELL			English	Article							NONMUSCLE MYOSIN IIB; HUMAN CORD BLOOD; HEAVY-CHAIN; BONE-MARROW; ACTOMYOSIN CONTRACTILITY; DIVISION; DICTYOSTELIUM; SEGREGATION; EXPANSION; MEGAKARYOCYTES	Self-renewal and differentiation of stem cells depend on asymmetric division and polarized motility processes that in other cell types are modulated by nonmuscle myosin-II (MII) forces and matrix mechanics. Here, mass spectrometry-calibrated intracellular flow cytometry of human hematopoiesis reveals MIIB to be a major isoform that is strongly polarized in hematopoietic stem cells and progenitors (HSC/Ps) and thereby downregulated in differentiated cells via asymmetric division. MIIA is constitutive and activated by dephosphorylation during cytokine-triggered differentiation of cells grown on stiff, endosteum-like matrix, but not soft, marrow-like matrix. In vivo, MIIB is required for generation of blood, while MIIA is required for sustained HSC/P engraftment. Reversible inhibition of both isoforms in culture with blebbistatin enriches for long-term hematopoietic multilineage reconstituting cells by 5-fold or more as assessed in vivo. Megakaryocytes also become more polyploid, producing 4-fold more platelets. MII is thus a multifunctional node in polarized division and niche sensing.	[Shin, Jae-Won; Buxboim, Amnon; Spinler, Kyle R.; Swift, Joe; Dingal, P. C. Dave P.; Ivanovska, Irena L.; Rehfeldt, Florian; Discher, Dennis E.] Univ Penn, Biophys Engn Lab, Philadelphia, PA 19104 USA; [Shin, Jae-Won; Discher, Dennis E.] Univ Penn, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA; [Shin, Jae-Won; Discher, Dennis E.] Univ Penn, Pharmacol Grad Grp, Philadelphia, PA 19104 USA; [Christian, David A.; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Leon, Catherine; Gachet, Christian] Univ Strasbourg, INSERM, Etab Francais Sang, UMR S949, F-67000 Strasbourg, France; [Chasis, Joel Anne] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Chasis, Joel Anne] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Discher, DE (corresponding author), Univ Penn, Biophys Engn Lab, Philadelphia, PA 19104 USA.	discher@seas.upenn.edu	Rehfeldt, Florian/A-1078-2007; Christian, David/AAE-6425-2019; Swift, Joe/A-5149-2014; Léon, Catherine/G-6473-2015; Gachet, Christian/H-9156-2016; leon, catherine/ABB-5242-2020	Rehfeldt, Florian/0000-0001-9086-3835; Swift, Joe/0000-0002-5039-9094; Léon, Catherine/0000-0002-8597-9929; leon, catherine/0000-0002-8597-9929; Dingal, P. C. Dave P./0000-0002-1052-2537; discher, dennis/0000-0001-6163-2229; Buxboim, Amnon/0000-0003-2412-9792	National Institutes of Health [P01DK032094, R01HL062352, R01-EB007049, P30-DK090969, NCATS-8UL1TR000003]; Human Frontier Science Program; National Science Foundation; Nano Science and Engineering Center-Nano Bio Interface Center; American Heart Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022575] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124106, R01HL062352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007049, R21EB003164, R21EB004489, R21EB004000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090969, P01DK032094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); National Science Foundation(National Science Foundation (NSF)); Nano Science and Engineering Center-Nano Bio Interface Center; American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Robert Adelstein, Dr. Mary Anne Conti (NIH-NHLBI), and Dr. Leonard Zon (Harvard) for invaluable comments. We gratefully acknowledge Arielle Glatman Zaretsky for technical assistance in mouse BM transplantation and the Stem Cell Xenograft Core at the University of Pennsylvania, A. Secreto, J. Glover, and Dr. G. Danet-Desnoyers for cells and engraftment studies. This study was supported by the National Institutes of Health (P01DK032094; R01HL062352; R01-EB007049; P30-DK090969; NCATS-8UL1TR000003), the Human Frontier Science Program (I. I. and D. E. D.), the National Science Foundation (D. E. D.), the Nano Science and Engineering Center-Nano Bio Interface Center (D. E. D.), and the American Heart Association (J.-W.S.).	Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Butler JM, 2012, BLOOD, V120, P1344, DOI 10.1182/blood-2011-12-398115; Canman JC, 2003, NATURE, V424, P1074, DOI 10.1038/nature01860; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Fuentes R, 2010, J CLIN INVEST, V120, P3917, DOI 10.1172/JCI43326; Fulcher DA, 1997, IMMUNOL CELL BIOL, V75, P446, DOI 10.1038/icb.1997.69; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Holst J, 2010, NAT BIOTECHNOL, V28, P1123, DOI 10.1038/nbt.1687; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; LICHTMAN MA, 1970, NEW ENGL J MED, V283, P943, DOI 10.1056/NEJM197010292831801; Lordier L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1704; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; MAUPIN P, 1994, J CELL SCI, V107, P3077; Merkel R, 2000, BIOPHYS J, V79, P707, DOI 10.1016/S0006-3495(00)76329-6; Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311; Nishino T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024298; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Ou GS, 2010, SCIENCE, V330, P677, DOI 10.1126/science.1196112; Pietrancosta N, 2005, BIOORG MED CHEM LETT, V15, P1561, DOI 10.1016/j.bmcl.2005.01.075; Raab M, 2012, J CELL BIOL, V199, P669, DOI 10.1083/jcb.201205056; Ren YX, 2009, CURR BIOL, V19, P1421, DOI 10.1016/j.cub.2009.07.018; Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; Shin JW, 2011, P NATL ACAD SCI USA, V108, P11458, DOI 10.1073/pnas.1017474108; Shu S, 2005, P NATL ACAD SCI USA, V102, P1472, DOI 10.1073/pnas.0409528102; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; SPRENT J, 1973, CELL IMMUNOL, V7, P40, DOI 10.1016/0008-8749(73)90181-0; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Ting SB, 2012, BLOOD, V119, P2510, DOI 10.1182/blood-2011-11-393272; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Ubukawa K, 2012, BLOOD, V119, P1036, DOI 10.1182/blood-2011-06-361907; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Vaziri C, 1997, J BIOL CHEM, V272, P2762, DOI 10.1074/jbc.272.5.2762; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zang JH, 1997, MOL BIOL CELL, V8, P2617, DOI 10.1091/mbc.8.12.2617; Zuco V, 2008, NEOPLASIA, V10, P587, DOI 10.1593/neo.08262	54	92	108	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					81	93		10.1016/j.stem.2013.10.009	http://dx.doi.org/10.1016/j.stem.2013.10.009			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24268694	Green Accepted, Bronze			2022-12-28	WOS:000329571900011
J	Boonsanay, V; Zhang, T; Georgieva, A; Kostin, S; Qi, H; Yuan, XJ; Zhou, YG; Braun, T				Boonsanay, Verawan; Zhang, Ting; Georgieva, Angelina; Kostin, Sawa; Qi, Hui; Yuan, Xuejun; Zhou, Yonggang; Braun, Thomas			Regulation of Skeletal Muscle Stem Cell Quiescence by Suv4-20h1-Dependent Facultative Heterochromatin Formation	CELL STEM CELL			English	Article							SATELLITE CELLS; SELF-RENEWAL; MUSCULAR-DYSTROPHY; CHROMATIN; REGENERATION; MYOD; MOUSE; MICE; EZH2; INACTIVATION	Skeletal muscle stem cells (MuSCs) are required for regeneration of adult muscle following injury, a response that demands activation of mainly quiescent MuSCs. Despite the need for dynamic regulation of MuSC quiescence, relatively little is known about the determinants of this property. Here, we show that Suv4-20h1, an H4K20 dimethyltransferase, controls MuSC quiescence by promoting formation of facultative heterochromatin (fHC). Deletion of Suv4-20h1 reduces fHC and induces transcriptional activation and repositioning of the MyoD locus away from the heterochromatic nuclear periphery. These effects promote MuSC activation, resulting in stem cell depletion and impaired long-term muscle regeneration. Genetic reduction of MyoD expression rescues fHC formation and lost MuSC quiescence, restoring muscle regeneration capacity in Suv4-20h1 mutants. Together, these findings reveal that Suv4-20h1 actively regulates MuSC quiescence via fHC formation and control of the MyoD locus, thereby guarding and preserving the stem cell pool over a lifetime.	[Boonsanay, Verawan; Zhang, Ting; Georgieva, Angelina; Kostin, Sawa; Qi, Hui; Yuan, Xuejun; Zhou, Yonggang; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Braun, Thomas] Max Planck Gesell, Inst Invest Biomed Buenos Aires IBioBA CONICET Pa, C1425FQD Buenos Aires, Buenos Aires, DF, Argentina	Max Planck Society; Max Planck Society	Zhou, YG; Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany.; Braun, T (corresponding author), Max Planck Gesell, Inst Invest Biomed Buenos Aires IBioBA CONICET Pa, C1425FQD Buenos Aires, Buenos Aires, DF, Argentina.	yonggang.zhou@mpi-bn.mpg.de; thomas.braun@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008; Zhang, Ting/K-5560-2018	Braun, Thomas/0000-0002-6165-4804; Boonsanay, Verawan/0000-0002-4781-1826	LOEWE Center for Cell and Gene Therapy; German Center for Cardiovascular Research; Center for Lung Research; Universities of Giessen and Marburg Lung Center (UGMLC); DFG (Excellence Cluster Cardio-Pulmonary System [ECCPS]);  [SFB TRR81]	LOEWE Center for Cell and Gene Therapy; German Center for Cardiovascular Research; Center for Lung Research; Universities of Giessen and Marburg Lung Center (UGMLC); DFG (Excellence Cluster Cardio-Pulmonary System [ECCPS]); 	We thank Kerstin Richter, Stefan Guenther, and Johnny Kim for help with FACS sorting; Johannes Besser for help with miRNA analyses; and Shuichi Watanabe for help with MuSC cultures and immunostaining. This work was supported by the DFG (Excellence Cluster Cardio-Pulmonary System [ECCPS] and SFB TRR81), the LOEWE Center for Cell and Gene Therapy, the German Center for Cardiovascular Research, the Center for Lung Research, and the Universities of Giessen and Marburg Lung Center (UGMLC).	Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chen JCJ, 2002, DEV BIOL, V245, P213, DOI 10.1006/dbio.2002.0638; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dedeic Z, 2011, J CELL SCI, V124, P1691, DOI 10.1242/jcs.080259; Forcales SV, 2012, EMBO J, V31, P301, DOI 10.1038/emboj.2011.391; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gopinath SD, 2014, STEM CELL REP, V2, P414, DOI 10.1016/j.stemcr.2014.02.002; Gunther S, 2013, CELL STEM CELL, V13, P590, DOI 10.1016/j.stem.2013.07.016; Hahn M, 2013, GENE DEV, V27, P859, DOI 10.1101/gad.210377.112; Hosoyama T, 2011, J BIOL CHEM, V286, P19556, DOI 10.1074/jbc.M111.229542; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Neguembor MV, 2013, J MOL CELL BIOL, V5, P294, DOI 10.1093/jmcb/mjt018; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Son J, 2013, GENE DEV, V27, P2663, DOI 10.1101/gad.225888.113; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang KM, 2010, J CELL BIOL, V188, P39, DOI 10.1083/jcb.200904144; Zhang T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8140; Zhou YG, 2011, CIRC RES, V109, P1067, DOI 10.1161/CIRCRESAHA.111.243709	48	88	89	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2016	18	2					229	242		10.1016/j.stem.2015.11.002	http://dx.doi.org/10.1016/j.stem.2015.11.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GT	26669898	Bronze			2022-12-28	WOS:000372321700013
J	Waskow, C				Waskow, Claudia			Maintaining What Is Already There: Strategies to Rectify HSC Transplantation Dilemmas	CELL STEM CELL			English	Editorial Material							STEM-CELL TRANSPLANTATION; ENGRAFTMENT	Hematopoietic stem cell (HSC) transplantation remains the only cure for various hematological diseases, but low HSC numbers in many donor samples are a critical problem preventing their clinical use. Now in Nature and Cell, two creative strategies to rescue and improve pre-existing engraftment potential are presented.	Tech Univ Dresden, Fac Med, Inst Immunol, Regenerat Hematopoiesis & Anim Models Hematopoies, D-01307 Dresden, Germany	Technische Universitat Dresden	Waskow, C (corresponding author), Tech Univ Dresden, Fac Med, Inst Immunol, Regenerat Hematopoiesis & Anim Models Hematopoies, Fetscherstr 74, D-01307 Dresden, Germany.	claudia.waskow@tu-dresden.de	Waskow, Claudia/F-8146-2010	Waskow, Claudia/0000-0003-3261-0922				Cosgun KN, 2014, CELL STEM CELL, V15, P227, DOI 10.1016/j.stem.2014.06.001; Danby R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00068; Goyama S, 2015, BLOOD, V125, P2630, DOI 10.1182/blood-2014-11-570218; Li HW, 2012, NAT REV IMMUNOL, V12, P403, DOI 10.1038/nri3226; Li PL, 2015, NATURE, V523, P468, DOI 10.1038/nature14569; Mantel CR, 2015, CELL, V161, P1553, DOI 10.1016/j.cell.2015.04.054; Vo LT, 2015, BLOOD, V125, P2641, DOI 10.1182/blood-2014-10-570234; Waskow C, 2009, NAT METHODS, V6, P267, DOI [10.1038/nmeth.1309, 10.1038/NMETH.1309]	8	9	9	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					258	259		10.1016/j.stem.2015.08.012	http://dx.doi.org/10.1016/j.stem.2015.08.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26340525	Bronze			2022-12-28	WOS:000364011000005
J	Kwon, HY; Bajaj, J; Ito, T; Blevins, A; Konuma, T; Weeks, J; Lytle, NK; Koechlein, CS; Rizzieri, D; Chuah, C; Oehler, VG; Sasik, R; Hardiman, G; Reya, T				Kwon, Hyog Young; Bajaj, Jeevisha; Ito, Takahiro; Blevins, Allen; Konuma, Takaaki; Weeks, Joi; Lytle, Nikki K.; Koechlein, Claire S.; Rizzieri, David; Chuah, Charles; Oehler, Vivian G.; Sasik, Roman; Hardiman, Gary; Reya, Tannishtha			Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia	CELL STEM CELL			English	Article							MYELOID-LEUKEMIA; STEM-CELLS; CXCR4; EXPRESSION; CHEMOSENSITIZATION; IDENTIFICATION; CHEMOTHERAPY; MICRODOMAINS; ASSOCIATION; RESISTANCE	Acute Myelogenous Leukemia (AML) is an aggressive cancer that strikes both adults and children and is frequently resistant to therapy. Thus, identifying signals needed for AML propagation is a critical step toward developing new approaches for treating this disease. Here, we show that Tetraspanin 3 is a target of the RNA binding protein Musashi 2, which plays a key role in AML. We generated Tspan3 knockout mice that were born without overt defects. However, Tspan3 deletion impaired leukemia stem cell self-renewal and disease propagation and markedly improved survival in mouse models of AML. Additionally, Tspan3 inhibition blocked growth of AML patient samples, suggesting that Tspan3 is also important in human disease. As part of the mechanism, we show that Tspan3 deficiency disabled responses to CXCL12/SDF-1 and led to defects in AML localization within the niche. These identify Tspan3 as an important regulator of aggressive leukemias and highlight a role for Tspan3 in oncogenesis.	[Kwon, Hyog Young; Bajaj, Jeevisha; Ito, Takahiro; Blevins, Allen; Konuma, Takaaki; Weeks, Joi; Lytle, Nikki K.; Koechlein, Claire S.; Reya, Tannishtha] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Kwon, Hyog Young] Soonchunhyang Univ, Soonchunhyang Inst Medibio Sci, Asan 336745, Chungcheongnam, South Korea; [Bajaj, Jeevisha; Ito, Takahiro; Blevins, Allen; Konuma, Takaaki; Weeks, Joi; Lytle, Nikki K.; Koechlein, Claire S.; Reya, Tannishtha] Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA; [Rizzieri, David] Duke Univ, Med Ctr, Div Cell Therapy, Dept Med, Durham, NC 27710 USA; [Chuah, Charles] Duke NUS Grad Sch Med, Singapore Gen Hosp, Dept Haematol, Canc & Stem Cell Biol Program, Singapore 169857, Singapore; [Oehler, Vivian G.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Sasik, Roman] Univ Calif San Diego, Sch Med, Ctr Computat Biol & Bioinformat, La Jolla, CA 92093 USA; [Hardiman, Gary] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Hardiman, Gary] San Diego State Univ, Biomed Informat Res Ctr, San Diego, CA 92182 USA; [Hardiman, Gary] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Reya, Tannishtha] Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA; [Reya, Tannishtha] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	University of California System; University of California San Diego; Soonchunhyang University; Duke University; National University of Singapore; Singapore General Hospital; Fred Hutchinson Cancer Center; University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego; Duke University	Reya, T (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.	treya@ucsd.edu	Ito, Takahiro/F-5006-2011	Ito, Takahiro/0000-0001-7165-0412; Hardiman, Gary/0000-0003-4558-0400; Konuma, Takaaki/0000-0002-1953-8463	National Cancer Center; California Institute for Regenerative Medicine interdisciplinary stem cell training program fellowship; Japanese Society for the Promotion of Science; NIH Pharmacological Sciences Training Program [T32 GM007752]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2A16052133]; Lymphoma and Leukemia Society Scholar Award; University of California San Diego Moores Cancer Center NCI Core Grant [P30CA23100]; NIH [HL097767, DP1 CA174422, DK099335, CA186043]; NATIONAL CANCER INSTITUTE [DP1CA174422, R01CA186043, P30CA023100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099335, R01DK063031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006430] Funding Source: NIH RePORTER	National Cancer Center; California Institute for Regenerative Medicine interdisciplinary stem cell training program fellowship; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH Pharmacological Sciences Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Lymphoma and Leukemia Society Scholar Award; University of California San Diego Moores Cancer Center NCI Core Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Jonathan Yang for technical support and Marcie Kritzik for help with manuscript preparation. We would also like to thank Scott Armstrong for the MLL-AF9 construct; Scott Lowe for the AML-ETO9a construct; Dong-Er Zhang for experimental advice; Warren Pear and Ann Marie Pendergast for the BCR-ABL construct; and Gary Gilliland for the NUP98-HOXA9 construct. J.B. is supported by a postdoctoral fellowship from the National Cancer Center, T.I. is a recipient of a California Institute for Regenerative Medicine interdisciplinary stem cell training program fellowship, T.K. is supported by a postdoctoral fellowship from the Japanese Society for the Promotion of Science, C.S.K. and N.L. received support from the NIH Pharmacological Sciences Training Program (T32 GM007752), and H.Y.K. was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2A16052133). This work was also supported by a Lymphoma and Leukemia Society Scholar Award and the University of California San Diego Moores Cancer Center NCI Core Grant, P30CA23100, as well as by NIH grants HL097767, DP1 CA174422, DK099335, and CA186043 awarded to T.R.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Boucheix C, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002381; Byers RJ, 2011, BLOOD, V118, P2857, DOI 10.1182/blood-2011-04-346767; Chen Y, 2013, J CLIN INVEST, V123, P2395, DOI 10.1172/JCI66553; Chen YM, 2011, J CLIN ONCOL, V29, P2507, DOI 10.1200/JCO.2010.34.2873; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Faber J, 2009, BLOOD, V113, P2375, DOI 10.1182/blood-2007-09-113597; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 1996, BBA-REV CANCER, V1287, P67, DOI 10.1016/0304-419X(96)00007-8; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; JANKOWSKI SA, 1994, ONCOGENE, V9, P1205; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li ZJ, 2013, BLOOD, V121, P1422, DOI 10.1182/blood-2012-07-442004; Moss Alan C, 2007, Transl Oncogenomics, V2, P1; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Paxinos G, 2012, PAXINOS FRANKLINS MO; Robak T, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.011; Robak T, 2009, CURR OPIN INVEST DR, V10, P1383; Roboz GJ, 2012, CURR OPIN ONCOL, V24, P711, DOI 10.1097/CCO.0b013e328358f62d; Rombouts EJC, 2004, BLOOD, V104, P550, DOI 10.1182/blood-2004-02-0566; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Shipley JL, 2009, EXP HEMATOL, V37, P649, DOI 10.1016/j.exphem.2009.04.002; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Sison EAR, 2013, MOL CANCER RES, V11, P1004, DOI 10.1158/1541-7786.MCR-13-0114; Spoo AC, 2007, BLOOD, V109, P786, DOI 10.1182/blood-2006-05-024844; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; SZALA S, 1990, P NATL ACAD SCI USA, V87, P6833, DOI 10.1073/pnas.87.17.6833; Tavor S, 2008, LEUKEMIA, V22, P2151, DOI 10.1038/leu.2008.238; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693; Tiwari-Woodruff SK, 2001, J CELL BIOL, V153, P295, DOI 10.1083/jcb.153.2.295; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uy GL, 2012, BLOOD, V119, P3917, DOI 10.1182/blood-2011-10-383406; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wright MD, 2004, TISSUE ANTIGENS, V64, P533, DOI 10.1111/j.1399-0039.2004.00321.x; Yagi T, 2003, BLOOD, V102, P1849, DOI 10.1182/blood-2003-02-0578; Zeisig Bernd B, 2012, Cancer Cell, V22, P698, DOI 10.1016/j.ccr.2012.10.017; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Zimdahl B, 2014, NAT GENET, V46, P245, DOI 10.1038/ng.2889	44	47	49	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					152	164		10.1016/j.stem.2015.06.006	http://dx.doi.org/10.1016/j.stem.2015.06.006			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26212080	Green Accepted, Bronze			2022-12-28	WOS:000361878500007
J	Savic, N; Bar, D; Leone, S; Frommel, SC; Weber, FA; Vollenweider, E; Ferrari, E; Ziegler, U; Kaech, A; Shakhova, O; Cinelli, P; Santoro, R				Savic, Natasa; Bar, Dominik; Leone, Sergio; Frommel, Sandra C.; Weber, Fabienne A.; Vollenweider, Eva; Ferrari, Elena; Ziegler, Urs; Kaech, Andres; Shakhova, Olga; Cinelli, Paolo; Santoro, Raffaella			lncRNA Maturation to Initiate Heterochromatin Formation in the Nucleolus Is Required for Exit from Pluripotency in ESCs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; REMODELING COMPLEX NORC; RIBOSOMAL-RNA GENES; FACTOR TTF-I; REGULATORY LANDSCAPE; NONCODING RNA; 3 DIMENSIONS; CHROMATIN; DIFFERENTIATION; TRANSCRIPTION	The open chromatin of embryonic stem cells (ESCs) condenses into repressive heterochromatin as cells exit the pluripotent state. How the 3D genome organization is orchestrated and implicated in pluripotency and lineage specification is not understood. Here, we find that maturation of the long noncoding RNA (lncRNA) pRNA is required for establishment of heterochromatin at ribosomal RNA genes, the genetic component of nucleoli, and this process is inactivated in pluripotent ESCs. By using mature pRNA to tether heterochromatin at nucleoli of ESCs, we find that localized heterochromatin condensation of ribosomal RNA genes initiates establishment of highly condensed chromatin structures outside of the nucleolus. Moreover, we reveal that formation of such highly condensed, transcriptionally repressed heterochromatin promotes transcriptional activation of differentiation genes and loss of pluripotency. Our findings unravel the nucleolus as an active regulator of chromatin plasticity and pluripotency and challenge current views on heterochromatin regulation and function in ESCs.	[Savic, Natasa; Bar, Dominik; Leone, Sergio; Frommel, Sandra C.; Vollenweider, Eva; Ferrari, Elena; Santoro, Raffaella] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland; [Savic, Natasa; Leone, Sergio; Frommel, Sandra C.; Weber, Fabienne A.; Vollenweider, Eva] Univ Zurich, Mol Life Sci Program, Life Sci Zurich Grad Sch, CH-8057 Zurich, Switzerland; [Weber, Fabienne A.; Cinelli, Paolo] Univ Zurich, Inst Lab Anim Sci, CH-8057 Zurich, Switzerland; [Ziegler, Urs; Kaech, Andres] Univ Zurich, Ctr Microscopy & Image Anal, CH-8057 Zurich, Switzerland; [Shakhova, Olga] Univ Zurich Hosp, Dept Oncol, CH-8952 Schlieren, Switzerland; [Cinelli, Paolo; Santoro, Raffaella] Univ Zurich, Ctr Appl Biotechnol & Mol Med, CH-8057 Zurich, Switzerland; [Cinelli, Paolo] Univ Zurich Hosp, Div Trauma Surg, Clin Res Ctr, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital	Santoro, R (corresponding author), Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland.	raffaella.santoro@vetbio.uzh.ch	Santoro, Raffaella/L-2637-2013	Leone, Sergio/0000-0001-7676-5366; Cinelli, Paolo/0000-0002-0163-9055; Savic, Natasa/0000-0003-3110-5780	Swiss National Science Foundation [310003A-135801, 31003A-152854, 31003A-118361, 323530-133905]; UBS-Promedica Stiftung; Forschungskredit of the University of Zurich; Maxi Stiftung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UBS-Promedica Stiftung; Forschungskredit of the University of Zurich; Maxi Stiftung	The authors thank Ursula Luethi, Lutz Slomianka, and the Center for Microscopy and Image Analysis, University of Zurich for performing transmission electron microscopy analyses. This work was supported by the Swiss National Science Foundation (310003A-135801 and 31003A-152854 to R.S., 31003A-118361 to P.C., and 323530-133905 to F.A.W.), UBS-Promedica Stiftung (to R.S. and O.S.), Forschungskredit of the University of Zurich (to N.S. and E.V.), and the Maxi Stiftung (to D.B. and R.S.).	Aoto T, 2006, DEV BIOL, V298, P354, DOI 10.1016/j.ydbio.2006.04.450; Bartova E, 2008, DIFFERENTIATION, V76, P24, DOI 10.1111/j.1432-0436.2007.00192.x; Bartova E, 2008, DEV DYNAM, V237, P3690, DOI 10.1002/dvdy.21773; Bhattacharya D, 2009, BIOPHYS J, V96, P3832, DOI 10.1016/j.bpj.2008.11.075; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bierhoff H, 2014, EPIGENETICS-US, V9, P53, DOI 10.4161/epi.26485; Cammas L, 2007, DEV DYNAM, V236, P2899, DOI 10.1002/dvdy.21312; Carvalho C, 2001, MOL BIOL CELL, V12, P3563, DOI 10.1091/mbc.12.11.3563; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; DEV VG, 1977, GENETICS, V86, P389; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; EVERS R, 1995, P NATL ACAD SCI USA, V92, P5827, DOI 10.1073/pnas.92.13.5827; Fussner E, 2010, COLD SH Q B, V75, P245, DOI 10.1101/sqb.2010.75.012; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gerber JK, 1997, CELL, V90, P559, DOI 10.1016/S0092-8674(00)80515-2; Gonzalez-Sandoval A, 2013, FEBS J, V280, P3212, DOI 10.1111/febs.12319; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Guetg C, 2012, MOL CELL, V45, P790, DOI 10.1016/j.molcel.2012.01.024; Guetg C, 2010, EMBO J, V29, P2135, DOI 10.1038/emboj.2010.17; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jorgensen HF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r169; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; KURIHARA Y, 1994, MAMM GENOME, V5, P225, DOI 10.1007/BF00360550; Langst G, 1997, EMBO J, V16, P760, DOI 10.1093/emboj/16.4.760; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; Melcer S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1915; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Nemeth A, 2004, NUCLEIC ACIDS RES, V32, P4091, DOI 10.1093/nar/gkh732; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Santoro R, 2010, EMBO REP, V11, P52, DOI 10.1038/embor.2009.254; Schlesinger S, 2009, GENE DEV, V23, P2437, DOI 10.1101/gad.544509; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Splinter E, 2011, EMBO J, V30, P4345, DOI 10.1038/emboj.2011.344; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; TANDLER CJ, 1982, HISTOCHEMISTRY, V76, P351, DOI 10.1007/BF00543957; TESTILLANO PS, 1991, J HISTOCHEM CYTOCHEM, V39, P1427, DOI 10.1177/39.10.1719069; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; West Mark J, 2012, Cold Spring Harb Protoc, V2012, P1129, DOI 10.1101/pdb.top071787; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Yoshida Y, 1998, ONCOGENE, V16, P2687, DOI 10.1038/sj.onc.1201805; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	56	91	96	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					720	734		10.1016/j.stem.2014.10.005	http://dx.doi.org/10.1016/j.stem.2014.10.005			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25479748	Bronze			2022-12-28	WOS:000347174300011
J	Laugesen, A; Helin, K				Laugesen, Anne; Helin, Kristian			Chromatin Repressive Complexes in Stem Cells, Development, and Cancer	CELL STEM CELL			English	Review							POLYCOMB GROUP PROTEINS; HISTONE METHYLTRANSFERASE EZH2; HEMATOPOIETIC STEM; SELF-RENEWAL; SOMATIC MUTATIONS; GENE EZH2; TRANSCRIPTIONAL NETWORKS; TARGETED DISRUPTION; TUMOR-SUPPRESSOR; SELECTIVE-INHIBITION	The chromatin environment is essential for the correct specification and preservation of cell identity through modulation and maintenance of transcription patterns. Many chromatin regulators are required for development, stem cell maintenance, and differentiation. Here, we review the roles of the polycomb repressive complexes, PRC1 and PRC2, and the HDAC1- and HDAC2-containing complexes, NuRD, Sin3, and CoREST, in stem cells, development, and cancer, as well as the ongoing efforts to develop therapies targeting these complexes in human cancer. Furthermore, we discuss the role of repressive complexes in modulating thresholds for gene activation and their importance for specification and maintenance of cell fate.	[Laugesen, Anne; Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Laugesen, Anne; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; [Laugesen, Anne; Helin, Kristian] Univ Copenhagen, Danish Stem Cell Ctr DanStem, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Helin, K (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	kristian.helin@bric.ku.dk	Laugesen, Anne/AAB-2519-2019; Helin, Kristian/HDM-8306-2022; Helin, Kristian/K-2526-2019	Helin, Kristian/0000-0003-1975-6097; Laugesen, Anne/0000-0003-1115-8201	Danish National Research Foundation [DNRF82]; Danish Cancer Society; Novo Nordisk Foundation; Danish Council for Strategic Research [12-110503]; Lundbeck Foundation; European Union; European Research Council [DNAMET-294666]	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation(Lundbeckfonden); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission)	We thank members of the Helin laboratory for discussions. The work in the Helin laboratory is supported by grants from the Danish National Research Foundation (DNRF82), the Danish Cancer Society, the Novo Nordisk Foundation, the Danish Council for Strategic Research (12-110503), the Lundbeck Foundation, the European Union and the European Research Council (DNAMET-294666). K. H. is a cofounder of EpiTherapeutics Aps, is a member of the EpiTherapeutics board of directors, and has shares and warrants in the company.	Akasaka T, 1996, DEVELOPMENT, V122, P1513; Akasaka T, 2001, DEVELOPMENT, V128, P1587; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brien GL, 2012, NAT STRUCT MOL BIOL, V19, P1273, DOI 10.1038/nsmb.2449; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Casa Valentina, 2012, Frontiers in Genetics, V3, P199, DOI 10.3389/fgene.2012.00199; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chi AS, 2009, SCIENCE, V323, P220, DOI 10.1126/science.1166261; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Denissov S, 2014, DEVELOPMENT, V141, P526, DOI 10.1242/dev.102681; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; dos Santos R.L., 2014, CELL STEM CELL, V14; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; FAUST C, 1995, DEVELOPMENT, V121, P273; Faust C, 1998, DEVELOPMENT, V125, P4495; Forzati F, 2012, J CLIN INVEST, V122, P612, DOI 10.1172/JCI58620; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; Fragola G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003292; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Guerillon C, 2014, CANCER LETT, V345, P1, DOI 10.1016/j.canlet.2013.11.016; Hagelkruys A, 2014, DEVELOPMENT, V141, P604, DOI 10.1242/dev.100487; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; He XT, 2009, WORLD J GASTROENTERO, V15, P2389, DOI 10.3748/wjg.15.2389; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Hidalgo I, 2012, CELL STEM CELL, V11, P649, DOI 10.1016/j.stem.2012.08.001; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Ho R, 2013, CELL REP, V3, P2113, DOI 10.1016/j.celrep.2013.05.015; Hu DQ, 2013, NAT STRUCT MOL BIOL, V20, P1093, DOI 10.1038/nsmb.2653; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hurst DR, 2012, CANCER METAST REV, V31, P641, DOI 10.1007/s10555-012-9363-y; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; Kerenyi MA, 2013, ELIFE, V2, DOI 10.7554/eLife.00633; Kidder BL, 2012, NUCLEIC ACIDS RES, V40, P2925, DOI 10.1093/nar/gkr1151; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Klauke K, 2013, NAT CELL BIOL, V15, P353, DOI 10.1038/ncb2701; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Konuma T, 2011, EXP HEMATOL, V39, P697, DOI 10.1016/j.exphem.2011.03.008; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee Y, 2000, CIRC RES, V86, P932, DOI 10.1161/01.RES.86.9.932; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu B, 2013, DEVELOPMENT, V140, P780, DOI 10.1242/dev.085035; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; Marchesi I, 2012, CELL CYCLE, V11, P3828, DOI 10.4161/cc.22025; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marino S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000519; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mochizuki-Kashio M, 2011, BLOOD, V118, P6553, DOI 10.1182/blood-2011-03-340554; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Mohty M, 2007, BLOOD, V110, P380, DOI 10.1182/blood-2006-12-065599; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Moon JH, 2011, CELL RES, V21, P1305, DOI 10.1038/cr.2011.107; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Motoyama J, 1997, MECH DEVELOP, V66, P27, DOI 10.1016/S0925-4773(97)00082-8; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nicolson GL, 2003, CLIN EXP METASTAS, V20, P19, DOI 10.1023/A:1022534217769; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Puda A, 2012, AM J HEMATOL, V87, P245, DOI 10.1002/ajh.22257; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Qureshi IA, 2010, CELL CYCLE, V9, P4477, DOI 10.4161/cc.9.22.13973; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Roman-Trufero M, 2009, STEM CELLS, V27, P1559, DOI 10.1002/stem.82; Ryan RJH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028585; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shafaroudi Afsaneh Malekzadeh, 2008, Urol J, V5, P99; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shinjo K, 2014, INT J CANCER, V135, P308, DOI 10.1002/ijc.28692; Simhadri C, 2014, J MED CHEM, V57, P2874, DOI 10.1021/jm401487x; Simon C, 2012, GENE DEV, V26, P651, DOI 10.1101/gad.186411.111; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; Takawa M, 2011, CANCER SCI, V102, P1298, DOI 10.1111/j.1349-7006.2011.01958.x; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Tie F, 2001, DEVELOPMENT, V128, P275; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Ueda T, 2012, LEUKEMIA, V26, P2557, DOI 10.1038/leu.2012.146; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wagener N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-524; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Wang JH, 2009, NANO, V4, P1, DOI 10.1142/S1793292009001447; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang SS, 2007, DEV DYNAM, V236, P853, DOI 10.1002/dvdy.21070; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Winter M, 2013, EMBO J, V32, P3176, DOI 10.1038/emboj.2013.243; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yao HL, 2014, BLOOD, V123, P3175, DOI 10.1182/blood-2013-11-538678; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150; Zhang XW, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-114; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zhu DM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4174; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	194	230	237	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					735	751		10.1016/j.stem.2014.05.006	http://dx.doi.org/10.1016/j.stem.2014.05.006			17	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905164	Bronze, Green Submitted			2022-12-28	WOS:000341248500011
J	Miyajima, A; Tanaka, M; Itoh, T				Miyajima, Atsushi; Tanaka, Minoru; Itoh, Tohru			Stem/Progenitor Cells in Liver Development, Homeostasis, Regeneration, and Reprogramming	CELL STEM CELL			English	Review							HEPATIC PROGENITOR CELLS; STEM-CELLS; IN-VITRO; ALAGILLE-SYNDROME; FETAL LIVER; MOUSE-LIVER; SURFACE-MARKERS; BILIARY TREE; OVAL CELLS; BILE-DUCTS	The liver is a central organ for homeostasis with unique regenerative capacities. Mature hepatocytes possess a remarkable capacity to proliferate upon injury, challenging efforts to discern the role of adult liver stem cells in this process. In contrast, stem/progenitor cells in the developing liver have been extensively characterized, and these investigations have informed efforts to produce functional hepatocytes in vitro for cell therapy and drug screening. In this Review, we describe recent advances in the characterization of liver stem cells and discuss evidence supporting and refuting whether self-renewable and bipotential liver stem cells exist in development, homeostasis, regeneration, and disease.	[Miyajima, Atsushi; Itoh, Tohru] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Bunkyo Ku, Tokyo 1130032, Japan; [Tanaka, Minoru] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Stem Cell Regulat, Bunkyo Ku, Tokyo 1130032, Japan; [Tanaka, Minoru] Natl Ctr Global Hlth & Med, Dept Regenerat Med, Res Inst, Tokyo 1628655, Japan	University of Tokyo; University of Tokyo; National Center for Global Health & Medicine - Japan	Miyajima, A (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	miyajima@iam.u-tokyo.ac.jp; tanaka@iam.u-tokyo.ac.jp; itohru@iam.u-tokyo.ac.jp	Itoh, Tohru/GYQ-8698-2022	Itoh, Tohru/0000-0002-6579-1638				Akhurst B, 2005, HEPATOLOGY, V41, P327, DOI 10.1002/hep.20520; Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751; ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Apte U, 2008, HEPATOLOGY, V47, P288, DOI 10.1002/hep.21973; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Burke ZD, 2009, GASTROENTEROLOGY, V136, P2316, DOI 10.1053/j.gastro.2009.02.063; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Carpino G, 2012, J ANAT, V220, P186, DOI 10.1111/j.1469-7580.2011.01462.x; Chiba T, 2007, GASTROENTEROLOGY, V133, P937, DOI 10.1053/j.gastro.2007.06.016; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; DiPaola F, 2013, HEPATOLOGY, V58, P1486, DOI 10.1002/hep.26485; Dolle L, 2012, HEPATOLOGY, V55, P540, DOI 10.1002/hep.24693; Dorrell C, 2008, HEPATOLOGY, V48, P1282, DOI 10.1002/hep.22468; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; FARBER E, 1956, CANCER RES, V16, P142; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Fiegel HC, 2003, BIOCHEM BIOPH RES CO, V305, P46, DOI 10.1016/S0006-291X(03)00662-4; Fiorotto R, 2013, J HEPATOL, V59, P124, DOI 10.1016/j.jhep.2013.02.025; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gadue P, 2009, STEM CELLS, V27, P2103, DOI 10.1002/stem.147; Goldman O, 2013, CELL STEM CELL, V12, P748, DOI 10.1016/j.stem.2013.04.026; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Hoppo T, 2004, HEPATOLOGY, V39, P1362, DOI 10.1002/hep.20180; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Ijpenberg A, 2007, DEV BIOL, V312, P157, DOI 10.1016/j.ydbio.2007.09.014; Irie T, 2007, STEM CELLS DEV, V16, P979, DOI 10.1089/scd.2007.0037; Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796; Itoh T, 2009, FEBS LETT, V583, P777, DOI 10.1016/j.febslet.2009.01.022; Iverson SV, 2011, HEPATOLOGY, V54, P655, DOI 10.1002/hep.24398; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kakinuma S, 2009, J HEPATOL, V51, P127, DOI 10.1016/j.jhep.2009.02.033; Kamiya A, 2002, HEPATOLOGY, V35, P1351, DOI 10.1053/jhep.2002.33331; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kamiya A, 2009, GASTROENTEROLOGY, V137, P1114, DOI 10.1053/j.gastro.2009.06.001; Kitade M, 2013, GENE DEV, V27, P1706, DOI 10.1101/gad.214601.113; Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809; Kodama Y, 2004, GASTROENTEROLOGY, V127, P1775, DOI 10.1053/j.gastro.2004.09.004; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kubota H, 2000, P NATL ACAD SCI USA, V97, P12132, DOI 10.1073/pnas.97.22.12132; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Li K, 2014, CELL STEM CELL, V14, P228, DOI 10.1016/j.stem.2014.01.006; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; MACDONALD R, 1961, ARCH INTERN MED, V107, P335, DOI 10.1001/archinte.1961.03620030023003; Magami Y, 2002, LIVER, V22, P419, DOI 10.1034/j.1600-0676.2002.01702.x; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Matsui T, 2002, EMBO J, V21, P1021, DOI 10.1093/emboj/21.5.1021; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Matsuo A, 2011, GENE EXPR PATTERNS, V11, P255, DOI 10.1016/j.gep.2011.01.001; McCright B, 2002, DEVELOPMENT, V129, P1075; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Minguet S, 2003, J CLIN INVEST, V112, P1152, DOI 10.1172/JCI200317409; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Nierhoff D, 2005, HEPATOLOGY, V42, P130, DOI 10.1002/hep.20735; Nierhoff D, 2007, HEPATOLOGY, V46, P535, DOI 10.1002/hep.21721; Nitou M, 2002, EXP CELL RES, V279, P330, DOI 10.1006/excr.2002.5615; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Oertel M, 2008, GASTROENTEROLOGY, V134, P823, DOI 10.1053/j.gastro.2008.01.007; Ogawa S, 2013, DEVELOPMENT, V140, P3285, DOI 10.1242/dev.090266; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Oikawa T, 2013, HEPATOLOGY, V57, P1469, DOI 10.1002/hep.26159; Oikawa T, 2009, GASTROENTEROLOGY, V136, P1000, DOI 10.1053/j.gastro.2008.11.018; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Onitsuka I, 2010, GASTROENTEROLOGY, V138, P1525, DOI 10.1053/j.gastro.2009.12.059; Paku S, 2001, AM J PATHOL, V158, P1313, DOI 10.1016/S0002-9440(10)64082-5; Preisegger KH, 1999, LAB INVEST, V79, P103; Qiu Q, 2011, STEM CELLS DEV, V20, P2177, DOI 10.1089/scd.2010.0352; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Roskams TA, 2003, SEMIN LIVER DIS, V23, P385; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176; Sackett SD, 2009, HEPATOLOGY, V49, P920, DOI 10.1002/hep.22705; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123; Suzuki A, 2000, HEPATOLOGY, V32, P1230, DOI 10.1053/jhep.2000.20349; Suzuki A, 2003, DEVELOPMENT, V130, P2513, DOI 10.1242/dev.00459; Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Takase HM, 2013, GENE DEV, V27, P169, DOI 10.1101/gad.204776.112; Takayama K, 2013, STEM CELL REP, V1, P322, DOI 10.1016/j.stemcr.2013.08.006; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Tanimizu N, 2004, J CELL SCI, V117, P6425, DOI 10.1242/jcs.01572; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Tremblay KD, 2005, DEV BIOL, V280, P87, DOI 10.1016/j.ydbio.2005.01.003; Tsuchiya A, 2005, GASTROENTEROLOGY, V128, P2089, DOI 10.1053/j.gastro.2005.03.030; Turanyi E, 2010, HISTOPATHOLOGY, V57, P607, DOI 10.1111/j.1365-2559.2010.03668.x; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Watanabe T, 2002, DEV BIOL, V250, P332, DOI 10.1006/dbio.2002.0781; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Yanagida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067541; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Yeoh GCT, 2007, HEPATOLOGY, V45, P486, DOI 10.1002/hep.21535; Yong KJ, 2013, NEW ENGL J MED, V368, P2266, DOI 10.1056/NEJMoa1300297; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047; Yovchev MI, 2007, HEPATOLOGY, V45, P139, DOI 10.1002/hep.21448; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; ZAJICEK G, 1985, LIVER, V5, P293; Zeng SS, 2014, J HEPATOL, V60, P127, DOI 10.1016/j.jhep.2013.08.024; Zhao DX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006468; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	134	350	366	2	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					561	574		10.1016/j.stem.2014.04.010	http://dx.doi.org/10.1016/j.stem.2014.04.010			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24792114	Bronze			2022-12-28	WOS:000335659900007
J	Tapias, A; Zhou, ZW; Shi, Y; Chong, ZC; Wang, P; Groth, M; Platzer, M; Huttner, W; Herceg, Z; Yang, YG; Wang, ZQ				Tapias, Alicia; Zhou, Zhong-Wei; Shi, Yue; Chong, Zechen; Wang, Pei; Groth, Marco; Platzer, Matthias; Huttner, Wieland; Herceg, Zdenko; Yang, Yun-Gui; Wang, Zhao-Qi			Trrap-Dependent Histone Acetylation Specifically Regulates Cell-Cycle Gene Transcription to Control Neural Progenitor Fate Decisions	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; ACETYLTRANSFERASE COFACTOR TRRAP; RUBINSTEIN-TAYBI-SYNDROME; CORTICAL NEUROGENESIS; CEREBRAL-CORTEX; SELF-RENEWAL; RNA-SEQ; NEURONAL DIFFERENTIATION; ADULT NEUROGENESIS; BRAIN-DEVELOPMENT	Fate decisions in neural progenitor cells are orchestrated via multiple pathways, and the role of histone acetylation in these decisions has been ascribed to a general function promoting gene activation. Here, we show that the histone acetyltransferase (HAT) cofactor transformation/transcription domain-associated protein (Trrap) specifically regulates activation of cell-cycle genes, thereby integrating discrete cell-intrinsic programs of cell-cycle progression and epigenetic regulation of gene transcription in order to control neurogenesis. Deletion of Trrap impairs recruitment of HATs and transcriptional machinery specifically to E2F cell-cycle target genes, disrupting their transcription with consequent cell-cycle lengthening specifically within cortical apical neural progenitors (APs). Consistently, Trrap conditional mutants exhibit microcephaly because of premature differentiation of APs into intermediate basal progenitors and neurons, and overexpressing cell-cycle regulators in vivo can rescue these premature differentiation defects. These results demonstrate an essential and highly specific role for Trrap-mediated histone regulation in controlling cell-cycle progression and neurogenesis.	[Tapias, Alicia; Zhou, Zhong-Wei; Wang, Pei; Groth, Marco; Platzer, Matthias; Wang, Zhao-Qi] FLI, Leibniz Inst Age Res, D-07745 Jena, Germany; [Shi, Yue; Chong, Zechen; Yang, Yun-Gui] Chinese Acad Sci, Dis Genom & Individualized Med Lab, Beijing Inst Genom, Beijing 100101, Peoples R China; [Shi, Yue; Chong, Zechen; Yang, Yun-Gui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Huttner, Wieland] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Herceg, Zdenko] IARC, F-69008 Lyon, France; [Wang, Zhao-Qi] Univ Jena, Fac Biol & Pharm, D-07743 Jena, Germany	Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Max Planck Society; World Health Organization; International Agency for Research on Cancer (IARC); Friedrich Schiller University of Jena	Wang, ZQ (corresponding author), FLI, Leibniz Inst Age Res, Beutenbergstr 11, D-07745 Jena, Germany.	zqwang@fli-leibniz.de	Yang, Yungui/ABF-2507-2021; Zhou, Zhongwei/F-9269-2014	Groth, Marco/0000-0002-9199-8990; Zhou, Zhongwei/0000-0001-7971-2921	Leibniz Institute for Age Research (FLI); China Scholarship Council; Deutschen Forschungsgemeinschaft (DFG)	Leibniz Institute for Age Research (FLI); China Scholarship Council(China Scholarship Council); Deutschen Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank L. Frappart for the advice and the discussion on histological analysis and A. Saidi and P.-O. Frappart for their help in the project. We are grateful to M. Baldauf for his histological assistance and A. Krueger for her technical support. We also thank C. Mueller and M. Rodriguez for their excellent assistance in the maintenance of the animal colonies. We are also grateful to many other members of our laboratory for the helpful discussions. A. T. was supported by a postdoc fellowship of the Leibniz Institute for Age Research (FLI), and Z.-W.Z. was a student of the Graduate School on Ageing (LGSA). P. W. is a recipient of the Student Fellowship from the China Scholarship Council. Z.-Q.W. is supported in part by the Deutschen Forschungsgemeinschaft (DFG).	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108; Balasubramaniyan V, 2006, NEUROSCIENCE, V143, P939, DOI 10.1016/j.neuroscience.2006.08.082; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Cooper-Kuhn CM, 2002, MOL CELL NEUROSCI, V21, P312, DOI 10.1006/mcne.2002.1176; Dugan KA, 2002, ONCOGENE, V21, P5835, DOI 10.1038/sj.onc.1205763; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228; Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006; Glickstein SB, 2007, CEREB CORTEX, V17, P632, DOI 10.1093/cercor/bhk008; Glickstein SB, 2009, J NEUROSCI, V29, P9614, DOI 10.1523/JNEUROSCI.2284-09.2009; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jawerka M, 2010, NEURON GLIA BIOL, V6, P93, DOI 10.1017/S1740925X10000049; Juliandi B, 2012, NEUROSCI RES, V72, P23, DOI 10.1016/j.neures.2011.09.012; Juliandi B, 2010, CURR OPIN NEUROBIOL, V20, P408, DOI 10.1016/j.conb.2010.04.001; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Lang SE, 2001, J BIOL CHEM, V276, P32627, DOI 10.1074/jbc.M102067200; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li H, 2004, EMBO J, V23, P4824, DOI 10.1038/sj.emboj.7600479; Loizou JI, 2009, J IMMUNOL, V183, P6422, DOI 10.4049/jimmunol.0901969; Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039456; Maurice T, 2008, NEUROPSYCHOPHARMACOL, V33, P1584, DOI 10.1038/sj.npp.1301551; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Murr R, 2007, ONCOGENE, V26, P5358, DOI 10.1038/sj.onc.1210605; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Pacey LKK, 2006, PROTOCOL EXCHANGE; Pilaz LJ, 2009, P NATL ACAD SCI USA, V106, P21924, DOI 10.1073/pnas.0909894106; Price V, 2013, J NEUROSCI RES, V91, P407, DOI 10.1002/jnr.23170; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Sawan C, 2013, STEM CELLS, V31, P979, DOI 10.1002/stem.1341; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Takahashi T, 1999, J NEUROSCI, V19, P10357; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Tiberi L, 2012, CURR OPIN CELL BIOL, V24, P269, DOI 10.1016/j.ceb.2012.01.010; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai SY, 2008, NATURE, V454, P1137, DOI 10.1038/nature07066; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Wurdak H, 2010, CELL STEM CELL, V6, P37, DOI 10.1016/j.stem.2009.11.002; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Zhang Y, 2011, BIOCHEM BIOPH RES CO, V404, P610, DOI 10.1016/j.bbrc.2010.12.014; Zhou ZW, 2012, DNA REPAIR, V11, P210, DOI 10.1016/j.dnarep.2011.10.021	64	37	37	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					632	643		10.1016/j.stem.2014.04.001	http://dx.doi.org/10.1016/j.stem.2014.04.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24792116	Bronze			2022-12-28	WOS:000335659900012
J	Kokubu, C; Takeda, J				Kokubu, Chikara; Takeda, Junji			When Half Is Better Than the Whole: Advances in Haploid Embryonic Stem Cell Technology	CELL STEM CELL			English	Editorial Material							DERIVATION; MICE	Recent advances in embryonic stem cell (ESC) derivation and genome editing offer efficient platforms for genetic screening. In this issue, Li et al. and Leeb et al., respectively, expand such applications by generating haploid rat ESCs for screening, mutagenesis, and CRISPR-Cas-mediated gene targeting and by developing a forward genetic screen for interrogating haploid mESCs.	[Kokubu, Chikara; Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan	Osaka University	Takeda, J (corresponding author), Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan.	takeda@mr-envi.med.osaka-u.ac.jp						Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Horie K, 2011, NAT METHODS, V8, P1071, DOI [10.1038/NMETH.1739, 10.1038/nmeth.1739]; Koike-Yusa H., 2013, NAT BIOTECHNOL; Leeb M, 2014, CELL STEM CELL, V14, P385, DOI 10.1016/j.stem.2013.12.008; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li W, 2014, CELL STEM CELL, V14, P404, DOI 10.1016/j.stem.2013.11.016; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002	10	10	10	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					265	267		10.1016/j.stem.2014.02.001	http://dx.doi.org/10.1016/j.stem.2014.02.001			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24607398	Bronze			2022-12-28	WOS:000332533400001
J	Rouault-Pierre, K; Lopez-Onieva, L; Foster, K; Anjos-Afonso, F; Lamrissi-Garcia, I; Serrano-Sanchez, M; Mitter, R; Ivanovic, Z; de Verneuil, H; Gribben, J; Taussig, D; Rezvani, HR; Mazurier, F; Bonnet, D				Rouault-Pierre, Kevin; Lopez-Onieva, Lourdes; Foster, Katie; Anjos-Afonso, Fernando; Lamrissi-Garcia, Isabelle; Serrano-Sanchez, Martin; Mitter, Richard; Ivanovic, Zoran; de Verneuil, Hubert; Gribben, John; Taussig, David; Rezvani, Hamid Reza; Mazurier, Frederic; Bonnet, Dominique			HIF-2 alpha Protects Human Hematopoietic Stem/Progenitors and Acute Myeloid Leukemic Cells from Apoptosis Induced by Endoplasmic Reticulum Stress	CELL STEM CELL			English	Article							HYPOXIA-INDUCIBLE FACTOR; STEM-CELLS; BONE-MARROW; CHUVASH POLYCYTHEMIA; RECEPTOR CXCR4; NICHE; HIF-1-ALPHA; MICE; ERYTHROPOIESIS; HOMEOSTASIS	Hematopoietic stem and progenitor cells (HSPCs) are exposed to low levels of oxygen in the bone marrow niche, and hypoxia-inducible factors (HIFs) are the main regulators of cellular responses to oxygen variation. Recent studies using conditional knockout mouse models have unveiled a major role for HIF-1 alpha in the maintenance of murine HSCs; however, the role of HIF-2 alpha is still unclear. Here, we show that knockdown of HIF-2 alpha, and to a much lesser extent HIF-1 alpha, impedes the long-term repopulating ability of human CD34(+) umbilical cord blood cells. HIF-2 alpha-deficient HSPCs display increased production of reactive oxygen species (ROS), which subsequently stimulates endoplasmic reticulum (ER) stress and triggers apoptosis by activation of the unfolded-protein-response (UPR) pathway. HIF-2 alpha deregulation also significantly decreased engraftment ability of human acute myeloid leukemia (AML) cells. Overall, our data demonstrate a key role for HIF-2 alpha in the maintenance of human HSPCs and in the survival of primary AML cells.	[Rouault-Pierre, Kevin; Lopez-Onieva, Lourdes; Foster, Katie; Anjos-Afonso, Fernando; Bonnet, Dominique] Canc Res UK, Haematopoiet Stem Cell Lab, London Res Inst, London WC2A 3LY, England; [Rouault-Pierre, Kevin; Lamrissi-Garcia, Isabelle; Serrano-Sanchez, Martin; de Verneuil, Hubert; Rezvani, Hamid Reza; Mazurier, Frederic] INSERM, U1035, F-33076 Bordeaux, France; [Rouault-Pierre, Kevin; Lamrissi-Garcia, Isabelle; Serrano-Sanchez, Martin; Ivanovic, Zoran; de Verneuil, Hubert; Rezvani, Hamid Reza; Mazurier, Frederic] Univ Bordeaux Segalen, F-33076 Bordeaux, France; [Mitter, Richard] Canc Res UK, Bioinformat & Biostat Dept, London Res Inst, London WC2A 3LY, England; [Ivanovic, Zoran] Etab Francais Sang Aquitaine Limousin, F-33000 Bordeaux, France; [Ivanovic, Zoran] CNRS UMR 5164, F-33076 Bordeaux, France; [Gribben, John; Taussig, David] Queen Mary Univ London, Barts Canc Inst, Dept Haematooncol, London EC1M 6BQ, England	Cancer Research UK; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Cancer Research UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of London; Queen Mary University London	Mazurier, F (corresponding author), INSERM, U1035, F-33076 Bordeaux, France.	mazurier@u-bordeaux2.fr; dominique.bonnet@cancer.org.uk	Ivanovic, Zoran/ABC-7667-2020; López-Onieva, Lourdes/A-6475-2019; Mazurier, FrÃ©dÃ©ric/O-1619-2018; Rezvani, Hamid Reza/G-3734-2013	Ivanovic, Zoran/0000-0001-6158-0270; López-Onieva, Lourdes/0000-0001-5509-3804; Rezvani, Hamid Reza/0000-0001-8067-1338; Mazurier, Frederic/0000-0002-6984-7096; Mitter, Richard/0000-0002-1279-3760; Anjos-Afonso, Fernando/0000-0003-4392-488X; Rouault-Pierre, Kevin/0000-0001-7671-7364	Cancer Research UK; COST Action [TD0901]; French Ministere de l'Enseignement Superieur et de la Recherche (MESR); Marie Curie fellowship; French Association of Cancer Research (ARC)	Cancer Research UK(Cancer Research UK); COST Action(European Cooperation in Science and Technology (COST)); French Ministere de l'Enseignement Superieur et de la Recherche (MESR)(Ministry of Research, France); Marie Curie fellowship(European Commission); French Association of Cancer Research (ARC)	The authors extend their thanks to all the staff at the Maison de Sante Protestante de Bordeaux-Bagatelle (Bordeaux, France), to Ms Besky at the Royal London Hospital for providing cord blood samples, and to the laboratory of virology headed by Professor Fleury. The authors are grateful to the Biological Resource Units, B. Rousseau (University of Bordeaux) for his valuable expertise, Dr. V. Pitard and the Flow Cytometry core facility members at LRI, and Gavin Kelly of the Bioinformatics Department at LRI for their expertise in sorting and statistical analysis. We would also like to thanks the electron microscopy core facility members at LRI for their help. This work was funded in part by Cancer Research UK to D.B. and by the COST Action TD0901 to FM. K.R.P. was financed in part by a grant from the French Ministere de l'Enseignement Superieur et de la Recherche (MESR) and by Cancer Research UK; L.L.O., by a Marie Curie fellowship; and M.S.S. by a fellowship from the French Association of Cancer Research (ARC).	Adelman DM, 1999, GENE DEV, V13, P2478, DOI 10.1101/gad.13.19.2478; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Bertout JA, 2009, P NATL ACAD SCI USA, V106, P14391, DOI 10.1073/pnas.0907357106; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Giuntoli S, 2007, STEM CELLS, V25, P1119, DOI 10.1634/stemcells.2006-0637; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hermitte F, 2006, STEM CELLS, V24, P65, DOI 10.1634/stemcells.2004-0351; Hickey MM, 2007, J CLIN INVEST, V117, P3879, DOI 10.1172/JCI32614; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Levesque JP, 2007, STEM CELLS, V25, P1954, DOI 10.1634/stemcells.2006-0688; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu YL, 2006, CANCER BIOL THER, V5, P1320, DOI 10.4161/cbt.5.10.3162; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Miharada K, 2011, CELL STEM CELL, V9, P330, DOI 10.1016/j.stem.2011.07.016; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Oktay Y, 2007, J BIOL CHEM, V282, P11750, DOI 10.1074/jbc.M611133200; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pedersen M, 2008, BIOCHEM BIOPH RES CO, V377, P98, DOI 10.1016/j.bbrc.2008.09.102; Piccoli C, 2007, FEBS LETT, V581, P3111, DOI 10.1016/j.febslet.2007.05.077; Pietras A, 2009, P NATL ACAD SCI USA, V106, P16805, DOI 10.1073/pnas.0904606106; Qing GL, 2009, CURR OPIN GENET DEV, V19, P60, DOI 10.1016/j.gde.2008.12.001; Rezvani HR, 2007, J BIOL CHEM, V282, P16413, DOI 10.1074/jbc.M611397200; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200	47	127	131	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					549	563		10.1016/j.stem.2013.08.011	http://dx.doi.org/10.1016/j.stem.2013.08.011			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24095676	Bronze			2022-12-28	WOS:000329571500008
J	Wagner, JE; Brunstein, CG; Boitano, AE; DeFor, TE; McKenna, D; Sumstad, D; Blazar, BR; Tolar, J; Le, C; Jones, J; Cooke, MP; Bleul, CC				Wagner, John E., Jr.; Brunstein, Claudio G.; Boitano, Anthony E.; DeFor, Todd E.; McKenna, David; Sumstad, Darin; Blazar, Bruce R.; Tolar, Jakub; Le, Chap; Jones, Julie; Cooke, Michael P.; Bleul, Conrad C.			Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft	CELL STEM CELL			English	Article							PLATELET ENGRAFTMENT; ENHANCE ENGRAFTMENT; PROGENITOR CELLS; LONG-TERM; TRANSPLANTATION; UNIT; EXPANSION; OUTCOMES; ADULTS; NEUTROPHIL	Clinical application of umbilical cord blood (UCB) as a source of hematopoietic stem cells for transplantation is limited by low CD34+ cell dose, increased risk of graft failure, and slow hematopoietic recovery. While the cell dose limitation is partially mitigated by using two UCB units, larger-dosed single units would be preferable. We have evaluated the feasibility and safety of StemRegenin-1 (SR-1), an aryl hydrocarbon receptor antagonist that expands CD34+ cells, by placing one of the two units in expansion culture. SR-1 produced a 330-fold increase in CD34+ cells and led to engraftment in 17/17 patients at a median of 15 days for neutrophils and 49 days for platelets, significantly faster than in patients treated with unmanipulated UCB. Taken together, the marked expansion, absence of graft failure, and enhanced hematopoietic recovery support testing of SR-1 expansion as a stand-alone graft and suggest it may ameliorate a limitation of UCB transplant.	[Wagner, John E., Jr.; Brunstein, Claudio G.; DeFor, Todd E.; Blazar, Bruce R.; Tolar, Jakub; Le, Chap] Univ Minnesota, Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA; [Wagner, John E., Jr.; McKenna, David; Sumstad, Darin] Univ Minnesota, Mol & Cellular Therapeut Facil, Minneapolis, MN 55108 USA; [Boitano, Anthony E.; Cooke, Michael P.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Jones, Julie; Bleul, Conrad C.] Novartis Inst BioMed Res, CH-4000 Basel, Switzerland	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Novartis; Novartis	Wagner, JE (corresponding author), Univ Minnesota, Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA.; Wagner, JE (corresponding author), Univ Minnesota, Mol & Cellular Therapeut Facil, Minneapolis, MN 55108 USA.	wagne002@umn.edu		Tolar, Jakub/0000-0002-0957-4380	Novartis Corporation; National Cancer Institute [P01 CA065493-20]; NATIONAL CANCER INSTITUTE [P30CA077598, P01CA065493] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER	Novartis Corporation(Novartis); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The project was supported by Novartis Corporation and a grant from the National Cancer Institute (P01 CA065493-20; J.E.W., C.G.B., T.E.D., D.M., B.R.B., J.T., and C.L.). We wish to thank Diane Kadidlo, Fran Rabe, and staff of the Cell Therapy Laboratory at the Molecular and Cellular Therapeutics Facility for their efforts in product manufacturing, development, and monitoring; Dr. Eros Lazzerini Denchi for his investigations on telomere length; Stefanie Hage of the University of Minnesota and Suzanne Maahs and Shazia Ali of the Novartis Institutes for Biomedical Research for their critical assistance in patient monitoring and moving the clinical trial forward; Albert E. Parker for performing the T cell alloreactivity assays; Stephanie Fiola for qualification of the media and cytokines; and the faculty, advanced practice providers, unit and clinic nurses, pharmacists, and social workers of the Blood and Marrow Transplant Program who cared for the 20 patients on this phase I clinical trial at the University of Minnesota Medical Center and Masonic Children's Hospital. Specific authors are employees and shareholders of Novartis (J.J. and C.C.B.) and the Genomics Institute of the Novartis Foundation (A.E.B. and M.P.C.).	Ballen KK, 2013, BLOOD, V122, P491, DOI 10.1182/blood-2013-02-453175; Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Barker JN, 2001, NEW ENGL J MED, V344, P1870, DOI 10.1056/NEJM200106143442417; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Brunstein CG, 2007, BLOOD, V110, P3064, DOI 10.1182/blood-2007-04-067215; Cairo MS, 2005, TRANSFUSION, V45, P856, DOI 10.1111/j.1537-2995.2005.04429.x; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Cheuk Daniel Kl, 2013, World J Transplant, V3, P99, DOI 10.5500/wjt.v3.i4.99; Cutler C, 2013, BLOOD, V122, P3074, DOI 10.1182/blood-2013-05-503177; de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979; de Lima M, 2012, NEW ENGL J MED, V367, P2305, DOI 10.1056/NEJMoa1207285; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Farag SS, 2013, STEM CELLS DEV, V22, P1007, DOI 10.1089/scd.2012.0636; Flores AI, 2009, TRANSFUSION, V49, P636, DOI 10.1111/j.1537-2995.2008.02035.x; Gutman JA, 2010, BLOOD, V115, P757, DOI 10.1182/blood-2009-07-228999; Horwitz ME, 2014, J CLIN INVEST, V124, P3121, DOI 10.1172/JCI74556; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Krenger W, 2011, BLOOD, V117, P6768, DOI 10.1182/blood-2011-02-334623; Kurtzberg J, 2008, BLOOD, V112, P4318, DOI 10.1182/blood-2007-06-098020; Lin DY, 1997, STAT MED, V16, P901, DOI 10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M; Lund TC, 2015, NAT REV CLIN ONCOL, V12, P163, DOI 10.1038/nrclinonc.2014.215; Migliaccio AR, 2000, BLOOD, V96, P2717, DOI 10.1182/blood.V96.8.2717.h8002717_2717_2722; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Nawrot M, 2011, TRANSFUSION, V51, P2001, DOI 10.1111/j.1537-2995.2011.03153.x; Page KM, 2011, BIOL BLOOD MARROW TR, V17, P1362, DOI 10.1016/j.bbmt.2011.01.011; Politikos I, 2014, BLOOD, V124, P3201, DOI 10.1182/blood-2014-07-589176; Popat U, 2015, BLOOD, V125, P2885, DOI 10.1182/blood-2015-01-607366; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Radtke S, 2015, BRIT J HAEMATOL, V169, P868, DOI 10.1111/bjh.13362; Ramirez P, 2012, BONE MARROW TRANSPL, V47, P799, DOI 10.1038/bmt.2011.184; Reisner Y, 2003, ANN NY ACAD SCI, V996, P72, DOI 10.1111/j.1749-6632.2003.tb03235.x; RICKINSON AB, 1984, CELL IMMUNOL, V87, P646, DOI 10.1016/0008-8749(84)90032-7; RUBINSTEIN P, 1995, P NATL ACAD SCI USA, V92, P10119, DOI 10.1073/pnas.92.22.10119; Rubinstein P, 1998, NEW ENGL J MED, V339, P1565, DOI 10.1056/NEJM199811263392201; Scaradavou A, 2010, SEMIN HEMATOL, V47, P13, DOI 10.1053/j.seminhematol.2009.10.003; Smith AR, 2009, BRIT J HAEMATOL, V147, P246, DOI 10.1111/j.1365-2141.2009.07828.x; Snedecor G.W., 1989, AMES IOWA STATE U PR; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; Wagner JE, 2014, NEW ENGL J MED, V371, P1685, DOI 10.1056/NEJMoa1405584; Weisdorf DJ, 2003, BIOL BLOOD MARROW TR, V9, P512, DOI 10.1016/S1083-8791(03)00162-9; Wong WM, 2013, STEM CELLS, V31, P360, DOI 10.1002/stem.1282; Yahata T, 2004, MOL THER, V10, P882, DOI 10.1016/j.ymthe.2004.07.029	42	214	221	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					144	155		10.1016/j.stem.2015.10.004	http://dx.doi.org/10.1016/j.stem.2015.10.004			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26669897	Green Accepted, Bronze			2022-12-28	WOS:000372321300019
J	Bird, TG; Forbes, SJ				Bird, Thomas G.; Forbes, Stuart J.			Two Fresh Streams to Fill the Liver's Hepatocyte Pool	CELL STEM CELL			English	Editorial Material							STEM-CELL NICHE; PERIPORTAL HEPATOCYTES; RENEWAL; RISE	Differentiated hepatocytes are known for their capacity to regenerate the adult liver. Two papers discussed here show that distinct subpopulations of adult hepatocytes may be the crucial populations underpinning such regeneration.	[Bird, Thomas G.; Forbes, Stuart J.] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH16 4SB, Midlothian, Scotland; [Bird, Thomas G.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University of Edinburgh; Beatson Institute	Forbes, SJ (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, 49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.	stuart.forbes@ed.ac.uk	Bird, Tom/H-3840-2019	Bird, Tom/0000-0002-6120-1581; Forbes, Stuart/0000-0003-3715-2561	Medical Research Council [MR/K026666/1] Funding Source: Medline; MRC [MR/K026666/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Donati G, 2015, CELL STEM CELL, V16, P465, DOI 10.1016/j.stem.2015.04.014; Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218; Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203; Magami Y, 2002, LIVER, V22, P419, DOI 10.1034/j.1600-0676.2002.01702.x; Michalopoulos G. K., 2015, GASTROENTER IN PRESS; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863	10	9	11	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 1	2015	17	4					377	378		10.1016/j.stem.2015.09.007	http://dx.doi.org/10.1016/j.stem.2015.09.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4TS	26431179	Bronze			2022-12-28	WOS:000365693800003
J	Ho, L; Tan, SYX; Wee, S; Wu, YX; Tan, SJC; Ramakrishna, NB; Chng, SC; Nama, S; Szczerbinska, I; Chan, YS; Avery, S; Tsuneyoshi, N; Ng, HH; Gunaratne, J; Dunn, NR; Reversade, B				Ho, Lena; Tan, Shawn Y. X.; Wee, Sheena; Wu, Yixuan; Tan, Sam J. C.; Ramakrishna, Navin B.; Chng, Serene C.; Nama, Srikanth; Szczerbinska, Iwona; Chan, Yun-Shen; Avery, Stuart; Tsuneyoshi, Norihiro; Huck Hui Ng; Gunaratne, Jayantha; Dunn, N. Ray; Reversade, Bruno			ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SIGNALING PATHWAY; MOUSE; RNA; APOPTOSIS; PROLIFERATION; PLURIPOTENCY; EXPRESSION; EPIBLAST; HORMONE	ELABELA (ELA) is a peptide hormone required for heart development that signals via the Apelin Receptor (APLNR, APJ). ELA is also abundantly secreted by human embryonic stem cells (hESCs), which do not express APLNR. Here we show that ELA signals in a paracrine fashion in hESCs to maintain self-renewal. ELA inhibition by CRISPR/Cas9-mediated deletion, shRNA, or neutralizing antibodies causes reduced hESC growth, cell death, and loss of pluri-potency. Global phosphoproteomic and transcriptomic analyses of ELA-pulsed hESCs show that it activates PI3K/AKT/mTORC1 signaling required for cell survival. ELA promotes hESC cell-cycle progression and protein translation and blocks stress-induced apoptosis. INSULIN and ELA have partially overlapping functions in hESC medium, but only ELA can potentiate the TGF beta pathway to prime hESCs toward the endoderm lineage. We propose that ELA, acting through an alternate cell-surface receptor, is an endogenous secreted growth factor in human embryos and hESCs that promotes growth and pluripotency.	[Ho, Lena; Tan, Shawn Y. X.; Wu, Yixuan; Tan, Sam J. C.; Ramakrishna, Navin B.; Chng, Serene C.; Nama, Srikanth; Avery, Stuart; Tsuneyoshi, Norihiro; Dunn, N. Ray; Reversade, Bruno] ASTAR, Human Genet & Embryol Lab, Inst Med Biol, Singapore 138648, Singapore; [Wee, Sheena; Gunaratne, Jayantha; Reversade, Bruno] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Szczerbinska, Iwona; Chan, Yun-Shen; Huck Hui Ng] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ho, L (corresponding author), ASTAR, Human Genet & Embryol Lab, Inst Med Biol, Singapore 138648, Singapore.	lena.ho@reversade.com; bruno@reversade.com	Ramakrishna, Navin Brian/GYA-4765-2022; Chan, Yun-Shen/GWC-4616-2022; Wu, Yixuan/GXG-9879-2022; Ng, Huck Hui/A-1135-2009; Dunn, Norris Ray/W-5124-2019	Ramakrishna, Navin Brian/0000-0003-2974-9886; Wu, Yixuan/0000-0001-9637-9219; Chng, Serene C/0000-0003-0500-8792; Dunn, Norris Ray/0000-0002-6259-2975; Ho, Lena/0000-0002-9358-621X; NG, HUCK HUI/0000-0001-6352-8417; Tan, Ying Xuan Shawn/0000-0002-6705-4770; REVERSADE, Bruno/0000-0002-4070-7997	Agency of Science Technology and Research, Singapore; Strategic Positioning Fund on Genetic Orphan Diseases from A*STAR, Singapore	Agency of Science Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Strategic Positioning Fund on Genetic Orphan Diseases from A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	L.H. and B.R. designed experiments and wrote the manuscript. S.Y.X.T, Y.W., S.A., N.T., S.J.C.T., N.B.R., S.C.C., and N.R.D. assisted with hESCs experiments. S.W. and J.G. performed SILAC experiments. S.A. made shELA hESCs lines. I.S., W.C.Y.S., and H.H.N. derived 3iL cells. S.N. contributed intellectually. All authors are funded by the Agency of Science Technology and Research, Singapore. B.R. is a fellow of the Branco Weiss Foundation, an A*STAR Investigator, and a Young EMBO Investigator. This work was partly funded by a Strategic Positioning Fund on Genetic Orphan Diseases from A*STAR, Singapore.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Avery S, 2013, STEM CELL REP, V1, P379, DOI 10.1016/j.stemcr.2013.10.005; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Gillies LA, 2014, J CELL BIOCHEM, V115, P632, DOI 10.1002/jcb.24709; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Inniss K, 2006, STEM CELLS DEV, V15, P789, DOI 10.1089/scd.2006.15.789; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kurzawa Rafal, 2002, Reprod Biol, V2, P143; Li MM, 2015, CELL STEM CELL, V16, P669, DOI 10.1016/j.stem.2015.04.002; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Markham KE, 2003, REPRODUCTION, V125, P327, DOI 10.1530/rep.0.1250327; Miura T, 2004, STEM CELLS DEV, V13, P694, DOI 10.1089/scd.2004.13.694; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; PERRY RP, 1962, P NATL ACAD SCI USA, V48, P2179, DOI 10.1073/pnas.48.12.2179; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; RAPPOLEE DA, 1992, GENE DEV, V6, P939, DOI 10.1101/gad.6.6.939; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang SY, 2007, PEPTIDES, V28, P708, DOI 10.1016/j.peptides.2006.10.005; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Voskas D, 2014, J CELL PHYSIOL, V229, P1312, DOI 10.1002/jcp.24603; Wang HT, 2012, CELL SIGNAL, V24, P17, DOI 10.1016/j.cellsig.2011.08.010; Warmflash A, 2012, WIRES SYST BIOL MED, V4, P443, DOI 10.1002/wsbm.1182; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Workman JJ, 2014, CELL CYCLE, V13, P714, DOI 10.4161/cc.28112; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Yu QC, 2012, BLOOD, V119, P6243, DOI 10.1182/blood-2011-12-396093; Zafarana G, 2009, STEM CELLS, V27, P776, DOI 10.1002/stem.5; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106	48	114	124	2	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 1	2015	17	4					435	447		10.1016/j.stem.2015.08.010	http://dx.doi.org/10.1016/j.stem.2015.08.010			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4TS	26387754	Bronze			2022-12-28	WOS:000365693800010
J	Dutta, P; Sager, HB; Stengel, KR; Naxerova, K; Courties, G; Saez, B; Silberstein, L; Heidt, T; Sebas, M; Sun, Y; Wojtkiewicz, G; Fumene Feruglio, P; King, K; Baker, JN; van der Laan, AM; Borodovsky, A; Fitzgerald, K; Hulsmans, M; Hoyer, F; Iwamoto, Y; Vinegoni, C; Brown, D; Di Carli, M; Libby, P; Hiebert, SW; Scadden, DT; Swirski, FK; Weissleder, R; Nahrendorf, M				Dutta, Partha; Sager, Hendrik B.; Stengel, Kristy R.; Naxerova, Kamila; Courties, Gabriel; Saez, Borja; Silberstein, Lev; Heidt, Timo; Sebas, Matthew; Sun, Yuan; Wojtkiewicz, Gregory; Fumene Feruglio, Paolo; King, Kevin; Baker, Joshua N.; van der Laan, Anja M.; Borodovsky, Anna; Fitzgerald, Kevin; Hulsmans, Maarten; Hoyer, Friedrich; Iwamoto, Yoshiko; Vinegoni, Claudio; Brown, Dennis; Di Carli, Marcelo; Libby, Peter; Hiebert, Scott W.; Scadden, David T.; Swirski, Filip K.; Weissleder, Ralph; Nahrendorf, Matthias			Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells	CELL STEM CELL			English	Article							BONE-MARROW; MONOCYTE EMIGRATION; SELF-RENEWAL; IN-VIVO; ATHEROSCLEROSIS; IDENTIFICATION; PROLIFERATION; INFLAMMATION; MACROPHAGES; MECHANISMS	Following myocardial infarction (MI), myeloid cells derived from the hematopoietic system drive a sharp increase in systemic leukocyte levels that correlates closely with mortality. The origin of these myeloid cells, and the response of hematopoietic stem and progenitor cells (HSPCs) to MI, however, is unclear. Here, we identify a CCR2(+)CD150(+)CD48(-) LSK hematopoietic subset as the most upstream contributor to emergency myelopoiesis after ischemic organ injury. This subset has 4-fold higher proliferation rates than CCR2(-)CD150(+)CD48(-) LSK cells, displays a myeloid differentiation bias, and dominates the migratory HSPC population. We further demonstrate that the myeloid translocation gene 16 (Mtg16) regulates CCR2(+) HSPC emergence. Mtg16(-/-) mice have decreased levels of systemic monocytes and infarct-associated macrophages and display compromised tissue healing and post-MI heart failure. Together, these data provide insights into regulation of emergency hematopoiesis after ischemic injury and identify potential therapeutic targets to modulate leukocyte output after MI.	[Dutta, Partha; Sager, Hendrik B.; Courties, Gabriel; Heidt, Timo; Sebas, Matthew; Sun, Yuan; Wojtkiewicz, Gregory; Fumene Feruglio, Paolo; King, Kevin; Hulsmans, Maarten; Hoyer, Friedrich; Iwamoto, Yoshiko; Vinegoni, Claudio; Brown, Dennis; Swirski, Filip K.; Weissleder, Ralph; Nahrendorf, Matthias] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Dutta, Partha; Sager, Hendrik B.; Courties, Gabriel; Heidt, Timo; Sebas, Matthew; Sun, Yuan; Wojtkiewicz, Gregory; Fumene Feruglio, Paolo; King, Kevin; Hulsmans, Maarten; Hoyer, Friedrich; Iwamoto, Yoshiko; Vinegoni, Claudio; Brown, Dennis; Swirski, Filip K.; Weissleder, Ralph; Nahrendorf, Matthias] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Stengel, Kristy R.; Hiebert, Scott W.] Vanderbilt Univ Sch Med, Dept Biochem, Nashville, TN 37235 USA; [Naxerova, Kamila] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02144 USA; [Saez, Borja; Silberstein, Lev; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Baker, Joshua N.] Massachusetts Gen Hosp, Dept Cardiac Surg, Boston, MA 02144 USA; [van der Laan, Anja M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Borodovsky, Anna; Fitzgerald, Kevin] Alnylam Pharmaceut, Cambridge, MA 02142 USA; [Di Carli, Marcelo] Brigham & Womens Hosp, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA 02115 USA; [Libby, Peter] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Dutta, P (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.	dutta.partha@mgh.harvard.edu; mnahrendorf@mgh.harvard.edu	vinegoni, claudio/AGU-2461-2022; Swirski, Filip/AAF-1340-2019; Hoyer, Friedrich/AAC-8097-2022; Sager, Hendrik B./AAP-5869-2021; Libby, Peter/AAY-6404-2021; Hulsmans, Maarten/AAI-9547-2020; Vinegoni, Claudio/A-9490-2012; Wojtkiewicz, Gregory/L-3660-2018; Saez, Borja/L-7411-2015	Sager, Hendrik B./0000-0002-0197-6553; Libby, Peter/0000-0002-1502-502X; Hulsmans, Maarten/0000-0003-1009-658X; Vinegoni, Claudio/0000-0002-9818-3639; Stengel, Kristy/0000-0002-8330-5744; Wojtkiewicz, Gregory/0000-0002-3148-8411; Saez, Borja/0000-0001-7908-7089; Courties, Gabriel/0000-0002-0003-7407; Naxerova, Kamila/0000-0001-7744-5110; Swirski, Filip/0000-0002-3163-9152	NIH [R01-HL096576, R01-HL117829, R01-NS084863, HHSN268201000044C, K99-HL121076]; Deutsche Forschungsgemeinschaft [SA1668/2-1, HE-6382/1-1]; Boston Area Diabetes and Endocrinology Research Center [DK57521]; MGH Center for the Study of Inflammatory Bowel Disease [DK43351];  [U24 DK059637]; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL121076, R01HL096576, K99HL121076, R01HL117829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, P30DK043351, P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084863] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boston Area Diabetes and Endocrinology Research Center; MGH Center for the Study of Inflammatory Bowel Disease; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Michael Waring and Adam Chicoine from Ragon Institute (of MGH, MIT, and Harvard) and Laura Prickett-Rice, Kat Folz-Donahue, and Meredith Weglarz from the Flow Cytometry Core Facility (Massachusetts General Hospital, Center for Regenerative Medicine andHarvard Stem Cell Institute) for assistance with cell sorting. We also acknowledge Dr. Chee Lim, Vanderbilt Medical Center MMPC (supported by U24 DK059637) for help with infarct surgery. We thank Mary McKee (Program in Membrane Biology Microscopy) for help with electron microscopy. This work was funded in part by grants from the NIH: R01-HL096576, R01-HL117829, and R01-NS084863 (M.N.); HHSN268201000044C (R.W.); and K99-HL121076 (P.D.). Hendrik B. Sager and Timo Heidt were funded by Deutsche Forschungsgemeinschaft (SA1668/2-1 to H.B.S and HE-6382/1-1 to T.H.). Support for the Program in Membrane Biology Microscopy Core comes from the Boston Area Diabetes and Endocrinology Research Center (DK57521) and the MGH Center for the Study of Inflammatory Bowel Disease (DK43351). A.B. and K.F. are Alnylam Pharmaceuticals employees.	Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Charo IF, 2003, MICROCIRCULATION, V10, P259, DOI 10.1038/sj.mn.7800191; Chyla BJ, 2008, MOL CELL BIOL, V28, P6234, DOI 10.1128/MCB.00404-08; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Glauche I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000447; HARDESTY B, 1963, P NATL ACAD SCI USA, V50, P1078, DOI 10.1073/pnas.50.6.1078; Hofmann WK, 2002, BLOOD, V100, P3553, DOI 10.1182/blood.V100.10.3553; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Konuma T, 2011, EXP HEMATOL, V39, P697, DOI 10.1016/j.exphem.2011.03.008; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Okuda T, 2001, INT J HEMATOL, V74, P252, DOI 10.1007/BF02982057; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Si Y, 2010, J CLIN INVEST, V120, P1192, DOI 10.1172/JCI40310; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Summers AR, 2013, J CLIN INVEST, V123, P3112, DOI 10.1172/JCI60806; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Young JC, 2004, CYTOTHERAPY, V6, P328, DOI 10.1080/14653240410004899; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	50	136	138	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					477	487		10.1016/j.stem.2015.04.008	http://dx.doi.org/10.1016/j.stem.2015.04.008			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25957903	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000354188600009
J	Piao, JH; Major, T; Auyeung, G; Policarpio, E; Menon, J; Droms, L; Gutin, P; Uryu, K; Tchieu, J; Soulet, D; Tabar, V				Piao, Jinghua; Major, Tamara; Auyeung, Gordon; Policarpio, Edelweiss; Menon, Jayanthi; Droms, Leif; Gutin, Philip; Uryu, Kunihiro; Tchieu, Jason; Soulet, Denis; Tabar, Viviane			Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors Remyelinate the Brain and Rescue Behavioral Deficits following Radiation	CELL STEM CELL			English	Article							CRANIAL IRRADIATION; INDUCED APOPTOSIS; MODEL; MYELINATE; CHILDREN; THERAPY; INJURY; MEMORY; FETAL	Radiation therapy to the brain is a powerful tool in the management of many cancers, but it is associated with significant and irreversible long-term side effects, including cognitive decline and impairment of motor coordination. Depletion of oligodendrocyte progenitors and demyelination are major pathological features that are particularly pronounced in younger individuals and severely limit therapeutic options. Here we tested whether human ESC-derived oligodendrocytes can functionally remyelinate the irradiated brain using a rat model. We demonstrate the efficient derivation and prospective isolation of human oligodendrocyte progenitors, which, upon transplantation, migrate throughout the major white matter tracts resulting in both structural and functional repair. Behavioral testing showed complete recovery of cognitive function while additional recovery from motor deficits required concomitant transplantation into the cerebellum. The ability to repair radiation-induced damage to the brain could dramatically improve the outlook for cancer survivors and enable more effective use of radiation therapies, especially in children.	[Piao, Jinghua; Major, Tamara; Auyeung, Gordon; Policarpio, Edelweiss; Menon, Jayanthi; Droms, Leif; Gutin, Philip; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Piao, Jinghua; Major, Tamara; Auyeung, Gordon; Policarpio, Edelweiss; Menon, Jayanthi; Droms, Leif; Gutin, Philip; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, New York, NY 10065 USA; [Tchieu, Jason] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Uryu, Kunihiro] Rockefeller Univ, Resource Ctr EMRC, New York, NY 10065 USA; [Soulet, Denis] Univ Laval, Fac Med, Dept Psychiat & Neurosci, Laval, PQ G1V 0A6, Canada; [Soulet, Denis] CHU Quebec, Ctr Rech, Axe Neurosci, Quebec City, PQ G1V 0A6, Canada	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University; Laval University; Laval University	Tabar, V (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA.	tabarv@mskcc.org	Soulet, Denis/P-4940-2019; Tchieu, Jason/AAG-1551-2020	Tchieu, Jason/0000-0002-9793-9836; Soulet, Denis/0000-0002-0937-7061; Major, Tamara/0000-0003-1383-3418	NINDS [R01NS054009]; New York State Stem Cell Board (NYSTEM); Tri-Institutional Stem Cell Initiative (Tri-Sci); Tri-Sci; Junior 1 Career Award; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054009] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); New York State Stem Cell Board (NYSTEM); Tri-Institutional Stem Cell Initiative (Tri-Sci); Tri-Sci; Junior 1 Career Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by a grant from the NINDS (R01NS054009), the New York State Stem Cell Board (NYSTEM), and the Tri-Institutional Stem Cell Initiative (Tri-Sci). T.M. was supported in part by a Fellowship from the Tri-Sci. D.S. is a Research Scholar from Le Fonds de Recherche du Quebec Sante (FRQ-S) and holds a Junior 1 Career Award. We would like to thank Alexander Lucaci and Rebecca Chen for help with the behavior experiments, Tom Losasso with the radiation dosimetry, Katia Manova, Vitaly Boyko, Fujisawa Sho, and Ke Xu at the Molecular Cytology Core Facility, and Nina Lampen at The Electron Microscopy facility, all at Memorial Sloan Kettering Cancer Center. We are grateful to William Stallcup for the gift of PDGFRa antibody and to Steve Goldman for O4 antibody aliquots.	Acharya MM, 2014, CELL TRANSPLANT, V23, P1255, DOI 10.3727/096368913X670200; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Douvaras P, 2014, STEM CELL REP, V3, P250, DOI 10.1016/j.stemcr.2014.06.012; DUFFNER PK, 1985, CANCER-AM CANCER SOC, V56, P1841, DOI 10.1002/1097-0142(19851001)56:7+<1841::AID-CNCR2820561325>3.0.CO;2-C; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gardner A, 2012, NAT PROTOC, V7, P1774, DOI 10.1038/nprot.2012.100; Gibbs IC, 2006, HEMATOL ONCOL CLIN N, V20, P455, DOI 10.1016/j.hoc.2006.01.015; Greene-Schloesser D, 2013, CLIN CANCER RES, V19, P2294, DOI 10.1158/1078-0432.CCR-11-2903; Greene-Schloesser D, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00073; Gu C, 2011, J BIOL CHEM, V286, P25835, DOI 10.1074/jbc.M111.219113; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Harauz G, 2013, J NEUROCHEM, V125, P334, DOI 10.1111/jnc.12195; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Kurita H, 2001, NEUROL RES, V23, P869, DOI 10.1179/016164101101199324; Mabbott DJ, 2006, NEURO-ONCOLOGY, V8, P244, DOI 10.1215/15228517-2006-002; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; OI S, 1990, Neurologia Medico-Chirurgica, V30, P36, DOI 10.2176/nmc.30.36; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Paumier A, 2011, CANCER TREAT REV, V37, P261, DOI 10.1016/j.ctrv.2010.08.009; Ringborg U, 2003, ACTA ONCOL, V42, P357, DOI 10.1080/02841860310010826; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Sano K, 2000, NEUROL MED-CHIR, V40, P495, DOI 10.2176/nmc.40.495; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schatz J, 2000, NEUROPSYCHOLOGY, V14, P189, DOI 10.1037//0894-4105.14.2.189; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057534; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Tadesse T, 2014, ANN CLIN TRANSL NEUR, V1, P900, DOI 10.1002/acn3.134; Uchida N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004371; Uh J, 2013, INT J RADIAT ONCOL, V86, P292, DOI 10.1016/j.ijrobp.2013.01.028; VanDongenMelman JEWW, 1997, LEUKEMIA, V11, P1197, DOI 10.1038/sj.leu.2400702; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Yabroff KR, 2004, JNCI-J NATL CANCER I, V96, P1322, DOI 10.1093/jnci/djh255	40	124	128	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					198	210		10.1016/j.stem.2015.01.004	http://dx.doi.org/10.1016/j.stem.2015.01.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25658373	Green Accepted, Bronze			2022-12-28	WOS:000349455000015
J	Kim, YJ; Lim, H; Li, Z; Oh, Y; Kovlyagina, I; Choi, IY; Dong, XZ; Lee, G				Kim, Yong Jun; Lim, Hotae; Li, Zhe; Oh, Yohan; Kovlyagina, Irina; Choi, In Young; Dong, Xinzhong; Lee, Gabsang			Generation of Multipotent Induced Neural Crest by Direct Reprogramming of Human Postnatal Fibroblasts with a Single Transcription Factor	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; PATIENT-SPECIFIC IPSCS; FAMILIAL DYSAUTONOMIA; FUNCTIONAL-NEURONS; DIRECT CONVERSION; DEFINED FACTORS; MOUSE; ISOFORMS; GENE; SPECIFICATION	Neural crest (NC) generates diverse lineages including peripheral neurons, glia, melanocytes, and mesenchymal derivatives. Isolating multipotent human NC has proven challenging, limiting our ability to understand NC development and model NC-associated disorders. Here, we report direct reprogramming of human fibroblasts into induced neural crest (iNC) cells by overexpression of a single transcription factor, SOX10, in combination with environmental cues including WNT activation. iNC cells possess extensive capacity for migration in vivo, and single iNC clones can differentiate into the fourmain NC lineages. We further identified a cell surface marker for prospective isolation of iNCs, which was used to generate and purify iNCs from familial dysautonomia (FD) patient fibroblasts. FD-iNC cells displayed defects in cellular migration and alternative mRNA splicing, providing insights into FD pathogenesis. Thus, this study provides an accessible platform for studying NC biology and disease through rapid and efficient reprogramming of human postnatal fibroblasts.	[Kim, Yong Jun; Lim, Hotae; Oh, Yohan; Kovlyagina, Irina; Choi, In Young; Lee, Gabsang] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Kim, Yong Jun; Oh, Yohan; Lee, Gabsang] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Li, Zhe; Dong, Xinzhong; Lee, Gabsang] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Lee, G (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	glee48@jhmi.edu	Oh, Yohan/C-9107-2013	Oh, Yohan/0000-0002-9249-8664; Lee, Gabsang/0000-0002-5052-5927; Kim, Yong Jun/0000-0002-5374-712X; Kovlyagina, Irina/0000-0003-0210-0550	NYSCF; Maryland Stem Cell Research Fund (TEDCO)	NYSCF; Maryland Stem Cell Research Fund (TEDCO)	We would like to thank the Lee lab members for valuable discussions. G. L. is a New York Stem Cell Foundation (NYSCF) Robertson Investigator and this research was supported by NYSCF and the Maryland Stem Cell Research Fund (TEDCO). We thank Dr. Mica, Dr. Cheng, Ms. Mukherjee-Clavin, and Dr. Fossati for sharing cDNA.	Ab Hakim NH, 2010, GENES CELLS, V15, P255, DOI 10.1111/j.1365-2443.2009.01378.x; Bachinski LL, 2010, MUSCLE NERVE, V42, P856, DOI 10.1002/mus.21789; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Chen XL, 2012, BRIT J OPHTHALMOL, V96, P1431, DOI 10.1136/bjophthalmol-2012-301546; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Kawaguchi J, 2010, DEVELOPMENT, V137, P693, DOI 10.1242/dev.046896; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Parker CJ, 2004, INT J CANCER, V108, P314, DOI 10.1002/ijc.11527; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; SCHAFER BW, 1990, NATURE, V344, P454, DOI 10.1038/344454a0; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Sieber-Blum M, 1997, J ANAT, V191, P493, DOI 10.1046/j.1469-7580.1997.19140493.x; Sieber-Blum M, 2000, INT REV CYTOL, V197, P1, DOI 10.1016/S0074-7696(00)97001-3; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wahlbuhl M, 2012, NUCLEIC ACIDS RES, V40, P88, DOI 10.1093/nar/gkr734; Wang QY, 2006, CANCER RES, V66, P8574, DOI 10.1158/0008-5472.CAN-06-0947; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156	29	97	100	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					497	506		10.1016/j.stem.2014.07.013	http://dx.doi.org/10.1016/j.stem.2014.07.013			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25158936	Bronze			2022-12-28	WOS:000343235800015
J	Tong, CK; Chen, JD; Cebrian-Silla, A; Mirzadeh, Z; Obernier, K; Guinto, CD; Tecott, LH; Garcia-Verdugo, JM; Kriegstein, A; Alvarez-Buylla, A				Tong, Cheuk Ka; Chen, Jiadong; Cebrian-Silla, Arantxa; Mirzadeh, Zaman; Obernier, Kirsten; Guinto, Cristina D.; Tecott, Laurence H.; Manuel Garcia-Verdugo, Jose; Kriegstein, Arnold; Alvarez-Buylla, Arturo			Axonal Control of the Adult Neural Stem Cell Niche	CELL STEM CELL			English	Article							SUBVENTRICULAR ZONE; CEREBROSPINAL-FLUID; VASCULAR NICHE; DENTATE GYRUS; RAPHE NUCLEI; RADIAL GLIA; RAT-BRAIN; NEUROGENESIS; FOREBRAIN; MIGRATION	The ventricular-subventricular zone (V-SVZ) is an extensive germinal niche containing neural stem cells (NSCs) in the walls of the lateral ventricles of the adult brain. How the adult brain's neural activity influences the behavior of adult NSCs remains largely unknown. We show that serotonergic (5HT) axons originating from a small group of neurons in the raphe form an extensive plexus on most of the ventricular walls. Electron microscopy revealed intimate contacts between 5HT axons and NSCs (B1) or ependymal cells (E1) and these cells were labeled by a transsynaptic viral tracer injected into the raphe. B1 cells express the 5HT receptors 2C and 5A. Electrophysiology showed that activation of these receptors in B1 cells induced small inward currents. Intraventricular infusion of 5HT2C agonist or antagonist increased or decreased V-SVZ proliferation, respectively. These results indicate that supraependymal 5HT axons directly interact with NSCs to regulate neurogenesis via 5HT2C.	[Tong, Cheuk Ka; Chen, Jiadong; Obernier, Kirsten; Guinto, Cristina D.; Kriegstein, Arnold; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Tong, Cheuk Ka; Chen, Jiadong; Obernier, Kirsten; Guinto, Cristina D.; Kriegstein, Arnold; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Tong, Cheuk Ka; Tecott, Laurence H.; Kriegstein, Arnold; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94158 USA; [Cebrian-Silla, Arantxa; Manuel Garcia-Verdugo, Jose] Univ Valencia, Inst Cavanilles, Lab Comparat Neurobiol, CIBERNED, Valencia 46980, Spain; [Manuel Garcia-Verdugo, Jose] IIS Hosp La Fe, Unidad Mixta Esclerosis Multiple & Neurorregenera, Valencia 46013, Spain; [Mirzadeh, Zaman] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Tecott, Laurence H.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; CIBERNED; University of Valencia; Barrow Neurological Institute; University of California System; University of California San Francisco	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu	Obernier, Kirsten/O-4967-2015; García-Verdugo, José Manuel/L-8421-2017	Obernier, Kirsten/0000-0002-4025-1299; García-Verdugo, José Manuel/0000-0001-9872-6499; Cebrian Silla, Arantxa/0000-0003-4623-7655; Alvarez-Buylla, Arturo/0000-0003-4426-8925	US National Institutes of Health [NS28478, HD32116]; Singapore Agency for Science, Technology and Research; CARE & CURE Pediatric Epilepsy Fellowship from the Epilepsy Foundation of Greater Los Angeles; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028478, R29NS028478, R01NS028478] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); CARE & CURE Pediatric Epilepsy Fellowship from the Epilepsy Foundation of Greater Los Angeles; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all members of the Alvarez-Buylla laboratory for helpful discussions. Special thanks to Michael Kissner for FACS technical support, Kenneth X. Probst for the illustration in the Graphical Abstract, and Luis C. Fuentealba and Thuhien Nguyen for critical reading of the manuscript. This work is funded by the US National Institutes of Health (NS28478 and HD32116). A.A.-B. is the Heather and Melanie Muss Endowed Chair of Neurological Surgery at UCSF. C. K. T. is supported by the Singapore Agency for Science, Technology and Research. J.D.C. is a recipient of the CARE & CURE Pediatric Epilepsy Fellowship from the Epilepsy Foundation of Greater Los Angeles.	Abrams JK, 2004, ANN NY ACAD SCI, V1018, P46, DOI 10.1196/annals.1296.005; AGHAJANIAN GK, 1975, BRAIN RES, V88, P221, DOI 10.1016/0006-8993(75)90386-8; ALVAREZMORUJO AJ, 1992, HISTOL HISTOPATHOL, V7, P259; Arrant AE, 2013, NEUROPHARMACOLOGY, V65, P213, DOI 10.1016/j.neuropharm.2012.10.010; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Bonsi P, 2007, NEUROPSYCHOPHARMACOL, V32, P1840, DOI 10.1038/sj.npp.1301294; Brezun JM, 1999, NEUROSCIENCE, V89, P999, DOI 10.1016/S0306-4522(98)00693-9; CHANPALAY V, 1976, BRAIN RES, V102, P103, DOI 10.1016/0006-8993(76)90578-3; Councill JH, 2006, NEUROSCIENCE, V140, P111, DOI 10.1016/j.neuroscience.2006.02.014; Diaz D, 2009, EXP NEUROL, V216, P357, DOI 10.1016/j.expneurol.2008.12.013; DINOPOULOS A, 1995, EXP NEUROL, V133, P73, DOI 10.1006/exnr.1995.1009; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Fu WY, 2010, J COMP NEUROL, V518, P3464, DOI 10.1002/cne.22407; Fuentealba LC, 2012, CELL STEM CELL, V10, P698, DOI 10.1016/j.stem.2012.05.012; Hale MW, 2010, EXP NEUROL, V224, P271, DOI 10.1016/j.expneurol.2010.04.002; Hitoshi S, 2007, J NEUROSCI RES, V85, P3574, DOI 10.1002/jnr.21455; Hornung JP, 2003, J CHEM NEUROANAT, V26, P331, DOI 10.1016/j.jchemneu.2003.10.002; Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Jahanshahi A, 2011, J CHEM NEUROANAT, V42, P297, DOI 10.1016/j.jchemneu.2011.09.001; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lacar B, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00043; Lieben CKJ, 2006, BEHAV BRAIN RES, V168, P197, DOI 10.1016/j.bbr.2005.11.003; Liu XX, 2006, GLIA, V54, P394, DOI 10.1002/glia.20392; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOREZ HP, 1982, BRAIN RES BULL, V9, P727, DOI 10.1016/0361-9230(82)90179-4; Mathew TC, 1999, ANAT HISTOL EMBRYOL, V28, P193, DOI 10.1046/j.1439-0264.1999.00191.x; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Monti JM, 2010, SLEEP MED REV, V14, P319, DOI 10.1016/j.smrv.2009.10.003; Nguyen T, 2001, J PHYSIOL-LONDON, V531, P131, DOI 10.1111/j.1469-7793.2001.0131j.x; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Ponti G, 2013, P NATL ACAD SCI USA, V110, pE1045, DOI 10.1073/pnas.1219563110; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; Sirerol-Piquer MS, 2012, MICRON, V43, P589, DOI 10.1016/j.micron.2011.10.008; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Soumier A, 2010, EUR NEUROPSYCHOPHARM, V20, P336, DOI 10.1016/j.euroneuro.2009.11.007; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tong C. K., 2014, NEURON, V81, pe1; Tong Cheuk Ka, 2014, Neuron, V81, P220, DOI 10.1016/j.neuron.2013.12.004; Weitemier AZ, 2006, NEUROSCIENCE, V137, P1439, DOI 10.1016/j.neuroscience.2005.10.021; Young SZ, 2011, EUR J NEUROSCI, V33, P1123, DOI 10.1111/j.1460-9568.2011.07611.x	46	93	96	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					500	511		10.1016/j.stem.2014.01.014	http://dx.doi.org/10.1016/j.stem.2014.01.014			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24561083	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000334766400013
J	Vasanthakumar, A; Godley, LA				Vasanthakumar, Aparna; Godley, Lucy A.			On the Origin of Leukemic Species	CELL STEM CELL			English	Editorial Material							MUTATIONS; EVOLUTION	Recent studies (Shlush et al., 2014; Corces-Zimmerman et al., 2014) have demonstrated that leukemias develop from hematopoietic stem cells that acquire preleukemic mutations, allowing clonal expansion and subsequent acquisition of mutations leading to cancer. Preleukemic cells survive chemotherapy and serve as reservoirs for disease, generating new clones and leading to relapse.	[Vasanthakumar, Aparna; Godley, Lucy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Godley, LA (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA.	lgodley@medicine.bsd.uchicago.edu						Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023	10	5	6	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					421	422		10.1016/j.stem.2014.03.008	http://dx.doi.org/10.1016/j.stem.2014.03.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24702991	Bronze			2022-12-28	WOS:000334766400004
J	van Galen, P; Kreso, A; Wienholds, E; Laurenti, E; Eppert, K; Lechman, ER; Mbong, N; Hermans, K; Dobson, S; April, C; Fan, JB; Dick, JE				van Galen, Peter; Kreso, Antonija; Wienholds, Erno; Laurenti, Elisa; Eppert, Kolja; Lechman, Eric R.; Mbong, Nathan; Hermans, Karin; Dobson, Stephanie; April, Craig; Fan, Jian-Bing; Dick, John E.			Reduced Lymphoid Lineage Priming Promotes Human Hematopoietic Stem Cell Expansion	CELL STEM CELL			English	Article							TRANSCRIPTION FACTOR-BINDING; SELF-RENEWAL CAPACITY; EX-VIVO EXPANSION; B-CELL; ID PROTEINS; IN-VIVO; GENE-EXPRESSION; PRECEDES COMMITMENT; PROGENITOR CELLS; SPECIFICATION	The hematopoietic system sustains regeneration throughout life by balancing self-renewal and differentiation. To stay poised for mature blood production, hematopoietic stem cells (HSCs) maintain low-level expression of lineage-associated genes, a process termed lineage priming. Here, we modulated expression levels of Inhibitor of DNA binding (ID) proteins to ask whether lineage priming affects self-renewal of human HSCs. We found that lentiviral overexpression of ID proteins in cord blood HSCs biases myeloerythroid commitment at the expense of lymphoid differentiation. Conversely, reducing ID2 expression levels increases lymphoid potential. Mechanistically, ID2 inhibits the transcription factor E47 to attenuate B-lymphoid priming in HSCs and progenitors. Strikingly, ID2 overexpression also results in a 10-fold expansion of HSCs in serial limiting dilution assays, indicating that early lymphoid transcription factors antagonize human HSC self-renewal. The relationship between lineage priming and self-renewal can be exploited to increase expansion of transplantable human HSCs and points to broader implications for other stem cell populations.	[van Galen, Peter; Kreso, Antonija; Wienholds, Erno; Laurenti, Elisa; Lechman, Eric R.; Mbong, Nathan; Hermans, Karin; Dobson, Stephanie; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Kreso, Antonija; Dobson, Stephanie; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Eppert, Kolja] McGill Univ, Dept Pediat, Westmount, PQ H3Z 2Z3, Canada; [Eppert, Kolja] McGill Univ, Ctr Hlth, Res Inst, Westmount, PQ H3Z 2Z3, Canada; [April, Craig; Fan, Jian-Bing] Illumina, San Diego, CA 92122 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; McGill University; McGill University; Illumina	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca		Eppert, Kolja/0000-0001-9061-8856	Canadian Institutes for Health Research; Canadian Cancer Society Research Institute; Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; Canada Research Chair; Princess Margaret Hospital Foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Princess Margaret Hospital Foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	We thank Arian Khandani, Pier Penttila, and the UHN/Sickkids flow cytometry facility for cell sorting; the entire Dick lab for critical review of the manuscript; and Dr. Luigi Naldini for providing the MA1 vector. This work was funded by the Canadian Institutes for Health Research, Canadian Cancer Society Research Institute, Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research, a Canada Research Chair, the Princess Margaret Hospital Foundation, and the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Cochrane SW, 2009, BLOOD, V113, P1016, DOI 10.1182/blood-2008-06-164996; Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Fan JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030794; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta R, 2007, SCIENCE, V316, P590, DOI 10.1126/science.1136031; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hong SH, 2011, J CELL SCI, V124, P1445, DOI 10.1242/jcs.077511; HSU HL, 1994, P NATL ACAD SCI USA, V91, P5947, DOI 10.1073/pnas.91.13.5947; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Ji M, 2008, BLOOD, V112, P1068, DOI 10.1182/blood-2008-01-133504; Jung S, 2010, STEM CELLS DEV, V19, P831, DOI 10.1089/scd.2009.0093; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Larochelle A, 2011, BLOOD, V117, P1550, DOI 10.1182/blood-2009-03-212803; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Lechman ER, 2012, CELL STEM CELL, V11, P799, DOI 10.1016/j.stem.2012.09.001; Li HJ, 2010, BLOOD, V116, P1060, DOI 10.1182/blood-2009-11-255075; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Lukin K, 2011, EUR J IMMUNOL, V41, P1787, DOI 10.1002/eji.201041137; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; May G, 2013, CELL STEM CELL, V13, P754, DOI 10.1016/j.stem.2013.09.003; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; Mercer EM, 2011, SEMIN IMMUNOL, V23, P317, DOI 10.1016/j.smim.2011.08.004; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Muller-Sieburg CE, 2012, BLOOD, V119, P3900, DOI 10.1182/blood-2011-12-376749; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Perry SS, 2007, BLOOD, V110, P2351, DOI 10.1182/blood-2007-01-069914; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Rossi MID, 2001, J IMMUNOL, V167, P3033, DOI 10.4049/jimmunol.167.6.3033; Schaniel C, 2002, BLOOD, V99, P2760, DOI 10.1182/blood.V99.8.2760; Schiedlmeier B, 2003, BLOOD, V101, P1759, DOI 10.1182/blood-2002-03-0767; Shao LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033499; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Staber PB, 2013, MOL CELL, V49, P934, DOI 10.1016/j.molcel.2013.01.007; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suh HC, 2009, BLOOD, V114, P1186, DOI 10.1182/blood-2008-09-179788; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Thal MA, 2009, P NATL ACAD SCI USA, V106, P552, DOI 10.1073/pnas.0802550106; Warner JK, 2005, LEUKEMIA, V19, P1794, DOI 10.1038/sj.leu.2403917; Yang Q, 2011, BLOOD, V117, P3529, DOI 10.1182/blood-2010-07-297689	70	74	75	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					94	106		10.1016/j.stem.2013.11.021	http://dx.doi.org/10.1016/j.stem.2013.11.021			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24388174	Bronze			2022-12-28	WOS:000329571900012
J	Wang, L; Miao, YL; Zheng, XF; Lackford, B; Zhou, BY; Han, L; Yao, CG; Ward, JM; Burkholder, A; Lipchina, I; Fargo, DC; Hochedlinger, K; Shi, YS; Williams, CJ; Hu, G				Wang, Li; Miao, Yi-Liang; Zheng, Xiaofeng; Lackford, Brad; Zhou, Bingying; Han, Leng; Yao, Chengguo; Ward, James M.; Burkholder, Adam; Lipchina, Inna; Fargo, David C.; Hochedlinger, Konrad; Shi, Yongsheng; Williams, Carmen J.; Hu, Guang			The THO Complex Regulates Pluripotency Gene mRNA Export and Controls Embryonic Stem Cell Self-Renewal and Somatic Cell Reprogramming	CELL STEM CELL			English	Article							GENOME-WIDE ANALYSIS; HUMAN TREX COMPLEX; TRANSCRIPTIONAL NETWORK; MOUSE; EXPRESSION; CIRCUITRY; PROTEIN; SCREEN; NANOG; DIFFERENTIATION	Embryonic stem cell (ESC) self-renewal and differentiation are governed by a broad-ranging regulatory network. Although the transcriptional regulatory mechanisms involved have been investigated extensively, posttranscriptional regulation is still poorly understood. Here we describe a critical role of the THO complex in ESC self-renewal and differentiation. We show that THO preferentially interacts with pluripotency gene transcripts through Thoc5 and is required for self-renewal at least in part by regulating their export and expression. During differentiation, THO loses its interaction with those transcripts due to reduced Thoc5 expression, leading to decreased expression of pluripotency proteins that facilitates exit from self-renewal. THO is also important for the establishment of pluripotency, because its depletion inhibits somatic cell reprogramming and blastocyst development. Together, our data indicate that THO regulates pluripotency gene mRNA export to control ESC self-renewal and differentiation, and therefore uncover a role for this aspect of posttranscriptional regulation in stem cell fate specification.	[Wang, Li; Zheng, Xiaofeng; Lackford, Brad; Hu, Guang] NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA; [Miao, Yi-Liang; Williams, Carmen J.] NIEHS, Reprod & Dev Toxicol Lab, Res Triangle Pk, NC 27709 USA; [Zhou, Bingying] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Zhou, Bingying] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Han, Leng] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Yao, Chengguo; Shi, Yongsheng] Univ Calif Irvine, Dept Microbiol & Mol Genet, Sch Med, Irvine, CA 92697 USA; [Ward, James M.; Burkholder, Adam; Fargo, David C.] NIEHS, Res Triangle Pk, NC 27709 USA; [Lipchina, Inna; Hochedlinger, Konrad] Massachusetts Gen Hosp, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Massachusetts General Hospital	Hu, G (corresponding author), NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA.	hug4@niehs.nih.gov	Hu, Guang/E-7474-2016; Han, Leng/HCH-3491-2022; Williams, Carmen J/E-2170-2013	Hu, Guang/0000-0003-0437-4723; Han, Leng/0000-0002-7380-2640; Williams, Carmen J/0000-0001-6440-7086; Ward, James/0000-0002-9510-2848; Burkholder, Adam/0000-0002-0237-6920	NIH, National Institute of Environmental Health Sciences [1ZIAES102745, 1ZIAES102985]; NIH [R01GM090056, R01HD058013]; American Cancer Society [RSG-12-186]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES102745, ZIAES102985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090056] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Karen Adelman, Perry Blackshear, Traci Hall, Raja Jothi, and Paul Wade for critically reading the manuscript. This study was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences 1ZIAES102745 (to L. W., X.Z., B. L., and G. H.) and 1ZIAES102985 (to Y.M. and C. W.), NIH R01GM090056 and American Cancer Society Grant RSG-12-186 (to C.Y. and Y.S.), and NIH R01HD058013 (to I. L. and K.H.).	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buckley SM, 2012, CELL STEM CELL, V11, P783, DOI 10.1016/j.stem.2012.09.011; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang CT, 2013, EMBO J, V32, P473, DOI 10.1038/emboj.2012.342; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Chi BK, 2013, NUCLEIC ACIDS RES, V41, P1294, DOI 10.1093/nar/gks1188; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Culjkovic-Kraljacic B, 2013, TRENDS CELL BIOL, V23, P328, DOI 10.1016/j.tcb.2013.03.004; Dejosez M, 2012, ANNU REV BIOCHEM, V81, P737, DOI 10.1146/annurev-biochem-052709-104948; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Griaud F, 2013, LEUKEMIA, V27, P932, DOI 10.1038/leu.2012.283; Guria A, 2011, RNA, V17, P1048, DOI 10.1261/rna.2607011; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Hautbergue GM, 2009, CURR BIOL, V19, P1918, DOI 10.1016/j.cub.2009.09.041; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Irion S, 2008, COLD SH Q B, V73, P101, DOI 10.1101/sqb.2008.73.065; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jimeno Sonia, 2010, Journal of Biology (London), V8, P6, DOI 10.1186/jbiol217; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Katahira J, 2012, BBA-GENE REGUL MECH, V1819, P507, DOI 10.1016/j.bbagrm.2011.12.001; Katahira J, 2009, EMBO J, V28, P556, DOI 10.1038/emboj.2009.5; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Luna R, 2012, BBA-GENE REGUL MECH, V1819, P514, DOI 10.1016/j.bbagrm.2011.11.012; Mancini A, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-1; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Osorno R, 2011, PHILOS T R SOC B, V366, P2230, DOI 10.1098/rstb.2011.0043; Pena A, 2012, EMBO J, V31, P1605, DOI 10.1038/emboj.2012.10; Piruat JI, 1998, EMBO J, V17, P4859, DOI 10.1093/emboj/17.16.4859; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Pryor A, 2004, NUCLEIC ACIDS RES, V32, P1857, DOI 10.1093/nar/gkh347; Ramachandran S, 2011, RNA, V17, P1957, DOI 10.1261/rna.2820911; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Rondon AG, 2010, BBA-GENE REGUL MECH, V1799, P533, DOI 10.1016/j.bbagrm.2010.06.002; Rossant J., 2006, CSH PROTOCOLS, V2006; Sampath P., 2011, CURR PROTOC STEM CEL; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Viphakone N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2005; Wang XL, 2006, MOL CELL BIOL, V26, P4362, DOI 10.1128/MCB.02163-05; Wang XL, 2009, MOL CELL BIOL, V29, P2794, DOI 10.1128/MCB.01633-08; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zheng XF, 2012, JOVE-J VIS EXP, DOI 10.3791/3987; Zheng XF, 2012, STEM CELLS, V30, P910, DOI 10.1002/stem.1070	68	63	64	4	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					676	690		10.1016/j.stem.2013.10.008	http://dx.doi.org/10.1016/j.stem.2013.10.008			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24315442	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000329571700011
J	Nicholls, H				Nicholls, Henry			VSELs: Is Ideology Overtaking Science?	CELL STEM CELL			English	News Item												henry@henrynicholls.com						[Anonymous], 2013, NATURE, V496, P269; Danova-Alt R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034899; Havens AM, 2013, STEM CELLS DEV, V22, P622, DOI 10.1089/scd.2012.0327; Kassmer SH, 2013, STEM CELLS, V31, P2759, DOI 10.1002/stem.1413; Miyanishi M, 2013, STEM CELL REP, V1, P198, DOI 10.1016/j.stemcr.2013.07.001; Szade K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063329	6	5	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					143	144		10.1016/j.stem.2013.07.003	http://dx.doi.org/10.1016/j.stem.2013.07.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	24066359	Bronze			2022-12-28	WOS:000329570600007
J	Chiacchiera, F; Rossi, A; Jammula, S; Piunti, A; Scelfo, A; Ordonez-Moran, P; Huelsken, J; Koseki, H; Pasini, D				Chiacchiera, Fulvio; Rossi, Alessandra; Jammula, SriGanesh; Piunti, Andrea; Scelfo, Andrea; Ordonez-Moran, Paloma; Huelsken, Joerg; Koseki, Haruhiko; Pasini, Diego			Polycomb Complex PRC1 Preserves Intestinal Stem Cell Identity by Sustaining Wnt/beta-Catenin Transcriptional Activity	CELL STEM CELL			English	Article							BETA-CATENIN; COLORECTAL-CANCER; HISTONE H2A; COLON; PROTEINS; UBIQUITYLATION; PROLIFERATION; SUPPRESSION; HOMEOSTASIS; ACTIVATION	Polycomb repressive complexes (PRCs) are among the most important gatekeepers of establishing and maintaining cell identity in metazoans. PRC1, which plays a dominant role in this context, executes its functions via multiple subcomplexes, which all contribute to H2AK119 mono-ubiquitination (H2Aubq). Despite our comprehensive knowledge of PRC1-dependent H2Aubq in embryonic stem cells and during early development, its role in adult stem cells still remains poorly characterized. Here we show that PRC1 activity is required for the integrity of the intestinal epithelium, regulating stem cell self-renewal via a cell-autonomous mechanism that is independent from Cdkn2a expression. By dissecting the PRC1-dependent transcription program in intestinal stem cells, we demonstrate that PRC1 represses a large number of non-lineage-specific transcription factors that directly affect beta-catenin/Tcf transcriptional activity. Our data reveal that PRC1 preserves Wnt/beta-catenin activity in adult stem cells to maintain intestinal homeostasis and supports tumor formation induced by the constitutive activation of this pathway.	[Chiacchiera, Fulvio; Rossi, Alessandra; Jammula, SriGanesh; Piunti, Andrea; Pasini, Diego] European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy; [Ordonez-Moran, Paloma; Huelsken, Joerg] Ecole Polytech Fed Lausanne, ISREC, CH-1015 Lausanne, Switzerland; [Koseki, Haruhiko] RIKEN Res Ctr Allergy & Immunol RCAI, Dev Genet Grp, 1-7-22 Suehiuro Cho, Yokohama, Kanagawa 2300045, Japan	IRCCS European Institute of Oncology (IEO); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; RIKEN	Pasini, D (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	diego.pasini@ieo.eu	rossi, alessandra/K-7535-2016; Chiacchiera, Fulvio/ABD-6137-2020; Chiacchiera, Fulvio/K-6740-2016; Huelsken, Joerg/AAC-9581-2021; Ordonez-Moran, Paloma/B-6371-2016; Pasini, Diego/J-9674-2012	rossi, alessandra/0000-0002-7067-5789; Chiacchiera, Fulvio/0000-0003-3830-2090; Huelsken, Joerg/0000-0003-3105-9606; Ordonez-Moran, Paloma/0000-0001-7688-1252; Pasini, Diego/0000-0002-9879-6486	Italian Association for Cancer Research (AIRC); Italian Ministry of Health; Umberto Veronesi Foundation (FUV); Italian Foundation for Cancer Research (FIRC); FUV fellowship	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Umberto Veronesi Foundation (FUV)(Fondazione Umberto Veronesi); Italian Foundation for Cancer Research (FIRC)(Fondazione AIRC per la ricerca sul cancro); FUV fellowship(Fondazione Umberto Veronesi)	We thank Veronica Raker for editing support, Makoto Taketo for the Ctnnb1<SUP>ex3</SUP> mice, Miguel Vidal for the Ring1a and Ring1b KO mice, Elisabetta Dejana for support with mice, and Didier Negre for the inducible lentiviral backbone. We thank all members of the D.P. group for helpful discussions. The work in the D.P. laboratory was supported by grants from the Italian Association for Cancer Research (AIRC), the Italian Ministry of Health, and the Umberto Veronesi Foundation (FUV). A.R., A.P., and A.S. were supported by fellowships from the Italian Foundation for Cancer Research (FIRC). F.C. was supported by an FUV fellowship.	Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Fujimi TJ, 2012, DEV BIOL, V361, P220, DOI 10.1016/j.ydbio.2011.10.026; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Johnson V, 2005, GUT, V54, P264, DOI 10.1136/gut.2004.048132; Jung C, 2005, BRIT J CANCER, V92, P2233, DOI 10.1038/sj.bjc.6602631; Jung CY, 2004, CANCER RES, V64, P3046, DOI 10.1158/0008-5472.CAN-03-2614; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Piunti A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4649; Popov N, 2010, EPIGENETICS-US, V5, P685, DOI 10.4161/epi.5.8.12996; Posfai E, 2012, GENE DEV, V26, P920, DOI 10.1101/gad.188094.112; Pourebrahim R, 2011, J BIOL CHEM, V286, P37732, DOI 10.1074/jbc.M111.242826; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scelfo A, 2015, FEBS J, V282, P1703, DOI 10.1111/febs.13112; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100	39	65	67	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					91	103		10.1016/j.stem.2015.09.019	http://dx.doi.org/10.1016/j.stem.2015.09.019			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26526724	Bronze, Green Published			2022-12-28	WOS:000372321300015
J	Sweet, DJ				Sweet, Deborah J.			Foxd3: A Repressor, an Activator, or Both?	CELL STEM CELL			English	Editorial Material							NAIVE PLURIPOTENCY	Two papers in this issue of Cell Stem Cell come to different conclusions about the role of the transcription factor Foxd3 in pluripotent cells. Here, the lead authors of both papers discuss their perspectives on the basis for these differences and how they might be reconciled.	[Sweet, Deborah J.] 50 Hampshire St,Fifth Floor, Cambridge, MA 02139 USA		Sweet, DJ (corresponding author), 50 Hampshire St,Fifth Floor, Cambridge, MA 02139 USA.	dsweet@cell.com						Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Krishnakumar R, 2016, CELL STEM CELL, V18, P104, DOI 10.1016/j.stem.2015.10.003; Plank JL, 2014, STEM CELL RES, V12, P233, DOI 10.1016/j.scr.2013.10.008; Respuela P, 2016, CELL STEM CELL, V18, P118, DOI 10.1016/j.stem.2015.09.010	5	5	5	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					1	2		10.1016/j.stem.2015.12.009	http://dx.doi.org/10.1016/j.stem.2015.12.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26748746	Bronze			2022-12-28	WOS:000372321300001
J	Mertens, J; Paquola, ACM; Ku, MC; Hatch, E; Bohnke, L; Ladjevardi, S; McGrath, S; Campbell, B; Lee, H; Herdy, JR; Goncalves, JT; Toda, T; Kim, Y; Winkler, J; Yao, J; Hetzer, MW; Gage, FH				Mertens, Jerome; Paquola, Apua C. M.; Ku, Manching; Hatch, Emily; Boehnke, Lena; Ladjevardi, Shauheen; McGrath, Sean; Campbell, Benjamin; Lee, Hyungjun; Herdy, Joseph R.; Goncalves, J. Tiago; Toda, Tomohisa; Kim, Yongsung; Winkler, Juergen; Yao, Jun; Hetzer, Martin W.; Gage, Fred H.			Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; HIGHLY EFFICIENT; GENE-REGULATION; DNA-DAMAGE; IDENTIFICATION; REJUVENATION; PROGERIA; DISEASE; CONVERSION	Aging is amajor risk factor for many human diseases, and in vitro generation of human neurons is an attractive approach for modeling aging-related brain disorders. However, modeling aging in differentiated human neurons has proved challenging. We generated neurons from human donors across a broad range of ages, either by iPSC-based reprogramming and differentiation or by direct conversion into induced neurons (iNs). While iPSCs and derived neurons did not retain aging-associated gene signatures, iNs displayed age-specific transcriptional profiles and revealed age-associated decreases in the nuclear transport receptor RanBP17. We detected an age-dependent loss of nucleocytoplasmic compartmentalization (NCC) in donor fibroblasts and corresponding iNs and found that reduced RanBP17 impaired NCC in young cells, while iPSC rejuvenation restored NCC in aged cells. These results show that iNs retain important aging-related signatures, thus allowing modeling of the aging process in vitro, and they identify impaired NCC as an important factor in human aging.	[Mertens, Jerome; Paquola, Apua C. M.; Boehnke, Lena; Ladjevardi, Shauheen; McGrath, Sean; Campbell, Benjamin; Lee, Hyungjun; Herdy, Joseph R.; Goncalves, J. Tiago; Toda, Tomohisa; Kim, Yongsung; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Ku, Manching] Salk Inst Biol Studies, Next Generat Sequencing Core, La Jolla, CA 92037 USA; [Hatch, Emily; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Winkler, Juergen] Univ Erlangen Nurnberg, Dept Mol Neurol, D-91054 Erlangen, Germany; [Yao, Jun] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, McGovern Inst Brain,State Key Lab Membrane Biol, Beijing 100084, Peoples R China	Salk Institute; Salk Institute; Salk Institute; University of Erlangen Nuremberg; Tsinghua University	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Mertens, Jerome/P-1931-2015; Toda, Tomohisa/AAN-5515-2021	Mertens, Jerome/0000-0002-4291-4121; Hatch, Emily/0000-0002-3393-4075; Yao, Jun/0000-0002-4916-3412; Winkler, Jurgen/0000-0003-0630-9204; Campbell, Benjamin/0000-0001-8041-5561; Goncalves, J. Tiago/0000-0003-2303-1822	G. Harold & Leila Y. Mathers Charitable Foundation; JPB Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Annette Merle-Smith; CIRM [TR201778]; German Federal Ministry of Education and Research (BMBF) [FKZ: 1315874, 01GN0979]; Bavarian State of Ministry of Education, Science and the Arts; Glenn Foundation Center For Aging Research; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	G. Harold & Leila Y. Mathers Charitable Foundation; JPB Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Annette Merle-Smith; CIRM(California Institute for Regenerative Medicine); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Bavarian State of Ministry of Education, Science and the Arts; Glenn Foundation Center For Aging Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Ken Diffenderfer and the Salk STEM core facility for technical support with iPSC generation; Caz O'Connor and Conor Fitzpatrick for FACSorting; and Lynne Moore, Neal Nathan, Eric Konkel, T.J. Eames, and Kim McIntyre for technical support. We thank the DNA and Cell Bank of ICM in Paris for fibroblast banking; Leah Boyer, Carol M. Marchetto, Andres Paucar, Alexandra Durr, Olga Corti, and Alexis Brice for their contribution to fibroblast collection; Peter Davies for antibodies; and Mary Lynn Gage for editorial comments. Human prefrontal cortex samples were provided by the NICHD Brain Bank. The study was supported by the G. Harold & Leila Y. Mathers Charitable Foundation, the JPB Foundation, the Leona M. and Harry B. Helmsley Charitable Trust grant #2012-PG-MED002, Annette Merle-Smith, CIRM (TR201778), the German Federal Ministry of Education and Research (BMBF, FKZ: 1315874, #01GN0979), the Bavarian State of Ministry of Education, Science and the Arts in the framework ForIPS, and the Glenn Foundation Center For Aging Research.	Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blomer U, 1997, J VIROL, V71, P6641; Bozdag S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062982; Broad Institute TCGA Genome Data Analysis Center, 2013, CORR MRNASEQ EXPR CL; Broad Institute TCGA Genome Data Analysis Center, 2013, CORR GEN METH STAT C; Broad institute TCGA genome data analysis center, 2014, CORR MRNA EXPR CLIN; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Capelson M, 2009, EMBO REP, V10, P697, DOI 10.1038/embor.2009.147; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cummings JL, 2008, PRIMARY PSYCHIAT, V15, P66; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Fraser HB, 2005, PLOS BIOL, V3, P1653, DOI 10.1371/journal.pbio.0030274; Frobel J, 2014, STEM CELL REP, V3, P414, DOI 10.1016/j.stemcr.2014.07.003; Gladyshev VN, 2013, TRENDS GENET, V29, P506, DOI 10.1016/j.tig.2013.05.004; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Guenzel CA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00127; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Koch P, 2000, BIOCHEM BIOPH RES CO, V278, P241, DOI 10.1006/bbrc.2000.3788; Koch P, 2012, AM J PATHOL, V180, P2404, DOI 10.1016/j.ajpath.2012.02.012; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lapasset L, 2011, GENE DEV, V25, P2248, DOI 10.1101/gad.173922.111; Lee JH, 2010, J CELL BIOCHEM, V111, P195, DOI 10.1002/jcb.22689; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Manukyan M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04789; Marchetto MC, 2011, HUM MOL GENET, V20, pR109, DOI 10.1093/hmg/ddr336; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mertens J, 2013, STEM CELL REP, V1, P491, DOI 10.1016/j.stemcr.2013.10.011; Mertens J, 2013, AM J PATHOL, V182, P1769, DOI 10.1016/j.ajpath.2013.01.043; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Murphy C. T., 2006, DRUG DISCOV TODAY DI, V3, P41; Musich PR, 2009, AGING-US, V1, P28, DOI 10.18632/aging.100012; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; PETERSON C, 1985, NEW ENGL J MED, V312, P1063; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Toyama BH, 2013, NAT REV MOL CELL BIO, V14, P55, DOI 10.1038/nrm3496; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044	54	388	395	3	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					705	718		10.1016/j.stem.2015.09.001	http://dx.doi.org/10.1016/j.stem.2015.09.001			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26456686	Bronze, Green Accepted			2022-12-28	WOS:000366139100012
J	Chen, YJ; Cao, JY; Xiong, M; Petersen, AJ; Dong, Y; Tao, YL; Huang, CTL; Du, ZW; Zhang, SC				Chen, Yuejun; Cao, Jingyuan; Xiong, Man; Petersen, Andrew J.; Dong, Yi; Tao, Yunlong; Huang, Cindy Tzu-Ling; Du, Zhongwei; Zhang, Su-Chun			Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9	CELL STEM CELL			English	Article							HOMOLOGOUS RECOMBINATION; BREAK REPAIR; HUMAN ESCS; GENOME; SPECIFICITY; SYSTEM; CAS9; EXPRESSION; IMMUNITY; REVEALS	Precise temporal control of gene expression or deletion is critical for elucidating gene function in biological systems. However, the establishment of human pluripotent stem cell (hPSC) lines with inducible gene knockout (iKO) remains challenging. We explored building iKO hPSC lines by combining CRISPR/Cas9-mediated genome editing with the Flp/FRT and Cre/LoxP system. We found that "dual-sgRNA targeting'' is essential for biallelic knockin of FRT sequences to flank the exon. We further developed a strategy to simultaneously insert an activity-controllable recombinase-expressing cassette and remove the drug-resistance gene, thus speeding up the generation of iKO hPSC lines. This two-step strategy was used to establish human embryonic stem cell (hESC) and induced pluripotent stem cell (iPSC) lines with iKO of SOX2, PAX6, OTX2, and AGO2, genes that exhibit diverse structural layout and temporal expression patterns. The availability of iKO hPSC lines will substantially transform the way we examine gene function in human cells.	[Chen, Yuejun; Cao, Jingyuan; Xiong, Man; Petersen, Andrew J.; Dong, Yi; Tao, Yunlong; Huang, Cindy Tzu-Ling; Du, Zhongwei; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Xiong, Man] Fudan Univ, Inst Pediat, Childrens Hosp, Shanghai 201102, Peoples R China; [Zhang, Su-Chun] Univ Wisconsin, Neurosci Training Program, Madison, WI 53705 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; Fudan University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chen, YJ (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	yuejunchenphd@gmail.com; zhang@waisman.wisc.edu	chen, yuejun/AAL-4070-2020; Tao, Yunlong/I-8328-2019	Tao, Yunlong/0000-0003-0377-7133; Chen, Yuejun/0000-0002-4625-2604	NIH-NINDS [NS045926, NS076352, NS086604]; NIH-NIMH [MH099587, MH100031]; Bleser Family Foundation; Busta Foundation; NICHD [P30 HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352, P01HD076892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100031, R01MH099587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045926, R01NS076352, R24NS086604] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Bleser Family Foundation; Busta Foundation; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Bhattacharyya for helpful comments on the manuscript and R. Bradley for helpful suggestions. This study was supported in part by the NIH-NINDS (NS045926, NS076352, and NS086604), NIH-NIMH (MH099587 and MH100031), the Bleser Family Foundation, the Busta Foundation, and the NICHD (P30 HD03352).	ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Bu L, 2010, CELL RES, V20, P379, DOI 10.1038/cr.2010.23; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Giudice A, 2008, CELL STEM CELL, V2, P422, DOI 10.1016/j.stem.2008.04.003; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hockemeyer D, 2010, COLD SH Q B, V75, P201, DOI 10.1101/sqb.2010.75.021; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mali P, 2012, STEM CELLS, V30, P75, DOI 10.1002/stem.735; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Osterwalder M, 2010, NAT METHODS, V7, P893, DOI 10.1038/nmeth.1521; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Qian K, 2014, STEM CELLS, V32, P1230, DOI 10.1002/stem.1653; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rizzino A, 2013, STEM CELLS, V31, P1033, DOI 10.1002/stem.1352; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zou JZ, 2010, CELL RES, V20, P250, DOI 10.1038/cr.2010.29; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	51	111	119	1	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					233	244		10.1016/j.stem.2015.06.001	http://dx.doi.org/10.1016/j.stem.2015.06.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26145478	Green Accepted, Bronze			2022-12-28	WOS:000361878500014
J	Wenner, DM; Kimmelman, J; London, AJ				Wenner, Danielle Marie; Kimmelman, Jonathan; London, Alex John			Patient-Funded Trials: Opportunity or Liability?	CELL STEM CELL			English	Editorial Material							CELL	Patient-funded trials (PFTs) are gaining traction as a means of accelerating clinical translation. However, such trials sidestep mechanisms that promote rigor, relevance, efficiency, and fairness. We recommend that funding bodies or research institutions establish mechanisms for merit review of patient-funded trials, and we offer some basic criteria for evaluating PFT protocols.	[Wenner, Danielle Marie; London, Alex John] Carnegie Mellon Univ, Dept Philosophy, Pittsburgh, PA 15213 USA; [Wenner, Danielle Marie; London, Alex John] Carnegie Mellon Univ, Ctr Eth & Policy, Pittsburgh, PA 15213 USA; [Kimmelman, Jonathan] McGill Univ, Biomed Eth Unit, Studies Translat Eth & Med STREAM, Social Studies Med, Montreal, PQ H3A 1X1, Canada	Carnegie Mellon University; Carnegie Mellon University; McGill University	Kimmelman, J (corresponding author), McGill Univ, Biomed Eth Unit, Studies Translat Eth & Med STREAM, Social Studies Med, Montreal, PQ H3A 1X1, Canada.	jonathan.kimmelman@mcgill.ca		Wenner, Danielle/0000-0001-7731-8357; London, Alex/0000-0002-6450-0309				Baker M, 2005, NAT BIOTECHNOL, V23, P1467, DOI 10.1038/nbt1205-1467; Cree BAC, 2010, ANN NEUROL, V68, P145, DOI 10.1002/ana.22006; Fikes B.J., 2013, SAN DIEGO UNION TRIB; Hyun I, 2013, CELL STEM CELL, V12, P505, DOI 10.1016/j.stem.2013.04.010; London AJ, 2010, SCIENCE, V328, P829, DOI 10.1126/science.1189369; Morreim E Haavi, 1991, IRB, V13, P1, DOI 10.2307/3564279; Sipp D, 2012, REGEN MED, V7, P105, DOI [10.2217/RME.12.75, 10.2217/rme.12.75]; Vayena E, 2013, NAT BIOTECHNOL, V31, P786, DOI 10.1038/nbt.2692; Vayena E, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001402	9	20	20	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					135	137		10.1016/j.stem.2015.07.016	http://dx.doi.org/10.1016/j.stem.2015.07.016			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26253199	Green Submitted, Bronze			2022-12-28	WOS:000361878500005
J	Pietras, EM; Reynaud, D; Kang, YA; Carlin, D; Calero-Nieto, FJ; Leavitt, AD; Stuart, JM; Gottgens, B; Passegue, E				Pietras, Eric M.; Reynaud, Damien; Kang, Yoon-A.; Carlin, Daniel; Calero-Nieto, Fernando J.; Leavitt, Andrew D.; Stuart, Joshua M.; Goettgens, Berthold; Passegue, Emmanuelle			Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; SELF-RENEWAL; HETEROGENEITY; DIFFERENTIATION; IDENTIFICATION; RECONSTITUTION; SPECIFICATION; EXPRESSION; HIERARCHY; REVEAL	Despite great advances in understanding the mechanisms underlying blood production, lineage specification at the level of multipotent progenitors (MPPs) remains poorly understood. Here, we show that MPP2 and MPP3 are distinct myeloid-biased MPP subsets that work together with lymphoid-primed MPP4 cells to control blood production. We find that all MPPs are produced in parallel by hematopoietic stem cells (HSCs), but with different kinetics and at variable levels depending on hematopoietic demands. We also show that the normally rare myeloid-biased MPPs are transiently overproduced by HSCs in regenerating conditions, hence supporting myeloid amplification to rebuild the hematopoietic system. This shift is accompanied by a reduction in self-renewal activity in regenerating HSCs and reprogramming of MPP4 fate toward the myeloid lineage. Our results support a dynamic model of blood development in which HSCs convey lineage specification through independent production of distinct lineage-biased MPP subsets that, in turn, support lineage expansion and differentiation.	[Pietras, Eric M.; Reynaud, Damien; Kang, Yoon-A.; Passegue, Emmanuelle] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Div Hematol Oncol, Dept Med, San Francisco, CA 94143 USA; [Carlin, Daniel; Stuart, Joshua M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 94720 USA; [Carlin, Daniel; Stuart, Joshua M.] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 94720 USA; [Calero-Nieto, Fernando J.; Goettgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Calero-Nieto, Fernando J.; Goettgens, Berthold] Wellcome Trust Res Labs, Cambridge CB2 0XY, England; [Calero-Nieto, Fernando J.; Goettgens, Berthold] MRC Cambridge Stem Cell Inst, Cambridge CB2 0XY, England; [Leavitt, Andrew D.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Leavitt, Andrew D.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Cambridge; Wellcome Trust Sanger Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Passegue, E (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Div Hematol Oncol, Dept Med, San Francisco, CA 94143 USA.	passeguee@stemcell.ucsf.edu		Gottgens, Berthold/0000-0001-6302-5705; Passegue, Emmanuelle/0000-0002-3516-297X; Stuart, Joshua/0000-0002-2171-565X; Calero-Nieto, Fernando/0000-0003-3358-8253	NIH [F32HL106989, K01DK098315, R01HL092471]; Leukaemia and Lymphoma Research; Cancer Research UK; Rita Allen Scholar Award; Leukemia Lymphoma Society Scholar Award; NATIONAL CANCER INSTITUTE [R01CA180778] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092471, F32HL106989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK098315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109031] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [MR/M008975/1, MC_PC_12009] Funding Source: researchfish; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [MR/M008975/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukaemia and Lymphoma Research; Cancer Research UK(Cancer Research UK); Rita Allen Scholar Award; Leukemia Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Dr. C. Nerlov (Oxford University) for Pu.1-eYFP mice, Dr. F. de Savage (Genentech) for Mpl<SUP>-/-</SUP> mice, M. Sanchez-Castillo for help with t-SNE and discriminant classification analyses, M. Kissner and M. Lee for management of our flow cytometry core facility, B. King for initial analyses of Mpl<SUP>-/-</SUP> mice, S. Wang for help with MegaCult experiments, Gladstone Genomics Core for microarray processing, and all members of the E.P. laboratory for critical insights and suggestions. This work was supported by NIH awards F32HL106989 and K01DK098315 (to E.M.P.); grants from Leukaemia and Lymphoma Research and Cancer Research UK and core support by the Wellcome Trust (to B.G.); and NIH grant R01HL092471, a Rita Allen Scholar Award, and a Leukemia Lymphoma Society Scholar Award (to E.P.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Buza-Vidas N, 2011, BLOOD, V118, P1544, DOI 10.1182/blood-2010-10-316232; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ema H, 2014, EXP HEMATOL, V42, P74, DOI 10.1016/j.exphem.2013.11.004; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hosen N, 2007, STEM CELLS, V25, P1635, DOI 10.1634/stemcells.2006-0229; Kawamoto H, 2006, TRENDS IMMUNOL, V27, P169, DOI 10.1016/j.it.2006.02.004; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kohli L, 2014, TRENDS CELL BIOL, V24, P479, DOI 10.1016/j.tcb.2014.04.001; Miyawaki K, 2015, STEM CELLS, V33, P976, DOI 10.1002/stem.1906; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Ooi AGL, 2009, STEM CELLS, V27, P653, DOI 10.1634/stemcells.2008-0824; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Tefferi A, 2007, CELL CYCLE, V6, P550, DOI 10.4161/cc.6.5.3919; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698	41	315	320	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2015	17	1					35	46		10.1016/j.stem.2015.05.003	http://dx.doi.org/10.1016/j.stem.2015.05.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DI	26095048	Bronze, Green Accepted			2022-12-28	WOS:000361877600007
J	Shimokawa, M; Sato, T				Shimokawa, Mariko; Sato, Toshiro			Back to 2D Culture for Ground State of Intestinal Stem Cells	CELL STEM CELL			English	Editorial Material								Generating highly uniform clonogenic stem cell populations has been remarkably difficult with stem cells from human small and large intestine. A recent report by Wang et al. (2015) demonstrated homogeneous expansion of human fetal intestinal stem cells, providing a new culture system to understand self-renewing mechanisms of intestinal stem cells.	[Shimokawa, Mariko; Sato, Toshiro] Keio Univ, Sch Med, Dept Gastroenterol, Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Sato, T (corresponding author), Keio Univ, Sch Med, Dept Gastroenterol, Shinjuku Ku, Tokyo 1608582, Japan.	t.sato@a7.keio.jp	Sato, Toshiro/J-3522-2014	Sato, Toshiro/0000-0001-8353-8137				Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Leslie JL, 2015, INFECT IMMUN, V83, P138, DOI 10.1128/IAI.02561-14; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Wang X, 2015, NATURE, V522, P173, DOI 10.1038/nature14484; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737	9	5	5	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2015	17	1					5	7		10.1016/j.stem.2015.06.008	http://dx.doi.org/10.1016/j.stem.2015.06.008			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DI	26140602	Bronze			2022-12-28	WOS:000361877600003
J	Asfaha, S; Hayakawa, Y; Muley, A; Stokes, S; Graham, TA; Ericksen, RE; Westphalen, CB; von Burstin, J; Mastracci, TL; Worthley, DL; Guha, C; Quante, M; Rustgi, AK; Wang, TC				Asfaha, Samuel; Hayakawa, Yoku; Muley, Ashlesha; Stokes, Sarah; Graham, Trevor A.; Ericksen, Russell E.; Westphalen, Christoph B.; von Burstin, Johannes; Mastracci, Teresa L.; Worthley, Daniel L.; Guha, Chandhan; Quante, Michael; Rustgi, Anil K.; Wang, Timothy C.			Krt19(+)/Lgr5(-) Cells Are Radioresistant Cancer-Initiating Stem Cells in the Colon and Intestine	CELL STEM CELL			English	Article							EXPRESSION MARKS; IN-VITRO; LGR5; IDENTIFICATION; POPULATIONS; ORIGIN; CRYPTS; TUMORS; BMI1; MICE	Epithelium of the colon and intestine are renewed every 3 days. In the intestine there are at least two principal stem cell pools. The first contains rapid cycling crypt-based columnar (CBC) Lgr5(+) cells, and the second is composed of slower cycling Bmi1-expressing cells at the +4 position above the crypt base. In the colon, however, the identification of Lgr5(-) stem cell pools has proven more challenging. Here, we demonstrate that the intermediate filament keratin-19 (Krt19) marks long-lived, radiation-resistant cells above the crypt base that generate Lgr5(+) CBCs in the colon and intestine. In colorectal cancer models, Krt19(+) cancer-initiating cells are also radioresistant, while Lgr5(+) stem cells are radiosensitive. Moreover, Lgr5(+) stem cells are dispensable in both the normal and neoplastic colonic epithelium, as ablation of Lgr5(+) stem cells results in their regeneration from Krt19-expressing cells. Thus, Krt19(+) stem cells are a discrete target relevant for cancer therapy.	[Asfaha, Samuel; Hayakawa, Yoku; Muley, Ashlesha; Stokes, Sarah; Ericksen, Russell E.; Westphalen, Christoph B.; Worthley, Daniel L.; Wang, Timothy C.] Columbia Univ, Irving Canc Res Ctr, Dept Med, Div Digest & Liver Dis, New York, NY 10032 USA; [Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Graham, Trevor A.] Barts Canc Inst, Ctr Tumour Biol, London EC1M 6BQ, England; [Mastracci, Teresa L.] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [von Burstin, Johannes; Quante, Michael] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 2, D-81675 Munich, Germany; [Guha, Chandhan] Albert Einstein Coll Med, Dept Radiat Oncol, New York, NY 10467 USA; [Asfaha, Samuel] Univ Western Ontario, Dept Med, London, ON N6A 5W9, Canada	Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of London; Queen Mary University London; Columbia University; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Yeshiva University; Western University (University of Western Ontario)	Wang, TC (corresponding author), Columbia Univ, Irving Canc Res Ctr, Dept Med, Div Digest & Liver Dis, New York, NY 10032 USA.	tcw21@columbia.edu	Asfaha, Samuel/I-8245-2015; Hayakawa, Yoku/AAI-8581-2020	Asfaha, Samuel/0000-0001-6972-0338; Hayakawa, Yoku/0000-0002-3988-2499; Westphalen, Benedikt/0000-0002-5310-3754; Graham, Trevor/0000-0001-9582-1597; Wang, Timothy/0000-0001-5730-3019	CIHR; AHFMR; NIH [UO1 DK103155, R37 DK052778, RO1 DK097016, R01 DK056645, P30 DK 050306]; Hansen Foundation; National Colon Cancer Research Alliance; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R37DK052778, R01DK097016, U01DK103155, R01DK056645] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); AHFMR(Alberta Heritage Foundation for Medical Research); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hansen Foundation; National Colon Cancer Research Alliance; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the members of the Irving Cancer Research Center Core Microscopy Core Facility for their technical assistance and also thank Victor Lin of the Columbia Mouse Transgenic Core Facility for his help with generation of Krt19-mApple mice. We thank Genentech for their generosity in providing the Lgr5-GFP-DTR knockin mice used for this study. The authors additionally recognize the technical assistance of Yagnesh Tailor, Karan Nagar, Chintan Kapadia, and Kelly Betz. Dr. Samuel Asfaha was supported by a CIHR Clinician Scientist Phase I Award and an AHFMR Clinical Fellowship Award. This work was supported by the NIH (UO1 DK103155, R37 DK052778, and RO1 DK097016) (to T.C.W.). This work received grants from the NIH (R01 DK056645). Support was received from the Hansen Foundation and National Colon Cancer Research Alliance and the NIH (P30 DK 050306) (to A.K.R.) and its Mouse Core Facility.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Brembeck FH, 2001, GASTROENTEROLOGY, V120, P1720, DOI 10.1053/gast.2001.24846; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025785; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kozar S, 2013, CELL STEM CELL, V13, P626, DOI 10.1016/j.stem.2013.08.001; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; PARK HS, 1995, AM J PATHOL, V147, P1416; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Quante M, 2010, GASTROENTEROLOGY, V139, P2018, DOI 10.1053/j.gastro.2010.08.003; Ramalingam S, 2012, AM J PHYSIOL-GASTR L, V302, pG10, DOI 10.1152/ajpgi.00277.2011; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	30	128	130	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					627	638		10.1016/j.stem.2015.04.013	http://dx.doi.org/10.1016/j.stem.2015.04.013			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26046762	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000355932300012
J	Beerman, I; Rossi, DJ				Beerman, Isabel; Rossi, Derrick J.			Epigenetic Control of Stem Cell Potential during Homeostasis, Aging, and Disease	CELL STEM CELL			English	Review							REGULATES HEMATOPOIETIC STEM; DNA METHYLATION CHANGES; ADULT HIPPOCAMPAL NEUROGENESIS; REPRESSIVE COMPLEX 2; LONG-TERM CULTURE; GENOME-WIDE MAPS; SELF-RENEWAL; MYELODYSPLASTIC SYNDROME; HISTONE DEACETYLASE; PROGENITOR CELLS	Stem cell decline is an important cellular driver of aging-associated pathophysiology in multiple tissues. Epigenetic regulation is central to establishing and maintaining stem cell function, and emerging evidence indicates that epigenetic dysregulation contributes to the altered potential of stem cells during aging. Unlike terminally differentiated cells, the impact of epigenetic dysregulation in stem cells is propagated beyond self; alterations can be heritably transmitted to differentiated progeny, in addition to being perpetuated and amplified within the stem cell pool through self-renewal divisions. This Review focuses on recent studies examining epigenetic regulation of tissue-specific stem cells in homeostasis, aging, and aging-related disease.	[Beerman, Isabel; Rossi, Derrick J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Beerman, Isabel; Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Beerman, Isabel; Rossi, Derrick J.] Boston Childrens Hosp, Div Hematol Oncol, Program Cellular & Mol Med, Boston, MA 02116 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Rossi, DJ (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	derrick.rossi@childrens.harvard.edu	Beerman, Isabel/AAN-4216-2020; Beerman, Isabel/Y-2555-2019	Beerman, Isabel/0000-0002-7758-8231	NIH [RO1HL107630, R00AG029760, UO1DK072473-01]; Leona M. and Harry B. Helmsley Charitable Trust; New York Stem Cell Foundation; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107630, U01HL107440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104218, U01DK072473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG029760, R00AG029760] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; New York Stem Cell Foundation; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank Shinpei Yamaguchi for his helpful input and Rossi Lab colleagues for thoughtful discussion and figure input. D.J.R. is supported by grants from the NIH (RO1HL107630, R00AG029760, and UO1DK072473-01) as well as grants from The Leona M. and Harry B. Helmsley Charitable Trust, The New York Stem Cell Foundation, and The Harvard Stem Cell Institute. D.J.R. is New York Stem Cell Foundation Robertson Investigator.	Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; [Anonymous], 2011, ANGEW CHEM INT EDIT; Attema JL, 2007, P NATL ACAD SCI USA, V104, P12371, DOI 10.1073/pnas.0704468104; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Beerman I, 2014, EXP CELL RES, V329, P192, DOI 10.1016/j.yexcr.2014.09.013; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Cellot S, 2013, BLOOD, V122, P1545, DOI 10.1182/blood-2013-04-496281; Challen GA, 2014, CELL STEM CELL, V15, P350, DOI 10.1016/j.stem.2014.06.018; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chan WI, 2011, MOL CELL BIOL, V31, P5046, DOI 10.1128/MCB.05830-11; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Cimmino L., 2015, NAT IMMUNOL IN PRESS; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Daskalakis M, 2002, BLOOD, V100, P2957, DOI 10.1182/blood.V100.8.2957; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Esteller M, 2003, LANCET ONCOL, V4, P351, DOI 10.1016/S1470-2045(03)01115-X; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Fernandez AF, 2015, GENOME RES, V25, P27, DOI 10.1101/gr.169011.113; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Fukumoto JS, 2005, CRIT REV ONCOL HEMAT, V56, P179, DOI 10.1016/j.critrevonc.2005.04.006; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Heideman MR, 2014, HAEMATOLOGICA, V99, P1292, DOI 10.3324/haematol.2013.092643; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Hidalgo I, 2012, CELL STEM CELL, V11, P649, DOI 10.1016/j.stem.2012.08.001; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Issa JPJ, 2013, BLOOD, V121, P3811, DOI 10.1182/blood-2013-02-451757; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Itzykson R, 2014, LEUKEMIA, V28, P497, DOI 10.1038/leu.2013.343; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kaaij LTJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r50; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kantarjian H, 2007, BLOOD, V109, P52, DOI 10.1182/blood-2006-05-021162; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Katsumoto T, 2008, CANCER SCI, V99, P1523, DOI 10.1111/j.1349-7006.2008.00865.x; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kerenyi MA, 2013, ELIFE, V2, DOI 10.7554/eLife.00633; Kinkel SA, 2015, BLOOD, V125, P1890, DOI 10.1182/blood-2014-10-603969; Ko M, 2015, IMMUNOL REV, V263, P6, DOI 10.1111/imr.12239; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Koch CM, 2011, AGING-US, V3, P1018, DOI 10.18632/aging.100395; Koestler DC, 2013, EPIGENETICS-US, V8, P816, DOI 10.4161/epi.25430; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kung AL, 2000, GENE DEV, V14, P272; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Li J, 2012, J INVEST DERMATOL, V132, P2681, DOI 10.1038/jid.2012.206; Li T, 2015, MOL NEUROBIOL, V51, P142, DOI 10.1007/s12035-014-8734-5; Li WB, 2007, J NEUROSCI, V27, P2606, DOI 10.1523/JNEUROSCI.4181-06.2007; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Loizou JI, 2009, J IMMUNOL, V183, P6422, DOI 10.4049/jimmunol.0901969; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Matsui K, 2012, BIOCHEM BIOPH RES CO, V418, P811, DOI 10.1016/j.bbrc.2012.01.109; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ming M, 2014, EXP DERMATOL, V23, P207, DOI 10.1111/exd.12323; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morselli M, 2015, ELIFE, V4, DOI 10.7554/eLife.06205; Neff T, 2013, BLOOD, V121, P4847, DOI 10.1182/blood-2013-02-474833; Neri F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r91; Neri F, 2013, CELL, V155, P121, DOI 10.1016/j.cell.2013.08.056; Noer A, 2009, STEM CELLS DEV, V18, P725, DOI 10.1089/scd.2008.0189; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Perez-Campo FM, 2014, STEM CELLS, V32, P1591, DOI 10.1002/stem.1606; Pu MT, 2015, GENE DEV, V29, P718, DOI 10.1101/gad.254144.114; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rafalski VA, 2013, NAT CELL BIOL, V15, P614, DOI 10.1038/ncb2735; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Rimmele P, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.04.015; Rose NR, 2014, BBA-GENE REGUL MECH, V1839, P1362, DOI 10.1016/j.bbagrm.2014.02.007; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Sheikh BN, 2012, J CELL SCI, V125, P295, DOI 10.1242/jcs.077271; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shide K, 2012, LEUKEMIA, V26, P2216, DOI 10.1038/leu.2012.94; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Stewart MH, 2015, BLOOD, V125, P2075, DOI 10.1182/blood-2014-08-596734; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tapias A, 2014, CELL STEM CELL, V14, P632, DOI 10.1016/j.stem.2014.04.001; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Turgeon N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073785; Waddington C.H, 1942, THE EPIGENOTYPE, P18; Wahlestedt M, 2013, BLOOD, V121, P4257, DOI 10.1182/blood-2012-11-469080; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Wang JP, 2014, BLOOD, V123, P541, DOI 10.1182/blood-2013-05-500272; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Watanabe Y, 2010, ADV CLIN CHEM, V52, P145, DOI 10.1016/S0065-2423(10)52006-7; Weishaupt H, 2010, BLOOD, V115, P247, DOI 10.1182/blood-2009-07-235176; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wijermans P, 2000, J CLIN ONCOL, V18, P956, DOI 10.1200/JCO.2000.18.5.956; Will B, 2012, BLOOD, V120, P2076, DOI 10.1182/blood-2011-12-399683; WILSON VL, 1983, SCIENCE, V220, P1054; Wilting RH, 2010, EMBO J, V29, P2586, DOI 10.1038/emboj.2010.136; Woodhouse S, 2013, J CELL SCI, V126, P565, DOI 10.1242/jcs.114843; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xie HF, 2014, CELL STEM CELL, V14, P68, DOI 10.1016/j.stem.2013.10.001; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Yang LB, 2015, NAT REV CANCER, V15, P152, DOI 10.1038/nrc3895; Yuan T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004996; Zhang J, 2014, J NEUROSCI, V34, P5184, DOI 10.1523/JNEUROSCI.4129-13.2014; Zhang RP, 2011, J BIOL CHEM, V286, P41083, DOI 10.1074/jbc.M111.258715; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006; Zimberlin CD, 2015, FASEB J, V29, P2070, DOI 10.1096/fj.14-257931; Zykovich A, 2014, AGING CELL, V13, P360, DOI 10.1111/acel.12180	159	107	108	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					613	625		10.1016/j.stem.2015.05.009	http://dx.doi.org/10.1016/j.stem.2015.05.009			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26046761	Green Accepted, Bronze			2022-12-28	WOS:000355932300011
J	Kurimoto, K; Yabuta, Y; Hayashi, K; Ohta, H; Kiyonari, H; Mitani, T; Moritoki, Y; Kohri, K; Kimura, H; Yamamoto, T; Katou, Y; Shirahige, K; Saitou, M				Kurimoto, Kazuki; Yabuta, Yukihiro; Hayashi, Katsuhiko; Ohta, Hiroshi; Kiyonari, Hiroshi; Mitani, Tadahiro; Moritoki, Yoshinobu; Kohri, Kenjiro; Kimura, Hiroshi; Yamamoto, Takuya; Katou, Yuki; Shirahige, Katsuhiko; Saitou, Mitinori			Quantitative Dynamics of Chromatin Remodeling during Germ Cell Specification from Mouse Embryonic Stem Cells	CELL STEM CELL			English	Article							NUCLEAR LAMINA INTERACTIONS; PROMOTER DNA METHYLATION; PRIMED PLURIPOTENCY; IN-VITRO; GENOME; MICE; TRANSCRIPTION; FATE; DIFFERENTIATION; REORGANIZATION	Germ cell specification is accompanied by epigenetic remodeling, the scale and specificity of which are unclear. Here, we quantitatively delineate chromatin dynamics during induction of mouse embryonic stem cells (ESCs) to epiblast-like cells (EpiLCs) and from there into primordial germ celllike cells (PGCLCs), revealing large-scale reorganization of chromatin signatures including H3K27me3 and H3K9me2 patterns. EpiLCs contain abundant bivalent gene promoters characterized by low H3K27me3, indicating a state primed for differentiation. PGCLCs initially lose H3K4me3 from many bivalent genes but subsequently regain this mark with concomitant upregulation of H3K27me3, particularly at developmental regulatory genes. PGCLCs progressively lose H3K9me2, including at lamina-associated perinuclear heterochromatin, resulting in changes in nuclear architecture. T recruits H3K27ac to activate BLIMP1 and early mesodermal programs during PGCLC specification, which is followed by BLIMP1-mediated repression of a broad range of targets, possibly through recruitment and spreading of H3K27me3. These findings provide a foundation for reconstructing regulatory networks of the germline epigenome.	[Kurimoto, Kazuki; Yabuta, Yukihiro; Hayashi, Katsuhiko; Ohta, Hiroshi; Mitani, Tadahiro; Moritoki, Yoshinobu; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Kurimoto, Kazuki; Yabuta, Yukihiro; Ohta, Hiroshi; Saitou, Mitinori] ERATO, JST, Sakyo Ku, Kyoto 6068501, Japan; [Hayashi, Katsuhiko] Kyushu Univ, Fac Med Sci, Dept Dev Stem Cell Biol, Higashi Ku, Fukuoka 8128582, Japan; [Hayashi, Katsuhiko] PRESTO, JST, Higashi Ku, Fukuoka 8128582, Japan; [Kiyonari, Hiroshi] RIKEN Ctr Life Sci Technol, Labs Anim Resource Dev & Genet Engn, Chuou Ku, Kobe, Hyogo 6500047, Japan; [Moritoki, Yoshinobu; Kohri, Kenjiro] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Kimura, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Yokohama, Kanagawa 2268501, Japan; [Yamamoto, Takuya; Saitou, Mitinori] Kyoto Univ, Ctr iPS Cell Res & Applicat, Sakyo Ku, Kyoto 6068507, Japan; [Katou, Yuki; Shirahige, Katsuhiko] Univ Tokyo, Lab Genome Struct & Funct, Ctr Epigenet Dis, Inst Mol & Cellular Biosci,Bunkyo Ku, Tokyo 1130032, Japan; [Yamamoto, Takuya; Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyushu University; Japan Science & Technology Agency (JST); RIKEN; Nagoya City University; Tokyo Institute of Technology; Kyoto University; University of Tokyo; Kyoto University	Kurimoto, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	kurimoto@anat2.med.kyoto-u.ac.jp; saitou@anat2.med.kyoto-u.ac.jp	Kiyonari, Hiroshi/N-7936-2015; Kimura, Hiroshi/B-9524-2015; Yamamoto, Takuya/H-2792-2017	Kimura, Hiroshi/0000-0003-0854-083X; Yamamoto, Takuya/0000-0002-0022-3947; Shirahige, Katsuhiko/0000-0002-7862-1144	Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST-CREST/ERATO; Takeda Science Foundation; Tanabe Medical Frontier Conference; Grants-in-Aid for Scientific Research [24681039] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-CREST/ERATO; Takeda Science Foundation(Takeda Science Foundation (TSF)); Tanabe Medical Frontier Conference; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Sasaki, K. Shirane, T. Abe, and M. Yamaji for discussion and R. Kabata, S. Ohsako, N. Konishi, S. Watanabe, M. Kabata, and T. Satoh for their assistance. We used the supercomputer of ACCMS, Kyoto University. The authors were supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by JST-CREST/ERATO, by the Takeda Science Foundation, and by the Tanabe Medical Frontier Conference.	Aramaki S, 2013, DEV CELL, V27, P516, DOI 10.1016/j.devcel.2013.11.001; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Hackett JA, 2012, DEVELOPMENT, V139, P3623, DOI 10.1242/dev.081661; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hayashi-Takanaka Y, 2011, NUCLEIC ACIDS RES, V39, P6475, DOI 10.1093/nar/gkr343; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Magnusdottir E, 2013, NAT CELL BIOL, V15, P905, DOI 10.1038/ncb2798; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; MONK M, 1987, DEVELOPMENT, V99, P371; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Runyan C, 2006, DEVELOPMENT, V133, P4861, DOI 10.1242/dev.02688; Sachs M, 2013, CELL REP, V3, P1777, DOI 10.1016/j.celrep.2013.04.032; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yokobayashi S, 2013, NATURE, V495, P236, DOI 10.1038/nature11918	36	127	128	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					517	532		10.1016/j.stem.2015.03.002	http://dx.doi.org/10.1016/j.stem.2015.03.002			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25800778	Bronze			2022-12-28	WOS:000354188600012
J	Biffi, A				Biffi, Alessandra			Clinical Translation of TALENS: Treating SCID-X1 by Gene Editing in iPSCs	CELL STEM CELL			English	Editorial Material							SEVERE COMBINED IMMUNODEFICIENCY; HEMATOPOIETIC STEM-CELLS; THERAPY	Mutations causing X-linked severe combined immunodeficiency (SCID-X1) reduce immune cell populations and function and may be amenable to targeted gene correction strategies. Now in Cell Stem Cell, Menon et al. (2015) correct SCID-X1-related blood differentiation defects by TALEN-mediated genome editing in patient-derived iPSCs, suggesting a possible strategy for autologous cell therapy of SCID-X1.	Ist Sci San Raffaele, San Raffaele Telethon Inst Gene, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Biffi, A (corresponding author), Ist Sci San Raffaele, San Raffaele Telethon Inst Gene, I-20132 Milan, Italy.	biffi.alessandra@hsr.it	Biffi, Alessandra/AAA-8890-2019		Telethon [TGT11D02] Funding Source: Medline; Fondazione Telethon Funding Source: Custom	Telethon(Fondazione Telethon); Fondazione Telethon(Fondazione Telethon)		Aiuti A, 2002, NAT MED, V8, P423, DOI 10.1038/nm0502-423; Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; Brown L, 2011, BLOOD, V117, P3243, DOI 10.1182/blood-2010-08-300384; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Menon T, 2015, CELL STEM CELL, V16, P367, DOI 10.1016/j.stem.2015.02.005	9	7	8	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					348	349		10.1016/j.stem.2015.03.009	http://dx.doi.org/10.1016/j.stem.2015.03.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25842973	Bronze			2022-12-28	WOS:000352228600005
J	Kim, SK; Lee, H; Han, K; Kim, SC; Choi, Y; Park, SW; Bak, G; Lee, Y; Choi, JK; Kim, TK; Han, YM; Lee, D				Kim, Seung-Kyoon; Lee, Hosuk; Han, Kyumin; Kim, Sang Cheol; Choi, Yoonjung; Park, Sang-Wook; Bak, Geunu; Lee, Younghoon; Choi, Jung Kyoon; Kim, Tae-Kyung; Han, Yong-Mahn; Lee, Daeyoup			SET7/9 Methylation of the Pluripotency Factor LIN28A Is a Nucleolar Localization Mechanism that Blocks let-7 Biogenesis in Human ESCs	CELL STEM CELL			English	Article							MICRORNA BIOGENESIS; LYSINE METHYLATION; MESSENGER-RNAS; SELF-RENEWAL; PRE-MICRORNA; DNA-BINDING; LIN-28; METHYLTRANSFERASE; REGULATOR; STABILITY	LIN28-mediated processing of the microRNA (miRNA) let-7 has emerged as a multilevel program that controls self-renewal in embryonic stem cells. LIN28A is believed to act primarily in the cytoplasm together with TUT4/7 to prevent final maturation of let-7 by Dicer, whereas LIN28B has been suggested to preferentially act on nuclear processing of let-7. Here, we find that SET7/9 monomethylation in a putative nucleolar localization region of LIN28A increases its nuclear retention and protein stability. In the nucleoli of human embryonic stem cells, methylated LIN28A sequesters pri-let-7 and blocks its processing independently of TUT4/7. The nuclear form of LIN28A regulates transcriptional changes in MYC-pathway targets, thereby maintaining stemness programs and inhibiting expression of early lineage-specific markers. These findings provide insight into the molecular mechanism underlying the post-translational methylation of nuclear LIN28A and its ability to modulate pluripotency by repressing let-7 miRNA expression in human embryonic stem cells.	[Kim, Seung-Kyoon; Lee, Hosuk; Han, Kyumin; Choi, Yoonjung; Park, Sang-Wook; Han, Yong-Mahn; Lee, Daeyoup] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Choi, Jung Kyoon] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Bak, Geunu; Lee, Younghoon] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Kim, Sang Cheol] Samsung Med Ctr, Samsung Genome Inst, Seoul 135710, South Korea; [Kim, Tae-Kyung] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Sungkyunkwan University (SKKU); Samsung Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Han, YM (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	ymhan@kaist.ac.kr; daeyoup@kaist.ac.kr	Lee, Daeyoup/C-1653-2011; Han, Yong-Mahn/C-1652-2011; Kim, Tae-Kyung/AAX-4230-2020; Choi, Jung Kyoon/C-2070-2011; Lee, Hosuk/AAE-9102-2022; Lee, Younghoon/C-1991-2011	Lee, Daeyoup/0000-0003-2006-1823; Kim, Tae-Kyung/0000-0001-5161-9864; Lee, Younghoon/0000-0002-3841-719X; Kim, Seung-Kyoon/0000-0001-9776-4047	Stem Cell Research Program [2011-0019509, 2012M 3A9B 4027953]; Basic Science Research Program [NRF-2012R1A6A3A01038981]; KAIST Future Systems Healthcare Project; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning [2011-0031955]; Welch Foundation [I-1786]; Klingenstein Fund; National Institute of Neurological Disorders and Stroke [R01NS085418]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085418] Funding Source: NIH RePORTER	Stem Cell Research Program; Basic Science Research Program; KAIST Future Systems Healthcare Project; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning; Welch Foundation(The Welch Foundation); Klingenstein Fund(Klingenstein Philanthropies); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Ryan D. Mohan and Tamaki Suganuma for critical readings and discussions. We wish to acknowledge V. Narry Kim for kindly providing the pRL-CMV, pGL3-CMV-let-7a binding sites, pGL3-CMV-miR-16 binding site, and pCK-FLAG-AGO2 constructs. This work was supported by grants from the Stem Cell Research Program (2011-0019509 and 2012M 3A9B 4027953), the Basic Science Research Program (NRF-2012R1A6A3A01038981), the KAIST Future Systems Healthcare Project, and the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Science, ICT and Future Planning (2011-0031955). This work was also funded by the Welch Foundation (I-1786), the Klingenstein Fund, and grant R01NS085418 from the National Institute of Neurological Disorders and Stroke (T.-K.K.).	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chang HM, 2013, NATURE, V497, P244, DOI 10.1038/nature12119; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Desjardins A, 2014, NUCLEIC ACIDS RES, V42, P4615, DOI 10.1093/nar/gkt1391; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Freiman RN, 2003, CELL, V112, P11, DOI 10.1016/S0092-8674(02)01278-3; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Ji HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026057; Kim SK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.384057; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Malynn BA, 2000, GENE DEV, V14, P1390; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Tao YZ, 2011, J CELL BIOL, V194, P551, DOI 10.1083/jcb.201010090; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang LX, 2014, BBA-MOL CELL RES, V1843, P1188, DOI 10.1016/j.bbamcr.2014.03.001; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	53	48	52	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					735	749		10.1016/j.stem.2014.10.016	http://dx.doi.org/10.1016/j.stem.2014.10.016			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25479749	Green Accepted, Bronze			2022-12-28	WOS:000347174300012
J	Liu, LQ; Xu, Y; He, MH; Zhang, M; Cui, FG; Lu, LN; Yao, MZ; Tian, WH; Benda, C; Zhuang, Q; Huang, ZJ; Li, WJ; Li, XC; Zhao, P; Fan, WX; Luo, ZW; Li, Y; Wu, YS; Hutchins, AP; Wang, DY; Tse, HF; Schambach, A; Frampton, J; Qin, BM; Bao, XC; Yao, HJ; Zhang, BL; Sun, H; Pei, DQ; Wang, HT; Wang, J; Esteban, MA				Liu, Longqi; Xu, Yan; He, Minghui; Zhang, Meng; Cui, Fenggong; Lu, Leina; Yao, Mingze; Tian, Weihua; Benda, Christina; Zhuang, Qiang; Huang, Zhijian; Li, Wenjuan; Li, Xiangchun; Zhao, Ping; Fan, Wenxia; Luo, Zhiwei; Li, Yuan; Wu, Yasong; Hutchins, Andrew P.; Wang, Dongye; Tse, Hung-Fat; Schambach, Axel; Frampton, Jon; Qin, Baoming; Bao, Xichen; Yao, Hongjie; Zhang, Biliang; Sun, Hao; Pei, Duanqing; Wang, Huating; Wang, Jun; Esteban, Miguel A.			Transcriptional Pause Release Is a Rate-Limiting Step for Somatic Cell Reprogramming	CELL STEM CELL			English	Article							GENE-EXPRESSION; SUPER-ENHANCERS; DOMAIN; ELONGATION; PROTEINS; DIFFERENTIATION; PLURIPOTENCY; CHECKPOINT; GENERATION; IDENTITY	Reactivation of the pluripotency network during somatic cell reprogramming by exogenous transcription factors involves chromatin remodeling and the recruitment of RNA polymerase II (Pol II) to target loci. Here, we report that Pol II is engaged at pluripotency promoters in reprogramming but remains paused and inefficiently released. We also show that bromodomain-containing protein 4 (BRD4) stimulates productive transcriptional elongation of pluripotency genes by dissociating the pause release factor P-TEFb from an inactive complex containing HEXIM1. Consequently, BRD4 overexpression enhances reprogramming efficiency and HEXIM1 suppresses it, whereas Brd4 and Hexim1 knockdown do the opposite. We further demonstrate that the reprogramming factor KLF4 helps recruit P-TEFb to pluripotency promoters. Our work thus provides a mechanism for explaining the reactivation of pluripotency genes in reprogramming and unveils an unanticipated role for KLF4 in transcriptional pause release.	[Liu, Longqi; Xu, Yan; Zhang, Meng; Cui, Fenggong; Tian, Weihua; Benda, Christina; Zhuang, Qiang; Huang, Zhijian; Li, Wenjuan; Zhao, Ping; Fan, Wenxia; Luo, Zhiwei; Wang, Dongye; Bao, Xichen; Esteban, Miguel A.] Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Lab Chromatin & Human Dis, Guangzhou 510530, Guangdong, Peoples R China; [Liu, Longqi; Xu, Yan; Zhang, Meng; Cui, Fenggong; Yao, Mingze; Tian, Weihua; Benda, Christina; Zhuang, Qiang; Huang, Zhijian; Li, Wenjuan; Zhao, Ping; Fan, Wenxia; Luo, Zhiwei; Li, Yuan; Wu, Yasong; Hutchins, Andrew P.; Wang, Dongye; Qin, Baoming; Bao, Xichen; Yao, Hongjie; Pei, Duanqing; Esteban, Miguel A.] Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [He, Minghui; Li, Xiangchun; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Zhang, Meng] Anhui Univ, Sch Life Sci, Hefei 230601, Peoples R China; [Liu, Longqi; Xu, Yan; Benda, Christina; Zhuang, Qiang; Li, Wenjuan; Zhao, Ping; Luo, Zhiwei; Wu, Yasong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Lu, Leina; Sun, Hao; Wang, Huating] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Dongye] Guangzhou Inst Biomed & Hlth, Drug Discovery Pipeline Grp, Guangzhou 510530, Guangdong, Peoples R China; [Tse, Hung-Fat] Univ Hong Kong, Queen Mary Hosp, Dept Med, Cardiol Div, Hong Kong, Hong Kong, Peoples R China; [Tse, Hung-Fat; Qin, Baoming; Pei, Duanqing; Esteban, Miguel A.] Univ Hong Kong, Hong Kong Guangdong Joint Lab Stem Cell & Regener, Hong Kong, Hong Kong, Peoples R China; [Tse, Hung-Fat; Qin, Baoming; Pei, Duanqing; Esteban, Miguel A.] Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Tse, Hung-Fat] Univ Hong Kong, Shenzhen Inst Res, Hong Kong, Hong Kong, Peoples R China; [Tse, Hung-Fat] Univ Hong Kong, Shenzhen Inst Innovat, Hong Kong, Hong Kong, Peoples R China; [Schambach, Axel] Hannover Med Sch, Dept Expt Hematol, D-30625 Hannover, Germany; [Frampton, Jon] Univ Birmingham, Coll Med & Dent Sci, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England; [Zhang, Biliang] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Lab RNA Chem Biol, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Beijing Genomics Institute (BGI); Anhui University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Hong Kong; University of Hong Kong; Hannover Medical School; University of Birmingham; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease	Xu, Y (corresponding author), Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Lab Chromatin & Human Dis, Guangzhou 510530, Guangdong, Peoples R China.	xu_yan@gibh.ac.cn; miguel@gibh.ac.cn	Tse, Hung-Fat/C-4426-2009; Sun, Hao/J-9964-2013; Schambach, Axel/C-5491-2011; Wang, Huating/C-6719-2014; Qin, Baoming/G-1553-2015; Sun, Hao/T-5576-2019; Tian, Weihua/AAC-8919-2022; sun, hao/GRS-7732-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; Hutchins, Andrew/O-5708-2018	Tse, Hung-Fat/0000-0002-9578-7808; Sun, Hao/0000-0002-5547-9501; Wang, Huating/0000-0001-5474-2905; Qin, Baoming/0000-0001-7652-161X; Sun, Hao/0000-0002-5547-9501; Wang, Jun/0000-0002-2113-5874; Tian, Weihua/0000-0003-2357-3947; Xu, Yan/0000-0001-5653-291X; Wang, Jun/0000-0002-8540-8931; Hutchins, Andrew/0000-0001-7784-2255; Tse, Hung Fat/0000-0003-4665-7887	Ministry of Science and Technology of China 973 program [2011CB965201]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020106]; National Science Foundation of China [31371513, 31271391]; Bureau of Science, Technology, and Information of Guanghzou Municipality [2012J5100040]; International Science and Technology Cooperation Program of China [2013DFE33080]; Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China [476310]; Theme Based Research Scheme [T12-705/11]; Innovation and Technology Support Programme (Tier 3) [ITS/303/12]; Medical Research Council [MR/K008781/1] Funding Source: researchfish; MRC [MR/K008781/1] Funding Source: UKRI	Ministry of Science and Technology of China 973 program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science, Technology, and Information of Guanghzou Municipality; International Science and Technology Cooperation Program of China; Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Theme Based Research Scheme; Innovation and Technology Support Programme (Tier 3); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all members of the Esteban lab for their support and Jiekai Chen, Hong Song, Yongqiang Chen, Tianran Peng, Jing Liu, Keyu Lai, Yingying Li, Xiujuan Cai, Rongping Luo, and Shijuan Huang for technical assistance. This work was supported by grants to M. A. E. from the Ministry of Science and Technology of China 973 program (2011CB965201), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01020106), the National Science Foundation of China (31371513), the Bureau of Science, Technology, and Information of Guanghzou Municipality (2012J5100040), and the International Science and Technology Cooperation Program of China (2013DFE33080). H. W. is funded by Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China (476310). H.Y. is funded by the National Science Foundation of China (31271391). H. T. is funded by Theme Based Research Scheme (T12-705/11) and Innovation and Technology Support Programme (Tier 3) (ITS/303/12).	Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Chen JK, 2010, J BIOL CHEM, V285, P31066, DOI 10.1074/jbc.M110.139436; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; Hong P, 2012, J CLIN INVEST, V122, P3873, DOI 10.1172/JCI62818; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Pijnappel WWMP, 2013, NATURE, V495, P516, DOI 10.1038/nature11970; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Romano G, 2008, CELL CYCLE, V7, P3664, DOI 10.4161/cc.7.23.7122; Rowland B. D., 2006, NAT REV CANCER, V6, P11; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sindhu C, 2012, J BIOL CHEM, V287, P30922, DOI 10.1074/jbc.R111.319046; Smith E, 2013, GENE DEV, V27, P1079, DOI 10.1101/gad.215137.113; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115; Zhuang Q, 2013, J BIOL CHEM, V288, P12022, DOI 10.1074/jbc.M113.460766	37	45	47	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					574	588		10.1016/j.stem.2014.09.018	http://dx.doi.org/10.1016/j.stem.2014.09.018			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25312495	Bronze			2022-12-28	WOS:000345012700011
J	Parson, AB				Parson, Ann B.			Alan Trounson, CIRM's Departed President: Surprises, Optimism, Malaise	CELL STEM CELL			English	News Item												parson-a@verizon.net							0	0	0	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					403	405		10.1016/j.stem.2014.09.001	http://dx.doi.org/10.1016/j.stem.2014.09.001			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25405247	Bronze			2022-12-28	WOS:000343235800006
J	Aurora, AB; Olson, EN				Aurora, Arin B.; Olson, Eric N.			Immune Modulation of Stem Cells and Regeneration	CELL STEM CELL			English	Review							ZEBRAFISH HEART REGENERATION; ACTIVATED MACROPHAGES; AXON REGENERATION; FACTOR-I; INFLAMMATION; MONOCYTES; INJURY; MOUSE; ANGIOGENESIS; HOMEOSTASIS	The immune system, best known as the first line of defense against invading pathogens, is integral to tissue development, homeostasis, and wound repair. In recent years, there has been a growing appreciation that cellular and humoral components of the immune system also contribute to regeneration of damaged tissues, including limbs, skeletal muscle, heart, and the nervous system. Here, we discuss key findings that implicate inflammatory cells and their secreted factors in tissue replacement after injury via stem cells and other reparative mechanisms. We highlight clinical conditions that are amenable to immune-mediated regeneration and suggest immune targeting strategies for tissue regeneration.	[Aurora, Arin B.; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Aurora, Arin B.; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu			NIH [HL-077439, HL-111665, HL-093039, DK-099653, U01-HL-100401]; Foundation Leducq Networks of Excellence; Cancer Prevention and Research Institute of Texas; Robert A. Welch Foundation [1-0025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093039, R01HL077439, R01HL111665, U01HL100401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099653] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq Networks of Excellence(Leducq Foundation); Cancer Prevention and Research Institute of Texas; Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Jose Cabrera for graphics. We apologize to authors whose papers we could not cite due to space limitations. Work in the laboratory of E.N.O. is supported by grants from the NIH (HL-077439, HL-111665, HL-093039, DK-099653, and U01-HL-100401), Foundation Leducq Networks of Excellence, the Cancer Prevention and Research Institute of Texas, and the Robert A. Welch Foundation (grant 1-0025 to E.N.O.).	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Barrette B, 2008, J NEUROSCI, V28, P9363, DOI 10.1523/JNEUROSCI.1447-08.2008; Binet F, 2013, CELL METAB, V17, P353, DOI 10.1016/j.cmet.2013.02.003; Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Evans MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3081; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Foote AK, 2005, BRAIN, V128, P528, DOI 10.1093/brain/awh417; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Fukazawa T, 2009, DEVELOPMENT, V136, P2323, DOI 10.1242/dev.033985; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; Gyorki DE, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2353; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kaikita K, 2004, AM J PATHOL, V165, P439, DOI 10.1016/S0002-9440(10)63309-3; Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; King MW, 2012, ANAT REC, V295, P1552, DOI 10.1002/ar.22443; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Kurimoto T, 2013, J NEUROSCI, V33, P14816, DOI 10.1523/JNEUROSCI.5511-12.2013; Kwon MJ, 2013, J NEUROSCI, V33, P15095, DOI 10.1523/JNEUROSCI.0278-13.2013; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Larson BJ, 2010, PLAST RECONSTR SURG, V126, P1172, DOI 10.1097/PRS.0b013e3181eae781; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Leuschner F, 2010, CIRC RES, V107, P1364, DOI 10.1161/CIRCRESAHA.110.227454; Lilla JN, 2010, DEV BIOL, V337, P124, DOI 10.1016/j.ydbio.2009.10.021; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; Mescher AL, 2005, ADV BIOCHEM ENG BIOT, V93, P39, DOI 10.1007/b99966; Mescher AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080477; Minino AM, 2011, NATL VITAL STAT REP, V59, P1; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Patel S, 2009, CURR TOP MED CHEM, V9, P599, DOI 10.2174/156802609789007327; Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Porrello ER, 2010, CIRC RES, V107, P1292, DOI 10.1161/CIRCRESAHA.110.235168; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rae F, 2007, DEV BIOL, V308, P232, DOI 10.1016/j.ydbio.2007.05.027; Ramos P, 2013, NAT MED, V19, P437, DOI 10.1038/nm.3126; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Santini MP, 2012, J CARDIOVASC TRANSL, V5, P700, DOI 10.1007/s12265-012-9383-6; Scheerer N, 2013, J IMMUNOL, V191, P407, DOI 10.4049/jimmunol.1103779; Setzu A, 2006, GLIA, V54, P297, DOI 10.1002/glia.20371; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Smart N, 2010, ANN NY ACAD SCI, V1194, P97, DOI 10.1111/j.1749-6632.2010.05478.x; Stefater JA, 2013, BLOOD, V121, P2574, DOI 10.1182/blood-2012-06-434621; Stefater JA, 2011, TRENDS MOL MED, V17, P743, DOI 10.1016/j.molmed.2011.07.009; Stella N, 2012, SCIENCE, V338, P1303, DOI 10.1126/science.1232331; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Zordan P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.558	87	187	191	5	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					15	26		10.1016/j.stem.2014.06.009	http://dx.doi.org/10.1016/j.stem.2014.06.009			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24996166	Green Accepted, Bronze			2022-12-28	WOS:000340878600007
J	Carreras, E; Kovats, S				Carreras, Esther; Kovats, Susan			Girl Power: Estrogen Promotes HSC Self-Renewal	CELL STEM CELL			English	Editorial Material							INCREASES HEMATOPOIETIC STEM; CELLS; BONE	Although some hematopoietic cell types are known to respond to sex hormones, hematopoietic stem cells (HSCs) are generally thought to function similarly in both sexes. Recently in Nature, Nakada et al. (2014) show that HSCs respond to higher levels of estrogen in females, resulting in enhanced self-renewal and increased erythropoiesis.	[Carreras, Esther] Ctr Esther Koplovitz, Inst Invest Biomed August Pi & Sunyer, Immune Receptors Innate & Adapt Syst Team, Barcelona 08036, Spain; [Kovats, Susan] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Oklahoma Medical Research Foundation	Kovats, S (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	susan-kovats@omrf.org	Carreras, Esther/U-7518-2019	Carreras, Esther/0000-0001-9184-8266; Kovats, Susan/0000-0001-5479-9952	NIAID NIH HHS [R21 AI092511, NIH AI92511] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092511] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Band AM, 2011, J MAMMARY GLAND BIOL, V16, P109, DOI 10.1007/s10911-011-9203-7; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Illing A, 2012, HAEMATOL-HEMATOL J, V97, P1131, DOI 10.3324/haematol.2011.052456; Kovats S, 2010, SEX HORMONES AND IMMUNITY TO INFECTION, P53, DOI 10.1007/978-3-642-02155-8_3; Medina KL, 2001, NAT IMMUNOL, V2, P718, DOI 10.1038/90659; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; Schuettpelz LG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00204; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007	10	5	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					137	138		10.1016/j.stem.2014.01.016	http://dx.doi.org/10.1016/j.stem.2014.01.016			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24506879	Green Accepted, Bronze			2022-12-28	WOS:000330835800004
J	Xie, HF; Xu, J; Hsu, JH; Nguyen, M; Fujiwara, Y; Peng, C; Orkin, SH				Xie, Huafeng; Xu, Jian; Hsu, Jessie H.; Minh Nguyen; Fujiwara, Yuko; Peng, Cong; Orkin, Stuart H.			Polycomb Repressive Complex 2 Regulates Normal Hematopoietic Stem Cell Function in a Developmental-Stage-Specific Manner	CELL STEM CELL			English	Article							HISTONE METHYLTRANSFERASE EZH2; ACUTE LYMPHOBLASTIC-LEUKEMIA; GROUP PROTEIN EZH2; B-CELL; SOMATIC MUTATIONS; GENE EZH2; MYELOID MALIGNANCIES; PROGENITOR CELLS; PROSTATE-CANCER; SELF-RENEWAL	Recent studies point to a pivotal role of Polycomb repressive complex 2 (PRC2) in stem cell function and cancer. Loss-of-function approaches targeting individual PRC2 subunits have, however, generated findings that are difficult to reconcile. Here, we prevent assembly of both Ezh1- and Ezh2-containing PRC2 complexes by conditional deletion of Eed, a core subunit, and assess hematopoiesis. We find that deletion of Eed exhausts adult bone marrow hematopoietic stem cells (HSCs), although fetal liver HSCs are produced in normal numbers. Eed-null neonatal HSCs express HSC signature genes but are defective in maintenance and differentiation. Comparative gene expression profiling revealed that neonatal and adult HSCs lacking Eed upregulated gene sets of conflicting pathways. Deletion of Cdkn2a, a PRC2 target gene, in Eed-null mice enhances hematopoietic stem/progenitor cell (HSPC) survival but fails to restore HSC functions. Taken together, our findings define developmental-stagespecific requirements for canonical PRC2 complexes in normal HSC function.	[Xie, Huafeng; Xu, Jian; Hsu, Jessie H.; Minh Nguyen; Fujiwara, Yuko; Peng, Cong; Orkin, Stuart H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Xie, Huafeng; Xu, Jian; Hsu, Jessie H.; Minh Nguyen; Fujiwara, Yuko; Peng, Cong; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Hematol Oncol,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Fujiwara, Yuko; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu			National Institutes of Health [CA105423]; Harvard Stem Cell Institute Blood Program; National Institute of Diabetes and Digestive and Kidney Diseases Career Development Award [K01DK093543]; NATIONAL CANCER INSTITUTE [U01CA105423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216, K01DK093543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute Blood Program; National Institute of Diabetes and Digestive and Kidney Diseases Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge Matthias Stadtfeld, Jennifer Trowbridge, and Boris Wilson for critical review of the manuscript. This work was supported in part by National Institutes of Health U01 grant CA105423 and the Harvard Stem Cell Institute Blood Program. S.H.O. is an investigator of the Howard Hughes Medical Institute (HHMI). H. X. was a Leukemia and Lymphoma Society fellow. J.X., an HHMI-Helen Hay Whitney Foundation fellow, is supported by a National Institute of Diabetes and Digestive and Kidney Diseases Career Development Award K01DK093543.	Auvray C, 2012, HAEMATOL-HEMATOL J, V97, P168, DOI 10.3324/haematol.2011.051235; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Costa G, 2012, DEVELOPMENT, V139, P1587, DOI 10.1242/dev.071282; Daga A, 2000, EXP HEMATOL, V28, P569, DOI 10.1016/S0301-472X(00)00135-1; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Gandillet A, 2009, BLOOD, V114, P4813, DOI 10.1182/blood-2009-06-226290; Harrison DE, 1997, EXP HEMATOL, V25, P293; Herrera-Merchan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1623; Hidalgo I, 2012, CELL STEM CELL, V11, P649, DOI 10.1016/j.stem.2012.08.001; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Ji M, 2008, BLOOD, V112, P1068, DOI 10.1182/blood-2008-01-133504; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Li HJ, 2010, BLOOD, V116, P1060, DOI 10.1182/blood-2009-11-255075; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; Majewski IJ, 2008, PLOS BIOL, V6, P796, DOI 10.1371/journal.pbio.0060093; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Mochizuki-Kashio M, 2011, BLOOD, V118, P6553, DOI 10.1182/blood-2011-03-340554; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Neff T, 2012, P NATL ACAD SCI USA, V109, P5028, DOI 10.1073/pnas.1202258109; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Puda A, 2012, AM J HEMATOL, V87, P245, DOI 10.1002/ajh.22257; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi J, 2013, ONCOGENE, V32, P930, DOI 10.1038/onc.2012.110; Simon C, 2012, GENE DEV, V26, P651, DOI 10.1101/gad.186411.111; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Ueda T, 2012, LEUKEMIA, V26, P2557, DOI 10.1038/leu.2012.146; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	60	227	230	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					68	80		10.1016/j.stem.2013.10.001	http://dx.doi.org/10.1016/j.stem.2013.10.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24239285	Green Accepted, Bronze			2022-12-28	WOS:000329571900010
J	Varga, J; Greten, FR				Varga, Julia; Greten, Florian R.			Lifting the Mist on Gastric Stem Cells	CELL STEM CELL			English	Editorial Material							STOMACH; EPITHELIUM	In a recent issue of Cancer Cell, Hayakawa et al. (2015) demonstrate that Mist1(+) gastric stem cells are supported by a specialized niche composed of Cxcl12(+) endothelium and Wnt5a-producing Cxcr4(+) innate lymphoid cells. In diffuse-type gastric cancer this perivascular stem cell niche is expanded and can be exploited for cancer therapy.	[Varga, Julia; Greten, Florian R.] Inst Tumor Biol & Expt Therapy, Georg Speyer Haus,Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany	Octapharma	Greten, FR (corresponding author), Inst Tumor Biol & Expt Therapy, Georg Speyer Haus,Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany.	greten@gsh.uni-frankfurt.de	Greten, Florian R/AAF-5196-2020	Greten, Florian R/0000-0002-3928-6080; Varga, Julia/0000-0002-5171-3671				[Anonymous], [No title captured]; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Hayakawa Y, 2015, CANCER CELL, V28, P800, DOI 10.1016/j.ccell.2015.10.003; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008	8	3	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					7	9		10.1016/j.stem.2015.12.008	http://dx.doi.org/10.1016/j.stem.2015.12.008			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26748749	Bronze			2022-12-28	WOS:000372321300004
J	Li, Q; Ip, YT				Li, Qi; Ip, Y. Tony			More Frequent than Desired: Midgut Stem Cell Somatic Mutations	CELL STEM CELL			English	Editorial Material							DROSOPHILA; CANCER; REGENERATION; CRYPT	The accumulation of somatic mutations in adult stem cells contributes to the decline of tissue functions and cancer initiation. In this issue of Cell Stem Cell, Siudeja et al. (2015) investigate the rate and mechanism of naturally occurring mutations in Drosophila midgut intestinal stem cells during aging and find high-frequency mutations arising from multiple mechanisms.	[Li, Qi; Ip, Y. Tony] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Ip, YT (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	tony.ip@umassmed.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107457] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1TR000161] Funding Source: Medline; NIDDK NIH HHS [DK83450, R01 DK083450] Funding Source: Medline; NIGMS NIH HHS [GM107457, R01 GM107457] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buchon N., 2015, INSECT BIOC IN PRESS; Carulli AJ, 2015, DEV BIOL, V402, P98, DOI 10.1016/j.ydbio.2015.03.012; Garcia AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r121; Lucchetta EM, 2012, WIRES DEV BIOL, V1, P781, DOI 10.1002/wdev.51; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Patel PH, 2015, NAT CELL BIOL, V17, P1182, DOI 10.1038/ncb3214; Philpott A, 2014, CURR OPIN CELL BIOL, V31, P39, DOI 10.1016/j.ceb.2014.07.002; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Wang YH, 2015, EMBO REP, V16, P1084, DOI 10.15252/embr.201439675	9	1	1	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					639	640		10.1016/j.stem.2015.11.011	http://dx.doi.org/10.1016/j.stem.2015.11.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26637937	Bronze			2022-12-28	WOS:000366139100002
J	Ohgushi, M; Minaguchi, M; Sasai, Y				Ohgushi, Masatoshi; Minaguchi, Maki; Sasai, Yoshiki			Rho-Signaling-Directed YAP/TAZ Activity Underlies the Long-Term Survival and Expansion of Human Embryonic Stem Cells	CELL STEM CELL			English	Article							HIPPO PATHWAY; SELF-RENEWAL; LBC ONCOGENE; AKAP-LBC; ACTIN; PROTEIN; GROWTH; YAP; DIFFERENTIATION; CYTOSKELETON	Human embryonic stem cells (hESCs) can survive and proliferate for an extended period of time in culture, but unlike that of tumor-derived cells, this form of cellular immortality does not depend on genomic aberrations. In this study, we sought to elucidate the molecular basis of this long-term growth property of hESCs. We found that the survival of hESCs depends on the small GTPase Rho and its activator AKAP-Lbc. We show that AKAP-Lbc/Rho signaling sustains the nuclear function of the transcriptional cofactors YAP and TAZ by modulating actin microfilament organization. By inducing reprogramming and differentiation, we found that dependency on this Rho signaling pathway is associated with the pluripotent state. Thus, our findings show that the capacity of hESCs to undergo long-term expansion in vitro is intrinsically coupled to their cellular identity through interconnected molecular circuits that link cell survival to pluripotency.	[Ohgushi, Masatoshi; Minaguchi, Maki; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Unit Human Stem Cell Technol, Kobe, Hyogo 6500047, Japan; [Ohgushi, Masatoshi; Minaguchi, Maki; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Lab Organogenesis & Neurogenesis, Kobe, Hyogo 6500047, Japan; [Ohgushi, Masatoshi] RIKEN, Ctr Dev Biol, Lab Pluripotent Stem Cell Studies, Kobe, Hyogo 6500047, Japan	RIKEN; RIKEN; RIKEN	Ohgushi, M (corresponding author), RIKEN, Ctr Dev Biol, Unit Human Stem Cell Technol, Kobe, Hyogo 6500047, Japan.	mohgushi@cdb.riken.jp			Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT); Research Center Network for Realization of Regenerative Medicine from the Japan Science and Technology Agency (JST); JSPS	Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Center Network for Realization of Regenerative Medicine from the Japan Science and Technology Agency (JST); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to A. Munazah and S. Kuraku for RNA-sequence (seq) experiments and data processing; H. Miyoshi for lentivirus vectors; A. Nagy for a PBase vector; H. Niwa for PiggyBac vectors; D. Nukaya for technical advices for RPE differentiation; Y. Imai for technical support with microscopic analyses; H. Inomata, M. Eiraku, N. Love, A. Kuwahara, M. Ikeya, H.D. Sipp, H. Sasaki, H. Niwa, and M. Takeichi for discussion and fruitful comments on the manuscript; and A. Ohgushi and all members of the Sasai group for support and encouragement. M.O. offers special thanks to Dr. Yoshiki Sasai for his enthusiastic mentoring, expresses tremendous respect for his passion for science, and is proud of the precious time he spent on the Sasai team. This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) (M.O. and Y.S.), the Research Center Network for Realization of Regenerative Medicine from the Japan Science and Technology Agency (JST) (Y.S.), and grant-in-aid for Young Scientist (B) from JSPS (M.O.).	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lucas EP, 2013, J CELL BIOL, V201, P875, DOI 10.1083/jcb.201210073; Mayers CM, 2010, J BIOL CHEM, V285, P12344, DOI 10.1074/jbc.M110.106856; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; MORII N, 1990, J BIOCHEM-TOKYO, V107, P769, DOI 10.1093/oxfordjournals.jbchem.a123123; Morikawa Y, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005781; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Olson MF, 1997, ONCOGENE, V15, P2827, DOI 10.1038/sj.onc.1201594; Porazinski S, 2015, NATURE, V521, P217, DOI 10.1038/nature14215; Qin H, 2012, HUM MOL GENET, V21, P2054, DOI 10.1093/hmg/dds023; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tremblay AM, 2012, SEMIN CELL DEV BIOL, V23, P818, DOI 10.1016/j.semcdb.2012.08.001; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang X, 2015, NATURE, V522, P173, DOI 10.1038/nature14484; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; ZHENG Y, 1995, J BIOL CHEM, V270, P9031, DOI 10.1074/jbc.270.16.9031	38	116	118	2	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 1	2015	17	4					448	461		10.1016/j.stem.2015.07.009	http://dx.doi.org/10.1016/j.stem.2015.07.009			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4TS	26321201	Bronze			2022-12-28	WOS:000365693800011
J	Brooks, MD; Burness, ML; Wicha, MS				Brooks, Michael D.; Burness, Monika L.; Wicha, Max S.			Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer	CELL STEM CELL			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; MAMMARY STEM-CELLS; KINASE 4/6 INHIBITOR; ADJUVANT TRASTUZUMAB; SIGNALING PATHWAY; INITIATING CELLS; GENE-EXPRESSION; TUMOR-GROWTH; PHASE-II; IN-VITRO	Cellular heterogeneity represents one of the greatest challenges in cancer therapeutics. In many malignancies, this heterogeneity is generated during tumor evolution through a combination of genetic alterations and epigenetic events that recapitulate normal developmental processes including stem cell self-renewal and differentiation. Many, if not most, tumors display similar hierarchal organization, at the apex of which are "stem-like cells'' that drive tumor growth, mediate metastasis, and contribute to treatment resistance. Using breast cancer as a model, we discuss how an improved understanding of tumor cellular heterogeneity and plasticity may lead to development of more effective therapeutic strategies.	[Brooks, Michael D.; Burness, Monika L.; Wicha, Max S.] Univ Michigan, Ctr Comprehens Canc, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Wicha, MS (corresponding author), Univ Michigan, Ctr Comprehens Canc, Dept Internal Med, Ann Arbor, MI 48109 USA.	mwicha@umich.edu	Wicha, Max/AAE-7268-2019		NIH [R01-CA129765-06A1, R01-CA101860-06]; Breast Cancer Research Foundation; Komen For Cure Foundation; Alfred Taubman Research Institute; Dompe Pharmaceuticals; MedImmune; Cormorant Pharmaceuticals; NATIONAL CANCER INSTITUTE [R01CA101860, R01CA129765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Komen For Cure Foundation; Alfred Taubman Research Institute; Dompe Pharmaceuticals; MedImmune(AstraZenecaMedimmune); Cormorant Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Jill Granger for her help editing the manuscript. The Wicha laboratory is supported, in part, by NIH grants R01-CA129765-06A1 and R01-CA101860-06, The Breast Cancer Research Foundation, Komen For the Cure Foundation, and the Alfred Taubman Research Institute. M.S.W. has financial holdings and is a scientific advisor for OncoMed Pharmaceuticals; is a scientific advisor for Verastem, Paganini, and MedImmune; and receives research support from Dompe Pharmaceuticals, MedImmune, and Cormorant Pharmaceuticals.	Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hussaini H, 2011, MOL CANCER THER, V10, P9, DOI 10.1158/1535-7163.MCT-10-0677; Alamgeer M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3648; Arendt LM, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0453-3; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Bicaku E, 2008, CANCER RES, V68, P1513, DOI 10.1158/0008-5472.CAN-07-2822; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Conley SJ, 2015, BREAST CANCER RES TR, V150, P559, DOI 10.1007/s10549-015-3349-8; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Deng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088034; Dent RA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3484; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fabi A, 2010, ONCOLOGY-BASEL, V78, P141, DOI 10.1159/000312656; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Harrison H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3396; Hodges-Gallagher L, 2007, BREAST CANCER RES TR, V105, P297, DOI 10.1007/s10549-006-9459-6; Holm K, 2012, MOL ONCOL, V6, P494, DOI 10.1016/j.molonc.2012.06.002; Honeth G, 2015, STEM CELL REP, V4, P699, DOI 10.1016/j.stemcr.2015.02.013; Horwitzt KB, 2008, P NATL ACAD SCI USA, V105, P5774, DOI 10.1073/pnas.0706216105; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ithimakin S, 2013, CANCER RES, V73, P1635, DOI 10.1158/0008-5472.CAN-12-3349; Jansen MPHM, 2013, CANCER RES, V73, P6632, DOI 10.1158/0008-5472.CAN-13-0704; Junankar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7548; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; King TD, 2012, J CELL BIOCHEM, V113, P13, DOI 10.1002/jcb.23350; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Koren S., 2015, NATURE IN PRESS; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2013, CANCER RES, V73, P3489, DOI 10.1158/0008-5472.CAN-13-0260; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lamb R, 2013, CELL CYCLE, V12, P2384, DOI 10.4161/cc.25403; Leder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014366; Lee M. Y., 2015, NATURE IN PRESS; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Luu TH, 2008, CLIN CANCER RES, V14, P7138, DOI 10.1158/1078-0432.CCR-08-0122; Magnani L, 2013, P NATL ACAD SCI USA, V110, pE1490, DOI 10.1073/pnas.1219992110; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Maugeri-Sacca M, 2012, MOL CANCER THER, V11, P1627, DOI 10.1158/1535-7163.MCT-11-1040; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Pal B, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0585-0; Pan Q, 2015, STEM CELLS, V33, P2085, DOI 10.1002/stem.2039; Pantel K, 2013, CANCER RES, V73, P6384, DOI 10.1158/0008-5472.CAN-13-2030; Park YH, 2014, BRIT J CANCER, V110, P384, DOI 10.1038/bjc.2013.757; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Piva M, 2014, EMBO MOL MED, V6, P66, DOI 10.1002/emmm.201303411; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rajaram RD, 2015, EMBO J, V34, P641, DOI 10.15252/embj.201490434; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Ruiterkamp J, 2011, BREAST CANCER RES TR, V128, P495, DOI 10.1007/s10549-011-1349-x; Samanta D, 2014, P NATL ACAD SCI USA, V111, pE5429, DOI 10.1073/pnas.1421438111; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schott AF, 2013, CLIN CANCER RES, V19, P1512, DOI 10.1158/1078-0432.CCR-11-3326; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Shen YQ, 2013, CLIN CANCER RES, V19, P5003, DOI 10.1158/1078-0432.CCR-13-1391; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stankic M, 2013, CELL REP, V5, P1228, DOI 10.1016/j.celrep.2013.11.014; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X; Sylvester PW, 2014, CLIN TRANSL MED, V3, DOI 10.1186/s40169-014-0030-5; Thomas S, 2011, BREAST CANCER RES TR, V130, P437, DOI 10.1007/s10549-011-1364-y; Tsavaris N, 2002, BRIT J CANCER, V87, P21, DOI 10.1038/sj.bjc.6600347; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Vignot S, 2013, J CLIN ONCOL, V31, P2167, DOI 10.1200/JCO.2012.47.7737; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Wagner A. D., 2012, COCHRANE DB SYST REV, V2012; Wang XY, 2012, J BIOMED RES, V26, P325, DOI 10.7555/JBR.26.20110050; Yao DB, 2011, MOL CANCER RES, V9, P1608, DOI 10.1158/1541-7786.MCR-10-0568; Zhang M, 2015, CANCER DISCOV, V5, P520, DOI 10.1158/2159-8290.CD-14-1101; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhang XB, 2012, EUR J CANCER, V48, P1581, DOI 10.1016/j.ejca.2012.02.053; Zhang XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030174; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	124	253	258	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					260	271		10.1016/j.stem.2015.08.014	http://dx.doi.org/10.1016/j.stem.2015.08.014			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26340526	Green Accepted, Bronze			2022-12-28	WOS:000364011000006
J	Sweet, DJ				Sweet, Deborah J.			Stamceller in Translation	CELL STEM CELL			English	Editorial Material																		Brand A, 2015, LEARN PUBL, V28, P151, DOI 10.1087/20150211	1	0	0	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					571	571		10.1016/j.stem.2015.05.012	http://dx.doi.org/10.1016/j.stem.2015.05.012			1	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26046752	Bronze			2022-12-28	WOS:000355932300001
J	Sahai-Hernandez, P; Traver, D				Sahai-Hernandez, Pankaj; Traver, David			Intimacy of the Niche: Perivascular Remodeling Cuddles Incoming HSCs	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS	Stem cells reside in "niches,'' which provide signaling cues necessary for self-renewal. In a recent issue of Cell, Tamplin et al. (2015) perform live imaging of hematopoietic stem and progenitor cells (HSPCs) and find dynamic remodeling of endothelial cells is triggered upon arrival of HSPCs at the caudal hematopoietic tissue.	[Sahai-Hernandez, Pankaj; Traver, David] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Traver, D (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	dtraver@ucsd.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074482] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007695] Funding Source: Medline; NIDDK NIH HHS [R01 DK074482] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bee T, 2009, BLOOD, V113, P5121, DOI 10.1182/blood-2008-12-193003; Clements WK, 2013, NAT REV IMMUNOL, V13, P336, DOI 10.1038/nri3443; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Joseph C, 2013, CELL STEM CELL, V13, P520, DOI 10.1016/j.stem.2013.10.010; Kang JJ, 2012, INT IMMUNOPHARMACOL, V12, P249, DOI 10.1016/j.intimp.2011.11.018; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032	10	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					109	110		10.1016/j.stem.2015.01.011	http://dx.doi.org/10.1016/j.stem.2015.01.011			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25658365	Bronze, Green Accepted			2022-12-28	WOS:000349455000004
J	Serpooshan, V; Wu, SM				Serpooshan, Vahid; Wu, Sean M.			Patching Up Broken Hearts: Cardiac Cell Therapy Gets a Bioengineered Boost	CELL STEM CELL			English	Editorial Material							MYOCARDIAL-INFARCTION; REPAIR	Preclinical and clinical studies for cardiac cell therapy have only seen moderate success due to poor engraftment and survival of transplanted cells. In this issue of Cell Stem Cell, Ye et al. (2014) employ a growth-factor-loaded fibrin patch and show improved cardiovascular cell survival after cell transplantation into a porcine model of ischemia reperfusion.	[Serpooshan, Vahid; Wu, Sean M.] Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Wu, Sean M.] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Wu, Sean M.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Wu, SM (corresponding author), Stanford Cardiovasc Inst, Stanford, CA 94305 USA.	smwu@stanford.edu		Wu, Sean/0000-0002-0000-3821; Serpooshan, Vahid/0000-0002-5304-095X	NATIONAL LIBRARY OF MEDICINE [DP1LM012179] Funding Source: NIH RePORTER; NLM NIH HHS [DP1 LM012179] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004; Serpooshan V, 2013, BIOMATERIALS, V34, P9048, DOI 10.1016/j.biomaterials.2013.08.017; Xiong Q, 2012, CIRC RES, V111, P455, DOI 10.1161/CIRCRESAHA.112.269894; Xiong QA, 2011, STEM CELLS, V29, P367, DOI 10.1002/stem.580; Ye L, 2014, CELL STEM CELL, V15, P750, DOI 10.1016/j.stem.2014.11.009; Ye L, 2013, CIRC RES, V113, P922, DOI 10.1161/CIRCRESAHA.113.300216	9	11	11	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					671	673		10.1016/j.stem.2014.11.008	http://dx.doi.org/10.1016/j.stem.2014.11.008			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25479741	Bronze, Green Accepted			2022-12-28	WOS:000347174300002
J	Hackett, JA; Surani, MA				Hackett, Jamie A.; Surani, M. Azim			Regulatory Principles of Pluripotency: From the Ground State Up	CELL STEM CELL			English	Review							EMBRYONIC STEM-CELLS; GENOMIC METHYLATION PATTERNS; SELF-RENEWAL; DNA METHYLATION; NAIVE PLURIPOTENCY; SIGNALING PATHWAYS; SYNERGISTIC ACTION; BETA-CATENIN; EPIBLAST; NANOG	Pluripotency is the remarkable capacity of a single cell to engender all the specialized cell types of an adult organism. This property can be captured indefinitely through derivation of self-renewing embryonic stem cells (ESCs), which represent an invaluable platform to investigate cell fate decisions and disease. Recent advances have revealed that manipulation of distinct signaling cues can render ESCs in a uniform "ground state" of pluripotency, which more closely recapitulates the pluripotent naive epiblast. Here we discuss the extrinsic and intrinsic regulatory principles that underpin the nature of pluripotency and consider the emerging spectrum of pluripotent states.	[Hackett, Jamie A.; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Hackett, Jamie A.; Surani, M. Azim] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Cambridge CB2 1QN, England; [Hackett, Jamie A.; Surani, M. Azim] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge; University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England.	a.surani@gurdon.cam.ac.uk		Hackett, Jamie/0000-0002-6237-3684	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank members of the M.A.S. lab for helpful comments and apologize to colleagues whose work could not be cited owing to space constraints. Work in the M.A.S. lab is supported by the Wellcome Trust.	Abranches E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059928; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bao SQ, 2012, CELL STEM CELL, V11, P110, DOI 10.1016/j.stem.2012.02.023; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Carter AC, 2014, STEM CELL REP, V2, P119, DOI 10.1016/j.stemcr.2013.12.010; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chappell J, 2013, GENE DEV, V27, P725, DOI 10.1101/gad.211300.112; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen YY, 2013, STEM CELL REP, V1, P209, DOI 10.1016/j.stemcr.2013.07.003; Christophorou MA, 2014, NATURE, V507, P104, DOI 10.1038/nature12942; Chu LF, 2011, CURR BIOL, V21, P1759, DOI 10.1016/j.cub.2011.09.010; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Do DV, 2013, GENE DEV, V27, P1378, DOI 10.1101/gad.221176.113; De Los Angeles A, 2012, CURR OPIN GENET DEV, V22, P272, DOI 10.1016/j.gde.2012.03.001; Denissov S, 2014, DEVELOPMENT, V141, P526, DOI 10.1242/dev.102681; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Fang RG, 2014, CELL STEM CELL, V15, P488, DOI 10.1016/j.stem.2014.09.004; Faunes F, 2013, DEVELOPMENT, V140, P1171, DOI 10.1242/dev.085654; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Filipczyk A, 2013, CELL STEM CELL, V13, P12, DOI 10.1016/j.stem.2013.04.025; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gardner RL, 1997, INT J DEV BIOL, V41, P235; Gillich A, 2012, CELL STEM CELL, V10, P425, DOI 10.1016/j.stem.2012.01.020; Grabole N, 2013, EMBO REP, V14, P629, DOI 10.1038/embor.2013.67; Guo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018189; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hassani SN, 2014, STEM CELL REV REP, V10, P16, DOI 10.1007/s12015-013-9473-0; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hirano K, 2012, STEM CELLS DEV, V21, P1287, DOI 10.1089/scd.2011.0283; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jasnos L, 2013, STEM CELL REP, V1, P360, DOI 10.1016/j.stemcr.2013.08.005; Kanda A, 2012, J REPROD DEVELOP, V58, P77, DOI 10.1262/jrd.10-178A; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Leeb M, 2014, CELL STEM CELL, V14, P385, DOI 10.1016/j.stem.2013.12.008; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2011, ANNU REV GENOM HUM G, V12, P165, DOI 10.1146/annurev-genom-082410-101506; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Malaguti M, 2013, ELIFE, V2, DOI 10.7554/eLife.01197; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McEwen KR, 2013, BIOCHEM SOC T, V41, P711, DOI 10.1042/BST20130049; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Oda M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003574; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Ohtsuka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045220; Okashita N, 2014, DEVELOPMENT, V141, P269, DOI 10.1242/dev.099622; Ooi SKT, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-17; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schulz EG, 2014, CELL STEM CELL, V14, P203, DOI 10.1016/j.stem.2013.11.022; Schwarz BA, 2014, CURR BIOL, V24, P347, DOI 10.1016/j.cub.2013.12.050; Shipony Z, 2014, NATURE, V513, P115, DOI 10.1038/nature13458; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith A, 2013, CELL STEM CELL, V13, P6, DOI 10.1016/j.stem.2013.06.016; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Tai CI, 2013, J CELL SCI, V126, P1093, DOI 10.1242/jcs.118273; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tee WW, 2014, CELL, V156, P678, DOI 10.1016/j.cell.2014.01.009; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen T.W., 2014, CELL STEM CELL; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Valamehr B, 2014, STEM CELL REP, V2, P366, DOI 10.1016/j.stemcr.2014.01.014; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Ye SD, 2013, EMBO J, V32, P2548, DOI 10.1038/emboj.2013.175; Yeo JC, 2014, CELL STEM CELL, V14, P864, DOI 10.1016/j.stem.2014.04.015; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; YOSHIDA K, 1994, MECH DEVELOP, V45, P163, DOI 10.1016/0925-4773(94)90030-2; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	150	235	243	2	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					416	430		10.1016/j.stem.2014.09.015	http://dx.doi.org/10.1016/j.stem.2014.09.015			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25280218	Bronze			2022-12-28	WOS:000343235800009
J	Huang, K; Maruyama, T; Fan, GP				Huang, Kevin; Maruyama, Toru; Fan, Guoping			The Naive State of Human Pluripotent Stem Cells: A Synthesis of Stem Cell and Preimplantation Embryo Transcriptome Analyses	CELL STEM CELL			English	Editorial Material							GROUND-STATE; EPIBLAST; DERIVATION; INDUCTION; CIRCUITRY; MASS	Here we use a systems biology approach to comprehensively assess the conservation of gene networks in naive pluripotent stem cells (PSCs) with preimplantation embryos. While gene networks in murine naive and primed pluripotent states are reproducible across data sets, different sources of human stem cells display high degrees of variation, partly reflecting disparities in culture conditions. Finally, naive gene networks between human and mouse PSCs are not well conserved and better resemble their respective blastocysts.	[Huang, Kevin; Maruyama, Toru; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Huang, Kevin; Fan, Guoping] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Maruyama, Toru] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Waseda University	Huang, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	khuang1@gmail.com; gfan@mednet.ucla.edu			NIH [DE 022928]; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE022928] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We would like to thank Rudolf Jaenisch and Thorold W. Theunissen for their insightful comments on our paper. This study is supported by NIH grant DE 022928. K. H. is supported by the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.	Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Fang RG, 2014, CELL STEM CELL, V15, P488, DOI 10.1016/j.stem.2014.09.004; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	20	114	119	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					410	415		10.1016/j.stem.2014.09.014	http://dx.doi.org/10.1016/j.stem.2014.09.014			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25280217	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000343235800008
J	Price, T; Sipkins, DA				Price, Trevor; Sipkins, Dorothy A.			Rewiring the Niche: Sympathetic Neuropathy Drives Malignant Niche Transformation	CELL STEM CELL			English	Editorial Material							BONE-MARROW NICHE; STEM-CELL NICHE	In recent years, it has become increasingly evident that hematological malignancies can alter their microenvironment, but the therapeutic implications of these changes and potential targets have not been well characterized. Recent findings now describe how sympathetic neuropathy can drive malignant transformation of the hematopoietic stem cell niche in hematopoietic malignancies.	[Price, Trevor; Sipkins, Dorothy A.] Duke Univ, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA	Duke University	Sipkins, DA (corresponding author), Duke Univ, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA.	dorothy.sipkins@duke.edu						Arranz L, 2014, NATURE, V512, P78, DOI 10.1038/nature13383; Boyerinas B, 2013, BLOOD, V121, P4821, DOI 10.1182/blood-2012-12-475483; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Doan PL, 2012, LEUKEMIA, V26, P54, DOI 10.1038/leu.2011.236; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Hanoun M, 2014, CELL STEM CELL, V15, P365, DOI 10.1016/j.stem.2014.06.020; Hu XX, 2009, BLOOD, V114, P3783, DOI 10.1182/blood-2009-06-227843; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009	10	5	5	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					261	262		10.1016/j.stem.2014.08.012	http://dx.doi.org/10.1016/j.stem.2014.08.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25192459	Bronze			2022-12-28	WOS:000341441600004
J	Wu, T; Liu, YF; Wen, DC; Tseng, ZT; Tahmasian, M; Zhong, M; Rafii, S; Stadtfeld, M; Hochedlinger, K; Xiao, A				Wu, Tao; Liu, Yifei; Wen, Duancheng; Tseng, Zito; Tahmasian, Martik; Zhong, Mei; Rafii, Shahin; Stadtfeld, Matthias; Hochedlinger, Konrad; Xiao, Andrew			Histone Variant H2A.X Deposition Pattern Serves as a Functional Epigenetic Mark for Distinguishing the Developmental Potentials of iPSCs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; TRANSCRIPTION FACTORS; GENOMIC INSTABILITY; REGULATORY NETWORKS; GENES; DIFFERENTIATION; CHROMATIN; FATE; CDX2	For future application of induced pluripotent stem cell (iPSC) technology, the ability to assess the overall quality of iPSC clones will be an important issue. Here we show that the histone variant H2A.X is a functional marker that can distinguish the developmental potentials of mouse iPSC lines. We found that H2A.X is specifically targeted to and negatively regulates extraembryonic lineage gene expression in embryonic stem cells (ESCs) and prevents trophectoderm lineage differentiation. ESC-specific H2A.X deposition patterns are faithfully recapitulated in iPSCs that support the development of "all-iPS'' animals via tetraploid complementation, the most stringent test available of iPSC quality. In contrast, iPSCs that fail to support all-iPS embryonic development show aberrant H2A.X deposition, upregulation of extraembryonic lineage genes, and a predisposition to extraembryonic differentiation. Thus, our work has highlighted an epigenetic mechanism for maintaining cell lineage commitment in ESCs and iPSCs that can be used to distinguish the quality of iPSC lines.	[Wu, Tao; Liu, Yifei; Tseng, Zito; Tahmasian, Martik; Zhong, Mei; Xiao, Andrew] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Wu, Tao; Liu, Yifei; Tseng, Zito; Tahmasian, Martik; Xiao, Andrew] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Wen, Duancheng; Rafii, Shahin] Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Zhong, Mei] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Stadtfeld, Matthias; Hochedlinger, Konrad] Harvard Univ, Howard Hughes Med Inst, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Stadtfeld, Matthias; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Med, Boston, MA 02114 USA	Yale University; Yale University; Cornell University; Yale University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University	Xiao, A (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, 333 Cedar St, New Haven, CT 06520 USA.	andrew.xiao@yale.edu	Wu, Tao/A-1063-2013; Liu, Yifei/H-1730-2014	Wu, Tao/0000-0002-9859-4534; Rafii, Shahin/0000-0001-5605-1067; Wen, Duancheng/0000-0002-3160-6289; Stadtfeld, Matthias/0000-0002-5852-9906	Howard Teming Award from NCI [K99/R00 CA1311560]; Yale startup funding; CT Stem Cell Foundation [11SCA34]	Howard Teming Award from NCI; Yale startup funding; CT Stem Cell Foundation	We thank Dr. Fredrick Alt (Harvard Medical School) for providing H2A.X KO ESC, Drs. David Gilbert and Tyrone Ryba for sharing the data, Dr. Anna-Katerina Hadjantonakis and Dr. Nestor Saiz Arenales for TSC line (TS3.5-GFP). A. X. is supported by a Howard Teming Award from NCI (K99/R00 CA1311560) and Yale startup funding. T. W. is partially supported by CT Stem Cell Foundation (11SCA34).	Adachi K, 2013, MOL CELL, V52, P380, DOI 10.1016/j.molcel.2013.09.002; Banaszynski LA, 2010, DEV CELL, V19, P662, DOI 10.1016/j.devcel.2010.10.014; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Fragola G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003292; Gonzalez F, 2013, CELL REP, V3, P651, DOI 10.1016/j.celrep.2013.02.005; Haffner-Krausz R, 1999, MECH DEVELOP, V85, P167, DOI 10.1016/S0925-4773(99)00082-9; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Micsinai M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks048; Muller LUW, 2012, BLOOD, V119, P5449, DOI 10.1182/blood-2012-02-408674; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Oda M, 2006, METHOD ENZYMOL, V419, P387, DOI 10.1016/S0076-6879(06)19015-1; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909	38	46	50	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					281	294		10.1016/j.stem.2014.06.004	http://dx.doi.org/10.1016/j.stem.2014.06.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25192463	Bronze			2022-12-28	WOS:000341441600009
J	Yanger, K; Knigin, D; Zong, YW; Maggs, L; Gu, GQ; Akiyama, H; Pikarsky, E; Stanger, BZ				Yanger, Kilangsungla; Knigin, David; Zong, Yiwei; Maggs, Lara; Gu, Guoqiang; Akiyama, Haruhiko; Pikarsky, Eli; Stanger, Ben Z.			Adult Hepatocytes Are Generated by Self-Duplication Rather than Stem Cell Differentiation	CELL STEM CELL			English	Article							LIVER PROGENITOR CELLS; INJURED MOUSE-LIVER; OVAL CELLS; PARTIAL-HEPATECTOMY; EPITHELIAL-CELLS; BETA-CELLS; IN-VITRO; REGENERATION; TRANSDIFFERENTIATION; PROLIFERATION	The liver is thought to utilize facultative stem cells, also known as "oval cells'' or "atypical ductal cells'' (ADCs), for regeneration following various types of injury. However, this notion has been based largely on in vitro studies and transplantation models; where lineage tracing has been used, results have been conflicting and effect sizes have been small. Here, we used genetic and nucleoside analog-based tools to mark and track the origin and contribution of various cell populations to liver regeneration in vivo following several ADC-inducing insults. We report that, contrary to prevailing stem-cell-based models of regeneration, virtually all new hepatocytes come from preexisting hepatocytes.	[Yanger, Kilangsungla; Zong, Yiwei; Maggs, Lara; Stanger, Ben Z.] Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Yanger, Kilangsungla; Zong, Yiwei; Maggs, Lara; Stanger, Ben Z.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Stanger, Ben Z.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Knigin, David; Pikarsky, Eli] Hadassah Hebrew Univ, Dept Immunol & Canc Res, Med Ctr, IL-91120 Jerusalem, Israel; [Knigin, David; Pikarsky, Eli] Hadassah Hebrew Univ, Dept Pathol, Med Ctr, IL-91120 Jerusalem, Israel; [Knigin, David] Hadassah Hebrew Univ, Dept Obstet & Gynecol, Med Ctr, IL-91120 Jerusalem, Israel; [Gu, Guoqiang] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Akiyama, Haruhiko] Gifu Univ, Dept Orthoped, Gifu 5011194, Japan	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Vanderbilt University; Gifu University	Stanger, BZ (corresponding author), Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA.	bstanger@exchange.upenn.edu	Yanger, Kilang/N-2888-2015; pikarsky, eli/GXV-7099-2022	Yanger, Kilang/0000-0002-1710-5306; Maggs, Lara/0000-0002-8642-2540; Knigin, David/0000-0001-9264-2796; pikarsky, eli/0000-0003-4186-7105	National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases [P30DK050306]; Public Health Service grant [DK083355]; European Research Council [281738 LIVERMICROENV]; Pew Charitable Trusts; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, R01DK065949, P30DK050306, R01DK083355] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases; Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); European Research Council(European Research Council (ERC)European Commission); Pew Charitable Trusts; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank V. Factor and D. Melton for providing A6 and Krt19 antibodies, respectively. We are grateful to A. Panikkar and C. Yang for technical assistance and the Abramson Family Center Research Institute histology core for sample processing. We are indebted to F. Camargo, K. Kaestner, K. Zaret, J. Rajagopal, and L. Greenbaum for helpful discussions and especially grateful to A. Penzo-Mendez for insightful comments on the manuscript. This work was supported in part by the National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases (P30DK050306) and its core facilities (Molecular Pathology and Imaging Core, Molecular Biology/Gene Expression Core, Transgenic and Chimeric Mouse Core, and Cell Culture Core), as well as by Public Health Service grant DK083355 (to B. Z. S.), a grant from the European Research Council within the FP-7 (281738 LIVERMICROENV to E. P.), and an award from the Pew Charitable Trusts (to B. Z. S.).	Alison MR, 2004, CELL PROLIFERAT, V37, P1, DOI 10.1111/j.1365-2184.2004.00297.x; Bird TG, 2008, CELL TISSUE RES, V331, P283, DOI 10.1007/s00441-007-0542-z; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Choi TY, 2014, GASTROENTEROLOGY, V146, P776, DOI 10.1053/j.gastro.2013.10.019; Coombes J, 2013, GASTROENTEROLOGY, V145, P254, DOI 10.1053/j.gastro.2013.02.051; Crawford AR, 1998, HEPATOLOGY, V28, P323, DOI 10.1002/hep.510280206; DESMET VJ, 1985, J HEPATOL, V1, P545, DOI 10.1016/S0168-8278(85)80752-2; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; EVARTS RP, 1989, CANCER RES, V49, P1541; EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737; Faa G, 1998, J HEPATOL, V29, P628, DOI 10.1016/S0168-8278(98)80158-X; FACTOR VM, 1994, AM J PATHOL, V145, P409; FARBER E, 1956, CANCER RES, V16, P142; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Friedman JR, 2011, J CLIN INVEST, V121, P4630, DOI 10.1172/JCI59652; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; GREENBAUM LE, 1995, J CLIN INVEST, V96, P1351, DOI 10.1172/JCI118170; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; GRISHAM J. W., 1964, EXP MOL PATHOL, V3, P242, DOI 10.1016/0014-4800(64)90057-7; He J., 2014, GASTROENTEROLOGY, V6, pe8, DOI DOI 10.1053/J.GASTR0.2013.11.045]; He JB, 2014, GASTROENTEROLOGY, V146, P789, DOI 10.1053/j.gastro.2013.11.045; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Limaye PB, 2008, LAB INVEST, V88, P865, DOI 10.1038/labinvest.2008.56; Limaye PB, 2008, HEPATOLOGY, V47, P1702, DOI 10.1002/hep.22221; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Nishikawa Y, 2005, AM J PATHOL, V166, P1077, DOI 10.1016/S0002-9440(10)62328-0; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Overturf K, 1997, AM J PATHOL, V151, P1273; POPPER HANS, 1957, JOUR MT SINAI HOSP, V24, P551; Preisegger KH, 1999, LAB INVEST, V79, P103; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Saxena R, 2004, SEMIN LIVER DIS, V24, P43; Scholten D, 2010, GASTROENTEROLOGY, V139, P987, DOI 10.1053/j.gastro.2010.05.005; Sekiya S, 2014, AM J PATHOL, V184, P1468, DOI 10.1016/j.ajpath.2014.01.005; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanimizu N, 2014, J BIOL CHEM, V289, P7589, DOI 10.1074/jbc.M113.517243; Tarlow B.D., 2014, HEPATOLOGY; TATEMATSU M, 1984, AM J PATHOL, V114, P418; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Theise ND, 1999, HEPATOLOGY, V30, P1425, DOI 10.1002/hep.510300614; Wang LL, 2010, MOL THER, V18, P118, DOI 10.1038/mt.2009.246; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Yamazaki Y, 2011, LAB INVEST, V91, P1624, DOI 10.1038/labinvest.2011.115; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Yanger K, 2011, DEV DYNAM, V240, P521, DOI 10.1002/dvdy.22561; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	55	289	299	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					340	349		10.1016/j.stem.2014.06.003	http://dx.doi.org/10.1016/j.stem.2014.06.003			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25130492	Green Accepted, Bronze			2022-12-28	WOS:000341441600013
J	Kannan, N; Eaves, CJ				Kannan, Nagarajan; Eaves, Connie J.			Tipping the Balance: MTDH-SND1 Curbs Oncogene-Induced Apoptosis and Promotes Tumorigenesis	CELL STEM CELL			English	Editorial Material							TELOMERE DYSFUNCTION; CANCER; CELLS; SND1	Tumorigenesis is a complex and poorly understood process in which oncogenes can activate competing proapoptotic and proneoplastic programs. A recent paper in Cancer Cell demonstrates a dual role of the MTDH-SND1 complex in suppressing the apoptotic response and promoting breast cancer development, suggesting a new therapeutic avenue.	[Kannan, Nagarajan; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency	Eaves, CJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca		Kannan, Nagarajan/0000-0002-8825-2178; Eaves, Connie/0000-0002-3452-1926				Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Blanco MA, 2011, J BIOL CHEM, V286, P19982, DOI 10.1074/jbc.M111.240077; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Huang SJ, 2014, BIOCHEM BIOPH RES CO, V444, P338, DOI 10.1016/j.bbrc.2014.01.046; Kannan N, 2014, P NATL ACAD SCI USA, V111, P7789, DOI 10.1073/pnas.1403813111; Kannan N, 2013, STEM CELL REP, V1, P28, DOI 10.1016/j.stemcr.2013.04.003; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Wan LL, 2014, CANCER CELL, V26, P92, DOI 10.1016/j.ccr.2014.04.027; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460	10	7	7	3	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					118	120		10.1016/j.stem.2014.07.010	http://dx.doi.org/10.1016/j.stem.2014.07.010			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	25105576	Bronze			2022-12-28	WOS:000340880100005
J	Zhu, Z; Khan, MA; Weiler, M; Blaes, J; Jestaedt, L; Geibert, M; Zou, P; Gronych, J; Bernhardt, O; Korshunov, A; Bugner, V; Lichter, P; Radlwimmer, B; Heiland, S; Bendszus, M; Wick, W; Liu, HK				Zhu, Zhe; Khan, Muhammad Amir; Weiler, Markus; Blaes, Jonas; Jestaedt, Leonie; Geibert, Madeleine; Zou, Peng; Gronych, Jan; Bernhardt, Olga; Korshunov, Andrey; Bugner, Verena; Lichter, Peter; Radlwimmer, Bernhard; Heiland, Sabine; Bendszus, Martin; Wick, Wolfgang; Liu, Hai-Kun			Targeting Self-Renewal in High-Grade Brain Tumors Leads to Loss of Brain Tumor Stem Cells and Prolonged Survival	CELL STEM CELL			English	Article							NUCLEAR RECEPTOR TAILLESS; MOUSE MODELS; TLX; GROWTH; CANCER; IDENTIFICATION; EXPRESSION; GLIOMA; GLIOMAGENESIS; TRANSCRIPTION	Cancer stem cells (CSCs) have been suggested as potential therapeutic targets for treating malignant tumors, but the in vivo supporting evidence is still missing. Using a GFP reporter driven by the promoter of the nuclear receptor tailless (Tlx), we demonstrate that Tlx(+) cells in primary brain tumors are mostly quiescent. Lineage tracing demonstrates that single Tlx(+) cells can self-renew and generate Tlx(-) tumor cells in primary tumors, suggesting that they are brain tumor stem cells (BTSCs). After introducing a BTSC-specific knock-out of the Tlx gene in primary mouse tumors, we observed a loss of self-renewal of BTSCs and prolongation of animal survival, accompanied by induction of essential signaling pathways mediating cell-cycle arrest, cell death, and neural differentiation. Our study demonstrates the feasibility of targeting glioblastomas and indicates the suitability of BTSCs as therapeutic targets, thereby supporting the CSC hypothesis.	[Zhu, Zhe; Khan, Muhammad Amir; Geibert, Madeleine; Zou, Peng; Bernhardt, Olga; Liu, Hai-Kun] German Canc Res Ctr, DKFZ ZMBH Alliance, Normal & Neoplast CNS Stem Cells, Helmholtz Young Investigator Grp, D-69120 Heidelberg, Germany; [Weiler, Markus; Blaes, Jonas; Wick, Wolfgang] German Canc Res Ctr, Clin Cooperat Unit Neurooncol, D-69120 Heidelberg, Germany; [Gronych, Jan; Bugner, Verena; Lichter, Peter; Radlwimmer, Bernhard] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Weiler, Markus; Wick, Wolfgang] Univ Clin Heidelberg, Dept Neurooncol, D-69120 Heidelberg, Germany; [Weiler, Markus; Wick, Wolfgang] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Jestaedt, Leonie; Heiland, Sabine; Bendszus, Martin] Univ Heidelberg Hosp, Dept Neuroradiol, D-69120 Heidelberg, Germany; [Korshunov, Andrey] Univ Heidelberg Hosp, Dept Neuropathol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Liu, HK (corresponding author), German Canc Res Ctr, DKFZ ZMBH Alliance, Normal & Neoplast CNS Stem Cells, Helmholtz Young Investigator Grp, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	l.haikun@dkfz-heidelberg.de	Zhu, Zhe/H-6009-2019; Wick, Wolfgang/AAA-2545-2020; Radlwimmer, Bernhard F/I-3229-2013	Zhu, Zhe/0000-0002-5385-948X; Wick, Wolfgang/0000-0002-6171-634X; Radlwimmer, Bernhard F/0000-0002-4553-7800; liu, hai-kun/0000-0003-3338-4066; Korshunov, Andrey/0000-0002-5257-3623	Helmholtz Association [VH-NG-702]; Deutsche Forschungsgemeinschaft [LI 2140/1-1]; Deutsche Krebshilfe [110226]; Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC); DKFZ Intramural Grant Program; DKFZ-Bayer Healthcare Alliance	Helmholtz Association(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC); DKFZ Intramural Grant Program; DKFZ-Bayer Healthcare Alliance	We thank Gunther Schutz for providing mice, the Imaging Facility of the Deutsches Krebsforschungszentrum (DKFZ) and the Carl Zeiss Imaging Center at the DKFZ for their support with image acquisition, the DKFZ Genomic Facility for their support in the microarray experiment, Eric Holland for providing the RCAS constructs, and Weijun Feng and Patricia Rusu for critical reading of the manuscript. This work was supported by the Helmholtz Association (VH-NG-702), the Deutsche Forschungsgemeinschaft (LI 2140/1-1), the Deutsche Krebshilfe (110226), the Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC), and the DKFZ Intramural Grant Program. This work was also supported in part by a grant from the DKFZ-Bayer Healthcare Alliance.	Barrett LE, 2012, CANCER CELL, V21, P11, DOI 10.1016/j.ccr.2011.11.025; Belz T, 2007, EUR J NEUROSCI, V26, P2222, DOI 10.1111/j.1460-9568.2007.05841.x; BICKENBACH JR, 1981, J DENT RES, V60, P1611, DOI 10.1177/002203458106000311011; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Feng WJ, 2013, CELL STEM CELL, V13, P62, DOI 10.1016/j.stem.2013.05.002; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; KAY MMB, 1975, P NATL ACAD SCI USA, V72, P3521, DOI 10.1073/pnas.72.9.3521; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; MONAGHAN AP, 1995, DEVELOPMENT, V121, P839; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang CL, 2006, GENE DEV, V20, P1308, DOI 10.1101/gad.1413606; Zou YH, 2012, MOL CELL BIOL, V32, P4811, DOI 10.1128/MCB.01122-12	38	98	103	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					185	198		10.1016/j.stem.2014.04.007	http://dx.doi.org/10.1016/j.stem.2014.04.007			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	24835569	Bronze			2022-12-28	WOS:000340880100011
J	Chung, YG; Eum, JH; Lee, JE; Shim, SH; Sepilian, V; Hong, SW; Lee, Y; Treff, NR; Choi, YH; Kimbrel, EA; Dittman, RE; Lanza, R; Lee, DR				Chung, Young Gie; Eum, Jin Hee; Lee, Jeoung Eun; Shim, Sung Han; Sepilian, Vicken; Hong, Seung Wook; Lee, Yumie; Treff, Nathan R.; Choi, Young Ho; Kimbrel, Erin A.; Dittman, Ralph E.; Lanza, Robert; Lee, Dong Ryul			Human Somatic Cell Nuclear Transfer Using Adult Cells	CELL STEM CELL			English	Article							FETAL; STATE	Derivation of patient-specific human pluripotent stem cells via somatic cell nuclear transfer (SCNT) has the potential for applications in a range of therapeutic contexts. However, successful SCNT with human cells has proved challenging to achieve, and thus far has only been reported with fetal or infant somatic cells. In this study, we describe the application of a recently developed methodology for the generation of human ESCs via SCNT using dermal fibroblasts from 35- and 75-year-old males. Our study therefore demonstrates the applicability of SCNT for adult human cells and supports further investigation of SCNT as a strategy for regenerative medicine.	[Chung, Young Gie; Lee, Yumie; Lee, Dong Ryul] CHA Hlth Syst, Res Inst Stem Cell Res, Los Angeles, CA 90036 USA; [Chung, Young Gie; Eum, Jin Hee; Lee, Jeoung Eun; Lee, Dong Ryul] CHA Univ, CHA Stem Cell Inst, Seoul 135081, South Korea; [Shim, Sung Han; Lee, Dong Ryul] CHA Univ 135 081, Dept Biomed Sci, Seoul 135081, South Korea; [Sepilian, Vicken; Hong, Seung Wook] CHA Fertil Ctr, Los Angeles, CA 90036 USA; [Treff, Nathan R.] Reprod Med Associates New Jersey, Basking Ridge, NJ 07920 USA; [Choi, Young Ho] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Kimbrel, Erin A.; Lanza, Robert] Adv Cell Technol, Marlborough, MA 01752 USA; [Dittman, Ralph E.] Stem Cell Source LLC, Houston, TX 77056 USA	Pochon Cha University; Reproductive Medicine Associates of New Jersey; Texas A&M University System; Texas A&M University College Station	Chung, YG (corresponding author), CHA Hlth Syst, Res Inst Stem Cell Res, Los Angeles, CA 90036 USA.	ychung@chahealthsystems.com; drleedr@cha.ac.kr	Chung, Young Gie/AAC-8149-2020	Lanza, Robert/0000-0002-3047-3074	Stem Cell Research grant from the Sung Kwang Medical Foundation; Bio & Medical Technology Development Program - Ministry of Science, ICT and Future Planning, Republic of Korea [2012M3A9C6049723]	Stem Cell Research grant from the Sung Kwang Medical Foundation; Bio & Medical Technology Development Program - Ministry of Science, ICT and Future Planning, Republic of Korea	We thank Irina Klimanskaya at ACT for her helpful comments. This research was partly supported by a Stem Cell Research grant from the Sung Kwang Medical Foundation and a grant from the Bio & Medical Technology Development Program (2012M3A9C6049723) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea. R. L. and E. K. are employees at Advanced Cell Technology, a biotechnology company in the area of stem cells and regenerative medicine.	Aston KI, 2006, REPRODUCTION, V131, P45, DOI 10.1530/rep.1.00714; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Chung Y, 2009, CLONING STEM CELLS, V11, P213, DOI 10.1089/clo.2009.0004; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Lanza RP, 1999, NAT BIOTECHNOL, V17, P1171, DOI 10.1038/70709; Lee JE, 2010, CELL TRANSPLANT, V19, P1383, DOI 10.3727/096368910X513991; Liu L, 2001, Cloning, V3, P51, DOI 10.1089/15204550152475554; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Simerly C, 2003, SCIENCE, V300, P297, DOI 10.1126/science.1082091; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Tian X Cindy, 2003, Reprod Biol Endocrinol, V1, P98, DOI 10.1186/1477-7827-1-98; Treff NR, 2010, FERTIL STERIL, V94, P2017, DOI 10.1016/j.fertnstert.2010.01.052; Wakayama S, 2013, CELL STEM CELL, V12, P293, DOI 10.1016/j.stem.2013.01.005; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zhang P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007844	19	129	136	0	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					777	780		10.1016/j.stem.2014.03.015	http://dx.doi.org/10.1016/j.stem.2014.03.015			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24746675	Bronze			2022-12-28	WOS:000341248500014
J	Wang, L; Du, Y; Ward, JM; Shimbo, T; Lackford, B; Zheng, XF; Miao, YL; Zhou, BY; Han, L; Fargo, DC; Jothi, R; Williams, CJ; Wade, PA; Hu, G				Wang, Li; Du, Ying; Ward, James M.; Shimbo, Takashi; Lackford, Brad; Zheng, Xiaofeng; Miao, Yi-liang; Zhou, Bingying; Han, Leng; Fargo, David C.; Jothi, Raja; Williams, Carmen J.; Wade, Paul A.; Hu, Guang			INO80 Facilitates Pluripotency Gene Activation in Embryonic Stem Cell Self-Renewal, Reprogramming, and Blastocyst Development	CELL STEM CELL			English	Article							CHROMATIN REMODELING COMPLEX; RNAI SCREEN; TRANSCRIPTIONAL NETWORK; GENOME; EXPRESSION; MEDIATOR; OCT4; DIFFERENTIATION; MECHANISMS; OCCUPANCY	The master transcription factors play integral roles in the pluripotency transcription circuitry of embryonic stem cells (ESCs). How they selectively activate expression of the pluripotency network while simultaneously repressing genes involved in differentiation is not fully understood. Here, we define a requirement for the INO80 complex, a SWI/SNF family chromatin remodeler, in ESC self-renewal, somatic cell reprogramming, and blastocyst development. We show that Ino80, the chromatin remodeling ATPase, co-occupies pluripotency gene promoters with the master transcription factors, and its occupancy is dependent on OCT4 and WDR5. At the pluripotency genes, Ino80 maintains an open chromatin architecture and licenses recruitment of Mediator and RNA polymerase II for gene activation. Our data reveal an essential role for INO80 in the expression of the pluripotency network and illustrate the coordination among chromatin remodeler, transcription factor, and histone-modifying enzyme in the regulation of the pluripotent state.	[Wang, Li; Shimbo, Takashi; Lackford, Brad; Zheng, Xiaofeng; Jothi, Raja; Wade, Paul A.; Hu, Guang] NIEHS, Lab Mol Carcinogenesis, Res Triangle Pk, NC 27709 USA; [Du, Ying; Ward, James M.; Fargo, David C.] NIEHS, Res Triangle Pk, NC 27709 USA; [Miao, Yi-liang; Williams, Carmen J.] NIEHS, Lab Reprod & Dev Toxicol, Res Triangle Pk, NC 27709 USA; [Zhou, Bingying] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Zhou, Bingying] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Han, Leng] Univ Texas Houston, Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Wade, PA (corresponding author), NIEHS, Lab Mol Carcinogenesis, Res Triangle Pk, NC 27709 USA.	wadep2@niehs.nih.gov; hug4@niehs.nih.gov	Williams, Carmen J/E-2170-2013; Hu, Guang/E-7474-2016; Wade, Paul A/D-2374-2019; Han, Leng/HCH-3491-2022; Jothi, Raja/G-3780-2015	Williams, Carmen J/0000-0001-6440-7086; Hu, Guang/0000-0003-0437-4723; Wade, Paul A/0000-0002-6042-357X; Han, Leng/0000-0002-7380-2640; Jothi, Raja/0000-0002-4833-1090; Ward, James/0000-0002-9510-2848	NIH, National Institute of Environmental Health Sciences [Z01ES102745, Z01ES101965, Z01ES102985, Z01ES102625]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101965, ZIAES102625, ZIAES102985, Z01ES101965, ZIAES102745, ZICES102445] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Drs. Trevor Archer and Karen Adelman for reading the manuscript. This study was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences Z01ES102745 (to G. H.), Z01ES101965 (to P. A. W.), Z01ES102985 (to C.J.W.), and Z01ES102625 (to R.J.).	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Ansari SA, 2013, CELL MOL LIFE SCI, V70, P2743, DOI 10.1007/s00018-013-1265-9; Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen XF, 2012, CELL REP, V2, P1061, DOI 10.1016/j.celrep.2012.10.019; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Dejosez M, 2012, ANNU REV BIOCHEM, V81, P737, DOI 10.1146/annurev-biochem-052709-104948; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Ku MC, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R85, 10.1186/gb-2012-13-10-r85]; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Mattout A, 2010, CURR OPIN CELL BIOL, V22, P334, DOI 10.1016/j.ceb.2010.02.001; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Ranjan A, 2013, CELL, V154, P1232, DOI 10.1016/j.cell.2013.08.005; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Rossant J., 2006, COLD SPRING HARB PRO; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Wang L, 2013, CELL STEM CELL, V13, P676, DOI 10.1016/j.stem.2013.10.008; Watanabe S, 2010, COLD SH Q B, V75, P35, DOI 10.1101/sqb.2010.75.063; Wei G, 2012, METHOD ENZYMOL, V513, P297, DOI 10.1016/B978-0-12-391938-0.00013-6; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yen KY, 2013, CELL, V154, P1246, DOI 10.1016/j.cell.2013.08.043; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang H, 2013, CELL STEM CELL, V13, P30, DOI 10.1016/j.stem.2013.05.012; Zheng XF, 2012, JOVE-J VIS EXP, DOI 10.3791/3987; Zheng XF, 2012, STEM CELLS, V30, P910, DOI 10.1002/stem.1070	55	107	110	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					575	591		10.1016/j.stem.2014.02.013	http://dx.doi.org/10.1016/j.stem.2014.02.013			17	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24792115	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000335659900008
J	Huang, PY; Zhang, LD; Gao, YM; He, ZY; Yao, D; Wu, ZT; Cen, J; Chen, XT; Liu, CC; Hu, YP; Lai, DM; Hu, ZL; Chen, L; Zhang, Y; Cheng, X; Ma, XJ; Pan, GY; Wang, X; Hui, LJ				Huang, Pengyu; Zhang, Ludi; Gao, Yimeng; He, Zhiying; Yao, Dan; Wu, Zhitao; Cen, Jin; Chen, Xiaotao; Liu, Changcheng; Hu, Yiping; Lai, Dongmei; Hu, Zhenlei; Chen, Li; Zhang, Ying; Cheng, Xin; Ma, Xiaojun; Pan, Guoyu; Wang, Xin; Hui, Lijian			Direct Reprogramming of Human Fibroblasts to Functional and Expandable Hepatocytes	CELL STEM CELL			English	Article							BIOARTIFICIAL LIVER; DRUG-METABOLISM; TRANSCRIPTION FACTORS; P53-DEFICIENT MICE; IN-VIVO; CELLS; CONVERSION; CHALLENGES; INDUCTION; FAILURE	The generation of large numbers of functional human hepatocytes for cell-based approaches to liver disease is an important and unmet goal. Direct reprogramming of fibroblasts to hepatic lineages could offer a solution to this problem but so far has only been achieved with mouse cells. Here, we generated human induced hepatocytes (hiHeps) from fibroblasts by lentiviral expression of FOXA3, HNF1A, and HNF4A. hiHeps express hepatic gene programs, can be expanded in vitro, and display functions characteristic of mature hepatocytes, including cytochrome P450 enzyme activity and biliary drug clearance. Upon transplantation into mice with concanavalin-A-induced acute liver failure and fatal metabolic liver disease due to fumarylacetoacetate dehydrolase (Fah) deficiency, hiHeps restore the liver function and prolong survival. Collectively, our results demonstrate successful lineage conversion of nonhepatic human cells into mature hepatocytes with potential for biomedical and pharmaceutical applications.	[Huang, Pengyu; Zhang, Ludi; Gao, Yimeng; Cen, Jin; Chen, Xiaotao; Cheng, Xin; Hui, Lijian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [He, Zhiying; Liu, Changcheng; Hu, Yiping] Second Mil Med Univ, Dept Cell Biol, Shanghai 200433, Peoples R China; [Yao, Dan; Wu, Zhitao; Pan, Guoyu] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Safety Evaluat & Res, Shanghai 201203, Peoples R China; [Lai, Dongmei] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai 200030, Peoples R China; [Hu, Zhenlei] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai 200127, Peoples R China; [Chen, Li; Zhang, Ying; Ma, Xiaojun] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, Dalian 116023, Peoples R China; [Wang, Xin] Inner Mongolia Univ, Key Lab Natl Educ, Minist Mammalian Reprod Biol & Biotechnol, Hohhot 010021, Peoples R China; [Wang, Xin] Univ Minnesota, Stem Cell Inst, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Wang, Xin] Hepatoscience Inc, Palo Alto, CA 94303 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Naval Medical University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Inner Mongolia University; University of Minnesota System; University of Minnesota Twin Cities	Hui, LJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China.	ljhui@sibcb.ac.cn	Huang, Pengyu/ABH-1721-2021; Huang, Pengyu/ABF-5330-2021	Huang, Pengyu/0000-0001-8394-7280; 	Chinese Academy of Sciences (CAS) [XDA01030301, XDA01020308]; Ministry of Science and Technology (MOST) of China [2012CB945001]; National Science Foundation of China (NSFC) [913193023, 31225016]; MOST of China [2011CB966200]; NSFC [31271469, 31271474, 31271042, 81302836, 21076207, 81101757]; MOST [2012ZX09301001-006, 2012ZX09302003]; CAS (the Hundred Talents Program); CAS [XDA01030303]	Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); MOST of China(Ministry of Science and Technology, China); NSFC(National Natural Science Foundation of China (NSFC)); MOST; CAS (the Hundred Talents Program); CAS(Chinese Academy of Sciences)	We thank Dr. Dangsheng Li for critical suggestions during the manuscript preparation and Min Du and Dr. Yuan Ji for support on histological analysis. The L. H. laboratory is funded by the Chinese Academy of Sciences (CAS; XDA01030301 and XDA01020308), the Ministry of Science and Technology (MOST) of China (2012CB945001), and the National Science Foundation of China (NSFC; 913193023 and 31225016). The X. W. laboratory is funded by the MOST of China (2011CB966200) and the NSFC (31271469, 31271474, and 31271042). The G. P. laboratory is supported by the NSFC (81302836), by the MOST (2012ZX09301001-006, 2012ZX09302003), and by the CAS (the Hundred Talents Program). The X. M. laboratory is supported by the NSFC (21076207 and 81101757) and by the CAS (XDA01030303).	Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Carpentier B, 2009, GUT, V58, P1690, DOI 10.1136/gut.2008.175380; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; Cherry ABC, 2012, CELL, V148, P1110, DOI 10.1016/j.cell.2012.02.031; Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44; Gomez-Lechon MJ, 2004, CURR DRUG METAB, V5, P443, DOI 10.2174/1389200043335414; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guengerich FP, 2002, NAT REV DRUG DISCOV, V1, P359, DOI 10.1038/nrd792; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HARVEY M, 1993, ONCOGENE, V8, P2457; He ZY, 2010, AM J PATHOL, V177, P1311, DOI 10.2353/ajpath.2010.091154; Hengstler Jan G, 2005, Expert Opin Drug Metab Toxicol, V1, P61, DOI 10.1517/17425255.1.1.61; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ji SY, 2013, J CELL BIOCHEM, V114, P256, DOI 10.1002/jcb.24380; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lazaro CA, 2007, AM J PATHOL, V170, P478, DOI 10.2353/ajpath.2007.060789; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liddle C, 2002, SEMIN LIVER DIS, V22, P115, DOI 10.1055/s-2002-30098; Liu XR, 1999, DRUG METAB DISPOS, V27, P637; Mei J, 2009, CELL TRANSPLANT, V18, P101, DOI 10.3727/096368909788237168; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Orive G, 2004, TRENDS BIOTECHNOL, V22, P87, DOI 10.1016/j.tibtech.2003.11.004; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Palakkan AA, 2013, LIVER INT, V33, P666, DOI 10.1111/liv.12134; Pan GY, 2012, J PHARM SCI-US, V101, P1898, DOI 10.1002/jps.23070; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Roger V, 1998, ANN SURG, V228, P1, DOI 10.1097/00000658-199807000-00001; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tiscornia G, 2011, NAT MED, V17, P1570, DOI 10.1038/nm.2504; TSUKADA T, 1993, ONCOGENE, V8, P3313; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Wang Q, 2006, HEPATOL RES, V35, P96, DOI 10.1016/j.hepres.2006.03.003; WONG H, 1986, INT J ARTIF ORGANS, V9, P335, DOI 10.1177/039139888600900515; Xie HG, 2011, J CONTROL RELEASE, V152, pE246, DOI 10.1016/j.jconrel.2011.09.040; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yu Y, 2012, LIVER TRANSPLANT, V18, P9, DOI 10.1002/lt.22467; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	47	346	382	3	103	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					370	384		10.1016/j.stem.2014.01.003	http://dx.doi.org/10.1016/j.stem.2014.01.003			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24582927	Bronze			2022-12-28	WOS:000332533400013
J	Le, RR; Kou, ZH; Jiang, YH; Li, M; Huang, B; Liu, WQ; Li, H; Kou, XC; He, WZ; Rudolph, KL; Ju, ZY; Gao, SR				Le, Rongrong; Kou, Zhaohui; Jiang, Yonghua; Li, Ming; Huang, Bo; Liu, Wenqiang; Li, Hui; Kou, Xiaochen; He, Wanzhong; Rudolph, Karl Lenhard; Ju, Zhenyu; Gao, Shaorong			Enhanced Telomere Rejuvenation in Pluripotent Cells Reprogrammed via Nuclear Transfer Relative to Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							CHROMOSOMAL INSTABILITY; TERMINAL TRANSFERASE; GENOMIC STABILITY; TETRAHYMENA; DISEASE; ZSCAN4; MICE; PROLIFERATION; MITOCHONDRIA; DYSFUNCTION	Although somatic cell nuclear transfer (SCNT) and induction of pluripotency (to form iPSCs) are both recognized reprogramming methods, there has been relatively little comparative analysis of the resulting pluripotent cells. Here, we examine the capacity of these two reprogramming approaches to rejuvenate telomeres using late-generation telomerase- deficient (Terc(-/-)) mice that exhibit telomere dysfunction and premature aging. We found that embryonic stem cells established from Terc(-/-) SCNT embryos (Terc(-/-) ntESCs) have greater differentiation potential and self-renewal capacity than Terc(-/-) iPSCs. Remarkably, SCNT results in extensive telomere lengthening in cloned embryos and improved telomere capping function in the established Terc(-/-) ntESCs. In addition, mitochondrial function is severely impaired in Terc(-/-) iPSCs and their differentiated derivatives but significantly improved in Terc(-/-) ntESCs. Thus, our results suggest that SCNT-mediated reprogramming mitigates telomere dysfunction and mitochondrial defects to a greater extent than iPSC-based reprogramming. Understanding the basis of this differential could help optimize reprogramming strategies.	[Le, Rongrong; Jiang, Yonghua; Liu, Wenqiang] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Le, Rongrong; Kou, Zhaohui; Jiang, Yonghua; Li, Ming; Huang, Bo; Liu, Wenqiang; Kou, Xiaochen; He, Wanzhong; Gao, Shaorong] NIBS, Beijing 102206, Peoples R China; [Li, Hui] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China; [Rudolph, Karl Lenhard] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Ju, Zhenyu] Hangzhou Normal Univ, Inst Aging Res, Sch Med, Hangzhou 310036, Zhejiang, Peoples R China; [Gao, Shaorong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	China Agricultural University; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Zoology, CAS; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Hangzhou Normal University; Tongji University	Ju, ZY (corresponding author), Hangzhou Normal Univ, Inst Aging Res, Sch Med, Hangzhou 310036, Zhejiang, Peoples R China.	zhenyuju@163.com; gaoshaorong@tongji.edu.cn	huang, bo/A-2690-2017	Rudolph, Karl Lenhard/0000-0002-4839-2862	Ministry of Science and Technology [2011CB964800, 2012CB911203, 2011CB812700, 2010CB944900]; National Natural Science Foundation of China [81130074]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank our laboratory colleagues for their assistance with experiments and preparation of the manuscript. We thank Dr. Lin Liu from Nankai University for his thoughtful comments. This work was supported by the Ministry of Science and Technology (2011CB964800, 2012CB911203, 2011CB812700, and 2010CB944900) and the National Natural Science Foundation of China (81130074).	Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Costa V, 2012, EMBO J, V31, P1853, DOI 10.1038/emboj.2012.65; Andrade LND, 2012, HUM MOL GENET, V21, P3825, DOI 10.1093/hmg/dds211; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Donald SP, 2001, CANCER RES, V61, P1810; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Ferron S, 2004, DEVELOPMENT, V131, P4059, DOI 10.1242/dev.01215; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mizutani E, 2008, GENESIS, V46, P478, DOI 10.1002/dvg.20420; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Sancho-Martinez I, 2013, CELL STEM CELL, V13, P141, DOI 10.1016/j.stem.2013.07.013; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Sperka T, 2012, NAT CELL BIOL, V14, P73, DOI 10.1038/ncb2388; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Vaziri H, 2010, REGEN MED, V5, P345, DOI 10.2217/RME.10.21; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wang F, 2012, CELL RES, V22, P757, DOI 10.1038/cr.2011.201; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005	42	44	51	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					27	39		10.1016/j.stem.2013.11.005	http://dx.doi.org/10.1016/j.stem.2013.11.005			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24268696	Bronze			2022-12-28	WOS:000329571900007
J	Taguchi, A; Kaku, Y; Ohmori, T; Sharmin, S; Ogawa, M; Sasaki, H; Nishinakamura, R				Taguchi, Atsuhiro; Kaku, Yusuke; Ohmori, Tomoko; Sharmin, Sazia; Ogawa, Minetaro; Sasaki, Hiroshi; Nishinakamura, Ryuichi			Redefining the In Vivo Origin of Metanephric Nephron Progenitors Enables Generation of Complex Kidney Structures from Pluripotent Stem Cells	CELL STEM CELL			English	Article							INTERMEDIATE MESODERM; MAMMALIAN KIDNEY; RETINOIC ACID; DIFFERENTIATION; MOUSE; EXPRESSION; INDUCTION; SPECIFICATION; MORPHOGENESIS; MESENCHYME	Recapitulating three-dimensional (3D) structures of complex organs, such as the kidney, from pluripotent stem cells (PSCs) is a major challenge. Here, we define the developmental origins of the metanephric mesenchyme (MM), which generates most kidney components. Unexpectedly, we find that posteriorly located T+ MM precursors are developmentally distinct from Osr1(+) ureteric bud progenitors during the postgastrulation stage, and we identify phasic Wnt stimulation and stage-specific growth factor addition as molecular cues that promote their development into the MM. We then use this information to derive MM from PSCs. These progenitors reconstitute the 3D structures of the kidney in vitro, including glomeruli with podocytes and renal tubules with proximal and distal regions and clear lumina. Furthermore, the glomeruli are efficiently vascularized upon transplantation. Thus, by reevaluating the developmental origins of metanephric progenitors, we have provided key insights into kidney specification in vivo and taken important steps toward kidney organogenesis in vitro.	[Taguchi, Atsuhiro; Kaku, Yusuke; Ohmori, Tomoko; Sharmin, Sazia; Nishinakamura, Ryuichi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Kidney Dev, Kumamoto 8600811, Japan; [Ogawa, Minetaro] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Differentiat, Kumamoto 8600811, Japan; [Ogawa, Minetaro; Nishinakamura, Ryuichi] Japan Sci & Technol Agcy, CREST, Kumamoto 8600811, Japan; [Sasaki, Hiroshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Fate Control, Kumamoto 8600811, Japan	Kumamoto University; Kumamoto University; Japan Science & Technology Agency (JST); Kumamoto University	Nishinakamura, R (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Kidney Dev, 2-2-1 Honjo, Kumamoto 8600811, Japan.	ryuichi@kumamoto-u.ac.jp		Taguchi, Atsuhiro/0000-0003-1741-2987	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21116003, 23390228, 32534020]; Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare; Global COE Program (Cell Fate Regulation Research and Education Unit, MEXT); Japan Science and Technology Agency, CREST	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Global COE Program (Cell Fate Regulation Research and Education Unit, MEXT); Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	We thank H. Sakamoto, S. S. Tanaka, Y. Uchiyama, S. Fujimura, N. Takeda, U. Imuta, D. Toyoda, D. Sakano, and K. Suzuki for technical advice and assistance; G. Dressler and K. Asanuma for providing the antibodies; and Y. Tomino for encouragement. This work was supported in part by KAKENHI Grants (21116003, 23390228, and 32534020) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan Society for the Promotion of Science, and the Ministry of Health, Labor and Welfare, the Global COE Program (Cell Fate Regulation Research and Education Unit, MEXT), and the Japan Science and Technology Agency, CREST.	Atsuta Y, 2013, DEV GROWTH DIFFER, V55, P579, DOI 10.1111/dgd.12047; Attia L, 2012, DEVELOPMENT, V139, P4143, DOI 10.1242/dev.085258; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Fleming BM, 2013, DEVELOPMENT, V140, P1819, DOI 10.1242/dev.093740; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Imuta Y, 2013, GENESIS, V51, P210, DOI 10.1002/dvg.22376; James RG, 2006, DEVELOPMENT, V133, P2995, DOI 10.1242/dev.02442; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; MORIYA N, 1993, DEV GROWTH DIFFER, V35, P123; Mugford JW, 2008, DEV BIOL, V319, P396, DOI 10.1016/j.ydbio.2008.03.044; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Narayanan K, 2013, KIDNEY INT, V83, P593, DOI 10.1038/ki.2012.442; Nelson LT, 2008, DEV DYNAM, V237, P3410, DOI 10.1002/dvdy.21756; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Obara-Ishihara T, 1999, DEVELOPMENT, V126, P1103; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; Saxen L., 1987, ORGANOGENESIS KIDNEY; Schnabel CA, 2003, DEV BIOL, V254, P262, DOI 10.1016/S0012-1606(02)00038-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi T, 2001, J AM SOC NEPHROL, V12, P2673, DOI 10.1681/ASN.V12122673; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wellik DM, 2002, GENE DEV, V16, P1423, DOI 10.1101/gad.993302; Williams LA, 2012, CELL, V149, P1174, DOI 10.1016/j.cell.2012.05.015; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	50	486	514	4	61	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					53	67		10.1016/j.stem.2013.11.010	http://dx.doi.org/10.1016/j.stem.2013.11.010			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24332837	Bronze			2022-12-28	WOS:000329571900009
J	Rizzoti, K; Akiyama, H; Lovell-Badge, R				Rizzoti, Karine; Akiyama, Haruhiko; Lovell-Badge, Robin			Mobilized Adult Pituitary Stem Cells Contribute to Endocrine Regeneration in Response to Physiological Demand	CELL STEM CELL			English	Article							RAT ANTERIOR-PITUITARY; PROGENITOR CELLS; ESTROGEN; SOX2; GONADECTOMY; LINEAGES; AXIS	Pituitary hormone deficiencies, with Growth Hormone deficiency being most frequent (1 in 3,50010,000 births), cause significant morbidity. Regeneration of missing endocrine cells would be a significant improvement over hormone replacement therapies, which incur side effects and do not mimic physiological secretion patterns. Recent in vitro studies have identified a population of adult pituitary progenitors that express the HMG box transcription factors SOX2 and SOX9. Here, we apply cell-lineage tracing analysis to demonstrate that SOX2- and SOX9-expressing progenitors can self-renew and give rise to endocrine cells in vivo, suggesting that they are tissue stem cells. Moreover, we show that they can become mobilized and differentiate into the appropriate endocrine cell types in response to physiological stress. Our results highlight the pituitary as a model for exploring how physiological changes influence stem cell behavior and suggest that manipulation of endogenous pituitary stem cells is a potential therapeutic strategy for pituitary deficiencies.	[Rizzoti, Karine; Lovell-Badge, Robin] MRC Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Akiyama, Haruhiko] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068507, Japan	MRC National Institute for Medical Research; Kyoto University	Rizzoti, K (corresponding author), MRC Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England.	krizzot@nimr.mrc.ac.uk	Rizzoti, Karine/AAW-1090-2021	Rizzoti, Karine/0000-0003-0711-5452; Lovell-Badge, Robin/0000-0001-9364-4179	UK Medical Research Council [U117512772]; MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Konrad Hochedlinger (Harvard University) for the Sox2<SUP>CreERT2</SUP> mice and to Larysa Pevny (University of North Carolina) for the Sox2<SUP>EGFP</SUP> animals. We thank Iain Robinson (NIMR), Paul Burgoyne (NIMR), Andy Levy (Bristol University), and Paul LeTissier (NIMR) for helpful discussions. We are indebted to Danielle Carmignac, Confocal Microscopy (Donald Bell and Yan Gu) and Flow Cytometry (Graeme Preece and Bhavik Patel) platforms, and Biological Services for animal husbandry. We would like to thank members of the Lovell-Badge's lab for help and support. This work was supported by the UK Medical Research Council (U117512772). K. R. and R. L.-B. designed the study and wrote the manuscript. K. R performed and analyzed experiments. H. A. provided the Sox9<SUP>ires-CreERT2/+</SUP> mice. The authors declare no competing financial interests with this paper.	Andoniadou CL, 2012, ACTA NEUROPATHOL, V124, P259, DOI 10.1007/s00401-012-0957-9; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Budry L, 2011, P NATL ACAD SCI USA, V108, P12515, DOI 10.1073/pnas.1105929108; Castinetti F, 2011, ENDOCR REV, V32, P453, DOI 10.1210/er.2010-0011; Castrique E, 2010, J ENDOCRINOL, V205, P49, DOI 10.1677/JOE-09-0414; Davis SW, 2011, DEV BIOL, V352, P215, DOI 10.1016/j.ydbio.2011.01.010; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Fu QL, 2012, STEM CELLS DEV, V21, P3245, DOI 10.1089/scd.2012.0290; Fu QL, 2012, ENDOCRINOLOGY, V153, P3224, DOI 10.1210/en.2012-1152; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Gonzalez M, 2008, GEN COMP ENDOCR, V155, P857, DOI 10.1016/j.ygcen.2007.10.007; Grompe M, 2012, CELL STEM CELL, V10, P685, DOI 10.1016/j.stem.2012.04.006; IBRAHIM SN, 1986, ENDOCRINOLOGY, V119, P629, DOI 10.1210/endo-119-2-629; Jayakody SA, 2012, J CLIN INVEST, V122, P3635, DOI 10.1172/JCI64311; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kominami R, 2003, HISTOCHEM CELL BIOL, V120, P223, DOI 10.1007/s00418-003-0565-9; Levy A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740147; Mollard P, 2012, TRENDS ENDOCRIN MET, V23, P261, DOI 10.1016/j.tem.2012.02.004; Nolan LA, 2006, J NEUROENDOCRINOL, V18, P655, DOI 10.1111/j.1365-2826.2006.01459.x; Nolan LA, 2009, J NEUROENDOCRINOL, V21, P457, DOI 10.1111/j.1365-2826.2009.01864.x; Nolan LA, 2006, J ENDOCRINOL, V188, P387, DOI 10.1677/joe.1.06508; Rizzoti K, 2004, NAT GENET, V36, P247, DOI 10.1038/ng1309; Rizzoti K, 2010, EUR J NEUROSCI, V32, P2053, DOI 10.1111/j.1460-9568.2010.07524.x; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Seilicovich A, 2010, J NEUROENDOCRINOL, V22, P758, DOI 10.1111/j.1365-2826.2010.02010.x; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Subburaju S, 2007, ENDOCRINOLOGY, V148, P3102, DOI 10.1210/en.2007-0103; Zhu D, 2010, METHODS MOL BIOL, V616, P207, DOI 10.1007/978-1-60761-461-6_14	33	114	115	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					419	432		10.1016/j.stem.2013.07.006	http://dx.doi.org/10.1016/j.stem.2013.07.006			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094323	Green Published, hybrid			2022-12-28	WOS:000329571100011
J	Mullally, A; Ebert, BL				Mullally, Ann; Ebert, Benjamin L.			Sinister Symbiosis: Pathological Hematopoietic-Stromal Interactions in CML	CELL STEM CELL			English	Editorial Material							STEM-CELL NICHE; LEUKEMIA	The impact of myeloid malignancies on the nonhematopoietic components of the bone marrow remains poorly understood. In this issue of Cell Stem Cell, Schepers et al. (2013) describe how malignant myeloid cells alter the endosteal hematopoietic stem cell (HSC) niche, resulting in the expansion of osteoblastic lineage cells that preferentially support malignant HSCs.	[Mullally, Ann; Ebert, Benjamin L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ebert, BL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol,Dept Med, Boston, MA 02115 USA.	bebert@partners.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL082945] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Koschmieder S, 2005, BLOOD, V105, P324, DOI 10.1182/blood-2003-12-4369; Mullally A, 2012, HEMATOL ONCOL CLIN N, V26, P1065, DOI 10.1016/j.hoc.2012.07.007; Park D, 2012, FRONT BIOSCI-LANDMRK, V17, P30, DOI 10.2741/3913; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534	9	3	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					257	258		10.1016/j.stem.2013.08.009	http://dx.doi.org/10.1016/j.stem.2013.08.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	24012363	Green Accepted, Bronze			2022-12-28	WOS:000329570800001
J	Shin, JW; Mooney, DJ				Shin, Jae-Won; Mooney, David J.			Improving Stem Cell Therapeutics with Mechanobiology	CELL STEM CELL			English	Editorial Material							MATRIX ELASTICITY; PROGENITOR CELLS; HYDROGELS; FATE	In recent years, it has become clear that mechanical cues play an integral role in maintaining stem cell functions. Here we discuss how integrating physical approaches and engineering principles in stem cell biology, including culture systems, preclinical models, and functional assessment, may improve clinical application in regenerative medicine.	[Shin, Jae-Won; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Shin, Jae-Won] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Shin, Jae-Won] Univ Illinois, Coll Med, Dept Bioengn, Chicago, IL 60612 USA	Harvard University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mooney, DJ (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	mooneyd@seas.harvard.edu		Mooney, David/0000-0001-6299-1194	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL125884, K99HL125884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014703] Funding Source: NIH RePORTER; NHLBI NIH HHS [K99 HL125884, R00 HL125884] Funding Source: Medline; NIBIB NIH HHS [R01 EB014703] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Chaudhuri O., 2015, NAT MA IN PRESS 1130; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Holst J, 2010, NAT BIOTECHNOL, V28, P1123, DOI 10.1038/nbt.1687; Huebsch N, 2015, NAT MATER, V14, P1269, DOI [10.1038/NMAT4407, 10.1038/nmat4407]; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Shin JW, 2014, CELL STEM CELL, V14, P81, DOI 10.1016/j.stem.2013.10.009; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104	10	23	23	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					16	19		10.1016/j.stem.2015.12.007	http://dx.doi.org/10.1016/j.stem.2015.12.007			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26748752	Green Accepted, Bronze			2022-12-28	WOS:000372321300007
J	Iwasaki, M; Liedtke, M; Gentles, AJ; Cleary, ML				Iwasaki, Masayuki; Liedtke, Michaela; Gentles, Andrew J.; Cleary, Michael L.			CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia	CELL STEM CELL			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; RECEPTOR-ALPHA CHAIN; GENE-EXPRESSION; HEMATOPOIETIC STEM; ENDOTHELIAL-CELLS; POOR-PROGNOSIS; HYPERMETHYLATION; P15(INK4B); C1QR(P); METHYLATION	Leukemia stem cells (LSCs) are thought to share several properties with hematopoietic stem cells (HSCs), including cell-cycle quiescence and a capacity for self-renewal. These features are hypothesized to underlie leukemic initiation, progression, and relapse, and they also complicate efforts to eradicate leukemia through therapeutic targeting of LSCs without adverse effects on HSCs. Here, we show that acute myeloid leukemias (AMLs) with genomic rearrangements of the MLL gene contain a non-quiescent LSC population. Although human CD34(+)CD38(-) LSCs are generally highly quiescent, the C-type lectin CD93 is expressed on a subset of actively cycling, non-quiescent AML cells enriched for LSC activity. CD93 expression is functionally required for engraftment of primary human AML LSCs and leukemogenesis, and it regulates LSC self-renewal predominantly by silencing CDKN2B, a major tumor suppressor in AML. Thus, CD93 expression identifies a predominantly cycling, non-quiescent leukemia-initiating cell population in MLL-rearranged AML, providing opportunities for selective targeting and eradication of LSCs.	[Iwasaki, Masayuki; Cleary, Michael L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Liedtke, Michaela] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Gentles, Andrew J.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Cleary, ML (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	mcleary@stanford.edu			Children's Health Initiative of the Packard Foundation; California Institute for Regenerative Medicine; Public Health Service (PHS) [CA116606]; NATIONAL CANCER INSTITUTE [R01CA116606] Funding Source: NIH RePORTER	Children's Health Initiative of the Packard Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Public Health Service (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Cita Nicolas and Maria Ambus for technical support, Norm Cyr for graphical assistance, and Ravindra Majeti and Lawrence Okumoto for AML patient samples. We thank Nicholas Leeper and Juraj Bies for providing Cdkn2b knockout mice. We acknowledge support from the Children's Health Initiative of the Packard Foundation, the California Institute for Regenerative Medicine, and Public Health Service (PHS) grant CA116606.	Aggerholm A, 2006, EUR J HAEMATOL, V76, P23, DOI 10.1111/j.1600-0609.2005.00559.x; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Bies J, 2010, BLOOD, V116, P979, DOI 10.1182/blood-2009-08-238360; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chim CS, 2001, J CLIN ONCOL, V19, P2033, DOI 10.1200/JCO.2001.19.7.2033; Danet GH, 2002, P NATL ACAD SCI USA, V99, P10441, DOI 10.1073/pnas.162104799; Dao MA, 2002, BLOOD, V99, P499, DOI 10.1182/blood.V99.2.499; Drexler HG, 1998, LEUKEMIA, V12, P845, DOI 10.1038/sj.leu.2401043; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fonseca MI, 2001, J LEUKOCYTE BIOL, V70, P793; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Herman JG, 1996, CANCER RES, V56, P722; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Iwasaki M, 2005, BLOOD, V105, P784, DOI 10.1182/blood-2004-04-1508; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jan M, 2011, P NATL ACAD SCI USA, V108, P5009, DOI 10.1073/pnas.1100551108; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Krug U, 2002, ONCOGENE, V21, P3475, DOI 10.1038/sj.onc.1205322; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; McGreal EP, 2002, J IMMUNOL, V168, P5222, DOI 10.4049/jimmunol.168.10.5222; Nepomuceno RR, 1997, IMMUNITY, V6, P119, DOI 10.1016/S1074-7613(00)80419-7; Nepomuceno RR, 1998, J IMMUNOL, V160, P1929; Norsworthy PJ, 2004, J IMMUNOL, V172, P3406, DOI 10.4049/jimmunol.172.6.3406; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0; Placke T, 2014, BLOOD, V124, P13, DOI 10.1182/blood-2014-02-558114; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Shimamoto T, 2005, LEUKEMIA RES, V29, P653, DOI 10.1016/j.leukres.2004.11.014; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Teofili L, 2003, LEUKEMIA, V17, P919, DOI 10.1038/sj.leu.2402907; Teofili L, 2000, EXP HEMATOL, V28, P519, DOI 10.1016/S0301-472X(00)00139-9; van Rhenen A, 2007, BLOOD, V110, P2659, DOI 10.1182/blood-2007-03-083048; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wolff L, 2003, ONCOGENE, V22, P9265, DOI 10.1038/sj.onc.1207092; Wong IHN, 2000, BLOOD, V95, P1942, DOI 10.1182/blood.V95.6.1942; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Zhang SL, 2003, ONCOGENE, V22, P2285, DOI 10.1038/sj.onc.1206257	48	72	75	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 1	2015	17	4					412	421		10.1016/j.stem.2015.08.008	http://dx.doi.org/10.1016/j.stem.2015.08.008			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4TS	26387756	Green Accepted, Bronze			2022-12-28	WOS:000365693800008
J	He, QY; Kim, H; Huang, R; Lu, WS; Tang, MF; Shi, FT; Yang, D; Zhang, XY; Huang, JJ; Liu, D; Zhou, SY				He, Quanyuan; Kim, Hyeung; Huang, Rui; Lu, Weisi; Tang, Mengfan; Shi, Fengtao; Yang, Dong; Zhang, Xiya; Huang, Junjiu; Liu, Dan; Zhou Songyang			The Daxx/Atrx Complex Protects Tandem Repetitive Elements during DNA Hypomethylation by Promoting H3K9 Trimethylation	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; PERICENTRIC HETEROCHROMATIN; PREIMPLANTATION EMBRYOS; MAMMALIAN DEVELOPMENT; SELF-RENEWAL; GERM-CELLS; ATRX; METHYLATION; DAXX; DNMT1	In mammals, DNA methylation is essential for protecting repetitive sequences from aberrant transcription and recombination. In some developmental contexts (e.g., preimplantation embryos) DNA is hypomethylated but repetitive elements are not dysregulated, suggesting that alternative protection mechanisms exist. Here we explore the processes involved by investigating the role of the chromatin factors Daxx and Atrx. Using genome-wide binding and transcriptome analysis, we found that Daxx and Atrx have distinct chromatin-binding profiles and are co-enriched at tandem repetitive elements in wild-type mouse ESCs. Global DNA hypomethylation further promoted recruitment of the Daxx/Atrx complex to tandem repeat sequences, including retrotransposons and telomeres. Knockdown of Daxx/Atrx in cells with hypomethylated genomes exacerbated aberrant transcriptional de-repression of repeat elements and telomere dysfunction. Mechanistically, Daxx/Atrx-mediated repression seems to involve Suv39h recruitment and H3K9 trimethylation. Our data therefore suggest that Daxx and Atrx safeguard the genome by silencing repetitive elements when DNA methylation levels are low.	[He, Quanyuan; Huang, Rui; Lu, Weisi; Tang, Mengfan; Zhang, Xiya; Huang, Junjiu; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, SYSU BCM Joint Ctr Biomed Sci, Minist Educ,Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [He, Quanyuan; Huang, Rui; Lu, Weisi; Tang, Mengfan; Zhang, Xiya; Huang, Junjiu; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, Inst Hlth Aging Res, Guangzhou 510275, Guangdong, Peoples R China; [He, Quanyuan; Kim, Hyeung; Shi, Fengtao; Yang, Dong; Liu, Dan; Zhou Songyang] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Huang, Junjiu; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, Key Lab Reprod Med Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Junjiu; Zhou Songyang] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Baylor College of Medicine; Sun Yat Sen University; Sun Yat Sen University	Zhou, SY (corresponding author), Sun Yat Sen Univ, Sch Life Sci, SYSU BCM Joint Ctr Biomed Sci, Minist Educ,Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China.	songyang@bcm.edu	Lu, Weisi/Q-2357-2015	Lu, Weisi/0000-0001-6039-6009	National Basic Research Program (973 Program) [2012CB911201]; National Natural Science Foundation of China (NSFC) [91213302, 81330055, 31371508]; Program of International ST Cooperation [2014DFB30020]; Science and Technology Planning Project of Guangdong Province [2015B020228002]; NIGMS [GM095599]; Welch Foundation [Q-1673]; C-BASS Shared Resource at Dan L. Duncan Cancer Center [P30CA125123]; shared Instrument Grant from NIH [1S10RR026550]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095599] Funding Source: NIH RePORTER	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program of International ST Cooperation; Science and Technology Planning Project of Guangdong Province; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); C-BASS Shared Resource at Dan L. Duncan Cancer Center; shared Instrument Grant from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Dr. Puping Liang for technical assistance. This work was supported by National Basic Research Program (973 Program 2012CB911201), National Natural Science Foundation of China (NSFC 91213302, 81330055, and 31371508), the Program of International S&T Cooperation (2014DFB30020), and Science and Technology Planning Project of Guangdong Province (2015B020228002). We would also like to acknowledge the support of NIGMS GM095599, the Welch Foundation Q-1673, and the C-BASS Shared Resource at the Dan L. Duncan Cancer Center (P30CA125123). ChIP-seq and RNA-seq experiments were conducted at the Functional Genomic Core (FGC) facility at the Baylor College of Medicine and supported by shared Instrument Grant 1S10RR026550 from NIH.	Ali S., 2012, FUNCTIONAL GENOMICS, P157; Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Baumann C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001137; Baumann C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-29; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Bower K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050062; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bulut-Karslioglu A, 2014, MOL CELL, V55, P277, DOI 10.1016/j.molcel.2014.05.029; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chiodi I, 2013, BBA-MOL CELL RES, V1833, P1885, DOI 10.1016/j.bbamcr.2013.03.030; Cirio MC, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; Emelyanov AV, 2010, J BIOL CHEM, V285, P15027, DOI 10.1074/jbc.M109.064790; Gao X, 2008, GENOME RES, V18, P359, DOI 10.1101/gr.7146408; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Grohmann M, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-18; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; HEARTLEIN MW, 1990, PROG CLIN BIOL RES, V340, P415; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Hutnick LK, 2010, J BIOL CHEM, V285, P21082, DOI 10.1074/jbc.M110.125674; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2007, ANNU REV GENOM HUM G, V8, P241, DOI 10.1146/annurev.genom.8.080706.092416; Kourmouli N, 2005, BIOCHEM BIOPH RES CO, V337, P901, DOI 10.1016/j.bbrc.2005.09.132; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Marinoni I, 2014, GASTROENTEROLOGY, V146, P453, DOI 10.1053/j.gastro.2013.10.020; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rebollo R, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R89, 10.1186/gb-2012-13-10-r89]; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Ross JP, 2010, EPIGENOMICS-UK, V2, P245, DOI 10.2217/EPI.10.2; Sadic D, 2015, EMBO REP, V16, P836, DOI 10.15252/embr.201439937; Sakaue M, 2010, CURR BIOL, V20, P1452, DOI 10.1016/j.cub.2010.06.050; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shalginskikh N, 2013, J VIROL, V87, P2137, DOI 10.1128/JVI.02026-12; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wilson A. S., 2007, J GEN VIROL, V1775, P138; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yang D, 2011, CELL RES, V21, P1013, DOI 10.1038/cr.2011.39; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang JL, 2013, JNCI-J NATL CANCER I, V105, P1005, DOI 10.1093/jnci/djt135	61	76	82	3	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					273	286		10.1016/j.stem.2015.07.022	http://dx.doi.org/10.1016/j.stem.2015.07.022			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26340527	Green Accepted, Bronze			2022-12-28	WOS:000364011000007
J	Snoeck, HW				Snoeck, Hans-Willem			Can Metabolic Mechanisms of Stem Cell Maintenance Explain Aging and the Immortal Germline?	CELL STEM CELL			English	Editorial Material								The mechanisms underlying the aging process are not understood. Even tissues endowed with somatic stem cells age while the germline appears immortal. I propose that this paradox may be explained by the pervasive use of glycolysis by somatic stem cells as opposed to the predominance of mitochondrial respiration in gametes.	Columbia Univ Coll Phys & Surg, Dept Med, Dept Microbiol & Immunol, Columbia Ctr Translat Immunol, New York, NY 10032 USA	Columbia University	Snoeck, HW (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, Dept Microbiol & Immunol, Columbia Ctr Translat Immunol, New York, NY 10032 USA.	hs2680@columbia.edu			NATIONAL INSTITUTE ON AGING [R01AG029626] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG029626] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beekman M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0440; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Snoeck HW, 2013, CURR OPIN HEMATOL, V20, P355, DOI 10.1097/MOH.0b013e3283623c77; Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398	10	5	5	2	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					582	584		10.1016/j.stem.2015.04.021	http://dx.doi.org/10.1016/j.stem.2015.04.021			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26046756	Green Accepted, Bronze			2022-12-28	WOS:000355932300006
J	Vallot, C; Ouimette, JF; Makhlouf, M; Feraud, O; Pontis, J; Come, J; Martinat, C; Bennaceur-Griscelli, A; Lalande, M; Rougeulle, C				Vallot, Celine; Ouimette, Jean-Francois; Makhlouf, Melanie; Feraud, Olivier; Pontis, Julien; Come, Julien; Martinat, Cecile; Bennaceur-Griscelli, Annelise; Lalande, Marc; Rougeulle, Claire			Erosion of X Chromosome Inactivation in Human Pluripotent Cells Initiates with XACT Coating and Depends on a Specific Heterochromatin Landscape	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; FACULTATIVE HETEROCHROMATIN; CHROMATIN-STRUCTURE; GENE-EXPRESSION; HISTONE H3; DIFFERENTIATION; MAINTENANCE; METHYLATION; CANCER; MEDICINE	Human pluripotent stem cells (hPSCs) display extensive epigenetic instability, particularly on the X chromosome. In this study, we show that, in hPSCs, the inactive X chromosome has a specific heterochromatin landscape that predisposes it to erosion of X chromosome inactivation (XCI), a process that occurs spontaneously in hPSCs. Heterochromatin remodeling and gene reactivation occur in a non-random fashion and are confined to specific H3K27me3-enriched domains, leaving H3K9me3-marked regions unaffected. Using single-cell monitoring of XCI erosion, we show that this instability only occurs in pluripotent cells. We also provide evidence that loss of XIST expression is not the primary cause of XCI instability and that gene reactivation from the inactive X (Xi) precedes loss of XIST coating. Notably, expression and coating by the long non-coding RNA XACT are early events in XCI erosion and, therefore, may play a role in mediating this process.	[Vallot, Celine; Ouimette, Jean-Francois; Makhlouf, Melanie; Pontis, Julien; Rougeulle, Claire] Univ Paris Diderot, Sorbonne Paris Cite, Epigenet & Cell Fate, F-75013 Paris, France; [Vallot, Celine; Ouimette, Jean-Francois; Makhlouf, Melanie; Pontis, Julien; Rougeulle, Claire] CNRS, Epigenet & Cell Fate UMR7216, F-75013 Paris, France; [Feraud, Olivier; Bennaceur-Griscelli, Annelise] Univ Paris 11, ESTeam Paris Sud, AP HP, INSERM U935, F-94802 Villejuif, France; [Come, Julien; Martinat, Cecile] AFM, ISTEM, INSERM UEVE UMR 861, F-91030 Evry, France; [Lalande, Marc] Univ Connecticut, Stem Cell Inst, Farmington, CT 06030 USA; [Lalande, Marc] Univ Connecticut, Syst Genom Inst, Farmington, CT 06030 USA	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Connecticut; University of Connecticut	Rougeulle, C (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Epigenet & Cell Fate, F-75013 Paris, France.	claire.rougeulle@univ-paris-diderot.fr	Martinat, Cécile S/F-6777-2010	Martinat, Cécile S/0000-0002-5234-1064; FERAUD, Olivier/0000-0002-5332-600X; Rougeulle, Claire/0000-0003-3861-4940; come, julien/0000-0001-9519-2436; bennaceur griscelli, annelise/0000-0002-3557-4499; Makhlouf, Melanie/0000-0003-4318-7269	European Research Council under the European Community [206875]; EpiGeneSys FP7 Network of Excellence [257082]; Inserm [R0721HS]; Agence Nationale de la Recherche (ANC) Investissements Avenir, INGESTEM Infrastructure; DIM-Stem Pole; Canadian Institutes of Health Research	European Research Council under the European Community(European Research Council (ERC)); EpiGeneSys FP7 Network of Excellence; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche (ANC) Investissements Avenir, INGESTEM Infrastructure(French National Research Agency (ANR)); DIM-Stem Pole; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank members of our laboratories for stimulating discussions and critical reading of the manuscript. We thank Claire Francastel for fruitful discussions about FISH experiments, Guillaume Filion for help with the use of jahmm, and the Genopole at Pasteur Institute for ChIP-seq sequencing. The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement 206875 and EpiGeneSys FP7 257082 Network of Excellence, the Inserm (Avenir Program R0721HS), and the Agence Nationale de la Recherche (ANC) Investissements Avenir, INGESTEM Infrastructure. J.F.O. was supported by a fellowship from DIM-Stem Pole and the Canadian Institutes of Health Research.	Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Bartova E, 2008, DEV DYNAM, V237, P3690, DOI 10.1002/dvdy.21773; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Deng XX, 2011, NAT GENET, V43, P1179, DOI 10.1038/ng.948; Filion G., 2014, JAHMM TOOL DISCRETIZ; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Giuliani M, 2011, BLOOD, V118, P3254, DOI 10.1182/blood-2010-12-325324; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Mitjavila-Garcia MT, 2010, J MOL CELL BIOL, V2, P291, DOI 10.1093/jmcb/mjq026; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Nozawa RS, 2013, NAT STRUCT MOL BIOL, V20, P566, DOI 10.1038/nsmb.2532; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Pontier DB, 2011, HUM GENET, V130, P223, DOI 10.1007/s00439-011-1008-7; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Shipony Z, 2014, NATURE, V513, P115, DOI 10.1038/nature13458; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Spatz A, 2004, NAT REV CANCER, V4, P617, DOI 10.1038/nrc1413; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Takahashi K, 2013, DEVELOPMENT, V140, P2457, DOI 10.1242/dev.092551; Vallot C., 2012, EPIGENOMICS CHROMATI, P118; Vallot C, 2013, NAT GENET, V45, P239, DOI 10.1038/ng.2530; Vincent-Salomon A, 2007, CANCER RES, V67, P5134, DOI 10.1158/0008-5472.CAN-07-0465; Vogel MJ, 2006, GENOME RES, V16, P1493, DOI 10.1101/gr.5391806; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Zhu ZR, 2013, DEVELOPMENT, V140, P705, DOI 10.1242/dev.086165	38	75	78	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					533	546		10.1016/j.stem.2015.03.016	http://dx.doi.org/10.1016/j.stem.2015.03.016			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25921272	Bronze			2022-12-28	WOS:000354188600013
J	Menon, T; Firth, AL; Scripture-Adams, DD; Galic, Z; Qualls, SJ; Gilmore, WB; Ke, E; Singer, O; Anderson, LS; Bornzin, AR; Alexander, IE; Zack, JA; Verma, IM				Menon, Tushar; Firth, Amy L.; Scripture-Adams, Deirdre D.; Galic, Zoran; Qualls, Susan J.; Gilmore, William B.; Ke, Eugene; Singer, Oded; Anderson, Leif S.; Bornzin, Alexander R.; Alexander, Ian E.; Zack, Jerome A.; Verma, Inder M.			Lymphoid Regeneration from Gene-Corrected SCID-X1 Subject-Derived iPSCs	CELL STEM CELL			English	Article							NATURAL-KILLER-CELLS; SEVERE COMBINED IMMUNODEFICIENCY; PLURIPOTENT STEM-CELLS; CD34(+) CELLS; III EFFECTORS; THERAPY; PLANT; RECOGNITION; GENERATION; VITRO	X-linked Severe Combined Immunodeficiency (SCID-X1) is a genetic disease that leaves newborns at high risk of serious infection and a predicted life span of less than 1 year in the absence of a matched bone marrow donor. The disease pathogenesis is due to mutations in the gene encoding the Interleukin-2 receptor gamma chain (IL-2Rg), leading to a lack of functional lymphocytes. With the leukemogenic concerns of viral gene therapy there is a need to explore alternative therapeutic options. We have utilized induced pluripotent stem cell (iPSC) technology and genome editing mediated by TALENs to generate isogenic subject-specific mutant and gene-corrected iPSC lines. While the subject-derived mutant iPSCs have the capacity to generate hematopoietic precursors and myeloid cells, only wild-type and gene-corrected iPSCs can additionally generate mature NK cells and T cell precursors expressing the correctly spliced IL-2R gamma. This study highlights the potential for the development of autologous cell therapy for SCID-X1 subjects.	[Menon, Tushar; Firth, Amy L.; Qualls, Susan J.; Gilmore, William B.; Ke, Eugene; Singer, Oded; Anderson, Leif S.; Bornzin, Alexander R.; Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Zack, Jerome A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Scripture-Adams, Deirdre D.; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Scripture-Adams, Deirdre D.; Zack, Jerome A.] Univ Calif Los Angeles, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Galic, Zoran; Zack, Jerome A.] Univ Calif Los Angeles, Broad Stem Cell Res Ctr, Los Angeles, CA 90095 USA; [Alexander, Ian E.] Childrens Med Res Inst, Gene Therapy Res Unit, Wentworthville, NSW 2145, Australia; [Alexander, Ian E.] Childrens Hosp Westmead, Wentworthville, NSW 2145, Australia	Salk Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Children's Medical Research Institute - Australia; University of Sydney	Verma, IM (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	verma@salk.edu	Firth, Amy/M-2302-2016; Ryan, Amy L/AFO-2326-2022	Firth, Amy/0000-0003-1363-905X; Ryan, Amy L/0000-0003-1363-905X; Alexander, Ian E/0000-0002-6213-5627; Scripture-Adams, Deirdre/0000-0002-3676-1771; Anderson, Leif/0000-0002-0721-7523; Gilmore, William/0000-0002-0653-4439	NIH [P30 CA016042, 5P30 AI028697, AI048034, HL053670]; Pioneer Fund Postdoctoral Scholar Award; CIRM Postdoctoral Training Fellowship [TG2-01158]; CIRM-Bridges Internships [TB-01175]; Cancer Center Core Grant [P30 CA14195-38]; Ipsen; Sanofi Aventis; H.N. and Frances C. Berger Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; California Institute for Regenerative Medicine (CIRM) [CL1-00500-1.2]; NATIONAL CANCER INSTITUTE [P30CA014195, P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048034, R01AI048034, P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS072031] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pioneer Fund Postdoctoral Scholar Award; CIRM Postdoctoral Training Fellowship; CIRM-Bridges Internships; Cancer Center Core Grant; Ipsen(Ipsen); Sanofi Aventis(Sanofi-Aventis); H.N. and Frances C. Berger Foundation; Leona M. and Harry B. Helmsley Charitable Trust; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Nianxin Zhong, Hongying Chen, and Dinithi Senadheera for excellent technical assistance. Research reported in this article made use of the Waitt Advanced Biophotonics Center Core Facility (supported by the Waitt Foundation, NCI P30 CA014195-40 and NINDS P30 NS072031-03), the Flow Cytometry and Functional Genomics Core Facilities (supported by NCI P30 CA014195-40), and the Stem Cell Core Facility. We would also like to acknowledge the UCLA JCCC and CFAR Flow Cytometry Core Facility (supported by NIH awards P30 CA016042 and 5P30 AI028697), the UCLA CFAR Gene and Cellular Therapy Core Facility (NIH 5P30 AI028697), and the Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA hESC Expansion Core. A collaboration with Jon Chestnut of Life Technologies resulted in the TALENs used in this study. T.M. was supported by a Pioneer Fund Postdoctoral Scholar Award. A.L.F. was supported by a CIRM Postdoctoral Training Fellowship #TG2-01158. W.B.G. (2012), A.R.B. (2010), and L.A. (2011) were supported by CIRM-Bridges Internships (#TB-01175). I.M.V. is an American Cancer Society Professor of Molecular Biology and holds the Irwin and Joan Jacobs Chair in Exemplary Life Science. This work was supported in part by grants from NIH (AI048034 and HL053670), Cancer Center Core Grant (P30 CA14195-38), Ipsen, Sanofi Aventis, the H.N. and Frances C. Berger Foundation, the Leona M. and Harry B. Helmsley Charitable Trust grant #2012-PG-MED002, and the California Institute for Regenerative Medicine (CIRM) CL1-00500-1.2.	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Firth AL, 2014, P NATL ACAD SCI USA, V111, pE1723, DOI 10.1073/pnas.1403470111; Geller MA, 2011, CYTOTHERAPY, V13, P98, DOI 10.3109/14653249.2010.515582; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Ginn Samantha L, 2004, Hum Mutat, V23, P522; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2002, INT J HEMATOL, V76, P295, DOI 10.1007/BF02982686; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Kao IT, 2007, STEM CELLS DEV, V16, P1043, DOI 10.1089/scd.2007.0033; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Meek B, 2010, BLOOD, V115, P261, DOI 10.1182/blood-2009-05-223990; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Ni ZY, 2011, J VIROL, V85, P43, DOI 10.1128/JVI.01774-10; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Tabatabaei-Zavareh N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000232; Verma I.M, 2013, SCIENCE, V341, P853	27	49	54	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					367	372		10.1016/j.stem.2015.02.005	http://dx.doi.org/10.1016/j.stem.2015.02.005			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25772073	Bronze, Green Accepted			2022-12-28	WOS:000352228600009
J	Plaks, V; Kong, NW; Werb, Z				Plaks, Vicki; Kong, Niwen; Werb, Zena			The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?	CELL STEM CELL			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; MATRIX METALLOPROTEINASES; BONE-MARROW; MICROENVIRONMENTAL REGULATION; METASTATIC COLONIZATION; CHEMOKINE RECEPTORS; INITIATING CELLS; HETEROGENEITY; DIFFERENTIATION	Cancer stem cells (CSCs) are tumor cells that have the principal properties of self-renewal, clonal tumor initiation capacity, and clonal long-term repopulation potential. CSCs reside in niches, which are anatomically distinct regions within the tumor microenvironment. These niches maintain the principle properties of CSCs, preserve their phenotypic plasticity, protect them from the immune system, and facilitate their metastatic potential. In this perspective, we focus on the CSC niche and discuss its contribution to tumor initiation and progression. Since CSCs survive many commonly employed cancer therapies, we examine the prospects of targeting the niche components as preferable therapeutic targets.	[Plaks, Vicki; Kong, Niwen; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu			NATIONAL CANCER INSTITUTE [R01CA180039, R01CA057621] Funding Source: NIH RePORTER; NCI NIH HHS [CA180039, CA057621, R01 CA180039, R01 CA057621] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bennewith KL, 2004, CANCER RES, V64, P6183, DOI 10.1158/0008-5472.CAN-04-0289; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Brurberg KG, 2006, RADIAT RES, V165, P16, DOI 10.1667/RR3491.1; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Casbon AJ, 2015, P NATL ACAD SCI USA, V112, pE566, DOI 10.1073/pnas.1424927112; Chaffer CL, 2015, CANCER DISCOV, V5, P22, DOI 10.1158/2159-8290.CD-14-0788; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Charles N, 2010, CELL CYCLE, V9, P3012, DOI 10.4161/cc.9.15.12710; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Cuiffo BG, 2014, CELL STEM CELL, V15, P762, DOI 10.1016/j.stem.2014.10.001; Cuiffo BG, 2012, CELL ADHES MIGR, V6, P220, DOI 10.4161/cam.20875; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Davis H, 2015, NAT MED, V21, P62, DOI 10.1038/nm.3750; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Ell B, 2012, CELL, V151, DOI 10.1016/j.cell.2012.10.005; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Fabbri M, 2012, CANCER RES, V72, P6333, DOI 10.1158/0008-5472.CAN-12-3229; Fessler E, 2013, CANCER LETT, V341, P97, DOI 10.1016/j.canlet.2012.10.015; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Greaves M, 2013, EVOL APPL, V6, P102, DOI 10.1111/eva.12017; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gu JW, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-7; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hambardzumyan D, 2008, CELL CYCLE, V7, P1371, DOI 10.4161/cc.7.10.5954; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hill RP, 2007, JNCI-J NATL CANCER I, V99, P1435, DOI 10.1093/jnci/djm136; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Jaiswal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061515; Jing YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043272; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Karreth F, 2004, CANCER BIOL THER, V3, P1058, DOI 10.4161/cbt.3.11.1302; Kessenbrock K, 2013, CELL STEM CELL, V13, P300, DOI 10.1016/j.stem.2013.06.005; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Klebanoff CA, 2012, J IMMUNOTHER, V35, P651, DOI 10.1097/CJI.0b013e31827806e6; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; LaBarge MA, 2010, CLIN CANCER RES, V16, P3121, DOI 10.1158/1078-0432.CCR-09-2933; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Lohela M, 2014, P NATL ACAD SCI USA, V111, pE5086, DOI 10.1073/pnas.1419899111; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Lopez JI, 2005, CANCER RES, V65, P6755, DOI 10.1158/0008-5472.CAN-05-0863; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Medyouf H, 2014, CELL STEM CELL, V14, P824, DOI 10.1016/j.stem.2014.02.014; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Milner LA, 1999, BLOOD, V93, P2431, DOI 10.1182/blood.V93.8.2431.408k33_2431_2448; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Muller V, 2005, CLIN CANCER RES, V11, P3678, DOI 10.1158/1078-0432.CCR-04-2469; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Ni C, 2013, CLIN TRANSL ONCOL, V15, P253, DOI 10.1007/s12094-012-0927-7; Nishimura K, 2012, PATHOBIOLOGY, V79, P290, DOI 10.1159/000337296; Noel A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00140; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Olaso E, 1997, HEPATOLOGY, V26, P634, DOI 10.1053/jhep.1997.v26.pm0009303493; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; PANTEL K, 1993, JNCI-J NATL CANCER I, V85, P1419, DOI 10.1093/jnci/85.17.1419; Passalidou E, 2002, BRIT J CANCER, V86, P244, DOI 10.1038/sj.bjc.6600015; Pavlides S, 2010, AGING-US, V2, P185, DOI 10.18632/aging.100134; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Plaks V, 2013, SCIENCE, V341, P1186, DOI 10.1126/science.1235226; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Quail DF, 2012, CURR STEM CELL RES T, V7, P197; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004599; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Rocco A, 2012, J CELL PHYSIOL, V227, P2686, DOI 10.1002/jcp.23013; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Roorda BD, 2010, CANCER INVEST, V28, P526, DOI 10.3109/07357900903179625; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Shirakawa K, 2002, CANCER RES, V62, P560; Siefert SA, 2012, VASCULAR, V20, P210, DOI 10.1258/vasc.2011.201202; Smith AL, 2012, CLIN CANCER RES, V18, P4514, DOI 10.1158/1078-0432.CCR-11-3224; Sneddon JB, 2007, CELL STEM CELL, V1, P607, DOI 10.1016/j.stem.2007.11.009; Stankic M, 2013, CELL REP, V5, P1228, DOI 10.1016/j.celrep.2013.11.014; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wei J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016195, 10.1371/journal.pone.0017868]; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Wong GS, 2013, BRIT J CANCER, V108, P755, DOI 10.1038/bjc.2012.592; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yan HH, 2010, CANCER RES, V70, P6139, DOI 10.1158/0008-5472.CAN-10-0706; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Ye J, 2014, TUMOR BIOL, V35, P3945, DOI 10.1007/s13277-013-1561-x; Yi SY, 2013, CANCER TREAT REV, V39, P290, DOI 10.1016/j.ctrv.2012.10.004; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	155	877	914	7	184	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					225	238		10.1016/j.stem.2015.02.015	http://dx.doi.org/10.1016/j.stem.2015.02.015			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25748930	Green Accepted, Bronze			2022-12-28	WOS:000350747700006
J	Cunningham, M; Cho, JH; Leung, A; Savvidis, G; Ahn, S; Moon, M; Lee, PKJ; Han, JJ; Azimi, N; Kim, KS; Bolshakov, VY; Chung, SM				Cunningham, Miles; Cho, Jun-Hyeong; Leung, Amanda; Savvidis, George; Ahn, Sandra; Moon, Minho; Lee, Paula K. J.; Han, Jason J.; Azimi, Nima; Kim, Kwang-Soo; Bolshakov, Vadim Y.; Chung, Sangmi			hPSC-Derived Maturing GABAergic Interneurons Ameliorate Seizures and Abnormal Behavior in Epileptic Mice	CELL STEM CELL			English	Article							TEMPORAL-LOBE EPILEPSY; PILOCARPINE MODEL; FUNCTIONAL MATURATION; STEM-CELLS; NEURONS; DIFFERENTIATION; TRANSPLANTATION; THERAPEUTICS; INHIBITION; MODULATION	Seizure disorders debilitate more than 65,000,000 people worldwide, with temporal lobe epilepsy (TLE) being the most common form. Previous studies have shown that transplantation of GABA-releasing cells results in suppression of seizures in epileptic mice. Derivation of interneurons from human pluripotent stem cells (hPSCs) has been reported, pointing to clinical translation of quality-controlled human cell sources that can enhance inhibitory drive and restore host circuitry. In this study, we demonstrate that hPSC-derived maturing GABAergic interneurons (mGINs) migrate extensively and integrate into dysfunctional circuitry of the epileptic mouse brain. Using optogenetic approaches, we find that grafted mGINs generate inhibitory postsynaptic responses in host hippocampal neurons. Importantly, even before acquiring full electrophysiological maturation, grafted neurons were capable of suppressing seizures and ameliorating behavioral abnormalities such as cognitive deficits, aggressiveness, and hyperactivity. These results provide support for the potential of hPSC-derived mGIN for restorative cell therapy for epilepsy.	[Leung, Amanda; Savvidis, George; Ahn, Sandra; Moon, Minho; Lee, Paula K. J.; Kim, Kwang-Soo; Chung, Sangmi] Harvard Univ, Sch Med, McLean Hosp, Mol Neurobiol Lab,Dept Psychiat, Belmont, MA 02478 USA; [Leung, Amanda; Savvidis, George; Ahn, Sandra; Moon, Minho; Lee, Paula K. J.; Kim, Kwang-Soo; Chung, Sangmi] Harvard Univ, Sch Med, McLean Hosp, Program Neurosci, Belmont, MA 02478 USA; [Leung, Amanda; Savvidis, George; Ahn, Sandra; Moon, Minho; Lee, Paula K. J.; Kim, Kwang-Soo; Chung, Sangmi] Harvard Univ, Sch Med, McLean Hosp, Harvard Stem Cell Inst, Belmont, MA 02478 USA; [Cunningham, Miles; Azimi, Nima] Harvard Univ, Sch Med, McLean Hosp, Lab Neural Reconstruct,Dept Psychiat, Belmont, MA 02478 USA; [Cho, Jun-Hyeong; Bolshakov, Vadim Y.] Harvard Univ, Sch Med, McLean Hosp, Cellular Neurobiol Lab,Dept Psychiat, Belmont, MA 02478 USA; [Han, Jason J.] Harvard Univ, Sch Med, McLean Hosp, MRC Electron & Light Microscopy Core Facil, Belmont, MA 02478 USA	Harvard University; McLean Hospital; Harvard University; McLean Hospital; Harvard University; McLean Hospital; Harvard University; McLean Hospital; Harvard University; McLean Hospital; Harvard University; McLean Hospital	Chung, SM (corresponding author), Harvard Univ, Sch Med, McLean Hosp, Mol Neurobiol Lab,Dept Psychiat, Belmont, MA 02478 USA.	schung@mclean.harvard.edu	Cho, Jun-Hyeong/GXM-7966-2022	Cho, Jun-Hyeong/0000-0002-6844-3583; Lee, Paula/0000-0002-2579-1203	NIH [NS079977, NS070577, MH090464]; Harvard Stem Cell Institute Seed Grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS079977, R01NS070577] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute Seed Grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH grants NS079977, NS070577, and MH090464 and a Harvard Stem Cell Institute Seed Grant. We thank Drs. Uwe Rudolph, Christopher Cowan, and Joseph Coyle for sharing animal behavioral equipment. We thank Dr. Pachnis for kind gift of anti-Lhx6 and Dr. Palmiter for anti-ZnT3.	Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Bjarkam CR, 2010, STEREOT FUNCT NEUROS, V88, P56, DOI 10.1159/000268743; Brooks-Kayal AR, 2013, EPILEPSIA, V54, P44, DOI 10.1111/epi.12298; Chen KG, 2014, CELL STEM CELL, V14, P13, DOI 10.1016/j.stem.2013.12.005; Cho JH, 2013, NEURON, V80, P1491, DOI 10.1016/j.neuron.2013.09.025; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Cramer JA, 2010, EXPERT REV NEUROTHER, V10, P885, DOI 10.1586/ERN.10.71; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Doischer D, 2008, J NEUROSCI, V28, P12956, DOI 10.1523/JNEUROSCI.2890-08.2008; Engel J, 2002, EPILEPSIA, V43, P12, DOI 10.1046/j.1528-1157.43.s.6.6.x; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; FINE A, 1990, NEUROPSYCHOLOGIA, V28, P627, DOI 10.1016/0028-3932(90)90038-P; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Hattiangady B, 2008, EXP NEUROL, V212, P468, DOI 10.1016/j.expneurol.2008.04.040; Helmstaedter C, 2008, NAT CLIN PRACT NEURO, V4, P66, DOI 10.1038/ncpneuro0657; Hirsch JC, 1999, NAT NEUROSCI, V2, P499, DOI 10.1038/9142; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Jensen FE, 2014, NAT REV NEUROL, V10, P63, DOI 10.1038/nrneurol.2013.277; Kim TG, 2014, STEM CELLS, V32, P1789, DOI 10.1002/stem.1704; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Le Magueresse C, 2013, NEURON, V77, P388, DOI 10.1016/j.neuron.2013.01.011; Lindvall O, 1992, Adv Neurol, V57, P561; Loscher W, 1998, J NEUROSCI RES, V51, P196; Maisano X, 2012, J NEUROSCI, V32, P46, DOI 10.1523/JNEUROSCI.2683-11.2012; Mallon BS, 2013, STEM CELL RES, V10, P57, DOI 10.1016/j.scr.2012.09.002; Marco P, 1996, BRAIN, V119, P1327, DOI 10.1093/brain/119.4.1327; Mazzuferi M, 2012, EXP NEUROL, V238, P156, DOI 10.1016/j.expneurol.2012.08.022; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Rice AC, 1998, EPILEPSIA, V39, P1148, DOI 10.1111/j.1528-1157.1998.tb01305.x; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Southwell DG, 2014, SCIENCE, V344, P167, DOI 10.1126/science.1240622; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Spreafico R, 1998, NEUROLOGY, V50, P27, DOI 10.1212/WNL.50.1.27; Walia Kulbir S, 2004, Pain Pract, V4, P194, DOI 10.1111/j.1533-2500.2004.04304.x; Wieser HG, 2004, EPILEPSIA, V45, P32; Yu DX, 2013, CELL STEM CELL, V12, P678, DOI 10.1016/j.stem.2013.05.018	39	132	134	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					559	573		10.1016/j.stem.2014.10.006	http://dx.doi.org/10.1016/j.stem.2014.10.006			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517465	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000345012700010
J	Charbord, P; Pouget, C; Binder, H; Dumont, F; Stik, G; Levy, P; Allain, F; Marchal, C; Richter, J; Uzan, B; Pflumio, F; Letourneur, F; Wirth, H; Dzierzak, E; Traver, D; Jaffredo, T; Durand, C				Charbord, Pierre; Pouget, Claire; Binder, Hans; Dumont, Florent; Stik, Gregoire; Levy, Pacifique; Allain, Fabrice; Marchal, Celine; Richter, Jenna; Uzan, Benjamin; Pflumio, Francoise; Letourneur, Franck; Wirth, Henry; Dzierzak, Elaine; Traver, David; Jaffredo, Thierry; Durand, Charles			A Systems Biology Approach for Defining the Molecular Framework of the Hematopoietic Stem Cell Niche	CELL STEM CELL			English	Article							PROGENITOR CELLS; MAINTENANCE; EXPRESSION; GENOME; MICROENVIRONMENT; DIFFERENTIATION; LANDSCAPE; PROFILE; LINES; GENE	Despite progress in identifying the cellular composition of hematopoietic stem/progenitor cell (HSPC) niches, little is known about the molecular requirements of HSPC support. To address this issue, we used a panel of six recognized HSPC-supportive stromal lines and less-supportive counterparts originating from embryonic and adult hematopoietic sites. Through comprehensive transcriptomic meta-analyses, we identified 481 mRNAs and 17 microRNAs organized in a modular network implicated in paracrine signaling. Further inclusion of 18 additional cell strains demonstrated that this mRNA subset was predictive of HSPC support. Our gene set contains most known HSPC regulators as well as a number of unexpected ones, such as Pax9 and Ccdc80, as validated by functional studies in zebrafish embryos. In sum, our approach has identified the core molecular network required for HSPC support. These cues, along with a searchable web resource, will inform ongoing efforts to instruct HSPC ex vivo amplification and formation from pluripotent precursors.	[Stik, Gregoire; Levy, Pacifique; Allain, Fabrice; Marchal, Celine; Jaffredo, Thierry; Durand, Charles] Univ Paris 06, Sorbonne Univ, IBPS, UMR 7622,Lab Biol Dev, F-75005 Paris, France; [Stik, Gregoire; Levy, Pacifique; Allain, Fabrice; Marchal, Celine; Jaffredo, Thierry; Durand, Charles] CNRS, UMR 7622, INSERM, U1156,IBPS,Lab Biol Dev, F-75005 Paris, France; [Charbord, Pierre] Univ Paris 11, Hop Paul Brousse, INSERM, U972, F-94807 Villejuif, France; [Pouget, Claire; Richter, Jenna; Traver, David] Univ Calif San Diego, Dept Cell & Dev Biol, La Jolla, CA 92093 USA; [Binder, Hans; Wirth, Henry] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04107 Leipzig, Germany; [Dumont, Florent; Letourneur, Franck] INSERM, U567, Inst Cochin, F-75014 Paris, France; [Uzan, Benjamin; Pflumio, Francoise] Univ Paris 07, CEA, LSHL, UMR967,INSERM,IRCM, F-92260 Fontenay Aux Roses, France; [Dzierzak, Elaine] Erasmus MC, Erasmus Stem Cell Inst, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California San Diego; Leipzig University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Erasmus University Rotterdam; Erasmus MC	Charbord, P (corresponding author), Univ Paris 11, Hop Paul Brousse, INSERM, U972, F-94807 Villejuif, France.	pierre.charbord@inserm.fr; charles.durand@upmc.fr	JAFFREDO, Thierry/K-7870-2017; stik, gregoire/R-1342-2016; Pflumio, Francoise/E-2074-2017; Pouget, Claire/M-9761-2016; Binder, Hans/U-5519-2018	JAFFREDO, Thierry/0000-0002-8724-3261; Pouget, Claire/0000-0003-4598-6291; Durand, Charles/0000-0002-1970-0467; Pflumio, Francoise/0000-0001-8995-596X; Stik, Gregoire/0000-0002-1404-1992; Loeffler-Wirth, Henry/0000-0001-8239-440X; UZAN, Benjamin/0000-0001-6323-5737; Binder, Hans/0000-0002-2242-4678; charbord, pierre/0000-0002-2254-3300	Fondation pour la Recherche Medicale [DEQ20100318258]; Agence Nationale pour la Recherche/California Institute for Regenerative Medicine [ANR/CIRM 0001-02]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherche/California Institute for Regenerative Medicine(French National Research Agency (ANR))	We are very grateful to Catherine Robin (Hubrecht Institute) for critical and constructive comments on this study. We thank David Stachura (Department of Cell and Developmental Biology, UCSD) for critical reading of the manuscript. We thank Nicole Boggetto (Institut Jacques Monod, ImagoSeine BioimagingCoreFacility) for cell sorting experiments. We also thank Sophie Gournet (UMR CNRS 7622) for her excellent photographic and drawing assistance. These studies were supported by grants from the Fondation pour la Recherche Medicale (DEQ20100318258) and Agence Nationale pour la Recherche/California Institute for Regenerative Medicine (ANR/CIRM 0001-02).	Bertrand JY, 2010, BLOOD, V115, P2777, DOI 10.1182/blood-2009-09-244590; Boisset JC, 2013, BIOL OPEN, V2, P525, DOI 10.1242/bio.20133715; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chateauvieux S, 2007, PHYSIOL GENOMICS, V29, P128, DOI 10.1152/physiolgenomics.00197.2006; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Corselli M, 2013, BLOOD, V121, P2891, DOI 10.1182/blood-2012-08-451864; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Durand C, 2007, P NATL ACAD SCI USA, V104, P20838, DOI 10.1073/pnas.0706923105; Durand C, 2006, HAEMATOLOGICA, V91, P1172; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hackney JA, 2002, P NATL ACAD SCI USA, V99, P13061, DOI 10.1073/pnas.192124499; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; ISSAAD C, 1993, BLOOD, V81, P2916; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Magnusson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053912; McKinney-Freeman S, 2012, CELL STEM CELL, V11, P701, DOI 10.1016/j.stem.2012.07.018; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mirshekar-Syahkal B, 2014, STEM CELLS, V32, P1691, DOI 10.1002/stem.1680; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Oostendorp RAJ, 2002, BLOOD, V99, P1183, DOI 10.1182/blood.V99.4.1183; Renstrom J, 2009, CELL STEM CELL, V5, P157, DOI 10.1016/j.stem.2009.05.020; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018; Wineman J, 1996, BLOOD, V87, P4082, DOI 10.1182/blood.V87.10.4082.bloodjournal87104082; Wirth H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-306; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; ZIPORI D, 1985, J CELL PHYSIOL, V122, P81, DOI 10.1002/jcp.1041220113	45	50	51	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					376	391		10.1016/j.stem.2014.06.005	http://dx.doi.org/10.1016/j.stem.2014.06.005			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25042701	Bronze			2022-12-28	WOS:000341441600016
J	Raaijmakers, MHGP				Raaijmakers, Marc H. G. P.			Disease Progression in Myelodysplastic Syndromes: Do Mesenchymal Cells Pave the Way?	CELL STEM CELL			English	Editorial Material							BONE-MARROW NICHE	Early events driving the initiation and evolution of neoplasms remain poorly defined but involvement of an instructive or permissive niche has been implicated. In this issue of Cell Stem Cell, Medyouf et al. (2014) provide insights into the role of the niche in myelodysplastic syndromes, the principle preleukemic disorder of the hematopoietic system.	[Raaijmakers, Marc H. G. P.] Erasmus MC Canc Inst, Dept Hematol, NL-3015 GE Rotterdam, Netherlands; [Raaijmakers, Marc H. G. P.] Erasmus Stem Cell Inst, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC	Raaijmakers, MHGP (corresponding author), Erasmus MC Canc Inst, Dept Hematol, Fac Bldg Rm Ee 1393,Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	m.h.g.raaijmakers@erasmusmc.nl						Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Medyouf H, 2014, CELL STEM CELL, V14, P824, DOI 10.1016/j.stem.2014.02.014; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Scadden DT, 2012, CELL STEM CELL, V10, P648, DOI 10.1016/j.stem.2012.05.011; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014	10	19	20	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					695	697		10.1016/j.stem.2014.05.010	http://dx.doi.org/10.1016/j.stem.2014.05.010			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905157	Bronze			2022-12-28	WOS:000341248500003
J	Dykstra, B; Bystrykh, LV				Dykstra, Brad; Bystrykh, Leonid V.			No Monkeying Around: Clonal Tracking of Stem Cells and Progenitors in the Macaque	CELL STEM CELL			English	Editorial Material							REVISION; LINEAGES	Clonal tracking of hematopoietic stem and progenitor cells (HSPCs) has proven valuable for studying their behavior in murine recipients. Now in Cell Stem Cell, Kim et al. (2014) and Wu et al. (2014) extend these analyses to nonhuman primates, providing insights into dynamics of HSPC expansion and lineage commitment following autologous transplantation.	[Dykstra, Brad] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Bystrykh, Leonid V.] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Lab Ageing Biol & Stem Cells, NL-9700 AD Groningen, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Groningen	Dykstra, B (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA.	bdykstra@partners.org; l.bystrykh@umcg.nl			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107146] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL107146] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; Bystrykh LV, 2012, NAT METHODS, V9, P567, DOI [10.1038/NMETH.2043, 10.1038/nmeth.2043]; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Gorgens A, 2013, CELL REP, V3, P1539, DOI 10.1016/j.celrep.2013.04.025; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; Kim S, 2014, CELL STEM CELL, V14, P473, DOI 10.1016/j.stem.2013.12.012; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Wu CF, 2014, CELL STEM CELL, V14, P486, DOI 10.1016/j.stem.2014.01.020	9	6	6	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					419	420		10.1016/j.stem.2014.03.006	http://dx.doi.org/10.1016/j.stem.2014.03.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24702990	Bronze, Green Accepted			2022-12-28	WOS:000334766400003
J	Loh, KM; Ang, LT; Zhang, JY; Kumar, V; Ang, J; Auyeong, JQ; Lee, KL; Choo, SH; Lim, CYY; Nichane, M; Tan, JR; Noghabi, MS; Azzola, L; Ng, ES; Durruthy-Durruthy, J; Sebastiano, V; Poellinger, L; Elefanty, AG; Stanley, EG; Chen, QF; Prabhakar, S; Weissman, IL; Lim, B				Loh, Kyle M.; Ang, Lay Teng; Zhang, Jingyao; Kumar, Vibhor; Ang, Jasmin; Auyeong, Jun Qiang; Lee, Kian Leong; Choo, Siew Hua; Lim, Christina Y. Y.; Nichane, Massimo; Tan, Junru; Noghabi, Monireh Soroush; Azzola, Lisa; Ng, Elizabeth S.; Durruthy-Durruthy, Jens; Sebastiano, Vittorio; Poellinger, Lorenz; Elefanty, Andrew G.; Stanley, Edouard G.; Chen, Qingfeng; Prabhakar, Shyam; Weissman, Irving L.; Lim, Bing			Efficient Endoderm Induction from Human Pluripotent Stem Cells by Logically Directing Signals Controlling Lineage Bifurcations	CELL STEM CELL			English	Article							PANCREATIC DIFFERENTIATION; WNT/BETA-CATENIN; LIVER; SPECIFICATION; GASTRULATION; FATE; GENE; WNT; EMBRYOGENESIS; GENERATION	Human pluripotent stem cell (hPSC) differentiation typically yields heterogeneous populations. Knowledge of signals controlling embryonic lineage bifurcations could efficiently yield desired cell types through exclusion of alternate fates. Therefore, we revisited signals driving induction and anterior-posterior patterning of definitive endoderm to generate a coherent roadmap for endoderm differentiation. With striking temporal dynamics, BMP and Wnt initially specified anterior primitive streak (progenitor to endoderm), yet, 24 hr later, suppressed endoderm and induced mesoderm. At lineage bifurcations, cross-repressive signals separated mutually exclusive fates; TGF-beta and BMP/MAPK respectively induced pancreas versus liver from endoderm by suppressing the alternate lineage. We systematically blockaded alternate fates throughout multiple consecutive bifurcations, thereby efficiently differentiating multiple hPSC lines exclusively into endoderm and its derivatives. Comprehensive transcriptional and chromatin mapping of highly pure endodermal populations revealed that endodermal enhancers existed in a surprising diversity of "pre-enhancer" states before activation, reflecting the establishment of a permissive chromatin landscape as a prelude to differentiation.	[Loh, Kyle M.; Ang, Lay Teng; Zhang, Jingyao; Kumar, Vibhor; Ang, Jasmin; Auyeong, Jun Qiang; Choo, Siew Hua; Lim, Christina Y. Y.; Nichane, Massimo; Tan, Junru; Noghabi, Monireh Soroush; Prabhakar, Shyam; Lim, Bing] ASTAR, Genome Inst Singapore, Stem Cell & Dev Biol Grp, Singapore 138672, Singapore; [Loh, Kyle M.; Durruthy-Durruthy, Jens; Sebastiano, Vittorio; Weissman, Irving L.] Stanford Univ Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol, Stanford, CA 94305 USA; [Lee, Kian Leong; Poellinger, Lorenz] Natl Univ Singapore, Ctr Translat Med, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Azzola, Lisa; Ng, Elizabeth S.; Elefanty, Andrew G.; Stanley, Edouard G.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Azzola, Lisa; Ng, Elizabeth S.; Elefanty, Andrew G.; Stanley, Edouard G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Chen, Qingfeng] ASTAR, Inst Mol & Cell Biol, Humanized Mouse Unit, Singapore 138673, Singapore; [Chen, Qingfeng] Singapore MIT Alliance Res & Technol, Interdisciplinary Res Grp Infect Dis, Singapore 138602, Singapore; [Chen, Qingfeng] Natl Univ Singapore, Yong Yoo Lin Sch Med, Dept Microbiol, Singapore 119228, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Lim, Bing] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Stanford University; National University of Singapore; Monash University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Loh, KM (corresponding author), ASTAR, Genome Inst Singapore, Stem Cell & Dev Biol Grp, Singapore 138672, Singapore.	kyleloh@stanford.edu; anglt1@gis.a-star.edu.sg; limb1@gis.a-star.edu.sg	Elefanty, Andrew G/A-6066-2008; LEE, Kian Leong/E-3584-2013; Stanley, Ed G/A-2985-2013	LEE, Kian Leong/0000-0002-0443-2746; Stanley, Ed G/0000-0002-6389-3665; Loh, Kyle/0000-0002-8042-0149; Kumar, Vibhor/0000-0002-9523-9422; Elefanty, Andrew/0000-0001-6448-8314; Ang, Lay Teng/0000-0002-6783-4662	Fannie and John Hertz Foundation; U.S. National Science Foundation; Davidson Institute for Talent Development; Singapore Agency for Science, Technology, and Research (A<SUP>star</SUP>STAR); California Institute for Regenerative Medicine [RT2-02060]; Stem Cells Australia; Qatar National Research Foundation; Australia National Health and Medical Research Council (NHMRC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999, U01HL099995] Funding Source: NIH RePORTER	Fannie and John Hertz Foundation; U.S. National Science Foundation(National Science Foundation (NSF)); Davidson Institute for Talent Development; Singapore Agency for Science, Technology, and Research (A<SUP>star</SUP>STAR)(Agency for Science Technology & Research (A*STAR)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Stem Cells Australia; Qatar National Research Foundation(National Research Foundation of Korea); Australia National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to the developmental biologists who set the precedent for this work decades ago. Margaret Fuller, Phillip Beachy, and Roel Nusse (Stanford Department of Developmental Biology) championed this work in all respects. We thank B. M. Brady, E. Lujan, H. T. Lim, E. K. M. Chia, S. W. Teo, S. Van Der Van, J. R. Tan, H. Ijo, J. J. Lum, X. Y. Huang, M. Rahmani, and J. Poschmann for technical assistance; S. Oh and S. Y. Ng for hESC; and A. M. Newman, R. Lu, P. W. Koh, E. Rim, P. Robson, M. M. J. Fischer, T. Meyer, and members of the Weissman and Lim groups for comments. We also thank R. Ettikian, T. A. Storm, P. A. Lovelace, K. Z. J. Chee, the GIS Solexa Group, the Biopolis Shared Facilities FACS Core, the Stanford Stem Cell Institute FACS core, and the Stanford PAN Microarray Core for logistical/core facility support. K. M. L. is supported by the Fannie and John Hertz Foundation, the U.S. National Science Foundation, and the Davidson Institute for Talent Development. L. T. A. and B. L. are supported by the Singapore Agency for Science, Technology, and Research (A<SUP>star</SUP>STAR). I. L. W. is supported by the California Institute for Regenerative Medicine (RT2-02060). L. A., E. S. N., A. G. E., and E. G. S. are supported by Stem Cells Australia, the Qatar National Research Foundation, and the Australia National Health and Medical Research Council (NHMRC) and A. G. E. and E. G. S. as NHMRC Senior Research Fellows. This work is dedicated to Dale L. Woodbury and M. William Lensch for their excellent mentorship.	Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Candia AF, 1997, DEVELOPMENT, V124, P4467; Chen QF, 2013, STEM CELLS, V31, P1160, DOI 10.1002/stem.1359; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]; Cho CHH, 2012, DIABETOLOGIA, V55, P3284, DOI 10.1007/s00125-012-2687-x; Chung WS, 2008, DEV CELL, V15, P738, DOI 10.1016/j.devcel.2008.08.019; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Deutsch G, 2001, DEVELOPMENT, V128, P871; Dunn NR, 2004, DEVELOPMENT, V131, P1717, DOI 10.1242/dev.01072; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gertow K, 2013, STEM CELL REP, V1, P53, DOI 10.1016/j.stemcr.2013.04.002; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Hansson M, 2009, DEV BIOL, V330, P286, DOI 10.1016/j.ydbio.2009.03.026; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kumar V, 2013, NAT BIOTECHNOL, V31, P615, DOI 10.1038/nbt.2596; LAWSON KA, 1991, DEVELOPMENT, V113, P891; LEVAKSVAJGER B, 1974, J EMBRYOL EXP MORPH, V32, P445; Li ZY, 2012, CELL, V151, P1608, DOI 10.1016/j.cell.2012.11.018; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; McKnight KD, 2010, CELL STEM CELL, V6, P300, DOI 10.1016/j.stem.2010.03.003; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Sherwood RI, 2011, MECH DEVELOP, V128, P387, DOI 10.1016/j.mod.2011.07.005; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; SVAJGER A, 1974, J EMBRYOL EXP MORPH, V32, P461; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; TAM PPL, 1987, DEVELOPMENT, V99, P109; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Tiso N, 2002, MECH DEVELOP, V118, P29, DOI 10.1016/S0925-4773(02)00252-6; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Waddington C.H., 1940, ORG GENES; Wandzioch E, 2009, SCIENCE, V324, P1707, DOI 10.1126/science.1174497; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhu YN, 2012, MOL CELL, V46, P408, DOI 10.1016/j.molcel.2012.05.011; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	59	226	239	3	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					237	252		10.1016/j.stem.2013.12.007	http://dx.doi.org/10.1016/j.stem.2013.12.007			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24412311	Bronze, Green Accepted			2022-12-28	WOS:000330835800015
J	Cope, EC; Gould, E				Cope, Elise C.; Gould, Elizabeth			Cytokines Make an Indelible Impression on Neural Stem Cells	CELL STEM CELL			English	Editorial Material							DENTATE GYRUS; OLFACTORY-BULB; SCHIZOPHRENIA; INTERLEUKIN-6; NEUROGENESIS; HIPPOCAMPUS; NEURONS	Infections during pregnancy have been associated with increased risks of neuropsychiatric disorders in offspring, although the underlying mechanisms have not been determined. Gallagher et al. (2013) show that maternal exposure to the infection-induced inflammatory cytokine IL-6 produces lasting effects on forebrain stem cell pools of offspring during embryogenesis and throughout life.	[Cope, Elise C.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA; [Gould, Elizabeth] Princeton Univ, Dept Psychol, Princeton Neurosci Inst, Princeton, NJ 08544 USA	State University System of Florida; Florida State University; Princeton University	Gould, E (corresponding author), Princeton Univ, Dept Psychol, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	goulde@princeton.edu		Cope, Elise/0000-0001-6239-690X				Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Boksa P, 2008, J PSYCHIATR NEUROSCI, V33, P183; Bowen KK, 2011, NEUROREPORT, V22, P126, DOI 10.1097/WNR.0b013e3283430a44; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Gallagher D, 2013, CELL STEM CELL, V13, P564, DOI 10.1016/j.stem.2013.10.002; Li GN, 2013, NEURON, V78, P658, DOI 10.1016/j.neuron.2013.03.019; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Uban KA, 2010, HORM BEHAV, V58, P835, DOI 10.1016/j.yhbeh.2010.08.007; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	10	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					507	508		10.1016/j.stem.2013.10.011	http://dx.doi.org/10.1016/j.stem.2013.10.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24209754	Bronze			2022-12-28	WOS:000329571500001
J	Denholtz, M; Bonora, G; Chronis, C; Splinter, E; de Laat, W; Ernst, J; Pellegrini, M; Plath, K				Denholtz, Matthew; Bonora, Giancarlo; Chronis, Constantinos; Splinter, Erik; de Laat, Wouter; Ernst, Jason; Pellegrini, Matteo; Plath, Kathrin			Long-Range Chromatin Contacts in Embryonic Stem Cells Reveal a Role for Pluripotency Factors and Polycomb Proteins in Genome Organization	CELL STEM CELL			English	Article							GENE-EXPRESSION; NANOG LOCUS; DOMAINS; INACTIVATION; ARCHITECTURE; PRINCIPLES; LANDSCAPE; MEDIATOR	The relationship between 3D organization of the genome and gene-regulatory networks is poorly understood. Here, we examined long-range chromatin interactions genome-wide in mouse embryonic stem cells (ESCs), iPSCs, and fibroblasts and uncovered a pluripotency-specific genome organization that is gradually reestablished during reprogramming. Our data confirm that long-range chromatin interactions are primarily associated with the spatial segregation of open and closed chromatin, defining overall chromosome conformation. Additionally, we identified two further levels of genome organization in ESCs characterized by colocalization of regions with high pluripotency factor occupancy and strong enrichment for Polycomb proteins/H3K27me3, respectively. Underlining the independence of these networks and their functional relevance for genome organization, loss of the Polycomb protein Eed diminishes interactions between Polycomb-regulated regions without altering overarching chromosome conformation. Together, our data highlight a pluripotency-specific genome organization in which pluripotency factors such as Nanog and H3K27me3 occupy distinct nuclear spaces and reveal a role for cell-type-specific gene-regulatory networks in genome organization.	[Denholtz, Matthew; Bonora, Giancarlo; Chronis, Constantinos; Ernst, Jason; Plath, Kathrin] Univ Calif Los Angeles, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Splinter, Erik; de Laat, Wouter] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Splinter, Erik; de Laat, Wouter] Univ Med Ctr, NL-3584 CT Utrecht, Netherlands	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Pellegrini, M (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	matteop@mcdb.ucla.edu; kplath@mednet.ucla.edu		Plath, Kathrin/0000-0001-7796-3372; Pellegrini, Matteo/0000-0001-9355-9564; de Laat, Wouter/0000-0002-6393-595X; chronis, Constantinos/0000-0002-7783-8202	UCLA Broad Center of Regenerative Medicine and Stem Cell Research; NIH [DP2OD001686, P01GM099134]; CIRM [RN1-00564]; NSF [HYS-1066293]; Whitcome Pre-doctoral Training Program; UCLA Graduate Division; CIRM; Leukemia and Lymphoma Research [10040]; UCLA David Geffen School of Medicine; ERC [209700]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134, P01GM081621] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686] Funding Source: NIH RePORTER	UCLA Broad Center of Regenerative Medicine and Stem Cell Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); Whitcome Pre-doctoral Training Program; UCLA Graduate Division; CIRM(California Institute for Regenerative Medicine); Leukemia and Lymphoma Research; UCLA David Geffen School of Medicine; ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Shawn Cokus for advice, Sanjeet Patel for RNA-seq data analysis, and Terry Magnuson for Eed<SUP>-/-</SUP> ESCs. K.P. is supported by the UCLA Broad Center of Regenerative Medicine and Stem Cell Research, NIH (DP2OD001686; P01GM099134), and CIRM (RN1-00564); M.P., by NIH (P01GM099134), NSF (HYS-1066293), and the hospitality of the Aspen Center for Physics; G.B., by the Whitcome Pre-doctoral Training Program; M.D., by fellowships from the UCLA Broad Center of Regenerative Medicine and Stem Cell Research, the UCLA Graduate Division, and CIRM; C.C., by a Leukemia and Lymphoma Research Fellowship 10040; J.E., by funds from the UCLA David Geffen School of Medicine; and W.d.L., by an ERC Starting Grant (209700). M.D. and G.B. designed research, performed experiments, analyzed data, and wrote the paper; C.C. performed experiments; E.S. and W.d.L. trained M.D. in 4C-seq library preparation in 2008; J.E. provided analytic tools; M.P. offered supervision and data analysis; and K.P. designed research, analyzed data, wrote the paper, and supervised the overall project.	Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Bantignies F, 2011, TRENDS GENET, V27, P454, DOI 10.1016/j.tig.2011.06.008; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Denholtz M, 2012, CURR OPIN CELL BIOL, V24, P793, DOI 10.1016/j.ceb.2012.11.001; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Hakim O, 2013, GENOME RES, V23, P462, DOI 10.1101/gr.147652.112; Hakim O, 2011, GENOME RES, V21, P697, DOI 10.1101/gr.111153.110; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takebayashi S, 2012, P NATL ACAD SCI USA, V109, P12574, DOI 10.1073/pnas.1207185109; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	40	196	197	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					602	616		10.1016/j.stem.2013.08.013	http://dx.doi.org/10.1016/j.stem.2013.08.013			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24035354	Green Accepted, Bronze			2022-12-28	WOS:000329571500012
J	Bernardo, ME; Fibbe, WE				Bernardo, Maria Ester; Fibbe, Willem E.			Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation	CELL STEM CELL			English	Review							VERSUS-HOST-DISEASE; TOLL-LIKE RECEPTORS; SUPPRESS T-LYMPHOCYTE; STEM-CELLS; BONE-MARROW; IN-VITRO; MSCS; MICE; MACROPHAGES; RECRUITMENT	In addition to their stem/progenitor properties, mesenchymal stromal cells (MSCs) possess broad immunoregulatory properties that are being investigated for potential clinical application in treating immune-based disorders. An informed view of the scope of this clinical potential will require a clear understanding of the dynamic interplay between MSCs and the innate and adaptive immune systems. In this Review, we outline current insights into the ways in which MSCs sense and control inflammation, highlighting the central role of macrophage polarization. We also draw attention to functional differences seen between vivo and in vitro contexts and between species. Finally, we discuss progress toward clinical application of MSCs, focusing on GvHD as a case study.	[Bernardo, Maria Ester] IRCCS Bambino Gesu Children Hosp, Dept Pediat Hematol & Oncol, I-00165 Rome, Italy; [Fibbe, Willem E.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands	IRCCS Bambino Gesu; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Fibbe, WE (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands.	w.e.fibbe@lumc.nl						Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Ball LM, 2013, BRIT J HAEMATOL, V163, P501, DOI 10.1111/bjh.12545; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Brandau S, 2010, J LEUKOCYTE BIOL, V88, P1005, DOI 10.1189/jlb.0410207; Burr SP, 2013, IMMUNOL CELL BIOL, V91, P12, DOI 10.1038/icb.2012.60; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662; Casiraghi F, 2013, CURR OPIN ORGAN TRAN, V18, P51, DOI 10.1097/MOT.0b013e32835c5016; Cassatella MA, 2011, STEM CELLS, V29, P1001, DOI 10.1002/stem.651; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Choi EW, 2012, ARTHRITIS RHEUM-US, V64, P243, DOI 10.1002/art.33313; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; Cutler AJ, 2010, J IMMUNOL, V185, P6617, DOI 10.4049/jimmunol.1002239; Dander E, 2012, LEUKEMIA, V26, P1681, DOI 10.1038/leu.2011.384; Dazzi F, 2012, IMMUNOLOGY, V137, P206, DOI 10.1111/j.1365-2567.2012.03621.x; DelaRosa O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00182; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duijvestein M, 2011, STEM CELLS, V29, P1549, DOI 10.1002/stem.698; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Eggenhofer E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-12; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Gordon S, 2011, EUR J IMMUNOL, V41, P2470, DOI 10.1002/eji.201141988; Gratz IK, 2013, ANN NY ACAD SCI, V1283, P8, DOI 10.1111/nyas.12011; Guilloton F, 2012, BLOOD, V119, P2556, DOI 10.1182/blood-2011-08-370908; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hall SRR, 2013, STEM CELLS, V31, P397, DOI 10.1002/stem.1270; Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005; Kawashima N, 2012, ARCH ORAL BIOL, V57, P1439, DOI 10.1016/j.archoralbio.2012.08.010; Ke CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069658; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Krampera M, 2011, LEUKEMIA, V25, P1408, DOI 10.1038/leu.2011.108; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee RH, 2012, CELL STEM CELL, V11, P825, DOI 10.1016/j.stem.2012.10.001; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Levy O., 2013, BLOOD IN PRESS, DOI DOI 10.1182/BL00D-2013-04-495119; Li W, 2012, CELL DEATH DIFFER, V19, P1505, DOI 10.1038/cdd.2012.26; Lucchini G, 2010, BIOL BLOOD MARROW TR, V16, P1293, DOI 10.1016/j.bbmt.2010.03.017; Luo Y, 2012, SURGERY, V151, P353, DOI 10.1016/j.surg.2011.09.033; Maccario R, 2005, HAEMATOLOGICA, V90, P516; Madec AM, 2009, DIABETOLOGIA, V52, P1391, DOI 10.1007/s00125-009-1374-z; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mantovani A, 2012, CELL STEM CELL, V11, P730, DOI 10.1016/j.stem.2012.11.016; Melief S. M., 2013, STEM CELLS IN PRESS; Melief SM, 2013, HAEMATOLOGICA, V98, P888, DOI 10.3324/haematol.2012.078055; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Mo IFY, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-52; Najar M, 2010, CELL IMMUNOL, V264, P171, DOI 10.1016/j.cellimm.2010.06.006; Nemeth K, 2010, J MOL MED, V88, P5, DOI 10.1007/s00109-009-0523-7; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sarkar D, 2010, BIOMATERIALS, V31, P5266, DOI 10.1016/j.biomaterials.2010.03.006; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Stagg J, 2013, CURR MOL MED, V13, P856, DOI 10.2174/1566524011313050016; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Tisato V, 2007, LEUKEMIA, V21, P1992, DOI 10.1038/sj.leu.2404847; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228	88	902	939	6	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					392	402		10.1016/j.stem.2013.09.006	http://dx.doi.org/10.1016/j.stem.2013.09.006			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094322	Bronze			2022-12-28	WOS:000329571100009
J	Guo, GJ; Luc, S; Marco, E; Lin, TW; Peng, C; Kerenyi, MA; Beyaz, S; Kim, W; Xu, J; Das, PP; Neff, T; Zou, KY; Yuan, GC; Orkin, SH				Guo, Guoji; Luc, Sidinh; Marco, Eugenio; Lin, Ta-Wei; Peng, Cong; Kerenyi, Marc A.; Beyaz, Semir; Kim, Woojin; Xu, Jian; Das, Partha Pratim; Neff, Tobias; Zou, Keyong; Yuan, Guo-Cheng; Orkin, Stuart H.			Mapping Cellular Hierarchy by Single-Cell Analysis of the Cell Surface Repertoire	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION ANALYSIS; ACUTE MYELOID-LEUKEMIA; MOUSE BONE-MARROW; MESSENGER-RNA-SEQ; TRANSCRIPTION FACTOR; PROGENITOR CELLS; IDENTIFICATION; GATA-1; LINEAGES	Stem cell differentiation pathways are most often studied at the population level, whereas critical decisions are executed at the level of single cells. We have established a highly multiplexed, quantitative PCR assay to profile in an unbiased manner a panel of all commonly used cell surface markers (280 genes) from individual cells. With this method, we analyzed over 1,500 single cells throughout the mouse hematopoietic system and illustrate its utility for revealing important biological insights. The comprehensive single cell data set permits mapping of the mouse hematopoietic stem cell differentiation hierarchy by computational lineage progression analysis. Further profiling of 180 intracellular regulators enabled construction of a genetic network to assign the earliest differentiation event during hematopoietic lineage specification. Analysis of acute myeloid leukemia elicited by MLL-AF9 uncovered a distinct cellular hierarchy containing two independent self-renewing lineages with different clonal activities. The strategy has broad applicability in other cellular systems.	[Guo, Guoji; Luc, Sidinh; Peng, Cong; Kerenyi, Marc A.; Beyaz, Semir; Kim, Woojin; Xu, Jian; Das, Partha Pratim; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Guo, Guoji; Luc, Sidinh; Peng, Cong; Kerenyi, Marc A.; Beyaz, Semir; Kim, Woojin; Xu, Jian; Das, Partha Pratim; Orkin, Stuart H.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Dana Farber Canc Inst, Boston, MA 02115 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Marco, Eugenio; Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Lin, Ta-Wei] Childrens Hosp, Mol Genet Core Facil, Boston, MA 02115 USA; [Neff, Tobias] Univ Colorado, Pediat Hematol Oncol BMT, Aurora, CO 80045 USA; [Zou, Keyong] Boston Open Labs, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Marco, Eugenio/F-4583-2011	Guo, Guoji/0000-0002-1716-4621; Luc, Sidinh/0000-0001-7006-6169; Neff, Tobias/0000-0002-0188-8393; Marco, Eugenio/0000-0002-3675-263X; Beyaz, Semir/0000-0003-4730-4012; Das, Partha Pratim/0000-0003-3544-2629	National Institutes of Health; Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE [K08CA154777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216, K01DK093543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Skaletsky from Whitehead Institute for extensive help on the multiplexed primer design; Y. Fujiwara, E. Baena, O. Yilmaz, M. Nguyen, X. Han, V. Bragt, D. Linn, and J. Buchman for help with different parts of the sample preparations; and H. Huang, Z. Li, D. Scadden, H. Xie, and H. Hock for insightful discussions on the project. This work was supported by funding from the National Institutes of Health and the Harvard Stem Cell Institute (S. H. O). S. H. O. is an investigator of the Howard Hughes Medical Institute.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cavalli G, 2012, SCIENCE, V338, P1430, DOI 10.1126/science.1232332; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gibbs KD, 2012, CELL STEM CELL, V10, P210, DOI 10.1016/j.stem.2012.01.004; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Huang Z, 2009, MOL CELL BIOL, V29, P5168, DOI 10.1128/MCB.00482-09; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kitajima K, 2006, BLOOD, V107, P1857, DOI 10.1182/blood-2005-06-2527; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lai L, 1998, J IMMUNOL, V160, P3861; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6; Neff T, 2012, P NATL ACAD SCI USA, V109, P5028, DOI 10.1073/pnas.1202258109; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; VISSER JWM, 1984, J EXP MED, V159, P1576, DOI 10.1084/jem.159.6.1576; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016	41	173	175	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					492	505		10.1016/j.stem.2013.07.017	http://dx.doi.org/10.1016/j.stem.2013.07.017			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24035353	Green Accepted, Bronze			2022-12-28	WOS:000329571100017
J	Yin, XL; Mead, BE; Safaee, H; Langer, R; Karp, JM; Levy, O				Yin, Xiaolei; Mead, Benjamin E.; Safaee, Helia; Langer, Robert; Karp, Jeffrey M.; Levy, Oren			Engineering Stem Cell Organoids	CELL STEM CELL			English	Review							IN-VITRO EXPANSION; DIRECTED DIFFERENTIATION; 3-DIMENSIONAL CULTURE; EXTRINSIC SIGNALS; NICHE MICROARRAYS; HIGH-THROUGHPUT; MOTOR-NEURONS; HUMAN ES; HYDROGELS; GROWTH	Organoid systems leverage the self-organizing properties of stem cells to create diverse multi-cellular tissue proxies. Most organoid models only represent single or partial components of a tissue, and it is often difficult to control the cell type, organization, and cell-cell/cell-matrix interactions within these systems. Herein, we discuss basic approaches to generate stem cell-based organoids, their advantages and limitations, and how bioengineering strategies can be used to steer the cell composition and their 3D organization within organoids to further enhance their utility in research and therapies.	[Yin, Xiaolei; Mead, Benjamin E.; Safaee, Helia; Karp, Jeffrey M.; Levy, Oren] Brigham & Womens Hosp, Ctr Regenerat Therapeut, Dept Med, Div Biomed Engn, Cambridge, MA 02115 USA; [Yin, Xiaolei; Mead, Benjamin E.; Safaee, Helia; Karp, Jeffrey M.; Levy, Oren] Harvard Univ, Sch Med, Cambridge, MA 02115 USA; [Yin, Xiaolei; Mead, Benjamin E.; Safaee, Helia; Karp, Jeffrey M.; Levy, Oren] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Yin, Xiaolei; Mead, Benjamin E.; Safaee, Helia; Langer, Robert; Karp, Jeffrey M.; Levy, Oren] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Yin, Xiaolei; Mead, Benjamin E.; Langer, Robert] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Karp, JM; Levy, O (corresponding author), Brigham & Womens Hosp, Ctr Regenerat Therapeut, Dept Med, Div Biomed Engn, Cambridge, MA 02115 USA.; Karp, JM; Levy, O (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02115 USA.; Karp, JM; Levy, O (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Karp, JM; Levy, O (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	jeffkarp.bwh@gmail.com; levyorn@gmail.com	Yin, Xiaolei/F-1989-2013; Levey, Allan/F-2104-2011	Levey, Allan/0000-0002-3153-502X	National Institutes of Health [HL095722]; NIH [DE013023]; Kenneth Rainin Foundation Break-through Award; Movember Prostate Cancer Foundation; Charles A. King Trust; William Randolph Hearst BWH DOM Young Investigator Award; NSF; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kenneth Rainin Foundation Break-through Award; Movember Prostate Cancer Foundation; Charles A. King Trust; William Randolph Hearst BWH DOM Young Investigator Award; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grant HL095722 to J.M.K., NIH grant DE013023 to R.S.L. A Kenneth Rainin Foundation Break-through Award to J.M.K., a Movember Prostate Cancer Foundation Challenge Award to J.M.K., The Charles A. King Trust Fellowship to O.L., The William Randolph Hearst BWH DOM Young Investigator Award to O.L.; and an NSF fellowship to B.E.M.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Chambers SM, 2013, CELL STEM CELL, V13, P377, DOI 10.1016/j.stem.2013.09.010; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheng AA, 2012, ANNU REV BIOMED ENG, V14, P155, DOI [10.1146/annurev-bioeng-071811-150118, 10.1146/annurev.bioeng-071811-150118]; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fluri DA, 2012, NAT METHODS, V9, P509, DOI [10.1038/NMETH.1939, 10.1038/nmeth.1939]; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Gjorevski N, 2014, DEVELOPMENT, V141, P1794, DOI 10.1242/dev.101048; Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]; Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j; Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Karal-Yilmaz O, 2011, J MICROENCAPSUL, V28, P46, DOI 10.3109/02652048.2010.523795; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; King JA, 2007, CURR OPIN CHEM BIOL, V11, P394, DOI 10.1016/j.cbpa.2007.05.034; King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522; Kirouac DC, 2008, CELL STEM CELL, V3, P369, DOI 10.1016/j.stem.2008.09.001; Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494; Kuhlman W, 2007, BIOMACROMOLECULES, V8, P3206, DOI 10.1021/bm070237o; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Layman H, 2012, J BIOMAT SCI-POLYM E, V23, P185, DOI 10.1163/092050610X546417; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lindemans C. A., 2015, NATURE IN PRESS; Lohmueller JJ, 2012, NUCLEIC ACIDS RES, V40, P5180, DOI 10.1093/nar/gks142; Lutz JF, 2006, J AM CHEM SOC, V128, P13046, DOI 10.1021/ja065324n; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; McDevitt TC, 2013, P NATL ACAD SCI USA, V110, P20852, DOI 10.1073/pnas.1320575111; McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103; Merceron TK., 2015, ESSENTIALS 3D BIOFAB; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]; Peerani R, 2010, J CLIN INVEST, V120, P60, DOI 10.1172/JCI41158; Perl A, 2009, ADV MATER, V21, P2257, DOI 10.1002/adma.200801864; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Petros TJ, 2011, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmo1.2011.00030, 10.3389/fnmol.2011.00030]; Przyborski SA, 2005, STEM CELLS, V23, P1242, DOI 10.1634/stemcells.2005-0014; Purcell O, 2014, CURR OPIN BIOTECH, V29, P146, DOI 10.1016/j.copbio.2014.04.009; Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682; Ranga A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5324; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Rustad KC, 2012, BIOMATERIALS, V33, P80, DOI 10.1016/j.biomaterials.2011.09.041; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shanks Niall, 2009, Philos Ethics Humanit Med, V4, P2, DOI 10.1186/1747-5341-4-2; Shyer AE, 2013, SCIENCE, V342, P212, DOI 10.1126/science.1238842; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Stephan MT, 2011, NANO TODAY, V6, P309, DOI 10.1016/j.nantod.2011.04.001; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tan S, 2013, GROWTH FACTORS, V31, P175, DOI 10.3109/08977194.2013.859683; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Vazin T, 2010, TRENDS BIOTECHNOL, V28, P117, DOI 10.1016/j.tibtech.2009.11.008; Vincent LG, 2013, BIOTECHNOL J, V8, P472, DOI 10.1002/biot.201200205; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Visconti RP, 2010, EXPERT OPIN BIOL TH, V10, P409, DOI 10.1517/14712590903563352; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wilson SS, 2015, MUCOSAL IMMUNOL, V8, P352, DOI 10.1038/mi.2014.72; Wischerhoff E, 2008, ANGEW CHEM INT EDIT, V47, P5666, DOI 10.1002/anie.200801202; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9	88	481	496	31	245	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					25	38		10.1016/j.stem.2015.12.005	http://dx.doi.org/10.1016/j.stem.2015.12.005			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26748754	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000372321300009
J	Colasante, G; Lignani, G; Rubio, A; Medrihan, L; Yekhlef, L; Sessa, A; Massimino, L; Giannelli, SG; Sacchetti, S; Caiazzo, M; Leo, D; Alexopoulou, D; Dell'Anno, MT; Ciabatti, E; Orlando, M; Studer, M; Dahl, A; Gainetdinov, RR; Taverna, S; Benfenati, F; Broccoli, V				Colasante, Gaia; Lignani, Gabriele; Rubio, Alicia; Medrihan, Lucian; Yekhlef, Latefa; Sessa, Alessandro; Massimino, Luca; Giannelli, Serena G.; Sacchetti, Silvio; Caiazzo, Massimiliano; Leo, Damiana; Alexopoulou, Dimitra; Dell'Anno, Maria Teresa; Ciabatti, Ernesto; Orlando, Marta; Studer, Michele; Dahl, Andreas; Gainetdinov, Raul R.; Taverna, Stefano; Benfenati, Fabio; Broccoli, Vania			Rapid Conversion of Fibroblasts into Functional Forebrain GABAergic Interneurons by Direct Genetic Reprogramming	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; VENTRAL TELENCEPHALON; CORTICAL INTERNEURONS; TRANSCRIPTION FACTORS; DOPAMINERGIC-NEURONS; MOUSE; PRECURSORS; EXPRESSION; MICE; TRANSPLANTATION	Transplantation of GABAergic interneurons (INs) can provide long-term functional benefits in animal models of epilepsy and other neurological disorders. Whereas GABAergic INs can be differentiated from embryonic stem cells, alternative sources of GABAergic INs may be more tractable for disease modeling and transplantation. We identified five factors (Foxg1, Sox2, Ascl1, Dlx5, and Lhx6) that convert mouse fibroblasts into induced GABAergic INs (iGABA-INs) possessing molecular signatures of telencephalic INs. Factor overexpression activates transcriptional networks required for GABAergic fate specification. iGABA-INs display progressively maturing firing patterns comparable to cortical INs, form functional synapses, and release GABA. Importantly, iGABA-INs survive and mature upon being grafted into mouse hippocampus. Optogenetic stimulation demonstrated functional integration of grafted iGABA-INs into host circuitry, triggering inhibition of host granule neuron activity. These five factors also converted human cells into functional GABAergic INs. These properties suggest that iGABA-INs have potential for disease modeling and cell-based therapeutic approaches to neurological disorders.	[Colasante, Gaia; Rubio, Alicia; Sessa, Alessandro; Massimino, Luca; Giannelli, Serena G.; Caiazzo, Massimiliano; Dell'Anno, Maria Teresa; Ciabatti, Ernesto; Broccoli, Vania] Osped San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Lignani, Gabriele; Medrihan, Lucian; Yekhlef, Latefa; Sacchetti, Silvio; Leo, Damiana; Orlando, Marta; Gainetdinov, Raul R.; Taverna, Stefano; Benfenati, Fabio] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Yekhlef, Latefa; Taverna, Stefano] Ist Sci San Raffaele, Div Neurosci, Neuroimmunol Unit, I-20132 Milan, Italy; [Alexopoulou, Dimitra; Dahl, Andreas] Tech Univ Dresden, Ctr Biotechnol, Deep Sequencing Grp, D-01307 Dresden, Germany; [Studer, Michele] Univ Nice Sophia Antipolis, F-06108 Nice, France; [Studer, Michele] INSERM, iBV, UMR 1091, F-06108 Nice, France; [Gainetdinov, Raul R.] St Petersburg State Univ, Inst Translat Biomed, St Petersburg 199034, Russia; [Broccoli, Vania] CNR, Inst Neurosci, I-20129 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Istituto Italiano di Tecnologia - IIT; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Technische Universitat Dresden; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Saint Petersburg State University; Consiglio Nazionale delle Ricerche (CNR)	Broccoli, V (corresponding author), Osped San Raffaele, Div Neurosci, I-20132 Milan, Italy.	broccoli.vania@hsr.it	Caiazzo, Massimiliano/C-1722-2016; Taverna, Stefano/AAN-1938-2020; Broccoli, Vania/K-3464-2016; Sessa, Alessandro/AAB-8777-2019; Gainetdinov, Raul R/G-5875-2011; Massimino, Luca/F-2244-2011; Giannelli, Serena Gea/AAO-7015-2020; Studer, Michele/P-4580-2016; Dahl, Andreas/E-3783-2017; rubio, alicia/I-7487-2018; Colasante, Gaia/K-4742-2016	Caiazzo, Massimiliano/0000-0002-8975-3257; Taverna, Stefano/0000-0003-1871-8662; Broccoli, Vania/0000-0003-4050-0926; Gainetdinov, Raul R/0000-0003-2951-6038; Massimino, Luca/0000-0003-3975-9148; Giannelli, Serena Gea/0000-0002-6787-7793; Studer, Michele/0000-0001-7105-2957; Dahl, Andreas/0000-0002-2668-8371; rubio, alicia/0000-0003-0897-4806; Medrihan, Lucian/0000-0002-8252-2595; Leo, Damiana/0000-0001-9219-5498; Alexopoulou, Dimitra/0000-0002-3715-1756; Lignani, Gabriele/0000-0002-3963-9296; Ciabatti, Ernesto/0000-0001-9361-5992; Sessa, Alessandro/0000-0003-3611-5056; Orlando, Marta/0000-0002-9017-0251; Dell'Anno, Maria Teresa/0000-0003-1825-671X; Colasante, Gaia/0000-0003-0954-7822	European Research Council [AdERC 340527]; IIT-SEED project; EC; Fondazione Veronesi; Collaborative Research Center 655 from the Deutsche Forschungsgemeinschaft; Russian Science Foundation [4-50-00069]; Russian Science Foundation [14-50-00069] Funding Source: Russian Science Foundation	European Research Council(European Research Council (ERC)European Commission); IIT-SEED project; EC(European CommissionEuropean Commission Joint Research Centre); Fondazione Veronesi(Fondazione Umberto Veronesi); Collaborative Research Center 655 from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	We thank A. Buffo, A. Dityatev, B. Berninger, V. Pachnis, B. Rudy, and T. Kaneko for helpful discussions and sharing of mice and reagents. We are grateful to the FRACTAL core facility for flow cytometry and to M. Andreazzoli for critical reading of the manuscript. This work was supported by the European Research Council (AdERC #340527) and IIT-SEED project (to V.B.) and EC FP7-Health-2013-Innovation integrating project "DESIRE'' (to F.B. and V.B.). G.C. is supported by a fellowship from Fondazione Veronesi. D.A. is supported by the Collaborative Research Center 655 from the Deutsche Forschungsgemeinschaft, and R.R.G. is supported by the Russian Science Foundation (grant #4-50-00069).	Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Anderson SA, 2001, DEVELOPMENT, V128, P353; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Braz JM, 2012, NEURON, V74, P663, DOI 10.1016/j.neuron.2012.02.033; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Calcagnotto ME, 2010, EPILEPSIA, V51, P71, DOI 10.1111/j.1528-1167.2010.02614.x; Casarosa S, 1999, DEVELOPMENT, V126, P525; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Colasante G, 2009, DEV BIOL, V334, P59, DOI 10.1016/j.ydbio.2009.07.014; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; Du J, 1996, J NEUROSCI, V16, P506; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; Ferri A, 2013, DEVELOPMENT, V140, P1250, DOI 10.1242/dev.073411; Fode C, 2000, GENE DEV, V14, P67; Gilani AI, 2014, P NATL ACAD SCI USA, V111, P7450, DOI 10.1073/pnas.1316488111; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Manuel M, 2010, DEVELOPMENT, V137, P487, DOI 10.1242/dev.039800; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Maroof AM, 2010, J NEUROSCI, V30, P4667, DOI 10.1523/JNEUROSCI.4255-09.2010; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Poitras L, 2007, DEVELOPMENT, V134, P1755, DOI 10.1242/dev.02845; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Theka I, 2013, STEM CELL TRANSL MED, V2, P473, DOI 10.5966/sctm.2012-0133; Tong LM, 2014, J NEUROSCI, V34, P9506, DOI 10.1523/JNEUROSCI.0693-14.2014; Tyson JA, 2015, DEVELOPMENT, V142, P1267, DOI 10.1242/dev.111526; Victor MB, 2014, NEURON, V84, P311, DOI 10.1016/j.neuron.2014.10.016; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang YL, 2010, J NEUROSCI, V30, P5334, DOI 10.1523/JNEUROSCI.5963-09.2010; Watts JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002277; Yun K, 2002, DEVELOPMENT, V129, P5029; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	41	107	112	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					719	734		10.1016/j.stem.2015.09.002	http://dx.doi.org/10.1016/j.stem.2015.09.002			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26526726	Bronze			2022-12-28	WOS:000366139100013
J	Hallett, PJ; Deleidi, M; Astradsson, A; Smith, GA; Cooper, O; Osborn, TM; Sundberg, M; Moore, MA; Perez-Torres, E; Brownell, AL; Schumacher, JM; Spealman, RD; Isacson, O				Hallett, Penelope J.; Deleidi, Michela; Astradsson, Arnar; Smith, Gaynor A.; Cooper, Oliver; Osborn, Teresia M.; Sundberg, Maria; Moore, Michele A.; Perez-Torres, Eduardo; Brownell, Anna-Liisa; Schumacher, James M.; Spealman, Roger D.; Isacson, Ole			Successful Function of Autologous iPSC-Derived Dopamine Neurons following Transplantation in a Non-Human Primate Model of Parkinson's Disease	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; RAT MODEL; NEURAL CELLS; BRAIN; DIFFERENTIATION; DEFICIENT; SYMPTOMS; RECOVERY; SURVIVAL; IMPROVE	Autologous transplantation of patient-specific induced pluripotent stem cell (iPSC)-derived neurons is a potential clinical approach for treatment of neurological disease. Preclinical demonstration of long-term efficacy, feasibility, and safety of iPSC-derived dopamine neurons in non-human primate models will be an important step in clinical development of cell therapy. Here, we analyzed cynomolgus monkey (CM) iPSC-derived midbrain dopamine neurons for up to 2 years following autologous transplantation in a Parkinson's disease (PD) model. In one animal, with the most successful protocol, we found that unilateral engraftment of CM-iPSCs could provide a gradual onset of functional motor improvement contralateral to the side of dopamine neuron transplantation, and increased motor activity, without a need for immunosuppression. Postmortem analyses demonstrated robust survival of midbrain-like dopaminergic neurons and extensive outgrowth into the transplanted putamen. Our proof of concept findings support further development of autologous iPSC-derived cell transplantation for treatment of PD.	[Hallett, Penelope J.; Deleidi, Michela; Astradsson, Arnar; Smith, Gaynor A.; Cooper, Oliver; Osborn, Teresia M.; Sundberg, Maria; Moore, Michele A.; Perez-Torres, Eduardo; Brownell, Anna-Liisa; Schumacher, James M.; Spealman, Roger D.; Isacson, Ole] McLean Hosp, Neuroregenerat Res Inst, Belmont, MA 02478 USA; [Hallett, Penelope J.; Deleidi, Michela; Astradsson, Arnar; Smith, Gaynor A.; Cooper, Oliver; Osborn, Teresia M.; Sundberg, Maria; Moore, Michele A.; Perez-Torres, Eduardo; Brownell, Anna-Liisa; Schumacher, James M.; Spealman, Roger D.; Isacson, Ole] Harvard Univ, Sch Med, Belmont, MA 02478 USA; [Moore, Michele A.; Spealman, Roger D.] Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA; [Brownell, Anna-Liisa] Massachusetts Gen Hosp, MGH HST Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Brownell, Anna-Liisa] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Isacson, Ole] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; McLean Hospital; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Isacson, O (corresponding author), McLean Hosp, Neuroregenerat Res Inst, Belmont, MA 02478 USA.	isacson@hms.harvard.edu		Cooper, Oliver/0000-0001-6567-7491; Isacson, Ole/0000-0001-8091-8302; Sundberg, Maria/0000-0002-6623-4411; Deleidi, Michela/0000-0003-0357-0124; Smith, Gaynor/0000-0003-4332-8383; Hallett, Penelope/0000-0002-8858-9096	Harvard Stem Cell Institute Miller Consortium; Udall Parkinson's Disease Center of Excellence [P50 NS39793]; Department of Defense [WX81XWH-11-1-0069]; Orchard Foundation; Poul Hansen Family; Consolidated Anti-Aging Foundation; Harold and Ronna Cooper Family; National Center for Research Resources [RR00168]; Office of Research Infrastructure Programs [OD011103]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039793] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103] Funding Source: NIH RePORTER	Harvard Stem Cell Institute Miller Consortium; Udall Parkinson's Disease Center of Excellence; Department of Defense(United States Department of Defense); Orchard Foundation; Poul Hansen Family; Consolidated Anti-Aging Foundation; Harold and Ronna Cooper Family; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the veterinary and research staff, including Dr. Leah Makaron, Dr. Angela Carville, Dr. Andrew Miller, Matthew Beck, Jack McDowell, Melissa Hayes, Jonathan Beagan, Zachary Schneider-Lynch, Sayantan Deb, and Alex Casler, at the New England Primate Research Center and the Neuroregeneration Research Institute for excellent veterinary and technical assistance. This study was supported by the Harvard Stem Cell Institute Miller Consortium for the Development of Nervous System Therapies and the Udall Parkinson's Disease Center of Excellence grant P50 NS39793, Department of Defense WX81XWH-11-1-0069, Orchard Foundation, Poul Hansen Family, Consolidated Anti-Aging Foundation and Harold and Ronna Cooper Family (to O.I.), National Center for Research Resources RR00168, and the Office of Research Infrastructure Programs OD011103 (to R.D.S.).	Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; Brownell AL, 1998, NAT MED, V4, P1308, DOI 10.1038/3300; Brownell AL, 1998, ANN NEUROL, V43, P387, DOI 10.1002/ana.410430318; Cooper O, 2010, MOL CELL NEUROSCI, V45, P258, DOI 10.1016/j.mcn.2010.06.017; Deleidi M, 2011, STEM CELLS, V29, P1052, DOI 10.1002/stem.662; DOUCET G, 1989, EXP NEUROL, V106, P1, DOI 10.1016/0014-4886(89)90139-8; DUAN WM, 1995, EXP BRAIN RES, V104, P227; Emborg ME, 2013, CELL REP, V3, P646, DOI 10.1016/j.celrep.2013.02.016; Grealish S, 2014, CELL STEM CELL, V15, P653, DOI 10.1016/j.stem.2014.09.017; Grealish S, 2010, BRAIN, V133, P482, DOI 10.1093/brain/awp328; Hallett PJ, 2014, CELL REP, V7, P1755, DOI 10.1016/j.celrep.2014.05.027; HANTRAYE P, 1992, NEUROREPORT, V3, P265, DOI 10.1097/00001756-199203000-00013; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Jenkins BG, 2004, J NEUROSCI, V24, P9553, DOI 10.1523/JNEUROSCI.1558-04.2004; Kefalopoulou Z, 2014, JAMA NEUROL, V71, P83, DOI 10.1001/jamaneurol.2013.4749; Kikuchi T, 2011, J PARKINSON DIS, V1, P395, DOI 10.3233/JPD-2011-11070; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Morizane A, 2013, STEM CELL REP, V1, P283, DOI 10.1016/j.stemcr.2013.08.007; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Redmond DE, 2008, NEUROBIOL DIS, V29, P103, DOI 10.1016/j.nbd.2007.08.008; Sanchez-Pernaute R, 2005, STEM CELLS, V23, P914, DOI 10.1634/stemcells.2004-0172; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Sundberg M, 2013, STEM CELLS, V31, P1548, DOI 10.1002/stem.1415; Tsui A, 2011, J NEUROL, V258, P1393, DOI 10.1007/s00415-011-6061-6; Vinuela A, 2008, BRAIN, V131, P3361, DOI 10.1093/brain/awn192; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; WULLNER U, 1994, EXP NEUROL, V126, P305, DOI 10.1006/exnr.1994.1069	28	196	205	1	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					269	274		10.1016/j.stem.2015.01.018	http://dx.doi.org/10.1016/j.stem.2015.01.018			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25732245	Green Accepted, Bronze			2022-12-28	WOS:000350747700009
J	Yan, KS; Kuo, CJ				Yan, Kelley S.; Kuo, Calvin J.			Ascl2 Reinforces Intestinal Stem Cell Identity	CELL STEM CELL			English	Editorial Material							CRYPT; LGR5	Ascl2 is a Wnt-responsive master transcription factor that controls the Lgr5(+) intestinal stem cell gene expression program. Now in Cell Stem Cell, Schuijers et al. (2015) report an Ascl2 positive feedback loop, tuned by previous Wnt pathway activity, that perpetuates intestinal stem cell identity in response to Wnt/R-spondin stimulation.	[Yan, Kelley S.; Kuo, Calvin J.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA	Stanford University	Kuo, CJ (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	cjkuo@stanford.edu		Kuo, Calvin/0000-0002-7427-5985	NIDDK NIH HHS [U01 DK085527, K08 DK096048, U01 DK085532] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK096048, U01DK085527] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	9	11	12	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					105	106		10.1016/j.stem.2015.01.014	http://dx.doi.org/10.1016/j.stem.2015.01.014			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25658363	Bronze			2022-12-28	WOS:000349455000002
J	Mandal, PK; Ferreira, LMR; Collins, R; Meissner, TB; Boutwell, CL; Friesen, M; Vrbanac, V; Garrison, BS; Stortchevoi, A; Bryder, D; Musunuru, K; Brand, H; Tager, AM; Allen, TM; Talkowski, ME; Rossi, DJ; Cowan, CA				Mandal, Pankaj K.; Ferreira, Leonardo M. R.; Collins, Ryan; Meissner, Torsten B.; Boutwell, Christian L.; Friesen, Max; Vrbanac, Vladimir; Garrison, Brian S.; Stortchevoi, Alexei; Bryder, David; Musunuru, Kiran; Brand, Harrison; Tager, Andrew M.; Allen, Todd M.; Talkowski, Michael E.; Rossi, Derrick J.; Cowan, Chad A.			Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9	CELL STEM CELL			English	Article							ZINC-FINGER NUCLEASES; OFF-TARGET ACTIVITY; CD4 T-CELLS; MAMMALIAN-CELLS; CCR5 GENE; GENOME; HIV-1; DNA; SYSTEMS; TALEN	Genome editing via CRISPR/Cas9 has rapidly become the tool of choice by virtue of its efficacy and ease of use. However, CRISPR/Cas9-mediated genome editing in clinically relevant human somatic cells remains untested. Here, we report CRISPR/Cas9 targeting of two clinically relevant genes, B2M and CCR5, in primary human CD4(+) T cells and CD34(+) hematopoietic stem and progenitor cells (HSPCs). Use of single RNA guides led to highly efficient mutagenesis in HSPCs but not in T cells. A dual guide approach improved gene deletion efficacy in both cell types. HSPCs that had undergone genome editing with CRISPR/Cas9 retained multilineage potential. We examined predicted on-and off-target mutations via target capture sequencing in HSPCs and observed low levels of off-target mutagenesis at only one site. These results demonstrate that CRISPR/Cas9 can efficiently ablate genes in HSPCs with minimal off-target mutagenesis, which could have broad applicability for hematopoietic cell-based therapy.	[Mandal, Pankaj K.; Ferreira, Leonardo M. R.; Meissner, Torsten B.; Friesen, Max; Garrison, Brian S.; Musunuru, Kiran; Rossi, Derrick J.; Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mandal, Pankaj K.; Garrison, Brian S.; Rossi, Derrick J.] Boston Childrens Hosp, Div Hematol Oncol, Program Cellular & Mol Med, Boston, MA 02116 USA; [Ferreira, Leonardo M. R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Collins, Ryan; Stortchevoi, Alexei; Brand, Harrison; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Mol Neurogenet Unit, Boston, MA 02114 USA; [Boutwell, Christian L.; Vrbanac, Vladimir; Tager, Andrew M.; Allen, Todd M.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Vrbanac, Vladimir; Tager, Andrew M.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Vrbanac, Vladimir; Tager, Andrew M.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Garrison, Brian S.; Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Bryder, David] Lund Univ, Immunol Sect, Inst Expt Med Res, S-22184 Lund, Sweden; [Musunuru, Kiran; Rossi, Derrick J.; Cowan, Chad A.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Musunuru, Kiran] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Musunuru, Kiran; Talkowski, Michael E.; Cowan, Chad A.] Broad Inst, Cambridge, MA 02142 USA; [Talkowski, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Harvard University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Lund University; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Rossi, DJ (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	derrick.rossi@childrens.harvard.edu; chad_cowan@harvard.edu	Allen, Todd/F-5473-2011; Ferreira, Leonardo/J-7984-2019; mandal, pankaj/B-4885-2016; Bryder, David/Q-6292-2019	Allen, Todd/0000-0002-6609-1318; Ferreira, Leonardo/0000-0003-2491-9866; Mandal, Pankaj/0000-0003-1993-9918; Talkowski, Michael/0000-0003-2889-0992; Collins, Ryan/0000-0003-1268-9995; Bryder, David/0000-0002-8761-4237	Portuguese Foundation for Science and Technology; National Institutes of Health [P01-AI104715, MH095867, R01HL107630, U01DK072473, R01DK097768, U01HL100408]; Simons Foundation; March of Dimes; Leona M. and Harry B. Helmsley Charitable Trust; Jane Brock-Wilson Fund; Harvard Stem Cell Institute; Harvard University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107630, U01HL107440, U01HL100408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, P01AI104715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072473, R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH095867] Funding Source: NIH RePORTER	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; March of Dimes(March of Dimes); Leona M. and Harry B. Helmsley Charitable Trust; Jane Brock-Wilson Fund; Harvard Stem Cell Institute; Harvard University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by a fellowship from the Portuguese Foundation for Science and Technology (L. M. R. F.); the National Institutes of Health P01-AI104715 (T. M. A.), MH095867 (M. E. T.), R01HL107630 (D.J.R.), U01DK072473 (D.J.R.), R01DK097768 (C. A. C.), and U01HL100408 (C. A. C.); the Simons Foundation (M. E. T); the March of Dimes (M. E. T.); the Leona M. and Harry B. Helmsley Charitable Trust (D.J.R.); the Jane Brock-Wilson Fund (D.J.R. and T. M. A.); the Harvard Stem Cell Institute (D.J.R. and C. A. C.); and Harvard University (C. A. C.). D.J.R. is a New York Stem Cell Foundation Robertson Investigator. We thank Jennifer Shay and Carrie Hanscom for excellent technical support and the staff of the HSCRB-HSCI Flow Cytometry Core for assistance.	Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Catano G, 2011, J INFECT DIS, V203, P263, DOI 10.1093/infdis/jiq023; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Pan YZ, 2013, MOL BIOTECHNOL, V55, P54, DOI 10.1007/s12033-012-9613-9; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Riolobos L, 2013, MOL THER, V21, P1232, DOI 10.1038/mt.2013.59; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Scharenberg AM, 2013, CURR GENE THER, V13, P291; Schleifman EB, 2011, CHEM BIOL, V18, P1189, DOI 10.1016/j.chembiol.2011.07.010; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093575; Wei CX, 2013, J GENET GENOMICS, V40, P281, DOI 10.1016/j.jgg.2013.03.013; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	52	314	372	5	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					643	652		10.1016/j.stem.2014.10.004	http://dx.doi.org/10.1016/j.stem.2014.10.004			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517468	Green Accepted, Bronze			2022-12-28	WOS:000345012700016
J	Zweigerdt, R; Gruh, I; Martin, U				Zweigerdt, Robert; Gruh, Ina; Martin, Ulrich			Your Heart on a Chip: iPSC-Based Modeling of Barth-Syndrome-Associated Cardiomyopathy	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELL; RNA	Disease-specific induced pluripotent stem cells (iPSCs) are invaluable tools for studying genetic disorders in a dish. A recent paper by Wang et al. (2014) powerfully combines analysis of human iPSCs with genome editing and tissue engineering, in conjunction with biochemical and physiological assays, to provide insights into Barth-syndrome-associated cardiomyopathy.	[Zweigerdt, Robert; Gruh, Ina; Martin, Ulrich] Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs L, Dept Cardiothorac Transplantat & Vasc Surg, D-30625 Hannover, Germany; [Zweigerdt, Robert; Gruh, Ina; Martin, Ulrich] REBIRTH Cluster Excellence, Hannover, Germany	Hannover Medical School	Martin, U (corresponding author), Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs L, Dept Cardiothorac Transplantat & Vasc Surg, D-30625 Hannover, Germany.	martin.ulrich@mh-hannover.de	Martin, Ulrich/F-4888-2017	Martin, Ulrich/0000-0003-1058-4540				Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Dudek J, 2013, STEM CELL RES, V11, P806, DOI 10.1016/j.scr.2013.05.005; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Kensah G, 2013, EUR HEART J, V34, P1134, DOI 10.1093/eurheartj/ehs349; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Rigaud C, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-70; Van Haute L, 2013, NAT BIOTECHNOL, V31, P20, DOI 10.1038/nbt.2473; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012	10	11	13	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					10	12		10.1016/j.stem.2014.06.015	http://dx.doi.org/10.1016/j.stem.2014.06.015			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24996164	Bronze			2022-12-28	WOS:000340878600005
J	Cheng, CW; Adams, GB; Perin, L; Wei, M; Zhou, XY; Lam, B; Da Sacco, S; Mirisola, M; Quinn, DI; Dorff, TB; Kopchick, JJ; Longo, VD				Cheng, Chia-Wei; Adams, Gregor B.; Perin, Laura; Wei, Min; Zhou, Xiaoying; Lam, Ben S.; Da Sacco, Stefano; Mirisola, Mario; Quinn, David I.; Dorff, Tanya B.; Kopchick, John J.; Longo, Valter D.			Prolonged Fasting Reduces IGF-1/PKA to Promote Hematopoietic-Stem-Cell-Based Regeneration and Reverse Immunosuppression	CELL STEM CELL			English	Article							RECEPTOR KNOCKOUT MICE; SELF-RENEWAL CAPACITY; DIETARY RESTRICTION; STRESS RESISTANCE; LIFE-SPAN; METABOLIC-REGULATION; OXIDATIVE STRESS; CANCER-TREATMENT; LONGEVITY; YEAST	Immune system defects are at the center of aging and a range of diseases. Here, we show that prolonged fasting reduces circulating IGF-1 levels and PKA activity in various cell populations, leading to signal transduction changes in long-term hematopoietic stem cells (LT-HSCs) and niche cells that promote stress resistance, self-renewal, and lineage- balanced regeneration. Multiple cycles of fasting abated the immunosuppression and mortality caused by chemotherapy and reversed age-dependent myeloid-bias in mice, in agreement with preliminary data on the protection of lymphocytes from chemotoxicity in fasting patients. The proregenerative effects of fasting on stem cells were recapitulated by deficiencies in either IGF-1 or PKA and blunted by exogenous IGF-1. These findings link the reduced levels of IGF-1 caused by fasting to PKA signaling and establish their crucial role in regulating hematopoietic stem cell protection, selfrenewal, and regeneration.	[Cheng, Chia-Wei; Wei, Min; Longo, Valter D.] Univ So Calif, Longev Inst, Sch Gerontol, Dept Biol Sci, Los Angeles, CA 90089 USA; [Adams, Gregor B.; Zhou, Xiaoying; Lam, Ben S.; Longo, Valter D.] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Perin, Laura; Da Sacco, Stefano] Univ So Calif, Childrens Hosp Los Angeles, Saban Res Inst, Div Urol, Los Angeles, CA 90027 USA; [Mirisola, Mario] Univ Palermo, Dept Med Biotechnol & Forens, I-90133 Palermo, Italy; [Quinn, David I.; Dorff, Tanya B.] Univ So Calif, Keck Sch Med, Translat Oncol Program, Kenneth J Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Kopchick, John J.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Longo, Valter D.] FIRC Inst Mol Oncol, IFOM, I-20139 Milan, Italy	University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Palermo; University of Southern California; University System of Ohio; Ohio University; IFOM - FIRC Institute of Molecular Oncology	Longo, VD (corresponding author), Univ So Calif, Longev Inst, Sch Gerontol, Dept Biol Sci, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	vlongo@usc.edu	mirisola, mario/ABC-7929-2020; Wei, Min/GSI-8510-2022; Quinn, David I/F-4343-2015; mirisola, mario/GZK-2599-2022; Quinn, David/N-3730-2019; Da Sacco, Stefano/G-6346-2011	mirisola, mario/0000-0003-2555-2226; Quinn, David I/0000-0002-1411-0417; Quinn, David/0000-0002-1411-0417; Da Sacco, Stefano/0000-0001-9654-6822; /0000-0003-1088-923X; Wei, Min/0000-0002-2649-9271	NIH/NIA [AG20642, AG025135, P01 AG034906]; NATIONAL INSTITUTE ON AGING [P01AG034906, R01AG020642, R01AG025135] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Lora Barsky (USC Flow Cytometry Core Facility) for assistance in the FACS analysis, and Dr. R. Baserga (Thomas Jefferson University) for providing R<SUP>+</SUP> and R<SUP>-</SUP> cells. This study was funded in part by NIH/NIA grants AG20642, AG025135, and P01 AG034906. V. D. L. has equity interest in L-Nutra, a company that develops medical food.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; BEDFORD P, 1984, J CANCER RES CLIN, V108, P141, DOI 10.1007/BF00390986; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Bondolfi L, 2004, NEUROBIOL AGING, V25, P333, DOI 10.1016/S0197-4580(03)00083-6; Brown-Borg HM, 2009, EXP GERONTOL, V44, P10, DOI 10.1016/j.exger.2008.07.002; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Chen H, 2008, J BIOL CHEM, V283, P29228, DOI 10.1074/jbc.M802906200; Chen JC, 2003, EXP HEMATOL, V31, P1097, DOI 10.1016/S0301-472X(03)00238-8; Chen XJ, 2012, GENE DEV, V26, P2499, DOI 10.1101/gad.200329.112; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ertl RP, 2008, BLOOD, V111, P1709, DOI 10.1182/blood-2007-01-069807; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Huang J, 2012, NAT MED, V18, P1778, DOI 10.1038/nm.2984; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Jasper H, 2010, CELL METAB, V12, P561, DOI 10.1016/j.cmet.2010.11.010; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kirschner LS, 2009, ENDOCR-RELAT CANCER, V16, P773, DOI 10.1677/ERC-09-0068; Kofman AE, 2012, AGING-US, V4, P279, DOI 10.18632/aging.100451; Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee CH, 2010, CANCER RES, V70, P1564, DOI 10.1158/0008-5472.CAN-09-3228; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; Lee JW, 2011, J BIOL CHEM, V286, P6423, DOI 10.1074/jbc.M110.180661; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Longo VD, 2002, CELL MOL LIFE SCI, V59, P903, DOI 10.1007/s00018-002-8477-8; Longo VD, 1997, J CELL BIOL, V137, P1581, DOI 10.1083/jcb.137.7.1581; MACKALL CL, 1994, BLOOD, V84, P2221; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Rafalski VA, 2011, PROG NEUROBIOL, V93, P182, DOI 10.1016/j.pneurobio.2010.10.007; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Rathinam C, 2011, NAT IMMUNOL, V12, P399, DOI 10.1038/ni.2021; Rinaldi J, 2010, STRUCTURE, V18, P1471, DOI 10.1016/j.str.2010.08.013; Safdie FM, 2009, AGING-US, V1, P988, DOI 10.18632/aging.100114; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453; Subramaniam S, 2005, J NEUROSCI, V25, P2838, DOI 10.1523/JNEUROSCI.5060-04.2005; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; van Tilburg CM, 2011, BRIT J HAEMATOL, V152, P201, DOI 10.1111/j.1365-2141.2010.08478.x; Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303; Wei M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000467; Williams MD, 2004, CRIT CARE, V8, pR291, DOI 10.1186/cc2893; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Yamamizu K, 2012, CELL STEM CELL, V10, P759, DOI 10.1016/j.stem.2012.02.022; Yamamizu K, 2012, STEM CELLS, V30, P687, DOI 10.1002/stem.1041; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	70	256	265	0	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					810	823		10.1016/j.stem.2014.04.014	http://dx.doi.org/10.1016/j.stem.2014.04.014			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905167	Bronze, Green Accepted			2022-12-28	WOS:000341248500017
J	Zon, L				Zon, Leonard			Translational Research: The Path for Bringing Discovery to Patients	CELL STEM CELL			English	Editorial Material								Translating basic research findings into therapeutic settings presents many scientific, logistic, and financial challenges for academic researchers. Here, I highlight some key insights for navigating such challenges based on recent clinical trials initiated by basic research from my lab.	[Zon, Leonard] Harvard Univ, Sch Med, Childrens Hosp, Stem Cell Program & Hematol Oncol, Boston, MA 02115 USA; [Zon, Leonard] Harvard Univ, Sch Med, Dana Farber Canc Inst, HHMI,Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Zon, L (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Stem Cell Program & Hematol Oncol, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL048801] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Cutler C, 2013, BLOOD, V122, P3074, DOI 10.1182/blood-2013-05-503177; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883	4	6	6	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					146	148		10.1016/j.stem.2014.01.004	http://dx.doi.org/10.1016/j.stem.2014.01.004			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24506882	Green Accepted, Bronze			2022-12-28	WOS:000330835800007
J	Willinger, T; Flavell, RA				Willinger, Tim; Flavell, Richard A.			ESCaping Rejection: A Step Forward for Embryonic-Stem-Cell-Based Regenerative Medicine	CELL STEM CELL			English	Editorial Material							INDUCED PLURIPOTENT; MICE	The use of human embryonic stem cells (hESCs) for regenerative medicine currently faces several hurdles, including immune rejection of transplanted cells. Now in Cell Stem Cell, Rong et al. (2014) describe a strategy to protect hESCs from immune rejection while avoiding systemic immunosuppression, potentially facilitating clinical implementation of hESC-based therapies.	[Willinger, Tim; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Willinger, Tim/B-4779-2013	Willinger, TIM/0000-0002-8720-7199				Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Boyd AS, 2012, STEM CELLS, V30, P797, DOI 10.1002/stem.1066; Chien KR, 2008, NATURE, V453, P302, DOI 10.1038/nature07037; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Rong ZL, 2014, CELL STEM CELL, V14, P121, DOI 10.1016/j.stem.2013.11.014; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311	10	1	1	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					3	4		10.1016/j.stem.2013.12.003	http://dx.doi.org/10.1016/j.stem.2013.12.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24388169	Bronze			2022-12-28	WOS:000329571900002
J	Chambers, SM; Tchieu, J; Studer, L				Chambers, Stuart M.; Tchieu, Jason; Studer, Lorenz			Build-a-Brain	CELL STEM CELL			English	Editorial Material							NEOCORTEX; CELLS	A major barrier in understanding nervous system development is modeling the cellular interactions that form the human brain. Recently, in the journal Nature, Lancaster et al. (2013) established a protocol for culturing pluripotent stem cell (PSC)-derived "cerebral organoids" that mimics the developing human brain's cellular organization, segregates into distinct brain regions, and models microcephaly.	[Chambers, Stuart M.; Tchieu, Jason; Studer, Lorenz] Sloan Kettering Inst, Ctr Stem Cell Biol, New York, NY 10065 USA; [Chambers, Stuart M.; Tchieu, Jason; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Studer, L (corresponding author), Sloan Kettering Inst, Ctr Stem Cell Biol, 1275 York Ave, New York, NY 10065 USA.	studerl@mskcc.org	Tchieu, Jason/AAG-1551-2020; Studer, Lorenz/ABH-1491-2021	Tchieu, Jason/0000-0002-9793-9836; Studer, Lorenz/0000-0003-0741-7987				Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; HONEGGER P, 1979, NATURE, V282, P305, DOI 10.1038/282305a0; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807	8	15	17	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					377	378		10.1016/j.stem.2013.09.010	http://dx.doi.org/10.1016/j.stem.2013.09.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094317	Bronze			2022-12-28	WOS:000329571100004
J	Gascon, S; Murenu, E; Masserdotti, G; Ortega, F; Russo, GL; Petrik, D; Deshpande, A; Heinrich, C; Karow, M; Robertson, SP; Schroeder, T; Beckers, J; Irmler, M; Berndt, C; Angeli, JPF; Conrad, M; Berninger, B; Gotz, M				Gascon, Sergio; Murenu, Elisa; Masserdotti, Giacomo; Ortega, Felipe; Russo, Gianluca L.; Petrik, David; Deshpande, Aditi; Heinrich, Christophe; Karow, Marisa; Robertson, Stephen P.; Schroeder, Timm; Beckers, Johannes; Irmler, Martin; Berndt, Carsten; Angeli, Jose P. Friedmann; Conrad, Marcus; Berninger, Benedikt; Goetz, Magdalena			Identification and Successful Negotiation of a Metabolic Checkpoint in Direct Neuronal Reprogramming	CELL STEM CELL			English	Article							NONAPOPTOTIC CELL-DEATH; OXIDATIVE STRESS; IN-VIVO; BRAIN-INJURY; VITAMIN-D; MITOCHONDRIAL METABOLISM; LIPID-PEROXIDATION; FUNCTIONAL-NEURONS; DIRECT CONVERSION; PROGENITOR CELLS	Despite the widespread interest in direct neuronal reprogramming, the mechanisms underpinning fate conversion remain largely unknown. Our study revealed a critical time point after which cells either successfully convert into neurons or succumb to cell death. Co-transduction with Bcl-2 greatly improved negotiation of this critical point by faster neuronal differentiation. Surprisingly, mutants with reduced or no affinity for Bax demonstrated that Bcl-2 exerts this effect by an apoptosis-independent mechanism. Consistent with a caspase-independent role, ferroptosis inhibitors potently increased neuronal reprogramming by inhibiting lipid peroxidation occurring during fate conversion. Genome-wide expression analysis confirmed that treatments promoting neuronal reprogramming elicit an anti-oxidative stress response. Importantly, co-expression of Bcl-2 and anti-oxidative treatments leads to an unprecedented improvement in glial-to-neuron conversion after traumatic brain injury in vivo, underscoring the relevance of these pathways in cellular reprograming irrespective of cell type in vitro and in vivo.	[Gascon, Sergio; Murenu, Elisa; Masserdotti, Giacomo; Ortega, Felipe; Russo, Gianluca L.; Petrik, David; Deshpande, Aditi; Heinrich, Christophe; Karow, Marisa; Berninger, Benedikt; Goetz, Magdalena] Univ Munich, Biomed Ctr, Physiol Genom, D-80336 Munich, Germany; [Gascon, Sergio; Murenu, Elisa; Masserdotti, Giacomo; Russo, Gianluca L.; Petrik, David; Goetz, Magdalena] Helmholtz Ctr Munich, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Ortega, Felipe; Berninger, Benedikt] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, D-55128 Mainz, Germany; [Ortega, Felipe] Univ Complutense, Fac Vet Med, Dept Biochem & Mol Biol, E-28040 Madrid, Spain; [Robertson, Stephen P.] Univ Otago, Dunedin Sch Med, Dept Womens & Childrens Hlth, Dunedin 9016, New Zealand; [Schroeder, Timm] Helmholtz Ctr Munich, Res Unit Stem Cell Dynam, D-85764 Neuherberg, Germany; [Beckers, Johannes] German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany; [Beckers, Johannes; Irmler, Martin] Helmholtz Ctr Munich GmbH, Inst Expt Genet, D-85764 Neuherberg, Germany; [Beckers, Johannes] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Berndt, Carsten] Univ Dusseldorf, Fac Med, Dept Neurol, Merowingerpl 1a, D-40225 Dusseldorf, Germany; [Angeli, Jose P. Friedmann; Conrad, Marcus] Helmholtz Ctr Munich, Inst Dev Genet, D-85764 Neuherberg, Germany; [Berninger, Benedikt] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci, D-55128 Mainz, Germany; [Goetz, Magdalena] Excellence Cluster Syst Neurol SYNERGY, D-80336 Munich, Germany; [Deshpande, Aditi] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Deshpande, Aditi] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Heinrich, Christophe] Univ Grenoble Alpes, INSERM, U1216, Grenoble Inst Neurosci, F-38000 Grenoble, France; [Schroeder, Timm] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Johannes Gutenberg University of Mainz; Complutense University of Madrid; University of Otago; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Heinrich Heine University Dusseldorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Johannes Gutenberg University of Mainz; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Swiss Federal Institutes of Technology Domain; ETH Zurich	Gascon, S; Gotz, M (corresponding author), Univ Munich, Biomed Ctr, Physiol Genom, D-80336 Munich, Germany.; Gascon, S; Gotz, M (corresponding author), Helmholtz Ctr Munich, Inst Stem Cell Res, D-85764 Neuherberg, Germany.; Gotz, M (corresponding author), Excellence Cluster Syst Neurol SYNERGY, D-80336 Munich, Germany.	sergio.gascon@med.uni-muenchen.de; magdalena.goetz@helmholtz-muenchen.de	Angeli, J Pedro Friedmann/ABG-6270-2020; Beckers, Johannes/K-7237-2012; Conrad, Marcus/E-8792-2015; Deshpande, Aditi/S-9657-2019; Ortega, Felipe/N-2749-2015; HEINRICH, Christophe/K-1300-2017; Berninger, Benedikt/H-4098-2019; Berndt, Carsten/X-6260-2018; Friedmann Angeli, Jose/C-9038-2014	Angeli, J Pedro Friedmann/0000-0001-7706-1379; Beckers, Johannes/0000-0001-7874-3822; Conrad, Marcus/0000-0003-1140-5612; Ortega, Felipe/0000-0001-6398-9520; HEINRICH, Christophe/0000-0003-1266-718X; Berninger, Benedikt/0000-0003-2652-2782; Berndt, Carsten/0000-0001-8583-7966; Karow, Marisa/0000-0003-4935-1365; Robertson, Stephen/0000-0002-5181-7809; Murenu, Elisa/0000-0003-0209-5448; Deshpande, Aditi/0000-0002-5184-5658; Petrik, David/0000-0003-3026-0770; Gascon, Sergio/0000-0001-8756-7082; Schroeder, Timm/0000-0001-9320-0252	German Research Foundation [GO 640/8-1, GO 640/10-1]; Helmholtz Portfolio Theme "Metabolic Dysfunction and Common Disease''; Helmholtz Alliance "ICEMED''; advanced ERC grant ChroNeuroRepair; German Research Foundation Priority Program "Pluripotency and Reprogramming'' [BE 4182/2-2, GO 640/9-2]; Ministry of Science and Education;  [SFB 870]	German Research Foundation(German Research Foundation (DFG)); Helmholtz Portfolio Theme "Metabolic Dysfunction and Common Disease''; Helmholtz Alliance "ICEMED''; advanced ERC grant ChroNeuroRepair; German Research Foundation Priority Program "Pluripotency and Reprogramming''; Ministry of Science and Education; 	We thank Tatjana Ebert, Carmen Meyer, Detlef Franzen, and Anke Pettenbrock for excellent technical assistance and Alex Lepier for advice with viral vector design. We are very grateful to Stefan Stricker, Leda Dimou, and Sofia Grade for excellent comments on the manuscript. Anti-Prx-AK was a kind gift of C.H. Lillig (Ernst-Moritz-Arndt-University, Greifswald, Germany). This work was supported by the German Research Foundation (M.G., GO 640/8-1, 10-1), the Helmholtz Portfolio Theme "Metabolic Dysfunction and Common Disease'' (J.B.) and the Helmholtz Alliance "ICEMED'' (J.B. and M.G.), the SFB 870 and the advanced ERC grant ChroNeuroRepair (M.G.), the grant "NewNeurons'' (B.B. and M.G.) financed by the Ministry of Science and Education, and German Research Foundation Priority Program "Pluripotency and Reprogramming'' (BE 4182/2-2 and GO 640/9-2).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Amamoto R, 2014, SCIENCE, V343, P504, DOI 10.1126/science.1239882; Anderova M, 2004, GLIA, V48, P311, DOI 10.1002/glia.20076; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bao BY, 2008, INT J CANCER, V122, P2699, DOI 10.1002/ijc.23460; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Blum R, 2011, CEREB CORTEX, V21, P413, DOI 10.1093/cercor/bhq107; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Deng XM, 2006, MOL CELL BIOL, V26, P4421, DOI 10.1128/MCB.01647-05; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dong JH, 2012, EUR HEART J, V33, P2980, DOI 10.1093/eurheartj/ehr459; Drummen GPC, 2002, FREE RADICAL BIO MED, V33, P473, DOI 10.1016/S0891-5849(02)00848-1; Fode C, 2000, GENE DEV, V14, P67; George N, 2012, BRIT J NUTR, V108, P1410, DOI 10.1017/S0007114511006830; Gianforcaro A, 2014, CNS NEUROSCI THER, V20, P101, DOI 10.1111/cns.12204; Godoy JR, 2011, FREE RADICAL BIO MED, V51, P552, DOI 10.1016/j.freeradbiomed.2011.04.036; Grande A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3373; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Halley-Stott RP, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001914; Heinrich C, 2014, STEM CELL REP, V3, P1000, DOI 10.1016/j.stemcr.2014.10.007; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Imayoshi I, 2014, NEURON, V82, P9, DOI 10.1016/j.neuron.2014.03.018; Jin ZH, 2006, J BIOL CHEM, V281, P14446, DOI 10.1074/jbc.M511914200; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kida YS, 2015, CELL STEM CELL, V16, P547, DOI 10.1016/j.stem.2015.03.001; Krishna S, 2011, BIOCHEM J, V435, P545, DOI 10.1042/BJ20101996; Kronenberg G, 2010, STROKE, V41, P2944, DOI 10.1161/STROKEAHA.110.583039; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Liu WB, 2013, BIOCHEM BIOPH RES CO, V431, P767, DOI 10.1016/j.bbrc.2012.12.148; Maryanovich M, 2013, TRENDS CELL BIOL, V23, P129, DOI 10.1016/j.tcb.2012.09.007; Masserdotti G, 2015, CELL STEM CELL, V17, P74, DOI 10.1016/j.stem.2015.05.014; MCKAY ND, 1983, BIOCHIM BIOPHYS ACTA, V762, P198, DOI 10.1016/0167-4889(83)90071-X; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ninkovic J, 2013, CELL STEM CELL, V13, P403, DOI 10.1016/j.stem.2013.07.002; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Park SK, 2012, CELL PHYSIOL BIOCHEM, V30, P334, DOI 10.1159/000339068; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Pedroni A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00044; Prozorovski T, 2015, BBA-GEN SUBJECTS, V1850, P1543, DOI 10.1016/j.bbagen.2015.01.022; Qi SX, 2015, STEM CELLS, V33, P1371, DOI 10.1002/stem.1946; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Theofilopoulos S, 2013, NAT CHEM BIOL, V9, P126, DOI [10.1038/NCHEMBIO.1156, 10.1038/nchembio.1156]; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005	58	200	210	2	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 3	2016	18	3					396	409		10.1016/j.stem.2015.12.003	http://dx.doi.org/10.1016/j.stem.2015.12.003			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GX	26748418	Bronze, Green Accepted			2022-12-28	WOS:000372322200015
J	Sanchez, CG; Teixeira, FK; Czech, B; Preall, JB; Zamparini, AL; Seifert, JRK; Malone, CD; Hannon, GJ; Lehmann, R				Sanchez, Carlos G.; Teixeira, Felipe Karam; Czech, Benjamin; Preall, Jonathan B.; Zamparini, Andrea L.; Seifert, Jessica R. K.; Malone, Colin D.; Hannon, Gregory J.; Lehmann, Ruth			Regulation of Ribosome Biogenesis and Protein Synthesis Controls Germline Stem Cell Differentiation	CELL STEM CELL			English	Article							DROSOPHILA-MELANOGASTER; SELF-RENEWAL; TRANSGENIC RNAI; PIRNA PATHWAY; C-MYC; TRANSCRIPTION; RAPAMYCIN; GENOME; MORPHOGENESIS; PROLIFERATION	Complex regulatory networks regulate stem cell behavior and contributions to tissue growth, repair, and homeostasis. A full understanding of the networks controlling stem cell self-renewal and differentiation, however, has not yet been realized. To systematically dissect these networks and identify their components, we performed an unbiased, transcriptome-wide in vivo RNAi screen in female Drosophila germline stem cells (GSCs). Based on characterized cellular defects, we classified 646 identified genes into phenotypic and functional groups and unveiled a comprehensive set of networks regulating GSC maintenance, survival, and differentiation. This analysis revealed an unexpected role for ribosomal assembly factors in controlling stem cell cytokinesis. Moreover, our data show that the transition from self-renewal to differentiation relies on enhanced ribosome biogenesis accompanied by increased protein synthesis. Collectively, these results detail the extensive genetic networks that control stem cell homeostasis and highlight the intricate regulation of protein synthesis during differentiation.	[Sanchez, Carlos G.; Teixeira, Felipe Karam; Zamparini, Andrea L.; Seifert, Jessica R. K.; Malone, Colin D.; Lehmann, Ruth] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Sanchez, Carlos G.; Teixeira, Felipe Karam; Zamparini, Andrea L.; Seifert, Jessica R. K.; Malone, Colin D.; Lehmann, Ruth] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst,Dept Cell Biol, New York, NY 10016 USA; [Czech, Benjamin; Preall, Jonathan B.; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Seifert, Jessica R. K.] State Univ New York, Farmingdale State Coll, Dept Biol, Farmingdale, NY 11735 USA	Howard Hughes Medical Institute; New York University; New York University; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; Farmingdale State College; SUNY Delhi	Teixeira, FK; Lehmann, R (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	felipe.teixeira@med.nyu.edu; ruth.lehmann@med.nyu.edu	Hannon, Gregory/AAB-3568-2019; Czech, Benjamin/AAJ-8592-2020	Czech, Benjamin/0000-0001-8471-0007; Karam Teixeira, Felipe/0000-0001-7651-1657; Lehmann, Ruth/0000-0002-8454-5651	NIH [F31/HD080380, 5R01GM062534, R01/R37HD41900, F32/GM082169]; EMBO fellowship; HFSP fellowship; Boehringer Ingelheim Fonds Ph.D. fellowship; ACS [121614-PF-11-277-01-RMC]; HHWF fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041900, F31HD080380, R37HD041900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062534, F32GM082169, R01GM062534] Funding Source: NIH RePORTER; Cancer Research UK [21143] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO fellowship(European Molecular Biology Organization (EMBO)); HFSP fellowship; Boehringer Ingelheim Fonds Ph.D. fellowship(Boehringer Ingelheim); ACS(American Cancer Society); HHWF fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK)	We are grateful to J. Sanny and M. Okuniewska for help with fly husbandry and R. Cinalli for comments. We thank B. Pradet-Balade (CNRS), M. Gstaiger, H. Stocker (ETHZ), and P. Lasko (McGill University) for sharing reagents and Alexey Soshnev for help with the design of the graphical abstract. We acknowledge the VDRC and BDSC for reagents. C.G.S. is supported by NIH F31/HD080380, F.K.T. by EMBO and HFSP fellowships, B.C. by a Boehringer Ingelheim Fonds Ph.D. fellowship, J.B.P. by ACS award 121614-PF-11-277-01-RMC, J.R.K.S. by NIH F32/GM082169, and C.D.M. by a HHWF fellowship. This work was supported by the NIH (5R01GM062534) and a gift from Kathryn W. Davis (to G.J.H.). R.L. is supported by NIH R01/R37HD41900. R.L. and G.J.H. are HHMI investigators.	Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Benbahouche NE, 2014, J BIOL CHEM, V289, P6236, DOI 10.1074/jbc.M113.499608; Buszczak M, 2014, CELL, V159, P242, DOI 10.1016/j.cell.2014.09.016; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eikenes AH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004904; Giordano E, 1999, J CELL BIOL, V144, P1123, DOI 10.1083/jcb.144.6.1123; Glatter T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.79; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Hsu HJ, 2008, DEV BIOL, V313, P700, DOI 10.1016/j.ydbio.2007.11.006; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Izumi N., 2012, NUCLEUS, V3, P29; Jack K, 2011, MOL CELL, V44, P660, DOI 10.1016/j.molcel.2011.09.017; Jankovics F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098579; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699; LaFever L, 2010, DEVELOPMENT, V137, P2117, DOI 10.1242/dev.050351; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046357; LIN HF, 1994, DEVELOPMENT, V120, P947; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Mathieu J, 2013, DEV CELL, V26, P250, DOI 10.1016/j.devcel.2013.07.005; Matias NR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004653; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Perrimon N, 1996, GENETICS, V144, P1681; ROBINSON DN, 1994, DEVELOPMENT, V120, P2015; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; SCHUPBACH T, 1991, GENETICS, V129, P1119; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Spradling A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002642; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Truitt ML, 2015, CELL, V162, P59, DOI 10.1016/j.cell.2015.05.049; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Vinayagam A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003629; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Xi RW, 2005, DEVELOPMENT, V132, P5365, DOI 10.1242/dev.02151; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yan D, 2014, DEV CELL, V28, P459, DOI 10.1016/j.devcel.2014.01.020; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384	50	117	117	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2016	18	2					276	290		10.1016/j.stem.2015.11.004	http://dx.doi.org/10.1016/j.stem.2015.11.004			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GT	26669894	Green Accepted, Bronze			2022-12-28	WOS:000372321700017
J	Burdick, JA; Mauck, RL; Gerecht, S				Burdick, Jason A.; Mauck, Robert L.; Gerecht, Sharon			To Serve and Protect: Hydrogels to Improve Stem Cell-Based Therapies	CELL STEM CELL			English	Editorial Material							INJECTABLE HYDROGEL; MATRIX	Harsh environments within damaged and diseased tissues and limited retention and survival of injected stem cells pose major challenges for stem cell therapeutics today. Here, we discuss promising hydrogel-based strategies for improving engraftment and viability of transplanted stem cells and stimulating recruitment of endogenous stem cells for repair.	[Burdick, Jason A.; Mauck, Robert L.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Mauck, Robert L.] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Gerecht, Sharon] Johns Hopkins Univ, Dept Biomol & Chem Engn, Baltimore, MD 21218 USA; [Gerecht, Sharon] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA	University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University	Burdick, JA (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	burdick2@seas.upenn.edu	Gerecht, Sharon/HCH-8629-2022	Gerecht, Sharon/0000-0002-8542-4835; Mauck, Robert/0000-0002-9537-603X				Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Ballios BG, 2015, STEM CELL REP, V4, P1031, DOI 10.1016/j.stemcr.2015.04.008; Cai L, 2015, ADV FUNCT MATER, V25, P1344, DOI 10.1002/adfm.201403631; Guvendiren M, 2013, CURR OPIN BIOTECH, V24, P841, DOI 10.1016/j.copbio.2013.03.009; Ko IK, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.118; Levit RD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000367; MACARTHUR JW, 2011, CIRCULATION S1, V128, pS79, DOI DOI 10.1161/CIRCULATIONAHA.112.000343; Parisi-Amon A, 2013, ADV HEALTHC MATER, V2, P428, DOI 10.1002/adhm.201200293; Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/NMAT3922, 10.1038/nmat3922]; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007	10	128	130	11	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					13	15		10.1016/j.stem.2015.12.004	http://dx.doi.org/10.1016/j.stem.2015.12.004			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26748751	Bronze			2022-12-28	WOS:000372321300006
J	Crowder, SW; Leonardo, V; Whittaker, T; Papathanasiou, P; Stevens, MM				Crowder, Spencer W.; Leonardo, Vincent; Whittaker, Thomas; Papathanasiou, Peter; Stevens, Molly M.			Material Cues as Potent Regulators of Epigenetics and Stem Cell Function	CELL STEM CELL			English	Review							ION CONDUCTANCE MICROSCOPY; FLUID SHEAR-STRESS; NUCLEAR-MEMBRANE PROTEIN; EXTRACELLULAR-MATRIX; LIVING CELLS; IN-VITRO; SUPERRESOLUTION MICROSCOPY; BIOPHYSICAL REGULATION; SUBSTRATE ELASTICITY; HISTONE DEACETYLASES	Biophysical signals act as potent regulators of stem cell function, lineage commitment, and epigenetic status. In recent years, synthetic biomaterials have been used to study a wide range of outside-in signaling events, and it is now well appreciated that material cues modulate the epigenome. Here, we review the role of extracellular signals in guiding stem cell behavior via epigenetic regulation, and we stress the role of physicochemical material properties as an often-overlooked modulator of intracellular signaling. We also highlight promising new research tools for ongoing interrogation of the stem cell-material interface.	[Crowder, Spencer W.; Leonardo, Vincent; Whittaker, Thomas; Papathanasiou, Peter; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, Prince Consort Rd, London SW7 2AZ, England; [Crowder, Spencer W.; Leonardo, Vincent; Whittaker, Thomas; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, Prince Consort Rd, London SW7 2AZ, England; [Crowder, Spencer W.; Leonardo, Vincent; Whittaker, Thomas; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, Prince Consort Rd, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London	Stevens, MM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Prince Consort Rd, London SW7 2AZ, England.; Stevens, MM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, Prince Consort Rd, London SW7 2AZ, England.; Stevens, MM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, Prince Consort Rd, London SW7 2AZ, England.	m.stevens@imperial.ac.uk	Whittaker, Thomas E/AAC-5237-2019	Whittaker, Thomas E/0000-0002-3181-4571; Stevens, Molly/0000-0002-7335-266X	United Kingdom Medical Research Council Hub "Acellular Approaches for Therapeutic Delivery" - Medical Research Council [MR/K026682/1]; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council; Wellcome Trust [098411/Z/12/Z]; ERC Seventh Framework Programme Consolidator grant "Naturale CG" [616417]; Whitaker International Program, Institute of International Education, United States of America; EPSRC; MRC [MR/K026682/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1857826] Funding Source: researchfish; Medical Research Council [MR/K026682/1] Funding Source: researchfish	United Kingdom Medical Research Council Hub "Acellular Approaches for Therapeutic Delivery" - Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); ERC Seventh Framework Programme Consolidator grant "Naturale CG"; Whitaker International Program, Institute of International Education, United States of America; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	M.M.S. acknowledges support from the United Kingdom Medical Research Council Hub "Acellular Approaches for Therapeutic Delivery" (MR/K026682/1), which is funded by the Medical Research Council, the Engineering and Physical Sciences Research Council, and the Biotechnology and Biological Sciences Research Council. M.M.S. is also funded by a Wellcome Trust Senior Investigator Award (098411/Z/12/Z) and the ERC Seventh Framework Programme Consolidator grant "Naturale CG" under grant agreement no. 616417. S.W.C. was also supported by the Whitaker International Program, Institute of International Education, United States of America. T.W. is supported by an EPSRC DTA Ph.D. award.	Alabert C, 2014, NAT CELL BIOL, V16, P281, DOI 10.1038/ncb2918; Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; Autefage H, 2015, P NATL ACAD SCI USA, V112, P4280, DOI 10.1073/pnas.1419799112; Baker BM, 2015, NAT MATER, V14, P1262, DOI [10.1038/NMAT4444, 10.1038/nmat4444]; Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110; Boo YC, 2006, EXP MOL MED, V38, P453, DOI 10.1038/emm.2006.53; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Celiz AD, 2015, ADV MATER, V27, P4006, DOI 10.1002/adma.201501351; Celiz AD, 2014, NAT MATER, V13, P570, DOI [10.1038/NMAT3972, 10.1038/nmat3972]; Chan HF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03462; Chancellor TJ, 2010, BIOPHYS J, V99, P115, DOI 10.1016/j.bpj.2010.04.011; Chaudhuri O., 2015, NAT MATER IN PRESS; Chaudhuri O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7365; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chiappini C, 2015, NAT MATER, V14, P532, DOI [10.1038/nmat4249, 10.1038/NMAT4249]; Chiappini C, 2015, ADV MATER, V27, P5147, DOI 10.1002/adma.201501304; Chiappini C, 2015, ACS NANO, V9, P5500, DOI [10.1021/acsnano.5b03652, 10.1021/acsnano.5b01490]; Conway A, 2013, NAT NANOTECHNOL, V8, P831, DOI [10.1038/nnano.2013.205, 10.1038/NNANO.2013.205]; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; Das R.K., 2015, NAT MATER IN PRESS; De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6; DeForest CA, 2015, NAT MATER, V14, P523, DOI [10.1038/NMAT4219, 10.1038/nmat4219]; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/NMAT3777, 10.1038/nmat3777]; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Dyba M, 2003, NAT BIOTECHNOL, V21, P1303, DOI 10.1038/nbt897; El-Said WA, 2015, J MATER CHEM C, V3, P3848, DOI 10.1039/c5tc00304k; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Flynn RA, 2014, CELL STEM CELL, V14, P752, DOI 10.1016/j.stem.2014.05.014; Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/NMAT2505, 10.1038/nmat2505]; Gudi S, 1998, P NATL ACAD SCI USA, V95, P2515, DOI 10.1073/pnas.95.5.2515; Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792; Holst J, 2010, NAT BIOTECHNOL, V28, P1123, DOI 10.1038/nbt.1687; Huddleson JP, 2005, J BIOL CHEM, V280, P23371, DOI 10.1074/jbc.M413839200; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Ihalainen TO, 2015, NAT MATER, V14, P1252, DOI [10.1038/NMAT4389, 10.1038/nmat4389]; Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63; Illi B, 2003, CIRC RES, V93, P155, DOI 10.1161/01.RES.0000080933.82105.29; Jain N, 2013, P NATL ACAD SCI USA, V110, P11349, DOI 10.1073/pnas.1300801110; Jans DC, 2013, P NATL ACAD SCI USA, V110, P8936, DOI 10.1073/pnas.1301820110; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim SN, 2014, DEVELOPMENT, V141, P3233, DOI 10.1242/dev.106039; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532; Ko KS, 2001, J BIOL CHEM, V276, P35967, DOI 10.1074/jbc.M104106200; Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520; Korchev YE, 1997, BIOPHYS J, V73, P653, DOI 10.1016/S0006-3495(97)78100-1; Kouwer PHJ, 2013, NATURE, V493, P651, DOI 10.1038/nature11839; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Le Beyec J, 2007, EXP CELL RES, V313, P3066, DOI 10.1016/j.yexcr.2007.04.022; Lee DY, 2012, P NATL ACAD SCI USA, V109, P1967, DOI 10.1073/pnas.1121214109; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li LY, 2011, P NATL ACAD SCI USA, V108, P11745, DOI 10.1073/pnas.1101454108; Li Y, 2011, BIOPHYS J, V100, P1902, DOI 10.1016/j.bpj.2011.03.008; Lu WS, 2012, CELL MOL LIFE SCI, V69, P3493, DOI 10.1007/s00018-012-1034-1; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Mabry KM, 2016, BIOMATERIALS, V74, P31, DOI 10.1016/j.biomaterials.2015.09.035; Majkut S, 2013, CURR BIOL, V23, P2434, DOI 10.1016/j.cub.2013.10.057; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; Morez C, 2015, BIOMATERIALS, V70, P94, DOI 10.1016/j.biomaterials.2015.07.063; Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720; Novak P, 2009, NAT METHODS, V6, P279, DOI [10.1038/NMETH.1306, 10.1038/nmeth.1306]; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Peng XQ, 2010, ACTA PHARMACOL SIN, V31, P175, DOI 10.1038/aps.2009.190; Ranga A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5324; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Shevchuk AI, 2006, ANGEW CHEM INT EDIT, V45, P2212, DOI 10.1002/anie.200503915; Shin JW, 2014, CELL STEM CELL, V14, P81, DOI 10.1016/j.stem.2013.10.009; Simon CG, 2011, ADV MATER, V23, P369, DOI 10.1002/adma.201001763; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Swain RJ, 2010, BIOPHYS J, V98, P1703, DOI 10.1016/j.bpj.2009.12.4289; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Sydor AM, 2015, TRENDS CELL BIOL, V25, P730, DOI 10.1016/j.tcb.2015.10.004; Takahashi M, 1996, J CLIN INVEST, V98, P2623, DOI 10.1172/JCI119083; Takahashi T, 2007, TISSUE ENG, V13, P1583, DOI 10.1089/ten.2006.0322; Tsimbouri PM, 2012, ACS NANO, V6, P10239, DOI 10.1021/nn304046m; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Uzer G, 2015, STEM CELLS, V33, P2063, DOI 10.1002/stem.2004; VanDersarl JJ, 2012, NANO LETT, V12, P3881, DOI 10.1021/nl204051v; von Erlach TC, 2015, ANALYST, V140, P1798, DOI 10.1039/c4an02346c; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang WJ, 2009, BIOMATERIALS, V30, P2705, DOI 10.1016/j.biomaterials.2009.01.030; Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Wrighton PJ, 2014, P NATL ACAD SCI USA, V111, P18126, DOI 10.1073/pnas.1409525111; Yan ZQ, 2009, J BIOMECH, V42, P945, DOI 10.1016/j.jbiomech.2009.01.012; Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/nmat3889, 10.1038/NMAT3889]; Zhang R, 2009, BIOMATERIALS, V30, P6193, DOI 10.1016/j.biomaterials.2009.07.055; Zhen YY, 2002, J CELL SCI, V115, P3207; Zhou J, 2014, CELL MOL BIOENG, V7, P218, DOI 10.1007/s12195-014-0325-z	107	142	145	2	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					39	52		10.1016/j.stem.2015.12.012	http://dx.doi.org/10.1016/j.stem.2015.12.012			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26748755	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000372321300010
J	Shaw, RJ				Shaw, Reuben J.			AMPK Keeps Tumor Cells from Starving to Death	CELL STEM CELL			English	Editorial Material							ENERGY STRESS; IN-VIVO; METABOLISM; SURVIVAL	In this issue of Cell Stem Cell, Saito et al. (2015) examine how leukemia-initiating cells react to metabolic stress imposed by different tissue environments. They find that inhibition of the metabolic stress sensor AMP-activated protein kinase (AMPK) led to deranged glucose metabolism and redox homeostasis, resulting in reduced leukemic progression that was further attenuated by dietary restriction.	[Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cellular Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Mol & Cellular Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shaw@salk.edu			NATIONAL CANCER INSTITUTE [P30CA014195, R01CA172229] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA172229, P30 CA014195] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Fu X., 2015, J BIOL CHEM IN PRESS; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Svensson RU, 2012, NATURE, V485, P590, DOI 10.1038/485590a; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035	9	7	7	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2015	17	5					503	504		10.1016/j.stem.2015.10.007	http://dx.doi.org/10.1016/j.stem.2015.10.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4UB	26544110	Bronze			2022-12-28	WOS:000365694700003
J	Bond, AM; Ming, GL; Song, HJ				Bond, Allison M.; Ming, Guo-li; Song, Hongjun			Adult Mammalian Neural Stem Cells and Neurogenesis: Five Decades Later	CELL STEM CELL			English	Review							HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; EMBRYONIC ORIGIN; VASCULAR NICHE; STEM/PROGENITOR CELLS; EPIGENETIC REGULATION; EXTRACELLULAR-MATRIX; POSTNATAL SVZ; SELF-RENEWAL; HUMAN BRAIN	Adult somatic stem cells in various organs maintain homeostatic tissue regeneration and enhance plasticity. Since its initial discovery five decades ago, investigations of adult neurogenesis and neural stem cells have led to an established and expanding field that has significantly influenced many facets of neuroscience, developmental biology, and regenerative medicine. Here we review recent progress and focus on questions related to adult mammalian neural stem cells that also apply to other somatic stem cells. We further discuss emerging topics that are guiding the field toward better understanding adult neural stem cells and ultimately applying these principles to improve human health.	[Bond, Allison M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Bond, Allison M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	shongju1@jhmi.edu		Ming, Guo-li/0000-0002-2517-6075	NIH [NS047344, NS093772, NS048271, MH105128, NS09538]; MSCRF; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344, R01NS047344, R56NS047344, R21NS093772, R01NS048271] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSCRF; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We apologize for not able to cite many original papers because of constrains on reference numbers. We thank K. Christian and three anonymous reviewers for suggestions. The research in authors' laboratories was supported by grants from NIH (NS047344, NS093772) and MSCRF to H.S. and from NIH (NS048271, MH105128, NS09538) and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation to G.-l.M.	Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Alfonso J, 2012, CELL STEM CELL, V10, P76, DOI 10.1016/j.stem.2011.11.011; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Andersen J, 2014, NEURON, V83, P1085, DOI 10.1016/j.neuron.2014.08.004; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Arlotta P, 2014, CURR OPIN NEUROBIOL, V27, P208, DOI 10.1016/j.conb.2014.04.007; Ashton RS, 2012, NAT NEUROSCI, V15, P1399, DOI 10.1038/nn.3212; Baker AM, 2014, CELL REP, V8, P940, DOI 10.1016/j.celrep.2014.07.019; Bar-Nur O, 2015, NAT BIOTECHNOL, V33, P761, DOI 10.1038/nbt.3247; Barbosa JS, 2015, SCIENCE, V348, P789, DOI 10.1126/science.aaa2729; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Berg Daniel A, 2015, [Frontiers in Biology, 生物学前沿], V10, P262; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Calzolari F, 2015, NAT NEUROSCI, V18, P490, DOI 10.1038/nn.3963; Candelario KM, 2013, J NEUROCHEM, V125, P420, DOI 10.1111/jnc.12204; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Christian KM, 2014, ANNU REV NEUROSCI, V37, P243, DOI 10.1146/annurev-neuro-071013-014134; DeCarolis NA, 2013, HIPPOCAMPUS, V23, P708, DOI 10.1002/hipo.22130; Delgado AC, 2014, NEURON, V83, P572, DOI 10.1016/j.neuron.2014.06.015; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Evrony GD, 2015, NEURON, V85, P49, DOI 10.1016/j.neuron.2014.12.028; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Ferent J, 2014, STEM CELL REP, V3, P312, DOI 10.1016/j.stemcr.2014.05.016; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Fuentealba LC, 2015, CELL, V161, P1644, DOI 10.1016/j.cell.2015.05.041; Furutachi S, 2015, NAT NEUROSCI, V18, P657, DOI 10.1038/nn.3989; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Han J, 2015, CELL REP, V10, P1158, DOI 10.1016/j.celrep.2015.01.049; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Jablonska B, 2010, NAT NEUROSCI, V13, P541, DOI 10.1038/nn.2536; Jang MH, 2013, CELL STEM CELL, V12, P215, DOI 10.1016/j.stem.2012.11.021; Jessberger S, 2015, FRONT BIOL, V10, P99; Jiang YD, 2014, P NATL ACAD SCI USA, V111, P13541, DOI 10.1073/pnas.1411939111; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kawaguchi D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2895; Kazanis I, 2011, DEV NEUROBIOL, V71, P1006, DOI 10.1002/dneu.20970; Kempermann G, 1999, SCI AM, V280, P48, DOI 10.1038/scientificamerican0599-48; Kerever A, 2007, STEM CELLS, V25, P2146, DOI 10.1634/stemcells.2007-0082; Kippin TE, 2005, J NEUROSCI, V25, P5815, DOI 10.1523/JNEUROSCI.1120-05.2005; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kunze A, 2009, P NATL ACAD SCI USA, V106, P11336, DOI 10.1073/pnas.0813160106; Lacar B, 2012, J NEUROSCI, V32, P16435, DOI 10.1523/JNEUROSCI.1457-12.2012; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Li GN, 2013, NEURON, V78, P658, DOI 10.1016/j.neuron.2013.03.019; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Luo YP, 2015, CELL, V161, P1175, DOI 10.1016/j.cell.2015.04.001; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Magnusson JP, 2014, SCIENCE, V346, P237, DOI 10.1126/science.346.6206.237; Marco E, 2014, P NATL ACAD SCI USA, V111, pE5643, DOI 10.1073/pnas.1408993111; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nato G, 2015, DEVELOPMENT, V142, P840, DOI 10.1242/dev.116657; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Ortega F, 2013, NAT CELL BIOL, V15, P602, DOI 10.1038/ncb2736; Ottone C, 2014, NAT CELL BIOL, V16, P1045, DOI 10.1038/ncb3045; Paez-Gonzalez P, 2014, NAT NEUROSCI, V17, P934, DOI 10.1038/nn.3734; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Porcheri C, 2014, J NEUROSCI, V34, P5222, DOI 10.1523/JNEUROSCI.4928-13.2014; Ramos AD, 2015, CELL STEM CELL, V16, P439, DOI 10.1016/j.stem.2015.02.007; Ramos AD, 2013, CELL STEM CELL, V12, P616, DOI 10.1016/j.stem.2013.03.003; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; Sequerra EB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00434; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Shin J, 2014, NAT NEUROSCI, V17, P1463, DOI 10.1038/nn.3814; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Su ZD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4338; Sun GJ, 2015, P NATL ACAD SCI USA, V112, P9484, DOI 10.1073/pnas.1508545112; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tong CK, 2014, CELL STEM CELL, V14, P500, DOI 10.1016/j.stem.2014.01.014; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xing YL, 2014, J NEUROSCI, V34, P14128, DOI 10.1523/JNEUROSCI.3491-13.2014; Zhang J, 2014, J NEUROSCI, V34, P5184, DOI 10.1523/JNEUROSCI.4129-13.2014; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006	113	433	453	25	165	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 1	2015	17	4					385	395		10.1016/j.stem.2015.09.003	http://dx.doi.org/10.1016/j.stem.2015.09.003			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4TS	26431181	Bronze, Green Accepted			2022-12-28	WOS:000365693800006
J	Funa, NS; Schachter, KA; Lerdrup, M; Ekberg, J; Hess, K; Dietrich, N; Honore, C; Hansen, K; Semb, H				Funa, Nina S.; Schachter, Karen A.; Lerdrup, Mads; Ekberg, Jenny; Hess, Katja; Dietrich, Nikolaj; Honore, Christian; Hansen, Klaus; Semb, Henrik			beta-Catenin Regulates Primitive Streak Induction through Collaborative Interactions with SMAD2/SMAD3 and OCT4	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; INSULIN-PRODUCING CELLS; DIRECT TARGET; FATE DECISIONS; MOUSE; MESODERM; WNT; EXPRESSION; GASTRULATION; NANOG	Canonical Wnt and Nodal signaling are both required for induction of the primitive streak (PS), which guides organization of the early embryo. The Wnt effector beta-catenin is thought to function in these early lineage specification decisions via transcriptional activation of Nodal signaling. Here, we demonstrate a broader role for beta-catenin in PS formation by analyzing its genome-wide binding in a human embryonic stem cell model of PS induction. beta-catenin occupies regulatory regions in numerous PS and neural crest genes, and direct interactions between beta-catenin and the Nodal effectors SMAD2/SMAD3 are required at these regions for PS gene activation. Furthermore, OCT4 binding in proximity to these sites is likewise required for PS induction, suggesting a collaborative interaction between beta-catenin and OCT4. Induction of neural crest genes by beta-catenin is repressed by SMAD2/SMAD3, ensuring proper lineage specification. This study provides mechanistic insight into how Wnt signaling controls early cell lineage decisions.	[Funa, Nina S.; Schachter, Karen A.; Hess, Katja; Semb, Henrik] Univ Copenhagen, Danish Stem Cell Ctr DanStem, DK-2200 Copenhagen N, Denmark; [Funa, Nina S.; Ekberg, Jenny; Hess, Katja; Semb, Henrik] Lund Univ, Fac Med, Lund Stem Cell Ctr, S-22100 Lund, Sweden; [Lerdrup, Mads; Dietrich, Nikolaj; Hansen, Klaus] Univ Copenhagen, Copenhagen Bioctr, BRIC, DK-2200 Copenhagen N, Denmark; [Lerdrup, Mads; Dietrich, Nikolaj; Hansen, Klaus] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen N, Denmark; [Honore, Christian] Novo Nordisk AS, Dept Stem Cell Biol, DK-2760 Malov, Denmark	University of Copenhagen; Lund University; University of Copenhagen; University of Copenhagen; Novo Nordisk	Semb, H (corresponding author), Univ Copenhagen, Danish Stem Cell Ctr DanStem, DK-2200 Copenhagen N, Denmark.	semb@sund.ku.dk	Ekberg, Jenny/AAV-2006-2020	Honore, Christian/0000-0003-4846-1319; Lerdrup, Mads/0000-0002-7730-8973; Funa, Nina/0000-0002-3188-2267; Semb, Henrik/0000-0002-6747-787X; Hansen, Klaus/0000-0001-9657-8816	Novo Nordisk A/S; Novo Nordisk Foundation, Section for Basic Stem Cell Biology, DanStem, University of Copenhagen, Denmark; Danish Strategic Research Council, DanStem, University of Copenhagen, Denmark; Stem Cell Center, Lund University, Sweden; Swedish Foundation for Strategic Research, Sweden; Danish National Research Foundation; Novo Nordisk Fonden [NNF15CC0018344] Funding Source: researchfish	Novo Nordisk A/S(Novo Nordisk); Novo Nordisk Foundation, Section for Basic Stem Cell Biology, DanStem, University of Copenhagen, Denmark; Danish Strategic Research Council, DanStem, University of Copenhagen, Denmark; Stem Cell Center, Lund University, Sweden; Swedish Foundation for Strategic Research, Sweden; Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank Q. Jin (Lund Stem Cell Center) and J. Larsen (DanStem) for technical assistance, S. Agrawal-Singh (BRIC) for technical advice regarding the ChIP protocol, and W. Sukparangsi (DanStem) for assistance in graphical design. We are grateful to J. Brickman, P. Serup, A. Martinez-Arias, and O. Lieven for comments on the manuscript. This work was supported by Novo Nordisk A/S; the Novo Nordisk Foundation, Section for Basic Stem Cell Biology, DanStem, University of Copenhagen, Denmark; the Danish Strategic Research Council, DanStem, University of Copenhagen, Denmark; the Stem Cell Center, Lund University, Sweden; and the Swedish Foundation for Strategic Research, Sweden. K.H. was supported by the Danish National Research Foundation. C.H. is an employee and shareholder of Novo Nordisk A/S, and K.H. is a cofounder of the biotech company EpiTherapeutics ApS.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; [Anonymous], 2011, P NATL ACAD SCI USA; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Bae C.J., 2014, NEURAL CREST CELLS E, P27, DOI [10.1016/b978-0-12-401730-6.00002-8, DOI 10.1016/B978-0-12-401730-6.00002-8]; Barrow JR, 2007, DEV BIOL, V312, P312, DOI 10.1016/j.ydbio.2007.09.030; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Choi EY, 2012, STEM CELLS, V30, P2297, DOI 10.1002/stem.1192; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; DeVeale B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003957; Dietrich N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002494; Dunn NR, 2004, DEVELOPMENT, V131, P1717, DOI 10.1242/dev.01072; Engert S, 2013, DEVELOPMENT, V140, P3128, DOI 10.1242/dev.088765; Faunes F, 2013, DEVELOPMENT, V140, P1171, DOI 10.1242/dev.085654; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Hald J, 2008, J HISTOCHEM CYTOCHEM, V56, P587, DOI 10.1369/jhc.2008.950675; HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Jennings RE, 2013, DIABETES, V62, P3514, DOI 10.2337/db12-1479; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Li B, 2009, DEVELOPMENT, V136, P3267, DOI 10.1242/dev.036954; Li YQ, 2013, STEM CELLS, V31, P1213, DOI 10.1002/stem.1362; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Naujok Ortwin, 2014, BMC Res Notes, V7, P273, DOI 10.1186/1756-0500-7-273; Norris DP, 1999, GENE DEV, V13, P1575, DOI 10.1101/gad.13.12.1575; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Plouhinec JL, 2014, DEV BIOL, V386, P461, DOI 10.1016/j.ydbio.2013.12.010; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Robertson EJ, 2014, SEMIN CELL DEV BIOL, V32, P73, DOI 10.1016/j.semcdb.2014.03.028; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Surmacz B, 2012, STEM CELLS, V30, P1875, DOI 10.1002/stem.1166; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Tam PPL, 2006, CURR OPIN GENET DEV, V16, P419, DOI 10.1016/j.gde.2006.06.008; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tan JY, 2013, STEM CELLS DEV, V22, P1893, DOI 10.1089/scd.2012.0590; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tortelote GG, 2013, DEV BIOL, V374, P164, DOI 10.1016/j.ydbio.2012.10.013; Tremblay KD, 2000, DEVELOPMENT, V127, P3079; Trott J, 2013, BIOL OPEN, V2, P1049, DOI 10.1242/bio.20135934; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wilson V, 1997, DEV BIOL, V192, P45, DOI 10.1006/dbio.1997.8701; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zafarana G, 2009, STEM CELLS, V27, P776, DOI 10.1002/stem.5	69	80	85	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					639	652		10.1016/j.stem.2015.03.008	http://dx.doi.org/10.1016/j.stem.2015.03.008			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	25921273	Bronze			2022-12-28	WOS:000355932300013
J	Bogdanovic, O; Lister, R				Bogdanovic, Ozren; Lister, Ryan			Of Mice and Man: Differential DNMT Dependence in Mammalian ESCs	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; DNA METHYLATION; MAINTENANCE	Liao et al. (2015) recently reported on the effects of disrupting DNA methyltransferase activity in human embryonic stem cells (hESCs). This work highlights key differences between mammalian ESC models upon the loss of these essential proteins and provides comprehensive base resolution methylome maps of DNMT targets during human development.	[Bogdanovic, Ozren; Lister, Ryan] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Perth, WA 6009, Australia; [Bogdanovic, Ozren; Lister, Ryan] Harry Perkins Inst Med Res, Perth, WA 6009, Australia	University of Western Australia; Harry Perkins Institute of Medical Research	Lister, R (corresponding author), Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Perth, WA 6009, Australia.	ryan.lister@uwa.edu.au	Bogdanovic, Ozren/ABG-9527-2020; Lister, Ryan/B-5168-2012	Bogdanovic, Ozren/0000-0001-5680-0056; Lister, Ryan/0000-0001-6637-7239				Bogdanovic O, 2011, GENOME RES, V21, P1313, DOI 10.1101/gr.114843.110; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Liao J., 2015, NAT GENET IN PRESS; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x	10	2	3	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					459	460		10.1016/j.stem.2015.04.009	http://dx.doi.org/10.1016/j.stem.2015.04.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25957900	Bronze			2022-12-28	WOS:000354188600006
J	Takebe, T; Enomura, M; Yoshizawa, E; Kimura, M; Koike, H; Ueno, Y; Matsuzaki, T; Yamazaki, T; Toyohara, T; Osafune, K; Nakauchi, H; Yoshikawa, HY; Taniguchi, H				Takebe, Takanori; Enomura, Masahiro; Yoshizawa, Emi; Kimura, Masaki; Koike, Hiroyuki; Ueno, Yasuharu; Matsuzaki, Takahisa; Yamazaki, Takashi; Toyohara, Takafumi; Osafune, Kenji; Nakauchi, Hiromitsu; Yoshikawa, Hiroshi Y.; Taniguchi, Hideki			Vascularized and Complex Organ Buds from Diverse Tissues via Mesenchymal Cell-Driven Condensation	CELL STEM CELL			English	Article							FUNCTIONAL HUMAN LIVER; SELF-ORGANIZATION; 3-DIMENSIONAL CULTURE; HEAVY-CHAIN; ORGANOGENESIS; MECHANISM; MIGRATION; STEM; CYTOSKELETON; FIBROBLASTS	Transplantation of in-vitro-generated organ buds is a promising approach toward regenerating functional and vascularized organs. Though it has been recently shown in the context of liver models, demonstrating the applicability of this approach to other systems by delineating the molecular mechanisms guiding organ bud formation is critical. Here, we demonstrate a generalized method for organ bud formation from diverse tissues by combining pluripotent stem cell-derived tissue-specific progenitors or relevant tissue samples with endothelial cells and mesenchymal stem cells (MSCs). The MSCs initiated condensation within these heterotypic cell mixtures, which was dependent upon substrate matrix stiffness. Defining optimal mechanical properties promoted formation of 3D, transplantable organ buds from tissues including kidney, pancreas, intestine, heart, lung, and brain. Transplanted pancreatic and renal buds were rapidly vascularized and self-organized into functional, tissue-specific structures. These findings provide a general platform for harnessing mechanical properties to generate vascularized, complex organ buds with broad applications for regenerative medicine.	[Takebe, Takanori; Enomura, Masahiro; Yoshizawa, Emi; Kimura, Masaki; Koike, Hiroyuki; Ueno, Yasuharu; Taniguchi, Hideki] Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Yokohama, Kanagawa 2360004, Japan; [Takebe, Takanori] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Matsuzaki, Takahisa; Yamazaki, Takashi; Yoshikawa, Hiroshi Y.] Saitama Univ, Fac Sci, Dept Chem, Sakura Ku, Saitama 3388570, Japan; [Toyohara, Takafumi; Osafune, Kenji] Kyoto Univ, Ctr iPS Cell Res & Applicat, Sakyo Ku, Kyoto 6068507, Japan; [Takebe, Takanori; Nakauchi, Hiromitsu] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Takebe, Takanori; Taniguchi, Hideki] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 2360004, Japan	Yokohama City University; Japan Science & Technology Agency (JST); Saitama University; Kyoto University; Stanford University; Yokohama City University	Takebe, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku 3-9, Yokohama, Kanagawa 2360004, Japan.	ttakebe@yokohama-cu.ac.jp; hiroshi@mail.saitama-u.ac.jp	Yoshikawa, Hiroshi Y/B-2746-2012; Koike, Hiroyuki/AAT-6065-2020; Koike, Hiroyuki/R-5103-2018; Koike, Hiroyuki/AAZ-9941-2020	Koike, Hiroyuki/0000-0001-9934-6930; Koike, Hiroyuki/0000-0001-9934-6930; Koike, Hiroyuki/0000-0001-9934-6930; Matsuzaki, Takahisa/0000-0001-9466-7495; Takebe, Takanori/0000-0002-6989-3041	PRESTO, Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan [24106510, 24689052, 24680050, 24106505, 21249071, 25253079]; JST through Research Center Network for Realization of Regenerative Medicine; Japan IDDM network; Grants-in-Aid for Scientific Research [25253079, 24680050] Funding Source: KAKEN	PRESTO, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST through Research Center Network for Realization of Regenerative Medicine; Japan IDDM network; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Kurimoto, N. Sasaki, Y. Takahashi, T.-S. Rashid, K. Sekine, Y.-W. Zheng, and the members of our laboratory for support. This work was mainly supported by PRESTO, Japan Science and Technology Agency (JST) (T. Takebe) and partly by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (nos. 24106510 and 24689052 to T. Takebe, nos. 24680050 and 24106505 to H.Y.Y., and nos. 21249071 and 25253079 to H.T.). This work was also partly supported by the JST through its research grant Research Center Network for Realization of Regenerative Medicine and a grant from the Japan IDDM network to K.O. and H.T. T. Takebe and H.T. have served on scientific advisory boards for Healios Inc. T. Takebe and H.T. have also granted a license to Healios through Yokohama City Univercity over their inventions that relate to the subject of this manuscript. T. Takebe and H.T. are conducting research under the collaborative research agreement with Healios and the subject of the research also relates to the subject of this manuscript. H.N. is a founder and shareholder of iCELL Inc. and ChimaERA Corp. and a founder, shareholder, and a scientific advisor for ReproCELL Inc.	Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Besser A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/425; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Ding QR, 2013, CELL RES, V23, P1242, DOI 10.1038/cr.2013.117; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; FUNG YC, 1993, BIOMECHANICS MAT PRO; Hackl MJ, 2013, NAT MED, V19, P1661, DOI 10.1038/nm.3405; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Mizutani T, 2006, J CELL PHYSIOL, V209, P726, DOI 10.1002/jcp.20773; Pouille PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000098; Raab M, 2012, J CELL BIOL, V199, P669, DOI 10.1083/jcb.201205056; Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Schwab K, 2003, KIDNEY INT, V64, P1588, DOI 10.1046/j.1523-1755.2003.00276.x; Shin JW, 2014, CELL STEM CELL, V14, P81, DOI 10.1016/j.stem.2013.10.009; Shindo A, 2014, SCIENCE, V343, P649, DOI 10.1126/science.1243126; Shutova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040814; STEINBERG MS, 1962, P NATL ACAD SCI USA, V48, P1769, DOI 10.1073/pnas.48.10.1769; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Takebe T, 2012, TRANSPL P, V44, P1018, DOI 10.1016/j.transproceed.2012.02.007; Takebe T, 2014, J CLIN INVEST, V124, P4325, DOI 10.1172/JCI76443; Takebe T, 2014, NAT PROTOC, V9, P396, DOI 10.1038/nprot.2014.020; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Takeichi M, 2011, DEV CELL, V21, P24, DOI 10.1016/j.devcel.2011.06.002; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006	34	288	300	5	91	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					556	565		10.1016/j.stem.2015.03.004	http://dx.doi.org/10.1016/j.stem.2015.03.004			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25891906	Bronze			2022-12-28	WOS:000354188600015
J	Yin, YF; Yan, PX; Lu, JL; Song, G; Zhu, YY; Li, ZH; Zhao, Y; Shen, B; Huang, XX; Zhu, H; Orkin, SH; Shen, XH				Yin, Yafei; Yan, Pixi; Lu, Jinlong; Song, Guang; Zhu, Yangyang; Li, Zhaohui; Zhao, Yi; Shen, Bin; Huang, Xingxu; Zhu, Heng; Orkin, Stuart H.; Shen, Xiaohua			Opposing Roles for the lncRNA Haunt and Its Genomic Locus in Regulating HOXA Gene Activation during Embryonic Stem Cell Differentiation	CELL STEM CELL			English	Article							NONCODING RNA; CHROMATIN INTERACTOME; SELF-RENEWAL; TRANSCRIPTION; EXPRESSION; EVOLUTION; ENHANCERS; LINCRNAS; IDENTITY; PLURIPOTENCY	Long noncoding RNAs (lncRNAs) have been implicated in controlling various aspects of embryonic stem cell (ESC) biology, although the functions of specific lncRNAs, and the molecular mechanisms through which they act, remain unclear. Here, we demonstrate discrete and opposing roles for the lncRNA transcript Haunt and its genomic locus in regulating the HOXA gene cluster during ESC differentiation. Reducing or enhancing Haunt expression, with minimal disruption of the Haunt locus, led to upregulation or downregulation of HOXA genes, respectively. In contrast, increasingly large genomic deletions within the Haunt locus attenuated HOXA activation. The Haunt DNA locus contains potential enhancers of HOXA activation, whereas Haunt RNA acts to prevent aberrant HOXA expression. This work reveals a multifaceted model of lncRNA-mediated transcriptional regulation of the HOXA cluster, with distinct roles for a lncRNA transcript and its genomic locus, while illustrating the power of rapid CRISPR/Cas9-based genome editing for assigning lncRNA functions.	[Yin, Yafei; Yan, Pixi; Lu, Jinlong; Zhu, Yangyang; Li, Zhaohui; Zhao, Yi; Shen, Xiaohua] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Yin, Yafei] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Song, Guang; Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Song, Guang; Zhu, Heng] Johns Hopkins Univ, Sch Med, HiT Ctr, Baltimore, MD 21205 USA; [Zhao, Yi] Chinese Acad Sci, Inst Comp Technol, Bioinformat Res Grp, Beijing 100190, Peoples R China; [Shen, Bin; Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Natl Resource Ctr Mutant Mice, Nanjing 210061, Jiangsu, Peoples R China; [Orkin, Stuart H.] Boston Childrens Hosp, Howard Hughes Med Inst, Dana Farber Canc Inst, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Tsinghua University; Peking University; Johns Hopkins University; Johns Hopkins University; Chinese Academy of Sciences; Institute of Computing Technology, CAS; Nanjing University; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Shen, XH (corresponding author), Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.	xshen@tsinghua.edu.cn	Zhao, Yi/A-2962-2011; Shen, Bin/ABD-5084-2021; Song, guang/I-6224-2019	Zhao, Yi/0000-0001-6046-8420; Shen, Bin/0000-0002-8946-8448; Song, guang/0000-0002-7630-716X; huang, xingxu/0000-0001-8934-1247	National Basic Research Program of China [2012CB966703]; National Natural Science Foundation of China [81171906, 31471219]; Center of Life Sciences (CLS) at Tsinghua University	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center of Life Sciences (CLS) at Tsinghua University	We thank L. Yu, Y. Chen, Y. Wang, F. Tang, T. Xie, J. Wang, Q. Xi, P. Das, Y. Huang, and X.S. laboratory members for critical reading of the manuscript and insightful discussions. Grant support was provided by the National Basic Research Program of China (2012CB966703), the National Natural Science Foundation of China (81171906, 31471219), and the Center of Life Sciences (CLS) at Tsinghua University.	Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Canver M.C., 2014, J BIOL CHEM; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Gutschner T, 2011, GENOME RES, V21, P1944, DOI 10.1101/gr.122358.111; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hu WQ, 2012, EMBO REP, V13, P971, DOI 10.1038/embor.2012.145; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Maamar H, 2013, GENE DEV, V27, P1260, DOI 10.1101/gad.217018.113; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Miele Adriana, 2008, V464, P105; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Nolte C, 2013, DEV BIOL, V383, P158, DOI 10.1016/j.ydbio.2013.09.016; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schorderet P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002071; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735	52	197	207	3	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					504	516		10.1016/j.stem.2015.03.007	http://dx.doi.org/10.1016/j.stem.2015.03.007			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25891907	Bronze			2022-12-28	WOS:000354188600011
J	Yu, C; Liu, YX; Ma, TH; Liu, K; Xu, SH; Zhang, Y; Liu, HL; La Russa, M; Xie, M; Ding, S; Qi, LS				Yu, Chen; Liu, Yanxia; Ma, Tianhua; Liu, Kai; Xu, Shaohua; Zhang, Yu; Liu, Honglei; La Russa, Marie; Xie, Min; Ding, Sheng; Qi, Lei S.			Small Molecules Enhance CRISPR Genome Editing in Pluripotent Stem Cells	CELL STEM CELL			English	Article							STRAND BREAK REPAIR; EMBRYO MICROINJECTION; KNOCKOUT RATS; SOMATIC-CELLS; SPECIFICITY; GENERATION; SELF	The bacterial CRISPR-Cas9 system has emerged as an effective tool for sequence-specific gene knockout through non-homologous end joining (NHEJ), but it remains inefficient for precise editing of genome sequences. Here we develop a reporter-based screening approach for high-throughput identification of chemical compounds that can modulate precise genome editing through homology-directed repair (HDR). Using our screening method, we have identified small molecules that can enhance CRISPR-mediated HDR efficiency, 3-fold for large fragment insertions and 9-fold for point mutations. Interestingly, we have also observed that a small molecule that inhibits HDR can enhance frame shift insertion and deletion (indel) mutations mediated by NHEJ. The identified small molecules function robustly in diverse cell types with minimal toxicity. The use of small molecules provides a simple and effective strategy to enhance precise genome engineering applications and facilitates the study of DNA repair mechanisms in mammalian cells.	[Yu, Chen; Ma, Tianhua; Liu, Kai; Xu, Shaohua; Zhang, Yu; Xie, Min; Ding, Sheng] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Liu, Yanxia; Liu, Honglei; La Russa, Marie; Qi, Lei S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Liu, Honglei] Tsinghua Univ, TNLIST Dept Automat, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing 100084, Peoples R China; [La Russa, Marie] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94158 USA; [Ding, Sheng] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Qi, Lei S.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Qi, Lei S.] Stanford Univ, ChEM H, Stanford, CA 94305 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Stanford University; Tsinghua University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University	Ding, S (corresponding author), Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	sheng.ding@gladstone.ucsf.edu; stanley.qi@stanford.edu	YU, CHEN/AAF-8780-2021; Zhang, Yu/F-6583-2016; Qi, Lei S/AAC-5088-2019; Xu, Shaohua/I-2252-2015; Liu, Yanxia/T-1338-2019; Yu, Chen/T-1317-2019	Xu, Shaohua/0000-0002-9915-5170; Yu, Chen/0000-0003-3232-3931; Zhang, Yu/0000-0001-5512-9272; Qi, Lei S/0000-0002-3965-3223	National Institute of Dental & Craniofacial Research (NIDCR); NICHD; NHLBI; NEI; NIMH/NIH; California Institute for Regenerative Medicine; DoD; Roddenberry Foundation; William K. Bowes, Jr. Foundation; Gladstone Institutes; NIH Director's Early Independence Award [OD017887]; NIH R01 [DA036858]; NHLBI [U01HL107436]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036858] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017887] Funding Source: NIH RePORTER	National Institute of Dental & Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); DoD(United States Department of Defense); Roddenberry Foundation; William K. Bowes, Jr. Foundation; Gladstone Institutes(University of California System); NIH Director's Early Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Sangamo for distribution of ACTA2 template DNA plasmid. The authors also thank Dr. Changsheng Lin, Dr. Saiyong Zhu, and Dr. Xiaojing Wang for their assistance and the Flow Cytometry Core of the Gladstone institutes and the University of California San Francisco Nikon Imaging Center. L.S.Q. acknowledges support from the National Institute of Dental & Craniofacial Research (NIDCR). S.D. acknowledges support from NICHD, NHLBI, NEI, and NIMH/NIH; California Institute for Regenerative Medicine; DoD; Roddenberry Foundation; William K. Bowes, Jr. Foundation; and Gladstone Institutes. This work was supported by NIH Director's Early Independence Award (grant OD017887, L.S.Q.), NIH R01 (grant DA036858, Y.L. and L.S.Q.) and NHLBI (U01HL107436, S.D.). The authors have filed a related patent.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Hollick JJ, 2003, BIOORG MED CHEM LETT, V13, P3083, DOI 10.1016/S0960-894X(03)00652-8; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kass EM, 2013, P NATL ACAD SCI USA, V110, P5564, DOI 10.1073/pnas.1216824110; KTISTAKIS NT, 1992, NATURE, V356, P344, DOI 10.1038/356344a0; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Lieber MR, 2010, CELL, V142, P496, DOI 10.1016/j.cell.2010.07.035; LITTLE JM, 1968, P SOC EXP BIOL MED, V127, P1028, DOI 10.3181/00379727-127-32862; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mazon G, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.006; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; Parmee ER, 1998, BIOORG MED CHEM LETT, V8, P1107, DOI 10.1016/S0960-894X(98)00170-X; Rahman SH, 2013, HUM GENE THER, V24, P67, DOI 10.1089/hum.2012.168; ROSEN DR, 1994, HUM MOL GENET, V3, P981, DOI 10.1093/hmg/3.6.981; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; UEYAMA H, 1990, JPN J HUM GENET, V35, P145, DOI 10.1007/BF01876459; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	32	283	312	2	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					142	147		10.1016/j.stem.2015.01.003	http://dx.doi.org/10.1016/j.stem.2015.01.003			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25658371	Green Accepted, Bronze			2022-12-28	WOS:000349455000010
J	Weissbein, U; Ben-David, U; Benvenisty, N				Weissbein, Uri; Ben-David, Uri; Benvenisty, Nissim			Virtual Karyotyping Reveals Greater Chromosomal Stability in Neural Cells Derived by Transdifferentiation than Those from Stem Cells	CELL STEM CELL			English	Editorial Material							GENE-EXPRESSION; ABERRATIONS	Neural cells can be derived either from pluripotent or adult stem cells via differentiation or by transdifferentiation from other cell types with the aid of tissue regulators. We compared the chromosomal stability of over 500 neural cell samples from human and mouse with virtual karyotyping (e-karyotyping). Wedetected notable genomic instability in cells derived from pluripotent or adult stem cells, but surprisingly, transdifferentiated cells seemed more chromosomally stable, except if they were reprogrammed using pluripotency factors.	[Weissbein, Uri; Benvenisty, Nissim] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Azrieli Ctr Stem Cells & Genet Res, IL-91904 Jerusalem, Israel; [Ben-David, Uri] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA	Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Azrieli Ctr Stem Cells & Genet Res, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il	Ben-David, Uri/H-4119-2019	Ben-David, Uri/0000-0001-7098-2378				Ben-David U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5825; Ben-David U, 2013, NAT PROTOC, V8, P989, DOI 10.1038/nprot.2013.051; Ben-David U, 2012, STEM CELLS, V30, P612, DOI 10.1002/stem.1057; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Ladewig J, 2013, NAT REV MOL CELL BIO, V14, P225, DOI 10.1038/nrm3543; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Morris SA, 2013, CELL RES, V23, P33, DOI 10.1038/cr.2013.1; Ruggieri M, 2014, PROG NEUROBIOL, V114, P15, DOI 10.1016/j.pneurobio.2013.11.001; Sareen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007630; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Weissbein U, 2014, J CELL BIOL, V204, P153, DOI 10.1083/jcb.201310135	14	20	20	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					687	691		10.1016/j.stem.2014.10.018	http://dx.doi.org/10.1016/j.stem.2014.10.018			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25479746	Bronze			2022-12-28	WOS:000347174300008
J	Calero-Garcia, M; Gaspar, HB				Calero-Garcia, Miguel; Gaspar, H. Bobby			Gene-ectomy: Gene Ablation with CRISPR/Cas9 in Human Hematopoietic Cells	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; HIV	CRISPR/ Cas9 has recently been introduced as a gene editing tool and shows considerable promise. In this issue of Cell Stem Cell, Mandal et al. (2014) show efficient CRISPR/ Cas9-mediated ablation of the CCR5 and B2M genes in primary human hematopoietic cells, two editing strategies that are potentially translatable into clinical application.	[Calero-Garcia, Miguel; Gaspar, H. Bobby] UCL Inst Child Hlth, Mol & Cellular Immunol Sect, Infect Immun Inflammat & Physiol Med Programme, London WC1N 1EH, England	University of London; University College London	Gaspar, HB (corresponding author), UCL Inst Child Hlth, Mol & Cellular Immunol Sect, Infect Immun Inflammat & Physiol Med Programme, 30 Guilford St, London WC1N 1EH, England.	h.gaspar@ucl.ac.uk		Calero-Garcia, Miguel/0000-0002-6921-9700				Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Riolobos L, 2013, MOL THER, V21, P1232, DOI 10.1038/mt.2013.59; Torikai H, 2013, BLOOD, V122, P1341, DOI 10.1182/blood-2013-03-478255; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	9	3	5	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					529	530		10.1016/j.stem.2014.10.014	http://dx.doi.org/10.1016/j.stem.2014.10.014			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517457	Bronze			2022-12-28	WOS:000345012700002
J	Soulier, J				Soulier, Jean			When Old Hematopoietic Stem Cells Get DamAged	CELL STEM CELL			English	Editorial Material							DNA-DAMAGE; REPLICATION; MUTATIONS; STRESS	Hematopoietic stem cells (HSCs) functionally decline and are prone to lineage bias and myeloid malignancies upon aging. Two recent studies (Beerman et al., 2014; Flach et al., 2014) investigate the underlying mechanisms associated with aged HSC phenotypes and highlight DNA damage, replication stress, and ribosomal stress in the process.	[Soulier, Jean] Hop St Louis, Inst Hematol IUH, INSERM, UMR944,UMR7212,CNRS, F-75010 Paris, France; [Soulier, Jean] Univ Paris Diderot, Sorbonne Paris Cite, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Soulier, J (corresponding author), Hop St Louis, Inst Hematol IUH, INSERM, UMR944,UMR7212,CNRS, Av Claude Vellefaux, F-75010 Paris, France.	jean.soulier@sls.aphp.fr						Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023	10	2	2	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					399	400		10.1016/j.stem.2014.09.012	http://dx.doi.org/10.1016/j.stem.2014.09.012			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25280214	Bronze			2022-12-28	WOS:000343235800004
J	Matsuzaki, Y; Mabuchi, Y; Okano, H				Matsuzaki, Yumi; Mabuchi, Yo; Okano, Hideyuki			Leptin Receptor Makes Its Mark on MSCs	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; NICHE	Although mesenchymal stem/stromal cells (MSCs) are an important component of the hematopoietic niche, the markers that correlate with their physiological functions have not been defined. In this issue of Cell Stem Cell, Zhou et al. (2014) identify the Leptin Receptor as a marker for prospective identification and in vivo fate mapping of bone marrow MSCs.	[Matsuzaki, Yumi] Shimane Univ, Fac Med, Lab Tumor Biol, Dept Life Sci, Izumo, Shimane 6938501, Japan; [Mabuchi, Yo] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo 1138510, Japan; [Mabuchi, Yo; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan	Shimane University; Tokyo Medical & Dental University (TMDU); Keio University	Okano, H (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan.	hidokano@a2.keio.jp	Mabuchi, Yo/L-1535-2013; Okano, Hideyuki/I-7584-2019	Mabuchi, Yo/0000-0001-8008-3966; Matsuzaki, Yumi/0000-0002-3729-2997				Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Mabuchi Y, 2013, STEM CELL REP, V1, P152, DOI 10.1016/j.stemcr.2013.06.001; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Omatsu Y, 2014, NATURE, V508, P536, DOI 10.1038/nature13071; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	10	22	22	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					112	114		10.1016/j.stem.2014.07.001	http://dx.doi.org/10.1016/j.stem.2014.07.001			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	25105573	Bronze			2022-12-28	WOS:000340880100002
J	dos Santos, RL; Tosti, L; Radzisheuskaya, A; Caballero, IM; Kaji, K; Hendrich, B; Silva, JCR				dos Santos, Rodrigo L.; Tosti, Luca; Radzisheuskaya, Aliaksandra; Caballero, Isabel M.; Kaji, Keisuke; Hendrich, Brian; Silva, Jose C. R.			MBD3/NuRD Facilitates Induction of Pluripotency in a Context-Dependent Manner	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GROUND-STATE; INTERACTION NETWORK; GENE-EXPRESSION; SOMATIC-CELLS; SELF-RENEWAL; NURD; COMPLEX; NANOG; MBD3	The Nucleosome Remodeling and Deacetylase (NuRD) complex is essential for embryonic development and pluripotent stem cell differentiation. In this study, we investigated whether NuRD is also involved in the reverse biological process of induction of pluripotency in neural stem cells. By knocking out MBD3, an essential scaffold subunit of the NuRD complex, at different time points in reprogramming, we found that efficient formation of reprogramming intermediates and induced pluripotent stem cells from neural stem cells requires NuRD activity. We also show that reprogramming of epiblast-derived stem cells to naive pluripotency requires NuRD complex function and that increased MBD3/NuRD levels can enhance reprogramming efficiency when coexpressed with the reprogramming factor NANOG. Our results therefore show that the MBD3/NuRD complex plays a key role in reprogramming in certain contexts and that a chromatin complex required for cell differentiation can also promote reversion back to a naive pluripotent cell state.	[dos Santos, Rodrigo L.; Radzisheuskaya, Aliaksandra; Hendrich, Brian; Silva, Jose C. R.] Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust, MRC, Cambridge CB2 2QR, England; [dos Santos, Rodrigo L.; Radzisheuskaya, Aliaksandra; Hendrich, Brian; Silva, Jose C. R.] Univ Cambridge, Dept Biochem, Cambridge CB2 2QR, England; [dos Santos, Rodrigo L.] Univ Coimbra, Doctoral Programme Expt Biol & Biomed, Ctr Neurosci & Cell Biol, P-3030789 Coimbra, Portugal; [dos Santos, Rodrigo L.] Univ Coimbra, Inst Interdisciplinary Res, P-3030789 Coimbra, Portugal; [Tosti, Luca; Caballero, Isabel M.; Kaji, Keisuke] Univ Edinburgh, Ctr Regenerat Med, MRC, Edinburgh EH16 4UU, Midlothian, Scotland	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Universidade de Coimbra; Universidade de Coimbra; University of Edinburgh	Silva, JCR (corresponding author), Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust, MRC, Tennis Court Rd, Cambridge CB2 2QR, England.	jcs64@cscr.cam.ac.uk	Silva, Jose/G-1920-2014; Hendrich, Brian/AAG-5898-2020; Silva, Jose C R/X-5140-2019; Radzisheuskaya, Aliaksandra/J-2073-2015; Radzisheuskaya, Aliaksandra/AAI-4975-2021	Silva, Jose/0000-0001-5487-1117; Hendrich, Brian/0000-0002-0231-3073; Silva, Jose C R/0000-0001-5487-1117; Radzisheuskaya, Aliaksandra/0000-0002-2695-6401; Tosti, Luca/0000-0003-2941-965X; Kaji, Keisuke/0000-0001-5946-8415; Luiz dos Santos, Rodrigo/0000-0002-9366-9920	Wellcome Trust Fellowship [WT101861]; ERC starting grant; Anne Rowling Clinic; Portuguese Foundation for Sciences and Technology, FCT [SFRH/BD/51198/2010]; College of Medicine and Veterinary Medicine, University of Edinburgh	Wellcome Trust Fellowship(Wellcome Trust); ERC starting grant(European Research Council (ERC)); Anne Rowling Clinic; Portuguese Foundation for Sciences and Technology, FCT(Portuguese Foundation for Science and Technology); College of Medicine and Veterinary Medicine, University of Edinburgh	We acknowledge N. Reynolds and J. Ramalho-Santos for advice and helpful discussions. We are also grateful to Y. Costa for critical reading of the manuscript. This study was supported by a Wellcome Trust Fellowship (WT101861), an ERC starting grant, and the Anne Rowling Clinic. J.C.R.S. and B.H. are Wellcome Trust Senior Research Fellows in the Basic Biomedical Sciences. R.L.S. is a recipient of a Ph.D. fellowship from the Portuguese Foundation for Sciences and Technology, FCT (SFRH/BD/51198/2010). L.T. is a recipient of a Ph.D. fellowship from The College of Medicine and Veterinary Medicine, University of Edinburgh.	Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Gagliardi A, 2013, EMBO J, V32, P2231, DOI 10.1038/emboj.2013.161; Gunther K, 2013, NUCLEIC ACIDS RES, V41, P3010, DOI 10.1093/nar/gkt035; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pollard SM, 2006, METHOD ENZYMOL, V418, P151, DOI 10.1016/S0076-6879(06)18010-6; Radzisheuskaya A, 2014, TRENDS CELL BIOL, V24, P275, DOI 10.1016/j.tcb.2013.11.010; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Shimbo T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004028; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sims JK, 2011, MOL BIOL CELL, V22, P3094, DOI 10.1091/mbc.E11-03-0258; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang S, 2013, CELL STEM CELL, V13, P617, DOI 10.1016/j.stem.2013.10.005; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	38	119	121	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					102	110		10.1016/j.stem.2014.04.019	http://dx.doi.org/10.1016/j.stem.2014.04.019			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24835571	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000340878600015
J	Sweet, DJ				Sweet, Deborah J.			Keeping Score	CELL STEM CELL			English	Editorial Material																		Janich P, 2013, CELL STEM CELL, V13, P745, DOI 10.1016/j.stem.2013.09.004; Marcus E, 2013, CELL, V154, P9, DOI 10.1016/j.cell.2013.06.017; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Sweet DJ, 2013, CELL STEM CELL, V12, P631, DOI 10.1016/j.stem.2013.05.021; Voices, 2013, CELL STEM CELL, V13, P517	6	2	2	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					691	692		10.1016/j.stem.2014.05.015	http://dx.doi.org/10.1016/j.stem.2014.05.015			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905155	Bronze			2022-12-28	WOS:000341248500001
J	Theunissen, TW; Jaenisch, R				Theunissen, Thorold W.; Jaenisch, Rudolf			Molecular Control of Induced Pluripotency	CELL STEM CELL			English	Review							REPROGRAMMING SOMATIC-CELLS; STEM-CELLS; HUMAN FIBROBLASTS; SELF-RENEWAL; REGULATES PLURIPOTENCY; EPIGENETIC MEMORY; MOUSE EPIBLAST; NANOG; EXPRESSION; OCT4	Deciphering the mechanisms of epigenetic reprogramming provides fundamental insights into cell fate decisions, which in turn reveal strategies to make the reprogramming process increasingly efficient. Here we review recent advances in epigenetic reprogramming to pluripotency with a focus on the principal molecular regulators. We examine the trajectories connecting somatic and pluripotent cells, genetic and chemical methodologies for inducing pluripotency, the role of endogenous master transcription factors in establishing the pluripotent state, and functional interactions between reprogramming factors and epigenetic regulators. Defining the crosstalk among the diverse molecular actors implicated in cellular reprogramming presents a major challenge for future inquiry.	[Theunissen, Thorold W.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Theunissen, Thorold/0000-0001-6943-7858	Sir Henry Wellcome Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198, P30CA014051] Funding Source: NIH RePORTER	Sir Henry Wellcome Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Meelad Dawlaty, Dina Faddah, Ben Powell, Frank Soldner, Yonatan Stelzer, and Jianlong Wang for comments on the manuscript and Tom DiCesare for assistance with figure preparation. T. W. T. is supported by a Sir Henry Wellcome Postdoctoral Fellowship. R.J. is a cofounder of Fate Therapeutics and an adviser to Stemgent. We apologize to authors whose work was not directly cited due to space limitations.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Carter AC, 2014, STEM CELL REP, V2, P119, DOI 10.1016/j.stemcr.2013.12.010; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Christophorou MA, 2014, NATURE, V507, P104, DOI 10.1038/nature12942; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Di Stefano B, 2014, NATURE, V506, P235, DOI 10.1038/nature12885; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Dos Santos R.L., 2014, CELL STEM CELL; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Filipczyk A, 2013, CELL STEM CELL, V13, P12, DOI 10.1016/j.stem.2013.04.025; Fong YW, 2011, CELL, V147, P120, DOI 10.1016/j.cell.2011.08.038; Foshay KM, 2012, MOL CELL, V46, P159, DOI 10.1016/j.molcel.2012.02.013; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gagliardi A, 2013, EMBO J, V32, P2231, DOI 10.1038/emboj.2013.161; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gao ZH, 2012, J BIOL CHEM, V287, P11384, DOI 10.1074/jbc.M111.320143; Gaspar-Maia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2582; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guo SQ, 2014, CELL, V156, P649, DOI 10.1016/j.cell.2014.01.020; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Ho R, 2013, CELL REP, V3, P2113, DOI 10.1016/j.celrep.2013.05.015; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Hu X, 2014, CELL STEM CELL, V14, P512, DOI 10.1016/j.stem.2014.01.001; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kumar R, 2013, NATURE, V500, P89, DOI 10.1038/nature12299; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Messerschmidt DM, 2010, DEV BIOL, V344, P129, DOI 10.1016/j.ydbio.2010.04.020; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Obokata H, 2014, NATURE, V505, P676, DOI 10.1038/nature12969; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Parchem RJ, 2014, CELL STEM CELL, V14, P617, DOI 10.1016/j.stem.2014.01.021; Pasque V, 2012, J CELL SCI, V125, P6094, DOI 10.1242/jcs.113019; Pijnappel WWMP, 2013, NATURE, V495, P516, DOI 10.1038/nature11970; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schwarz BA, 2014, CURR BIOL, V24, P347, DOI 10.1016/j.cub.2013.12.050; Shimamoto R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094735; Shinagawa T, 2014, CELL STEM CELL, V14, P217, DOI 10.1016/j.stem.2013.12.015; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stuart HT, 2014, CURR BIOL, V24, P340, DOI 10.1016/j.cub.2013.12.040; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tahmasebi S, 2014, CELL STEM CELL, V14, P606, DOI 10.1016/j.stem.2014.02.005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Tsubouchi T, 2013, CELL, V152, P873, DOI 10.1016/j.cell.2013.01.012; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang L, 2014, CELL STEM CELL, V14, P575, DOI 10.1016/j.stem.2014.02.013; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Worringer KA, 2014, CELL STEM CELL, V14, P40, DOI 10.1016/j.stem.2013.11.001; Wu GM, 2013, NAT CELL BIOL, V15, P1089, DOI 10.1038/ncb2816; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	123	91	94	2	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					720	734		10.1016/j.stem.2014.05.002	http://dx.doi.org/10.1016/j.stem.2014.05.002			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905163	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000341248500010
J	Seguin, L; Weis, SM; Cheresh, DA				Seguin, Laetitia; Weis, Sara M.; Cheresh, David A.			Variety in the Tumor Microenvironment: Integrin Splicing Regulates Stemness	CELL STEM CELL			English	Editorial Material									[Seguin, Laetitia; Weis, Sara M.; Cheresh, David A.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Seguin, Laetitia; Weis, Sara M.; Cheresh, David A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Cheresh, DA (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu		SEGUIN, Laetitia/0000-0003-2950-4766; Seguin, Laetitia/0000-0002-9610-7093				Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Goel HL, 2014, CELL REP, V7, P747, DOI 10.1016/j.celrep.2014.03.059; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Yoshioka T, 2013, J CLIN INVEST, V123, P682, DOI 10.1172/JCI60720	10	5	5	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					557	558		10.1016/j.stem.2014.04.011	http://dx.doi.org/10.1016/j.stem.2014.04.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24792112	Bronze			2022-12-28	WOS:000335659900005
J	Welner, RS; Kincade, PW				Welner, Robert S.; Kincade, Paul W.			9-1-1: HSCs Respond to Emergency Calls	CELL STEM CELL			English	Editorial Material							CELLS; INFECTION	In this issue of Cell Stem Cell, Zhao et al. (2014) and Schurch et al. (2014) describe two new stem cell mechanisms underlying protective responses to infection. In response to inflammatory signals, HSPCs and MSCs produce cytokines that stimulate HSC mobilization and differentiation toward innate immune cells at the expense of adaptive immune lineages.	[Welner, Robert S.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02151 USA; [Kincade, Paul W.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Harvard University; Harvard Medical School; Oklahoma Medical Research Foundation	Kincade, PW (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kincade@omrf.org			NHLBI NIH HHS [R01 HL107138, HL07138] Funding Source: Medline; NIAID NIH HHS [AI020069, R01 AI020069] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020069, R01AI020069] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Maeda K, 2005, BLOOD, V106, P879, DOI 10.1182/blood-2005-02-0456; METCALF D, 1971, IMMUNOLOGY, V21, P427; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Schurch CM, 2014, CELL STEM CELL, V14, P460, DOI 10.1016/j.stem.2014.01.002; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Zhang YB, 2013, J IMMUNOL, V190, P4725, DOI 10.4049/jimmunol.1203024; Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007	10	10	10	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					415	416		10.1016/j.stem.2014.03.010	http://dx.doi.org/10.1016/j.stem.2014.03.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24702988	Green Accepted, Bronze			2022-12-28	WOS:000334766400001
J	Liu, HL; Chen, YC; Niu, YY; Zhang, KS; Kang, Y; Ge, WH; Liu, XJ; Zhao, EF; Wang, CC; Lin, SY; Jing, B; Si, CY; Lin, Q; Chen, XY; Lin, HJ; Pu, XQ; Wang, YY; Qin, BL; Wang, F; Wang, H; Si, W; Zhou, J; Tan, T; Li, TQ; Ji, SH; Xue, ZG; Luo, YP; Cheng, LM; Zhou, Q; Li, SG; Sun, YE; Ji, WZ				Liu, Hailiang; Chen, Yongchang; Niu, Yuyu; Zhang, Kunshan; Kang, Yu; Ge, Weihong; Liu, Xiaojing; Zhao, Enfeng; Wang, Chencheng; Lin, Shaoyun; Jing, Bo; Si, Chenyang; Lin, Quan; Chen, Xiaoying; Lin, Haijun; Pu, Xiuqiong; Wang, Yingying; Qin, Binlian; Wang, Fang; Wang, Hong; Si, Wei; Zhou, Jing; Tan, Tao; Li, Tianqing; Ji, Shaohui; Xue, Zhigang; Luo, Yuping; Cheng, Liming; Zhou, Qi; Li, Siguang; Sun, Yi Eve; Ji, Weizhi			TALEN-Mediated Gene Mutagenesis in Rhesus and Cynomolgus Monkeys	CELL STEM CELL			English	Article							HISTONE DEACETYLASE; NONHUMAN PRIMATE; RETTS SYNDROME; MECP2; EXPRESSION; EMBRYOS; CELLS; DNA; RECOGNITION; GENERATION	Recent advances in gene editing technology have introduced the potential for application of mutagenesis approaches in nonhuman primates to model human development and disease. Here we report successful TALEN-mediated mutagenesis of an X-linked, Rett syndrome (RTT) gene, methyl-CpG binding protein 2 (MECP2), in both rhesus and cynomolgus monkeys. Microinjection of MECP2-targeting TALEN plasmids into rhesus and cynomolgus zygotes leads to effective gene editing of MECP2 with no detected off-target mutagenesis. Male rhesus (2) and cynomolgous (1) fetuses carrying MECP2 mutations in various tissues including testes were miscarried during midgestation, consistent with RTT-linked male embryonic lethality in humans. One live delivery of a female cynomolgus monkey occurred after 162 days of gestation, with abundant MECP2 mutations in peripheral tissues. We conclude that TALEN-mediated mutagenesis can be an effective tool for genetic modeling of human disease in nonhuman primates.	[Liu, Hailiang; Chen, Yongchang; Niu, Yuyu; Kang, Yu; Wang, Chencheng; Si, Chenyang; Pu, Xiuqiong; Wang, Fang; Wang, Hong; Si, Wei; Tan, Tao; Li, Tianqing; Ji, Shaohui; Sun, Yi Eve; Ji, Weizhi] Yunnan Key Lab Primate Biomed Res, Kunming 650500, Peoples R China; [Liu, Hailiang; Zhang, Kunshan; Liu, Xiaojing; Zhao, Enfeng; Wang, Chencheng; Lin, Shaoyun; Jing, Bo; Lin, Quan; Chen, Xiaoying; Lin, Haijun; Wang, Yingying; Qin, Binlian; Zhou, Jing; Xue, Zhigang; Luo, Yuping; Cheng, Liming; Li, Siguang; Sun, Yi Eve] Tongji Univ, Sch Med, Tongji Hosp, Translat Stem Cell Res Ctr, Shanghai 200092, Peoples R China; [Chen, Yongchang; Niu, Yuyu; Kang, Yu; Si, Chenyang; Pu, Xiuqiong; Wang, Fang; Wang, Hong; Si, Wei; Tan, Tao; Li, Tianqing; Ji, Shaohui; Ji, Weizhi] Kunming Biomed Int & Natl Engn Res Ctr Biomed & A, Kunming 650500, Peoples R China; [Chen, Yongchang; Niu, Yuyu; Wang, Hong; Si, Wei; Tan, Tao; Li, Tianqing; Ji, Shaohui] Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Peoples R China; [Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Ge, Weihong; Lin, Quan; Chen, Xiaoying; Sun, Yi Eve] Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Ji, Weizhi] Kunming Univ Sci & Technol, Kunming 650224, Peoples R China; [Zhao, Enfeng] Shanghai Huadong Hosp, Shanghai 200040, Peoples R China	Tongji University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Institute of Zoology, CAS; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kunming University of Science & Technology; Fudan University	Li, SG (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Translat Stem Cell Res Ctr, Shanghai 200092, Peoples R China.	siguangli@163.com; ysun@mednet.ucla.edu; wji@kbimed.com	cheng, liming/GMX-4116-2022; Xiao, Hu/GMX-0258-2022	Chen, Xiaoying/0000-0002-6710-3798; tan, tao/0000-0002-7589-602X; Ji, Weizhi/0000-0003-2550-4224; Jing, Bo/0000-0002-4899-0213	Major State Basic Research Development Program of China (973 Program) [2012CBA01300, 2012CB966900, 2010CB945202, 2011CB965103]; National High Technology Research and Development Program of China (863 Program) [2012AA020701]; Yunnan Innovation Talents of Science and Technology [2012HA013]; National Natural Science Foundation of China [31271599, U1302227, 31301058, 90919057, 31271371, 91319309]; Key program for the basic research of the science and technology commission of Shanghai [13JC1407102]; "Western Light" Talents Training Program of CAS; Yunnan Academic Leaders and Reserve Personnel, and Young Talents Training Program of Tongji University; NIH [P01 GM081621-01A1, 1R01MH082068-01A2]; CIRM [RB3-02129]; Transcriptome and Epigenetics Core of Center for Study of Opioid Receptors and Drugs of Abuse (CSORDA center) at UCLA [NIH-P50DA005010]; Intellectual and Developmental Disabilities Research Center (IDDRC center) at UCLA [NIH-P30HD004612]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH082068, R01MH082068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Yunnan Innovation Talents of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key program for the basic research of the science and technology commission of Shanghai; "Western Light" Talents Training Program of CAS; Yunnan Academic Leaders and Reserve Personnel, and Young Talents Training Program of Tongji University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Transcriptome and Epigenetics Core of Center for Study of Opioid Receptors and Drugs of Abuse (CSORDA center) at UCLA; Intellectual and Developmental Disabilities Research Center (IDDRC center) at UCLA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to acknowledge the Division of Animal Resources at the Kunming Biomed International for providing expertise and services that contributed to this project. This work was supported by the Major State Basic Research Development Program of China (973 Program) (No. 2012CBA01300, 2012CB966900, 2010CB945202, and 2011CB965103), the National High Technology Research and Development Program of China (863 Program) (No. 2012AA020701), Yunnan Innovation Talents of Science and Technology (No. 2012HA013), the National Natural Science Foundation of China (31271599, U1302227, 31301058, 90919057, 31271371, and 91319309), Key program for the basic research of the science and technology commission of Shanghai (13JC1407102), "Western Light" Talents Training Program of CAS and Yunnan Academic Leaders and Reserve Personnel, and Young Talents Training Program of Tongji University. We also acknowledge grants from NIH (P01 GM081621-01A1 and 1R01MH082068-01A2) and CIRM (RB3-02129) to Y.E.S. and the Transcriptome and Epigenetics Core of Center for Study of Opioid Receptors and Drugs of Abuse (CSORDA center grant: NIH-P50DA005010) and Intellectual and Developmental Disabilities Research Center (IDDRC center grant: NIH-P30HD004612) at UCLA.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Chan AWS, 2001, SCIENCE, V291, P309, DOI 10.1126/science.291.5502.309; Chen YC, 2012, J GENET GENOMICS, V39, P247, DOI 10.1016/j.jgg.2012.04.007; Chen Y, 2012, AM J PRIMATOL, V74, P165, DOI 10.1002/ajp.21017; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Iqbal K, 2009, BIOTECHNIQUES, V47, P959, DOI 10.2144/000113270; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Niu YY, 2010, P NATL ACAD SCI USA, V107, P17663, DOI 10.1073/pnas.1006563107; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Ousterout DG, 2013, MOL THER, V21, P1718, DOI 10.1038/mt.2013.111; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Takada S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076004; Wolfgang MJ, 2001, P NATL ACAD SCI USA, V98, P10728, DOI 10.1073/pnas.181336098; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975	28	152	181	6	92	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					323	328		10.1016/j.stem.2014.01.018	http://dx.doi.org/10.1016/j.stem.2014.01.018			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24529597	Bronze, Green Accepted			2022-12-28	WOS:000332533400009
J	Ye, M; Zhang, H; Yang, H; Koche, R; Staber, PB; Cusan, M; Levantini, E; Welner, RS; Bach, CS; Zhang, JY; Krivtsov, AV; Armstrong, SA; Tenen, DG				Ye, Min; Zhang, Hong; Yang, Henry; Koche, Richard; Staber, Philipp B.; Cusan, Monica; Levantini, Elena; Welner, Robert S.; Bach, Christian S.; Zhang, Junyan; Krivtsov, Andrei V.; Armstrong, Scott A.; Tenen, Daniel G.			Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia	CELL STEM CELL			English	Article							C/EBP-ALPHA; STEM-CELLS; TRANSCRIPTION FACTORS; REPOPULATING CELLS; MOZ-TIF2; REGULATOR; AML; IDENTIFICATION; PROGENITORS; HOMEOSTASIS	Mutations in acute myeloid leukemia (AML)-associated oncogenes often arise in hematopoietic stem cells (HSCs) and promote acquisition of leukemia stem cell (LSC) phenotypes. However, as LSCs often share features of lineage-restricted progenitors, the relative contribution of differentiation status to LSC transformation is unclear. Using murine MLL-AF9 and MOZ-TIF2 AML models, we show that myeloid differentiation to granulocyte macrophage progenitors (GMPs) is critical for LSC generation. Disrupting GMP formation by deleting the lineage-restricted transcription factor C/EBPa blocked normal granulocyte formation and prevented initiation of AML. However, restoring myeloid differentiation in C/EBPa mutants with inflammatory cytokines reestablished AML transformation capacity. Genomic analyses of GMPs, including gene expression and H3K79me2 profiling in conjunction with ATAC-seq, revealed a permissive genomic environment for activation of a minimal transcription program shared by GMPs and LSCs. Together, these findings show that myeloid differentiation is a prerequisite for LSC formation and AML development, providing insights for therapeutic development.	[Ye, Min; Zhang, Hong; Staber, Philipp B.; Levantini, Elena; Welner, Robert S.; Bach, Christian S.; Zhang, Junyan; Tenen, Daniel G.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Yang, Henry; Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore; [Staber, Philipp B.] Med Univ Vienna, Comprehens Canc Ctr Vienna, Div Hematol & Hemostaseol, A-1090 Vienna, Austria; [Levantini, Elena] CNR, Inst Biomed Technol, I-56124 Pisa, Italy; [Bach, Christian S.] Univ Hosp Erlangen, Dept Hematol Oncol, D-91054 Erlangen, Germany; [Koche, Richard; Cusan, Monica; Krivtsov, Andrei V.; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Koche, Richard; Cusan, Monica; Krivtsov, Andrei V.; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA	Harvard University; Harvard Medical School; National University of Singapore; Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Erlangen Nuremberg; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Tenen, DG (corresponding author), Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA.	daniel.tenen@nus.edu.sg	Krivtsov, Andrei/AAJ-9966-2021; levantini, elena/AAK-7201-2021; Levantini, Elena/AGY-0242-2022; Staber, Philipp Bernhard/ADK-1536-2022	levantini, elena/0000-0003-4612-3105; Staber, Philipp Bernhard/0000-0001-6729-7708; Koche, Richard/0000-0002-6820-5083; Krivtsov, Andrei/0000-0002-5511-1686; Bach, Christian/0000-0003-4675-7896	National Institutes of Health [HL112719, CA66996, DK103858, P01CA066996]; Singapore Ministry of Health's National Medical Research Council under Singapore Translational Research (STaR) Investigator Award; National Research Foundation Singapore; Singapore Ministry of Education under Research Centres of Excellence initiative; FAMRI YCSA and CIA grant; Austrian Research Foundation; European Union; Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg; German Research Foundation [BA 4186/1-1]; Leukemia & Lymphoma Society (LLS);  [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748, R35CA197697, P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Ministry of Health's National Medical Research Council under Singapore Translational Research (STaR) Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under Research Centres of Excellence initiative(Ministry of Education, Singapore); FAMRI YCSA and CIA grant; Austrian Research Foundation(Austrian Science Fund (FWF)); European Union(European Commission); Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg; German Research Foundation(German Research Foundation (DFG)); Leukemia & Lymphoma Society (LLS)(Leukemia and Lymphoma Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health grants HL112719, CA66996, and DK103858 to D.G.T., the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award, and the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centres of Excellence initiative. E.L. was supported by a FAMRI YCSA and CIA grant. P.B.S. was supported by the Austrian Research Foundation and European Union. C.S.B. was supported by the Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg and the German Research Foundation (BA 4186/1-1). S.A.A. was supported by the National Institutes of Health grant P01CA066996, Grant P30 CA008748, and the Leukemia & Lymphoma Society (LLS). We thank Huafeng Xie, Matthias Stadtfeld, and Thomas Graf for careful reading of the manuscript and suggestions; Joyce LaVecchio and Girijesh Buruzula from the Harvard Stem Cell Institute/Joslin Diabetes Center flow cytometry facility for expertise in cell sorting; and Gilbert Chong from CSI Singapore for sample handling and data transfer.	Aikawa Y, 2010, NAT MED, V16, P580, DOI 10.1038/nm.2122; Bereshchenko O, 2009, CANCER CELL, V16, P390, DOI 10.1016/j.ccr.2009.09.036; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bhatia M, 1997, J EXP MED, V186, P619, DOI 10.1084/jem.186.4.619; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Collins C, 2014, P NATL ACAD SCI USA, V111, P9899, DOI 10.1073/pnas.1402238111; DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7; de Groot RP, 1998, CELL SIGNAL, V10, P619, DOI 10.1016/S0898-6568(98)00023-0; De Obaldia ME, 2013, NAT IMMUNOL, V14, P1277, DOI 10.1038/ni.2760; FIALKOW PJ, 1989, BONE MARROW TRANSPL, V4, P76; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kindle KB, 2005, MOL CELL BIOL, V25, P988, DOI 10.1128/MCB.25.3.988-1002.2005; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kvinlaug BT, 2011, CANCER RES, V71, P4117, DOI 10.1158/0008-5472.CAN-11-0176; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lobry C, 2013, J EXP MED, V210, P301, DOI 10.1084/jem.20121484; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; MCKNIGHT SL, 1989, GENE DEV, V3, P2021, DOI 10.1101/gad.3.12b.2021; Miyamoto T, 1996, BLOOD, V87, P4789, DOI 10.1182/blood.V87.11.4789.bloodjournal87114789; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Ohlsson E, 2014, J EXP MED, V211, P5, DOI 10.1084/jem.20130932; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Staber PB, 2014, BLOOD, V124, P2391, DOI 10.1182/blood-2014-01-550855; Tam WF, 2013, CANCER RES, V73, P373, DOI 10.1158/0008-5472.CAN-12-0255; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zhang H, 2013, CANCER CELL, V24, P575, DOI 10.1016/j.ccr.2013.09.018; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	38	77	78	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2015	17	5					611	623		10.1016/j.stem.2015.08.011	http://dx.doi.org/10.1016/j.stem.2015.08.011			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4UB	26412561	Bronze, Green Accepted			2022-12-28	WOS:000365694700013
J	Linnarsson, S				Linnarsson, Sten			Sequencing Single Cells Reveals Sequential Stem Cell States	CELL STEM CELL			English	Editorial Material							RNA-SEQ	Understanding the molecular mechanisms underlying activation of quiescent neural stem cells (NSCs) is complicated by heterogeneity in coexisting NSC pools. Two papers in this issue of Cell Stem Cell (Llorens-Bobadilla et al., 2015; Shin et al., 2015) report sequencing of single NSCs, providing insights into the transition from quiescence to activation and highlighting common themes in NSCs from distinct brain regions.	Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, S-17177 Stockholm, Sweden	Karolinska Institutet	Linnarsson, S (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, Scheeles Vag 1, S-17177 Stockholm, Sweden.	sten.linnarsson@ki.se	Linnarsson, Sten/HCH-3909-2022					Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Mich JK, 2014, ELIFE, V3, DOI 10.7554/eLife.02669; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	10	3	3	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					251	252		10.1016/j.stem.2015.08.016	http://dx.doi.org/10.1016/j.stem.2015.08.016			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26340522	Bronze			2022-12-28	WOS:000364011000002
J	Zak, J; Lu, X				Zak, Jaroslav; Lu, Xin			Aspp1: A Guardian of Hematopoietic Stem Cell Integrity	CELL STEM CELL			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA; TP53; P53	Eliminating hematopoietic stem cells (HSCs) with DNA damage is necessary to maintain the homeostasis of HSCs, but the mechanisms underlying this apoptotic elimination are unclear. Now in Cell Stem Cell, Yamashita et al. (2015) show that Aspp1 coordinates with p53 to protect HSC pool integrity, guarding against hematological malignancies.	[Zak, Jaroslav; Lu, Xin] Univ Oxford, Ludwig Inst Canc Res, Oxford OX3 7DQ, England	Ludwig Institute for Cancer Research; University of Oxford	Lu, X (corresponding author), Univ Oxford, Ludwig Inst Canc Res, Oxford OX3 7DQ, England.	xin.lu@ludwig.ox.ac.uk		Lu, Xin/0000-0002-6587-1152				Agirre X, 2006, ONCOGENE, V25, P1862, DOI 10.1038/sj.onc.1209236; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Fogal V, 2005, CELL DEATH DIFFER, V12, P369, DOI 10.1038/sj.cdd.4401562; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Wong TN, 2015, NATURE, V518, P552, DOI 10.1038/nature13968; Yamashita M, 2015, CELL STEM CELL, V17, P23, DOI 10.1016/j.stem.2015.05.013	9	5	5	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2015	17	1					3	5		10.1016/j.stem.2015.06.012	http://dx.doi.org/10.1016/j.stem.2015.06.012			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DI	26140601	Bronze			2022-12-28	WOS:000361877600002
J	Zhao, B; Zhang, WD; Duan, YL; Lu, YQ; Cun, YX; Li, CH; Guo, K; Nie, WH; Li, L; Zhang, RG; Zheng, P				Zhao, Bo; Zhang, Wei-dao; Duan, Ying-liang; Lu, Yong-qing; Cun, Yi-xian; Li, Chao-hui; Guo, Kun; Nie, Wen-hui; Li, Lei; Zhang, Rugang; Zheng, Ping			Filia Is an ESC-Specific Regulator of DNA Damage Response and Safeguards Genomic Stability	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; CENTROSOME; REPAIR; CHECKPOINT; MAINTENANCE; POLY(ADP-RIBOSYL)ATION; KINASE; ATM; P53; ESTABLISHMENT	Pluripotent stem cells (PSCs) hold great promise in cell-based therapy, but the genomic instability seen in culture hampers their full application. A greater understanding of the factors that regulate genomic stability in PSCs could help address this issue. Here we describe the identification of Filia as a specific regulator of genomic stability in mouse embryonic stem cells (ESCs). Filia expression is induced by genotoxic stress. Filia promotes centrosome integrity and regulates the DNA damage response (DDR) through multiple pathways, including DDR signaling, cell-cycle checkpoints and damage repair, ESC differentiation, and apoptosis. Filia depletion causes ESC genomic instability, induces resistance to apoptosis, and promotes malignant transformation. As part of its role in DDR, Filia interacts with PARP1 and stimulates its enzymatic activity. Filia also constitutively resides on centrosomes and translocates to DNA damage sites and mitochondria, consistent with its multifaceted roles in regulating centrosome integrity, damage repair, and apoptosis.	[Zhao, Bo; Zhang, Wei-dao; Duan, Ying-liang; Lu, Yong-qing; Cun, Yi-xian; Li, Chao-hui; Guo, Kun; Nie, Wen-hui; Zheng, Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China; [Zhao, Bo; Zhang, Wei-dao; Duan, Ying-liang; Lu, Yong-qing; Cun, Yi-xian; Li, Chao-hui; Guo, Kun; Zheng, Ping] Chinese Acad Sci, Kunming Inst Zool, Yunnan Key Lab Anim Reprod, Kunming 650223, Yunnan, Peoples R China; [Zhang, Wei-dao; Li, Chao-hui; Guo, Kun] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming 650204, Peoples R China; [Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Zhang, Rugang] Wistar Inst Anat & Biol, Wistar Inst Canc Ctr, Gene Express & Regulat Program, Philadelphia, PA 19104 USA	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; The Wistar Institute	Zheng, P (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China.	zhengp@mail.kiz.ac.cn	Duan, Ying-Liang/GYJ-4113-2022	Zhao, Bo/0000-0002-1000-8239; zheng, ping/0000-0003-0402-5507; Li, Lei/0000-0001-5478-5681	Chinese NSFC [31171424]; CAS Strategic Priority Research Program [XDA01010203]; Yunnan Province; NIH/NCI [R01CA160331]; Cancer Center Core Grant [CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815, R01CA160331] Funding Source: NIH RePORTER	Chinese NSFC(National Natural Science Foundation of China (NSFC)); CAS Strategic Priority Research Program; Yunnan Province; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Jurrien Dean at the NIH for providing Filia mutant mice; Wei-jian Sang, Rui Bi, and Zhengyuan Xie for technical support in making lentiviral expression vectors; the Protein Mass Spectrometry Center at the Shanghai Institute of Materia Medica, CAS, for performing the mass spectrometry analysis; and Dr. Jurrien Dean at the NIH and Dr. Jiali Li at the Kunming Institute of Zoology, CAS, for carefully reading and editing the paper. This work was supported by the Chinese NSFC grant 31171424 (to P.Z.), by CAS Strategic Priority Research Program Grant XDA01010203, and by a talent grant from Yunnan Province. R.Z. is supported by NIH/NCI Grant R01CA160331 and Cancer Center Core Grant CA010815.	Aguilar-Quesada R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-29; Alpatov R, 2014, CELL, V157, P869, DOI 10.1016/j.cell.2014.03.040; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; BAILLY E, 1992, J CELL SCI, V101, P529; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Card DAG, 2010, J BIOL CHEM, V285, P15653, DOI 10.1074/jbc.M109.096156; Davis AJ, 2014, DNA REPAIR, V17, P21, DOI 10.1016/j.dnarep.2014.02.020; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Farber-Katz SE, 2014, CELL, V156, P413, DOI 10.1016/j.cell.2013.12.023; Golan A, 2010, CELL CYCLE, V9, P2647, DOI 10.4161/cc.9.13.12121; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Haince JF, 2007, J BIOL CHEM, V282, P16441, DOI 10.1074/jbc.M608406200; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Liang YL, 2009, WORLD J SURG, V33, P661, DOI 10.1007/s00268-008-9840-1; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Liu QH, 2000, GENE DEV, V14, P1448; Loffler H, 2013, ONCOGENE, V32, P2963, DOI 10.1038/onc.2012.310; Loffler H, 2006, EXP CELL RES, V312, P2633, DOI 10.1016/j.yexcr.2006.06.008; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Min W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3993; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Momcilovic O, 2011, RESULTS PROBL CELL D, V53, P415, DOI 10.1007/978-3-642-19065-0_18; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; Nagy Z, 2009, TRENDS CELL BIOL, V19, P617, DOI 10.1016/j.tcb.2009.08.010; Narva E, 2012, STEM CELLS, V30, P452, DOI 10.1002/stem.1013; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Pines A, 2011, MOL CELL BIOL, V31, P4964, DOI 10.1128/MCB.05258-11; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Shimada M, 2009, J RADIAT RES, V50, P295, DOI 10.1269/jrr.09039; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tallis M, 2014, CHROMOSOMA, V123, P79, DOI 10.1007/s00412-013-0442-9; Tamanini F, 1999, HUM MOL GENET, V8, P863, DOI 10.1093/hmg/8.5.863; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; van der Laan S, 2013, MOL CELL, V52, P366, DOI 10.1016/j.molcel.2013.10.003; Wyles SP, 2014, INT J MOL SCI, V15, P20948, DOI 10.3390/ijms151120948; Yamamoto K, 2012, J CELL BIOL, V198, P305, DOI 10.1083/jcb.201204098; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zeng CQ, 2000, MICROSC RES TECHNIQ, V49, P467, DOI 10.1002/(SICI)1097-0029(20000601)49:5<467::AID-JEMT9>3.3.CO;2-M; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195; Zhao TBA, 2010, TRENDS CELL BIOL, V20, P170, DOI 10.1016/j.tcb.2009.12.004; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	65	30	31	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					684	698		10.1016/j.stem.2015.03.017	http://dx.doi.org/10.1016/j.stem.2015.03.017			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	25936915	Green Accepted, Bronze			2022-12-28	WOS:000355932300016
J	Konomi, K; Tobita, M; Kimura, K; Sato, D				Konomi, Kenji; Tobita, Morikuni; Kimura, Kenichi; Sato, Daisaku			New Japanese Initiatives on Stem Cell Therapies	CELL STEM CELL			English	Editorial Material								Two laws aiming to provide a new legal framework to promote regenerative medicine, while ensuring the efficacy and safety of the treatments, came into effect in Japan on November 25, 2014. The scope of these laws is briefly described here.	[Konomi, Kenji; Tobita, Morikuni; Kimura, Kenichi] Minist Hlth Labour & Welf, Hlth Policy Bur, Res & Dev Div, Chiyoda Ku, Tokyo 1008916, Japan; [Sato, Daisaku] Pharmaceut & Med Devices Agcy, Chiyoda Ku, Tokyo 1000013, Japan		Konomi, K (corresponding author), Minist Hlth Labour & Welf, Hlth Policy Bur, Res & Dev Div, Chiyoda Ku, 1-2-2,Kasumigaseki, Tokyo 1008916, Japan.	jzt02060@nifty.ne.jp						[Anonymous], 2013, NATURE, V494, P5; Dolgin E, 2014, NAT MED, V20, P796, DOI 10.1038/nm0814-796; Eichler HG, 2012, CLIN PHARMACOL THER, V91, P426, DOI 10.1038/clpt.2011.345; European Medicines Agency, AD PATHW; Food and Drug Administration, ACC APPR; Hara A, 2014, THER INNOV REGUL SCI, V48, P681, DOI 10.1177/2168479014526877; MHLW, 2014, REP PAT REG SYST REG; PMDA, SUMM PMDAS MIDT PLAN; Reardon S, 2014, NATURE, V513, P287, DOI 10.1038/513287a	9	80	83	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					350	355		10.1016/j.stem.2015.03.012	http://dx.doi.org/10.1016/j.stem.2015.03.012			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25842974	Bronze			2022-12-28	WOS:000352228600006
J	Sipp, D				Sipp, Douglas			Conditional Approval: Japan Lowers the Bar for Regenerative Medicine Products	CELL STEM CELL			English	Editorial Material							DRUGS	A new system for conditional approval of regenerative medicine products will allow products of undetermined efficacy to enter the Japanese market. The potential scientific, economic, and ethical implications of this program highlight the need for further discussion and refinement.	RIKEN Ctr Dev Biol, Minamimachi Chuo Ku, Kobe, Hyogo, Japan	RIKEN	Sipp, D (corresponding author), RIKEN Ctr Dev Biol, Minamimachi Chuo Ku, 2-2-3 Minatojima, Kobe, Hyogo, Japan.	sipp@cdb.riken.jp	Sipp, Doug/C-9218-2017	Sipp, Doug/0000-0002-5979-0938				Bianco P, 2014, NATURE, V510, P336, DOI 10.1038/510336a; Dlouhy BJ, 2014, J NEUROSURG-SPINE, V21, P618, DOI 10.3171/2014.5.SPINE13992; Food and Drug Administration (FDA), JUST EST APPR COMM; FUKUSHIMA M, 1989, NATURE, V342, P850, DOI 10.1038/342850a0; Hashimoto Y., 2014, REGENERATIVE MED TRE; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Japanese Society for Regenerative Medicine (JSRM), DECL; Japanese Society for Regenerative Medicine (JSRM), CALL REG MED REG REF; Japanese Society for Regenerative Medicine (JSRM), YOK DECL; Konomi K, 2015, CELL STEM CELL, V16, P350, DOI 10.1016/j.stem.2015.03.012; Oh Il-Hoan, 2012, Korean J Hematol, V47, P87, DOI 10.5045/kjh.2012.47.2.87; Sakagami H., 2013, LIGHT DARK REGENERAT; Thomas L.G., 2001, JAPANESE PHARM IND N; Umemura Maki, 2011, JAPANESE PHARM IND I	14	45	45	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					353	356		10.1016/j.stem.2015.03.013	http://dx.doi.org/10.1016/j.stem.2015.03.013			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25842975	Bronze			2022-12-28	WOS:000352228600007
J	Wen, L; Tang, FC				Wen, Lu; Tang, Fuchou			Charting a Map through the Cellular Reprogramming Landscape	CELL STEM CELL			English	Editorial Material								Analysis of the molecular mechanisms underlying somatic cell reprogramming into iPSCs is hampered by low efficiency of conversion and resulting cellular heterogeneity. In this issue of Cell Stem Cell, Zunder et al. (2015) utilize mass cytometry to perform high-throughput, single-cell analyses and provide a detailed molecular roadmap of the reprogramming process.	[Wen, Lu; Tang, Fuchou] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China	Peking University	Wen, L (corresponding author), Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China.	wenlu.wl@gmail.com; tangfuchou@pku.edu.cn						Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Hoppe PS, 2014, NAT CELL BIOL, V16, P919, DOI 10.1038/ncb3042; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Radzisheuskaya A, 2014, TRENDS CELL BIOL, V24, P275, DOI 10.1016/j.tcb.2013.11.010; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Wen L, 2014, CELL, V157, P771, DOI 10.1016/j.cell.2014.04.024; Xu J, 2015, CELL STEM CELL, V16, P119, DOI 10.1016/j.stem.2015.01.013; Zunder ER, 2015, CELL STEM CELL, V16, P323, DOI 10.1016/j.stem.2015.01.015	10	3	3	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					215	216		10.1016/j.stem.2015.02.010	http://dx.doi.org/10.1016/j.stem.2015.02.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25748926	Bronze			2022-12-28	WOS:000350747700002
J	Pardo-Saganta, A; Law, BM; Tata, PR; Villoria, J; Saez, B; Mou, HM; Zhao, R; Rajagopal, J				Pardo-Saganta, Ana; Law, Brandon M.; Tata, Purushothama Rao; Villoria, Jorge; Saez, Borja; Mou, Hongmei; Zhao, Rui; Rajagopal, Jayaraj			Injury Induces Direct Lineage Segregation of Functionally Distinct Airway Basal Stem/Progenitor Cell Subpopulations	CELL STEM CELL			English	Article							STEM-CELLS; IN-VIVO; CILIATED CELLS; EPITHELIAL-CELLS; LUNG DEVELOPMENT; MIND BOMB-1; NOTCH; REPAIR; DIFFERENTIATION; REGENERATION	Following injury, stem cells restore normal tissue architecture by producing the proper number and proportions of differentiated cells. Current models of airway epithelial regeneration propose that distinct cytokeratin 8-expressing progenitor cells, arising from p63(+) basal stem cells, subsequently differentiate into secretory and ciliated cell lineages. We now show that immediately following injury, discrete subpopulations of p63(+) airway basal stem/progenitor cells themselves express Notch pathway components associated with either secretory or ciliated cell fate commitment. One basal cell population displays intracellular Notch2 activation and directly generates secretory cells; the other expresses c-myb and directly yields ciliated cells. Furthermore, disrupting Notch ligand activity within the basal cell population at large disrupts the normal pattern of lineage segregation. These non-cell-autonomous effects demonstrate that effective airway epithelial regeneration requires intercellular communication within the broader basal stem/progenitor cell population. These findings have broad implications for understanding epithelial regeneration and stem cell heterogeneity.	[Pardo-Saganta, Ana; Law, Brandon M.; Tata, Purushothama Rao; Villoria, Jorge; Saez, Borja; Mou, Hongmei; Zhao, Rui; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Pardo-Saganta, Ana; Law, Brandon M.; Tata, Purushothama Rao; Villoria, Jorge; Mou, Hongmei; Zhao, Rui; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Dept Internal Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Pardo-Saganta, Ana; Law, Brandon M.; Tata, Purushothama Rao; Villoria, Jorge; Mou, Hongmei; Zhao, Rui; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Dept Pediat, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Pardo-Saganta, Ana; Law, Brandon M.; Tata, Purushothama Rao; Villoria, Jorge; Saez, Borja; Mou, Hongmei; Zhao, Rui; Rajagopal, Jayaraj] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Rajagopal, J (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	jrajagopal@mgh.harvard.edu	; Saez, Borja/L-7411-2015	Tata, Purushothama Rao/0000-0003-4837-0337; Pardo-Saganta, Ana/0000-0002-5926-6255; Saez, Borja/0000-0001-7908-7089	New York Stem Cell Foundation; NIH-NHLBI Early Career Research New Faculty (P30) award [5P30HL101287-02]; NIH/NHLBI [R01HL118185]; Harvard Stem Cell Institute Junior Investigator Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118185, R01HL116756, P30HL101287] Funding Source: NIH RePORTER	New York Stem Cell Foundation; NIH-NHLBI Early Career Research New Faculty (P30) award; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Harvard Stem Cell Institute Junior Investigator Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Adam Glick for providing the CK5rtTA mice, Brigid Hogan for providing Mib1 floxed mice (originally from Young-Yun Kong who kindly offered to share the mice), and Ben Z. Stanger for providing the RBPJk floxed mice. We also thank Barry Stripp for providing the goat anti-SCGB1A1 antibody and Joseph Pearlberg for providing the lentiviral donor vectors. We wish to extend our thanks to all of the members of the Rajagopal Laboratory for their constructive criticisms and comments and for valuable discussion and support. This research was supported by the New York Stem Cell Foundation (J.R. is a New York Stem Cell Foundation-Robertson Investigator), by an NIH-NHLBI Early Career Research New Faculty (P30) award (5P30HL101287-02), an R01 (R01HL118185) from NIH/NHLBI (to J.R.), and a Harvard Stem Cell Institute Junior Investigator Grant (to J.R.).	Deblandre GA, 1999, DEVELOPMENT, V126, P4715; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Dubaissi E, 2014, DEVELOPMENT, V141, P1514, DOI 10.1242/dev.102426; Dubaissi E, 2011, DIS MODEL MECH, V4, P179, DOI 10.1242/dmm.006494; Ghosh M, 2013, STEM CELLS, V31, P2767, DOI 10.1002/stem.1440; Ghosh M, 2013, AM J RESP CELL MOL, V49, P1127, DOI 10.1165/rcmb.2013-0049OC; Ghosh M, 2011, AM J RESP CELL MOL, V45, P403, DOI 10.1165/rcmb.2010-0283OC; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Kauffman S L, 1980, Int Rev Exp Pathol, V22, P131; Kim JK, 2012, AM J RESP CELL MOL, V47, P864, DOI 10.1165/rcmb.2012-0164OC; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Morimoto M, 2012, DEVELOPMENT, V139, P4365, DOI 10.1242/dev.083840; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Musah S, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-107; Pan JH, 2014, STEM CELLS, V32, P3245, DOI 10.1002/stem.1814; Pardo-Saganta A, 2013, AM J RESP CELL MOL, V48, P364, DOI 10.1165/rcmb.2012-0146OC; Pattabiraman DR, 2013, LEUKEMIA, V27, P269, DOI 10.1038/leu.2012.225; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Tadokoro T, 2014, P NATL ACAD SCI USA, V111, pE3641, DOI 10.1073/pnas.1409781111; Tan FE, 2013, DEVELOPMENT, V140, P4277, DOI 10.1242/dev.094102; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tata PR, 2013, AM J RESP CELL MOL, V49, P1048, DOI 10.1165/rcmb.2012-0412OC; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Teixeira VH, 2013, ELIFE, V2, DOI 10.7554/eLife.00966; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Zhao R, 2014, DEV CELL, V30, P151, DOI 10.1016/j.devcel.2014.06.004	33	120	124	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					184	197		10.1016/j.stem.2015.01.002	http://dx.doi.org/10.1016/j.stem.2015.01.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25658372	Green Accepted, Bronze			2022-12-28	WOS:000349455000014
J	Goldberg, EM; Coulter, DA				Goldberg, Ethan M.; Coulter, Douglas A.			Seizing the Opportunity: Stem Cells Take On Epilepsy	CELL STEM CELL			English	Editorial Material							TEMPORAL-LOBE EPILEPSY; INTERNEURONS; THERAPY	Stem cells represent a promising source of neurons for the potential treatment of a host of neurological conditions, including epilepsy. In this issue of Cell Stem Cell, Cunningham et al. (2014) use cortical GABAergic interneuron progenitors derived from human embryonic stem cells to treat chronic temporal lobe epilepsy in a mouse model.	[Goldberg, Ethan M.; Coulter, Douglas A.] Univ Penn, Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19083 USA; [Goldberg, Ethan M.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19083 USA; [Coulter, Douglas A.] Univ Penn, Perelman Sch Med, Dept Pediat & Neurosci, Philadelphia, PA 19083 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Coulter, DA (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19083 USA.	coulterd@email.chop.edu		Goldberg, Ethan/0000-0002-7404-735X; Coulter, Douglas/0000-0002-1486-119X				Cunningham M, 2014, CELL STEM CELL, V15, P559, DOI 10.1016/j.stem.2014.10.006; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Loscher W, 2008, TRENDS NEUROSCI, V31, P62, DOI 10.1016/j.tins.2007.11.012; Maisano X, 2012, J NEUROSCI, V32, P46, DOI 10.1523/JNEUROSCI.2683-11.2012; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Sebe JY, 2011, DEV NEUROBIOL, V71, P107, DOI 10.1002/dneu.20813; Shetty AK, 2011, NEUROTHERAPEUTICS, V8, P721, DOI 10.1007/s13311-011-0064-y; Southwell DG, 2014, SCIENCE, V344, P167, DOI 10.1126/science.1240622; Tyson JA, 2014, TRENDS NEUROSCI, V37, P169, DOI 10.1016/j.tins.2014.01.003	10	6	6	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					527	528		10.1016/j.stem.2014.10.017	http://dx.doi.org/10.1016/j.stem.2014.10.017			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517456	Bronze			2022-12-28	WOS:000345012700001
J	Fang, RG; Liu, K; Zhao, Y; Li, HB; Zhu, DC; Du, YY; Xiang, CG; Li, X; Liu, HS; Miao, ZC; Zhang, X; Shi, Y; Yang, WF; Xu, J; Deng, HK				Fang, Riguo; Liu, Kang; Zhao, Yang; Li, Haibo; Zhu, Dicong; Du, Yuanyuan; Xiang, Chengang; Li, Xiang; Liu, Haisong; Miao, Zhenchuan; Zhang, Xing; Shi, Yan; Yang, Weifeng; Xu, Jun; Deng, Hongkui			Generation of Naive Induced Pluripotent Stem Cells from Rhesus Monkey Fibroblasts	CELL STEM CELL			English	Article							MAINTAINS PLURIPOTENCY; TRANSCRIPTION FACTOR; GROUND-STATE; DERIVATION; PATHWAYS; INDUCTION; NANOG; LINES	Conventional embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) derived from primates resemble mouse epiblast stem cells, raising an intriguing question regarding whether the naive pluripotent state resembling mouse embryonic stem cells (mESCs) exists in primates and how to capture it in vitro. Here we identified several specific signaling modulators that are sufficient to generate rhesus monkey fibroblast-derived iPSCs with the features of naive pluripotency in terms of growth properties, gene expression profiles, self-renewal signaling, X-reactivation, and the potential to generate cross-species chimeric embryos. Interestingly, together with recent reports of naive human pluripotent stem cells, our findings suggest several conserved signaling pathways shared with rodents and specific to primates, providing significant in-sights for acquiring naive pluripotency from other species. In addition, the derivation of rhesus monkey naive iPSCs also provides a valuable cell source for use in preclinical research and disease modeling.	[Fang, Riguo; Liu, Kang; Zhao, Yang; Du, Yuanyuan; Xiang, Chengang; Li, Xiang; Zhang, Xing; Shi, Yan; Xu, Jun; Deng, Hongkui] Peking Univ, Peking Tsinghua Ctr Life Sci, Coll Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Fang, Riguo; Liu, Kang; Zhao, Yang; Li, Haibo; Zhu, Dicong; Du, Yuanyuan; Xiang, Chengang; Li, Xiang; Liu, Haisong; Zhang, Xing; Xu, Jun; Deng, Hongkui] Peking Univ, Hlth Sci Ctr, Stem Cell Res Ctr, Dept Cell Biol,Sch Basic Med Sci, Beijing 100191, Peoples R China; [Zhu, Dicong; Liu, Haisong; Shi, Yan; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Genom, Shenzhen Stem Cell Engn Lab, Shenzhen 518055, Peoples R China; [Miao, Zhenchuan; Yang, Weifeng] Beijing Vitalstar Biotechnol, Beijing 100012, Peoples R China	Peking University; Peking University; Peking University; University Town of Shenzhen	Xu, J (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Coll Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China.	jun_xu@pku.edu.cn; hongkui_deng@pku.edu.cn	Zhu, Dicong/P-6990-2019; kang, liu/ABB-8964-2020	Zhu, Dicong/0000-0001-9834-2436; liu, Haisong/0000-0002-7645-0855; xiang, chen gang/0000-0001-8630-6446	National Basic Research Program of China (973 Program) [2012CB966401]; National Natural Science Foundation of China [91310305]; National Science and Technology Major Project [2013ZX10001003]; Ministry of Science and Technology [2013DFG30680]; Ministry of Education of China (111 Project)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education of China (111 Project)	We thank H.X. Lv, M. Lai, and J. Zhao for confocal imaging assistance, C. Han and Y. Li for mouse embryo injection assistance, and S.J. Zhang and C.Y Li for RNA-seq analysis assistance. This work was supported by the National Basic Research Program of China (973 Program 2012CB966401), the National Natural Science Foundation of China (91310305), the National Science and Technology Major Project (2013ZX10001003), the Ministry of Science and Technology (2013DFG30680), and the Ministry of Education of China (111 Project).	BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Grabole N, 2013, EMBO REP, V14, P629, DOI 10.1038/embor.2013.67; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hassani SN, 2014, STEM CELL REV REP, V10, P16, DOI 10.1007/s12015-013-9473-0; Hassani SN, 2012, STEM CELL REV REP, V8, P472, DOI 10.1007/s12015-011-9306-y; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smagghe BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058601; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen T.W., 2014, CELL STEM CELL; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	37	83	95	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					488	496		10.1016/j.stem.2014.09.004	http://dx.doi.org/10.1016/j.stem.2014.09.004			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25280221	Bronze			2022-12-28	WOS:000343235800014
J	Rashid, T; Kobayashi, T; Nakauchi, H				Rashid, Tamir; Kobayashi, Toshihiro; Nakauchi, Hiromitsu			Revisiting the Flight of Icarus: Making Human Organs from PSCs with Large Animal Chimeras	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; BLASTOCYST COMPLEMENTATION; GENERATION; PANCREAS	While cell therapies hold great potential for treating many conditions, their utility for treating patients that require whole organ replacement is unclear. To address this challenge, we propose using genetically engineered "organ niches" in large animals to generate human organs from pluripotent stem cells and discuss the hurdles facing such strategies.	[Rashid, Tamir; Nakauchi, Hiromitsu] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Kobayashi, Toshihiro] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Rashid, Tamir] Kings Coll London, Ctr Stem Cells & Regenerat Med, London SE1 9RT, England; [Rashid, Tamir] Kings Coll London, Inst Liver Studies, London SE1 9RT, England; [Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy, Tokyo 1080071, Japan; [Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Tokyo 1088639, Japan	Stanford University; University of Cambridge; University of London; King's College London; University of London; King's College London; University of Tokyo; Japan Science & Technology Agency (JST)	Nakauchi, H (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	nakauchi@stanford.edu		Kobayashi, Toshihiro/0000-0001-8019-0008	Medical Research Council [MR/L006537/1] Funding Source: Medline; MRC [MR/L006537/1] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL7-Rashid] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))		CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Isotani A, 2011, GENES CELLS, V16, P397, DOI 10.1111/j.1365-2443.2011.01495.x; Kobayashi T., 2014, STEM CELLS IN PRESS; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Sumazaki R, 2004, NAT GENET, V36, P83, DOI 10.1038/ng1273; Usui JI, 2012, AM J PATHOL, V180, P2417, DOI 10.1016/j.ajpath.2012.03.007	10	80	89	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					406	409		10.1016/j.stem.2014.09.013	http://dx.doi.org/10.1016/j.stem.2014.09.013			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25280216	Bronze			2022-12-28	WOS:000343235800007
J	Buttitta, L; Lee, CY				Buttitta, Laura; Lee, Cheng-Yu			Ch-Ch-Changes: Hormones Link Stem Cell Differentiation with Metabolic Flux	CELL STEM CELL			English	Editorial Material							DROSOPHILA; PROLIFERATION; ECDYSONE	Emerging evidence strongly suggests that stem cells and their differentiated progeny display distinct metabolic profiles, but how metabolic changes are coupled with organogenesis has remained unclear. Homem et al. (2014) now reveal a hormone-dependent pathway that couples metabolic changes with stem cell differentiation, thereby terminating neurogenesis in the Drosophila brain.	[Buttitta, Laura] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Lee, Cheng-Yu] Univ Michigan, Sch Med, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Lee, Cheng-Yu] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Lee, Cheng-Yu] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Buttitta, L (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	buttitta@umich.edu; leecheng@umich.edu		Buttitta, Laura/0000-0002-5064-0650				Agathocleous M, 2012, NAT CELL BIOL, V14, P859, DOI 10.1038/ncb2531; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Homem CCF, 2014, CELL, V158, P874, DOI 10.1016/j.cell.2014.06.024; Icreverzi A, 2012, CELL CYCLE, V11, P554, DOI 10.4161/cc.11.3.19062; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Nagaraj R, 2012, GENE DEV, V26, P2027, DOI 10.1101/gad.183061.111; Siegrist SE, 2010, CURR BIOL, V20, P643, DOI 10.1016/j.cub.2010.01.060; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608	9	0	0	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					262	264		10.1016/j.stem.2014.08.006	http://dx.doi.org/10.1016/j.stem.2014.08.006			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25192460	Bronze			2022-12-28	WOS:000341441600005
J	Hara, K; Nakagawa, T; Enomoto, H; Suzuki, M; Yamamoto, M; Simons, BD; Yoshida, S				Hara, Kenshiro; Nakagawa, Toshinori; Enomoto, Hideki; Suzuki, Mikiko; Yamamoto, Masayuki; Simons, Benjamin D.; Yoshida, Shosei			Mouse Spermatogenic Stem Cells Continually Interconvert between Equipotent Singly Isolated and Syncytial States	CELL STEM CELL			English	Article							UNDIFFERENTIATED SPERMATOGONIA; NICHE; IDENTIFICATION; MECHANISMS; RENEWAL; PROTEIN	The identity and behavior of mouse spermatogenic stem cells have been a long-standing focus of interest. In the prevailing "A(s) model,'' stem cell function is restricted to singly isolated (As) spermatogonia. By examining single-cell dynamics of GFR alpha 1+ stem cells in vivo, we evaluate an alternative hypothesis that, through fragmentation, syncytial spermatogonia also contribute to stem cell function in homeostasis. We use live imaging and pulse labeling to quantitatively determine the fates of individual GFR alpha 1+ cells and find that, during steady-state spermatogenesis, the entire GFR alpha 1+ population comprises a single stem cell pool, in which cells continually interconvert between As and syncytial states. A minimal biophysical model, relying only on the rates of incomplete cell division and syncytial fragmentation, precisely predicts the stochastic fates of GFR alpha 1+ cells during steady state and post-insult regeneration. Thus, our results define an alternative and dynamic model for spermatogenic stem cell function in the mouse testis.	[Hara, Kenshiro; Yoshida, Shosei] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Germ Cell Biol, Okazaki, Aichi 4448787, Japan; [Hara, Kenshiro; Yoshida, Shosei] Grad Univ Adv Studies Sokendai, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448787, Japan; [Nakagawa, Toshinori] Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Sakyo Ku, Kyoto 6068507, Japan; [Enomoto, Hideki] Kobe Univ, Grad Sch Med, Div Neural Differentiat & Regenerat, Dept Physiol & Cell Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Enomoto, Hideki] RIKEN Ctr Dev Biol, Lab Neuronal Differentiat & Regenerat, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Suzuki, Mikiko; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Simons, Benjamin D.] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge CB3 0HE, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Kyoto University; Kobe University; RIKEN; Tohoku University; University of Cambridge; University of Cambridge; University of Cambridge	Simons, BD (corresponding author), Univ Cambridge, Dept Phys, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	bds10@cam.ac.uk; shosei@nibb.ac.jp	Simons, Benjamin/AAY-8920-2020; Yamamoto, Masayuki/A-4873-2010	Simons, Benjamin/0000-0002-3875-7071; Yamamoto, Masayuki/0000-0002-9073-9436; Yoshida, Shosei/0000-0001-8861-1866; Nakagawa, Toshinori/0000-0001-7620-1720	KAKENHI [20116004, 24247041, 25114004, 22780267]; Wellcome Trust [098357/Z/12/Z]; National Institutes of Natural Sciences International Exchange Program; Grants-in-Aid for Scientific Research [20116004] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Natural Sciences International Exchange Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Milbrandt for providing GFR alpha 1-EGFP and GFR alpha 1-CreER<SUP>T2</SUP> mice and J.-I. Miyazaki for providing CAG-CAT-EGFP mice. We are grateful to R. Sugimoto and K. Inada for technical instruction and assistance. We are grateful to K. Hara-Harikae, K. Ikami, Y. Kitadate, A. M. Klein, H. Mizuguchi, T. Nagasawa, Y. Nakamura, T. Ogawa, A. Philpott, M. Tokue, and E. Watanabe for useful discussions and encouragement and Y. Kuboki for secretarial assistance. We thank members of the Model Animal Research Facility of the National Institute for Basic Biology Bioresource Center for animal care. This work was partly supported by a Grant-in-Aid for Scientific Research (KAKENHI; 20116004, 24247041, and 25114004 to S. Y. and 22780267 to K. H.), Wellcome Trust (098357/Z/12/Z to B. D. S.), and the National Institutes of Natural Sciences International Exchange Program (to S. Y. and K.H.).	Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; De Rooij DG, 2000, J ANDROL, V21, P776; ERICKSON BH, 1981, RADIAT RES, V86, P34, DOI 10.2307/3575597; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Hermann BP, 2010, REPRODUCTION, V139, P479, DOI 10.1530/REP-09-0255; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; HUCKINS C, 1971, ANAT REC, V169, P533, DOI 10.1002/ar.1091690306; HUCKINS C, 1978, ANAT REC, V192, P519, DOI 10.1002/ar.1091920406; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Lin HF, 1997, DEVELOPMENT, V124, P2463; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sheng XR, 2011, DEVELOPMENT, V138, P3367, DOI 10.1242/dev.065797; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Spradling A, 2010, CELL STEM CELL, V6, P405, DOI 10.1016/j.stem.2010.04.012; Stine RR, 2013, TRENDS CELL BIOL, V23, P357, DOI 10.1016/j.tcb.2013.03.001; Suzuki H, 2009, DEV BIOL, V336, P222, DOI 10.1016/j.ydbio.2009.10.002; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Uesaka T, 2007, DEVELOPMENT, V134, P2171, DOI 10.1242/dev.001388; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Yoshida S, 2012, REPRODUCTION, V144, P293, DOI 10.1530/REP-11-0320; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38	34	184	187	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					658	672		10.1016/j.stem.2014.01.019	http://dx.doi.org/10.1016/j.stem.2014.01.019			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24792118	Green Published, hybrid			2022-12-28	WOS:000335659900014
J	Todaro, M; Gaggianesi, M; Catalano, V; Benfante, A; Iovino, F; Biffoni, M; Apuzzo, T; Sperduti, I; Volpe, S; Cocorullo, G; Gulotta, G; Dieli, F; De Maria, R; Stassi, G				Todaro, Matilde; Gaggianesi, Miriam; Catalano, Veronica; Benfante, Antonina; Iovino, Flora; Biffoni, Mauro; Apuzzo, Tiziana; Sperduti, Isabella; Volpe, Silvia; Cocorullo, Gianfranco; Gulotta, Gaspare; Dieli, Francesco; De Maria, Ruggero; Stassi, Giorgio			CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis	CELL STEM CELL			English	Article							COLORECTAL-CANCER; TUMOR-GROWTH; IDENTIFICATION; EXPRESSION; OSTEOPONTIN; RECEPTORS; GENE	Cancer stem cells drive tumor formation and metastasis, but how they acquire metastatic traits is not well understood. Here, we show that all colorectal cancer stem cells (CR-CSCs) express CD44v6, which is required for their migration and generation of metastatic tumors. CD44v6 expression is low in primary tumors but demarcated clonogenic CR-CSC populations. Cytokines hepatocyte growth factor (HGF), osteopontin (OPN), and stromal-derived factor 1 alpha (SDF-1), secreted from tumor associated cells, increase CD44v6 expression in CR-CSCs by activating the Wnt/beta-catenin pathway, which promotes migration and metastasis. CD44v6(-) progenitor cells do not give rise to metastatic lesions but, when treated with cytokines, acquire CD44v6 expression and metastatic capacity. Importantly, phosphatidylinositol 3-kinase (PI3K) inhibition selectively killed CD44v6 CR-CSCs and reduced metastatic growth. In patient cohorts, low levels of CD44v6 predict increased probability of survival. Thus, the metastatic process in colorectal cancer is initiated by CSCs through the expression of CD44v6, which is both a functional biomarker and therapeutic target.	[Todaro, Matilde; Gaggianesi, Miriam; Catalano, Veronica; Benfante, Antonina; Iovino, Flora; Apuzzo, Tiziana; Volpe, Silvia; Cocorullo, Gianfranco; Gulotta, Gaspare; Stassi, Giorgio] Univ Palermo, I-90127 Palermo, Italy; [Biffoni, Mauro] Ist Super Sanita, Dept Hematol & Oncol, I-00161 Rome, Italy; [Sperduti, Isabella; De Maria, Ruggero] Regina Elena Inst Canc Res, I-00144 Rome, Italy; [Dieli, Francesco] Univ Palermo, I-90134 Palermo, Italy; [Todaro, Matilde; Catalano, Veronica; Benfante, Antonina; Apuzzo, Tiziana; Dieli, Francesco] Univ Palermo, Cent Lab Adv Diag & Biomed Res CLADIBIOR, I-90127 Palermo, Italy	University of Palermo; Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Palermo; University of Palermo	De Maria, R (corresponding author), Regina Elena Inst Canc Res, I-00144 Rome, Italy.	demaria@ifo.it; giorgio.stassi@unipa.it	Iovino, Flora/K-8834-2016; apuzzo, tiziana/K-3395-2018; De Maria, Ruggero/S-6385-2019; Sperduti, Isabella/K-8902-2016; Biffoni, Mauro/J-8318-2016; Stassi, Giorgio/AAC-1175-2022; todaro, matilde/AAC-1003-2022; Cocorullo, Gianfranco/L-3744-2016	Iovino, Flora/0000-0002-6374-5582; apuzzo, tiziana/0000-0002-2852-5461; De Maria, Ruggero/0000-0003-2255-0583; Sperduti, Isabella/0000-0001-5115-3099; Biffoni, Mauro/0000-0002-1304-9060; todaro, matilde/0000-0001-8686-8043; Dieli, Francesco/0000-0002-6685-352X; Gulotta, Gaspare/0000-0001-8683-6623; GAGGIANESI, Miriam/0000-0002-7810-856X; Cocorullo, Gianfranco/0000-0003-2660-6724	AIRC [5x1000 (9979)]; FIRC	AIRC(Fondazione AIRC per la ricerca sul cancro); FIRC(Fondazione AIRC per la ricerca sul cancro)	We thank Francesco Calo for graphic images help, Alessandro Gorgone and Giovanni Tomaselli for technical assistance, and Alessandro Scopelliti for immunohistochemical analyses and critical comments. This work was funded by AIRC 5x1000 (9979) to G. S. and R. D. M. M. G. is a FIRC fellowship recipient.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Cantor H, 2009, NAT REV IMMUNOL, V9, P137, DOI 10.1038/nri2460; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Fan CW, 2012, HEPATO-GASTROENTEROL, V59, P1421, DOI 10.5754/hge10727; Ghiso E, 2013, CURR OPIN PHARMACOL, V13, P511, DOI 10.1016/j.coph.2013.05.018; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Leedham SJ, 2013, GUT, V62, P83, DOI 10.1136/gutjnl-2011-301601; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Minoo P, 2010, INT J ONCOL, V37, P707, DOI 10.3892/ijo_00000720; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Peng J, 2008, CANCER J, V14, P54, DOI 10.1097/PPO.0b013e3181629a67; Pries R, 2008, IN VIVO, V22, P89; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ricci-Vitiani L, 2010, FASEB J, V24, P4291, DOI 10.1096/fj.10-159970; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Saito S, 2013, ONCOL REP, V29, P1570, DOI 10.3892/or.2013.2273; Schimanski CC, 2005, CLIN CANCER RES, V11, P1743, DOI 10.1158/1078-0432.CCR-04-1195; Takeuchi H, 2003, CLIN CANCER RES, V9, P1480; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; TOLG C, 1993, NUCLEIC ACIDS RES, V21, P1225, DOI 10.1093/nar/21.5.1225; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wielenga VJM, 2000, ADV CANCER RES, V77, P169; Zeilstra J, 2014, ONCOGENE, V33, P665, DOI 10.1038/onc.2012.611; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	48	505	521	2	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					342	356		10.1016/j.stem.2014.01.009	http://dx.doi.org/10.1016/j.stem.2014.01.009			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24607406	Bronze			2022-12-28	WOS:000332533400011
J	Brennand, KJ				Brennand, Kristen J.			Inducing Cellular Aging: Enabling Neurodegeneration-in-a-Dish	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS		[Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Brennand, KJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, 1425 Madison Ave, New York, NY 10029 USA.	kristen.brennand@mssm.edu	Brennand, Kristen J/U-5470-2019; Brennand, Kristen J/J-8704-2012	Brennand, Kristen J/0000-0003-0993-5956	NIMH NIH HHS [R01 MH101454] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101454] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Byers B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026159; Chung C.Y., 2013, SCIENCE IN PRESS; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529	10	8	9	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					635	636		10.1016/j.stem.2013.11.017	http://dx.doi.org/10.1016/j.stem.2013.11.017			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24315433	Bronze, Green Accepted			2022-12-28	WOS:000329571700001
J	Zismanov, V; Chichkov, V; Colangelo, V; Jamet, S; Wang, S; Syme, A; Koromilas, AE; Crist, C				Zismanov, Victoria; Chichkov, Victor; Colangelo, Veronica; Jamet, Solene; Wang, Shuo; Syme, Alasdair; Koromilas, Antonis E.; Crist, Colin			Phosphorylation of eIF2 alpha Is a Translational Control Mechanism Regulating Muscle Stem Cell Quiescence and Self-Renewal	CELL STEM CELL			English	Article							MESSENGER-RNA TRANSLATION; UNFOLDED PROTEIN RESPONSE; SATELLITE CELLS; STRESS; EXPANSION; INJURY; PAX7	Regeneration of adult tissues depends on somatic stem cells that remain quiescent yet are primed to enter a differentiation program. The molecular pathways that prevent activation of these cells are not well understood. Using mouse skeletal muscle stem cells as a model, we show that a general repression of translation, mediated by the phosphorylation of translation initiation factor eIF2 alpha at serine 51 (P-eIF2 alpha), is required to maintain the quiescent state. Skeletal muscle stem cells unable to phosphorylate eIF2 alpha exit quiescence, activate the myogenic program, and differentiate, but do not self-renew. P-eIF2 alpha ensures in part the robust translational silencing of accumulating mRNAs that is needed to prevent the activation of muscle stem cells. Additionally, P-eIF2 alpha-dependent translation of mRNAs regulated by upstream open reading frames (uORFs) contributes to the molecular signature of stemness. Pharmacological inhibition of eIF2 alpha dephosphorylation enhances skeletal muscle stem cell self-renewal and regenerative capacity.	[Zismanov, Victoria; Chichkov, Victor; Colangelo, Veronica; Jamet, Solene; Wang, Shuo; Syme, Alasdair; Koromilas, Antonis E.; Crist, Colin] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Zismanov, Victoria; Chichkov, Victor; Colangelo, Veronica; Crist, Colin] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Colangelo, Veronica] Univ Milano Bicocca, Dept Hlth Sci, I-20900 Monza, Italy; [Syme, Alasdair; Koromilas, Antonis E.] McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada	Lady Davis Institute; McGill University; McGill University; University of Milano-Bicocca; McGill University	Crist, C (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.; Crist, C (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada.	colin.crist@mcgill.ca			Canadian Institute for Health Research [CIHR 286519]; Stem Cell Network; Muscular Dystrophy Association [351259]; CIHR [38160]; Canadian Cancer Society Research Institute [700886]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Stem Cell Network; Muscular Dystrophy Association(Muscular Dystrophy Association); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	We thank J. Chung for technical help, C. Young for providing assistance with flow cytometry, and A. Mouland for assistance with polysome fractionation. R. Kaufman and D. Cavener generously provided eIF2 alpha<SUP>S51A/S51A</SUP>; tg(actb-eIF2 alpha<SUP>fl</SUP>-GFP) and Perk<SUP>fl/fl</SUP> mice, respectively. C. C. and co-workers are funded by the Canadian Institute for Health Research (CIHR 286519), the Stem Cell Network, and the Muscular Dystrophy Association (351259). A.E.K. is supported by the CIHR (38160) and the Canadian Cancer Society Research Institute (700886).	Alter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029498; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; COUTEAUX R, 1988, BIOL CELL, V62, P171, DOI 10.1016/0248-4900(88)90034-2; Crist CG, 2012, CELL STEM CELL, V11, P118, DOI 10.1016/j.stem.2012.03.011; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hausburg MA, 2015, ELIFE, V4, DOI 10.7554/eLife.03390; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Koromilas AE, 2015, BBA-GENE REGUL MECH, V1849, P871, DOI 10.1016/j.bbagrm.2014.12.007; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Matsunawa M, 2014, LEUKEMIA, V28, P1844, DOI 10.1038/leu.2014.73; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Zhang T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8140; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	46	129	129	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					79	90		10.1016/j.stem.2015.09.020	http://dx.doi.org/10.1016/j.stem.2015.09.020			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26549106	Green Submitted, Bronze			2022-12-28	WOS:000372321300014
J	Cai, XW; Gao, L; Teng, L; Ge, JP; Oo, ZM; Kumar, AR; Gilliland, DG; Mason, PJ; Tan, K; Speck, NA				Cai, Xiongwei; Gao, Long; Teng, Li; Ge, Jingping; Oo, Zaw Min; Kumar, Ashish R.; Gilliland, D. Gary; Mason, Philip J.; Tan, Kai; Speck, Nancy A.			Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells	CELL STEM CELL			English	Article							FAMILIAL PLATELET DISORDER; ACUTE MYELOGENOUS LEUKEMIA; STEM/PROGENITOR CELLS; PROTEIN-SYNTHESIS; POINT MUTATIONS; L-LEUCINE; C-MPL; AML1; GENES; HAPLOINSUFFICIENCY	The transcription factor RUNX1 is frequently mutated in myelodysplastic syndrome and leukemia. RUNX1 mutations can be early events, creating preleukemic stem cells that expand in the bone marrow. Here we show, counterintuitively, that Runx1-deficient hematopoietic stem and progenitor cells (HSPCs) have a slow growth, low biosynthetic, small cell phenotype and markedly reduced ribosome biogenesis (Ribi). The reduced Ribi involved decreased levels of rRNA and many mRNAs encoding ribosome proteins. Runx1 appears to directly regulate Ribi; Runx1 is enriched on the promoters of genes encoding ribosome proteins and binds the rDNA repeats. Runx1-deficient HSPCs have lower p53 levels, reduced apoptosis, an attenuated unfolded protein response, and accordingly are resistant to genotoxic and ER stress. The low biosynthetic activity and corresponding stress resistance provides a selective advantage to Runx1-deficient HSPCs, allowing them to expand in the bone marrow and outcompete normal HSPCs.	[Cai, Xiongwei; Oo, Zaw Min; Gilliland, D. Gary; Speck, Nancy A.] Univ Penn, Abramson Family Canc Res Inst, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Cai, Xiongwei; Oo, Zaw Min; Gilliland, D. Gary; Speck, Nancy A.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Gao, Long] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Teng, Li; Tan, Kai] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Ge, Jingping; Mason, Philip J.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Kumar, Ashish R.] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA; [Gilliland, D. Gary] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Gilliland, D. Gary] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Iowa; University of Iowa; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Speck, NA (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Inst Regenerat Med, Philadelphia, PA 19104 USA.	nancyas@exchange.upenn.edu	Kumar, Ashish/GRJ-3967-2022; Kumar, Ashish/GRR-3470-2022	Kumar, Ashish/0000-0002-4476-3494; Gao, Long/0000-0002-2631-6914; Tan, Kai/0000-0002-9104-5567	NIH [R01 CA149976, R01 CA106995, R01 HL111192, R01 HG006130]; Abramson Family Cancer Research Institute; Cancer Center Support Grant [P30 CA016520]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD081054] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA149976, P30CA016520, R01CA106995] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111192] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108716] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Family Cancer Research Institute; Cancer Center Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH R01 CA149976 and the Abramson Family Cancer Research Institute (to N.A.S.), NIH R01 CA106995 (to P.M.), NIH R01 HL111192 (to A.R.K.), and NIH R01 HG006130 (to K.T.) supported this work. Core facilities at the University of Pennsylvania are supported by a Cancer Center Support Grant to the Abramson Cancer Center (P30 CA016520). Technical support was provided by Daniel Marmer of the Diagnostic Immunology Laboratory, Cincinnati Children's Hospital Medical Center.	Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105; Beck D, 2013, BLOOD, V122, pE12, DOI 10.1182/blood-2013-03-490425; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Boultwood Jacqueline, 2013, Advances in Biological Regulation, V53, P8, DOI 10.1016/j.jbior.2012.09.002; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Cai XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028430; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cook M, 2007, CURR OPIN BIOTECH, V18, P341, DOI 10.1016/j.copbio.2007.07.006; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Donati G, 2011, ONCOGENE, V30, P3274, DOI 10.1038/onc.2011.48; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Friedman AD, 2009, J CELL PHYSIOL, V219, P520, DOI 10.1002/jcp.21738; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Ganly P, 2004, LEUKEMIA LYMPHOMA, V45, P1, DOI 10.1080/1042819031000139611; Gao R, 2015, STEM CELLS, V33, P925, DOI 10.1002/stem.1896; Golomb L, 2014, FEBS LETT, V588, P2571, DOI 10.1016/j.febslet.2014.04.014; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Harada H, 2003, BLOOD, V101, P673, DOI 10.1182/blood-2002-04-1010; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heller PG, 2005, BLOOD, V105, P4664, DOI 10.1182/blood-2005-01-0050; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Jacob B, 2010, BLOOD, V115, P1610, DOI 10.1182/blood-2009-07-232249; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Juban G, 2009, MOL CELL BIOL, V29, P2852, DOI 10.1128/MCB.01435-08; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Mangan James K., 2011, Critical Reviews in Oncogenesis, V16, P77; Michaud J, 2002, BLOOD, V99, P1364, DOI 10.1182/blood.V99.4.1364; Motoda L, 2007, STEM CELLS, V25, P2976, DOI 10.1634/stemcells.2007-0061; Pandolfi A, 2013, STEM CELL TRANSL MED, V2, P143, DOI 10.5966/sctm.2012-0109; Payne EM, 2012, BLOOD, V120, P2214, DOI 10.1182/blood-2011-10-382986; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Simonnet AJ, 2009, STEM CELLS, V27, P1400, DOI 10.1002/stem.66; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Sun W, 2004, BLOOD, V104, P3565, DOI 10.1182/blood-2003-12-4349; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Teng T, 2013, CURR OPIN GENET DEV, V23, P63, DOI 10.1016/j.gde.2013.02.001; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Yu M, 2012, MOL CELL, V45, P330, DOI 10.1016/j.molcel.2011.11.032; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326; Zharlyganova D, 2008, J RADIAT RES, V49, P549, DOI 10.1269/jrr.08040	50	127	130	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					165	177		10.1016/j.stem.2015.06.002	http://dx.doi.org/10.1016/j.stem.2015.06.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26165925	Bronze, Green Accepted			2022-12-28	WOS:000361878500008
J	Ito, K; Ito, K				Ito, Kyoko; Ito, Keisuke			Resistance in the Ribosome: RUNX1, pre-LSCs, and HSPCs	CELL STEM CELL			English	Editorial Material								Therapeutic targeting of pre-leukemic stem cells (pre-LSCs) may be a viable strategy to eradicate residual disease and prevent leukemia relapse. Now in Cell Stem Cell, Cai et al. (2015) show that loss-of-function mutations in RUNX1 reduce ribosome biogenesis and provide pre-LSCs a selective advantage over normal hematopoietic cells through increased stress resistance.	[Ito, Kyoko; Ito, Keisuke] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Ito, Keisuke] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Ito, Kyoko; Ito, Keisuke] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Ito, Keisuke] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; [Ito, Keisuke] Albert Einstein Coll Med, Einstein Diabet Res Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Ito, K (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.	keisuke.ito@einstein.yu.edu			NIDDK NIH HHS [R01 DK100689, R01 DK098263] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100689, R01DK098263] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cai X., 2015, CELL STEM CELL, V8, P767; Cai XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028430; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Garcia-Manero G, 2012, AM J HEMATOL, V87, P692, DOI 10.1002/ajh.23264; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Heaney ML, 1999, NEW ENGL J MED, V340, P1649, DOI 10.1056/NEJM199905273402107; Lam K, 2012, FRONT BIOSCI-LANDMRK, V17, P1120, DOI 10.2741/3977; Pandolfi A, 2013, STEM CELL TRANSL MED, V2, P143, DOI 10.5966/sctm.2012-0109; Reschke M, 2013, CELL REP, V4, P1276, DOI 10.1016/j.celrep.2013.08.014; Wang CQ, 2014, CELL REP, V8, P767, DOI 10.1016/j.celrep.2014.06.046	10	0	0	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					129	131		10.1016/j.stem.2015.07.012	http://dx.doi.org/10.1016/j.stem.2015.07.012			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26253196	Green Accepted, Bronze			2022-12-28	WOS:000361878500002
J	Nelson, AM; Reddy, SK; Ratliff, TS; Hossain, MZ; Katseff, AS; Zhu, AS; Chang, E; Resnik, SR; Page, C; Kim, D; Whittam, AJ; Miller, LS; Garza, LA				Nelson, Amanda M.; Reddy, Sashank K.; Ratliff, Tabetha S.; Hossain, M. Zulfiquer; Katseff, Adiya S.; Zhu, Amadeus S.; Chang, Emily; Resnik, Sydney R.; Page, Carly; Kim, Dongwon; Whittam, Alexander J.; Miller, Lloyd S.; Garza, Luis A.			dsRNA Released by Tissue Damage Activates TLR3 to Drive Skin Regeneration	CELL STEM CELL			English	Article							HAIR FOLLICLE NEOGENESIS; EPITHELIAL STEM-CELLS; TOLL-LIKE RECEPTOR-3; SIGNALING PATHWAY; INFLAMMATION; INDUCTION; LIGAND; MICE; RNA	Regeneration of skin and hair follicles after wounding-a process known as wound-induced hair neogenesis (WIHN)-is a rare example of adult organogenesis in mammals. As such, WIHN provides a unique model system for deciphering mechanisms underlying mammalian regeneration. Here, we show that dsRNA, which is released from damaged skin, activates Toll-Like Receptor 3 (TLR3) and its downstream effectors IL-6 and STAT3 to promote hair follicle regeneration. Conversely, TLR3-deficient animals fail to initiate WIHN. TLR3 activation promotes expression of hair follicle stem cell markers and induces elements of the core hair morphogenetic program, including ectodysplasin A receptor (EDAR) and the Wnt and Shh pathways. Our results therefore show that dsRNA and TLR3 link the earliest events of mammalian skin wounding to regeneration and suggest potential therapeutic approaches for promoting hair neogenesis.	[Nelson, Amanda M.; Ratliff, Tabetha S.; Hossain, M. Zulfiquer; Katseff, Adiya S.; Zhu, Amadeus S.; Chang, Emily; Resnik, Sydney R.; Page, Carly; Kim, Dongwon; Whittam, Alexander J.; Miller, Lloyd S.; Garza, Luis A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21231 USA; [Reddy, Sashank K.] Johns Hopkins Univ, Sch Med, Dept Plast Surg, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins University	Garza, LA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21231 USA.	lag@jhmi.edu		Miller, Lloyd/0000-0002-8332-2210; Nelson, Amanda/0000-0001-6375-8706; Katseff, Adiya/0000-0003-1174-8957	National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the NIH [F32AR062932, R01AR064297]; Department of Defense, Armed Forces Institute of Regenerative Medicine, Extremities Regeneration [AFIRM2-ER11]; Northrop Grumman Electronic Systems; Alliance for Veterans Support, Inc. (Veteran/Amputee Skin Regeneration Program Initiative); Thomas Provost, MD Young Faculty Development Fund of Johns Hopkins Dermatology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055666, F32AR062932, R01AR064297] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the NIH; Department of Defense, Armed Forces Institute of Regenerative Medicine, Extremities Regeneration; Northrop Grumman Electronic Systems; Alliance for Veterans Support, Inc. (Veteran/Amputee Skin Regeneration Program Initiative); Thomas Provost, MD Young Faculty Development Fund of Johns Hopkins Dermatology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Conover Talbot Jr. (JHU Microarray Core) for assistance with microarray analysis; Lillian Dasko-Vincent, Cell Imaging Core Facility for assistance with immunocytochemistry analysis; and Dr. Pierre Coulombe and his laboratory for critical discussions. The authors thank Pierre Chambon for use of the K14-Ert2-Cre and K5-Ert2-Cre mouse lines. Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the NIH, under Award Number F32AR062932 to A.M.N. and R01AR064297 to L.A.G. This work was also supported by the Department of Defense, Armed Forces Institute of Regenerative Medicine, Extremities Regeneration (AFIRM2-ER11), Northrop Grumman Electronic Systems, and Alliance for Veterans Support, Inc. (Veteran/Amputee Skin Regeneration Program Initiative), as well as the Thomas Provost, MD Young Faculty Development Fund of Johns Hopkins Dermatology to L.A.G. Johns Hopkins is the owner of a patent application with A.M.N. and L.A.G. as inventors on the use of dsRNA and pathway to promote regeneration and hair follicle neogenesis.	ANDERSON KV, 1985, CELL, V42, P791, DOI 10.1016/0092-8674(85)90275-2; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Blaskovich MA, 2003, CANCER RES, V63, P1270; BREEDIS C, 1954, CANCER RES, V14, P575; Brockes JP, 2001, J ANAT, V199, P3; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Doles J, 2012, GENE DEV, V26, P2144, DOI 10.1101/gad.192294.112; Fan CX, 2011, SKIN RES TECHNOL, V17, P387, DOI 10.1111/j.1600-0846.2011.00508.x; Galun Eithan, 2013, Methods Mol Biol, V982, P59, DOI 10.1007/978-1-62703-308-4_4; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Imokawa Y, 2003, CURR BIOL, V13, P877, DOI 10.1016/S0960-9822(03)00294-X; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jia CK, 2011, EXPERT REV GASTROENT, V5, P105, DOI [10.1586/egh.10.87, 10.1586/EGH.10.87]; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Karim R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017848; KLIGMAN AM, 1956, J INVEST DERMATOL, V27, P19, DOI 10.1038/jid.1956.71; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Lin Q, 2012, J INVEST DERMATOL, V132, P2085, DOI 10.1038/jid.2012.120; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Melkamu T, 2013, J CELL COMMUN SIGNAL, V7, P109, DOI 10.1007/s12079-012-0185-z; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Myung PS, 2013, J INVEST DERMATOL, V133, P31, DOI 10.1038/jid.2012.230; Nelson AM, 2013, J INVEST DERMATOL, V133, P881, DOI 10.1038/jid.2012.398; Sanchez-Alvarado A, 2006, CELL, V124, P241, DOI 10.1016/j.cell.2006.01.012; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Tadeu AMB, 2014, CURR TOP DEV BIOL, V107, P109, DOI 10.1016/B978-0-12-416022-4.00004-4; Takeda K, 1998, J IMMUNOL, V161, P4652; Torok MA, 1999, J EXP ZOOL, V284, P197, DOI 10.1002/(SICI)1097-010X(19990701)284:2<197::AID-JEZ9>3.0.CO;2-F; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Yan CL, 2010, AM J PATHOL, V176, P2247, DOI 10.2353/ajpath.2010.090048	38	106	109	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					139	151		10.1016/j.stem.2015.07.008	http://dx.doi.org/10.1016/j.stem.2015.07.008			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26253200	Green Accepted, Bronze			2022-12-28	WOS:000361878500006
J	Wu, HD; Lee, J; Vincent, LG; Wang, QT; Gu, MX; Lan, F; Churko, JM; Sallam, KI; Matsa, E; Sharma, A; Gold, JD; Engler, AJ; Xiang, YK; Bers, DM; Wu, JC				Wu, Haodi; Lee, Jaecheol; Vincent, Ludovic G.; Wang, Qingtong; Gu, Mingxia; Lan, Feng; Churko, Jared M.; Sallam, Karim I.; Matsa, Elena; Sharma, Arun; Gold, Joseph D.; Engler, Adam J.; Xiang, Yang K.; Bers, Donald M.; Wu, Joseph C.			Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised beta-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELL; HEART-FAILURE; VENTRICULAR MYOCARDIUM; DIFFERENTIATION; RECEPTORS; PROTEIN; MUTATIONS; SURVIVAL; COMPLEX	beta-adrenergic signaling pathways mediate key aspects of cardiac function. Its dysregulation is associated with a range of cardiac diseases, including dilated cardiomyopathy (DCM). Previously, we established an iPSC model of familial DCM from patients with a mutation in TNNT2, a sarcomeric protein. Here, we found that the beta-adrenergic agonist isoproterenol induced mature beta-adrenergic signaling in iPSC-derived cardiomyocytes (iPSC-CMs) but that this pathway was blunted in DCM iPSC-CMs. Although expression levels of several beta-adrenergic signaling components were unaltered between control and DCM iPSC-CMs, we found that phosphodiesterases (PDEs) 2A and PDE3A were upregulated in DCM iPSC-CMs and that PDE2A was also upregulated in DCM patient tissue. We further discovered increased nuclear localization of mutant TNNT2 and epigenetic modifications of PDE genes in both DCM iPSC-CMs and patient tissue. Notably, pharmacologic inhibition of PDE2A and PDE3A restored cAMP levels and ameliorated the impaired beta-adrenergic signaling of DCM iPSC-CMs, suggesting therapeutic potential.	[Wu, Haodi; Lee, Jaecheol; Gu, Mingxia; Lan, Feng; Churko, Jared M.; Sallam, Karim I.; Matsa, Elena; Sharma, Arun; Gold, Joseph D.; Wu, Joseph C.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Wu, Haodi; Lee, Jaecheol; Gu, Mingxia; Lan, Feng; Churko, Jared M.; Sallam, Karim I.; Matsa, Elena; Sharma, Arun; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA 94305 USA; [Wu, Haodi; Lee, Jaecheol; Gu, Mingxia; Lan, Feng; Churko, Jared M.; Sallam, Karim I.; Matsa, Elena; Sharma, Arun; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Vincent, Ludovic G.; Engler, Adam J.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Wang, Qingtong; Xiang, Yang K.; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Engler, Adam J.] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Diego; University of California System; University of California Davis	Wu, JC (corresponding author), Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.	joewu@stanford.edu	Engler, Adam/AAF-4016-2019; WU, HAODI/G-7659-2019; Lan, Feng/I-2023-2012; lee, jaecheol/AAS-3747-2020; Wu, Joseph/H-1067-2013	Engler, Adam/0000-0003-1642-5380; Lan, Feng/0000-0002-9038-4014; lee, jaecheol/0000-0002-2070-7463; Bers, Donald/0000-0002-2237-9483; Wang, Qingtong/0000-0001-8249-6350; Wu, Joseph/0000-0002-6068-8041; Sharma, Arun/0000-0002-0607-5455	American Heart Association [14420025]; NIH [U01 HL099776, R01 HL113006, R01 HL123968, R24 HL117756]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105242, R01HL113006, R01HL123968, R24HL117756, U01HL099776, R01HL030077] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank Andrew Olson from Neuroscience Microscopy Service (NMS) and Jon Mulholland from Cell Sciences Imaging Facility (CSIF) for their help with confocal imaging. We thank Dr. Bhagat Patlolla from the Stanford Cardiovascular Institute for his help with human tissue sampling. We would like to thank Chris Adams and Ryan Leib at the Vincent Coates Foundation Stanford University Mass Spectrometry facility for their assistance in mass spectrometry data collection and analysis. We would like to thank Yonglu Che and Tianying Su for their help with MATLAB programming and data analysis. This work was supported by the American Heart Association Established Investigator Award 14420025 and the NIH U01 HL099776, R01 HL113006, R01 HL123968, and R24 HL117756 (J.C.W.). J.C.W. is a co-founder of Stem Cell Theranostics.	Ahmet I, 2008, J PHARMACOL EXP THER, V325, P491, DOI 10.1124/jpet.107.135335; Asrih M, 2013, CARDIOVASC PATHOL, V22, P117, DOI 10.1016/j.carpath.2012.07.004; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; BRODDE OE, 1991, PHARMACOL REV, V43, P203; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Chaturvedi CP, 2012, P NATL ACAD SCI USA, V109, P18845, DOI 10.1073/pnas.1213951109; Cho MC, 1999, J BIOL CHEM, V274, P22251, DOI 10.1074/jbc.274.32.22251; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; DELMONTE F, 1993, CIRCULATION, V88, P854, DOI 10.1161/01.CIR.88.3.854; Engelhardt S, 1996, J AM COLL CARDIOL, V27, P146, DOI 10.1016/0735-1097(95)00425-4; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Jeon YH, 2005, CELL MOL LIFE SCI, V62, P1198, DOI 10.1007/s00018-005-4533-5; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Kaumann A, 1999, CIRCULATION, V99, P65, DOI 10.1161/01.CIR.99.1.65; Khan M, 2013, CIRC RES, V112, P476, DOI 10.1161/CIRCRESAHA.112.280735; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Lan F, 2013, CELL STEM CELL, V12, P101, DOI 10.1016/j.stem.2012.10.010; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Mehel H, 2013, J AM COLL CARDIOL, V62, P1596, DOI 10.1016/j.jacc.2013.05.057; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Post SR, 1999, ANNU REV PHARMACOL, V39, P343, DOI 10.1146/annurev.pharmtox.39.1.343; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Xiang YK, 2011, CIRC RES, V109, P231, DOI 10.1161/CIRCRESAHA.110.231340; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	43	117	120	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2015	17	1					89	100		10.1016/j.stem.2015.04.020	http://dx.doi.org/10.1016/j.stem.2015.04.020			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DI	26095046	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000361877600011
J	Pera, MF				Pera, Martin F.			In Search of Naivety	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; CULTURE-CONDITIONS; STATE; INDUCTION; CIRCUITRY	Devising a cell culture method that maintains human pluripotent stem cells (PSCs) in a state similar to naive mouse embryonic stem cells (ESCs) has been a much sought after goal in recent years. Here I consider the historical background to this quest and ask why it is considered consequential.	Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3010, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne	Pera, MF (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3010, Australia.	mpera@unimelb.edu.au	PERA, MARTIN/A-9812-2012	PERA, MARTIN/0000-0001-6239-0428				Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Fang RG, 2014, CELL STEM CELL, V15, P488, DOI 10.1016/j.stem.2014.09.004; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hough SR, 2014, STEM CELL REP, V2, P881, DOI 10.1016/j.stemcr.2014.04.014; Huang K, 2014, CELL STEM CELL, V15, P410, DOI 10.1016/j.stem.2014.09.014; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Nichols J, 2001, DEVELOPMENT, V128, P2333; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111	12	19	19	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					543	545		10.1016/j.stem.2014.10.013	http://dx.doi.org/10.1016/j.stem.2014.10.013			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517463	Bronze			2022-12-28	WOS:000345012700008
J	Guo, F; Li, XL; Liang, D; Li, T; Zhu, P; Guo, HS; Wu, XL; Wen, L; Gu, TP; Hu, BQ; Walsh, CP; Li, JS; Tang, FC; Xu, GL				Guo, Fan; Li, Xianlong; Liang, Dan; Li, Tong; Zhu, Ping; Guo, Hongshan; Wu, Xinglong; Wen, Lu; Gu, Tian-Peng; Hu, Boqiang; Walsh, Colum P.; Li, Jinsong; Tang, Fuchou; Xu, Guo-Liang			Active and Passive Demethylation of Male and Female Pronuclear DNA in the Mammalian Zygote	CELL STEM CELL			English	Article							BASE EXCISION-REPAIR; MOUSE PREIMPLANTATION DEVELOPMENT; EMBRYONIC STEM-CELLS; METHYLTRANSFERASES DNMT3A; METHYLATION LANDSCAPE; PATERNAL GENOME; 5-HYDROXYMETHYLCYTOSINE; TET; DYNAMICS; TDG	The epigenomes of mammalian sperm and oocytes, characterized by gamete-specific 5-methylcytosine (5mC) patterns, are reprogrammed during early embryogenesis to establish full developmental potential. Previous studies have suggested that the paternal genome is actively demethylated in the zygote while the maternal genome undergoes subsequent passive demethylation via DNA replication during cleavage. Active demethylation is known to depend on 5mC oxidation by Tet dioxygenases and excision of oxidized bases by thymine DNA glycosylase (TDG). Here we show that both maternal and paternal genomes undergo widespread active and passive demethylation in zygotes before the first mitotic division. Passive demethylation was blocked by the replication inhibitor aphidicolin, and active demethylation was abrogated by deletion of Tet3 in both pronuclei. At actively demethylated loci, 5mCs were processed to unmodified cytosines. Surprisingly, the demethylation process was unaffected by the deletion of TDG from the zygote, suggesting the existence of other demethylation mechanisms downstream of Tet3-mediated oxidation.	[Guo, Fan; Li, Xianlong; Zhu, Ping; Guo, Hongshan; Wu, Xinglong; Wen, Lu; Hu, Boqiang; Tang, Fuchou] Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Guo, Fan; Li, Tong; Gu, Tian-Peng; Xu, Guo-Liang] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Liang, Dan; Li, Jinsong] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Grp Epigenet Reprogramming, Shanghai 200031, Peoples R China; [Walsh, Colum P.] Univ Ulster, Sch Biomed Sci, Ctr Mol Biosci, Coleraine BT52 1SA, Londonderry, North Ireland; [Tang, Fuchou] Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China	Peking University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Ulster University; Peking University	Li, JS (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Grp Epigenet Reprogramming, Shanghai 200031, Peoples R China.	jsli@sibcb.ac.cn; tangfuchou@pku.edu.cn; glxu@sibcb.ac.cn	Walsh, Colum/ABD-7013-2020; Wu, Xinglong/GQH-0693-2022; Guo, Fan/AAX-4952-2021; Guo, Fan/J-1857-2019	Walsh, Colum/0000-0001-9921-7506; Wu, Xinglong/0000-0003-4373-2511; Guo, Fan/0000-0002-0165-073X; Liang, Dan/0000-0003-2404-3075; Zhu, Ping/0000-0002-4521-7524; li, jin song/0000-0003-3456-662X; Li, Xianlong/0000-0001-7745-2695	Ministry of Sciences and Technology of China [2012CB966903, 2014CB964802, 2012CB966704, 2011CB966303]; National Science Foundation of China [31230039, 31221001, 31322037, 31271543, 31225017, 91319310]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA01010301, XDQ01010403]; National Science and Technology Major Project of China [2014ZX09507-002]; Medical Research Council [MR/J007773/1]; MRC [MR/J007773/1] Funding Source: UKRI	Ministry of Sciences and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Major Project of China; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Xin Sun for critical reading of the manuscript and Lin Li for providing the Tdg conditional knockout mouse. This work was supported by grants from the Ministry of Sciences and Technology of China (2012CB966903 and 2014CB964802), the National Science Foundation of China (31230039 and 31221001), the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDA01010301), and the National Science and Technology Major Project of China (2014ZX09507-002) to G.-L.X.. F.T. was supported by grants from the Ministry of Sciences and Technology of China (2012CB966704 and 2011CB966303) and the National Science Foundation of China (31322037 and 31271543). J.L. was supported by grants from the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDQ01010403) and the National Science Foundation of China (31225017 and 91319310). C.P.W. was supported by a grant from the Medical Research Council (MR/J007773/1).	Bian CJ, 2014, NUCLEIC ACIDS RES, V42, P2893, DOI 10.1093/nar/gkt1261; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Guo HS, 2013, GENOME RES, V23, P2126, DOI 10.1101/gr.161679.113; Hackett JA, 2013, CELL, V153, P737, DOI 10.1016/j.cell.2013.04.044; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Hu X, 2014, CELL STEM CELL, V14, P512, DOI 10.1016/j.stem.2014.01.001; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Santos F, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-39; Schiesser S, 2012, ANGEW CHEM INT EDIT, V51, P6516, DOI 10.1002/anie.201202583; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035	47	247	263	2	98	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					447	458		10.1016/j.stem.2014.08.003	http://dx.doi.org/10.1016/j.stem.2014.08.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25220291	Bronze			2022-12-28	WOS:000343235800011
J	Master, Z; Robertson, K; Frederick, D; Rachul, C; Caulfield, T				Master, Zubin; Robertson, Kelsey; Frederick, Daniel; Rachul, Christen; Caulfield, Timothy			Stem Cell Tourism and Public Education: The Missing Elements	CELL STEM CELL			English	Editorial Material								Stem cell tourism describes the Internet-based industry where in patients receive unproven stem cell interventions. To better inform the public, several organizations provide educational material on stem cell therapies and tourism; however, an assessment of the currently available resources reveals a lack of comprehensive information, suggesting that further efforts are needed.	[Master, Zubin] Albany Med Coll, Alden March Bioeth Inst, Albany, NY 12208 USA; [Master, Zubin; Robertson, Kelsey; Caulfield, Timothy] Univ Alberta, Ctr Law, Hlth Law Inst, Edmonton, AB AB T6G, Canada; [Frederick, Daniel] SUNY Albany, Sch Publ Hlth, Albany, NY 12222 USA; [Rachul, Christen] Carleton Univ, Sch Linguist & Language Studies, Ottawa, ON K1S 5B6, Canada	Albany Medical College; University of Alberta; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Carleton University	Caulfield, T (corresponding author), Univ Alberta, Ctr Law, Hlth Law Inst, 89 Ave & 111 St, Edmonton, AB AB T6G, Canada.	caulfield@ualberta.ca		Master, Zubin/0000-0002-3462-4546				Caulfield T, 2012, STEM CELL REV REP, V8, P1037, DOI 10.1007/s12015-012-9404-5; Levine AD, 2012, J LAW MED ETHICS, V40, P122, DOI 10.1111/j.1748-720X.2012.00650.x; MASTER Z, 2013, MONITOR, V27, P26; Master Z, 2013, J LAW MED ETHICS, V41, P254, DOI 10.1111/jlme.12017; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Petersen A., 2013, SOCIOL HLTH ILLN; Rachul C, 2011, HLTH LAW REV, V20, P5; Zarzeczny A., 2014, STEM CELLS IN PRESS; Zarzeczny A, 2010, NAT BIOTECHNOL, V28, P1243, DOI 10.1038/nbt1210-1243b; Zarzeczny A, 2010, AM J BIOETHICS, V10, P3, DOI 10.1080/15265161003702865	10	37	37	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					267	270		10.1016/j.stem.2014.08.009	http://dx.doi.org/10.1016/j.stem.2014.08.009			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cell Biology	AO6EF	25192461	Bronze			2022-12-28	WOS:000341441600007
J	Sun, DQ; Luo, M; Jeong, M; Rodriguez, B; Xia, Z; Hannah, R; Wang, H; Le, T; Faull, KF; Chen, R; Gu, HC; Bock, C; Meissner, A; Gottgens, B; Darlington, GJ; Li, W; Goodell, MA				Sun, Deqiang; Luo, Min; Jeong, Mira; Rodriguez, Benjamin; Xia, Zheng; Hannah, Rebecca; Wang, Hui; Le, Thuc; Faull, Kym F.; Chen, Rui; Gu, Hongcang; Bock, Christoph; Meissner, Alexander; Goettgens, Berthold; Darlington, Gretchen J.; Li, Wei; Goodell, Margaret A.			Epigenomic Profiling of Young and Aged HSCs Reveals Concerted Changes during Aging that Reinforce Self-Renewal	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; DNA METHYLATION LANDSCAPE; LIFE-SPAN; TGF-BETA; TET2; DIFFERENTIATION; PROLIFERATION; GROWTH; MUTATIONS; DNMT3A	To investigate the cell-intrinsic aging mechanisms that erode the function of somatic stem cells during aging, we have conducted a comprehensive integrated genomic analysis of young and aged cells. We profiled the transcriptome, DNA methylome, and histone modifications of young and old murine hematopoietic stem cells (HSCs). Transcriptome analysis indicated reduced TGF-beta signaling and perturbation of genes involved in HSC proliferation and differentiation. Aged HSCs exhibited broader H3K4me3 peaks across HSC identity and self-renewal genes and showed increased DNA methylation at transcription factor binding sites associated with differentiation-promoting genes combined with a reduction at genes associated with HSC maintenance. Altogether, these changes reinforce HSC self-renewal and diminish differentiation, paralleling phenotypic HSC aging behavior. Ribosomal biogenesis emerged as a particular target of aging with increased transcription of ribosomal protein and RNA genes and hypomethylation of rRNA genes. This data set will serve as a reference for future epigenomic analysis of stem cell aging.	[Luo, Min; Jeong, Mira; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Dept Pediat & Mol & Human Genet, Houston, TX 77030 USA; [Sun, Deqiang; Rodriguez, Benjamin; Xia, Zheng; Li, Wei; Goodell, Margaret A.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Sun, Deqiang; Rodriguez, Benjamin; Xia, Zheng; Li, Wei; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Hannah, Rebecca; Goettgens, Berthold] Univ Cambridge, Dept Dermatol, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Hannah, Rebecca; Goettgens, Berthold] Univ Cambridge, Wellcome Trust & MRC Cambridge Stem Cell Inst, Cambridge CB2 0XY, England; [Wang, Hui; Chen, Rui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Le, Thuc; Faull, Kym F.] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Le, Thuc; Faull, Kym F.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Darlington, Gretchen J.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Gu, Hongcang; Bock, Christoph; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Bock, Christoph] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02142 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Cambridge; University of Cambridge; Baylor College of Medicine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Baylor College of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Li, W (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	wl1@bcm.edu; goodell@bcm.edu	Bock, Christoph/AAE-7618-2019; Xia, Zheng/F-6561-2014; Xia, Zheng/AAC-5360-2022	Bock, Christoph/0000-0001-6091-3088; Xia, Zheng/0000-0003-3364-8324; Xia, Zheng/0000-0003-3364-8324; Goodell, Margaret A./0000-0003-1111-2932; sun, deqiang/0000-0002-5806-7289; Li, Wei/0000-0001-9931-5990; Gu, Hongcang/0000-0002-1439-7606; luo, min/0000-0003-4883-4189; Gottgens, Berthold/0000-0001-6302-5705	Ellison Medical Foundation; CPRIT [RP110028, RP110471]; Samuel Waxman Cancer Research Foundation; DOD [W81XWH-10-1-0501]; Eugene V. Cota-Robles Fellowship;  [AG036562];  [AG288652];  [CA126752];  [DK092883];  [CA125123];  [DK084259];  [DK056338];  [AI07495];  [AG000183];  [HG007538];  [T32 MH 19384-14];  [T32-HD007032]; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [G0900951] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [MC_PC_12009, G0900951] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007032] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA126752, P30CA125123] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092883, R56DK092883, P30DK056338, R00DK084259, K99DK084259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036562, R21AG034451, R01AG028865, T32AG000183, Z01AG000183] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); CPRIT; Samuel Waxman Cancer Research Foundation; DOD(United States Department of Defense); Eugene V. Cota-Robles Fellowship; ; ; ; ; ; ; ; ; ; ; ; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is dedicated to Estela Medrano. We thank Julio Hernandez for mouse management and Chris Threeton for flow cytometry. This work was supported by grants AG036562, AG288652, CA126752, DK092883, CA125123, DK084259, DK056338, AI07495, and AG000183 as well as the Ellison Medical Foundation, CPRIT grant RP110028, and the Samuel Waxman Cancer Research Foundation as well as HG007538, CPRIT RP110471, and DOD W81XWH-10-1-0501 to W. L. Support for T. L. came from T32 MH 19384-14, T32-HD007032, and the Eugene V. Cota-Robles Fellowship.	Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; Cook WD, 2004, BLOOD, V104, P3437, DOI 10.1182/blood-2004-06-2234; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Davidson ENB, 2005, ARTHRITIS RES THER, V7, pR1338, DOI 10.1186/ar1833; de Haan G, 1999, BLOOD, V93, P3294, DOI 10.1182/blood.V93.10.3294.410k07_3294_3301; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730; Fan XL, 2002, J IMMUNOL, V168, P755, DOI 10.4049/jimmunol.168.2.755; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Grewal SS, 2009, INT J BIOCHEM CELL B, V41, P1006, DOI 10.1016/j.biocel.2008.10.010; Grundemann D, 1998, NAT NEUROSCI, V1, P349, DOI 10.1038/1557; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hidalgo I, 2012, CELL STEM CELL, V11, P649, DOI 10.1016/j.stem.2012.08.001; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; JACOBSEN FW, 1995, BLOOD, V86, P2957; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Mayle A, 2013, CYTOM PART A, V83A, P27, DOI 10.1002/cyto.a.22093; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Ramos-Casals M, 2003, LUPUS, V12, P341, DOI 10.1191/0961203303lu383ed; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sirin O, 2010, NAT CELL BIOL, V12, P1213, DOI 10.1038/ncb2125; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Sun DQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r38; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Weishaupt H, 2010, BLOOD, V115, P247, DOI 10.1182/blood-2009-07-235176; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Yu Q, 2000, GENE DEV, V14, P163; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	64	375	380	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					673	688		10.1016/j.stem.2014.03.002	http://dx.doi.org/10.1016/j.stem.2014.03.002			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24792119	Green Accepted, Bronze			2022-12-28	WOS:000335659900015
J	Nakamura, S; Takayama, N; Hirata, S; Seo, H; Endo, H; Ochi, K; Fujita, K; Koike, T; Harimoto, K; Dohda, T; Watanabe, A; Okita, K; Takahashi, N; Sawaguchi, A; Yamanaka, S; Nakauchi, H; Nishimura, S; Eto, K				Nakamura, Sou; Takayama, Naoya; Hirata, Shinji; Seo, Hideya; Endo, Hiroshi; Ochi, Kiyosumi; Fujita, Ken-ichi; Koike, Tomo; Harimoto, Ken-ichi; Dohda, Takeaki; Watanabe, Akira; Okita, Keisuke; Takahashi, Nobuyasu; Sawaguchi, Akira; Yamanaka, Shinya; Nakauchi, Hiromitsu; Nishimura, Satoshi; Eto, Koji			Expandable Megakaryocyte Cell Lines Enable Clinically Applicable Generation of Platelets from Human Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							IN-VITRO; FUNCTIONAL PLATELETS; HUMAN FIBROBLASTS; BONE-MARROW; BLOOD-CELLS; CORD BLOOD; APOPTOSIS; MOUSE; MICE; ESTABLISHMENT	The donor-dependent supply of platelets is frequently insufficient to meet transfusion needs. To address this issue, we developed a clinically applicable strategy for the derivation of functional platelets from human pluripotent stem cells (PSCs). This approach involves the establishment of stable immortalized megakaryocyte progenitor cell lines (imMKCLs) from PSC-derived hematopoietic progenitors through the overexpression of BMI1 and BCL-XL to respectively suppress senescence and apoptosis and the constrained overexpression of c-MYC to promote proliferation. The resulting imMKCLs can be expanded in culture over extended periods (4-5 months), even after cryopreservation. Halting the overexpression of c-MYC, BMI1, and BCL-XL in growing imMKCLs led to the production of CD42b(+) platelets with functionality comparable to that of native platelets on the basis of a range of assays in vitro and in vivo. The combination of robust expansion capacity and efficient platelet production means that appropriately selected imMKCL clones represent a potentially inexhaustible source of hPSC-derived platelets for clinical application.	[Nakamura, Sou; Takayama, Naoya; Hirata, Shinji; Seo, Hideya; Endo, Hiroshi; Ochi, Kiyosumi; Fujita, Ken-ichi; Koike, Tomo; Harimoto, Ken-ichi; Dohda, Takeaki; Eto, Koji] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Clin Applicat, Kyoto 6068507, Japan; [Watanabe, Akira; Okita, Keisuke; Yamanaka, Shinya] Kyoto Univ, CiRA, Dept Reprogramming Sci, Kyoto 6068507, Japan; [Takahashi, Nobuyasu; Sawaguchi, Akira] Miyazaki Univ, Fac Med, Dept Anat, Miyazaki 8891692, Japan; [Nakauchi, Hiromitsu; Eto, Koji] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Lab Stem Cell Therapy, Tokyo 1088639, Japan; [Nishimura, Satoshi] Univ Tokyo, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Nishimura, Satoshi] Jichi Med Univ, Ctr Mol Med, Dept Cell & Mol Med, Shimotsuke, Tochigi 3290498, Japan	Kyoto University; Kyoto University; University of Miyazaki; University of Tokyo; University of Tokyo	Eto, K (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Clin Applicat, Kyoto 6068507, Japan.	kojieto@cira.kyoto-u.ac.jp		Seo, Hideya/0000-0002-8823-8608; Okita, Keisuke/0000-0001-5806-1090	MEXT; Project of Realization of Regenerative Medicine and Highway Program from MEXT/ JST; A-STEP; CREST from JST; Ministry of Health Labor and Welfare; JSPS	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project of Realization of Regenerative Medicine and Highway Program from MEXT/ JST; A-STEP(National Aeronautics & Space Administration (NASA)); CREST from JST(Core Research for Evolutional Science and Technology (CREST)); Ministry of Health Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank H. Suemori, T. Kitamura, M. Onodera, H. Mano, M. Nakanishi, R. Mulligan, H. Kashiwagi, K. Soejima, and Y. Kurose. Electron microscopy was supported by Integrated Imaging Research Support (nonprofit organization). This work was supported by grants-in-aid from MEXT (K. E.) and the Project of Realization of Regenerative Medicine and Highway Program from MEXT/ JST (K. E.), A-STEP, and CREST from JST (K. E.) and a Health Labor Sciences Research Grant from the Ministry of Health Labor and Welfare (K. E.). This research was also supported in part by the first Program from JSPS (S. Y.). Visiting fellows S. H. (Kaken Pharmaceutical), T. K. (Nissan Chemical), and K. H. (Toray Industries) were supported by each company. S. Y. is a member without salary of scientific advisory board (SAB) of iPierian, iPS Academia Japan, Megakaryon, and HEALIOS K. K. Japan. H.N. and K. E. are members without salary of SAB of Megakaryon. H.N. is an outside board member of ReproCELL. S.N., N.T., H.N., and K. E. submitted the patent related with this manuscript.	Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bergmeier W, 2003, BLOOD, V102, P4229, DOI 10.1182/blood-2003-04-1305; Chen C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-384; De Cuyper IM, 2013, BLOOD, V121, pE70, DOI 10.1182/blood-2012-06-437723; Eto K, 2007, BLOOD, V110, P3637, DOI 10.1182/blood-2007-04-085860; Fuentes R, 2010, J CLIN INVEST, V120, P3917, DOI 10.1172/JCI43326; Gardiner EE, 2012, METHODS MOL BIOL, V788, P321, DOI 10.1007/978-1-61779-307-3_22; Hirata S, 2013, J CLIN INVEST, V123, P3802, DOI 10.1172/JCI64721; Hirose S, 2013, STEM CELL REP, V1, P499, DOI 10.1016/j.stemcr.2013.10.010; Hotti A, 2000, ONCOGENE, V19, P2354, DOI 10.1038/sj.onc.1203567; Isakari Y, 2009, BIOL PHARM BULL, V32, P354, DOI 10.1248/bpb.32.354; Josefsson EC, 2011, J EXP MED, V208, P2017, DOI 10.1084/jem.20110750; Juin P, 2002, MOL CELL BIOL, V22, P6158, DOI 10.1128/MCB.22.17.6158-6169.2002; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kaluzhny Y, 2002, BLOOD, V100, P1670, DOI 10.1182/blood-2001-12-0263; Kumar S, 2004, TRENDS BIOCHEM SCI, V29, P193, DOI 10.1016/j.tibs.2004.02.001; Lambert MP, 2013, BLOOD, V121, P3319, DOI 10.1182/blood-2012-09-455428; Leytin V, 2004, TRANSFUSION, V44, P1487, DOI 10.1111/j.1537-2995.2004.04042.x; Lu SJ, 2011, CELL RES, V21, P530, DOI 10.1038/cr.2011.8; Nakagawa Y, 2013, EXP HEMATOL, V41, P742, DOI 10.1016/j.exphem.2013.04.007; Nishikii H, 2008, J EXP MED, V205, P1917, DOI 10.1084/jem.20071482; Nishimura S, 2012, BLOOD, V119, pE45, DOI 10.1182/blood-2011-09-381400; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Ohmine K, 2001, ONCOGENE, V20, P8249, DOI 10.1038/sj.onc.1205029; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Ono Y, 2012, BLOOD, V120, P3812, DOI 10.1182/blood-2012-02-413617; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Prouix C, 2004, BIOTECHNOL BIOENG, V88, P675, DOI 10.1002/bit.20288; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; Schiffer CA, 2001, BLOOD REV, V15, P175, DOI 10.1054/blre.2001.0164; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Takizawa H, 2010, J CLIN INVEST, V120, P179, DOI 10.1172/JCI39503; Terui Y, 1998, EXP HEMATOL, V26, P236; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yu M, 2012, MOL CELL, V45, P330, DOI 10.1016/j.molcel.2011.11.032	40	207	221	0	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					535	548		10.1016/j.stem.2014.01.011	http://dx.doi.org/10.1016/j.stem.2014.01.011			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24529595	Bronze, Green Submitted			2022-12-28	WOS:000334766400016
J	Sakurai, K; Talukdar, I; Patil, VS; Dang, J; Li, ZH; Chang, KY; Lu, CC; Delorme-Walker, V; DerMardirossian, C; Anderson, K; Hanein, D; Yang, CS; Wu, DM; Liu, Y; Rana, TM				Sakurai, Kumi; Talukdar, Indrani; Patil, Veena S.; Dang, Jason; Li, Zhonghan; Chang, Kung-Yen; Lu, Chih-Chung; Delorme-Walker, Violaine; DerMardirossian, Celine; Anderson, Karen; Hanein, Dorit; Yang, Chao-Shun; Wu, Dongmei; Liu, Yang; Rana, Tariq M.			Kinome-wide Functional Analysis Highlights the Role of Cytoskeletal Remodeling in Somatic Cell Reprogramming	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; COFILIN PHOSPHORYLATION; FIBROBLASTS; REORGANIZATION; EXPRESSION; INDUCTION; OCT4	The creation of induced pluripotent stem cells (iPSCs) from somatic cells by ectopic expression of transcription factors has galvanized the fields of regenerative medicine and developmental biology. Here, we report a kinome-wide RNAi-based analysis to identify kinases that regulate somatic cell reprogramming to iPSCs. We prepared 3,686 small hairpin RNA (shRNA) lentiviruses targeting 734 kinase genes covering the entire mouse kinome and individually examined their effects on iPSC generation. We identified 59 kinases as barriers to iPSC generation and characterized seven of them further. We found that shRNA-mediated knockdown of the serine/threonine kinases TESK1 or LIMK2 promoted mesenchymal-to-epithelial transition, decreased COFILIN phosphorylation, and disrupted Actin filament structures during reprogramming of mouse embryonic fibroblasts. Similarly, knockdown of TESK1 in human fibroblasts also promoted reprogramming to iPSCs. Our study reveals the breadth of kinase networks regulating pluripotency and identifies a role for cytoskeletal remodeling in modulating the somatic cell reprogramming process.	[Sakurai, Kumi; Talukdar, Indrani; Patil, Veena S.; Dang, Jason; Li, Zhonghan; Chang, Kung-Yen; Lu, Chih-Chung; Yang, Chao-Shun; Rana, Tariq M.] Sanford Burnham Med Res Inst, Program RNA Biol, La Jolla, CA 92037 USA; [Dang, Jason] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Li, Zhonghan; Yang, Chao-Shun; Rana, Tariq M.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Delorme-Walker, Violaine; DerMardirossian, Celine] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Anderson, Karen; Hanein, Dorit] Sanford Burnham Med Res Inst, Bioinformat & Syst Biol Program, La Jolla, CA 92037 USA; [Wu, Dongmei; Liu, Yang] Sanford Burnham Med Res Inst, CIRM Stem Cell & iPSC Core Facil, La Jolla, CA 92037 USA; [Rana, Tariq M.] Rady Childrens Hosp San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Rana, Tariq M.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Rana, Tariq M.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of Massachusetts System; University of Massachusetts Worcester; Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Rana, TM (corresponding author), Sanford Burnham Med Res Inst, Program RNA Biol, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	trana@sanfordburnham.org	DerMardirossian, Celine/P-1020-2015	Li, Zhonghan/0000-0001-5752-3417; Yang, Chao-Shun/0000-0002-1532-3377; Sakurai, Kumi/0000-0002-7535-3412	National Institutes of Health (NIH); California Institute for Regenerative Medicine (CIRM); NIH [P01-GM098412]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043198, R01AI041404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM098412, R01GM099837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030199] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful for the following shared resource facilities at the Sanford-Burnham Medical Research Institute: genomics and informatics and data management cores for help with mRNA array experiments and data analysis, the animal facility for generation of teratomas and chimeric mice, the histology and molecular pathology core for characterization of tissues, and the cell imaging core for confocal microscopy. This work was supported in part by National Institutes of Health (NIH) grants (to T. M. R. and C. D.). Stem cell and iPS core is supported in part by a grant from California Institute for Regenerative Medicine (CIRM). The correlative light and electron microscopy studies were supported by NIH grant P01-GM098412 (to D. H.). C.-C. Lu died at a young age from nonsmall cell lung cancer on October 9, 2011.	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Lee DF, 2012, CELL STEM CELL, V11, P179, DOI 10.1016/j.stem.2012.05.020; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Li ZH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2059; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wiggan O, 2012, DEV CELL, V22, P530, DOI 10.1016/j.devcel.2011.12.026; Yang CS, 2011, STEM CELLS, V29, P1528, DOI 10.1002/stem.717; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	31	49	50	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					523	534		10.1016/j.stem.2014.03.001	http://dx.doi.org/10.1016/j.stem.2014.03.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24702998	Green Accepted, Bronze			2022-12-28	WOS:000334766400015
J	Kreso, A; Dick, JE				Kreso, Antonija; Dick, John E.			Evolution of the Cancer Stem Cell Model	CELL STEM CELL			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; B-16 MELANOMA VARIANTS; IMMUNE-DEFICIENT MICE; BREAST-CANCER; IN-VITRO; BONE-MARROW; PROSPECTIVE IDENTIFICATION; MUTATIONAL PROCESSES; TUMOR HETEROGENEITY	Genetic analyses have shaped much of our understanding of cancer. However, it is becoming increasingly clear that cancer cells display features of normal tissue organization, where cancer stem cells (CSCs) can drive tumor growth. Although often considered as mutually exclusive models to describe tumor heterogeneity, we propose that the genetic and CSC models of cancer can be harmonized by considering the role of genetic diversity and nongenetic influences in contributing to tumor heterogeneity. We offer an approach to integrating CSCs and cancer genetic data that will guide the field in interpreting past observations and designing future studies.	[Kreso, Antonija; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Kreso, Antonija; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada.	jdick@uhnresearch.ca		Dick, John/0000-0002-9527-8317				Abdel-Wahab O, 2010, CANCER CELL, V18, P105, DOI 10.1016/j.ccr.2010.07.006; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Amendola M, 2013, MOL THER, V21, P934, DOI 10.1038/mt.2013.12; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; [Anonymous], 1861, ORIGIN SPECIES MEANS; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BARRANCO SC, 1972, CANCER RES, V32, P2733; Bartholdy B., 2014, J CLIN INVEST; Bateman CM, 2010, BLOOD, V115, P3553, DOI 10.1182/blood-2009-10-251413; BAYLIN SB, 1978, NEW ENGL J MED, V299, P105, DOI 10.1056/NEJM197807202990301; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; BENNETT DC, 1978, CELL, V15, P283, DOI 10.1016/0092-8674(78)90104-6; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; BONNER WA, 1972, REV SCI INSTRUM, V43, P404, DOI 10.1063/1.1685647; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; BUICK RN, 1977, LANCET, V1, P862; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Cheung AMS, 2013, BLOOD, V122, P3129, DOI 10.1182/blood-2013-06-508432; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; CLARKSON B, 1967, J CLIN INVEST, V46, P506, DOI 10.1172/JCI105553; CLARKSON B, 1970, CANCER, V25, P1237, DOI 10.1002/1097-0142(197006)25:6<1237::AID-CNCR2820250602>3.0.CO;2-7; CLARKSON B, 1965, J CLIN INVEST, V44, P1035; CLARKSON B D, 1974, P945; CLARKSON BD, 1969, NATL CANCER I MONOGR, P81; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cohneim J, 1875, ARCH PATH ANAT, V65, P64, DOI DOI 10.1007/BF01978936; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; DANIELSON KG, 1980, CANCER RES, V40, P1812; DEXTER DL, 1978, CANCER RES, V38, P3174; DEXTER DL, 1979, P AM ASSOC CANC RES, V20, P199; DICK JE, 1991, IMMUNOL REV, V124, P25, DOI 10.1111/j.1600-065X.1991.tb00614.x; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; GAVOSTO F, 1967, NATURE, V216, P188, DOI 10.1038/216188a0; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Gentner B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001522; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; GRAY JM, 1964, J NATL CANCER I, V32, P1201, DOI 10.1093/jnci/32.6.1201; Greaves M, 2009, HEMATOL-AM SOC HEMAT, P3, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.3; Greaves M, 2013, EVOL APPL, V6, P102, DOI 10.1111/eva.12017; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Greenman CD, 2012, GENOME RES, V22, P346, DOI 10.1101/gr.118414.110; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; HAGER JC, 1981, CANCER RES, V41, P1293; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HENDERSON JAMES S., 1962, JOUR EXPTL MED, V115, P1211, DOI 10.1084/jem.115.6.1211; HEPPNER GH, 1978, CANCER RES, V38, P3758; HEPPNER GH, 1984, CANCER RES, V44, P2259; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; HEWITT HB, 1958, BRIT J CANCER, V12, P378, DOI 10.1038/bjc.1958.47; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; KAMELREID S, 1991, BLOOD, V78, P2973; KAMELREID S, 1988, SCIENCE, V242, P1706, DOI 10.1126/science.2904703; KAMELREID S, 1989, SCIENCE, V246, P1597, DOI 10.1126/science.2595371; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; KILLMANN SA, 1963, LAB INVEST, V12, P671; KLEIN G, 1956, ANN NY ACAD SCI, V63, P640, DOI 10.1111/j.1749-6632.1956.tb50883.x; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lechman ER, 2012, CELL STEM CELL, V11, P799, DOI 10.1016/j.stem.2012.09.001; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung-Hagesteijn C, 2013, CANCER CELL, V24, P289, DOI 10.1016/j.ccr.2013.08.009; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li AH, 2003, BLOOD, V102, P4520, DOI 10.1182/blood-2003-05-1455; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; MCCULLOCH EA, 1983, BLOOD, V62, P1; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Melchor L, 2014, LEUKEMIA; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; METCALF D, 1969, J NATL CANCER I, V43, P983; MITELMAN F, 1971, HEREDITAS-GENETISK A, V69, P155; MITELMAN F, 1972, SCIENCE, V176, P1340, DOI 10.1126/science.176.4041.1340; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MOORE MAS, 1973, J NATL CANCER I, V50, P603, DOI 10.1093/jnci/50.3.603; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Brien C.A., 2012, CANCER CELL, V21, P777; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; PERTSCHUK LP, 1978, CANCER, V41, P907, DOI 10.1002/1097-0142(197803)41:3<907::AID-CNCR2820410318>3.0.CO;2-V; Pierce G.B., 1978, CELL DIFFER, P1996; PIERCE GB, 1988, CANCER RES, V48, P1996; PIERCE GB, 1960, LAB INVEST, V9, P583; POSTE G, 1980, CANCER RES, V40, P1636; Potter NE, 2013, GENOME RES, V23, P2115, DOI 10.1101/gr.159913.113; PREHN RT, 1970, J NATL CANCER I, V45, P1039; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; RAZ A, 1980, CANCER RES, V40, P1645; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shah MY, 2011, NAT GENET, V43, P289, DOI 10.1038/ng0411-289; SHAPIRO JR, 1981, CANCER RES, V41, P2349; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shlush LI, 2012, BLOOD, V120, P603, DOI 10.1182/blood-2011-10-388629; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Southam C, 1962, BIOLOGICAL INTERACTI, P723; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Sprouffske K, 2013, EVOL APPL, V6, P92, DOI 10.1111/eva.12030; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; YUNG WKA, 1982, CANCER RES, V42, P992; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zuna J, 2004, CLIN CANCER RES, V10, P5355, DOI 10.1158/1078-0432.CCR-04-0584	168	1416	1464	12	354	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					275	291		10.1016/j.stem.2014.02.006	http://dx.doi.org/10.1016/j.stem.2014.02.006			17	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24607403	Bronze			2022-12-28	WOS:000332533400006
J	Tam, PPL				Tam, Patrick P. L.			Human StemCells Can Differentiate in Post-implantation Mouse Embryos	CELL STEM CELL			English	Editorial Material							PRIMITIVE-STREAK; CELLS; ORGANOGENESIS; GASTRULATION; PLURIPOTENCY	The potency of human pluripotent stem cells (hPSCs) to differentiate into germ layer derivatives is conventionally assessed by teratoma induction and in vitro differentiation. In this issue of Cell Stem Cell, Mascetti and Pedersen (2016) demonstrate that the human-mouse post-implantation chimera offers an efficient avenue to test the germ layer differentiation potential of hPSCs in mouse embryos ex vivo.	[Tam, Patrick P. L.] Univ Sydney, Sydney Med Sch, Childrens Med Res Inst, Embryol Unit, 214 Hawkesbury Rd, Westmead, NSW 2145, Australia	Children's Medical Research Institute - Australia; University of Sydney	Tam, PPL (corresponding author), Univ Sydney, Sydney Med Sch, Childrens Med Res Inst, Embryol Unit, 214 Hawkesbury Rd, Westmead, NSW 2145, Australia.	ptam@cmri.org.au						BEDDINGTON RSP, 1981, J EMBRYOL EXP MORPH, V64, P87; BEDDINGTON RSP, 1985, J EMBRYOL EXP MORPH, V88, P281; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; Hyun I, 2015, DEVELOPMENT, V142, P6, DOI 10.1242/dev.119206; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Mascetti VL, 2016, CELL STEM CELL, V18, P67, DOI 10.1016/j.stem.2015.11.017; Rivera-Perez JA, 2010, METHOD ENZYMOL, V476, P185, DOI 10.1016/S0076-6879(10)76011-0; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; TAM PPL, 1987, DEVELOPMENT, V99, P109; Wu J, 2015, NATURE, V521, P316, DOI 10.1038/nature14413	11	2	2	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					3	4		10.1016/j.stem.2015.12.010	http://dx.doi.org/10.1016/j.stem.2015.12.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26748747	Bronze			2022-12-28	WOS:000372321300002
J	Saito, Y; Chapple, RH; Lin, A; Kitano, A; Nakada, D				Saito, Yusuke; Chapple, Richard H.; Lin, Angelique; Kitano, Ayumi; Nakada, Daisuke			AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; CALORIC RESTRICTION; ENERGY-METABOLISM; SKELETAL-MUSCLE; GROWTH-CONTROL; KINASE; CANCER; ACTIVATION; DIETARY; PATHWAY	How cancer cells adapt to metabolically adverse conditions in patients and strive to proliferate is a fundamental question in cancer biology. Here we show that AMP-activated protein kinase (AMPK), a metabolic checkpoint kinase, confers metabolic stress resistance to leukemia-initiating cells (LICs) and promotes leukemogenesis. Upon dietary restriction, MLL-AF9-induced murine acute myeloid leukemia (AML) activated AMPK and maintained leukemogenic potential. AMPK deletion significantly delayed leukemogenesis and depleted LICs by reducing the expression of glucose transporter 1 (Glut1), compromising glucose flux, and increasing oxidative stress and DNA damage. LICs were particularly dependent on AMPK to suppress oxidative stress in the hypoglycemic bone marrow environment. Strikingly, AMPK inhibition synergized with physiological metabolic stress caused by dietary restriction and profoundly suppressed leukemogenesis. Our results indicate that AMPK protects LICs from metabolic stress and that combining AMPK inhibition with physiological metabolic stress potently suppresses AML by inducing oxidative stress and DNA damage.	[Saito, Yusuke; Chapple, Richard H.; Lin, Angelique; Kitano, Ayumi; Nakada, Daisuke] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Nakada, D (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	nakada@bcm.edu		Nakada, Daisuke/0000-0001-6010-7094	Cancer Prevention and Research Institute of Texas; Gabrielle's Angel Foundation for Cancer Research; National Institutes of Health [R01CA193235]; NIH (NCRR) [S10RR024574, NIAID AI036211, NCI P30CA125123]; NIH Common Funds Project [U24 DK097153]; NATIONAL CANCER INSTITUTE [P30CA125123, R01CA193235] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060445, U24DK097153] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; Gabrielle's Angel Foundation for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Common Funds Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Cancer Prevention and Research Institute of Texas, the Gabrielle's Angel Foundation for Cancer Research, and the National Institutes of Health R01CA193235 (D.N.). Flow cytometry was partially supported by the NIH (NCRR grant S10RR024574, NIAID AI036211, and NCI P30CA125123) for the BCM Cytometry and Cell Sorting Core. Metabolomics Core Services was supported by grant U24 DK097153 of NIH Common Funds Project to the University of Michigan.	Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Barnes K, 2002, J CELL SCI, V115, P2433; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Bochner BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018147; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Curry NL, 2013, CANCER DISCOV, V3, P908, DOI 10.1158/2159-8290.CD-12-0507; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Ertl RP, 2008, BLOOD, V111, P1709, DOI 10.1182/blood-2007-01-069807; Faubert B, 2015, CANCER LETT, V356, P165, DOI 10.1016/j.canlet.2014.01.018; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Ferrara F, 2013, LANCET, V381, P484, DOI 10.1016/S0140-6736(12)61727-9; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jeon SM, 2015, ARCH PHARM RES, V38, P346, DOI 10.1007/s12272-015-0549-z; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Longo VD, 2010, TRENDS PHARMACOL SCI, V31, P89, DOI 10.1016/j.tips.2009.11.004; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Mihaylova MM, 2014, CELL STEM CELL, V14, P292, DOI 10.1016/j.stem.2014.02.008; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Saito Yusuke, 2014, Critical Reviews in Oncogenesis, V19, P383; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang YH, 2014, CELL, V158, P1309, DOI 10.1016/j.cell.2014.07.048; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	68	150	154	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2015	17	5					585	596		10.1016/j.stem.2015.08.019	http://dx.doi.org/10.1016/j.stem.2015.08.019			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4UB	26440282	Bronze, Green Accepted			2022-12-28	WOS:000365694700011
J	Park, CY; Kim, DH; Son, JS; Sung, JJ; Lee, J; Bae, S; Kim, JH; Kim, DW; Kim, JS				Park, Chul-Yong; Kim, Duk Hyoung; Son, Jeong Sang; Sung, Jin Jea; Lee, Jaehun; Bae, Sangsu; Kim, Jong-Hoon; Kim, Dong-Wook; Kim, Jin-Soo			Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9	CELL STEM CELL			English	Article							OFF-TARGET CLEAVAGE; HUMAN-CELLS; NUCLEASES; CRISPR/CAS9; SPECIFICITY; TALENS	Hemophilia A is an X-linked genetic disorder caused by mutations in the F8 gene, which encodes the blood coagulation factor VIII. Almost half of all severe hemophilia A cases result from two gross (140-kbp or 600-kbp) chromosomal inversions that involve introns 1 and 22 of the F8 gene, respectively. We derived induced pluripotent stem cells (iPSCs) from patients with these inversion genotypes and used CRISPR-Cas9 nucleases to revert these chromosomal segments back to the WT situation. We isolated inversion-corrected iPSCs with frequencies of up to 6.7% without detectable off-target mutations based on whole-genome sequencing or targeted deep sequencing. Endothelial cells differentiated from corrected iPSCs expressed the F8 gene and functionally rescued factor VIII deficiency in an otherwise lethal mouse model of hemophilia. Our results therefore provide a proof of principle for functional correction of large chromosomal rearrangements in patient-derived iPSCs and suggest potential therapeutic applications.	[Park, Chul-Yong; Sung, Jin Jea; Kim, Dong-Wook] Yonsei Univ, Coll Med, Dept Physiol, Seoul 120752, South Korea; [Park, Chul-Yong; Sung, Jin Jea; Kim, Dong-Wook] Yonsei Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Seoul 120752, South Korea; [Kim, Duk Hyoung; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul 151742, South Korea; [Kim, Duk Hyoung; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea; [Son, Jeong Sang; Lee, Jaehun; Kim, Jong-Hoon] Korea Univ, Div Biotechnol, Coll Life Sci & Biotechnol, Lab Stem Cell Biol, Seoul 136713, South Korea; [Bae, Sangsu] Hanyang Univ, Dept Chem, Seoul 133791, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Korea University; Hanyang University	Kim, DW (corresponding author), Yonsei Univ, Coll Med, Dept Physiol, Seoul 120752, South Korea.	dwkim2@yuhs.ac; jskim01@snu.ac.kr	Kim, Jong-Hoon/F-2504-2013; Huang, ZhiXin/H-5123-2017; Bae, Sangsu/E-5324-2017; KIM, Jin-Soo/M-6918-2013; Lee, JaeHun/N-4236-2014	Kim, Jong-Hoon/0000-0003-3419-0538; Huang, ZhiXin/0000-0003-0705-1970; Bae, Sangsu/0000-0003-3615-8566; KIM, Jin-Soo/0000-0003-4847-1306; Lee, JaeHun/0000-0001-6962-0628; Park, Chul-Yong/0000-0002-4467-9268; Dong-Wook, Kim/0000-0002-5025-1532	National Research Foundation of Korea (the Bio and Medical Technology Development Program) [2012M3A9B4028631, 2012M3A9C7050126]; Korean Ministry of Health and Welfare [A120254]; IBS [IBS-R021-D1]; National Research Foundation of Korea [2012M3A9C7050139]	National Research Foundation of Korea (the Bio and Medical Technology Development Program); Korean Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); IBS; National Research Foundation of Korea(National Research Foundation of Korea)	D.-W.K. was supported by grants from the National Research Foundation of Korea (the Bio and Medical Technology Development Program, 2012M3A9B4028631 and 2012M3A9C7050126) and from the Korean Ministry of Health and Welfare (A120254). J.-S.K. was supported by a grant from IBS (IBS-R021-D1). J.-H.K. was supported by a grant from the National Research Foundation of Korea (2012M3A9C7050139). D.-W.K, J.-S.K, C.-Y.P, and D.H.K filed a patent application based on this work.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bagnall RD, 2006, J THROMB HAEMOST, V4, P591, DOI 10.1111/j.1538-7836.2006.01840.x; BONDESON ML, 1995, HUM MOL GENET, V4, P615, DOI 10.1093/hmg/4.4.615; Chao HJ, 2001, MOL THER, V4, P217, DOI 10.1006/mthe.2001.0449; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Graw J, 2005, NAT REV GENET, V6, P488, DOI 10.1038/nrg1617; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kim D., 2015, NAT METHODS, V12, P1; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim S., 2010, COLD SPRING HARB PRO; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/nmeth.2364, 10.1038/NMETH.2364]; Koo T, 2015, MOL CELLS, V38, P475, DOI 10.14348/molcells.2015.0103; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Merkely B, 2015, STEM CELLS DEV, V24, P869, DOI 10.1089/scd.2014.0247; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Pandey GS, 2013, NAT MED, V19, P1318, DOI 10.1038/nm.3270; Park CY, 2014, P NATL ACAD SCI USA, V111, P9253, DOI 10.1073/pnas.1323941111; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Shahani T, 2010, BLOOD, V115, P4902, DOI 10.1182/blood-2009-07-232546; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127	34	201	226	4	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					213	220		10.1016/j.stem.2015.07.001	http://dx.doi.org/10.1016/j.stem.2015.07.001			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26212079	Bronze			2022-12-28	WOS:000361878500012
J	Masserdotti, G; Gillotin, S; Sutor, B; Drechsel, D; Irmler, M; Jorgensen, HF; Sass, S; Theis, FJ; Beckers, J; Berninger, B; Guillemot, F; Gotz, M				Masserdotti, Giacomo; Gillotin, Sebastien; Sutor, Bernd; Drechsel, Daniela; Irmler, Martin; Jorgensen, Helle F.; Sass, Steffen; Theis, Fabian J.; Beckers, Johannes; Berninger, Benedikt; Guillemot, Francois; Goetz, Magdalena			Transcriptional Mechanisms of Proneural Factors and REST in Regulating Neuronal Reprogramming of Astrocytes	CELL STEM CELL			English	Article							FUNCTIONAL-NEURONS; DIRECT CONVERSION; HUMAN FIBROBLASTS; GLIAL-CELLS; STEM-CELLS; IN-VITRO; EXPRESSION; FATE; GENERATION	Direct lineage reprogramming induces dramatic shifts in cellular identity, employing poorly understood mechanisms. Recently, we demonstrated that expression of Neurog2 or Ascl1 in postnatal mouse astrocytes generates glutamatergic or GABAergic neurons. Here, we take advantage of this model to study dynamics of neuronal cell fate acquisition at the transcriptional level. We found that Neurog2 and Ascl1 rapidly elicited distinct neurogenic programs with only a small subset of shared target genes. Within this subset, only NeuroD4 could by itself induce neuronal reprogramming in both mouse and human astrocytes, while co-expression with Insm1 was required for glutamatergic maturation. Cultured astrocytes gradually became refractory to reprogramming, in part by the repressor REST preventing Neurog2 from binding to the NeuroD4 promoter. Notably, in astrocytes refractory to Neurog2 activation, the underlying neurogenic program remained amenable to reprogramming by exogenous NeuroD4. Our findings support a model of temporal hierarchy for cell fate change during neuronal reprogramming.	[Masserdotti, Giacomo; Sutor, Bernd; Goetz, Magdalena] Univ Munich, Biomed Ctr, Physiol Genom, D-80336 Munich, Germany; [Masserdotti, Giacomo; Goetz, Magdalena] Helmholtz Ctr Munich, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Gillotin, Sebastien; Drechsel, Daniela; Guillemot, Francois] Mill Hill Lab, Francis Crick Inst, London NW7 1AA, England; [Gillotin, Sebastien] Univ Cambridge, Hutchison MRC Res Ctr, Cambridge CB2 0XZ, England; [Irmler, Martin; Beckers, Johannes] Helmholtz Ctr Munich, Inst Expt Genet, D-85764 Neuherberg, Germany; [Jorgensen, Helle F.] Univ Cambridge, Dept Med, Cambridge CB2 0QQ, England; [Sass, Steffen; Theis, Fabian J.] Helmholtz Ctr Munich, Inst Computat Biol, D-85764 Neuherberg, Germany; [Theis, Fabian J.] Tech Univ Munich, Dept Math, D-85748 Garching, Germany; [Berninger, Benedikt] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, D-55128 Mainz, Germany; [Berninger, Benedikt] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci, D-55128 Mainz, Germany; [Beckers, Johannes] Tech Univ, Ctr Life & Food Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Goetz, Magdalena] Univ Munich, Munich Cluster Syst Neurol SyNergy, D-80539 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Francis Crick Institute; University of Cambridge; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cambridge; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Munich	Guillemot, F (corresponding author), Mill Hill Lab, Francis Crick Inst, London NW7 1AA, England.	francois.guillemot@crick.ac.uk; magdalena.goetz@helmholtz-muenchen.de	Guillemot, Francois/AAV-1482-2021; Beckers, Johannes/K-7237-2012; Berninger, Benedikt/H-4098-2019; Theis, Fabian J/ABD-5212-2021	Beckers, Johannes/0000-0001-7874-3822; Berninger, Benedikt/0000-0003-2652-2782; Theis, Fabian J/0000-0002-2419-1943; Gillotin, Sebastien/0000-0002-4129-4936; Jorgensen, Helle/0000-0002-7909-2977	Wellcome Trust [WT091800MA]; Medical Research Council [U117570528]; Deutsche Forschungsgemeinschaft [SPP1356, BE 4182/2-2, GO 640/9-2]; BMBF ("NewNeurons''); Advanced ERC grant ChroNeuroRepair GA [340793]; BBSRC [BB/K005316/1] Funding Source: UKRI; MRC [G0800784, G1000847, MC_U117570528] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K005316/1] Funding Source: researchfish; Medical Research Council [G1000847, G0800784, MC_U117570528] Funding Source: researchfish; The Francis Crick Institute [10089] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF ("NewNeurons'')(Federal Ministry of Education & Research (BMBF)); Advanced ERC grant ChroNeuroRepair GA; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	We are particularly grateful to Tatiana Simon-Ebert, Detlef Franzen, Ines Muhlhahn, Carmen Meyer, and Gabi Jager for excellent technical support; Alexandra Lepier for the support in viral vector production; Sergio Gascon for discussions; and Emily Violette Baumgart for reading the manuscript. We thank Ismini Rozani and Chiara Galante for their assistance in cloning. We thank members of the Gotz and Guillemot groups for their discussion and support. This work was supported by a project grant from the Wellcome Trust (WT091800MA) and a Grant-in-Aid from the Medical Research Council (U117570528) to F.G and by grants from SPP1356 of the Deutsche Forschungsgemeinschaft (BE 4182/2-2; GO 640/9-2), the BMBF ("NewNeurons'') (both to M.G. and B.B.), and the Advanced ERC grant ChroNeuroRepair GA No. 340793 (to M.G.).	Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Heinrich C, 2011, NAT PROTOC, V6, P214, DOI 10.1038/nprot.2010.188; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imayoshi I, 2014, NEURON, V82, P9, DOI 10.1016/j.neuron.2014.03.018; Imura T, 2006, GLIA, V53, P277, DOI 10.1002/glia.20281; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Jorgensen HF, 2009, DEVELOPMENT, V136, P715, DOI 10.1242/dev.028548; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Martynoga B, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008359; Poitras L, 2007, DEVELOPMENT, V134, P1755, DOI 10.1242/dev.02845; Price JD, 2014, J NEUROSCI, V34, P12560, DOI 10.1523/JNEUROSCI.3159-13.2014; Raposo A.A., 2015, CELL REP IN PRESS; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Voss AK, 2007, GENE EXPR PATTERNS, V7, P858, DOI 10.1016/j.modgep.2007.06.007; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Wongtawan T, 2011, J CELL SCI, V124, P1878, DOI 10.1242/jcs.080721; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zolles G, 2009, CEREB CORTEX, V19, P1079, DOI 10.1093/cercor/bhn158	33	117	118	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2015	17	1					74	88		10.1016/j.stem.2015.05.014	http://dx.doi.org/10.1016/j.stem.2015.05.014			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DI	26119235	hybrid, Green Published			2022-12-28	WOS:000361877600010
J	Orlova, VV; Mummery, CL				Orlova, Valeria V.; Mummery, Christine L.			What Endothelial Cells from Patient iPSCs Can Tell Us about Aortic Valve Disease	CELL STEM CELL			English	Editorial Material								In a recent issue of Cell, Theodoris et al. (2015) used a complex systems biology approach to model vascular aortic calcification caused by mutations in the NOTCH1 gene. Comparison of endothelial cells from patient hiPSCs and genetically matched controls under fluid flow revealed novel mechanisms underlying the disease.	[Orlova, Valeria V.; Mummery, Christine L.] Leiden Univ, Med Ctr, Dept Anat & Embryol, NL-2300 ZA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mummery, CL (corresponding author), Leiden Univ, Med Ctr, Dept Anat & Embryol, NL-2300 ZA Leiden, Netherlands.	c.l.mummery@lumc.nl	Orlova, Valeria V/C-6065-2014	Orlova, Valeria V/0000-0002-1169-2802; Mummery, Christine/0000-0002-4549-6535				Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; DeRuiter MC, 2008, CURR OPIN LIPIDOL, V19, P333, DOI 10.1097/MOL.0b013e328304b670; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Hofmann JJ, 2012, DEVELOPMENT, V139, P4449, DOI 10.1242/dev.084871; Johnstone SE, 2010, NAT REV GENET, V11, P806, DOI 10.1038/nrg2881; Theodoris CV, 2015, CELL, V160, P1072, DOI 10.1016/j.cell.2015.02.035; Weinberg EJ, 2010, CARDIOVASC ENG, V10, P5, DOI 10.1007/s10558-009-9089-9; White MP, 2013, STEM CELLS, V31, P92, DOI 10.1002/stem.1267; Wirrig EE, 2011, CARDIOVASC PATHOL, V20, P162, DOI 10.1016/j.carpath.2010.06.010	10	3	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					455	457		10.1016/j.stem.2015.04.006	http://dx.doi.org/10.1016/j.stem.2015.04.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25957898	Bronze			2022-12-28	WOS:000354188600004
J	Grealish, S; Diguet, E; Kirkeby, A; Mattsson, B; Heuer, A; Bramoulle, Y; Van Camp, N; Perrier, AL; Hantraye, P; Bjorklund, A; Parmar, M				Grealish, Shane; Diguet, Elsa; Kirkeby, Agnete; Mattsson, Bengt; Heuer, Andreas; Bramoulle, Yann; Van Camp, Nadja; Perrier, Anselme L.; Hantraye, Philippe; Bjorklund, Anders; Parmar, Malin			Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson's Disease	CELL STEM CELL			English	Article							VENTRAL TEGMENTAL AREA; AXONAL PROJECTIONS; SUBSTANTIA-NIGRA; TRANSPLANTATION; CELLS; EXPRESSION; MESENCEPHALON; VULNERABILITY; SURVIVAL; GROWTH	Considerable progress has been made in generating fully functional and transplantable dopamine neurons from human embryonic stem cells (hESCs). Before these cells can be used for cell replacement therapy in Parkinson's disease (PD), it is important to verify their functional properties and efficacy in animal models. Here we provide a comprehensive preclinical assessment of hESC-derived midbrain dopamine neurons in a rat model of PD. We show long-term survival and functionality using clinically relevant MRI and PET imaging techniques and demonstrate efficacy in restoration of motor function with a potency comparable to that seen with human fetal dopamine neurons. Furthermore, we show that hESC-derived dopamine neurons can project sufficiently long distances for use in humans, fully regenerate midbrain-to-forebrain projections, and innervate correct target structures. This provides strong preclinical support for clinical translation of hESC-derived dopamine neurons using approaches similar to those established with fetal cells for the treatment of Parkinson's disease.	[Grealish, Shane; Kirkeby, Agnete; Mattsson, Bengt; Heuer, Andreas; Bjorklund, Anders; Parmar, Malin] Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, S-22184 Lund, Sweden; [Grealish, Shane; Kirkeby, Agnete; Heuer, Andreas; Parmar, Malin] Lund Univ, Lund Stem Cell Ctr, S-22184 Lund, Sweden; [Diguet, Elsa; Bramoulle, Yann; Van Camp, Nadja; Hantraye, Philippe] CEA, Mol Imaging Res Ctr MIRCen, F-92264 Fontenay Aux Roses, France; [Perrier, Anselme L.] AFM, I Stem, Inserm U861, F-91030 Evry, France; [Perrier, Anselme L.] AFM, I Stem, UEVE U861, F-91030 Evry, France	Lund University; Lund University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Grealish, S (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, S-22184 Lund, Sweden.	shane.grealish@med.lu.se; malin.parmar@med.lu.se	Van Camp, Nadja/AAC-4357-2019; Kirkeby, Agnete/AAR-8432-2020; Perrier, Anselme L/B-2272-2019; Perrier, Anselme/E-3764-2010; Van Camp, Nadja/H-5141-2017; Björklund, Anders/ABA-1326-2020; Heuer, Andreas/F-8975-2013	Van Camp, Nadja/0000-0002-2261-7314; Kirkeby, Agnete/0000-0001-8203-6901; Perrier, Anselme L/0000-0001-7915-1968; Van Camp, Nadja/0000-0002-2261-7314; Heuer, Andreas/0000-0003-0300-7606; Parmar, Malin/0000-0001-5002-4199; Grealish, Shane/0000-0002-7676-7924; Bjorklund, Anders/0000-0002-5676-6203	European Community's 7th Framework Programme through NeuroStemcell [222943]; European Community's 7th Framework Programme through NeuroStemcellRepair [602278]; European Community's 7th Framework Programme through TransEuro [HEALTH-F5-2010-242003]; strategic research area at Lund University Multipark (multidisciplinary research in Parkinson's disease); Swedish Research Council [70862601/Bagadilico, K2012-99X-22324-01-5, K2014-61X-20391-08-4]; Swedish Parkinson Foundation (Parkinsonfonden); Swedish Brain Foundation (Hjarnfonden); Lundbeck foundation [R44-A3856]; European Research Council under the European Union's 7th Framework Programme (FP)/ERC [309712]; Lundbeck Foundation [R44-2009-3856] Funding Source: researchfish	European Community's 7th Framework Programme through NeuroStemcell; European Community's 7th Framework Programme through NeuroStemcellRepair; European Community's 7th Framework Programme through TransEuro; strategic research area at Lund University Multipark (multidisciplinary research in Parkinson's disease); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Parkinson Foundation (Parkinsonfonden); Swedish Brain Foundation (Hjarnfonden); Lundbeck foundation(Lundbeckfonden); European Research Council under the European Union's 7th Framework Programme (FP)/ERC; Lundbeck Foundation(Lundbeckfonden)	We would like to thank Jan Reimer, Olle Lindvall, and Jenny Nelander-Wahlestedt for acquisition and processing of human fetal material and Aurore Bugi for preparation and handling of hESC derivatives at I-Stem and Mircen. We would like to recognize the excellent technical assistance provided by Ulla Jarl, Michael Sparrenius, Anneli Josefsson, and Ingar Nilsson. The excellent technical support of Martine Guillermier in the PET imaging studies as well as the supply of PET radioligands by the radiochemistry unit of the Service Hospitalier Frederic Joliot (directed by Frederic Dolle) were very appreciated. This study was supported by grants from the European Community's 7th Framework Programme through NeuroStemcell (no. 222943), NeuroStemcellRepair (no. 602278), and TransEuro (HEALTH-F5-2010-242003); the strategic research area at Lund University Multipark (multidisciplinary research in Parkinson's disease); the Swedish Research Council (70862601/Bagadilico, K2012-99X-22324-01-5, and K2014-61X-20391-08-4); and the Swedish Parkinson Foundation (Parkinsonfonden). S. G. was supported by a postdoctoral stipend from the Swedish Brain Foundation (Hjarnfonden) and A. K. was supported via a grant from the Lundbeck foundation (R44-A3856). The research leading to these results has received funding from the European Research Council under the European Union's 7th Framework Programme (FP/2007-2013)/ERC Grant Agreement no. 309712.	Barker RA, 2014, CELL STEM CELL, V15, P539, DOI 10.1016/j.stem.2014.09.016; Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; BRUNDIN P, 1986, EXP BRAIN RES, V65, P235; Chung CY, 2010, BRAIN, V133, P2022, DOI 10.1093/brain/awq142; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Denham M, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00011; Di Salvio M, 2010, NAT NEUROSCI, V13, P1481, DOI 10.1038/nn.2661; Di Salvio M, 2010, INT J DEV BIOL, V54, P939, DOI 10.1387/ijdb.092974ms; Doi D, 2014, STEM CELL REP, V2, P337, DOI 10.1016/j.stemcr.2014.01.013; Dolle F, 2007, J LABELLED COMPD RAD, V50, P716, DOI 10.1002/jlcr.1412; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Freeman TB, 2006, RESTORATIVE THERAPIES IN PARKINSON'S DISEASE, P131; Gates MA, 1998, NEUROSCIENCE, V84, P1013, DOI 10.1016/S0306-4522(97)00512-5; Grealish S, 2010, BRAIN, V133, P482, DOI 10.1093/brain/awp328; Hagell P, 2001, J NEUROPATH EXP NEUR, V60, P741, DOI 10.1093/jnen/60.8.741; ISACSON O, 1995, NAT MED, V1, P1189, DOI 10.1038/nm1195-1189; Kefalopoulou Z, 2014, JAMA NEUROL, V71, P83, DOI 10.1001/jamaneurol.2013.4749; Kirkeby A, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00064; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kuhnast B, 2012, APPL RADIAT ISOTOPES, V70, P489, DOI 10.1016/j.apradiso.2011.10.015; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Moon BS, 2010, APPL RADIAT ISOTOPES, V68, P2279, DOI 10.1016/j.apradiso.2010.06.016; Mouton PR, 2002, J MICROSC-OXFORD, V206, P54, DOI 10.1046/j.1365-2818.2002.01006.x; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Piccini P, 2000, ANN NEUROL, V48, P689, DOI 10.1002/1531-8249(200011)48:5<689::AID-ANA1>3.0.CO;2-N; PUNDT LL, 1995, BRAIN RES, V695, P25, DOI 10.1016/0006-8993(95)00753-D; Rath A, 2013, CELL TRANSPLANT, V22, P1281, DOI 10.3727/096368912X654984; Reyes S, 2012, J COMP NEUROL, V520, P2591, DOI 10.1002/cne.23051; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Sachdeva R, 2010, P NATL ACAD SCI USA, V107, P11602, DOI 10.1073/pnas.1006568107; Thompson L, 2005, J NEUROSCI, V25, P6467, DOI 10.1523/JNEUROSCI.1676-05.2005; WICTORIN K, 1992, J COMP NEUROL, V323, P475, DOI 10.1002/cne.903230403	34	274	280	1	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					653	665		10.1016/j.stem.2014.09.017	http://dx.doi.org/10.1016/j.stem.2014.09.017			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517469	Green Published, hybrid			2022-12-28	WOS:000345012700017
J	Tarlow, BD; Pelz, C; Naugler, WE; Wakefield, L; Wilson, EM; Finegold, MJ; Grompe, M				Tarlow, Branden D.; Pelz, Carl; Naugler, Willscott E.; Wakefield, Leslie; Wilson, Elizabeth M.; Finegold, Milton J.; Grompe, Markus			Bipotential Adult Liver Progenitors Are Derived from Chronically Injured Mature Hepatocytes	CELL STEM CELL			English	Article							STEM-CELLS; MOUSE MODEL; OVAL CELLS; RAT; REGENERATION; IDENTIFICATION; REPOPULATION; HOMEOSTASIS; EXPRESSION; PLASTICITY	Adult liver progenitor cells are biliary-like epithelial cells that emerge only under injury conditions in the periportal region of the liver. They exhibit phenotypes of both hepatocytes and bile ducts. However, their origin and their significance to injury repair remain unclear. Here, we used a chimeric lineage tracing system to demonstrate that hepatocytes contribute to the progenitor pool. RNA-sequencing, ultrastructural analysis, and in vitro progenitor assays revealed that hepatocyte-derived progenitors were distinct from their biliary-derived counterparts. In vivo lineage tracing and serial transplantation assays showed that hepatocyte-derived proliferative ducts retained a memory of their origin and differentiated back into hepatocytes upon cessation of injury. Similarly, human hepatocytes in chimeric mice also gave rise to biliary progenitors in vivo. We conclude that human and mouse hepatocytes can undergo reversible ductal metaplasia in response to injury, expand as ducts, and subsequently contribute to restoration of the hepatocyte mass.	[Tarlow, Branden D.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA; [Tarlow, Branden D.; Pelz, Carl; Wakefield, Leslie; Grompe, Markus] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA; [Naugler, Willscott E.] Oregon Hlth & Sci Univ, Dept Gastroenterol & Hepatol, Portland, OR 97239 USA; [Wilson, Elizabeth M.] Yecuris Corp, Tualatin, OR 97062 USA; [Finegold, Milton J.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Baylor College of Medicine	Tarlow, BD (corresponding author), Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	tarlowb@ohsu.edu	Tarlow, Branden D/I-5404-2019	Tarlow, Branden D/0000-0001-5116-5794; Wakefield, Leslie/0000-0001-5623-4285; Grompe, Markus/0000-0002-6616-4345	National Institutes of Diabetes and Digestive and Kidney Diseases [F30-DK095514, R01-DK051592, P01-DK044080]; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051592, F30DK095514, F32DK009551, P01DK044080, P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Diabetes and Digestive and Kidney Diseases grants F30-DK095514 to B. D. T., R01-DK051592 to M. G., and P01-DK044080 to M.J.F. The Sox9-CreERT2 mouse was a kind gift from Dr. Maike Sander. OHSU provided core services MPSSR Core/RNA-seq (Robert Searles), flow cytometry (Miranda Gilchrist), and microscopy (Aurelie Synder, Stefanie Kaech Petrie). We also thank Annelise Haft, Bin Li, and James Barrish for their excellent technical assistance. M. G. is a founder and shareholder of Yecuris. M. G. receives royalties from Novus. E. M. W. is an employee of Yecuris.	Alison MR, 1996, GASTROENTEROLOGY, V110, P1182, DOI 10.1053/gast.1996.v110.pm8613008; Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Chen YX, 2012, HEPATOLOGY, V55, P563, DOI 10.1002/hep.24712; Demetris AJ, 1996, AM J PATHOL, V149, P439; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; ELMORE LW, 1992, HEPATOLOGY, V16, P1220, DOI 10.1002/hep.1840160519; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; FARBER E, 1956, CANCER RES, V16, P142; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; FUJIO K, 1994, LAB INVEST, V70, P511; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gleiberman AS, 2005, DEV DYNAM, V234, P413, DOI 10.1002/dvdy.20536; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jeliazkova P, 2013, HEPATOLOGY, V57, P2469, DOI 10.1002/hep.26254; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kuo FY, 2009, AM J SURG PATHOL, V33, P66, DOI 10.1097/PAS.0b013e31818c8482; Li B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017092; Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Michalopoulos GK, 2014, AM J PATHOL, V184, P1263, DOI 10.1016/j.ajpath.2014.02.020; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Mosnier JF, 2009, MODERN PATHOL, V22, P182, DOI 10.1038/modpathol.2008.123; Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9; Overturf K, 1997, AM J PATHOL, V151, P1273; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Preisegger KH, 1999, LAB INVEST, V79, P103; Rodrigo-Torres D, 2014, HEPATOLOGY; ROSKAMS T, 1990, AM J PATHOL, V137, P1019; Sancho-Bru P, 2012, HEPATOLOGY, V55, P1931, DOI 10.1002/hep.25614; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Sekiya S, 2014, AM J PATHOL, V184, P1468, DOI 10.1016/j.ajpath.2014.01.005; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; SELL S, 1990, CANCER RES, V50, P3811; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Slack JMW, 2009, J PATHOL, V217, P161, DOI 10.1002/path.2442; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tanimizu N, 2014, J BIOL CHEM, V289, P7589, DOI 10.1074/jbc.M113.517243; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047; Zhou HC, 2007, HEPATOLOGY, V45, P716, DOI 10.1002/hep.21557	53	320	327	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					605	618		10.1016/j.stem.2014.09.008	http://dx.doi.org/10.1016/j.stem.2014.09.008			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25312494	Bronze, Green Accepted			2022-12-28	WOS:000345012700013
J	Theunissen, TW; Powell, BE; Wang, HY; Mitalipova, M; Faddah, DA; Reddy, J; Fan, ZP; Maetzel, D; Ganz, K; Shi, LY; Lungjangwa, T; Imsoonthornruksa, S; Stelzer, Y; Rangarajan, S; D'Alessio, A; Zhang, JM; Gao, Q; Dawlaty, MM; Young, RA; Gray, NS; Jaenisch, R				Theunissen, Thorold W.; Powell, Benjamin E.; Wang, Haoyi; Mitalipova, Maya; Faddah, Dina A.; Reddy, Jessica; Fan, Zi Peng; Maetzel, Dorothea; Ganz, Kibibi; Shi, Linyu; Lungjangwa, Tenzin; Imsoonthornruksa, Sumeth; Stelzer, Yonatan; Rangarajan, Sudharshan; D'Alessio, Ana; Zhang, Jianming; Gao, Qing; Dawlaty, Meelad M.; Young, Richard A.; Gray, Nathanael S.; Jaenisch, Rudolf			Systematic Identification of Culture Conditions for Induction and Maintenance of Naive Human Pluripotency	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GROUND-STATE; SOMATIC-CELLS; DERIVATION; INACTIVATION	Embryonic stem cells (ESCs) of mice and humans have distinct molecular and biological characteristics, raising the question of whether an earlier, "naive" state of pluripotency may exist in humans. Here we took a systematic approach to identify small molecules that support self-renewal of naive human ESCs based on maintenance of endogenous OCT4 distal enhancer activity, a molecular signature of ground state pluripotency. Iterative chemical screening identified a combination of five kinase inhibitors that induces and maintains OCT4 distal enhancer activity when applied directly to conventional human ESCs. These inhibitors generate human pluripotent cells in which transcription factors associated with the ground state of pluripotency are highly upregulated and bivalent chromatin domains are depleted. Comparison with previously reported naive human ESCs indicates that our conditions capture a distinct pluripotent state in humans that closely resembles that of mouse ESCs. This study presents a framework for defining the culture requirements of naive human pluripotent cells.	[Theunissen, Thorold W.; Powell, Benjamin E.; Wang, Haoyi; Mitalipova, Maya; Faddah, Dina A.; Reddy, Jessica; Fan, Zi Peng; Maetzel, Dorothea; Ganz, Kibibi; Shi, Linyu; Lungjangwa, Tenzin; Imsoonthornruksa, Sumeth; Stelzer, Yonatan; Rangarajan, Sudharshan; D'Alessio, Ana; Gao, Qing; Dawlaty, Meelad M.; Young, Richard A.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Faddah, Dina A.; Reddy, Jessica; Young, Richard A.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA; [Fan, Zi Peng] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Zhang, Jianming; Gray, Nathanael S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Powell, Benjamin/0000-0003-2533-8262; Zhang, Jianming/0000-0001-6326-3906; Theunissen, Thorold/0000-0001-6943-7858	Simons Foundation (SFLIFE) [286977]; NIH [RO1-CA084198]; Sir Henry Wellcome Postdoctoral Fellowship [098889/Z/12/Z]; Boehringer Ingelheim Fonds Ph.D. Fellowship; Jerome and Florence Brill Graduate Student Fellowship; National Science Foundation Graduate Research Fellowship; Human Frontier Science Program Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA084198, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042, T32GM007287] Funding Source: NIH RePORTER	Simons Foundation (SFLIFE); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sir Henry Wellcome Postdoctoral Fellowship; Boehringer Ingelheim Fonds Ph.D. Fellowship(Boehringer Ingelheim); Jerome and Florence Brill Graduate Student Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Human Frontier Science Program Postdoctoral Fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dongdong Fu for sectioning, Raaji Alagappan and Ping Xu for preparation of MEFs, Ruth Flannery for embryo processing, Patti Wisniewski and Colin Zollo for cell sorting, David Sabatini and Kathleen Ottina for use of the Zymark Liquid Handling system, the Whitehead Genome Technology Core for assistance with expression array and ChIP-Seq analysis, and Jacob Hanna (Weizmann Institute) for providing C1-AAVS1-GFP human ESCs. This study was supported by a grant from the Simons Foundation (SFLIFE #286977 to R.J) and was supported in part by NIH grant RO1-CA084198 to R.J. T.W.T. is supported by a Sir Henry Wellcome Postdoctoral Fellowship (098889/Z/12/Z). B.E.P. is supported by a Boehringer Ingelheim Fonds Ph.D. Fellowship and a Jerome and Florence Brill Graduate Student Fellowship. D.A.F. is supported by a National Science Foundation Graduate Research Fellowship and a Jerome and Florence Brill Graduate Student Fellowship. Y.S. is supported by a Human Frontier Science Program Postdoctoral Fellowship. R.J. is a cofounder of Fate Therapeutics and an adviser to Stemgent.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Chan EM, 2008, CLONING STEM CELLS, V10, P107, DOI 10.1089/clo.2007.0064; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; De Los Angeles A, 2012, CURR OPIN GENET DEV, V22, P272, DOI 10.1016/j.gde.2012.03.001; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hirano K, 2012, STEM CELLS DEV, V21, P1287, DOI 10.1089/scd.2011.0283; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martin MW, 2006, J MED CHEM, V49, P4981, DOI 10.1021/jm060435i; Meek S, 2013, STEM CELLS, V31, P2104, DOI 10.1002/stem.1466; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Valamehr B, 2014, STEM CELL REP, V2, P366, DOI 10.1016/j.stemcr.2014.01.014; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	36	490	517	1	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					471	487		10.1016/j.stem.2014.07.002	http://dx.doi.org/10.1016/j.stem.2014.07.002			17	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25090446	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000343235800013
J	Oburoglu, L; Tardito, S; Fritz, V; de Barros, SC; Merida, P; Craveiro, M; Mamede, J; Cretenet, G; Mongellaz, C; An, XL; Klysz, D; Touhami, J; Boyer-Clavel, M; Battini, JL; Dardalhon, V; Zimmermann, VS; Mohandas, N; Gottlieb, E; Sitbon, M; Kinet, S; Taylor, N				Oburoglu, Leal; Tardito, Saverio; Fritz, Vanessa; de Barros, Stephanie C.; Merida, Peggy; Craveiro, Marco; Mamede, Joao; Cretenet, Gaspard; Mongellaz, Cedric; An, Xiuli; Klysz, Dorota; Touhami, Jawida; Boyer-Clavel, Myriam; Battini, Jean-Luc; Dardalhon, Valerie; Zimmermann, Valerie S.; Mohandas, Narla; Gottlieb, Eyal; Sitbon, Marc; Kinet, Sandrina; Taylor, Naomi			Glucose and Glutamine Metabolism Regulate Human Hematopoietic Stem Cell Lineage Specification	CELL STEM CELL			English	Article							DISTINCT STAGES; TCA CYCLE; ACID; DIFFERENTIATION; TRANSPORT; PATHWAY; CANCER; GLYCOLYSIS; EXPRESSION; GROWTH	The metabolic state of quiescent hematopoietic stem cells (HSCs) is an important regulator of self-renewal, but it is unclear whether or how metabolic parameters contribute to HSC lineage specification and commitment. Here, we show that the commitment of human and murine HSCs to the erythroid lineage is dependent upon glutamine metabolism. HSCs require the ASCT2 glutamine transporter and active glutamine metabolism for erythroid specification. Blocking this pathway diverts EPO-stimulated HSCs to differentiate into myelomonocytic fates, altering in vivo HSC responses and erythroid commitment under stress conditions such as hemolytic anemia. Mechanistically, erythroid specification of HSCs requires glutamine-dependent de novo nucleotide biosynthesis. Exogenous nucleosides rescue erythroid commitment of human HSCs under conditions of limited glutamine catabolism, and glucose-stimulated nucleotide biosynthesis further enhances erythroid specification. Thus, the availability of glutamine and glucose to provide fuel for nucleotide biosynthesis regulates HSC lineage commitment under conditions of metabolic stress.	[Oburoglu, Leal; Fritz, Vanessa; de Barros, Stephanie C.; Merida, Peggy; Craveiro, Marco; Mamede, Joao; Cretenet, Gaspard; Mongellaz, Cedric; Klysz, Dorota; Touhami, Jawida; Boyer-Clavel, Myriam; Battini, Jean-Luc; Dardalhon, Valerie; Zimmermann, Valerie S.; Sitbon, Marc; Kinet, Sandrina; Taylor, Naomi] Univ Montpellier I, CNRS, Inst Genet Mol Montpellier, UMR5535, F-34293 Montpellier, France; [Oburoglu, Leal; Fritz, Vanessa; de Barros, Stephanie C.; Merida, Peggy; Craveiro, Marco; Mamede, Joao; Cretenet, Gaspard; Mongellaz, Cedric; Klysz, Dorota; Touhami, Jawida; Boyer-Clavel, Myriam; Battini, Jean-Luc; Dardalhon, Valerie; Zimmermann, Valerie S.; Sitbon, Marc; Kinet, Sandrina; Taylor, Naomi] Univ Montpellier 2, CNRS, Inst Genet Mol Montpellier, UMR5535, F-34293 Montpellier, France; [Oburoglu, Leal; Fritz, Vanessa; de Barros, Stephanie C.; Merida, Peggy; Craveiro, Marco; Mamede, Joao; Cretenet, Gaspard; Mongellaz, Cedric; Klysz, Dorota; Touhami, Jawida; Battini, Jean-Luc; Dardalhon, Valerie; Zimmermann, Valerie S.; Sitbon, Marc; Kinet, Sandrina; Taylor, Naomi] Lab Excellence GR Ex, F-75015 Paris, France; [Tardito, Saverio; Gottlieb, Eyal] Beatson Inst, Canc Res UK, Glasgow G61 1BD, Lanark, Scotland; [An, Xiuli; Mohandas, Narla] New York Blood Ctr, New York, NY 10032 USA; [An, Xiuli] Zhengzhou Univ, Dept Bioengn, Zhengzhou 450051, Peoples R China	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Beatson Institute; Cancer Research UK; New York Blood Center; Zhengzhou University	Kinet, S (corresponding author), Univ Montpellier I, CNRS, Inst Genet Mol Montpellier, UMR5535, F-34293 Montpellier, France.	kinet@igmm.cnrs.fr; taylor@igmm.cnrs.fr	Sitbon, Marc/A-6771-2010; Gottlieb, Eyal/G-6450-2010; Taylor, Naomi/H-4016-2014; Tardito, Saverio/AAJ-7727-2020; Oburoglu, Leal/AAG-4791-2019	Sitbon, Marc/0000-0003-3616-2338; Gottlieb, Eyal/0000-0002-9770-0956; Tardito, Saverio/0000-0002-5294-8683; Oburoglu, Leal/0000-0003-0130-6602; Craveiro, Marco/0000-0002-7405-4621; Battini, Jean-Luc/0000-0002-5884-9934; kinet, sandrina/0000-0003-0699-108X; , Valerie/0000-0001-8919-0071; C. de Barros, Stephanie/0000-0003-1168-069X; Mamede, Joao/0000-0002-6048-1876	Ligue Contre le Cancer; Association de la Recherche contre le Cancer (ARC); AIRC/Marie Curie International Fellowship for Cancer Research; AFM; Fondation de la Recherche Medicale; Portuguese Foundation for Science and Technology; EU Marie Curie grant (ATTRACT); CNRS; Cancer Research UK; INSERM; French national (ANR) research grant GlutStem; ARC; AFMTelethon; INCA; French laboratory of excellence (Labex) GR-Ex [ANR-11-LABX-0051]; French laboratory of excellence (Labex) EpiGenMed; Cancer Research UK [18278] Funding Source: researchfish	Ligue Contre le Cancer(Ligue nationale contre le cancer); Association de la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); AIRC/Marie Curie International Fellowship for Cancer Research(Fondazione AIRC per la ricerca sul cancro); AFM(Association Francaise contre les Myopathies); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); EU Marie Curie grant (ATTRACT); CNRS(Centre National de la Recherche Scientifique (CNRS)); Cancer Research UK(Cancer Research UK); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French national (ANR) research grant GlutStem(French National Research Agency (ANR)); ARC(Australian Research Council); AFMTelethon(Association Francaise contre les Myopathies); INCA(Institut National du Cancer (INCA) France); French laboratory of excellence (Labex) GR-Ex; French laboratory of excellence (Labex) EpiGenMed; Cancer Research UK(Cancer Research UK)	We thank all members of our laboratories for discussions, scientific critique, and continual support. We are indebted to the maternity staff at the Clinique St. Roch, Montpellier, for their precious assistance and continual support. We are indebted to Alfred Singer and David Scadden for their important insights and critical input. We are very grateful to Megan Bywater, Cathy Wilson, and Gerard Evan for sharing their expertise on the relationship between Myc and metabolic function and to Lise Willems and Didier Bouscary for their assistance with SLC1A5 shRNA plasmids. We thank Montpellier Rio Imaging and the RAM animal facility for assistance with cytometry and animal experiments, respectively. L.O. and G. C. have been supported by a fellowship from the Ligue Contre le Cancer. L.O. is presently supported by the Association de la Recherche contre le Cancer (ARC), S. T. by an AIRC/Marie Curie International Fellowship for Cancer Research, V. F. and S.d.B. by the AFM, P. M. by a grant from the Fondation de la Recherche Medicale, M. C. and J.M. by the Portuguese Foundation for Science and Technology, and D. K. by an EU Marie Curie grant (ATTRACT). C. M., V. D., V.Z., S. K., and M. B.-C. are supported by CNRS, E.G. by Cancer Research UK, and J.-L.B., M. S., and N.T. by INSERM. This work was supported by generous funding from a French national (ANR) research grant GlutStem, the ARC, the AFMTelethon, the Fondation de la Recherche Medicale, la Ligue contre le Cancer, INCA, and the French laboratories of excellence (Labex) GR-Ex (ANR-11-LABX-0051) and EpiGenMed.	Berlicki L, 2008, MINI-REV MED CHEM, V8, P869, DOI 10.2174/138955708785132800; Chen JQ, 2012, BBA-REV CANCER, V1826, P370, DOI 10.1016/j.bbcan.2012.06.004; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Fuchs BC, 2007, AM J PHYSIOL-CELL PH, V293, pC55, DOI 10.1152/ajpcell.00330.2006; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Kaadige MR, 2010, TRANSCR-AUSTIN, V1, P36, DOI 10.4161/trns.1.1.12142; Kanai Y, 2004, PFLUG ARCH EUR J PHY, V447, P469, DOI 10.1007/s00424-003-1146-4; Laval J, 2013, J IMMUNOL, V190, P6043, DOI 10.4049/jimmunol.1201755; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; LEVITZKI A, 1971, BIOCHEMISTRY-US, V10, P3365, DOI 10.1021/bi00794a008; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Loisel-Meyer S, 2012, P NATL ACAD SCI USA, V109, P2549, DOI 10.1073/pnas.1121427109; Lyssiotis CA, 2013, CELL CYCLE, V12, P1987, DOI 10.4161/cc.25307; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Miharada K, 2011, CELL STEM CELL, V9, P330, DOI 10.1016/j.stem.2011.07.016; Miwa H, 2013, ONCOL REP, V29, P2053, DOI 10.3892/or.2013.2299; Montel-Hagen A, 2008, CELL, V132, P1039, DOI 10.1016/j.cell.2008.01.042; Montel-Hagen A, 2009, CURR OPIN HEMATOL, V16, P165, DOI 10.1097/MOH.0b013e328329905c; Montel-Hagen A, 2009, CELL, V137, P201, DOI 10.1016/j.cell.2009.04.009; Montel-Hagen A, 2008, BLOOD, V112, P4729, DOI 10.1182/blood-2008-05-159269; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Ogawa E, 2008, J COMP PHYSIOL B, V178, P699, DOI 10.1007/s00360-008-0258-8; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Reynolds MR, 2014, ONCOGENE, V33, P556, DOI 10.1038/onc.2012.635; Sandulache VC, 2011, CANCER-AM CANCER SOC, V117, P2926, DOI 10.1002/cncr.25868; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; SOLS A, 1954, J BIOL CHEM, V210, P581; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; SUZUKI M, 1983, COMP BIOCHEM PHYS B, V75, P195, DOI 10.1016/0305-0491(83)90312-7; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022	51	174	181	4	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					169	184		10.1016/j.stem.2014.06.002	http://dx.doi.org/10.1016/j.stem.2014.06.002			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	24953180	Bronze			2022-12-28	WOS:000340880100010
J	Lu, Y; Loh, YH; Li, H; Cesana, M; Ficarro, SB; Parikh, JR; Salomonis, N; Toh, CXD; Andreadis, ST; Luckey, CJ; Collins, JJ; Daley, GQ; Marto, JA				Lu, Yu; Loh, Yuin-Han; Li, Hu; Cesana, Marcella; Ficarro, Scott B.; Parikh, Jignesh R.; Salomonis, Nathan; Toh, Cheng-Xu Delon; Andreadis, Stelios T.; Luckey, C. John; Collins, James J.; Daley, George Q.; Marto, Jarrod A.			Alternative Splicing of MBD2 Supports Self-Renewal in Human Pluripotent Stem Cells	CELL STEM CELL			English	Article							TRANSCRIPTIONAL REGULATORY CIRCUITRY; GENE-EXPRESSION; SOMATIC-CELLS; REVEALS; NURD; DIFFERENTIATION; METHYLATION; DYNAMICS; COMPLEX; NANOG	Alternative RNA splicing (AS) regulates proteome diversity, including isoform-specific expression of several pluripotency genes. Here, we integrated global gene expression and proteomic analyses and identified a molecular signature suggesting a central role for AS in maintaining human pluripotent stem cell (hPSC) self-renewal. We demonstrate that the splicing factor SFRS2 is an OCT4 target gene required for pluripotency. SFRS2 regulates AS of the methyl-CpG binding protein MBD2, whose isoforms play opposing roles in maintenance of and reprogramming to pluripotency. Although both MDB2a and MBD2c are enriched at the OCT4 and NANOG promoters, MBD2a preferentially interacts with repressive NuRD chromatin remodeling factors and promotes hPSC differentiation, whereas overexpression of MBD2c enhances reprogramming of fibroblasts to pluripotency. The miR-301 and miR-302 families provide additional regulation by targeting SFRS2 and MDB2a. These data suggest that OCT4, SFRS2, and MBD2 participate in a positive feedback loop, regulating proteome diversity in support of hPSC self-renewal and reprogramming.	[Lu, Yu; Ficarro, Scott B.; Marto, Jarrod A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Lu, Yu; Loh, Yuin-Han; Cesana, Marcella; Ficarro, Scott B.; Daley, George Q.; Marto, Jarrod A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lu, Yu; Luckey, C. John] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Loh, Yuin-Han; Cesana, Marcella; Daley, George Q.] Childrens Hosp Boston, Howard Hughes Med Inst, Div Pediat Hematol Oncol, Dept Med, Boston, MA 02115 USA; [Loh, Yuin-Han; Cesana, Marcella; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Loh, Yuin-Han; Toh, Cheng-Xu Delon] Natl Univ Singapore, A STAR Inst Mol & Cell Biol, Singapore 138673, Singapore; [Loh, Yuin-Han; Toh, Cheng-Xu Delon] Natl Univ Singapore, Dept Biol Sci, Singapore 138673, Singapore; [Li, Hu; Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Boston Univ, Ctr Synthet Biol, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Li, Hu] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Ctr Individualized Med, Rochester, MN 55905 USA; [Ficarro, Scott B.; Parikh, Jignesh R.; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Boston, MA 02115 USA; [Parikh, Jignesh R.] Boston Univ, Bioinformat Program, Boston, MA 02115 USA; [Salomonis, Nathan] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Andreadis, Stelios T.] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; Boston University; Howard Hughes Medical Institute; Boston University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Boston University; University of California System; University of California San Francisco; The J David Gladstone Institutes; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Daley, GQ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; jarrod_marto@dfci.harvard.edu	Cesana, Marcella/AAC-2697-2022; Loh, Yuin-Han/E-1096-2014	Cesana, Marcella/0000-0002-9099-8681; Luckey, Chance John/0000-0002-0787-9121; Loh, Yuin-Han/0000-0002-4715-6454	A*STAR Investigator research award; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Center for Regenerative Medicine; Pathology Department of the Brigham and Women's Hospital; National Blood Foundation; Howard Hughes Medical Institute; SysCODE (Systems-based Consortium for Organ Design Engineering); NIH grant [RL1DE019021]; Dana-Farber Cancer Institute; Harvard Stem Cell Institute [P01GM099117]; NIH/NINDS [P01NS047572]; NIGMS [5P50GM099117]; NIH/NHLBI [5RC2HL102815-02];  [T32HL66987-11]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987, R01HL086582, RC2HL102815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RL1DE019021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047572] Funding Source: NIH RePORTER	A*STAR Investigator research award(Agency for Science Technology & Research (A*STAR)); Mayo Clinic Center for Individualized Medicine; Mayo Clinic Center for Regenerative Medicine; Pathology Department of the Brigham and Women's Hospital; National Blood Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); SysCODE (Systems-based Consortium for Organ Design Engineering); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber Cancer Institute; Harvard Stem Cell Institute; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Sahalie for technical assistance, M.W. Lensch for teratoma interpretation, and G. Adelmant for critical reading of the manuscript. Y.-H.L. is supported by the A*STAR Investigator research award. H.L. is supported by Mayo Clinic Center for Individualized Medicine and Mayo Clinic Center for Regenerative Medicine. Generous support for this work was provided (to C.J.L.) by the Pathology Department of the Brigham and Women's Hospital and the National Blood Foundation. J. J. C. is supported by Howard Hughes Medical Institute, SysCODE (Systems-based Consortium for Organ Design & Engineering), and NIH grant RL1DE019021. Generous support for this work was provided (to J. A. M.) by the Dana-Farber Cancer Institute, the Harvard Stem Cell Institute (P01GM099117), and the NIH/NINDS P01NS047572. Y.L. acknowledges support from T32HL66987-11. G.Q.D. is supported by the Howard Hughes Medical Institute and NIGMS 5P50GM099117. G.Q.D., J.J.C., and J.A.M. acknowledge support from NIH/NHLBI 5RC2HL102815-02. G.Q.D. serves on the scientific advisory boards of iPierian, Inc., Verastem, Inc., and MPM Capital.	Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Das S, 2011, J BIOL CHEM, V286, P42690, DOI 10.1074/jbc.M111.290189; De Los Angeles A, 2012, CURR OPIN GENET DEV, V22, P272, DOI 10.1016/j.gde.2012.03.001; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Ficarro SB, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O111.011064; Ficarro SB, 2009, ANAL CHEM, V81, P4566, DOI 10.1021/ac9004452; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee MR, 2013, STEM CELLS, V31, P666, DOI 10.1002/stem.1302; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 2005, MOL CELL BIOL, V25, P7929, DOI 10.1128/MCB.25.18.7929-7939.2005; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	46	71	75	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					92	101		10.1016/j.stem.2014.04.002	http://dx.doi.org/10.1016/j.stem.2014.04.002			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24813856	Green Accepted, Bronze			2022-12-28	WOS:000340878600014
J	Palii, CG; Vulesevic, B; Fraineau, S; Pranckeviciene, E; Griffith, AJ; Chu, A; Faralli, H; Li, YH; McNeill, B; Sun, J; Perkins, TJ; Dilworth, FJ; Perez-Iratxeta, C; Suuronen, EJ; Allan, DS; Brand, M				Palii, Carmen G.; Vulesevic, Branka; Fraineau, Sylvain; Pranckeviciene, Erinija; Griffith, Alexander J.; Chu, Alphonse; Faralli, Herve; Li, Yuhua; McNeill, Brian; Sun, Jie; Perkins, Theodore J.; Dilworth, F. Jeffrey; Perez-Iratxeta, Carol; Suuronen, Erik J.; Allan, David S.; Brand, Marjorie			Trichostatin A Enhances Vascular Repair by Injected Human Endothelial Progenitors through Increasing the Expression of TAL1-Dependent Genes	CELL STEM CELL			English	Article							COLONY-FORMING CELLS; GENOME-WIDE ANALYSIS; TRANSCRIPTIONAL CONTROL; HAEMOGENIC ENDOTHELIUM; BLOOD FORMATION; VE-CADHERIN; ADULT; SCL; NEOVASCULARIZATION; CHROMATIN	A major goal of cell therapy for vascular diseases is to promote revascularization through the injection of endothelial stem/progenitor cells. The gene regulatory mechanisms that underlie endothelial progenitor-mediated vascular repair, however, remain elusive. Here, we identify the transcription factor TAL1/SCL as a key mediator of the vascular repair function of primary human endothelial colony-forming cells (ECFCs). Genome-wide analyses in ECFCs demonstrate that TAL1 activates a transcriptional program that promotes cell adhesion and migration. At the mechanistic level, we show that TAL1 upregulates the expression of migratory and adhesion genes through recruitment of the histone acetyltransferase p300. Based on these findings, we establish a strategy that enhances the revascularization efficiency of ECFCs after ischemia through ex vivo priming with the histone deacetylase inhibitor TSA. Thus, small molecule epigenetics drugs are effective tools for modifying the epigenome of stem/progenitor cells prior to transplantation as a means to enhance their therapeutic potential.	[Palii, Carmen G.; Fraineau, Sylvain; Pranckeviciene, Erinija; Griffith, Alexander J.; Chu, Alphonse; Faralli, Herve; Li, Yuhua; Sun, Jie; Perkins, Theodore J.; Dilworth, F. Jeffrey; Perez-Iratxeta, Carol; Allan, David S.; Brand, Marjorie] Ottawa Hosp, Res Inst, Sprott Ctr Stem Cell Res, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada; [Vulesevic, Branka; McNeill, Brian; Suuronen, Erik J.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada; [Vulesevic, Branka; Fraineau, Sylvain; Pranckeviciene, Erinija; Faralli, Herve; Dilworth, F. Jeffrey; Perez-Iratxeta, Carol; Suuronen, Erik J.; Brand, Marjorie] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8L6, Canada; [Griffith, Alexander J.; Perkins, Theodore J.] Univ Ottawa, Ottawa Carleton Joint Program Biomed Engn, Ottawa, ON K1H 8L6, Canada; [Perkins, Theodore J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa; University of Ottawa	Brand, M (corresponding author), Ottawa Hosp, Res Inst, Sprott Ctr Stem Cell Res, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada.	mbrand@ohri.ca	Pranckeviciene, Erinija/G-7777-2017; Fraineau, Sylvain/AAA-1745-2020; Li, yu/HHZ-5236-2022; SUN, JIE/AAC-3145-2022	Pranckeviciene, Erinija/0000-0003-1365-3564; Fraineau, Sylvain/0000-0001-6301-562X; Allan, David/0000-0003-3261-8289; Chu, Alphonse/0000-0003-4091-9575; Vulesevic, Branka/0000-0003-2297-2209; Perkins, Theodore J./0000-0002-6622-8003; Dilworth, F. Jeffrey/0000-0002-6265-8102	Canadian Institutes of Health Research [MOP-82813]; Department of Medicine, University of Ottawa; Heart & Stroke Foundation of Canada [GIA-000225]; Cardiovascular Repair using Enhanced Stem Cell Therapy program; CIHR; Cushing Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Department of Medicine, University of Ottawa; Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Cardiovascular Repair using Enhanced Stem Cell Therapy program; CIHR(Canadian Institutes of Health Research (CIHR)); Cushing Fund	We thank C. L. Addison (OHRI) for help with the collagen assay; E. Chernetsova, J.J. Collins, and B. Thebaud (OHRI) for help with immunohistochemistry; Z. Yao (Fred Hutchinson Cancer Research Center, Seattle, WA) for help with bioinformatics analysis; L. Megeney (OHRI) for reagents; and M. Rudnicki and B. Thebaud (OHRI) for critically reading the manuscript. Affymetrix microarray analysis was done at the StemCore Laboratories (Ottawa, ON). High-throughput DNA sequencing was done at the McGill University and Genome Quebec Innovation Centre (Montreal, QC). This project was funded with grants from the Canadian Institutes of Health Research (MOP-82813 to M. B.); the Department of Medicine, University of Ottawa (to D. A.); and the Heart & Stroke Foundation of Canada (GIA-000225 to E.J.S.). C. G. P. is supported in part by the Cardiovascular Repair using Enhanced Stem Cell Therapy program. B. V. is supported by a graduate scholarship from CIHR. S. F. is supported by the Cushing Fund. M. B. holds the Canadian Research Chair in the Regulation of Gene Expression, and D. A. holds a New Investigator Award from CIHR.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318; Bouvard C, 2010, ARTERIOSCL THROM VAS, V30, P1569, DOI 10.1161/ATVBAHA.110.209163; Brand M, 2008, NAT PROTOC, V3, P398, DOI 10.1038/nprot.2008.8; Bruhl T, 2004, CIRC RES, V94, P743, DOI 10.1161/01.RES.0000120861.27064.09; Callum K, 2000, BRIT MED J, V320, P764, DOI 10.1136/bmj.320.7237.764; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chetty R, 1997, J PATHOL, V181, P311, DOI 10.1002/(SICI)1096-9896(199703)181:3<311::AID-PATH775>3.0.CO;2-B; Costa G, 2012, DEVELOPMENT, V139, P1587, DOI 10.1242/dev.071282; Creager MA, 2012, NEW ENGL J MED, V366, P2198, DOI 10.1056/NEJMcp1006054; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Deleuze V, 2007, MOL CELL BIOL, V27, P2687, DOI 10.1128/MCB.00493-06; Dooley KA, 2005, DEV BIOL, V277, P522, DOI 10.1016/j.ydbio.2004.09.004; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Fong AP, 2012, DEV CELL, V22, P721, DOI 10.1016/j.devcel.2012.01.015; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Huang SM, 1999, ONCOGENE, V18, P4958, DOI 10.1038/sj.onc.1202889; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lee RH, 2006, BLOOD, V107, P2153, DOI 10.1182/blood-2005-07-2701; Leeper NJ, 2010, CIRCULATION, V122, P517, DOI 10.1161/CIRCULATIONAHA.109.881441; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Liu J, 2012, FRONT BIOSCI-LANDMRK, V17, P2559, DOI 10.2741/4071; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Moubarik C, 2011, STEM CELL REV REP, V7, P208, DOI 10.1007/s12015-010-9157-y; Palii CG, 2011, JOVE-J VIS EXP, DOI 10.3791/2813; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Patterson LJ, 2005, BLOOD, V105, P3502, DOI 10.1182/blood-2004-09-3547; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Rossig L, 2005, J EXP MED, V201, P1825, DOI 10.1084/jem.20042097; Saif J, 2010, ARTERIOSCL THROM VAS, V30, P1897, DOI 10.1161/ATVBAHA.110.207928; Salvucci O, 2012, ADV CANCER RES, V114, P21, DOI 10.1016/B978-0-12-386503-8.00002-8; Schwarz TM, 2012, ARTERIOSCL THROM VAS, V32, pE13, DOI 10.1161/ATVBAHA.111.239822; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Van Handel B, 2012, CELL, V150, P590, DOI 10.1016/j.cell.2012.06.026; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoder MC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006692; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Ziebart T, 2008, CIRC RES, V103, P1327, DOI 10.1161/CIRCRESAHA.108.180463	50	44	44	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					644	657		10.1016/j.stem.2014.03.003	http://dx.doi.org/10.1016/j.stem.2014.03.003			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24792117	Bronze			2022-12-28	WOS:000335659900013
J	David, L; Hirsch, CL				David, Laurent; Hirsch, Calley L.			How Tets and Cytoskeleton Dynamics MET in Reprogramming	CELL STEM CELL			English	Editorial Material							PLURIPOTENCY; TRANSITION	Two studies by Sakurai et al. (2014) and Hu et al. (2014) in this issue of Cell Stem Cell add a new level of understanding to the mesenchymal-to-epithelial transition taking place during reprogramming, showing how this morphological transformation is promoted by Tet enzymes and blocked by kinase-dependent cytoskeletal organization.	[David, Laurent] INSERM, UMR 1064, F-44093 Nantes 1, France; [David, Laurent] Univ Nantes, Fac Med, F-44035 Nantes 1, France; [David, Laurent] Univ Nantes, iPSC Core Facil, SFR F Bonamy, F-44035 Nantes, France; [Hirsch, Calley L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	David, L (corresponding author), INSERM, UMR 1064, F-44093 Nantes 1, France.	laurent.david@univ-nantes.fr		David, Laurent/0000-0003-3594-0353				Bagci H, 2013, CELL STEM CELL, V13, P265, DOI 10.1016/j.stem.2013.08.005; David L., 2014, STEM CELL R IN PRESS; Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/NMAT3777, 10.1038/nmat3777]; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Hu X, 2014, CELL STEM CELL, V14, P512, DOI 10.1016/j.stem.2014.01.001; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Sakurai K, 2014, CELL STEM CELL, V14, P523, DOI 10.1016/j.stem.2014.03.001; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005	10	0	0	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					417	418		10.1016/j.stem.2014.03.007	http://dx.doi.org/10.1016/j.stem.2014.03.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24702989	Bronze			2022-12-28	WOS:000334766400002
J	Du, YY; Wang, JL; Jia, J; Song, N; Xiang, CG; Xu, J; Hou, ZY; Su, XH; Liu, B; Jiang, T; Zhao, DX; Sun, YL; Shu, J; Guo, QL; Yin, M; Sun, D; Lu, SC; Shi, Y; Deng, HK				Du, Yuanyuan; Wang, Jinlin; Jia, Jun; Song, Nan; Xiang, Chengang; Xu, Jun; Hou, Zhiyuan; Su, Xiaohua; Liu, Bei; Jiang, Tao; Zhao, Dongxin; Sun, Yingli; Shu, Jian; Guo, Qingliang; Yin, Ming; Sun, Da; Lu, Shichun; Shi, Yan; Deng, Hongkui			Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming	CELL STEM CELL			English	Article							CELL-DERIVED HEPATOCYTES; PANCREAS PROGENITORS; LIVER; DIFFERENTIATION; MATURATION; SYSTEMS	Obtaining fully functional cell types is a major challenge for drug discovery and regenerative medicine. Currently, a fundamental solution to this key problem is still lacking. Here, we show that functional human induced hepatocytes (hiHeps) can be generated from fibroblasts by overexpressing the hepatic fate conversion factors HNF1A, HNF4A, and HNF6 along with the maturation factors ATF5, PROX1, and CEBPA. hiHeps express a spectrum of phase I and II drug-metabolizing enzymes and phase III drug transporters. Importantly, the metabolic activities of CYP3A4, CYP1A2, CYP2B6, CYP2C9, and CYP2C19 are comparable between hiHeps and freshly isolated primary human hepatocytes. Transplanted hiHeps repopulate up to 30% of the livers of Tet-uPA/Rag2(-/-)/gamma c(-/-) mice and secrete more than 300 mu g/ml human ALBUMIN in vivo. Our data demonstrate that human hepatocytes with drug metabolic function can be generated by lineage reprogramming, thus providing a cell resource for pharmaceutical applications.	[Du, Yuanyuan; Jia, Jun; Song, Nan; Xiang, Chengang; Xu, Jun; Su, Xiaohua; Zhao, Dongxin; Shu, Jian; Yin, Ming; Deng, Hongkui] Peking Univ, Peking Tsinghua Ctr Life Sci, Coll Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Wang, Jinlin; Jia, Jun; Song, Nan; Liu, Bei; Sun, Da; Shi, Yan; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Genom, Shenzhen Stem Cell Engn Lab, Shenzhen 518055, Peoples R China; [Deng, Hongkui] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Peking Univ Stem Cell Res Ctr,Dept Cell Biol, Beijing 100191, Peoples R China; [Hou, Zhiyuan] Beijing Vitalstar Biotechnol, Beijing 100012, Peoples R China; [Jiang, Tao; Guo, Qingliang; Lu, Shichun] Chinese Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing 100853, Peoples R China; [Sun, Yingli] Chinese Acad Sci, Beijing Inst Genom, Lab Genome Variat & Precis Biomed, Beijing 100101, Peoples R China	Peking University; Peking University; University Town of Shenzhen; Peking University; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Lu, SC (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing 100853, Peoples R China.	lsc620213@aliyun.com; shiyan@pkusz.edu.cn; hongkui_deng@pku.edu.cn	Zhao, Dongxin/K-4932-2016	song, Nan/0000-0002-1743-9402; xiang, chen gang/0000-0001-8630-6446	National Basic Research Program of China [973 Program 2012CB966401]; Ministry of Science and Technology [2011AA020107, 2013DFG30680]; Science and Technology Commission of Beijing [Z121100005212001]; Key New Drug Creation and Manufacturing Program [2011ZX09102-010-03]; Ministry of Education of China (111 Project); Bill & Melinda Gates Foundation [1023963, 37871]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Science and Technology Commission of Beijing; Key New Drug Creation and Manufacturing Program; Ministry of Education of China (111 Project); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	We thank Yinan Liu for qRT-PCR analysis; Jun Zhang of the 306th Hospital of PLA for karyotype analysis; and Yang Zhao, Chengyan Wang, and Xiang Li for discussions in the course of the preparation of this manuscript. This work was supported by the National Basic Research Program of China (973 Program 2012CB966401), Ministry of Science and Technology (2011AA020107 and 2013DFG30680), Science and Technology Commission of Beijing (Z121100005212001), Key New Drug Creation and Manufacturing Program (2011ZX09102-010-03), Ministry of Education of China (111 Project), and Bill & Melinda Gates Foundation (grants 1023963 and 37871).	Baranczewski P, 2006, PHARMACOL REP, V58, P453; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44; Elaut G, 2006, CURR DRUG METAB, V7, P629, DOI 10.2174/138920006778017759; Gebhardt R, 2003, DRUG METAB REV, V35, P145, DOI 10.1081/DMR-120023684; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Nagaoka M, 2010, PROG MOL BIOL TRANSL, V97, P79, DOI 10.1016/B978-0-12-385233-5.00003-9; Nakata K, 2006, DRUG METAB PHARMACOK, V21, P437, DOI 10.2133/dmpk.21.437; Ogawa S, 2013, DEVELOPMENT, V140, P3285, DOI 10.1242/dev.090266; Sahi Jasminder, 2010, Curr Drug Discov Technol, V7, P188; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Song XJ, 2009, AM J PATHOL, V175, P1975, DOI 10.2353/ajpath.2009.090349; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Willenbring H, 2011, CELL STEM CELL, V9, P89, DOI 10.1016/j.stem.2011.07.009; Woo DH, 2012, GASTROENTEROLOGY, V142, P602, DOI 10.1053/j.gastro.2011.11.030; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhao DX, 2013, CELL RES, V23, P157, DOI 10.1038/cr.2012.144; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483	22	216	234	0	96	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					394	403		10.1016/j.stem.2014.01.008	http://dx.doi.org/10.1016/j.stem.2014.01.008			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24582926	Bronze			2022-12-28	WOS:000332533400015
J	Pietras, A; Katz, AM; Ekstrom, EJ; Wee, B; Halliday, JJ; Pitter, KL; Werbeck, JL; Amankulor, NM; Huse, JT; Holland, EC				Pietras, Alexander; Katz, Amanda M.; Ekstroem, Elin J.; Wee, Boyoung; Halliday, John J.; Pitter, Kenneth L.; Werbeck, Jillian L.; Amankulor, Nduka M.; Huse, Jason T.; Holland, Eric C.			Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth	CELL STEM CELL			English	Article							HYPOXIA-INDUCIBLE FACTORS; GENE-EXPRESSION; CD44; HIF-2-ALPHA; POPULATION; IDENTIFICATION; PROTEOLYSIS; INHIBITION; INCREASES; PROGNOSIS	Stem-like glioma cells reside within a perivascular niche and display hallmark radiation resistance. An understanding of the mechanisms underlying these properties will be vital for the development of effective therapies. Here, we show that the stem cell marker CD44 promotes cancer stem cell phenotypes and radiation resistance. In a mouse model of glioma, Cd44(-/-) and Cd44(+/-) animals showed improved survival compared to controls. The CD44 ligand osteopontin shared a perivascular expression pattern with CD44 and promoted glioma stem cell-like phenotypes. These effects were mediated via the gamma-secretase-regulated intracellular domain of CD44, which promoted aggressive glioma growth in vivo and stem cell-like phenotypes via CBP/p300-dependent enhancement of HIF-2 alpha activity. In human glioblastoma multiforme, expression of CD44 correlated with hypoxia-induced gene signatures and poor survival. Altogether, these data suggest that in the glioma perivascular niche, osteopontin promotes stem cell-like properties and radiation resistance in adjacent tumor cells via activation of CD44 signaling.	[Pietras, Alexander; Holland, Eric C.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; [Pietras, Alexander; Holland, Eric C.] Univ Washington, Alvord Brain Tumor Ctr, Seattle, WA 98104 USA; [Pietras, Alexander; Katz, Amanda M.; Wee, Boyoung; Halliday, John J.; Pitter, Kenneth L.; Werbeck, Jillian L.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Pietras, Alexander; Katz, Amanda M.; Wee, Boyoung; Halliday, John J.; Pitter, Kenneth L.; Werbeck, Jillian L.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [Ekstroem, Elin J.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Amankulor, Nduka M.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Holland, EC (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA.	eholland@fhcrc.org	Amankulor, Nduka/CAJ-3564-2022	Pietras, Alexander/0000-0002-5783-9347; Pitter, Kenneth/0000-0002-9450-313X; Pietras, Elin Josefina/0000-0003-1645-8916	National Institues of Health [U01 CA141502, U54 CA143798, U54CA163167, RO1 CA94842]; Swedish Research Council; Tegger Foundation; Swedish Childhood Cancer Foundation; NATIONAL CANCER INSTITUTE [U01CA141502, U01CA105492, T32CA157323, U54CA163167, U54CA126518, R01CA094842, U54CA143798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076028] Funding Source: NIH RePORTER	National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Tegger Foundation; Swedish Childhood Cancer Foundation(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Madhu Menon at the Memorial Sloan-Kettering Cancer Center Flow Cytometry Core Facility, Research Animal Resource Center staff, the experimental histopathology core facility at the Fred Hutchinson Cancer Research Center; Jim Finney, Deby Kumasaka, and Quanchao Zhang for skillful technical assistance; and members of the Holland lab for helpful discussions. We thank Dr. William G. Kaelin, Jr. (Dana Farber Cancer Institute), Dr. Navdeep Chandel (Northwestern University), and Dr. Robert Weinberg (Whitehead Institute for Biomedical Research) for plasmids. This work was supported by National Institues of Health grants U01 CA141502, U54 CA143798, U54CA163167, and RO1 CA94842. A. P. was supported by fellowships from the Swedish Research Council, the Tegger Foundation, and the Swedish Childhood Cancer Foundation.	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Barrett LE, 2012, CANCER CELL, V21, P11, DOI 10.1016/j.ccr.2011.11.025; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; De Falco V, 2012, CANCER RES, V72, P1449, DOI 10.1158/0008-5472.CAN-11-3320; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Haylock DN, 2005, CELL CYCLE, V4, P1353, DOI 10.4161/cc.4.10.2056; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Hsu KH, 2010, ANN SURG ONCOL, V17, P2199, DOI 10.1245/s10434-010-0927-1; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Katz AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032453; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Miletti-Gonzalez KE, 2012, J BIOL CHEM, V287, P18995, DOI 10.1074/jbc.M111.318774; Murakami D, 2003, ONCOGENE, V22, P1511, DOI 10.1038/sj.onc.1206298; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Pelletier L, 2006, CANCER RES, V66, P3681, DOI 10.1158/0008-5472.CAN-05-3870; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pietras A, 2008, J PATHOL, V214, P482, DOI 10.1002/path.2304; Pietras A, 2011, ADV CANCER RES, V112, P255, DOI 10.1016/B978-0-12-387688-1.00009-0; Pietras A, 2010, CURR TOP MICROBIOL, V345, P1, DOI 10.1007/82_2010_72; Semenza G. L., 2007, SCI STKE, V2007; Singh SK, 2003, CANCER RES, V63, P5821; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weiss JM, 2001, J EXP MED, V194, P1219, DOI 10.1084/jem.194.9.1219; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	48	328	340	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					357	369		10.1016/j.stem.2014.01.005	http://dx.doi.org/10.1016/j.stem.2014.01.005			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24607407	Bronze, Green Accepted			2022-12-28	WOS:000332533400012
J	Nguyen, LV; Makarem, M; Carles, A; Moksa, M; Kannan, N; Pandoh, P; Eirew, P; Osako, T; Kardel, M; Cheung, AMS; Kennedy, W; Tse, K; Zeng, T; Zhao, YJ; Humphries, RK; Aparicio, S; Eaves, CJ; Hirst, M				Nguyen, Long V.; Makarem, Maisam; Carles, Annaick; Moksa, Michelle; Kannan, Nagarajan; Pandoh, Pawan; Eirew, Peter; Osako, Tomo; Kardel, Melanie; Cheung, Alice M. S.; Kennedy, William; Tse, Kane; Zeng, Thomas; Zhao, Yongjun; Humphries, R. Keith; Aparicio, Samuel; Eaves, Connie J.; Hirst, Martin			Clonal Analysis via Barcoding Reveals Diverse Growth and Differentiation of Transplanted Mouse and Human Mammary Stem Cells	CELL STEM CELL			English	Article							BREAST-CANCER; INTEGRATION SITES; EPITHELIAL-CELLS; GLAND; POPULATION; EVOLUTION; PROGENITORS; GENERATION; MUTATIONS; TRACKING	Cellular barcoding offers a powerful approach to characterize the growth and differentiation activity of large numbers of cotransplanted stem cells. Here, we describe a lentiviral genomic-barcoding and analysis strategy and its use to compare the clonal outputs of transplants of purified mouse and human basal mammary epithelial cells. We found that both sources of transplanted cells produced many bilineage mammary epithelial clones in primary recipients, although primary clones containing only one detectable mammary lineage were also common. Interestingly, regardless of the species of origin, many clones evident in secondary recipients were not detected in the primary hosts, and others that were changed from appearing luminal-restricted to appearing bilineage. This barcoding methodology has thus revealed conservation between mice and humans of a previously unknown diversity in the growth and differentiation activities of their basal mammary epithelial cells stimulated to grow in transplanted hosts.	[Nguyen, Long V.; Makarem, Maisam; Kannan, Nagarajan; Kardel, Melanie; Kennedy, William; Humphries, R. Keith; Eaves, Connie J.] BC Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Carles, Annaick; Moksa, Michelle; Hirst, Martin] Univ British Columbia, Ctr High Throughput Biol, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; [Pandoh, Pawan; Tse, Kane; Zeng, Thomas; Zhao, Yongjun; Hirst, Martin] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Eirew, Peter; Osako, Tomo; Aparicio, Samuel] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Cheung, Alice M. S.] Univ Hong Kong, La Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Aparicio, Samuel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; British Columbia Cancer Agency; University of Hong Kong; University of British Columbia	Eaves, CJ (corresponding author), BC Canc Agcy, Terry Fox Lab, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca; mhirst@bcgsc.ca	Hirst, Martin/B-7684-2016; Cheung, Alice/B-3264-2011	Eaves, Connie/0000-0002-3452-1926; Cheung, Alice/0000-0003-2195-4017; Aparicio, Samuel/0000-0002-0487-9599; Humphries, Richard/0000-0003-0540-7005; Kannan, Nagarajan/0000-0002-8825-2178; Nguyen, Long/0000-0002-3347-438X	Canadian Breast Cancer Research Alliance; Canadian Cancer Society (CCS); Canadian Breast Cancer Foundation (CBCF); Avon Canada; Canadian Breast Cancer Network; Canadian Institutes of Health Research (CIHR); Stem Cell Network; Terry Fox Foundation [TFF-122869]; Health Canada; Public Health Agency of Canada; BC; Yukon Division of the CBCF; Canada Research Chair in Molecular Oncology	Canadian Breast Cancer Research Alliance; Canadian Cancer Society (CCS)(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation (CBCF); Avon Canada; Canadian Breast Cancer Network; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Stem Cell Network; Terry Fox Foundation; Health Canada; Public Health Agency of Canada; BC; Yukon Division of the CBCF; Canada Research Chair in Molecular Oncology(Canada Research Chairs)	The authors thank J. Emerman, U. Kuuske, J. Sproul, and N. Van Laeken for assistance in obtaining reduction mammoplasty samples; D. Ko and W. Xu (Flow Cytometry Facility, Terry Fox Laboratory) for assistance with flow cytometry; G. Edin, M. Hale, D. Wilkinson, and Patty Rosten for excellent technical support; and T. MacDonald for assistance with rodent husbandry. This work was supported by grants from the Canadian Breast Cancer Research Alliance funded by the Canadian Cancer Society (CCS) and the Canadian Breast Cancer Foundation (CBCF), in partnership with Avon Canada, the Canadian Breast Cancer Network, the CCS, the Canadian Institutes of Health Research (CIHR), the Stem Cell Network, a Terry Fox Foundation program project grant (TFF-122869), Health Canada, and the Public Health Agency of Canada. L. V. N. received a Vanier Canada Graduate Scholarship from the CIHR, M. M. and M. K. received Doctoral Canada Graduate Scholarships from CIHR, N. K. received a postdoctoral fellowship from the BC and Yukon Division of the CBCF, and T. O. is supported by a CIHR pathology training fellowship. S. A. is supported by a Canada Research Chair in Molecular Oncology.	Arens A, 2012, HUM GENE THER METHOD, V23, P111, DOI 10.1089/hgtb.2011.219; Bystrykh LV, 2012, NAT METHODS, V9, P567, DOI [10.1038/NMETH.2043, 10.1038/nmeth.2043]; Cheung AMS, 2013, BLOOD, V122, P3129, DOI 10.1182/blood-2013-06-508432; Choudhury S, 2013, CELL STEM CELL, V13, P117, DOI 10.1016/j.stem.2013.05.004; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Eirew P, 2012, STEM CELLS, V30, P344, DOI 10.1002/stem.1001; Eirew P, 2010, NAT PROTOC, V5, P1945, DOI 10.1038/nprot.2010.148; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Imren S, 2004, J CLIN INVEST, V114, P953, DOI 10.1172/JCI200421838; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kannan N, 2013, STEM CELL REP, V1, P28, DOI 10.1016/j.stemcr.2013.04.003; Kustikova Olga S., 2008, V430, P255, DOI 10.1007/978-1-59745-182-6_18; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Logan AC, 2004, HUM GENE THER, V15, P976, DOI 10.1089/hum.2004.15.976; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Makarem M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001630; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Raouf A, 2005, JNCI-J NATL CANCER I, V97, P1302, DOI 10.1093/jnci/dji254; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Regan JL, 2012, ONCOGENE, V31, P869, DOI 10.1038/onc.2011.289; Sambrook J., 2002, MOL CLONING LAB MANU; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Schmidt Manfred, 2009, V506, P363, DOI 10.1007/978-1-59745-409-4_24; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Smalley MJ, 2010, METHODS MOL BIOL, V633, P139, DOI 10.1007/978-1-59745-019-5_11; Spike BT, 2012, CELL STEM CELL, V10, P183, DOI 10.1016/j.stem.2011.12.018; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2012, J CELL BIOL, V197, P575, DOI 10.1083/jcb.201201041; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433	37	46	46	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					253	263		10.1016/j.stem.2013.12.011	http://dx.doi.org/10.1016/j.stem.2013.12.011			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24440600	Bronze			2022-12-28	WOS:000330835800016
J	Shinagawa, T; Takagi, T; Tsukamoto, D; Tomaru, C; Huynh, LM; Sivaraman, P; Kumarevel, T; Inoue, K; Nakato, R; Katou, Y; Sado, T; Takahashi, S; Ogura, A; Shirahige, K; Ishii, S				Shinagawa, Toshie; Takagi, Tsuyoshi; Tsukamoto, Daisuke; Tomaru, Chinatsu; Linh My Huynh; Sivaraman, Padavattan; Kumarevel, Thirumananseri; Inoue, Kimiko; Nakato, Ryuichiro; Katou, Yuki; Sado, Takashi; Takahashi, Satoru; Ogura, Atsuo; Shirahige, Katsuhiko; Ishii, Shunsuke			Histone Variants Enriched in Oocytes Enhance Reprogramming to Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							NUCLEAR TRANSFER; SOMATIC-CELLS; LINKER HISTONE; MOUSE EMBRYOS; CHROMATIN; TRANSCRIPTION; TESTIS; GENES; DECONDENSATION; NUCLEOPLASMIN	Expression of Oct3/4, Sox2, Klf4, and c-Myc (OSKM) can reprogram somatic cells into induced pluripotent stem cells (iPSCs). Somatic cell nuclear transfer (SCNT) can also be used for reprogramming, suggesting that factors present in oocytes could potentially augment OSKM-mediated induction of pluripotency. Here, we report that two histone variants, TH2A and TH2B, which are highly expressed in oocytes and contribute to activation of the paternal genome after fertilization, enhance OSKM-dependent generation of iPSCs and can induce reprogramming with Klf4 and Oct3/4 alone. TH2A and TH2B are enriched on the X chromosome during the reprogramming process, and their expression in somatic cells increases the DNase I sensitivity of chromatin. In addition, Xist deficiency, which was reported to enhance SCNT reprogramming efficiency, stimulates iPSC generation using TH2A/TH2B in conjunction with OSKM, but not OSKM alone. Thus, TH2A/TH2B may enhance reprogramming by introducing processes that normally operate in zygotes and during SCNT.	[Shinagawa, Toshie; Takagi, Tsuyoshi; Tsukamoto, Daisuke; Tomaru, Chinatsu; Linh My Huynh; Ishii, Shunsuke] RIKEN Tsukuba Inst, CREST Res Project JST Japan Sci & Technol Agcy, Lab Mol Genet, Tsukuba, Ibaraki 3050074, Japan; [Shinagawa, Toshie; Tomaru, Chinatsu; Linh My Huynh; Ishii, Shunsuke] Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Basic Med Sci, Dept Funct Genom, Tsukuba, Ibaraki 3058575, Japan; [Takahashi, Satoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Basic Med Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan; [Sivaraman, Padavattan; Kumarevel, Thirumananseri] RIKEN SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan; [Inoue, Kimiko; Ogura, Atsuo] RIKEN BioResource Ctr, Tsukuba, Ibaraki 3050074, Japan; [Nakato, Ryuichiro; Katou, Yuki; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan; [Nakato, Ryuichiro; Katou, Yuki; Shirahige, Katsuhiko] JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan; [Sado, Takashi] Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan	RIKEN; University of Tsukuba; University of Tsukuba; RIKEN; RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); Kyushu University	Shinagawa, T (corresponding author), RIKEN Tsukuba Inst, CREST Res Project JST Japan Sci & Technol Agcy, Lab Mol Genet, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	sinagawa@rtc.riken.jp; sishii@rtc.riken.jp	Sado, Takashi/AAI-1689-2019; Ishii, Shunsuke/A-5271-2016; Ogura, Atsuo/J-3916-2014; Kumarevel, Thirumananseri/C-6275-2012; Nakato, Ryuichiro/AAV-6405-2020	Ishii, Shunsuke/0000-0002-6530-2478; Ogura, Atsuo/0000-0003-0447-1988; Kumarevel, Thirumananseri/0000-0001-9326-6585; Nakato, Ryuichiro/0000-0003-3019-5817; Padavattan, Sivaraman/0000-0002-1732-5421; Sado, Takashi/0000-0002-1232-0250; HUYNH, MY LINH/0000-0003-4467-7067; Shirahige, Katsuhiko/0000-0002-7862-1144	Grants-in-Aid for Scientific Research [23370079] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Banaszynski LA, 2010, DEV CELL, V19, P662, DOI 10.1016/j.devcel.2010.10.014; Banuelos S, 2007, J BIOL CHEM, V282, P21213, DOI 10.1074/jbc.M702842200; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Edelman LB, 2012, CURR OPIN GENET DEV, V22, P110, DOI 10.1016/j.gde.2012.01.010; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hebbar PB, 2008, J BIOL CHEM, V283, P4595, DOI 10.1074/jbc.M709121200; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; HUH NE, 1991, NUCLEIC ACIDS RES, V19, P93, DOI 10.1093/nar/19.1.93; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Jullien J, 2010, P NATL ACAD SCI USA, V107, P5483, DOI 10.1073/pnas.1000599107; KIM YJ, 1987, DEV BIOL, V124, P23, DOI 10.1016/0012-1606(87)90455-6; LATHAM KE, 1992, DEV BIOL, V149, P457, DOI 10.1016/0012-1606(92)90300-6; Li A, 2005, BIOCHEMISTRY-US, V44, P2529, DOI 10.1021/bi048061n; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Montellier E, 2013, GENE DEV, V27, P1680, DOI 10.1101/gad.220095.113; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; SHIRES A, 1976, J BIOL CHEM, V251, P4155; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka M, 2001, DEVELOPMENT, V128, P655; TARKOWSKI AK, 1959, NATURE, V184, P1286, DOI 10.1038/1841286a0; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; TROSTLEWEIGE PK, 1982, J BIOL CHEM, V257, P5560; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	46	109	116	2	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					217	227		10.1016/j.stem.2013.12.015	http://dx.doi.org/10.1016/j.stem.2013.12.015			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24506885	Bronze			2022-12-28	WOS:000330835800013
J	O'Brien, LE				O'Brien, Lucy Erin			Regional Specificity in the Drosophila Midgut: Setting Boundaries with Stem Cells	CELL STEM CELL			English	Editorial Material							STOMACH	Many organs consist of distinct subregions with specialized physiological roles, but how regional boundaries are upheld during cellular renewal is largely unknown. Recently, Buchon et al. (2013) and Marianes and Spradling (2013) showed that subregions of the Drosophila midgut are maintained by patterned transcription factors and compartmentalized stem cell progeny.	Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	O'Brien, LE (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	lucye@stanford.edu			NIDDK NIH HHS [K01 DK083505] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK083505] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; O'Brien L.E., 2013, ANN REV CEL IN PRESS, DOI DOI 10.1146/ANNUREV-CELLBI0-101512-122319; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; San Roman AK, 2011, EXP CELL RES, V317, P2711, DOI 10.1016/j.yexcr.2011.07.011; Strand M, 2011, P NATL ACAD SCI USA, V108, P17696, DOI 10.1073/pnas.1109794108	10	10	10	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					375	376		10.1016/j.stem.2013.09.008	http://dx.doi.org/10.1016/j.stem.2013.09.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094316	Bronze, Green Accepted			2022-12-28	WOS:000329571100003
J	Folgueras, AR; Guo, XY; Pasolli, HA; Stokes, N; Polak, L; Zheng, DY; Fuchs, E				Folgueras, Alicia R.; Guo, Xingyi; Pasolli, H. Amalia; Stokes, Nicole; Polak, Lisa; Zheng, Deyou; Fuchs, Elaine			Architectural Niche Organization by LHX2 Is Linked to Hair Follicle Stem Cell Function	CELL STEM CELL			English	Article							LIM-HOMEOBOX GENE; SELF-RENEWAL; DIFFERENTIATION; LINEAGE; HOMEOSTASIS; ACTIVATION; CONTRIBUTE; PROGENY; DEFINES; ROLES	In adult skin, self-renewing, undifferentiated hair follicle stem cells (HF-SCs) reside within a specialized niche, where they spend prolonged times as a single layer of polarized, quiescent epithelial cells. When sufficient activating signals accumulate, HF-SCs become mobilized to fuel tissue regeneration and hair growth. Here, we show that architectural organization of the HF-SC niche by transcription factor LHX2 plays a critical role in HF-SC behavior. Using genome-wide chromatin and transcriptional profiling of HF-SCs in vivo, we show that LHX2 directly transactivates genes that orchestrate cytoskeletal dynamics and adhesion. Conditional ablation of LHX2 results in gross cellular disorganization and HF-SC polarization within the niche. LHX2 loss leads to a failure to maintain HF-SC quiescence and hair anchoring, as well as progressive transformation of the niche into a sebaceous gland. These findings suggest that niche organization underlies the requirement for LHX2 in hair follicle structure and function.	[Folgueras, Alicia R.; Pasolli, H. Amalia; Stokes, Nicole; Polak, Lisa; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Guo, Xingyi; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Folgueras, Alicia/B-3281-2017; Fuchs, Elaine/G-1565-2016	Folgueras, Alicia/0000-0003-3426-9502; Pasolli, Hilda Amalia/0000-0003-3899-3530; Zheng, Deyou/0000-0003-4354-5337	EMBO Postdoctoral Fellowship; National Institutes of Health NIAMS [R01AR31737]; New York State Department of Health [NYSTEM/C026427]; NIH/NIMH [R21MH099452]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099452] Funding Source: NIH RePORTER	EMBO Postdoctoral Fellowship(European Molecular Biology Organization (EMBO)); National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); New York State Department of Health; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Dewell for assistance in high-throughput sequencing and analysis (RU Genomics Resource Center); S. Mazel, L. Li, S. Semova, and S. Tadesse for FACS sorting (RU FACS facility); the RU Bioimaging Center for advice on image acquisition; and the MSKCC Genomics Core Facility for RNA and microarray processing. We thank E.F.' laboratory members D. Oristian and A. Aldeguer for assistance in mouse research; E. Heller for advice on image analyses and quantifications; M. Nikolova, J. Racelis, S. Chai, E. Wong, and P. Janki for technical assistance; and W.-H. Lien, C. Luxenburg, M. Kadaja, B. Keyes, and C.P. Lu for valuable discussions. A.R.F. was supported by an EMBO Postdoctoral Fellowship. E.F. is an HHMI Investigator. This work was supported by grants to E.F. (National Institutes of Health NIAMS R01AR31737 and New York State Department of Health NYSTEM/C026427) and to D.Z. (NIH/NIMH R21MH099452).	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bertrand V, 2009, DEV CELL, V16, P563, DOI 10.1016/j.devcel.2009.02.011; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940; Chou SJ, 2009, NAT NEUROSCI, V12, P1381, DOI 10.1038/nn.2427; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; DasGupta R, 1999, DEVELOPMENT, V126, P4557; do O PP, 2002, BLOOD, V99, P3939, DOI 10.1182/blood.V99.11.3939; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Giangreco A, 2009, DEVELOPMENT, V136, P3505, DOI 10.1242/dev.038232; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Hagglund AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023387; Hebert AM, 2012, GENE DEV, V26, P2709, DOI 10.1101/gad.194027.112; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kitajima K, 2011, BLOOD, V117, P3748, DOI 10.1182/blood-2010-07-298596; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Luxenburg C, 2011, NAT CELL BIOL, V13, P203, DOI 10.1038/ncb2163; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Mardaryev AN, 2011, DEVELOPMENT, V138, P4843, DOI 10.1242/dev.070284; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Niemann C, 2002, DEVELOPMENT, V129, P95; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Ou GS, 2010, SCIENCE, V330, P677, DOI 10.1126/science.1196112; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Porter FD, 1997, DEVELOPMENT, V124, P2935; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rodriguez-Esteban C, 1998, DEVELOPMENT, V125, P3925; Subramanian L, 2011, P NATL ACAD SCI USA, V108, pE265, DOI 10.1073/pnas.1101109108; Tornqvist G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000904; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Xie YS, 2012, J INVEST DERMATOL, V132, P547, DOI 10.1038/jid.2011.381; Xu XM, 2007, DEV BIOL, V312, P484, DOI 10.1016/j.ydbio.2007.09.052; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao YG, 2010, DEV BIOL, V337, P313, DOI 10.1016/j.ydbio.2009.11.002	51	62	65	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					314	327		10.1016/j.stem.2013.06.018	http://dx.doi.org/10.1016/j.stem.2013.06.018			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	24012369	Green Accepted, Bronze			2022-12-28	WOS:000329570800009
J	Li, WL; Li, K; Wei, WG; Ding, S				Li, Wenlin; Li, Ke; Wei, Wanguo; Ding, Sheng			Chemical Approaches to Stem Cell Biology and Therapeutics	CELL STEM CELL			English	Review							SMALL-MOLECULE INHIBITOR; PLUS G-CSF; HEMATOPOIETIC STEM; HUMAN FIBROBLASTS; SELF-RENEWAL; MOUSE FIBROBLASTS; DIRECT CONVERSION; SOMATIC-CELLS; FUNCTIONAL-NEURONS; PROGENITOR CELLS	Small molecules that modulate stem cell fate and function offer significant opportunities that will allow the full realization of the therapeutic potential of stem cells. Rational design and screening for small molecules have identified useful compounds to probe fundamental mechanisms of stem cell self-renewal, differentiation, and reprogramming and have facilitated the development of cell-based therapies and therapeutic drugs targeting endogenous stem and progenitor cells for repair and regeneration. Here, we will discuss recent scientific and therapeutic progress, as well as new perspectives and future challenges for using chemical approaches in stem cell biology and regenerative medicine.	[Li, Wenlin] Second Mil Med Univ, Dept Cell Biol, Shanghai 200433, Peoples R China; [Li, Ke; Ding, Sheng] Univ Calif San Francisco, Dept Pharmaceut Chem, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Wei, Wanguo] Chinese Acad Sci, Shanghai Adv Res Inst, Stem Cell & Regenerat Med Ctr, Shanghai 201210, Peoples R China	Naval Medical University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS	Ding, S (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	sheng.ding@gladstone.ucsf.edu	Li, Ke/K-9417-2015; Wei, Wanguo/H-3172-2012	Wei, Wanguo/0000-0002-2429-8281; li, wenlin/0000-0002-0842-222X	National Institutes of Health; California Institute for Regenerative Medicine; Gladstone Institutes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Gladstone Institutes(University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Sheng Ding is supported by funding from National Institutes of Health, California Institute for Regenerative Medicine, and the Gladstone Institutes. We would like to thank Gary Howard and Anna Lisa Lucido for the editing of this manuscript. The authors apologize to all scientists whose research could not be properly discussed and cited in this Review owing to space limitations. Author contributions were as follows: Wenlin Li, Ke Li, and Wanguo Wei wrote the manuscript and Sheng Ding wrote, conceived of, and designed the manuscript. S.D. is a founder of Fate Therapeutics and Stemgent.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Broxmeyer HE, 2012, NAT MED, V18, P1786, DOI 10.1038/nm.2991; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Calandra G, 2008, BONE MARROW TRANSPL, V41, P331, DOI 10.1038/sj.bmt.1705908; Cao N, 2013, CELL RES, V23, P1119, DOI 10.1038/cr.2013.102; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Flomenberg N, 2005, BLOOD, V106, P1867, DOI 10.1182/blood-2005-02-0468; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Gonzalez R, 2011, ANGEW CHEM INT EDIT, V50, P11181, DOI 10.1002/anie.201103909; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Kawamata M, 2010, P NATL ACAD SCI USA, V107, P14223, DOI 10.1073/pnas.1009582107; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Li HR, 2012, P NATL ACAD SCI USA, V109, P4609, DOI 10.1073/pnas.1200305109; Li J, 2013, ARTERIOSCL THROM VAS, V33, P1366, DOI 10.1161/ATVBAHA.112.301167; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3000996; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Li WL, 2009, STEM CELLS, V27, P2992, DOI 10.1002/stem.240; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; MacMillan KS, 2011, J AM CHEM SOC, V133, P1428, DOI 10.1021/ja108211m; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Miller FD, 2012, CELL STEM CELL, V10, P650, DOI 10.1016/j.stem.2012.05.004; Minami I, 2012, CELL REP, V2, P1448, DOI 10.1016/j.celrep.2012.09.015; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Pitchford SC, 2009, CELL STEM CELL, V4, P62, DOI 10.1016/j.stem.2008.10.017; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Ramirez P, 2009, BLOOD, V114, P1340, DOI 10.1182/blood-2008-10-184721; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; Schugar RC, 2008, GENE THER, V15, P126, DOI 10.1038/sj.gt.3303062; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Stadtfeld M., 2012, NAT GENET, V44, pS1, DOI DOI 10.1038/NG.1110; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Staerk J, 2011, ANGEW CHEM INT EDIT, V50, P5733, DOI 10.1002/anie.201101042; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018; Walker A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1074; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Wang L, 2007, P NATL ACAD SCI USA, V104, P1248, DOI 10.1073/pnas.0609149104; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Wang Y, 2011, STEM CELL REV REP, V7, P331, DOI 10.1007/s12015-010-9209-3; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yang W, 2009, STEM CELLS, V27, P383, DOI 10.1634/stemcells.2008-0974; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yuan X, 2011, STEM CELLS, V29, P549, DOI 10.1002/stem.594; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005; Zhou HY, 2010, J BIOL CHEM, V285, P29676, DOI 10.1074/jbc.C110.150599; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	117	126	131	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					270	283		10.1016/j.stem.2013.08.002	http://dx.doi.org/10.1016/j.stem.2013.08.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	24012368	Bronze, Green Accepted			2022-12-28	WOS:000329570800006
J	Ishii, T; Pera, RAR; Greely, HT				Ishii, Tetsuya; Pera, Renee A. Reijo; Greely, Henry T.			Ethical and Legal Issues Arising in Research on Inducing Human Germ Cells from Pluripotent Stem Cells	CELL STEM CELL			English	Editorial Material							DIFFERENTIATION; EMBRYOS	Derivation of eggs or sperm from pluripotent stem cells or direct reprogramming from somatic cells would have huge effects on assisted reproductive technology. Here we discuss important ethical, legal, and social issues that would be raised by the development of such female or male gametes for clinical use.	[Ishii, Tetsuya] Hokkaido Univ, Off Hlth & Safety, Sapporo, Hokkaido 0600808, Japan; [Pera, Renee A. Reijo] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Greely, Henry T.] Stanford Law Sch, Stanford, CA 94305 USA	Hokkaido University; Stanford University; Stanford University	Ishii, T (corresponding author), Hokkaido Univ, Off Hlth & Safety, Sapporo, Hokkaido 0600808, Japan.	tishii@general.hokudai.ac.jp		Ishii, Tetsuya/0000-0002-7085-7750; Reijo Pera, Renee/0000-0002-6487-1329				Easley CA, 2012, CELL REP, V2, P440, DOI 10.1016/j.celrep.2012.07.015; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Lomax GP, 2013, NAT BIOTECHNOL, V31, P288, DOI 10.1038/nbt.2541; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; The President's Council on Bioethics, 2002, HUM CLON HUM DIGN ET; Trounson A, 2013, CELL STEM CELL, V12, P636, DOI 10.1016/j.stem.2013.05.022	9	32	32	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					145	148		10.1016/j.stem.2013.07.005	http://dx.doi.org/10.1016/j.stem.2013.07.005			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910081	Bronze, Green Submitted			2022-12-28	WOS:000329570600008
J	Eliazer, S; Brack, AS				Eliazer, Susan; Brack, Andrew S.			Lost in Translation: Preserving Satellite Cell Function with Global Translational Control	CELL STEM CELL			English	Editorial Material							STEM-CELLS; SKELETAL-MUSCLE; QUIESCENCE	Quiescence is highly regulated to preserve stem cell function. In this issue of Cell Stem Cell, Zismanov et al. (2016) show that P-eIF2 alpha, a translational initiation factor, reinforces the quiescent state of muscle stem cells by safeguarding against cell-cycle entry and lineage progression.	[Eliazer, Susan; Brack, Andrew S.] Univ Calif San Francisco, Dept Orthopaed Surg, 35 Med Ctr Way, San Francisco, CA 94143 USA; [Eliazer, Susan; Brack, Andrew S.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, 35 Med Ctr Way, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Brack, AS (corresponding author), Univ Calif San Francisco, Dept Orthopaed Surg, 35 Med Ctr Way, San Francisco, CA 94143 USA.; Brack, AS (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, 35 Med Ctr Way, San Francisco, CA 94143 USA.	andrew.brack@ucsf.edu			NIAMS NIH HHS [F32AR067594, R01AR061002, R01AR060868] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060868, R01AR061002, F32AR067594] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Crist CG, 2012, CELL STEM CELL, V11, P118, DOI 10.1016/j.stem.2012.03.011; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Hausburg MA, 2015, ELIFE, V4, DOI 10.7554/eLife.03390; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Zismanov V, 2016, CELL STEM CELL, V18, P79, DOI 10.1016/j.stem.2015.09.020	10	2	2	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					5	7		10.1016/j.stem.2015.12.006	http://dx.doi.org/10.1016/j.stem.2015.12.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26748748	Bronze			2022-12-28	WOS:000372321300003
J	Aguilo, F; Zhang, F; Sancho, A; Fidalgo, M; Di Cecilia, S; Vashisht, A; Lee, DF; Chen, CH; Rengasamy, M; Andino, B; Jahouh, F; Roman, A; Krig, SR; Wang, R; Zhang, WJ; Wohlschlegel, JA; Wang, JL; Walsh, MJ				Aguilo, Francesca; Zhang, Fan; Sancho, Ana; Fidalgo, Miguel; Di Cecilia, Serena; Vashisht, Ajay; Lee, Dung-Fang; Chen, Chih-Hung; Rengasamy, Madhumitha; Andino, Blanca; Jahouh, Farid; Roman, Angel; Krig, Sheryl R.; Wang, Rong; Zhang, Weijia; Wohlschlegel, James A.; Wang, Jianlong; Walsh, Martin J.			Coordination of m(6)A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming	CELL STEM CELL			English	Article							BREAST-CANCER; ONCOGENE ZNF217; RECOGNITION; EXPRESSION; N-6-METHYLADENOSINE; IDENTIFICATION; TRANSITION; REPRESSION; PROTEINS; SUBUNIT	Epigenetic and epitranscriptomic networks have important functions in maintaining the pluripotency of embryonic stem cells (ESCs) and somatic cell reprogramming. However, the mechanisms integrating the actions of these distinct networks are only partially understood. Here we show that the chromatin-associated zinc finger protein 217 (ZFP217) coordinates epigenetic and epitranscriptomic regulation. ZFP217 interacts with several epigenetic regulators, activates the transcription of key pluripotency genes, and modulates N6-methyladenosine (m(6)A) deposition on their transcripts by sequestering the enzyme m(6)A methyltransferase-like 3 (METTL3). Consistently, Zfp217 depletion compromises ESC self-renewal and somatic cell reprogramming, globally increases m(6)A RNA levels, and enhances m(6)A modification of the Nanog, Sox2, Klf4, and c-Myc mRNAs, promoting their degradation. ZFP217 binds its own target gene mRNAs, which are also METTL3 associated, and is enriched at promoters of m(6)A-modified transcripts. Collectively, these findings shed light on how a transcription factor can tightly couple gene transcription to m(6)A RNA modification to ensure ESC identity.	[Aguilo, Francesca; Sancho, Ana; Di Cecilia, Serena; Chen, Chih-Hung; Rengasamy, Madhumitha; Andino, Blanca; Wang, Rong; Walsh, Martin J.] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA; [Aguilo, Francesca; Sancho, Ana; Di Cecilia, Serena; Chen, Chih-Hung; Rengasamy, Madhumitha; Andino, Blanca; Walsh, Martin J.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Zhang, Fan; Zhang, Weijia] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, Bioinformat Lab, New York, NY 10029 USA; [Fidalgo, Miguel; Lee, Dung-Fang; Wang, Jianlong] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Fidalgo, Miguel; Lee, Dung-Fang; Wang, Jianlong] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Vashisht, Ajay; Wohlschlegel, James A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Vashisht, Ajay; Wohlschlegel, James A.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Andino, Blanca; Jahouh, Farid; Wang, Rong; Walsh, Martin J.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Roman, Angel] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Krig, Sheryl R.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Icahn School of Medicine at Mount Sinai; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); University of California System; University of California Davis	Aguilo, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA.	francesca.aguilo@mssm.edu; martin.walsh@mssm.edu	Wang, Jianlong/GQR-1191-2022; Wang, Jianlong/AAG-9425-2020; Fidalgo, Miguel/I-7006-2019; Aguilo, Francesca/ABF-2800-2020	Wang, Jianlong/0000-0002-1317-6457; Fidalgo, Miguel/0000-0003-1134-2674; Aguilo, Francesca/0000-0002-2374-2045; Lee, Dung-Fang/0000-0003-2387-597X	Catalan Agency for Administration of University and Research (AGAUR) under a Beatriu de Pinos postdoctoral fellowship; Senior Scholar Award in Aging [AG-SS-2482-10]; Ellison Medical Foundation; NIH [HL103967, DA028776, CA154903, GM089778, 1R01-GM095942, P30 NS061777]; Empire State Stem Cell Fund through the New York State Department of Health (NYSTEM) [C028103, C028121]; NATIONAL CANCER INSTITUTE [R01CA154809, R24CA088325] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112763, R01GM089778, R01GM095942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028776] Funding Source: NIH RePORTER	Catalan Agency for Administration of University and Research (AGAUR) under a Beatriu de Pinos postdoctoral fellowship; Senior Scholar Award in Aging; Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell Fund through the New York State Department of Health (NYSTEM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. A. Alonso of the Weill-Cornell College of Medicine's Epigenomic Sequencing Core for expert advice regarding sequencing and library preparation. We thank Dr. Carvajal-Gonzalez (University of Extremadura), Dr. Marrero (University of Barcelona), and Dr. Gacias (Icahn School of Medicine at Mount Sinai) for critically reading the manuscript and D. Munoz for graphical design. F.A. is supported by the Catalan Agency for Administration of University and Research (AGAUR) under a Beatriu de Pinos postdoctoral fellowship. This research was supported by the Senior Scholar Award in Aging AG-SS-2482-10 (to M.J.W.) from the Ellison Medical Foundation and awards HL103967, DA028776, and CA154903 from the NIH (to M.J.W.). J.A.W. was supported by award GM089778 from the NIH. J.W. was funded by a grant from the NIH (1R01-GM095942) and the Empire State Stem Cell Fund through the New York State Department of Health (NYSTEM C028103 and C028121). R.W. was funded by award P30 NS061777 from the NIH.	Banck MS, 2009, EPIGENETICS-US, V4, P100, DOI 10.4161/epi.4.2.7953; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bujnicki JM, 2002, J MOL EVOL, V55, P431, DOI 10.1007/s00239-002-2339-8; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Huang GQ, 2005, HUM MOL GENET, V14, P3219, DOI 10.1093/hmg/ddi352; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Lee DF, 2012, CELL STEM CELL, V11, P179, DOI 10.1016/j.stem.2012.05.020; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li PX, 2007, INT J CANCER, V120, P1863, DOI 10.1002/ijc.22300; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Littlepage LE, 2012, CANCER DISCOV, V2, P638, DOI 10.1158/2159-8290.CD-12-0093; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nonet GH, 2001, CANCER RES, V61, P1250; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Quinlan KGR, 2007, BBA-REV CANCER, V1775, P333, DOI 10.1016/j.bbcan.2007.05.001; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Thollet A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-291; TUCK MT, 1992, INT J BIOCHEM, V24, P379, DOI 10.1016/0020-711X(92)90028-Y; Vandevenne M, 2013, J BIOL CHEM, V288, P10616, DOI 10.1074/jbc.M112.441451; Vendrell JA, 2012, CANCER RES, V72, P3593, DOI 10.1158/0008-5472.CAN-11-3095; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Welham MJ, 2011, BIOCHEM SOC T, V39, P674, DOI 10.1042/BST0390674; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Yu HB, 2011, GENOME RES, V21, P1284, DOI 10.1101/gr.114488.110; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151	41	193	210	3	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					689	704		10.1016/j.stem.2015.09.005	http://dx.doi.org/10.1016/j.stem.2015.09.005			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26526723	Green Accepted, Bronze			2022-12-28	WOS:000366139100011
J	Joshi, O; Wang, SY; Kuznetsova, T; Atlasi, Y; Peng, TR; Fabre, PJ; Habibi, E; Shaik, J; Saeed, S; Handoko, L; Richmond, T; Spivakov, M; Burgess, D; Stunnenberg, HG				Joshi, Onkar; Wang, Shuang-Yin; Kuznetsova, Tatyana; Atlasi, Yaser; Peng, Tianran; Fabre, Pierre J.; Habibi, Ehsan; Shaik, Jani; Saeed, Sadia; Handoko, Lusy; Richmond, Todd; Spivakov, Mikhail; Burgess, Daniel; Stunnenberg, Hendrik G.			Dynamic Reorganization of Extremely Long-Range Promoter-Promoter Interactions between Two States of Pluripotency	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; CHROMATIN-STRUCTURE; DNA METHYLATION; GROUND-STATE; POLYCOMB; GENOME; NAIVE; PROTEINS; GENES	Serum-to-2i interconversion of mouse embryonic stem cells (mESCs) is a valuable in vitro model for early embryonic development. To assess whether 3D chromatin organization changes during this transition, we established Capture Hi-C with target-sequence enrichment of DNase I hypersensitive sites. We detected extremely long-range intra-and inter-chromosomal interactions between a small subset of H3K27me3 marked bivalent promoters involving the Hox clusters in serum-grown cells. Notably, these promoter-mediated interactions are not present in 2i ground-state pluripotent mESCs but appear upon their further development into primed-like serum mESCs. Reverting serum mESCs to ground-state 2i mESCs removes these promoter-promoter interactions in a spatiotemporal manner. H3K27me3, which is largely absent at bivalent promoters in ground-state 2i mESCs, is necessary, but not sufficient, to establish these interactions, as confirmed by Capture Hi-C on Eed(-/-) serum mESCs. Our results implicate H3K27me3 and PRC2 as critical players in chromatin alteration during priming of ESCs for differentiation.	[Joshi, Onkar; Wang, Shuang-Yin; Kuznetsova, Tatyana; Atlasi, Yaser; Peng, Tianran; Habibi, Ehsan; Shaik, Jani; Saeed, Sadia; Handoko, Lusy; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Fac Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Fabre, Pierre J.] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Richmond, Todd; Burgess, Daniel] Roche NimbleGen Inc, Madison, WI 53719 USA; [Spivakov, Mikhail] Babraham Inst, Nucl Dynam Programme, Cambridge CB22 3AT, Cambs, England	Radboud University Nijmegen; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Roche Holding; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Stunnenberg, HG (corresponding author), Radboud Univ Nijmegen, Fac Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands.	h.stunnenberg@ncmls.ru.nl	Habibi, Ehsan/R-7756-2019; Peng, Tianran/AAG-9825-2022; Fabre, Pierre/O-5763-2019; Stunnenberg, Hendrik G./D-6875-2012; Habibi, Ehsan/E-3196-2016; Peng, Tianran/AES-0353-2022; Handoko, Lusy/C-3645-2017; Atlasi, Yaser/AAI-5396-2021; Atlasi, Yaser/F-2885-2018; Habibi, Ehsan/AAE-6053-2021; Fabre, Pierre J/A-6800-2017	Stunnenberg, Hendrik G./0000-0002-0066-1576; Habibi, Ehsan/0000-0002-7208-7999; Handoko, Lusy/0000-0001-7989-4243; Atlasi, Yaser/0000-0002-7350-1784; Fabre, Pierre J/0000-0002-5936-8120; Saeed, Sadia/0000-0002-6587-6543; Spivakov, Mikhail/0000-0002-0383-3943; Kuznetsova, Tatyana/0000-0001-7533-3334; Wang, Shuang-Yin/0000-0001-9683-4103; Peng, Tianran/0000-0001-8309-4652	ERC [ERC-2013-AdG, 339431 - SysStemCell]; BBSRC [BBS/E/B/000C0405, BBS/E/B/000C0404] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0405, BBS/E/B/000C0404] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank members of the stem cell group and Hendrik Marks in particular for discussions, and Luciano di Croce and Anton Wutz for the Eed<SUP>-/-</SUP> KO mESCs. We thank Eva Janssen-Megens, Kim Berentsen, Nilofar Sharifi, and Bowon Kim for sequencing; Jonathan Cairns and Paula Freire Pritchett for help with the CHiCAGO pipeline; Denise Raterman, Jennifer Wendt, and Heidi Rosenbaum for advice with the capture part of the CHi-C technique; Denis Duboule for advice on the subject; and Biola M. Javierre for advice on the traditional HiC protocol. The computational work was carried out on the Dutch national e-infrastructure with the support of SURF Cooperative. This work was supported by ERC grant ERC-2013-AdG No. 339431 - SysStemCell.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cairns J., 2015, CHICAGO ROBUST DETEC; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Creppe C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004851; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dodsworth BT, 2015, STEM CELLS, V33, P3181, DOI 10.1002/stem.2085; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Huang K, 2014, CELL STEM CELL, V15, P410, DOI 10.1016/j.stem.2014.09.014; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Marks H, 2014, BBA-GENE REGUL MECH, V1839, P129, DOI 10.1016/j.bbagrm.2013.09.005; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Nagano T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0753-7; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Plusa B, 2014, NAT CELL BIOL, V16, P502, DOI 10.1038/ncb2984; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schoenfelder S, 2015, NAT GENET, V47, P1179, DOI 10.1038/ng.3393; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Senthilkumar R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-549; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Vieux-Rochas M, 2015, P NATL ACAD SCI USA, V112, P4672, DOI 10.1073/pnas.1504783112; Wang JB, 2002, MAMM GENOME, V13, P493, DOI 10.1007/s00335-002-2182-7; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	40	125	126	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					748	757		10.1016/j.stem.2015.11.010	http://dx.doi.org/10.1016/j.stem.2015.11.010			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26637943	Bronze			2022-12-28	WOS:000366139100015
J	Shen, MM				Shen, Michael M.			Illuminating the Properties of Prostate Luminal Progenitors	CELL STEM CELL			English	Editorial Material							CELLS; BASAL; ORIGIN	The identification of tumor-initiating cells represents a significant challenge for studies of prostate cancer. In a recent issue of Cell Reports, Agarwal and colleagues use organoid culture to ascertain two distinct luminal progenitors in a mouse model of prostate cancer, shedding new light on lineage relationships in the prostate epithelium.	[Shen, Michael M.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Med,Dept Genet & Dev,Dept Urol, New York, NY 10032 USA; [Shen, Michael M.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Syst Biol, New York, NY 10032 USA	Columbia University; Columbia University	Shen, MM (corresponding author), Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Med,Dept Genet & Dev,Dept Urol, New York, NY 10032 USA.	mshen@columbia.edu	Shen, Michael M/C-7546-2009	Shen, Michael M/0000-0002-4042-1657; Shen, Mouquan/0000-0001-6448-4866	NATIONAL CANCER INSTITUTE [P01CA154293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076602] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA154293] Funding Source: Medline; NIDDK NIH HHS [R01 DK076602] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agarwal S., 2015, CELL REP IN PRESS, V13; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Chua CW, 2014, NAT CELL BIOL, V16, P951, DOI 10.1038/ncb3047; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Kwon S, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/195928; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Stoyanova T, 2013, P NATL ACAD SCI USA, V110, P20111, DOI 10.1073/pnas.1320565110; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2011, ONCOGENE, V30, P1261, DOI 10.1038/onc.2010.530; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697	10	5	5	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					644	646		10.1016/j.stem.2015.11.018	http://dx.doi.org/10.1016/j.stem.2015.11.018			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26637940	Bronze			2022-12-28	WOS:000366139100005
J	Kolodziejczyk, AA; Kim, JK; Tsang, JCH; Ilicic, T; Henriksson, J; Natarajan, KN; Tuck, AC; Gao, XF; Buhler, M; Liu, PT; Marioni, JC; Teichmann, SA				Kolodziejczyk, Aleksandra A.; Kim, Jong Kyoung; Tsang, Jason C. H.; Ilicic, Tomislav; Henriksson, Johan; Natarajan, Kedar N.; Tuck, Alex C.; Gao, Xuefei; Buehler, Marc; Liu, Pentao; Marioni, John C.; Teichmann, Sarah A.			Single Cell RNA-Sequencing of Pluripotent States Unlocks Modular Transcriptional Variation	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GROUND-STATE; SELF-RENEWAL; PROTHYMOSIN-ALPHA; GENE-EXPRESSION; REGULATORY CIRCUITRY; SIGNALING PATHWAYS; THYMOSIN ALPHA-1; NANOG; INHIBITION	Embryonic stem cell (ESC) culture conditions are important for maintaining long-term self-renewal, and they influence cellular pluripotency state. Here, we report single cell RNA-sequencing of mESCs cultured in three different conditions: serum, 2i, and the alternative ground state a2i. We find that the cellular transcriptomes of cells grown in these conditions are distinct, with 2i being the most similar to blastocyst cells and including a subpopulation resembling the two-cell embryo state. Overall levels of intercellular gene expression heterogeneity are comparable across the three conditions. However, this masks variable expression of pluripotency genes in serum cells and homogeneous expression in 2i and a2i cells. Additionally, genes related to the cell cycle are more variably expressed in the 2i and a2i conditions. Mining of our dataset for correlations in gene expression allowed us to identify additional components of the pluripotency network, including Ptma and Zfp640, illustrating its value as a resource for future discovery.	[Kolodziejczyk, Aleksandra A.; Kim, Jong Kyoung; Ilicic, Tomislav; Henriksson, Johan; Natarajan, Kedar N.; Tuck, Alex C.; Marioni, John C.; Teichmann, Sarah A.] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge CB10 1SD, England; [Kolodziejczyk, Aleksandra A.; Tsang, Jason C. H.; Ilicic, Tomislav; Natarajan, Kedar N.; Gao, Xuefei; Liu, Pentao; Marioni, John C.; Teichmann, Sarah A.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Tuck, Alex C.; Buehler, Marc] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Marioni, John C.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Friedrich Miescher Institute for Biomedical Research; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Marioni, JC (corresponding author), European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	marioni@ebi.ac.uk; st9@sanger.ac.uk	Henriksson, Johan/ABD-2430-2021; Bühler, Marc/B-1134-2010; Buehler, Marc/S-5866-2019; Kołodziejczyk, Aleksandra/K-1985-2014; Kołodziejczyk, Aleksandra A/H-6850-2019; Kim, Jong Kyoung/AAF-3414-2021	Henriksson, Johan/0000-0002-7745-2844; Bühler, Marc/0000-0001-6661-9795; Buehler, Marc/0000-0001-6661-9795; Kołodziejczyk, Aleksandra/0000-0002-2903-8884; Kołodziejczyk, Aleksandra A/0000-0002-2903-8884; Teichmann, Sarah/0000-0002-6294-6366; Marioni, John/0000-0001-9092-0852; Tuck, Alex/0000-0003-0748-9913; Natarajan, Kedar Nath/0000-0002-9264-1280; Kim, Jong Kyoung/0000-0002-0257-0547	BBSRC; Sanger-EBI Single Cell Genomics Centre; Wellcome Trust [103977]; Biotechnology and Biological Sciences Research Council [1300642] Funding Source: researchfish; Cancer Research UK [22231] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sanger-EBI Single Cell Genomics Centre; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We are grateful to David Adams and Anne Ferguson-Smith for mESCs, to Nathalie Smerdon for sequencing support, and to Xiuwei Zhang for helpful discussions. We thank Rebecca Berrens, Julia Tischler, Wolf Reik, and Azim Surani for their comments on the manuscript. We acknowledge the BBSRC for a CASE Studentship to A.A.K. and the Sanger-EBI Single Cell Genomics Centre for support. This work was supported by a Wellcome Trust Fellowship to A.T. (103977).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Ciancio A, 2010, ANN NY ACAD SCI, V1194, P141, DOI 10.1111/j.1749-6632.2010.05487.x; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Ding B, 2015, BIOINFORMATICS, V31, P2225, DOI 10.1093/bioinformatics/btv122; Etzrodt M, 2014, CELL STEM CELL, V15, P546, DOI 10.1016/j.stem.2014.10.015; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Gao XF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku836; Garaci E, 2012, ANN NY ACAD SCI, V1269, P26, DOI 10.1111/j.1749-6632.2012.06697.x; George EM, 2010, FEBS LETT, V584, P2833, DOI 10.1016/j.febslet.2010.04.065; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Guo Y, 2015, APOPTOSIS, V20, P1109, DOI 10.1007/s10495-015-1138-9; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Ioannou K, 2012, CANCER IMMUNOL IMMUN, V61, P599, DOI 10.1007/s00262-012-1222-8; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Papatsenko D, 2015, STEM CELL REP, V5, P207, DOI 10.1016/j.stemcr.2015.07.004; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Shimizu T, 2012, STEM CELLS, V30, P1394, DOI 10.1002/stem.1119; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsang JCH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0739-5; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Xu HL, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat045; Yang CH, 2004, EXP CELL RES, V298, P197, DOI 10.1016/j.yexcr.2004.04.008; Ye SD, 2013, EMBO J, V32, P2548, DOI 10.1038/emboj.2013.175; Yeo JC, 2014, CELL STEM CELL, V14, P864, DOI 10.1016/j.stem.2014.04.015; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	72	295	296	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 1	2015	17	4					471	485		10.1016/j.stem.2015.09.011	http://dx.doi.org/10.1016/j.stem.2015.09.011			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4TS	26431182	Green Published, hybrid			2022-12-28	WOS:000365693800013
J	Wang, CZ; Fong, HL; Huang, YD				Wang, Chengzhong; Fong, Helen; Huang, Yadong			Direct Reprogramming of RESTing Astrocytes	CELL STEM CELL			English	Editorial Material							GLIAL-CELLS; NEURONS; BRAIN	Understanding the mechanisms underlying neuronal fate determination will provide important insights into brain development and regenerative approaches to neurological diseases. Now in Cell Stem Cell, Masserdotti et al. (2015) use neuronal conversion of astrocytes to dissect transcriptional mechanisms of fate determination and identify circuits that mediate cellular identity.	[Wang, Chengzhong; Fong, Helen; Huang, Yadong] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Wang, Chengzhong; Fong, Helen; Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Huang, YD (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	yadong.huang@gladstone.ucsf.edu						Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Martynoga B, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008359; Masserdotti G, 2015, CELL STEM CELL, V17, P74, DOI 10.1016/j.stem.2015.05.014; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015	9	4	4	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2015	17	1					1	3		10.1016/j.stem.2015.06.011	http://dx.doi.org/10.1016/j.stem.2015.06.011			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DI	26140600	Bronze			2022-12-28	WOS:000361877600001
J	Ramos, AD; Andersen, RE; Liu, SJ; Nowakowski, TJ; Hong, SJ; Gertz, CC; Salinas, RD; Zarabi, H; Kriegstein, AR; Lim, DA				Ramos, Alexander D.; Andersen, Rebecca E.; Liu, Siyuan John; Nowakowski, Tomasz Jan; Hong, Sung Jun; Gertz, Caitlyn C.; Salinas, Ryan D.; Zarabi, Hosniya; Kriegstein, Arnold R.; Lim, Daniel A.			The Long Noncoding RNA Pnky Regulates Neuronal Differentiation of Embryonic and Postnatal Neural Stem Cells	CELL STEM CELL			English	Article							TRACT-BINDING-PROTEINS; ADULT BRAIN; GENE-EXPRESSION; TRANSCRIPTS; PRECURSORS; JUNCTIONS; PTBP1	While thousands of long noncoding RNAs (IncRNAs) have been identified, few IncRNAs that control neural stem cell (NSC) behavior are known. Here, we identify Pinky (Pnky) as a neural-specific IncRNA that regulates neurogenesis from NSCs in the embryonic and postnatal brain. In postnatal NSCs, Pnky knockdown potentiates neuronal lineage commitment and expands the transit-amplifying cell population, increasing neuron production several-fold. Pnky is evolutionarily conserved and expressed in NSCs of the developing human brain. In the embryonic mouse cortex, Pnky knockdown increases neuronal differentiation and depletes the NSC population. Pnky interacts with the splicing regulator PTBP1, and PTBP1 knockdown also enhances neurogenesis. In NSCs, Pnky and PTBP1 regulate the expression and alternative splicing of a core set of transcripts that relates to the cellular phenotype. These data thus unveil Pnky as a conserved IncRNA that interacts with a key RNA processing factor and regulates neurogenesis from embryonic and postnatal NSC populations.	[Ramos, Alexander D.; Andersen, Rebecca E.; Liu, Siyuan John; Hong, Sung Jun; Salinas, Ryan D.; Zarabi, Hosniya; Lim, Daniel A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Ramos, Alexander D.; Andersen, Rebecca E.; Liu, Siyuan John; Nowakowski, Tomasz Jan; Hong, Sung Jun; Gertz, Caitlyn C.; Salinas, Ryan D.; Zarabi, Hosniya; Kriegstein, Arnold R.; Lim, Daniel A.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Ramos, Alexander D.; Liu, Siyuan John] Univ Calif San Francisco, Med Sci Training Program, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Andersen, Rebecca E.] Univ Calif San Francisco, Dev & Stem Cell Biol Grad Program, San Francisco, CA 94143 USA; [Nowakowski, Tomasz Jan; Gertz, Caitlyn C.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Gertz, Caitlyn C.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Hong, Sung Jun] San Francisco State Univ, CIRM Bridges Scholar Program, San Francisco, CA 94132 USA; [Lim, Daniel A.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California State University System; San Francisco State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Lim, DA (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	daniel.lim@ucsf.edu		Andersen, Rebecca/0000-0002-0702-3120	NIH [DP2-OD006505-01, VA 1I01 BX000252-04, R01 NS35710, 1F31NS080501-01A1]; Shurl and Kay Curci Foundation Award; National Science Foundation Graduate Research Fellowship [1144247]; MSTP [2T32GM007618-34]; SFSU CIRM Bridges fellowship [TB1-01194]; HHMI Medical Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS092319, F31NS080501, R01NS035710] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006505] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shurl and Kay Curci Foundation Award; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); MSTP; SFSU CIRM Bridges fellowship; HHMI Medical Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	We thank Robert Darnell for the PTBP2 antibody; David Weinberg for helpful discussions; Kenneth Probst for help with the graphical abstract; and Ewa Witkowski, Steven Hall, and The Sandler-Moore Mass Spectrometry Core Facility at UCSF for help with mass spectrometry. This project was supported by NIH DP2-OD006505-01, VA 1I01 BX000252-04, and a Shurl and Kay Curci Foundation Award to D.A.L; NIH R01 NS35710 to A.R.K.; NIH 1F31NS080501-01A1 to A.D.R.; National Science Foundation Graduate Research Fellowship Grant No. 1144247 to R.E.A.; MSTP training grant 2T32GM007618-34 to S.J.L.; SFSU CIRM Bridges TB1-01194 fellowship to S.H.; HHMI Medical Research Fellowship to H.Z.; and facilities and resources provided by the San Francisco Veterans Affairs Medical Center.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Chalei V, 2014, ELIFE, V3, DOI 10.7554/eLife.04530; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Ferrarese R, 2014, J CLIN INVEST, V124, P2861, DOI 10.1172/JCI68836; Hacisuleyman E, 2014, NAT STRUCT MOL BIOL, V21, P198, DOI 10.1038/nsmb.2764; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Keppetipola N, 2012, CRIT REV BIOCHEM MOL, V47, P360, DOI 10.3109/10409238.2012.691456; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Licatalosi DD, 2012, GENE DEV, V26, P1626, DOI 10.1101/gad.191338.112; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Luskin MB, 1998, J NEUROBIOL, V36, P221; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Ng SY, 2013, MOL CELL, V51, P349, DOI 10.1016/j.molcel.2013.07.017; Park DH, 2014, CELL REP, V8, P1290, DOI 10.1016/j.celrep.2014.07.060; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Peretto P, 1997, BRAIN RES BULL, V42, P9, DOI 10.1016/S0361-9230(96)00116-5; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Ponti G, 2013, CELL CYCLE, V12, P1649, DOI 10.4161/cc.24984; Ramos AD, 2013, CELL STEM CELL, V12, P616, DOI 10.1016/j.stem.2013.03.003; Rapicavoli NA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-32; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Roan NR, 2014, J INFECT DIS, V210, P1062, DOI 10.1093/infdis/jiu220; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Shibasaki T, 2013, CEREB CORTEX, V23, P1824, DOI 10.1093/cercor/bhs161; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yap K, 2012, GENE DEV, V26, P1209, DOI 10.1101/gad.188037.112; Zheng S, 2012, NAT NEUROSCI, V15, P381, DOI 10.1038/nn.3026	44	223	238	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					439	447		10.1016/j.stem.2015.02.007	http://dx.doi.org/10.1016/j.stem.2015.02.007			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25800779	Bronze, Green Accepted			2022-12-28	WOS:000352228600015
J	Vidal, SE; Stadtfeld, M; Apostolou, E				Vidal, Simon E.; Stadtfeld, Matthias; Apostolou, Eftychia			F-Class Cells: New Routes and Destinations for Induced Pluripotency	CELL STEM CELL			English	Editorial Material							SOMATIC-CELLS; DISTINCT; ROADMAP; STATES	A series of five related publications describe an alternative pluripotent state that is dependent on continuous high levels of exogenous reprogramming factor expression. A comprehensive effort to molecularly compare the acquisition of this state to induced pluripotency aims at providing new insights into the mechanisms underlying cellular reprogramming.	[Vidal, Simon E.; Stadtfeld, Matthias] NYU, Sch Med, Dept Cell Biol, Helen L & Martin S Kimmel Ctr Biol & Med,Skirball, New York, NY 10016 USA; [Apostolou, Eftychia] Weill Cornell Med Coll, Div Hematol Oncol, Dept Med, New York, NY 10021 USA; [Apostolou, Eftychia] Weill Cornell Med Coll, Meyer Canc Ctr, New York, NY 10021 USA	New York University; Cornell University; Cornell University	Stadtfeld, M (corresponding author), NYU, Sch Med, Dept Cell Biol, Helen L & Martin S Kimmel Ctr Biol & Med,Skirball, New York, NY 10016 USA.	matthias.stadtfeld@med.nyu.edu; efa2001@med.cornell.edu		Stadtfeld, Matthias/0000-0002-5852-9906	NIGMS NIH HHS [R01 GM111852] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benevento M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6613; Clancy JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6522; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Hussein SMI, 2014, NATURE, V516, P198, DOI 10.1038/nature14046; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Lee DS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6619; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Tonge PD, 2014, NATURE, V516, P192, DOI 10.1038/nature14047	10	5	5	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					9	10		10.1016/j.stem.2014.12.007	http://dx.doi.org/10.1016/j.stem.2014.12.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25575077	Bronze			2022-12-28	WOS:000347708400005
J	Etzrodt, M; Endele, M; Schroeder, T				Etzrodt, Martin; Endele, Max; Schroeder, Timm			Quantitative Single-Cell Approaches to Stem Cell Research	CELL STEM CELL			English	Review							HEMATOPOIETIC STEM; RNA-SEQ; PROGENITOR CELLS; GENE-EXPRESSION; CLONAL ANALYSIS; GENOME-WIDE; FLUORESCENT PROTEINS; AORTIC ENDOTHELIUM; ANALYSIS REVEALS; BLOOD STEM	Understanding the molecular control of cell fates is central to stem cell research. Such insight requires quantification of molecular and cellular behavior at the single-cell level. Recent advances now permit high-throughput molecular readouts from single cells as well as continuous, noninvasive observation of cell behavior over time. Here, we review current state-of-the-art approaches used to query stem cell fate at the single-cell level, including advances in lineage tracing, time-lapse imaging, and molecular profiling. We also offer our perspective on the advantages and drawbacks of available approaches, key technical limitations, considerations for data interpretation, and future innovation.	[Etzrodt, Martin; Endele, Max; Schroeder, Timm] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Schroeder, T (corresponding author), ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.	timm.schroeder@bsse.ethz.ch	Etzrodt, Martin/P-3325-2015	Etzrodt, Martin/0000-0003-1928-3904; Schroeder, Timm/0000-0001-9320-0252	EMBO Long Term Postdoctoral Fellowship	EMBO Long Term Postdoctoral Fellowship(European Molecular Biology Organization (EMBO))	M.E. is supported by an EMBO Long Term Postdoctoral Fellowship.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Asami M, 2011, DEVELOPMENT, V138, P5067, DOI 10.1242/dev.074591; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; BRADY G, 1990, Methods in Molecular and Cellular Biology, V2, P17; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; CAPEL B, 1990, BLOOD, V75, P2267; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Cohen AR, 2010, NAT METHODS, V7, P213, DOI [10.1038/NMETH.1424, 10.1038/nmeth.1424]; Costa MR, 2011, DEVELOPMENT, V138, P1057, DOI 10.1242/dev.061663; Coutu DL, 2013, J CELL SCI, V126, P3805, DOI 10.1242/jcs.118349; de Souza N, 2014, NAT METHODS, V11, P125, DOI 10.1038/nmeth.2826; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Du Z, 2014, CELL, V156, P359, DOI 10.1016/j.cell.2013.11.046; Eilken H., 2011, PROTOCOL EXCHANGE, DOI [10.1038/protex.2011.205, DOI 10.1038/PROTEX.2011.205]; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Endele M., 2014, EXP CELL RE IN PRESS; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Faust N, 2000, BLOOD, V96, P719; Filipczyk A, 2013, CELL STEM CELL, V13, P12, DOI 10.1016/j.stem.2013.04.025; Frey O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5250; Frumkin D, 2008, CANCER RES, V68, P5924, DOI 10.1158/0008-5472.CAN-07-6216; Gazit R, 2014, J EXP MED, V211, P1314, DOI 10.1084/jem.20130428; Germain RN, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-2; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Gregori G, 2014, CURR TOP MICROBIOL, V377, P191, DOI 10.1007/82_2013_359; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Guo HS, 2013, GENOME RES, V23, P2126, DOI 10.1101/gr.161679.113; Guo MT, 2012, LAB CHIP, V12, P2146, DOI 10.1039/c2lc21147e; Hockendorf B, 2012, DEV CELL, V23, P1111, DOI 10.1016/j.devcel.2012.10.008; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Hughes AJ, 2014, NAT METHODS, V11, P749, DOI [10.1038/NMETH.2992, 10.1038/nmeth.2992]; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Junker JP, 2014, CELL, V157, P8, DOI 10.1016/j.cell.2014.02.010; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kemper K, 2012, STEM CELLS, V30, P2378, DOI 10.1002/stem.1233; Kirkegaard K, 2013, HUM REPROD, V28, P2643, DOI 10.1093/humrep/det300; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Landry ZC, 2013, METHOD ENZYMOL, V531, P61, DOI 10.1016/B978-0-12-407863-5.00004-6; Lecault V, 2011, NAT METHODS, V8, P581, DOI [10.1038/NMETH.1614, 10.1038/nmeth.1614]; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Loulier K, 2014, NEURON, V81, P505, DOI 10.1016/j.neuron.2013.12.016; Lovatt D, 2014, NAT METHODS, V11, P190, DOI [10.1038/NMETH.2804, 10.1038/nmeth.2804]; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Ludin A, 2012, NAT IMMUNOL, V13, P1072, DOI 10.1038/ni.2408; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Naik SH, 2014, EXP HEMATOL, V42, P598, DOI 10.1016/j.exphem.2014.05.003; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Newman RH, 2011, CHEM REV, V111, P3614, DOI 10.1021/cr100002u; Nguyen PK, 2014, CELL STEM CELL, V14, P431, DOI 10.1016/j.stem.2014.03.009; Okita C, 2004, BIOTECHNIQUES, V36, P418, DOI 10.2144/04363ST01; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Schroeder T, 2011, NAT METHODS, V8, pS30, DOI [10.1038/NMETH.1577, 10.1038/nmeth.1577]; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Strack RL, 2013, NAT METHODS, V10, P1219, DOI [10.1038/NMETH.2701, 10.1038/nmeth.2701]; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/NMETH.1700, 10.1038/nmeth.1700]; Torisawa YS, 2014, NAT METHODS, V11, P663, DOI [10.1038/NMETH.2938, 10.1038/nmeth.2938]; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Verovskaya E, 2014, J EXP MED, V211, P487, DOI 10.1084/jem.20131804; Verovskaya E, 2013, BLOOD, V122, P523, DOI 10.1182/blood-2013-01-481135; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Wells D, 2014, FERTIL STERIL, V101, P1250, DOI 10.1016/j.fertnstert.2014.03.006; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; WHITLOCK CA, 1987, CELL, V48, P1009, DOI 10.1016/0092-8674(87)90709-4; Willison KR, 2013, CURR OPIN BIOTECH, V24, P745, DOI 10.1016/j.copbio.2013.06.001; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	129	84	84	1	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					546	558		10.1016/j.stem.2014.10.015	http://dx.doi.org/10.1016/j.stem.2014.10.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517464	Bronze			2022-12-28	WOS:000345012700009
J	Sancho, R; Gruber, R; Gu, GQ; Behrens, A				Sancho, Rocio; Gruber, Ralph; Gu, Guoqiang; Behrens, Axel			Loss of Fbw7 Reprograms Adult Pancreatic Ductal Cells into alpha, delta, and beta Cells	CELL STEM CELL			English	Article							TUMOR-SUPPRESSOR; UBIQUITIN LIGASE; F-BOX; MOUSE; ENDOCRINE; DIFFERENTIATION; NOTCH; NEUROGENIN3; EXPRESSION; PROGENITORS	The adult pancreas is capable of limited regeneration after injury but has no defined stem cell population. The cell types and molecular signals that govern the production of new pancreatic tissue are not well understood. Here, we show that inactivation of the SCF-type E3 ubiquitin ligase substrate recognition component Fbw7 induces pancreatic ductal cells to reprogram into alpha, delta, and beta cells. Loss of Fbw7 stabilized the transcription factor Ngn3, a key regulator of endocrine cell differentiation. The induced beta cells resemble islet beta cells in morphology and histology, express genes essential for beta cell function, and release insulin after glucose challenge. Thus, loss of Fbw7 appears to reawaken an endocrine developmental differentiation program in adult pancreatic ductal cells. Our study highlights the plasticity of seemingly differentiated adult cells, identifies Fbw7 as a master regulator of cell fate decisions in the pancreas, and reveals adult pancreatic duct cells as a latent multipotent cell type.	[Sancho, Rocio; Gruber, Ralph; Behrens, Axel] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Mammalian Genet Lab, London WC2A 3LY, England; [Gu, Guoqiang] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Behrens, Axel] Kings Coll London, Sch Med, London SE1 1UL, England	Cancer Research UK; Vanderbilt University; University of London; King's College London	Behrens, A (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Mammalian Genet Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	axel.behrens@cancer.org.uk		Sancho, Rocio/0000-0002-4894-5391; Behrens, Axel/0000-0002-1557-1143	Marie Curie grant [MEIF-CT-2006-041119]; MRC [G0901677]; ERC [281661]; EMBO long-term fellowship; Cancer Research UK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065949] Funding Source: NIH RePORTER; Cancer Research UK [15679] Funding Source: researchfish; Medical Research Council [G0901677] Funding Source: researchfish	Marie Curie grant(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to the London Research Institute Animal Unit, Equipment Park, FACS facility; Bradley Spencer-Dene and Emma Nye in the Experimental Histopathology lab; and Richard Mitter in the Bioinformatics facility for technical help. We thank Hamamatsu for allowing us to perform the full slide scans using their NanoZoomer 2.0-HT. We thank D. Tuveson for Pdx1-Cre mice; J.J. Haigh for providing the pRosa26-DV1 vector used for generating the Ngn3-AA conditional transgenic mouse; and Nikita Popov and Bruce Clurman for providing reagents. We thank Stephen Pollard, Taija Makinen, and Ilaria Malanchi for critical reading of the manuscript. R.S. was funded by Marie Curie (MEIF-CT-2006-041119), MRC (G0901677), and ERC (281661) grants. R.G. was supported by an EMBO long-term fellowship. A.B. and R.S. are listed as inventors on an International Patent Application based on this work. The London Research Institute is funded by Cancer Research UK.	Al-Hasani K, 2013, DEV CELL, V26, P86, DOI 10.1016/j.devcel.2013.05.018; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Bonner-Weir S, 2008, BIOCHEM SOC T, V36, P353, DOI 10.1042/BST0360353; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Davies CC, 2010, NAT CELL BIOL, V12, P963, DOI 10.1038/ncb2098; DEKRIJGER RR, 1992, DEV BIOL, V153, P368, DOI 10.1016/0012-1606(92)90121-V; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Ejarque M, 2013, J BIOL CHEM, V288, P11705, DOI 10.1074/jbc.M112.388173; Esni F, 2004, DEVELOPMENT, V131, P4213, DOI 10.1242/dev.01280; Fujikura J, 2006, CELL METAB, V3, P59, DOI 10.1016/j.cmet.2005.12.005; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Iriuchishima H, 2011, BLOOD, V117, P2373, DOI 10.1182/blood-2010-07-294801; Ishikawa Y, 2008, ONCOGENE, V27, P6164, DOI 10.1038/onc.2008.216; Jandke A, 2011, DEV BIOL, V358, P201, DOI 10.1016/j.ydbio.2011.07.030; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Lysy PA, 2012, STEM CELL TRANSL MED, V1, P150, DOI 10.5966/sctm.2011-0025; Matsumoto A, 2011, J BIOL CHEM, V286, P13754, DOI 10.1074/jbc.M110.194936; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; OKA C, 1995, DEVELOPMENT, V121, P3291; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Onoyama I, 2011, J CLIN INVEST, V121, P342, DOI 10.1172/JCI40725; Pagliuca FW, 2013, DEVELOPMENT, V140, P2472, DOI 10.1242/dev.093187; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Roark R, 2012, BIOL OPEN, V1, P1264, DOI 10.1242/bio.20121750; Sancho R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001586; Sancho R, 2010, GASTROENTEROLOGY, V139, P929, DOI 10.1053/j.gastro.2010.05.078; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Swales N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037055; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Van de Casteele M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.52; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052; Wang ZW, 2012, EMBO REP, V13, P36, DOI 10.1038/embor.2011.231; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	61	89	96	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					139	153		10.1016/j.stem.2014.06.019	http://dx.doi.org/10.1016/j.stem.2014.06.019			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	25105579	hybrid, Green Published			2022-12-28	WOS:000340880100008
J	Veres, A; Gosis, BS; Ding, QR; Collins, R; Ragavendran, A; Brand, H; Erdin, S; Cowan, CA; Talkowski, ME; Musunuru, K				Veres, Adrian; Gosis, Bridget S.; Ding, Qiurong; Collins, Ryan; Ragavendran, Ashok; Brand, Harrison; Erdin, Serkan; Cowan, Chad A.; Talkowski, Michael E.; Musunuru, Kiran			Low Incidence of Off-Target Mutations in Individual CRISPR-Cas9 and TALEN Targeted Human Stem Cell Clones Detected by Whole-Genome Sequencing	CELL STEM CELL			English	Article							DISEASE-MODELS; CAS9; SPECIFICITY; NUCLEASES; ENDONUCLEASE; NICKASES; SYSTEMS	Genome editing has attracted wide interest for the generation of cellular models of disease using human pluripotent stem cells and other cell types. CRISPR-Cas systems and TALENs can target desired genomic sites with high efficiency in human cells, but recent publications have led to concern about the extent to which these tools may cause off-target mutagenic effects that could potentially confound disease-modeling studies. Using CRISPR-Cas9 and TALEN targeted human pluripotent stem cell clones, we performed whole-genome sequencing at high coverage in order to assess the degree of mutagenesis across the entire genome. In both types of clones, we found that off-target mutations attributable to the nucleases were very rare. From this analysis, we suggest that, although some cell types may be at risk for off-target mutations, the incidence of such effects in human pluripotent stem cells may be sufficiently low and thus not a significant concern for disease modeling and other applications.	[Veres, Adrian; Gosis, Bridget S.; Ding, Qiurong; Cowan, Chad A.; Musunuru, Kiran] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Veres, Adrian; Gosis, Bridget S.; Ding, Qiurong; Cowan, Chad A.; Musunuru, Kiran] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Veres, Adrian; Cowan, Chad A.; Musunuru, Kiran] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Collins, Ryan; Ragavendran, Ashok; Brand, Harrison; Erdin, Serkan; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Mol Neurogenet Unit, Boston, MA 02114 USA; [Talkowski, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Cowan, Chad A.; Talkowski, Michael E.; Musunuru, Kiran] Broad Inst, Cambridge, MA 02142 USA; [Musunuru, Kiran] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital	Musunuru, K (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	kiranmusunuru@gmail.com	Erdin, Serkan/AAE-4288-2019; Erdin, Serkan/B-4988-2008	Erdin, Serkan/0000-0001-6587-2625; Veres, Adrian/0000-0002-3849-3475; Gosis, Bridget/0000-0003-0068-621X; Collins, Ryan/0000-0003-1268-9995; Talkowski, Michael/0000-0003-2889-0992	Harvard Presidential Scholars Fund of the Harvard Medical School MD/PhD Program; National Institutes of Health (NIH) [R00-HL098364, R01-HL118744, R01-DK097768, U01-HL100408, R00-MH095867]; Harvard Stem Cell Institute; Harvard University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL098364, R01HL118744, U01HL100408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH095867] Funding Source: NIH RePORTER	Harvard Presidential Scholars Fund of the Harvard Medical School MD/PhD Program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Harvard University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the Harvard Presidential Scholars Fund of the Harvard Medical School MD/PhD Program (A.V.); grants R00-HL098364 (K.M.), R01-HL118744 (K.M.), R01-DK097768 (K.M. and C.A.C.), U01-HL100408 (C.A.C.), and R00-MH095867 (M.E.T.) from the National Institutes of Health (NIH); the Harvard Stem Cell Institute (K.M.); and Harvard University (Q.D. and K.M.). We thank Vamsee Pillalamarri, Carrie Hanscom, and the staff of the MGH Genomics and Technology Core and NextGen Sequencing Core for technical assistance.	Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Musunuru K, 2013, DIS MODEL MECH, V6, P896, DOI 10.1242/dmm.012054; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	21	362	390	1	80	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					27	30		10.1016/j.stem.2014.04.020	http://dx.doi.org/10.1016/j.stem.2014.04.020			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24996167	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000340878600008
J	Matus, S; Medinas, DB; Hetz, C				Matus, Soledad; Medinas, Danilo B.; Hetz, Claudio			Common Ground: Stem Cell Approaches Find Shared Pathways Underlying ALS	CELL STEM CELL			English	Editorial Material								The development of curative therapies for genetically complex diseases such as ALS has been delayed by the lack of relevant disease models. Recent advances using induced-pluripotent-stem-cell-derived motoneurons from patients harboring distinct ALS mutations have recapitulated essential disease features and have identified some common pathways driving disease pathogenesis.	[Matus, Soledad; Medinas, Danilo B.; Hetz, Claudio] Univ Chile, Biomed Neurosci Inst, Fac Med, Independencia 1027, Chile; [Matus, Soledad; Hetz, Claudio] Neurounion Biomed Fdn, Santiago, Chile; [Medinas, Danilo B.; Hetz, Claudio] Univ Chile, Inst Biomed Sci, Program Cellular & Mol Biol, Ctr Mol Studies Cell, Santiago 1027, Chile	Universidad de Chile; Universidad de Chile	Matus, S (corresponding author), Univ Chile, Biomed Neurosci Inst, Fac Med, Independencia 1027, Chile.	soledad.matus@neurounion.com; chetz@med.uchile.cl	Matus, Soledad/AAA-3857-2020; Hetz, Claudio/ABD-7514-2021; Medinas, Danilo/ABA-1182-2021	Bilches Medinas, Danilo/0000-0002-1822-1974				Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Burkhardt MF, 2013, MOL CELL NEUROSCI, V56, P355, DOI 10.1016/j.mcn.2013.07.007; Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003	10	16	18	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					697	699		10.1016/j.stem.2014.05.001	http://dx.doi.org/10.1016/j.stem.2014.05.001			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905158	Bronze			2022-12-28	WOS:000341248500004
J	Tahmasebi, S; Alain, T; Rajasekhar, VK; Zhang, JP; Prager-Khoutorsky, M; Khoutorsky, A; Dogan, Y; Gkogkas, CG; Petroulakis, E; Sylvestre, A; Ghorbani, M; Assadian, S; Yamanaka, Y; Vinagolu-Baur, JR; Teodoro, JG; Kim, K; Yang, XJ; Sonenberg, N				Tahmasebi, Soroush; Alain, Tommy; Rajasekhar, Vinagolu K.; Zhang, Jiang-Ping; Prager-Khoutorsky, Masha; Khoutorsky, Arkady; Dogan, Yildirim; Gkogkas, Christos G.; Petroulakis, Emmanuel; Sylvestre, Annie; Ghorbani, Mohammad; Assadian, Sarah; Yamanaka, Yojiro; Vinagolu-Baur, Julia R.; Teodoro, Jose G.; Kim, Kitai; Yang, Xiang-Jiao; Sonenberg, Nahum			Multifaceted Regulation of Somatic Cell Reprogramming by mRNA Translational Control	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; INITIATION-FACTOR 4E; PROTEIN-SYNTHESIS; EXPRESSION; GENERATION; CANCER; MOUSE; GROWTH; 4E-BP1; P53	Translational control plays a pivotal role in the regulation of the pluripotency network in embryonic stem cells, but its effect on reprogramming somatic cells to pluripotency has not been explored. Here, we show that eukaryotic translation initiation factor 4E (eIF4E) binding proteins (4E-BPs), which are translational repressors, have a multifaceted effect on the reprogramming of mouse embryonic fibroblasts (MEFs) into induced pluripotent stem cells (iPSCs). Loss of 4E-BP expression attenuates the induction of iPSCs at least in part through increased translation of p21, a known inhibitor of somatic cell reprogramming. However, MEFs lacking both p53 and 4E-BPs show greatly enhanced reprogramming resulting from a combination of reduced p21 transcription and enhanced translation of endogenous mRNAs such as Sox2 and Myc and can be reprogrammed through the expression of only exogenous Oct4. Thus, 4E-BPs exert both positive and negative effects on reprogramming, highlighting the key role that translational control plays in regulating this process.	[Tahmasebi, Soroush; Zhang, Jiang-Ping; Khoutorsky, Arkady; Petroulakis, Emmanuel; Sylvestre, Annie; Ghorbani, Mohammad; Assadian, Sarah; Yamanaka, Yojiro; Teodoro, Jose G.; Yang, Xiang-Jiao; Sonenberg, Nahum] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Tahmasebi, Soroush; Khoutorsky, Arkady; Petroulakis, Emmanuel; Sylvestre, Annie; Assadian, Sarah; Teodoro, Jose G.; Yang, Xiang-Jiao; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Rajasekhar, Vinagolu K.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Zhang, Jiang-Ping; Ghorbani, Mohammad; Yang, Xiang-Jiao; Sonenberg, Nahum] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A3, Canada; [Prager-Khoutorsky, Masha] McGill Univ, Ctr Hlth, Ctr Res Neurosci, Res Inst,Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Dogan, Yildirim; Vinagolu-Baur, Julia R.; Kim, Kitai] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Yamanaka, Yojiro] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A3, Canada; [Alain, Tommy] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON K1H 8L1, Canada; [Alain, Tommy] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L1, Canada; [Gkogkas, Christos G.] Univ Edinburgh, Ctr Integrat Physiol, Patrick Wild Ctr, Edinburgh EH8 9XD, Midlothian, Scotland	McGill University; McGill University; Memorial Sloan Kettering Cancer Center; McGill University; McGill University; Memorial Sloan Kettering Cancer Center; McGill University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Edinburgh	Yang, XJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca; nahum.sonenberg@mcgill.ca	Gkogkas, Christos/GQH-2659-2022; Teodoro, Joe/AFT-2440-2022; Gkogkas, Christos/GLR-5348-2022	Gkogkas, Christos/0000-0001-6281-3419; Teodoro, Joe/0000-0002-3713-6839; Yamanaka, Yojiro/0000-0003-1483-8691; Vinagolu, Rajasekhar/0000-0002-7364-2675; Khoutorsky, Arkady/0000-0003-3846-8728	McGill University; NSERC; Canadian Cancer Society; CIHR [MOP-115195, MOP-111197]; Brain Tumor Foundation of Canada Fellowship; CIHR	McGill University; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Cancer Society(Canadian Cancer Society (CCS)); CIHR(Canadian Institutes of Health Research (CIHR)); Brain Tumor Foundation of Canada Fellowship; CIHR(Canadian Institutes of Health Research (CIHR))	We thank L. Studer and A. Meissner for thoughtful discussions, R. Simmons for text proofreading, and lab members of E. Fuchs and O. Surriga for fluorescent imaging and the photography of the chimeras. This work was supported by a bridge funding grant from McGill University (N.S.), operating grants from NSERC and Canadian Cancer Society (X.-J.Y.), CIHR grants MOP-115195 (J.G.T.) and MOP-111197 (Y.Y.), a Brain Tumor Foundation of Canada Fellowship (T. A.), and a CIHR Studentship (S.A.).	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Courtes FC, 2013, J BIOTECHNOL, V167, P215, DOI 10.1016/j.jbiotec.2013.07.010; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; de Vries WN, 2008, COLD SH Q B, V73, P33, DOI 10.1101/sqb.2008.73.016; Dogan Y, 2010, EXP HEMATOL, V38, P11, DOI 10.1016/j.exphem.2009.10.006; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Edel MJ, 2010, GENE DEV, V24, P561, DOI 10.1101/gad.1876710; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Ge YQ, 2010, BIOCHEM BIOPH RES CO, V397, P711, DOI 10.1016/j.bbrc.2010.06.015; Gifford CA, 2012, CURR OPIN GENET DEV, V22, P409, DOI 10.1016/j.gde.2012.08.002; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; He J, 2012, STEM CELLS DEV, V21, P2630, DOI 10.1089/scd.2012.0015; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kannan-Thulasiraman P, 2008, BIOCHEM BIOPH RES CO, V368, P983, DOI 10.1016/j.bbrc.2008.02.028; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim J, 2011, STEM CELLS, V29, P992, DOI 10.1002/stem.641; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2007, CELL STEM CELL, V1, P346, DOI 10.1016/j.stem.2007.07.001; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; LATHAM KE, 1991, DEVELOPMENT, V112, P921; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Menendez S, 2010, CELL CYCLE, V9, P3887, DOI 10.4161/cc.9.19.13301; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Petroulakis E, 2009, CANCER CELL, V16, P439, DOI 10.1016/j.ccr.2009.09.025; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stoyanova T, 2013, P NATL ACAD SCI USA, V110, P20111, DOI 10.1073/pnas.1320565110; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanabe K, 2013, P NATL ACAD SCI USA, V110, P12172, DOI 10.1073/pnas.1310291110; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; WARNER JR, 1963, P NATL ACAD SCI USA, V49, P122, DOI 10.1073/pnas.49.1.122; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	63	32	32	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					606	616		10.1016/j.stem.2014.02.005	http://dx.doi.org/10.1016/j.stem.2014.02.005			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24630793	Green Published, Bronze			2022-12-28	WOS:000335659900010
J	Hu, X; Zhang, L; Mao, SQ; Li, Z; Chen, JK; Zhang, RR; Wu, HP; Gao, J; Guo, F; Liu, W; Xu, GF; Dai, HQ; Shi, YG; Li, XL; Hu, BQ; Tang, FC; Pei, DQ; Xu, GL				Hu, Xiao; Zhang, Lei; Mao, Shi-Qing; Li, Zheng; Chen, Jiekai; Zhang, Run-Rui; Wu, Hai-Ping; Gao, Juan; Guo, Fan; Liu, Wei; Xu, Gui-Fang; Dai, Hai-Qiang; Shi, Yujiang Geno; Li, Xianlong; Hu, Boqiang; Tang, Fuchou; Pei, Duanqing; Xu, Guo-Liang			Tet and TDG Mediate DNA Demethylation Essential for Mesenchymal-to-Epithelial Transition in Somatic Cell Reprogramming	CELL STEM CELL			English	Article							METHYLATION; PROTEINS; 5-HYDROXYMETHYLCYTOSINE; ROLES; MOUSE; 5-CARBOXYLCYTOSINE; 5-FORMYLCYTOSINE; 5-METHYLCYTOSINE; PLURIPOTENCY; GLYCOSYLASE	Tet-mediated DNA oxidation is a recently identified mammalian epigenetic modification, and its functional role in cell-fate transitions remains poorly understood. Here, we derive mouse embryonic fibroblasts (MEFs) deleted in all three Tet genes and examine their capacity for reprogramming into induced pluripotent stem cells (iPSCs). We show that Tet-deficient MEFs cannot be reprogrammed because of a block in the mesenchymal-to-epithelial transition (MET) step. Reprogramming of MEFs deficient in TDG is similarly impaired. The block in reprogramming is caused at least in part by defective activation of key miRNAs, which depends on oxidative demethylation promoted by Tet and TDG. Reintroduction of either the affected miRNAs or catalytically active Tet and TDG restores reprogramming in the knockout MEFs. Thus, oxidative demethylation to promote gene activation appears to be functionally required for reprogramming of fibroblasts to pluripotency. These findings provide mechanistic insight into the role of epigenetic barriers in cell-lineage conversion.	[Hu, Xiao; Zhang, Lei; Mao, Shi-Qing; Li, Zheng; Zhang, Run-Rui; Wu, Hai-Ping; Gao, Juan; Guo, Fan; Liu, Wei; Xu, Gui-Fang; Dai, Hai-Qiang; Xu, Guo-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Ke Lab Mol Biol, Shanghai 200031, Peoples R China; [Chen, Jiekai; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Shi, Yujiang Geno] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Shi, Yujiang Geno] Brigham & Womens Hosp, BCMP, Boston, MA 02115 USA; [Shi, Yujiang Geno] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Li, Xianlong; Hu, Boqiang; Tang, Fuchou] Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Peking University	Xu, GL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Ke Lab Mol Biol, Shanghai 200031, Peoples R China.	glxu@sibs.ac.cn	Guo, Fan/J-1857-2019; Mao, Shiqing/AAV-1168-2020; li, zheng/AAI-1750-2020; Guo, Fan/AAX-4952-2021; gao, juan/GXV-1381-2022; Hu, Xiao/L-3962-2019	Guo, Fan/0000-0002-0165-073X; Mao, Shiqing/0000-0001-9902-0199; li, zheng/0000-0002-4987-0205; Hu, Xiao/0000-0002-6215-9127; Chen, Jiekai/0000-0001-5168-7074; Zhang, Lei/0000-0002-0222-4417; Dai, Hai-Qiang/0000-0003-4337-9770; Li, Xianlong/0000-0001-7745-2695	Ministry of Sciences and Technology of China [2012CB966903, 2014CB964802]; National Science Foundation of China [31230039, 31221001]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA01010301]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China [2014ZX09507-002]	Ministry of Sciences and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China	We thank Jiemin Wong, Pentao Liu, and Colum Walsh for critical reading of the manuscript. This work was supported by grants from the Ministry of Sciences and Technology of China (2012CB966903 and 2014CB964802), the National Science Foundation of China (31230039 and 31221001), the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDA01010301), and the National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China (grant number 2014ZX09507-002) to G.-L.X.	Bagci H, 2013, CELL STEM CELL, V13, P265, DOI 10.1016/j.stem.2013.08.005; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsubouchi T, 2013, CELL, V152, P873, DOI 10.1016/j.cell.2013.01.012; Vincent JJ, 2013, CELL STEM CELL, V12, P470, DOI 10.1016/j.stem.2013.01.016; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Yu M, 2012, NAT PROTOC, V7, P2159, DOI 10.1038/nprot.2012.137; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	40	228	245	4	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					512	522		10.1016/j.stem.2014.01.001	http://dx.doi.org/10.1016/j.stem.2014.01.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24529596	Bronze			2022-12-28	WOS:000334766400014
J	Mullen, AC				Mullen, Alan C.			Hippo Tips the TGF-beta Scale in Favor of Pluripotency	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; ENDODERM; PATHWAY	How TGF-beta signaling switches from enforcing pluripotency to promoting mesendodermal differentiation remains an open question. Recently in Cell Reports, Beyer et al. demonstrated that Hippo signaling components recruit the NuRD complex to repress expression of key genes targeted by TGF-beta and thus determine whether TGF-beta signaling will favor pluripotency or differentiation.	[Mullen, Alan C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Mullen, Alan C.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Mullen, AC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA.	acmullen@partners.org		Mullen, Alan/0000-0002-4096-3106	NIDDK NIH HHS [K08 DK090122] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090122] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Oshimori N, 2012, CELL STEM CELL, V11, P751, DOI 10.1016/j.stem.2012.11.001; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031	10	16	17	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					6	8		10.1016/j.stem.2013.12.009	http://dx.doi.org/10.1016/j.stem.2013.12.009			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24388171	Green Accepted, Bronze			2022-12-28	WOS:000329571900004
J	Matulka, K; Lin, HH; Hribkova, H; Uwanogho, D; Dvorak, P; Sun, YM				Matulka, Kamil; Lin, Hsuan-Hwai; Hribkova, Hana; Uwanogho, Dafe; Dvorak, Petr; Sun, Yuh-Man			PTP1B Is an Effector of Activin Signaling and Regulates Neural Specification of Embryonic Stem Cells	CELL STEM CELL			English	Article							TYROSINE-PHOSPHATASE 1B; PLURIPOTENT CELLS; FATE DECISIONS; MOUSE EPIBLAST; SELF-RENEWAL; DIFFERENTIATION; NEUROECTODERM; INHIBITION; KINASE; ENDODERM	During embryogenesis, the Activin/Nodal pathway promotes the mesendodermal lineage and inhibits neural fate. The molecular mechanisms underlying this role of the Activin/Nodal pathway are not clear. In this study, we report a role for protein tyrosine phosphatase 1B (PTP1B) in Activin-mediated early fate decisions during ESC differentiation and show that PTP1B acts as an effector of the Activin pathway to specify mesendodermal or neural fate. We found that the Activin/ALK4 pathway directly recruits PTP1B and stimulates its release from the endoplasmic reticulum through ALK4-mediated cleavage. Subsequently, PTP1B suppresses p-ERK1/2 signaling to inhibit neural specification and promote mesendodermal commitment. These findings suggest that a noncanonical Activin signaling pathway functions in lineage specification of mouse and human embryonic stem cells.	[Matulka, Kamil; Hribkova, Hana; Dvorak, Petr; Sun, Yuh-Man] Masaryk Univ, Fac Med, Dept Biol, Brno 62500, Czech Republic; [Lin, Hsuan-Hwai] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Taipei, Taiwan; [Uwanogho, Dafe] Kings Coll London, Ctr Cellular Basis Behav, Inst Psychiat, London SE5 9NU, England	Masaryk University Brno; National Defense Medical Center; Tri-Service General Hospital; University of London; King's College London	Sun, YM (corresponding author), Masaryk Univ, Fac Med, Dept Biol, Brno 62500, Czech Republic.	wadeley@med.muni.cz	Sun, Yuh-Man/N-1579-2014; Dvorak, Petr/G-2509-2013; Dvorak, Petr/N-8936-2016; Matulka, Kamil/G-6320-2014	Dvorak, Petr/0000-0002-3229-140X; Dvorak, Petr/0000-0002-3229-140X; Hribkova, Hana/0000-0002-3403-7085	SoMoPro [2SGA2878]; Ministry of Education, Youth, and Sport of the Czech Republic [MSM0021622430, CZ.1.07/2.3.00/20.0011]	SoMoPro; Ministry of Education, Youth, and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	We thank Mr. A. Salykin for help in dot-counting for the PLA. This study was funded by grants from SoMoPro (2SGA2878) and the Ministry of Education, Youth, and Sport of the Czech Republic (MSM0021622430 and CZ.1.07/2.3.00/20.0011).	Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Combs AP, 2010, J MED CHEM, V53, P2333, DOI 10.1021/jm901090b; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dadke S, 2002, BIOCHEM J, V364, P377, DOI 10.1042/BJ20011372; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Ferrari E, 2011, J BIOL CHEM, V286, P4173, DOI 10.1074/jbc.M110.157420; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jiang WN, 2010, INT J MOL MED, V26, P571, DOI 10.3892/ijmm_00000501; Jin SH, 2000, J BIOL CHEM, V275, P34344, DOI 10.1074/jbc.M004927200; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; LaVaute TM, 2009, STEM CELLS, V27, P1741, DOI 10.1002/stem.99; Lee KL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002130; Li FF, 2009, BIOCHEM BIOPH RES CO, V386, P289, DOI 10.1016/j.bbrc.2009.05.084; Lin HH, 2010, STEM CELLS, V28, P1950, DOI 10.1002/stem.530; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Na J, 2010, STEM CELL RES, V5, P157, DOI 10.1016/j.scr.2010.06.002; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Rodriguez RT, 2007, EXP BIOL MED, V232, P1368, DOI 10.3181/0703-RM-63; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Sun YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003656; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Werner S., 2006, CYTOKINE GROWTH F R, V17; Yoo YD, 2011, STEM CELLS, V29, P1975, DOI 10.1002/stem.758; Zhou JM, 2008, CELL BIOL INT, V32, P1169, DOI 10.1016/j.cellbi.2008.04.025	39	21	23	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					706	719		10.1016/j.stem.2013.09.016	http://dx.doi.org/10.1016/j.stem.2013.09.016			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24139759	Bronze			2022-12-28	WOS:000329571700013
J	Ninkovic, J; Steiner-Mezzadri, A; Jawerka, M; Akinci, U; Messerdotti, G; Petricca, S; Fischer, J; von Holst, A; Beckers, J; Lie, CD; Petrik, D; Miller, E; Tang, J; Wu, J; Lefebvre, V; Demmers, J; Eisch, A; Metzger, D; Crabtree, G; Irmler, M; Poot, R; Gotz, M				Ninkovic, Jovica; Steiner-Mezzadri, Andrea; Jawerka, Melanie; Akinci, Umut; Messerdotti, Giacomo; Petricca, Stefania; Fischer, Judith; von Holst, Alexander; Beckers, Johanes; Lie, Chichung D.; Petrik, David; Miller, Erik; Tang, Jiong; Wu, Jiang; Lefebvre, Veronique; Demmers, Jeroen; Eisch, Amelia; Metzger, Daniel; Crabtree, Gerald; Irmler, Martin; Poot, Raymond; Goetz, Magdalena			The BAF Complex Interacts with Pax6 in Adult Neural Progenitors to Establish a Neurogenic Cross-Regulatory Transcriptional Network	CELL STEM CELL			English	Article							CHROMATIN-REMODELING COMPLEXES; SCHWANN-CELL DIFFERENTIATION; MOUSE CEREBRAL-CORTEX; STEM-CELLS; OLFACTORY-BULB; RADIAL GLIA; IN-VITRO; EXPRESSION; GENES; NEURONS	Numerous transcriptional regulators of neurogenesis have been identified in the developing and adult brain, but how neurogenic fate is programmed at the epigenetic level remains poorly defined. Here, we report that the transcription factor Pax6 directly interacts with the Brg1-containing BAF complex in adult neural progenitors. Deletion of either Brg1 or Pax6 in the subependymal zone (SEZ) causes the progeny of adult neural stem cells to convert to the ependymal lineage within the SEZ while migrating neuroblasts convert to different glial lineages en route to or in the olfactory bulb (OB). Genome-wide analyses reveal that the majority of genes downregulated in the Brg1 null SEZ and OB contain Pax6 binding sites and are also downregulated in Pax6 null SEZ and OB. Downstream of the Pax6-BAF complex, we find that Sox11, Nfib, and Pou3f4 form a transcriptional cross-regulatory network that drives neurogenesis and can convert postnatal glia into neurons. Taken together, elements of our work identify a tripartite effector network activated by Pax6-BAF that programs neuronal fate.	[Ninkovic, Jovica; Steiner-Mezzadri, Andrea; Messerdotti, Giacomo; Petricca, Stefania; Fischer, Judith; Goetz, Magdalena] Helmholtz Ctr Munich German Res Ctr Environm Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Lie, Chichung D.] Helmholtz Ctr Munich German Res Ctr Environm Hlth, Inst Dev Genet, D-85764 Neuherberg, Germany; [Beckers, Johanes; Irmler, Martin] Helmholtz Ctr Munich German Res Ctr Environm Hlth, Inst Expt Genet, D-85764 Neuherberg, Germany; [Ninkovic, Jovica; Jawerka, Melanie; Messerdotti, Giacomo; Goetz, Magdalena] Univ Munich, Fac Med, D-80633 Munich, Germany; [Akinci, Umut; Poot, Raymond] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Demmers, Jeroen] Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [von Holst, Alexander] Heidelberg Univ, Dept Anat & Cell Biol, D-69120 Heidelberg, Germany; [von Holst, Alexander] Interdisciplinary Ctr Neurosci IZN, D-69120 Heidelberg, Germany; [Beckers, Johanes] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Lie, Chichung D.] Univ Erlangen Nurnberg, Emil Fischer Ctr, Inst Biochem, D-91054 Erlangen, Germany; [Petrik, David; Eisch, Amelia] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Wu, Jiang] Univ Texas SW Med Ctr Dallas, Dept Physiol & Dev Biol, Dallas, TX 75390 USA; [Miller, Erik; Tang, Jiong; Crabtree, Gerald] Stanford Univ, Sch Med, Howard Hughes Med Inst, Beckman Ctr B211, Stanford, CA 94305 USA; [Lefebvre, Veronique] Cleveland Clin, Lerner Res Inst, Dept Cell Biol NC10, Cleveland, OH 44195 USA; [Metzger, Daniel] Univ Strasbourg, CNRS UMR 7104, INSERM U964, IGBMC, F-67404 Illkirch Graffenstaden, France; [Goetz, Magdalena] Univ Munich, Munich Cluster Syst Neurol EXC SyNergy 1010, D-80539 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technical University of Munich; University of Erlangen Nuremberg; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Stanford University; Cleveland Clinic Foundation; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Munich	Gotz, M (corresponding author), Helmholtz Ctr Munich German Res Ctr Environm Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany.	magdalena.goetz@helmholtz-muenchen.de	Lie, Dieter Chichung/AAS-8604-2020; Demmers, Jeroen AA/F-4046-2016; Beckers, Johannes/K-7237-2012; Irmler, Martin/B-3317-2013; Ninkovic, Jovica/AAH-5220-2019; von Holst, Alexander/I-3061-2014; Lie, Dieter Chichung/S-7914-2017	Lie, Dieter Chichung/0000-0002-6035-6442; Demmers, Jeroen AA/0000-0002-8757-9611; Beckers, Johannes/0000-0001-7874-3822; Irmler, Martin/0000-0003-3169-479X; Ninkovic, Jovica/0000-0002-4381-0041; Lie, Dieter Chichung/0000-0002-6035-6442; Eisch, Amelia/0000-0001-6476-5385; Metzger, Daniel/0000-0002-5555-046X; Petrik, David/0000-0003-3026-0770; Crabtree, Robert/0000-0002-6639-8707; Fischer-Sternjak, Judith/0000-0003-0398-7720	German Research foundation (DFG) [SFB 870]; German Research foundation (DFG) by SPP "Integrative Analysis of Olfaction"; Leibniz Prize; Munich Cluster for Systems Neurology [EXC 1010 SyNergy]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016765, K02DA023555] Funding Source: NIH RePORTER	German Research foundation (DFG)(German Research Foundation (DFG)); German Research foundation (DFG) by SPP "Integrative Analysis of Olfaction"; Leibniz Prize(German Research Foundation (DFG)); Munich Cluster for Systems Neurology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We want to thank Peter Becker, Ales Cvekl, and Maren Eckey for help with establishment of ChIP experiments, and Karel Bezstarosti for help with the mass spectrometry analysis. We are also thankful to Timucin Ozturk, Emily Violette-Baumgardt, and Angelika Waiser for excellent technical help, Alexandra Lepier for the viral vector production, Jelena Ninkovic for the help with statistical analysis, and Leda Dimou for critical reading of the manuscript. We also gratefully acknowledge funding to J.N. from the German Research foundation (DFG) by the SFB 870 and SPP "Integrative Analysis of Olfaction," and to M. G. from the German Research foundation (DFG) by the SFB 870, the Leibniz Prize, and the Munich Cluster for Systems Neurology (EXC 1010 SyNergy).	Asami M, 2011, DEVELOPMENT, V138, P5067, DOI 10.1242/dev.074591; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Baker NE, 2001, BIOESSAYS, V23, P763, DOI 10.1002/bies.1110; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Costa MR, 2011, DEVELOPMENT, V138, P1057, DOI 10.1242/dev.061663; Cuddapah S, 2009, COLD SPRING HARB PRO, V2009; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Feng WJ, 2013, CELL STEM CELL, V13, P62, DOI 10.1016/j.stem.2013.05.002; Fischer J, 2011, NAT PROTOC, V6, P1981, DOI 10.1038/nprot.2011.412; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Haslinger A, 2009, EUR J NEUROSCI, V29, P2103, DOI 10.1111/j.1460-9568.2009.06768.x; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; Limpert AS, 2013, J NEUROSCI, V33, P2388, DOI 10.1523/JNEUROSCI.3223-12.2013; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Mu LF, 2012, J NEUROSCI, V32, P3067, DOI 10.1523/JNEUROSCI.4679-11.2012; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Ninkovic J, 2013, BIOESSAYS, V35, P242, DOI 10.1002/bies.201200108; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weider M, 2012, DEV CELL, V23, P193, DOI 10.1016/j.devcel.2012.05.017; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Yip DJ, 2012, DEV CELL, V22, P871, DOI 10.1016/j.devcel.2012.01.020; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yu Y, 2013, CELL, V152, P248, DOI 10.1016/j.cell.2012.12.006; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	52	138	139	3	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					403	418		10.1016/j.stem.2013.07.002	http://dx.doi.org/10.1016/j.stem.2013.07.002			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	23933087	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000329571100010
J	Ryall, JG; Cliff, T; Dalton, S; Sartorelli, V				Ryall, James G.; Cliff, Tim; Dalton, Stephen; Sartorelli, Vittorio			Metabolic Reprogramming of Stem Cell Epigenetics	CELL STEM CELL			English	Review							ACETYLGLUCOSAMINE TRANSFERASE OGT; HEMATOPOIETIC STEM; SELF-RENEWAL; GLYCOLYTIC METABOLISM; HISTONE DEMETHYLATION; SOMATIC-CELLS; BONE-MARROW; TRANSCRIPTIONAL NETWORK; ENERGY-METABOLISM; PLURIPOTENT CELLS	For many years, stem cell metabolism was viewed as a byproduct of cell fate status rather than an active regulatory mechanism; however, there is now a growing appreciation that metabolic pathways influence epigenetic changes associated with lineage commitment, specification, and self-renewal. Here we review how metabolites generated during glycolytic and oxidative processes are utilized in enzymatic reactions leading to epigenetic modifications and transcriptional regulation. We discuss how "metabolic reprogramming" contributes to global epigenetic changes in the context of naive and primed pluripotent states, somatic reprogramming, and hematopoietic and skeletal muscle tissue stem cells, and we discuss the implications for regenerative medicine.	[Ryall, James G.] Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Stem Cell Metab & Regenerat Med Grp, Melbourne, Vic 3010, Australia; [Cliff, Tim; Dalton, Stephen] Univ Georgia, Paul D Coverdell Ctr Biomed & Hlth Sci, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Sartorelli, Vittorio] NIAMSD, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20829 USA	University of Melbourne; University System of Georgia; University of Georgia; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Ryall, JG (corresponding author), Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Stem Cell Metab & Regenerat Med Grp, Melbourne, Vic 3010, Australia.	jgryall@gmail.com; sartorev@mail.nih.gov	Ryall, James/J-9771-2019	Ryall, James/0000-0003-4702-1143; Sartorelli, Vittorio/0000-0002-9284-3675; Dalton, Stephen/0000-0002-3450-1263	Intramural Research Program of NIAMS; National Institute for General Medical Sciences [P01 GM085354]; Australian Research Council (ARC) [DP150100206]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER	Intramural Research Program of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Australian Research Council (ARC)(Australian Research Council); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Intramural Research Program of NIAMS, a grant to S.D. from the National Institute for General Medical Sciences (P01 GM085354), and a grant to J.G.R. from the Australian Research Council (ARC, DP150100206). We thank Stefania Dell'Orso, John J. O'Shea, and Richard M. Siegel (NIAMS); Thomas Rando (Stanford University); and Eytan Ruppin and Noam Auslander (University of Maryland and Tel-Aviv University) for stimulating discussions. The comments of three anonymous reviewers are also kindly acknowledged.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Brinster R L, 1979, J Anim Sci, V49 Suppl 2, P26; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Cao Y, 2015, EMBO J, V34, P609, DOI 10.15252/embj.201490441; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chakkalakal JV, 2014, DEVELOPMENT, V141, P1649, DOI 10.1242/dev.100842; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chen TT, 2011, AGING CELL, V10, P908, DOI 10.1111/j.1474-9726.2011.00722.x; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Comes S, 2013, STEM CELL REP, V1, P307, DOI 10.1016/j.stemcr.2013.09.001; Cullen SM, 2014, CURR TOP DEV BIOL, V107, P39, DOI 10.1016/B978-0-12-416022-4.00002-0; Das G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008813; Dolle C, 2013, FEBS J, V280, P3530, DOI 10.1111/febs.12304; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Gao Y, 2013, BIOCHIMIE, V95, P2107, DOI 10.1016/j.biochi.2013.08.001; Giancaspero TA, 2013, J BIOL CHEM, V288, P29069, DOI 10.1074/jbc.M113.500066; Goulas S, 2012, CELL STEM CELL, V11, P529, DOI 10.1016/j.stem.2012.06.017; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Hino S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1755; Houghton FD, 1996, MOL REPROD DEV, V44, P476, DOI 10.1002/(SICI)1098-2795(199608)44:4&lt;476::AID-MRD7&gt;3.0.CO;2-I; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Jansen S, 2008, BIOL REPROD, V79, P84, DOI 10.1095/biolreprod.107.066811; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Khaw SL, 2015, CELL REP, V12, P1080, DOI 10.1016/j.celrep.2015.07.032; Kida YS, 2015, CELL STEM CELL, V16, P547, DOI 10.1016/j.stem.2015.03.001; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim MJ, 1998, BLOOD, V91, P4106, DOI 10.1182/blood.V91.11.4106.411k40_4106_4117; Koopman R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00032; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Leese HJ, 2012, REPRODUCTION, V143, P417, DOI 10.1530/REP-11-0484; LEESE HJ, 1984, J REPROD FERTIL, V72, P9, DOI 10.1530/jrf.0.0720009; Li WL, 2013, CELL STEM CELL, V13, P270, DOI 10.1016/j.stem.2013.08.002; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Lin RY, 1998, J BIOL CHEM, V273, P28959, DOI 10.1074/jbc.273.44.28959; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Liu XS, 2015, ONCOTARGET, V6, P4214, DOI 10.18632/oncotarget.2929; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546; MARTIN KL, 1995, MOL REPROD DEV, V40, P436, DOI 10.1002/mrd.1080400407; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; Moussaieff A, 2015, STEM CELLS, V33, P2374, DOI 10.1002/stem.2041; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap; Rimmele P, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.04.015; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; Ryall JG, 2013, FEBS J, V280, P4004, DOI 10.1111/febs.12189; Ryall JG, 2012, CURR OPIN CLIN NUTR, V15, P561, DOI 10.1097/MCO.0b013e3283590914; Shi FT, 2013, J BIOL CHEM, V288, P20776, DOI 10.1074/jbc.M113.460386; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shiraki N, 2014, CELL METAB, V19, P780, DOI 10.1016/j.cmet.2014.03.017; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tang AH, 2014, EMBO J, V33, P2782, DOI 10.15252/embj.201488278; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; van der Wath RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006972; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang YH, 2014, CELL, V158, P1309, DOI 10.1016/j.cell.2014.07.048; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Washington JM, 2010, AM J PHYSIOL-CELL PH, V298, pC982, DOI 10.1152/ajpcell.00498.2009; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yang H, 2014, CELL RES, V24, P1017, DOI 10.1038/cr.2014.81; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Young JI, 2015, ANNU REV NUTR, V35, P545, DOI 10.1146/annurev-nutr-071714-034228; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015; Zimdahl B, 2014, NAT GENET, V46, P245, DOI 10.1038/ng.2889	123	176	183	2	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					651	662		10.1016/j.stem.2015.11.012	http://dx.doi.org/10.1016/j.stem.2015.11.012			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26637942	Green Accepted, Bronze			2022-12-28	WOS:000366139100008
J	Hiler, D; Chen, X; Hazen, J; Kupriyanov, S; Carroll, PA; Qu, CX; Xu, BS; Johnson, D; Griffiths, L; Frase, S; Rodriguez, AR; Martin, G; Zhang, JK; Jeon, J; Fan, YP; Finkelstein, D; Eisenman, RN; Baldwin, K; Dyer, MA				Hiler, Daniel; Chen, Xiang; Hazen, Jennifer; Kupriyanov, Sergey; Carroll, Patrick A.; Qu, Chunxu; Xu, Beisi; Johnson, Dianna; Griffiths, Lyra; Frase, Sharon; Rodriguez, Alberto R.; Martin, Greg; Zhang, Jiakun; Jeon, Jongrye; Fan, Yiping; Finkelstein, David; Eisenman, Robert N.; Baldwin, Kristin; Dyer, Michael A.			Quantification of Retinogenesis in 3D Cultures Reveals Epigenetic Memory and Higher Efficiency in iPSCs Derived from Rod Photoreceptors	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; VESICLE-LIKE STRUCTURES; CTCF; TRANSPLANTATION; AMACRINE; HETEROGENEITY; MECHANISMS; GENERATION; TISSUE	Cell-based therapies to treat retinal degeneration are now being tested in clinical trials. However, it is not known whether the source of stem cells is important for the production of differentiated cells suitable for transplantation. To test this, we generated induced pluripotent stem cells (iPSCs) from murine rod photoreceptors (r-iPSCs) and scored their ability to make retinae by using a standardized quantitative protocol called STEM-RET. We discovered that r-iPSCs more efficiently produced differentiated retinae than did embryonic stem cells (ESCs) or fibroblast-derived iPSCs (f-iPSCs). Retinae derived from f-iPSCs had fewer amacrine cells and other inner nuclear layer cells. Integrated epigenetic analysis showed that DNA methylation contributes to the defects in f-iPSC retinogenesis and that rod-specific CTCF insulator protein-binding sites may promote r-iPSC retinogenesis. Together, our data suggest that the source of stem cells is important for producing retinal neurons in three-dimensional (3D) organ cultures.	[Hiler, Daniel; Griffiths, Lyra; Zhang, Jiakun; Jeon, Jongrye; Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Biol, Memphis, TN 38105 USA; [Chen, Xiang; Qu, Chunxu; Xu, Beisi; Fan, Yiping; Finkelstein, David] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Hazen, Jennifer; Baldwin, Kristin] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Kupriyanov, Sergey; Rodriguez, Alberto R.; Martin, Greg] Scripps Res Inst, Mouse Genet Core Facil, La Jolla, CA 92037 USA; [Carroll, Patrick A.; Eisenman, Robert N.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98108 USA; [Johnson, Dianna; Dyer, Michael A.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA; [Frase, Sharon] St Jude Childrens Res Hosp, Cell & Tissue Imaging Shared Resource, Memphis, TN 38105 USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Scripps Research Institute; Scripps Research Institute; Fred Hutchinson Cancer Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Howard Hughes Medical Institute	Dyer, MA (corresponding author), St Jude Childrens Res Hosp, Dept Dev Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.dyer@stjude.org	Martin, Greg/B-4085-2009; Dyer, Michael/N-8134-2018; Chen, Xiang/N-2524-2018; Xu, Beisi/C-8560-2009	Martin, Greg/0000-0002-9684-7593; Chen, Xiang/0000-0002-2499-8261; Xu, Beisi/0000-0003-0099-858X; Baldwin, Kristin/0000-0002-6137-030X; Carroll, Patrick/0000-0001-8147-5750	National Cancer Institute (NCI) [CA21765]; NIH [EY014867, EY018599, CA168875]; American Lebanese Syrian Associated Charities (ALSAC); Alex's Lemonade Stand Foundation for Childhood Cancer; NCI [RO1CA20525, T32 CA009657]; NATIONAL CANCER INSTITUTE [P30CA021765, T32CA009657, R01CA020525, R01CA168875] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023619, R01EY014867, R01EY018599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012592] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Alex's Lemonade Stand Foundation for Childhood Cancer; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Konrad Hochedlinger for the reprogrammable mice, Anand Swaroop for Nrl- GFP and Nrl<SUP>-/-</SUP> mice, Samantha Cicero for assistance with viral reprogramming, and Vani Shanker and Angela McArthur for editing the manuscript. FEI assisted with image acquisition for the 3D TEM (Hillsboro, OR). This work was supported, in part, by a Cancer Center Support grant (CA21765) from the National Cancer Institute (NCI), grants to M.A.D. from the NIH (EY014867, EY018599, and CA168875), and the American Lebanese Syrian Associated Charities (ALSAC). M.A.D. was also supported by a grant from Alex's Lemonade Stand Foundation for Childhood Cancer. R.N.E. was supported by grant RO1CA20525 from the NCI. P.A.C. was supported by an NCI training grant (T32 CA009657).	Alunni A, 2007, J COMP NEUROL, V505, P221, DOI 10.1002/cne.21488; Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011; Balasubramanian R, 2014, GENE EXPR PATTERNS, V14, P1, DOI 10.1016/j.gep.2013.12.001; Belliveau MJ, 1999, DEVELOPMENT, V126, P555; Belliveau MJ, 2000, J NEUROSCI, V20, P2247; Birk OS, 2000, NATURE, V403, P909, DOI 10.1038/35002622; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Cherry TJ, 2009, P NATL ACAD SCI USA, V106, P9495, DOI 10.1073/pnas.0903264106; Cramer AO, 2013, CURR GENE THER, V13, P139; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005; Eiraku M, 2012, NAT PROTOC, V7, P69, DOI 10.1038/nprot.2011.429; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hargus G, 2014, CELL REP, V8, P1697, DOI 10.1016/j.celrep.2014.08.014; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Hyatt GA, 1996, P NATL ACAD SCI USA, V93, P13298, DOI 10.1073/pnas.93.23.13298; Kim J, 2011, STEM CELLS, V29, P992, DOI 10.1002/stem.641; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Morrow EM, 1998, J NEUROSCI, V18, P3738; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Phillips MJ, 2012, INVEST OPHTH VIS SCI, V53, P2007, DOI 10.1167/iovs.11-9313; Pottin K, 2011, DEVELOPMENT, V138, P2467, DOI 10.1242/dev.054106; Prickett AR, 2013, GENOME RES, V23, P1624, DOI 10.1101/gr.150136.112; Ramsden CM, 2013, DEVELOPMENT, V140, P2576, DOI 10.1242/dev.092270; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Trimarchi JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001588; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047	41	68	71	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2015	17	1					101	115		10.1016/j.stem.2015.05.015	http://dx.doi.org/10.1016/j.stem.2015.05.015			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DI	26140606	Bronze, Green Accepted			2022-12-28	WOS:000361877600012
J	McNeish, J; Gardner, JP; Wainger, BJ; Woolf, CJ; Eggan, K				McNeish, John; Gardner, Jason P.; Wainger, Brian J.; Woolf, Clifford J.; Eggan, Kevin			From Dish to Bedside: Lessons Learned While Translating Findings from a Stem Cell Model of Disease to a Clinical Trial	CELL STEM CELL			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS; DRUG DISCOVERY; MOTOR-NEURONS; HYPEREXCITABILITY; PATIENT	While iPSCs have created unprecedented opportunities for drug discovery, there remains uncertainty concerning the path to the clinic for candidate therapeutics discovered with their use. Here we share lessons that we learned, and believe are generalizable to similar efforts, while taking a discovery made using iPSCs into a clinical trial.	[McNeish, John; Gardner, Jason P.] GlaxoSmithKline, Regenerat Med Discovery Performance Unit, Cambridge, MA 02139 USA; [Wainger, Brian J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Wainger, Brian J.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Wainger, Brian J.; Woolf, Clifford J.; Eggan, Kevin] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Woolf, Clifford J.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Woolf, Clifford J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Eggan, Kevin] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA	GlaxoSmithKline; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	McNeish, J (corresponding author), GlaxoSmithKline, Regenerat Med Discovery Performance Unit, Cambridge, MA 02139 USA.	john.d.mcneish@gsk.com; eggan@mcb.harvard.edu	Woolf, Clifford/A-9784-2010; Eggan, Kevin/P-7119-2018; Wainger, Brian/L-7553-2017		Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS038253] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bae JS, 2013, J CLIN NEUROL, V9, P65, DOI 10.3988/jcn.2013.9.2.65; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Bellingham MC, 2011, CNS NEUROSCI THER, V17, P4, DOI 10.1111/j.1755-5949.2009.00116.x; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; McNeish J, 2004, NAT REV DRUG DISCOV, V3, P70, DOI 10.1038/nrd1281; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Saha K, 2014, CELL STEM CELL, V14, P559, DOI 10.1016/j.stem.2014.04.012; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019	9	54	55	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2015	17	1					8	10		10.1016/j.stem.2015.06.013	http://dx.doi.org/10.1016/j.stem.2015.06.013			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DI	26140603	Bronze			2022-12-28	WOS:000361877600004
J	Donati, G; Watt, FM				Donati, Giacomo; Watt, Fiona M.			Stem Cell Heterogeneity and Plasticity in Epithelia	CELL STEM CELL			English	Review							TRANSIT-AMPLIFYING CELLS; DNA METHYLATION DYNAMICS; HUMAN EPIDERMAL STEM; PROGENITOR CELLS; IN-VIVO; GENE-EXPRESSION; TISSUE REGENERATION; SMALL-INTESTINE; MAMMARY-GLAND; HUMAN COLON	Epithelia cover the surfaces and line the cavities of the body. Recent studies have highlighted the existence of multiple stem cell compartments within individual epithelia that exhibit striking plasticity in response to tissue damage, transplantation, or tumor development. New knowledge about the composition of the epithelial niche and the transcription factor networks that maintain cell identity has provided new insights into the extrinsic and intrinsic regulation of stem cell behavior. In addition new in vitro tissue substitutes allow better integration of data from human and mouse models.	[Donati, Giacomo; Watt, Fiona M.] Kings Coll London, Ctr Stem Cells & Regenerat Med, London SE1 9RT, England	University of London; King's College London	Watt, FM (corresponding author), Kings Coll London, Ctr Stem Cells & Regenerat Med, 28th Floor,Tower Wing,Guys Campus, London SE1 9RT, England.	fiona.watt@kcl.ac.uk	Watt, Fiona/AHB-0226-2022	Watt, Fiona/0000-0001-9151-5154; DONATI, Giacomo/0000-0002-0370-8288	Wellcome Trust; Medical Research Council; BBSRC; UKRMP; MRC [G1100073, MR/K026666/1] Funding Source: UKRI; Medical Research Council [MR/K026666/1, G1100073] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UKRMP; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We gratefully acknowledge input from all our colleagues (http://www.wattlab.org). We thank the Wellcome Trust, Medical Research Council, BBSRC, and UKRMP for funding.	Adam R.C., 2015, NATURE IN PRESS; Alcolea MP, 2014, NAT CELL BIOL, V16, P612, DOI 10.1038/ncb2963; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Baker AM, 2014, CELL REP, V8, P940, DOI 10.1016/j.celrep.2014.07.019; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bilousova G, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015164; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Boxer LD, 2014, GENE DEV, V28, P2013, DOI 10.1101/gad.246579.114; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; DeWard AD, 2014, CELL REP, V9, P701, DOI 10.1016/j.celrep.2014.09.027; Donati G, 2014, P NATL ACAD SCI USA, V111, pE1501, DOI 10.1073/pnas.1312880111; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Driskell I, 2012, EMBO J, V31, P616, DOI 10.1038/emboj.2011.421; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Estrach S, 2008, J INVEST DERMATOL, V128, P825, DOI 10.1038/sj.jid.5701113; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Gomez C, 2013, STEM CELL REP, V1, P19, DOI 10.1016/j.stemcr.2013.04.001; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grompe M, 2014, CELL STEM CELL, V15, P257, DOI 10.1016/j.stem.2014.08.004; HALL PA, 1989, DEVELOPMENT, V106, P619; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Hoste E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6932; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Hu B, 2012, CELL, V149, P1207, DOI 10.1016/j.cell.2012.03.048; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Kaaij LTJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r50; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Kaukua N, 2014, NATURE, V513, P551, DOI 10.1038/nature13536; Kim DH, 2015, CELL STEM CELL, V16, P88, DOI 10.1016/j.stem.2014.11.005; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Klein AM, 2010, P NATL ACAD SCI USA, V107, P270, DOI 10.1073/pnas.0909738107; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Kumar ME, 2014, SCIENCE, V346, P827, DOI 10.1126/science.1258810; Lane SW, 2014, NAT BIOTECHNOL, V32, P795, DOI 10.1038/nbt.2978; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li N, 2014, STEM CELL REP, V3, P876, DOI 10.1016/j.stemcr.2014.09.011; Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Mejetta S, 2011, EMBO J, V30, P3635, DOI 10.1038/emboj.2011.265; Mouw JK, 2014, NAT MED, V20, P360, DOI 10.1038/nm.3497; Mulder KW, 2012, NAT CELL BIOL, V14, P753, DOI 10.1038/ncb2520; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Nanduri LSY, 2014, STEM CELL REP, V3, P957, DOI 10.1016/j.stemcr.2014.09.015; Nigro G, 2014, CELL HOST MICROBE, V15, P792, DOI 10.1016/j.chom.2014.05.003; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Page ME, 2013, CELL STEM CELL, V13, P471, DOI 10.1016/j.stem.2013.07.010; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Scherz-Shouval R, 2014, CELL, V158, P564, DOI 10.1016/j.cell.2014.05.045; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Shaw T, 2009, EMBO REP, V10, P881, DOI 10.1038/embor.2009.102; Sigal M., 2015, GASTROENTER IN PRESS; Simmini S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6728; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Snippert HJ, 2014, EMBO REP, V15, P62, DOI 10.1002/embr.201337799; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stutchfield BM, 2010, LIVER TRANSPLANT, V16, P827, DOI 10.1002/lt.22083; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Takeo M, 2013, NATURE, V499, P228, DOI 10.1038/nature12214; Tan DWM, 2013, DEVELOPMENT, V140, P1433, DOI 10.1242/dev.087551; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tobin DJ, 2011, METHODS MOL BIOL, V695, P213, DOI 10.1007/978-1-60761-984-0_14; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Watanabe K, 2014, DEV CELL, V29, P59, DOI 10.1016/j.devcel.2014.03.006; Watt F.M., 2011, COLD SPRING HARB PER, V3; Watt FM, 2014, SCIENCE, V346, P937, DOI 10.1126/science.1253734; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Zhang LJ, 2015, SCIENCE, V347, P67, DOI 10.1126/science.1260972; Zomer A, 2013, STEM CELLS, V31, P602, DOI 10.1002/stem.1296; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	118	101	102	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					465	476		10.1016/j.stem.2015.04.014	http://dx.doi.org/10.1016/j.stem.2015.04.014			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25957902	Green Submitted, Bronze			2022-12-28	WOS:000354188600008
J	Lin, NW; Dang, J; Rana, TM				Lin, Nianwei; Dang, Jason; Rana, Tariq M.			Haunting the HOXA Locus: Two Faces of lncRNA Regulation	CELL STEM CELL			English	Editorial Material							NONCODING RNAS; DIFFERENTIATION; PLURIPOTENCY	Long non-coding RNAs (lncRNAs) regulate diverse biological functions through mechanisms ascribed to the lncRNA transcript itself. Now in Cell Stem Cell, Yin et al. (2015) use CRISPR/Cas9-mediated genome editing to demonstrate discrete and opposing roles for the lncRNA Haunt transcript and DNA at the HOXA locus during ESC differentiation.	[Lin, Nianwei; Dang, Jason; Rana, Tariq M.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Rana, TM (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, 9500 Gilman Dr, La Jolla, CA 92093 USA.	trana@ucsd.edu	Lin, Nianwei/AAD-9805-2019					Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Ramos AD, 2015, CELL STEM CELL, V16, P439, DOI 10.1016/j.stem.2015.02.007; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schorderet P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002071; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Yin Y., 2015, CELL STEM CELL, V16	10	3	3	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					449	450		10.1016/j.stem.2015.04.010	http://dx.doi.org/10.1016/j.stem.2015.04.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25957895	Bronze			2022-12-28	WOS:000354188600001
J	Nakai-Futatsugi, Y; Niwa, H				Nakai-Futatsugi, Yoko; Niwa, Hitoshi			Epiblast and Primitive Endoderm Differentiation: Fragile Specification Ensures Stable Commitment	CELL STEM CELL			English	Editorial Material							MOUSE BLASTOCYST; NANOG; PLURIPOTENCY; EXPRESSION	Specification of the epiblast and primitive endoderm is one of the earliest differentiation steps during embryogenesis. In vitro tracking of pluripotency markers in ESCs suggests that epiblast specification may be plastic; however, live imaging of blastocysts, as detailed in a recent paper from Xenopoulos et al (2015), showed that, unlike in ESCs, fate commitment in vivo is largely irreversible.	[Nakai-Futatsugi, Yoko; Niwa, Hitoshi] RIKEN Ctr Dev Biol, Lab Pluripotent Stem Cell Studies, Chuo Ku, Kobe, Hyogo 6500047, Japan	RIKEN	Niwa, H (corresponding author), RIKEN Ctr Dev Biol, Lab Pluripotent Stem Cell Studies, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	niwa@cdb.riken.jp		Nakai-Futatsugi, Yoko/0000-0003-4187-6060				Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Filipczyk A, 2013, CELL STEM CELL, V13, P12, DOI 10.1016/j.stem.2013.04.025; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Xenopoulos P, 2015, CELL REP, V10, P1508, DOI 10.1016/j.celrep.2015.02.010	6	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					346	347		10.1016/j.stem.2015.03.005	http://dx.doi.org/10.1016/j.stem.2015.03.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25842972	Bronze			2022-12-28	WOS:000352228600004
J	Kareta, MS; Gorges, LL; Hafeez, S; Benayoun, BA; Marro, S; Zmoos, AF; Cecchini, MJ; Spacek, D; Batista, LFZ; O'Brien, M; Ng, YH; Ang, CE; Vaka, D; Artandi, SE; Dick, FA; Brunet, A; Sage, J; Wernig, M				Kareta, Michael S.; Gorges, Laura L.; Hafeez, Sana; Benayoun, Berenice A.; Marro, Samuele; Zmoos, Anne-Flore; Cecchini, Matthew J.; Spacek, Damek; Batista, Luis F. Z.; O'Brien, Megan; Ng, Yi-Han; Ang, Cheen Euong; Vaka, Dedeepya; Artandi, Steven E.; Dick, Frederick A.; Brunet, Anne; Sage, Julien; Wernig, Marius			Inhibition of Pluripotency Networks by the Rb Tumor Suppressor Restricts Reprogramming and Tumorigenesis	CELL STEM CELL			English	Article							STEM-CELLS; RETINOBLASTOMA PROTEIN; MOUSE FIBROBLASTS; GENOMIC ANALYSIS; FAMILY-MEMBERS; SOMATIC-CELLS; G(1) CONTROL; IN-VIVO; EXPRESSION; CANCER	Mutations in the retinoblastoma tumor suppressor gene Rb are involved in many forms of human cancer. In this study, we investigated the early consequences of inactivating Rb in the context of cellular reprogramming. We found that Rb inactivation promotes the reprogramming of differentiated cells to a pluripotent state. Unexpectedly, this effect is cell cycle independent, and instead reflects direct binding of Rb to pluripotency genes, including Sox2 and Oct4, which leads to a repressed chromatin state. More broadly, this regulation of pluripotency networks and Sox2 in particular is critical for the initiation of tumors upon loss of Rb in mice. These studies therefore identify Rb as a global transcriptional repressor of pluripotency networks, providing a molecular basis for previous reports about its involvement in cell fate pliability, and implicate misregulation of pluripotency factors such as Sox2 in tumorigenesis related to loss of Rb function.	[Kareta, Michael S.; Gorges, Laura L.; Zmoos, Anne-Flore; Spacek, Damek; O'Brien, Megan; Vaka, Dedeepya; Sage, Julien] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Kareta, Michael S.; Gorges, Laura L.; Benayoun, Berenice A.; Zmoos, Anne-Flore; Spacek, Damek; O'Brien, Megan; Vaka, Dedeepya; Brunet, Anne; Sage, Julien] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Kareta, Michael S.; Hafeez, Sana; Marro, Samuele; Ng, Yi-Han; Ang, Cheen Euong; Wernig, Marius] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Batista, Luis F. Z.; Artandi, Steven E.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Batista, Luis F. Z.; Artandi, Steven E.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Kareta, Michael S.; Hafeez, Sana; Marro, Samuele; Batista, Luis F. Z.; Ng, Yi-Han; Ang, Cheen Euong; Artandi, Steven E.; Wernig, Marius] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Benayoun, Berenice A.; Brunet, Anne] Stanford Univ, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA; [Cecchini, Matthew J.; Dick, Frederick A.] Univ Western Ontario, Childrens Res Inst, London Reg Canc Program, London, ON N6A 4L6, Canada	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Western University (University of Western Ontario)	Sage, J (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	julsage@stanford.edu; wernig@stanford.edu	Benayoun, Bérénice A./K-7048-2012; Marro, Samuele G./I-4493-2014; Vaka, Dedeepya/L-9041-2016	Benayoun, Bérénice A./0000-0002-7401-4777; Marro, Samuele G./0000-0002-9326-6945; Kareta, Michael/0000-0002-6980-9065; Ang, Cheen Euong/0000-0002-9050-6122; Vaka, Dedeepya/0000-0001-7951-5514; Batista, Luis/0000-0002-7538-3240	PHS [T32 CA09151]; NCI; DHHS; Spectrum Child Health Child Health Research Institute; CIHR; Lucile Packard Foundation for Children's Health; CIRM (CIRM) [RB1-01385 -]; NATIONAL CANCER INSTITUTE [R01CA114102, R01CA125453, T32CA009302, T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036695] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DHHS; Spectrum Child Health Child Health Research Institute; CIHR(Canadian Institutes of Health Research (CIHR)); Lucile Packard Foundation for Children's Health; CIRM (CIRM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank Gary Mantalas, Ben Passarelli, and Steven Quake for sequencing; Helen Blau for critical reading of the manuscript; Moritz Mall for the CRISPR vectors; and Jamie Imam for assistance with teratoma assays. This work was supported by PHS Grant #T32 CA09151, awarded by the NCI; DHHS (M.S.K.); the Spectrum Child Health Child Health Research Institute (M.S.K.); CIHR MD/PhD (M.J.C.); the Lucile Packard Foundation for Children's Health (J.S.); and the CIRM (CIRM RB1-01385 - J.S.). F.A.D. is the Wolfe Senior Fellow in Tumor Suppressor Genes at Western University, M.W. is a New York Stem Cell Foundation-Robertson Investigator and a Tashia and John Morgridge Faculty Scholar, and J.S. is the Harriet and Mary Zelencik Scientist in Children's Cancer and Blood Diseases.	Andrusiak MG, 2013, CELL CYCLE, V12, P1416, DOI 10.4161/cc.24527; Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Bourgo RJ, 2011, MOL CELL, V43, P663, DOI 10.1016/j.molcel.2011.06.029; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Burkhart DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001003; Burkhart DL, 2010, MOL CELL BIOL, V30, P1729, DOI 10.1128/MCB.00952-09; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Cecchini MJ, 2014, MOL CELL BIOL, V34, P2029, DOI 10.1128/MCB.01589-13; Cecchini MJ, 2011, BIOCHEM J, V434, P297, DOI 10.1042/BJ20101210; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Chinnam M, 2011, CURR TOP DEV BIOL, V94, P129, DOI 10.1016/B978-0-12-380916-2.00005-X; Conklin JF, 2009, J CELL BIOCHEM, V108, P1023, DOI 10.1002/jcb.22342; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Goding CR, 2014, NAT REV CANCER, V14, P568, DOI 10.1038/nrc3781; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Isaac CE, 2006, MOL CELL BIOL, V26, P3659, DOI 10.1128/MCB.26.9.3659-3671.2006; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Julian LM, 2013, CELL STEM CELL, V12, P440, DOI 10.1016/j.stem.2013.02.001; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Li F, 2010, CELL STEM CELL, V7, P508, DOI 10.1016/j.stem.2010.09.003; Li H, 2012, CELL STEM CELL, V11, P845, DOI 10.1016/j.stem.2012.09.014; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Longworth MS, 2010, CHROMOSOMA, V119, P1, DOI 10.1007/s00412-009-0238-0; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nicolay BN, 2013, CURR OPIN CELL BIOL, V25, P735, DOI 10.1016/j.ceb.2013.07.012; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Talluri S, 2010, MOL CELL BIOL, V30, P948, DOI 10.1128/MCB.01168-09; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Viatour P, 2011, DIS MODEL MECH, V4, P581, DOI 10.1242/dmm.008060; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507	50	119	125	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					39	50		10.1016/j.stem.2014.10.019	http://dx.doi.org/10.1016/j.stem.2014.10.019			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25467916	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000347708400010
J	Leandra, S; Calvanese, V; Yao, CY; Kaiser, J; Wang, YL; Sasidharan, R; Crooks, G; Magnusson, M; Mikkola, HKA				Leandra, Sacha; Calvanese, Vincenzo; Yao, Catherine Yao; Kaiser, Joshua; Wang, Yanling; Sasidharan, Rajkumar; Crooks, Gay; Magnusson, Mattias; Mikkola, Hanna Katri Annikki			GPI-80 Defines Self-Renewal Ability in Hematopoietic Stem Cells during Human Development	CELL STEM CELL			English	Article							CORD BLOOD; FETAL LIVER; PROGENITOR CELLS; HUMAN PLACENTA; BONE-MARROW; LONG-TERM; PROTEIN; REGENERATION; ADHERENCE; MIGRATION	Advances in pluripotent stem cell and reprogramming technologies have given us the hope of generating hematopoietic stem cells (HSCs) in culture. To succeed, greater understanding of the self-renewing HSC during human development is required. We discovered that the glycophosphatidylinositol-anchored surface protein GPI-80 defines a sub-population of human fetal liver hematopoietic stem/progenitor cells (HSPCs) with self-renewal ability. CD34(+)CD38(lo/-)CD90(+)GPI-80(+) HSPCs were the sole population that maintained proliferative potential and an undifferentiated state in stroma coculture and engrafted in immunodeficient mice. GPI-80 expression also enabled tracking of HSPCs once they emerged from endothelium and migrated between human fetal hematopoietic niches. GPI-80 co-localized on the surface of HSPCs with Integrin alpha-M (ITGAM), which in leukocytes cooperates with GPI-80 to support migration. Knockdown of GPI-80 or ITGAM was sufficient to compromise HSPC expansion in culture and engraftment in vivo. These findings indicate that human fetal HSCs employ mechanisms used in leukocyte adhesion and migration to mediate HSC self-renewal.	[Leandra, Sacha; Calvanese, Vincenzo; Yao, Catherine Yao; Kaiser, Joshua; Wang, Yanling; Sasidharan, Rajkumar; Crooks, Gay; Magnusson, Mattias; Mikkola, Hanna Katri Annikki] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Leandra, Sacha; Calvanese, Vincenzo; Yao, Catherine Yao; Kaiser, Joshua; Sasidharan, Rajkumar; Crooks, Gay; Magnusson, Mattias; Mikkola, Hanna Katri Annikki] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Leandra, Sacha; Mikkola, Hanna Katri Annikki] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Crooks, Gay] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Crooks, Gay; Mikkola, Hanna Katri Annikki] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Mikkola, HKA (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	hmikkola@mcdb.ucla.edu	Calvanese, Vincenzo/AAO-4311-2020; Calvanese, Vincenzo/E-1145-2016	Calvanese, Vincenzo/0000-0002-7937-1511; Calvanese, Vincenzo/0000-0002-7937-1511	NIH [HL097766, DK100959, P01 HL073104]; CIRM New Faculty Award [RN1-00557-1]; Broad Stem Cell Center at University of California Research Award; Jonsson Cancer Center Foundation; Leukemia & Lymphoma Society (LLS); Howard Hughes Medical Institute Gilliam fellowship; Howard Hughes Undergraduate Research scholarship; Leukemia & Lymphoma Society; Swedish Research Council; Tegger Foundation; Novogenix Laboratories, LLC; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073104, R01HL097766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK100959, R01DK100959] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM New Faculty Award; Broad Stem Cell Center at University of California Research Award; Jonsson Cancer Center Foundation; Leukemia & Lymphoma Society (LLS)(Leukemia and Lymphoma Society); Howard Hughes Medical Institute Gilliam fellowship(Howard Hughes Medical Institute); Howard Hughes Undergraduate Research scholarship; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Tegger Foundation; Novogenix Laboratories, LLC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Felicia Codrea, Jessica Scholes, Min Zhou, and Jesse Oakes at FACS Core facilities at BSCRC and JCCC at UCLA for assistance with cell sorting; Ann George at Children's Hospital Los Angeles for Image-Stream analysis; the UCLA Clinical Microarray Core for the microarray analysis; Owen Witte, Batoul Amir-Ahmady, Donny Johnson, and Melissa McCracken for help with homing assays in mice; Alvin Welch at UCLA Warren Hall staff for animal care; and UCLA Tissue and Pathology Core and Heather Martin at Novogenix LLC for provision of human hematopoietic tissue. This work was supported by NIH RO1s HL097766 and DK100959, a CIRM New Faculty Award RN1-00557-1, a Broad Stem Cell Center at University of California Research Award, the Jonsson Cancer Center Foundation, a Leukemia & Lymphoma Society (LLS) Scholar award for H.K.A.M, and NIH P01 HL073104 for G.C. S.L.P. was supported by the Howard Hughes Medical Institute Gilliam fellowship, C.Y.Y. by the Howard Hughes Undergraduate Research scholarship, V.C. by a Leukemia & Lymphoma Society Special Fellow Award, and M.M. by the Swedish Research Council and Tegger Foundation. M.M. is a cofounder of and owns significant financial stakes in Novogenix Laboratories, LLC.	Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Bordignon C, 2006, NATURE, V441, P1100, DOI 10.1038/nature04962; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Ciriza J, 2013, EXP HEMATOL, V41, P411, DOI 10.1016/j.exphem.2013.01.009; Dehn J, 2008, BIOL BLOOD MARROW TR, V14, P1334, DOI 10.1016/j.bbmt.2008.09.009; Dravid GG, 2011, ADV DRUG DELIVER REV, V63, P331, DOI 10.1016/j.addr.2010.12.006; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Hogan CJ, 2002, P NATL ACAD SCI USA, V99, P413, DOI 10.1073/pnas.012336799; Holyoake TL, 1999, EXP HEMATOL, V27, P1418, DOI 10.1016/S0301-472X(99)00078-8; Huang JB, 2004, MOL IMMUNOL, V40, P1249, DOI 10.1016/j.molimm.2003.11.033; Ivanovs A, 2011, J EXP MED, V208, P2417, DOI 10.1084/jem.20111688; Larochelle A, 2011, BLOOD, V117, P1550, DOI 10.1182/blood-2009-03-212803; Magnusson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053912; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Matsubara A, 2005, J EXP MED, V202, P1483, DOI 10.1084/jem.20051325; McKenzie JL, 2007, EXP HEMATOL, V35, P1429, DOI 10.1016/j.exphem.2007.05.017; McKinney-Freeman S, 2012, CELL STEM CELL, V11, P701, DOI 10.1016/j.stem.2012.07.018; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Risueno RM, 2012, STEM CELLS, V30, P131, DOI 10.1002/stem.1684; Robin C, 2009, CELL STEM CELL, V5, P385, DOI 10.1016/j.stem.2009.08.020; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shenoy S, 2013, STEM CELL TRANSL MED, V2, P337, DOI 10.5966/sctm.2012-0180; Suzuki K, 1999, J IMMUNOL, V162, P4277; Tavian M, 2010, INT J DEV BIOL, V54, P1061, DOI 10.1387/ijdb.103097mt; Van Handel B, 2010, BLOOD, V116, P3321, DOI 10.1182/blood-2010-04-279489; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	32	47	47	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					80	87		10.1016/j.stem.2014.10.020	http://dx.doi.org/10.1016/j.stem.2014.10.020			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25465114	Green Accepted, Bronze			2022-12-28	WOS:000347708400013
J	Durak, O; Tsai, LH				Durak, Omer; Tsai, Li-Huei			Human Induced Pluripotent Stem Cells: Now Open to Discovery	CELL STEM CELL			English	Editorial Material								Human induced pluripotent stem cells represent a promising tool for investigating the underlying causes of disease; however, this potential currently remains unfulfilled. In this issue of Cell Stem Cell, Yoon et al. (2014) used iPSCs derived from patients harboring common genetic risk variants as the starting point to discover novel insights into disease pathology.	[Durak, Omer; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu		Durak, Omer/0000-0001-8426-6188				Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; Durak O., 2014, MOL PSYCHIA IN PRESS; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Ishizuka K, 2011, NATURE, V473, P92, DOI 10.1038/nature09859; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Silva JM, 2009, CELL, V137, P1047, DOI 10.1016/j.cell.2009.04.013; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003	9	5	6	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					4	7		10.1016/j.stem.2014.06.014	http://dx.doi.org/10.1016/j.stem.2014.06.014			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24996162	Bronze			2022-12-28	WOS:000340878600003
J	Wang, N				Wang, Ning			Stem Cells Go Soft: Pliant Substrate Surfaces Enhance Motor Neuron Differentiation	CELL STEM CELL			English	Editorial Material								Derivation of motor neurons from human pluripotent stem cells is inefficient and requires complex culture protocols. Recently in Nature Materials, Sun et al. (2014) report that differentiating human pluripotent stem cells on soft substrates increases the efficiency of mature motor neuron differentiation by altering cytoskeletal mechanotransduction through the Hippo/YAP/Smad pathway.	[Wang, Ning] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China; [Wang, Ning] Univ Illinois, Coll Engn, Dept Mech Sci & Engn, Urbana, IL 61801 USA	Huazhong University of Science & Technology; University of Illinois System; University of Illinois Urbana-Champaign	Wang, N (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China.	nwangrw@illinois.edu	Wang, Ning/B-6966-2008		NIGMS NIH HHS [R01 GM072744] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072744] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Poh Y.C., 2014, NAT COMMUN IN PRESS; Qu QH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4449; Sun Y., 2014, NAT MAT IN PRESS; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748	9	3	3	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					701	703		10.1016/j.stem.2014.05.007	http://dx.doi.org/10.1016/j.stem.2014.05.007			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905160	Bronze, Green Accepted			2022-12-28	WOS:000341248500006
J	Barna, M; Ruggero, D				Barna, Maria; Ruggero, Davide			Tailor Made Protein Synthesis for HSCs	CELL STEM CELL			English	Editorial Material							STEM-CELL LINEAGE; TRANSLATIONAL CONTROL; DIFFERENTIATION; PROLIFERATION	Translation control is a prevalent form of gene expression regulation in developmental and stem cell biology. A recent paper by Signer et al. (2014) measures protein synthesis in the mouse hematopoietic compartment and reveals the importance of diminished protein production for maintaining hematopoietic stem cell function and restraining oncogenic potential.	[Barna, Maria] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Barna, Maria] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA	Stanford University; Stanford University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Barna, M (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	mbarna@stanford.edu; davide.ruggero@ucsf.edu			NATIONAL CANCER INSTITUTE [R01CA154916, R01CA140456] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008509] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA140456, R01 CA154916] Funding Source: Medline; NIH HHS [DP2 OD008509] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Insco ML, 2012, CELL STEM CELL, V11, P689, DOI 10.1016/j.stem.2012.08.012; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; McCann KL, 2013, SCIENCE, V341, P849, DOI 10.1126/science.1244156; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Signer R.A., 2014, NATURE IN PRESS; Thompson B, 2007, TRANSLATIONAL CONTRO, V48, P507; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384	10	3	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					423	424		10.1016/j.stem.2014.03.011	http://dx.doi.org/10.1016/j.stem.2014.03.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24702992	Bronze, Green Accepted			2022-12-28	WOS:000334766400005
J	Qin, HY; Qu, CY; Yamaza, T; Yang, RL; Lin, X; Duan, XY; Akiyama, K; Liu, Y; Zhang, QZ; Chen, CD; Chen, YB; Qi, HH; Feng, XH; Le, AD; Shi, ST				Qin, Haiyan; Qu, Cunye; Yamaza, Takayoshi; Yang, Ruili; Lin, Xia; Duan, Xue-Yan; Akiyama, Kentaro; Liu, Yi; Zhang, Qunzhou; Chen, Chider; Chen, Yibu; Qi, Hank Heng; Feng, Xin-Hua; Le, Anh D.; Shi, Songtao			RETRACTED: Ossifying Fibroma Tumor Stem Cells Are Maintained by Epigenetic Regulation of a TSP1/TGF-beta/SMAD3 Autocrine Loop (Retracted article. See vol. 16, pg. 569, 2015)	CELL STEM CELL			English	Article; Retracted Publication							TGF-BETA; BONE-FORMATION; THROMBOSPONDIN-1; ACTIVATION; MECHANISMS; GROWTH; PROLIFERATION; METHYLATION; CANCER; NOTCH	Abnormal stem cell function makes a known contribution to many malignant tumors, but the role of stem cells in benign tumors is not well understood. Here, we show that ossifying fibroma (OF) contains a stem cell population that resembles mesenchymal stem cells (OFMSCs) and is capable of generating OF-like tumor xenografts. Mechanistically, OFMSCs show enhanced TGF-beta signaling that induces aberrant proliferation and deficient osteogenesis via Notch and BMP signaling pathways, respectively. The elevated TGF-beta activity is tightly regulated by JHDM1D-mediated epigenetic regulation of thrombospondin-1 (TSP1), forming a JHDM1D/TSP1/TGF-beta/SMAD3 autocrine loop. Inhibition of TGF-beta signaling in OFMSCs can rescue their abnormal osteogenic differentiation and elevated proliferation rate. Furthermore, chronic activation of TGF-beta can convert normal MSCs into OF-like MSCs via establishment of this JHDM1D/TSP1/TGF-beta/SMAD3 autocrine loop. These results reveal that epigenetic regulation of TGF-beta signaling in MSCs governs the benign tumor phenotype in OF and highlight TGF-beta signaling as a candidate therapeutic target.	[Qin, Haiyan; Qu, Cunye; Yamaza, Takayoshi; Yang, Ruili; Akiyama, Kentaro; Liu, Yi; Chen, Chider; Shi, Songtao] Univ So Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Duan, Xue-Yan; Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Zhang, Qunzhou; Le, Anh D.] Univ Penn, Dept Oral & Maxillofacial Surg & Pharmacol, Sch Dent Med & Penn Med, Hosp Univ Penn, Philadelphia, PA 19104 USA; [Chen, Yibu] Univ So Calif, Keck Sch Med, Norris Med Lib, Los Angeles, CA 90033 USA; [Qi, Hank Heng] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of Southern California; Baylor College of Medicine; Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Southern California; University of Iowa	Shi, ST (corresponding author), Univ So Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA.	songtaos@usc.edu	Zhang, Qunzhou/X-4504-2019	Yamaza, Takayoshi/0000-0001-7055-3370	National Institute of Dental and Craniofacial Research; National Institutes of Health, Department of Health and Human Services [R01DE017449, R01 DE019932]; California Institute for Regenerative Medicine [RN1-00572]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017449, R01DE019932] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Yan Jin of the Fourth Military University for assistance with microarrays. We appreciate the assistance from Drs. Diana V. Messadi and Russell Christensen of UCLA in the confirmation of diagnosis for all OF samples used in this study. This work was supported by grants from the National Institute of Dental and Craniofacial Research, the National Institutes of Health, Department of Health and Human Services (R01DE017449 and R01 DE019932 to S.S.) and a grant from the California Institute for Regenerative Medicine (RN1-00572 to S.S.).	Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Boukamp P, 1997, J CELL PHYSIOL, V173, P256, DOI 10.1002/(SICI)1097-4652(199711)173:2<256::AID-JCP31>3.3.CO;2-L; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Colmenero-Ruiz C, 2011, J ORAL MAXIL SURG, V69, P2055, DOI 10.1016/j.joms.2010.10.001; Engin F, 2010, BONE, V46, P274, DOI 10.1016/j.bone.2009.05.027; Filleur S, 2001, GENE DEV, V15, P1373, DOI 10.1101/gad.193501; Gondivkar SM, 2011, ORAL ONCOL, V47, P804, DOI 10.1016/j.oraloncology.2011.06.014; Ikegaki N, 2013, P NATL ACAD SCI USA, V110, P6097, DOI 10.1073/pnas.1118262110; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; MacDonald-Jankowski DS, 2009, DENTOMAXILLOFAC RAD, V38, P495, DOI 10.1259/dmfr/70933621; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pedrozo HA, 1999, ENDOCRINOLOGY, V140, P5806, DOI 10.1210/en.140.12.5806; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; PFEILSCHIFTER J, 1990, J BONE MINER RES, V5, P49, DOI 10.1002/jbmr.5650050109; Pimenta FJ, 2006, ORAL ONCOL, V42, P735, DOI 10.1016/j.oraloncology.2005.11.019; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Roelen Bernard A J, 2003, J Orthop Sci, V8, P740, DOI 10.1007/s00776-003-0702-2; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Valdez JM, 2012, CELL STEM CELL, V11, P676, DOI 10.1016/j.stem.2012.07.003; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Volpert OV, 1998, P NATL ACAD SCI USA, V95, P6343, DOI 10.1073/pnas.95.11.6343; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Williams JP, 2008, CELL STEM CELL, V3, P658, DOI 10.1016/j.stem.2008.10.003; Xu Q, 2009, BRIT J CANCER, V101, P303, DOI 10.1038/sj.bjc.6605142; Yamaza T, 2011, J DENT RES, V90, P317, DOI 10.1177/0022034510387796; Zama M, 2004, PLAST RECONSTR SURG, V113, P970, DOI 10.1097/01.PRS.0000105629.56850.AA; Zhang QZ, 2009, PLOS ONE, V4, pA192, DOI 10.1371/journal.pone.0007798	41	10	11	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					577	589		10.1016/j.stem.2013.08.010	http://dx.doi.org/10.1016/j.stem.2013.08.010			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24209761	Green Accepted, Bronze			2022-12-28	WOS:000329571500010
J	Mascetti, VL; Pedersen, RA				Mascetti, Victoria L.; Pedersen, Roger A.			Human-Mouse Chimerism Validates Human Stem Cell Pluripotency	CELL STEM CELL			English	Article							EMBRYO; ALLOCATION; DIFFERENTIATION; GASTRULATION; BLASTOCYSTS; GENERATION; DERIVATION; STATE; LINES	Pluripotent stem cells are defined by their capacity to differentiate into all three tissue layers that comprise the body. Chimera formation, generated by stem cell transplantation to the embryo, is a stringent assessment of stem cell pluripotency. However, the ability of human pluripotent stem cells (hPSCs) to form embryonic chimeras remains in question. Here we show using a stage-matching approach that human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) have the capacity to participate in normalmouse development when transplanted into gastrula-stage embryos, providing in vivo functional validation of hPSC pluripotency. hiPSCs and hESCs form interspecies chimeras with high efficiency, colonize the embryo in a manner predicted from classical developmental fate mapping, and differentiate into each of the three primary tissue layers. This faithful recapitulation of tissue-specific fate post-transplantation underscores the functional potential of hPSCs and provides evidence that human-mouse interspecies developmental competency can occur.	[Mascetti, Victoria L.; Pedersen, Roger A.] Univ Cambridge, Anne McLaren Lab, Wellcome Trust Med Res Council, Dept Surg,Cambridge Stem Cell Inst, Cambridge CB2 0SZ, England; [Mascetti, Victoria L.; Pedersen, Roger A.] Univ Cambridge, British Heart Fdn, Ctr Regenerat Med, Cambridge CB2 0SZ, England	University of Cambridge; University of Cambridge	Mascetti, VL (corresponding author), Univ Cambridge, Anne McLaren Lab, Wellcome Trust Med Res Council, Dept Surg,Cambridge Stem Cell Inst, Cambridge CB2 0SZ, England.; Mascetti, VL (corresponding author), Univ Cambridge, British Heart Fdn, Ctr Regenerat Med, Cambridge CB2 0SZ, England.	vlm37@cam.ac.uk			National Institutes of Health [1R21ID012228]; Medical Research Council/British Heart Foundation [G1000847]; British Heart Foundation; British Heart Foundation Centre of Regenerative Medicine [RM/13/3/3015]; Medical Research Council [G0800784, G0600275, G1000847] Funding Source: researchfish; MRC [G0800784, G1000847, G0600275] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council/British Heart Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)British Heart Foundation); British Heart Foundation(British Heart Foundation); British Heart Foundation Centre of Regenerative Medicine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by National Institutes of Health grant No. 1R21ID012228 (R.A.P.); Medical Research Council/British Heart Foundation grant No. G1000847 (R.A.P.); British Heart Foundation Ph.D. studentship (V.L.M.); British Heart Foundation Centre of Regenerative Medicine (Oxford grant RM/13/3/3015); core support from the Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute; and the Cambridge NIHR Biomedical Research Centre. We thank Ludovic Vallier for providing the BBHX8, A1ATD-1, and H9-GFP lines and advice; Peter Andrews for providing the Shef-6 line; Austin Smith for providing the FiPS line; Barry Rosen for the H2B-Venus vector; M.-Saadeh Suleiman for comments and advice; and John Brown and Peter Humphreys for advice on histology and imaging. AP-2 alpha monoclonal antibody was obtained from the Developmental Studies Hybridoma Bank, University of Iowa.	BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chen YC, 2015, CELL STEM CELL, V17, P116, DOI 10.1016/j.stem.2015.06.004; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Krtolica A, 2007, STEM CELLS, V25, P2215, DOI 10.1634/stemcells.2007-0230; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Masaki H, 2015, DEVELOPMENT, V142, P3222, DOI 10.1242/dev.124016; Mascetti VL, 2014, NAT BIOTECHNOL, V32, P68, DOI 10.1038/nbt.2789; McLaren A., 1976, MAMMALIAN CHIMAERAS; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; TAM PPL, 1989, DEVELOPMENT, V107, P55; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu J, 2015, NATURE, V521, P316, DOI 10.1038/nature14413	21	77	78	2	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					67	72		10.1016/j.stem.2015.11.017	http://dx.doi.org/10.1016/j.stem.2015.11.017			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26712580	Green Published, hybrid			2022-12-28	WOS:000372321300012
J	Parenti, A; Ralston, A				Parenti, Anthony; Ralston, Amy			Three, two, one ... TROPHO-BLAST OFF!	CELL STEM CELL			English	Editorial Material							PLURIPOTENCY	Trophoblast stem cells (TSCs) are derived from the early mouse embryo and can substantially contribute to placental development. Two studies by Kubaczka et al. (2015) and Benchetrit et al. (2015) in this issue of Cell Stem Cell now report reprogramming mouse fibroblasts into TSCs, surmounting the first lineage barrier established in development and providing new tools for researching placental specification and diseases.	[Parenti, Anthony; Ralston, Amy] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA; [Parenti, Anthony; Ralston, Amy] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Ralston, A (corresponding author), Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA.	aralston@msu.edu		Ralston, Amy/0000-0003-3755-8262	NIGMS NIH HHS [R01 GM104009] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104009] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bar-Nur O, 2015, NAT BIOTECHNOL, V33, P761, DOI 10.1038/nbt.3247; Benchetrit H, 2015, CELL STEM CELL, V17, P543, DOI 10.1016/j.stem.2015.08.006; Guttmacher AE, 2014, PLACENTA, V35, P303, DOI 10.1016/j.placenta.2014.02.012; Kubaczka C, 2015, CELL STEM CELL, V17, P557, DOI 10.1016/j.stem.2015.08.005; Latos PA, 2014, PLACENTA, V35, pS81, DOI 10.1016/j.placenta.2013.10.013; Maltepe E., 2015, ANN REV CEL IN PRESS; Maza I, 2015, NAT BIOTECHNOL, V33, P769, DOI 10.1038/nbt.3270; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072	9	0	0	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2015	17	5					499	500		10.1016/j.stem.2015.10.005	http://dx.doi.org/10.1016/j.stem.2015.10.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4UB	26544108	Bronze			2022-12-28	WOS:000365694700001
J	Wu, J; Belmonte, JCI				Wu, Jun; Belmonte, Juan Carlos Izpisua			Dynamic Pluripotent Stem Cell States and Their Applications	CELL STEM CELL			English	Review							ZINC-FINGER NUCLEASES; PANCREATIC BETA-CELLS; PRIMORDIAL GERM-CELLS; MOUSE EMBRYOS; IN-VITRO; GROUND-STATE; BLASTOCYST COMPLEMENTATION; SELF-RENEWAL; INTERSPECIFIC CHIMERAS; RETINITIS-PIGMENTOSA	Embryonic pluripotency can be recapitulated in vitro by a spectrum of pluripotent stem cell states stabilized with different culture conditions. Their distinct spatiotemporal characteristics provide an unprecedented tool for the study of early human development. The newly unveiled ability of some stem cell types for crossing xeno-barriers will facilitate the generation of interspecies chimeric embryos from distant species, including humans. When combined with efficient zygote genome editing technologies, xenogeneic human pluripotent stem cells may also open new frontiers for regenerative medicine applications, including the possibility of generating human organs in animals via interspecies chimeric complementation.	[Wu, Jun; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Wu, Jun/AAF-1830-2019	Wu, Jun/0000-0001-9863-1668	G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Moxie Foundation; Universidad Catolica San Antonio de Murcia (UCAM)	G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Moxie Foundation; Universidad Catolica San Antonio de Murcia (UCAM)	We apologize to all of those whose works are not covered due to space limitations. We would like to thank Dr. Pablo Ross, Dr. Emilio Martinez, Dr. Estrella Nunez, Dr. Jeronimo Lajara, and Dr. J.M. Campistol for stimulating discussions. We would like to thank all members from the Izpisua Belmonte laboratory for their experimental and conceptual contributions that lead to some of the ideas presented in this Perspective. We would like to thank May Schwarz for her critical reading of the manuscript and James Simon for help with the illustrations. Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002), the Moxie Foundation, and the Universidad Catolica San Antonio de Murcia (UCAM).	Amoyel M, 2014, DEVELOPMENT, V141, P988, DOI 10.1242/dev.079129; Aramaki S, 2013, DEV CELL, V27, P516, DOI 10.1016/j.devcel.2013.11.001; Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021; Berge D., 2011, NATURE CELL BIOL, V13, P1; Bernemann C, 2011, STEM CELLS, V29, P1496, DOI 10.1002/stem.709; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chang KH, 2013, STEM CELLS, V31, P918, DOI 10.1002/stem.1330; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Chen LR, 1999, THERIOGENOLOGY, V52, P195, DOI 10.1016/S0093-691X(99)00122-3; Chen YC, 2015, CELL STEM CELL, V17, P116, DOI 10.1016/j.stem.2015.06.004; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Claveria C, 2013, NATURE, V500, P39, DOI 10.1038/nature12389; Dejosez M, 2013, SCIENCE, V341, P1511, DOI 10.1126/science.1241628; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Duggal G, 2015, STEM CELLS, V33, P2686, DOI 10.1002/stem.2071; Espejel S, 2010, J CLIN INVEST, V120, P3120, DOI 10.1172/JCI43267; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; EVANS MJ, 1990, THERIOGENOLOGY, V33, P125, DOI 10.1016/0093-691X(90)90603-Q; Fang RG, 2014, CELL STEM CELL, V15, P488, DOI 10.1016/j.stem.2014.09.004; FEHILLY CB, 1984, NATURE, V307, P634, DOI 10.1038/307634a0; Fisher JE, 2013, LIVER TRANSPLANT, V19, P328, DOI 10.1002/lt.23598; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GARDNER RL, 1985, J EMBRYOL EXP MORPH, V88, P349; GARDNER RL, 1973, NATURE-NEW BIOL, V246, P86, DOI 10.1038/newbio246086a0; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Hermeren G, 2015, DEVELOPMENT, V142, P3, DOI 10.1242/dev.119024; Hough SR, 2014, STEM CELL REP, V2, P881, DOI 10.1016/j.stemcr.2014.04.014; Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111; Huang K, 2014, CELL STEM CELL, V15, P410, DOI 10.1016/j.stem.2014.09.014; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; Hyun I, 2007, CELL STEM CELL, V1, P367, DOI 10.1016/j.stem.2007.09.006; Hyun I, 2015, DEVELOPMENT, V142, P6, DOI 10.1242/dev.119206; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Ishiuchi T, 2015, NAT STRUCT MOL BIOL, V22, P662, DOI 10.1038/nsmb.3066; Isotani A, 2011, GENES CELLS, V16, P397, DOI 10.1111/j.1365-2443.2011.01495.x; IZPISUABELMONTE JC, 1992, DEVELOPMENT, V115, P553; IZPISUABELMONTE JC, 1993, CELL, V74, P645, DOI 10.1016/0092-8674(93)90512-O; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Joo JY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07477; KAWASE E, 1994, INT J DEV BIOL, V38, P385; Kim H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3403; Kobayashi T, 2015, STEM CELLS DEV, V24, P182, DOI 10.1089/scd.2014.0270; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Kolodziejczyk AA, 2015, CELL STEM CELL, V17, P471, DOI 10.1016/j.stem.2015.09.011; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Kurek D, 2015, STEM CELL REP, V4, P114, DOI 10.1016/j.stemcr.2014.11.007; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lensch MW, 2007, CELL STEM CELL, V1, P253, DOI 10.1016/j.stem.2007.07.019; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Lienert F, 2014, NAT REV MOL CELL BIO, V15, P95, DOI 10.1038/nrm3738; Lorson MA, 2011, TRANSGENIC RES, V20, P1293, DOI 10.1007/s11248-011-9496-8; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masaki H, 2015, DEVELOPMENT, V142, P3222, DOI 10.1242/dev.124016; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; MULNARD J, 1973, CR ACAD SCI D NAT, V276, P379; MYSTKOWSKA ET, 1975, J EMBRYOL EXP MORPH, V33, P731; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; National Research Council, 2005, GUID HUM EMBR STEM C; National Research Council, 2007, AM NAT AC GUID HUM E; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; O'Leary T, 2012, NAT BIOTECHNOL, V30, P278, DOI 10.1038/nbt.2135; Oestrup O, 2009, REPROD DOMEST ANIM, V44, P39, DOI 10.1111/j.1439-0531.2009.01482.x; Offield MF, 1996, DEVELOPMENT, V122, P983; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Park KW, 2001, ANIM BIOTECHNOL, V12, P173, DOI 10.1081/ABIO-100108344; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; Prather RS, 2013, ANNU REV ANIM BIOSCI, V1, P203, DOI 10.1146/annurev-animal-031412-103715; Rashid T, 2014, CELL STEM CELL, V15, P406, DOI 10.1016/j.stem.2014.09.013; Renner S, 2010, DIABETES, V59, P1228, DOI 10.2337/db09-0519; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Ross JW, 2012, INVEST OPHTH VIS SCI, V53, P501, DOI 10.1167/iovs.11-8784; ROSSANT J, 1976, J EMBRYOL EXP MORPH, V36, P163; ROSSANT J, 1980, SCIENCE, V208, P419, DOI 10.1126/science.7367871; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Simerly C, 2011, STEM CELL RES, V7, P28, DOI 10.1016/j.scr.2011.03.002; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith KK, 2003, INT J DEV BIOL, V47, P613; SOLTER D, 1970, NATURE, V227, P503, DOI 10.1038/227503a0; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Stephenson R. O., 2012, COLD SPRING HARB PER, V4, pa008235; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; STERN MS, 1973, NATURE, V244, P472; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Sturzu AC, 2015, CIRCULATION, V132, P109, DOI 10.1161/CIRCULATIONAHA.114.011490; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tonge PD, 2014, NATURE, V516, P192, DOI 10.1038/nature14047; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; Tsukiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095329; Umeyama K, 2009, TRANSGENIC RES, V18, P697, DOI 10.1007/s11248-009-9262-3; Usui JI, 2012, AM J PATHOL, V180, P2417, DOI 10.1016/j.ajpath.2012.03.007; Valamehr B, 2014, STEM CELL REP, V2, P366, DOI 10.1016/j.stemcr.2014.01.014; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08256; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Whyte JJ, 2012, J ANIM SCI, V90, P1111, DOI 10.2527/jas.2011-4546; WILLIAMS TJ, 1990, REPROD FERT DEVELOP, V2, P385, DOI 10.1071/RD9900385; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; Wu J, 2015, NATURE, V521, P316, DOI 10.1038/nature14413; Wu J, 2014, NATURE, V516, P172, DOI 10.1038/516172a; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Wu ZQ, 2002, MOL CELL BIOL, V22, P2441, DOI 10.1128/MCB.22.8.2441-2449.2002; Xiang AP, 2008, HUM MOL GENET, V17, P27, DOI 10.1093/hmg/ddm282; Yang Y, 2015, P NATL ACAD SCI USA, V112, pE2337, DOI 10.1073/pnas.1504778112; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; ZEILMAKER GH, 1973, NATURE, V242, P115, DOI 10.1038/242115a0; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020	163	107	109	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2015	17	5					509	525		10.1016/j.stem.2015.10.009	http://dx.doi.org/10.1016/j.stem.2015.10.009			17	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4UB	26544113	Bronze			2022-12-28	WOS:000365694700006
J	Hicks, M; Pyle, A				Hicks, Michael; Pyle, April			The Path from Pluripotency to Skeletal Muscle: Developmental Myogenesis Guides the Way	CELL STEM CELL			English	Editorial Material							STEM-CELLS; DERIVATION; MOUSE	Following cues from mouse embryogenesis, Chal et al. (2015) identified key regulators of skeletal myogenesis from mouse and human pluripotent stem cells. Emerging myogenic progenitors were specified to form multinucleated fibers that enabled development of quiescent, satellite cell-like progenitors and a model for Duchenne Muscular Dystrophy.	[Hicks, Michael; Pyle, April] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Ctr Duchenne Muscular Dystrophy, Los Angeles, CA 90095 USA; [Hicks, Michael; Pyle, April] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Pyle, A (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Ctr Duchenne Muscular Dystrophy, Los Angeles, CA 90095 USA.	apyle@mednet.ucla.edu			NIAMS NIH HHS [R01 AR064327] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064327] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Borchin B, 2013, STEM CELL REP, V1, P620, DOI 10.1016/j.stemcr.2013.10.007; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Chal J., 2015, NAT BIOTECH IN PRESS; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Pavlath GK, 2010, CELL ADHES MIGR, V4, P502, DOI 10.4161/cam.4.4.12291; Shelton M, 2014, STEM CELL REP, V3, P516, DOI 10.1016/j.stemcr.2014.07.001; TREMBLAY JP, 1993, CELL TRANSPLANT, V2, P99, DOI 10.1177/096368979300200203; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Xu C, 2013, CELL, V155, P909, DOI 10.1016/j.cell.2013.10.023	10	7	7	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					255	257		10.1016/j.stem.2015.08.017	http://dx.doi.org/10.1016/j.stem.2015.08.017			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26340524	Green Accepted, Bronze			2022-12-28	WOS:000364011000004
J	Trounson, A; McDonald, C				Trounson, Alan; McDonald, Courtney			Stem Cell Therapies in Clinical Trials: Progress and Challenges	CELL STEM CELL			English	Review							VERSUS-HOST-DISEASE; MESENCHYMAL STROMAL CELLS; AMYOTROPHIC-LATERAL-SCLEROSIS; STEROID-REFRACTORY ACUTE; BONE-MARROW-CELLS; PHASE-I; DOUBLE-BLIND; MULTIPLE-SCLEROSIS; CROHNS-DISEASE; TRANSENDOCARDIAL INJECTION	Clinical investigations using stem cell products in regenerative medicine are addressing a wide spectrum of conditions using a variety of stem cell types. To date, there have been few reports of safety issues arising from autologous or allogeneic transplants. Many cells administered show transient presence for a few days with trophic influences on immune or inflammatory responses. Limbal stem cells have been registered as a product for eye burns in Europe and mesenchymal stem cells have been approved for pediatric graft versus host disease in Canada and New Zealand. Many other applications are progressing in trials, some with early benefits to patients.	[Trounson, Alan; McDonald, Courtney] Hudson Inst Med Res, Clayton, Vic 3168, Australia	Hudson Institute of Medical Research	Trounson, A (corresponding author), Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	alan.trounson@hudson.org.au		McDonald, Courtney/0000-0001-8421-461X; Trounson, Alan/0000-0001-5469-0500				Abbott A, 2014, NATURE, V510, P195, DOI 10.1038/510195a; Aboody KS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005365; Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Ascheim DD, 2014, CIRCULATION, V129, P2287, DOI 10.1161/CIRCULATIONAHA.113.007412; Barker RA, 2014, CELL STEM CELL, V15, P539, DOI 10.1016/j.stem.2014.09.016; Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bersenev A., 2015, CELLTRIALS BLOG 0122; Bianco P, 2014, ANNU REV CELL DEV BI, V30, P677, DOI 10.1146/annurev-cellbio-100913-013132; Bonab MM, 2012, CURR STEM CELL RES T, V7, P407; Burillon C, 2012, INVEST OPHTH VIS SCI, V53, P1325, DOI 10.1167/iovs.11-7744; Chambers DC, 2014, RESPIROLOGY, V19, P1013, DOI 10.1111/resp.12343; Chang YS, 2014, J PEDIATR-US, V164, P966, DOI 10.1016/j.jpeds.2013.12.011; Chen HCJ, 2009, INVEST OPHTH VIS SCI, V50, P4660, DOI 10.1167/iovs.09-3377; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Cuenca N, 2013, INVEST OPHTH VIS SCI, V54, P6745, DOI 10.1167/iovs.13-12860; Cyranoski D., 2014, NATURE NEWS; Diez-Tejedor E, 2014, J STROKE CEREBROVASC, V23, P2694, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.011; Dimmeler S, 2014, NAT MED, V20, P814, DOI 10.1038/nm.3627; Dlouhy BJ, 2014, J NEUROSURG-SPINE, V21, P618, DOI 10.3171/2014.5.SPINE13992; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; El-Ansary M, 2012, STEM CELL REV REP, V8, P972, DOI 10.1007/s12015-011-9322-y; Feldman EL, 2014, ANN NEUROL, V75, P363, DOI 10.1002/ana.24113; Forbes GM, 2014, CLIN GASTROENTEROL H, V12, P64, DOI 10.1016/j.cgh.2013.06.021; Glass JD, 2012, STEM CELLS, V30, P1144, DOI 10.1002/stem.1079; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; Grealish S, 2014, CELL STEM CELL, V15, P653, DOI 10.1016/j.stem.2014.09.017; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Gupta PK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-143; Gyongyosi M, 2015, CIRC RES, V116, P1346, DOI 10.1161/CIRCRESAHA.116.304346; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Herrmann R, 2012, INT J HEMATOL, V95, P182, DOI 10.1007/s12185-011-0989-2; Hess DC, 2014, INT J STROKE, V9, P381, DOI 10.1111/ijs.12065; Hirmand S., 2014, NEURAL STEM CELLS FR; Hong SH, 2013, CANCER GENE THER, V20, P678, DOI 10.1038/cgt.2013.69; Huo WX, 2014, NEURAL REGEN RES, V9, P1643, DOI 10.4103/1673-5374.141793; Introna M, 2014, BIOL BLOOD MARROW TR, V20, P375, DOI 10.1016/j.bbmt.2013.11.033; Jang YO, 2014, LIVER INT, V34, P33, DOI 10.1111/liv.12218; Jimenez-Quevedo P, 2014, CIRC RES, V115, P950, DOI 10.1161/CIRCRESAHA.115.303463; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kawamoto A, 2009, STEM CELLS, V27, P2857, DOI 10.1002/stem.207; Kharaziha P, 2009, EUR J GASTROEN HEPAT, V21, P1199, DOI 10.1097/MEG.0b013e32832a1f6c; Kinoshita M, 2012, ATHEROSCLEROSIS, V224, P440, DOI 10.1016/j.atherosclerosis.2012.07.031; Kolli S, 2010, STEM CELLS, V28, P597, DOI 10.1002/stem.276; Konomi K, 2015, CELL STEM CELL, V16, P350, DOI 10.1016/j.stem.2015.03.012; Kushner JA, 2014, CELL STEM CELL, V15, P535, DOI 10.1016/j.stem.2014.10.012; Kuzmina LA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/968213; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097518; Lee JW, 2014, J KOREAN MED SCI, V29, P23, DOI 10.3346/jkms.2014.29.1.23; Li C, 2013, INVEST OPHTH VIS SCI, V54, P4041, DOI 10.1167/iovs.13-11648; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Liebergall M, 2013, MOL THER, V21, P1631, DOI 10.1038/mt.2013.109; Lim R, 2013, PLACENTA, V34, P486, DOI 10.1016/j.placenta.2013.03.010; Liu KY, 2011, STEM CELLS DEV, V20, P1679, DOI 10.1089/scd.2010.0447; Liu XB, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt446; Llufriu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113936; Logan AC, 2012, CURR OPIN IMMUNOL, V24, P640, DOI 10.1016/j.coi.2012.08.002; Lublin FD, 2014, MULT SCLER RELAT DIS, V3, P696, DOI 10.1016/j.msard.2014.08.002; Mayer L, 2013, INFLAMM BOWEL DIS, V19, P754, DOI 10.1097/MIB.0b013e31827f27df; Maziarz RT, 2015, BIOL BLOOD MARROW TR, V21, P720, DOI 10.1016/j.bbmt.2014.12.025; Mazzini L, 2010, EXP NEUROL, V223, P229, DOI 10.1016/j.expneurol.2009.08.007; Mazzini L, 2012, CYTOTHERAPY, V14, P56, DOI 10.3109/14653249.2011.613929; McGill TJ, 2012, EUR J NEUROSCI, V35, P468, DOI 10.1111/j.1460-9568.2011.07970.x; Mitchell A, 2015, FUTUR CARDIOL, V11, P45, DOI [10.2217/fca.14.77, 10.2217/FCA.14.77]; Maldonado GEM, 2011, CYTOTHERAPY, V13, P1249, DOI 10.3109/14653249.2011.594791; Muroi K, 2013, INT J HEMATOL, V98, P206, DOI 10.1007/s12185-013-1399-4; Murphy SV, 2014, JOVE-J VIS EXP, DOI 10.3791/52085; Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688; Orozco L, 2013, TRANSPLANTATION, V95, P1535, DOI 10.1097/TP.0b013e318291a2da; Orozco L, 2011, TRANSPLANTATION, V92, P822, DOI 10.1097/TP.0b013e3182298a15; Pellegrini G, 2014, CELL STEM CELL, V15, P121, DOI 10.1016/j.stem.2014.07.011; Pellegrini G, 2014, STEM CELLS, V32, P26, DOI 10.1002/stem.1517; Perez-Simon JA, 2011, HAEMATOL-HEMATOL J, V96, P1072, DOI 10.3324/haematol.2010.038356; Prasad VK, 2011, BIOL BLOOD MARROW TR, V17, P534, DOI 10.1016/j.bbmt.2010.04.014; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Ratcliffe E, 2013, BRIT MED BULL, V108, P73, DOI 10.1093/bmb/ldt034; Raval AN, 2014, CYTOTHERAPY, V16, P1720, DOI 10.1016/j.jcyt.2014.07.011; Reinders MEJ, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0331-x; Reinders MEJ, 2013, STEM CELL TRANSL MED, V2, P107, DOI 10.5966/sctm.2012-0114; Rennie K, 2013, BIOCHEM CELL BIOL, V91, P271, DOI 10.1139/bcb-2013-0019; Riley J, 2012, NEUROSURGERY, V71, P405, DOI 10.1227/NEU.0b013e31825ca05f; Savitz SI, 2014, STROKE, V45, P634, DOI 10.1161/STROKEAHA.113.003379; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Selden NR, 2013, J NEUROSURG-PEDIATR, V11, P643, DOI 10.3171/2013.3.PEDS12397; Shizuru J A, 1996, Biol Blood Marrow Transplant, V2, P3; Shortt AJ, 2014, STEM CELL TRANSL MED, V3, P265, DOI 10.5966/sctm.2013-0025; Shroff G, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0318-7; Suncion VY, 2014, CIRC RES, V114, P1292, DOI 10.1161/CIRCRESAHA.114.302854; Tabakow P, 2013, CELL TRANSPLANT, V22, P1591, DOI 10.3727/096368912X663532; Thomsen GM, 2014, EXP NEUROL, V262, P127, DOI 10.1016/j.expneurol.2014.02.021; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Trounson A, 2010, CELL STEM CELL, V6, P513, DOI 10.1016/j.stem.2010.05.008; Turner M, 2013, CELL STEM CELL, V13, P382, DOI 10.1016/j.stem.2013.08.003; Wang XG, 2007, J AM COLL CARDIOL, V49, P1566, DOI 10.1016/j.jacc.2006.12.037; Wilson JG, 2015, LANCET RESP MED, V3, P24, DOI [10.1016/S2213-2600(14)70291-7, 10.1016/s2213-2600(14)70291-7]; Yamout B, 2010, J NEUROIMMUNOL, V227, P185, DOI 10.1016/j.jneuroim.2010.07.013; Yang Shin-Seok, 2013, International Journal of Stem Cells, V6, P37; Zakaria N, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-58	105	836	873	32	333	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2015	17	1					11	22		10.1016/j.stem.2015.06.007	http://dx.doi.org/10.1016/j.stem.2015.06.007			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DI	26140604	Bronze			2022-12-28	WOS:000361877600005
J	Qiao, WL; Zandstra, PW				Qiao, Wenlian; Zandstra, Peter W.			Bringing Blood Stem Cell Phenotype, Genotype, and Function Closer Together	CELL STEM CELL			English	Editorial Material								Imperfect purity, subtypes, and retrospective functional assays compromise efforts to define the molecular identity of hematopoietic stem cells (HSCs). In this issue of Cell Stem Cell, Wilson et al. (2015) use a single-cell-based bioinformatics-experimental strategy to extract a consensus molecular signature from heterogeneous HSC pools. Their data and strategy provide a powerful resource for stem cell characterization.	[Qiao, Wenlian; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada; [Qiao, Wenlian; Zandstra, Peter W.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Toronto	Zandstra, PW (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada.	peter.zandstra@utoronto.ca						Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Etzrodt M, 2014, CELL STEM CELL, V15, P546, DOI 10.1016/j.stem.2014.10.015; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Qiao WL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002838; Sandberg R, 2014, NAT METHODS, V11, P22, DOI 10.1038/nmeth.2764; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wilson NK, 2015, CELL STEM CELL, V16, P712, DOI 10.1016/j.stem.2015.04.004	9	0	0	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					574	575		10.1016/j.stem.2015.05.001	http://dx.doi.org/10.1016/j.stem.2015.05.001			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26046754	Bronze			2022-12-28	WOS:000355932300003
J	Bronner, M				Bronner, Marianne			Confetti Clarifies Controversy: Neural Crest Stem Cells Are Multipotent	CELL STEM CELL			English	Editorial Material							FATE RESTRICTIONS; LINEAGE	Neural crest precursors generate diverse cell lineages during development, which have been proposed to arise either from multipotent precursor cells or pools of heterogeneous, restricted progenitors. Now in Cell Stem Cell, Baggiolini et al. (2015) perform rigorous in vivo lineage tracing to show that individual neural crest precursors are multipotent.	CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Bronner, M (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mbronner@caltech.edu		Bronner, Marianne/0000-0003-4274-1862				Baggiolini A, 2015, CELL STEM CELL, V16, P314, DOI 10.1016/j.stem.2015.02.017; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; BRONNERFRASER M, 1989, NEURON, V3, P755, DOI 10.1016/0896-6273(89)90244-4; Dupin E, 2010, CELL CYCLE, V9, P238, DOI 10.4161/cc.9.2.10491; Henion PD, 1997, DEVELOPMENT, V124, P4351; Krispin S, 2010, DEVELOPMENT, V137, P585, DOI 10.1242/dev.041509; Luo R, 2003, DEVELOPMENT, V130, P321, DOI 10.1242/dev.00213; McKinney MC, 2013, DEVELOPMENT, V140, P820, DOI 10.1242/dev.083725; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q	10	9	10	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					217	218		10.1016/j.stem.2015.02.016	http://dx.doi.org/10.1016/j.stem.2015.02.016			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25748927	Bronze			2022-12-28	WOS:000350747700003
J	Krivega, I; Dean, A				Krivega, Ivan; Dean, Ann			Chromosome Togetherness at the Onset of ESC Differentiation	CELL STEM CELL			English	Editorial Material							TRANSCRIPTIONAL REGULATION	Pairing of homologous alleles is a phenomenon generally associated with imprinted and mono-allelically expressed loci. In this issue, Hogan et al. (2015) examine the earliest steps between pluripotency and lineage commitment in ESCs and find a critical role for transient pairing of Oct4 alleles in exiting the pluripotent state.	[Krivega, Ivan; Dean, Ann] NIDDK, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dean, A (corresponding author), NIDDK, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA.	anndean@helix.nih.gov	Krivega, Ivan/G-9247-2015	Krivega, Ivan/0000-0002-3473-4198	Intramural NIH HHS [Z01 DK015508-20] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015508] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anguera MC, 2006, COLD SPRING HARB SYM, V71, P429, DOI 10.1101/sqb.2006.71.012; Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Hogan MS, 2015, CELL STEM CELL, V16, P275, DOI 10.1016/j.stem.2015.02.001; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Thatcher KN, 2005, HUM MOL GENET, V14, P785, DOI 10.1093/hmg/ddi073; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984	10	0	0	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					213	214		10.1016/j.stem.2015.02.009	http://dx.doi.org/10.1016/j.stem.2015.02.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25748925	Bronze, Green Accepted			2022-12-28	WOS:000350747700001
J	Schepers, K; Campbell, TB; Passegue, E				Schepers, Koen; Campbell, Timothy B.; Passegue, Emmanuelle			Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities	CELL STEM CELL			English	Review							MESENCHYMAL STROMAL CELLS; BONE-MARROW STROMA; HEMATOPOIETIC PROGENITOR CELLS; COLONY-FORMING CELL; MYELODYSPLASTIC SYNDROME; ENDOTHELIAL-CELLS; SELF-RENEWAL; PDGFR-ALPHA; IN-VITRO; MICROENVIRONMENT	Hematopoietic stem cells (HSCs) rely on instructive cues from the bone marrow (BM) niche to maintain their quiescence and adapt blood production to the organism's needs. Alterations in the BM niche are commonly observed in blood malignancies and directly contribute to the aberrant function of disease-initiating leukemic stem cells (LSCs). Here, we review recent insights into the cellular and molecular determinants of the normal HSC niche and describe how genetic changes in stromal cells and leukemia-induced BM niche remodeling contribute to blood malignancies. Moreover, we discuss how these findings can be applied to non-cell-autonomous therapies targeting the LSC niche.	[Schepers, Koen] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands; [Schepers, Koen] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Campbell, Timothy B.; Passegue, Emmanuelle] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco	Passegue, E (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA.	passeguee@stemcell.ucsf.edu	Schepers, Koen/H-7108-2013	Schepers, Koen/0000-0003-2442-242X; Passegue, Emmanuelle/0000-0002-3516-297X	Dutch NIRM [FES0908]; NIH [T32 CA108462]; LLS Scholar award, NIH [R01 HL092471]; MF Challenge Concept Grant from MPN Research Foundation; NATIONAL CANCER INSTITUTE [T32CA108462] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092471] Funding Source: NIH RePORTER	Dutch NIRM; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LLS Scholar award, NIH; MF Challenge Concept Grant from MPN Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank members of the Passegue laboratory for critical reading and insights on the manuscript. K.S. is supported by a Dutch NIRM FES0908; T.C., by NIH T32 CA108462; and E.P., by an LLS Scholar award, NIH R01 HL092471, and an MF Challenge Concept Grant from the MPN Research Foundation. E.P. is a member of Geron scientific advisory board.	Abdel-Wahab OI, 2009, ANNU REV MED, V60, P233, DOI 10.1146/annurev.med.60.041707.160528; Aizawa S, 1999, LEUKEMIA RES, V23, P239, DOI 10.1016/S0145-2126(98)00163-5; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Arranz L, 2014, NATURE, V512, P78, DOI 10.1038/nature13383; Asada N, 2013, CELL STEM CELL, V12, P737, DOI 10.1016/j.stem.2013.05.001; Bakker ST, 2013, EXP HEMATOL, V41, P915, DOI 10.1016/j.exphem.2013.09.007; Blau O, 2007, EXP HEMATOL, V35, P221, DOI 10.1016/j.exphem.2006.10.012; Borojevic R, 2004, LEUKEMIA RES, V28, P831, DOI 10.1016/j.leukres.2003.11.019; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Chen Y, 2012, BLOOD, V119, P4971, DOI 10.1182/blood-2011-11-389957; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Daly A, 2003, BONE MARROW TRANSPL, V32, P35, DOI 10.1038/sj.bmt.1704075; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Duhrsen U, 1996, ANN HEMATOL, V73, P53, DOI 10.1007/s002770050203; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Flores-Figueroa E, 2012, LAB INVEST, V92, P1330, DOI 10.1038/labinvest.2012.93; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Ge J, 2011, INT J HEMATOL, V93, P750, DOI 10.1007/s12185-011-0869-9; Gidali J, 1996, STEM CELLS, V14, P577, DOI 10.1002/stem.140577; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; GORDON MY, 1987, NATURE, V328, P342, DOI 10.1038/328342a0; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; GRIFFIN JD, 1987, BLOOD, V70, P1218; Groen RWJ, 2012, BLOOD, V120, pE9, DOI 10.1182/blood-2012-03-414920; Guezguez B, 2013, CELL STEM CELL, V13, P175, DOI 10.1016/j.stem.2013.06.015; Hanoun M, 2014, CELL STEM CELL, V15, P365, DOI 10.1016/j.stem.2014.06.020; Hsieh YT, 2014, LEUKEMIA, V28, P2101, DOI 10.1038/leu.2014.182; Huntly BJP, 2005, NATURE, V435, P1169, DOI 10.1038/4351169a; Jabbour E, 2013, SEMIN HEMATOL, V50, P271, DOI 10.1053/j.seminhematol.2013.09.006; Jacamo R, 2014, BLOOD, V123, P2691, DOI 10.1182/blood-2013-06-511527; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jin LH, 2008, MOL CANCER THER, V7, P48, DOI 10.1158/1535-7163.MCT-07-0042; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kastrinaki MC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/265608; Kent DG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001576; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim YW, 2008, BLOOD, V112, P4628, DOI 10.1182/blood-2008-03-148999; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Krause DS, 2014, BLOOD, V123, P1361, DOI 10.1182/blood-2013-11-538694; Krause DS, 2013, NAT MED, V19, P1513, DOI 10.1038/nm.3364; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lane SW, 2011, BLOOD, V118, P2849, DOI 10.1182/blood-2011-03-345165; Lassailly F, 2013, BLOOD, V122, P1730, DOI 10.1182/blood-2012-11-467498; Leisten I, 2012, BIOMATERIALS, V33, P1736, DOI 10.1016/j.biomaterials.2011.11.034; Li HZ, 2014, STEM CELL REP, V3, P965, DOI 10.1016/j.stemcr.2014.09.018; Li Q, 2013, NATURE, V504, P143, DOI 10.1038/nature12830; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Mansour A, 2012, J EXP MED, V209, P537, DOI 10.1084/jem.20110994; Mansour A, 2011, CELL RES, V21, P1102, DOI 10.1038/cr.2011.21; Medyouf H, 2014, CELL STEM CELL, V14, P824, DOI 10.1016/j.stem.2014.02.014; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2015, ANN NY ACAD SCI, V1335, P32, DOI 10.1111/nyas.12641; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Milosevic JD, 2013, INT J HEMATOL, V97, P183, DOI 10.1007/s12185-012-1235-2; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nair RR, 2010, BIOCHEM PHARMACOL, V80, P602, DOI 10.1016/j.bcp.2010.04.003; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Nakamura-Ishizu A, 2014, BIOCHEM BIOPH RES CO, V454, P353, DOI 10.1016/j.bbrc.2014.10.095; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; PEREIRA A, 1990, EUR J HAEMATOL, V44, P94; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Raic A, 2014, BIOMATERIALS, V35, P929, DOI 10.1016/j.biomaterials.2013.10.038; Rambaldi Alessandro, 2008, Hematology Am Soc Hematol Educ Program, P83, DOI 10.1182/asheducation-2008.1.83; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Schmidt T, 2011, CANCER CELL, V19, P740, DOI 10.1016/j.ccr.2011.05.007; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sharma MB, 2012, HAEMATOL-HEMATOL J, V97, P651, DOI 10.3324/haematol.2011.050500; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032; Thiele J, 2006, HISTOL HISTOPATHOL, V21, P1367, DOI 10.14670/HH-21.1367; Uy GL, 2012, BLOOD, V119, P3917, DOI 10.1182/blood-2011-10-383406; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wang L, 2014, CELL STEM CELL, V15, P51, DOI 10.1016/j.stem.2014.04.021; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Weisberg E, 2012, LEUKEMIA, V26, P985, DOI 10.1038/leu.2011.360; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Wiseman DH, 2011, BIOL BLOOD MARROW TR, V17, P771, DOI 10.1016/j.bbmt.2010.10.010; Woll PS, 2014, CANCER CELL, V25, P794, DOI 10.1016/j.ccr.2014.03.036; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	116	280	292	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					254	267		10.1016/j.stem.2015.02.014	http://dx.doi.org/10.1016/j.stem.2015.02.014			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25748932	Green Accepted, Bronze			2022-12-28	WOS:000350747700008
J	Gkountela, S; Clark, AT				Gkountela, Sofia; Clark, Amander T.			A Big Surprise in the Little Zygote: The Curious Business of Losing Methylated Cytosines	CELL STEM CELL			English	Editorial Material							DNA; 5-HYDROXYMETHYLCYTOSINE; EXCISION	In stem cell biology, the dynamic addition and removal of 5-methylcytosines (5mCs) are necessary for lineage differentiation, nuclear reprogramming, and embryonic development. Recent investigations have sought to understand the mechanisms of how 5mCs are added and in particular how 5mCs are removed from DNA during embryogenesis.	[Gkountela, Sofia; Clark, Amander T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Clark, AT (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	clarka@ucla.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058047] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD058047, 2 R01 HD058047] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo F, 2014, CELL STEM CELL, V15, P447, DOI 10.1016/j.stem.2014.08.003; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Shen L, 2014, CELL STEM CELL, V15, P459, DOI 10.1016/j.stem.2014.09.002; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	10	9	9	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					393	394		10.1016/j.stem.2014.09.005	http://dx.doi.org/10.1016/j.stem.2014.09.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25280211	Bronze, Green Accepted			2022-12-28	WOS:000343235800001
J	Zeisig, BB; So, CWE				Zeisig, Bernd B.; So, Chi Wai Eric			A Knockout Combo: Eradicating AML Stem Cells with TKI plus SIRT1 Inhibition	CELL STEM CELL			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; ACTIVATION; CANCER; EVOLUTION; P53	SIRT1 inhibition facilitates elimination of CML stem cells by Imatinib, in part via p53 activation. In this issue of Cell Stem Cell, Li et al. (2014) demonstrate a similar role for SIRT1 inhibition in eradicating FLT3-ITD AML stem cells, potentially through a positive feedback loop with c-MYC, highlighting SIRT1 as a potential target in combination cancer therapy.	[Zeisig, Bernd B.; So, Chi Wai Eric] Kings Coll London, Div Canc Studies, Dept Haematol Med, Leukaemia & Stem Cell Biol Grp, London WC2R 2LS, England	University of London; King's College London	So, CWE (corresponding author), Kings Coll London, Div Canc Studies, Dept Haematol Med, Leukaemia & Stem Cell Biol Grp, London WC2R 2LS, England.	eric.so@kcl.ac.uk			Cancer Research UK [16753] Funding Source: researchfish; MRC [G0800892] Funding Source: UKRI; Medical Research Council [G0800892] Funding Source: Medline; Worldwide Cancer Research [11-0729] Funding Source: Medline	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Worldwide Cancer Research		Barneda-Zahonero B, 2012, MOL ONCOL, V6, P579, DOI 10.1016/j.molonc.2012.07.003; Brooks CL, 2009, AGING-US, V1, P278, DOI 10.18632/aging.100031; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Li L, 2014, CELL STEM CELL, V15, P431, DOI 10.1016/j.stem.2014.08.001; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Sasca D, 2014, BLOOD, V124, P121, DOI 10.1182/blood-2013-11-538819; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Zeisig Bernd B, 2012, Cancer Cell, V22, P698, DOI 10.1016/j.ccr.2012.10.017	10	2	2	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					395	397		10.1016/j.stem.2014.09.006	http://dx.doi.org/10.1016/j.stem.2014.09.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25280212	Bronze			2022-12-28	WOS:000343235800002
J	Gao, YW; Gao, SR				Gao, Yawei; Gao, Shaorong			Quality Control: H2A.X Links to Better iPSCs	CELL STEM CELL			English	Editorial Material							METHYLATION; REVEALS; GENES; MICE	Incorporating induced pluripotent stem cell (iPSC) technology in regenerative medicine requires better methods for defining and obtaining high-quality lines. Two papers in this issue of Cell Stem Cell (Buganim et al., 2014; Wu et al., 2014) now show that H2A. X deposition can serve as a functional epigenetic marker for distinguishing the quality of iPSCs, thus providing insights for better reprogramming methods.	[Gao, Yawei; Gao, Shaorong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tongji University	Gao, SR (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	gaoshaorong@tongji.edu.cn		gao, yawei/0000-0001-8946-9697				Banaszynski LA, 2010, DEV CELL, V19, P662, DOI 10.1016/j.devcel.2010.10.014; Buganim Y, 2014, CELL STEM CELL, V15, P295, DOI 10.1016/j.stem.2014.07.003; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chang G, 2014, CELL RES, V24, P293, DOI 10.1038/cr.2013.173; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gonzalez F, 2013, CELL REP, V3, P651, DOI 10.1016/j.celrep.2013.02.005; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Wu T, 2014, CELL STEM CELL, V15, P281, DOI 10.1016/j.stem.2014.06.004	10	3	3	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					259	260		10.1016/j.stem.2014.08.011	http://dx.doi.org/10.1016/j.stem.2014.08.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25192458	Bronze			2022-12-28	WOS:000341441600003
J	Beerman, I; Seita, J; Inlay, MA; Weissman, IL; Rossi, DJ				Beerman, Isabel; Seita, Jun; Inlay, Matthew A.; Weissman, Irving L.; Rossi, Derrick J.			Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle	CELL STEM CELL			English	Article							BONE-MARROW; SELF-RENEWAL; TELOMERASE ACTIVITY; IONIZING-RADIATION; PROGENITOR CELLS; GENE-EXPRESSION; COMET ASSAY; DIFFERENTIATION; PROLIFERATION; MICE	Hematopoietic stem cells (HSCs) maintain homeostasis and regenerate the blood system throughout life. It has been postulated that HSCs may be uniquely capable of preserving their genomic integrity in order to ensure lifelong function. To directly test this, we quantified DNA damage in HSCs and downstream progenitors from young and old mice, revealing that strand breaks significantly accrue in HSCs during aging. DNA damage accumulation in HSCs was associated with broad attenuation of DNA repair and response pathways that was dependent upon HSC quiescence. Accordingly, cycling fetal HSCs and adult HSCs driven into cycle upregulated these pathways leading to repair of strand breaks. Our results demonstrate that HSCs are not comprehensively geno-protected during aging. Rather, HSC quiescence and concomitant attenuation of DNA repair and response pathways underlies DNA damage accumulation in HSCs during aging. These results provide a potential mechanism through which premalignant mutations accrue in HSCs.	[Beerman, Isabel; Rossi, Derrick J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Beerman, Isabel; Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Beerman, Isabel; Rossi, Derrick J.] Boston Childrens Hosp, Div Hematol Oncol, Program Cellular & Mol Med, Boston, MA 02116 USA; [Seita, Jun; Inlay, Matthew A.; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Inlay, Matthew A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA; [Rossi, Derrick J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Stanford University; University of California System; University of California Irvine; Harvard University	Rossi, DJ (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	derrick.rossi@childrens.harvard.edu	Seita, Jun/AAM-1478-2020; Beerman, Isabel/AAN-4216-2020; Beerman, Isabel/Y-2555-2019	Seita, Jun/0000-0002-3008-3615; Beerman, Isabel/0000-0002-7758-8231	National Institutes of Health [R01CA86065, U01HL099999, R03HL096234, RO1HL107630, R00AG029760, UO1DK072473-01]; Virginia and D.K. Ludwig Fund for Cancer Research; Leona M. and Harry B. Helmsley Charitable Trust; New York Stem Cell Foundation; Harvard Stem Cell Institute; Joint Program in Transfusion Medicine fellowship [5T32HL066987-12]; NATIONAL CANCER INSTITUTE [R01CA086065, R01CA086017] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099995, T32HL066987, U01HL107440, U01HL099999, R01HL107630, R03HL096234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG029760, R00AG029760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and D.K. Ludwig Fund for Cancer Research; Leona M. and Harry B. Helmsley Charitable Trust; New York Stem Cell Foundation; Harvard Stem Cell Institute; Joint Program in Transfusion Medicine fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to sincerely thank Elizabeth Zuo and the Gene Expression Core of the Stanford Protein and Nucleic Acid (PAN) for microarray processing; L. Jerabek and T. Storm for laboratory management; T.J. Naik for technical assistance; A. Mosley, C. Wang, and A. McCarty for animal care; and A. Zguro for animal husbandry and technical assistance as well as all members of the D.J.R. and I.L.W. labs. This work was supported by grants from the National Institutes of Health (R01CA86065 to I. L. W., U01HL099999 to I.L.W., R03HL096234 to I.L.W., RO1HL107630 to D.J.R., R00AG029760 to D.J.R., UO1DK072473-01 to D.J.R.) and the Virginia and D.K. Ludwig Fund for Cancer Research (to I. L. W.), the Leona M. and Harry B. Helmsley Charitable Trust (to D.J.R.), the New York Stem Cell Foundation (to D.J.R.), and the Harvard Stem Cell Institute (to D.J.R.). I.B. received funding from a Joint Program in Transfusion Medicine fellowship (5T32HL066987-12). D.J.R. is a New York Stem Cell Foundation Robertson Investigator. I.L.W. is a member of the scientific advisory board of StemCells, Inc.	Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Cho JS, 2013, STEM CELLS, V31, P511, DOI 10.1002/stem.1261; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; HARRISON DE, 1991, BLOOD, V78, P1237; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jan M, 2013, ONCOGENE, V32, P135, DOI 10.1038/onc.2012.48; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krivtsov AV, 2013, LEUKEMIA, V27, P852, DOI 10.1038/leu.2012.363; Kumaravel TS, 2006, MUTAT RES-GEN TOX EN, V605, P7, DOI 10.1016/j.mrgentox.2006.03.002; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Mead AJ, 2013, CELL REP, V3, P1766, DOI 10.1016/j.celrep.2013.04.031; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Nygren JM, 2006, J IMMUNOL, V177, P201, DOI 10.4049/jimmunol.177.1.201; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Olive PL, 2001, METHOD CELL BIOL, V64, P235; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Parmar K, 2010, STEM CELLS, V28, P1186, DOI 10.1002/stem.437; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Taussig DC, 2005, BLOOD, V106, P4086, DOI 10.1182/blood-2005-03-1072; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANZANT G, 1984, J EXP MED, V159, P679, DOI 10.1084/jem.159.3.679; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Will B, 2012, BLOOD, V120, P2076, DOI 10.1182/blood-2011-12-399683; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	69	277	280	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					37	50		10.1016/j.stem.2014.04.016	http://dx.doi.org/10.1016/j.stem.2014.04.016			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24813857	Green Accepted, Bronze			2022-12-28	WOS:000340878600010
J	Van Bortle, K; Corces, VG				Van Bortle, Kevin; Corces, Victor G.			Lost in Transition: Dynamic Enhancer Organization across Naive and Primed Stem Cell States	CELL STEM CELL			English	Editorial Material							CHROMATIN; DISEASE	Pluripotent stem cells transition between distinct naive and primed states that are controlled by overlapping sets of master regulatory transcription factors. In this issue of Cell Stem Cell, Buecker et al. (2014) and Factor et al. (2014) demonstrate that alternate enhancer usage, regulated by state-specific binding partners of master regulators, defines these pluripotent state transitions.	[Van Bortle, Kevin; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Corces, VG (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	vcorces@emory.edu		Corces, Victor/0000-0001-5140-4337	NIGMS NIH HHS [R01 GM035463, T32 GM008367] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM035463] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Shlyueva D, 2014, MOL CELL, V54, P180, DOI 10.1016/j.molcel.2014.02.026; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043	10	7	7	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					693	694		10.1016/j.stem.2014.05.004	http://dx.doi.org/10.1016/j.stem.2014.05.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905156	Bronze, Green Accepted			2022-12-28	WOS:000341248500002
J	Oskarsson, T; Batlle, E; Massague, J				Oskarsson, Thordur; Batlle, Eduard; Massague, Joan			Metastatic Stem Cells: Sources, Niches, and Vital Pathways	CELL STEM CELL			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER METASTASIS; CIRCULATING TUMOR-CELLS; CYTOKERATIN-POSITIVE CELLS; ENDOTHELIAL GROWTH-FACTOR; MAMMARY-CARCINOMA CELLS; ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; BONE-MARROW; EXTRACELLULAR-MATRIX	Metastasis is powered by disseminated cancer cells that re-create a full-fledged tumor in unwelcoming tissues, away from the primary site. How cancer cells moving from a tumor into the circulation manage to infiltrate distant organs and initiate metastatic growth is of interest to cancer biologists and clinical oncologists alike. Recent findings have started to define the sources, phenotypic properties, hosting niches, and signaling pathways that support the survival, self-renewal, dormancy, and reactivation of cancer cells that initiate metastasis: metastatic stem cells. By dissecting the biology of this process, vulnerabilities are being exposed that could be exploited to prevent metastasis.	[Oskarsson, Thordur] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany; [Oskarsson, Thordur] German Canc Res Ctr, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Oskarsson, Thordur] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Batlle, Eduard] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Batlle, Eduard] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	j-massague@ski.mskcc.org	Batlle, Eduard/K-8080-2014; Xia, Bo/P-9380-2016; Oskarsson, Thordur/HBP-9601-2022	Batlle, Eduard/0000-0003-2422-0326; Massague, Joan/0000-0001-9324-8408; Oskarsson, Thordur/0000-0002-0983-6969	BioRN Spitzencluster "Molecular and Cell Based Medicine" from the German Bundesministerium fur Bildung und Forschung; Dietmar Hopp Foundation; European Research Council; Ministerio de Economia y Competitividad; Marcelino Botin Foundation; Josef Steiner Foundation; HHMI; National Cancer Institute; Department of Defense; BBVA Foundation; MSKCC Metastasis Research Center; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [P01CA129243, R37CA034610, P30CA008748] Funding Source: NIH RePORTER	BioRN Spitzencluster "Molecular and Cell Based Medicine" from the German Bundesministerium fur Bildung und Forschung; Dietmar Hopp Foundation; European Research Council(European Research Council (ERC)European Commission); Ministerio de Economia y Competitividad(Spanish Government); Marcelino Botin Foundation; Josef Steiner Foundation; HHMI(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); BBVA Foundation(BBVA Foundation); MSKCC Metastasis Research Center; ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank E. Sancho, S. Malladi, and X. Jin for useful input. Work on metastasis by T.O. was supported by the BioRN Spitzencluster "Molecular and Cell Based Medicine" from the German Bundesministerium fur Bildung und Forschung and by the Dietmar Hopp Foundation. E. B. was supported by the European Research Council, Ministerio de Economia y Competitividad, The Marcelino Botin Foundation, and The Josef Steiner Foundation. J.M. was supported by HHMI, the National Cancer Institute, the Department of Defense, the BBVA Foundation, and the MSKCC Metastasis Research Center.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Auvinen P, 2013, INT J CANCER, V132, P531, DOI 10.1002/ijc.27707; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Barbieri I, 2010, MOL CARCINOGEN, V49, P114, DOI 10.1002/mc.20605; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Becker S, 2006, BREAST CANCER RES TR, V97, P91, DOI 10.1007/s10549-005-9095-6; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Cameron MD, 2000, CANCER RES, V60, P2541; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chabottaux V, 2009, J CELL MOL MED, V13, P4002, DOI 10.1111/j.1582-4934.2009.00764.x; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Charles N, 2010, CELL CYCLE, V9, P3012, DOI 10.4161/cc.9.15.12710; Chen J., 2011, CANCER CELL, V19, P541; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Cheung WKC, 2013, CANCER CELL, V23, P725, DOI 10.1016/j.ccr.2013.04.009; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Doberstein K, 2011, CARCINOGENESIS, V32, P262, DOI 10.1093/carcin/bgq249; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Eisinger-Mathason TSK, 2013, CANCER DISCOV, V3, P1190, DOI 10.1158/2159-8290.CD-13-0118; Ell B, 2013, CANCER CELL, V24, P542, DOI 10.1016/j.ccr.2013.09.008; Ell B, 2012, CELL, V151, DOI 10.1016/j.cell.2012.10.005; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fehm T, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1611; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Gilkes DM, 2013, J BIOL CHEM, V288, P10819, DOI 10.1074/jbc.M112.442939; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Guise T, 2010, SEMIN ONCOL, V37, pS2, DOI 10.1053/j.seminoncol.2010.10.007; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hambardzumyan D, 2008, CELL CYCLE, V7, P1371, DOI 10.4161/cc.7.10.5954; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Heyn C, 2006, MAGN RESON MED, V56, P1001, DOI 10.1002/mrm.21029; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Janni W, 2011, CLIN CANCER RES, V17, P2967, DOI 10.1158/1078-0432.CCR-10-2515; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kozar S, 2013, CELL STEM CELL, V13, P626, DOI 10.1016/j.stem.2013.08.001; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li YJ, 2007, INT J CANCER, V120, P2557, DOI 10.1002/ijc.22550; Liu S., 2014, STEM CELL REP, V2, P1; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Maeda S, 2009, HEPATOLOGY, V50, P1851, DOI 10.1002/hep.23199; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massard C, 2011, NAT REV CLIN ONCOL, V8, P701, DOI 10.1038/nrclinonc.2011.158; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Muller V, 2005, CLIN CANCER RES, V11, P3678, DOI 10.1158/1078-0432.CCR-04-2469; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Connell JT, 2011, P NATL ACAD SCI USA, V108, P16002, DOI 10.1073/pnas.1109493108; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Okuda H, 2012, CANCER RES, V72, P537, DOI 10.1158/0008-5472.CAN-11-1678; Oskarsson T, 2012, EMBO J, V31, P254, DOI 10.1038/emboj.2011.469; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; PANTEL K, 1993, JNCI-J NATL CANCER I, V85, P1419, DOI 10.1093/jnci/85.17.1419; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pencheva N, 2013, NAT CELL BIOL, V15, P546, DOI 10.1038/ncb2769; Perera M, 2012, TRANSL ONCOL, V5, P217, DOI 10.1593/tlo.12109; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004599; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Reticker-Flynn NE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2128; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schroder C, 2009, ONCOL REP, V22, P1109, DOI 10.3892/or_00000543; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Sosa MS, 2011, CLIN CANCER RES, V17, P5850, DOI 10.1158/1078-0432.CCR-10-2574; Stankic M, 2013, CELL REP, V5, P1228, DOI 10.1016/j.celrep.2013.11.014; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Stephens JK, 2000, TRANSPLANTATION, V70, P232; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Strauss DC, 2010, LANCET ONCOL, V11, P790, DOI 10.1016/S1470-2045(10)70024-3; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Valastyan S, 2011, GENE DEV, V25, P646, DOI 10.1101/gad.2004211; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; von Holst A, 2008, CELLS TISSUES ORGANS, V188, P170, DOI 10.1159/000112848; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Waning DL, 2013, CANCER CELL, V24, P407, DOI 10.1016/j.ccr.2013.10.001; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wong CW, 2001, CANCER RES, V61, P333; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Xie TX, 2006, CANCER RES, V66, P3188, DOI 10.1158/0008-5472.CAN-05-2674; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamamoto M, 2008, CANCER RES, V68, P9754, DOI 10.1158/0008-5472.CAN-08-1748; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Zhang WZ, 2013, CANCER CELL, V23, P647, DOI 10.1016/j.ccr.2013.03.012; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	189	460	476	4	135	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					306	321		10.1016/j.stem.2014.02.002	http://dx.doi.org/10.1016/j.stem.2014.02.002			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24607405	Green Accepted, Bronze			2022-12-28	WOS:000332533400008
J	Li, K; Zhu, SY; Russ, HA; Xu, SH; Xu, T; Zhang, Y; Ma, TH; Hebrok, M; Ding, S				Li, Ke; Zhu, Saiyong; Russ, Holger A.; Xu, Shaohua; Xu, Tao; Zhang, Yu; Ma, Tianhua; Hebrok, Matthias; Ding, Sheng			Small Molecules Facilitate the Reprogramming of Mouse Fibroblasts into Pancreatic Lineages	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; INSULIN-PRODUCING CELLS; PROGENITOR CELLS; IN-VIVO; CONVERSION	Pancreatic beta cells are of great interest for the treatment of type 1 diabetes. A number of strategies already exist for the generation of beta cells, but a general approach for reprogramming nonendodermal cells into beta cells could provide an attractive alternative in a variety of contexts. Here, we describe a step-wise method in which pluripotency reprogramming factors were transiently expressed in fibroblasts in conjunction with a unique combination of soluble molecules to generate definitive endoderm-like cells that did not pass through a pluripotent state. These endoderm-like cells were then directed toward pancreatic lineages using further combinations of small molecules in vitro. The resulting pancreatic progenitor-like cells could mature into cells of all three pancreatic lineages in vivo, including functional, insulin-secreting beta-like cells that help to ameliorate hyperglycemia. Our findings may therefore provide a useful approach for generating large numbers of functional beta cells for disease modeling and, ultimately, cell-based therapy.	[Li, Ke; Zhu, Saiyong; Xu, Shaohua; Xu, Tao; Zhang, Yu; Ma, Tianhua; Ding, Sheng] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Li, Ke; Zhu, Saiyong; Xu, Shaohua; Xu, Tao; Zhang, Yu; Ma, Tianhua; Ding, Sheng] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Russ, Holger A.; Hebrok, Matthias] Univ Calif San Francisco, Ctr Diabet, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ding, S (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	sheng.ding@gladstone.ucsf.edu	Xu, Tao/I-1561-2014; Xu, Shaohua/I-2252-2015; Li, Ke/K-9417-2015; Zhang, Yu/F-6583-2016	Xu, Tao/0000-0002-3436-3024; Xu, Shaohua/0000-0002-9915-5170; Zhang, Yu/0000-0001-5512-9272; Xu, Tao/0000-0002-4085-6191	Roddenberry fellowship; NICHD; NHLBI; NEI; NIMH/NIH; California Institute for Regenerative Medicine; DoD; Roddenberry Foundation; William K. Bowes, Jr. Foundation; Gladstone Institutes; Richard G. Klein fellowship; JDRF fellowship [3-2012-266]; Leona M. & Harry B. Helmsley Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064610] Funding Source: NIH RePORTER	Roddenberry fellowship; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); DoD(United States Department of Defense); Roddenberry Foundation; William K. Bowes, Jr. Foundation; Gladstone Institutes(University of California System); Richard G. Klein fellowship; JDRF fellowship; Leona M. & Harry B. Helmsley Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Dr. Shuai Han and Dr. Chen Yu for scientific discussion. K. L. is supported by a Roddenberry fellowship. S. D. is supported by funding from NICHD, NHLBI, NEI, and NIMH/NIH; California Institute for Regenerative Medicine; DoD; Roddenberry Foundation; William K. Bowes, Jr. Foundation; and Gladstone Institutes. H. A. R is supported by a Richard G. Klein fellowship and a JDRF fellowship (3-2012-266). Research in M.H.'s laboratory is supported by funds from the Leona M. & Harry B. Helmsley Charitable Trust.	D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Li FM, 2011, J CELL BIOCHEM, V112, P1022, DOI 10.1002/jcb.22962; Li J, 2013, ARTERIOSCL THROM VAS, V33, P1366, DOI 10.1161/ATVBAHA.112.301167; Nelson SB, 2007, DEVELOPMENT, V134, P2491, DOI 10.1242/dev.002691; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Schroeder IS, 2006, NAT PROTOC, V1, P495, DOI 10.1038/nprot.2006.71; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	14	99	105	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					228	236		10.1016/j.stem.2014.01.006	http://dx.doi.org/10.1016/j.stem.2014.01.006			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24506886	Bronze, Green Accepted			2022-12-28	WOS:000330835800014
J	Dasgupta, I; Bollinger, J; Mathews, DJH; Neumann, NM; Rattani, A; Sugarman, J				Dasgupta, Ishan; Bollinger, Juli; Mathews, Debra J. H.; Neumann, Neil M.; Rattani, Abbas; Sugarman, Jeremy			Patients' Attitudes toward the Donation of Biological Materials for the Derivation of Induced Pluripotent Stem Cells	CELL STEM CELL			English	Editorial Material							ETHICS	Although academics have raised ethical issues with iPSCs, patients' perspectives on them and their attitudes toward donating biological materials for iPSC research are unclear. Here, we provide such information to aid in developing policies for consent, collection, and use of biological materials for deriving iPSCs based on patient focus groups.	[Dasgupta, Ishan; Bollinger, Juli; Mathews, Debra J. H.; Rattani, Abbas; Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA; [Bollinger, Juli] Johns Hopkins Univ, Genet & Publ Policy Ctr, Washington, DC 20036 USA; [Mathews, Debra J. H.; Neumann, Neil M.; Sugarman, Jeremy] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Neumann, Neil M.] Johns Hopkins Univ, Med Scientist Training Program, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Sugarman, J (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA.	jsugarman@jhu.edu		Neumann, Neil/0000-0001-9779-7754; Mathews, Debra/0000-0002-4897-7617; Sugarman, Jeremy/0000-0001-7022-8332	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007309] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aalto-Setala K, 2009, PLOS BIOL, V7, P204, DOI 10.1371/journal.pbio.1000042; Couzin-Frankel J, 2009, SCIENCE, V324, P166, DOI 10.1126/science.324.5924.166; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Hug K, 2008, FERTIL STERIL, V89, P263, DOI 10.1016/j.fertnstert.2007.09.017; Lowenthal J, 2012, STEM CELL TRANSL MED, V1, P409, DOI 10.5966/sctm.2012-0029; Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203; Skloot R., 2011, IMMORTAL LIFE HENRIE; Sugarman J, 2008, CELL STEM CELL, V2, P529, DOI 10.1016/j.stem.2008.05.005; Zarzeczny A, 2009, CELL, V139, P1032, DOI 10.1016/j.cell.2009.11.039	10	21	21	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					9	12		10.1016/j.stem.2013.12.006	http://dx.doi.org/10.1016/j.stem.2013.12.006			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24388172	Green Accepted, Bronze			2022-12-28	WOS:000329571900005
J	Janich, P; Toufighi, K; Solanas, G; Luis, NM; Minkwitz, S; Serrano, L; Lehner, B; Benitah, SA				Janich, Peggy; Toufighi, Kiana; Solanas, Guiomar; Luis, Nuno Miguel; Minkwitz, Susann; Serrano, Luis; Lehner, Ben; Benitah, Salvador Aznar			Human Epidermal Stem Cell Function Is Regulated by Circadian Oscillations	CELL STEM CELL			English	Article							HAIR FOLLICLE CELLS; KERATINOCYTE DIFFERENTIATION; DIURNAL-VARIATION; CLOCK GENES; KINASE-II; PROLIFERATION; EXPRESSION; MOUSE; RHYTHMS; TRANSCRIPTION	Human skin copes with harmful environmental factors that are circadian in nature, yet how circadian rhythms modulate the function of human epidermal stem cells is mostly unknown. Here we show that in human epidermal stem cells and their differentiated counterparts, core clock genes peak in a successive and phased manner, establishing distinct temporal intervals during the 24 hr day period. Each of these successive clock waves is associated with a peak in the expression of subsets of transcripts that temporally segregate the predisposition of epidermal stem cells to respond to cues that regulate their proliferation or differentiation, such as TGF beta and calcium. Accordingly, circadian arrhythmia profoundly affects stem cell function in culture and in vivo. We hypothesize that this intricate mechanism ensures homeostasis by providing epidermal stem cells with environmentally relevant temporal functional cues during the course of the day and that its perturbation may contribute to aging and carcinogenesis.	[Toufighi, Kiana; Solanas, Guiomar; Serrano, Luis; Lehner, Ben; Benitah, Salvador Aznar] CRG, Barcelona 08003, Spain; [Toufighi, Kiana; Solanas, Guiomar; Serrano, Luis; Lehner, Ben; Benitah, Salvador Aznar] UPF, Barcelona 08003, Spain; [Serrano, Luis; Lehner, Ben; Benitah, Salvador Aznar] ICREA, Barcelona 08010, Spain; [Toufighi, Kiana; Serrano, Luis; Lehner, Ben] CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain; [Janich, Peggy] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Luis, Nuno Miguel] Buck Inst Res Aging, Novato, CA 94945 USA; [Minkwitz, Susann] Charite Campus Virchow Klinikum, Julius Wolff Inst, D-13353 Berlin, Germany	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Lausanne; Buck Institute for Research on Aging; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Serrano, L (corresponding author), CRG, Dr Aiguader 88, Barcelona 08003, Spain.	luis.serrano@crg.eu; ben.lehner@crg.eu; salvador.aznar-benitah@crg.eu	Luis, Nuno/F-2405-2012; Minkwitz, Susann/G-6183-2017; Aznar-Benitah, Salvador/F-4761-2016; Lehner, Ben/L-3413-2014; Luis, Nuno Miguel/ABD-9784-2020; Lehner, Ben/ABH-6562-2020; Serrano, Luis/B-3355-2013	Luis, Nuno/0000-0001-5438-9638; Minkwitz, Susann/0000-0003-4331-1450; Aznar-Benitah, Salvador/0000-0002-9059-5049; Lehner, Ben/0000-0002-8817-1124; Luis, Nuno Miguel/0000-0001-5438-9638; Lehner, Ben/0000-0002-8817-1124; Serrano, Luis/0000-0002-5276-1392; Solanas, Guiomar/0000-0001-8388-8647; Janich, Peggy/0000-0003-1045-7365	ERC; European Union [HEALTH-F4-2008-201648]; AXA; La Caixa Ph.D. fellowship; European Research Council (ERC); MINECO Plan Nacional grant [BFU2011-26206]; ERASysBio+ ERANET project [EUI2009-04059 GRAPPLE]; EMBO; EU [277899 4DCellFate]; EMBL/CRG Systems Biology Program; ICREA Funding Source: Custom	ERC(European Research Council (ERC)European Commission); European Union(European Commission); AXA; La Caixa Ph.D. fellowship(La Caixa Foundation); European Research Council (ERC)(European Research Council (ERC)European Commission); MINECO Plan Nacional grant; ERASysBio+ ERANET project; EMBO(European Molecular Biology Organization (EMBO)); EU(European Commission); EMBL/CRG Systems Biology Program; ICREA(ICREA)	We would like thank all the core facilities of the CRG, especially the Genomics and Bioinformatics facilities for their help in obtaining and analyzing the gene expression data. This work has been funded by an ERC Consolidator Grant (STEMCLOCK) to S. A. B. and by the PROSPECTS, grant agreement number HEALTH-F4-2008-201648, to L. S. from the European Union. G. S. is funded by an AXA Fund fellowship. K. T. is funded by a La Caixa Ph.D. fellowship. Research in the lab of B. L. is funded by the European Research Council (ERC), MINECO Plan Nacional grant BFU2011-26206, ERASysBio+ ERANET project EUI2009-04059 GRAPPLE, the EMBO Young Investigator Program, EU Framework 7 project 277899 4DCellFate, and the EMBL/CRG Systems Biology Program.	Akashi M, 2010, P NATL ACAD SCI USA, V107, P15643, DOI 10.1073/pnas.1003878107; Akiyama M, 2001, J NEUROCHEM, V78, P499, DOI 10.1046/j.1471-4159.2001.00452.x; Bikle DD, 2001, MOL CELL ENDOCRINOL, V177, P161, DOI 10.1016/S0303-7207(01)00452-X; Blanco S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002403; BROWN WR, 1991, J INVEST DERMATOL, V97, P273, DOI 10.1111/1523-1747.ep12480379; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Gaddameedhi S, 2011, P NATL ACAD SCI USA, V108, P18790, DOI 10.1073/pnas.1115249108; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Geyfman M, 2012, P NATL ACAD SCI USA, V109, P11758, DOI 10.1073/pnas.1209592109; Geyfman M, 2010, AGING-US, V2, P122, DOI 10.18632/aging.100130; Honma M, 2006, J BIOMOL SCREEN, V11, P977, DOI 10.1177/1087057106292556; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Lin KK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000573; Lucas D, 2008, CELL STEM CELL, V3, P364, DOI 10.1016/j.stem.2008.09.004; Maria SRS, 2007, MOL CELL BIOL, V27, P8409, DOI 10.1128/MCB.01543-07; Masse I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.62; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Nomura K, 2003, J NEUROSCI RES, V72, P384, DOI 10.1002/jnr.10581; Nomura K, 2006, BRAIN RES, V1118, P25, DOI 10.1016/j.brainres.2006.08.087; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Ranganathan P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-98; Sando GN, 2003, J INVEST DERMATOL, V120, P531, DOI 10.1046/j.1523-1747.2003.12051.x; SCHELL H, 1981, ARCH DERMATOL RES, V271, P41, DOI 10.1007/BF00417386; SCHELL H, 1983, J INVEST DERMATOL, V80, P529, DOI 10.1111/1523-1747.ep12535127; SCHELL H, 1981, ARCH DERMATOL RES, V271, P49, DOI 10.1007/BF00417387; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Sertic S, 2011, P NATL ACAD SCI USA, V108, P13647, DOI 10.1073/pnas.1108547108; Sporl F, 2012, P NATL ACAD SCI USA, V109, P10903, DOI 10.1073/pnas.1118641109; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Wang W, 2011, NATURE, V470, P110, DOI 10.1038/nature09766; Watanabe M, 2012, BIOCHEM BIOPH RES CO, V425, P902, DOI 10.1016/j.bbrc.2012.08.008; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010	42	98	100	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					745	753		10.1016/j.stem.2013.09.004	http://dx.doi.org/10.1016/j.stem.2013.09.004			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24120744	Bronze, Green Published			2022-12-28	WOS:000329571700016
J	Gallagher, D; Norman, AA; Woodard, CL; Yang, G; Gauthier-Fisher, A; Fujitani, M; Vessey, JP; Cancino, GI; Sachewsky, N; Woltjen, K; Fatt, MP; Morshead, CM; Kaplan, DR; Miller, FD				Gallagher, Denis; Norman, Andreea A.; Woodard, Cameron L.; Yang, Guang; Gauthier-Fisher, Andree; Fujitani, Masashi; Vessey, John P.; Cancino, Gonzalo I.; Sachewsky, Nadia; Woltjen, Knut; Fatt, Michael P.; Morshead, Cindi M.; Kaplan, David R.; Miller, Freda D.			Transient Maternal IL-6 Mediates Long-Lasting Changes in Neural Stem Cell Pools by Deregulating an Endogenous Self-Renewal Pathway	CELL STEM CELL			English	Article							OLFACTORY-BULB INTERNEURONS; SUBVENTRICULAR ZONE; RADIAL GLIA; BRAIN; INTERLEUKIN-6; NEUROGENESIS; NEURONS; IMMUNE; MAINTENANCE; GENERATION	The mechanisms that regulate the establishment of adult stem cell pools during normal and perturbed mammalian development are still largely unknown. Here, we asked whether a maternal cytokine surge, which occurs during human maternal infections and has been implicated in cognitive disorders, might have long-lasting consequences for neural stem cell pools in adult progeny. We show that transient, maternally administered interleukin-6 (IL-6) resulted in an expanded adult forebrain neural precursor pool and perturbed olfactory neurogenesis in offspring months after fetal exposure. This increase is likely the long-term consequence of acute hyper-activation of an endogenous autocrine/paracrine IL-6-dependent self-renewal pathway that normally regulates the number of forebrain neural precursors. These studies therefore identify an IL-6-dependent neural stem cell self-renewal pathway in vivo, and support a model in which transiently increased maternal cytokines can act through this pathway in offspring to deregulate neural precursor biology from embryogenesis throughout life.	[Gallagher, Denis; Norman, Andreea A.; Woodard, Cameron L.; Yang, Guang; Gauthier-Fisher, Andree; Fujitani, Masashi; Vessey, John P.; Cancino, Gonzalo I.; Fatt, Michael P.; Miller, Freda D.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; [Gallagher, Denis; Gauthier-Fisher, Andree; Fujitani, Masashi; Vessey, John P.; Cancino, Gonzalo I.; Fatt, Michael P.; Kaplan, David R.] Hosp Sick Children, Program Cell Biol, Toronto, ON M5G 1L7, Canada; [Gallagher, Denis; Woltjen, Knut; Miller, Freda D.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Sachewsky, Nadia; Fatt, Michael P.; Morshead, Cindi M.; Kaplan, David R.; Miller, Freda D.] Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X5, Canada; [Kaplan, David R.; Miller, Freda D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Miller, Freda D.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X5, Canada; [Morshead, Cindi M.] Univ Toronto, Dept Surg, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Miller, FD (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada.	fredam@sickkids.ca	Cancino, Gonzalo/ABF-6049-2021; Fujitani, Masashi/AAD-8874-2022	Gauthier-Fisher, Andree/0000-0002-1932-4684; Yang, Guang/0000-0002-2754-410X; Cancino, Gonzalo/0000-0001-8697-7282; Fujitani, Masashi/0000-0002-1731-9793; Woltjen, Knut/0000-0003-2293-1183	CIHR [MOP-125945]; Three to Be Foundation; Brain Canada; McEwen Center; Heart and Stroke Foundation of Canada; CIHR	CIHR(Canadian Institutes of Health Research (CIHR)); Three to Be Foundation; Brain Canada; McEwen Center; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); CIHR(Canadian Institutes of Health Research (CIHR))	We thank Andres Nagy, Paul Frankland, and David Tsui for advice, and Sarah Burns and Dennis Aquino for valuable technical assistance. This work was funded by CIHR grant MOP-125945 and grants from the Three to Be Foundation and Brain Canada. F.D.M. is an HHMI Senior International Research Scholar, and F.D.M. and D.R.K. are CRC chairholders. D.G., G.I.C., G.Y., and N.S. were funded by a McEwen Center McMurrich Fellowship, a Heart and Stroke Foundation of Canada Fellowship, a Brain Canada Mental Health Fellowship, and a CIHR Regenerative Medicine Studentship, respectively.	BANKS WA, 1994, NEUROSCI LETT, V179, P53, DOI 10.1016/0304-3940(94)90933-4; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; Bowen KK, 2011, NEUROREPORT, V22, P126, DOI 10.1097/WNR.0b013e3283430a44; Brandon NJ, 2009, J NEUROSCI, V29, P12768, DOI 10.1523/JNEUROSCI.3355-09.2009; Breton-Provencher V, 2012, BEHAV BRAIN RES, V227, P480, DOI 10.1016/j.bbr.2011.08.001; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Cancino GI, 2013, J NEUROSCI, V33, P12569, DOI 10.1523/JNEUROSCI.1251-13.2013; Dahlgren J, 2006, PEDIATR RES, V60, P147, DOI 10.1203/01.pdr.0000230026.74139.18; Fujitani M, 2010, CURR BIOL, V20, P2058, DOI 10.1016/j.cub.2010.10.029; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Gauthier-Fisher A, 2009, NAT NEUROSCI, V12, P735, DOI 10.1038/nn.2339; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Hutton SR, 2011, DEV BIOL, V352, P40, DOI 10.1016/j.ydbio.2011.01.015; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Nagy K, 2011, STEM CELL REV REP, V7, P693, DOI 10.1007/s12015-011-9239-5; Patterson PH, 2007, SCIENCE, V318, P576, DOI 10.1126/science.1150196; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Tsui D, 2013, J NEUROSCI, V33, P244, DOI 10.1523/JNEUROSCI.1665-12.2013; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; Vessey JP, 2012, CELL STEM CELL, V11, P517, DOI 10.1016/j.stem.2012.06.010; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Willaime-Morawek S, 2006, J CELL BIOL, V175, P159, DOI 10.1083/jcb.200604123; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	34	56	56	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					564	576		10.1016/j.stem.2013.10.002	http://dx.doi.org/10.1016/j.stem.2013.10.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24209760	Bronze			2022-12-28	WOS:000329571500009
J	Turner, M; Leslie, S; Martin, NG; Peschanski, M; Rao, M; Taylor, CJ; Trounson, A; Turner, D; Yamanaka, S; Wilmut, I				Turner, Marc; Leslie, Stephen; Martin, Nicholas G.; Peschanski, Marc; Rao, Mahendra; Taylor, Craig J.; Trounson, Alan; Turner, David; Yamanaka, Shinya; Wilmut, Ian			Toward the Development of a Global Induced Pluripotent Stem Cell Library	CELL STEM CELL			English	Editorial Material							IPS CELLS; TRANSPLANTATION; BANKING	The ability to preselect the donor genotype of iPSC lines provides important opportunities for immunematching in cell therapy. Here we propose that an international assessment should be made of how immune incompatibility can best be managed and how a network of GMP HLA homozygous haplobanks could be operated.	[Turner, Marc] SNBTS HeadQuarters, Edinburgh EH17 7QT, Midlothian, Scotland; [Leslie, Stephen] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Leslie, Stephen] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia; [Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld Q4029, Australia; [Peschanski, Marc] INSERM UMR861, AFM, F-91030 Evry, France; [Peschanski, Marc] UEVE UMR861, F-91030 Evry, France; [Rao, Mahendra] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA; [Taylor, Craig J.] Addenbrookes Hosp, Cambridge Univ Hosp NHS Fdn Trust, Tissue Typing Lab, Cambridge CB2 0QQ, England; [Trounson, Alan] Calif Inst Regenerat Med, San Francisco, CA 94107 USA; [Turner, David] Royal Infirm Edinburgh NHS Trust, SNBTS, Edinburgh EH16 4SA, Midlothian, Scotland; [Yamanaka, Shinya] Kyoto Univ, Ctr IPS Cell Res & Applicat, Dept Reprogramming Sci, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Wilmut, Ian] Univ Edinburgh, Edinburgh BioQuarter, Scottish Ctr Regenerat Med, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; QIMR Berghofer Medical Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Royal Infirmary of Edinburgh; University of Edinburgh; Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Edinburgh	Wilmut, I (corresponding author), Univ Edinburgh, Edinburgh BioQuarter, Scottish Ctr Regenerat Med, MRC Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	ian.wilmut@ed.ac.uk	Peschanski, Marc/N-5769-2017; Martin, Nicholas/R-9235-2019	Martin, Nicholas/0000-0003-4069-8020; Trounson, Alan/0000-0001-5469-0500; Turner, David/0000-0003-4007-6248	Medical Research Council [G0700711B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Campbell PM, 2007, AM J TRANSPLANT, V7, P2311, DOI 10.1111/j.1600-6143.2007.01923.x; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Gourraud PA, 2012, STEM CELLS, V30, P180, DOI 10.1002/stem.772; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Rao M, 2012, STEM CELLS, V30, P55, DOI 10.1002/stem.770; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Taylor CJ, 2012, CELL STEM CELL, V11, P147, DOI 10.1016/j.stem.2012.07.014	10	156	159	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					382	384		10.1016/j.stem.2013.08.003	http://dx.doi.org/10.1016/j.stem.2013.08.003			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094319	Bronze			2022-12-28	WOS:000329571100006
J	Ji, X; Dadon, DB; Powell, BE; Fan, ZP; Borges-Rivera, D; Shachar, S; Weintraub, AS; Hnisz, D; Pegoraro, G; Lee, TI; Misteli, T; Jaenisch, R; Young, RA				Ji, Xiong; Dadon, Daniel B.; Powell, Benjamin E.; Fan, Zi Peng; Borges-Rivera, Diego; Shachar, Sigal; Weintraub, Abraham S.; Hnisz, Denes; Pegoraro, Gianluca; Lee, Tong Ihn; Misteli, Tom; Jaenisch, Rudolf; Young, Richard A.			3D Chromosome Regulatory Landscape of Human Pluripotent Cells	CELL STEM CELL			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; CHROMATIN ARCHITECTURE; GENOME ORGANIZATION; SUPER-ENHANCERS; BINDING SITES; CTCF-BINDING; PROTEIN CTCF; STEM-CELL; COHESIN	In this study, we describe the 3D chromosome regulatory landscape of human naive and primed embryonic stem cells. To devise this map, we identified transcriptional enhancers and insulators in these cells and placed them within the context of cohesin-associated CTCF-CTCF loops using cohesin ChIA-PET data. The CTCF-CTCF loops we identified form a chromosomal framework of insulated neighborhoods, which in turn form topologically associating domains (TADs) that are largely preserved during the transition between the naive and primed states. Regulatory changes in enhancer-promoter interactions occur within insulated neighborhoods during cell state transition. The CTCF anchor regions we identified are conserved across species, influence gene expression, and are a frequent site of mutations in cancer cells, underscoring their functional importance in cellular regulation. These 3D regulatory maps of human pluripotent cells therefore provide a foundation for future interrogation of the relationships between chromosome structure and gene control in development and disease.	[Ji, Xiong; Dadon, Daniel B.; Powell, Benjamin E.; Fan, Zi Peng; Borges-Rivera, Diego; Weintraub, Abraham S.; Hnisz, Denes; Lee, Tong Ihn; Jaenisch, Rudolf; Young, Richard A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Dadon, Daniel B.; Borges-Rivera, Diego; Weintraub, Abraham S.; Jaenisch, Rudolf; Young, Richard A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Fan, Zi Peng] MIT, Computat & Syst Biol Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Shachar, Sigal; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA; [Pegoraro, Gianluca] NCI, High Throughput Imaging Facil HiTIF, NIH, Bethesda, MD 20892 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jaenisch, R; Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Jaenisch, R; Young, RA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jaenisch@wi.mit.edu; young@wi.mit.edu	Hnisz, Denes/AAE-9592-2019; Young, Richard A/F-6495-2012; Pegoraro, Gianluca/K-4233-2016	Hnisz, Denes/0000-0002-6256-1693; Young, Richard A/0000-0001-8855-8647; Powell, Benjamin/0000-0003-2533-8262; Pegoraro, Gianluca/0000-0003-2843-9464	Intramural Research Program of NIH, NCI, Center for Cancer Research; Erwin Schrodinger Fellowship from Austrian Science Fund (FWF) [J3490]; Ludwig Graduate Fellowship Funds; NIH [HG002668, HD 045022]; Simons Foundation SFLIFE [286977]; Austrian Science Fund (FWF) [J 3490] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZICBC011567, ZIABC010309] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R25HG007631, R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088538] Funding Source: NIH RePORTER	Intramural Research Program of NIH, NCI, Center for Cancer Research; Erwin Schrodinger Fellowship from Austrian Science Fund (FWF); Ludwig Graduate Fellowship Funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation SFLIFE; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Brian J. Abraham and Jill Dowen for data analysis. We thank Tom Volkert at the Whitehead Genome Technology Core for sequencing. We thank Wendy Salmon for assistance with confocal microscopy and Raaji Alagappan, Dongdong Fu, and Tenzin Lungjangwa for preparation of mouse embryonic fibroblasts. This research was in part supported by the Intramural Research Program of the NIH, NCI, Center for Cancer Research. This work was supported by an Erwin Schrodinger Fellowship (J3490) from the Austrian Science Fund (FWF) (to D.H.), Ludwig Graduate Fellowship Funds (A.S.W.), NIH Grants HG002668 (to R.A.Y.) and HD 045022 (to R.J.), and a grant from the Simons Foundation SFLIFE 286977 (to R.J.). R.J. is a founder of Fate Therapeutics and R.A.Y. is a founder of Syros Pharmaceuticals.	BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Calhoun ES, 2003, AM J PATHOL, V163, P1255, DOI 10.1016/S0002-9440(10)63485-2; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de Graaf CA, 2013, CURR OPIN GENET DEV, V23, P185, DOI 10.1016/j.gde.2012.11.011; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Dekker J, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-25; DeMare LE, 2013, GENOME RES, V23, P1224, DOI 10.1101/gr.156570.113; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorsett D, 2013, CURR OPIN CELL BIOL, V25, P327, DOI 10.1016/j.ceb.2013.02.003; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dowen JM, 2013, STEM CELL REP, V1, P371, DOI 10.1016/j.stemcr.2013.09.002; Doyle B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003867; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Etemadmoghadam D, 2013, P NATL ACAD SCI USA, V110, P19489, DOI 10.1073/pnas.1314302110; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Giorgio E, 2015, HUM MOL GENET, V24, P3143, DOI 10.1093/hmg/ddv065; Gomez-Diaz E, 2014, TRENDS CELL BIOL, V24, P703, DOI 10.1016/j.tcb.2014.08.003; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; GRUSS P, 1981, P NATL ACAD SCI-BIOL, V78, P943, DOI 10.1073/pnas.78.2.943; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang K, 2014, CELL STEM CELL, V15, P410, DOI 10.1016/j.stem.2014.09.014; Ji X, 2015, P NATL ACAD SCI USA, V112, P3841, DOI 10.1073/pnas.1502971112; Jung YJ, 2001, CANCER LETT, V168, P57, DOI 10.1016/S0304-3835(01)00403-7; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rose SL, 2010, GYNECOL ONCOL, V117, P130, DOI 10.1016/j.ygyno.2009.12.003; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schwalie PC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r148; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zhang J., 2011, DATABASE J BIOL DATA; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	74	236	242	1	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2016	18	2					262	275		10.1016/j.stem.2015.11.007	http://dx.doi.org/10.1016/j.stem.2015.11.007			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GT	26686465	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000372321700016
J	Mazumdar, C; Shen, Y; Xavy, S; Zhao, FF; Reinisch, A; Li, R; Corces, MR; Flynn, RA; Buenrostro, JD; Chan, SM; Thomas, D; Koenig, JL; Hong, WJ; Chang, HY; Majeti, R				Mazumdar, Claire; Shen, Ying; Xavy, Seethu; Zhao, Feifei; Reinisch, Andreas; Li, Rui; Corces, M. Ryan; Flynn, Ryan A.; Buenrostro, Jason D.; Chan, Steven M.; Thomas, Daniel; Koenig, Julie L.; Hong, Wan-Jen; Chang, Howard Y.; Majeti, Ravindra			Leukemia-Associated Cohesin Mutants Dominantly Enforce Stem Cell Programs and Impair Human Hematopoietic Progenitor Differentiation	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTORS; MUTATIONS; CANCER; STAG2; INACTIVATION; INHIBITION; EVOLUTION; DISCOVERY; CHROMATIN	Recurrent mutations in cohesin complex proteins have been identified in pre-leukemic hematopoietic stem cells and during the early development of acute myeloid leukemia and other myeloid malignancies. Although cohesins are involved in chromosome separation and DNA damage repair, cohesin complex functions during hematopoiesis and leukemic development are unclear. Here, we show that mutant cohesin proteins block differentiation of human hematopoietic stem and progenitor cells (HSPCs) in vitro and in vivo and enforce stem cell programs. These effects are restricted to immature HSPC populations, where cohesin mutants show increased chromatin accessibility and likelihood of transcription factor binding site occupancy by HSPC regulators including ERG, GATA2, and RUNX1, as measured by ATAC-seq and ChIP-seq. Epistasis experiments show that silencing these transcription factors rescues the differentiation block caused by cohesin mutants. Together, these results show that mutant cohesins impair HSPC differentiation by controlling chromatin accessibility and transcription factor activity, possibly contributing to leukemic disease.	[Mazumdar, Claire; Xavy, Seethu; Zhao, Feifei; Reinisch, Andreas; Corces, M. Ryan; Chan, Steven M.; Thomas, Daniel; Koenig, Julie L.; Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Sch Med, Inst Canc, Dept Med,Div Hematol, Stanford, CA 94305 USA; [Mazumdar, Claire; Xavy, Seethu; Zhao, Feifei; Reinisch, Andreas; Corces, M. Ryan; Chan, Steven M.; Thomas, Daniel; Koenig, Julie L.; Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Shen, Ying; Li, Rui; Flynn, Ryan A.; Buenrostro, Jason D.; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Shen, Ying; Li, Rui; Flynn, Ryan A.; Buenrostro, Jason D.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Buenrostro, Jason D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Majeti, R (corresponding author), Stanford Univ, Sch Med, Inst Canc, Dept Med,Div Hematol, Stanford, CA 94305 USA.	rmajeti@stanford.edu	Corces, M. Ryan/ABG-6947-2020	Corces, M. Ryan/0000-0001-7465-7652; Flynn, Ryan/0000-0001-5013-0442; Majeti, Ravindra/0000-0002-5814-0984; Reinisch, Andreas/0000-0001-9333-7689	California Institute of Regenerative Medicine Stanford Training Program [TG2-01159]; New York Stem Cell Foundation; Stinehart-Reed Foundation; Ludwig Institute; National Institutes of Health [R01CA188055, P50-HG007735]; Stanford Cancer Center; Austrian Science Fund (FWF) [J 3358] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA188055] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, P50HG007735] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine Stanford Training Program; New York Stem Cell Foundation; Stinehart-Reed Foundation; Ludwig Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Cancer Center; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the Hematology Division Tissue Bank and the patients for donating their samples. C.M. is supported by the California Institute of Regenerative Medicine Stanford Training Program (TG2-01159). This research was supported by grants from the New York Stem Cell Foundation (R.M.), Stinehart-Reed Foundation (R.M.), Ludwig Institute (R.M.), National Institutes of Health Grant R01CA188055 (R.M.), Stanford Cancer Center (H.Y.C.), and National Institutes of Health Grant P50-HG007735 (H.Y.C.). R.M. is a New York Stem Cell Foundation Robertson Investigator.	Balbas-Martinez C, 2013, NAT GENET, V45, P1464, DOI 10.1038/ng.2799; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Calo E, 2015, NATURE, V518, P249, DOI 10.1038/nature13923; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chan SM, 2015, NAT MED, V21, P178, DOI 10.1038/nm.3788; Chen C, 2013, GENE DEV, V27, P1974, DOI 10.1101/gad.226613.113; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Corces-Zimmerman MR, 2014, LEUKEMIA, V28, P2276, DOI 10.1038/leu.2014.211; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Diaz-Martinez LA, 2009, CELL CYCLE, V8, P2733, DOI 10.4161/cc.8.17.9403; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Jan M, 2013, ONCOGENE, V32, P135, DOI 10.1038/onc.2012.48; Jan M, 2012, SCI TRANSL MED, V4; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Leeke B, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-13; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lichtinger M, 2012, EMBO J, V31, P4318, DOI 10.1038/emboj.2012.275; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Panigrahi AK, 2012, EXP HEMATOL, V40, P967, DOI 10.1016/j.exphem.2012.09.010; Pronier E, 2011, BLOOD, V118, P2551, DOI 10.1182/blood-2010-12-324707; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Sinha S, 2015, BLOOD, V125, P316, DOI 10.1182/blood-2014-03-566018; Solomon DA, 2013, NAT GENET, V45, P1428, DOI 10.1038/ng.2800; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Spencer DH, 2015, LEUKEMIA, V29, P1279, DOI 10.1038/leu.2015.6; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034	38	132	132	3	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					1	14		10.1016/j.stem.2015.09.017	http://dx.doi.org/10.1016/j.stem.2015.09.017			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26607380	Green Accepted, Bronze			2022-12-28	WOS:000366139100010
J	Gontier, G; Lin, K; Villeda, SA				Gontier, Geraldine; Lin, Karin; Villeda, Saul A.			Fat Chance for Neural Stem Cells in Alzheimer's Disease	CELL STEM CELL			English	Editorial Material							COGNITIVE FUNCTION; NEUROGENESIS; REJUVENATION; BRAIN	Identifying factors driving neural stem cell dysfunction in age-related neurodegenerative diseases remains critical for the development of potential regenerative therapies. Now in Cell Stem Cell, Hamilton et al. (2015) find that lipid accumulation observed during early stages of Alzheimer's disease impairs neural stem cell activity in the adult brain.	[Gontier, Geraldine; Lin, Karin; Villeda, Saul A.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Gontier, Geraldine; Lin, Karin; Villeda, Saul A.] Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Lin, Karin; Villeda, Saul A.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Villeda, SA (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	saul.villeda@ucsf.edu						Bouchard J, 2015, J NEUROCHEM, V132, P5, DOI 10.1111/jnc.12969; Cajal S., 1928, DEGENERATION REGENER; Hamilton LK, 2015, CELL STEM CELL, V17, P397, DOI 10.1016/j.stem.2015.08.001; Hamilton LK, 2010, EUR J NEUROSCI, V32, P905, DOI 10.1111/j.1460-9568.2010.07379.x; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Lazarov O, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00043; Lim DA, 2014, TRENDS NEUROSCI, V37, P563, DOI 10.1016/j.tins.2014.08.006; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	10	3	5	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 1	2015	17	4					373	374		10.1016/j.stem.2015.09.006	http://dx.doi.org/10.1016/j.stem.2015.09.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4TS	26431177	Bronze			2022-12-28	WOS:000365693800001
J	Hu, WX; Qiu, BL; Guan, WQ; Wang, QY; Wang, M; Li, W; Gao, LF; Shen, L; Huang, Y; Xie, GC; Zhao, HZ; Jin, Y; Tang, BS; Yu, YC; Zhao, J; Pei, G				Hu, Wenxiang; Qiu, Binlong; Guan, Wuqiang; Wang, Qinying; Wang, Min; Li, Wei; Gao, Longfei; Shen, Lu; Huang, Yin; Xie, Gangcai; Zhao, Hanzhi; Jin, Ying; Tang, Beisha; Yu, Yongchun; Zhao, Jian; Pei, Gang			Direct Conversion of Normal and Alzheimer's Disease Human Fibroblasts into Neuronal Cells by Small Molecules	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; DOPAMINERGIC-NEURONS; DEFINED FACTORS; FUNCTIONAL-NEURONS; GENERATION; DIFFERENTIATION; INDUCTION; BRAIN; MOUSE	Neuronal conversion from human fibroblasts can be induced by lineage-specific transcription factors; however, the introduction of ectopic genes limits the therapeutic applications of such induced neurons (iNs). Here, we report that human fibroblasts can be directly converted into neuronal cells by a chemical cocktail of seven small molecules, bypassing a neural progenitor stage. These human chemical-induced neuronal cells (hciNs) resembled hiPSC-derived neurons and human iNs (hiNs) with respect to morphology, gene expression profiles, and electrophysiological properties. This approach was further applied to generate hciNs from familial Alzheimer's disease patients. Taken together, our transgene-free and chemical-only approach for direct reprogramming of human fibroblasts into neurons provides an alternative strategy for modeling neurological diseases and for regenerative medicine.	[Hu, Wenxiang; Qiu, Binlong; Wang, Qinying; Li, Wei; Gao, Longfei; Zhao, Jian; Pei, Gang] Univ Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci,Chinese Acad Sci, Shanghai 200031, Peoples R China; [Hu, Wenxiang; Qiu, Binlong; Wang, Qinying; Li, Wei; Gao, Longfei; Zhao, Jian; Pei, Gang] Univ Chinese Acad Sci, Grad Sch, Chinese Acad Sci, Shanghai 200031, Peoples R China; [Guan, Wuqiang; Wang, Min; Yu, Yongchun] Fudan Univ, Inst Neurobiol, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [Guan, Wuqiang; Wang, Min; Yu, Yongchun] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200032, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Collaborat Innovat Ctr Brain Sci, Shanghai 200092, Peoples R China; [Zhao, Jian] Tongji Univ, Shanghai East Hosp, Sch Med, Translat Med Ctr Stem Cell Therapy, Shanghai 200120, Peoples R China; [Shen, Lu; Tang, Beisha] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China; [Huang, Yin; Jin, Ying] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200032, Peoples R China; [Xie, Gangcai] CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University; Fudan University; Tongji University; Tongji University; Central South University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Zhao, J (corresponding author), Univ Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci,Chinese Acad Sci, Shanghai 200031, Peoples R China.	jzhao@sibs.ac.cn; gpei@sibs.ac.cn	Hu, Wenxiang/W-3737-2017; Xie, Gangcai/AAN-9197-2021; HUANG, YIN/AAH-6871-2020; Zhao, Jian/E-2008-2019	Hu, Wenxiang/0000-0002-6754-5625; Xie, Gangcai/0000-0002-8286-2987; HUANG, YIN/0000-0001-5602-9871; Zhao, Jian/0000-0002-8862-0591	Chinese Academy of Sciences [XDA01010302]; Ministry of Science and Technology [2015CB964502]; Shanghai Zhangjiang Stem Cell Research Project [ZJ2014-ZD-002]; National Natural Science Foundation of China [31371419]; National Science and Technology Support Program [2012BAI10B03]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Shanghai Zhangjiang Stem Cell Research Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program	We thank Dr. Duanqing Pei (Guangzhou Institutes of Biomedicine and Health) for providing the human fibroblasts (SF001 and SF002). We thank Dr. Benedikt Berninger (University Mainz, Germany) for providing the CAG-Ngn2-IRES-DsRed plasmid. We thank Dr. Xiaoqing Zhang (Tongji University, China) for helping with neural differentiation assay. We thank all members of the labs for sharing reagents and advice. We also thank Yang Yu, Yan Wang, and National Center for Protein Science Shanghai for technical support. This work was supported by grants from Chinese Academy of Sciences (XDA01010302), the Ministry of Science and Technology (2015CB964502), Shanghai Zhangjiang Stem Cell Research Project (ZJ2014-ZD-002), the National Natural Science Foundation of China (31371419), and the National Science and Technology Support Program (2012BAI10B03).	Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Cheng L, 2014, CELL RES, V24, P665, DOI 10.1038/cr.2014.32; Dell'Anno MT, 2014, J CLIN INVEST, V124, P3215, DOI 10.1172/JCI74664; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Guo JF, 2010, NEUROSCI LETT, V468, P34, DOI 10.1016/j.neulet.2009.10.055; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jiao B., 2014, NEUROBIOL AGING, V35; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Ladewig J, 2013, NAT REV MOL CELL BIO, V14, P225, DOI 10.1038/nrm3543; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lamas NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110324; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; MINANA MD, 1990, P NATL ACAD SCI USA, V87, P4335, DOI 10.1073/pnas.87.11.4335; Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pennarossa G, 2013, P NATL ACAD SCI USA, V110, P8948, DOI 10.1073/pnas.1220637110; Sayed N, 2015, CIRCULATION, V131, P300, DOI 10.1161/CIRCULATIONAHA.113.007394; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Xi Guangjun, 2013, Genomics Proteomics & Bioinformatics, V11, P312, DOI 10.1016/j.gpb.2013.09.003; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Zhang XQ, 2010, METHODS MOL BIOL, V584, P355, DOI 10.1007/978-1-60761-369-5_19; Zhu S, 2014, CELL RES, V24, P126, DOI 10.1038/cr.2013.156	30	315	342	7	99	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					204	212		10.1016/j.stem.2015.07.006	http://dx.doi.org/10.1016/j.stem.2015.07.006			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26253202	Bronze			2022-12-28	WOS:000361878500011
J	Sasaki, K; Yokobayashi, S; Nakamura, T; Okamoto, I; Yabuta, Y; Kurimoto, K; Ohta, H; Moritoki, Y; Iwatani, C; Tsuchiya, H; Nakamura, S; Sekiguchi, K; Sakuma, T; Yamamoto, T; Mori, T; Woltjen, K; Nakagawa, M; Yamamoto, T; Takahashi, K; Yamanaka, S; Saitou, M				Sasaki, Kotaro; Yokobayashi, Shihori; Nakamura, Tomonori; Okamoto, Ikuhiro; Yabuta, Yukihiro; Kurimoto, Kazuki; Ohta, Hiroshi; Moritoki, Yoshinobu; Iwatani, Chizuru; Tsuchiya, Hideaki; Nakamura, Shinichiro; Sekiguchi, Kiyotoshi; Sakuma, Tetsushi; Yamamoto, Takashi; Mori, Takahide; Woltjen, Knut; Nakagawa, Masato; Yamamoto, Takuya; Takahashi, Kazutoshi; Yamanaka, Shinya; Saitou, Mitinori			Robust In Vitro Induction of Human Germ Cell Fate from Pluripotent Stem Cells	CELL STEM CELL			English	Article							GENE-EXPRESSION; MICE; SPECIFICATION; LINEAGE; DYNAMICS; PRDM14; SOX2; ESTABLISHMENT; DETERMINANTS; BLASTOCYSTS	Mechanisms underlying human germ cell development are unclear, partly due to difficulties in studying human embryos and lack of suitable experimental systems. Here, we show that human induced pluripotent stem cells (hiPSCs) differentiate into incipient mesoderm-like cells (iMeLCs), which robustly generate human primordial germ cell-like cells (hPGCLCs) that can be purified using the surface markers EpCAM and INTEGRIN alpha 6. The transcriptomes of hPGCLCs and primordial germ cells (PGCs) isolated from non-human primates are similar, and although specification of hPGCLCs and mouse PGCs rely on similar signaling pathways, hPGCLC specification transcriptionally activates germline fate without transiently inducing eminent somatic programs. This includes genes important for naive pluripotency and repression of key epigenetic modifiers, concomitant with epigenetic reprogramming. Accordingly, BLIMP1, which represses somatic programs in mice, activates and stabilizes a germline transcriptional circuit and represses a default neuronal differentiation program. Together, these findings provide a foundation for understanding and reconstituting human germ cell development in vitro.	[Sasaki, Kotaro; Yokobayashi, Shihori; Nakamura, Tomonori; Okamoto, Ikuhiro; Yabuta, Yukihiro; Kurimoto, Kazuki; Ohta, Hiroshi; Moritoki, Yoshinobu; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Sasaki, Kotaro; Yokobayashi, Shihori; Nakamura, Tomonori; Okamoto, Ikuhiro; Yabuta, Yukihiro; Kurimoto, Kazuki; Ohta, Hiroshi; Moritoki, Yoshinobu; Saitou, Mitinori] JST, ERATO, Sakyo Ku, Kyoto 6068501, Japan; [Yokobayashi, Shihori; Woltjen, Knut; Nakagawa, Masato; Yamamoto, Takuya; Takahashi, Kazutoshi; Yamanaka, Shinya; Saitou, Mitinori] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Sakyo Ku, Kyoto 6068507, Japan; [Moritoki, Yoshinobu] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Iwatani, Chizuru; Tsuchiya, Hideaki; Nakamura, Shinichiro] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Otsu, Shiga 5202192, Japan; [Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Mori, Takahide] Acad Reproregenerat Med, Kamigyo Ku, Kyoto 6020917, Japan; [Woltjen, Knut] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan; [Yamamoto, Takuya; Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto 6068501, Japan; [Yamamoto, Takuya] JST, CREST, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Nagoya City University; Shiga University of Medical Science; Osaka University; Hiroshima University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Saitou, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	saitou@anat2.med.kyoto-u.ac.jp	Yamamoto, Takashi/U-4790-2017; Takahashi, Kazutoshi/ABE-5504-2020; Nakamura, Tomonori/V-8828-2019; Sakuma, Tetsushi/A-7615-2013; Yamamoto, Takuya/H-2792-2017	Yamamoto, Takashi/0000-0002-6516-2903; Takahashi, Kazutoshi/0000-0002-5329-8395; Nakamura, Tomonori/0000-0002-0173-0780; Sakuma, Tetsushi/0000-0003-0396-1563; Yamamoto, Takuya/0000-0002-0022-3947; Woltjen, Knut/0000-0003-2293-1183	MEXT; JST-ERATO; Academia for Repro-Regenerative Medicine	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-ERATO(Japan Science & Technology Agency (JST)); Academia for Repro-Regenerative Medicine	We are grateful to K. Okita for providing us with hiPSCs (585A1 and 585B1), to H. Suemori for cyESCs (CMK9), and to J. Toga for rLN511E8. We also thank Y. Nagai, R. Kabata, T. Sato, and M. Kabata for their technical assistance. This work was supported in part by a Grant-in-Aid from MEXT, by JST-ERATO, and by the Academia for Repro-Regenerative Medicine.	Aramaki S, 2013, DEV CELL, V27, P516, DOI 10.1016/j.devcel.2013.11.001; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; Eckert D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-106; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hayashi Y, 2012, FERTIL STERIL, V97, P1250, DOI 10.1016/j.fertnstert.2012.04.037; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Kurimoto K, 2015, CELL STEM CELL, V16, P517, DOI 10.1016/j.stem.2015.03.002; Lin IY, 2014, STEM CELL REP, V2, P189, DOI 10.1016/j.stemcr.2013.12.009; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nakaki F, 2014, TRENDS BIOCHEM SCI, V39, P289, DOI 10.1016/j.tibs.2014.04.003; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Nakamura T, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv134; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Pauls K, 2005, INT J CANCER, V115, P470, DOI 10.1002/ijc.20913; Perrett RM, 2008, BIOL REPROD, V78, P852, DOI 10.1095/biolreprod.107.066175; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M, 2010, REPRODUCTION, V139, P931, DOI 10.1530/REP-10-0043; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Sugawa F, 2015, EMBO J, V34, P1009, DOI 10.15252/embj.201488049; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Weber S, 2010, BIOL REPROD, V82, P214, DOI 10.1095/biolreprod.109.078717; Wilson JF, 1998, BIOL CHEM, V379, P1287; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yamasaki J, 2011, THERIOGENOLOGY, V76, P33, DOI 10.1016/j.theriogenology.2011.01.010; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	35	277	287	3	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					178	194		10.1016/j.stem.2015.06.014	http://dx.doi.org/10.1016/j.stem.2015.06.014			17	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26189426	Bronze			2022-12-28	WOS:000361878500009
J	Wu, ZM; Wei, D; Gao, WC; Xu, YT; Hu, ZQ; Ma, ZY; Gao, CF; Zhu, XY; Li, QQ				Wu, ZhengMing; Wei, Dong; Gao, WenChao; Xu, YuTing; Hu, ZhiQian; Ma, ZhenYu; Gao, ChunFang; Zhu, XiaoYan; Li, QingQuan			TPO-Induced Metabolic Reprogramming Drives Liver Metastasis of Colorectal Cancer CD110+Tumor-Initiating Cells	CELL STEM CELL			English	Article							PROTEIN-KINASE-C; STEM-CELLS; HUMAN GENOME; THROMBOPOIETIN; PHOSPHORYLATION; TRANSPLANTATION; SACCHAROPINE; INHIBITION; EXPRESSION; PATHWAY	Liver metastasis is a leading cause of death in patients with colorectal cancer. We previously found that colorectal cancer tumor-initiating cells (TICs) expressing CD110, the thrombopoietin (TPO)-binding receptor, mediate liver metastasis. Here, we show that TPO promotes metastasis of CD110+ TICs to the liver by activating lysine degradation. Lysine catabolism generates acetyl-CoA, which is used in p300-dependent LRP6 acetylation. This triggers tyrosine phosphorylation of LRP6, ultimately activating Wnt signaling to promote self-renewal of CD110+ TICs. Lysine catabolism also generates glutamate, which modulates the redox status of CD110+ TICs to promote liver colonization and drug resistance. Mechanistically, TPO-mediated induction of c-myc orchestrates recruitment of chromatin modifiers to regulate metabolic gene expression. Our findings, therefore, establish TPO as a component of the physiological environment critical for metastasis of colorectal cancer to the liver.	[Wu, ZhengMing; Xu, YuTing; Li, QingQuan] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200032, Peoples R China; [Wei, Dong; Gao, ChunFang] PLA Cent Hosp 150, Dept Anus & Intestine Surg, Luoyang 471031, Henan, Peoples R China; [Gao, WenChao; Hu, ZhiQian] Second Mil Med Univ, Changzheng Hosp, Dept Gen Surg, Shanghai 200003, Peoples R China; [Ma, ZhenYu] Fudan Univ, Huashan Hosp, Dept Gen Surg, Shanghai 200040, Peoples R China; [Zhu, XiaoYan] Fudan Univ, Shanghai Canc Hosp, Dept Tradit Chinese Med, Shanghai 200032, Peoples R China	Fudan University; Naval Medical University; Fudan University; Fudan University	Li, QQ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200032, Peoples R China.	061101040@fudan.edu.cn		Gao, Chunfang/0000-0001-6979-4871	National Nature Science Foundation of China [81372350, 81172099]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation of China (81372350 and 81172099).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Chanprasert S, 2006, CELL SIGNAL, V18, P1212, DOI 10.1016/j.cellsig.2005.09.010; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; Gao WC, 2013, GASTROENTEROLOGY, V145, P636, DOI 10.1053/j.gastro.2013.05.049; HIGASHINO K, 1965, BIOCHEM BIOPH RES CO, V20, P285, DOI 10.1016/0006-291X(65)90361-X; Hong Y, 1998, BLOOD, V91, P813, DOI 10.1182/blood.V91.3.813.813_813_822; Jessup JM, 1999, CANCER RES, V59, P1825; Kaochar S, 2012, TRENDS BIOCHEM SCI, V37, P477, DOI 10.1016/j.tibs.2012.07.008; Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Liu YH, 2010, CLIN EXP PHARMACOL P, V37, P115, DOI 10.1111/j.1440-1681.2009.05252.x; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Martin TG, 1997, ANN INTERN MED, V127, P285, DOI 10.7326/0003-4819-127-4-199708150-00005; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Papes F, 1999, BIOCHEM J, V344, P555, DOI 10.1042/0264-6021:3440555; Papes F, 2001, FEBS LETT, V488, P34, DOI 10.1016/S0014-5793(00)02401-7; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; SANGEETHA P, 1990, FREE RADICAL BIO MED, V8, P15, DOI 10.1016/0891-5849(90)90139-A; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Tao GZ, 2013, J BIOL CHEM, V288, P17214, DOI 10.1074/jbc.M112.445965; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Voutsadakis IA, 2014, WORLD J GASTRO ONCOL, V6, P34, DOI 10.4251/wjgo.v6.i2.34; Wang FS, 2012, HEPATO-GASTROENTEROL, V59, P1390, DOI 10.5754/hge11747; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200	37	83	90	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2015	17	1					47	59		10.1016/j.stem.2015.05.016	http://dx.doi.org/10.1016/j.stem.2015.05.016			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DI	26140605	Bronze			2022-12-28	WOS:000361877600008
J	Sherkow, JS; Scott, CT				Sherkow, Jacob S.; Scott, Christopher Thomas			Stem Cell Patents after the America Invents Act	CELL STEM CELL			English	Editorial Material							LANDSCAPE	Under the newly passed Leahy-Smith America Invents Act (AIA), the U.S. Patent and Trademark Office may hear new challenges to stem cell patents. Here, we explore how the new law affects challenges to stem cell patents, focusing on two recent cases, and discuss the future of stem cell patent disputes.	[Sherkow, Jacob S.] New York Law Sch, Innovat Ctr Law & Technol, New York, NY 10013 USA; [Scott, Christopher Thomas] Stanford Univ, Program Stem Cells Soc, Ctr Biomed Eth, Stanford Sch Med, Stanford, CA 94305 USA	Stanford University	Sherkow, JS (corresponding author), New York Law Sch, Innovat Ctr Law & Technol, New York, NY 10013 USA.	jacob.sherkow@nyls.edu; cscott@stanford.edu		Sherkow, Jacob/0000-0002-9724-9261	NCATS NIH HHS [2U54TR000123] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR000123] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Iancu Andrei, 2012, J PAT TRADEMARK OFF, V93, P476; Kesselheim AS, 2013, NEW ENGL J MED, V369, P869, DOI 10.1056/NEJMhle1308199; Love Brian J., 2014, U CHI L REV DIALOGUE, V81, P93; Plomer A, 2008, CELL STEM CELL, V2, P13, DOI 10.1016/j.stem.2007.12.006; Roberts M, 2014, NAT BIOTECHNOL, V32, P742, DOI 10.1038/nbt.2975; Simon BM, 2010, NAT BIOTECHNOL, V28, P557, DOI 10.1038/nbt0610-557; Tindell Amyl, 2007, J PAT TRADEMARK OFF, V89, P787	7	3	3	2	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					461	464		10.1016/j.stem.2015.04.015	http://dx.doi.org/10.1016/j.stem.2015.04.015			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25957901	Bronze, Green Published			2022-12-28	WOS:000354188600007
J	Soldner, F; Jaenisch, R				Soldner, Frank; Jaenisch, Rudolf			Dissecting Risk Haplotypes in Sporadic Alzheimer's Disease	CELL STEM CELL			English	Editorial Material							RECEPTOR LR11	Understanding how genetic risk variants contribute to complex diseases is crucial for predicting disease susceptibility and developing patient-tailored therapies. In this issue of Cell Stem Cell, Young et al. (2015) dissect the function of common non-coding risk haplotypes in the SORL1 locus in the pathogenesis of sporadic Alzheimer's disease using patient-derived induced pluripotent stem cells.	[Soldner, Frank; Jaenisch, Rudolf] Whitehead Inst, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Soldner, F (corresponding author), Whitehead Inst, Cambridge Ctr 9, Cambridge, MA 02142 USA.	soldner@wi.mit.edu; jaenisch@wi.mit.edu			NCI NIH HHS [R01 CA084198] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Goate A, 2012, J NEUROCHEM, V120, P3, DOI 10.1111/j.1471-4159.2011.07575.x; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Young JE, 2015, CELL STEM CELL, V16, P373, DOI 10.1016/j.stem.2015.02.004	10	6	6	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					341	342		10.1016/j.stem.2015.03.010	http://dx.doi.org/10.1016/j.stem.2015.03.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25842969	Bronze			2022-12-28	WOS:000352228600001
J	Szot, GL; Yadav, M; Lang, J; Kroon, E; Kerr, J; Kadoya, K; Brandon, EP; Baetge, EE; Bour-Jordan, H; Bluestone, JA				Szot, Gregory L.; Yadav, Mahesh; Lang, Jiena; Kroon, Evert; Kerr, Justin; Kadoya, Kuniko; Brandon, Eugene P.; Baetge, Emmanuel E.; Bour-Jordan, Helene; Bluestone, Jeffrey A.			Tolerance Induction and Reversal of Diabetes in Mice Transplanted with Human Embryonic Stem Cell-Derived Pancreatic Endoderm	CELL STEM CELL			English	Article							REGULATORY T-CELLS; INSULIN-PRODUCING CELLS; LONG-TERM SURVIVAL; ISLET TRANSPLANTATION; COSTIMULATION BLOCKADE; IMMUNOSUPPRESSIVE THERAPY; MONOCLONAL-ANTIBODY; IMMUNE REJECTION; BETA-CELLS; IN-VITRO	Type 1 diabetes (T1D) is an autoimmune disease caused by T cell-mediated destruction of insulin-producing beta cells in the islets of Langerhans. In most cases, reversal of disease would require strategies combining islet cell replacement with immunotherapy that are currently available only for the most severely affected patients. Here, we demonstrate that immunotherapies that target T cell costimulatory pathways block the rejection of xenogeneic human embryonic-stem-cell-derived pancreatic endoderm (hESC-PE) in mice. The therapy allowed for long-term development of hESC-PE into islet-like structures capable of producing human insulin and maintaining normoglycemia. Moreover, short-term costimulation blockade led to robust immune tolerance that could be transferred independently of regulatory T cells. Importantly, costimulation blockade prevented the rejection of allogeneic hESC-PE by human PBMCs in a humanized model in vivo. These results support the clinical development of hESC-derived therapy, combined with tolerogenic treatments, as a sustainable alternative strategy for patients with T1D.	[Szot, Gregory L.; Yadav, Mahesh; Lang, Jiena; Bour-Jordan, Helene; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Kroon, Evert; Kerr, Justin; Kadoya, Kuniko; Brandon, Eugene P.; Baetge, Emmanuel E.] ViaCyte Inc, San Diego, CA 92121 USA	University of California System; University of California San Francisco	Bluestone, JA (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	jeff.bluestone@ucsf.edu		KROON, EVERT/0000-0002-4069-3644; Szot, Gregory/0000-0002-3921-049X	CIRM [RM1-01703, DR1-01423]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049799] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dorothy Fuentes for animal care and Matthias Hebrok and members of the Bluestone and Hebrok laboratories for discussions. We thank Holly Young and Laura Martinson for technical assistance in preparing hESC-PE for implant. This research was supported by CIRM grants RM1-01703 and DR1-01423. J.A.B. is a consultant for ViaCyte, Inc., and E.K., J.K., K.K., E.P.B., and E.E.B. are employed or formerly employed by, and are shareholders of, ViaCyte, Inc., which is developing ESC-based products.	Adams AB, 2005, J IMMUNOL, V174, P542, DOI 10.4049/jimmunol.174.1.542; Arefanian H, 2010, DIABETES, V59, P958, DOI 10.2337/db09-0413; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Bellin MD, 2012, AM J TRANSPLANT, V12, P1576, DOI 10.1111/j.1600-6143.2011.03977.x; Benda B, 2002, CELL TRANSPLANT, V11, P715, DOI 10.3727/000000002783985440; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Chatenoud L, 2008, NEW ENGL J MED, V358, P1192, DOI 10.1056/NEJMcibr0708067; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; de Almeida PE, 2013, CIRC RES, V112, P549, DOI 10.1161/CIRCRESAHA.111.249243; Deuse T, 2011, CIRCULATION, V124, pS3, DOI 10.1161/CIRCULATIONAHA.111.020727; Deuse T, 2011, J CELL SCI, V124, P3029, DOI 10.1242/jcs.087718; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Eshpeter A, 2008, CELL PROLIFERAT, V41, P843, DOI 10.1111/j.1365-2184.2008.00564.x; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Frenzel LP, 2009, STEM CELLS, V27, P307, DOI 10.1634/stemcells.2008-0528; Grinnemo KH, 2008, STEM CELLS, V26, P1850, DOI 10.1634/stemcells.2008.0111; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; Hebrok M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007674; Holditch SJ, 2014, STEM CELL TRANSL MED, V3, P653, DOI 10.5966/sctm.2013-0184; Hosokawa M, 2001, BIOCHEM BIOPH RES CO, V289, P1114, DOI 10.1006/bbrc.2001.6145; Huber BC, 2013, STEM CELLS, V31, P2354, DOI 10.1002/stem.1501; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Kanmaz T, 2004, TRANSPLANTATION, V77, P914, DOI 10.1097/01.TP.0000116392.72152.75; Kenyon NS, 1999, DIABETES, V48, P1473, DOI 10.2337/diabetes.48.7.1473; Kilpatrick ES, 2009, NAT REV ENDOCRINOL, V5, P537, DOI 10.1038/nrendo.2009.179; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; Levisetti MG, 1997, J IMMUNOL, V159, P5187; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Ljung K, 2013, BIORESEARCH OPEN ACC, V2, P455, DOI 10.1089/biores.2013.0039; Lui KO, 2010, STEM CELLS, V28, P1905, DOI 10.1002/stem.506; Ma MC, 2010, STEM CELLS, V28, P1465, DOI 10.1002/stem.475; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Magliocca JF, 2006, STEM CELLS DEV, V15, P707, DOI 10.1089/scd.2006.15.707; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Posselt AM, 2010, AM J TRANSPLANT, V10, P1870, DOI 10.1111/j.1600-6143.2010.03073.x; Posselt AM, 2010, TRANSPLANTATION, V90, P1595, DOI 10.1097/TP.0b013e3181fe1377; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Rong ZL, 2014, CELL STEM CELL, V14, P121, DOI 10.1016/j.stem.2013.11.014; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Shapiro AMJ, 2014, TEXTBOOK OF ORGAN TRANSPLANTATION, P1314; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Szot GL, 2007, JOVE-J VIS EXP, V9, P404, DOI DOI 10.3791/404; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Thatava T, 2013, MOL THER, V21, P228, DOI 10.1038/mt.2012.245; Thompson P, 2011, AM J TRANSPLANT, V11, P947, DOI 10.1111/j.1600-6143.2011.03509.x; Tiwari JL, 2012, AM J TRANSPLANT, V12, P1898, DOI 10.1111/j.1600-6143.2012.04038.x; Van Hoof D, 2009, STEM CELL RES, V3, P73, DOI 10.1016/j.scr.2009.08.003; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Wu DC, 2013, TRANSPLANTATION, V96, P707, DOI 10.1097/TP.0b013e31829fa271	59	68	71	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					148	157		10.1016/j.stem.2014.12.001	http://dx.doi.org/10.1016/j.stem.2014.12.001			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25533131	Green Submitted, Bronze			2022-12-28	WOS:000349455000011
J	Sieweke, MH				Sieweke, Michael H.			Waddington's Valleys and Captain Cook's Islands	CELL STEM CELL			English	Editorial Material							CELLS	Somatic reprogramming has relied heavily on theoretical models that view differentiation in terms of developmental branch point decisions. Recent studies in Cell now reveal a dominant role of the microenvironment in shaping epigenetic identity of macrophages, thus providing support for alternative models of cell fate acquisition.	[Sieweke, Michael H.] Aix Marseille Univ UM2, Ctr Immunol Marseille Luminy CIML, F-13288 Marseille 09, France; [Sieweke, Michael H.] Inst Natl Sante & Rech Med INSERM, U1104, Marseille, France; [Sieweke, Michael H.] Ctr Natl Rech Sci CNRS, UMR7280, Marseille, France; [Sieweke, Michael H.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Sieweke, MH (corresponding author), Aix Marseille Univ UM2, Ctr Immunol Marseille Luminy CIML, Campus Luminy,Case 906, F-13288 Marseille 09, France.	sieweke@ciml.univ-mrs.fr	Sieweke, Michael/AAR-7515-2020	Sieweke, Michael/0000-0002-3228-9537				Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Perdiguero E.G., 2014, NATURE IN PRESS; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Waddington C., 1957, STRATEGY GENES	10	18	18	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					7	8		10.1016/j.stem.2014.12.009	http://dx.doi.org/10.1016/j.stem.2014.12.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25575076	Bronze			2022-12-28	WOS:000347708400004
J	Bruedigam, C; Bagger, FO; Heidel, FH; Kuhn, CP; Guignes, S; Song, A; Austin, R; Vu, T; Lee, E; Riyat, S; Moore, AS; Lock, RB; Bullinger, L; Hill, GR; Armstrong, SA; Williams, DA; Lane, SW				Bruedigam, Claudia; Bagger, Frederik O.; Heidel, Florian H.; Kuhn, Catherine Paine; Guignes, Solene; Song, Axia; Austin, Rebecca; Vu, Therese; Lee, Erwin; Riyat, Sarbjit; Moore, Andrew S.; Lock, Richard B.; Bullinger, Lars; Hill, Geoffrey R.; Armstrong, Scott A.; Williams, David A.; Lane, Steven W.			Telomerase Inhibition Effectively Targets Mouse and Human AML Stem Cells and Delays Relapse following Chemotherapy	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; SELF-RENEWAL; COMMITTED PROGENITOR; GENE-EXPRESSION; DNA-DAMAGE; LIFE-SPAN; MICE; TRANSFORMATION; MUTATIONS; HIERARCHY	Acute myeloid leukemia (AML) is an aggressive and lethal blood cancer maintained by rare populations of leukemia stem cells (LSCs). Selective targeting of LSCs is a promising approach for treating AML and preventing relapse following chemotherapy, and developing such therapeutic modalities is a key priority. Here, we show that targeting telomerase activity eradicates AML LSCs. Genetic deletion of the telomerase subunit Terc in a retroviral mouse AML model induces cell-cycle arrest and apoptosis of LSCs, and depletion of telomerase-deficient LSCs is partially rescued by p53 knockdown. Murine Terc(-/-) LSCs express a specific gene expression signature that can be identified in human AML patient cohorts and is positively correlated with patient survival following chemotherapy. In xenografts of primary human AML, genetic or pharmacological inhibition of telomerase targets LSCs, impairs leukemia progression, and delays relapse following chemotherapy. Altogether, these results establish telomerase inhibition as an effective strategy for eliminating AML LSCs.	[Bruedigam, Claudia; Kuhn, Catherine Paine; Guignes, Solene; Song, Axia; Austin, Rebecca; Vu, Therese; Hill, Geoffrey R.; Lane, Steven W.] QIMR Berghofer Med Res Inst, Div Immunol, Brisbane, Qld 4006, Australia; [Bagger, Frederik O.] Univ Copenhagen, Finsen Lab, Bioinformat Ctr, Dept Biol, DK-1165 Copenhagen, Denmark; [Bagger, Frederik O.] Univ Copenhagen, BRIC, DK-1165 Copenhagen, Denmark; [Heidel, Florian H.] Otto Von Guericke Univ, Univ Hosp, Dept Hematol & Oncol, D-39120 Magdeburg, Germany; [Lee, Erwin; Lock, Richard B.] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Sydney, NSW 2052, Australia; [Riyat, Sarbjit; Hill, Geoffrey R.; Lane, Steven W.] Royal Brisbane & Womens Hosp, Dept Haematol, Brisbane, Qld 4006, Australia; [Moore, Andrew S.] Queensland Childrens Med Res Inst, Brisbane, Qld 4029, Australia; [Moore, Andrew S.; Hill, Geoffrey R.; Lane, Steven W.] Univ Queensland, Brisbane, Qld 4072, Australia; [Bullinger, Lars] Univ Hosp Ulm, Dept Hematol & Oncol, D-89081 Ulm, Germany; [Armstrong, Scott A.] Mem Sloan Kettering Leukemia Ctr, Dept Pediat, New York, NY 10065 USA; [Williams, David A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Hematol & Oncol, Cambridge, MA 02138 USA; [Williams, David A.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	QIMR Berghofer Medical Research Institute; University of Copenhagen; University of Copenhagen; Otto von Guericke University; University Hospital Magdeburg; Children's Cancer Institute; University of New South Wales Sydney; Royal Brisbane & Women's Hospital; University of Queensland; Ulm University; Harvard University; Dana-Farber Cancer Institute; Harvard University	Lane, SW (corresponding author), QIMR Berghofer Med Res Inst, Div Immunol, Brisbane, Qld 4006, Australia.	steven.lane@qimrberghofer.edu.au	Hill, Geoffrey/O-2630-2016; Bullinger, Lars/AAL-7965-2020; Lock, Richard/G-4253-2013; Bruedigam, Claudia/P-6326-2018; Moore, Andrew S/I-6275-2012; Bruedigam, Claudia/ABC-8681-2020	Hill, Geoffrey/0000-0003-2994-0429; Bruedigam, Claudia/0000-0002-9580-1446; Moore, Andrew S/0000-0001-8062-1779; Bruedigam, Claudia/0000-0002-9580-1446; Heidel, Florian/0000-0003-2438-1955; Lock, Richard/0000-0002-3436-9071; Otzen Bagger, Frederik/0000-0003-0636-8845; Vu, Therese/0000-0003-2831-2957; Vu, Therese/0000-0002-5924-9359; Bullinger, Lars/0000-0002-5890-5510	Leukaemia Foundation of Queensland; National Health and Medical Research Council; In Vitro Technologies; Pfizer Cancer Research Grant; Rio Tinto Ride to Conquer Cancer; NIH [CA66996, CA140575]; NATIONAL CANCER INSTITUTE [P01CA066996, R01CA140575] Funding Source: NIH RePORTER	Leukaemia Foundation of Queensland; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); In Vitro Technologies; Pfizer Cancer Research Grant; Rio Tinto Ride to Conquer Cancer; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the generous contribution of imetelstat, provided by Geron Corporation. We gratefully acknowledge the technical assistance of Amity Roberts, Glen Boyle, Grace Chojnowski, and Paula Hall (flow cytometry) and the members of the QIMR-Berghofer Animal House. We thank Stephen Sykes, Mark Smyth, Kelli MacDonald, and members of their laboratories for their helpful discussion. S.W.L. and G.R.H. have received funding from the Leukaemia Foundation of Queensland and the National Health and Medical Research Council. S.W.L. is the recipient of the Rhys Pengelly Fellowship in Leukaemia Research from In Vitro Technologies and Pfizer Cancer Research Grant. C.B., G.R.H., and S.W.L. have received funding from the Rio Tinto Ride to Conquer Cancer. S. A. A. acknowledges funding from the NIH (CA66996 and CA140575).	Aalbers AM, 2013, LEUKEMIA, V27, P1786, DOI 10.1038/leu.2013.57; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Bagger FO, 2012, BLOOD, V119, P6394, DOI 10.1182/blood-2012-05-427310; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Bernard L, 2009, LEUKEMIA, V23, P287, DOI 10.1038/leu.2008.319; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chou FS, 2011, BLOOD, V117, P2237, DOI 10.1182/blood-2010-01-264119; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Drummond MW, 2005, LEUKEMIA, V19, P381, DOI 10.1038/sj.leu.2403616; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Gessner A, 2010, LEUKEMIA, V24, P1751, DOI 10.1038/leu.2010.155; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Heidel FH, 2012, CELL STEM CELL, V10, P412, DOI 10.1016/j.stem.2012.02.017; Herbert BS, 2005, ONCOGENE, V24, P5262, DOI 10.1038/sj.onc.1208760; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ishwaran H, 2010, STAT PROBABIL LETT, V80, P1056, DOI 10.1016/j.spl.2010.02.020; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Krivtsov AV, 2009, ANN NY ACAD SCI, V1176, P144, DOI 10.1111/j.1749-6632.2009.04966.x; Lane SW, 2011, BLOOD, V118, P2849, DOI 10.1182/blood-2011-03-345165; Lane SW, 2010, SEMIN CANCER BIOL, V20, P71, DOI 10.1016/j.semcancer.2009.12.001; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Metzeler KH, 2011, J CLIN ONCOL, V29, P1373, DOI 10.1200/JCO.2010.32.7742; Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873; Ritchie ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002276; Ruckner FG, 2012, BLOOD, V119, P2114, DOI 10.1182/blood-2011-08-375758; Scholl C, 2007, J CLIN INVEST, V117, P1037, DOI 10.1172/JCI30182; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Szer J, 2012, HEMATOL-AM SOC HEMAT, P43, DOI 10.1182/asheducation-2012.1.43; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Vicente-Duenas C, 2012, ONCOTARGET, V3, P261, DOI 10.18632/oncotarget.461; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Zhao SM, 2014, CELL PHYSIOL BIOCHEM, V33, P78, DOI 10.1159/000356651; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	47	58	64	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					775	790		10.1016/j.stem.2014.11.010	http://dx.doi.org/10.1016/j.stem.2014.11.010			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25479751	Green Accepted, Bronze			2022-12-28	WOS:000347174300015
J	Ye, L; Chang, YH; Xiong, Q; Zhang, PY; Zhang, LY; Somasundaram, P; Lepley, M; Swingen, C; Su, LP; Wendel, JS; Guo, J; Jang, A; Rosenbush, D; Greder, L; Dutton, JR; Zhang, JH; Kamp, TJ; Kaufman, DS; Ge, Y; Zhang, JY				Ye, Lei; Chang, Ying-Hua; Xiong, Qiang; Zhang, Pengyuan; Zhang, Liying; Somasundaram, Porur; Lepley, Mike; Swingen, Cory; Su, Liping; Wendel, Jacqueline S.; Guo, Jing; Jang, Albert; Rosenbush, Daniel; Greder, Lucas; Dutton, James R.; Zhang, Jianhua; Kamp, Timothy J.; Kaufman, Dan S.; Ge, Ying; Zhang, Jianyi			Cardiac Repair in a Porcine Model of Acute Myocardial Infarction with Human Induced Pluripotent Stem Cell-Derived Cardiovascular Cells	CELL STEM CELL			English	Article							GROWTH-FACTOR-I; FUNCTIONAL CONSEQUENCES; PROGENITOR CELLS; RAT HEARTS; CARDIOMYOCYTES; THERAPY; TRANSPLANTATION; SURVIVAL; DIFFERENTIATION; PERFORMANCE	Human induced pluripotent stem cells (hiPSCs) hold promise for myocardial repair following injury, but preclinical studies in large animal models are required to determine optimal cell preparation and delivery strategies to maximize functional benefits and to evaluate safety. Here, we utilized a porcine model of acute myocardial infarction (MI) to investigate the functional impact of intramyocardial transplantation of hiPSC-derived cardiomyocytes, endothelial cells, and smooth muscle cells, in combination with a 3D fibrin patch loaded with insulin growth factor (IGF)-encapsulated microspheres. hiPSC-derived cardiomyocytes integrated into host myocardium and generated organized sarcomeric structures, and endothelial and smooth muscle cells contributed to host vasculature. Trilineage cell transplantation significantly improved left ventricular function, myocardial metabolism, and arteriole density, while reducing infarct size, ventricular wall stress, and apoptosis without inducing ventricular arrhythmias. These findings in a large animal MI model highlight the potential of utilizing hiPSC-derived cells for cardiac repair.	[Ye, Lei; Xiong, Qiang; Zhang, Pengyuan; Zhang, Liying; Somasundaram, Porur; Swingen, Cory; Su, Liping; Guo, Jing; Rosenbush, Daniel; Zhang, Jianyi] Univ Minnesota, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA; [Ye, Lei; Lepley, Mike; Greder, Lucas; Dutton, James R.; Kaufman, Dan S.; Zhang, Jianyi] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Chang, Ying-Hua; Kamp, Timothy J.; Ge, Ying] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53705 USA; [Lepley, Mike; Kaufman, Dan S.] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA; [Wendel, Jacqueline S.; Zhang, Jianyi] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Jang, Albert; Zhang, Jianyi] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA; [Zhang, Jianhua; Kamp, Timothy J.] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Ge, Ying] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, JY (corresponding author), Univ Minnesota, Dept Med, Div Cardiol, Box 736 UMHC, Minneapolis, MN 55455 USA.	zhang047@umn.edu	Kamp, Timothy/ABD-1343-2020; Zhang, Jianyi/N-1949-2018	Kamp, Timothy/0000-0003-2103-7876; Zhang, Jianyi/0000-0002-3955-6554; Ye, Lei/0000-0001-5039-6224; Kaufman, Dan/0000-0002-2003-2494	US Public Health Service [NIH RO1s, HL UO1 100407, HL UO1 099773, P41RR08079]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099773, U01HL100407, R01HL096971, R01HL109810, R01HL114120, R01HL095077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors would like to thank W. Kevin Meisner, Ph.D., E.L.S., for his editorial assistance. This work was supported by US Public Health Service grants NIH RO1s, HL UO1 100407, HL UO1 099773, and P41RR08079.	Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chen D, 2009, J THROMB HAEMOST, V7, P122, DOI 10.1111/j.1538-7836.2009.03413.x; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Cibelli J, 2013, CELL STEM CELL, V12, P271, DOI 10.1016/j.stem.2013.01.004; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; FRAME MDS, 1993, CIRC RES, V73, P155, DOI 10.1161/01.RES.73.1.155; Hill KL, 2010, EXP HEMATOL, V38, P246, DOI 10.1016/j.exphem.2010.01.001; Hsieh PCH, 2006, ANNU REV PHYSIOL, V68, P51, DOI 10.1146/annurev.physiol.68.040104.124629; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Toko H, 2002, J BIOL CHEM, V277, P24735, DOI 10.1074/jbc.M107669200; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Wang L, 1998, CIRC RES, V83, P516, DOI 10.1161/01.RES.83.5.516; Wilber A, 2007, STEM CELLS, V25, P2919, DOI 10.1634/stemcells.2007-0026; Woll PS, 2008, BLOOD, V111, P122, DOI 10.1182/blood-2007-04-084186; Xiong Q, 2013, CIRCULATION, V127, P997, DOI 10.1161/CIRCULATIONAHA.112.000641; Xiong Q, 2012, CIRC RES, V111, P455, DOI 10.1161/CIRCRESAHA.112.269894; Xu CH, 2006, STEM CELLS DEV, V15, P631, DOI 10.1089/scd.2006.15.631; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; Zhang JH, 2012, CIRC RES, V111, P1125, DOI 10.1161/CIRCRESAHA.112.273144	28	309	317	3	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					750	761		10.1016/j.stem.2014.11.009	http://dx.doi.org/10.1016/j.stem.2014.11.009			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25479750	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000347174300013
J	Hanoun, M; Zhang, DC; Mizoguchi, T; Pinho, S; Pierce, H; Kunisaki, Y; Lacombe, J; Armstrong, SA; Duhrsen, U; Frenette, PS				Hanoun, Maher; Zhang, Dachuan; Mizoguchi, Toshihide; Pinho, Sandra; Pierce, Halley; Kunisaki, Yuya; Lacombe, Julie; Armstrong, Scott A.; Duehrsen, Ulrich; Frenette, Paul S.			Acute Myelogenous Leukemia-Induced Sympathetic Neuropathy Promotes Malignancy in an Altered Hematopoietic Stem Cell Niche	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; BONE-MARROW NICHE; NERVOUS-SYSTEM; INCREASED ANGIOGENESIS; PROGENITOR CELLS; MICROENVIRONMENT; REGENERATION; MAINTENANCE; MLL-AF9; MODEL	Perivascular mesenchymal stem and progenitor cells (MSPCs) are critical for forming a healthy hematopoietic stem cell (HSC) niche. However, the interactions and influence of acute myelogenous leukemia (AML) stem cells with the microenvironment remain largely unexplored. We have unexpectedly found that neuropathy of the sympathetic nervous system (SNS) promotes leukemic bone marrow infiltration in an MLL-AF9 AML model. Development of AML disrupts SNS nerves and the quiescence of Nestin(+) niche cells, leading to an expansion of phenotypic MSPCs primed for osteoblastic differentiation at the expense of HSC-maintaining NG2(+) periarteriolar niche cells. Adrenergic signaling promoting leukemogenesis is transduced by the beta 2, but not beta 3, adrenergic receptor expressed on stromal cells of leukemic bone marrow. These results indicate that sympathetic neuropathy may represent a mechanism for the malignancy in order to co-opt the microenvironment and suggest separate mesenchymal niche activities for malignant and healthy hematopoietic stem cells in the bone marrow.	[Hanoun, Maher; Zhang, Dachuan; Mizoguchi, Toshihide; Pinho, Sandra; Pierce, Halley; Kunisaki, Yuya; Lacombe, Julie; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Hanoun, Maher; Zhang, Dachuan; Mizoguchi, Toshihide; Pinho, Sandra; Pierce, Halley; Kunisaki, Yuya; Lacombe, Julie; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Mem Hosp Res Labs, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Duehrsen, Ulrich] Univ Duisburg Essen, Univ Hosp, Dept Hematol, D-45122 Essen, Germany	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; University of Duisburg Essen	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.	paul.frenette@einstein.yu.edu	Zhang, Dachuan/GZA-8781-2022; Pinho, Sandra/GWC-8029-2022; Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922; Pinho, Sandra/0000-0002-5241-7364; Zhang, Dachuan/0000-0002-1746-275X	National Institutes of Health [DK056638, HL116340, HL097819]; New York Stem Cell Foundation; National Cancer Institute [CA140575, CA66996]; German Research Foundation (DFG) [Ha 6731/1-1]; Training Program in Cellular and Molecular Biology and Genetics [T32 GM007491]; NATIONAL CANCER INSTITUTE [P30CA008748, P30CA013330, P01CA066996, R01CA140575] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097819, R01HL116340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Research Foundation (DFG)(German Research Foundation (DFG)); Training Program in Cellular and Molecular Biology and Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Colette Prophete, Lauren Schiff, Paul Ciero, Matthew Huggins, Sana Mohamad, and Michael Mollmann for technical assistance; the Stem Cell FACS Facility and Einstein Flow Cytometry Core Facility for expert cell sorting; Dr. Luis Cardoso for micro-CT analyses; Dr. Raymond Johnson for noradrenaline measurements; Dr. Rani Sellers for histopathological examinations; and Dr. Britta Will for helpful scientific discussions. This work was supported by R01 grants from the National Institutes of Health (DK056638, HL116340, and HL097819 to P. S. F), the New York Stem Cell Foundation, and the National Cancer Institute (CA140575 and CA66996 to S. A. A.). M. H. is supported by a fellowship of the German Research Foundation (DFG, Ha 6731/1-1), S. P. is a New York Stem Cell Foundation-Druckenmiller Fellow, and H. P. is supported by a Training Program in Cellular and Molecular Biology and Genetics (T32 GM007491).	Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Boyerinas B, 2013, BLOOD, V121, P4821, DOI 10.1182/blood-2012-12-475483; BRYON PA, 1979, PATHOL BIOL, V27, P209; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Ferrara F, 2013, LANCET, V381, P484, DOI 10.1016/S0140-6736(12)61727-9; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Frisch BJ, 2012, BLOOD, V119, P540, DOI 10.1182/blood-2011-04-348151; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Hussong JW, 2000, BLOOD, V95, P309; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Krause DS, 2013, NAT MED, V19, P1513, DOI 10.1038/nm.3364; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lane SW, 2011, BLOOD, V118, P2849, DOI 10.1182/blood-2011-03-345165; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Medyouf H, 2014, CELL STEM CELL, V14, P824, DOI 10.1016/j.stem.2014.02.014; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Miller PG, 2013, CANCER CELL, V24, P45, DOI 10.1016/j.ccr.2013.05.004; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Padro T, 2000, BLOOD, V95, P2637, DOI 10.1182/blood.V95.8.2637.008k07_2637_2644; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018	36	238	243	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					365	375		10.1016/j.stem.2014.06.020	http://dx.doi.org/10.1016/j.stem.2014.06.020			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25017722	Green Accepted, Bronze			2022-12-28	WOS:000341441600015
J	Ye, J; Blelloch, R				Ye, Julia; Blelloch, Robert			Regulation of Pluripotency by RNA Binding Proteins	CELL STEM CELL			English	Review							3' UNTRANSLATED REGIONS; LONG NONCODING RNAS; SELF-RENEWAL; MESSENGER-RNAS; ALTERNATIVE POLYADENYLATION; STEM-CELLS; MICRORNA; MOUSE; DIFFERENTIATION; COMPLEX	Establishment, maintenance, and exit from pluripotency require precise coordination of a cell's molecular machinery. Substantial headway has been made in deciphering many aspects of this elaborate system, particularly with respect to epigenetics, transcription, and noncoding RNAs. Less attention has been paid to posttranscriptional regulatory processes such as alternative splicing, RNA processing and modification, nuclear export, regulation of transcript stability, and translation. Here, we introduce the RNA binding proteins that enable the posttranscriptional regulation of gene expression, summarizing current and ongoing research on their roles at different regulatory points and discussing how they help script the fate of pluripotent stem cells.	[Ye, Julia; Blelloch, Robert] Univ Calif San Francisco, Ctr Reprod Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Ye, Julia; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blelloch, R (corresponding author), Univ Calif San Francisco, Ctr Reprod Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	blellochr@stemcell.ucsf.edu			National Institutes of Health [R01: NS057221, GM101180]; Leona M. and Harry B. Helmsley Charitable Trust [09PG-T1D002]; California Institute of Regenerative Medicine [RN2-00906-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We apologize to the authors whose work could not be in this Review due to limitations in space. This work was supported by funds to R. B. from the National Institutes of Health (R01: NS057221 and GM101180), the Leona M. and Harry B. Helmsley Charitable Trust (09PG-T1D002), and the California Institute of Regenerative Medicine (New Faculty Award: RN2-00906-1).	Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Chang HM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1909; Cheong CY, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/560261; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Dardenne E, 2014, CELL REP, V7, P1900, DOI 10.1016/j.celrep.2014.05.010; Das S, 2011, J BIOL CHEM, V286, P42690, DOI 10.1074/jbc.M111.290189; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Fagoonee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072300; Flynn RA, 2014, CELL STEM CELL, V14, P752, DOI 10.1016/j.stem.2014.05.014; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Ghosal S, 2013, STEM CELLS DEV, V22, P2240, DOI 10.1089/scd.2013.0014; Gopalakrishnan S, 2009, MOL CANCER RES, V7, P1622, DOI 10.1158/1541-7786.MCR-09-0018; Greve TS, 2013, ANNU REV CELL DEV BI, V29, P213, DOI 10.1146/annurev-cellbio-101512-122343; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kosinski PA, 2003, J IMMUNOL, V170, P979, DOI 10.4049/jimmunol.170.2.979; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lackford B, 2014, EMBO J, V33, P878, DOI 10.1002/embj.201386537; Lee MR, 2013, STEM CELLS, V31, P666, DOI 10.1002/stem.1302; Leeb M, 2014, CELL STEM CELL, V14, P385, DOI 10.1016/j.stem.2013.12.008; Leontieva OV, 2009, CELL CYCLE, V8, P490, DOI 10.4161/cc.8.3.7679; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Loedige I, 2013, NUCLEIC ACIDS RES, V41, P518, DOI 10.1093/nar/gks1032; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Lu XY, 2013, NAT CELL BIOL, V15, P1141, DOI 10.1038/ncb2839; Lu Y, 2014, CELL STEM CELL, V15, P92, DOI 10.1016/j.stem.2014.04.002; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100; Neff AT, 2012, GENOME RES, V22, P1457, DOI 10.1101/gr.134312.111; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Ohno S, 2011, CELL CYCLE, V10, P3706, DOI 10.4161/cc.10.21.17903; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Simone LE, 2013, CURR OPIN GENET DEV, V23, P35, DOI 10.1016/j.gde.2012.12.006; Spies N, 2013, GENOME RES, V23, P2078, DOI 10.1101/gr.156919.113; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tahmasebi S, 2014, CELL STEM CELL, V14, P606, DOI 10.1016/j.stem.2014.02.005; Tan FE, 2014, P NATL ACAD SCI USA, V111, pE1740, DOI 10.1073/pnas.1320873111; Ustianenko D, 2013, RNA, V19, P1632, DOI 10.1261/rna.040055.113; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang L, 2013, CELL STEM CELL, V13, P676, DOI 10.1016/j.stem.2013.10.008; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wang YM, 2013, CELL REP, V4, P99, DOI 10.1016/j.celrep.2013.05.027; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wang YC, 2014, CELL RES, V24, P143, DOI 10.1038/cr.2013.151; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Watanabe A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0292; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Worringer KA, 2014, CELL STEM CELL, V14, P40, DOI 10.1016/j.stem.2013.11.001; Wright JE, 2013, TRENDS GENET, V29, P99, DOI 10.1016/j.tig.2012.10.007; Wu D, 2011, NAT STRUCT MOL BIOL, V18, P1094, DOI 10.1038/nsmb.2129; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yamanaka S, 2000, EMBO J, V19, P5533, DOI 10.1093/emboj/19.20.5533; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	75	66	67	4	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					271	280		10.1016/j.stem.2014.08.010	http://dx.doi.org/10.1016/j.stem.2014.08.010			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25192462	Green Accepted, Bronze			2022-12-28	WOS:000341441600008
J	Suzuki, K; Yu, C; Qu, J; Li, M; Yao, XT; Yuan, TT; Goebl, A; Tang, SW; Ren, RT; Aizawa, E; Zhang, F; Xu, XL; Soligalla, RD; Chen, F; Kim, J; Kim, NY; Liao, HK; Benner, C; Esteban, CR; Jin, YB; Liu, GH; Li, YR; Belmonte, JCI				Suzuki, Keiichiro; Yu, Chang; Qu, Jing; Li, Mo; Yao, Xiaotian; Yuan, Tingting; Goebl, April; Tang, Senwei; Ren, Ruotong; Aizawa, Emi; Zhang, Fan; Xu, Xiuling; Soligalla, Rupa Devi; Chen, Feng; Kim, Jessica; Kim, Na Young; Liao, Hsin-Kai; Benner, Chris; Esteban, Concepcion Rodriguez; Jin, Yabin; Liu, Guang-Hui; Li, Yingrui; Belmonte, Juan Carlos Izpisua			Targeted Gene Correction Minimally Impacts Whole-Genome Mutational Load in Human-Disease-Specific Induced Pluripotent Stem Cell Clones	CELL STEM CELL			English	Article							ZINC-FINGER NUCLEASES; STRAND-BREAK-REPAIR; MUTAGENESIS; IPSCS; GENERATION; TALENS; REV3	The utility of genome editing technologies for disease modeling and developing cellular therapies has been extensively documented, but the impact of these technologies on mutational load at the whole-genome level remains unclear. We performed whole-genome sequencing to evaluate the mutational load at single-base resolution in individual gene-corrected human induced pluripotent stem cell (hiPSC) clones in three different disease models. In single-cell clones, gene correction by helper-dependent adenoviral vector (HDAdV) or Transcription Activator-Like Effector Nuclease (TALEN) exhibited few off-target effects and a low level of sequence variation, comparable to that accumulated in routine hiPSC culture. The sequence variants were randomly distributed and unique to individual clones. We also combined both technologies and developed a TALEN-HDAdV hybrid vector, which significantly increased gene-correction efficiency in hiPSCs. Therefore, with careful monitoring via whole-genome sequencing it is possible to apply genome editing to human pluripotent cells with minimal impact on genomic mutational load.	[Suzuki, Keiichiro; Li, Mo; Goebl, April; Aizawa, Emi; Soligalla, Rupa Devi; Kim, Jessica; Kim, Na Young; Liao, Hsin-Kai; Esteban, Concepcion Rodriguez; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Yu, Chang; Yao, Xiaotian; Tang, Senwei; Zhang, Fan; Chen, Feng; Jin, Yabin; Li, Yingrui] BGI, Shenzhen 518083, Peoples R China; [Qu, Jing] Chinese Acad Sci, Inst Biophys, Lab RNA Biol, Beijing 100101, Peoples R China; [Yuan, Tingting; Ren, Ruotong; Xu, Xiuling; Liu, Guang-Hui] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Tang, Senwei] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Tang, Senwei] Chinese Univ Hong Kong, Dept Med & Therapeut, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Fan] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Benner, Chris] Salk Inst Biol Studies, Integrat Genom & Bioinformat Core, La Jolla, CA 92037 USA; [Liu, Guang-Hui] Ctr Age Related Dis CAD, Beijing, Peoples R China; [Liu, Guang-Hui] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China	Salk Institute; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Michigan System; University of Michigan; Salk Institute	Liu, GH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	ghliu@ibp.ac.cn; liyr@genomics.cn; belmonte@salk.edu	Li, Mo/J-2090-2014; Li, Mo/AAM-8266-2021; Yu, Chang/AAE-8538-2019; Liao, Hsin-Kai/H-9608-2015; Ren, Ruotong/AAF-4046-2020; Qu, Jing/ABB-9088-2020; Tang, Senwei/F-2278-2015; Li, Yingrui/K-1064-2015	Li, Mo/0000-0003-0827-8907; Tang, Senwei/0000-0001-6112-4232; Yao, Xiaotian/0000-0002-3466-461X; Benner, Christopher/0000-0002-4618-0719; Suzuki, Keiichiro/0000-0001-5603-9105; qu, jing/0000-0002-3988-5067	National Basic Research Program (973 program) [2014CB910500, 2014CB964600]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020312]; NSFC [81271266, 31222039, 81330008, 81371342, 31201111, 81300261, 81300677]; Key Research Program of the Chinese Academy of Sciences [KJZD-EW-TZ-L05]; Beijing Natural Science Foundation [7141005, 5142016]; Thousand Young Talents program of China; National Laboratory of Biomacromolecules [2013kf05, 2013kf1, 2014kf02]; State Key Laboratory of Drug Research [SIMM1302KF-17]; California Institute for Regenerative Medicine training fellowship; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Glenn Foundation; CIRM; NIH [5U01HL107442]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107442] Funding Source: NIH RePORTER	National Basic Research Program (973 program)(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC)); Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Thousand Young Talents program of China(Chinese Academy of Sciences); National Laboratory of Biomacromolecules; State Key Laboratory of Drug Research; California Institute for Regenerative Medicine training fellowship; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Glenn Foundation; CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank K. Mitani, P. Ng, and A. Lieber for HDAdV production; L. de Onate for technical help; and M. Schwarz, P. Schwarz, and R. Chen for administrative help. G.H.L., J.Q., and X.X. were supported by National Basic Research Program (973 program: 2014CB910500, 2014CB964600), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01020312), NSFC (81271266, 31222039, 81330008, 81371342, 31201111, 81300261, and 81300677), Key Research Program of the Chinese Academy of Sciences (KJZD-EW-TZ-L05), Beijing Natural Science Foundation (7141005 and 5142016), the Thousand Young Talents program of China, National Laboratory of Biomacromolecules (2013kf05, 2013kf1, and 2014kf02), and State Key Laboratory of Drug Research (SIMM1302KF-17). K. S. and M. L. were supported by a California Institute for Regenerative Medicine training fellowship. Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust (#2012-PG-MED002), The Glenn Foundation, CIRM, and NIH (5U01HL107442).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Corti S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004108; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Fong H, 2013, STEM CELL REP, V1, P226, DOI 10.1016/j.stemcr.2013.08.001; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Goldstein DB, 2013, NAT REV GENET, V14, P460, DOI 10.1038/nrg3455; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holbeck SL, 1997, GENETICS, V147, P1017; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Li M, 2014, J BIOL CHEM, V289, P4594, DOI 10.1074/jbc.R113.488247; Li M, 2011, CELL RES, V21, P1740, DOI 10.1038/cr.2011.186; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Rattray AJ, 2002, GENETICS, V162, P1063; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; STRATHERN JN, 1995, GENETICS, V140, P965; Sugiura M, 2014, STEM CELL REP, V2, P52, DOI 10.1016/j.stemcr.2013.11.006; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	35	118	128	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					31	36		10.1016/j.stem.2014.06.016	http://dx.doi.org/10.1016/j.stem.2014.06.016			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24996168	Bronze, Green Accepted			2022-12-28	WOS:000340878600009
J	Benitah, SA; Bracken, A; Dou, YL; Huangfu, DW; Ivanova, N; Koseki, H; Laurent, L; Lim, DA; Meshorer, E; Pombo, A; Sander, M; Xu, GL				Aznar Benitah, Salvador; Bracken, Adrian; Dou, Yali; Huangfu, Danwei; Ivanova, Natalia; Koseki, Haruhiko; Laurent, Louise; Lim, Daniel A.; Meshorer, Eran; Pombo, Ana; Sander, Maike; Xu, Guo-Liang			Stem Cell Epigenetics: Looking Forward	CELL STEM CELL			English	Editorial Material									[Aznar Benitah, Salvador] Inst Res Biomed, Barcelona, Spain; [Bracken, Adrian] Trinity Coll Dublin, Dublin, Ireland; [Dou, Yali] Univ Michigan, Ann Arbor, MI 48109 USA; [Huangfu, Danwei] Sloan Kettering Inst, New York, NY USA; [Ivanova, Natalia] Yale Univ, New Haven, CT 06520 USA; [Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Laurent, Louise; Sander, Maike] Univ Calif San Diego, San Diego, CA 92103 USA; [Lim, Daniel A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Meshorer, Eran] Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel; [Pombo, Ana] Berlin Inst Med Syst Biol, Berlin, Germany; [Xu, Guo-Liang] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Beijing 100864, Peoples R China	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Trinity College Dublin; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Yale University; RIKEN; University of California System; University of California San Diego; University of California System; University of California San Francisco; Hebrew University of Jerusalem; Chinese Academy of Sciences	Benitah, SA (corresponding author), Inst Res Biomed, Barcelona, Spain.		Sander, Maike/N-6615-2016; Aznar-Benitah, Salvador/F-4761-2016; Koseki, Haruhiko/I-3825-2014; Pombo, Ana/A-1045-2010	Sander, Maike/0000-0001-5308-7785; Aznar-Benitah, Salvador/0000-0002-9059-5049; Koseki, Haruhiko/0000-0001-8424-5854; Bracken, Adrian/0000-0002-1547-9443; Huangfu, Danwei/0000-0002-1145-6199; Pombo, Ana/0000-0002-7493-6288	Medical Research Council [MC_U120061476] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082856] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	0	0	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					706	709						4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	25032261				2022-12-28	WOS:000341248500008
J	Medyouf, H; Mossner, M; Jann, JC; Nolte, F; Raffel, S; Herrmann, C; Lier, A; Eisen, C; Nowak, V; Zens, B; Mudder, K; Klein, C; Oblander, J; Fey, S; Vogler, J; Fabarius, A; Riedl, E; Roehl, H; Kohlmann, A; Staller, M; Haferlach, C; Muller, N; John, T; Platzbecker, U; Metzgeroth, G; Hofmann, WK; Trumpp, A; Nowak, D				Medyouf, Hind; Mossner, Maximilian; Jann, Johann-Christoph; Nolte, Florian; Raffel, Simon; Herrmann, Carl; Lier, Amelie; Eisen, Christian; Nowak, Verena; Zens, Bettina; Muedder, Katja; Klein, Corinna; Oblaender, Julia; Fey, Stephanie; Vogler, Jovita; Fabarius, Alice; Riedl, Eva; Roehl, Henning; Kohlmann, Alexander; Staller, Marita; Haferlach, Claudia; Mueller, Nadine; John, Thilo; Platzbecker, Uwe; Metzgeroth, Georgia; Hofmann, Wolf-Karsten; Trumpp, Andreas; Nowak, Daniel			Myelodysplastic Cells in Patients Reprogram Mesenchymal Stromal Cells to Establish a Transplantable Stem Cell Niche Disease Unit	CELL STEM CELL			English	Article							MUTATIONS; DELETION; MICE; MICROENVIRONMENT; INVOLVEMENT; ENGRAFTMENT; ROBUSTNESS; DEFECTS; MODEL; TET2	Myelodysplastic syndromes (MDSs) are a heterogeneous group of myeloid neoplasms with defects in hematopoietic stem and progenitor cells (HSPCs) and possibly the HSPC niche. Here, we show that patient-derived mesenchymal stromal cells (MDS MSCs) display a disturbed differentiation program and are essential for the propagation of MDS-initiating Li(-)CD34(+)CD38(-) stem cells in orthotopic xenografts. Overproduction of niche factors such as CDH2 (N-Cadherin), IGFBP2, VEGFA, and LIF is associated with the ability of MDS MSCs to enhance MDS expansion. These factors represent putative therapeutic targets in order to disrupt critical hematopoietic- stromal interactions in MDS. Finally, healthy MSCs adopt MDS MSC-like molecular features when exposed to hematopoietic MDS cells, indicative of an instructive remodeling of the microenvironment. Therefore, this patient-derived xenograft model provides functional and molecular evidence that MDS is a complex disease that involves both the hematopoietic and stromal compartments. The resulting deregulated expression of niche factors may well also be a feature of other hematopoietic malignancies.	[Medyouf, Hind; Zens, Bettina; Muedder, Katja; Klein, Corinna; Trumpp, Andreas] Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Mossner, Maximilian; Jann, Johann-Christoph; Nolte, Florian; Nowak, Verena; Oblaender, Julia; Fey, Stephanie; Vogler, Jovita; Fabarius, Alice; Mueller, Nadine; Metzgeroth, Georgia; Hofmann, Wolf-Karsten; Nowak, Daniel] Heidelberg Univ, Med Fac Mannheim, Univ Hosp Mannheim, Dept Hematol & Oncol, D-68167 Mannheim, Germany; [Raffel, Simon; Lier, Amelie; Eisen, Christian; Zens, Bettina; Muedder, Katja; Klein, Corinna; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany; [Herrmann, Carl] Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany; [Herrmann, Carl] DKFZ, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Riedl, Eva] Univ Hosp Mannheim, Dept Pathol, D-68167 Mannheim, Germany; [Roehl, Henning] Univ Hosp Mannheim, Dept Orthoped, D-68167 Mannheim, Germany; [Kohlmann, Alexander; Staller, Marita; Haferlach, Claudia] MLL, D-81377 Munich, Germany; [John, Thilo] DRK Hosp Westend, Dept Traumatol, D-14050 Berlin, Germany; [Platzbecker, Uwe] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Med Clin & Policlin 1, D-01307 Dresden, Germany; [Medyouf, Hind; Trumpp, Andreas] German Canc Consortium, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; MLL Munich Leukemia Laboratory; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ)	Medyouf, H (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	hind.medyouf@uniklinikum-dresden.de; a.trumpp@dkfz-heidelberg.de	Mossner, Maximilian/D-2292-2018; Herrmann, Carl/AAR-3167-2020; Herrmann, Carl/H-5859-2011; Trumpp, Andreas/Z-2141-2019	Mossner, Maximilian/0000-0001-9751-3803; Herrmann, Carl/0000-0003-4989-4722; Trumpp, Andreas/0000-0002-6212-3466; Raffel, Simon/0000-0003-4671-1097; Medyouf, Hind/0000-0003-4652-9455; Nowak, Daniel/0000-0001-7130-7921	BioRN Spitzencluster Molecular and Cell-Based Medicine; German Bundesministerium fur Bildung und Forschung (BMBF); Deutsche Forschungsgemeinschaft (DFG) [SFB 873]; Dietmar Hopp Foundation; National Center for Tumor Diseases; Human Frontier Science Program (HFSP); EMBO	BioRN Spitzencluster Molecular and Cell-Based Medicine; German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Dietmar Hopp Foundation; National Center for Tumor Diseases(Deutsche KrebshilfeHelmholtz Association); Human Frontier Science Program (HFSP)(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO))	We thank Dr. Michael Milsom, Dr. Aine Prendergast, and David Wikstrom for critical comments on the manuscript. We thank Melanie Neubauer and Andrea Takacs for animal husbandry; Steffen Schmitt, Ann Atzberger, and Jens Hartwig for assistance with FACS sorting (DKFZ, Heidelberg, Germany); and Verena Haselmann and Romy Eichner (Institute of Clinical Chemistry, Mannheim, Germany) for their pyrosequencing device. A. K., M. S., and C. H. are employees of the Munich Leukemia Laboratory (MLL). The amplicon deep-sequencing assays on GS FLX and GS Junior instruments have been supported by Roche Diagnostics as part of the IRON-II study (Roche Diagnostics, Penzberg, Germany). This work was supported by the BioRN Spitzencluster Molecular and Cell-Based Medicine supported by the German Bundesministerium fur Bildung und Forschung (BMBF), the SFB 873 funded by the Deutsche Forschungsgemeinschaft (DFG), the Dietmar Hopp Foundation (all A. T.), and a joint grant (IFP) of the National Center for Tumor Diseases (NCT; A. T. and D.N). H. M. was supported by a Human Frontier Science Program (HFSP) and EMBO long-term postdoctoral fellowships.	Abdel-Wahab O, 2013, J EXP MED, V210, P2641, DOI 10.1084/jem.20131141; Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Drake AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018382; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; ESCARY JL, 1993, NATURE, V363, P361, DOI 10.1038/363361a0; Flores-Figueroa E, 2005, LEUKEMIA RES, V29, P215, DOI 10.1016/j.leukres.2004.06.011; Garcia-Manero G, 2012, AM J HEMATOL, V87, P692, DOI 10.1002/ajh.23264; Grossmann V, 2013, J MOL DIAGN, V15, P473, DOI 10.1016/j.jmoldx.2013.03.003; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Huynh H, 2011, BLOOD, V118, P3236, DOI 10.1182/blood-2011-01-331876; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Kohlmann A, 2011, LEUKEMIA, V25, P1840, DOI 10.1038/leu.2011.155; LAWRENCE HJ, 1987, BLOOD, V70, P1003; Martin MG, 2010, LEUKEMIA, V24, P1662, DOI 10.1038/leu.2010.156; Matsuoka A, 2010, LEUKEMIA, V24, P748, DOI 10.1038/leu.2009.296; Miller PH, 2013, BLOOD, V121, pE1, DOI 10.1182/blood-2012-09-456566; Muguruma Y, 2011, HAEMATOL-HEMATOL J, V96, P543, DOI 10.3324/haematol.2010.027557; Muto T, 2013, J EXP MED, V210, P2627, DOI 10.1084/jem.20131144; Nilsson L, 2000, BLOOD, V96, P2012, DOI 10.1182/blood.V96.6.2012.h8002012a_2012_2021; Nowak D, 2012, GENE CHROMOSOME CANC, V51, P756, DOI 10.1002/gcc.21961; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Raaijmakers MHGP, 2012, INT J HEMATOL, V95, P17, DOI 10.1007/s12185-011-1001-x; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rehn M, 2011, BLOOD, V118, P1534, DOI 10.1182/blood-2011-01-332890; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Sloma I, 2010, LEUKEMIA, V24, P1823, DOI 10.1038/leu.2010.159; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Thanopoulou E, 2004, BLOOD, V103, P4285, DOI 10.1182/blood-2003-09-3192; Walenda T, 2011, EXP HEMATOL, V39, P617, DOI 10.1016/j.exphem.2011.02.011; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; WHITE NJ, 1994, BLOOD, V83, P2809, DOI 10.1182/blood.V83.10.2809.2809; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Zhang B, 2013, BLOOD, V121, P1824, DOI 10.1182/blood-2012-02-412890; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095	40	265	275	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					824	837		10.1016/j.stem.2014.02.014	http://dx.doi.org/10.1016/j.stem.2014.02.014			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24704494	Bronze			2022-12-28	WOS:000341248500018
J	Wahlestedt, M; Bryder, D				Wahlestedt, Martin; Bryder, David			Induced Hematopoietic Stem Cells: Unlocking Restrictions in Lineage Potential and Self-renewal	CELL STEM CELL			English	Editorial Material							BLOOD; FIBROBLASTS; PROGENITORS; INDUCTION		[Wahlestedt, Martin; Bryder, David] Lund Univ, Inst Expt Med Sci, Immunol Sect, S-22184 Lund, Sweden	Lund University	Bryder, D (corresponding author), Lund Univ, Inst Expt Med Sci, Immunol Sect, Solvegatan 17,BMC D14, S-22184 Lund, Sweden.	david.bryder@med.lu.se	Bryder, David/Q-6292-2019	Bryder, David/0000-0002-8761-4237				Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Olsen AL, 2006, BLOOD, V107, P1265, DOI 10.1182/blood-2005-09-3621; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Walasek MA, 2012, ANN NY ACAD SCI, V1266, P138, DOI 10.1111/j.1749-6632.2012.06549.x	7	1	1	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					555	556		10.1016/j.stem.2014.04.008	http://dx.doi.org/10.1016/j.stem.2014.04.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24792111	Bronze			2022-12-28	WOS:000335659900004
J	Hobbs, RM; Polo, JM				Hobbs, Robin M.; Polo, Jose M.			Reprogramming Can Be a Transforming Experience	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; IPS CELLS	Since the inception of nuclear reprogramming, the parallels between this process and tumorigenesis have become increasingly apparent. Recent studies by Abad et al. and Ohnishi et al. have now formalized this connection by demonstrating that the same transcription factors used for reprogramming to pluripotency drive tumor initiation in vivo.	[Hobbs, Robin M.; Polo, Jose M.] Monash Univ, Australian Regenerat Med Inst, Melbourne, Vic 3800, Australia; [Hobbs, Robin M.; Polo, Jose M.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3800, Australia	Australian Regenerative Medicine Institute; Monash University; Monash University	Polo, JM (corresponding author), Monash Univ, Australian Regenerat Med Inst, Melbourne, Vic 3800, Australia.	jose.polo@monash.edu	Hobbs, Robin/I-2577-2014	Hobbs, Robin/0000-0002-3853-2614; Polo, Jose M/0000-0002-2531-778X				Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	10	4	5	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					269	271		10.1016/j.stem.2014.02.003	http://dx.doi.org/10.1016/j.stem.2014.02.003			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24607400	Bronze			2022-12-28	WOS:000332533400003
J	Morey, R; Laurent, LC				Morey, Robert; Laurent, Louise C.			Getting Off the Ground State: X Chromosome Inactivation Knocks Down Barriers to Differentiation	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS	Female mouse embryonic stem cells (mESCs) contain two active X chromosomes, with one undergoing random inactivation upon differentiation. Schulz et al. (2014) now demonstrate that the presence of two active X chromosomes in mESCs prevents exit from pluripotency by blocking MAPK signaling, ensuring synchronization between X chromosome dosage compensation and development.	[Morey, Robert; Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Laurent, LC (corresponding author), Univ Calif San Diego, Dept Reprod Med, Sanford Consortium Regenerat Med, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.	llaurent@ucsd.edu		Laurent, Louise/0000-0002-2095-7534	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000906] Funding Source: NIH RePORTER; NCATS NIH HHS [UH2 TR000906] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Escamilla-Del-Arenal M, 2011, HUM GENET, V130, P307, DOI 10.1007/s00439-011-1029-2; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Lessing D, 2013, ANNU REV GENOM HUM G, V14, P85, DOI 10.1146/annurev-genom-091212-153530; MITTWOCH U, 1993, HUM REPROD, V8, P1550, DOI 10.1093/oxfordjournals.humrep.a137889; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Schulz EG, 2014, CELL STEM CELL, V14, P203, DOI 10.1016/j.stem.2013.11.022; TAKAGI N, 1990, DEVELOPMENT, V109, P189; Wutz A, 2012, CELL STEM CELL, V11, P9, DOI 10.1016/j.stem.2012.06.012	10	1	1	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					131	132		10.1016/j.stem.2014.01.012	http://dx.doi.org/10.1016/j.stem.2014.01.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24506876	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000330835800001
J	Morgan, BA				Morgan, Bruce A.			The "Skinny" on Wnt Signaling in Stem Cells	CELL STEM CELL			English	Editorial Material							EPIDERMIS; FOLLICLE		[Morgan, Bruce A.] Harvard Univ, Sch Med, Cutaneous Biol Res Ctr, Boston, MA 02129 USA; [Morgan, Bruce A.] Mass Gen Hosp, Boston, MA 02129 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Morgan, BA (corresponding author), Harvard Univ, Sch Med, Cutaneous Biol Res Ctr, Boston, MA 02129 USA.	bmorgan@mgh.harvard.edu						Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Fuchs E, 2001, DEV CELL, V1, P13, DOI 10.1016/S1534-5807(01)00022-3; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lim X., 2013, SCIENCE IN PRESS; Myung PS, 2013, J INVEST DERMATOL, V133, P31, DOI 10.1038/jid.2012.230; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; POTTEN CS, 1975, J INVEST DERMATOL, V65, P488, DOI 10.1111/1523-1747.ep12610194; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602	10	3	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					638	640		10.1016/j.stem.2013.11.012	http://dx.doi.org/10.1016/j.stem.2013.11.012			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24315435	Bronze			2022-12-28	WOS:000329571700003
J	Silberstein, LE; Lin, CP				Silberstein, Leslie E.; Lin, Charles P.			A New Image of the Hematopoietic Stem Cell Vascular Niche	CELL STEM CELL			English	Editorial Material							BONE-MARROW	The microenvironment within the bone marrow that maintains hematopoietic stem cell (HSC) quiescence is the subject of intense study. In a recent Nature paper, Kunisaki et al. combine imaging techniques and computational modeling to define a novel arteriolar niche for quiescent HSCs within the bone marrow.	[Silberstein, Leslie E.] Boston Childrens Hosp, Dept Lab Med, Div Transfus Med, Boston, MA 02115 USA; [Lin, Charles P.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Lin, Charles P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Lin, Charles P.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lin, CP (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	charles_lin@hms.harvard.edu			NHLBI NIH HHS [P01 HL095489] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095489] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kunisaki Y., 2013, NATURE IN PRESS; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010	9	20	20	2	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					514	516		10.1016/j.stem.2013.10.012	http://dx.doi.org/10.1016/j.stem.2013.10.012			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24209758	Green Accepted, Bronze			2022-12-28	WOS:000329571500005
J	Page, ME; Lombard, P; Ng, F; Gottgens, B; Jensen, KB				Page, Mahalia E.; Lombard, Patrick; Ng, Felicia; Goettgens, Berthold; Jensen, Kim B.			The Epidermis Comprises Autonomous Compartments Maintained by Distinct Stem Cell Populations	CELL STEM CELL			English	Article							HAIR FOLLICLE; PROGENITOR CELLS; SEBACEOUS GLAND; MOUSE EPIDERMIS; WOUND REPAIR; SKIN; LRIG1; HOMEOSTASIS; KERATINOCYTES; MAINTENANCE	The complex anatomy of the epidermis contains multiple adult stem cell populations, but the extent to which they functionally overlap during homeostasis, wound healing, and tumor initiation remains poorly defined. Here, we demonstrate that Lrig1(+ve) cells are highly proliferative epidermal stem cells. Longterm clonal analysis reveals that Lrig1(+ve) cells maintain the upper pilosebaceous unit, containing the infundibulum and sebaceous gland as independent compartments, but contribute to neither the hair follicle nor the interfollicular epidermis, which are maintained by distinct stem cell populations. In contrast, upon wounding, stem cell progeny from multiple compartments acquire lineage plasticity and make permanent contributions to regenerating tissue. We further show that oncogene activation in Lrig1(+ve) cells drives hyperplasia but requires auxiliary stimuli for tumor formation. In summary, our data demonstrate that epidermal stem cells are lineage restricted during homeostasis and suggest that compartmentalization may constitute a conserved mechanism underlying epithelial tissue maintenance.	[Page, Mahalia E.; Lombard, Patrick; Ng, Felicia; Goettgens, Berthold; Jensen, Kim B.] Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England; [Page, Mahalia E.; Jensen, Kim B.] Univ Cambridge, Dept Oncol, Cambridge CB2 0QQ, England; [Lombard, Patrick; Ng, Felicia; Goettgens, Berthold] Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Jensen, Kim B.] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark	University of Cambridge; University of Cambridge; University of Copenhagen	Jensen, KB (corresponding author), Wellcome Trust Med Res Council Cambridge Stem Cel, Tennis Court Rd, Cambridge CB2 1QR, England.	kim.jensen@bric.ku.dk	Jensen, Kim/F-5333-2014	Gottgens, Berthold/0000-0001-6302-5705; Jensen, Kim/0000-0001-6569-1664	UK Medical Research Council (MRC); Wellcome Trust; Lundbeck Foundation; Danish Medical Research Council; MRC; BBSRC [BB/I00050X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Lundbeck Foundation [R105-2011-9755] Funding Source: researchfish; Medical Research Council [MC_PC_12009, 979886] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	We thank Fiona Watt for assistance in generating the Lrig1 KI mouse model; Tyler Jacks and Guoqiang Gu for making their mouse models available; the Cambridge Stem Cell Institute core facilities and the Cambridge Genomics Services for technical assistance; Michaela Frye for excellent suggestions; and Austin Smith, Kristian Helin, and members of the Jensen laboratory for comments on the manuscript. We acknowledge Ferda Oeztuerk-Winder and Juan Jose Ventura for tissue from the Lgr6 mouse, and Clare Blackburn for the Plet1 antibody. This work was supported by the UK Medical Research Council (MRC), the Wellcome Trust, the Lundbeck Foundation, and the Danish Medical Research Council. K.J. is a Wellcome Trust Career Development fellow (WT088454MA). M. E. P. and F.N. are funded by an MRC PhD studentship and a Yousef Jameel Scholarship, respectively. M. E. P. and K.B.J. conceived and designed the study, performed experiments, analyzed the data, and wrote the manuscript. P. L., F.N., and B. G. performed the bioinformatics analysis of the microarray data. All authors commented on the manuscript. K.B.J. supervised the project.	Alcolea MP, 2013, NAT REV CANCER, V13, P161, DOI 10.1038/nrc3460; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Blanpain C, 2010, NATURE, V464, P686, DOI 10.1038/464686a; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Caulin C, 2007, J CLIN INVEST, V117, P1893, DOI 10.1172/JCI31721; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Cottle DL, 2013, CELL REP, V3, P427, DOI 10.1016/j.celrep.2013.01.013; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Frances D, 2012, DEV BIOL, V363, P138, DOI 10.1016/j.ydbio.2011.12.028; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jaks V, 2010, EXP CELL RES, V316, P1422, DOI 10.1016/j.yexcr.2010.03.014; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Lu L, 2013, J PATHOL, V229, P608, DOI 10.1002/path.4148; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Ousset M, 2012, NAT CELL BIOL, V14, P1130, DOI 10.1038/ncb2600; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Petersson M, 2011, EMBO J, V30, P3004, DOI 10.1038/emboj.2011.199; Plikus MV, 2012, SEMIN CELL DEV BIOL, V23, P946, DOI 10.1016/j.semcdb.2012.10.001; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Weyden LD, 2011, J PATHOL, V224, P22, DOI 10.1002/path.2853; Van Keymeulen A, 2012, J CELL BIOL, V197, P575, DOI 10.1083/jcb.201201041; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; White AC, 2011, P NATL ACAD SCI USA, V108, P7425, DOI 10.1073/pnas.1012670108; Wong SY, 2011, P NATL ACAD SCI USA, V108, P4093, DOI 10.1073/pnas.1013098108; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031	51	204	206	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					471	482		10.1016/j.stem.2013.07.010	http://dx.doi.org/10.1016/j.stem.2013.07.010			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	23954751	hybrid, Green Published			2022-12-28	WOS:000329571100015
J	Williams, DA				Williams, David A.			Broadening the Indications for Hematopoietic Stem Cell Genetic Therapies	CELL STEM CELL			English	Editorial Material							MOUSE	The use of recombinant retroviral vectors to effect corrective genetic therapies in hematopoietic stem cells (HSCs) has long been predicted to revolutionize medicine. Two recent papers in Science now show that this technology could be considered as effective as, and perhaps superior to, allogeneic HSC transplants in some rare diseases.	[Williams, David A.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Williams, David A.] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute	Williams, DA (corresponding author), Childrens Hosp, Div Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	dawilliams@childrens.harvard.edu						Aiuti A., 2013, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1233151; Aiuti A, 2007, J CLIN INVEST, V117, P2233, DOI 10.1172/JCI31666; Biffi A., 2013, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1233158; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Diez IA, 2011, MOL PHARMACEUT, V8, P1525, DOI 10.1021/mp200132u; JOYNER A, 1983, NATURE, V305, P556, DOI 10.1038/305556a0; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Seymour LW, 2012, NAT BIOTECHNOL, V30, P588, DOI 10.1038/nbt.2290; WILLIAMS DA, 1984, NATURE, V310, P476, DOI 10.1038/310476a0	9	11	17	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					263	264		10.1016/j.stem.2013.08.006	http://dx.doi.org/10.1016/j.stem.2013.08.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	24012366	Bronze			2022-12-28	WOS:000329570800004
J	Hendriks, WT; Warren, CR; Cowan, CA				Hendriks, William T.; Warren, Curtis R.; Cowan, Chad A.			Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions	CELL STEM CELL			English	Review							ZINC-FINGER NUCLEASES; RNA-GUIDED ENDONUCLEASES; TAL EFFECTOR NUCLEASES; OFF-TARGET SITES; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; GENE CORRECTION; DISEASE-MODELS; ENGINEERED NUCLEASES; ANALYSIS REVEALS	Human pluripotent stem cells (hPSCs) with knockout or mutant alleles can be generated using custom-engineered nucleases. Transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 nucleases are the most commonly employed technologies for editing hPSC genomes. In this Protocol Review, we provide a brief overview of custom-engineered nucleases in the context of gene editing in hPSCs with a focus on the application of TALENs and CRISPR/Cas9. We will highlight the advantages and disadvantages of each method and discuss theoretical and technical considerations for experimental design.	[Hendriks, William T.] Massachusetts Gen Hosp, Collaborat Ctr X Linked Dystonia Parkinsonism, Dept Neurol, Charlestown, MA 02129 USA; [Hendriks, William T.] Harvard Univ, Sch Med, Harvard Brain Sci Initiat, Boston, MA 02114 USA; [Warren, Curtis R.; Cowan, Chad A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts General Hospital	Cowan, CA (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Cowan, CA (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	chad_cowan@harvard.edu			MGH Collaborative Center for X-linked Dystonia-Parkinsonism; NIH [U01HL100408, U01HL107440, R01DK095384, R01DK097768]; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100408, U01HL107440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095384, R01DK097768] Funding Source: NIH RePORTER	MGH Collaborative Center for X-linked Dystonia-Parkinsonism; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank members of the Bragg, Joung, and C.A.C. labs for helpful discussions during the preparation of this protocol review. The authors also apologize for any references that were left out due to space constraints. Funding for this work was provided by the MGH Collaborative Center for X-linked Dystonia-Parkinsonism (W.T.H.); NIH grants U01HL100408, U01HL107440, R01DK095384, and R01DK097768; and the Harvard Stem Cell Institute (C.A.C.).	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Byrne SM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1246; Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; Chen WJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05404; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Ellis BL, 2013, GENE THER, V20, P35, DOI 10.1038/gt.2011.211; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Frank S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-773; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Heigwer F, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt789; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hendel A, 2015, TRENDS BIOTECHNOL, V33, P132, DOI 10.1016/j.tibtech.2014.12.001; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Hendriks W. T., 2015, CURR PROTOC STEM CEL, V34; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holkers M, 2012, NUCLEIC ACIDS RES, V40, P1984, DOI 10.1093/nar/gkr976; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jankele R, 2014, BRIEF FUNCT GENOMICS, V13, P409, DOI 10.1093/bfgp/elu013; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Karagiannis P, 2014, NAT METHODS, V11, P1006, DOI 10.1038/nmeth.3109; Khan IF, 2010, MOL THER, V18, P1192, DOI 10.1038/mt.2010.55; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Lamb BM, 2013, NUCLEIC ACIDS RES, V41, P9779, DOI 10.1093/nar/gkt754; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu JC, 2014, TRENDS CELL BIOL, V24, P268, DOI 10.1016/j.tcb.2014.03.002; Ma Y., 2012, CURR PROTOC STEM CEL; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Merkle FT, 2015, CELL REP, V11, P875, DOI 10.1016/j.celrep.2015.04.007; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Miller JC, 2015, NAT METHODS, V12, P465, DOI 10.1038/nmeth.3330; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Peters D.T., 2008, STEMBOOK; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ru Renli, 2013, Cell Regen, V2, P5, DOI 10.1186/2045-9769-2-5; Sakurai T, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-69; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wefers B, 2013, NAT PROTOC, V8, P2355, DOI 10.1038/nprot.2013.142; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405; Zhu FF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1290; Zhu HB, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt721; Zou J, 2014, CURR PROTOC STEM CEL, V29; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	121	70	73	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					53	65		10.1016/j.stem.2015.12.002	http://dx.doi.org/10.1016/j.stem.2015.12.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26748756	Green Accepted, Bronze			2022-12-28	WOS:000372321300011
J	Faiz, M; Sachewsky, N; Gascon, S; Bang, KWA; Morshead, CM; Nagy, A				Faiz, Maryam; Sachewsky, Nadia; Gascon, Sergio; Bang, K. W. Annie; Morshead, Cindi M.; Nagy, Andras			Adult Neural Stem Cells from the Subventricular Zone Give Rise to Reactive Astrocytes in the Cortex after Stroke	CELL STEM CELL			English	Article							IN-VIVO; FUNCTIONAL-NEURONS; CEREBRAL-CORTEX; DIRECT CONVERSION; TRANSGENIC MICE; MAMMALIAN BRAIN; INJURED BRAIN; SPINAL-CORD; FOREBRAIN; DISEASE	Reactive astrocytes (RAs) have been reported to convert to multipotent neural stem cells (NSCs) capable of neurosphere (NS) formation and multiline-age differentiation in vitro. Using genetic tagging, we determined that subventricular zone (SVZ) NSCs give rise to NSs derived from the stroke-injured cortex. We demonstrate that these cells can be isolated from the cortex in two different models of stroke and from different stroke-lesioned cortical regions. Interestingly, SVZ NSCs give rise to a subpopulation of RAs in the cortex that contribute to astrogliosis and scar formation. Last, we show that these SVZ derived RAs can be converted to neurons in vivo by forced expression of Ascl1. Identifying the contribution of cells originating from the SVZ to injury repair has implications for neural regeneration strategies.	[Faiz, Maryam; Bang, K. W. Annie; Nagy, Andras] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5T 3H7, Canada; [Sachewsky, Nadia; Morshead, Cindi M.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Gascon, Sergio] Univ Munich, Inst Physiol, Dept Physiol Genom, D-80336 Munich, Germany; [Gascon, Sergio] Helmholtz Ctr Munich, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Sachewsky, Nadia; Morshead, Cindi M.] Univ Toronto, Dept Surg, Toronto, ON M5T 1P5, Canada; [Nagy, Andras] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON M5G 1E2, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Toronto; University of Toronto	Morshead, CM (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada.	cindi.morshead@utoronto.ca; nagy@lunenfeld.ca	Nagy, Andras/G-6465-2013	Nagy, Andras/0000-0003-4311-0413; Faiz, Maryam/0000-0003-0671-3557; Gascon, Sergio/0000-0001-8756-7082	Canadian Institute of Health Research (CIHR) [224002]; Ontario Research Fund Global Leadership Round in Genomics and Life Sciences (GL2) Stem Cell Network [9/5254 (TR3)]; CIHR [MOP 1025, MOP 126198]; Canadian Heart and Stroke Foundation	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund Global Leadership Round in Genomics and Life Sciences (GL2) Stem Cell Network; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	The authors are grateful to M. Puri for critical reading of the manuscript and M. Gotz for both critical reading of the manuscript and plasmids CAG-Ascl1-IRES-Dsred and CAG-Dsred. ImageStream analysis was done at the Lunenfeld-Tanenbaum Research Institute Flow Cytometry Core Facility. M.F. was supported by the Canadian Institute of Health Research (CIHR) postdoctoral fellowship 224002. This work was supported by grants to A.N. from the Ontario Research Fund Global Leadership Round in Genomics and Life Sciences (GL2) Stem Cell Network (9/5254 (TR3)) and CIHR (MOP 1025) and operating grants to C.M.M from CIHR (MOP 126198) and the Canadian Heart and Stroke Foundation.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Casper KB, 2007, GENESIS, V45, P292, DOI 10.1002/dvg.20287; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; CLARKE SR, 1994, NEUROREPORT, V5, P1885, DOI 10.1097/00001756-199410000-00011; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Corti S, 2012, EXP CELL RES, V318, P1528, DOI 10.1016/j.yexcr.2012.02.040; Dibajnia P, 2013, ACTA PHARMACOL SIN, V34, P78, DOI 10.1038/aps.2012.107; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Erlandsson A, 2011, EXP NEUROL, V230, P48, DOI 10.1016/j.expneurol.2010.05.018; Fuentealba LC, 2015, CELL, V161, P1644, DOI 10.1016/j.cell.2015.05.041; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Heinrich C, 2014, STEM CELL REP, V3, P1000, DOI 10.1016/j.stemcr.2014.10.007; Heinrich C, 2011, NAT PROTOC, V6, P214, DOI 10.1038/nprot.2010.188; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Hua R, 2006, BRAIN RES, V1090, P172, DOI 10.1016/j.brainres.2006.03.072; Huttner HB, 2014, NAT NEUROSCI, V17, P801, DOI 10.1038/nn.3706; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Imura T, 2003, J NEUROSCI, V23, P2824; Kim HJ, 2009, STEM CELLS, V27, P390, DOI 10.1634/stemcells.2007-1047; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Leong SY, 2011, NEUROCHEM INT, V59, P382, DOI 10.1016/j.neuint.2010.12.024; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magnusson JP, 2014, SCIENCE, V346, P237, DOI 10.1126/science.346.6206.237; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Morshead CM, 2003, EUR J NEUROSCI, V18, P76, DOI 10.1046/j.1460-9568.2003.02727.x; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nato G, 2015, DEVELOPMENT, V142, P840, DOI 10.1242/dev.116657; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Petit A, 2001, J NEUROSCI, V21, P7182, DOI 10.1523/JNEUROSCI.21-18-07182.2001; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; Pollak J, 2013, DEVELOPMENT, V140, P2619, DOI 10.1242/dev.091355; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Seidenfaden R, 2006, MOL CELL NEUROSCI, V32, P187, DOI 10.1016/j.mcn.2006.04.003; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Su ZD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4338; Sun MY, 2014, J COMP NEUROL, V522, P1191, DOI 10.1002/cne.23497; Synowitz Michael, 2006, Clin Neurosurg, V53, P336; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tzeng SF, 1999, NEUROREPORT, V10, P2287, DOI 10.1097/00001756-199908020-00012; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu LJ, 2001, EXP NEUROL, V169, P416, DOI 10.1006/exnr.2001.7678; Yang YJ, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-22; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	61	151	161	2	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2015	17	5					624	634		10.1016/j.stem.2015.08.002	http://dx.doi.org/10.1016/j.stem.2015.08.002			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4UB	26456685	Green Submitted, Bronze			2022-12-28	WOS:000365694700014
J	Hamilton, LK; Dufresne, M; Joppe, SE; Petryszyn, S; Aumont, A; Calon, F; Barnabe-Heider, F; Furtos, A; Parent, M; Chaurand, P; Fernandes, KJL				Hamilton, Laura K.; Dufresne, Martin; Joppe, Sandra E.; Petryszyn, Sarah; Aumont, Anne; Calon, Frederic; Barnabe-Heider, Fanie; Furtos, Alexandra; Parent, Martin; Chaurand, Pierre; Fernandes, Karl J. L.			Aberrant Lipid Metabolism in the Forebrain Niche Suppresses Adult Neural Stem Cell Proliferation in an Animal Model of Alzheimer's Disease	CELL STEM CELL			English	Article							PRESENILIN-1 MUTATION CARRIERS; HIPPOCAMPAL NEUROGENESIS; AMYLOID DEPOSITION; APOLIPOPROTEIN-E; TRANSGENIC MICE; FATTY-ACIDS; IMPAIRED NEUROGENESIS; PERIVENTRICULAR ZONE; TANGLE FORMATION; MAMMALIAN BRAIN	Lipid metabolism is fundamental for brain development and function, but its roles in normal and pathological neural stem cell (NSC) regulation remain largely unexplored. Here, we uncover a fatty acid-mediated mechanism suppressing endogenous NSC activity in Alzheimer's disease (AD). We found that postmortem AD brains and triple-transgenic Alzheimer's disease (3xTg-AD) mice accumulate neutral lipids within ependymal cells, the main support cell of the forebrain NSC niche. Mass spectrometry and microarray analyses identified these lipids as oleic acid-enriched triglycerides that originate from niche-derived rather than peripheral lipid metabolism defects. In wild-type mice, locally increasing oleic acid was sufficient to recapitulate the AD-associated ependymal triglyceride phenotype and inhibit NSC proliferation. Moreover, inhibiting the rate-limiting enzyme of oleic acid synthesis rescued proliferative defects in both adult neurogenic niches of 3xTg-AD mice. These studies support a pathogenic mechanism whereby AD-induced perturbation of niche fatty acid metabolism suppresses the homeostatic and regenerative functions of NSCs.	[Hamilton, Laura K.; Joppe, Sandra E.; Aumont, Anne; Fernandes, Karl J. L.] Univ Montreal Hosp CRCHUM, Res Ctr, Montreal, PQ H2X 0A9, Canada; [Hamilton, Laura K.; Joppe, Sandra E.; Aumont, Anne; Fernandes, Karl J. L.] CNS Res Grp GRSNC, Montreal, PQ H3T 1J4, Canada; [Hamilton, Laura K.; Joppe, Sandra E.; Aumont, Anne; Fernandes, Karl J. L.] Univ Montreal, Dept Neurosci, Fac Med, Montreal, PQ H3T 1J4, Canada; [Dufresne, Martin; Furtos, Alexandra; Chaurand, Pierre] Univ Montreal, Fac Arts & Sci, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Petryszyn, Sarah; Parent, Martin] Univ Laval, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ G1J 2G3, Canada; [Calon, Frederic] Univ Laval, Fac Pharm, Quebec City, PQ G1V 0A6, Canada; [Calon, Frederic] CHU Q Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Barnabe-Heider, Fanie] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden	Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University; Laval University; Karolinska Institutet	Fernandes, KJL (corresponding author), Univ Montreal Hosp CRCHUM, Res Ctr, Montreal, PQ H2X 0A9, Canada.	karl.jl.fernandes@umontreal.ca	Calon, Frederic/AAF-4390-2020	Joppe, Sandra/0000-0002-0435-3706; Petryszyn, Sarah/0000-0001-8880-5097; Calon, Frederic/0000-0002-4203-0887	Alzheimer Society of Canada; Fonds de recherche de Quebec en Sante (FRQS); Canadian Institutes of Health Research (CIHR)	Alzheimer Society of Canada; Fonds de recherche de Quebec en Sante (FRQS); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank Dr. S. Lacroix and N. Fortin for CSF and plasma extractions; Bruker Daltonics for access to the FT-ICR; K. Kellersberger for assistance with all FT-ICR-related data acquisition; the Genomics platform at The Institute for Research on Immunology and Cancer (IRIC) for microarray and bio-informatics analyses; and D. Gauchat at the CRCHUM cytometry core facility for assistance with flow cytometry. L.K.H. is funded by studentships from the Alzheimer Society of Canada and the Fonds de recherche de Quebec en Sante (FRQS). K.J.L.F. holds a Canada Research Chair in neural stem cell biology. This work has been supported by the Canadian Institutes of Health Research (CIHR).	Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; Astarita G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024777; Barnabe-Heider F, 2008, NAT METHODS, V5, P189, DOI 10.1038/NMETH.1174; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Bergmann O., 2015, COLD SPRING HARB PER, V7, P1; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bouab M, 2011, NEUROSCIENCE, V173, P135, DOI 10.1016/j.neuroscience.2010.11.032; Cash DM, 2013, NEUROLOGY, V81, P1425, DOI 10.1212/WNL.0b013e3182a841c6; Cho H, 2013, NEUROBIOL AGING, V34, P1740, DOI 10.1016/j.neurobiolaging.2013.01.001; Chorna NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077845; Chuang TT, 2010, BBA-MOL BASIS DIS, V1802, P872, DOI 10.1016/j.bbadis.2009.12.008; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Cunnane SC, 2012, J ALZHEIMERS DIS, V29, P691, DOI 10.3233/JAD-2012-110629; de Chevigny A, 2008, STEM CELLS, V26, P2349, DOI 10.1634/stemcells.2008-0080; de Jong LW, 2008, BRAIN, V131, P3277, DOI 10.1093/brain/awn278; de Jong LW, 2011, J ALZHEIMERS DIS, V23, P49, DOI 10.3233/JAD-2010-101026; de la Monte SM, 2014, BIOCHEM PHARMACOL, V88, P548, DOI 10.1016/j.bcp.2013.12.012; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1997, J NEUROSCI, V17, P5046; Erlandsson A, 2011, EXP NEUROL, V230, P48, DOI 10.1016/j.expneurol.2010.05.018; Ernst A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002045; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Etschmaier K, 2011, J NEUROCHEM, V119, P1016, DOI 10.1111/j.1471-4159.2011.07498.x; Fraser T, 2010, NEUROCHEM RES, V35, P503, DOI 10.1007/s11064-009-0087-5; Guschina I, 2011, LIPIDS, V46, P121, DOI 10.1007/s11745-010-3486-0; Hamilton LK, 2013, EUR J NEUROSCI, V37, P1978, DOI 10.1111/ejn.12207; Hamilton LK, 2010, EUR J NEUROSCI, V32, P905, DOI 10.1111/j.1460-9568.2010.07379.x; Hussain G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00144; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Klunk WE, 2007, J NEUROSCI, V27, P6174, DOI 10.1523/JNEUROSCI.0730-07.2007; Knight WD, 2011, BRAIN, V134, P293, DOI 10.1093/brain/awq310; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Lee GJ, 2013, J NEUROL NEUROSUR PS, V84, P154, DOI 10.1136/jnnp-2011-302087; Lee SM, 2014, MOL MED REP, V10, P292, DOI 10.3892/mmr.2014.2155; Levi O, 2007, J NEUROCHEM, V100, P202, DOI 10.1111/j.1471-4159.2006.04189.x; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Matsumata M, 2012, STEM CELLS, V30, P1532, DOI 10.1002/stem.1124; Merlo S, 2010, TRENDS ENDOCRIN MET, V21, P537, DOI 10.1016/j.tem.2010.05.005; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Nho K, 2015, ANN NEUROL, V77, P547, DOI 10.1002/ana.24349; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Pasinetti GM, 2008, J NEUROCHEM, V106, P1503, DOI 10.1111/j.1471-4159.2008.05454.x; Perry EK, 2012, NEUROBIOL DIS, V47, P155, DOI 10.1016/j.nbd.2012.03.033; Pievani M, 2013, NEUROBIOL AGING, V34, P1728, DOI 10.1016/j.neurobiolaging.2013.01.016; Podtelezhnikov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029610; Polo-Hernandez E, 2014, BRAIN RES, V1570, P13, DOI 10.1016/j.brainres.2014.04.038; Polo-Hernandez E, 2010, J NEUROCHEM, V114, P1756, DOI 10.1111/j.1471-4159.2010.06891.x; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ryan NS, 2013, BRAIN, V136, P1399, DOI 10.1093/brain/awt065; Sakamoto M, 2014, J NEUROSCI, V34, P5788, DOI 10.1523/JNEUROSCI.0674-14.2014; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Shibata E, 2013, CELL PHYSIOL BIOCHEM, V32, P871, DOI 10.1159/000354489; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Stoll EA, 2015, STEM CELLS, V33, P2306, DOI 10.1002/stem.2042; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Talwar P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-199; Tanzi R.E, 2012, COLD SPRING HARB PER, V2, P10, DOI DOI 10.1101/CSHPERSPECT.A006296; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Yang CP, 2011, DEVELOPMENT, V138, P4351, DOI 10.1242/dev.065540; Yun MR, 2006, PHARMACOL RES, V54, P97, DOI 10.1016/j.phrs.2006.03.001; Ziabreva I, 2006, J PSYCHOSOM RES, V61, P311, DOI 10.1016/j.jpsychores.2006.07.017	74	133	138	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 1	2015	17	4					397	411		10.1016/j.stem.2015.08.001	http://dx.doi.org/10.1016/j.stem.2015.08.001			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4TS	26321199	Bronze			2022-12-28	WOS:000365693800007
J	Morey, L; Santanach, A; Blanco, E; Aloia, L; Nora, EP; Bruneau, BG; Di Croce, L				Morey, Lluis; Santanach, Alexandra; Blanco, Enrique; Aloia, Luigi; Nora, Elphege P.; Bruneau, Benoit G.; Di Croce, Luciano			Polycomb Regulates Mesoderm Cell Fate-Specification in Embryonic Stem Cells through Activation and Repression Mechanisms	CELL STEM CELL			English	Article							GENE-EXPRESSION; GROUP PROTEIN; H2A UBIQUITYLATION; PCGF HOMOLOGS; SELF-RENEWAL; CPG ISLANDS; COMPLEX; DIFFERENTIATION; MOUSE; BMI1	Polycomb complexes (PRC1 and PRC2) are essential regulators of epigenetic gene silencing in embryonic and adult stem cells. Emerging evidence suggests that the core subunit composition regulates distinct biological processes, yet little is known about the mechanistic underpinnings of how differently composed Polycomb complexes instruct and maintain cell fate. Here we find that Mel18, also known as Pcgf2 and one of six Pcgf paralogs, uniquely regulates PRC1 to specify mesoderm cell fate in embryonic stem cells. Mechanistically, Mel18 functions as a classical Polycomb protein during early cardiac mesoderm differentiation by repressing pluripotency, lineage specification, late cardiac differentiation, and negative regulators of the BMP pathway. However, Mel18 also positively regulates expression of key mesoderm transcription factors, revealing an unexpected function of Mel18 in gene activation during cardiac differentiation. Taken together, our findings reveal that Mel18 is required to specify PRC1 function in both a context- and stage-specific manner.	[Morey, Lluis; Santanach, Alexandra; Blanco, Enrique; Aloia, Luigi; Di Croce, Luciano] Ctr Genom Regulat CRG, Barcelona 08003, Spain; [Morey, Lluis; Santanach, Alexandra; Blanco, Enrique; Aloia, Luigi; Di Croce, Luciano] Univ Pompeu Fabra, Barcelona 08003, Spain; [Nora, Elphege P.; Bruneau, Benoit G.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Nora, Elphege P.; Bruneau, Benoit G.] Roddenberry Ctr Stem Cell Biol & Med Gladstone, San Francisco, CA 94158 USA; [Nora, Elphege P.; Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Pediat, San Francisco, CA 94158 USA; [Di Croce, Luciano] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Morey, Lluis] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; ICREA; University of Miami	Morey, L (corresponding author), Ctr Genom Regulat CRG, Doctor Aiguader 88, Barcelona 08003, Spain.	lmorey@med.miami.edu; luciano.dicroce@crg.eu	Blanco, Enrique/I-5902-2015; Nora, Elphège/AAW-9646-2021; Santanach Buxaderas, Alexandra/K-7462-2015; Di Croce, Luciano/E-7759-2015	Blanco, Enrique/0000-0001-6261-7370; Nora, Elphège/0000-0002-8347-4396; Santanach Buxaderas, Alexandra/0000-0002-1577-8910; Morey, Lluis/0000-0001-9851-4066; Aloia, Luigi/0000-0003-4509-2730; Di Croce, Luciano/0000-0003-3488-6228	Spanish "Ministerio de Educacion y Ciencia'' [SAF2013-48926-P]; Fundacio "La Marato de TV3''; European Commission's 7th Framework Program 4DCellFate [277899]; AGAUR; ICREA Funding Source: Custom	Spanish "Ministerio de Educacion y Ciencia''(Spanish Government); Fundacio "La Marato de TV3''; European Commission's 7th Framework Program 4DCellFate; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ICREA(ICREA)	We are indebted to V.A. Raker for help in preparing the manuscript, members of the Di Croce laboratory for discussions, the CRG Genomic Unit, the CRG Advanced Light Microscopy Unit, and the CRG Proteomics Unit. We also thank John Wylie and Dr. April Craft for help with the cardiomyocyte and cartilage differentiation protocols, respectively. This work was supported by grants from the Spanish "Ministerio de Educacion y Ciencia'' (SAF2013-48926-P), from AGAUR, from Fundacio "La Marato de TV3,'' and from the European Commission's 7th Framework Program 4DCellFate (277899).	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Aloia L, 2014, GENE DEV, V28, P182, DOI 10.1101/gad.228510.113; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Bruneau B. G., 2013, EMBO J, V5; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Craft AM, 2013, DEVELOPMENT, V140, P2597, DOI 10.1242/dev.087890; Creppe C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004851; David R, 2011, CARDIOVASC RES, V92, P115, DOI 10.1093/cvr/cvr158; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Frangini A, 2013, MOL CELL, V51, P647, DOI 10.1016/j.molcel.2013.08.022; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Junco SE, 2013, STRUCTURE, V21, P665, DOI 10.1016/j.str.2013.02.013; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Larrain J, 2000, DEVELOPMENT, V127, P821; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Luis NM, 2012, CELL STEM CELL, V11, P16, DOI 10.1016/j.stem.2012.06.005; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Ramel MC, 2012, FEBS LETT, V586, P1929, DOI 10.1016/j.febslet.2012.02.035; Ross K, 2012, BLOOD, V119, P4152, DOI 10.1182/blood-2011-09-382390; Saga Y, 1999, DEVELOPMENT, V126, P3437; Schaaf CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003560; Smith LL, 2011, CELL STEM CELL, V8, P649, DOI 10.1016/j.stem.2011.05.004; Suzuki M, 2002, DEVELOPMENT, V129, P4171; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Zdzieblo D, 2014, STEM CELLS, V32, P3112, DOI 10.1002/stem.1826; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005	44	95	101	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					300	315		10.1016/j.stem.2015.08.009	http://dx.doi.org/10.1016/j.stem.2015.08.009			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26340528	Green Accepted, Bronze			2022-12-28	WOS:000364011000009
J	Amoyel, M; Bach, EA				Amoyel, Marc; Bach, Erika A.			MT-Nanotubes: Lifelines for Stem Cells	CELL STEM CELL			English	Editorial Material							NICHE	Niche cells produce secreted factors that promote the self-renewal of stem cells in their immediate proximity, but how signaling is restricted to stem cells is not well understood. Inaba et al. ( 2015) report that microtubule (MT) structures called MT-nanotubes control activation of the primary self-renewal pathway in Drosophila testes.	[Amoyel, Marc; Bach, Erika A.] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, Dept Mol Pharmacol & Biochem, New York, NY 10016 USA	New York University	Bach, EA (corresponding author), NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, Dept Mol Pharmacol & Biochem, 550 First Ave,MSB 497B, New York, NY 10016 USA.	erika.bach@nyu.edu	Amoyel, Marc/GLR-0962-2022	Amoyel, Marc/0000-0002-2691-2097; Bach, Erika/0000-0002-5997-4489	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085075] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM085075] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Byrd DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088372; Inaba M., 2015, NATURE IN PRESS, pJuly 1; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Michel M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1426; Roy S, 2014, SCIENCE, V343, P852, DOI 10.1126/science.1244624; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Schmidt ED, 2004, CELL TISSUE RES, V318, P383, DOI 10.1007/s00441-004-0983-6; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Spradling A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002642	10	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					133	134		10.1016/j.stem.2015.07.004	http://dx.doi.org/10.1016/j.stem.2015.07.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26253198	Bronze			2022-12-28	WOS:000361878500004
J	Ding, JJ; Huang, X; Shao, NY; Zhou, HW; Lee, DF; Faiola, F; Fidalgo, M; Guallar, D; Saunders, A; Shliaha, PV; Wang, HL; Waghray, A; Papatsenko, D; Sanchez-Priego, C; Li, D; Yuan, Y; Lemischka, IR; Shen, L; Kelley, K; Deng, HT; Shen, XH; Wang, JL				Ding, Junjun; Huang, Xin; Shao, Ningyi; Zhou, Hongwei; Lee, Dung-Fang; Faiola, Francesco; Fidalgo, Miguel; Guallar, Diana; Saunders, Arven; Shliaha, Pavel V.; Wang, Hailong; Waghray, Avinash; Papatsenko, Dmitri; Sanchez-Priego, Carlos; Li, Dan; Yuan, Ye; Lemischka, Ihor R.; Shen, Li; Kelley, Kevin; Deng, Haiteng; Shen, Xiaohua; Wang, Jianlong			Tex10 Coordinates Epigenetic Control of Super-Enhancer Activity in Pluripotency and Reprogramming	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; CORE TRANSCRIPTIONAL NETWORK; PROTEIN-INTERACTION NETWORK; SELF-RENEWAL; GENE-EXPRESSION; SOMATIC-CELLS; CHROMATIN; DIFFERENTIATION; COMPLEX; NANOG	Super-enhancers (SEs) are large clusters of transcriptional enhancers that are co-occupied by multiple lineage-specific transcription factors driving expression of genes that define cell identity. In embryonic stem cells (ESCs), SEs are highly enriched for the core pluripotency factors Oct4, Sox2, and Nanog. In this study, we sought to dissect the molecular control mechanism of SE activity in pluripotency and reprogramming. Starting from a protein interaction network surrounding Sox2, we identified Tex10 as a key pluripotency factor that plays a functionally significant role in ESC self-renewal, early embryo development, and reprogramming. Tex10 is enriched at SEs in a Sox2-dependent manner and coordinates histone acetylation and DNA demethylation at SEs. Tex10 activity is also important for pluripotency and reprogramming in human cells. Our study therefore highlights Tex10 as a core component of the pluripotency network and sheds light on its role in epigenetic control of SE activity for cell fate determination.	[Ding, Junjun; Huang, Xin; Zhou, Hongwei; Lee, Dung-Fang; Faiola, Francesco; Fidalgo, Miguel; Guallar, Diana; Saunders, Arven; Waghray, Avinash; Papatsenko, Dmitri; Sanchez-Priego, Carlos; Li, Dan; Yuan, Ye; Lemischka, Ihor R.; Wang, Jianlong] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Saunders, Arven; Waghray, Avinash; Li, Dan; Yuan, Ye; Lemischka, Ihor R.; Wang, Jianlong] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Ding, Junjun; Huang, Xin; Zhou, Hongwei; Lee, Dung-Fang; Faiola, Francesco; Fidalgo, Miguel; Guallar, Diana; Saunders, Arven; Waghray, Avinash; Papatsenko, Dmitri; Sanchez-Priego, Carlos; Li, Dan; Yuan, Ye; Lemischka, Ihor R.; Kelley, Kevin; Wang, Jianlong] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Shao, Ningyi] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Shao, Ningyi] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Shliaha, Pavel V.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Wang, Hailong] Xiamen Univ, Organ Transplantat Inst, Xiamen 361102, Fujian Province, Peoples R China; [Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Deng, Haiteng; Shen, Xiaohua] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Cambridge; Xiamen University; Icahn School of Medicine at Mount Sinai; Tsinghua University	Wang, JL (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA.	jianlong.wang@mssm.edu	SHAO, Ning-Yi/N-4947-2015; Guallar, Diana/AAJ-1812-2020; Papatsenko, Dmitri/G-7375-2016; Wang, Jianlong/GQR-1191-2022; Fidalgo, Miguel/I-7006-2019; Ding, Junjun/C-4098-2012; Faiola, Francesco/Q-4218-2018; Ding, Junjun/F-8618-2015; Wang, Jianlong/AAG-9425-2020; Waghray, Avinash/AAD-5292-2021	SHAO, Ning-Yi/0000-0003-4231-828X; Guallar, Diana/0000-0001-5834-7507; Papatsenko, Dmitri/0000-0002-4390-5446; Wang, Jianlong/0000-0002-1317-6457; Fidalgo, Miguel/0000-0003-1134-2674; Faiola, Francesco/0000-0002-3512-8253; Waghray, Avinash/0000-0003-3242-2227; Deng, Haiteng/0000-0001-9496-1280; Ding, Junjun/0000-0002-9936-882X; Li, Dan/0000-0002-6332-1093; Shliaha, Pavel/0000-0003-3092-0724	NIH [1R01-GM095942]; Empire State Stem Cell Fund through New York State Department of Health (NYSTEM) [C028103, C028121]; Irma T. Hirschl Trust; Weill-Caulier Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell Fund through New York State Department of Health (NYSTEM); Irma T. Hirschl Trust; Weill-Caulier Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. Jose Silva (United Kingdom) for the pre-iPSCs; Dr. Hitoshi Niwa (Japan) for the 2TS22C ESCs; Dr. Thamar van Dijk (The Nethelands) for Wdr18, Tex10, and Las1L plasmids; and Dr. Huck-Hui Ng (Singapore) for the Nanogenhancer luciferase construct. Production of the knockout mouse model and injections of siRNAs in early embryos were performed in the Mouse Genetics Shared Resource Facility at the Icahn School of Medicine at Mount Sinai. This research was funded by grants from the NIH to J.W. (1R01-GM095942) and the Empire State Stem Cell Fund through New York State Department of Health (NYSTEM) to J.W. (C028103 and C028121). J.W. is a recipient of an Irma T. Hirschl and Weill-Caulier Trusts Career Scientist Award. A.S. is an awardee of the Traineeship of NIDCR-Interdisciplinary Training in Systems and Developmental Biology and Birth Defects (T32HD075735).	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Castle CD, 2012, MOL BIOL CELL, V23, P716, DOI 10.1091/mbc.E11-06-0530; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; dos Santos RL, 2014, CELL STEM CELL, V15, P102, DOI 10.1016/j.stem.2014.04.019; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fanis P, 2012, MOL CELL PROTEOMICS, V11, P1263, DOI 10.1074/mcp.M112.017194; Fong YW, 2014, ELIFE, V3, DOI 10.7554/eLife.03573; Gagliardi A, 2013, EMBO J, V32, P2231, DOI 10.1038/emboj.2013.161; Gao ZH, 2012, J BIOL CHEM, V287, P11384, DOI 10.1074/jbc.M111.320143; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; Hindley C, 2013, BIOCHEM J, V451, P135, DOI 10.1042/BJ20121627; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hon GC, 2014, MOL CELL, V56, P286, DOI 10.1016/j.molcel.2014.08.026; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Huang X, 2014, CURR OPIN GENET DEV, V28, P16, DOI 10.1016/j.gde.2014.08.003; Huang Y, 2014, P NATL ACAD SCI USA, V111, P1361, DOI 10.1073/pnas.1322921111; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lam CS, 2012, BIOCHEM J, V448, P21, DOI 10.1042/BJ20120725; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lee DF, 2012, CELL STEM CELL, V11, P179, DOI 10.1016/j.stem.2012.05.020; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lu FL, 2014, GENE DEV, V28, P2103, DOI 10.1101/gad.248005.114; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meissner Alexander, 2009, V482, P3, DOI 10.1007/978-1-59745-060-7_1; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Pulakanti K, 2013, EPIGENETICS-US, V8, P1303, DOI 10.4161/epi.26597; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Schoeftner S, 2013, STEM CELLS, V31, P717, DOI 10.1002/stem.1315; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang L, 2014, CELL STEM CELL, V14, P575, DOI 10.1016/j.stem.2014.02.013; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009	53	65	66	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					653	668		10.1016/j.stem.2015.04.001	http://dx.doi.org/10.1016/j.stem.2015.04.001			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	25936917	Green Accepted, Bronze			2022-12-28	WOS:000355932300014
J	Wrighton, PJ; Kiessling, LL				Wrighton, Paul J.; Kiessling, Laura L.			Forces of Change: Mechanics Underlying Formation of Functional 3D Organ Buds	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; DIFFERENTIATION	3D organ buds that can recapitulate organ function have myriad applications for regenerative and personalized medicine. Here, Takebe et al. (2015) describe a generalized method for organ bud formation, demonstrating that mechanosensitive mesenchymal stem cells drive condensation of heterotypic cell mixtures to create buds from diverse organs.	[Wrighton, Paul J.; Kiessling, Laura L.] Univ Wisconsin, Dept Biochem, Madison, WI 53792 USA; [Kiessling, Laura L.] Univ Wisconsin, Dept Chem, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kiessling, LL (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53792 USA.	kiessling@chem.wisc.edu		Kiessling, Laura/0000-0001-6829-1500; Wrighton, Paul/0000-0002-0354-0278	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM049975] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM049975, T32 GM007215] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cerchiari AE, 2015, P NATL ACAD SCI USA, V112, P2287, DOI 10.1073/pnas.1410776112; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Musah S, 2014, P NATL ACAD SCI USA, V111, P13805, DOI 10.1073/pnas.1415330111; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Takebe T, 2015, CELL STEM CELL, V16, P556, DOI 10.1016/j.stem.2015.03.004; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Wrighton PJ, 2014, P NATL ACAD SCI USA, V111, P18126, DOI 10.1073/pnas.1409525111	10	9	10	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					453	454		10.1016/j.stem.2015.04.018	http://dx.doi.org/10.1016/j.stem.2015.04.018			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25957897	Bronze, Green Accepted			2022-12-28	WOS:000354188600003
J	Luo, M; Jeong, M; Sun, DQ; Park, HJ; Rodriguez, BAT; Xia, Z; Yang, LB; Zhang, XT; Sheng, KW; Darlington, GJ; Li, W; Goodell, MA				Luo, Min; Jeong, Mira; Sun, Deqiang; Park, Hyun Jung; Rodriguez, Benjamin A. T.; Xia, Zheng; Yang, Liubin; Zhang, Xiaotian; Sheng, Kuanwei; Darlington, Gretchen J.; Li, Wei; Goodell, Margaret A.			Long Non-Coding RNAs Control Hematopoietic Stem Cell Function	CELL STEM CELL			English	Article							GENE; TRANSCRIPTION; PRINCIPLES; REVEALS; MUTATIONS; LINCRNAS; LINEAGE; DNMT3A; CANCER; HSCS	Hematopoietic stem cells (HSCs) possess unique gene expression programs that enforce their identity and regulate lineage commitment. Long non-coding RNAs (IncRNAs) have emerged as important regulators of gene expression and cell fate decisions, although their functions in HSCs are unclear. Here we profiled the transcriptome of purified HSCs by deep sequencing and identified 323 unannotated IncRNAs. Comparing their expression in differentiated lineages revealed 159 IncRNAs enriched in HSCs, some of which are likely HSC specific (LncHSCs). These IncRNA genes share epigenetic features with protein-coding genes, including regulated expression via DNA methylation, and knocking down two LncHSCs revealed distinct effects on HSC self-renewal and lineage commitment. We mapped the genomic binding sites of one of these candidates and found enrichment for key hematopoietic transcription factor binding sites, especially E2A. Together, these results demonstrate that IncRNAs play important roles in regulating HSCs, providing an additional layer to the genetic circuitry controlling HSC function.	[Luo, Min; Jeong, Mira; Yang, Liubin; Zhang, Xiaotian; Sheng, Kuanwei; Goodell, Margaret A.] Baylor Coll Med, Dept Pediat & Mol & Human Genet, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Sun, Deqiang; Park, Hyun Jung; Rodriguez, Benjamin A. T.; Xia, Zheng; Li, Wei; Goodell, Margaret A.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Darlington, Gretchen J.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Li, W (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	wl1@bcm.edu; goodell@bcm.edu	Xia, Zheng/AAC-5360-2022; Sheng, Kuanwei/F-4550-2017	Xia, Zheng/0000-0003-3364-8324; luo, min/0000-0003-4883-4189; Sheng, Kuanwei/0000-0002-7155-9915; Goodell, Margaret A./0000-0003-1111-2932; sun, deqiang/0000-0002-5806-7289; Li, Wei/0000-0001-9931-5990; Zhang, Xiaotian/0000-0002-9533-4761	NIH [5T32AI007495, AG036562, AG28865, CA126752, DK092883, DK084259, R01HG007538]; CPRIT [RP110028, RP110471, RP150292]; Samuel Waxman Cancer Research Foundation; Edward P. Evans Foundation; Cytometry and Cell Sorting core at Baylor College of Medicine [AI036211, CA125123, RR024574]; Genomic and RNA Profiling core at Baylor College of Medicine [CA125123]; Integrated Microscopy core at Baylor College of Medicine [CA125123, HD007495, DK56338]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD007495, T32HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123, P50CA126752] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, T32AI007495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK084259, P30DK056338, T32DK060445, R01DK092883, R56DK092883, K99DK084259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036562, R01AG028865] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Samuel Waxman Cancer Research Foundation; Edward P. Evans Foundation; Cytometry and Cell Sorting core at Baylor College of Medicine; Genomic and RNA Profiling core at Baylor College of Medicine; Integrated Microscopy core at Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants 5T32AI007495, AG036562, AG28865, CA126752, DK092883, and DK084259; by CPRIT grant RP110028; by the Samuel Waxman Cancer Research Foundation; and by the Edward P. Evans Foundation. W.L. was supported by CPRIT grants RP110471 and RP150292 and NIH grant R01HG007538. We thank the Cytometry and Cell Sorting (grants AI036211, CA125123, and RR024574), the Genomic and RNA Profiling (grant CA125123), and Integrated Microscopy (grants HD007495, DK56338, and CA125123) cores at Baylor College of Medicine.	Alvarez-Dominguez JR, 2014, BLOOD, V123, P570, DOI 10.1182/blood-2013-10-530683; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; do O PP, 2002, BLOOD, V99, P3939, DOI 10.1182/blood.V99.11.3939; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Goodell MA, 2013, BLOOD, V121, P5131, DOI 10.1182/blood-2013-04-427724; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hannah R, 2011, EXP HEMATOL, V39, P531, DOI 10.1016/j.exphem.2011.02.009; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Iwanaga E, 2011, INT J ONCOL, V38, P25, DOI 10.3892/ijo_00000820; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Lechman ER, 2012, CELL STEM CELL, V11, P799, DOI 10.1016/j.stem.2012.09.001; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Paralkar VR, 2014, BLOOD, V123, P1927, DOI 10.1182/blood-2013-12-544494; Pouillon V, 2003, NAT IMMUNOL, V4, P1136, DOI 10.1038/ni980; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Tallack MR, 2012, GENOME RES, V22, P2385, DOI 10.1101/gr.135707.111; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trubia M, 2006, LEUKEMIA, V20, P48, DOI 10.1038/sj.leu.2404020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303; Wagner LA, 2007, BLOOD, V109, P5191, DOI 10.1182/blood-2006-06-027987; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Zhang LB, 2013, NATURE, V499, P92, DOI 10.1038/nature12215; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164	48	105	112	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					426	438		10.1016/j.stem.2015.02.002	http://dx.doi.org/10.1016/j.stem.2015.02.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25772072	Bronze, Green Accepted			2022-12-28	WOS:000352228600014
J	Hogan, MS; Parfitt, DE; Zepeda-Mendoza, CJ; Shen, MM; Spector, DL				Hogan, Megan S.; Parfitt, David-Emlyn; Zepeda-Mendoza, Cinthya J.; Shen, Michael M.; Spector, David L.			Transient Pairing of Homologous Oct4 Alleles Accompanies the Onset of Embryonic Stem Cell Differentiation	CELL STEM CELL			English	Article							TRANSCRIPTIONAL REGULATORY CIRCUITRY; IMPRINTING CONTROL REGION; X-INACTIVATION; CHROMATIN ORGANIZATION; NUCLEAR-ORGANIZATION; SPATIAL-ORGANIZATION; PLURIPOTENCY FACTORS; GENE-EXPRESSION; MOUSE; GENOME	The relationship between chromatin organization and transcriptional regulation is an area of intense investigation. We characterized the spatial relationships between alleles of the Oct4, Sox2, and Nanog genes in single cells during the earliest stages of mouse embryonic stem cell (ESC) differentiation and during embryonic development. We describe homologous pairing of the Oct4 alleles during ESC differentiation and embryogenesis, and we present evidence that pairing is correlated with the kinetics of ESC differentiation. Importantly, we identify critical DNA elements within the Oct4 promoter/enhancer region that mediate pairing of Oct4 alleles. Finally, we show that mutation of OCT4/SOX2 binding sites within this region abolishes inter-chromosomal interactions and affects accumulation of the repressive H3K9me2 modification at the Oct4 enhancer. Our findings demonstrate that chromatin organization and transcriptional programs are intimately connected in ESCs and that the dynamic positioning of the Oct4 alleles is associated with the transition from pluripotency to lineage specification.	[Hogan, Megan S.; Zepeda-Mendoza, Cinthya J.; Spector, David L.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Parfitt, David-Emlyn; Shen, Michael M.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Parfitt, David-Emlyn; Shen, Michael M.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Parfitt, David-Emlyn; Shen, Michael M.] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA	Cold Spring Harbor Laboratory; Columbia University; Columbia University; Columbia University	Spector, DL (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, One Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	spector@cshl.edu	Shen, Michael M/C-7546-2009	Shen, Michael M/0000-0002-4042-1657; Hogan, Megan/0000-0003-4752-3872; Shen, Mouquan/0000-0001-6448-4866	Watson School of Biological Sciences; Starr Foundation;  [GM42694];  [CA121852]; NATIONAL CANCER INSTITUTE [P30CA045508, U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042694] Funding Source: NIH RePORTER	Watson School of Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Starr Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Edith Heard, Alea Mills, Jane Skok, Mona Spector, Bruce Stillman, and all members of the Spector Laboratory for helpful discussions and suggestions. We also thank Sang-Yong Kim and Scott Lowe for providing ESC lines used in this study. We gratefully acknowledge the CSHL Microscopy Shared Resource for assistance with microscopic imaging and the CSHL Histology Shared Resource for assistance with cryosections (NCI 2P3OCA45508). M.S.H. was supported by The Watson School of Biological Sciences and the Starr Foundation. This research was supported by GM42694 (to D.L.S.) and CA121852 (to M.M.S.).	Aoto T, 2006, DEV BIOL, V298, P354, DOI 10.1016/j.ydbio.2006.04.450; Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Babu DA, 2008, J BIOL CHEM, V283, P8164, DOI 10.1074/jbc.M800336200; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brickner DG, 2012, DEV CELL, V22, P1234, DOI 10.1016/j.devcel.2012.03.012; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; Chaumeil J, 2012, CURR OPIN IMMUNOL, V24, P153, DOI 10.1016/j.coi.2012.01.003; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Downs KM, 2008, DEV DYNAM, V237, P464, DOI 10.1002/dvdy.21438; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Duan ZJ, 2012, BIOESSAYS, V34, P800, DOI 10.1002/bies.201200034; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Eckersley-Maslin MA, 2014, DEV CELL, V28, P351, DOI 10.1016/j.devcel.2014.01.017; Eckersley-Maslin MA, 2013, NUCLEUS-PHILA, V4, P53, DOI 10.4161/nucl.23384; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fong YW, 2011, CELL, V147, P120, DOI 10.1016/j.cell.2011.08.038; Habib WA, 2014, HUM MOL GENET, V23, P5763, DOI 10.1093/hmg/ddu290; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Hori N, 2012, J BIOL CHEM, V287, P44006, DOI 10.1074/jbc.M112.424580; Hubner MR, 2013, CURR OPIN GENET DEV, V23, P89, DOI 10.1016/j.gde.2012.11.006; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Joffe B, 2010, CURR OPIN GENET DEV, V20, P562, DOI 10.1016/j.gde.2010.05.009; Jost KL, 2011, NUCLEIC ACIDS RES, V39, pE113, DOI 10.1093/nar/gkr486; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Klein F.A., 2014, FOURCSEQ ANAL 4C SEQ; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; Krueger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038983; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lodato MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003288; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui O, 2011, CELL, V145, P447, DOI 10.1016/j.cell.2011.03.032; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Melcer S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1915; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Papantonis A, 2012, EMBO J, V31, P4404, DOI 10.1038/emboj.2012.288; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Thatcher KN, 2005, HUM MOL GENET, V14, P785, DOI 10.1093/hmg/ddi073; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yamamizu K, 2012, CELL STEM CELL, V10, P759, DOI 10.1016/j.stem.2012.02.022; Yan J, 2007, AM J HUM GENET, V80, P518, DOI 10.1086/512043; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zimmerman DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081962	75	36	36	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					275	288		10.1016/j.stem.2015.02.001	http://dx.doi.org/10.1016/j.stem.2015.02.001			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25748933	Green Accepted, Bronze			2022-12-28	WOS:000350747700010
J	Xu, J; Du, YY; Deng, HK				Xu, Jun; Du, Yuanyuan; Deng, Hongkui			Direct Lineage Reprogramming: Strategies, Mechanisms, and Applications	CELL STEM CELL			English	Review							NEURAL STEM-CELLS; CARDIOMYOCYTE-LIKE CELLS; INDUCED NEURONAL CELLS; MOUSE SOMATIC-CELLS; ELEGANS GERM-CELLS; HUMAN FIBROBLASTS; DEFINED FACTORS; DIRECT CONVERSION; IN-VIVO; PROGENITOR CELLS	The direct lineage reprogramming of one specialized cell type into another using defined factors has fundamentally re-shaped traditional concepts regarding the epigenetic stability of differentiated cells. With the rapid increase in cell types generated through direct conversion in recent years, this strategy has become a promising approach for producing functional cells. Here, we review recent advances in lineage reprogramming, including the identification of novel reprogramming factors, underlying molecular mechanisms, strategies for generating functionally mature cells, and assays for characterizing induced cells. We also discuss progress toward the application of lineage reprogramming and the major future challenges for this strategy.	[Xu, Jun; Du, Yuanyuan; Deng, Hongkui] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Stem Cell Res Ctr,Dept Cell Biol, Beijing 100191, Peoples R China; [Xu, Jun; Du, Yuanyuan; Deng, Hongkui] Peking Univ, Peking Tsinghua Ctr Life Sci, Coll Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Genom, Shenzhen Stem Cell Engn Lab, Shenzhen 518055, Peoples R China	Peking University; Peking University; Peking University; University Town of Shenzhen	Deng, HK (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Stem Cell Res Ctr,Dept Cell Biol, Beijing 100191, Peoples R China.	hongkui_deng@pku.edu.cn			National Basic Research Program of China (973 Program) [2012CB966401]; National Natural Science Foundation of China [91310305]; Ministry of Science and Technology [2013DFG30680]; Key New Drug Creation and Manufacturing Program [2011ZX09102-010-03]; Ministry of Education of China (111 Project)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Key New Drug Creation and Manufacturing Program; Ministry of Education of China (111 Project)	We apologize to all those scientists whose outstanding work could not be discussed and cited in this review due to space limitations. We thank Dr. D.S. Li, Dr. Q. Zhou, Dr. G. Chen, Dr. C.R. Xu, Dr. Y.M. Wang, Dr. Z. Wang, Dr. J. Chen, X. Li, Dr. C.Y. Wang, Y. Liu, Dr. Y. Zhao, Dr. R.G. Fang, Dr. K. Liu, and T. Zhao for critical discussion. We also thank all members of our laboratory for their comments on this manuscript. Work in the laboratory of H.K.D. is funded by the National Basic Research Program of China (973 Program 2012CB966401), the National Natural Science Foundation of China (91310305), Ministry of Science and Technology (2013DFG30680), Key New Drug Creation and Manufacturing Program (2011ZX09102-010-03), and Ministry of Education of China (111 Project). The authors declare no competing financial interests.	Addis RC, 2013, J MOL CELL CARDIOL, V60, P97, DOI 10.1016/j.yjmcc.2013.04.004; Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batta K, 2014, CELL REP, V9, P1871, DOI 10.1016/j.celrep.2014.11.002; Bhatia SN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3005975; Bredenkamp N, 2014, NAT CELL BIOL, V16, P902, DOI 10.1038/ncb3023; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Buganim Y, 2012, CELL STEM CELL, V11, P373, DOI 10.1016/j.stem.2012.07.019; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Caiazzo M, 2015, STEM CELL REP, V4, P25, DOI 10.1016/j.stemcr.2014.12.002; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Cheng L, 2014, CELL RES, V24, P665, DOI 10.1038/cr.2014.32; Chera S, 2014, NATURE, V514, P503, DOI 10.1038/nature13633; Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063577; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Corti S, 2012, EXP CELL RES, V318, P1528, DOI 10.1016/j.yexcr.2012.02.040; Courtney M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003934; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Forsberg M, 2010, P NATL ACAD SCI USA, V107, P14657, DOI 10.1073/pnas.1009412107; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Han JK, 2014, CIRCULATION, V130, P1168, DOI 10.1161/CIRCULATIONAHA.113.007727; Hayashi T, 2006, MECH DEVELOP, V123, P793, DOI 10.1016/j.mod.2006.08.009; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hendry CE, 2013, J AM SOC NEPHROL, V24, P1424, DOI 10.1681/ASN.2012121143; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Huang X, 2014, CURR OPIN GENET DEV, V28, P16, DOI 10.1016/j.gde.2014.08.003; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Ionta V, 2015, STEM CELL REP, V4, P129, DOI 10.1016/j.stemcr.2014.11.004; Islas JF, 2012, P NATL ACAD SCI USA, V109, P13016, DOI 10.1073/pnas.1120299109; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kaneto H, 2005, DIABETES, V54, P1009, DOI 10.2337/diabetes.54.4.1009; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Kim YJ, 2014, CELL STEM CELL, V15, P497, DOI 10.1016/j.stem.2014.07.013; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lemper M., 2014, CELL DEATH DIFFER; Li J, 2013, ARTERIOSCL THROM VAS, V33, P1366, DOI 10.1161/ATVBAHA.112.301167; Li K, 2014, CELL STEM CELL, V14, P228, DOI 10.1016/j.stem.2014.01.006; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Li WD, 2014, ELIFE, V3, DOI 10.7554/eLife.01846; Li WL, 2013, CELL STEM CELL, V13, P270, DOI 10.1016/j.stem.2013.08.002; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Liu XJ, 2012, CELL RES, V22, P321, DOI 10.1038/cr.2011.181; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Ma TH, 2013, CIRC RES, V112, P562, DOI 10.1161/CIRCRESAHA.111.249235; Maki N, 2010, MOL VIS, V16, P72; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Mathison M, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005652; Montana CL, 2013, P NATL ACAD SCI USA, V110, P1732, DOI 10.1073/pnas.1214387110; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Neo WH, 2014, J BIOL CHEM, V289, P20788, DOI 10.1074/jbc.M113.525493; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Ouyang H, 2014, NATURE, V511, P358, DOI 10.1038/nature13465; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Patel T, 2012, CELL REP, V2, P1178, DOI 10.1016/j.celrep.2012.09.020; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Protze S, 2012, J MOL CELL CARDIOL, V53, P323, DOI 10.1016/j.yjmcc.2012.04.010; Pulecio J, 2014, STEM CELLS, V32, P2923, DOI 10.1002/stem.1800; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rouaux C, 2013, NAT CELL BIOL, V15, P214, DOI 10.1038/ncb2660; Sandler VM, 2014, NATURE, V511, P312, DOI 10.1038/nature13547; Sayed N, 2015, CIRCULATION, V131, P300, DOI 10.1161/CIRCULATIONAHA.113.007394; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Sheng C, 2012, CELL RES, V22, P769, DOI 10.1038/cr.2012.32; Sheng C, 2012, CELL RES, V22, P208, DOI 10.1038/cr.2011.175; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Theunissen TW, 2014, CELL STEM CELL, V14, P720, DOI 10.1016/j.stem.2014.05.002; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tiemann U, 2011, CYTOM PART A, V79A, P426, DOI 10.1002/cyto.a.21072; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wada R, 2013, P NATL ACAD SCI USA, V110, P12667, DOI 10.1073/pnas.1304053110; Wang L, 2015, CIRC RES, V116, P237, DOI 10.1161/CIRCRESAHA.116.305547; Wang LH, 2013, NAT METHODS, V10, P84, DOI [10.1038/NMETH.2283, 10.1038/nmeth.2283]; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu HS, 2012, CELL RES, V22, P1521, DOI 10.1038/cr.2012.101; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yamaguchi S, 2011, STEM CELL RES, V6, P177, DOI 10.1016/j.scr.2010.09.004; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564; Yang RF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6807; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017; Yuan Y, 2013, CHEM BIOL, V20, P1513, DOI 10.1016/j.chembiol.2013.10.013; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang K, 2013, PROTEIN CELL, V4, P432, DOI 10.1007/s13238-013-3026-9; Zhao DX, 2013, CELL RES, V23, P157, DOI 10.1038/cr.2012.144; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020; Zhu S, 2014, CELL RES, V24, P126, DOI 10.1038/cr.2013.156; Zuryn S, 2014, SCIENCE, V345, P826, DOI 10.1126/science.1255885	147	262	276	3	141	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					119	134		10.1016/j.stem.2015.01.013	http://dx.doi.org/10.1016/j.stem.2015.01.013			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25658369	Bronze			2022-12-28	WOS:000349455000008
J	Barker, RA				Barker, Roger A.			Developing Stem Cell Therapies for Parkinson's Disease: Waiting Until the Time Is Right	CELL STEM CELL			English	Editorial Material							DOPAMINERGIC TRANSPLANTATION; RAT MODEL; FUTURE; PHASE	The ability to successfully replace lost nigral dopaminergic neurons in Parkinson's disease (PD) has been clearly shown with fetal ventral mesencephalic transplants, albeit inconsistently. The need to trial this approach with stem-cell-derived neurons is approaching, but it should only commence when all the key issues have been adequately resolved.	[Barker, Roger A.] Addenbrookes Hosp, Dept Clin Neurosci, John van Geest Ctr Brain Repair, Cambridge CB2 0PY, England; [Barker, Roger A.] Univ Cambridge, Cambridge CB2 0PY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Barker, RA (corresponding author), Addenbrookes Hosp, Dept Clin Neurosci, John van Geest Ctr Brain Repair, Forvie Site, Cambridge CB2 0PY, England.	rab46@cam.ac.uk		Barker, Roger Alistair/0000-0001-8843-7730				Abbott A, 2014, NATURE, V510, P195, DOI 10.1038/510195a; Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; BRUNDIN P, 1986, EXP BRAIN RES, V65, P235; Brundin P, 2012, PROG BRAIN RES, V200, P221, DOI 10.1016/B978-0-444-59575-1.00010-7; Grealish S, 2010, BRAIN, V133, P482, DOI 10.1093/brain/awp328; Kefalopoulou Z, 2014, JAMA NEUROL, V71, P83, DOI 10.1001/jamaneurol.2013.4749; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Olanow CW, 2009, ANN NEUROL, V66, P591, DOI 10.1002/ana.21778; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Rizzone MG, 2014, PARKINSONISM RELAT D, V20, P376, DOI 10.1016/j.parkreldis.2014.01.012	10	28	28	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					539	542		10.1016/j.stem.2014.09.016	http://dx.doi.org/10.1016/j.stem.2014.09.016			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517462	Bronze			2022-12-28	WOS:000345012700007
J	Cosgun, KN; Rahmig, S; Mende, N; Reinke, S; Hauber, I; Schafer, C; Petzold, A; Weisbach, H; Heidkamp, G; Purbojo, A; Cesnjevar, R; Platz, A; Bornhauser, M; Schmitz, M; Dudziak, D; Hauber, J; Kirberg, J; Waskow, C				Cosgun, Kadriye Nehir; Rahmig, Susann; Mende, Nicole; Reinke, Soeren; Hauber, Ilona; Schaefer, Carola; Petzold, Anke; Weisbach, Henry; Heidkamp, Gordon; Purbojo, Ariawan; Cesnjevar, Robert; Platz, Alexander; Bornhaeuser, Martin; Schmitz, Marc; Dudziak, Diana; Hauber, Joachim; Kirberg, Joerg; Waskow, Claudia			Kit Regulates HSC Engraftment across the Human-Mouse Species Barrier	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSGENIC EXPRESSION; IMMUNE-SYSTEM; CORD BLOOD; IN-VIVO; MICE; RECEPTOR; MODEL; PROGENITORS; POPULATIONS	In-depth analysis of the cellular and molecular mechanisms regulating human HSC function will require a surrogate host that supports robust maintenance of transplanted human HSCs in vivo, but the currently available options are problematic. Previously we showed that mutations in the Kit receptor enhance engraftment of transplanted HSCs in the mouse. To generate an improved model for human HSC transplantation and analysis, we developed immune-deficient mouse strains containing Kit mutations. We found that mutation of the Kit receptor enables robust, uniform, sustained, and serially transplantable engraftment of human HSCs in adult mice without a requirement for irradiation conditioning. Using this model, we also showed that differential KIT expression identifies two functionally distinct subpopulations of human HSCs. Thus, we have found that the capacity of this Kit mutation to open up stem cell niches across species barriers has significant potential and broad applicability in human HSC research.	[Cosgun, Kadriye Nehir; Rahmig, Susann; Mende, Nicole; Reinke, Soeren; Weisbach, Henry; Waskow, Claudia] Tech Univ Dresden, Fac Med, Inst Immunol, D-01307 Dresden, Germany; [Hauber, Ilona; Schaefer, Carola; Hauber, Joachim] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany; [Petzold, Anke; Schmitz, Marc] Tech Univ Dresden, Fac Med, Inst Immunol, D-01307 Dresden, Germany; [Heidkamp, Gordon; Dudziak, Diana] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Dermatol, Lab Dendrit Cell Biol, D-91052 Erlangen, Germany; [Purbojo, Ariawan; Cesnjevar, Robert] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Paediat Cardiac Surg, D-91054 Erlangen, Germany; [Platz, Alexander] DKMS Lifeline Cord Blood Bank, D-01307 Dresden, Germany; [Bornhaeuser, Martin] Tech Univ Dresden, Univ Hosp, Dept Hematol Oncol, D-01307 Dresden, Germany; [Kirberg, Joerg] Paul Ehrlich Inst, Fed Inst Vaccines & Biomed, D-63225 Langen, Germany	Technische Universitat Dresden; Heinrich Pette Institute; Technische Universitat Dresden; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Paul Ehrlich Institute	Waskow, C (corresponding author), Tech Univ Dresden, Fac Med, Inst Immunol, Fetscherstr 74, D-01307 Dresden, Germany.	claudia.waskow@tu-dresden.de	Waskow, Claudia/F-8146-2010; Cesnjevar, Robert/AAD-6215-2019; Mende, Nicole/CAF-3541-2022; Dudziak, Diana/B-2432-2017	Waskow, Claudia/0000-0003-3261-0922; Cesnjevar, Robert/0000-0002-3575-6647; Mende, Nicole/0000-0002-5078-2333; Reinke, Soren/0000-0003-2412-385X; Dudziak, Diana/0000-0001-9358-134X; Rahmig, Susann/0000-0002-8836-9552; Cosgun, Kadriye/0000-0003-4181-744X	Center for Regenerative Therapies Dresden; German Research Foundation (DFG) [WA2837, SFB655-B9, SFB127-A3, FOR2033-A03]; European Union [261387]; BayGene; DFG [SFB643-A7]	Center for Regenerative Therapies Dresden; German Research Foundation (DFG)(German Research Foundation (DFG)); European Union(European Commission); BayGene; DFG(German Research Foundation (DFG))	We thank Melanie Portz, Sabrina Piontek, and Sindy Bohme for expert help with mouse maintenance and genotyping; Tatyana Grinenko for discussion; and Ulrike Lohr for critical reading of the manuscript. We thank the entire laboratory staff from the DKMS Lifeline Cord Blood Bank for providing cord blood samples, and we thank Frank Miedema and Sigrid Otto for providing the cloned Sj fragment for TREC analysis. C.W. is supported by the Center for Regenerative Therapies Dresden, by the German Research Foundation (DFG) WA2837, SFB655-B9, SFB127-A3, and FOR2033-A03, and by funding from the European Union's Seventh Programme for research, technological development, and demonstration under grant agreement No. 261387 (CELL-PID). D.D. is supported by BayGene and the DFG (SFB643-A7).	Arndt K, 2013, P NATL ACAD SCI USA, V110, P5582, DOI 10.1073/pnas.1215438110; Brehm MA, 2012, BLOOD, V119, P2778, DOI 10.1182/blood-2011-05-353243; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Carbonneau CL, 2012, BLOOD, V119, P717, DOI 10.1182/blood-2011-06-361626; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Ghia P, 1996, J EXP MED, V184, P2217, DOI 10.1084/jem.184.6.2217; Grinenko T, 2014, J EXP MED, V211, P209, DOI 10.1084/jem.20131115; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kawashima I, 1996, BLOOD, V87, P4136, DOI 10.1182/blood.V87.10.4136.bloodjournal87104136; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Miller PH, 2013, BLOOD, V121, pE1, DOI 10.1182/blood-2012-09-456566; Nicolini FE, 2004, LEUKEMIA, V18, P341, DOI 10.1038/sj.leu.2403222; Nilsson SK, 1997, BLOOD, V89, P4013, DOI 10.1182/blood.V89.11.4013; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rongvaux A, 2011, P NATL ACAD SCI USA, V108, P2378, DOI 10.1073/pnas.1019524108; Scheeren FA, 2008, J EXP MED, V205, P2033, DOI 10.1084/jem.20070447; Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619; Shen HM, 2012, BLOOD, V119, P3629, DOI 10.1182/blood-2011-08-373621; Shin JY, 2014, J EXP MED, V211, P217, DOI 10.1084/jem.20131128; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Strowig T, 2011, P NATL ACAD SCI USA, V108, P13218, DOI 10.1073/pnas.1109769108; Takagi S, 2012, BLOOD, V119, P2768, DOI 10.1182/blood-2011-05-353201; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; von Bonin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060680; Waskow C, 2004, BLOOD, V104, P1688, DOI 10.1182/blood-2004-04-1247; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Waskow C, 2009, NAT METHODS, V6, P267, DOI [10.1038/nmeth.1309, 10.1038/NMETH.1309]; Willinger T, 2011, TRENDS IMMUNOL, V32, P321, DOI 10.1016/j.it.2011.04.005	35	101	106	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					227	238		10.1016/j.stem.2014.06.001	http://dx.doi.org/10.1016/j.stem.2014.06.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	25017720	Bronze			2022-12-28	WOS:000340880100014
J	Li, W; Li, X; Li, TD; Jiang, MG; Wan, HF; Luo, GZ; Feng, CJ; Cui, XL; Teng, F; Yuan, Y; Zhou, Q; Gu, Q; Shuai, L; Sha, JH; Xiao, YM; Wang, L; Liu, ZH; Wang, XJ; Zhao, XY; Zhou, Q				Li, Wei; Li, Xin; Li, Tianda; Jiang, Ming-Gui; Wan, Haifeng; Luo, Guan-Zheng; Feng, Chunjing; Cui, Xiaolong; Teng, Fei; Yuan, Yan; Zhou, Quan; Gu, Qi; Shuai, Ling; Sha, Jiahao; Xiao, Yamei; Wang, Liu; Liu, Zhonghua; Wang, Xiu-Jie; Zhao, Xiao-Yang; Zhou, Qi			Genetic Modification and Screening in Rat Using Haploid Embryonic Stem Cells	CELL STEM CELL			English	Article							MOUSE EMBRYOS; KNOCKOUT RATS; BLASTOCYSTS; DERIVATION; GENOME; MICE; COMPLEMENTATION; MICROINJECTION; LINE	The rat is an important animal model in biomedical research, but practical limitations to genetic manipulation have restricted the application of genetic analysis. Here we report the derivation of rat androgenetic haploid embryonic stem cells (RahESCs) as a tool to facilitate such studies. Our approach is based on removal of the maternal pronucleus from zygotes to generate androgenetic embryos followed by derivation of ESCs. The resulting RahESCs have 21 chromosomes, express pluripotency markers, differentiate into three germ layer cells, and contribute to the germline. Homozygous mutations can be introduced by both large-scale gene trapping and precise gene targeting via homologous recombination or the CRISPR-Cas system. RahESCs can also produce fertile rats after intracytoplasmic injection into oocytes and are therefore able to transmit genetic modifications to offspring. Overall, RahESCs represent a practical tool for functional genetic studies and production of transgenic lines in rat.	[Li, Wei; Li, Xin; Li, Tianda; Jiang, Ming-Gui; Wan, Haifeng; Feng, Chunjing; Cui, Xiaolong; Teng, Fei; Yuan, Yan; Zhou, Quan; Gu, Qi; Shuai, Ling; Wang, Liu; Zhao, Xiao-Yang; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Li, Wei; Li, Tianda; Jiang, Ming-Gui; Wan, Haifeng; Feng, Chunjing; Teng, Fei; Wang, Liu; Zhao, Xiao-Yang; Zhou, Qi] Chinese Acad Sci, Inst Zool, Key Lab Translat Stem Cell Res, Beijing 100101, Peoples R China; [Li, Xin; Gu, Qi; Shuai, Ling; Liu, Zhonghua] Northeast Agr Univ China, Coll Life Sci, Harbin 150030, Peoples R China; [Luo, Guan-Zheng; Cui, Xiaolong; Wang, Xiu-Jie] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Genet Network Biol, Beijing 100101, Peoples R China; [Jiang, Ming-Gui; Xiao, Yamei] Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China; [Feng, Chunjing; Cui, Xiaolong; Teng, Fei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Yuan, Yan; Zhou, Quan; Sha, Jiahao] Nanjing Med Univ, Dept Histol & Embryol, Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Northeast Agricultural University - China; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Hunan Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing Medical University	Zhou, Q (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	qzhou@ioz.ac.cn	CUI, XIAOLONG/GRF-0957-2022; Liu, Zhunghua/F-2485-2010; Gu, Qi/AAX-1945-2021; CUI, XIAOLONG/ABB-2030-2020; Liu, Zhonghua/AAO-3590-2021; Wang, Xiu-Jie/L-1312-2019	CUI, XIAOLONG/0000-0002-1345-2271; Liu, Zhunghua/0000-0002-9199-6493; Gu, Qi/0000-0001-9387-9525; Liu, Zhonghua/0000-0002-9199-6493; ZHAO, Xiao-Yang/0000-0003-2544-8293; Shuai, Ling/0000-0003-0671-7478	China National Basic Research Program [2012CBA01300, 2009CB941000]; Chinese Academy of Sciences [XDA01020101, 2011CB965301]	China National Basic Research Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank all members of the Group of Reproductive Engineering for discussion and help. This work was supported by grants from the China National Basic Research Program 2012CBA01300 and 2009CB941000 (to Q.Z.), a grant from the Strategic Priority Research Program of the Chinese Academy of Sciences XDA01020101 (to Q.Z.), and a grant from 2011CB965301 (to X.-Y.Z.). We thank Eppendorf, Leica, and Beckman for supporting the facility. We thank Ting Li, Qing Meng, and Tong Zhao for their help with fluorescence-activated cell sorting.	Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Hirabayashi M, 2012, MOL REPROD DEV, V79, P402, DOI 10.1002/mrd.22043; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li TD, 2012, J GENET GENOMICS, V39, P603, DOI 10.1016/j.jgg.2012.06.006; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Medeiros-Domingo A, 2007, CIRCULATION, V116, P134, DOI 10.1161/CIRCULATIONAHA.106.659086; Potter CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010168; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhao XY, 2010, J GENET GENOMICS, V37, P467, DOI 10.1016/S1673-8527(09)60066-7	27	77	104	1	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					404	414		10.1016/j.stem.2013.11.016	http://dx.doi.org/10.1016/j.stem.2013.11.016			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24360884	Bronze			2022-12-28	WOS:000332533400016
J	Pera, MF				Pera, Martin F.			Stress Management: A New Path to Pluripotency	CELL STEM CELL			English	Editorial Material							CELLS	Two recent papers in Nature describe a remarkable new technique for reprogramming somatic cells back to the embryonic state. Obokata et al. (2014a, 2014b) show that applying stressful stimuli can convert mature cells into progenitors capable of generating all three embryonic germ layer lineages, as well as placental tissue.	Univ Melbourne, Florey Neurosci & Mental Hlth Inst, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3010, Australia	University of Melbourne	Pera, MF (corresponding author), Univ Melbourne, Florey Neurosci & Mental Hlth Inst, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3010, Australia.	martin.pera@unimelb.edu.au	PERA, MARTIN/A-9812-2012	PERA, MARTIN/0000-0001-6239-0428				BLAU HM, 1992, ANNU REV BIOCHEM, V61, P1213, DOI 10.1146/annurev.bi.61.070192.010025; Bonfanti P, 2012, EMBO MOL MED, V4, P353, DOI 10.1002/emmm.201200220; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chambers SM, 2011, CELL, V145, P827, DOI 10.1016/j.cell.2011.05.036; Obokata H, 2014, NATURE, V505, P676, DOI 10.1038/nature12969; Obokata H, 2014, NATURE, V505, P641, DOI 10.1038/nature12968; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1356-9597.2004.00736.x; Surani MA, 2012, CELL STEM CELL, V11, P748, DOI 10.1016/j.stem.2012.11.014; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wakao S, 2014, PATHOL INT, V64, P1, DOI 10.1111/pin.12129	10	0	0	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					273	274		10.1016/j.stem.2014.02.009	http://dx.doi.org/10.1016/j.stem.2014.02.009			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24607402	Bronze			2022-12-28	WOS:000332533400005
J	Sandoval-Guzman, T; Wang, H; Khattak, S; Schuez, M; Roensch, K; Nacu, E; Tazaki, A; Joven, A; Tanaka, EM; Simon, A				Sandoval-Guzman, Tatiana; Wang, Heng; Khattak, Shahryar; Schuez, Maritta; Roensch, Kathleen; Nacu, Eugeniu; Tazaki, Akira; Joven, Alberto; Tanaka, Elly M.; Simon, Andras			Fundamental Differences in Dedifferentiation and Stem Cell Recruitment during Skeletal Muscle Regeneration in Two Salamander Species	CELL STEM CELL			English	Article							ZEBRAFISH HEART REGENERATION; LIMB REGENERATION; LENS REGENERATION; SATELLITE CELLS; AXOLOTL; FIN; PLASTICITY; BLASTEMA; MYOTUBES; GENE	Salamanders regenerate appendages via a progenitor pool called the blastema. The cellular mechanisms underlying regeneration of muscle have been much debated but have remained unclear. Here we applied Cre-loxP genetic fate mapping to skeletal muscle during limb regeneration in two salamander species, Notophthalmus viridescens (newt) and Ambystoma mexicanum (axolotl). Remarkably, we found that myofiber dedifferentiation is an integral part of limb regeneration in the newt, but not in axolotl. In the newt, myofiber fragmentation results in proliferating, PAX7(-) mononuclear cells in the blastema that give rise to the skeletal muscle in the new limb. In contrast, myofibers in axolotl do not generate proliferating cells, and do not contribute to newly regenerated muscle; instead, resident PAX7(+) cells provide the regeneration activity. Our results therefore show significant diversity in limb muscle regeneration mechanisms among salamanders and suggest that multiple strategies may be feasible for inducing regeneration in other species, including mammals.	[Sandoval-Guzman, Tatiana; Khattak, Shahryar; Schuez, Maritta; Roensch, Kathleen; Nacu, Eugeniu; Tazaki, Akira; Tanaka, Elly M.] Tech Univ Dresden, DFG Res Ctr Regenerat Therapies, CRTD, Dresden, Germany; [Khattak, Shahryar; Schuez, Maritta] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Wang, Heng; Joven, Alberto; Simon, Andras] Karolinska Inst, Ctr Dev Biol Regenerat Med, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Technische Universitat Dresden; Max Planck Society; Karolinska Institutet	Tanaka, EM (corresponding author), Tech Univ Dresden, DFG Res Ctr Regenerat Therapies, CRTD, Dresden, Germany.	elly.tanaka@crt-dresden.de; andras.simon@ki.se	Sandoval-Guzman, Tatiana/P-3795-2018; Sandoval-Guzmán, Tatiana/P-2473-2019; Sandoval-Guzmán, Tatiana/B-8172-2017; Joven, Alberto/AAU-5656-2020; Tanaka, Elly M/F-8572-2010	Sandoval-Guzmán, Tatiana/0000-0003-1802-5145; Sandoval-Guzmán, Tatiana/0000-0003-1802-5145; Joven Araus, Alberto/0000-0002-0926-4665; Tanaka, Elly/0000-0003-4240-2158; Tazaki, Akira/0000-0002-7151-0089; Simon, Andras/0000-0002-1018-1891	Volkswagen Foundation; DFG [TA 274/2-2, TA 274/3-1, TA 274/3-2, TA 274/5-1]; ERC; MPI-CBG; CRTD; Cancerfonden; Swedish Research Council; Wenner-Gren Foundation	Volkswagen Foundation(Volkswagen); DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); MPI-CBG; CRTD; Cancerfonden(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren Foundation	We are grateful to Heino Andreas, Jitka Michling, Christel Junghans, Sabine Moegel, and Beate Gruhl for dedicated animal care. We thank Dunja Knapp and Serghei Novojilev for advice. Thanks to Joshua Currie for advice and for creating the graphical abstract. Thanks to Christopher Antos, and Ezio Bonifacio, Jeremy Brockes, and Peter Currie for comments on the manuscript. The work from E.M.T.'s lab was supported by grants from the Volkswagen Foundation, DFG (TA 274/2-2, TA 274/3-1, TA 274/3-2, TA 274/5-1), an ERC Advanced Investigator Award, central funds from the MPI-CBG, and CRTD. The work from the Simon lab was supported by grants from Cancerfonden, the Swedish Research Council, ERC, and the Wenner-Gren Foundation.	Blau HM, 2011, JAMA-J AM MED ASSOC, V305, P87, DOI 10.1001/jama.2010.1938; Calve S, 2011, DEV DYNAM, V240, P1233, DOI 10.1002/dvdy.22530; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Rodrigues AMC, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-9; Duckmanton A, 2005, CHEM BIOL, V12, P1117, DOI 10.1016/j.chembiol.2005.07.011; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Grogg MW, 2005, NATURE, V438, P858, DOI 10.1038/nature04175; HAY ED, 1959, DEV BIOL, V1, P555, DOI 10.1016/0012-1606(59)90018-1; Iten L.E., 1973, ARCH ENTWICKLUNGSMEC, V173, P263; JAYNES JB, 1988, MOL CELL BIOL, V8, P62, DOI 10.1128/MCB.8.1.62; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Khattak S., 2009, COLD SPRING HARB PRO, V2009; Khattak S, 2013, STEM CELL REP, V1, P90, DOI 10.1016/j.stemcr.2013.03.002; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; Kumar A, 2000, DEV BIOL, V218, P125, DOI 10.1006/dbio.1999.9569; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Morrison JI, 2010, FASEB J, V24, P750, DOI 10.1096/fj.09-134825; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Nacu E., 2009, COLD SPRING HARB PRO, V2009; Nacu E, 2013, DEVELOPMENT, V140, P513, DOI 10.1242/dev.081752; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Rossi SG, 2000, J NEUROSCI, V20, P919, DOI 10.1523/JNEUROSCI.20-03-00919.2000; Simon A, 2013, WIRES DEV BIOL, V2, P291, DOI 10.1002/wdev.73; Singh SP, 2012, DEV CELL, V22, P879, DOI 10.1016/j.devcel.2012.03.006; Slack JMW, 2006, TRENDS CELL BIOL, V16, P273, DOI 10.1016/j.tcb.2006.04.007; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; Sousa S, 2011, DEVELOPMENT, V138, P3897, DOI 10.1242/dev.064717; Steinfartz S, 2007, J EXP ZOOL PART B, V308B, P139, DOI 10.1002/jez.b.21119; Stocum DL, 2011, DEV DYNAM, V240, P943, DOI 10.1002/dvdy.22553; Suetsugu-Maki R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-103; Tanaka EM, 1997, J CELL BIOL, V136, P155, DOI 10.1083/jcb.136.1.155; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983	38	208	213	1	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					174	187		10.1016/j.stem.2013.11.007	http://dx.doi.org/10.1016/j.stem.2013.11.007			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24268695	Bronze			2022-12-28	WOS:000330835800010
J	Kojima, Y; Kaufman-Francis, K; Studdert, JB; Steiner, KA; Power, MD; Loebel, DAF; Jones, V; Hor, A; de Alencastro, G; Logan, GJ; Teber, ET; Tam, OH; Stutz, MD; Alexander, IE; Pickett, HA; Tam, PPL				Kojima, Yoji; Kaufman-Francis, Keren; Studdert, Joshua B.; Steiner, Kirsten A.; Power, Melinda D.; Loebel, David A. F.; Jones, Vanessa; Hor, Angelyn; de Alencastro, Gustavo; Logan, Grant J.; Teber, Erdahl T.; Tam, Oliver H.; Stutz, Michael D.; Alexander, Ian E.; Pickett, Hilda A.; Tam, Patrick P. L.			The Transcriptional and Functional Properties of Mouse Epiblast Stem Cells Resemble the Anterior Primitive Streak	CELL STEM CELL			English	Article							FLUORESCENT PROTEIN; EXPRESSION PATTERN; PROGENITOR CELLS; TELOMERE-LENGTH; SELF-RENEWAL; ES CELLS; EMBRYOS; PLURIPOTENCY; POSTIMPLANTATION; DIFFERENTIATION	Mouse epiblast stem cells (EpiSCs) can be derived from a wide range of developmental stages. To characterize and compare EpiSCs with different origins, we derived a series of EpiSC lines from pregastrula stage to late-bud-stage mouse embryos. We found that the transcriptomes of these cells are hierarchically distinct from those of the embryonic stem cells, induced pluripotent stem cells (iPSCs), and epiblast/ectoderm. The EpiSCs display globally similar gene expression profiles irrespective of the original developmental stage of the source tissue. They are developmentally similar to the ectoderm of the late-gastrula-stage embryo and behave like anterior primitive streak cells when differentiated in vitro and in vivo. The EpiSC lines that we derived can also be categorized based on a correlation between gene expression signature and predisposition to differentiate into particular germ-layer derivatives. Our findings therefore highlight distinct identifying characteristics of EpiSCs and provide a foundation for further examination of EpiSC properties and potential.	[Kojima, Yoji; Kaufman-Francis, Keren; Studdert, Joshua B.; Steiner, Kirsten A.; Power, Melinda D.; Loebel, David A. F.; Jones, Vanessa; Hor, Angelyn; Tam, Oliver H.; Tam, Patrick P. L.] Childrens Med Res Inst, Embryol Unit, Westmead, NSW 2145, Australia; [de Alencastro, Gustavo; Logan, Grant J.; Alexander, Ian E.] Childrens Med Res Inst, Gene Therapy Res Unit, Westmead, NSW 2145, Australia; [Teber, Erdahl T.] Childrens Med Res Inst, Bioinformat Grp, Westmead, NSW 2145, Australia; [Stutz, Michael D.] Childrens Med Res Inst, Canc Res Unit, Westmead, NSW 2145, Australia; [Loebel, David A. F.; Alexander, Ian E.; Pickett, Hilda A.; Tam, Patrick P. L.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Children's Medical Research Institute - Australia; Children's Medical Research Institute - Australia; Children's Medical Research Institute - Australia; Children's Medical Research Institute - Australia; University of Sydney	Tam, PPL (corresponding author), Childrens Med Res Inst, Embryol Unit, Westmead, NSW 2145, Australia.	ptam@cmri.org.au		/0000-0001-9365-342X; Stutz, Michael/0000-0002-9298-1728; Alexander, Ian E/0000-0002-6213-5627	NHMRC of Australia [632776, 1022498, 1051897]; Mr. James Fairfax; Manpei Suzuki Diabetes Foundation Fellowship; Research Fellowship of Uehara Memorial Foundation; NHMRC [1003100]	NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); Mr. James Fairfax; Manpei Suzuki Diabetes Foundation Fellowship; Research Fellowship of Uehara Memorial Foundation(Uehara Memorial Foundation); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Wethank BioResources staff at CMRI for the care of animals, Dr. Paul Tesar for providing the EpiSC9 line and the RNA sample, and Life Technologies Corporation (Melbourne branch) for assistance with the PCR arrays. Our work is supported by the NHMRC of Australia (grants 632776, 1022498, and 1051897 to G. L., I. E. A., and P. P. L. T.) and Mr. James Fairfax (to CMRI). Y.K. is supported by the Manpei Suzuki Diabetes Foundation Fellowship and the Research Fellowship of Uehara Memorial Foundation. H. A. P. is a Career Development Fellow of Cancer Institute NSW, and P. P. L. T. is a NHMRC Senior Principal Research Fellow (grant 1003100).	Alev C, 2010, DEVELOPMENT, V137, P2863, DOI 10.1242/dev.053462; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bernemann C, 2011, STEM CELLS, V29, P1496, DOI 10.1002/stem.709; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Franklin V.J., 2007, CSH PROTOC; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hart AH, 2002, DEVELOPMENT, V129, P3597; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; Iwafuchi-Doi M, 2012, DEVELOPMENT, V139, P3926, DOI 10.1242/dev.085936; Kim H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3403; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Najm FJ, 2011, NAT METHODS, V8, P957, DOI [10.1038/NMETH.1712, 10.1038/nmeth.1712]; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Pickett HA, 2009, EMBO J, V28, P799, DOI 10.1038/emboj.2009.42; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rivera-Perez JA, 2010, METHOD ENZYMOL, V476, P185, DOI 10.1016/S0076-6879(10)76011-0; Sun BW, 2012, STEM CELLS, V30, P161, DOI 10.1002/stem.793; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; TAM PPL, 1987, DEVELOPMENT, V99, P109; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Varela E, 2011, P NATL ACAD SCI USA, V108, P15207, DOI 10.1073/pnas.1105414108; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095	42	191	197	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					107	120		10.1016/j.stem.2013.09.014	http://dx.doi.org/10.1016/j.stem.2013.09.014			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24139757	Bronze, Green Published			2022-12-28	WOS:000329571900013
J	Miyoshi, H; Stappenbeck, TS				Miyoshi, Hiroyuki; Stappenbeck, Thaddeus S.			The Young and the Wnt-less: Transplantable Fetal Intestinal Spheroids without Wnts	CELL STEM CELL			English	Editorial Material							IN-VITRO; EPITHELIUM		[Miyoshi, Hiroyuki; Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Stappenbeck, TS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	stappenb@wustl.edu		Miyoshi, Hiroyuki/0000-0001-7400-0714	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071619] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK071619] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Kaufman M.H., 1992, ATLAS MOUSE DEV; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Mustata RC, 2013, CELL REP, V5, P421, DOI 10.1016/j.celrep.2013.09.005; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	9	2	2	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					637	638		10.1016/j.stem.2013.11.019	http://dx.doi.org/10.1016/j.stem.2013.11.019			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24315434	Green Accepted, Bronze			2022-12-28	WOS:000329571700002
J	Boiers, C; Carrelha, J; Lutteropp, M; Luc, S; Green, JCA; Azzoni, E; Woll, PS; Mead, AJ; Hultquist, A; Swiers, G; Perdiguero, EG; Macaulay, IC; Melchiori, L; Luis, TC; Kharazi, S; Bouriez-Jones, T; Deng, QL; Ponten, A; Atkinson, D; Jensen, CT; Sitnicka, E; Geissmann, F; Godin, I; Sandberg, R; de Bruijn, MFTR; Jacobsen, SEW				Boiers, Charlotta; Carrelha, Joana; Lutteropp, Michael; Luc, Sidinh; Green, Joanna C. A.; Azzoni, Emanuele; Woll, Petter S.; Mead, Adam J.; Hultquist, Anne; Swiers, Gemma; Perdiguero, Elisa Gomez; Macaulay, Iain C.; Melchiori, Luca; Luis, Tiago C.; Kharazi, Shabnam; Bouriez-Jones, Tiphaine; Deng, Qiaolin; Ponten, Annica; Atkinson, Deborah; Jensen, Christina T.; Sitnicka, Ewa; Geissmann, Frederic; Godin, Isabelle; Sandberg, Rickard; de Bruijn, Marella F. T. R.; Jacobsen, Sten Eirik W.			Lymphomyeloid Contribution of an Immune-Restricted Progenitor Emerging Prior to Definitive Hematopoietic Stem Cells	CELL STEM CELL			English	Article							T-CELL; B-CELL; BONE-MARROW; AGM REGION; YOLK-SAC; MULTIPOTENT PROGENITORS; LYMPHOID PROGENITORS; LINEAGE COMMITMENT; FETAL LIVER; MOUSE	In jawed vertebrates, development of an adaptive immune-system is essential for protection of the born organism against otherwise life-threatening pathogens. Myeloid cells of the innate immune system are formed early in development, whereas lymphopoiesis has been suggested to initiate much later, following emergence of definitive hematopoietic stem cells (HSCs). Herein, we demonstrate that the embryonic lymphoid commitment process initiates earlier than previously appreciated, prior to emergence of definitive HSCs, through establishment of a previously unrecognized entirely immune-restricted and lymphoid-primed progenitor. Notably, this immune-restricted progenitor appears to first emerge in the yolk sac and contributes physiologically to the establishment of lymphoid and some myeloid components of the immune-system, establishing the lymphomyeloid lineage restriction process as an early and physiologically important line-age-commitment step in mammalian hematopoiesis.	[Boiers, Charlotta; Hultquist, Anne; Kharazi, Shabnam; Sitnicka, Ewa] Lund Univ, Lund Stem Cell Ctr, Haematopoiet Stem Cell Lab, S-22184 Lund, Sweden; [Boiers, Charlotta] Lund Univ, Lund Stem Cell Ctr, S-22184 Lund, Sweden; [Carrelha, Joana; Lutteropp, Michael; Luc, Sidinh; Green, Joanna C. A.; Woll, Petter S.; Mead, Adam J.; Macaulay, Iain C.; Melchiori, Luca; Luis, Tiago C.; Bouriez-Jones, Tiphaine; Atkinson, Deborah; Jensen, Christina T.; Jacobsen, Sten Eirik W.] Univ Oxford, Haematopoiet Stem Cell Lab, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Azzoni, Emanuele; Swiers, Gemma; de Bruijn, Marella F. T. R.; Jacobsen, Sten Eirik W.] Univ Oxford, MRC Mol Haematol Unit, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Perdiguero, Elisa Gomez; Geissmann, Frederic] Kings Coll London, Div Immunol Infect & Inflammatory Dis, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England; [Deng, Qiaolin; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Ponten, Annica] Lund Univ, Lund Stem Cell Ctr, Cardiovasc Grp, S-22184 Lund, Sweden; [Godin, Isabelle] Univ Paris 11, INSERM 1009, Inst Natl Sante & Rech Med, F-94805 Villejuif, France; [Jacobsen, Sten Eirik W.] Karolinska Inst, Dept Cell & Mol Biol, Wallenberg Inst Regenerat Med, S-17177 Stockholm, Sweden; [Jacobsen, Sten Eirik W.] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med, S-17177 Stockholm, Sweden	Lund University; Lund University; University of Oxford; University of Oxford; University of London; King's College London; Karolinska Institutet; Lund University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Karolinska Institutet	Jacobsen, SEW (corresponding author), Univ Oxford, Haematopoiet Stem Cell Lab, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	sten.jacobsen@imm.ox.ac.uk	Mead, Adam/A-8796-2012; Azzoni, Emanuele/AAE-8064-2022; Jacobsen, Sten Eirik W/D-3974-2018; Perdiguero, Elisa Gomez/U-2120-2018; Deng, Qiaolin/AAD-6905-2020; GODIN, Isabelle/K-5769-2013	Mead, Adam/0000-0001-8522-1002; Azzoni, Emanuele/0000-0002-4572-5692; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Macaulay, Iain/0000-0002-6761-757X; geissmann, frederic/0000-0001-5029-2468; Deng, Qiaolin/0000-0001-5934-7816; Sandberg, Rickard/0000-0001-6473-1740; GODIN, Isabelle/0000-0001-8577-8388; Woll, Petter S./0000-0002-2340-2526; Luc, Sidinh/0000-0001-7006-6169; Cunha Luis, Tiago/0000-0002-6305-1257; Carrelha, Joana/0000-0002-0324-2617; Boiers, Charlotta/0000-0002-4876-1218	Medical Research Council UK [H4RPLK0]; Knut och Alice Wallenberg Foundation (WIRM); StratRegen, KI; EU; ALF; Swedish Research Council Linnaeus; MRC Molecular Haematology Unit; Leukaemia and Lymphoma Research; Swedish Cancer foundation; Swedish Society of Medicine; Crafoord Foundation; Georg Danielsson's foundation; Medical Research Council [G84/6443, MC_U137970202, MC_UU_12009/2, G1000801h, MC_UU_12009/5, G0501838, G0900867, G0801073] Funding Source: researchfish; MRC [G84/6443, G0900867, G0801073, MC_UU_12009/5, MC_UU_12009/2, G0501838, MC_U137970202] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Knut och Alice Wallenberg Foundation (WIRM); StratRegen, KI; EU(European Commission); ALF; Swedish Research Council Linnaeus(Swedish Research Council); MRC Molecular Haematology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia and Lymphoma Research; Swedish Cancer foundation; Swedish Society of Medicine; Crafoord Foundation; Georg Danielsson's foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Lilian Wittmann, Ingbritt Astrand-Grundstrom, and Hanane Boukarabila for skillful technical assistance, the Biomedical Services at Oxford University for expert animal support, and Sally-Ann Clark, Paul Sopp, and the WIMM FACS facility for FACS support. Asa Bjorklund, Daniel Ramskold, and Ersen Kavak are thanked for skillful technical assistance with the RNA sequencing. This work was supported by a programme grant (H4RPLK0) from the Medical Research Council UK (S.E.W.J.), Knut och Alice Wallenberg Foundation (WIRM; S.E.W.J.), StratRegen, KI (S.E.W.J.), EU-FP7 EuroSyStem Integrated projects (S.E.W.J.), ALF (Government Public Health Grant; C.B.), the Hemato-Linne grant (Swedish Research Council Linnaeus; S.E.W.J.), the MRC Molecular Haematology Unit core award (M.F.T.R.d.-B., E.A., S.E.W.J.), a Leukaemia and Lymphoma Research project grant (M.B., G.S.), Swedish Cancer foundation (A.H.), Swedish Society of Medicine (A.H.), Crafoord Foundation (A.H.), Georg Danielsson's foundation (A.H.), and the Leukaemia and Lymphoma Research Senior Bennett Fellowship (A.J.M.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Bene MC, 2009, HAEMATOL-HEMATOL J, V94, P891, DOI 10.3324/haematol.2009.007799; Boyer SW, 2012, CELL CYCLE, V11, P3180, DOI 10.4161/cc.21279; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Buza-Vidas N, 2011, BLOOD, V118, P1544, DOI 10.1182/blood-2010-10-316232; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cunningham-Rundles C, 2005, NAT REV IMMUNOL, V5, P880, DOI 10.1038/nri1713; Douagi I, 2002, SEMIN IMMUNOL, V14, P361, DOI 10.1016/S1044532302000702; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Ehrlich LIR, 2011, BLOOD, V117, P2618, DOI 10.1182/blood-2010-05-287102; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Ikawa T, 2004, BLOOD, V103, P530, DOI 10.1182/blood-2003-06-1797; Katsura Y, 2001, Int Rev Immunol, V20, P1, DOI 10.3109/08830180109056720; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Kieusseian A, 2012, DEVELOPMENT, V139, P3521, DOI 10.1242/dev.079210; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Luc S, 2008, SEMIN IMMUNOL, V20, P213, DOI 10.1016/j.smim.2008.07.005; Luc S, 2008, BLOOD, V111, P3424, DOI 10.1182/blood-2007-08-108324; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; Ohmura K, 1999, J IMMUNOL, V163, P4788; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; OWEN JJT, 1969, J EXP MED, V129, P431, DOI 10.1084/jem.129.2.431; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Rybtsov S, 2011, J EXP MED, V208, P1305, DOI 10.1084/jem.20102419; Schlenner SM, 2010, TRENDS IMMUNOL, V31, P303, DOI 10.1016/j.it.2010.06.002; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; Welner RS, 2009, J IMMUNOL, V183, P7768, DOI 10.4049/jimmunol.0902333; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Yokota T, 2006, DEVELOPMENT, V133, P2041, DOI 10.1242/dev.02349; Yoshimoto M, 2012, BLOOD, V119, P5706, DOI 10.1182/blood-2011-12-397489; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557	52	162	167	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					535	548		10.1016/j.stem.2013.08.012	http://dx.doi.org/10.1016/j.stem.2013.08.012			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24054998	Green Submitted, Bronze			2022-12-28	WOS:000329571500007
J	Malouf, C; Ottersbach, K				Malouf, Camille; Ottersbach, Katrin			The Unconventional Embryo: Immune-Restricted Potential Precedes Multipotentiality	CELL STEM CELL			English	Editorial Material							YOLK-SAC; LINEAGE	Little is currently known about the developmental origins of the immune system and the lineage restriction processes that lead to its establishment. In this issue, Boiers et al. (2013) now demonstrate immune-restricted potential originating from the yolk sac even before the emergence of the first hematopoietic stem cells.	[Malouf, Camille; Ottersbach, Katrin] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 0XY, England	University of Cambridge	Ottersbach, K (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 0XY, England.	ko268@cam.ac.uk		Malouf, Camille/0000-0002-1066-8376; Ottersbach, Katrin/0000-0002-6880-4895	Wellcome Trust [100140, 079249] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Frame J.M., 2013, BLOOD CELLS IN PRESS; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Yoshimoto M, 2012, BLOOD, V119, P5706, DOI 10.1182/blood-2011-12-397489; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108	8	1	1	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					509	510		10.1016/j.stem.2013.10.015	http://dx.doi.org/10.1016/j.stem.2013.10.015			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24209755	Bronze			2022-12-28	WOS:000329571500002
J	Willenbring, H; Soto-Gutierrez, A				Willenbring, Holger; Soto-Gutierrez, Alejandro			Transplantable Liver Organoids Made from Only Three Ingredients	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; BLOOD-VESSELS; IN-VIVO; REGENERATION	Liver cell therapies using induced pluripotent stem cells (iPSCs) are in development. A recent paper in Nature by Takebe et al. expands the range of liver diseases that could be treated with iPSC-derived hepatocytes by combining them with endothelial and stromal cells to generate organoids that survive and function extrahepatically.	[Willenbring, Holger] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Surg, San Francisco, CA 94143 USA; [Willenbring, Holger] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; [Soto-Gutierrez, Alejandro] Univ Pittsburgh, Childrens Hosp Pittsburgh, McGowan Inst Regenerat Med, Dept Pathol, Pittsburgh, PA 15231 USA; [Soto-Gutierrez, Alejandro] Univ Pittsburgh, Childrens Hosp Pittsburgh, McGowan Inst Regenerat Med, Dept Surg, Pittsburgh, PA 15231 USA; [Soto-Gutierrez, Alejandro] Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15231 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Willenbring, H (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Surg, San Francisco, CA 94143 USA.	willenbringh@stemcell.ucsf.edu; sotogutierreza@upmc.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000487, UH3TR000487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R00DK083556] Funding Source: NIH RePORTER; NCATS NIH HHS [UH2 TR000487, UH3 TR000487] Funding Source: Medline; NIDDK NIH HHS [P30 DK26743, P30 DK026743, R00 DK083556] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Gruenloh W, 2011, TISSUE ENG PT A, V17, P1517, DOI [10.1089/ten.tea.2010.0460, 10.1089/ten.TEA.2010.0460]; Hoppo T, 2011, GASTROENTEROLOGY, V140, P656, DOI 10.1053/j.gastro.2010.11.006; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Liu LP, 2012, HEPATOLOGY, V55, P1529, DOI 10.1002/hep.24815; Puppi J, 2012, CELL TRANSPLANT, V21, P1, DOI 10.3727/096368911X566208; Takebe T., 2013, NATURE IN PRESS, DOI DOI 10.1038/NATURE12271; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	10	7	8	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					139	140		10.1016/j.stem.2013.07.014	http://dx.doi.org/10.1016/j.stem.2013.07.014			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910079	Green Accepted, Bronze			2022-12-28	WOS:000329570600005
J	Carraro, G; Stripp, BR				Carraro, Gianni; Stripp, Barry R.			A New Notch for Lung Stem Cells	CELL STEM CELL			English	Editorial Material							DIFFERENTIATION; SUBPOPULATIONS	Homeostasis and repair of different lung compartments require the selective activation of specific progenitor/stem cells and their regulated differentiation to yield cell types that fulfill specialized regional functions. In this issue of Cell Stem Cell, Pardo-Saganta et al. (2015) identify Notch signaling as a determinant of basal cell heterogeneity and fate decisions in pseudostratified airways.	[Carraro, Gianni; Stripp, Barry R.] Cedars Sinai Med Ctr, Lung Inst, Dept Med Sci, Los Angeles, CA 90048 USA; [Carraro, Gianni; Stripp, Barry R.] Cedars Sinai Med Ctr, Lung Inst, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Carraro, Gianni; Stripp, Barry R.] Cedars Sinai Med Ctr, Regenerat Med Inst, Dept Med Sci, Los Angeles, CA 90048 USA; [Carraro, Gianni; Stripp, Barry R.] Cedars Sinai Med Ctr, Regenerat Med Inst, Dept Biomed Sci, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Stripp, BR (corresponding author), Cedars Sinai Med Ctr, Lung Inst, Dept Med Sci, Los Angeles, CA 90048 USA.	barry.stripp@cshs.org	Stripp, Barry/AAI-1467-2021	Carraro, Gianni/0000-0003-0824-7692; Stripp, Barry/0000-0003-4348-2137				Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Mori M, 2015, DEVELOPMENT, V142, P258, DOI 10.1242/dev.116855; Pan JH, 2014, STEM CELLS, V32, P3245, DOI 10.1002/stem.1814; Pardo-Saganta A, 2015, CELL STEM CELL, V16, P184, DOI 10.1016/j.stem.2015.01.002; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Teixeira VH, 2013, ELIFE, V2, DOI 10.7554/eLife.00966; Vaughan A.E., 2014, NATURE IN PRESS	8	5	5	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					107	109		10.1016/j.stem.2015.01.012	http://dx.doi.org/10.1016/j.stem.2015.01.012			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25658364	Bronze			2022-12-28	WOS:000349455000003
J	Crossan, GP; Garaycoechea, JI; Patel, KJ				Crossan, Gerry P.; Garaycoechea, Juan I.; Patel, Ketan J.			Do Mutational Dynamics in Stem Cells Explain the Origin of Common Cancers?	CELL STEM CELL			English	Editorial Material							CLONAL HEMATOPOIESIS; TISSUES; RISK	For more than 60 years, we have known that the incidence of certain common human cancers increases with age. Recently in Science, Tomasetti and Vogelstein (2015) refined this model by providing a potential explanation, arguing that early random mutational events within individual stem cells of regenerating organs may underlie this correlation.	[Crossan, Gerry P.; Garaycoechea, Juan I.; Patel, Ketan J.] MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Crossan, GP (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.	gcrossan@mrc-lmb.cam.ac.uk; kjp@mrc-lmb.cam.ac.uk		Crossan, Gerry/0000-0002-7974-009X	Cancer Research UK [13647] Funding Source: researchfish; Wellcome Trust [106202/Z/14/Z] Funding Source: researchfish; Medical Research Council [MC_U105178811] Funding Source: Medline; MRC [MC_U105178811] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Garaycoechea JI, 2014, BLOOD, V123, P26, DOI 10.1182/blood-2013-09-427740; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110	9	6	6	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					111	112		10.1016/j.stem.2015.01.009	http://dx.doi.org/10.1016/j.stem.2015.01.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25658366	Bronze			2022-12-28	WOS:000349455000005
J	Kramann, R; Schneider, RK; DiRocco, DP; Machado, F; Fleig, S; Bondzie, PA; Henderson, JM; Ebert, BL; Humphreys, BD				Kramann, Rafael; Schneider, Rebekka K.; DiRocco, Derek P.; Machado, Flavia; Fleig, Susanne; Bondzie, Philip A.; Henderson, Joel M.; Ebert, Benjamin L.; Humphreys, Benjamin D.			Perivascular Gli1(+) Progenitors Are Key Contributors to Injury-Induced Organ Fibrosis	CELL STEM CELL			English	Article							MESENCHYMAL STEM-CELLS; BONE-MARROW NICHE; GROWTH FACTOR-AA; SONIC HEDGEHOG; NG2 PROTEOGLYCAN; ORIGIN; EXPRESSION; REGULATOR; PATHWAY; MYOFIBROBLASTS	Mesenchymal stem cells (MSCs) reside in the perivascular niche of many organs, including kidney, lung, liver, and heart, although their roles in these tissues are poorly understood. Here, we demonstrate that Gli1 marks perivascular MSC-like cells that substantially contribute to organ fibrosis. In vitro, Gli1(+) cells express typical MSC markers, exhibit trilineage differentiation capacity, and possess colony-forming activity, despite constituting a small fraction of the platelet-derived growth factor-beta (PDGFR beta)(+) cell population. Genetic lineage tracing analysis demonstrates that tissue-resident, but not circulating, Gli1(+) cells proliferate after kidney, lung, liver, or heart injury to generate myofibroblasts. Genetic ablation of these cells substantially ameliorates kidney and heart fibrosis and preserves ejection fraction in a model of induced heart failure. These findings implicate perivascular Gli1(+) MSC-like cells as a major cellular origin of organ fibrosis and demonstrate that these cells may be a relevant therapeutic target to prevent solid organ dysfunction after injury.	[Kramann, Rafael; DiRocco, Derek P.; Machado, Flavia; Fleig, Susanne; Humphreys, Benjamin D.] Harvard Univ, Sch Med, Dept Med, Renal Div,Brigham & Womens Hosp, Boston, MA 02115 USA; [Kramann, Rafael] Rhein Westfal TH Aachen, Div Nephrol & Clin Immunol, D-52074 Aachen, Germany; [Kramann, Rafael] Rhein Westfal TH Aachen, Fac Med, D-52074 Aachen, Germany; [Schneider, Rebekka K.; Ebert, Benjamin L.] Harvard Univ, Sch Med, Dept Med, Div Hematol,Brigham & Womens Hosp, Boston, MA 02115 USA; [Bondzie, Philip A.; Henderson, Joel M.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Ebert, Benjamin L.; Humphreys, Benjamin D.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; RWTH Aachen University; RWTH Aachen University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University; Harvard University	Kramann, R (corresponding author), Harvard Univ, Sch Med, Dept Med, Renal Div,Brigham & Womens Hosp, Boston, MA 02115 USA.	rkramann@gmx.net; bhumphreys@partners.org	Fleig, Susanne/AHA-7209-2022; Kramann, Rafael/K-7995-2013	Fleig, Susanne/0000-0002-2886-2222; Bondzie, Philip Apraku/0000-0002-9755-6130; Kramann, Rafael/0000-0003-4048-6351	NIH/NIDDK [DK088923, DK103050]; NIDDK Diabetic Complications Consortium [DK076169]; Harvard Stem Cell Institute; American Heart Association; Deutsche Forschungsgemeinschaft [Kr 40731-1, Schn 1188/3-1]; Evotec AG; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103050, R01DK088923, U24DK076169] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK Diabetic Complications Consortium; Harvard Stem Cell Institute; American Heart Association(American Heart Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Evotec AG; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NIDDK (DK088923 and DK103050), the NIDDK Diabetic Complications Consortium (DK076169), the Harvard Stem Cell Institute (B.D.H.), an Established Investigator Award of the American Heart Association (B.D.H.), and a fellowship from the Deutsche Forschungsgemeinschaft (to R.K., Kr 40731-1, and R.K.S., Schn 1188/3-1). We thank Sudeshna Fisch and Soeun Ngoy from the cardiovascular core of the Brigham and Women's Hospital and Janewit Wongboonsin for technical support. B.D.H. has received research funding in the past from Evotec AG for discovery of antifibrotic therapies.	Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Atkins R, 1875, Br Med J, V1, P444; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Carlson S, 2011, CARDIOVASC RES, V91, P99, DOI 10.1093/cvr/cvr061; Cilloni D, 2000, BLOOD, V96, P3637; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; DANIS A, 1957, Acta Chir Belg, V56, P1; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Goretzki L, 1999, J BIOL CHEM, V274, P16831, DOI 10.1074/jbc.274.24.16831; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Kramann R, 2014, J AM SOC NEPHROL, V25, P1924, DOI 10.1681/ASN.2013101121; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Le YZ, 2006, MOL VIS, V12, P389; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Maccallum J B, 1899, J Exp Med, V4, P409, DOI 10.1084/jem.4.3-4.409; Merchant A, 2010, BLOOD, V115, P2391, DOI 10.1182/blood-2009-09-241703; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Murfee WL, 2006, MICROCIRCULATION, V13, P261, DOI 10.1080/10739680600559153; Murray IR, 2014, CELL MOL LIFE SCI, V71, P1353, DOI 10.1007/s00018-013-1462-6; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pelekanos RA, 2012, STEM CELL RES, V8, P58, DOI 10.1016/j.scr.2011.08.003; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Pola R, 2003, CIRCULATION, V108, P479, DOI 10.1161/01.CIR.0000080338.60981.FA; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Schrimpf C, 2014, J VASC RES, V51, P247, DOI 10.1159/000365149; Shikada Y, 2005, CANCER RES, V65, P7241, DOI 10.1158/0008-5472.CAN-04-4171; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; WEBER KT, 1995, EUR HEART J, V16, P24, DOI 10.1093/eurheartj/16.suppl_C.24; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhao H, 2014, CELL STEM CELL, V14, P160, DOI 10.1016/j.stem.2013.12.013	50	560	575	12	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					51	66		10.1016/j.stem.2014.11.004	http://dx.doi.org/10.1016/j.stem.2014.11.004			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25465115	Green Accepted, Bronze			2022-12-28	WOS:000347708400011
J	Paul, MK; Bisht, B; Darmawan, DO; Chiou, R; Ha, VL; Wallace, WD; Chon, AT; Hegab, AE; Grogan, T; Elashoff, DA; Alva-Ornelas, JA; Gomperts, BN				Paul, Manash K.; Bisht, Bharti; Darmawan, Daphne O.; Chiou, Richard; Ha, Vi L.; Wallace, William D.; Chon, Andrew T.; Hegab, Ahmed E.; Grogan, Tristan; Elashoff, David A.; Alva-Ornelas, Jackelyn A.; Gomperts, Brigitte N.			Dynamic Changes in Intracellular ROS Levels Regulate Airway Basal Stem Cell Homeostasis through Nrf2-Dependent Notch Signaling	CELL STEM CELL			English	Article							SELF-RENEWAL; NRF2; ACTIVATION; PATHWAY; CANCER; MAINTENANCE; ROLES; PROLIFERATION; MECHANISMS; STRESS	Airways are exposed to myriad environmental and damaging agents such as reactive oxygen species (ROS), which also have physiological roles as signaling molecules that regulate stem cell function. However, the functional significance of both steady and dynamically changing ROS levels in different stem cell populations, as well as downstream mechanisms that integrate ROS sensing into decisions regarding stem cell homeostasis, are unclear. Here, we show in mouse and human airway basal stem cells (ABSCs) that intracellular flux from low to moderate ROS levels is required for stem cell self-renewal and proliferation. Changing ROS levels activate Nrf2, which activates the Notch pathway to stimulate ABSC self-renewal and an antioxidant program that scavenges intracellular ROS, returning overall ROS levels to a low state to maintain homeostatic balance. This redox-mediated regulation of lung stem cell function has significant implications for stem cell biology, repair of lung injuries, and diseases such as cancer.	[Paul, Manash K.; Bisht, Bharti; Darmawan, Daphne O.; Chiou, Richard; Ha, Vi L.; Chon, Andrew T.; Alva-Ornelas, Jackelyn A.; Gomperts, Brigitte N.] Univ Calif Los Angeles, Dept Pediat, Mattel Childrens Hosp, Los Angeles, CA 90095 USA; [Wallace, William D.] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA; [Hegab, Ahmed E.] Keio Univ, Sch Med, Dept Med, Div Pulm Med, Tokyo 1608582, Japan; [Grogan, Tristan; Elashoff, David A.] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90095 USA; [Elashoff, David A.; Gomperts, Brigitte N.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Gomperts, Brigitte N.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Gomperts, Brigitte N.] Univ Calif Los Angeles, Eli & Edythe Broad Stem Cell Res Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Keio University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gomperts, BN (corresponding author), Univ Calif Los Angeles, Dept Pediat, Mattel Childrens Hosp, Los Angeles, CA 90095 USA.	bgomperts@mednet.ucla.edu	Paul, Manash K/AAX-9962-2020	Paul, Manash K/0000-0002-9404-0024	California Institute for Regenerative Medicine (CIRM) [RN2-00904-1]; National Heart, Lung, and Blood Institute (NHLBI) [HL094561]; American Thoracic Society [ATS-06-065]; Concern Foundation; UCLA Jonsson Comprehensive Cancer Center Impact Award; UCLA Jonsson Comprehensive Cancer Center Thoracic Oncology Program/Lung Cancer SPORE; University of California Cancer Research Coordinating Committee; Gwynne Hazen Cherry Memorial Laboratories; National Cancer Institute (NCI) [P30CA016042]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094561] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Thoracic Society; Concern Foundation; UCLA Jonsson Comprehensive Cancer Center Impact Award; UCLA Jonsson Comprehensive Cancer Center Thoracic Oncology Program/Lung Cancer SPORE; University of California Cancer Research Coordinating Committee(University of California System); Gwynne Hazen Cherry Memorial Laboratories; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank Dr. William H. McBride for the Nrf2<SUP>-/-</SUP> mice and Dr. Kupiec-Weglinski and Dr. Yamamoto for the Keap1<SUP>fl/fl</SUP> mice. We thank Dr. Gerry Weinmaster for helpful discussions and reagents. pIRES Puro-Nrf2 V36 del and pIRES Puro-Nrf2 E821 mutant plasmids are kindly provided by Dr. Aikseng Ooi. We are grateful to Dr. K. Plath, Dr. V. Hartenstein, Dr. T. Chatila, Dr. D. Shackelford, and Dr. G. Crooks for critically reading the manuscript. This work was supported by California Institute for Regenerative Medicine (CIRM) (RN2-00904-1), National Heart, Lung, and Blood Institute (NHLBI) (HL094561), American Thoracic Society (ATS-06-065), the Concern Foundation, the UCLA Jonsson Comprehensive Cancer Center Impact Award, the UCLA Jonsson Comprehensive Cancer Center Thoracic Oncology Program/Lung Cancer SPORE, the University of California Cancer Research Coordinating Committee, and the Gwynne Hazen Cherry Memorial Laboratories (to B.N.G.). We appreciate assistance from the UCLA Eli and Edythe Broad Stem Cell Research Center Microscopy core and Flow Cytometry Core, the Electron Microscopy Services Center of the UCLA Brain Research Institute (under the supervision of Sirus Kohan), and the statistical analyses were supported by the NIH National Center for Advancing Translational Sciences (NCATS) UCLA CTSI (UL1TR000124). Research reported in this publication includes work performed in the Jonsson Comprehensive Cancer Center Flow Cytometry Core facility supported by the National Cancer Institute (NCI) (P30CA016042).	Barreiro E, 2010, AM J RESP CRIT CARE, V182, P477, DOI 10.1164/rccm.200908-1220OC; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Borthwick DW, 2001, AM J RESP CELL MOL, V24, P662, DOI 10.1165/ajrcmb.24.6.4217; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Gao X, 2013, P NATL ACAD SCI USA, V110, P9356, DOI 10.1073/pnas.1307589110; Ghosh M, 2013, AM J RESP CELL MOL, V49, P1127, DOI 10.1165/rcmb.2013-0049OC; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hegab AE, 2012, STEM CELL TRANSL MED, V1, P719, DOI 10.5966/sctm.2012-0056; Hegab AE, 2012, JOVE-J VIS EXP, DOI 10.3791/3731; Hegab AE, 2011, STEM CELLS, V29, P1283, DOI 10.1002/stem.680; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kim JH, 2014, J CLIN INVEST, V124, P730, DOI 10.1172/JCI70812; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Luxenburg C, 2011, NAT CELL BIOL, V13, P203, DOI 10.1038/ncb2163; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Malkoski SP, 2010, INT J BIOL SCI, V6, P68; McDonald JT, 2010, CANCER RES, V70, P8886, DOI 10.1158/0008-5472.CAN-10-0171; Morimoto H, 2013, CELL STEM CELL, V12, P774, DOI 10.1016/j.stem.2013.04.001; Myant KB, 2013, CELL STEM CELL, V12, P761, DOI 10.1016/j.stem.2013.04.006; Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114; Nakamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036209; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Ooi A, 2013, CANCER RES, V73, P2044, DOI 10.1158/0008-5472.CAN-12-3227; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Satoh H, 2010, CARCINOGENESIS, V31, P1833, DOI 10.1093/carcin/bgq105; Snyder JC, 2009, J PATHOL, V217, P254, DOI 10.1002/path.2473; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Wang K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.50; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106	48	180	189	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					199	214		10.1016/j.stem.2014.05.009	http://dx.doi.org/10.1016/j.stem.2014.05.009			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	24953182	Green Accepted, Bronze			2022-12-28	WOS:000340880100012
J	Khalaj, M; Park, CY				Khalaj, Mona; Park, Christopher Y.			Notch One Up to Stroma: Endothelial Notch Prevents Inflammation and Myeloproliferation	CELL STEM CELL			English	Editorial Material								In this issue of Cell Stem Cell, Wang et al. (2014) describe a signaling axis present in bone marrow stromal cells that suppresses inflammation and myeloid expansions. Loss of endothelial Notch signaling leads to deregulation of miR-155 expression, activation of NF-kappa B, and increased proinflammatory cytokine production, which promotes a myeloproliferative phenotype.	[Khalaj, Mona; Park, Christopher Y.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Dept Pathol, New York, NY 10065 USA; [Khalaj, Mona; Park, Christopher Y.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Dept Lab Med, New York, NY 10065 USA; [Khalaj, Mona; Park, Christopher Y.] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Park, CY (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Dept Pathol, New York, NY 10065 USA.	parkc@mskcc.org						Kim YW, 2008, BLOOD, V112, P4628, DOI 10.1182/blood-2008-03-148999; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Sandy AR, 2009, EXPERT OPIN BIOL TH, V9, P1383, DOI 10.1517/14712590903260777; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Wang L, 2014, CELL STEM CELL, V15, P51, DOI 10.1016/j.stem.2014.04.021; Weber JM, 2010, BONE, V46, P281, DOI 10.1016/j.bone.2009.08.007; Yao D, 2011, BLOOD, V117, P5652, DOI 10.1182/blood-2010-12-326074; Yoda M, 2011, BLOOD, V118, P6939, DOI 10.1182/blood-2011-06-357210	10	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					1	2		10.1016/j.stem.2014.06.010	http://dx.doi.org/10.1016/j.stem.2014.06.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24996160	Bronze			2022-12-28	WOS:000340878600001
J	Zhao, JL; Ma, C; O'Connell, RM; Mehta, A; DiLoreto, R; Heath, JR; Baltimore, D				Zhao, Jimmy L.; Ma, Chao; O'Connell, Ryan M.; Mehta, Arnav; DiLoreto, Race; Heath, James R.; Baltimore, David			Conversion of Danger Signals into Cytokine Signals by Hematopoietic Stem and Progenitor Cells for Regulation of Stress-Induced Hematopoiesis	CELL STEM CELL			English	Article							NF-KAPPA-B; IN-VIVO; IMMUNE; MICE; CANCER; BLOOD	During an infection, the body increases the output of mature immune cells in order to fight off the pathogen. Despite convincing evidence that hematopoietic stem and progenitor cells (HSPCs) can sense pathogens directly, how this contributes to hematopoietic cell output remains unknown. Here, we have combined mouse models with a single-cell proteomics platform to show that, in response to Toll-like receptor stimulation, short-term HSCs and multipotent progenitor cells produce copious amounts of diverse cytokines through nuclear factor kappa B (NF-kappa B) signaling. Interestingly, the cytokine production ability of HSPCs trumps mature immune cells in both magnitude and breadth. Among cytokines produced by HSPCs, IL-6 is a particularly important regulator of myeloid differentiation and HSPC proliferation in a paracrine manner and in mediating rapid myeloid cell recovery during neutropenia. This study has uncovered an important property of HSPCs that enables them to convert danger signals into versatile cytokine signals for the regulation of stress hematopoiesis.	[Zhao, Jimmy L.; Mehta, Arnav; Baltimore, David] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Ma, Chao; DiLoreto, Race; Heath, James R.] CALTECH, NanoSyst Biol Canc Ctr, Pasadena, CA 91125 USA; [Heath, James R.] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA; [O'Connell, Ryan M.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Utah System of Higher Education; University of Utah	Zhao, JL (corresponding author), CALTECH, Div Biol & Biol Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	jzhao@caltech.edu; heath@caltech.edu; baltimo@caltech.edu		DiLoreto, Rose/0000-0001-8565-5281; Mehta, Arnav/0000-0002-0313-2848	National Research Service Award [F30HL110691]; UCLA/Caltech Medical Scientist Training Program; Rosen Fellowship; NIH New Innovator Award [DP2GM111099]; Pathway to Independence Award [R00HL102228]; American Cancer Society Research grant; NIH [R01CA170689, 5U54CA119347]; National Institute of Allergy and Infectious Diseases [R01AI079243]; NATIONAL CANCER INSTITUTE [U54CA151819, R01CA170689, U54CA119347] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL110691, R00HL102228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM111099, T32GM008042] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA/Caltech Medical Scientist Training Program; Rosen Fellowship; NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research grant(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank Caltech animal facility and flow cytometry core facility and Drs. Alejandro Balazs, Devdoot Majumdar, and Michael Bethune of the D. B. lab for their help. RELA-GFP knockin and NF-kappa B-eGFP reporter mice were obtained from Dr. Manolis Pasparakis of the University of Cologne and Dr. Christian Jobin of the University of North Carolina, respectively. The work was supported by research grants R01AI079243 (D. B.), R01CA170689 (J.R.H.), National Research Service Award F30HL110691 (J.L.Z.), UCLA/Caltech Medical Scientist Training Program (J.L.Z. and A. M.), Rosen Fellowship (C. M.), NIH New Innovator Award DP2GM111099 (R.M.O.), the Pathway to Independence Award R00HL102228 (R.M.O.), and an American Cancer Society Research grant (R.M.O.) with core facilities support from 5U54CA119347 (J.R.H.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bennett CL, 2013, NEW ENGL J MED, V368, P1131, DOI 10.1056/NEJMct1210890; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; De Lorenzi R, 2009, GENESIS, V47, P323, DOI 10.1002/dvg.20468; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Han J, 2010, BLOOD, V115, P957, DOI 10.1182/blood-2009-05-219923; HARRISON DE, 1991, BLOOD, V78, P1237; Jaiswal S, 2009, ANN NY ACAD SCI, V1174, P118, DOI 10.1111/j.1749-6632.2009.04930.x; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375; Maeda K, 2009, BLOOD, V113, P4534, DOI 10.1182/blood-2008-12-192559; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Megias J, 2012, STEM CELLS, V30, P1486, DOI 10.1002/stem.1110; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Pronk CJH, 2011, J EXP MED, V208, P1563, DOI 10.1084/jem.20110752; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shen Y, 2012, CURR OPIN HEMATOL, V19, P250, DOI 10.1097/MOH.0b013e328353c714; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Zhao JL, 2013, ELIFE, V2, DOI 10.7554/eLife.00537; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	32	216	218	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					445	459		10.1016/j.stem.2014.01.007	http://dx.doi.org/10.1016/j.stem.2014.01.007			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24561084	Bronze, Green Accepted			2022-12-28	WOS:000334766400009
J	Lu, JF; Bradley, RA; Zhang, SC				Lu, Jianfeng; Bradley, Robert A.; Zhang, Su-Chun			Turning Reactive Glia into Functional Neurons in the Brain	CELL STEM CELL			English	Editorial Material							FIBROBLASTS; CELLS	Following brain injury, reactive glial cells can create scars that inhibit neural repair responses. In this issue of Cell Stem Cell, Guo et al. report that overexpression of NeuroD1 in vivo can directly reprogram reactive glial cells into glutamatergic and GABAergic neurons that integrate into the host's neural circuitry.	[Lu, Jianfeng; Bradley, Robert A.; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA; [Lu, Jianfeng; Bradley, Robert A.; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, SC (corresponding author), Univ Wisconsin, Waisman Ctr, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA.	zhang@waisman.wisc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100031, R01MH099587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045926, R01NS076352] Funding Source: NIH RePORTER; NICHD NIH HHS [P30 HD003352] Funding Source: Medline; NIGMS NIH HHS [T32 GM007215] Funding Source: Medline; NIMH NIH HHS [P50 MH100031, R01 MH099587] Funding Source: Medline; NINDS NIH HHS [R01 NS076352, R01 NS045926] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Lu JF, 2013, CELL REP, V3, P1580, DOI 10.1016/j.celrep.2013.04.004; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015	9	12	13	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					133	134		10.1016/j.stem.2014.01.010	http://dx.doi.org/10.1016/j.stem.2014.01.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24506877	Bronze, Green Accepted			2022-12-28	WOS:000330835800002
J	Choi, YS; Zhang, YH; Xu, MG; Yang, YG; Ito, M; Peng, T; Cui, Z; Nagy, A; Hadjantonakis, AK; Lang, RA; Cotsarelis, G; Andl, T; Morrisey, EE; Millar, SE				Choi, Yeon Sook; Zhang, Yuhang; Xu, Mingang; Yang, Yongguang; Ito, Mayumi; Peng, Tien; Cui, Zheng; Nagy, Andras; Hadjantonakis, Anna-Katerina; Lang, Richard A.; Cotsarelis, George; Andl, Thomas; Morrisey, Edward E.; Millar, Sarah E.			Distinct Functions for Wnt/beta-Catenin in Hair Follicle Stem Cell Proliferation and Survival and Interfollicular Epidermal Homeostasis	CELL STEM CELL			English	Article							BETA-CATENIN; GENE-EXPRESSION; MORPHOGENESIS; ACTIVATION; BULGE; DIFFERENTIATION; KERATINOCYTES; MAINTENANCE; INITIATION; PROTEINS	Wnt/beta-catenin signaling is a central regulator of adult stem cells. Variable sensitivity of Wnt reporter transgenes, beta-catenin's dual roles in adhesion and signaling, and hair follicle degradation and inflammation resulting from broad deletion of epithelial beta-catenin have precluded clear understanding of Wnt/beta-catenin's functions in adult skin stem cells. By inducibly deleting beta-catenin globally in skin epithelia, only in hair follicle stem cells, or only in interfollicular epidermis and comparing the phenotypes with those caused by ectopic expression of the Wnt/beta-catenin inhibitor Dkk1, we show that this pathway is necessary for hair follicle stem cell proliferation. However, beta-catenin is not required within hair follicle stem cells for their maintenance, and follicles resume proliferating after ectopic Dkk1 has been removed, indicating persistence of functional progenitors. We further unexpectedly discovered a broader role for Wnt/beta-catenin signaling in contributing to progenitor cell proliferation in nonhairy epithelia and interfollicular epidermis under homeostatic, but not inflammatory, conditions.	[Choi, Yeon Sook; Zhang, Yuhang; Xu, Mingang; Ito, Mayumi; Cotsarelis, George; Andl, Thomas; Millar, Sarah E.] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; [Zhang, Yuhang; Yang, Yongguang] Univ Cincinnati, Coll Pharm, Div Pharmaceut Sci, Cincinnati, OH 45267 USA; [Peng, Tien; Cui, Zheng; Morrisey, Edward E.] Univ Penn, Perelman Sch Med, Dept Med, Div Cardiol, Philadelphia, PA 19104 USA; [Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Hadjantonakis, Anna-Katerina] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Ophthalmol, Cincinnati, OH 45229 USA; [Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Millar, Sarah E.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Memorial Sloan Kettering Cancer Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; Pennsylvania Medicine	Morrisey, EE (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Cardiol, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu; millars@mail.med.upenn.edu	Nagy, Andras/G-6465-2013; Zhang, Yuhang/AAC-8583-2019	Nagy, Andras/0000-0003-4311-0413; Zhang, Yuhang/0000-0002-9738-5343; Lang, Richard/0000-0002-5212-254X; Andl, Thomas/0000-0002-5555-468X; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124	NIAMS [R37AR47709]; Penn SDRC [P30AR057217]; University of Cincinnati NIEHS [P30-ES006096, UL1RR026314]; NHLBI [HL087825, HL100405, HL110942]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052115] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748, P30CA016520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016241, R01EY021636] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405, U01HL110942, R01HL087825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057217, R01AR055309, R01AR047709, R37AR047709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Penn SDRC; University of Cincinnati NIEHS; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Adam Glick for Krt5-rtTA mice, Boris Jerchow and Walter Birchmeier for Axin2<SUP>lacZ</SUP> mice, Pierre Coulombe for anti-KRT17, and Jean Richa for production of transgenic mice. This work was supported by NIAMS R37AR47709 and the Penn SDRC P30AR057217 (S. E. M.); University of Cincinnati NIEHS P30-ES006096 and UL1RR026314 (Y.Z.); and NHLBI HL087825, HL100405, and HL110942 (E.E.M.).	Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Augustin I, 2013, J EXP MED, V210, P1761, DOI 10.1084/jem.20121871; Brault V, 2001, DEVELOPMENT, V128, P1253; Ching W, 2006, CELL, V125, P432, DOI 10.1016/j.cell.2006.04.018; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Incassati A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2723; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kirkham N., 2009, LEVERS HISTOPATHOLOG, P791; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Kwack MH, 2012, J INVEST DERMATOL, V132, P1554, DOI 10.1038/jid.2012.24; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Myung P, 2012, J CLIN INVEST, V122, P448, DOI 10.1172/JCI57414; Myung PS, 2013, J INVEST DERMATOL, V133, P31, DOI 10.1038/jid.2012.230; Narhi K, 2008, DEVELOPMENT, V135, P1019, DOI 10.1242/dev.016550; Petrof G, 2011, AUSTRALAS J DERMATOL, V52, P224, DOI 10.1111/j.1440-0960.2011.00788.x; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Reddy ST, 2004, J INVEST DERMATOL, V123, P275, DOI 10.1111/j.0022-202X.2004.23215.x; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Voronkov A, 2013, CURR PHARM DESIGN, V19, P634, DOI 10.2174/138161213804581837; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	46	216	224	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					720	733		10.1016/j.stem.2013.10.003	http://dx.doi.org/10.1016/j.stem.2013.10.003			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24315444	Green Accepted, Bronze			2022-12-28	WOS:000329571700014
J	Cheng, CW; Yilmaz, OH				Cheng, Chia-Wei; Yilmaz, Oemer H.			IGFBP3 and T1D: Systemic Factors in Colonic Stem Cell Function and Diabetic Enteropathy	CELL STEM CELL			English	Editorial Material								Patients with type 1 diabetes (T1D) often experience gastrointestinal enteropathy (DE) of unclear etiology. Now in Cell Stem Cell, D'Addio et al. (2015) utilize organoid culture models to study the roles of stem cells in DE and show that circulating IGF/IGFBP3 controls colonic stem cell function during homeostasis and in T1D patients.	[Cheng, Chia-Wei; Yilmaz, Oemer H.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Cheng, Chia-Wei; Yilmaz, Oemer H.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Yilmaz, Oemer H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Yilmaz, Oemer H.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Yilmaz, OH (corresponding author), MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.	ohyilmaz@mit.edu		/0000-0003-1088-923X	NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG045144] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA014051] Funding Source: Medline; NIA NIH HHS [R00 AG045144] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baxter RC, 2013, J CELL COMMUN SIGNAL, V7, P179, DOI 10.1007/s12079-013-0203-9; D'Addio F, 2015, CELL STEM CELL, V17, P486, DOI 10.1016/j.stem.2015.07.010; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Mihaylova MM, 2014, CELL STEM CELL, V14, P292, DOI 10.1016/j.stem.2014.02.008; Shakil A, 2008, AM FAM PHYSICIAN, V77, P1697; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163	6	5	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 1	2015	17	4					379	380		10.1016/j.stem.2015.09.008	http://dx.doi.org/10.1016/j.stem.2015.09.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4TS	26431180	Bronze, Green Submitted			2022-12-28	WOS:000365693800004
J	Kumar, I; Ivanova, N				Kumar, Ishan; Ivanova, Natalia			Moving Toward the Ground State	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; SELF-RENEWAL; PLURIPOTENCY; PATHWAYS	Transferring mouse ESCs to a media supplemented with Mek and Gsk3 beta inhibitors (2i) provokes marked transcriptional and epigenetic changes, embodying a shift toward ground-state pluripotency. In this issue of Cell Stem Cell, Kolodziejczyk et al. (2015) examine population structures of ESCs while Galonska et al. (2015) unravel the mechanisms underlying regulatory network rewiring during 2i-mediated reprogramming.	[Kumar, Ishan; Ivanova, Natalia] Yale Univ, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Kumar, Ishan; Ivanova, Natalia] Yale Univ, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University	Ivanova, N (corresponding author), Yale Univ, Yale Stem Cell Ctr, 10 Amistad St, New Haven, CT 06520 USA.	natalia.ivanova@yale.edu			NIGMS NIH HHS [R01 GM105772] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105772] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Galonska C, 2015, CELL STEM CELL, V17, P462, DOI 10.1016/j.stem.2015.07.005; Gonzales KAU, 2015, CELL, V162, P564, DOI 10.1016/j.cell.2015.07.001; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kolodziejczyk AA, 2015, CELL STEM CELL, V17, P471, DOI 10.1016/j.stem.2015.09.011; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	10	4	4	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 1	2015	17	4					375	376		10.1016/j.stem.2015.09.009	http://dx.doi.org/10.1016/j.stem.2015.09.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4TS	26431178	Bronze			2022-12-28	WOS:000365693800002
J	Pak, C; Danko, T; Zhang, YS; Aoto, J; Anderson, G; Maxeiner, S; Yi, F; Wernig, M; Sudhof, TC				Pak, ChangHui; Danko, Tamas; Zhang, Yingsha; Aoto, Jason; Anderson, Garret; Maxeiner, Stephan; Yi, Fei; Wernig, Marius; Suedhof, Thomas C.			Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1	CELL STEM CELL			English	Article							DE-NOVO MUTATIONS; PLURIPOTENT STEM-CELLS; NEUREXIN GENES; HUMAN ES; SPECTRUM; ALPHA; CASK; DIFFERENTIATION; TRANSCRIPTION; CARTOGRAPHY	Heterozygous mutations of the NRXN1 gene, which encodes the presynaptic cell-adhesion molecule neurexin-1, were repeatedly associated with autism and schizophrenia. However, diverse clinical presentations of NRXN1 mutations in patients raise the question of whether heterozygous NRXN1 mutations alone directly impair synaptic function. To address this question under conditions that precisely control for genetic background, we generated human ESCs with different heterozygous conditional NRXN1 mutations and analyzed two different types of isogenic control and NRXN1 mutant neurons derived from these ESCs. Both heterozygous NRXN1 mutations selectively impaired neurotransmitter release in human neurons without changing neuronal differentiation or synapse formation. Moreover, both NRXN1 mutations increased the levels of CASK, a critical synaptic scaffolding protein that binds to neurexin-1. Our results show that, unexpectedly, heterozygous inactivation of NRXN1 directly impairs synaptic function in human neurons, and they illustrate the value of this conditional deletion approach for studying the functional effects of disease-associated mutations.	[Pak, ChangHui; Danko, Tamas; Zhang, Yingsha; Aoto, Jason; Anderson, Garret; Maxeiner, Stephan; Yi, Fei; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Danko, Tamas; Wernig, Marius] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Wernig, Marius] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 265 Campus Dr, Stanford, CA 94305 USA.	tcs1@stanford.edu	Anderson, Garret/AAX-7011-2021; Maxeiner, Stephan/Y-7692-2019; Aoto, Jason/AAR-3604-2021	Maxeiner, Stephan/0000-0002-4472-695X; Aoto, Jason/0000-0003-0568-634X	NIMH [MH-092931, U19-MH104172]; CIRM [RT2 02061]; NICHD [F32 HD078051-02]; Stanford Schizophrenia Genetics Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD078051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH104172, R01MH092931] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); CIRM(California Institute for Regenerative Medicine); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Stanford Schizophrenia Genetics Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Drs. Yan Han, Nan Yang, Samuele Marro, Csaba Foldy, Justin Trotter, Patrick Rothwell, and Daniel Haag for advice. This paper was supported by grants from the NIMH (MH-092931 to M.W.; U19-MH104172 to T.C.S.), and CIRM (RT2 02061 to M.W.); a fellowship from the NICHD (F32 HD078051-02 to C.P.); and the Stanford Schizophrenia Genetics Research Fund established by an anonymous donor. M.W. is a New York Stem Cell Foundation - Robertson Investigator.	Anderson GR, 2012, P NATL ACAD SCI USA, V109, P18120, DOI 10.1073/pnas.1216398109; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Bena F, 2013, AM J MED GENET B, V162B, P388, DOI 10.1002/ajmg.b.32148; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Clarke RA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00052; Doherty JL, 2012, CLIN GENET, V81, P103, DOI 10.1111/j.1399-0004.2011.01773.x; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Giusti-Rodriguez P, 2013, J CLIN INVEST, V123, P4557, DOI 10.1172/JCI66031; Hackett A, 2010, EUR J HUM GENET, V18, P544, DOI 10.1038/ejhg.2009.220; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hata Y, 1996, J NEUROSCI, V16, P2488; Hoeffding LKE, 2014, AM J MED GENET B, V165, P52, DOI 10.1002/ajmg.b.32204; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Imaizumi Y, 2014, J NEUROCHEM, V129, P388, DOI 10.1111/jnc.12625; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Lett TAP, 2011, SCHIZOPHR RES, V132, P121, DOI 10.1016/j.schres.2011.08.007; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Murdoch JD, 2013, CURR OPIN GENET DEV, V23, P310, DOI 10.1016/j.gde.2013.02.003; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pang ZP, 2010, J BIOL CHEM, V285, P33930, DOI 10.1074/jbc.M110.150151; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Rees E, 2014, BRIT J PSYCHIAT, V204, P108, DOI 10.1192/bjp.bp.113.131052; Regehr WG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005702; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Souza RP, 2010, HUM PSYCHOPHARM CLIN, V25, P582, DOI 10.1002/hup.1146; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Todarello G, 2014, SCHIZOPHR RES, V155, P1, DOI 10.1016/j.schres.2014.02.023; Treutlein B, 2014, P NATL ACAD SCI USA, V111, pE1291, DOI 10.1073/pnas.1403244111; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xu W, 2012, NEURON, V73, P990, DOI 10.1016/j.neuron.2011.12.036; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	50	129	133	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					316	328		10.1016/j.stem.2015.07.017	http://dx.doi.org/10.1016/j.stem.2015.07.017			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26279266	Green Accepted, Bronze			2022-12-28	WOS:000364011000010
J	Yamashita, M; Nitta, E; Suda, T				Yamashita, Masayuki; Nitta, Eriko; Suda, Toshio			Aspp1 Preserves Hematopoietic Stem Cell Pool Integrity and Prevents Malignant Transformation	CELL STEM CELL			English	Article							SELF-RENEWAL; DNA-DAMAGE; EPIGENETIC REGULATORS; MOUSE; IDENTIFICATION; RHOA; ABNORMALITIES; INACTIVATION; QUIESCENCE; INHIBITOR	Quiescent hematopoietic stem cells (HSCs) are prone to mutagenesis, and accumulation of mutations can result in hematological malignancies. The mechanisms through which HSCs prevent such detrimental accumulation, however, are unclear. Here, we show that Aspp1 coordinates with p53 to maintain the genomic integrity of the HSC pool. Aspp1 is preferentially expressed in HSCs and restricts HSC pool size by attenuating self-renewal under steady-state conditions. After genotoxic stress, Aspp1 promotes HSC cycling and induces p53-dependent apoptosis in cells with persistent DNA damage foci. Beyond these p53-dependent functions, Aspp1 attenuates HSC self-renewal and accumulation of DNA damage in p53 null HSCs. Consequently, concomitant loss of Aspp1 and p53 leads to the development of hematological malignancies, especially T cell leukemia and lymphoma. Together, these data highlight coordination between Aspp1 and p53 in regulating HSC self-renewal and DNA damage tolerance and suggest that HSCs possess specific mechanisms that prevent accumulation of mutations and malignant transformation.	[Yamashita, Masayuki; Nitta, Eriko; Suda, Toshio] Keio Univ, Sakaguchi Lab Dev Biol, Dept Cell Differentiat,Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Nitta, Eriko] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chuo Ku, Chiba 2608670, Japan; [Suda, Toshio] Natl Univ Singapore, Ctr Translat Med, Canc Sci Inst, Singapore 117599, Singapore	Keio University; Chiba University; National University of Singapore	Nitta, E (corresponding author), Keio Univ, Sakaguchi Lab Dev Biol, Dept Cell Differentiat,Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	nittaeli@gmail.com; sudato@z3.keio.jp		Yamashita, Masayuki/0000-0001-9459-4329	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Global COE program "Education and Research Center for Stem Cell Medicine" of Keio University; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26221309] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE program "Education and Research Center for Stem Cell Medicine" of Keio University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr. Tohru Minamino (currently Niigata University, Niigata, Japan) for providing the p53<SUP>flox/flox</SUP> mice; Dr. John E. Dick (University of Toronto, Toronto, Canada), Dr. Michael Milyavsky (Tel Aviv University, Ramat Aviv, Israel), and Dr. Masanori Hirashima (Kobe University, Kobe, Japan) for insights and constructive suggestions; and all members of the Suda laboratory for comments and discussion. We are grateful to the Collaborative Research Resources, School of Medicine, Keio University for technical support and reagents. This work was supported by a Grant-in-Aid for Scientific Research and a Grant-in-Aid for Scientific Research on Innovative Areas "Cancer Stem Cells" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; the Global COE program "Education and Research Center for Stem Cell Medicine" of Keio University; a Grant-in-Aid for Japan Society for the Promotion of Science Fellows; and a grant-in-aid from Takeda Science Foundation. M.Y. and E.N. are Research Fellows of the Japan Society for the Promotion of Science.	Agirre X, 2006, ONCOGENE, V25, P1862, DOI 10.1038/sj.onc.1209236; Alexandrova EM, 2012, LEUKEMIA LYMPHOMA, V53, P2116, DOI 10.3109/10428194.2012.684348; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; de Laval B, 2013, CELL STEM CELL, V12, P37, DOI 10.1016/j.stem.2012.10.012; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Helps NR, 1995, FEBS LETT, V377, P295, DOI 10.1016/0014-5793(95)01347-4; Hirashima M, 2004, BLOOD, V104, P711, DOI 10.1182/blood-2004-01-0254; Hirashima M, 2008, DEV BIOL, V316, P149, DOI 10.1016/j.ydbio.2008.01.023; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jia YJ, 2014, FASEB J, V28, P2816, DOI 10.1096/fj.13-244632; Kim H, 2014, ONCOGENE, V33, P2004, DOI 10.1038/onc.2013.149; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LERNER C, 1990, EXP HEMATOL, V18, P114; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Marino S, 2000, GENE DEV, V14, P994; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Nitta E, 2011, BLOOD, V117, P4169, DOI 10.1182/blood-2010-08-297390; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Pronk CJH, 2011, J EXP MED, V208, P1563, DOI 10.1084/jem.20110752; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roman-Gomez J, 2005, J CLIN ONCOL, V23, P7043, DOI 10.1200/JCO.2005.01.4944; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; VANZANT G, 1984, J EXP MED, V159, P679, DOI 10.1084/jem.159.3.679; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Wang Y, 2013, CELL DEATH DIFFER, V20, P525, DOI 10.1038/cdd.2013.3; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamashita M, 2013, BIOCHEM BIOPH RES CO, V441, P196, DOI 10.1016/j.bbrc.2013.10.032; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153	53	22	23	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2015	17	1					23	34		10.1016/j.stem.2015.05.013	http://dx.doi.org/10.1016/j.stem.2015.05.013			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DI	26119234	Bronze			2022-12-28	WOS:000361877600006
J	Sierra, A; Martin-Suarez, S; Valcarcel-Martin, R; Pascual-Brazo, J; Aelvoet, SA; Abiega, O; Deudero, JJ; Brewster, AL; Bernales, I; Anderson, AE; Baekelandt, V; Maletic-Savatic, M; Encinas, JM				Sierra, Amanda; Martin-Suarez, Soraya; Valcarcel-Martin, Roberto; Pascual-Brazo, Jesus; Aelvoet, Sarah-Ann; Abiega, Oihane; Deudero, Juan J.; Brewster, Amy L.; Bernales, Irantzu; Anderson, Anne E.; Baekelandt, Veerle; Maletic-Savatic, Mirjana; Encinas, Juan M.			Neuronal Hyperactivity Accelerates Depletion of Neural Stem Cells and Impairs Hippocampal Neurogenesis	CELL STEM CELL			English	Article							TEMPORAL-LOBE EPILEPSY; ADULT DENTATE GYRUS; PROGENITOR CELLS; MOUSE MODEL; SEIZURES; PROLIFERATION; DISPERSION; ASTROCYTES; EXPRESSION; INTRAHIPPOCAMPAL	Adult hippocampal neurogenesis is believed to maintain a range of cognitive functions, many of which decline with age. We recently reported that radial neural stem cells (rNSCs) in the hippocampus undergo activation-dependent conversion into astrocytes, a mechanism that over time contributes to a reduction in the rNSC population. Here, we injected low and high levels of kainic acid (KA) in the dentate gyrus to assess whether neuronal hyperexcitation, a hallmark of epileptic disorders, could accelerate this conversion. At low levels of KA, generating epileptiform activity without seizures, we indeed found increased rNSC activation and conversion into astrocytes. At high levels, generating sustained epileptic seizures, however, we find that rNSCs divide symmetrically and that both mother and daughter cells convert into reactive astrocytes. Our results demonstrate that a threshold response for neuronal hyperexcitation provokes a dramatic shift in rNSC function, which impairs adult hippocampal neurogenesis in the long term.	[Sierra, Amanda; Martin-Suarez, Soraya; Valcarcel-Martin, Roberto; Abiega, Oihane; Encinas, Juan M.] Achucarro Basque Ctr Neurosci, Zamudio 48170, Spain; [Sierra, Amanda; Encinas, Juan M.] Ikerbasque Fdn, Bilbao 48013, Spain; [Sierra, Amanda; Bernales, Irantzu; Encinas, Juan M.] Univ Basque Country UPV EHU, Leioa 48940, Spain; [Aelvoet, Sarah-Ann; Baekelandt, Veerle] Katholieke Univ Leuven, B-3000 Leuven, Belgium; [Pascual-Brazo, Jesus; Deudero, Juan J.; Brewster, Amy L.; Anderson, Anne E.; Maletic-Savatic, Mirjana] Texas Childrens Hosp, Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Basque Foundation for Science; University of Basque Country; KU Leuven; Baylor College of Medicine	Maletic-Savatic, M (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, 1250 Morsund St, Houston, TX 77030 USA.	maletics@bcm.edu; jm.encinas@ikerbasque.org	Baekelandt, Veerle/ABB-9736-2020; Encinas, Juan Manuel/ABB-5304-2020; Sierra, Amanda/E-3305-2010	Baekelandt, Veerle/0000-0001-8966-2921; Encinas, Juan Manuel/0000-0002-0402-972X; Sierra, Amanda/0000-0001-8415-096X; Bernales, Irantzu/0000-0003-0997-3741; Maletic-Savatic, Mirjana/0000-0002-6548-4662; Valcarcel-Martin, Roberto/0000-0003-1776-6419; Pena Deudero, Juan Jose/0000-0002-0203-2247	Spanish Ministry of Economy and Competitiveness; FEDER funds [SAF2012-40085, BFU2012-32089]; Basque Government [Saiotek S-PC 12UN014]; Ikerbasque start-up funds; NIH [P30HD024064, R01 NS, 39943, 49427, T32 NS, 43124]; Dana Foundation; McKnight Endowment for Science; Epilepsy Foundation; EC [HEALTH-F2-2011-278850]; KU Leuven [IMIR EF/05/008, SCIL PF/10/019]; Fundacion "La Caixa"; Basque Government; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092, P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124, R01NS049427, R01NS039943] Funding Source: NIH RePORTER	Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER funds(European Commission); Basque Government(Basque Government); Ikerbasque start-up funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; McKnight Endowment for Science; Epilepsy Foundation; EC(European CommissionEuropean Commission Joint Research Centre); KU Leuven(KU Leuven); Fundacion "La Caixa"(La Caixa Foundation); Basque Government(Basque Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Grigory Enikolopov and Amelia Eisch for providing the Nestin-GFP and the Nestin-CreER<SUP>T2</SUP> mice, respectively. This work was supported by grants from the Spanish Ministry of Economy and Competitiveness with FEDER funds to J.M.E. (SAF2012-40085) and A.S. (BFU2012-32089); from the Basque Government (Saiotek S-PC 12UN014); Ikerbasque start-up funds to J.M.E. and A.S; NIH Intellectual and Developmental Disabilities Research Grant (P30HD024064), Dana Foundation, and McKnight Endowment for Science grants to M.M.-S.; grants from NIH R01 NS, 39943, and 49427 to A.E.A.; and T32 NS and 43124 to A.L.B., who, in addition, is a recipient of an Epilepsy Foundation Postdoctoral Fellowship. Work by V.B., J.P.-B., and S.-A.A. was supported by EC-FP7/2007-2013 project, HEALTH-F2-2011-278850 (INMiND), and by the KU Leuven grants IMIR EF/05/008 and SCIL PF/10/019. In addition, S.-A.A. is a doctoral fellow of the IWT Vlaanderen. R.V.-M. is a recipient of a Master fellowship from Fundacion "La Caixa" and of predoctoral fellowship from the Basque Government. O.A. is recipient of a predoctoral fellowship from the Basque Government. We thank the UPV/EHU SGIker-Genomics Unit for their help with the microarray experiments. We thank Vicky Brant for expert editorial review.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Andersen J, 2014, NEURON, V83, P1085, DOI 10.1016/j.neuron.2014.08.004; Anderson MF, 2002, DEV BRAIN RES, V134, P115; BABB TL, 1995, ITAL J NEUROL SCI, V16, P39, DOI 10.1007/BF02229073; Blumcke I, 2001, HIPPOCAMPUS, V11, P311, DOI 10.1002/hipo.1045; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Encinas JM, 2011, J COMP NEUROL, V519, P6, DOI 10.1002/cne.22503; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gargaro AC, 2013, EPILEPSY BEHAV, V27, P461, DOI 10.1016/j.yebeh.2013.03.002; Gibbons MB, 2013, NEUROCHEM INT, V63, P660, DOI 10.1016/j.neuint.2012.12.008; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Heuser K, 2009, ACTA NEUROL SCAND, V120, P8, DOI 10.1111/j.1600-0404.2009.01205.x; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kralic JE, 2005, EUR J NEUROSCI, V22, P1916, DOI 10.1111/j.1460-9568.2005.04386.x; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Mathern GW, 2002, EPILEPSIA, V43, P68, DOI 10.1046/j.1528-1157.43.s.5.28.x; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mikkonen M, 1998, ANN NEUROL, V44, P923, DOI 10.1002/ana.410440611; Nitta N, 2008, EPILEPSIA, V49, P1711, DOI 10.1111/j.1528-1167.2008.01595.x; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Paradisi M, 2010, NEUROPATH APPL NEURO, V36, P535, DOI 10.1111/j.1365-2990.2010.01102.x; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Pirttila TJ, 2005, ANN NEUROL, V58, P211, DOI 10.1002/ana.20545; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Segi-Nishida E, 2008, P NATL ACAD SCI USA, V105, P11352, DOI 10.1073/pnas.0710858105; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	53	157	161	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					488	503		10.1016/j.stem.2015.04.003	http://dx.doi.org/10.1016/j.stem.2015.04.003			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25957904	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000354188600010
J	Kim, DH; Marinov, GK; Pepke, S; Singer, ZS; He, P; Williams, B; Schroth, GP; Elowitz, MB; Wold, BJ				Kim, Daniel H.; Marinov, Georgi K.; Pepke, Shirley; Singer, Zakary S.; He, Peng; Williams, Brian; Schroth, Gary P.; Elowitz, Michael B.; Wold, Barbara J.			Single-Cell Transcriptome Analysis Reveals Dynamic Changes in lncRNA Expression during Reprogramming	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; LONG NONCODING RNAS; PROSTATE-CANCER; DNA METHYLATION; SELF-RENEWAL; GENE; SEQ; DIFFERENTIATION; METASTASIS; STATE	Cellular reprogramming highlights the epigenetic plasticity of the somatic cell state. Long noncoding RNAs (lncRNAs) have emerging roles in epigenetic regulation, but their potential functions in reprogramming cell fate have been largely unexplored. We used single-cell RNA sequencing to characterize the expression patterns of over 16,000 genes, including 437 lncRNAs, during defined stages of reprogramming to pluripotency. Self-organizing maps (SOMs) were used as an intuitive way to structure and interrogate transcriptome data at the single-cell level. Early molecular events during reprogramming involved the activation of Ras signaling pathways, along with hundreds of lncRNAs. Loss-of-function studies showed that activated lncRNAs can repress lineage-specific genes, while lncRNAs activated in multiple reprogramming cell types can regulate metabolic gene expression. Our findings demonstrate that reprogramming cells activate defined sets of functionally relevant lncRNAs and provide a resource to further investigate how dynamic changes in the transcriptome reprogram cell state.	[Kim, Daniel H.; Marinov, Georgi K.; Singer, Zakary S.; He, Peng; Williams, Brian; Elowitz, Michael B.; Wold, Barbara J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Singer, Zakary S.; Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Pepke, Shirley] CALTECH, Ctr Adv Comp Res, Pasadena, CA 91125 USA; [Schroth, Gary P.] Illumina Inc, San Diego, CA 92122 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Illumina	Kim, DH (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	dkim@caltech.edu; woldb@caltech.edu	He, Peng/AAT-3673-2021	He, Peng/0000-0002-2457-3554; Kim, Daniel/0000-0003-0684-6245	Damon Runyon Cancer Research Foundation; Beckman Fellows Program at the California Institute of Technology; NIH [R01HD075605A, HFSP.RGP0200]; Gordon and Betty Moore Foundation [GBMF2809]; Bren Chair, Caltech Beckman Institute; NIH NHGRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075605] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007990, U54HG006998] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Beckman Fellows Program at the California Institute of Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Bren Chair, Caltech Beckman Institute; NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Ellen Rothenberg, Paul Sternberg, and Chuck Murry for helpful discussions; Jorge Mata and Scott Wang for tail tip excision; Josh Verceles, Diana Perez, and Rochelle Diamond for cell sorting; Igor Antoshechkin for sequencing; Henry Amrhein and Diane Trout for data curation; Shujun Luo for single-cell protocol development; and Maria Moon and Hank Huang for illustration and graphic design. D.H.K. was supported by a Fellowship Award from the Damon Runyon Cancer Research Foundation and the Beckman Fellows Program at the California Institute of Technology. G.P.S. is an employee and shareholder of Illumina. M.B.E. is an Investigator of the Howard Hughes Medical Institute. This work was supported by NIH R01HD075605A and HFSP.RGP0200 funding to M.B.E.; Gordon and Betty Moore Foundation Grant GBMF2809 to the Caltech Programmable Molecular Technology Initiative; and the Bren Chair, Caltech Beckman Institute, and NIH NHGRI funding to B.J.W.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Chang G, 2014, CELL RES, V24, P293, DOI 10.1038/cr.2013.173; Cooke SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4644; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Flynn RA, 2014, CELL STEM CELL, V14, P752, DOI 10.1016/j.stem.2014.05.014; Goding CR, 2014, NAT REV CANCER, V14, P568, DOI 10.1038/nrc3781; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Han L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4963; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Huang WC, 2014, CANCER RES, V74, P751, DOI 10.1158/0008-5472.CAN-13-1297; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee CYF, 2014, CANCER RES, V74, P341, DOI 10.1158/0008-5472.CAN-13-1055; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Stadtfeld M., 2012, NAT GENET, V44, pS1, DOI DOI 10.1038/NG.1110; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stuwe E, 2014, GENE DEV, V28, P423, DOI 10.1101/gad.236414.113; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Theunissen TW, 2014, CELL STEM CELL, V14, P720, DOI 10.1016/j.stem.2014.05.002; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Yang DZ, 2010, CANCER RES, V70, P7905, DOI 10.1158/0008-5472.CAN-09-4729; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang A, 2013, CELL RES, V23, P340, DOI 10.1038/cr.2012.164; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	63	105	108	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					88	101		10.1016/j.stem.2014.11.005	http://dx.doi.org/10.1016/j.stem.2014.11.005			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25575081	Green Accepted, Bronze			2022-12-28	WOS:000347708400014
J	Kim, J; Braun, T				Kim, Johnny; Braun, Thomas			Targeting the Cellular Origin of Organ Fibrosis	CELL STEM CELL			English	Editorial Material								Organ fibrosis after injury, which can significantly compromise tissue function, is in part due to proliferation of fibroblasts and myofibroblasts of unclear cellular origin. Now in Cell Stem Cell, Kramann et al. (2015) show that perivascular Gli1+ mesenchymal-stem-cell-like cells generate a large fraction of myofibroblasts in disease conditions.	[Kim, Johnny; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany	Max Planck Society	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany.	thomas.braun@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008; Kim, Johnny/AAY-2149-2020	Kim, Johnny/0000-0002-5226-5460; Braun, Thomas/0000-0002-6165-4804				Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	8	8	9	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					3	4		10.1016/j.stem.2014.12.008	http://dx.doi.org/10.1016/j.stem.2014.12.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25575074	Bronze			2022-12-28	WOS:000347708400002
J	Chazaud, B; Mouchiroud, G				Chazaud, Benedicte; Mouchiroud, Guy			Inflamm-aging: STAT3 Signaling Pushes Muscle Stem Cells off Balance	CELL STEM CELL			English	Editorial Material							SATELLITE CELL; REGENERATION; NICHE	Two recent studies shed light on mechanisms underlying muscle dysfunction in age and disease. They reveal that JAK-STAT signaling regulates myogenic differentiation, leading to a reduced reservoir of muscle stem cells. Both genetic and pharmacologic inhibition of STAT3 signaling improve stem cell homeostasis and physiology of aged and dystrophic muscles.	[Chazaud, Benedicte; Mouchiroud, Guy] Univ Lyon 1, CNRS, UMR5534, Ctr Genet & Mol & Cellular Physiol, F-69100 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Chazaud, B (corresponding author), Univ Lyon 1, CNRS, UMR5534, Ctr Genet & Mol & Cellular Physiol, F-69100 Villeurbanne, France.	benedicte.chazaud@inserm.fr	Chazaud, Benedicte/N-9291-2017; Mouchiroud, Guy/K-1153-2018	Chazaud, Benedicte/0000-0002-1262-502X; 				Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Hankey PA, 2009, FRONT BIOSCI-LANDMRK, V14, P5273, DOI 10.2741/3597; Mounier R, 2011, CURR TOP DEV BIOL, V96, P121, DOI 10.1016/B978-0-12-385940-2.00005-X; Paylor B, 2011, CURR TOP DEV BIOL, V96, P139, DOI 10.1016/B978-0-12-385940-2.00006-1; Price F.D., 2014, NAT MED IN PRESS; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Tadokoro T, 2014, P NATL ACAD SCI USA, V111, pE3641, DOI 10.1073/pnas.1409781111; Tierney M.T., 2014, NAT MED IN PRESS; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630	10	16	17	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					401	402		10.1016/j.stem.2014.09.010	http://dx.doi.org/10.1016/j.stem.2014.09.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25280215	Bronze			2022-12-28	WOS:000343235800005
J	Mendjan, S; Mascetti, VL; Ortmann, D; Ortiz, M; Karjosukarso, DW; Ng, Y; Moreau, T; Pedersen, RA				Mendjan, Sasha; Mascetti, Victoria L.; Ortmann, Daniel; Ortiz, Mariaestela; Karjosukarso, Dyah W.; Ng, Yifan; Moreau, Thomas; Pedersen, Roger A.			NANOG and CDX2 Pattern Distinct Subtypes of Human Mesoderm during Exit from Pluripotency	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; POSTERIOR MESODERM; MOUSE EMBRYO; DIFFERENTIATION; INDUCTION; GASTRULATION; ENDODERM; EMERGENCE; BRACHYURY; EPIBLAST	Mesoderm is induced at the primitive streak (PS) and patterns subsequently into mesodermal subtypes and organ precursors. It is unclear whether mesoderm induction generates a multipotent PS progenitor or several distinct ones with restricted subtype potentials. We induced mesoderm in human pluripotent stem cells with ACTIVIN and BMP or with GSK3-beta inhibition. Both approaches induced BRACHYURY(+) mesoderm of distinct PS-like identities, which had differing patterning potential. ACTIVIN and BMP-induced mesoderm patterned into cardiac but not somitic subtypes. Conversely, PS precursors induced by GSK3-beta inhibition did not generate lateral plate and cardiac mesoderm and favored instead somitic differentiation. The mechanism of these cell fate decisions involved mutual repression of NANOGand CDX2. Although NANOG was required for cardiac specification but blocked somitic subtypes, CDX2 was required for somitic mesoderm but blocked cardiac differentiation. In sum, rather than forming a common PS progenitor, separate induction mechanisms distinguish human mesoderm subtypes.	[Mendjan, Sasha; Mascetti, Victoria L.; Ortmann, Daniel; Ortiz, Mariaestela; Karjosukarso, Dyah W.; Ng, Yifan; Moreau, Thomas; Pedersen, Roger A.] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England; [Mendjan, Sasha; Mascetti, Victoria L.; Ortmann, Daniel; Ortiz, Mariaestela; Karjosukarso, Dyah W.; Ng, Yifan; Moreau, Thomas; Pedersen, Roger A.] Univ Cambridge, Dept Surg, Cambridge CB2 0SZ, England	University of Cambridge; University of Cambridge	Mendjan, S (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England.	sm687@cam.ac.uk; ralp2@cam.ac.uk	Mendjan, Sasha/HHN-7384-2022; Karjosukarso, Dyah Winiarty/A-9523-2016	Karjosukarso, Dyah Winiarty/0000-0002-0881-9905; Moreau, Thomas/0000-0003-1090-6685; Mendjan, Sasha/0000-0001-7539-3951	EMBO; British Heart Foundation PhD fellowships; UK Medical Research Council; British Heart Foundation grants; Cambridge Hospitals National Institute for Health Research Biomedical Research Centre; British Heart Foundation [FS/10/022/28262] Funding Source: researchfish; Medical Research Council [G0800784, G1000847, G0600275] Funding Source: researchfish; MRC [G1000847, G0800784, G0600275] Funding Source: UKRI	EMBO(European Molecular Biology Organization (EMBO)); British Heart Foundation PhD fellowships; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation grants; Cambridge Hospitals National Institute for Health Research Biomedical Research Centre; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Tiago Faial, Paulina Latos, and Kathy Niakan for helpful comments. We are grateful to Stefania Carobbio and Antonio Vidal-Puig for help and support. We thank Stephanie Brown, Alessandro Bertero, Ludovic Vallier, H. Suemori, Jane Bardwell, Andrew Elefanty, Edward Stanley, Barry Rosen, and Bill Skarnes (Wellcome Trust Sanger Institute, EUCOMMTOOLs program) for expert advice, collaboration, and key reagents. This work was supported by EMBO (postdoctoral fellowship to S. M.), British Heart Foundation PhD fellowships (to D. O. and V. L. M.), UK Medical Research Council and British Heart Foundation grants (to R. A. P.), and the Cambridge Hospitals National Institute for Health Research Biomedical Research Centre funding (to R. A. P.). R. A. P. is a cofounder of DefiniGEN, a UK start-up company that generates hepatocytes and other endodermal cell types for drug development and toxicity testing. This work was done, however, entirely independently of DefiniGEN.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Cho CHH, 2012, DIABETOLOGIA, V55, P3284, DOI 10.1007/s00125-012-2687-x; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033346; Harvey SA, 2010, DEVELOPMENT, V137, P1127, DOI 10.1242/dev.046318; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Ladewig J, 2013, NAT REV MOL CELL BIO, V14, P225, DOI 10.1038/nrm3543; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Lohnes D, 2003, BIOESSAYS, V25, P971, DOI 10.1002/bies.10340; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; Martin BL, 2010, GENE DEV, V24, P2778, DOI 10.1101/gad.1962910; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Mummery Christine L, 2007, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01f02s2; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Savory JGA, 2009, DEV BIOL, V330, P114, DOI 10.1016/j.ydbio.2009.03.016; Schultheiss TM, 1995, DEVELOPMENT, V121, P4203; Stern CD, 2006, INT J DEV BIOL, V50, P3, DOI 10.1387/ijdb.052095cs; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tam PPL, 1997, DEVELOPMENT, V124, P1631; Tortelote GG, 2013, DEV BIOL, V374, P164, DOI 10.1016/j.ydbio.2012.10.013; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; van Rooijen C, 2012, DEVELOPMENT, V139, P2576, DOI 10.1242/dev.079848; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Xu C, 2013, CELL, V155, P909, DOI 10.1016/j.cell.2013.10.023	40	107	110	3	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					310	325		10.1016/j.stem.2014.06.006	http://dx.doi.org/10.1016/j.stem.2014.06.006			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25042702	Bronze			2022-12-28	WOS:000341441600011
J	Hammoud, SS; Low, DHP; Yi, CI; Carrell, DT; Guccione, E; Cairns, BR				Hammoud, Saher Sue; Low, Diana H. P.; Yi, Chongil; Carrell, Douglas T.; Guccione, Ernesto; Cairns, Bradley R.			Chromatin and Transcription Transitions of Mammalian Adult Germline Stem Cells and Spermatogenesis	CELL STEM CELL			English	Article							SEX-CHROMOSOME INACTIVATION; DNA METHYLATION; MOUSE SPERMATOZOA; SELF-RENEWAL; HUMAN SPERM; IN-VIVO; GENOME; GENES; PLURIPOTENCY; DYNAMICS	Adult germline stem cells (AGSCs) self-renew (Thy1(+) enriched) or commit to gametogenesis (Kit(+) enriched). To better understand how chromatin regulates AGSC biology and gametogenesis, we derived stage-specific high-resolution profiles of DNA methylation, 5hmC, histone modifications/variants, and RNA-seq in AGSCs and during spermatogenesis. First, we define striking signaling and transcriptional differences between AGSC types, involving key self-renewal and proliferation pathways. Second, key pluripotency factors (e. g., Nanog) are silent in AGSCs and bear particular chromatin/DNAme attributes that may "poise'' them for reactivation after fertilization. Third, AGSCs display chromatin "poising/bivalency'' of enhancers and promoters for embryonic transcription factors. Remarkably, gametogenesis occurs without significant changes in DNAme and instead involves transcription of DNA-methylated promoters bearing high RNAPol2, H3K9ac, H3K4me3, low CG content, and (often) 5hmC. Furthermore, key findings were confirmed in human sperm. Here, we reveal AGSC signaling asymmetries and chromatin/DNAme strategies in AGSCs to poise key transcription factors and to activate DNA-methylated promoters during gametogenesis.	[Hammoud, Saher Sue; Yi, Chongil; Cairns, Bradley R.] Univ Utah, Sch Med, Dept Oncol Sci, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Hammoud, Saher Sue; Yi, Chongil; Cairns, Bradley R.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Low, Diana H. P.; Guccione, Ernesto] ASTAR, Inst Mol & Cell Biol, Div Canc Genet & Therapeut, Singapore 119074, Singapore; [Low, Diana H. P.; Guccione, Ernesto] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 119074, Singapore; [Hammoud, Saher Sue; Carrell, Douglas T.] Univ Utah, Sch Med, Dept Surg, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Utah System of Higher Education; University of Utah	Guccione, E (corresponding author), ASTAR, Inst Mol & Cell Biol, Div Canc Genet & Therapeut, Singapore 119074, Singapore.	eguccione@imcb.a-star.edu.sg; brad.cairns@hci.utah.edu		Low, Diana/0000-0002-6054-8524	JCO-ASTAR grant [JCOAG03_FG06_2009]; IMCB-A*STAR core funding; Department of Urology, University of Utah; Howard Hughes Medical Institute (HHMI) (genomics, biologicals); Huntsman Cancer Institute core facilities [CA24014]; Helen Hay Whitney Foundation	JCO-ASTAR grant; IMCB-A*STAR core funding; Department of Urology, University of Utah; Howard Hughes Medical Institute (HHMI) (genomics, biologicals); Huntsman Cancer Institute core facilities; Helen Hay Whitney Foundation	We thank Brian Dalley for sequencing expertise; Ken Boucher for statistical analysis; and David Nix, Tim Mosbruger, Brett Milash, Darren Ames, and Tim Parnell for bioinformatics assistance. We thank Doria Filipponi and Susanna Dolci for germ cell purification protocols, Antonis Giannakakis for ChIP-seq libraries, and Marco Bezzi and Shun Xie Teo for help with mouse husbandry. Financial support was from a JCO-ASTAR grant (JCOAG03_FG06_2009) and IMCB-A*STAR core funding (to E.G. and D.L); the Department of Urology, University of Utah; the Howard Hughes Medical Institute (HHMI) (genomics, biologicals); and CA24014 for Huntsman Cancer Institute core facilities. S.S.H. is funded by the Helen Hay Whitney Foundation. B.R.C. is an investigator with HHMI.	Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Choi YC, 1997, MAMM GENOME, V8, P317, DOI 10.1007/s003359900431; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Delaval K, 2007, EMBO J, V26, P720, DOI 10.1038/sj.emboj.7601513; Dorus S, 2006, NAT GENET, V38, P1440, DOI 10.1038/ng1915; Dovere L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059431; Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hao J, 2008, STEM CELLS, V26, P1587, DOI 10.1634/stemcells.2007-0502; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Lei ZN, 2011, J NEUROPATH EXP NEUR, V70, P736, DOI 10.1097/NEN.0b013e31822830e5; Lesch BJ, 2013, P NATL ACAD SCI USA, V110, P16061, DOI 10.1073/pnas.1315204110; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Meyer S, 2010, MOL HUM REPROD, V16, P846, DOI 10.1093/molehr/gaq060; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ng JH, 2013, DEV CELL, V24, P324, DOI 10.1016/j.devcel.2012.12.011; Oakes CC, 2007, DEV BIOL, V307, P368, DOI 10.1016/j.ydbio.2007.05.002; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; Ohnishi Y, 2010, NUCLEIC ACIDS RES, V38, P5141, DOI 10.1093/nar/gkq229; Okada Y, 2010, J ANDROL, V31, P75, DOI 10.2164/jandrol.109.008052; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Ro SH, 2013, ARCH BIOCHEM BIOPHYS, V534, P55, DOI 10.1016/j.abb.2012.07.017; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	46	209	212	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					239	253		10.1016/j.stem.2014.04.006	http://dx.doi.org/10.1016/j.stem.2014.04.006			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	24835570	Bronze			2022-12-28	WOS:000340880100015
J	Buecker, C; Srinivasan, R; Wu, ZX; Calo, E; Acampora, D; Faial, T; Simeone, A; Tan, MJ; Swigut, T; Wysocka, J				Buecker, Christa; Srinivasan, Rajini; Wu, Zhixiang; Calo, Eliezer; Acampora, Dario; Faial, Tiago; Simeone, Antonio; Tan, Minjia; Swigut, Tomasz; Wysocka, Joanna			Reorganization of Enhancer Patterns in Transition from Naive to Primed Pluripotency	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; MASTER TRANSCRIPTION FACTORS; COLLABORATIVE COMPETITION; INTERACTION NETWORK; STATE; CHROMATIN; EPIBLAST; BINDING; OCT4; PATHWAYS	Naive and primed pluripotency is characterized by distinct signaling requirements, transcriptomes, and developmental properties, but both cellular states share key transcriptional regulators: Oct4, Sox2, and Nanog. Here, we demonstrate that transition between these two pluripotent states is associated with widespread Oct4 relocalization, mirrored by global rearrangement of enhancer chromatin landscapes. Our genomic and biochemical analyses identified candidate mediators of primed state-specific Oct4 binding, including Otx2 and Zic2/3. Even when differentiation cues are blocked, premature Otx2 overexpression is sufficient to exit the naive state, induce transcription of a substantial subset of primed pluripotency-associated genes, and redirect Oct4 to previously inaccessible enhancer sites. However, the ability of Otx2 to engage new enhancer regions is determined by its levels, cis-encoded properties of the sites, and the signaling environment. Our results illuminate regulatory mechanisms underlying pluripotency and suggest that the capacity of transcription factors such as Otx2 and Oct4 to pioneer new enhancer sites is highly context dependent.	[Buecker, Christa; Srinivasan, Rajini; Calo, Eliezer; Faial, Tiago; Swigut, Tomasz; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Wu, Zhixiang; Tan, Minjia] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Acampora, Dario; Simeone, Antonio] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy; [Acampora, Dario; Simeone, Antonio] IRCCS Neuromed, I-86077 Pozzilli, IS, Italy; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); IRCCS Neuromed; Stanford University	Swigut, T (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	swigut@stanford.edu; wysocka@stanford.edu	Acampora, Dario/C-2156-2013; Tan, Minjia/C-4491-2014; Simeone, Antonio/ABG-5269-2020	Tan, Minjia/0000-0002-6784-9653; Simeone, Antonio/0000-0003-2693-9836; Swigut, Tomek/0000-0002-7649-6781; Faial, Tiago/0000-0003-0864-1200; Buecker, Christa/0000-0003-3055-2642	NIH [P01 GM099130]; California Institute for Regenerative Medicine (CIRM) [RB3-05100]; Stanford Genome Training Program [5 T32 HG 44-17]; Italian Association for Cancer Research (AIRC) [IG2013 N. 14152]; CNR-MIUR Epigenetics Flagship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099130] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Stanford Genome Training Program; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); CNR-MIUR Epigenetics Flagship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Rada-Iglesias for insightful comments on the manuscript, the J.W. lab members for critical reading, Y. Zhang for assistance, Z. Weng, Stanford Sequencing Service Center, and Stanford Functional Genomics Facility for Illumina sequencing. This work was supported by the NIH (P01 GM099130 to J.W.) and the California Institute for Regenerative Medicine (CIRM) (RB3-05100 to J.W.), the Stanford Genome Training Program (5 T32 HG 44-17 to C. B.), the Italian Association for Cancer Research (AIRC) (IG2013 N. 14152 to A. S.), and the CNR-MIUR Epigenetics Flagship grants (to A.S.).	Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Moyle-Heyrman G, 2011, J MOL BIOL, V412, P634, DOI 10.1016/j.jmb.2011.07.032; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yanez-Cuna JO, 2012, GENOME RES, V22, P2018, DOI 10.1101/gr.132811.111; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	43	287	292	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					838	853		10.1016/j.stem.2014.04.003	http://dx.doi.org/10.1016/j.stem.2014.04.003			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905168	Green Accepted, Bronze			2022-12-28	WOS:000341248500019
J	Chen, H; Qian, K; Du, ZW; Cao, JY; Petersen, A; Liu, HS; Blackbourn, LW; Huang, CL; Errigo, A; Yin, YN; Lu, JF; Ayala, M; Zhang, SC				Chen, Hong; Qian, Kun; Du, Zhongwei; Cao, Jingyuan; Petersen, Andrew; Liu, Huisheng; Blackbourn, Lisle W.; Huang, CindyTzu-Ling; Errigo, Anthony; Yin, Yingnan; Lu, Jianfeng; Ayala, Melvin; Zhang, Su-Chun			Modeling ALS with iPSCs Reveals that Mutant SOD1 Misregulates Neurofilament Balance in Motor Neurons	CELL STEM CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PLURIPOTENT STEM-CELLS; CU,ZN SUPEROXIDE-DISMUTASE; SUBUNIT-NF-L; TRANSGENIC MICE; MOUSE MODEL; MESSENGER-RNA; LINKED SOD1; HEAVY GENE; DISEASE	Amyotrophic lateral sclerosis (ALS) presents motoneuron (MN)-selective protein inclusions and axonal degeneration but the underlying mechanisms of such are unknown. Using induced pluripotent cells (iPSCs) from patients with mutation in the Cu/Zn superoxide dismutase (SOD1) gene, we show that spinal MNs, but rarely non-MNs, exhibited neurofilament (NF) aggregation followed by neurite degeneration when glia were not present. These changes were associated with decreased stability of NF-L mRNA and binding of its 3' UTR by mutant SOD1 and thus altered protein proportion of NF subunits. Such MN-selective changes were mimicked by expression of a single copy of the mutant SOD1 in human embryonic stem cells and were prevented by genetic correction of the SOD1 mutation in patient's iPSCs. Importantly, conditional expression of NF-L in the SOD1 iPSC-derived MNs corrected the NF subunit proportion, mitigating NF aggregation and neurite degeneration. Thus, NF misregulation underlies mutant SOD1-mediated NF aggregation and axonal degeneration in ALS MNs.	[Chen, Hong] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Rehabil Med, Tongji Med Coll, Wuhan 430030, Peoples R China; [Qian, Kun] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Reprod Med Ctr, Wuhan 430030, Peoples R China; [Chen, Hong; Qian, Kun; Du, Zhongwei; Cao, Jingyuan; Petersen, Andrew; Liu, Huisheng; Blackbourn, Lisle W.; Huang, CindyTzu-Ling; Errigo, Anthony; Yin, Yingnan; Lu, Jianfeng; Ayala, Melvin; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53705 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, SC (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	zhang@waisman.wisc.edu	Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022	Ayala, Melvin/0000-0002-8669-1046; Chen, Hong/0000-0002-8848-282X	Bleser Family Foundation; Busta Foundation; NICHD [P30 HD03352]; University of Wisconsin Foundation; National Natural Science Foundation of China [81070986]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100031] Funding Source: NIH RePORTER	Bleser Family Foundation; Busta Foundation; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Wisconsin Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Lucie Bruijn for critical reading of the manuscript. This study was supported in part by the Bleser Family Foundation, the Busta Foundation, the NICHD (P30 HD03352), the University of Wisconsin Foundation, and the National Natural Science Foundation of China (81070986).	Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; BERGERON C, 1994, J NEUROPATH EXP NEUR, V53, P221, DOI 10.1097/00005072-199405000-00002; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Calvo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032632; CARPENTER S, 1968, NEUROLOGY, V18, P841, DOI 10.1212/WNL.18.9.841; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Ge WW, 2005, J BIOL CHEM, V280, P118, DOI 10.1074/jbc.M405065200; Giannini F, 2010, AMYOTROPH LATERAL SC, V11, P216, DOI 10.3109/17482960902721642; GOLDSTEIN ME, 1983, P NATL ACAD SCI-BIOL, V80, P3101, DOI 10.1073/pnas.80.10.3101; Gros-Louis F, 2010, J NEUROCHEM, V113, P1188, DOI 10.1111/j.1471-4159.2010.06683.x; Guillaume DJ, 2006, J NEUROSCI RES, V84, P1165, DOI 10.1002/jnr.21022; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P471, DOI 10.1097/00005072-198409000-00002; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Julien JP, 2006, BBA-MOL BASIS DIS, V1762, P1013, DOI 10.1016/j.bbadis.2006.03.006; Kong JM, 2000, NEUROSCI LETT, V281, P72, DOI 10.1016/S0304-3940(00)00808-9; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; LEE VMY, 1986, J NEUROSCI, V6, P850; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Meier J, 1999, J NEUROPATH EXP NEUR, V58, P1099, DOI 10.1097/00005072-199910000-00009; Musaro A, 2013, FEBS J, V280, P4315, DOI 10.1111/febs.12087; Qian K., 2014, STEM CELLS IN PRESS; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Saeed M, 2009, NEUROLOGY, V72, P1634, DOI 10.1212/01.wnl.0000343509.76828.2a; Serio A, 2013, P NATL ACAD SCI USA, V110, P4697, DOI 10.1073/pnas.1300398110; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Szaro BG, 2010, TRENDS NEUROSCI, V33, P27, DOI 10.1016/j.tins.2009.10.002; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xi JJ, 2012, STEM CELLS, V30, P1655, DOI 10.1002/stem.1152; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L	44	200	216	3	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					796	809		10.1016/j.stem.2014.02.004	http://dx.doi.org/10.1016/j.stem.2014.02.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24704493	Bronze, Green Accepted			2022-12-28	WOS:000341248500016
J	Factor, DC; Corradin, O; Zentner, GE; Saiakhova, A; Song, LY; Chenoweth, JG; McKay, RD; Crawford, GE; Scacheri, PC; Tesar, PJ				Factor, Daniel C.; Corradin, Olivia; Zentner, Gabriel E.; Saiakhova, Alina; Song, Lingyun; Chenoweth, Josh G.; McKay, Ronald D.; Crawford, Gregory E.; Scacheri, Peter C.; Tesar, Paul J.			Epigenomic Comparison Reveals Activation of "Seed" Enhancers during Transition from Naive to Primed Pluripotency	CELL STEM CELL			English	Article							EPIBLAST STEM-CELLS; SUPER-ENHANCERS; GROUND-STATE; DISTINCT; DERIVATION; SIGNATURES; INDUCTION; PATTERNS; IDENTITY; MEDIATOR	Naive mouse embryonic stem cells (mESCs) and primed epiblast stem cells (mEpiSCs) represent successive snapshots of pluripotency during embryogenesis. Using transcriptomic and epigenomic mapping we show that a small fraction of transcripts are differentially expressed between mESCs and mEpiSCs and that these genes show expected changes in chromatin at their promoters and enhancers. Unexpectedly, the cis-regulatory circuitry of genes that are expressed at identical levels between these cell states also differs dramatically. In mESCs, these genes are associated with dominant proximal enhancers and dormant distal enhancers, which we term seed enhancers. In mEpiSCs, the naive-dominant enhancers are lost, and the seed enhancers take up primary transcriptional control. Seed enhancers have increased sequence conservation and show preferential usage in downstream somatic tissues, often expanding into super enhancers. We propose that seed enhancers ensure proper enhancer utilization and transcriptional fidelity as mammalian cells transition from naive pluripotency to a somatic regulatory program.	[Factor, Daniel C.; Corradin, Olivia; Zentner, Gabriel E.; Saiakhova, Alina; Scacheri, Peter C.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Scacheri, Peter C.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Natl Ctr Regenerat Med, Cleveland, OH 44106 USA; [Chenoweth, Josh G.; McKay, Ronald D.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Song, Lingyun; Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27709 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Duke University	Scacheri, PC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	peter.scacheri@case.edu; paul.tesar@case.edu	song, ling/GQZ-5934-2022; Tesar, Paul J/C-9848-2014; Tesar, Paul/GPK-5942-2022	Tesar, Paul J/0000-0003-1532-3155; Tesar, Paul/0000-0003-1532-3155; Factor, Daniel/0000-0002-3200-7560; Corradin, Olivia/0000-0002-9484-0873; Zentner, Gabriel/0000-0002-0801-7646	NIH [R01HD056369, R01CA160356]; New York Stem Cell Foundation; Mt. Sinai Health Care Foundation; Genomics and Cytometry core facilities of the Case Comprehensive Cancer Center [P30CA043703]; CWRU Cellular and Molecular Biology training grant [T32GM008056]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056369] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA160356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; Mt. Sinai Health Care Foundation; Genomics and Cytometry core facilities of the Case Comprehensive Cancer Center; CWRU Cellular and Molecular Biology training grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by funding from the NIH (R01HD056369 and R01CA160356), the New York Stem Cell Foundation, the Mt. Sinai Health Care Foundation, the Genomics and Cytometry core facilities of the Case Comprehensive Cancer Center (P30CA043703), and CWRU Cellular and Molecular Biology training grant T32GM008056 (O.C.). P.J.T. is a New York Stem Cell Foundation Robertson Investigator. We are grateful to Thomas LaFramboise, Cindy Bartels, Simone Edelheit, and Neil Molyneaux for technical assistance, James Morrow and Tyler Miller for discussion, and Joanna Wysocka and Jacob Hanna for sharing data.	BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chenoweth JG, 2010, METHODS MOL BIOL, V636, P25, DOI 10.1007/978-1-60761-691-7_2; Chenoweth JG, 2010, DEV GROWTH DIFFER, V52, P293, DOI 10.1111/j.1440-169X.2010.01171.x; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	44	105	106	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					854	863		10.1016/j.stem.2014.05.005	http://dx.doi.org/10.1016/j.stem.2014.05.005			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905169	Green Accepted, Bronze			2022-12-28	WOS:000341248500020
J	Lee, HJ; Hore, TA; Reik, W				Lee, Heather J.; Hore, Timothy A.; Reik, Wolf			Reprogramming the Methylome: Erasing Memory and Creating Diversity	CELL STEM CELL			English	Review							EMBRYONIC STEM-CELLS; PRIMORDIAL GERM-CELLS; DNA METHYLATION; GROUND-STATE; NAIVE PLURIPOTENCY; HISTONE METHYLATION; SYSTEMS BIOLOGY; DEMETHYLATION; GENOME; DYNAMICS	The inheritance of epigenetic marks, in particular DNA methylation, provides a molecular memory that ensures faithful commitment to transcriptional programs during mammalian development. Epigenetic reprogramming results in global hypomethylation of the genome together with a profound loss of memory, which underlies naive pluripotency. Such global reprogramming occurs in primordial germ cells, early embryos, and embryonic stem cells where reciprocal molecular links connect the methylation machinery to pluripotency. Priming for differentiation is initiated upon exit from pluripotency, and we propose that epigenetic mechanisms create diversity of transcriptional states, which help with symmetry breaking during cell fate decisions and lineage commitment.	[Lee, Heather J.; Hore, Timothy A.; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Lee, Heather J.; Reik, Wolf] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellcome Trust Sanger Institute; University of Cambridge	Reik, W (corresponding author), Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England.	wolf.reik@babraham.ac.uk	Lee, Heather/M-2670-2019; Reik, Wolf/I-6794-2012	Lee, Heather/0000-0002-6482-0337; Hore, Timothy/0000-0002-6735-225X; Reik, Wolf/0000-0003-0216-9881	EU Blueprint Epigenome Consortium; Human Frontiers Science Program; EU EpiGeneSys Network; Wellcome Trust; BBSRC; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0403, BBS/E/B/000C0400, BBS/E/B/0000H334, BBS/E/B/0000S266] Funding Source: researchfish; BBSRC [BBS/E/B/000C0400, BBS/E/B/0000H334, BBS/E/B/000C0403, BBS/E/B/0000S266] Funding Source: UKRI	EU Blueprint Epigenome Consortium; Human Frontiers Science Program(Human Frontier Science Program); EU EpiGeneSys Network; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to thank all members of the Reik lab for helpful discussions, particularly Julian Peat and Melanie Eckersley-Maslin for critical reading of the manuscript. We also thank Sebastien Smallwood for assistance with compiling data for Figure 1. Funding from the following organizations is greatly appreciated; the EU Blueprint Epigenome Consortium (H. L. and W. R.), the Human Frontiers Science Program (T. H.), the EU EpiGeneSys Network (T. H. and W. R.), The Wellcome Trust (W. R.), and the BBSRC (W. R.). W. R. acts as a consultant for Cambridge Epigenetix Limited.	Abranches E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059928; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Beraldi R, 2006, MOL REPROD DEV, V73, P279, DOI 10.1002/mrd.20423; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Bond DM, 2014, TRENDS CELL BIOL, V24, P100, DOI 10.1016/j.tcb.2013.08.001; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; CARLSON LL, 1992, GENE DEV, V6, P2536, DOI 10.1101/gad.6.12b.2536; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chia NY, 2012, WIRES SYST BIOL MED, V4, P39, DOI 10.1002/wsbm.151; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Evsikov AV, 2004, CYTOGENET GENOME RES, V105, P240, DOI 10.1159/000078195; Ferguson-Smith AC, 2011, CELL METAB, V13, P115, DOI 10.1016/j.cmet.2011.01.011; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Grabole N, 2013, EMBO REP, V14, P629, DOI 10.1038/embor.2013.67; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hackett JA, 2013, STEM CELL REP, V1, P518, DOI 10.1016/j.stemcr.2013.11.010; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hirasawa R, 2009, GENE EXPR PATTERNS, V9, P27, DOI 10.1016/j.gep.2008.09.002; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Huang Y, 2014, P NATL ACAD SCI USA, V111, P1361, DOI 10.1073/pnas.1322921111; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ishiuchi T, 2013, CURR OPIN GENET DEV, V23, P512, DOI 10.1016/j.gde.2013.06.006; Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119; Jasnos L, 2013, STEM CELL REP, V1, P360, DOI 10.1016/j.stemcr.2013.08.005; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; Macaulay IC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004126; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Magnusdottir E, 2013, NAT CELL BIOL, V15, P905, DOI 10.1038/ncb2798; Mallanna SK, 2012, J CELL PHYSIOL, V227, P27, DOI 10.1002/jcp.22721; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Oda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068846; Ohno R, 2013, DEVELOPMENT, V140, P2892, DOI 10.1242/dev.093229; Okashita N, 2014, DEVELOPMENT, V141, P269, DOI 10.1242/dev.099622; Pasque V, 2011, TRENDS GENET, V27, P516, DOI 10.1016/j.tig.2011.08.002; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Riggs A. D., 1996, EPIGENETIC MECH GENE, P29; Santos F, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-39; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schmidt CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052629; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Shirane K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003439; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Theunissen TW, 2014, CELL STEM CELL, V14, P720, DOI 10.1016/j.stem.2014.05.002; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Vincent JJ, 2013, CELL STEM CELL, V12, P470, DOI 10.1016/j.stem.2013.01.016; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yamaguchi S, 2013, NATURE, V504, P460, DOI 10.1038/nature12805; Yamaguchi S, 2013, CELL RES, V23, P329, DOI 10.1038/cr.2013.22; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	103	220	226	5	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					710	719		10.1016/j.stem.2014.05.008	http://dx.doi.org/10.1016/j.stem.2014.05.008			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905162	Green Published, hybrid			2022-12-28	WOS:000341248500009
J	Mihaylova, MM; Sabatini, DM; Yilmaz, OH				Mihaylova, Maria M.; Sabatini, David M.; Yilmaz, Oemer H.			Dietary and Metabolic Control of Stem Cell Function in Physiology and Cancer	CELL STEM CELL			English	Review							ACUTE MYELOGENOUS LEUKEMIA; RESTRICTED KETOGENIC DIET; IN-VITRO EXPANSION; HIGH-FAT DIET; HEMATOPOIETIC STEM; SELF-RENEWAL; CALORIC RESTRICTION; ENERGY-METABOLISM; INTESTINAL TUMORIGENESIS; OXIDATIVE STRESS	Organismal diet has a profound impact on tissue homeostasis and health in mammals. Adult stem cells are a keystone of tissue homeostasis that alters tissue composition by balancing self-renewal and differentiation divisions. Because somatic stem cells may respond to shifts in organismal physiology to orchestrate tissue remodeling and some cancers are understood to arise from transformed stem cells, there is a likely possibility that organismal diet, stem cell function, and cancer initiation are interconnected. Here we will explore the emerging effects of diet on nutrient-sensing pathways active in mammalian tissue stem cells and their relevance to normal and cancerous growth.	[Mihaylova, Maria M.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Mihaylova, Maria M.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Mihaylova, Maria M.; Sabatini, David M.] Broad Inst Harvard & MIT, Seven Cambridge Ctr, Cambridge, MA 02142 USA; [Mihaylova, Maria M.; Sabatini, David M.; Yilmaz, Oemer H.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Mihaylova, Maria M.; Sabatini, David M.; Yilmaz, Oemer H.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Yilmaz, Oemer H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Yilmaz, Oemer H.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu; ohyilmaz@mit.edu	Mihaylova, Maria M./ACZ-4949-2022	Mihaylova, Maria M./0000-0002-2725-767X; /0000-0002-1446-7256	NIH [CA129105, CA103866, AI047389]; Koch Institute Frontier Research Program; Ellison Medical Foundation; K99/R00 Pathway to Independence Award from the NIH/NIA [AG045144]; CSIBD from NIDDK/NIH [DK043351]; NATIONAL CANCER INSTITUTE [R01CA129105, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG045144] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koch Institute Frontier Research Program; Ellison Medical Foundation(Lawrence Ellison Foundation); K99/R00 Pathway to Independence Award from the NIH/NIA; CSIBD from NIDDK/NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We apologize for being unable to discuss multiple primary studies due to references and space limitations. M. M. is a Robert Black Fellow of the Damon Runyon Cancer Research Foundation, DRG-2146-13. D. M. S. is an investigator of the Howard Hughes Medical Institute and is supported by awards from the NIH (CA129105, CA103866, and AI047389), Koch Institute Frontier Research Program, and the Ellison Medical Foundation. O.H.Y. is supported by a K99/R00 Pathway to Independence Award from the NIH/NIA AG045144 and a CSIBD grant from the NIDDK/NIH (DK043351).	Baltgalvis KA, 2009, CANCER PREV RES, V2, P641, DOI 10.1158/1940-6207.CAPR-09-0017; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Brow KA, 2010, CANCER RES, V70, P4, DOI 10.1158/0008-5472.CAN-09-2257; Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chen JC, 2003, EXP HEMATOL, V31, P1097, DOI 10.1016/S0301-472X(03)00238-8; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Dias CC, 2013, PEPTIDES, V50, P24, DOI 10.1016/j.peptides.2013.09.012; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Dunn SE, 1997, CANCER RES, V57, P4667; Ertl RP, 2008, BLOOD, V111, P1709, DOI 10.1182/blood-2007-01-069807; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Feng YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047286; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Freeman JM, 2007, PEDIATRICS, V119, P535, DOI 10.1542/peds.2006-2447; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hartman AL, 2007, EPILEPSIA, V48, P31, DOI 10.1111/j.1528-1167.2007.00914.x; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Hoshii T, 2012, J CLIN INVEST, V122, P2114, DOI 10.1172/JCI62279; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hu ZY, 2010, DIABETES, V59, P1312, DOI 10.2337/db09-1155; Huang J, 2012, NAT MED, V18, P1778, DOI 10.1038/nm.2984; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jamieson CHM, 2004, CANCER CELL, V6, P531, DOI 10.1016/S1535-6108(04)00342-3; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kakuni M, 2002, JPN J CANCER RES, V93, P236, DOI 10.1111/j.1349-7006.2002.tb02163.x; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kritchevsky D, 1999, TOXICOL SCI, V52, P13, DOI 10.1093/toxsci/52.suppl_1.13; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Lefevre F, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e46; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Leko V, 2012, BLOOD, V119, P1856, DOI 10.1182/blood-2011-09-377077; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Lofdahl HE, 2011, EUR J GASTROEN HEPAT, V23, P128, DOI 10.1097/MEG.0b013e3283424e25; Longo VD, 2010, TRENDS PHARMACOL SCI, V31, P89, DOI 10.1016/j.tips.2009.11.004; Lopez-Juarez A, 2012, CELL STEM CELL, V10, P531, DOI 10.1016/j.stem.2012.04.008; Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6; Lu CP, 2012, CELL, V150, P136, DOI 10.1016/j.cell.2012.04.045; Ma YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053916; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mai V, 2003, CANCER RES, V63, P1752; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Mukouyama YS, 1998, IMMUNITY, V8, P105, DOI 10.1016/S1074-7613(00)80463-X; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Myant KB, 2013, CELL STEM CELL, V12, P761, DOI 10.1016/j.stem.2013.04.006; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965; NEBELING LC, 1995, J AM COLL NUTR, V14, P202; Nickoloff BJ, 2005, J INVEST DERMATOL, V124, pX, DOI 10.1111/j.0022-202X.2005.23724.x; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Ochocki JD, 2013, J CELL BIOL, V203, P23, DOI 10.1083/jcb.201303110; Okabayashi K, 2012, AM J GASTROENTEROL, V107, P1175, DOI 10.1038/ajg.2012.180; Onate B, 2012, FASEB J, V26, P4327, DOI 10.1096/fj.12-207217; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Pugh TD, 1999, CANCER RES, V59, P1642; Rafalski VA, 2013, NAT CELL BIOL, V15, P614, DOI 10.1038/ncb2735; Rafalski VA, 2012, J CELL SCI, V125, P5597, DOI 10.1242/jcs.114827; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schmidt M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-54; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Seitz O, 2010, EXP DIABETES RES, DOI 10.1155/2010/476969; Seyfried TN, 2012, EPILEPSY RES, V100, P310, DOI 10.1016/j.eplepsyres.2011.06.017; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shorning BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004264; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Strickler H D, 2001, Diabetes Technol Ther, V3, P263, DOI 10.1089/152091501300209633; Tokuda Y, 2003, BJU INT, V91, P716, DOI 10.1046/j.1464-410X.2003.04218.x; TOMAS FM, 1994, BIOCHEM J, V301, P769, DOI 10.1042/bj3010769; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsao JL, 2002, CARCINOGENESIS, V23, P1807, DOI 10.1093/carcin/23.11.1807; Vigneri P, 2006, NUTR METAB CARDIOVAS, V16, P1, DOI 10.1016/j.numecd.2005.10.013; von Roon AC, 2007, DIS COLON RECTUM, V50, P839, DOI 10.1007/s10350-006-0848-z; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Webb AE, 2013, CELL REP, V4, P477, DOI 10.1016/j.celrep.2013.06.035; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yamaza H, 2010, AGING CELL, V9, P372, DOI 10.1111/j.1474-9726.2010.00563.x; Yanger K, 2011, DEV DYNAM, V240, P521, DOI 10.1002/dvdy.22561; Yeo H, 2013, EMBO J, V32, P2589, DOI 10.1038/emboj.2013.186; Yilmaz OH, 2008, BLOOD CELL MOL DIS, V41, P73, DOI 10.1016/j.bcmd.2008.02.004; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589; Zuccoli G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-33	142	100	103	3	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					292	305		10.1016/j.stem.2014.02.008	http://dx.doi.org/10.1016/j.stem.2014.02.008			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24607404	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000332533400007
J	Tajbakhsh, S				Tajbakhsh, Shahragim			Ballroom Dancing with Stem Cells: Placement and Displacement in the Intestinal Crypt	CELL STEM CELL			English	Editorial Material								Intestinal homeostasis is dependent upon stem cells that reside in the intestinal crypt, although the identity and dynamics of this population are unclear. Ritsma et al. (2014) recently reported temporal live imaging of mouse intestinal stem cells and their progeny, providing insights into spatial dynamics underlying stem cell behavior.	Inst Pasteur, CNRS URA 2578, Dept Dev & Stem Cell Biol, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tajbakhsh, S (corresponding author), Inst Pasteur, CNRS URA 2578, Dept Dev & Stem Cell Biol, 25 Rue Dr Roux, F-75015 Paris, France.	shahragim.tajbakhsh@pasteur.fr						Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Kozar S, 2013, CELL STEM CELL, V13, P626, DOI 10.1016/j.stem.2013.08.001; Ritsma L., 2014, NATURE; Ritsma L, 2013, NAT PROTOC, V8, P583, DOI 10.1038/nprot.2013.026; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408	9	2	2	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					271	273		10.1016/j.stem.2014.02.011	http://dx.doi.org/10.1016/j.stem.2014.02.011			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24607401	Bronze			2022-12-28	WOS:000332533400004
J	Mendicino, M; Bailey, AM; Wonnacott, K; Puri, RK; Bauer, SR				Mendicino, Michael; Bailey, Alexander M.; Wonnacott, Keith; Puri, Raj K.; Bauer, Steven R.			MSC-Based Product Characterization for Clinical Trials: An FDA Perspective	CELL STEM CELL			English	Editorial Material							MESENCHYMAL STROMAL CELLS; POTENCY	Proposals submitted to the FDA for MSC-based products are undergoing a rapid expansion that is characterized by increased variability in donor and tissue sources, manufacturing processes, proposed functional mechanisms, and characterization methods. Here we discuss the diversity in MSC-based clinical trial product proposals and highlight potential challenges for clinical translation.	[Mendicino, Michael] OC, ORSI, OCS, Silver Spring, MD 20993 USA; [Mendicino, Michael; Wonnacott, Keith; Puri, Raj K.; Bauer, Steven R.] CBER, OCTGT, DCGT, Rockville, MD 20852 USA; [Bailey, Alexander M.] CBER, OCTGT, DCEPT, Rockville, MD 20852 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Mendicino, M (corresponding author), OC, ORSI, OCS, 10903 New Hampshire Blvd, Silver Spring, MD 20993 USA.	m.mendicino.phd@gmail.com; steven.bauer@fda.hhs.gov						Bravery CA, 2013, CYTOTHERAPY, V15, P9, DOI 10.1016/j.jcyt.2012.10.008; Carmen J, 2012, REGEN MED, V7, P85, DOI [10.2217/RME.11.105, 10.2217/rme.11.105]; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Galipeau J, 2013, CYTOTHERAPY, V15, P2, DOI 10.1016/j.jcyt.2012.10.002; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Lo Surdo JL, 2013, CYTOTHERAPY, V15, P1527, DOI 10.1016/j.jcyt.2013.04.010; Melief SM, 2013, STEM CELL TRANSL MED, V2, P455, DOI 10.5966/sctm.2012-0184; Mindaye ST, 2013, STEM CELL RES, V11, P793, DOI 10.1016/j.scr.2013.05.006; P Mafi, 2011, Open Orthop J, V5, P253, DOI 10.2174/1874325001105010253; Phinney DG, 2013, CYTOTHERAPY, V15, P140, DOI 10.1016/j.jcyt.2012.11.005	10	296	308	3	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					141	+		10.1016/j.stem.2014.01.013	http://dx.doi.org/10.1016/j.stem.2014.01.013			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24506881	Bronze			2022-12-28	WOS:000330835800006
J	Shivdasani, RA				Shivdasani, Ramesh A.			Radiation Redux: Reserve Intestinal Stem Cells Miss the Call to Duty	CELL STEM CELL			English	Editorial Material							LGR5	Distinct stem cell populations in intestinal crypts mediate tissue homeostasis and responses to epithelial damage such as radiation. Now in Cell Stem Cell, Metcalfe et al. (2014) demonstrate that homeostatic, proliferative Lrg5(+) cells are necessary to regenerate the epithelium after radiation, whereas quiescent Lgr5(-) reserve stem cells are surprisingly radiosensitive.	[Shivdasani, Ramesh A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Shivdasani, Ramesh A.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Shivdasani, Ramesh A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shivdasani, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	ramesh_shivdasani@dfci.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081113, R01DK082889] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK082889, R01 DK082889, U01 DK085532, R01DK081113, R01 DK081113] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Kim T.H., 2014, NATURE IN PRESS, DOI DOI 10.1038/NATURE12903; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	9	4	5	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					135	136		10.1016/j.stem.2014.01.015	http://dx.doi.org/10.1016/j.stem.2014.01.015			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24506878	Green Accepted, Bronze			2022-12-28	WOS:000330835800003
J	Worringer, KA; Rand, TA; Hayashi, Y; Sami, S; Takahashi, K; Tanabe, K; Narita, M; Srivastava, D; Yamanaka, S				Worringer, Kathleen A.; Rand, Tim A.; Hayashi, Yohei; Sami, Salma; Takahashi, Kazutoshi; Tanabe, Koji; Narita, Megumi; Srivastava, Deepak; Yamanaka, Shinya			The let-7/LIN-41 Pathway Regulates Reprogramming to Human Induced Pluripotent Stem Cells by Controlling Expression of Prodifferentiation Genes	CELL STEM CELL			English	Article							TRANSCRIPTION FACTOR EGR-1; LET-7 MICRORNA; SOMATIC-CELLS; UBIQUITIN LIGASE; FEEDBACK LOOP; NAB PROTEINS; TARGET GENE; C-MYC; DIFFERENTIATION; MOUSE	Reprogramming differentiated cells into induced pluripotent stemcells (iPSCs) promotes a broad array of cellular changes. Here we show that the let-7 family of microRNAs acts as an inhibitory influence on the reprogramming process through a regulatory pathway involving prodifferentiation factors, including EGR1. Inhibiting let-7 in human cells promotes reprogramming to a comparable extent to c-MYC when combined with OCT4, SOX2, and KLF4, and persistence of let-7 inhibits reprogramming. Inhibiting let-7 during reprogramming leads to an increase in the level of the let-7 target LIN-41/TRIM71, which in turn promotes reprogramming and is important for overcoming the let-7 barrier to reprogramming. Mechanistic studies revealed that LIN-41 regulates a broad array of differentiation genes, and more specifically, inhibits translation of EGR1 through binding its cognate mRNA. Together our findings outline a let-7-based pathway that counteracts the activity of reprogramming factors through promoting the expression of prodifferentiation genes.	[Worringer, Kathleen A.; Rand, Tim A.; Hayashi, Yohei; Sami, Salma; Srivastava, Deepak; Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Worringer, Kathleen A.; Rand, Tim A.; Hayashi, Yohei; Sami, Salma; Srivastava, Deepak; Yamanaka, Shinya] Roddenberry Ctr Stem Cell Biol & Med Gladstone, San Francisco, CA 94158 USA; [Takahashi, Kazutoshi; Tanabe, Koji; Narita, Megumi; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Yamanaka, Shinya] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Kyoto University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Srivastava, D (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu; syamanaka@gladstone.ucsf.edu	Hayashi, Yohei/L-8190-2019; Takahashi, Kazutoshi/ABE-5504-2020; Hayashi, Yohei/AAF-6059-2020	Takahashi, Kazutoshi/0000-0002-5329-8395; Hayashi, Yohei/0000-0001-5490-7052; Srivastava, Deepak/0000-0002-3480-5953; Worringer, Kathleen/0000-0001-7807-2344	NIH [F32GM88988-02]; California Institute for Regenerative Medicine; L.K. Whittier Foundation; Roddenberry Foundation; Gladstone Institutes; NHLBI/NIH [U01-HL100406, U01-HL098179]; National Center for Research Resources Grant [RR18928-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098179, U01HL100406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM088988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); L.K. Whittier Foundation; Roddenberry Foundation; Gladstone Institutes(University of California System); NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the Yamanaka and Srivastava lab members for helpful discussions, Alex Williams of the Gladstone Bioinformatics Core for RNAseq analysis, Yanxia Hao of the Gladstone Genomics Core for RNAseq library preparation, the Gladstone Histology Core for teratoma sectioning, Anna Lisa Lucido and Gary Howard for editorial review, Bethany Taylor and Karena Essex for administrative support, Pengzhi Yu for providing E8 medium, and F. Gregory Wulczyn for providing a LIN-41 antibody. K. A. W. was supported by an NIH fellowship (F32GM88988-02) and is a California Institute for Regenerative Medicine scholar. These studies were also made possible by funding from the L.K. Whittier Foundation (S.Y. and D. S.), the Roddenberry Foundation (S.Y. and D. S.), the Gladstone Institutes, and NHLBI/NIH (U01-HL100406, U01-HL098179) (D. S. and S.Y.). The Gladstone Institutes received support from a National Center for Research Resources Grant RR18928-01. S.Y. is a member without salary of the scientific advisory boards of iPierian, iPS Academia Japan, Megakaryon Corporation, and HEALIOS K. K. Japan; D. S. is a member of the scientific advisory boards of iPierian, Berkeley Lights, and RegeneRx Pharmaceuticals.	Banito A, 2010, EMBO REP, V11, P353, DOI 10.1038/embor.2010.47; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; Carter JH, 2007, J IMMUNOL, V178, P6796, DOI 10.4049/jimmunol.178.11.6796; Chang HM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1909; Chen JF, 2012, GENE DEV, V26, P803, DOI 10.1101/gad.187641.112; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Collins S, 2006, J IMMUNOL, V177, P8301, DOI 10.4049/jimmunol.177.12.8301; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dinkel A, 1998, J EXP MED, V188, P2215, DOI 10.1084/jem.188.12.2215; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Dubchak I, 2013, BIOINFORMATICS, V29, P2059, DOI 10.1093/bioinformatics/btt318; EDWARDS SA, 1991, DEV BIOL, V148, P165, DOI 10.1016/0012-1606(91)90327-Y; Fragola G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003292; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Gaspar-Maia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2582; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Harris DT, 2011, DEVELOPMENT, V138, P4051, DOI 10.1242/dev.065417; Hunter SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003353; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; KRISHNARAJU K, 1995, MOL CELL BIOL, V15, P5499; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; Lanoix J, 1998, ONCOGENE, V17, P2495, DOI 10.1038/sj.onc.1202166; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Le N, 2005, NAT NEUROSCI, V8, P932, DOI 10.1038/nn1490; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Lin YC, 2007, MOL BIOL EVOL, V24, P2525, DOI 10.1093/molbev/msm195; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; Maekawa M, 2011, CELL CYCLE, V10, P3613, DOI 10.4161/cc.10.21.17834; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mayr F, 2013, INT J MOL SCI, V14, P16532, DOI 10.3390/ijms140816532; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; O'Farrell F, 2008, DEV DYNAM, V237, P196, DOI 10.1002/dvdy.21396; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pasque V, 2012, J CELL SCI, V125, P6094, DOI 10.1242/jcs.113019; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robertson Barbara, 2010, Silence, V1, P10, DOI 10.1186/1758-907X-1-10; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schulman BRM, 2008, CELL CYCLE, V7, P3935; Schulman BRM, 2005, DEV DYNAM, V234, P1046, DOI 10.1002/dvdy.20599; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Spaapen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058083; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanabe K, 2013, P NATL ACAD SCI USA, V110, P12172, DOI 10.1073/pnas.1310291110; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zhang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056108	70	151	153	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					40	52		10.1016/j.stem.2013.11.001	http://dx.doi.org/10.1016/j.stem.2013.11.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24239284	Green Accepted, Bronze			2022-12-28	WOS:000329571900008
J	Lysaght, T; Kerridge, I; Sipp, D; Porter, G; Capps, BJ				Lysaght, Tamra; Kerridge, Ian; Sipp, Douglas; Porter, Gerard; Capps, Benjamin J.			Oversight for Clinical Uses of Autologous Adult Stem Cells: Lessons from International Regulations	CELL STEM CELL			English	Editorial Material									[Lysaght, Tamra] Natl Univ Singapore, Asia Res Inst, Singapore 259770, Singapore; [Kerridge, Ian] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2050, Australia; [Kerridge, Ian] Royal N Shore Hosp, Dept Haematol, Sydney, NSW 2065, Australia; [Sipp, Douglas] RIKEN Ctr Dev Biol, Sci Policy & Eth Studies Unit, Kobe, Hyogo 6500057, Japan; [Porter, Gerard] Univ Edinburgh, Sch Law, Edinburgh EH8 9YL, Midlothian, Scotland; [Capps, Benjamin J.] Natl Univ Singapore, Ctr Biomed Eth, Singapore 117597, Singapore	National University of Singapore; University of Sydney; Royal North Shore Hospital; University of Sydney; RIKEN; University of Edinburgh; National University of Singapore	Lysaght, T (corresponding author), Natl Univ Singapore, Asia Res Inst, Singapore 259770, Singapore.	tlysaght@nus.edu.sg	Sipp, Doug/C-9218-2017; Lysaght, Tamra/AAU-9525-2020; Porter, Gerard/D-8269-2017	Sipp, Doug/0000-0002-5979-0938; Capps, Benjamin/0000-0002-9104-6025; Porter, Gerard/0000-0002-1566-039X; Kerridge, Ian/0000-0001-7445-4660				Bianco P, 2013, NATURE, V499, P255, DOI 10.1038/499255a; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Fleder J. R., 2011, FDA CONTINUES EFFORT; Ishii T, 2013, CELL STEM CELL, V13, P145, DOI 10.1016/j.stem.2013.07.005; Kiatpongsan S., 2008, NATURE REPORTS STEM; Levine AD, 2012, REGEN MED, V7, P451, DOI [10.2217/RME.12.43, 10.2217/rme.12.43]; Lysaght T, 2013, AM J MED, V126, P941, DOI 10.1016/j.amjmed.2013.06.031; Mahalatchimy A, 2012, J LAW SOC, V39, P131, DOI 10.1111/j.1467-6478.2012.00574.x; Singapore Medical Council, 2010, DISC INQ WY MENG; Singapore Medical Council, 2009, DISC INQ MHH SHUI; Taylor PL, 2010, J LAW MED ETHICS, V38, P286, DOI 10.1111/j.1748-720X.2010.00489.x	11	22	22	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					647	651		10.1016/j.stem.2013.11.013	http://dx.doi.org/10.1016/j.stem.2013.11.013			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24315438	Green Accepted, Bronze			2022-12-28	WOS:000329571700007
J	Verovskaya, E; de Haan, G				Verovskaya, Evgenia; de Haan, Gerald			Noncanonical Wnt Comes of Age in Hematopoietic Stem Cells	CELL STEM CELL			English	Editorial Material							REJUVENATION		[Verovskaya, Evgenia; de Haan, Gerald] Univ Groningen, Univ Med Ctr Groningen, Lab Ageing Biol & Stem Cells, European Res Inst Biol Ageing, NL-9713 AV Groningen, Netherlands	University of Groningen	de Haan, G (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Lab Ageing Biol & Stem Cells, European Res Inst Biol Ageing, Antonius Deusinglaan 1,Bldg 3226, NL-9713 AV Groningen, Netherlands.	g.de.haan@umcg.nl	de Haan, Gerald/D-2081-2015; de Haan, Gerald/AAF-8963-2019	de Haan, Gerald/0000-0001-9706-0138; de Haan, Gerald/0000-0001-9706-0138				Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Florian M.C., 2013, NATURE IN PRESS; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Luis TC, 2012, LEUKEMIA, V26, P86, DOI 10.1038/leu.2011.260; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001	9	3	4	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					642	643		10.1016/j.stem.2013.11.009	http://dx.doi.org/10.1016/j.stem.2013.11.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24315437	Bronze			2022-12-28	WOS:000329571700005
J	Andoniadou, CL; Matsushima, D; Gharavy, SNM; Signore, M; Mackintosh, AI; Schaeffer, M; Gaston-Massuet, C; Mollard, P; Jacques, TS; Le Tissier, P; Dattani, MT; Pevny, LH; Martinez-Barbera, JP				Andoniadou, Cynthia Lilian; Matsushima, Danielle; Gharavy, Seyedeh Neda Mousavy; Signore, Massimo; Mackintosh, Albert Ian; Schaeffer, Marie; Gaston-Massuet, Carles; Mollard, Patrice; Jacques, Thomas Stanley; Le Tissier, Paul; Dattani, Mehul Tulsidas; Pevny, Larysa Halyna; Martinez-Barbera, Juan Pedro			Sox2(+) Stem/Progenitor Cells in the Adult Mouse Pituitary Support Organ Homeostasis and Have Tumor-Inducing Potential	CELL STEM CELL			English	Article							CANCER STEM-CELLS; BETA-CATENIN; ANTERIOR-PITUITARY; DIFFERENTIATION; PATHOGENESIS; MUTATIONS; GROWTH; CRANIOPHARYNGIOMAS; IDENTIFICATION; TRANSFORMATION	Sox2(+) adult mouse pituitary cells can self-renew and terminally differentiate in vitro, but their physiological role in vivo and possible contribution to oncogenesis remain largely unknown. Using genetic lineage tracing, we show here that the Sox2(+) cell compartment of both the embryonic and adult pituitary contains stem/progenitor cells that are able to differentiate into all hormone-producing lineages and contribute to organ homeostasis during postnatal life. In addition, we show that targeted expression of oncogenic beta-catenin in Sox2(+) cells gives rise to pituitary tumors, but, unexpectedly, the tumor mass is not derived from the Sox2(+) mutation-sustaining cells, suggesting a paracrine role of Sox2(+) cells in pituitary oncogenesis. Our data therefore provide in vivo evidence of a role for Sox2(+) stem/progenitor cells in long-term physiological maintenance of the adult pituitary, and highlight an unexpected non-cell-autonomous role for these cells in the induction of pituitary tumors.	[Andoniadou, Cynthia Lilian; Gharavy, Seyedeh Neda Mousavy; Signore, Massimo; Mackintosh, Albert Ian; Gaston-Massuet, Carles; Jacques, Thomas Stanley; Le Tissier, Paul; Martinez-Barbera, Juan Pedro] UCL Inst Child Hlth, Neural Dev Unit, Birth Defects Res Ctr, London WC1N 1EH, England; [Matsushima, Danielle; Pevny, Larysa Halyna] Univ N Carolina, Ctr Neurosci, Dept Genet, Chapel Hill, NC 27599 USA; [Schaeffer, Marie; Mollard, Patrice] CNRS, Inst Genom Fonct, UMR 5203, F-34000 Montpellier, France; [Schaeffer, Marie; Mollard, Patrice] INSERM, U661, F-34000 Montpellier, France; [Schaeffer, Marie; Mollard, Patrice] Univ Montpellier I, UMR 5203, F-34000 Montpellier, France; [Schaeffer, Marie; Mollard, Patrice] Univ Montpellier 2, UMR 5203, F-34000 Montpellier, France; [Jacques, Thomas Stanley] Great Ormond St Hosp Children NHS Fdn Trust, Dept Histopathol, London WC1N 3JH, England; [Dattani, Mehul Tulsidas] UCL Inst Child Hlth, Dev Endocrinol Res Grp, London WC1N 1EH, England; [Dattani, Mehul Tulsidas] Great Ormond St Hosp Children NHS Fdn Trust, Dept Endocrinol, London WC1N 1EH, England	University of London; University College London; University of North Carolina; University of North Carolina Chapel Hill; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Andoniadou, CL (corresponding author), UCL Inst Child Hlth, Neural Dev Unit, Birth Defects Res Ctr, London WC1N 1EH, England.	cynthia.andoniadou@kcl.ac.uk; j.martinez-barbera@ucl.ac.uk	Schaeffer, Marie/C-9815-2019; Martinez-Barbera, Juan Pedro/AAE-9284-2020; Jacques, Thomas/C-2209-2008	Schaeffer, Marie/0000-0002-2063-5324; Martinez-Barbera, Juan Pedro/0000-0002-5292-7276; Jacques, Thomas/0000-0002-7833-2158; Andoniadou, Cynthia/0000-0003-4311-5855; Le Tissier, Paul/0000-0002-7220-5705; Matsushima, Danielle/0000-0002-4538-2992	UCL Institute of Child Health; Great Ormond Street Hospital Flow Cytometry Core Facility; Montpellier RIO Imaging Cytometry Facility; UCL Genomics; ICH Embryonic Stem Cell/Chimera Production Facility; UCL Biological Services Unit; UCL Cancer Institute; WIBR Scientific Support Services; Wellcome Trust [086545, 084361]; Great Ormond Street Children's Hospital Charity; MRC [MC_U117570590] Funding Source: UKRI; Medical Research Council [MC_U117570590] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [W1055, V1255] Funding Source: researchfish	UCL Institute of Child Health; Great Ormond Street Hospital Flow Cytometry Core Facility; Montpellier RIO Imaging Cytometry Facility; UCL Genomics; ICH Embryonic Stem Cell/Chimera Production Facility; UCL Biological Services Unit; UCL Cancer Institute; WIBR Scientific Support Services; Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Children's Hospital Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity	This work was carried out with the support of the UCL Institute of Child Health and Great Ormond Street Hospital Flow Cytometry Core Facility, the Montpellier RIO Imaging Cytometry Facility, UCL Genomics, the ICH Embryonic Stem Cell/Chimera Production Facility, UCL Biological Services Unit, and UCL Cancer Institute and WIBR Scientific Support Services. We thank Dr. JrGang Cheng and the BAC Recombineering Core Facility at UNC Chapel Hill, C. Legraverend for providing the S100beta-eGFP transgenic mice, and the Developmental Studies Hybridoma Bank (University of Iowa) and the National Hormone and Peptide Program (Harbor-UCLA Medical Center) for providing some of the antibodies used in this study. We thank Gabriella Carreno and Mario Gonzalez-Meljem for technical assistance; Prof. Jacques Drouin and Prof. Simon Rhodes for TPIT and PIT1 antibodies, respectively; and Prof. Sally Camper, Prof. Steve Jones, and Prof. Gregory Shackleford for Wnt6, Wnt5a, and Wnt10a probes, respectively. This work was supported by grants 086545 and 084361 from The Wellcome Trust. M. T. D. is funded by the Great Ormond Street Children's Hospital Charity.	Alatzoglou KS, 2011, HUM MUTAT, V32, P1376, DOI 10.1002/humu.21606; ALLAERTS W, 1990, MOL CELL ENDOCRINOL, V71, P73, DOI 10.1016/0303-7207(90)90244-3; Andoniadou CL, 2007, DEVELOPMENT, V134, P1499, DOI 10.1242/dev.02829; Andoniadou CL, 2012, ACTA NEUROPATHOL, V124, P259, DOI 10.1007/s00401-012-0957-9; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bilodeau S, 2009, MOL CELL BIOL, V29, P1895, DOI 10.1128/MCB.01885-08; BORSON S, 1994, NEUROENDOCRINOLOGY, V59, P466, DOI 10.1159/000126693; Buslei R, 2005, ACTA NEUROPATHOL, V109, P589, DOI 10.1007/s00401-005-1004-x; CARBAJOPEREZ E, 1990, CELL TISSUE RES, V261, P333, DOI 10.1007/BF00318674; Castinetti F, 2011, ENDOCR REV, V32, P453, DOI 10.1210/er.2010-0011; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Davis SW, 2011, DEV BIOL, V352, P215, DOI 10.1016/j.ydbio.2011.01.010; Devnath S, 2008, J NEUROENDOCRINOL, V20, P687, DOI 10.1111/j.1365-2826.2008.01716.x; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Dworakowska D, 2012, MINERVA ENDOCRINOL, V37, P157; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Florio T, 2011, NEUROENDOCRINOLOGY, V94, P265, DOI 10.1159/000330857; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Fu QL, 2012, STEM CELLS DEV, V21, P3245, DOI 10.1089/scd.2012.0290; Fu QL, 2012, ENDOCRINOLOGY, V153, P3224, DOI 10.1210/en.2012-1152; Garcia-Lavandeira M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004815; Gaston-Massuet C, 2011, P NATL ACAD SCI USA, V108, P11482, DOI 10.1073/pnas.1101553108; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Gremeaux L, 2012, STEM CELLS DEV, V21, P801, DOI 10.1089/scd.2011.0496; Gueorguiev M, 2011, NAT REV ENDOCRINOL, V7, P71, DOI 10.1038/nrendo.2010.233; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hofmann BM, 2006, AM J SURG PATHOL, V30, P1595, DOI 10.1097/01.pas.0000213328.64121.12; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; Jayakody SA, 2012, J CLIN INVEST, V122, P3635, DOI 10.1172/JCI64311; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Labeur M, 2010, MOL CELL ENDOCRINOL, V326, P85, DOI 10.1016/j.mce.2010.04.006; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; Levy A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740147; Levy A, 2008, J NEUROENDOCRINOL, V20, P139; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Mollard P, 2012, TRENDS ENDOCRIN MET, V23, P261, DOI 10.1016/j.tem.2012.02.004; Muller HL, 2010, NAT REV ENDOCRINOL, V6, P609, DOI 10.1038/nrendo.2010.168; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Pevny L, 2003, TRENDS NEUROSCI, V26, P351, DOI 10.1016/S0166-2236(03)00169-3; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; Taniguchi Y, 2002, ANAT EMBRYOL, V206, P1, DOI 10.1007/s00429-002-0271-8; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Vives V, 2003, J COMP NEUROL, V457, P404, DOI 10.1002/cne.10552; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yoshida S, 2011, J NEUROENDOCRINOL, V23, P933, DOI 10.1111/j.1365-2826.2011.02198.x; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	66	187	189	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					433	445		10.1016/j.stem.2013.07.004	http://dx.doi.org/10.1016/j.stem.2013.07.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094324	Green Published, Bronze			2022-12-28	WOS:000329571100012
J	Geijsen, N				Geijsen, Niels			Primed to Perish: Heightened Mitochondrial Priming Explains hESC Apoptosis Sensitivity	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; P53; FAMILY	Human embryonic stem cells (hESCs) are hypersensitive to apoptotic stimuli, though the underlying mechanisms are poorly characterized. In this issue of Cell Stem Cell, Liu et al. (2013) report that mitochondria of human ESCs exist in an apoptosis-prone state, ready to act as cellular executioners upon detecting DNA damage.	[Geijsen, Niels] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [Geijsen, Niels] Univ Utrecht, Dept Compan Anim, Fac Vet Med, NL-3508 TD Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University	Geijsen, N (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	n.geijsen@hubrecht.eu						Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Grandela C, 2008, STEM CELL RES, V1, P116, DOI 10.1016/j.scr.2007.10.003; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	10	3	3	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					371	372		10.1016/j.stem.2013.09.011	http://dx.doi.org/10.1016/j.stem.2013.09.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094314	Bronze			2022-12-28	WOS:000329571100001
J	Guezguez, B; Campbell, CJV; Boyd, AL; Karanu, F; Casado, FL; Di Cresce, C; Collins, TJ; Shapovalova, Z; Xenocostas, A; Bhatia, M				Guezguez, Borhane; Campbell, Clinton J. V.; Boyd, Allison L.; Karanu, Francis; Casado, Fanny L.; Di Cresce, Christine; Collins, Tony J.; Shapovalova, Zoya; Xenocostas, Anargyros; Bhatia, Mickie			Regional Localization within the Bone Marrow Influences the Functional Capacity of Human HSCs	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELL; CORD BLOOD TRANSPLANTATION; NOTCH LIGAND JAGGED1; NOD-SCID MICE; PROGENITOR CELLS; SELF-RENEWAL; INTRAFEMORAL TRANSPLANTATION; MURINE BONE; IN-VIVO; NICHE	Numerous studies have shown that the bone marrow (BM) niche plays a key role in mouse hematopoietic stem cell (HSC) function and involves contributions from a broad array of cell types. However, the composition and role of the human BM HSC niche have not been investigated. Here, using human bone biopsy specimens, we provide evidence of HSC propensity to localize to endosteal regions of the trabecular bone area (TBA). Through functional xenograft transplantation, we found that human HSCs localizing to the TBA have superior regenerative and self-renewal capacity and are molecularly distinct from those localizing to the long bone area (LBA). In addition, osteoblasts in the TBA possess unique characteristics and express a key network of factors that regulate TBA-versus LBA-localized human HSCs in vivo. Our study reveals that BM localization and architecture play a critical role in defining the functional and molecular properties of human HSCs.	[Guezguez, Borhane; Campbell, Clinton J. V.; Boyd, Allison L.; Karanu, Francis; Casado, Fanny L.; Collins, Tony J.; Shapovalova, Zoya; Bhatia, Mickie] McMaster Univ, Michael G DeGroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Campbell, Clinton J. V.; Boyd, Allison L.; Bhatia, Mickie] McMaster Univ, Dept Biochem, Hamilton, ON L8N 3Z5, Canada; [Di Cresce, Christine] Univ Western Ontario, Lawson Hlth Res Inst, London, ON N6A 5C1, Canada; [Di Cresce, Christine] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Xenocostas, Anargyros] Univ Western Ontario, London Hlth Sci Ctr, London, ON N6A 5C1, Canada; [Xenocostas, Anargyros] Univ Western Ontario, Schulich Sch Med, London, ON N6A 5C1, Canada	McMaster University; McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario)	Bhatia, M (corresponding author), McMaster Univ, Michael G DeGroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada.	mbhatia@mcmaster.ca	Xenocostas, Anargyros/G-3358-2011; Casado, Fanny L/D-8266-2015; Campbell, Clinton/Z-1986-2019	Casado, Fanny L/0000-0002-8791-626X; Campbell, Clinton/0000-0002-8896-1134; Guezguez, Borhane/0000-0002-1474-8074	Canadian Institutes of Health Research (CIHR); Ontario Cancer Research Institute (OICR); Canadian Research Chair Program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Cancer Research Institute (OICR); Canadian Research Chair Program(Canada Research Chairs)	We thank J. McNicol and J. Russell for imaging scanning and analysis assistance; David Carter (LRGC, Robarts Research Institute) for the quality of the probes and arrays; A. Fiebig-Comyn, Claudia I. Hopkins, and Monica Graham for general technical assistance; M. Levadoux-Martin for FACS analysis and cell sorting; Mary-Jo Smith for histology assistance and troubleshooting of in situ staining; and Drs. Kristin Hope, T. Ogilvie Werbowetski, and B. McIntyre for critical review of the manuscript prior to submission. We also thank members of the Labor and Delivery ward at the McMaster Children's Hospital for supplying human cord blood samples. Funding for this research was provided by a research grant from the Canadian Institutes of Health Research (CIHR) and the Ontario Cancer Research Institute (OICR). M. B. is supported by the Canadian Research Chair Program and holds a chair in human stem cell biology. B. G. designed and performed experiments, analyzed and interpreted data, and wrote manuscript draft; Z.S. performed bioinformatic and gene expression analysis; T.J.C. wrote the image processing and analysis scripts; C.J.V.C. performed experiments, analyzed and interpreted data, and edited the manuscript; F. C. and A. B. performed and assisted with the human biopsy analysis and transplant experiments; F. K. performed the Notch-HSC-related experiments; and M. B. designed the experiments, interpreted data, and wrote the manuscript.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Anjos-Afonso F, 2007, BLOOD, V109, P1298, DOI 10.1182/blood-2006-06-030551; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Blank U, 2006, BLOOD, V108, P4246, DOI 10.1182/blood-2006-02-005611; Bowman Teresa V., 2007, V134, P1; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173; Christianson SW, 1997, J IMMUNOL, V158, P3578; Chung YJ, 2006, BLOOD, V108, P1208, DOI 10.1182/blood-2006-01-010199; Colvin GA, 2010, J CELL PHYSIOL, V222, P57, DOI 10.1002/jcp.21918; Conneally E, 1997, P NATL ACAD SCI USA, V94, P9836, DOI 10.1073/pnas.94.18.9836; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Guezguez B, 2008, CURR OPIN ORGAN TRAN, V13, P44, DOI 10.1097/MOT.0b013e3282f42486; Hansson EM, 2010, J CELL SCI, V123, P2931, DOI 10.1242/jcs.073239; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Heuss SF, 2008, P NATL ACAD SCI USA, V105, P11212, DOI 10.1073/pnas.0800695105; Hodby K, 2011, STEM CELLS, V29, P1322, DOI 10.1002/stem.689; Hope K, 2011, NAT METHODS, V8, pS36, DOI [10.1038/NMETH.1590, 10.1038/nmeth.1590]; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jansen M, 2005, STEM CELLS, V23, P335, DOI 10.1634/stemcells.2004-0216; Jiang X, 2005, J HISTOCHEM CYTOCHEM, V53, P593, DOI 10.1369/jhc.4A6401.2005; Karanu FN, 2001, BLOOD, V97, P1960, DOI 10.1182/blood.V97.7.1960; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kelly SS, 2010, CYTOTHERAPY, V12, P121, DOI 10.3109/14653240903440111; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim YW, 2008, BLOOD, V112, P4628, DOI 10.1182/blood-2008-03-148999; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lundberg P, 2007, J BIOL CHEM, V282, P19082, DOI 10.1074/jbc.M609629200; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Medyouf H, 2010, BLOOD, V115, P1175, DOI 10.1182/blood-2009-04-214718; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Naresh KN, 2006, J CLIN PATHOL, V59, P903, DOI 10.1136/jcp.2004.020610; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schoemans H, 2006, BONE MARROW TRANSPL, V38, P83, DOI 10.1038/sj.bmt.1705403; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shojaei F, 2005, DEV CELL, V8, P651, DOI 10.1016/j.devcel.2005.03.004; Short Brenton J., 2009, V482, P259, DOI 10.1007/978-1-59745-060-7_16; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Weber JM, 2006, BONE, V39, P485, DOI 10.1016/j.bone.2006.03.002; Windler SL, 2010, CURR BIOL, V20, P538, DOI 10.1016/j.cub.2010.01.049; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	73	78	78	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					175	189		10.1016/j.stem.2013.06.015	http://dx.doi.org/10.1016/j.stem.2013.06.015			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910084	Bronze			2022-12-28	WOS:000329570600011
J	Webster, MT; Manor, U; Lippincott-Schwartz, J; Fan, CM				Webster, Micah T.; Manor, Uri; Lippincott-Schwartz, Jennifer; Fan, Chen-Ming			Intravital Imaging Reveals Ghost Fibers as Architectural Units Guiding Myogenic Progenitors during Regeneration	CELL STEM CELL			English	Article							MUSCLE SATELLITE CELL; SKELETAL-MUSCLE; STEM-CELLS; PRECURSOR CELLS; MIGRATION; MOUSE; MOTILITY; PROLIFERATION	How resident stem cells and their immediate progenitors rebuild tissues of pre-injury organization and size for proportional regeneration is not well understood. Using 3D, time-lapse intravital imaging for direct visualization of the muscle regeneration process in live mice, we report that extracellular matrix remnants from injured skeletal muscle fibers, "ghost fibers,'' govern muscle stem/progenitor cell behaviors during proportional regeneration. Stem cells were immobile and quiescent without injury whereas their activated progenitors migrated and divided after injury. Unexpectedly, divisions and migration were primarily bi-directionally oriented along the ghost fiber longitudinal axis, allowing for spreading of progenitors throughout ghost fibers. Re-orienting ghost fibers impacted myogenic progenitors' migratory paths and division planes, causing disorganization of regenerated muscle fibers. We conclude that ghost fibers are autonomous, architectural units necessary for proportional regeneration after tissue injury. This finding reinforces the need to fabricate bioengineered matrices that mimic living tissue matrices for tissue regeneration therapy.	[Webster, Micah T.; Fan, Chen-Ming] Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA; [Manor, Uri; Lippincott-Schwartz, Jennifer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Branch, NIH, Bldg 35A,9000 Rockville Pike, Bethesda, MD 20892 USA	Carnegie Institution for Science; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fan, CM (corresponding author), Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	fan@ciwemb.edu		Manor, Uri/0000-0002-9802-1955	NIAMS of NIH [F32AR065366, RO1AR060042]; intramural funds of NICHD of NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR065366, R01AR060042] Funding Source: NIH RePORTER	NIAMS of NIH; intramural funds of NICHD of NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Fan and Lepper Lab members as well as Drs. Allan Spradling and Yixian Zheng for reading the manuscript, Ms. S. Satchell and Ms. E. Dikovsky for maintaining mice, and Dr. Mahmud Siddiqi for microscopy assistance. Research reported in this publication was supported by the NIAMS of the NIH under award numbers F32AR065366 (to M.W.) and RO1AR060042 (to C.-M.F.), as well as intramural funds of the NICHD of the NIH (to U.M. and J.L.-S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Alameddine H S, 1991, Neuromuscul Disord, V1, P143, DOI 10.1016/0960-8966(91)90062-W; Bentzinger CF, 2014, J CELL BIOL, V205, P97, DOI 10.1083/jcb.201310035; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Bischoff R, 1997, DEV DYNAM, V208, P505, DOI 10.1002/(SICI)1097-0177(199704)208:4<505::AID-AJA6>3.0.CO;2-M; BISCHOFF R, 1986, DEV BIOL, V115, P140, DOI 10.1016/0012-1606(86)90235-6; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Carmignac V, 2012, J PATHOL, V226, P200, DOI 10.1002/path.3020; Chen YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046171; CLARK WEL, 1946, J ANAT, V80, P24; Cosgrove BD, 2009, DIFFERENTIATION, V78, P185, DOI 10.1016/j.diff.2009.08.004; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; El Fahime E, 2000, EXP CELL RES, V258, P279, DOI 10.1006/excr.2000.4962; Grasman JM, 2015, ACTA BIOMATER, V25, P2, DOI 10.1016/j.actbio.2015.07.038; Griffin CA, 2010, J CELL SCI, V123, P3052, DOI 10.1242/jcs.066241; Jansen KM, 2006, J CELL BIOL, V174, P403, DOI 10.1083/jcb.200601102; Jockusch H, 2003, J CELL SCI, V116, P1611, DOI 10.1242/jcs.00364; KONIGSBERG UR, 1975, DEV BIOL, V45, P260, DOI 10.1016/0012-1606(75)90065-2; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Scognamiglio F., 2015, J BIOMED B IN PRESS; Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085; Siegel AL, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-7; Siegel AL, 2009, STEM CELLS, V27, P2527, DOI 10.1002/stem.178; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stark DA, 2011, DEVELOPMENT, V138, P5279, DOI 10.1242/dev.068411; TROTTER JA, 1992, J MORPHOL, V212, P109, DOI 10.1002/jmor.1052120203; VRACKO R, 1972, J CELL BIOL, V55, P406, DOI 10.1083/jcb.55.2.406; WATT DJ, 1987, ANAT EMBRYOL, V175, P527, DOI 10.1007/BF00309688; WATT DJ, 1982, J NEUROL SCI, V57, P319, DOI 10.1016/0022-510X(82)90038-7; Webster MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081757; Yennek S, 2014, CELL REP, V7, P961, DOI 10.1016/j.celrep.2014.04.016; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011	40	113	117	2	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2016	18	2					243	252		10.1016/j.stem.2015.11.005	http://dx.doi.org/10.1016/j.stem.2015.11.005			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GT	26686466	Green Accepted, Bronze			2022-12-28	WOS:000372321700014
J	Zhang, L; Yin, JC; Yeh, H; Ma, NX; Lee, G; Chen, XA; Wang, YM; Lin, L; Chen, L; Jin, P; Wu, GY; Chen, G				Zhang, Lei; Yin, Jiu-Chao; Yeh, Hana; Ma, Ning-Xin; Lee, Grace; Chen, Xiangyun Amy; Wang, Yanming; Lin, Li; Chen, Li; Jin, Peng; Wu, Gang-Yi; Chen, Gong			Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; IN-VIVO; HUMAN FIBROBLASTS; PROGENITOR CELLS; ADULT BRAIN; METHYLATION PATTERNS; MOUSE FIBROBLASTS; DIRECT CONVERSION; DEFINED FACTORS; SONIC HEDGEHOG	We have recently demonstrated that reactive glial cells can be directly reprogrammed into functional neurons by a single neural transcription factor, NeuroD1. Here we report that a combination of small molecules can also reprogram human astrocytes in culture into fully functional neurons. We demonstrate that sequential exposure of human astrocytes to a cocktail of nine small molecules that inhibit glial but activate neuronal signaling pathways can successfully reprogram astrocytes into neurons in 8-10 days. This chemical reprogramming is mediated through epigenetic regulation and involves transcriptional activation of NEUROD1 and NEUROGENIN2. The human astrocyte-converted neurons can survive for >5 months in culture and form functional synaptic networks with synchronous burst activities. The chemically reprogrammed human neurons can also survive for >1 month in the mouse brain in vivo and integrate into local circuits. Our study opens a new avenue using chemical compounds to reprogram reactive glial cells into functional neurons.	[Zhang, Lei; Yin, Jiu-Chao; Yeh, Hana; Ma, Ning-Xin; Lee, Grace; Wu, Gang-Yi; Chen, Gong] Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA; [Wu, Gang-Yi] S China Normal Univ, Sch Life Sci, Guangzhou 510631, Guangdong, Peoples R China; [Chen, Xiangyun Amy; Wang, Yanming] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Lin, Li; Chen, Li; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; South China Normal University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Emory University	Wu, GY (corresponding author), Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA.	gangyiwu1@gmail.com; gongchen@psu.edu	Ma, Ningxin/GLT-9760-2022	Chen JNU, Gong/0000-0002-1857-3670; Wang, Yanming/0000-0002-0710-043X; Chen, Li/0000-0001-9372-5606; Yeh, Hana/0000-0003-3517-0547	National Institutes of Health [MH083911, AG045656]; Pennsylvania State University Stem Cell Fund; Recruitment Program of High-end Foreign Experts of the State Administration of Foreign Experts Affairs [GDT20144400031]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania State University Stem Cell Fund; Recruitment Program of High-end Foreign Experts of the State Administration of Foreign Experts Affairs; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank Yuting Bai and Yi Hu for technical support and the Chen laboratory members for vigorous discussion and helpful comments during the progress of this project. This work was supported by grants from National Institutes of Health (MH083911 and AG045656) and Pennsylvania State University Stem Cell Fund to G.C. and the Recruitment Program of High-end Foreign Experts of the State Administration of Foreign Experts Affairs (GDT20144400031) to G.-Y.W.	Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheng L, 2014, CELL RES, V24, P665, DOI 10.1038/cr.2014.32; Cheng PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022018; CONDORELLI DF, 1994, J NEUROSCI RES, V39, P694, DOI 10.1002/jnr.490390610; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Grande A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3373; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Heinrich C, 2014, STEM CELL REP, V3, P1000, DOI 10.1016/j.stemcr.2014.10.007; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Li K, 2014, CELL STEM CELL, V14, P228, DOI 10.1016/j.stem.2014.01.006; Li SQ, 2012, J NEUROSCI, V32, P7791, DOI 10.1523/JNEUROSCI.1309-12.2012; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Liu YG, 2015, J NEUROSCI, V35, P9336, DOI 10.1523/JNEUROSCI.3975-14.2015; Lukovic D, 2014, STEM CELLS DEV, V23, P1, DOI 10.1089/scd.2013.0266; Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Niu WZ, 2015, STEM CELL REP, V4, P780, DOI 10.1016/j.stemcr.2015.03.006; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Qu QH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4449; Rodriguez-Martinez G, 2012, CNS NEUROL DISORD-DR, V11, P844, DOI 10.2174/1871527311201070844; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Su ZD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4338; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Torper O, 2015, CELL REP, V12, P474, DOI 10.1016/j.celrep.2015.06.040; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu TL, 2015, NUCLEIC ACIDS RES, V43, P2757, DOI 10.1093/nar/gkv151; Yao B, 2014, GENE DEV, V28, P1253, DOI 10.1101/gad.241547.114; Zhang L, 2011, DIFFERENTIATION, V81, P233, DOI 10.1016/j.diff.2011.02.005	47	183	196	7	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					735	747		10.1016/j.stem.2015.09.012	http://dx.doi.org/10.1016/j.stem.2015.09.012			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26481520	Bronze, Green Accepted			2022-12-28	WOS:000366139100014
J	Zhong, CQ; Yin, Q; Xie, ZF; Bai, MZ; Dong, R; Tang, W; Xing, YH; Zhang, HL; Yang, SM; Chen, LL; Bartolomei, MS; Ferguson-Smith, A; Li, DS; Yang, L; Wu, YX; Li, JS				Zhong, Cuiqing; Yin, Qi; Xie, Zhenfei; Bai, Meizhu; Dong, Rui; Tang, Wei; Xing, Yu-Hang; Zhang, Hongling; Yang, Suming; Chen, Ling-Ling; Bartolomei, Marisa S.; Ferguson-Smith, Anne; Li, Dangsheng; Yang, Li; Wu, Yuxuan; Li, Jinsong			CRISPR-Cas9-Mediated Genetic Screening in Mice with Haploid Embryonic Stem Cells Carrying a Guide RNA Library	CELL STEM CELL			English	Article							GENERATION; SYSTEM; MOUSE; DERIVATION; INJECTION; OOCYTES; MONKEY; CAS9	Mouse androgenetic haploid embryonic stem cells (AG-haESCs) can support full-term development of semi-cloned (SC) embryos upon injection into MII oocytes and thus have potential applications in genetic modifications. However, the very low birth rate of SC pups limits practical use of this approach. Here, we show that AG-haESCs carrying deletions in the DMRs (differentially DNA methylated regions) controlling two paternally repressed imprinted genes, H19 and Gtl2, can efficiently support the generation of SC pups. Genetic manipulation of these DKO-AG-haESCs in vitro using CRISPR-Cas9 can produce SC mice carrying multiple modifications with high efficiency. Moreover, transfection of DKO-AG-haESCs with a constitutively expressed sgRNA library and Cas9 allows functional mutagenic screening. DKO-AG-haESCs are therefore an effective tool for the introduction of organism-wide mutations in mice in a single generation.	[Zhong, Cuiqing; Yin, Qi; Xie, Zhenfei; Bai, Meizhu; Zhang, Hongling; Yang, Suming; Wu, Yuxuan; Li, Jinsong] Chinese Acad Sci, Grp Epigenet Reprogramming, State Key Lab Cell Biol, Inst Biochem & Cell Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Zhong, Cuiqing; Yin, Qi; Xie, Zhenfei; Bai, Meizhu; Xing, Yu-Hang; Zhang, Hongling; Yang, Suming; Chen, Ling-Ling; Wu, Yuxuan; Li, Jinsong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl, Shanghai 200031, Peoples R China; [Zhong, Cuiqing; Yin, Qi; Xie, Zhenfei; Dong, Rui; Xing, Yu-Hang; Yang, Suming; Chen, Ling-Ling] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Zhang, Hongling; Li, Jinsong] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Dong, Rui; Yang, Li] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China; [Dong, Rui; Yang, Li] Chinese Acad Sci, CAS Ctr Excellence Brain Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Tang, Wei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Anim Core Facil, Shanghai 200031, Peoples R China; [Xing, Yu-Hang; Chen, Ling-Ling] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Bartolomei, Marisa S.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Ferguson-Smith, Anne] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Li, Dangsheng] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Li, Dangsheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Pennsylvania; Pennsylvania Medicine; University of Cambridge; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences	Yang, L (corresponding author), Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China.	liyang@picb.ac.cn; yuxuan.wu@sibcb.ac.cn; jsli@sibcb.ac.cn	Chen, Ling-Ling/AAY-3547-2021; Liu, Dominic/AAH-5057-2021	Bai, Meizhu/0000-0001-8208-4073; chen, ling ling/0000-0001-9501-0305; Ferguson-Smith, Anne/0000-0002-7608-5894; Dong, Rui/0000-0003-0985-6211; yang, li/0000-0001-8833-7473; Bartolomei, Marisa/0000-0001-9410-5222; li, jin song/0000-0003-3456-662X; Yin, Qi/0000-0001-5628-5015	Ministry of Science and Technology of China [2014CB964803, 2015AA020307]; National Natural Science Foundation of China [91319310, 31225017, 31271390]; Chinese Academy of Sciences [XDA01010403, 2012OHTP08]; Shanghai Municipal Commission for Science and Technology [12JC1409600, 13XD1404000]; NIH [GM051279]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051279, R01GM051279] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Commission for Science and Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Wei Bian, Xuedong Wang, and Fang Zhang for support with cell sorting and Yongqiong Yu, Zhoujie Li, Qian Yu, and Liangwen Zhou for support with embryo transfer. We thank Yuelei Chen and Xiaoyan Ding from the Stem Cell Facility for support with cell cultures. This study was supported by grants from the Ministry of Science and Technology of China (2014CB964803 and 2015AA020307) (to J.L.), the National Natural Science Foundation of China (91319310 and 31225017 to J.L.; 31271390 to L.Y.), the Chinese Academy of Sciences (XDA01010403 to J.L.; 2012OHTP08 to L.Y.), and the Shanghai Municipal Commission for Science and Technology (12JC1409600 and 13XD1404000) (to J.L.). The M.S.B. laboratory was supported by the NIH (GM051279).	Barlow DP, 2014, COLD SPRING HARB PER, V6; Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Horii T, 2013, PEERJ, V1, DOI 10.7717/peerj.230; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; Kishigami S, 2004, BIOL REPROD, V70, P1863, DOI 10.1095/biolreprod.103.025171; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kokubu C, 2014, CELL STEM CELL, V14, P265, DOI 10.1016/j.stem.2014.02.001; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Leeb M, 2014, CELL STEM CELL, V14, P385, DOI 10.1016/j.stem.2013.12.008; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li W, 2014, CELL STEM CELL, V14, P404, DOI 10.1016/j.stem.2013.11.016; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi LY, 2012, PROTEIN CELL, V3, P806, DOI 10.1007/s13238-012-2096-4; Thorvaldsen JL, 2002, MOL CELL BIOL, V22, P2450, DOI 10.1128/MCB.22.8.2450-2462.2002; Tu CF, 2008, J BIOL CHEM, V283, P12478, DOI 10.1074/jbc.M705872200; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang H, 2013, CELL RES, V23, P1187, DOI 10.1038/cr.2013.93; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Yang H, 2010, CELL RES, V20, P1034, DOI 10.1038/cr.2010.97; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	34	71	90	6	77	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					221	232		10.1016/j.stem.2015.06.005	http://dx.doi.org/10.1016/j.stem.2015.06.005			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26165924	Bronze			2022-12-28	WOS:000361878500013
J	Chen, YC; Niu, YY; Li, YJ; Ai, ZY; Kang, Y; Shi, H; Xiang, Z; Yang, ZH; Tan, T; Si, W; Li, W; Xia, XS; Zhou, Q; Ji, WZ; Li, TQ				Chen, Yongchang; Niu, Yuyu; Li, Yanjiao; Ai, Zongyong; Kang, Yu; Shi, Hong; Xiang, Zheng; Yang, Zhaohui; Tan, Tao; Si, Wei; Li, Wei; Xia, Xueshan; Zhou, Qi; Ji, Weizhi; Li, Tianqing			Generation of Cynomolgus Monkey Chimeric Fetuses using Embryonic Stem Cells	CELL STEM CELL			English	Article							RHESUS-MONKEYS; GROUND-STATE; PLURIPOTENCY; EPIBLAST; MOUSE; DERIVATION; INDUCTION; CIRCUITRY; CULTURE; GENE	Because of their similarity to humans, non-human primates are important models for studying human disease and developing therapeutic strategies. Establishment of chimeric animals using embryonic stem cells (ESCs) could help with these investigations, but has not so far been achieved. Here, we show that cynomolgus monkey ESCs (cESCs) grown in adjusted culture conditions are able to incorporate into host embryos and develop into chimeras with contribution in all three germ layers and in germ cell progenitors. Under the optimized culture conditions, which are based on an approach developed previously for naive human ESCs, the cESCs displayed altered growth properties, gene expression profiles, and self-renewal signaling pathways, suggestive of an altered naive-like cell state. Thus our findings show that it is feasible to generate chimeric monkeys using ESCs and open up new avenues for the use of non-human primate models to study both pluripotency and human disease.	[Chen, Yongchang; Niu, Yuyu; Li, Yanjiao; Ai, Zongyong; Kang, Yu; Shi, Hong; Xiang, Zheng; Yang, Zhaohui; Tan, Tao; Si, Wei; Xia, Xueshan; Ji, Weizhi; Li, Tianqing] Kunming Univ Sci & Technol, Inst Primate Translat Med, Yunnan Key Lab Primate Biomed Res, Kunming 650500, Yunnan, Peoples R China; [Li, Wei; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Chen, Yongchang; Niu, Yuyu; Li, Yanjiao; Ai, Zongyong; Kang, Yu; Shi, Hong; Xiang, Zheng; Yang, Zhaohui; Tan, Tao; Si, Wei; Ji, Weizhi; Li, Tianqing] Natl Engn Res Ctr Biomed & Anim Sci, Kunming 650500, Yunnan, Peoples R China; [Chen, Yongchang; Niu, Yuyu; Li, Yanjiao; Ai, Zongyong; Kang, Yu; Shi, Hong; Xiang, Zheng; Yang, Zhaohui; Tan, Tao; Si, Wei; Ji, Weizhi; Li, Tianqing] Kunming Biomed Int, Kunming 650500, Yunnan, Peoples R China	Kunming University of Science & Technology; Chinese Academy of Sciences; Institute of Zoology, CAS	Zhou, Q (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	qzhou@ioz.ac.cn; wji@kbimed.com; litq@kbimed.com	yang, zhaohui/AAD-2158-2019	yang, zhaohui/0000-0003-0958-4439; tan, tao/0000-0002-7589-602X; Si, Wei/0000-0003-0861-0682; Ji, Weizhi/0000-0003-2550-4224	National Basic Research Program of China [2012CBA01300, 2014CB560701]; Key Technologies Research and Development Program of China [2014BAI03B01]; National High Technology Research and Development Program of China [2012AA020701]; National Natural Science Foundation of China [31360231, 31271599]; Yunnan Innovation Talents of Science and Technology [2014HB054, 2013HB133]	National Basic Research Program of China(National Basic Research Program of China); Key Technologies Research and Development Program of China(National Key Technology R&D Program); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Innovation Talents of Science and Technology	This study was supported by grants from the National Basic Research Program of China (2012CBA01300 and 2014CB560701), the Key Technologies Research and Development Program of China (2014BAI03B01), the National High Technology Research and Development Program of China (2012AA020701), the National Natural Science Foundation of China (31360231 and 31271599), and Yunnan Innovation Talents of Science and Technology (2014HB054 and 2013HB133).	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cattavarayane S, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0051-y; Chan AWS, 2013, ILAR J, V54, P211, DOI 10.1093/ilar/ilt035; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen Y, 2012, AM J PRIMATOL, V74, P165, DOI 10.1002/ajp.21017; Fang RG, 2014, CELL STEM CELL, V15, P488, DOI 10.1016/j.stem.2014.09.004; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Huang K, 2014, CELL STEM CELL, V15, P410, DOI 10.1016/j.stem.2014.09.014; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; McKiernan SH, 2000, HUM REPROD, V15, P157, DOI 10.1093/humrep/15.1.157; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Niu YY, 2010, P NATL ACAD SCI USA, V107, P17663, DOI 10.1073/pnas.1006563107; Pera MF, 2013, NAT GENET, V45, P1412, DOI 10.1038/ng.2834; Sun ZH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-276; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Usui JI, 2012, AM J PATHOL, V180, P2417, DOI 10.1016/j.ajpath.2012.03.007; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	26	83	92	0	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2015	17	1					116	124		10.1016/j.stem.2015.06.004	http://dx.doi.org/10.1016/j.stem.2015.06.004			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DI	26119236	Bronze			2022-12-28	WOS:000361877600013
J	Peterson, SC; Eberl, M; Vagnozzi, AN; Belkadi, A; Veniaminova, NA; Verhaegen, ME; Bichakjian, CK; Ward, NL; Dlugosz, AA; Wong, SY				Peterson, Shelby C.; Eberl, Markus; Vagnozzi, Alicia N.; Belkadi, Abdelmadjid; Veniaminova, Natalia A.; Verhaegen, Monique E.; Bichakjian, Christopher K.; Ward, Nicole L.; Dlugosz, Andrzej A.; Wong, Sunny Y.			Basal Cell Carcinoma Preferentially Arises from Stem Cells within Hair Follicle and Mechanosensory Niches	CELL STEM CELL			English	Article							MERKEL CELLS; IMPROVES ACANTHOSIS; HUMAN HOMOLOG; MICE; TOUCH; DENERVATION; LINEAGE; BIOLOGY; TRICHOEPITHELIOMAS; IDENTIFICATION	Basal cell carcinoma (BCC) is characterized by frequent loss of PTCH1, leading to constitutive activation of the Hedgehog pathway. Although the requirement for Hedgehog in BCC is well established, the identity of disease-initiating cells and the compartments in which they reside remain controversial. By using several inducible Cre drivers to delete Ptch1 in different cell compartments in mice, we show here that multiple hair follicle stem cell populations readily develop BCC-like tumors. In contrast, stem cells within the interfollicular epidermis do not efficiently form tumors. Notably, we observed that innervated Gli1-expressing progenitors within mechanosensory touch dome epithelia are highly tumorigenic. Sensory nerves activate Hedgehog signaling in normal touch domes, while denervation attenuates touch dome-derived tumors. Together, our studies identify varying tumor susceptibilities among different stem cell populations in the skin, highlight touch dome epithelia as "hot spots'' for tumor formation, and implicate cutaneous nerves as mediators of tumorigenesis.	[Peterson, Shelby C.; Eberl, Markus; Vagnozzi, Alicia N.; Veniaminova, Natalia A.; Verhaegen, Monique E.; Bichakjian, Christopher K.; Dlugosz, Andrzej A.; Wong, Sunny Y.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Peterson, Shelby C.; Eberl, Markus; Vagnozzi, Alicia N.; Veniaminova, Natalia A.; Verhaegen, Monique E.; Bichakjian, Christopher K.; Dlugosz, Andrzej A.; Wong, Sunny Y.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Belkadi, Abdelmadjid; Ward, Nicole L.] Case Western Reserve Univ, Dept Dermatol, Cleveland, OH 44106 USA; [Belkadi, Abdelmadjid; Ward, Nicole L.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Case Western Reserve University; Case Western Reserve University	Wong, SY (corresponding author), Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA.	sunnyw@umich.edu	Ward, Nicole Leanne/L-2642-2019	Ward, Nicole Leanne/0000-0003-1907-2621; Unsworth, Shelby/0000-0003-2719-8187	NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R00AR059796, R01AR065409]; University of Michigan Department of Dermatology; Biological Sciences Scholars Program; Center for Organogenesis; University of Michigan Comprehensive Cancer Center; John S. and Suzanne C. Munn Cancer Fund; NIAMS [R01AR063437, R01AR062546, R21AR063852, R01AR045973, NCI R01CA087837]; National Institute of General Medical Sciences [T32 GM007315]; NATIONAL CANCER INSTITUTE [P30CA046592, R01CA087837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062546, R01AR065409, R21AR063852, R01AR063437, K99AR059796, R01AR045973, R00AR059796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Michigan Department of Dermatology(University of Michigan System); Biological Sciences Scholars Program; Center for Organogenesis; University of Michigan Comprehensive Cancer Center; John S. and Suzanne C. Munn Cancer Fund; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Isaac Brownell (National Cancer Institute [NCI]) for helpful discussions; to the Dlugosz lab at the University of Michigan for sharing reagents; and to Nisha Meireles, University of Michigan Skin Cancer Biobank, for Biobank coordination and management. S.Y.W. acknowledges the support of the NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (grants R00AR059796 and R01AR065409); the University of Michigan Department of Dermatology; the Biological Sciences Scholars Program; the Center for Organogenesis; the University of Michigan Comprehensive Cancer Center; and the John S. and Suzanne C. Munn Cancer Fund. This work was also supported in part by NIAMS grants R01AR063437, R01AR062546, and R21AR063852 to N.L.W.; by NIAMS grants R01AR045973 and NCI R01CA087837 to A.A.D.; and by National Institute of General Medical Sciences grant T32 GM007315 to S.C.P.	Adolphe C, 2014, J INVEST DERMATOL, V134, P1981, DOI 10.1038/jid.2014.63; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Bastiaens MT, 1998, J INVEST DERMATOL, V110, P880, DOI 10.1046/j.1523-1747.1998.00217.x; Berton TR, 2003, ONCOGENE, V22, P5415, DOI 10.1038/sj.onc.1206825; BONIFAS JM, 1994, HUM MOL GENET, V3, P447, DOI 10.1093/hmg/3.3.447; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Colmont CS, 2013, P NATL ACAD SCI USA, V110, P1434, DOI 10.1073/pnas.1211655110; Doucet YS, 2013, CELL REP, V3, P1759, DOI 10.1016/j.celrep.2013.04.026; ENGLISH KB, 1983, ANAT REC, V207, P79, DOI 10.1002/ar.1092070109; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Epstein EH, 2011, J CLIN INVEST, V121, P1681, DOI 10.1172/JCI57700; Fradette J, 1995, BIOCHEM CELL BIOL, V73, P635, DOI 10.1139/o95-070; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Grachtchouk M, 2011, J CLIN INVEST, V121, P1768, DOI 10.1172/JCI46307; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Jaks V, 2010, EXP CELL RES, V316, P1422, DOI 10.1016/j.yexcr.2010.03.014; Jih DM, 1999, J CUTAN PATHOL, V26, P113, DOI 10.1111/j.1600-0560.1999.tb01814.x; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kasper M, 2012, J CLIN INVEST, V122, P455, DOI 10.1172/JCI58779; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; LACOUR JP, 1991, BRIT J DERMATOL, V125, P535, DOI 10.1111/j.1365-2133.1991.tb14790.x; Lemeshow S, 2011, CANCER EPIDEM BIOMAR, V20, P2273, DOI 10.1158/1055-9965.EPI-11-0249; Lumpkin EA, 2010, J CELL BIOL, V191, P237, DOI 10.1083/jcb.201006074; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; Marino S, 2000, GENE DEV, V14, P994; MOLL I, 1993, J INVEST DERMATOL, V100, P69, DOI 10.1111/1523-1747.ep12354535; Moll I, 2005, EUR J CELL BIOL, V84, P259, DOI 10.1016/j.ejcb.2004.12.023; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Nitzki F, 2012, J SKIN CANCER, V2012, DOI 10.1155/2012/907543; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; NURSE CA, 1984, NEUROSCIENCE, V11, P521, DOI 10.1016/0306-4522(84)90042-3; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Ostrowski SM, 2011, J INVEST DERMATOL, V131, P1530, DOI 10.1038/jid.2011.60; Page ME, 2013, CELL STEM CELL, V13, P471, DOI 10.1016/j.stem.2013.07.010; Polli-Lopes AC, 2003, CANCER LETT, V190, P45, DOI 10.1016/S0304-3835(02)00584-0; Ponten F, 1997, ONCOGENE, V15, P1059, DOI 10.1038/sj.onc.1201435; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Schirren CG, 1997, AM J DERMATOPATH, V19, P341, DOI 10.1097/00000372-199708000-00005; Schulz T, 1997, J CUTAN PATHOL, V24, P14, DOI 10.1111/j.1600-0560.1997.tb00780.x; Scrivener Y, 2002, BRIT J DERMATOL, V147, P41, DOI 10.1046/j.1365-2133.2002.04804.x; Sellheyer K, 2012, BRIT J DERMATOL, V166, P88, DOI 10.1111/j.1365-2133.2011.10612.x; Sellheyer K, 2011, J CUTAN PATHOL, V38, P542, DOI 10.1111/j.1600-0560.2011.01693.x; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Veniaminova NA, 2013, DEVELOPMENT, V140, P4870, DOI 10.1242/dev.101725; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Ward NL, 2012, J INVEST DERMATOL, V132, P1927, DOI 10.1038/jid.2012.60; Wong SY, 2011, P NATL ACAD SCI USA, V108, P4093, DOI 10.1073/pnas.1013098108; Woo SH, 2010, DEVELOPMENT, V137, P3965, DOI 10.1242/dev.055970; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	63	200	203	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					400	412		10.1016/j.stem.2015.02.006	http://dx.doi.org/10.1016/j.stem.2015.02.006			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25842978	Green Accepted, Bronze			2022-12-28	WOS:000352228600012
J	Chen, T; Hao, YJ; Zhang, Y; Li, MM; Wang, M; Han, WF; Wu, YS; Lv, Y; Hao, J; Wang, LB; Li, A; Yang, Y; Jin, KX; Zhao, X; Li, YH; Ping, XL; Lai, WY; Wu, LG; Jiang, GB; Wang, HL; Sang, LS; Wang, XJ; Yang, YG; Zhou, Q				Chen, Tong; Hao, Ya-Juan; Zhang, Ying; Li, Miao-Miao; Wang, Meng; Han, Weifang; Wu, Yongsheng; Lv, Ying; Hao, Jie; Wang, Libin; Li, Ang; Yang, Ying; Jin, Kang-Xuan; Zhao, Xu; Li, Yuhuan; Ping, Xiao-Li; Lai, Wei-Yi; Wu, Li-Gang; Jiang, Guibin; Wang, Hai-Lin; Sang, Lisi; Wang, Xiu-Jie; Yang, Yun-Gui; Zhou, Qi			m(6)A RNA Methylation Is Regulated by MicroRNAs and Promotes Reprogramming to Pluripotency	CELL STEM CELL			English	Article							ARABIDOPSIS MESSENGER-RNA; NUCLEAR-RNA; REVEALS; N6-METHYLADENOSINE; M6A; IDENTIFICATION; RECOGNITION; NUCLEOSIDES; RESOLUTION; MECHANISM	N-6-methyladenosine (m(6)A) has been recently identified as a conserved epitranscriptomic modification of eukaryotic mRNAs, but its features, regulatory mechanisms, and functions in cell reprogramming are largely unknown. Here, we report m(6)A modification profiles in the mRNA transcriptomes of four cell types with different degrees of pluripotency. Comparative analysis reveals several features of m(6)A, especially gene-and cell-type-specific m(6)A mRNA modifications. We also show that microRNAs (miRNAs) regulate m(6)A modification via a sequence pairing mechanism. Manipulation of miRNA expression or sequences alters m(6)A modification levels through modulating the binding of METTL3 methyltransferase to mRNAs containing miRNA targeting sites. Increased m(6)A abundance promotes the reprogramming of mouse embryonic fibroblasts (MEFs) to pluripotent stem cells; conversely, reduced m(6)A levels impede reprogramming. Our results therefore uncover a role for miRNAs in regulating m(6)A formation of mRNAs and provide a foundation for future functional studies of m(6)A modification in cell reprogramming.	[Chen, Tong; Wang, Meng; Wang, Xiu-Jie] Chinese Acad Sci, Inst Genet & Dev Biol, Collaborat Innovat Ctr Genet & Dev, Key Lab Genet Network Biol, Beijing 100101, Peoples R China; [Hao, Ya-Juan; Li, Miao-Miao; Wu, Yongsheng; Lv, Ying; Li, Ang; Yang, Ying; Jin, Kang-Xuan; Zhao, Xu; Ping, Xiao-Li; Yang, Yun-Gui] Chinese Acad Sci, Beijing Inst Genom, Collaborat Innovat Ctr Genet & Dev, Key Lab Genom & Precis Med, Beijing 100101, Peoples R China; [Zhang, Ying; Han, Weifang; Hao, Jie; Wang, Libin; Li, Yuhuan; Sang, Lisi; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Lai, Wei-Yi; Jiang, Guibin; Wang, Hai-Lin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China; [Wu, Li-Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Chen, Tong; Hao, Ya-Juan; Li, Miao-Miao; Han, Weifang; Lv, Ying; Wang, Libin; Li, Ang; Yang, Ying; Jin, Kang-Xuan; Zhao, Xu; Ping, Xiao-Li; Sang, Lisi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XJ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Collaborat Innovat Ctr Genet & Dev, Key Lab Genet Network Biol, Beijing 100101, Peoples R China.	xjwang@genetics.ac.cn; ygyang@big.ac.cn; qzhou@ioz.ac.cn	Wang, Xiu-Jie/L-1312-2019; Chen, Tong/AAC-3555-2022; Ping, Xiaoli/AAC-6730-2021; Yang, Yungui/ABF-2507-2021; Yang, Ying/GRO-4537-2022	Chen, Tong/0000-0003-3134-3113; Yang, Ying/0000-0002-8104-5985; Zhao, Xu/0000-0002-0233-9660; Yang, Yun-Gui/0000-0002-2821-8541; PING, XIAOLI/0000-0003-1493-1263	China 973 programs [2011CBA01101, 2014CB964900]; CAS Strategic Priority Research Program [XDA01020101, XDA01020105, XDB14030300]; National Natural Science Foundation of China [91319308, 31430022, 31370796]	China 973 programs(National Basic Research Program of China); CAS Strategic Priority Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by China 973 programs (2011CBA01101 to Q.Z. and X.-J.W. and 2014CB964900 to X.-J.W.); CAS Strategic Priority Research Program Grants XDA01020101 (to Q.Z.), XDA01020105 (to X.-J.W.), and XDB14030300 (to Y.-G.Y.); and the National Natural Science Foundation of China (91319308 to Q.Z. and 31430022 and 31370796 to Y.-G.Y.). We thank BIG sequencing core facility for sequencing.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bodi Z, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00048; Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266; Bokar JA, 1997, RNA, V3, P1233; Bokar JA, 2005, TOP CURR GENET, V12, P141, DOI 10.1007/b106365; CAMPER SA, 1984, MOL CELL BIOL, V4, P538, DOI 10.1128/MCB.4.3.538; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Cenik ES, 2011, CURR BIOL, V21, pR446, DOI 10.1016/j.cub.2011.05.020; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dai Q, 2007, NUCLEIC ACIDS RES, V35, P6322, DOI 10.1093/nar/gkm657; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; FINKEL D, 1983, VIROLOGY, V131, P409, DOI 10.1016/0042-6822(83)90508-1; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Geula S., 2015, SCIENCE IN PRESS; Globisch D, 2011, ANGEW CHEM INT EDIT, V50, P9739, DOI 10.1002/anie.201103229; HARPER JE, 1990, NUCLEIC ACIDS RES, V18, P5735, DOI 10.1093/nar/18.19.5735; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu J, 2014, J GENET GENOMICS, V41, P21, DOI 10.1016/j.jgg.2013.10.002; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Sibbritt T, 2013, WIRES RNA, V4, P397, DOI 10.1002/wrna.1166; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tuck MT, 1999, INT J BIOCHEM CELL B, V31, P837, DOI 10.1016/S1357-2725(99)00041-2; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zhu TT, 2014, CELL RES, V24, P1493, DOI 10.1038/cr.2014.152	52	379	403	9	169	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					289	301		10.1016/j.stem.2015.01.016	http://dx.doi.org/10.1016/j.stem.2015.01.016			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25683224	Bronze			2022-12-28	WOS:000350747700011
J	Ryall, JG; Dell'Orso, S; Derfoul, A; Juan, A; Zare, H; Feng, XS; Clermont, D; Koulnis, M; Gutierrez-Cruz, G; Fulco, M; Sartorelli, V				Ryall, James G.; Dell'Orso, Stefania; Derfoul, Assia; Juan, Aster; Zare, Hossein; Feng, Xuesong; Clermont, Daphney; Koulnis, Miroslav; Gutierrez-Cruz, Gustavo; Fulco, Marcella; Sartorelli, Vittorio			The NAD(+)-Dependent SIRT1 Deacetylase Translates a Metabolic Switch into Regulatory Epigenetics in Skeletal Muscle Stem Cells	CELL STEM CELL			English	Article							SATELLITE CELLS; SELF-RENEWAL; QUIESCENT; SIRTUINS; DIFFERENTIATION; GENE; HOMEOSTASIS; MYOGENESIS; EXPRESS; PATHWAY	Stem cells undergo a shift in metabolic substrate utilization during specification and/or differentiation, a process that has been termed metabolic reprogramming. Here, we report that during the transition from quiescence to proliferation, skeletal muscle stem cells experience a metabolic switch from fatty acid oxidation to glycolysis. This reprogramming of cellular metabolism decreases intracellular NAD(+) levels and the activity of the histone deacetylase SIRT1, leading to elevated H4K16 acetylation and activation of muscle gene transcription. Selective genetic ablation of the SIRT1 deacetylase domain in skeletal muscle results in increased H4K16 acetylation and deregulated activation of the myogenic program in SCs. Moreover, mice with muscle-specific inactivation of the SIRT1 deacetylase domain display reduced myofiber size, impaired muscle regeneration, and derepression of muscle developmental genes. Overall, these findings reveal how metabolic cues can be mechanistically translated into epigenetic modifications that regulate skeletal muscle stem cell biology.	[Ryall, James G.; Dell'Orso, Stefania; Derfoul, Assia; Juan, Aster; Zare, Hossein; Feng, Xuesong; Clermont, Daphney; Koulnis, Miroslav; Gutierrez-Cruz, Gustavo; Fulco, Marcella; Sartorelli, Vittorio] NIAMSD, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20829 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Sartorelli, V (corresponding author), NIAMSD, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20829 USA.	sartorev@mail.nih.gov	Ryall, James/J-9771-2019; zare, hossein/ABB-5871-2021	Ryall, James/0000-0003-4702-1143; Sartorelli, Vittorio/0000-0002-9284-3675; Dell'Orso, Stefania/0000-0002-1634-5631	Overseas Biomedical Research Fellowship from the National Health & Medical Research Council of Australia; Intramural Research Program of NIAMS at the NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041181, ZICAR041207, ZICAR041186, ZIAAR041164] Funding Source: NIH RePORTER	Overseas Biomedical Research Fellowship from the National Health & Medical Research Council of Australia; Intramural Research Program of NIAMS at the NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Yansong Gu (University of Washington, Seattle) for sharing the Sirt1 floxed mice, Kristina Zaal (Light Imaging Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS]) for help in evaluating Pax7<SUP>+</SUP>/MyoD<SUP>+</SUP> immunofluorescence staining, and Jim Simone (Flow Cytometry Section, NIAMS) for help with FACS. J.G.R. was supported, in part, via an Overseas Biomedical Research Fellowship from the National Health & Medical Research Council of Australia. This work was supported by the Intramural Research Program of NIAMS at the NIH.	Abe S, 2009, ANAT SCI INT, V84, P305, DOI 10.1007/s12565-009-0039-9; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Collins Charlotte A., 2009, V482, P319, DOI 10.1007/978-1-59745-060-7_20; Crist CG, 2012, CELL STEM CELL, V11, P118, DOI 10.1016/j.stem.2012.03.011; Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016; Dentice M, 2010, J CLIN INVEST, V120, P4021, DOI 10.1172/JCI43670; Dey BK, 2014, GENE DEV, V28, P491, DOI 10.1101/gad.234419.113; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Goetsch SC, 2005, STEM CELLS DEV, V14, P181, DOI 10.1089/scd.2005.14.181; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Grifone R, 2007, DEV BIOL, V302, P602, DOI 10.1016/j.ydbio.2006.08.059; Guarente L, 2000, GENE DEV, V14, P1021; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Jeong J, 2013, ACTA PHARMACOL SIN, V34, P1052, DOI 10.1038/aps.2013.67; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Koo JH, 2007, BIOCHEM BIOPH RES CO, V363, P405, DOI 10.1016/j.bbrc.2007.08.186; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Oburoglu L, 2014, CELL STEM CELL, V15, P169, DOI 10.1016/j.stem.2014.06.002; Ono Y, 2011, CELL DEATH DIFFER, V18, P222, DOI 10.1038/cdd.2010.95; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ryall JG, 2013, FEBS J, V280, P4004, DOI 10.1111/febs.12189; Ryall JG, 2012, CURR OPIN CLIN NUTR, V15, P561, DOI 10.1097/MCO.0b013e3283590914; Sauve AA, 2012, CURR OPIN CHEM BIOL, V16, P535, DOI 10.1016/j.cbpa.2012.10.003; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; Tang AH, 2014, EMBO J, V33, P2782, DOI 10.15252/embj.201488278; Taylor GCA, 2013, GENOME RES, V23, P2053, DOI 10.1101/gr.155028.113; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; WEYDERT A, 1987, CELL, V49, P121, DOI 10.1016/0092-8674(87)90762-8; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	56	326	337	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					171	183		10.1016/j.stem.2014.12.004	http://dx.doi.org/10.1016/j.stem.2014.12.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25600643	Bronze, Green Accepted			2022-12-28	WOS:000349455000013
J	Deuse, T; Wang, D; Stubbendorff, M; Itagaki, R; Grabosch, A; Greaves, LC; Alawi, M; Grunewald, A; Hu, XM; Hua, XQ; Velden, J; Reichenspurner, H; Robbins, RC; Jaenisch, R; Weissman, IL; Schrepfer, S				Deuse, Tobias; Wang, Dong; Stubbendorff, Mandy; Itagaki, Ryo; Grabosch, Antje; Greaves, Laura C.; Alawi, Malik; Gruenewald, Anne; Hu, Xiaomeng; Hua, Xiaoqin; Velden, Joachim; Reichenspurner, Hermann; Robbins, Robert C.; Jaenisch, Rudolf; Weissman, Irving L.; Schrepfer, Sonja			SCNT-Derived ESCs with Mismatched Mitochondria Trigger an Immune Response in Allogeneic Hosts	CELL STEM CELL			English	Article							CELL NUCLEAR TRANSFER; EMBRYONIC STEM-CELLS; MINOR HISTOCOMPATIBILITY ANTIGEN; INDUCED PLURIPOTENT; DNA; MICE; GENERATION; SYSTEM; RAT	The generation of pluripotent stem cells by somatic cell nuclear transfer (SCNT) has recently been achieved in human cells and sparked new interest in this technology. The authors reporting this methodical breakthrough speculated that SCNT would allow the creation of patient-matched embryonic stem cells, even in patients with hereditary mitochondrial diseases. However, herein we show that mismatched mitochondria in nuclear-transfer-derived embryonic stem cells (NT-ESCs) possess alloantigenicity and are subject to immune rejection. In a murine transplantation setup, we demonstrate that allogeneic mitochondria in NT-ESCs, which are nucleus-identical to the recipient, may trigger an adaptive alloimmune response that impairs the survival of NT-ESC grafts. The immune response is adaptive, directed against mitochondrial content, and amenable for tolerance induction. Mitochondrial alloantigenicity should therefore be considered when developing therapeutic SCNT-based strategies.	[Deuse, Tobias; Wang, Dong; Stubbendorff, Mandy; Itagaki, Ryo; Grabosch, Antje; Hu, Xiaomeng; Hua, Xiaoqin; Schrepfer, Sonja] Univ Heart Ctr Hamburg, TSI Lab, D-20246 Hamburg, Germany; [Deuse, Tobias; Wang, Dong; Stubbendorff, Mandy; Itagaki, Ryo; Grabosch, Antje; Hu, Xiaomeng; Hua, Xiaoqin; Reichenspurner, Hermann; Schrepfer, Sonja] Cardiovasc Res Ctr Hamburg CVRC, D-20246 Hamburg, Germany; [Deuse, Tobias; Wang, Dong; Stubbendorff, Mandy; Itagaki, Ryo; Grabosch, Antje; Hu, Xiaomeng; Hua, Xiaoqin; Reichenspurner, Hermann; Schrepfer, Sonja] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Luebeck, D-20246 Hamburg, Germany; [Deuse, Tobias; Reichenspurner, Hermann] Univ Heart Ctr Hamburg, D-20246 Hamburg, Germany; [Greaves, Laura C.] Newcastle Univ, Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Alawi, Malik] Univ Med Ctr Hamburg Eppendorf, Bioinformat Serv Facil, D-20246 Hamburg, Germany; [Alawi, Malik] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20246 Hamburg, Germany; [Gruenewald, Anne] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Velden, Joachim] Univ Hosp Erlangen, Inst Pathol, Dept Nephropathol, D-91054 Erlangen, Germany; [Robbins, Robert C.; Schrepfer, Sonja] Stanford Univ, Stanford Cardiovasc Inst, Sch Med, Stanford, CA 94305 USA; [Robbins, Robert C.; Schrepfer, Sonja] Stanford Univ, Dept Cardiothorac Surg, Sch Med, Stanford, CA 94305 USA; [Jaenisch, Rudolf] MIT, Cambridge Ctr 9, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; University of Hamburg; University Medical Center Hamburg-Eppendorf; Newcastle University - UK; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; Newcastle University - UK; University of Erlangen Nuremberg; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Stanford University	Schrepfer, S (corresponding author), Univ Heart Ctr Hamburg, TSI Lab, Martinistr 52, D-20246 Hamburg, Germany.	schrepfer@stanford.edu	, Malik/AAB-7437-2021; Grünewald, Anne/ABD-1255-2021	, Malik/0000-0002-5993-7709; Grünewald, Anne/0000-0002-4179-2994; Greaves, Laura/0000-0002-8071-5916	Else-Kroner-Fresenius-Stiftung [2012_EKES.04]; Fondation Leducq [CDA 2013-2015]; German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG: SCHR992/3-1, SCHR992/4-1]; MRC [MR/L016354/1, G0700718] Funding Source: UKRI; Medical Research Council [MR/L016354/1, G0700718] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10187] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198] Funding Source: NIH RePORTER	Else-Kroner-Fresenius-Stiftung; Fondation Leducq(Leducq Foundation); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Kirsten Fischer Lindahl for her critical comments and editing of the manuscript. We further thank Christiane Pahrmann for performing all cell cultures and for her overall technical assistance and Oktay Kirak and Hidde Ploegh for generating the experimental cells. We extend special thanks to the UKE Imaging Facility (UMIF, Bernd Zobiak) and the UKE Animal Facility. This study was supported by the Else-Kroner-Fresenius-Stiftung (2012_EKES.04; T.D.), a grant from the Fondation Leducq (CDA 2013-2015; S.S.), and the German Research Foundation (Deutsche Forschungsgemeinschaft; DFG: SCHR992/3-1 and SCHR992/4-1; S.S.).	Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bhuyan PK, 1997, J IMMUNOL, V158, P3753; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Chung YG, 2014, CELL STEM CELL, V14, P777, DOI 10.1016/j.stem.2014.03.015; Cibelli JB, 2014, CELL STEM CELL, V14, P699, DOI 10.1016/j.stem.2014.05.013; Dabhi VM, 1995, METHOD ENZYMOL, V260, P466, DOI 10.1016/0076-6879(95)60159-7; DAVIES JD, 1991, J EXP MED, V173, P823, DOI 10.1084/jem.173.4.823; de Almeida PE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4903; Duvvuri B, 2014, J IMMUNOL, V192, P4581, DOI 10.4049/jimmunol.1300774; Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Gu YP, 2003, J IMMUNOL, V170, P3603, DOI 10.4049/jimmunol.170.7.3603; Ishikawa K, 2010, J EXP MED, V207, P2297, DOI 10.1084/jem.20092296; JOHNSON LL, 1981, IMMUNOGENETICS, V13, P451, DOI 10.1007/BF00346026; Kirak O, 2010, SCIENCE, V328, P243, DOI 10.1126/science.1178590; Kwak HH, 2013, TRANSPL P, V45, P1754, DOI 10.1016/j.transproceed.2013.02.103; Lanza R, 2005, CLONING STEM CELLS, V7, P95, DOI 10.1089/clo.2005.7.95; Lanza RP, 2002, NAT BIOTECHNOL, V20, P689, DOI 10.1038/nbt703; LINDAHL KF, 1980, J EXP MED, V152, P1583; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Miyata Y, 2003, NAT BIOTECHNOL, V21, P359, DOI 10.1038/nbt0403-359; Morse MC, 1996, J IMMUNOL, V156, P3301; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Ridge PG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S6; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Yamada M, 2014, NATURE, V510, P533, DOI 10.1038/nature13287; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	30	41	42	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					33	38		10.1016/j.stem.2014.11.003	http://dx.doi.org/10.1016/j.stem.2014.11.003			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25465116	Green Published, Bronze			2022-12-28	WOS:000347708400009
J	Janiszewska, M; Polyak, K				Janiszewska, Michalina; Polyak, Kornelia			Clonal Evolution in Cancer: A Tale of Twisted Twines	CELL STEM CELL			English	Editorial Material								Intra-tumor heterogeneity of cancer cells hampers the design of effective therapies and yet it is poorly reproduced in experimental models. A recent report by Eirew at al. provides an in-depth analysis of genetic heterogeneity of breast tumor xenografts and shows that changes in clonal diversity might not be stochastic.	[Janiszewska, Michalina; Polyak, Kornelia] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Janiszewska, Michalina; Polyak, Kornelia] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Polyak, K (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	kornelia_polyak@dfci.harvard.edu						Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Eirew P., 2014, NATURE IN PRESS; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840	8	14	16	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					11	12		10.1016/j.stem.2014.12.011	http://dx.doi.org/10.1016/j.stem.2014.12.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25575078	Bronze			2022-12-28	WOS:000347708400006
J	Lu, R				Lu, Rong			Sleeping Beauty Wakes Up the Clonal Succession Model for Homeostatic Hematopoiesis	CELL STEM CELL			English	Editorial Material							STEM-CELLS; SELF-RENEWAL; DYNAMICS; BEHAVIOR	Recently in Nature, Sun et al. (2014) used a sleeping beauty transposon system to demonstrate that natural hematopoiesis is sustained by the successive recruitment of thousands of clones that are mostly lineage restricted. These findings call into question whether homeostatic hematopoiesis is sustained by hematopoietic stem cells traditionally identified by transplantation.	Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90033 USA	University of Southern California	Lu, R (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Stem Cell Biol & Regenerat Med, 1425 San Pablo St, Los Angeles, CA 90033 USA.	ronglu@usc.edu			NHLBI NIH HHS [R00 HL113104] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL113104] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABKOWITZ JL, 1995, P NATL ACAD SCI USA, V92, P2031, DOI 10.1073/pnas.92.6.2031; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Kim S, 2014, CELL STEM CELL, V14, P473, DOI 10.1016/j.stem.2013.12.012; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Prchal JT, 1996, J EXP MED, V183, P561, DOI 10.1084/jem.183.2.561; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408	10	4	4	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					677	678		10.1016/j.stem.2014.11.015	http://dx.doi.org/10.1016/j.stem.2014.11.015			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25479744	Bronze			2022-12-28	WOS:000347174300005
J	Li, L; Osdal, T; Ho, YW; Chun, S; McDonald, T; Agarwal, P; Lin, A; Chu, S; Qi, J; Li, L; Hsieh, YT; Dos Santos, C; Yuan, HF; Ha, TQ; Popa, M; Hovland, R; Bruserud, O; Gjertsen, BT; Kuo, YH; Chen, WY; Lain, S; McCormack, E; Bhatia, R				Li, Ling; Osdal, Tereza; Ho, Yinwei; Chun, Sookhee; McDonald, Tinisha; Agarwal, Puneet; Lin, Allen; Chu, Su; Qi, Jing; Li, Liang; Hsieh, Yao-Te; Dos Santos, Cedric; Yuan, Hongfeng; Ha, Trung-Quang; Popa, Mihaela; Hovland, Randi; Bruserud, Oystein; Gjertsen, Bjorn Tore; Kuo, Ya-Huei; Chen, Wenyong; Lain, Sonia; McCormack, Emmet; Bhatia, Ravi			SIRT1 Activation by a c-MYC Oncogenic Network Promotes the Maintenance and Drug Resistance of Human FLT3-ITD Acute Myeloid Leukemia Stem Cells	CELL STEM CELL			English	Article							GENE-EXPRESSION; THERAPEUTIC TARGET; P53; USP22; INHIBITOR; APOPTOSIS; MOUSE; TRANSCRIPTION; ACETYLATION; MARKER	The FLT3-ITD mutation is frequently observed in acute myeloid leukemia (AML) and is associated with poor prognosis. In such patients, FLT3 tyrosine kinase inhibitors (TKIs) are only partially effective and do not eliminate the leukemia stem cells (LSCs) that are assumed to be the source of treatment failure. Here, we show that the NAD-dependent SIRT1 deacetylase is selectively overexpressed in primary human FLT3-ITD AML LSCs. This SIRT1 overexpression is related to enhanced expression of the USP22 deubiquitinase induced by c-MYC, leading to reduced SIRT1 ubiquitination and enhanced stability. Inhibition of SIRT1 expression or activity reduced the growth of FLT3-ITD AML LSCs and significantly enhanced TKI-mediated killing of the cells. Therefore, these results identify a c-MYC-related network that enhances SIRT1 protein expression in human FLT3-ITD AML LSCs and contributes to their maintenance. Inhibition of this oncogenic network could be an attractive approach for targeting FLT3-ITD AML LSCs to improve treatment outcomes.	[Li, Ling; Ho, Yinwei; Chun, Sookhee; McDonald, Tinisha; Agarwal, Puneet; Lin, Allen; Chu, Su; Qi, Jing; Li, Liang; Hsieh, Yao-Te; Dos Santos, Cedric; Kuo, Ya-Huei; Bhatia, Ravi] City Hope Natl Med Ctr, Div Hematopoiet Stem Cell & Leukemia Res, Duarte, CA 91010 USA; [Osdal, Tereza; Ha, Trung-Quang; Bruserud, Oystein; Gjertsen, Bjorn Tore; McCormack, Emmet] Univ Bergen, Dept Clin Sci, Hematol Sect, N-5021 Bergen, Norway; [Popa, Mihaela] KinN Therapeut AS, N-5008 Bergen, Norway; [Bruserud, Oystein; Gjertsen, Bjorn Tore; McCormack, Emmet] Haukeland Hosp, Dept Internal Med, Hematol Sect, N-5021 Bergen, Norway; [Yuan, Hongfeng; Chen, Wenyong] City Hope Natl Med Ctr, Dept Canc Biol, Duarte, CA 91010 USA; [Lain, Sonia] Karolinska Inst, S-17177 Stockholm, Sweden; [Hovland, Randi] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway	City of Hope; University of Bergen; University of Bergen; Haukeland University Hospital; City of Hope; Karolinska Institutet; University of Bergen; Haukeland University Hospital	McCormack, E (corresponding author), Univ Bergen, Dept Clin Sci, Hematol Sect, N-5021 Bergen, Norway.	emmet.mc.cormack@k2.uib.no; rbhatia@coh.org	Gjertsen, Bjørn T/AAP-3281-2020; Chen, WenYong/D-6748-2012; qi, jing/Q-1009-2015; Cormack, Emmet Mc/D-2922-2012; Gjertsen, Bjorn T/O-1542-2015; Agarwal, Puneet/I-6262-2012; Lain, Sonia/B-6980-2014	Gjertsen, Bjørn T/0000-0001-9358-9704; qi, jing/0000-0003-3210-2784; Cormack, Emmet Mc/0000-0002-7621-4625; Gjertsen, Bjorn T/0000-0001-9358-9704; Agarwal, Puneet/0000-0001-6144-1246; Lain, Sonia/0000-0001-9693-5246; Agarwal, Puneet/0000-0003-1688-3840; Chen, WenYong/0000-0001-6913-5729	National Cancer Institute [R01 CA95684, P30CA033572, K99CA184411]; Leukemia and Lymphoma Society; Bergen Research Foundation; Norwegian Cancer Society; Western Norway Regional Health Authority; NATIONAL CANCER INSTITUTE [R00CA184411, K99CA184411, R01CA178387, R01CA095684, P30CA033572, R01CA143421] Funding Source: NIH RePORTER; Worldwide Cancer Research [13-0086] Funding Source: researchfish	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Bergen Research Foundation; Norwegian Cancer Society(Norwegian Cancer Society); Western Norway Regional Health Authority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Worldwide Cancer Research	This work was supported by National Cancer Institute grants R01 CA95684, P30CA033572, and K99CA184411; the Leukemia and Lymphoma Society; the Bergen Research Foundation; the Norwegian Cancer Society; and the Western Norway Regional Health Authority. We thank StemCyte for CB samples. We thank Linda Seymour and Vincent Paterno for sample acquisition; Xiwei Wu for microarray analysis; the COH Analytical Cytometry Core Facility; and Line Wergeland, Michael Sterhaug, Sahba Shafiee, Zina Fandalyuk, and Ingvild Haaland for assistance in cell viability assays and preclinical studies. All imaging was conducted at the Molecular Imaging Center, the Department of Biomedicine, University of Bergen.	Alcain FJ, 2009, EXPERT OPIN THER PAT, V19, P283, DOI 10.1517/13543770902755111; Armour SM, 2013, MOL CELL BIOL, V33, P1487, DOI 10.1128/MCB.00971-12; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Bullinger L, 2008, BLOOD, V111, P4490, DOI 10.1182/blood-2007-09-115055; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Chu SHH, 2012, CELL STEM CELL, V11, P346, DOI 10.1016/j.stem.2012.05.027; Dan L, 2012, HAEMATOL-HEMATOL J, V97, P551, DOI 10.3324/haematol.2011.055236; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Horton SJ, 2012, HAEMATOL-HEMATOL J, V97, P966, DOI 10.3324/haematol.2011.054734; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kim KT, 2007, BRIT J HAEMATOL, V138, P603, DOI 10.1111/j.1365-2141.2007.06696.x; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Leko V, 2012, BLOOD, V119, P1856, DOI 10.1182/blood-2011-09-377077; Levis M, 2011, BLOOD, V117, P6987, DOI 10.1182/blood-2011-03-340273; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Long JT, 2010, BLOOD, V116, P71, DOI 10.1182/blood-2010-01-261628; MacCallum SF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01275; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Marshall GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002135; McCormack E, 2012, LEUKEMIA, V26, P910, DOI 10.1038/leu.2011.315; McCormack E, 2013, BLOOD, V121, pE34, DOI 10.1182/blood-2012-05-429555; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Nakao M, 1996, LEUKEMIA, V10, P1911; O'Donnell MR, 2012, J NATL COMPR CANC NE, V10, P984, DOI 10.6004/jnccn.2012.0103; Ou XA, 2011, BLOOD, V117, P440, DOI 10.1182/blood-2010-03-273011; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Sasca D, 2014, BLOOD, V124, P121, DOI 10.1182/blood-2013-11-538819; Schrecengost RS, 2014, CANCER RES, V74, P272, DOI 10.1158/0008-5472.CAN-13-1954; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; VANDERLUGT NMT, 1995, EMBO J, V14, P2536, DOI 10.1002/j.1460-2075.1995.tb07251.x; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wang Z, 2013, ONCOGENE, V32, P589, DOI 10.1038/onc.2012.83; Yang QS, 2012, BLOOD, V120, P3491, DOI 10.1182/blood-2012-02-412643; Yuan HF, 2012, BLOOD, V119, P1904, DOI 10.1182/blood-2011-06-361691; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015	46	151	158	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					431	446		10.1016/j.stem.2014.08.001	http://dx.doi.org/10.1016/j.stem.2014.08.001			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25280219	Bronze, Green Accepted			2022-12-28	WOS:000343235800010
J	Challen, GA; Sun, DQ; Mayle, A; Jeong, M; Luo, M; Rodriguez, B; Mallaney, C; Celik, H; Yang, LB; Xia, Z; Cullen, S; Berg, J; Zheng, YY; Darlington, GJ; Li, W; Goodell, MA				Challen, Grant A.; Sun, Deqiang; Mayle, Allison; Jeong, Mira; Luo, Min; Rodriguez, Benjamin; Mallaney, Cates; Celik, Hamza; Yang, Liubin; Xia, Zheng; Cullen, Sean; Berg, Jonathan; Zheng, Yayun; Darlington, Gretchen J.; Li, Wei; Goodell, Margaret A.			Dnmt3a and Dnmt3b Have Overlapping and Distinct Functions in Hematopoietic Stem Cells	CELL STEM CELL			English	Article							DNA METHYLATION; SELF-RENEWAL; MULTILINEAGE DIFFERENTIATION; SOMATIC MUTATIONS; METHYLTRANSFERASE; ACTIVATION; EXPRESSION; DEFECTS; CATENIN; CLONING	Epigenetic regulation of hematopoietic stem cells (HSCs) ensures lifelong production of blood and bone marrow. Recently, we reported that loss of de novo DNA methyltransferase Dnmt3a results in HSC expansion and impaired differentiation. Here, we report conditional inactivation of Dnmt3b in HSCs either alone or combined with Dnmt3a deletion. Combined loss of Dnmt3a and Dnmt3b was synergistic, resulting in enhanced HSC self-renewal and a more severe block in differentiation than in Dnmt3a-null cells, whereas loss of Dnmt3b resulted in a mild phenotype. Although the predominant Dnmt3b isoform in adult HSCs is catalytically inactive, its residual activity in Dnmt3a-null HSCs can drive some differentiation and generates paradoxical hypermethylation of CpG islands. Dnmt3a/Dnmt3b-null HSCs displayed activated beta-catenin signaling, partly accounting for the differentiation block. These data demonstrate distinct roles for Dnmt3b in HSC differentiation and provide insights into complementary de novo methylation patterns governing regulation of HSC fate decisions.	[Challen, Grant A.; Mallaney, Cates; Celik, Hamza] Washington Univ, Dept Internal Med, Sect Mol Oncol, Div Oncol, St Louis, MO 63110 USA; [Sun, Deqiang; Rodriguez, Benjamin; Xia, Zheng; Li, Wei; Goodell, Margaret A.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Mayle, Allison; Jeong, Mira; Luo, Min; Yang, Liubin; Cullen, Sean; Berg, Jonathan; Zheng, Yayun; Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Stem Cell & Regenerat Med Ctr, Houston, TX 77030 USA; [Mayle, Allison; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Luo, Min; Darlington, Gretchen J.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Sun, Deqiang; Rodriguez, Benjamin; Xia, Zheng; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Challen, GA (corresponding author), Washington Univ, Dept Internal Med, Sect Mol Oncol, Div Oncol, St Louis, MO 63110 USA.	gchallen@dom.wustl.edu; goodell@bcm.edu	Xia, Zheng/F-6561-2014; Xia, Zheng/AAC-5360-2022	Xia, Zheng/0000-0003-3364-8324; Xia, Zheng/0000-0003-3364-8324; sun, deqiang/0000-0002-5806-7289; Li, Wei/0000-0001-9931-5990; Goodell, Margaret A./0000-0003-1111-2932; Mayle, Allison/0000-0001-5060-5487	NIH [DK084259, AG036562, CA126752, DK092883, CA125123, AI07495, R01HG007538]; Ellison Medical Foundation, CPRIT [RP110028]; Samuel Waxman foundation;  [CPRIT RP110471]; NATIONAL CANCER INSTITUTE [R01CA183252, P30CA125123, P50CA126752] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL092332] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK084259, T32DK060445, R56DK092883, R00DK084259, R01DK092883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036562] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation, CPRIT; Samuel Waxman foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the G. A. C., W. L., and M. A. G. labs for helpful discussions. This work was supported by NIH grants DK084259, AG036562, CA126752, DK092883, CA125123, and AI07495 as well as the Ellison Medical Foundation, CPRIT grant RP110028, the Samuel Waxman foundation, and grants CPRIT RP110471 and NIH R01HG007538 to W.L.	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Figueroa ME, 2009, BLOOD, V114, P3448, DOI 10.1182/blood-2009-01-200519; Gopalakrishnan S, 2009, MOL CANCER RES, V7, P1622, DOI 10.1158/1541-7786.MCR-09-0018; Grossmann V, 2013, GENE CHROMOSOME CANC, V52, P410, DOI 10.1002/gcc.22039; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Hata K, 2002, DEVELOPMENT, V129, P1983; JAENISCH R, 1984, BIOCHIM BIOPHYS ACTA, V782, P1, DOI 10.1016/0167-4781(84)90099-X; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Lei H, 1996, DEVELOPMENT, V122, P3195; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ostler K, 2007, ONCOGENE, V26, P5553, DOI 10.1038/sj.onc.1210351; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Peters SL, 2014, LEUKEMIA, V28, P1138, DOI 10.1038/leu.2013.364; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shen LL, 2010, J CLIN ONCOL, V28, P605, DOI 10.1200/JCO.2009.23.4781; Stein SJ, 2013, BLOOD, V121, P5015, DOI 10.1182/blood-2013-02-486142; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Zhao C, 2012, STEM CELLS, V30, P709, DOI 10.1002/stem.1050	40	213	219	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					350	364		10.1016/j.stem.2014.06.018	http://dx.doi.org/10.1016/j.stem.2014.06.018			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25130491	Green Accepted, Bronze			2022-12-28	WOS:000341441600014
J	Wang, S; Xia, PY; Ye, BQ; Huang, GL; Liu, J; Fan, ZS				Wang, Shuo; Xia, Pengyan; Ye, Buqing; Huang, Guanling; Liu, Jing; Fan, Zusen			Transient Activation of Autophagy via Sox2-Mediated Suppression of mTOR Is an Important Early Step in Reprogramming to Pluripotency	CELL STEM CELL			English	Article							MAMMALIAN TARGET; CELLS; EXPRESSION; COMPLEX; NURD; PHOSPHORYLATION; TUMORIGENESIS; REGULATORS; COMPONENT; PATHWAYS	Autophagy is an essential cellular mechanism that degrades cytoplasmic proteins and organelles to recycle their components. Here we show that autophagy is required for reprogramming of somatic cells to form induced pluripotent stem cells (iPSCs). Our data indicate that mammalian target of rapamycin (mTOR) is downregulated by Sox2 at an early stage of iPSC generation and that this transient downregulation of mTOR is required for reprogramming to take place. In the absence of Sox2, mTOR remains at a high level and inhibits autophagy. Mechanistically, Sox2 binds to a repressive region on the mTOR promoter and recruits the NuRD complex to mediate transcriptional repression. We also detected enhanced autophagy at the four-to eight-cell stage of embryonic development, and a similar Sox2 and mTOR-mediated regulatory pathway seems to operate in this context as well. Thus, our findings reveal Sox2-dependent temporal regulation of autophagy as a key step in cellular reprogramming processes.	[Wang, Shuo; Xia, Pengyan; Ye, Buqing; Huang, Guanling; Liu, Jing; Fan, Zusen] Chinese Acad Sci, CAS Key Lab Infect & Immun, Inst Biophys, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Fan, ZS (corresponding author), Chinese Acad Sci, CAS Key Lab Infect & Immun, Inst Biophys, Beijing 100101, Peoples R China.	fanz@moon.ibp.ac.cn	Huang, Guanling/AAE-3779-2020	Huang, Guanling/0000-0002-2597-6195	National Natural Science Foundation of China [81330047, 30830030]; 973 Program of the MOST of China [2010CB911902]; Strategic Priority Research Programs of the Chinese Academy of Sciences [XDA01010407]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of the MOST of China(National Basic Research Program of China); Strategic Priority Research Programs of the Chinese Academy of Sciences	We thank Drs. Yang Xu and Tongbiao Zhao for providing OSKM plasmids. We thank Dr. Xinjiang Yu, Dr. Zhenao Zhao, Lei Sun, and Yan Teng for technical support. We thank Dr. Zhonghua Dai for useful advice. This work was supported by the National Natural Science Foundation of China (81330047 and 30830030), 973 Program of the MOST of China (2010CB911902), and the Strategic Priority Research Programs of the Chinese Academy of Sciences (XDA01010407).	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Gonzalez IM, 2012, DEV BIOL, V361, P286, DOI 10.1016/j.ydbio.2011.10.021; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He J, 2012, STEM CELLS DEV, V21, P2630, DOI 10.1089/scd.2012.0015; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Keramari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013952; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wang S, 2012, CELL DEATH DIFFER, V19, P605, DOI 10.1038/cdd.2011.130; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Xia PY, 2013, EMBO J, V32, P2685, DOI 10.1038/emboj.2013.189; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007684; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	43	151	166	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					617	625		10.1016/j.stem.2013.10.005	http://dx.doi.org/10.1016/j.stem.2013.10.005			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24209762	Bronze			2022-12-28	WOS:000329571500013
J	Chou, BK; Cheng, LZ				Chou, Bin-Kuan; Cheng, Linzhao			And Then There Were None: No Need for Pluripotency Factors to Induce Reprogramming	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; PRIMORDIAL GERM-CELLS; MOUSE SOMATIC-CELLS; LINEAGE SPECIFIERS; CULTURE	While most factors used as reprogramming transgenes can be replaced by other means, Oct4 has remained essential until now. Three recent papers have now broken this barrier through the use of opposing lineage specifying transgenes and chemical modulation, thus signifying a milestone in advancing our understanding of pluripotency induction.	[Chou, Bin-Kuan; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA; [Chou, Bin-Kuan; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Cheng, LZ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA.	lcheng2@jhmi.edu			NCI NIH HHS [P30 CA006973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016	9	10	12	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					261	262		10.1016/j.stem.2013.08.004	http://dx.doi.org/10.1016/j.stem.2013.08.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	24012365	Bronze, Green Accepted			2022-12-28	WOS:000329570800003
J	Anjos-Afonso, F; Currie, E; Palmer, HG; Foster, KE; Taussig, DC; Bonnet, D				Anjos-Afonso, Fernando; Currie, Erin; Palmer, Hector G.; Foster, Katie E.; Taussig, David C.; Bonnet, Dominique			CD34(-) Cells at the Apex of the Human Hematopoietic Stem Cell Hierarchy Have Distinctive Cellular and Molecular Signatures	CELL STEM CELL			English	Article							BONE-MARROW; CORD BLOOD; IN-VIVO; DYE EFFLUX; ACTIVATION; DIFFERENTIATION; EXPRESSION; INJECTION; RISE	In addition to well-characterized CD34(+) hematopoietic stem and progenitor cells (HSPCs), the human hematopoietic stem cell (HSC) hierarchy contains a rare CD34(-) population with severe combined immunodeficiency-repopulating capacity. However, little is known about the molecular characteristics of these CD34(-) cells or their relationship to the CD34(+) populations. Here, we show that the self-renewing Lin(-)CD34(-)CD38(-)CD93(hi) population contains cells that not only function as HSCs, but can also be placed above the CD34(+) populations in the hematopoietic hierarchy. These cells have an active Notch pathway, in which signaling through Delta4 is crucial for maintenance of the primitive state, and combined signals from Jagged1 and TGF-beta are important in controlling its quiescence. They are also refractory to proliferative signals and show a repressed canonical Wnt pathway, in part regulated by Notch. Overall, therefore, CD34(-) cells represent an immature and quiescent human HSC population maintained through a distinctive network of cellular signaling interactions.	[Anjos-Afonso, Fernando; Currie, Erin; Foster, Katie E.; Bonnet, Dominique] Canc Res UK London Res Inst, Haematopoiet Stem Cell Lab, London WC2A 3LY, England; [Palmer, Hector G.] Vall dHebron Inst Oncol, Stem Cells & Canc Lab, Barcelona 08035, Spain; [Taussig, David C.] Queen Mary Univ London, Barts Canc Inst, Dept Haematooncol, London EC1M 6BQ, England	Cancer Research UK; Vall d'Hebron Institut d'Oncologia (VHIO); University of London; Queen Mary University London	Anjos-Afonso, F (corresponding author), Canc Res UK London Res Inst, Haematopoiet Stem Cell Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	fernando.afonso@cancer.org.uk; d.bonnet@cancer.org.uk	Palmer, Héctor G./AAG-8332-2019; Seoane, Joan/AAG-9173-2019	Anjos-Afonso, Fernando/0000-0003-4392-488X; Palmer, Hector/0000-0002-9823-5638; Seoane, Joan/0000-0002-6541-5974	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK (to D. B.). Authors are grateful to the staff at the Biological Resources Unit and Flow Cytometry core facilities for their valuable technical help. We would like to thank Dr. Stuart Horswell for his valuable help with the statistical analysis and Dr. Elena Siapati for her valuable comments. We are thankful to Drs. Evelyne Lauret (Cochin University Hospital, Paris, France) and Anne-Marie Buckle (Univeristy of Manchester, Manchester, UK) for providing different S17 stroma cell lines. F.A.-A. designed and performed all experiments, analyzed data, and wrote the manuscript. E. C. helped perform experiments and wrote the manuscript. K. E. F. and D. C. T. helped perform experiments; H. G. P. helped design experiments and provided reagents. D. B. supervised the project, provided resources, and edited the manuscript.	Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Danet GH, 2002, P NATL ACAD SCI USA, V99, P10441, DOI 10.1073/pnas.162104799; Dao MA, 2003, BLOOD, V101, P112, DOI 10.1182/blood-2002-01-0025; Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Ilagan MXG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001656; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Kuci S, 2003, BLOOD, V101, P869, DOI 10.1182/blood-2002-03-0711; Lauret E, 2004, LEUKEMIA, V18, P788, DOI 10.1038/sj.leu.2403288; Lemoli RM, 2003, BRIT J HAEMATOL, V123, P720, DOI 10.1046/j.1365-2141.2003.04673.x; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Nakamura Y, 1999, BLOOD, V94, P4053, DOI 10.1182/blood.V94.12.4053.424k41_4053_4059; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Storms RW, 2000, BLOOD, V96, P2125; Wang JF, 2003, BLOOD, V101, P2924, DOI 10.1182/blood-2002-09-2782; Yahata T, 2003, BLOOD, V101, P2905, DOI 10.1182/blood-2002-07-1995; Zanjani ED, 1998, EXP HEMATOL, V26, P353	22	59	62	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					161	174		10.1016/j.stem.2013.05.025	http://dx.doi.org/10.1016/j.stem.2013.05.025			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910083	hybrid			2022-12-28	WOS:000329570600010
J	Siudeja, K; Nassari, S; Gervais, L; Skorski, P; Lameiras, S; Stolfa, D; Zande, M; Bernard, V; Frio, TR; Bardin, AJ				Siudeja, Katarzyna; Nassari, Sonya; Gervais, Louis; Skorski, Patricia; Lameiras, Sonia; Stolfa, Donato; Zande, Maria; Bernard, Virginie; Frio, Thomas Rio; Bardin, Allison J.			Frequent Somatic Mutation in Adult Intestinal Stem Cells Drives Neoplasia and Genetic Mosaicism during Aging	CELL STEM CELL			English	Article							DETECTABLE CLONAL MOSAICISM; DNA-DAMAGE; COPY NUMBER; DROSOPHILA-MELANOGASTER; GENOMIC REARRANGEMENTS; SEQUENCING DATA; HUMAN NEURONS; CANCER-RISK; AGE; HEMATOPOIESIS	Adult stem cells may acquire mutations that modify cellular behavior, leading to functional declines in homeostasis or providing a competitive advantage resulting in premalignancy. However, the frequency, phenotypic impact, and mechanisms underlying spontaneous mutagenesis during aging are unclear. Here, we report two mechanisms of genome instability in adult Drosophila intestinal stem cells (ISCs) that cause phenotypic alterations in the aging intestine. First, we found frequent loss of heterozygosity arising from mitotic homologous recombination in ISCs that results in genetic mosaicism. Second, somatic deletion of DNA sequences and large structural rearrangements, resembling those described in cancers and congenital diseases, frequently result in gene inactivation. Such modifications induced somatic inactivation of the X-linked tumor suppressor Notch in ISCs, leading to spontaneous neoplasias in wild-type males. Together, our findings reveal frequent genomic modification in adult stem cells and show that somatic genetic mosaicism has important functional consequences on aging tissues.	[Siudeja, Katarzyna; Nassari, Sonya; Gervais, Louis; Skorski, Patricia; Stolfa, Donato; Zande, Maria; Bardin, Allison J.] Inst Curie, F-75248 Paris, France; [Siudeja, Katarzyna; Nassari, Sonya; Gervais, Louis; Skorski, Patricia; Stolfa, Donato; Zande, Maria; Bardin, Allison J.] CNRS UMR3215, F-75248 Paris, France; [Siudeja, Katarzyna; Nassari, Sonya; Gervais, Louis; Skorski, Patricia; Stolfa, Donato; Zande, Maria; Bardin, Allison J.] INSERM U934, F-75248 Paris, France; [Lameiras, Sonia; Bernard, Virginie; Frio, Thomas Rio] Hop Curie, Inst Curie, Next Generat Sequencing Platform, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Bardin, AJ (corresponding author), Inst Curie, 26 Rue Ulm, F-75248 Paris, France.	allison.bardin@curie.fr	Gervais, Louis/AAG-3543-2021	Bardin, Allison J./0000-0002-0200-4465; NASSARI, Sonya/0000-0002-2895-6800; Gervais, Louis/0000-0002-7284-7900; Siudeja, Katarzyna/0000-0002-2522-7776	Institut Curie [ANR-10-EQPX-03, ANR10-INBS-09-08]; Canceropole IdF; PICT-IBiSA (France-Bioimaging) [ANR-10-INSB-04]	Institut Curie; Canceropole IdF(Region Ile-de-France); PICT-IBiSA (France-Bioimaging)	We thank R. Basto, A. Brand, Y. Bellaiche, E. Blackburn, M. Debatisse, P.-A. Defossez, G. Fischer, E. Heard, M. McVey, and the members of the A.J.B. lab for discussions and comments and S. Bray, B. Edgar, H. Jasper, M. McVey, B. Ohlstein, J. de Navascues, F. Schweisguth, and R. Xi for fly reagents. The A. J. B. lab is supported by grants from Worldwide Cancer Research, ATIP-AVENIR, La Ligue Contre le Cancer, and the Fondation ARC as well as funding from the Laboratoires d'Excellence DEEP, CNRS, INSERM, and the Institute Curie. The NGS platform of the Institut Curie is supported by grants: ANR-10-EQPX-03 and ANR10-INBS-09-08 and Canceropole IdF. We would like to acknowledge the PICT-IBiSA (France-Bioimaging, ANR-10-INSB-04), S. Ritzenthaler, and L. Renesson for help.	Adams PD, 2015, CELL STEM CELL, V16, P601, DOI 10.1016/j.stem.2015.05.002; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Bardin AJ, 2010, DEVELOPMENT, V137, P705, DOI 10.1242/dev.039404; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Boeva V, 2011, BIOINFORMATICS, V27, P268, DOI 10.1093/bioinformatics/btq635; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; FAILLA G, 1958, ANN NY ACAD SCI, V71, P1124, DOI 10.1111/j.1749-6632.1958.tb54674.x; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Garcia AM, 2007, NAT METHODS, V4, P401, DOI 10.1038/NMETH1027; Garcia AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r121; Garcia AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000950; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Holland AJ, 2012, NAT MED, V18, P1630, DOI 10.1038/nm.2988; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Hsieh JCF, 2013, AGING CELL, V12, P269, DOI 10.1111/acel.12053; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; LaFave MC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000411; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; Malkova A, 2013, CURR OPIN GENET DEV, V23, P271, DOI 10.1016/j.gde.2013.05.007; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Mathur D, 2010, SCIENCE, V327, P210, DOI 10.1126/science.1181958; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; O'Huallachain M, 2012, P NATL ACAD SCI USA, V109, P18018, DOI 10.1073/pnas.1213736109; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Park JS, 2012, EXP GERONTOL, V47, P401, DOI 10.1016/j.exger.2012.02.007; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stern C, 1936, GENETICS, V21, P625; SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Yang LX, 2013, CELL, V153, P919, DOI 10.1016/j.cell.2013.04.010; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	63	48	48	4	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					663	674		10.1016/j.stem.2015.09.016	http://dx.doi.org/10.1016/j.stem.2015.09.016			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26607382	hybrid, Green Published			2022-12-28	WOS:000366139100009
J	Williams, MS; Somervaille, TCP				Williams, Mark S.; Somervaille, Tim C. P.			Leukemogenic Activity of Cohesin Rings True	CELL STEM CELL			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; GENETIC ALTERATIONS; COMPLEX; MUTATIONS	Cohesin complex components are frequently mutated in human myeloid cancers. Three new studies now show that cohesin mutations disrupt the differentiation of normal hematopoietic stem and progenitor cells and enhance self-renewal, shedding light on how these alterations may contribute to leukemic transformation.	[Williams, Mark S.; Somervaille, Tim C. P.] Univ Manchester, Canc Res UK Manchester Inst, Leukaemia Biol Lab, Manchester M20 4BX, Lancs, England	Cancer Research UK; University of Manchester	Somervaille, TCP (corresponding author), Univ Manchester, Canc Res UK Manchester Inst, Leukaemia Biol Lab, Manchester M20 4BX, Lancs, England.	tim.somervaille@cruk.manchester.ac.uk		Williams, Mark/0000-0002-7738-3594	Cancer Research UK [19280] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kihara R, 2014, LEUKEMIA, V28, P1586, DOI 10.1038/leu.2014.55; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; Mazumdar C, 2015, CELL STEM CELL, V17, P1, DOI 10.1016/j.stem.2015.09.017; Mullenders J, 2015, J EXP MED, V212, P1833, DOI 10.1084/jem.20151323; Thol F, 2014, BLOOD, V123, P914, DOI 10.1182/blood-2013-07-518746; Thota S, 2014, BLOOD, V124, P1790, DOI 10.1182/blood-2014-04-567057; Viny AD, 2015, J EXP MED, V212, P1819, DOI 10.1084/jem.20151317	10	4	4	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					642	644		10.1016/j.stem.2015.11.008	http://dx.doi.org/10.1016/j.stem.2015.11.008			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26637939	Bronze			2022-12-28	WOS:000366139100004
J	Peron, S; Berninger, B				Peron, Sophie; Berninger, Benedikt			Imported Stem Cells Strike against Stroke	CELL STEM CELL			English	Editorial Material							INJURED BRAIN; ORIGIN	Cells with neural stem cell (NSC)-like properties can be isolated from the cortex of adult brains following injury, but their origins and function are unclear. Now in Cell Stem Cell, Faiz et al. (2015) show that subventricular-zone-derived NSCs home to injured cortical area following stroke, where they generate reactive astrocytes.	[Peron, Sophie; Berninger, Benedikt] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, Lab Adult Neurogenesis & Cellular Reprogramming, D-55128 Mainz, Germany; [Peron, Sophie; Berninger, Benedikt] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci, D-55131 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Berninger, B (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, Lab Adult Neurogenesis & Cellular Reprogramming, Hanns Dieter Husch Weg 19, D-55128 Mainz, Germany.	berningb@uni-mainz.de	Berninger, Benedikt/H-4098-2019	Berninger, Benedikt/0000-0003-2652-2782; Peron, Sophie/0000-0002-7167-4585				Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Calzolari F, 2015, NAT NEUROSCI, V18, P490, DOI 10.1038/nn.3963; Faiz M, 2015, CELL STEM CELL, V17, P624, DOI 10.1016/j.stem.2015.08.002; Fuentealba LC, 2015, CELL, V161, P1644, DOI 10.1016/j.cell.2015.05.041; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Magnusson JP, 2014, SCIENCE, V346, P237, DOI 10.1126/science.346.6206.237; Nato G, 2015, DEVELOPMENT, V142, P840, DOI 10.1242/dev.116657; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019	10	7	9	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2015	17	5					501	502		10.1016/j.stem.2015.10.006	http://dx.doi.org/10.1016/j.stem.2015.10.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4UB	26544109	Bronze			2022-12-28	WOS:000365694700002
J	Baggiolini, A; Varum, S; Mateos, JM; Bettosini, D; John, N; Bonalli, M; Ziegler, U; Dimou, L; Clevers, H; Furrer, R; Sommer, L				Baggiolini, Arianna; Varum, Sandra; Mateos, Jose Maria; Bettosini, Damiano; John, Nessy; Bonalli, Mario; Ziegler, Urs; Dimou, Leda; Clevers, Hans; Furrer, Reinhard; Sommer, Lukas			Premigratory and Migratory Neural Crest Cells Are Multipotent In Vivo	CELL STEM CELL			English	Article							STEM-CELLS; FATE RESTRICTIONS; LINEAGE	The neural crest (NC) is an embryonic stem/progenitor cell population that generates a diverse array of cell lineages, including peripheral neurons, myelinating Schwann cells, and melanocytes, among others. However, there is a long-standing controversy as to whether this broad developmental perspective reflects in vivo multipotency of individual NC cells or whether the NC is comprised of a heterogeneous mixture of lineage-restricted progenitors. Here, we resolve this controversy by performing in vivo fate mapping of single trunk NC cells both at premigratory and migratory stages using the R26R-Confetti mouse model. By combining quantitative clonal analyses with definitive markers of differentiation, we demonstrate that the vast majority of individual NC cells are multipotent, with only few clones contributing to single derivatives. Intriguingly, multipotency is maintained in migratory NC cells. Thus, our findings provide definitive evidence for the in vivo multipotency of both premigratory and migrating NC cells in the mouse.	[Baggiolini, Arianna; Varum, Sandra; Bettosini, Damiano; John, Nessy; Bonalli, Mario; Sommer, Lukas] Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland; [Mateos, Jose Maria; Ziegler, Urs] Univ Zurich, Ctr Microscopy & Image Anal, CH-8057 Zurich, Switzerland; [Dimou, Leda] Univ Munich, Dept Physiol Genom, D-80336 Munich, Germany; [Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Furrer, Reinhard] Univ Zurich, Inst Math, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich; University of Munich; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Zurich	Sommer, L (corresponding author), Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland.	lukas.sommer@anatom.uzh.ch	John, Nessy/AAV-7640-2021; Furrer, Reinhard/N-3027-2019; Dimou, Leda/E-7968-2012; Furrer, Reinhard/A-4580-2011	John, Nessy/0000-0002-4114-4946; Furrer, Reinhard/0000-0002-6319-2332; Furrer, Reinhard/0000-0002-6319-2332; Sommer, Lukas/0000-0002-1143-7908; Mateos, Jose Maria/0000-0002-3675-6198; Baggiolini, Arianna/0000-0002-2476-561X	Swiss National Science Foundation; National Research Program [NRP-63]; University Research Priority Programs (URPPs)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Research Program; University Research Priority Programs (URPPs)	We thank Sherif Idriss and Justin Strauss for their contributions to the collection of the data. We thank Prof. Alexandra Joyner for sharing the Wnt1-CreER<SUP>T</SUP> mouse line and Prof. Marianne Bronner for her critical reading of the manuscript. This study was supported by the Swiss National Science Foundation, the National Research Program (NRP-63) "Stem Cells and Regenerative Medicine," and the University Research Priority Programs (URPPs) "Translational Cancer Research" and "Systems Biology/Functional Genomics."	BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; BRONNERFRASER M, 1989, NEURON, V3, P755, DOI 10.1016/0896-6273(89)90244-4; Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035; Dupin E, 2010, CELL CYCLE, V9, P238, DOI 10.4161/cc.9.2.10491; ERICKSON CA, 1992, DEV BIOL, V151, P251, DOI 10.1016/0012-1606(92)90231-5; Gonsalvez DG, 2013, J NEUROSCI, V33, P5969, DOI 10.1523/JNEUROSCI.4350-12.2013; Hari L, 2012, DEVELOPMENT, V139, P2107, DOI 10.1242/dev.073064; Harris ML, 2007, DEV DYNAM, V236, P1, DOI 10.1002/dvdy.20919; Henion PD, 1997, DEVELOPMENT, V124, P4351; Krispin S, 2010, DEVELOPMENT, V137, P585, DOI 10.1242/dev.041509; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; McKinney MC, 2013, DEVELOPMENT, V140, P820, DOI 10.1242/dev.083725; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nitzan E, 2013, DEVELOPMENT, V140, P2269, DOI 10.1242/dev.093294; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Simon C, 2012, GENESIS, V50, P506, DOI 10.1002/dvg.22003; Smith A, 2006, NATURE, V441, P1060, DOI 10.1038/nature04954; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Woodhoo A, 2008, GLIA, V56, P1481, DOI 10.1002/glia.20723; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	28	127	128	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					314	322		10.1016/j.stem.2015.02.017	http://dx.doi.org/10.1016/j.stem.2015.02.017			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25748934	Green Accepted, Bronze			2022-12-28	WOS:000350747700013
J	Batista, PJ; Molinie, B; Wang, JK; Qu, K; Zhang, JJ; Li, LJ; Bouley, DM; Lujan, E; Haddad, B; Daneshvar, K; Carter, AC; Flynn, RA; Zhou, C; Lim, KS; Dedon, P; Wernig, M; Mullen, AC; Xing, Y; Giallourakis, CC; Chang, HY				Batista, Pedro J.; Molinie, Benoit; Wang, Jinkai; Qu, Kun; Zhang, Jiajing; Li, Lingjie; Bouley, Donna M.; Lujan, Ernesto; Haddad, Bahareh; Daneshvar, Kaveh; Carter, Ava C.; Flynn, Ryan A.; Zhou, Chan; Lim, Kok-Seong; Dedon, Peter; Wernig, Marius; Mullen, Alan C.; Xing, Yi; Giallourakis, Cosmas C.; Chang, Howard Y.			m(6)A RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells	CELL STEM CELL			English	Article							LONG NONCODING RNA; MESSENGER-RNA; LINEAGE SPECIFIERS; SACCHAROMYCES-CEREVISIAE; POSTNATAL-DEVELOPMENT; NUCLEAR-RNA; PLURIPOTENCY; MOUSE; METHYLATION; REVEALS	N6-methyl-adenosine (m(6)A) is the most abundant modification on messenger RNAs and is linked to human diseases, but its functions in mammalian development are poorly understood. Here we reveal the evolutionary conservation and function of m(6)A by mapping the m(6)A methylome in mouse and human embryonic stem cells. Thousands of messenger and long noncoding RNAs show conserved m(6)A modification, including transcripts encoding core pluripotency transcription factors. m(6)A is enriched over 30 untranslated regions at defined sequence motifs and marks unstable transcripts, including transcripts turned over upon differentiation. Genetic inactivation or depletion of mouse and human Mettl3, one of the m(6)A methylases, led to m(6)A erasure on select target genes, prolonged Nanog expression upon differentiation, and impaired ESC exit from self-renewal toward differentiation into several lineages in vitro and in vivo. Thus, m(6)A is a mark of transcriptome flexibility required for stem cells to differentiate to specific lineages.	[Batista, Pedro J.; Qu, Kun; Zhang, Jiajing; Li, Lingjie; Carter, Ava C.; Flynn, Ryan A.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Batista, Pedro J.; Qu, Kun; Zhang, Jiajing; Li, Lingjie; Carter, Ava C.; Flynn, Ryan A.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Molinie, Benoit; Daneshvar, Kaveh; Zhou, Chan; Mullen, Alan C.; Giallourakis, Cosmas C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Zhang, Jiajing; Xing, Yi] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Bouley, Donna M.] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; [Lujan, Ernesto; Haddad, Bahareh; Wernig, Marius] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Lujan, Ernesto; Haddad, Bahareh; Wernig, Marius] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Lujan, Ernesto] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Lim, Kok-Seong; Dedon, Peter] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Mullen, Alan C.; Giallourakis, Cosmas C.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California Los Angeles; Stanford University; Stanford University; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); Harvard University	Xing, Y (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	yxing@ucla.edu; cgiallourakis@mgh.harvard.edu; howchang@stanford.edu	Daneshvar, Kaveh/M-9443-2014; Qu, Kun/G-3359-2012; Batista, Pedro J/K-5303-2012; Wang, Jinkai/H-1750-2015; ZHOU, Chan/A-7110-2009; Fang, Fengqin/F-4387-2016	Daneshvar, Kaveh/0000-0002-7863-0489; ZHOU, Chan/0000-0002-0351-6235; Dedon, Peter/0000-0003-0011-3067; Flynn, Ryan/0000-0001-5013-0442; Wang, Jinkai/0000-0002-2577-7575; Mullen, Alan/0000-0002-4096-3106	California Institute for Regenerative Medicine; NIH [R01-CA118750, DK090122]; MGH Start-Up Funds; MGH ECOR [2013A051178]; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Research Award; NATIONAL CANCER INSTITUTE [R01CA118750, T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090122] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH Start-Up Funds; MGH ECOR; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. He, C. Mason, S. Schwartz, A. Regev, J.M. Claycomb, N. Van Wittenberghe, B.D. Howard, and members of the Chang and Giallourakis labs for discussions and assistance. We thank H.E. Arda and S.K. Kim for help with FACS analysis and A. Memmelaar for his expertise in graphic arts. This work was supported by the California Institute for Regenerative Medicine and NIH R01-CA118750 (H.Y.C.), the MGH Start-Up Funds and MGH ECOR grant 2013A051178 (C.C.G.), NIH grant DK090122 (A.C.M.), and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Research Award (Y.X.). P.J.B. is the Kenneth G. and Elaine A. Langone Fellow of the Damon Runyon Cancer Research Foundation. Y.X. is an Alfred Sloan Foundation Research Fellow. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Bodi Z, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00048; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Fu Y, 2012, CURR OPIN CHEM BIOL, V16, P516, DOI 10.1016/j.cbpa.2012.10.002; Fukusumi Y, 2008, DEV DYNAM, V237, P618, DOI 10.1002/dvdy.21444; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Harcourt EM, 2013, J AM CHEM SOC, V135, P19079, DOI 10.1021/ja4105792; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Horiuchi K, 2013, J BIOL CHEM, V288, P33292, DOI 10.1074/jbc.M113.500397; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kang HJ, 2014, BIOCHEM J, V457, P391, DOI 10.1042/BJ20130862; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Neff AT, 2012, GENOME RES, V22, P1457, DOI 10.1101/gr.134312.111; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schnerch A, 2010, STEM CELLS, V28, P419, DOI 10.1002/stem.298; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Sibbritt T, 2013, WIRES RNA, V4, P397, DOI 10.1002/wrna.1166; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	44	721	760	6	109	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					707	719		10.1016/j.stem.2014.09.019	http://dx.doi.org/10.1016/j.stem.2014.09.019			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25456834	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000347174300010
J	Feinberg, AP				Feinberg, Andrew P.			The Nucleolus Gets the Silent Treatment	CELL STEM CELL			English	Editorial Material							MECHANISMS	In this issue of Cell Stem Cell, Savic et al. (2014) and Kim et al. (2014) provide insight into how global heterochromatin condensation and LIN28 sequestration in embryonic stem cells are independent mechanisms regulating pluripotency in the oft-overlooked nucleolus.	[Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA; [Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA.	afeinberg@jhu.edu	Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003233] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Chen XJ, 2012, GENE DEV, V26, P2499, DOI 10.1101/gad.200329.112; Diesch J, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-43; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Kim SK, 2014, CELL STEM CELL, V15, P735, DOI 10.1016/j.stem.2014.10.016; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Savic N, 2014, CELL STEM CELL, V15, P720, DOI 10.1016/j.stem.2014.10.005; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	10	5	5	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					675	676		10.1016/j.stem.2014.11.017	http://dx.doi.org/10.1016/j.stem.2014.11.017			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25479743	Green Accepted, Bronze			2022-12-28	WOS:000347174300004
J	Colman, A; Burley, J				Colman, Alan; Burley, Justine			Human Somatic Cell Reprogramming: Does the Egg Know Best?	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; DIFFERENTIATION	Somatic cell nuclear transfer offers an alternative approach to the use of exogenous transcription factors for the reprogramming of somatic cells. But is it a better way? Two groups have performed detailed molecular comparisons between human cell lines made by the two methods and report different conclusions.	[Colman, Alan] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Colman, Alan] Genea Biocells Pty Ltd, Sydney, NSW 2000, Australia; [Burley, Justine] Gaibian Associates, Singapore 138638, Singapore	Harvard University	Colman, A (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	colman@fas.harvard.edu						Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Johannesson B, 2014, CELL STEM CELL, V15, P634, DOI 10.1016/j.stem.2014.10.002; Kim H, 2011, CELL STEM CELL, V8, P695, DOI 10.1016/j.stem.2011.04.002; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Shinagawa T, 2014, CELL STEM CELL, V14, P217, DOI 10.1016/j.stem.2013.12.015; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012	10	4	4	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					531	532		10.1016/j.stem.2014.10.011	http://dx.doi.org/10.1016/j.stem.2014.10.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517458	Bronze			2022-12-28	WOS:000345012700003
J	Sowden, JC				Sowden, Jane C.			ESC-Derived Retinal Pigmented Epithelial Cell Transplants in Patients: So Far, So Good	CELL STEM CELL			English	Editorial Material							MACULAR DEGENERATION; STEM-CELLS	Many untreatable blinding diseases involve degeneration of retinal pigmented epithelial (RPE) cells, which has prompted exploration of the therapeutic potential of human-pluripotent-stem-cell-derived RPE. The first safety trials reported in The Lancet of embryonic-stem-cell-derived RPE cell transplants indicate no serious adverse outcomes and encourage further investigation.	UCL, UCL Inst Child Hlth, Stem Cells & Regenerat Med Sect, London WC1N 1EN, England	University of London; University College London	Sowden, JC (corresponding author), UCL, UCL Inst Child Hlth, Stem Cells & Regenerat Med Sect, 30 Guilford St, London WC1N 1EN, England.	j.sowden@ucl.ac.uk		Sowden, Jane/0000-0003-0937-2479	Medical Research Council [G0901550] Funding Source: Medline; Rosetrees Trust [M257] Funding Source: researchfish; Fight for Sight [1351/52] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1257] Funding Source: researchfish; MRC [G0901550] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetrees Trust(Rosetrees Trust); Fight for Sight; Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Quazi F, 2014, P NATL ACAD SCI USA, V111, P5024, DOI 10.1073/pnas.1400780111; Ramsden CM, 2013, DEVELOPMENT, V140, P2576, DOI 10.1242/dev.092270; Schwartz S.D., 2014, LANCET IN PRESS; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; van Zeeburg EJT, 2012, AM J OPHTHALMOL, V153, P120, DOI 10.1016/j.ajo.2011.06.007; Wright LS, 2014, EXP EYE RES, V123, P161, DOI 10.1016/j.exer.2013.12.001	10	11	14	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					537	538		10.1016/j.stem.2014.10.008	http://dx.doi.org/10.1016/j.stem.2014.10.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517461	Bronze			2022-12-28	WOS:000345012700006
J	Wu, CF; Li, B; Lu, R; Koelle, SJ; Yang, YQ; Jares, A; Krouse, AE; Metzger, M; Liang, F; Lore, K; Wu, CO; Donahue, RE; Chen, ISY; Weissman, I; Dunbar, CE				Wu, Chuanfeng; Li, Brian; Lu, Rong; Koelle, Samson J.; Yang, Yanqin; Jares, Alexander; Krouse, Alan E.; Metzger, Mark; Liang, Frank; Lore, Karin; Wu, Colin O.; Donahue, Robert E.; Chen, Irvin S. Y.; Weissman, Irving; Dunbar, Cynthia E.			Clonal Tracking of Rhesus Macaque Hematopoiesis Highlights a Distinct Lineage Origin for Natural Killer Cells	CELL STEM CELL			English	Article							COMMON LYMPHOID PROGENITORS; STEM-CELLS; VECTOR INTEGRATION; LENTIVIRAL VECTOR; BONE-MARROW; RETROVIRAL VECTORS; INSERTION SITES; DENDRITIC CELLS; GENE-THERAPY; IDENTIFICATION	Analysis of hematopoietic stem cell function in nonhuman primates provides insights that are relevant for human biology and therapeutic strategies. In this study, we applied quantitative genetic barcoding to track the clonal output of transplanted autologous rhesus macaque hematopoietic stem and progenitor cells over a time period of up to 9.5 months. We found that unilineage short-term progenitors reconstituted myeloid and lymphoid lineages at 1 month but were supplanted over time by multilineage clones, initially myeloid restricted, then myeloid-B clones, and then stable myeloid-B-T multilineage, long-term repopulating clones. Surprisingly, reconstitution of the natural killer (NK) cell lineage, and particularly the major CD16(+)/CD56(-) peripheral blood NK compartment, showed limited clonal overlap with T, B, or myeloid lineages, and therefore appears to be ontologically distinct. Thus, in addition to providing insights into clonal behavior over time, our analysis suggests an unexpected paradigm for the relationship between NK cells and other hematopoietic lineages in primates.	[Wu, Chuanfeng; Li, Brian; Koelle, Samson J.; Jares, Alexander; Krouse, Alan E.; Metzger, Mark; Donahue, Robert E.; Dunbar, Cynthia E.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Lu, Rong; Weissman, Irving] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94305 USA; [Yang, Yanqin] NHLBI, DNA Sequencing & Genom Core, NIH, Bethesda, MD 20892 USA; [Liang, Frank; Lore, Karin] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Wu, Colin O.] NHLBI, Off Biostat Res, NIH, Bethesda, MD 20892 USA; [Chen, Irvin S. Y.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Stanford University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dunbar, CE (corresponding author), NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA.	dunbarc@nhlbi.nih.gov	Liang, Frank/AAT-6566-2020; wu, Chuanfeng/AAG-1017-2019; Wu, Chuanfeng/A-1109-2016	Dunbar, Cynthia/0000-0002-7645-838X; Jares, Alexander/0000-0001-8387-2362; Liang, Frank/0000-0003-3675-3816; /0000-0001-7321-776X	Division of Intramural Research of the NHLBI [NIH-UO1-HL099999, NIH-K99-HL11304, CIRM-TG2-01159]; NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999, ZICHL002338, R00HL113104, ZIAHL002339, ZIAHL006063, ZICHL006058, U01HL099995, ZIAHL006062] Funding Source: NIH RePORTER	Division of Intramural Research of the NHLBI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Naoya Uchida for the chi HIV packaging system, Danny Douek for helpful comments, and Ann Williams (NHLBI FACS Core) and Jun Zhu (DNA Sequencing and Genomics Core) for technical assistance. This research was supported by the Division of Intramural Research of the NHLBI (grants NIH-UO1-HL099999 to I. W., NIH-K99-HL11304 to R. L., and CIRM-TG2-01159 to R.L.).	Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; Abkowitz JL, 1996, NAT MED, V2, P190, DOI 10.1038/nm0296-190; An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; Andrews RG, 2000, EXP HEMATOL, V28, P508, DOI 10.1016/S0301-472X(00)00137-5; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Berry CC, 2012, BIOINFORMATICS, V28, P755, DOI 10.1093/bioinformatics/bts004; Biffi A, 2011, BLOOD, V117, P5332, DOI 10.1182/blood-2010-09-306761; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Cheung AMS, 2013, BLOOD, V122, P3129, DOI 10.1182/blood-2013-06-508432; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Coulombel L, 2004, ONCOGENE, V23, P7210, DOI 10.1038/sj.onc.1207941; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Deichmann A, 2011, MOL THER, V19, P2031, DOI 10.1038/mt.2011.178; Donahue RE, 2001, HUM GENE THER, V12, P607, DOI 10.1089/104303401300057289; Donahue Robert E, 2005, Curr Protoc Immunol, VChapter 22, DOI 10.1002/0471142735.im22a01s69; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Gujer C, 2011, IMMUNOLOGY, V134, P257, DOI 10.1111/j.1365-2567.2011.03484.x; JONES RJ, 1990, NATURE, V347, P188, DOI 10.1038/347188a0; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kim HJ, 2000, BLOOD, V96, P1; Kim S, 2014, CELL STEM CELL, V14, P473, DOI 10.1016/j.stem.2013.12.012; Kim YJ, 2009, BLOOD, V113, P5434, DOI 10.1182/blood-2008-10-185199; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Kustikova OS, 2003, BLOOD, V102, P3934, DOI 10.1182/blood-2003-05-1424; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Larochelle A, 2011, BLOOD, V117, P1550, DOI 10.1182/blood-2009-03-212803; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Mace EM, 2013, BLOOD, V121, P2669, DOI 10.1182/blood-2012-09-453969; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Mavilio D, 2005, BLOOD, V106, P1718, DOI 10.1182/blood-2004-12-4762; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park CY, 2008, NAT PROTOC, V3, P1932, DOI 10.1038/nprot.2008.194; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Schmidt M, 2002, BLOOD, V100, P2737, DOI 10.1182/blood-2002-02-0407; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Seggewiss R, 2007, BLOOD, V110, P441, DOI 10.1182/blood-2006-12-065623; Shepherd BE, 2007, BLOOD, V110, P1806, DOI 10.1182/blood-2007-02-075382; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Uchida N, 2012, MOL THER, V20, P1882, DOI 10.1038/mt.2012.159; Uchida N, 2009, J VIROL, V83, P9854, DOI 10.1128/JVI.00357-09; Verovskaya E, 2013, BLOOD, V122, P523, DOI 10.1182/blood-2013-01-481135; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wu CF, 2013, HUM GENE THER, V24, P38, DOI 10.1089/hum.2012.082	67	109	111	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					486	499		10.1016/j.stem.2014.01.020	http://dx.doi.org/10.1016/j.stem.2014.01.020			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24702997	Bronze, Green Accepted			2022-12-28	WOS:000334766400012
J	Guo, ZY; Zhang, L; Wu, Z; Chen, YC; Wang, F; Chen, G				Guo, Ziyuan; Zhang, Lei; Wu, Zheng; Chen, Yuchen; Wang, Fan; Chen, Gong			In Vivo Direct Reprogramming of Reactive Glial Cells into Functional Neurons after Brain Injury and in an Alzheimer's Disease Model	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; NEURAL STEM/PROGENITOR CELLS; ADULT HUMAN FIBROBLASTS; DIRECT CONVERSION; DOPAMINERGIC-NEURONS; SPINAL-CORD; MOUSE; INDUCTION; GENERATION; ASTROCYTES	Loss of neurons after brain injury and in neurodegenerative disease is often accompanied by reactive gliosis and scarring, which are difficult to reverse with existing treatment approaches. Here, we show that reactive glial cells in the cortex of stab-injured or Alzheimer's disease (AD) model mice can be directly reprogrammed into functional neurons in vivo using retroviral expression of a single neural transcription factor, NeuroD1. Following expression of NeuroD1, astrocytes were reprogrammed into glutamatergic neurons, while NG2 cells were reprogrammed into glutamatergic and GABAergic neurons. Cortical slice recordings revealed both spontaneous and evoked synaptic responses in NeuroD1-converted neurons, suggesting that they integrated into local neural circuits. NeuroD1 expression was also able to reprogram cultured human cortical astrocytes into functional neurons. Our studies therefore suggest that direct reprogramming of reactive glial cells into functional neurons in vivo could provide an alternative approach for repair of injured or diseased brain.	[Guo, Ziyuan; Zhang, Lei; Wu, Zheng; Chen, Yuchen; Wang, Fan; Chen, Gong] Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Chen, G (corresponding author), Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA.	gongchen@psu.edu	Chen, Yuchen/HIR-9347-2022; Wu, Zheng/H-3234-2019	Chen JNU, Gong/0000-0002-1857-3670	Pennsylvania State University Eberly College of Science; National Institutes of Health [MH083911, MH092740]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH092740, R01MH083911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045656] Funding Source: NIH RePORTER	Pennsylvania State University Eberly College of Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank Drs. Bernhard Luscher, Richard Ordway, and Timothy Jegla, as well as Chen lab members for vigorous discussion and helpful comments on the manuscript. This work was supported by a stem cell fund from Pennsylvania State University Eberly College of Science and grants from National Institutes of Health (MH083911 and MH092740) to G.C.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Bayart E, 2013, CURR GENE THER, V13, P73, DOI 10.2174/1566523211313020002; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Boutin C, 2010, P NATL ACAD SCI USA, V107, P1201, DOI 10.1073/pnas.0909015107; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Cho JH, 2004, MOL NEUROBIOL, V30, P35, DOI 10.1385/MN:30:1:035; Deng L, 2007, J NEUROSCI, V27, P10860, DOI 10.1523/JNEUROSCI.2744-07.2007; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Gwak YS, 2012, EXP NEUROL, V234, P362, DOI 10.1016/j.expneurol.2011.10.010; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Hines DJ, 2009, GLIA, V57, P1610, DOI 10.1002/glia.20874; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Li WL, 2013, CELL STEM CELL, V13, P270, DOI 10.1016/j.stem.2013.08.002; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Liu XJ, 2012, CELL RES, V22, P321, DOI 10.1038/cr.2011.181; Meng FX, 2012, CELL RES, V22, P436, DOI 10.1038/cr.2011.185; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Steele M.L., 2010, NEUROBIOL AGING, V33, P423; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wu X, 2012, J BIOL CHEM, V287, P27417, DOI 10.1074/jbc.M112.360461; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	59	475	506	9	148	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					188	202		10.1016/j.stem.2013.12.001	http://dx.doi.org/10.1016/j.stem.2013.12.001			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24360883	Green Accepted, Bronze			2022-12-28	WOS:000330835800011
J	Vallier, L				Vallier, Ludovic			Cell Cycle Rules Pluripotency	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; STATE; DIFFERENTIATION; PROGENITORS	Stem cell self-renewal is intrinsically associated with cell cycle control. However, the precise mechanisms coordinating cell fate choices and cell cycle remain to be fully uncovered. Now in Cell, Gonzales et al. (2015) and colleagues demonstrate that factors controlling the G2/M phase are necessary to block pluripotency upon induction of differentiation.	[Vallier, Ludovic] MRC, Wellcome Trust, Stem Cell Inst, Dept Surg,Anne McLaren Lab, Cambridge CB2 0SZ, England; [Vallier, Ludovic] Sanger Inst, Wellcome Trust, Hinxton CB10 1SA, England	Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute	Vallier, L (corresponding author), MRC, Wellcome Trust, Stem Cell Inst, Dept Surg,Anne McLaren Lab, West Forvie Site,Robinson Way, Cambridge CB2 0SZ, England.	lv225@cam.ac.uk		Vallier, Ludovic/0000-0002-3848-2602	Medical Research Council [G1000847, G0800784] Funding Source: Medline; MRC [G1000847, G0800784] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; Gonzales KAU, 2015, CELL, V162, P564, DOI 10.1016/j.cell.2015.07.001; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Mende N., 2015, J EXP MED IN PRESS; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031	9	12	12	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					131	132		10.1016/j.stem.2015.07.019	http://dx.doi.org/10.1016/j.stem.2015.07.019			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26253197	Bronze			2022-12-28	WOS:000361878500003
J	Sacco, A; Puri, PL				Sacco, Alessandra; Puri, Pier Lorenzo			Regulation of Muscle Satellite Cell Function in Tissue Homeostasis and Aging	CELL STEM CELL			English	Editorial Material							SKELETAL-MUSCLE; REJUVENATION; QUIESCENCE; ADULT; MICE	Age-related muscle decline is associated with functional impairment of satellite cells (SCs). Conflicting data suggest dysregulation of cell-extrinsic or - intrinsic factors can independently contribute to such impairment. Here, we emphasize the importance of identifying nodes that integrate these factors into feed-forward circuits, which could provide targets for therapeutic intervention.	[Sacco, Alessandra; Puri, Pier Lorenzo] Sanford Burnham Med Res Inst, Dev Aging & Regenerat Program, La Jolla, CA 92037 USA; [Puri, Pier Lorenzo] IRCCS Fdn Santa Lucia, Epigenet & Regenerat Med, Rome, Italy	Sanford Burnham Prebys Medical Discovery Institute; IRCCS Santa Lucia	Sacco, A (corresponding author), Sanford Burnham Med Res Inst, Dev Aging & Regenerat Program, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	asacco@sanfordburnham.org; lpuri@sanfordburnham.org			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052779, R03AR063328, R01AR056712, R01AR064873, P30AR061303] Funding Source: NIH RePORTER; NIAMS NIH HHS [P30 AR061303, R01 AR064873, R01AR052779, P30AR061303, R03 AR063328, R01AR056712, R01 AR052779, R01AR064873, R01 AR056712] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Sousa-Victor P., 2014, NATURE, V506, P316; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656	10	28	29	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					585	587		10.1016/j.stem.2015.05.007	http://dx.doi.org/10.1016/j.stem.2015.05.007			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26046757	Bronze, Green Accepted			2022-12-28	WOS:000355932300007
J	Smith, KA; Arlotta, P; Watt, FM; Solomon, SL				Smith, Kristin A.; Arlotta, Paola; Watt, Fiona M.; Solomon, Susan L.		Initiative Women Sci Engn	Seven Actionable Strategies for Advancing Women in Science, Engineering, and Medicine	CELL STEM CELL			English	Editorial Material								Achieving gender equality in science will require devising and implementing strategies to overcome the political, administrative, financial, and cultural challenges that exist in the current environment. In this forum, we propose an initial shortlist of recommendations to promote gender equality in science and stimulate future efforts to level the field.	[Smith, Kristin A.; Solomon, Susan L.] New York Stem Cell Fdn, New York, NY 10023 USA; [Arlotta, Paola] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Watt, Fiona M.] Kings Coll London, Ctr Stem Cells & Regenerat Med, London SE1 9RT, England	The New York Stem Cell Foundation; Harvard University; University of London; King's College London	Solomon, SL (corresponding author), New York Stem Cell Fdn, New York, NY 10023 USA.	ssolomon@nyscf.org	Watt, Fiona/AHB-0226-2022	Watt, Fiona/0000-0001-9151-5154; Pola, Carolina/0000-0002-3005-876X; fossati, valentina/0000-0003-1825-9371	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER; NIBIB NIH HHS [P41 EB002520] Funding Source: Medline; Wellcome Trust [096540] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Wellcome Trust(Wellcome TrustEuropean Commission)		DesRoches CM, 2010, ACAD MED, V85, P631, DOI 10.1097/ACM.0b013e3181d2b095; Fang FC, 2013, MBIO, V4, DOI 10.1128/mBio.00640-12; Jagsi R, 2007, ARCH INTERN MED, V167, P343, DOI 10.1001/archinte.167.4.343; Ley TJ, 2008, SCIENCE, V322, P1472, DOI 10.1126/science.1165878; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Munir Fehmidah., 2013, ADV WOMENS CAREERS S; Munson M., 2014, AM SOC CELL BIOL NEW, V37, P9; National Research Council Office for Central Europe and Eurasia Committee on Prevention of Proliferation of Biological Weapons, 2007, BIOL THREAT RED PROG, P50; Schroeder J, 2013, J EVOLUTION BIOL, V26, P2063, DOI 10.1111/jeb.12198	9	30	30	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					221	224		10.1016/j.stem.2015.02.012	http://dx.doi.org/10.1016/j.stem.2015.02.012			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25748929	Green Accepted, Bronze			2022-12-28	WOS:000350747700005
J	Schuijers, J; Junker, JP; Mokry, M; Hatzis, P; Koo, BK; Sasselli, V; van der Flier, LG; Cuppen, E; van Oudenaarden, A; Clevers, H				Schuijers, Jurian; Junker, Jan Philipp; Mokry, Michal; Hatzis, Pantelis; Koo, Bon-Kyoung; Sasselli, Valentina; van der Flier, Laurens G.; Cuppen, Edwin; van Oudenaarden, Alexander; Clevers, Hans			Ascl2 Acts as an R-spondin/Wnt-Responsive Switch to Control Stemness in Intestinal Crypts	CELL STEM CELL			English	Article							TRANSCRIPTIONAL REGULATORY CIRCUITRY; BETA-CATENIN; WNT/BETA-CATENIN; MOUSE INTESTINE; PANETH CELLS; EXPRESSION PATTERN; GENE-EXPRESSION; WNT RECEPTORS; IN-VITRO; LGR5	The Wnt signaling pathway controls stem cell identity in the intestinal epithelium and in many other adult organs. The transcription factor Ascl2 (a Wnt target gene) is a master regulator of intestinal stem cell identity. It is unclear how the continuous Wnt gradient along the crypt axis is translated into discrete expression of Ascl2 and discrete specification of stem cells at crypt bottoms. We show that (1) Ascl2 is regulated in a direct autoactivatory loop, leading to a distinct on/off expression pattern, and (2) Wnt/R-spondin can activate this regulatory loop. This mechanism interprets the Wnt levels in the intestinal crypt and translates the continuous Wnt signal into a discrete Ascl2 "on'' or "off'' decision. In turn, Ascl2, together with beta-catenin/Tcf, activates the genes fundamental to the stem cell state. In this manner, Ascl2 forms a transcriptional switch that is both Wnt responsive and Wnt dependent to define stem cell identity.	[Schuijers, Jurian; Junker, Jan Philipp; Koo, Bon-Kyoung; Sasselli, Valentina; van der Flier, Laurens G.; Cuppen, Edwin; van Oudenaarden, Alexander; Clevers, Hans] CancerGenomiCs Nl, Univ Med Ctr Utrecht, Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Mokry, Michal] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Gastroenterol, NL-3508 AB Utrecht, Netherlands; [Hatzis, Pantelis] Biomed Sci Res Ctr Alexander Fleming, Vari 16672, Greece; [Koo, Bon-Kyoung] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England; [Koo, Bon-Kyoung] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [van der Flier, Laurens G.] SomantiX BV, NL-3584 CH Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Alexander Fleming Biomedical Sciences Research Center; University of Cambridge; University of Cambridge	Clevers, H (corresponding author), CancerGenomiCs Nl, Univ Med Ctr Utrecht, Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011; Koo, Bon-Kyoung/V-5219-2017; Mokry, Michal/AAN-3809-2021; van Oudenaarden, Alexander/AAA-1705-2019; Junker, Jan Philipp/A-9754-2010	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Koo, Bon-Kyoung/0000-0002-4134-8033; Mokry, Michal/0000-0002-5298-4852; Junker, Jan Philipp/0000-0002-2826-8290; Sasselli, Valentina/0000-0002-7118-0067; Schuijers, Jurian/0000-0003-2531-3516				Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Davies PS, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-57; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Hirata A, 2013, DEVELOPMENT, V140, P66, DOI 10.1242/dev.084103; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Jubb AM, 2006, ONCOGENE, V25, P3445, DOI 10.1038/sj.onc.1209382; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mokry M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015092; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Reed KR, 2012, GUT, V61, P1435, DOI 10.1136/gutjnl-2011-300842; Roman AKS, 2014, STEM CELL REP, V2, P127, DOI 10.1016/j.stemcr.2013.12.012; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schuijers J, 2014, EMBO J, V33, P146, DOI 10.1002/embj.201385358; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; STEVENS CE, 1947, ANAT REC, V97, P373; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TENKATE J, 1989, J HISTOCHEM CYTOCHEM, V37, P541, DOI 10.1177/37.4.2647841; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wu CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4149; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737	70	160	164	6	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					158	170		10.1016/j.stem.2014.12.006	http://dx.doi.org/10.1016/j.stem.2014.12.006			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25620640	Bronze			2022-12-28	WOS:000349455000012
J	Jung, HY; Yang, J				Jung, Hae-Yun; Yang, Jing			Unraveling the TWIST between EMT and Cancer Stemness	CELL STEM CELL			English	Editorial Material							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-METASTASIS; CELLS	Twist1 has a well-established role in inducing Epithelial-Mesenchymal Transition (EMT) to promote tumor invasion and metastasis and can also inhibit apoptosis and confer stemness. In this issue of Cell Stem Cell, Beck et al. (2015) now show that low levels of Twist1 are essential for tumor initiation, maintenance, and stemness independent of its EMT-inducing activity.	[Jung, Hae-Yun; Yang, Jing] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Yang, Jing] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Yang, Jing] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Yang, J (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	jingyang@ucsd.edu		Jung, Hae-Yun/0000-0001-9467-2219				Beck B, 2015, CELL STEM CELL, V16, P67, DOI 10.1016/j.stem.2014.12.002; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Schmidt J. M., 2015, CELL REP IN PRESS, V10; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	10	56	60	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					1	2		10.1016/j.stem.2014.12.005	http://dx.doi.org/10.1016/j.stem.2014.12.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25575073	Bronze			2022-12-28	WOS:000347708400001
J	Jalkanen, AL; Wilusz, J				Jalkanen, Aimee L.; Wilusz, Jeffrey			Stem Cell RNA Epigenetics: M(6)Arking Your Territory	CELL STEM CELL			English	Editorial Material							MESSENGER-RNA; NUCLEAR-RNA; METHYLATION	Modifications of mRNAs can have a profound effect on cellular function and differentiation. In this issue of Cell Stem Cell, Batista et al. (2014) describe fundamental parameters of N-6-methyl-adenosine modification of mRNAs in embryonic stem cells and provide strong evidence that modification plays a role in exit from pluripotency toward differentiation.	[Jalkanen, Aimee L.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Wilusz, J (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	jeffrey.wilusz@colostate.edu						Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bellodi C, 2013, CELL REP, V3, P1493, DOI 10.1016/j.celrep.2013.04.030; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	10	1	1	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					669	670		10.1016/j.stem.2014.11.011	http://dx.doi.org/10.1016/j.stem.2014.11.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25479740	Bronze			2022-12-28	WOS:000347174300001
J	van Wolfswinkel, JC; Wagner, DE; Reddien, PW				van Wolfswinkel, Josien C.; Wagner, Daniel E.; Reddien, Peter W.			Single-Cell Analysis Reveals Functionally Distinct Classes within the Planarian Stem Cell Compartment	CELL STEM CELL			English	Article							GENE-EXPRESSION; GENOME-WIDE; REGENERATION; PROLIFERATION; DIFFERENTIATION; HETEROGENEITY; PLURIPOTENCY; MAINTENANCE; REGULATORS; SMEDWI-2	Planarians are flatworms capable of regenerating any missing body region. This capacity is mediated by neoblasts, a proliferative cell population that contains pluripotent stem cells. Although population-based studies have revealed many neoblast characteristics, whether functionally distinct classes exist within this population is unclear. Here, we used high-dimensional single-cell transcriptional profiling from over a thousand individual neoblasts to directly compare gene expression fingerprints during homeostasis and regeneration. We identified two prominent neoblast classes that we named zeta (zeta) and sigma (sigma). Zeta-neoblasts encompass specified cells that give rise to an abundant postmitotic lineage, including epidermal cells, and are not required for regeneration. By contrast, sigma-neoblasts proliferate in response to injury, possess broad lineage capacity, and can give rise to zeta-neoblasts. These findings indicate that planarian neoblasts comprise two major and functionally distinct cellular compartments.	[van Wolfswinkel, Josien C.; Wagner, Daniel E.; Reddien, Peter W.] Whitehead Inst Biomed Res, Howard Hughes Med Inst, MIT Biol, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Reddien, PW (corresponding author), Whitehead Inst Biomed Res, Howard Hughes Med Inst, MIT Biol, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	reddien@wi.mit.edu		Wagner, Daniel/0000-0002-2983-635X; /0000-0002-5569-333X	Human Frontier Science Program; NIH [R01GM080639]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080639] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the P. W. R. lab for comments on the manuscript. J.C.vW. is supported by the Human Frontier Science Program. P. W. R. is an Investigator of the Howard Hughes Medical Institute and an associate member of the Broad Institute of Harvard and MIT. We acknowledge support from the NIH (R01GM080639).	Blvthe M.J., 2010, PLOS ONE, V5; Cowles MW, 2013, DEVELOPMENT, V140, P4691, DOI 10.1242/dev.098616; Currie KW, 2013, DEVELOPMENT, V140, P3577, DOI 10.1242/dev.098590; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Forsthoefel DJ, 2012, DEV CELL, V23, P691, DOI 10.1016/j.devcel.2012.09.008; Galloni M, 2012, INT J DEV BIOL, V56, P103, DOI 10.1387/ijdb.113455mg; Guedelhoefer OC, 2012, DEVELOPMENT, V139, P3510, DOI 10.1242/dev.082099; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Hayashi T, 2010, DEV GROWTH DIFFER, V52, P131, DOI 10.1111/j.1440-169X.2009.01157.x; Junker JP, 2014, CELL, V157, P8, DOI 10.1016/j.cell.2014.02.010; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Lapan SW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002226; Livak KJ, 2013, METHODS, V59, P71, DOI 10.1016/j.ymeth.2012.10.004; Moritz S, 2012, INT J DEV BIOL, V56, P117, DOI 10.1387/ijdb.113440sm; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Onal P, 2012, EMBO J, V31, P2755, DOI 10.1038/emboj.2012.110; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Resch AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034447; Rossi A, 2014, GENE, V533, P156, DOI 10.1016/j.gene.2013.09.101; Salvetti A, 2000, DEV DYNAM, V218, P603, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1016>3.0.CO;2-C; Salvetti A, 2005, DEVELOPMENT, V132, P1863, DOI 10.1242/dev.01785; Scimone ML, 2011, DEVELOPMENT, V138, P4387, DOI 10.1242/dev.068098; Scimone ML, 2010, DEVELOPMENT, V137, P1231, DOI 10.1242/dev.042051; Shibata N, 2012, INT J DEV BIOL, V56, P93, DOI 10.1387/ijdb.113434ns; Solana J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r19; Solana J, 2009, DEV BIOL, V328, P410, DOI 10.1016/j.ydbio.2009.01.043; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Wagner DE, 2012, CELL STEM CELL, V10, P299, DOI 10.1016/j.stem.2012.01.016; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; WOLFF ETIENNE, 1948, REV SUISSE ZOOL, V55, P218; Zayas RM, 2010, DEV DYNAM, V239, P2888, DOI 10.1002/dvdy.22427; Zhu SJ, 2013, DEV BIOL, V373, P442, DOI 10.1016/j.ydbio.2012.10.025	42	180	180	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					326	339		10.1016/j.stem.2014.06.007	http://dx.doi.org/10.1016/j.stem.2014.06.007			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25017721	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000341441600012
J	Hogan, BLM; Barkauskas, CE; Chapman, HA; Epstein, JA; Jain, R; Hsia, CCW; Niklason, L; Calle, E; Le, A; Randell, SH; Rock, J; Snitow, M; Krummel, M; Stripp, BR; Vu, T; White, ES; Whitsett, JA; Morrisey, EE				Hogan, Brigid L. M.; Barkauskas, Christina E.; Chapman, Harold A.; Epstein, Jonathan A.; Jain, Rajan; Hsia, Connie C. W.; Niklason, Laura; Calle, Elizabeth; Le, Andrew; Randell, Scott H.; Rock, Jason; Snitow, Melinda; Krummel, Matthew; Stripp, Barry R.; Thiennu Vu; White, Eric S.; Whitsett, Jeffrey A.; Morrisey, Edward E.			Repair and Regeneration of the Respiratory System: Complexity, Plasticity, and Mechanisms of Lung Stem Cell Function	CELL STEM CELL			English	Review							EPIDERMAL-GROWTH-FACTOR; ALVEOLAR EPITHELIUM; BASAL-CELLS; INTUSSUSCEPTIVE ANGIOGENESIS; PULMONARY-FIBROSIS; BRANCHING PROGRAM; BASEMENT-MEMBRANE; REGULATE LUNG; TYPE-2 CELLS; CLARA CELLS	Respiratory disease is the third leading cause of death in the industrialized world. Consequently, the trachea, lungs, and cardiopulmonary vasculature have been the focus of extensive investigations. Recent studies have provided new information about the mechanisms driving lung development and differentiation. However, there is still much to learn about the ability of the adult respiratory system to undergo repair and to replace cells lost in response to injury and disease. This Review highlights the multiple stem/progenitor populations in different regions of the adult lung, the plasticity of their behavior in injury models, and molecular pathways that support homeostasis and repair.	[Hogan, Brigid L. M.] Duke Med, Dept Cell Biol, Durham, NC 27705 USA; [Barkauskas, Christina E.] Duke Med, Div Pulm Allergy & Crit Care Med, Durham, NC 27705 USA; [Chapman, Harold A.; Krummel, Matthew; Thiennu Vu] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care, San Francisco, CA 94143 USA; [Epstein, Jonathan A.; Jain, Rajan] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Hsia, Connie C. W.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Niklason, Laura] Yale Univ, Dept Anesthesiol, New Haven, CT 06520 USA; [Niklason, Laura] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Randell, Scott H.] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Rock, Jason] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Snitow, Melinda] Univ Penn, Perleman Sch Med, Philadelphia, PA 19104 USA; [Stripp, Barry R.] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA; [White, Eric S.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Whitsett, Jeffrey A.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Ctr, Sect Neonatol Perinatal & Pulm Biol,Dept Pediat, Cincinnati, OH 45229 USA; [Morrisey, Edward E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Duke University; Duke University; University of California System; University of California San Francisco; University of Pennsylvania; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Yale University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; Cedars Sinai Medical Center; University of Michigan System; University of Michigan; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Pennsylvania; University of Pennsylvania	Hogan, BLM (corresponding author), Duke Med, Dept Cell Biol, Durham, NC 27705 USA.	brigid.hogan@duke.edu; emorrise@mail.med.upenn.edu	Stripp, Barry/AAI-1467-2021	Stripp, Barry/0000-0003-4348-2137; Epstein, Jonathan/0000-0001-8637-4465; White, Eric/0000-0003-4060-8443	National Institutes of Health; Lung Repair and Regeneration Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087825, K08HL122521, U01HL111016, U01HL110942, U01HL110964, R01HL064632, R01HL071589, U01HL111146, P01HL024136, T32HL007749, K08HL119553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM086287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung Repair and Regeneration Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors apologize for the omission of any references due to the space constraints of this Review and wish to thank members of their laboratories for input and helpful criticism of this Review. The authors wish to acknowledge the important support from the National Institutes of Health including the Lung Repair and Regeneration Consortium.	Ackermann M, 2014, ANGIOGENESIS, V17, P541, DOI 10.1007/s10456-013-9399-9; Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Alanis DM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4923; Aumiller V, 2013, AM J RESP CELL MOL, V49, P96, DOI 10.1165/rcmb.2012-0524OC; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Beattie Jr. E. J., 1956, J THORAC SURG, V32, P725; Blackwell TS, 2011, J IMMUNOL, V187, P2740, DOI 10.4049/jimmunol.1101495; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Bonvillain RW, 2013, JOVE-J VIS EXP, DOI 10.3791/50825; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Burri PH, 2004, DEV DYNAM, V231, P474, DOI 10.1002/dvdy.20184; Cardoso Wellington V, 2008, Proc Am Thorac Soc, V5, P767, DOI 10.1513/pats.200803-026HR; Chang DR, 2013, P NATL ACAD SCI USA, V110, P18042, DOI 10.1073/pnas.1311760110; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chen HY, 2012, STEM CELLS, V30, P1948, DOI 10.1002/stem.1150; Chen LL, 2012, AM J RESP CELL MOL, V47, P517, DOI 10.1165/rcmb.2012-0030OC; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Chokas AL, 2010, J BIOL CHEM, V285, P13304, DOI 10.1074/jbc.M109.088468; CLAGETT OT, 1952, ANN SURG, V136, P520; Cole BB, 2010, AM J PATHOL, V177, P362, DOI 10.2353/ajpath.2010.090870; COTTON BH, 1952, J THORAC SURG, V24, P231; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Dane DM, 2013, J APPL PHYSIOL, V114, P99, DOI 10.1152/japplphysiol.01213.2012; DANTO SI, 1995, AM J RESP CELL MOL, V12, P497, DOI 10.1165/ajrcmb.12.5.7742013; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Dixit R, 2013, DEVELOPMENT, V140, P4398, DOI 10.1242/dev.098079; Eisenhauer P, 2013, STEM CELLS, V31, P1330, DOI 10.1002/stem.1377; EKESTROM S, 1959, Acta Chir Scand Suppl, VSuppl 245, P71; El Agha E, 2014, DEVELOPMENT, V141, P296, DOI 10.1242/dev.099747; Epaud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048071; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; EVANS MJ, 1973, AM J PATHOL, V70, P175; Flozak AS, 2010, J BIOL CHEM, V285, P3157, DOI 10.1074/jbc.M109.070326; Foster DJ, 2002, AM J PHYSIOL-LUNG C, V283, pL981, DOI 10.1152/ajplung.00053.2002; Fuhrmann S, 2014, EXP EYE RES, V123, P141, DOI 10.1016/j.exer.2013.09.003; Ghaedi M, 2013, J CLIN INVEST, V123, P4950, DOI 10.1172/JCI68793; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Gilpin SE, 2014, J HEART LUNG TRANSPL, V33, P298, DOI 10.1016/j.healun.2013.10.030; Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6; Guha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088848; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Gunawardhana LP, 2014, CLIN EXP ALLERGY, V44, P47, DOI 10.1111/cea.12168; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Hashimoto S, 2012, J CELL SCI, V125, P932, DOI 10.1242/jcs.092734; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Herriges JC, 2012, DEV DYNAM, V241, P1432, DOI 10.1002/dvdy.23823; Herriges M, 2014, DEVELOPMENT, V141, P502, DOI 10.1242/dev.098186; Herriges MJ, 2014, GENE DEV, V28, P1363, DOI 10.1101/gad.238782.114; Hinenoya N, 2008, ARCH HISTOL CYTOL, V71, P185, DOI 10.1679/aohc.71.185; HIRANO M, 1989, ANN OTO RHINOL LARYN, V98, P713, DOI 10.1177/000348948909800910; Hoffman AM, 2010, AM J PHYSIOL-LUNG C, V298, pL158, DOI 10.1152/ajplung.90594.2008; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hsia CCW, 2004, J APPL PHYSIOL, V97, P1992, DOI 10.1152/japplphysiol.00530.2004; Hsia CCW, 2004, AM J RESP CRIT CARE, V170, P319, DOI 10.1164/rccm.200209-1062ST; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K, 2002, AM J RESP CRIT CARE, V166, P392, DOI 10.1164/rccm.2110060; KAPLAN HP, 1969, LAB INVEST, V20, P94; Kaza AK, 2002, CIRCULATION, V106, pI120, DOI 10.1161/01.cir.0000032918.33237.04; Kaza AK, 2000, J THORAC CARDIOV SUR, V120, P916, DOI 10.1067/mtc.2000.110460; KESHISHIAN JM, 1956, J THORAC SURG, V32, P707; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lau Christine L, 2004, J Intensive Care Med, V19, P83, DOI 10.1177/0885066603261509; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Li SR, 2012, DEVELOPMENT, V139, P2500, DOI 10.1242/dev.079699; LIU JY, 1994, AM J PHYSIOL, V266, pL296, DOI 10.1152/ajplung.1994.266.3.L296; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Lu MM, 2002, MECH DEVELOP, V119, pS197, DOI 10.1016/S0925-4773(03)00116-3; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Lucchetta EM, 2012, WIRES DEV BIOL, V1, P781, DOI 10.1002/wdev.51; Macchiarini P, 2004, J THORAC CARDIOV SUR, V128, P638, DOI 10.1016/j.jtcvs.2004.02.042; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; MASSARO GD, 1993, AM J PHYSIOL, V265, pL319, DOI 10.1152/ajplung.1993.265.4.L319; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Moreno-Barriuso N, 2006, DEV DYNAM, V235, P2040, DOI 10.1002/dvdy.20842; Morimoto M, 2012, DEVELOPMENT, V139, P4365, DOI 10.1242/dev.083840; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; NEVILLE WE, 1990, J THORAC CARDIOV SUR, V99, P604; Nichols JE, 2013, TISSUE ENG PT A, V19, P2045, DOI [10.1089/ten.tea.2012.0250, 10.1089/ten.TEA.2012.0250]; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; O'Koren EG, 2013, AM J RESP CELL MOL, V49, P788, DOI 10.1165/rcmb.2012-0369OC; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Ornitz DM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008318; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Paul MK, 2014, CELL STEM CELL, V15, P199, DOI 10.1016/j.stem.2014.05.009; Peng T, 2013, NATURE, V500, P589, DOI 10.1038/nature12358; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]; Ramirez MI, 2000, AM J RESP CELL MOL, V22, P367, DOI 10.1165/ajrcmb.22.3.3923; Ravikumar P, 2014, J APPL PHYSIOL, V116, P816, DOI 10.1152/japplphysiol.01291.2013; Ravikumar P, 2013, J APPL PHYSIOL, V114, P961, DOI 10.1152/japplphysiol.01394.2012; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rockich BE, 2013, P NATL ACAD SCI USA, V110, pE4456, DOI 10.1073/pnas.1311847110; SANNES PL, 1984, J HISTOCHEM CYTOCHEM, V32, P827, DOI 10.1177/32.8.6747274; Shi Wei, 2009, Proc Am Thorac Soc, V6, P558, DOI 10.1513/pats.200905-031RM; Short K, 2013, DEVELOPMENT, V140, P471, DOI 10.1242/dev.088500; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Sirianni FE, 2003, AM J RESP CRIT CARE, V168, P1532, DOI 10.1164/rccm.200303-371OC; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; Takeda N, 2013, DEVELOPMENT, V140, P1655, DOI 10.1242/dev.093005; Tanjore H, 2013, AM J RESP CRIT CARE, V187, P630, DOI 10.1164/rccm.201205-0972OC; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Teixeira VH, 2013, ELIFE, V2, DOI 10.7554/eLife.00966; Thane K, 2014, TRANSL RES, V163, P363, DOI 10.1016/j.trsl.2013.11.010; Toufen C, 2011, CLINICS, V66, P933, DOI 10.1590/S1807-59322011000600002; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Tropea KA, 2012, AM J PHYSIOL-LUNG C, V302, pL829, DOI 10.1152/ajplung.00347.2011; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; Voswinckel R, 2004, EUR RESPIR J, V24, P524, DOI 10.1183/09031936.04.10004904; Wagner DE, 2014, BIOMATERIALS, V35, P2664, DOI 10.1016/j.biomaterials.2013.11.078; Wang B, 2013, GENE, V531, P101, DOI 10.1016/j.gene.2013.08.069; Wang XF, 2014, CLIN GASTROENTEROL H, V12, P394, DOI 10.1016/j.cgh.2013.09.023; Wang Y, 2013, DEV CELL, V24, P345, DOI 10.1016/j.devcel.2013.01.012; Wansleeben C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093496; Weibel ER, 2013, AM J RESP CRIT CARE, V187, P342, DOI 10.1164/rccm.201212-2260OE; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Wirtz HR, 2000, RESP PHYSIOL, V119, P1, DOI 10.1016/S0034-5687(99)00092-4; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Xian W, 2012, CELL CYCLE, V11, P887, DOI 10.4161/cc.11.5.19328; Xing YM, 2012, STEM CELLS, V30, P946, DOI 10.1002/stem.1059; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109; Yilmaz C, 2011, J APPL PHYSIOL, V111, P1150, DOI 10.1152/japplphysiol.00527.2011; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; Zemke AC, 2009, AM J RESP CELL MOL, V41, P535, DOI 10.1165/rcmb.2008-0407OC; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zheng DH, 2014, AM J RESP CELL MOL, V50, P595, DOI 10.1165/rcmb.2013-0327OC	143	504	512	12	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					123	138		10.1016/j.stem.2014.07.012	http://dx.doi.org/10.1016/j.stem.2014.07.012			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	25105578	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000340880100007
J	Zhou, BO; Yue, R; Murphy, MM; Peyer, JG; Morrison, SJ				Zhou, Bo O.; Yue, Rui; Murphy, Malea M.; Peyer, James G.; Morrison, Sean J.			Leptin-Receptor-Expressing Mesenchymal Stromal Cells Represent the Main Source of Bone Formed by Adult Bone Marrow	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; PERIVASCULAR CELLS; NG2 PROTEOGLYCAN; SCHWANN-CELLS; NEURAL CREST; IN-VIVO; PTEN; MICE; GENE; MAINTENANCE	Studies of the identity and physiological function of mesenchymal stromal cells (MSCs) have been hampered by a lack of markers that permit both prospective identification and fate mapping in vivo. We found that Leptin Receptor (LepR) is a marker that highly enriches bone marrow MSCs. Approximately 0.3% of bone marrow cells were LepR(+), 10% of which were CFU-Fs, accounting for 94% of bone marrow CFU-Fs. LepR(+) cells formed bone, cartilage, and adipocytes in culture and upon transplantation in vivo. LepR(+) cells were Scf-GFP(+), Cxcl12-DsRed(high), and Nestin-GFP(low), markers which also highly enriched CFU-Fs, but negative for Nestin-CreER and NG2-CreER, markers which were unlikely to be found in CFU-Fs. Fate-mapping showed that LepR(+) cells arose postnatally and gave rise to most bone and adipocytes formed in adult bone marrow, including bone regenerated after irradiation or fracture. LepR(+) cells were quiescent, but they proliferated after injury. Therefore, LepR(+) cells are the major source of bone and adipocytes in adult bone marrow.	[Zhou, Bo O.; Yue, Rui; Murphy, Malea M.; Peyer, James G.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA; [Zhou, Bo O.; Yue, Rui; Murphy, Malea M.; Peyer, James G.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Morrison, Sean J.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329; Murphy, Malea/0000-0001-7071-6862	National Heart, Lung and Blood Institute [HL097760]; Cancer Prevention and Research Institute of Texas; Leukemia and Lymphoma Society; Damon Runyon Foundation; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097760] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cancer Prevention and Research Institute of Texas; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Damon Runyon Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S.J.M. is a Howard Hughes Medical Institute Investigator, the Mary McDermott Cook Chair in Pediatric Genetics, and the director of the Hamon Laboratory for Stem Cells and Cancer. This work was supported by the National Heart, Lung and Blood Institute (HL097760) and the Cancer Prevention and Research Institute of Texas. B.O.Z. was supported by a fellowship from the Leukemia and Lymphoma Society. R.Y. was supported by a fellowship from the Damon Runyon Foundation. J.G.P. was supported by a fellowship from the National Science Foundation. We thank Dr. Hung Luu in Children's Medical Center for his expert analysis of hematopoiesis in ossicles and Dr. Aktar Ali in the Mouse Metabolic Phenotyping Core at UT Southwestern for microCT analysis of bone.	Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Chou DB, 2012, J LEUKOCYTE BIOL, V92, P123, DOI 10.1189/jlb.1011527; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Fukushi J, 2003, DEV DYNAM, V228, P143, DOI 10.1002/dvdy.10359; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Komada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046436; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071318; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Murfee WL, 2005, MICROCIRCULATION, V12, P151, DOI 10.1080/10739680590904955; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raghunath J, 2005, CURR OPIN BIOTECH, V16, P503, DOI 10.1016/j.copbio.2005.08.004; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schneider S, 2001, J NEUROSCI, V21, P920, DOI 10.1523/JNEUROSCI.21-03-00920.2001; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	51	730	760	15	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					154	168		10.1016/j.stem.2014.06.008	http://dx.doi.org/10.1016/j.stem.2014.06.008			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	24953181	Bronze, Green Accepted			2022-12-28	WOS:000340880100009
J	Gorkin, DU; Leung, D; Ren, B				Gorkin, David U.; Leung, Danny; Ren, Bing			The 3D Genome in Transcriptional Regulation and Pluripotency	CELL STEM CELL			English	Review							NUCLEAR LAMINA INTERACTIONS; POLYMERASE-II TRANSCRIPTION; ENHANCER-BLOCKING ACTIVITY; EMBRYONIC STEM-CELLS; LONG NONCODING RNAS; BETA-GLOBIN LOCUS; CHROMATIN INTERACTIONS; GENE-EXPRESSION; CHROMOSOME CONFORMATION; HIGH-RESOLUTION	It can be convenient to think of the genome as simply a string of nucleotides, the linear order of which encodes an organism's genetic blueprint. However, the genome does not exist as a linear entity within cells where this blueprint is actually utilized. Inside the nucleus, the genome is organized in three-dimensional (3D) space, and lineage-specific transcriptional programs that direct stem cell fate are implemented in this native 3D context. Here, we review principles of 3D genome organization in mammalian cells. We focus on the emerging relationship between genome organization and lineage-specific transcriptional regulation, which we argue are inextricably linked.	[Gorkin, David U.; Leung, Danny; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Inst Genome Med,Moores Canc Ctr, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Gorkin, DU (corresponding author), Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dgorkin@ucsd.edu; biren@ucsd.edu		Gorkin, David/0000-0003-4944-4107; Leung, Danny Chi Yeu/0000-0002-2472-894X	Ludwig Institute for Cancer Research; NIH [U01ES017166, U01HL107442, P50GM085764, U54 HG006997]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107442] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, K12GM068524] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Ren laboratory for helpful discussion and feedback, particularly Tinting Du, Anthony Schmitt, Andrea Local, Chloe Rivera, Fulai Jin, and Jesse Dixon. We also thank our reviewers for their valuable input. This work was supported by funds from the Ludwig Institute for Cancer Research and the NIH (grants U01ES017166, U01HL107442, P50GM085764, and U54 HG006997) to B.R.	Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Bornfleth H, 1999, BIOPHYS J, V77, P2871, DOI 10.1016/S0006-3495(99)77119-5; Boyle S, 2011, CHROMOSOME RES, V19, P901, DOI 10.1007/s10577-011-9245-0; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Carlsten JOP, 2013, TRENDS BIOCHEM SCI, V38, P531, DOI 10.1016/j.tibs.2013.08.007; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chen HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041374; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheutin T, 2014, CURR OPIN GENET DEV, V25, P30, DOI 10.1016/j.gde.2013.11.016; Chien R, 2011, J BIOL CHEM, V286, P17870, DOI 10.1074/jbc.M110.207365; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; de Laat W, 2012, METHODS, V58, P189, DOI 10.1016/j.ymeth.2012.11.005; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; DeMare LE, 2013, GENOME RES, V23, P1224, DOI 10.1101/gr.156570.113; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Denholtz M, 2012, CURR OPIN CELL BIOL, V24, P793, DOI 10.1016/j.ceb.2012.11.001; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eijkelenboom A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.74; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Faure AJ, 2012, GENOME RES, V22, P2163, DOI 10.1101/gr.136507.111; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hakim O, 2011, GENOME RES, V21, P697, DOI 10.1101/gr.111153.110; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang D, 2013, CELL CYCLE, V12, P3351, DOI 10.4161/cc.26577; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Jin FL, 2011, P NATL ACAD SCI USA, V108, P5290, DOI 10.1073/pnas.1017214108; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lariviere L, 2012, CURR OPIN CELL BIOL, V24, P305, DOI 10.1016/j.ceb.2012.01.007; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Melcer S, 2010, ESSAYS BIOCHEM, V48, P245, DOI [10.1042/BSE0480245, 10.1042/bse0480245]; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Misteli T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000794; Misteli T, 2009, P NATL ACAD SCI USA, V106, P6885, DOI 10.1073/pnas.0902010106; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Muller WG, 2012, J STRUCT BIOL, V177, P179, DOI 10.1016/j.jsb.2011.11.025; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Noordermeer D, 2008, IUBMB LIFE, V60, P824, DOI 10.1002/iub.129; Nora EP, 2013, BIOESSAYS, V35, P818, DOI 10.1002/bies.201300040; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Padeken J, 2014, CURR OPIN CELL BIOL, V28, P54, DOI 10.1016/j.ceb.2014.03.001; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Papantonis A, 2013, CHEM REV, V113, P8683, DOI 10.1021/cr300513p; Parada LA, 2003, TRENDS CELL BIOL, V13, P393, DOI 10.1016/S0962-8924(03)00149-1; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Praetorius C, 2013, CELL, V155, P1022, DOI 10.1016/j.cell.2013.10.022; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Remeseiro S, 2013, DEVELOPMENT, V140, P3715, DOI 10.1242/dev.090605; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; Tiwari VK, 2008, GENOME RES, V18, P1171, DOI 10.1101/gr.073452.107; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tutter AV, 2009, J BIOL CHEM, V284, P3709, DOI 10.1074/jbc.M805677200; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Weedon MN, 2014, NAT GENET, V46, P61, DOI 10.1038/ng.2826; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; Zhang H, 2013, CELL STEM CELL, V13, P30, DOI 10.1016/j.stem.2013.05.012; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	147	233	239	5	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					762	775		10.1016/j.stem.2014.05.017	http://dx.doi.org/10.1016/j.stem.2014.05.017			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905166	Green Accepted, Bronze			2022-12-28	WOS:000341248500013
J	Kats, LM; Reschke, M; Taulli, R; Pozdnyakova, O; Burgess, K; Bhargava, P; Straley, K; Karnik, R; Meissner, A; Small, D; Su, SM; Yen, K; Zhang, JW; Pandolfi, PP				Kats, Lev M.; Reschke, Markus; Taulli, Riccardo; Pozdnyakova, Olga; Burgess, Kerri; Bhargava, Parul; Straley, Kimberly; Karnik, Rahul; Meissner, Alexander; Small, Donald; Su, Shinsan M.; Yen, Katharine; Zhang, Jiangwen; Pandolfi, Pier Paolo			Proto-Oncogenic Role of Mutant IDH2 in Leukemia Initiation and Maintenance	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; IN-VIVO; DIFFERENTIATION; MUTATIONS; 2-HYDROXYGLUTARATE; INHIBITION; MICE; AML	Mutations in the metabolic enzymes isocitrate dehydrogenase-1 (IDH1) and IDH2 that produce the oncometabolite D-2-hydroxyglutarate (2-HG) occur frequently in human acute myeloid leukemia (AML). 2-HG modulates numerous biological pathways implicated in malignant transformation, but the contribution of mutant IDH proteins to maintenance and progression of AML in vivo is currently unknown. To answer this crucial question we have generated transgenic mice that express IDH2(R140Q) in an on/off- and tissue-specific manner using a tetracycline-inducible system. We found that IDH2(R140Q) can cooperate with overexpression of HoxA9 and Meis1a and with mutations in FMS-like tyrosine kinase 3 (FLT3) to drive acute leukemia in vivo. Critically, we show that genetic deinduction of mutant IDH2 in leukemic cells in vivo has profound effects on their growth and/or maintenance. Our data demonstrate the proto-oncogenic role of mutant IDH2 and support its relevance as a therapeutic target for the treatment of human AML.	[Kats, Lev M.; Reschke, Markus; Taulli, Riccardo; Burgess, Kerri; Bhargava, Parul; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Canc Res Inst,Dept Med & Pathol,Med Sch, Boston, MA 02215 USA; [Pozdnyakova, Olga] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Straley, Kimberly; Su, Shinsan M.; Yen, Katharine] Agios Pharmaceut, Cambridge, MA 02139 USA; [Karnik, Rahul; Meissner, Alexander] Broad Inst & Harvard, Cambridge, MA 02142 USA; [Karnik, Rahul; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Karnik, Rahul; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Small, Donald] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Zhang, Jiangwen] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Agios Pharmaceuticals; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Johns Hopkins University; Johns Hopkins Medicine; University of Hong Kong	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Canc Res Inst,Dept Med & Pathol,Med Sch, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	TAULLI, Riccardo/J-7347-2018; Zhang, Jiangwen/A-7654-2013; Kats, Lev/AAW-3252-2021	TAULLI, Riccardo/0000-0003-1277-6263; Zhang, Jiangwen/0000-0002-2911-8446; Kats, Lev/0000-0001-8742-8138; Pandolfi, Pier Paolo/0000-0002-5352-5295; Karnik, Rahul/0000-0002-0400-635X	National Health and Research Council of Australia; German Academy of Sciences Leopoldina [LPDS 2009-27]; Marie Curie International Outgoing Fellowship for Career Development; NATIONAL CANCER INSTITUTE [P30CA006973, R01CA090668] Funding Source: NIH RePORTER	National Health and Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); German Academy of Sciences Leopoldina; Marie Curie International Outgoing Fellowship for Career Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Robert Welner, Dr. Christian Bach, and members of the Pandolfi laboratory for critical discussion. L. M. K. was supported by an Overseas Postdoctoral Fellowship from the National Health and Research Council of Australia. M. R. was supported by the German Academy of Sciences Leopoldina (Leopoldina Research Fellowship grant number: LPDS 2009-27). R. T. was supported by a Marie Curie International Outgoing Fellowship for Career Development. K.Y., M. S., and K. S. are employees and shareholders of Agios Pharmaceuticals.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Chaturvedi A, 2013, BLOOD, V122, P2877, DOI 10.1182/blood-2013-03-491571; Chen C, 2013, GENE DEV, V27, P1974, DOI 10.1101/gad.226613.113; Chu SHH, 2012, CELL STEM CELL, V11, P346, DOI 10.1016/j.stem.2012.05.027; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li L, 2008, BLOOD, V111, P3849, DOI 10.1182/blood-2007-08-109942; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Popovici-Muller J, 2012, ACS MED CHEM LETT, V3, P850, DOI 10.1021/ml300225h; Rau R., 2013, EXP HEMAT IN PRESS; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yin X, 2010, J CELL SCI, V123, P3558, DOI 10.1242/jcs.064915	33	144	156	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					329	341		10.1016/j.stem.2013.12.016	http://dx.doi.org/10.1016/j.stem.2013.12.016			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24440599	Green Accepted, Bronze			2022-12-28	WOS:000332533400010
J	Vallier, L				Vallier, Ludovic			Heps with Pep: Direct Reprogramming into Human Hepatocytes	CELL STEM CELL			English	Editorial Material							EXPANSION; CELLS; LIVER	The limited supply and expansion capacity of primary human hepatocytes presents major challenges for pharmaceutical applications and development of cell-based therapies for liver diseases. Now in Cell Stem Cell, two papers demonstrate efficient direct reprogramming of human fibroblasts into induced hepatocytes, which exhibit metabolic properties similar to primary hepatocytes.	[Vallier, Ludovic] Wellcome Trust Med Res Council Stem Cell Inst, Anne McLaren Inst Regenerat Med, Dept Surg, Cambridge CB2 0SZ, England; [Vallier, Ludovic] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	Wellcome Trust Sanger Institute	Vallier, L (corresponding author), Wellcome Trust Med Res Council Stem Cell Inst, Anne McLaren Inst Regenerat Med, Dept Surg, West Forvie Site,Robinson Way, Cambridge CB2 0SZ, England.	lv225@cam.ac.uk	vallier, ludovic/C-6368-2011	Vallier, Ludovic/0000-0002-3848-2602	MRC [G0701448] Funding Source: UKRI; Medical Research Council [G0701448] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ogawa S, 2013, DEVELOPMENT, V140, P3285, DOI 10.1242/dev.090266; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271	9	13	13	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					267	269		10.1016/j.stem.2014.02.010	http://dx.doi.org/10.1016/j.stem.2014.02.010			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24607399	Bronze			2022-12-28	WOS:000332533400002
J	Brumbaugh, J; Hochedlinger, K				Brumbaugh, Justin; Hochedlinger, Konrad			Removing Reprogramming Roadblocks: Mbd3 Depletion Allows Deterministic iPSC Generation	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS	Transcription factor-induced pluripotency is extremely inefficient and assumed to be stochastic. In a recent Nature publication, Rais et al. show that depletion of the methyl-binding protein 3 yields reprogramming efficiencies of up to 100% within days, suggesting that elimination of a single gene suffices to render reprogramming a deterministic process.	[Brumbaugh, Justin; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Brumbaugh, Justin; Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA 02114 USA; [Brumbaugh, Justin; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St, Boston, MA 02114 USA.	khochedlinger@helix.mgh.harvard.edu		Brumbaugh, Justin/0000-0002-9605-2010				Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rais Y., 2013, NATURE IN PRESS, DOI DOI 10.1038/NATURE12587; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	9	10	12	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					379	381		10.1016/j.stem.2013.09.012	http://dx.doi.org/10.1016/j.stem.2013.09.012			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094318	Bronze			2022-12-28	WOS:000329571100005
J	Liu, JC; Guan, X; Ryan, JA; Rivera, AG; Mock, C; Agarwal, V; Letai, A; Lerou, PH; Lahav, G				Liu, Julia C.; Guan, Xiao; Ryan, Jeremy A.; Rivera, Ana G.; Mock, Caroline; Agarwal, Vishesh; Letai, Anthony; Lerou, Paul H.; Lahav, Galit			High Mitochondrial Priming Sensitizes hESCs to DNA-Damage-Induced Apoptosis	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; BCL-2 FAMILY; SELF-RENEWAL; P53; DIFFERENTIATION; PUMA; ACTIVATION; EXPRESSION; RADIATION; RESPONSES	Human embryonic stem cells (hESCs) are highly sensitive to DNA damage and have low survival ability relative to differentiated cells. We investigated the source of this difference by comparing damage response pathways in hESCs and differentiated cells. We found that hESCs undergo more rapid p53-dependent apoptosis after DNA damage than differentiated cells do. However, p53 localization and function are similar between hESCs and differentiated cells, suggesting that p53 alone cannot explain the difference in sensitivity. Instead, we show that mitochondrial readiness for apoptosis, known as mitochondrial priming, differs between hESCs and differentiated cells. Specifically, the balance between proapoptotic and antiapoptotic proteins is shifted closer to the apoptotic threshold in hESCs than in differentiated cells. Altering this balance in differentiated cells increases their sensitivity and results in cell death, suggesting that manipulation of mitochondrial priming could potentially alter the sensitivity of other stem cells, including cancer stem cells.	[Liu, Julia C.; Rivera, Ana G.; Mock, Caroline; Lahav, Galit] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Letai, Anthony] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Guan, Xiao; Agarwal, Vishesh; Lerou, Paul H.] Brigham & Womens Hosp, Dept Pediat Newborn Med, Boston, MA 02115 USA; [Guan, Xiao; Agarwal, Vishesh; Lerou, Paul H.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Ryan, Jeremy A.; Letai, Anthony] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Lerou, Paul H.] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Lerou, Paul H.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University	Lerou, PH (corresponding author), Brigham & Womens Hosp, Dept Pediat Newborn Med, 75 Francis St, Boston, MA 02115 USA.	plerou@partners.org; galit@hms.harvard.edu		Liu, Julia/0000-0002-8604-1633; Mock, Charles/0000-0002-0564-568X; Ryan, Jeremy/0000-0002-3327-1283	Molecular Biophysics Training Grant [NIH/NIGMS T32008313]; National Science Foundation; Harvard College Program for Research in Science and Engineering; FAS Center for Systems Biology; Charles H. Hood Foundation; NIH/NICHD [HD061981]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD061981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083303] Funding Source: NIH RePORTER	Molecular Biophysics Training Grant; National Science Foundation(National Science Foundation (NSF)); Harvard College Program for Research in Science and Engineering; FAS Center for Systems Biology; Charles H. Hood Foundation; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Agami for the p53shRNA construct; G. Daley for the CHB8 cell line; D. Melton for the HUES9 cell line; Y. Xu for the HUES9 p53<SUP>-/-</SUP> cell line; A. Baccei, B. Gorman, and K. Karhohs for assistance with IF imaging and analysis; J. Moore and J. Stewart-Ornstein for assistance with flow cytometry and analysis; J. Reyes for assistance with illustration; and E. Batchelor and all members of our laboratory for comments and discussions. J. C. L. was supported by the Molecular Biophysics Training Grant (NIH/NIGMS T32008313) and the National Science Foundation Graduate Research Fellowship. A. G. R. was supported by the Harvard College Program for Research in Science and Engineering and the FAS Center for Systems Biology. P. H. L. was supported by the Charles H. Hood Foundation and NIH/NICHD HD061981.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Filion TM, 2009, J CELL PHYSIOL, V220, P586, DOI 10.1002/jcp.21735; Filipczyk AA, 2007, STEM CELL RES, V1, P45, DOI 10.1016/j.scr.2007.09.002; Grandela C, 2008, STEM CELL RES, V1, P116, DOI 10.1016/j.scr.2007.10.003; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Komarova EA, 1997, EMBO J, V16, P1391, DOI 10.1093/emboj/16.6.1391; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Keefe K, 2003, MOL CELL BIOL, V23, P6396, DOI 10.1128/MCB.23.18.6396-6405.2003; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robles AI, 2001, CANCER RES, V61, P6660; SHILOH Y, 1983, CARCINOGENESIS, V4, P917, DOI 10.1093/carcin/4.7.917; Sokolov MV, 2011, MUTAT RES-FUND MOL M, V709-10, P40, DOI 10.1016/j.mrfmmm.2011.02.008; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Thornborrow EC, 2002, ONCOGENE, V21, P990, DOI 10.1038/sj.onc.1205069; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wilson KD, 2010, CANCER RES, V70, P5539, DOI 10.1158/0008-5472.CAN-09-4238	33	107	110	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					483	491		10.1016/j.stem.2013.07.018	http://dx.doi.org/10.1016/j.stem.2013.07.018			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	23954752	Green Accepted, Bronze			2022-12-28	WOS:000329571100016
J	Leijten, J; Khademhosseini, A				Leijten, Jeroen; Khademhosseini, Ali			From Nano to Macro: Multiscale Materials for Improved Stem Cell Culturing and Analysis	CELL STEM CELL			English	Editorial Material							DIFFERENTIATION; FATE	Stem cells respond to nanoscale, microscale, and macroscale cues, such as matrix, growth factors, and niche organization, which are difficult to physiologically recapitulate in culture. We discuss how utilizing bioengineering approaches to manipulate and integrate spatiotemporal cues across these discrete length scales can improve traditional methods for controlling cell fate.	[Leijten, Jeroen; Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Leijten, Jeroen; Khademhosseini, Ali] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Biomat Innovat Res Ctr, Cambridge, MA 02139 USA; [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Khademhosseini, Ali] Konkuk Univ, Coll Anim Biosci & Technol, Dept Bioind Technol, Seoul 143701, South Korea; [Khademhosseini, Ali] King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Konkuk University; King Abdulaziz University	Khademhosseini, A (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.; Khademhosseini, A (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Biomat Innovat Res Ctr, Cambridge, MA 02139 USA.; Khademhosseini, A (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Khademhosseini, A (corresponding author), Konkuk Univ, Coll Anim Biosci & Technol, Dept Bioind Technol, Seoul 143701, South Korea.; Khademhosseini, A (corresponding author), King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia.	alik@rics.bwh.harvard.edu	Khademhosseini, Ali/A-9435-2010; Leijten, Jeroen/G-5311-2011	Khademhosseini, Ali/0000-0002-2692-1524; Leijten, Jeroen/0000-0002-8063-207X; Khademhosseini, Ali/0000-0001-6322-8852	NHLBI NIH HHS [HL099073] Funding Source: Medline; NIAID NIH HHS [AI105024] Funding Source: Medline; NIAMS NIH HHS [AR057837, AR063745] Funding Source: Medline; NIBIB NIH HHS [EB012597] Funding Source: Medline; NIDCR NIH HHS [DE021468] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL099073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI105024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR063745, R01AR057837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021468] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Gandavarapu NR, 2014, ADV MATER, V26, P2521, DOI 10.1002/adma.201304847; Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]; Hinton TJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500758; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Lee TT, 2015, NAT MATER, V14, P352, DOI [10.1038/nmat4157, 10.1038/NMAT4157]; Nandakumar A, 2013, SMALL, V9, P3405, DOI 10.1002/smll.201300220; Qi H, 2010, ADV MATER, V22, P5276, DOI 10.1002/adma.201002873; Stephanopoulos N, 2015, NANO LETT, V15, P603, DOI 10.1021/nl504079q; Stevens KR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2853; Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/nmat3889, 10.1038/NMAT3889]	10	32	32	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					20	24		10.1016/j.stem.2015.12.013	http://dx.doi.org/10.1016/j.stem.2015.12.013			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26748753	Bronze			2022-12-28	WOS:000372321300008
J	Benchetrit, H; Herman, S; van Wietmarschen, N; Wu, T; Makedonski, K; Maoz, N; Tov, NY; Stave, D; Lasry, R; Zayat, V; Xiao, A; Lansdorp, PM; Sebban, S; Buganim, Y				Benchetrit, Hana; Herman, Shay; van Wietmarschen, Niek; Wu, Tao; Makedonski, Kirill; Maoz, Noam; Tov, Nataly Yom; Stave, Danielle; Lasry, Rachel; Zayat, Valery; Xiao, Andrew; Lansdorp, Peter M.; Sebban, Shulamit; Buganim, Yosef			Extensive Nuclear Reprogramming Underlies Lineage Conversion into Functional Trophoblast Stem-like Cells	CELL STEM CELL			English	Article							TROPHECTODERM FORMATION; SELF-RENEWAL; C-MYC; MOUSE; PLURIPOTENCY; FATE; CDX2; DIFFERENTIATION; FIBROBLASTS; INDUCTION	Induced pluripotent stem cells (iPSCs) undergo extensive nuclear reprogramming and are generally indistinguishable from embryonic stem cells (ESCs) in their functional capacity and transcriptome and DNA methylation profiles. However, direct conversion of cells from one lineage to another often yields incompletely reprogrammed, functionally compromised cells, raising the question of whether pluripotency is required to achieve a high degree of nuclear reprogramming. Here, we show that transient expression of Gata3, Eomes, and Tfap2c in mouse fibroblasts induces stable, transgene-independent trophoblast stem-like cells (iTSCs). iTSCs possess transcriptional profiles highly similar to blastocyst-derived TSCs, with comparable methylation and H3K27ac patterns and genome-wide H2A. X deposition. iTSCs generate trophoectodermal lineages upon differentiation, form hemorrhagic lesions, and contribute to developing placentas in chimera assays, indicating a high degree of nuclear reprogramming, with no evidence of passage through a transient pluripotent state. Together, these data demonstrate that extensive nuclear reprogramming can be achieved independently of pluripotency.	[Benchetrit, Hana; Herman, Shay; Makedonski, Kirill; Maoz, Noam; Tov, Nataly Yom; Stave, Danielle; Lasry, Rachel; Zayat, Valery; Sebban, Shulamit; Buganim, Yosef] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [van Wietmarschen, Niek; Lansdorp, Peter M.] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, NL-9713 AV Groningen, Netherlands; [Wu, Tao; Xiao, Andrew] Yale Univ, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Wu, Tao; Xiao, Andrew] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Lansdorp, Peter M.] Skolkovo Inst Sci & Technol Skoltech, Skolkovo 143025, Moscow Region, Russia	Hebrew University of Jerusalem; University of Groningen; Yale University; Yale University; Skolkovo Institute of Science & Technology	Buganim, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel.	yossibug@ekmd.huji.ac.il	Zayat, Valery/P-8392-2019; Zayat, Valery/U-3885-2019; van Wietmarschen, Niek/ABE-8269-2020	Zayat, Valery/0000-0002-3917-2948; Herman, Shay/0000-0002-1490-1411; Lansdorp, Peter/0000-0001-7435-1071; van Wietmarschen, Niek/0000-0001-6136-5757; Yom Tov, Nataly/0000-0002-2613-4029	Israeli Centers of Research Excellence (I-CORE) program [41/11]; Israel Science Foundation (ISF); Kamin Fund; Abisch-Frenkel Foundation; Alon Foundation Scholar-Program for distinguished junior faculty; Edward & Millie Carew-Shaw Distinguished Medical Faculty Award	Israeli Centers of Research Excellence (I-CORE) program; Israel Science Foundation (ISF)(Israel Science Foundation); Kamin Fund; Abisch-Frenkel Foundation; Alon Foundation Scholar-Program for distinguished junior faculty; Edward & Millie Carew-Shaw Distinguished Medical Faculty Award	We thank Dr. Yuval Nevo and Dr. Sharona Elgavish of the Bioinformatics unit of the Hebrew University for computational and technical assistance. We also thank Dr. Shlomit Rak Yahalom from Rhenium for technical assistance with the Beckman Coulter flow cytometer. Y.B. is supported by a gift from the Morningstar Foundation and Edward & Millie Carew-Shaw Distinguished Medical Faculty Award and research grants from the Israeli Centers of Research Excellence (I-CORE) program (Center No. 41/11), the Israel Science Foundation (ISF), Kamin Fund, Abisch-Frenkel Foundation, and Alon Foundation Scholar-Program for distinguished junior faculty.	Adachi K, 2013, MOL CELL, V52, P380, DOI 10.1016/j.molcel.2013.09.002; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Bar-Nur O, 2015, NAT BIOTECHNOL, V33, P761, DOI 10.1038/nbt.3247; Buganim Y, 2014, CELL STEM CELL, V15, P295, DOI 10.1016/j.stem.2014.07.003; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Buganim Y, 2012, CELL STEM CELL, V11, P373, DOI 10.1016/j.stem.2012.07.019; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Cambuli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6538; Chen LY, 2010, CELL RES, V20, P982, DOI 10.1038/cr.2010.106; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Falconer E, 2012, NAT METHODS, V9, P1107, DOI [10.1038/NMETH.2206, 10.1038/nmeth.2206]; Genbacev O, 2013, SEMIN REPROD MED, V31, P56, DOI 10.1055/s-0032-1331798; James JL, 2014, PLACENTA, V35, P77, DOI 10.1016/j.placenta.2013.12.010; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kibschull M, 2004, DEV BIOL, V273, P63, DOI 10.1016/j.ydbio.2004.04.037; Kubaczka C, 2014, STEM CELL REP, V2, P232, DOI 10.1016/j.stemcr.2013.12.013; Kuckenberg P, 2010, MOL CELL BIOL, V30, P3310, DOI 10.1128/MCB.01215-09; Latos PA, 2014, PLACENTA, V35, pS81, DOI 10.1016/j.placenta.2013.10.013; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Oda M, 2006, METHOD ENZYMOL, V419, P387, DOI 10.1016/S0076-6879(06)19015-1; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wu T, 2014, CELL STEM CELL, V15, P281, DOI 10.1016/j.stem.2014.06.004; Xu J, 2015, CELL STEM CELL, V16, P119, DOI 10.1016/j.stem.2015.01.013	47	46	46	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2015	17	5					543	556		10.1016/j.stem.2015.08.006	http://dx.doi.org/10.1016/j.stem.2015.08.006			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4UB	26412562	Bronze, Green Published			2022-12-28	WOS:000365694700008
J	Larsimont, JC; Youssef, KK; Sanchez-Danes, A; Sukumaran, V; Defrance, M; Delatte, B; Liagre, M; Baatsen, P; Marine, JC; Lippens, S; Guerin, C; Del Marmol, V; Vanderwinden, JM; Fuks, F; Blanpain, C				Larsimont, Jean-Christophe; Youssef, Khalil Kass; Sanchez-Danes, Adriana; Sukumaran, Vijayakumar; Defrance, Matthieu; Delatte, Benjamin; Liagre, Melanie; Baatsen, Pieter; Marine, Jean-Christophe; Lippens, Saskia; Guerin, Christopher; Del Marmol, Veronique; Vanderwinden, Jean-Marie; Fuks, Francois; Blanpain, Cedric			Sox9 Controls Self-Renewal of Oncogene Targeted Cells and Links Tumor Initiation and Invasion	CELL STEM CELL			English	Article							FOLLICLE STEM-CELLS; TRANSIT-AMPLIFYING CELLS; HUMAN EPIDERMAL STEM; PROSTATE-CANCER; GENE-EXPRESSION; SKIN; DIFFERENTIATION; REGULATOR; CARCINOMA; HEDGEHOG	Sox9 is a transcription factor expressed in most solid tumors. However, the molecular mechanisms underlying Sox9 function during tumorigenesis remain unclear. Here, using a genetic mouse model of basal cell carcinoma (BCC), the most frequent cancer in humans, we show that Sox9 is expressed from the earliest step of tumor formation in a Wnt/beta-catenin-dependent manner. Deletion of Sox9 together with the constitutive activation of Hedgehog signaling completely prevents BCC formation and leads to a progressive loss of oncogene-expressing cells. Transcriptional profiling of oncogene-expressing cells with Sox9 deletion, combined with in vivo ChIP sequencing, uncovers a cancer-specific gene network regulated by Sox9 that promotes stemness, extracellular matrix deposition, and cytoskeleton remodeling while repressing epidermal differentiation. Our study identifies the molecular mechanisms regulated by Sox9 that link tumor initiation and invasion.	[Larsimont, Jean-Christophe; Youssef, Khalil Kass; Sanchez-Danes, Adriana; Sukumaran, Vijayakumar; Liagre, Melanie; Vanderwinden, Jean-Marie; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Blanpain, Cedric] Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium; [Defrance, Matthieu; Delatte, Benjamin; Fuks, Francois] Univ Libre Bruxelles, Fac Med, Lab Canc Epigenet, B-1070 Brussels, Belgium; [Baatsen, Pieter] Katholieke Univ Leuven, Ctr Human Genet, VIB BIO Imaging Core, EM Facil EMoNe, B-3000 Louvain, Belgium; [Marine, Jean-Christophe] VIB, Ctr Biol Dis, Lab Mol Canc Biol, B-3000 Louvain, Belgium; [Lippens, Saskia; Guerin, Christopher] VIB, Image Core Facil, Inflammat Res Ctr, B-9052 Ghent, Belgium; [Lippens, Saskia; Guerin, Christopher] VIB Bio Imaging Core, B-9052 Ghent, Belgium; [Lippens, Saskia; Guerin, Christopher] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium; [Del Marmol, Veronique] Univ Libre Bruxelles, Erasme Hosp, Dept Dermatol, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO; Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Ghent University; Universite Libre de Bruxelles	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	cedric.blanpain@ulb.ac.be	Youssef, Khalil Kass/AAB-6528-2021; Guerin, Christopher/AAM-3233-2020; Delatte, Benjamin/AAE-9276-2020; Marine, Jean-Christophe/K-3292-2016; del marmol, veronique/AAZ-8117-2020; Blanpain, Cedric/ABD-8392-2021; Sukumaran, Vijayakumar/K-8523-2015	Youssef, Khalil Kass/0000-0002-4572-3160; Marine, Jean-Christophe/0000-0003-2433-9837; Sukumaran, Vijayakumar/0000-0002-2686-7329; Sanchez-Danes, Adriana/0000-0001-7895-9973; Delatte, Benjamin/0000-0002-6798-0600; Lippens, Saskia/0000-0002-8261-3462; Defrance, Matthieu/0000-0002-3090-3142	Fonds de la Recherche Scientifique (FNRS)/Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture; FNRS; Charge de Recherche grant from FNRS; Televie; PAI program; Fondation Contre le Cancer; ULB Fondation; Fond Gaston Ithier; Fondation Bettencourt Schueller; Fondation Baillet-Latour; European Research Council	Fonds de la Recherche Scientifique (FNRS)/Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture(Fonds de la Recherche Scientifique - FNRS); FNRS(Fonds de la Recherche Scientifique - FNRS); Charge de Recherche grant from FNRS(Fonds de la Recherche Scientifique - FNRS); Televie; PAI program; Fondation Contre le Cancer; ULB Fondation; Fond Gaston Ithier; Fondation Bettencourt Schueller; Fondation Baillet-Latour; European Research Council(European Research Council (ERC)European Commission)	We thank the animal house facility from Universite Libre de Bruxelles (ULB) (Erasme campus). We thank Sylvain Brohee (Jules Bordet Institute) for his help with the bioinformatics analysis. We thank Hoang Nguyen (Baylor College of Medicine) for providing us with Tcf3 antibody. C.B. is an investigator of WELBIO. J.-C.L. is supported by a fellowship from Fonds de la Recherche Scientifique (FNRS)/Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture. B.D. is supported by a fellowship from FNRS. A.S.-D. is supported by a Charge de Recherche grant from FNRS. This work was supported by FNRS, Televie, the PAI program, a research grant from Fondation Contre le Cancer, ULB Fondation, Fond Gaston Ithier, the Fondation Bettencourt Schueller, Fondation Baillet-Latour, and the European Research Council.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Cai CM, 2013, J CLIN INVEST, V123, P1109, DOI 10.1172/JCI66666; Camaj P, 2014, MOL CANCER RES, V12, P421, DOI 10.1158/1541-7786.MCR-13-0351; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Dai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070392; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; FAUS I, 1994, MOL CELL BIOL, V14, P3263, DOI 10.1128/MCB.14.5.3263; Fessing MY, 2011, J CELL BIOL, V194, P825, DOI 10.1083/jcb.201101148; Fortunel NO, 2003, SCIENCE, V302, P393; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Grachtchouk M, 2011, J CLIN INVEST, V121, P1768, DOI 10.1172/JCI46307; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Najm P, 2014, CELL ADHES MIGR, V8, P29, DOI 10.4161/cam.28024; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Palmer CJ, 2014, CANCER RES, V74, P5914, DOI 10.1158/0008-5472.CAN-14-0834; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Shi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054355; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Thomsen MK, 2010, CANCER RES, V70, P979, DOI 10.1158/0008-5472.CAN-09-2370; Vidal VPI, 2008, J CUTAN PATHOL, V35, P373, DOI 10.1111/j.1600-0560.2007.00815.x; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Wong SY, 2011, P NATL ACAD SCI USA, V108, P4093, DOI 10.1073/pnas.1013098108; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Youssef KK, 2012, NAT CELL BIOL, V14, P1282, DOI 10.1038/ncb2628; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031	45	108	112	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2015	17	1					60	73		10.1016/j.stem.2015.05.008	http://dx.doi.org/10.1016/j.stem.2015.05.008			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DI	26095047	Bronze			2022-12-28	WOS:000361877600009
J	Wang, A; Yue, F; Li, Y; Xie, RY; Harper, T; Patel, NA; Muth, K; Palmer, J; Qiu, YJ; Wang, JZ; Lam, DK; Raum, JC; Stoffers, DA; Ren, B; Sander, M				Wang, Allen; Yue, Feng; Li, Yan; Xie, Ruiyu; Harper, Thomas; Patel, Nisha A.; Muth, Kayla; Palmer, Jeffrey; Qiu, Yunjiang; Wang, Jinzhao; Lam, Dieter K.; Raum, Jeffrey C.; Stoffers, Doris A.; Ren, Bing; Sander, Maike			Epigenetic Priming of Enhancers Predicts Developmental Competence of hESC-Derived Endodermal Lineage Intermediates	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS; HISTONE MODIFICATIONS; PANCREAS DEVELOPMENT; CHROMATIN-STRUCTURE; NEURAL INDUCTION; GENE-EXPRESSION; BINDING-SITES; IN-VITRO; GENOME	Embryonic development relies on the capacity of progenitor cells to appropriately respond to inductive cues, a cellular property known as developmental competence. Here, we report that epigenetic priming of enhancers signifies developmental competence during endodermal lineage diversification. Chromatin mapping during pancreatic and hepatic differentiation of human embryonic stem cells revealed the en masse acquisition of a poised chromatin state at enhancers specific to endoderm-derived cell lineages in gut tube intermediates. Experimentally, the acquisition of this poised enhancer state predicts the ability of endodermal intermediates to respond to inductive signals. Furthermore, these enhancers are first recognized by the pioneer transcription factors FOXA1 and FOXA2 when competence is acquired, while subsequent recruitment of lineage-inductive transcription factors, such as PDX1, leads to enhancer and target gene activation. Together, our results identify the acquisition of a poised chromatin state at enhancers as a mechanism by which progenitor cells acquire developmental competence.	[Wang, Allen; Xie, Ruiyu; Harper, Thomas; Patel, Nisha A.; Muth, Kayla; Palmer, Jeffrey; Wang, Jinzhao; Lam, Dieter K.; Sander, Maike] Univ Calif San Diego, Dept Pediat, Pediat Diabet Res Ctr, La Jolla, CA 92093 USA; [Wang, Allen; Xie, Ruiyu; Harper, Thomas; Patel, Nisha A.; Muth, Kayla; Palmer, Jeffrey; Wang, Jinzhao; Lam, Dieter K.; Sander, Maike] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Yue, Feng] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA; [Li, Yan; Qiu, Yunjiang; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Raum, Jeffrey C.; Stoffers, Doris A.] Univ Penn, Div Endocrinol Diabet & Metab, Inst Diabet Obes & Metab, Dept Med,Perelman Sch Med, Philadelphia, PA 19104 USA; [Ren, Bing; Sander, Maike] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing; Sander, Maike] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Ren, Bing; Sander, Maike] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Ludwig Institute for Cancer Research; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	biren@ucsd.edu; masander@ucsd.edu	Qiu, Yunjiang/AAC-1395-2019; Sander, Maike/N-6615-2016	Sander, Maike/0000-0001-5308-7785; Lam, Dieter/0000-0001-8374-8409; Xie, Ruiyu/0000-0003-0518-2897; Qiu, Yunjiang/0000-0002-0539-9714	NIH [U01-DK089567, U01-DK072473, U01-ES017166, U01-DK089540]; California Institute for Regenerative Medicine (CIRM) [RB5-07236]; Helmsley Charitable Trust [2012PG-T1D074, JDRF-3-2012-177, T32 DK7494-27]; CIRM Bridges to Stem Cells Program;  [CIRM-TG201154]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007494, U01DK072473, U01DK089540, U01DK089567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Helmsley Charitable Trust; CIRM Bridges to Stem Cells Program; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J. Wysocka for the GFP enhancer-reporter construct, C. Wright for anti-Pdx1 antibody, and members of the M.S. and B.R. laboratories for helpful discussions and critical reading of the manuscript. We are grateful to Viacyte, Incorporated, for CyT49 hESCs and advice on hESC differentiation. This work was supported by NIH grants U01-DK089567 to M.S., U01-DK072473 to M.S. and B.R., U01-ES017166 to B.R., and U01-DK089540 to D.A.S.; California Institute for Regenerative Medicine (CIRM) grant RB5-07236 and Helmsley Charitable Trust grant 2012PG-T1D074 to M.S.; JDRF-3-2012-177 postdoctoral fellowship and T32 DK7494-27 training grant to A.W.; CIRM-TG201154 training grant to R.X. and N.A.P.; and the CIRM Bridges to Stem Cells Program (T.H., K.M., and J.P.).	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Allen HL, 2012, NAT GENET, V44, P20, DOI 10.1038/ng.1035; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boj SF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000970; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jin FL, 2011, P NATL ACAD SCI USA, V108, P5290, DOI 10.1073/pnas.1017214108; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Li JX, 2000, GENE DEV, V14, P464; Li ZY, 2012, CELL, V151, P1608, DOI 10.1016/j.cell.2012.11.018; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shih HP, 2013, ANNU REV CELL DEV BI, V29, P81, DOI 10.1146/annurev-cellbio-101512-122405; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; STOREY KG, 1992, DEVELOPMENT, V114, P729; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Waddington C. H, 1940, ORG AND GENES; Wang A, 2012, J MOL MED, V90, P763, DOI 10.1007/s00109-012-0923-y; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Watt AJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-37; Weedon MN, 2014, NAT GENET, V46, P61, DOI 10.1038/ng.2826; Wells JM, 2000, DEVELOPMENT, V127, P1563; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	53	149	151	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					386	399		10.1016/j.stem.2015.02.013	http://dx.doi.org/10.1016/j.stem.2015.02.013			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25842977	Bronze, Green Accepted			2022-12-28	WOS:000352228600011
J	Young, JE; Boulanger-Weill, J; Williams, DA; Woodruff, G; Buen, F; Revilla, AC; Herrera, C; Israel, MA; Yuan, SH; Edland, SD; Goldstein, LSB				Young, Jessica E.; Boulanger-Weill, Jonathan; Williams, Daniel A.; Woodruff, Grace; Buen, Floyd; Revilla, Arra C.; Herrera, Cheryl; Israel, Mason A.; Yuan, Shauna H.; Edland, Steven D.; Goldstein, Lawrence S. B.			Elucidating Molecular Phenotypes Caused by the SORL1 Alzheimer's Disease Genetic Risk Factor Using Human Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							APOLIPOPROTEIN-E RECEPTOR; NEUROTROPHIC FACTOR; CODING MUTATIONS; ASSOCIATION; METAANALYSIS; EXPRESSION; VARIANTS; PROTEIN; LR11	Predisposition to sporadic Alzheimer's disease (SAD) involves interactions between a person's unique combination of genetic variants and the environment. The molecular effect of these variants may be subtle and difficult to analyze with standard in vitro or in vivo models. Here we used hIPSCs to examine genetic variation in the SORL1 gene and possible contributions to SAD-related phenotypes in human neurons. We found that human neurons carrying SORL1 variants associated with an increased SAD risk show a reduced response to treatment with BDNF, at the level of both SORL1 expression and APP processing. shRNA knockdown of SORL1 demonstrates that the differences in BDNF-induced APP processing between genotypes are dependent on SORL1 expression. We propose that the variation in SORL1 expression induction by BDNF is modulated by common genetic variants and can explain how genetic variation in this one locus can contribute to an individual's risk of developing SAD.	[Young, Jessica E.; Boulanger-Weill, Jonathan; Williams, Daniel A.; Woodruff, Grace; Buen, Floyd; Revilla, Arra C.; Herrera, Cheryl; Israel, Mason A.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Yuan, Shauna H.; Edland, Steven D.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Edland, Steven D.] Univ Calif San Diego, Div Biostat, Dept Family & Prevent Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Goldstein, LSB (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	lgoldstein@ucsd.edu		Israel, Mason/0000-0003-0867-0626; Yuan, Shauna/0000-0003-4058-4146	California Institute of Regenerative Medicine; A.P. Gianinni Foundation for Medical Research; BrightFocus Foundation; California Institute of Regenerative Medicine (CIRM) [RT2-01927, RR5-07011]; NIH (NIH-NIA) [2P50AG005131-31]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, RF1AG048083] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); A.P. Gianinni Foundation for Medical Research; BrightFocus Foundation(BrightFocus Foundation); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NIH (NIH-NIA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J.E.Y. is funded by postdoctoral fellowships from the California Institute of Regenerative Medicine, the A.P. Gianinni Foundation for Medical Research, and the BrightFocus Foundation. L.S.B.G. is funded by the California Institute of Regenerative Medicine (CIRM Tools and Technologies II, RT2-01927), CIRM Basic Biology V, (RR5-07011), and the NIH (NIH-NIA 2P50AG005131-31). We thank the donors of fibroblast samples from the UCSD Shiley-Marcos ADRC.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; [Anonymous], 2009, ARCH NEUROL-CHICAGO; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bettens K, 2008, HUM MUTAT, V29, P769, DOI 10.1002/humu.20725; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Chouraki V, 2014, ADV GENET, V87, P245, DOI 10.1016/B978-0-12-800149-3.00005-6; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Goldstein LSB, 2015, NEUROTHERAPEUTICS, V12, P121, DOI 10.1007/s13311-014-0326-6; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Grear KE, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-46; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Holton P, 2013, ANN HUM GENET, V77, P85, DOI 10.1111/ahg.12000; Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Kitago T. Y., 2014, SCI TRANSL MED, V6; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee JH, 2007, ARCH NEUROL-CHICAGO, V64, P501, DOI 10.1001/archneur.64.4.501; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; McCarthy J.J., 2012, AGING, V33, pe1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morwald S, 1997, ARTERIOSCL THROM VAS, V17, P996, DOI 10.1161/01.ATV.17.5.996; Motoi Y, 1999, BRAIN RES, V833, P209, DOI 10.1016/S0006-8993(99)01542-5; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Olgiati Paolo, 2011, Int J Alzheimers Dis, V2011, P832379, DOI 10.4061/2011/832379; Parthsarathy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058784; Pottier C, 2012, MOL PSYCHIATR, V17, P875, DOI 10.1038/mp.2012.15; Reitz C, 2012, FUTUR NEUROL, V7, P423, DOI 10.2217/FNL.12.31; Reitz C, 2011, ARCH NEUROL-CHICAGO, V68, P99, DOI 10.1001/archneurol.2010.346; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rohe M, 2009, J NEUROSCI, V29, P15472, DOI 10.1523/JNEUROSCI.3960-09.2009; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schmidt V, 2012, EMBO J, V31, P187, DOI 10.1038/emboj.2011.352; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Team RC., 2022, LANG ENV STAT COMP; Vardarajan BN, 2015, ANN NEUROL, V77, P215, DOI 10.1002/ana.24305; Wen YA, 2013, J ALZHEIMERS DIS, V35, P387, DOI 10.3233/JAD-122395; Woodruff G, 2013, CELL REP, V5, P974, DOI 10.1016/j.celrep.2013.10.018; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zhu XQ, 2014, CASE REP NEUROL MED, V2014, DOI 10.1155/2014/270654	48	103	104	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					373	385		10.1016/j.stem.2015.02.004	http://dx.doi.org/10.1016/j.stem.2015.02.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25772071	Green Accepted, Bronze			2022-12-28	WOS:000352228600010
J	Sanchez-Aguilera, A; Arranz, L; Martin-Perez, D; Garcia-Garcia, A; Stavropoulou, V; Kubovcakova, L; Isern, J; Martin-Salamanca, S; Langa, X; Skoda, RC; Schwaller, J; Mendez-Ferrer, S				Sanchez-Aguilera, Abel; Arranz, Lorena; Martin-Perez, Daniel; Garcia-Garcia, Andres; Stavropoulou, Vaia; Kubovcakova, Lucia; Isern, Joan; Martin-Salamanca, Sandra; Langa, Xavier; Skoda, Radek C.; Schwaller, Juerg; Mendez-Ferrer, Simon			Estrogen Signaling Selectively Induces Apoptosis of Hematopoietic Progenitors and Myeloid Neoplasms without Harming Steady-State Hematopoiesis	CELL STEM CELL			English	Article							HIGH-DOSE CHEMOTHERAPY; STEM-CELL TRANSPLANTATION; TYROSINE KINASE JAK2; BREAST-CANCER; RECEPTOR-ALPHA; SELF-RENEWAL; BONE-MARROW; POLYCYTHEMIA-VERA; GENE NETWORKS; RISK	Estrogens are potent regulators of mature hematopoietic cells; however, their effects on primitive and malignant hematopoietic cells remain unclear. Using genetic and pharmacological approaches, we observed differential expression and function of estrogen receptors (ERs) in hematopoietic stem cell (HSC) and progenitor subsets. ER alpha activation with the selective ER modulator (SERM) tamoxifen induced apoptosis in short-term HSCs and multipotent progenitors. In contrast, tamoxifen induced proliferation of quiescent long-term HSCs, altered the expression of self-renewal genes, and compromised hematopoietic reconstitution after myelotoxic stress, which was reversible. In mice, tamoxifen treatment blocked development of JAK2(V617F)-induced myeloproliferative neoplasm in vivo, induced apoptosis of human JAK2(V617F+) HSPCs in a xenograft model, and sensitized MLL-AF9(+) leukemias to chemotherapy. Apoptosis was selectively observed in mutant cells, and tamoxifen treatment only had a minor impact on steady-state hematopoiesis in disease-free animals. Together, these results uncover specific regulation of hematopoietic progenitors by estrogens and potential antileukemic properties of SERMs.	[Sanchez-Aguilera, Abel; Arranz, Lorena; Martin-Perez, Daniel; Garcia-Garcia, Andres; Isern, Joan; Martin-Salamanca, Sandra; Langa, Xavier; Mendez-Ferrer, Simon] CNIC, Stem Cell Niche Pathophysiol Grp, Madrid 28029, Spain; [Stavropoulou, Vaia; Kubovcakova, Lucia; Skoda, Radek C.; Schwaller, Juerg] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland	Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Basel	Sanchez-Aguilera, A (corresponding author), CNIC, Stem Cell Niche Pathophysiol Grp, Madrid 28029, Spain.	abel.sanchez-aguilera@cnic.es; smendez@cnic.es	Isern, Joan/C-1250-2017; Schwaller, Juerg/A-3044-2016; Martín Pérez, Daniel/AFW-0499-2022; Méndez-Ferrer, Simón/L-8088-2014; Arranz, Lorena/Z-3635-2019; Méndez-Ferrer, Simón/ABG-8547-2020; Pérez, Daniel Martín/M-4264-2018	Isern, Joan/0000-0002-1401-9779; Schwaller, Juerg/0000-0001-8616-0096; Martín Pérez, Daniel/0000-0001-6125-2955; Méndez-Ferrer, Simón/0000-0002-9805-9988; Arranz, Lorena/0000-0002-5896-4238; Méndez-Ferrer, Simón/0000-0002-9805-9988; Pérez, Daniel Martín/0000-0001-6125-2955; Garcia-Garcia, Andres/0000-0002-8797-649X	Centro Nacional de Investigaciones Cardiovasculares Carlos III; Spanish Ministry of Economy and Competitiveness [SAF-2011-30308, RYC-2011-09726, RYC-2011-09209, RYC-2009-04703]; Spanish Ministry of Economy and Competitiveness (Spanish Cell Therapy Network TerCel); Marie Curie Career Integration Program grants [FP7-PEOPLE-2011-RG-294262/294096]; ConSEPOC-Comunidad de Madrid grant [S2010/BMD-2542]; Fundacion Ramon Areces; Fundacion La Caixa; European Hematology Association; Howard Hughes Medical Institute	Centro Nacional de Investigaciones Cardiovasculares Carlos III; Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Economy and Competitiveness (Spanish Cell Therapy Network TerCel); Marie Curie Career Integration Program grants; ConSEPOC-Comunidad de Madrid grant; Fundacion Ramon Areces; Fundacion La Caixa(La Caixa Foundation); European Hematology Association; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Wethank S.B.C. Lama, A.M. Martin de Ana, A.B. Ricote, J.M. Ligos, S. Bartlett, and the CNIC Genomics and Bioinformatics Units for assistance; M. Torres and C. Claveria for their kind gift of Pol2-cre<SUP>ERT2</SUP>; Myc<SUP>loxP/loxP</SUP> mice; members of S.M.-F. and M. Ricote labs for helpful discussions; and G. Roncador and A. Kerguelen for kindly providing reagents. This work was supported by the Centro Nacional de Investigaciones Cardiovasculares Carlos III; the Spanish Ministry of Economy and Competitiveness (Plan Nacional grant SAF-2011-30308 to S.M.-F.; Ramon y Cajal Program grants RYC-2011-09726 to A.S.A., RYC-2011-09209 to J.I., and RYC-2009-04703 to S.M.-F.; Spanish Cell Therapy Network TerCel to S.M.-F.); Marie Curie Career Integration Program grants (FP7-PEOPLE-2011-RG-294262/294096) to A. S.-A. and S.M.-F.; and a ConSEPOC-Comunidad de Madrid grant (S2010/BMD-2542) to S.M.-F. A. G.-G. is the recipient of Fundacion Ramon Areces and Fundacion La Caixa fellowships. This research was partly funded by a European Hematology Association Research Fellowship awarded to A. S.-A. S.M.-F. is supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute.	Adkins D, 1999, J CLIN ONCOL, V17, P2006, DOI 10.1200/JCO.1999.17.7.2006; Agrawal S, 2007, CANCER RES, V67, P1370, DOI 10.1158/0008-5472.CAN-06-1681; Anghel A, 2010, PATHOL ONCOL RES, V16, P485, DOI 10.1007/s12253-010-9263-9; Arranz L, 2012, CELL CYCLE, V11, P65, DOI 10.4161/cc.11.1.18097; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Blum W, 2007, J CLIN ONCOL, V25, P3884, DOI 10.1200/JCO.2006.09.4169; Bowel Cancer Incidence by Deprivation, 2020, ENGL 2013 2017 CANC; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Colaianni G, 2012, J BIOL CHEM, V287, P29159, DOI 10.1074/jbc.M112.365049; Compston JE, 2001, PHYSIOL REV, V81, P419, DOI 10.1152/physrev.2001.81.1.419; Cuzick J, 2013, LANCET, V381, P1827, DOI 10.1016/S0140-6736(13)60140-3; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; DUBIK D, 1988, J BIOL CHEM, V263, P12705; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Ghosh MG, 2000, CANCER RES, V60, P6367; Gong YQ, 2011, ARTERIOSCL THROM VAS, V31, P2035, DOI 10.1161/ATVBAHA.111.229583; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Herman JG, 1996, CANCER RES, V56, P722; Hess CJ, 2008, LEUKEMIA LYMPHOMA, V49, P1132, DOI 10.1080/10428190802035990; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Illing A, 2012, HAEMATOL-HEMATOL J, V97, P1131, DOI 10.3324/haematol.2011.052456; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; JILKA RL, 1995, EXP HEMATOL, V23, P500; KAWASHIMA I, 1992, THYMUS, V20, P115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kubovcakova L, 2013, BLOOD, V121, P1188, DOI 10.1182/blood-2012-03-415646; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Laganiere J, 2005, MOL ENDOCRINOL, V19, P1584, DOI 10.1210/me.2005-0040; LERNER HJ, 1976, CANCER TREAT REP, V60, P1431; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Medina KL, 2001, NAT IMMUNOL, V2, P718, DOI 10.1038/90659; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Mosselman S, 1996, P NATL ACAD SCI USA, V93, P2884, DOI 10.1073/pnas.93.7.2884; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Rodenhuis S, 2003, NEW ENGL J MED, V349, P7, DOI 10.1056/NEJMoa022794; Ross JA, 2005, CANCER CAUSE CONTROL, V16, P483, DOI 10.1007/s10552-004-7117-z; Shim GJ, 2003, P NATL ACAD SCI USA, V100, P6694, DOI 10.1073/pnas.0731830100; SMITHSON G, 1995, J IMMUNOL, V155, P3409; STIMSON WH, 1988, SCAND J IMMUNOL, V28, P345, DOI 10.1111/j.1365-3083.1988.tb01459.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tallman MS, 2003, NEW ENGL J MED, V349, P17, DOI 10.1056/NEJMoa030684; Thurmond TS, 2000, ENDOCRINOLOGY, V141, P2309, DOI 10.1210/en.141.7.2309; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Wang DY, 2004, MOL ENDOCRINOL, V18, P402, DOI 10.1210/me.2003-0202; Wang LH, 2004, NAT MED, V10, P40, DOI 10.1038/nm969; Will B, 2013, NAT IMMUNOL, V14, P437, DOI 10.1038/ni.2572; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yao J, 2010, BIOSCIENCE REP, V30, P217, DOI 10.1042/BSR20090044; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	56	77	82	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					791	804		10.1016/j.stem.2014.11.002	http://dx.doi.org/10.1016/j.stem.2014.11.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25479752	Bronze			2022-12-28	WOS:000347174300016
J	Aguirre, A; Montserrat, N; Zacchigna, S; Nivet, E; Hishida, T; Krause, MN; Kurian, L; Ocampo, A; Vazquez-Ferrer, E; Rodriguez-Esteban, C; Kumar, S; Moresco, JJ; Yates, JR; Campistol, JM; Sancho-Martinez, I; Giacca, M; Belmonte, JCI				Aguirre, Aitor; Montserrat, Nuria; Zacchigna, Serena; Nivet, Emmanuel; Hishida, Tomoaki; Krause, Marie N.; Kurian, Leo; Ocampo, Alejandro; Vazquez-Ferrer, Eric; Rodriguez-Esteban, Concepcion; Kumar, Sachin; Moresco, James J.; Yates, John R., III; Campistol, Josep M.; Sancho-Martinez, Ignacio; Giacca, Mauro; Belmonte, Juan Carlos Izpisua			In Vivo Activation of a Conserved MicroRNA Program Induces Mammalian Heart Regeneration	CELL STEM CELL			English	Article							CELLS; DEDIFFERENTIATION; REPAIR; DIFFERENTIATION; REGULATORS; CAPACITY	Heart failure is a leading cause of mortality and morbidity in the developed world, partly because mammals lack the ability to regenerate heart tissue. Whether this is due to evolutionary loss of regenerative mechanisms present in other organisms or to an inability to activate such mechanisms is currently unclear. Here we decipher mechanisms underlying heart regeneration in adult zebrafish and show that the molecular regulators of this response are conserved in mammals. We identified miR-99/100 and Let-7a/c and their protein targets smarca5 and fntb as critical regulators of cardiomyocyte dedifferentiation and heart regeneration in zebrafish. Although human and murine adult cardiomyocytes fail to elicit an endogenous regenerative response after myocardial infarction, we show that in vivo manipulation of this molecular machinery in mice results in cardiomyocyte dedifferentiation and improved heart functionality after injury. These data provide a proof of concept for identifying and activating conserved molecular programs to regenerate the damaged heart.	[Aguirre, Aitor; Nivet, Emmanuel; Hishida, Tomoaki; Krause, Marie N.; Kurian, Leo; Ocampo, Alejandro; Vazquez-Ferrer, Eric; Rodriguez-Esteban, Concepcion; Kumar, Sachin; Sancho-Martinez, Ignacio; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Montserrat, Nuria] CMRB, Barcelona 08003, Spain; [Zacchigna, Serena; Giacca, Mauro] ICGEB, I-34149 Trieste, Italy; [Moresco, James J.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Campistol, Josep M.] Univ Barcelona, IDIBAPS, Hosp Clin, Renal Div, E-08036 Barcelona, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; International Center for Genetic Engineering & Biotechnology (ICGEB); Scripps Research Institute; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Kurian, Leo/M-1598-2014; Aguirre, Aitor/L-6407-2019; Nivet, Emmanuel/C-2729-2014; Giacca, Mauro/J-9287-2016; Montserrat, Nuria/F-3136-2016; ZACCHIGNA, SERENA/E-9496-2017	Kurian, Leo/0000-0001-7466-5169; Aguirre, Aitor/0000-0002-1383-2792; Nivet, Emmanuel/0000-0001-7903-4059; Giacca, Mauro/0000-0003-2927-7225; Montserrat, Nuria/0000-0002-1603-1755; ZACCHIGNA, SERENA/0000-0001-6705-3076; Josep M, Campistol/0000-0001-6244-0253; Moresco, James/0000-0003-1178-1642; Ocampo, Alejandro/0000-0002-3731-3647	Ipsen Foundation; California Institute for Regenerative Medicine; Nomis Foundation postdoctoral fellowship; National Institute of General Medical Sciences [8 P41 GM103533]; UCLA/NHLBI Proteomics Centers [HHSN268201000035C]; MINECO [PLE2009-0100]; NHLBI [U01 HL107442-04]; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER	Ipsen Foundation(Ipsen); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Nomis Foundation postdoctoral fellowship; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UCLA/NHLBI Proteomics Centers; MINECO(Spanish Government); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Schwarz and P. Schwarz for administrative support. We are grateful to Thai B. Nguyen, Yun Xia, Chris Benner, Daiji Okamura, Manching Ku, James Kasubowski, Merce Marti, and the Waitt Advanced Biophotonicis Core at the Salk Institute for excellent technical assistance and useful discussions. We would also like to thank Louise C. Laurent and Robert Morey for their help with bioinformatics analyses. A. A. was partially supported by the Ipsen Foundation. L. K. was partially supported by a training grant from the California Institute for Regenerative Medicine. I. S. M. was partially supported by a Nomis Foundation postdoctoral fellowship. Work in the lab of J.Y. was supported by National Institute of General Medical Sciences (8 P41 GM103533) and UCLA/NHLBI Proteomics Centers (HHSN268201000035C). Work in the laboratory of J.C.I.B. was supported by grants from MINECO PLE2009-0100 (CMRB), the NHLBI (U01 HL107442-04), the G. Harold and Leila Y. Mathers Charitable Foundation, and The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002) (Salk Institute).	Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Addis RC, 2013, NAT MED, V19, P829, DOI 10.1038/nm.3225; Aguirre A, 2013, CELL STEM CELL, V12, P275, DOI 10.1016/j.stem.2013.02.008; Andersen DC, 2014, STEM CELL REP, V2, P406, DOI 10.1016/j.stemcr.2014.02.008; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Brandenburger M, 2012, CARDIOVASC RES, V93, P50, DOI 10.1093/cvr/cvr259; Brenner JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037185; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Chen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080625; Coppola A, 2014, STEM CELL RES, V12, P323, DOI 10.1016/j.scr.2013.11.008; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Han P, 2011, CIRC RES, V108, P378, DOI 10.1161/CIRCRESAHA.110.224287; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kasahara A, 2013, SCIENCE, V342, P734, DOI 10.1126/science.1241359; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Liang GX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092592; Mueller AC, 2013, ONCOGENE, V32, P1164, DOI 10.1038/onc.2012.131; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Stewart S, 2009, P NATL ACAD SCI USA, V106, P19889, DOI 10.1073/pnas.0904132106; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Witman N, 2011, DEV BIOL, V354, P67, DOI 10.1016/j.ydbio.2011.03.021; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhang RL, 2013, NATURE, V498, P497, DOI 10.1038/nature12322; Ziv O, 2013, DEV CELL, V26, P3, DOI 10.1016/j.devcel.2013.06.013	46	138	146	3	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					589	604		10.1016/j.stem.2014.10.003	http://dx.doi.org/10.1016/j.stem.2014.10.003			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517466	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000345012700012
J	Cibelli, JB				Cibelli, Jose B.			Human Somatic Cell Nuclear Transfer Is Alive and Well	CELL STEM CELL			English	Editorial Material							TRANSFER EMBRYOS; OOCYTES	In this issue, Chung et al. (2014) generate human embryonic stem cells by fusing an adult somatic cell to a previously enucleated human oocyte, in agreement with recent reports by the Mitalipov and Egli groups. We can now safely say that human somatic cell nuclear transfer is alive and well.	[Cibelli, Jose B.] Michigan State Univ, Dept Physiol, E Lansing, MI 48834 USA; [Cibelli, Jose B.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48834 USA; [Cibelli, Jose B.] BIONAND, LARCel, Malaga 29590, Spain	Michigan State University; Michigan State University	Cibelli, JB (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48834 USA.	cibelli@msu.edu		Cibelli, Jose/0000-0002-2176-3854				Chung YG, 2014, CELL STEM CELL, V14, P777, DOI 10.1016/j.stem.2014.03.015; Cibelli J.B., 2001, E BIOMED J REGENERAT, V2, P26; Fan Y, 2011, STEM CELLS DEV, V20, P1951, DOI 10.1089/scd.2010.0451; French AJ, 2008, STEM CELLS, V26, P485, DOI 10.1634/stemcells.2007-0252; LATHAM KE, 1991, DEVELOPMENT, V113, P561; Liu J, 2013, CELL REPROGRAM, V15, P134, DOI 10.1089/cell.2012.0052; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Stojkovic M, 2005, REPROD BIOMED ONLINE, V11, P226; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Yamada M., 2014, NATURE; Zheng Z, 2012, J BIOL CHEM, V287, P19949, DOI 10.1074/jbc.M112.355099	11	10	10	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					699	701		10.1016/j.stem.2014.05.013	http://dx.doi.org/10.1016/j.stem.2014.05.013			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905159	Bronze			2022-12-28	WOS:000341248500005
J	Flynn, RA; Chang, HY				Flynn, Ryan A.; Chang, Howard Y.			Long Noncoding RNAs in Cell-Fate Programming and Reprogramming	CELL STEM CELL			English	Review							STEM-CELLS; SELF-RENEWAL; DIFFERENTIATION; GENE; CHROMATIN; PRC2; REVEALS; BINDING; TRANSCRIPTION; PLURIPOTENCY	In recent years, long noncoding RNAs (IncRNAs) have emerged as an important class of regulators of gene expression. IncRNAs exhibit several distinctive features that confer unique regulatory functions, including exquisite cell-and tissue-specific expression and the capacity to transduce higher-order spatial information. Here we review evidence showing that lncRNAs exert critical functions in adult tissue stem cells, including skin, brain, and muscle, as well as in developmental patterning and pluripotency. We highlight new approaches for ascribing IncRNA functions and discuss mammalian dosage compensation as a classic example of an lncRNA network coupled to stem cell differentiation.	[Flynn, Ryan A.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Flynn, Ryan A.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	howchang@stanford.edu		Flynn, Ryan/0000-0001-5013-0442	NIH Medical Scientist Training Program; NIH [RO1-CA118750, RO1-ES023168]; California Institute for Regenerative Medicine; NATIONAL CANCER INSTITUTE [R01CA118750, T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023168] Funding Source: NIH RePORTER	NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We apologize to colleagues whose work was not discussed due to space constraints. We thank M. Wernig, E. Heard, R. C. Spitale, A.J. Rubin, and members of the H.Y.C. lab for comments. This work was supported by NIH Medical Scientist Training Program (R. A. F.) and NIH (RO1-CA118750, RO1-ES023168) and California Institute for Regenerative Medicine (H.Y.C.). H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Berghoff EG, 2013, DEVELOPMENT, V140, P4407, DOI 10.1242/dev.099390; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Bosia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066609; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Deng ZY, 2010, TRANSCR-AUSTIN, V1, P81, DOI 10.4161/trns.1.2.12375; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Grote P., 2013, RNA BIOL; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kaneko S, 2013, NAT STRUCT MOL BIOL, V20, P1258, DOI 10.1038/nsmb.2700; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kretz M, 2012, GENE DEV, V26, P338, DOI 10.1101/gad.182121.111; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Legnini I, 2014, MOL CELL, V53, P506, DOI 10.1016/j.molcel.2013.12.012; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lu LN, 2013, EMBO J, V32, P2575, DOI 10.1038/emboj.2013.182; Lu LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027596; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Maamar H, 2013, GENE DEV, V27, P1260, DOI 10.1101/gad.217018.113; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mehler MF, 2007, PHYSIOL REV, V87, P799, DOI 10.1152/physrev.00036.2006; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Mercer TR, 2008, NEUROSCIENTIST, V14, P434, DOI 10.1177/1073858408319187; Mercer TR, 2012, NAT BIOTECHNOL, V30, P99, DOI 10.1038/nbt.2024; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Onoguchi M, 2012, P NATL ACAD SCI USA, V109, P16939, DOI 10.1073/pnas.1202956109; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Payer B, 2013, MOL CELL, V52, P805, DOI 10.1016/j.molcel.2013.10.023; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Ramos AD, 2013, CELL STEM CELL, V12, P616, DOI 10.1016/j.stem.2013.03.003; Rapicavoli NA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-32; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Saldana-Meyer R, 2014, GENE DEV, V28, P723, DOI 10.1101/gad.236869.113; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schulz EG, 2014, CELL STEM CELL, V14, P203, DOI 10.1016/j.stem.2013.11.022; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Yang YW, 2014, ELIFE, V3, DOI 10.7554/eLife.02046; Zhang A, 2013, CELL RES, V23, P340, DOI 10.1038/cr.2012.164; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	78	366	392	2	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					752	761		10.1016/j.stem.2014.05.014	http://dx.doi.org/10.1016/j.stem.2014.05.014			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905165	Green Accepted, Bronze			2022-12-28	WOS:000341248500012
J	Saunders, A; Wang, JL				Saunders, Arven; Wang, Jianlong			Export and Expression: mRNAs Deliver New Messages for Controlling Pluripotency	CELL STEM CELL			English	Editorial Material							CELL SELF-RENEWAL; COMPLEX; DIFFERENTIATION; TRANSLATION; SCREEN		[Saunders, Arven; Wang, Jianlong] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Saunders, Arven; Wang, Jianlong] Icahn Sch Med Mt Sinai, Grad Sch Biol Sci, New York, NY 10029 USA; [Saunders, Arven; Wang, Jianlong] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Wang, JL (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA.	jianlong.wang@mssm.edu	Wang, Jianlong/AAG-9425-2020; Wang, Jianlong/GQR-1191-2022	Wang, Jianlong/0000-0002-1317-6457				Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Katahira J, 2012, BBA-GENE REGUL MECH, V1819, P507, DOI 10.1016/j.bbagrm.2011.12.001; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Tahmasebi S, 2014, CELL STEM CELL, V14, P606, DOI 10.1016/j.stem.2014.02.005; Wang L, 2013, CELL STEM CELL, V13, P676, DOI 10.1016/j.stem.2013.10.008; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012	10	3	4	2	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					549	550		10.1016/j.stem.2014.04.009	http://dx.doi.org/10.1016/j.stem.2014.04.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24792108	Bronze			2022-12-28	WOS:000335659900001
J	Tumpel, S; Rudolph, KL				Tuempel, Stefan; Rudolph, K. Lenhard			Aging Stem Cells: Transcriptome Meets Epigenome Meets Methylome	CELL STEM CELL			English	Editorial Material							QUIESCENCE; MUTATIONS; DAMAGE		[Tuempel, Stefan; Rudolph, K. Lenhard] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Rudolph, KL (corresponding author), Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany.	klrudolph@fli-leibniz.de		Rudolph, Karl Lenhard/0000-0002-4839-2862				Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Song ZF, 2012, AGING CELL, V11, P449, DOI 10.1111/j.1474-9726.2012.00802.x; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023	10	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					551	552		10.1016/j.stem.2014.04.013	http://dx.doi.org/10.1016/j.stem.2014.04.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24792109	Bronze			2022-12-28	WOS:000335659900002
J	Leeb, M; Dietmann, S; Paramor, M; Niwa, H; Smith, A				Leeb, Martin; Dietmann, Sabine; Paramor, Maike; Niwa, Hitoshi; Smith, Austin			Genetic Exploration of the Exit from Self-Renewal Using Haploid Embryonic Stem Cells	CELL STEM CELL			English	Article							MOUSE ES CELLS; GROUND-STATE; GENOME-WIDE; PLURIPOTENCY; DIFFERENTIATION; PIGGYBAC; NANOG; TRANSCRIPTION; RECRUITMENT; REPRESSION	Self-renewal circuitry in embryonic stem cells( ESCs) is increasingly defined. How the robust pluripotency program is dissolved to enable fate transition is less appreciated. Here we develop a forward genetic approach using haploid ESCs. We created libraries of transposon integrations and screened for persistent self-renewal in differentiation-permissive culture. This yielded multiple mutants in the Fgf/Erk and GSK3/Tcf3 modules known to drive differentiation and in epigenetic modifiers implicated in lineage commitment. We also identified and validated factors not previously considered. These include the conserved small zinc finger protein Zfp706 and the RNA binding protein Pum1. Pum1 targets several mRNAs for naive pluripotency transcription factors and accelerates their downregulation at the onset of differentiation. These findings indicate that the dismantling of pluripotent circuitry proceeds at multiple levels. More broadly they exemplify the power of haploid ESCs for genetic interrogation of developmental processes.	[Leeb, Martin; Dietmann, Sabine; Paramor, Maike; Smith, Austin] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England; [Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Niwa, Hitoshi] RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan	University of Cambridge; University of Cambridge; RIKEN	Leeb, M (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	ml553@cam.ac.uk; austin.smith@cscr.cam.ac.uk	Leeb, Martin/AAE-7498-2020; Leeb, Martin/N-3861-2015	Leeb, Martin/0000-0001-5114-4782; Leeb, Martin/0000-0001-5114-4782; Dietmann, Sabine./0000-0001-6672-8457; Smith, Austin/0000-0002-3029-4682	Wellcome Trust; BBSRC Japan Partnering Award; Austrian Science Fund [J3459]; BBSRC [BB/H531527/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H531527/1] Funding Source: researchfish; Medical Research Council [MC_PC_12009, G1100526] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC Japan Partnering Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Austrian Science Fund(Austrian Science Fund (FWF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Joerg Betschinger for comments on the manuscript and Tuzer Kalkan for unpublished transcriptome data. We are grateful to Carla Mulas for providing homozygous Rex1GFPd2 ESCs and to Rosalind Drummond for technical support. We thank William Mansfield and Charles-Etienne Dumeau for blastocyst injection. We also thank the Eastern Sequence and Informatics Hub and the EMBL Genomics Core Facility for DNA sequencing and Andy Riddell at the Stem Cell Institute flow sorting facility. This study was funded by the Wellcome Trust and by a BBSRC Japan Partnering Award to A. S. and H.N. M. L. was an EMBO long-term postdoctoral fellow and is currently an Erwin Schrodinger fellow of the Austrian Science Fund (J3459). A. S. is a Medical Research Council Professor. M. L. is listed as inventor on a patent application covering haploid ESCs (WO2012117254 A1).	Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Chen D, 2012, CURR BIOL, V22, P420, DOI 10.1016/j.cub.2012.01.039; Dutta D, 2011, STEM CELLS, V29, P618, DOI 10.1002/stem.605; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Gagliardi A, 2013, EMBO J, V32, P2231, DOI 10.1038/emboj.2013.161; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Guo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018189; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Leeb M, 2012, DEVELOPMENT, V139, P3301, DOI 10.1242/dev.083675; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Li MA, 2010, METHOD ENZYMOL, V477, P217, DOI 10.1016/S0076-6879(10)77012-9; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Schmitz SU, 2011, EMBO J, V30, P4586, DOI 10.1038/emboj.2011.383; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Wang C., 2012, P NATL ACAD SCI USA, V109, P15324; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang W, 2009, GENOME RES, V19, P667, DOI 10.1101/gr.085621.108; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	33	130	141	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2014	14	3					385	393		10.1016/j.stem.2013.12.008	http://dx.doi.org/10.1016/j.stem.2013.12.008			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AC5AR	24412312	Green Published, hybrid			2022-12-28	WOS:000332533400014
J	Rong, ZL; Wang, MY; Hu, Z; Stradner, M; Zhu, SY; Kong, HJ; Yi, HF; Goldrath, A; Yang, YG; Xu, Y; Fu, XM				Rong, Zhili; Wang, Meiyan; Hu, Zheng; Stradner, Martin; Zhu, Shengyun; Kong, Huijuan; Yi, Huanfa; Goldrath, Ananda; Yang, Yong-Guang; Xu, Yang; Fu, Xuemei			An Effective Approach to Prevent Immune Rejection of Human ESC-Derived Allografts	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SUICIDE GENE; HEMATOPOIETIC PRECURSORS; RENAL-TRANSPLANTATION; STROMAL CELLS; TOLERANCE; SYSTEM; MICE; THERAPY; MOUSE	Human embryonic stem cells (hESCs) hold great promise for cell therapy as a source of diverse differentiated cell types. One key bottleneck to realizing such potential is allogenic immune rejection of hESC-derived cells by recipients. Here, we optimized humanized mice (Hu-mice) reconstituted with a functional human immune system that mounts a vigorous rejection of hESCs and their derivatives. We established knockin hESCs that constitutively express CTLA4-Ig and PD-L1 before and after differentiation, denoted CP hESCs. We then demonstrated that allogenic CP hESC-derived teratomas, fibroblasts, and cardiomyocytes are immune protected in Hu-mice, while cells derived from parental hESCs are effectively rejected. Expression of both CTLA4-Ig, which disrupts T cell costimulatory pathways, and PD-L1, which activates T cell inhibitory pathway, is required to confer immune protection, as neither was sufficient on their own. These findings are instrumental for developing a strategy to protect hESC-derived cells from allogenic immune responses without requiring systemic immune suppression.	[Wang, Meiyan; Zhu, Shengyun; Fu, Xuemei] Shenzhen Childrens Hosp, Shenzhen 518026, Guangdong, Peoples R China; [Rong, Zhili; Wang, Meiyan; Stradner, Martin; Zhu, Shengyun; Kong, Huijuan; Goldrath, Ananda; Xu, Yang] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Hu, Zheng; Yi, Huanfa; Yang, Yong-Guang] Jilin Univ, Hosp 1, Changchun 130021, Jilin, Peoples R China; [Yang, Yong-Guang] Columbia Univ, Sch Med, Columbia Ctr Translat Immunol, New York, NY 10032 USA; [Fu, Xuemei] Chongqing Med Univ, Childrens Hosp, Chongqing 400016, Peoples R China	University of California System; University of California San Diego; Jilin University; Columbia University; Chongqing Medical University	Xu, Y (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu; fxmzj2004@163.com	Stradner, Martin H/D-6473-2011; Rong, Zhili/H-7561-2014	Stradner, Martin H/0000-0002-7884-6626; Rong, Zhili/0000-0002-1699-7074; Wang, Meiyan/0000-0002-4838-7182; Yang, Yong-Guang/0000-0003-4985-1247; Xu, Yang/0000-0001-5574-921X	Chinese Ministry of Science and Technology [2013CB966902, 2013CB966903]; National Institutes of Health [AI-064569, AI-045897]; National Natural Science Foundation of China [81172828, 81373166]; California Institute for Regenerative Medicine [RM-0173, TR3-05559, RB4-06244]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045897, R01AI064569] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Jack Bui for help with HLA genotyping and the University of California, San Diego, pathology core for histologic analysis. This work was supported by grants from Chinese Ministry of Science and Technology (2013CB966902, 2013CB966903) and the National Institutes of Health (AI-064569 and AI-045897) to Y.G.Y. and H.F.Y, grants from the National Natural Science Foundation of China (81172828, 81373166) to X. F., and grants from the California Institute for Regenerative Medicine (RM-0173, TR3-05559, RB4-06244) to A. G and Y.X.	Blomer U, 2005, GENE THER, V12, P67, DOI 10.1038/sj.gt.3302384; Boyd AS, 2012, STEM CELLS, V30, P797, DOI 10.1002/stem.1066; Cheng FY, 2012, BIOMATERIALS, V33, P3195, DOI 10.1016/j.biomaterials.2012.01.023; Ciancio G, 2001, TRANSPLANT P, V33, P1295, DOI 10.1016/S0041-1345(00)02485-4; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Elster EA, 2004, TRANSPL IMMUNOL, V13, P87, DOI 10.1016/j.trim.2004.05.010; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Fu X, 2011, REGEN MED, V6, P327, DOI [10.2217/RME.11.18, 10.2217/rme.11.18]; Fugier-Vivier IJ, 2005, J EXP MED, V201, P373, DOI 10.1084/jem.20041399; Gallagher MP, 2010, J AM SOC NEPHROL, V21, P852, DOI 10.1681/ASN.2009101043; Haley PJ, 2003, TOXICOLOGY, V188, P49, DOI 10.1016/S0300-483X(03)00043-X; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Kalscheuer H, 2012, SCI TRANSL MED, V4; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Rong ZL, 2012, J BIOL CHEM, V287, P32338, DOI 10.1074/jbc.M112.383810; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Selzner N, 2010, LIVER TRANSPLANT, V16, P1359, DOI 10.1002/lt.22193; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Springer CJ, 2000, J CLIN INVEST, V105, P1161, DOI 10.1172/JCI10001; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian C, 2007, J IMMUNOL, V179, P6762, DOI 10.4049/jimmunol.179.10.6762; Tillson M, 2006, EXP HEMATOL, V34, P1759, DOI 10.1016/j.exphem.2006.08.004; Tonomura N, 2008, BLOOD, V111, P4293, DOI 10.1182/blood-2007-11-121319; van der Touw W, 2010, AM J TRANSPLANT, V10, P1354, DOI 10.1111/j.1600-6143.2010.03086.x; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; Wekerle T, 2012, TRANSPL INT, V25, P139, DOI 10.1111/j.1432-2277.2011.01386.x; Wirth E, 2011, CELL STEM CELL, V8, P476, DOI 10.1016/j.stem.2011.04.008; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Woods NB, 2011, STEM CELLS, V29, P1158, DOI 10.1002/stem.657; Xu XQ, 2008, CYTOTHERAPY, V10, P376, DOI 10.1080/14653240802105307; Zhang BJ, 2009, J CELL MOL MED, V13, P1043, DOI 10.1111/j.1582-4934.2008.00347.x; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	44	149	161	1	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					121	130		10.1016/j.stem.2013.11.014	http://dx.doi.org/10.1016/j.stem.2013.11.014			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24388175	Green Accepted, Bronze			2022-12-28	WOS:000329571900014
J	Rao, M				Rao, Mahendra			iPSC Crowdsourcing: A Model for Obtaining Large Panels of Stem Cell Lines for Screening	CELL STEM CELL			English	Editorial Material								A key to tapping the potential of iPSCs is the establishment of readily accessible well-characterized panels of lines for custom screening. Here, we propose a crowdsourcing strategy to rapidly develop a large repository of iPSCs and provide a model for how the NIH could support this effort.			Rao, M (corresponding author), 50 South Dr,Suite 1140, Bethesda, MD 20892 USA.	mahendra.rao@nih.gov						Brewer GJ, 2009, TRANSL RES, V154, P314, DOI 10.1016/j.trsl.2009.03.008; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Engle SJ, 2013, CELL STEM CELL, V12, P669, DOI 10.1016/j.stem.2013.05.011; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Kalia M, 2013, METABOLISM, V62, pS11, DOI 10.1016/j.metabol.2012.08.016; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Prebula Randy J, 2010, J Contemp Health Law Policy, V26, P343; Ranard BL, 2014, J GEN INTERN MED, V29, P187, DOI 10.1007/s11606-013-2536-8; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019	10	20	20	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					389	391		10.1016/j.stem.2013.09.005	http://dx.doi.org/10.1016/j.stem.2013.09.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094321	Bronze			2022-12-28	WOS:000329571100008
J	Stacey, GN; Crook, JM; Hei, D; Ludwig, T				Stacey, Glyn N.; Crook, Jeremy M.; Hei, Derek; Ludwig, Tenneille			Banking Human Induced Pluripotent Stem Cells: Lessons Learned from Embryonic Stem Cells?	CELL STEM CELL			English	Editorial Material							GUIDANCE; LINES	The generation of human embryonic stem cell banking networks has ensured that well-characterized and quality controlled stem cell lines are broadly accessible to researchers worldwide. Here, we provide recommendations for engaging these established networks in efforts to build similar resources for the distribution and collection of induced pluripotent stem cells.	[Stacey, Glyn N.] Natl Inst Biol Stand & Controls, S Mimms EN6 3QG, Herts, England; [Crook, Jeremy M.] Univ Wollongong, Australian Inst Innovat Mat, Wollongong, NSW 2522, Australia; [Crook, Jeremy M.] Univ Wollongong, AIIM Facil, Intelligent Polymer Res Inst, ARC Ctr Excellence Elect Sci ACES, Wollongong, NSW 2522, Australia; [Crook, Jeremy M.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Crook, Jeremy M.] Univ Melbourne, St Vincents Hosp, Dept Surg, East Melbourne, Vic 3002, Australia; [Hei, Derek] Univ Wisconsin, Waisman Biomfg, Madison, WI 53705 USA; [Ludwig, Tenneille] WiCell Res Inst, Madison, WI 53726 USA	National Institute for Biological Standards & Control; University of Wollongong; University of Wollongong; University of Wollongong; University of Melbourne; University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute	Stacey, GN (corresponding author), Natl Inst Biol Stand & Controls, S Mimms EN6 3QG, Herts, England.	glyn.stacey@nibsc.org	Crook, Jeremy Micah/AAH-8441-2020	Crook, Jeremy Micah/0000-0002-6415-1639	Medical Research Council [G1001045] Funding Source: Medline; MRC [G1001045] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x; Coecke S, 2005, ATLA-ALTERN LAB ANIM, V33, P261, DOI 10.1177/026119290503300313; Crook JM, 2010, IN VITRO CELL DEV-AN, V46, P169, DOI 10.1007/s11626-010-9301-7; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Luong M.X., 2011, HUMAN STEM CELL MANU, P106; MacLeod RAF, 1999, INT J CANCER, V83, P555; Podolac E., 2010, BIOTECHNIQUES; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005	9	49	50	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					385	388		10.1016/j.stem.2013.09.007	http://dx.doi.org/10.1016/j.stem.2013.09.007			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094320	Bronze			2022-12-28	WOS:000329571100007
J	Lamm, N; Ben-David, U; Golan-Lev, T; Storchova, Z; Benvenisty, N; Kerem, B				Lamm, Noa; Ben-David, Uri; Golan-Lev, Tamar; Storchova, Zuzana; Benvenisty, Nissim; Kerem, Batsheva			Genomic Instability in Human Pluripotent Stem Cells Arises from Replicative Stress and Chromosome Condensation Defects	CELL STEM CELL			English	Article							GENE-EXPRESSION; DNA-REPLICATION; CHECKPOINT; CANCER; ABERRATIONS; PROGRESSION; ANEUPLOIDY; CULTURE; SERUM	Human pluripotent stem cells (hPSCs) frequently acquire chromosomal aberrations such as aneuploidy in culture. These aberrations progressively increase over time and may compromise the properties and clinical utility of the cells. The underlying mechanisms that drive initial genomic instability and its continued progression are largely unknown. Here, we show that aneuploid hPSCs undergo DNA replication stress, resulting in defective chromosome condensation and segregation. Aneuploid hPSCs show altered levels of actin cytoskeletal genes controlled by the transcription factor SRF, and overexpression of SRF rescues impaired chromosome condensation and segregation defects in aneuploid hPSCs. Furthermore, SRF downregulation in diploid hPSCs induces replication stress and perturbed condensation similar to that seen in aneuploid cells. Together, these results suggest that decreased SRF expression induces replicative stress and chromosomal condensation defects that underlie the ongoing chromosomal instability seen in aneuploid hPSCs. A similar mechanism may also operate during initiation of instability in diploid cells.	[Lamm, Noa; Kerem, Batsheva] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel; [Ben-David, Uri; Golan-Lev, Tamar; Benvenisty, Nissim] Hebrew Univ Jerusalem, Dept Genet, Azrieli Ctr Stem Cells & Genet Res, IL-91904 Jerusalem, Israel; [Ben-David, Uri] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA; [Storchova, Zuzana] Max Planck Inst Biochem, Grp Maintenance Genome Stabil, Klopferspitz 18, D-82152 Martinsried, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Max Planck Society	Kerem, B (corresponding author), Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel.; Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Azrieli Ctr Stem Cells & Genet Res, IL-91904 Jerusalem, Israel.	nissimb@mail.huji.ac.il; batshevak@savion.huji.ac.il	Ben-David, Uri/H-4119-2019	Ben-David, Uri/0000-0001-7098-2378; Storchova, Zuzana/0000-0003-2376-7047	Israel Science Foundation [176/11, 269/12]; Israeli Cancer Association; Chief Scientist's Office of the Israel Ministry of Health; Israeli Centers of Research Excellence (I-CORE); Gene Regulation in Complex Human Disease [41/11]; Azrieli Foundation; Rosetrees Trust; Israel Cancer Research Fund; Human Frontiers Science Program (HFSP) postdoctoral fellowship; Rosetrees Trust [M108-F1] Funding Source: researchfish	Israel Science Foundation(Israel Science Foundation); Israeli Cancer Association; Chief Scientist's Office of the Israel Ministry of Health; Israeli Centers of Research Excellence (I-CORE); Gene Regulation in Complex Human Disease; Azrieli Foundation; Rosetrees Trust(Rosetrees Trust); Israel Cancer Research Fund; Human Frontiers Science Program (HFSP) postdoctoral fellowship; Rosetrees Trust(Rosetrees Trust)	This research was partially supported by the Israel Science Foundation (grant No. 176/11), the Israeli Cancer Association, the Chief Scientist's Office of the Israel Ministry of Health and the Israeli Centers of Research Excellence (I-CORE), and Gene Regulation in Complex Human Disease, Center No 41/11 to B.K. The Azrieli Foundation, the Rosetrees Trust, and the Israel Science Foundation (grant number 269/12) supported N.B. N.B. is the Herbert Cohn Chair in Cancer Research. N.L. was supported by a postdoctoral fellowship from the Israel Cancer Research Fund. U.B.-D. was supported by a Human Frontiers Science Program (HFSP) postdoctoral fellowship. We thank Aline Sewo Pires de Campos from the Storchova laboratory who is mostly responsible for the construction, determination, and maintenance of the somatic trisomies cell lines.	Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Ben-David U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5825; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Biancotti JC, 2010, STEM CELLS, V28, P1530, DOI 10.1002/stem.483; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Damelin M, 2005, CANCER CELL, V8, P479, DOI 10.1016/j.ccr.2005.11.004; Desmarais JA, 2012, STEM CELLS, V30, P1385, DOI 10.1002/stem.1117; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Filion TM, 2009, J CELL PHYSIOL, V220, P586, DOI 10.1002/jcp.21735; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gotoh E, 2007, CHROMOSOMA, V116, P453, DOI 10.1007/s00412-007-0109-5; Holubcova Z, 2011, STEM CELLS, V29, P46, DOI 10.1002/stem.549; Lund RJ, 2012, NAT REV GENET, V13, P732, DOI 10.1038/nrg3271; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Ozeri-Galai E, 2012, TRENDS GENET, V28, P295, DOI 10.1016/j.tig.2012.02.006; Peterson Suzanne E., 2008, V438, P197, DOI 10.1007/978-1-59745-133-8_16; Spencer JA, 1999, MOL CELL BIOL, V19, P3977; Weissbein U, 2014, J CELL BIOL, V204, P153, DOI 10.1083/jcb.201310135; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Yang S, 2008, GENE CHROMOSOME CANC, V47, P665, DOI 10.1002/gcc.20574	26	62	65	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2016	18	2					253	261		10.1016/j.stem.2015.11.003	http://dx.doi.org/10.1016/j.stem.2015.11.003			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GT	26669899	Bronze			2022-12-28	WOS:000372321700015
J	Koch, P				Koch, Philipp			Direct Conversion Provides Old Neurons from Aged Donor's Skin	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; INDUCTION; DISEASE	Modeling human neuronal aging at a cellular level remains challenging. Human neurons are accessible from iPSCs, but during reprogramming age-associated traits of somatic cells get lost. In this issue of Cell Stem Cell, Mertens et al. (2015) demonstrate that neurons obtained by direct cell conversion retain age-associated transcriptional traits and functional deficits of the donor cell population.	[Koch, Philipp] Univ Bonn, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany	University of Bonn	Koch, P (corresponding author), Univ Bonn, Inst Reconstruct Neurobiol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	philipp.koch@uni-bonn.de	Koch, Philipp/AAZ-3751-2020; Koch, Philipp/M-1186-2016	Koch, Philipp/0000-0003-3713-8786				Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lapasset L, 2011, GENE DEV, V25, P2248, DOI 10.1101/gad.173922.111; Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Rohani L, 2014, AGING CELL, V13, P2, DOI 10.1111/acel.12182; Studer L, 2015, CELL STEM CELL, V16, P591, DOI 10.1016/j.stem.2015.05.004; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019	10	3	3	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					637	638		10.1016/j.stem.2015.11.009	http://dx.doi.org/10.1016/j.stem.2015.11.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26637936	Bronze			2022-12-28	WOS:000366139100001
J	Kurmann, AA; Serra, M; Hawkins, F; Rankin, SA; Mori, M; Astapova, I; Ullas, S; Lin, S; Bilodeau, M; Rossant, J; Jean, JC; Ikonomou, L; Deterding, RR; Shannon, JM; Zorn, AM; Hollenberg, AN; Kotton, DN				Kurmann, Anita A.; Serra, Maria; Hawkins, Finn; Rankin, Scott A.; Mori, Munemasa; Astapova, Inna; Ullas, Soumya; Lin, Sui; Bilodeau, Melanie; Rossant, Janet; Jean, Jyh C.; Ikonomou, Laertis; Deterding, Robin R.; Shannon, John M.; Zorn, Aaron M.; Hollenberg, Anthony N.; Kotton, Darrell N.			Regeneration of Thyroid Function by Transplantation of Differentiated Pluripotent Stem Cells	CELL STEM CELL			English	Article							FIBROBLAST GROWTH-FACTORS; FOLLICLE FORMATION; GENE; GENERATION; LUNG; EXPRESSION; FOREGUT; MOUSE; PROGENITORS; INDUCTION	Differentiation of functional thyroid epithelia from pluripotent stem cells (PSCs) holds the potential for application in regenerative medicine. However, progress toward this goal is hampered by incomplete understanding of the signaling pathways needed for directed differentiation without forced overexpression of exogenous transgenes. Here we use mouse PSCs to identify key conserved roles for BMP and FGF signaling in regulating thyroid lineage specification from foregut endoderm in mouse and Xenopus. Thyroid progenitors derived from mouse PSCs can be matured into thyroid follicular organoids that provide functional secretion of thyroid hormones in vivo and rescue hypothyroid mice after transplantation. Moreover, by stimulating the same pathways, we were also able to derive human thyroid progenitors from normal anddisease-specific iPSCs generated from patients with hypothyroidism resulting from NKX2-1 haploinsufficiency. Our studies have therefore uncovered the regulatory mechanisms that underlie early thyroid organogenesis and provide a significant step toward cell-based regenerative therapy for hypothyroidism.	[Kurmann, Anita A.; Astapova, Inna; Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kurmann, Anita A.; Astapova, Inna; Hollenberg, Anthony N.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Kurmann, Anita A.; Serra, Maria; Hawkins, Finn; Mori, Munemasa; Jean, Jyh C.; Ikonomou, Laertis; Kotton, Darrell N.] Boston Univ, Ctr Regenerat Med, Boston, MA 02118 USA; [Kurmann, Anita A.; Serra, Maria; Hawkins, Finn; Mori, Munemasa; Jean, Jyh C.; Ikonomou, Laertis; Kotton, Darrell N.] Boston Med Ctr, Boston, MA 02118 USA; [Serra, Maria; Hawkins, Finn; Mori, Munemasa; Jean, Jyh C.; Ikonomou, Laertis; Kotton, Darrell N.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Serra, Maria; Hawkins, Finn; Mori, Munemasa; Jean, Jyh C.; Ikonomou, Laertis; Kotton, Darrell N.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Rankin, Scott A.; Zorn, Aaron M.] Cincinnati Childrens Hosp, Perinatal Inst, Div Dev Biol, Cincinnati, OH 45229 USA; [Lin, Sui; Shannon, John M.] Cincinnati Childrens Hosp, Div Pulm Biol, Cincinnati, OH 45229 USA; [Ullas, Soumya] Beth Israel Deaconess Med Ctr, Longwood Small Anim Imaging Facil, Boston, MA 02215 USA; [Bilodeau, Melanie; Rossant, Janet] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Dev & Stem Cell Biol, Toronto, ON M5G 0A4, Canada; [Rossant, Janet] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Deterding, Robin R.] Childrens Hosp Colorado, Breathing Inst, Aurora, CO 80045 USA; [Deterding, Robin R.] Univ Colorado, Sect Pediat Pulm Med, Aurora, CO 80045 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Boston University; Boston Medical Center; Boston University; Boston University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Hollenberg, AN (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.	thollenb@bidmc.harvard.edu; dkotton@bu.edu	Ikonomou, Laertis/D-4579-2009; Serra, Maria/AAA-9222-2020	Ikonomou, Laertis/0000-0003-0993-6713; Bilodeau, Melanie/0000-0001-7648-1021; Serra, Maria/0000-0002-1559-250X; Mori, Munemasa/0000-0002-7283-7198	Swiss National Science Foundation [PBBS P3-146612]; chILD Foundation/American Thoracic Society; Canadian Institutes of Health Research/Canadian Lung Association/GlaxoSmithKline partnership; Fonds de Recherche du Quebec;  [R01 HL111574];  [R01 HL114898];  [R01 HL095993];  [R01 HL108678];  [R01 HL122442];  [U01HL110-967]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114898, R01HL111574, U01HL110967, R01HL122442, R01HL095993, R01HL108678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007516] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); chILD Foundation/American Thoracic Society; Canadian Institutes of Health Research/Canadian Lung Association/GlaxoSmithKline partnership(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec; ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We wish to thank the members of the Kotton and Hollenberg labs for insightful discussions. We thank Ron Gluck and Elizabeth Brody-Gluck for project ignition and Dr. Meinrad Busslinger for kindly sharing the Pax8<SUP>cre</SUP> mouse. We thank Brian R. Tilton and Patrick Autissier of the Boston University Flow Cytometry Core Facility for technical assistance and Amulya Iyer of the Kotton lab and Marianne James of the iPS core at the CReM for maintenance and characterization of patient-specific iPSCs. A.A.K. was supported by a grant from the Swiss National Science Foundation (PBBS P3-146612), L.I. by grant R01 HL111574 and an award co-sponsored by the chILD Foundation/American Thoracic Society, M.B. by a postdoctoral fellowships from the Canadian Institutes of Health Research/Canadian Lung Association/GlaxoSmithKline partnership and from Fonds de Recherche du Quebec, A.M.Z. by grant R01 HL114898, and D.N.K. by grants R01 HL095993, R01 HL108678, R01 HL122442, and U01HL110-967.	Antonica F, 2012, NATURE, V491, P66, DOI 10.1038/nature11525; Arufe MC, 2006, ENDOCRINOLOGY, V147, P3007, DOI 10.1210/en.2005-1239; Arufe MC, 2009, BIOCHEM BIOPH RES CO, V381, P264, DOI 10.1016/j.bbrc.2009.02.035; Bachiller D, 2003, DEVELOPMENT, V130, P3567, DOI 10.1242/dev.00581; Bilodeau M, 2014, STEM CELL REP, V3, P634, DOI 10.1016/j.stemcr.2014.07.010; Bouchard M, 2004, GENESIS, V38, P105, DOI 10.1002/gene.20008; Celli G, 1998, EMBO J, V17, P1642, DOI 10.1093/emboj/17.6.1642; Crane AM, 2015, STEM CELL REP, V4, P569, DOI 10.1016/j.stemcr.2015.02.005; Fagman H, 2007, HUM MOL GENET, V16, P276, DOI 10.1093/hmg/ddl455; Fagman H, 2010, MOL CELL ENDOCRINOL, V323, P35, DOI 10.1016/j.mce.2009.12.008; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Hamvas A, 2013, CHEST, V144, P794, DOI 10.1378/chest.12-2502; HILFER SP, 1968, Z ZELLFORSCH MIK ANA, V92, P256, DOI 10.1007/BF00335651; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Jiang NY, 2010, THYROID, V20, P77, DOI 10.1089/thy.2008.0291; Kameda Y, 2009, DEV DYNAM, V238, P503, DOI 10.1002/dvdy.21867; Krude H, 2002, J CLIN INVEST, V109, P475, DOI 10.1172/JC1200214341; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lania G, 2009, DEV BIOL, V328, P109, DOI 10.1016/j.ydbio.2009.01.014; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Ma RS, 2015, THYROID, V25, P455, DOI 10.1089/thy.2014.0537; Ma RS, 2013, THYROID, V23, P385, DOI 10.1089/thy.2012.0644; Ma RS, 2009, ENDOCRINOLOGY, V150, P1970, DOI 10.1210/en.2008-1374; MALLETTE JM, 1966, EXP CELL RES, V41, P642, DOI 10.1016/S0014-4827(66)80115-5; MARTIN A, 1993, J CLIN ENDOCR METAB, V77, P305, DOI 10.1210/jc.77.2.305; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Parlato R, 2004, DEV BIOL, V276, P464, DOI 10.1016/j.ydbio.2004.08.048; Petryk A, 2004, DEV BIOL, V267, P374, DOI 10.1016/j.ydbio.2003.11.015; Postiglione MP, 2002, P NATL ACAD SCI USA, V99, P15462, DOI 10.1073/pnas.242328999; Serls AE, 2005, DEVELOPMENT, V132, P35, DOI 10.1242/dev.01570; Shifley ET, 2012, BMC DEV BIOL, V12, P1, DOI 10.1186/1471-213X-12-27; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Trueba SS, 2005, J CLIN ENDOCR METAB, V90, P455, DOI 10.1210/jc.2004-1358; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Wendl T, 2007, DEVELOPMENT, V134, P2871, DOI 10.1242/dev.02872; Zuckier LS, 2004, J NUCL MED, V45, P500	39	110	112	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2015	17	5					527	542		10.1016/j.stem.2015.09.004	http://dx.doi.org/10.1016/j.stem.2015.09.004			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4UB	26593959	Green Accepted, Bronze			2022-12-28	WOS:000365694700007
J	D'Addio, F; La Rosa, S; Maestroni, A; Jung, P; Orsenigo, E; Ben Nasr, M; Tezza, S; Bassi, R; Finzi, G; Marando, A; Vergani, A; Frego, R; Albarello, L; Andolfo, A; Manuguerra, R; Viale, E; Staudacher, C; Corradi, D; Batlle, E; Breault, D; Secchi, A; Folli, F; Fiorina, P				D'Addio, Francesca; La Rosa, Stefano; Maestroni, Anna; Jung, Peter; Orsenigo, Elena; Ben Nasr, Moufida; Tezza, Sara; Bassi, Roberto; Finzi, Giovanna; Marando, Alessandro; Vergani, Andrea; Frego, Roberto; Albarello, Luca; Andolfo, Annapaola; Manuguerra, Roberta; Viale, Edi; Staudacher, Carlo; Corradi, Domenico; Batlle, Eduard; Breault, David; Secchi, Antonio; Folli, Franco; Fiorina, Paolo			Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy	CELL STEM CELL			English	Article							STAGE RENAL-DISEASE; GASTROINTESTINAL SYMPTOMS; NATURAL-HISTORY; INSULIN; PANCREAS; MELLITUS; TRANSPLANTATION; EXPRESSION; EXPANSION; IMPACT	The role of circulating factors in regulating colonic stem cells (CoSCs) and colonic epithelial homeostasis is unclear. Individuals with long-standing type 1 diabetes (T1D) frequently have intestinal symptoms, termed diabetic enteropathy (DE), though its etiology is unknown. Here, we report that T1D patients with DE exhibit abnormalities in their intestinal mucosa and CoSCs, which fail to generate in vitro mini-guts. Proteomic profiling of T1D+DE patient serum revealed altered levels of insulin-like growth factor 1 (IGF-I) and its binding protein 3 (IGFBP3). IGFBP3 prevented in vitro growth of patient-derived organoids via binding its receptor TMEM219, in an IGF-I-independent manner, and disrupted in vivo CoSC function in a preclinical DE model. Restoration of normoglycemia in patients with long-standing T1D via kidney-pancreas transplantation or in diabetic mice by treatment with an ecto-TMEM219 recombinant protein normalized circulating IGF-I/IGFBP3 levels and reestablished CoSC homeostasis. These findings demonstrate that peripheral IGF-I/IGFBP3 controls CoSCs and their dysfunction in DE.	[D'Addio, Francesca; Ben Nasr, Moufida; Tezza, Sara; Bassi, Roberto; Vergani, Andrea; Fiorina, Paolo] Harvard Univ, Sch Med, Div Nephrol, Boston Childrens Hosp, Boston, MA 02115 USA; [D'Addio, Francesca; Maestroni, Anna; Ben Nasr, Moufida; Tezza, Sara; Bassi, Roberto; Vergani, Andrea; Secchi, Antonio; Fiorina, Paolo] IRCCS, Osped San Raffaele, Transplant Med, I-20132 Milan, Italy; [La Rosa, Stefano; Finzi, Giovanna; Marando, Alessandro] Osped Circolo Varese, Dept Pathol, I-21100 Varese, Italy; [Jung, Peter; Batlle, Eduard] IRB Barcelona, Barcelona 08028, Spain; [Orsenigo, Elena; Staudacher, Carlo] IRCCS, Osped San Raffaele, Surg, I-20132 Milan, Italy; [Frego, Roberto; Viale, Edi] IRCCS, Osped San Raffaele, Gastroenterol, I-20132 Milan, Italy; [Albarello, Luca] IRCCS, Osped San Raffaele, Pathol Unit, I-20132 Milan, Italy; [Andolfo, Annapaola] IRCCS, Osped San Raffaele, ProMiFa, Prot Microsequencing Facil, I-20132 Milan, Italy; [Manuguerra, Roberta; Corradi, Domenico] Univ Parma, Dept Biomed Biotechnol & Translat Sci, Unit Pathol, I-43121 Parma, Italy; [Batlle, Eduard] ICREA, Barcelona 08028, Spain; [Breault, David] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Secchi, Antonio] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Folli, Franco] Univ Texas Hlth Sci Ctr San Antonio, Div Diabet, Dept Med, San Antonio, TX 78229 USA; [Folli, Franco] Univ Estadual Campinas, OCRC, Dept Internal Med, BR-13100 Sao Paulo, Brazil	Harvard University; Boston Children's Hospital; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Parma; ICREA; Harvard University; Boston Children's Hospital; Harvard Medical School; Vita-Salute San Raffaele University; University of Texas System; University of Texas Health San Antonio; Universidade Estadual de Campinas	Fiorina, P (corresponding author), Harvard Univ, Sch Med, Div Nephrol, Boston Childrens Hosp, Boston, MA 02115 USA.	paolo.fiorina@childrens.harvard.edu	Batlle, Eduard/K-8080-2014; ALBARELLO, LUCA/AAN-3876-2020; La+Rosa, Stefano/AAF-3366-2022; folli, franco/J-2795-2018; D'Addio, Francesca/F-3417-2017; Nasr, Moufida Ben/AAI-5020-2021; La+Rosa, Stefano/AFH-8608-2022; Breault, David/HDN-6048-2022; Fiorina, Paolo/B-4532-2019; Tezza, Sara/A-6046-2015	Batlle, Eduard/0000-0003-2422-0326; ALBARELLO, LUCA/0000-0003-4846-5096; La+Rosa, Stefano/0000-0003-1941-2403; folli, franco/0000-0001-9824-5222; D'Addio, Francesca/0000-0002-0345-0694; La+Rosa, Stefano/0000-0003-1941-2403; Fiorina, Paolo/0000-0002-1093-7724; Tezza, Sara/0000-0002-0048-5824; Andolfo, Annapaola/0000-0002-0566-2391	Italian Scientists and Scholars of North America Foundation (ISSNAF)-Fondazione Marche Fellowship; ADA mentor-based fellowship; EFSD/Sanofi European Research Programme; American Heart Association (AHA); AST fellowship; FAPESP; CNPq;  [RF-2010-2314794];  [RF-2010-233119];  [RO1DK084056];  [P30DK034854]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084056, P30DK034854] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Italian Scientists and Scholars of North America Foundation (ISSNAF)-Fondazione Marche Fellowship; ADA mentor-based fellowship; EFSD/Sanofi European Research Programme; American Heart Association (AHA)(American Heart Association); AST fellowship; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ICREA(ICREA)	We thank Protein Micro Sequencing Facility, Ospedale San Raffaele, Milan, Italy for proteomic analysis and Gabriella Becchi (Department of Biomedical, Biotechnological and Translational Sciences, Unit of Pathology, University of Parma, Parma) for immunohistochemistry studies. F.D. is a recipient of an Italian Scientists and Scholars of North America Foundation (ISSNAF)-Fondazione Marche Fellowship. P.F., C.S., and A.S. are recipients of a Minister of Health of Italy grant RF-2010-2314794. P.F. received a Minister of Health of Italy grant RF-2010-233119. P.F. is the recipient of an ADA mentor-based fellowship and an EFSD/Sanofi European Research Programme and is supported by an American Heart Association (AHA) Grant-in-Aid. R.B. is supported by an AST fellowship. M.B.N. is supported by an ADA mentor-based fellowship. D.B. is supported by RO1DK084056 and P30DK034854. F.F. is on sabbatical leave from the University of Texas Health Science Center, San Antonio, TX, USA at Unicamp, Campinas, Brazil and he is supported by FAPESP, CNPq.	Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Baxter RC, 2013, J CELL COMMUN SIGNAL, V7, P179, DOI 10.1007/s12079-013-0203-9; BONDY CA, 1994, ANN INTERN MED, V120, P593, DOI 10.7326/0003-4819-120-7-199404010-00011; Bortvedt SF, 2012, CURR OPIN GASTROEN, V28, P89, DOI 10.1097/MOG.0b013e32835004c6; Boucher J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001173; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Bytzer P, 2002, AM J GASTROENTEROL, V97, P604; Camilleri M, 2007, NEW ENGL J MED, V356, P820, DOI 10.1056/NEJMcp062614; Cano AE, 2007, AM J GASTROENTEROL, V102, P1990, DOI 10.1111/j.1572-0241.2007.01321.x; Carlone DL, 2012, CELL STEM CELL, V10, P2, DOI 10.1016/j.stem.2011.12.012; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; Domenech A, 2011, INT J EXP PATHOL, V92, P400, DOI 10.1111/j.1365-2613.2011.00789.x; Faraj J, 2007, DIABETIC MED, V24, P1235, DOI 10.1111/j.1464-5491.2007.02236.x; FELDMAN M, 1983, ANN INTERN MED, V98, P378, DOI 10.7326/0003-4819-98-3-378; Fiorina P, 2005, DIABETES CARE, V28, P1303, DOI 10.2337/diacare.28.6.1303; Fiorina P, 2004, DIABETES, V53, P2291, DOI 10.2337/diabetes.53.9.2291; Fiorina P, 2001, DIABETES, V50, P496, DOI 10.2337/diabetes.50.3.496; Folli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009923; Giustina A, 2015, ACTA DIABETOL, V52, P433, DOI 10.1007/s00592-014-0635-6; Gracz AD, 2013, STEM CELLS, V31, P2024, DOI 10.1002/stem.1391; Hughes KR, 2011, INFLAMM BOWEL DIS, V17, P213, DOI 10.1002/ibd.21353; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; LeRoith D, 1997, NEW ENGL J MED, V336, P633, DOI 10.1056/NEJM199702273360907; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; Pupim LB, 2005, KIDNEY INT, V68, P2368, DOI 10.1111/j.1523-1755.2005.00699.x; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Secchi A, 1998, LANCET, V352, P65, DOI 10.1016/S0140-6736(05)79546-5; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Smets YFC, 1999, LANCET, V353, P1915, DOI 10.1016/S0140-6736(98)07513-8; Sridhar SS, 2009, J CLIN ONCOL, V27, P165, DOI 10.1200/JCO.2008.19.8937; Stange DE, 2013, STEM CELLS, V31, P2287, DOI 10.1002/stem.1475; Talley NJ, 2001, AM J GASTROENTEROL, V96, P71; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Williams AC, 2007, CELL DEATH DIFFER, V14, P137, DOI 10.1038/sj.cdd.4401919; Wu MJ, 2004, AM J KIDNEY DIS, V44, P322, DOI 10.1053/j.ajkd.2004.04.048; Zeki SS, 2011, NAT REV GASTRO HEPAT, V8, P90, DOI 10.1038/nrgastro.2010.211; Zhao J, 2003, DIABETOLOGIA, V46, P1688, DOI 10.1007/s00125-003-1233-2; Ziskin JL, 2013, GUT, V62, P1012, DOI 10.1136/gutjnl-2011-301195	43	48	51	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 1	2015	17	4					486	498		10.1016/j.stem.2015.07.010	http://dx.doi.org/10.1016/j.stem.2015.07.010			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4TS	26431183	Bronze, Green Accepted			2022-12-28	WOS:000365693800014
J	Adams, PD; Jasper, H; Rudolph, KL				Adams, Peter D.; Jasper, Heinrich; Rudolph, K. Lenhard			Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer	CELL STEM CELL			English	Review							MITOCHONDRIAL-DNA MUTATIONS; SELFISH SPERMATOGONIAL SELECTION; DETECTABLE CLONAL MOSAICISM; HEMATOPOIETIC-STEM; INTESTINAL STEM; LIFE-SPAN; TELOMERE DYSFUNCTION; TISSUE HOMEOSTASIS; REPLICATION STRESS; EPIGENETIC REGULATORS	Aging is characterized by a decrease in genome integrity, impaired organ maintenance, and an increased risk of cancer, which coincide with clonal dominance of expanded mutant stem and progenitor cell populations in aging tissues, such as the intestinal epithelium, the hematopoietic system, and the male germline. Here we discuss possible explanations for age-associated increases in the initiation and/or progression of mutant stem/progenitor clones and highlight the roles of stem cell quiescence, replication-associated DNA damage, telomere shortening, epigenetic alterations, and metabolic challenges as determinants of stem cell mutations and clonal dominance in aging.	[Adams, Peter D.] Univ Glasgow, Glasgow G61 1BD, Lanark, Scotland; [Adams, Peter D.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Jasper, Heinrich] Buck Inst Res Aging, Novato, CA 94945 USA; [Rudolph, K. Lenhard] Leibniz Inst Age Res, Fritz Lipmann Inst e V FLI, D-07745 Jena, Germany	University of Glasgow; Beatson Institute; Buck Institute for Research on Aging; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Rudolph, KL (corresponding author), Leibniz Inst Age Res, Fritz Lipmann Inst e V FLI, Beutenbergstr 11, D-07745 Jena, Germany.	KLRudolph@FLI-Leibniz.de		Rudolph, Karl Lenhard/0000-0002-4839-2862; Adams, Peter/0000-0002-0684-1770	Else Kroner-Fresenius-Stiftung (EKFS); BBSRC; CRUK [C10652/A16566]; MRC; NIA [AG031862]; NIH [AG028127, GM100196, AG047497, EY018177]; Leibniz Association; European Union [ERC - 323136]; BBSRC [BB/K017233/1] Funding Source: UKRI; MRC [MR/M000605/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K017233/1] Funding Source: researchfish; Cancer Research UK [22311, 16566] Funding Source: researchfish; Medical Research Council [MR/M000605/1] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY018177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028127, P01AG031862, R01AG047497] Funding Source: NIH RePORTER	Else Kroner-Fresenius-Stiftung (EKFS); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CRUK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leibniz Association; European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Else Kroner-Fresenius-Stiftung (EKFS) in preparation for the "VII. Else Kroner-Fresenius Symposium on Adult Stem Cells in Aging, Diseases, and Cancer," hosted by the Ettore Majorana Foundation And Centre For Scientific Culture. The lab of P.D.A. is funded by BBSRC, CRUK (C10652/A16566), MRC, and NIA (AG031862). Work in Dr. Jasper's lab is supported by NIH grants AG028127, GM100196, AG047497, and EY018177. K.L.R. is supported by intramural funds of the Leibniz Association and the European Union (ERC - 323136).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Begus-Nahrmann Y, 2009, NAT GENET, V41, P1138, DOI 10.1038/ng.426; Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928; Berdasco M, 2012, AGING CELL, V11, P181, DOI 10.1111/j.1474-9726.2012.00806.x; Bilousova G, 2005, PLOS BIOL, V3, P2135, DOI 10.1371/journal.pbio.0030401; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Challen GA, 2014, CELL STEM CELL, V15, P350, DOI 10.1016/j.stem.2014.06.018; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Colla S, 2015, CANCER CELL, V27, P644, DOI 10.1016/j.ccell.2015.04.007; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Cruickshanks HA, 2013, NAT CELL BIOL, V15, P1495, DOI 10.1038/ncb2879; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; de Navascues J, 2012, EMBO J, V31, P2473, DOI 10.1038/emboj.2012.106; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Fernandez P, 2014, CELL REP, V9, P248, DOI 10.1016/j.celrep.2014.08.069; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Hackett JA, 2003, MOL CELL BIOL, V23, P8450, DOI 10.1128/MCB.23.23.8450-8461.2003; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Henry CJ, 2010, P NATL ACAD SCI USA, V107, P21713, DOI 10.1073/pnas.1005486107; Hiyama E, 1996, INT J ONCOL, V9, P453; Holohan B, 2014, J CELL BIOL, V205, P289, DOI 10.1083/jcb.201401012; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Hsieh JCF, 2013, AGING CELL, V12, P269, DOI 10.1111/acel.12053; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kapuria S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003045; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim JY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-10; Kim KM, 2002, ONCOGENE, V21, P5441, DOI 10.1038/sj.onc.1205604; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kozar S, 2013, CELL STEM CELL, V13, P626, DOI 10.1016/j.stem.2013.08.001; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Maegawa S, 2014, GENOME RES, V24, P580, DOI 10.1101/gr.157529.113; Maher GJ, 2014, ANDROLOGY-US, V2, P304, DOI 10.1111/j.2047-2927.2013.00175.x; Marino G, 2010, P NATL ACAD SCI USA, V107, P16268, DOI 10.1073/pnas.1002696107; Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6; Maryanovich M, 2012, NAT CELL BIOL, V14, P535, DOI 10.1038/ncb2468; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Mayle A, 2015, BLOOD, V125, P629, DOI 10.1182/blood-2014-08-594648; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; Meena JK, 2015, EMBO J, V34, P1371, DOI 10.15252/embj.201490070; Missios P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5924; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; North BJ, 2014, EMBO J, V33, P1438, DOI 10.15252/embj.201386907; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105; Rai TS, 2014, GENE DEV, V28, P2712, DOI 10.1101/gad.247528.114; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; SHAVERWALKER PM, 1995, P NATL ACAD SCI USA, V92, P11470, DOI 10.1073/pnas.92.25.11470; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Sirin O, 2010, NAT CELL BIOL, V12, P1213, DOI 10.1038/ncb2125; Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Swierczek SI, 2008, BLOOD, V112, P3186, DOI 10.1182/blood-2008-03-143925; TAO KS, 1993, P NATL ACAD SCI USA, V90, P10681, DOI 10.1073/pnas.90.22.10681; Tao S, 2015, EMBO J, V34, P624, DOI 10.15252/embj.201490700; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Townsley DM, 2014, BLOOD, V124, P2775, DOI 10.1182/blood-2014-05-526285; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Vas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042080; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Velarde MC, 2013, INTERD TOP GERONTOL, V38, P17, DOI 10.1159/000343572; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Wang JW, 2014, BLOOD, V124, P3237, DOI 10.1182/blood-2014-04-568055; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Weidner CI, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r24; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yancik R, 2005, CANCER J, V11, P437, DOI 10.1097/00130404-200511000-00002; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163	149	115	118	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					601	612		10.1016/j.stem.2015.05.002	http://dx.doi.org/10.1016/j.stem.2015.05.002			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26046760	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000355932300010
J	Buganim, Y				Buganim, Yosef			Tex10: A New Player in the Core Pluripotency Circuitry	CELL STEM CELL			English	Editorial Material							STEM; CELLS	Revealing how the core pluripotency circuitry is orchestrated to maintain the ground state of embryonic stem cells (ESCs) is fundamental for understanding self-renewal and early lineage specifications. In this issue of Cell Stem Cell, Ding et al. (2015) identify a new Sox2-interacting protein, Tex10, which, together with Tet1 and p300, regulate super-enhancers to sustain pluripotency.	Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Buganim, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel.	yossibug@ekmd.huji.ac.il						Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Bagci H, 2013, CELL STEM CELL, V13, P265, DOI 10.1016/j.stem.2013.08.005; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Ding JJ, 2015, CELL STEM CELL, V16, P653, DOI 10.1016/j.stem.2015.04.001; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	10	3	3	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					572	573		10.1016/j.stem.2015.04.019	http://dx.doi.org/10.1016/j.stem.2015.04.019			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26046753	Bronze			2022-12-28	WOS:000355932300002
J	Diaz-Ruiz, A; Gonzalez-Freire, M; Ferrucci, L; Bernier, M; de Cabo, R				Diaz-Ruiz, Alberto; Gonzalez-Freire, Marta; Ferrucci, Luigi; Bernier, Michel; de Cabo, Rafael			SIRT1 Synchs Satellite Cell Metabolism with Stem Cell Fate	CELL STEM CELL			English	Editorial Material								Metabolic reprogramming of muscle stem cells modulates myogenic cell fate. In this issue of Cell Stem Cell, Ryall et al. (2015) show that SIRT1, a NAD(+)- dependent histone deacetylase, acts as an epigenetic regulator that connects changes in satellite cell metabolism with changes in the transcriptional machinery toward myogenic commitment.	[Diaz-Ruiz, Alberto; Gonzalez-Freire, Marta; Ferrucci, Luigi; Bernier, Michel; de Cabo, Rafael] NIA, Expt Gerontol Sect, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	de Cabo, R (corresponding author), NIA, Expt Gerontol Sect, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.	deCaboRa@mail.nih.gov	Bernier, Michel/Y-7139-2019; Gonzalez-Freire, Marta/ABG-1197-2020; de Cabo, Rafael Carlos/J-5230-2016; Bernier, Michel/AAO-3983-2021; de Cabo, Rafael/E-7996-2010; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael Carlos/0000-0003-2830-5693; Bernier, Michel/0000-0002-5948-368X; de Cabo, Rafael/0000-0003-2830-5693; Gonzalez-Freire, Marta/0000-0001-9741-2826; Diaz-Ruiz, Alberto/0000-0002-0488-4216; de Cabo, Rafael/0000-0002-3354-2442	NATIONAL INSTITUTE ON AGING [ZIAAG000368] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bosch-Presegue L., 2014, FEBS J; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Manzano R, 2011, J CELL BIOCHEM, V112, P2825, DOI 10.1002/jcb.23197; Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; Segales J., 2014, FEBS J; Tang AH, 2014, EMBO J, V33, P2782, DOI 10.15252/embj.201488278; Tonkin J, 2012, CURR OPIN PHARMACOL, V12, P372, DOI 10.1016/j.coph.2012.02.010; Zhong L, 2010, TRANSCR-AUSTIN, V1, P17, DOI 10.4161/trns.1.1.12143	10	9	12	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					103	104		10.1016/j.stem.2015.01.006	http://dx.doi.org/10.1016/j.stem.2015.01.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25658362	Bronze			2022-12-28	WOS:000349455000001
J	Puri, S; Folias, AE; Hebrok, M				Puri, Sapna; Folias, Alexandra E.; Hebrok, Matthias			Plasticity and Dedifferentiation within the Pancreas: Development, Homeostasis, and Disease	CELL STEM CELL			English	Review							BETA-CELL DEDIFFERENTIATION; ONCOGENIC KRAS; ACINAR-CELL; ALPHA-CELL; TRANSCRIPTION FACTORS; ENDOCRINE PANCREAS; PROGENITOR CELLS; DUCTAL CELLS; DIFFERENTIATION; EXPRESSION	Cellular identity is established by genetic, epigenetic, and environmental factors that regulate organogenesis and tissue homeostasis. Although some flexibility in fate potential is beneficial to overall organ health, dramatic changes in cellular identity can have disastrous consequences. Emerging data within the field of pancreas biology are revising current beliefs about how cellular identity is shaped by developmental and environmental cues under homeostasis and stress conditions. Here, we discuss the changes occurring in cellular states upon fate modulation and address how our understanding of the nature of this fluidity is shaping therapeutic approaches to pancreatic disorders such as diabetes and cancer.	[Puri, Sapna; Folias, Alexandra E.; Hebrok, Matthias] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Hebrok, M (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA.	mhebrok@diabetes.ucsf.edu			Leona M. and Harry B. Helmsley Charitable Trust [09PG-T1D018]; Juvenile Diabetes Research Foundation (JDRF) [17-2013-380]; NIH; NCI [R01CA172045]; Juvenile Diabetes Research Foundation [3-2011-95]; NATIONAL CANCER INSTITUTE [R01CA172045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Audrey Parent, Nilotpal Roy, and Holger A. Russ for critically reading the manuscript. We thank The Leona M. and Harry B. Helmsley Charitable Trust (09PG-T1D018), the Juvenile Diabetes Research Foundation (JDRF 17-2013-380), and the NIH and NCI (R01CA172045) for supporting the work in the laboratory of M.H. and the Juvenile Diabetes Research Foundation (3-2011-95) for supporting the postdoctoral fellowship of A.E.F.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Arda HE, 2013, DEV CELL, V25, P5, DOI 10.1016/j.devcel.2013.03.016; Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Baeyens L, 2009, GASTROENTEROLOGY, V136, P1750, DOI 10.1053/j.gastro.2009.01.047; Benitez CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012401; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bertolino P, 2003, CANCER RES, V63, P4836; Blum B, 2014, ELIFE, V3, DOI 10.7554/eLife.02809; Bonal C, 2009, GASTROENTEROLOGY, V136, P309, DOI 10.1053/j.gastro.2008.10.015; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carriere C, 2007, P NATL ACAD SCI USA, V104, P4437, DOI 10.1073/pnas.0701117104; Chera S, 2014, NATURE, V514, P503, DOI 10.1038/nature13633; Cherry ABC, 2012, CELL, V148, P1110, DOI 10.1016/j.cell.2012.02.031; Cleveland MH, 2012, SEMIN CELL DEV BIOL, V23, P711, DOI 10.1016/j.semcdb.2012.06.008; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Courtney M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003934; Delous M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002754; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; Direnzo D, 2012, GASTROENTEROLOGY, V143, P469, DOI 10.1053/j.gastro.2012.04.011; Feldmann G, 2007, J HEPATO-BILIARY-PAN, V14, P224, DOI 10.1007/s00534-006-1166-5; Folias AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102125; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Harmon JS, 1999, DIABETES, V48, P1995, DOI 10.2337/diabetes.48.10.1995; Hart AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054173; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Haumaitre C, 2008, MOL CELL BIOL, V28, P6373, DOI 10.1128/MCB.00413-08; Hesselson D, 2011, CURR BIOL, V21, P712, DOI 10.1016/j.cub.2011.03.041; Holmstrom SR, 2011, GENE DEV, V25, P1674, DOI 10.1101/gad.16860911; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kamisawa T, 2002, DIGEST DIS SCI, V47, P2254, DOI 10.1023/A:1020139328215; Kaspi H, 2014, TRENDS ENDOCRIN MET, V25, P285, DOI 10.1016/j.tem.2014.01.003; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kloppel G, 2011, ENDOCR-RELAT CANCER, V18, pS1, DOI 10.1530/ERC-11-0013; Kopinke D, 2012, DEV BIOL, V362, P57, DOI 10.1016/j.ydbio.2011.11.010; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kordowich S, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-52; Kubicek S, 2012, P NATL ACAD SCI USA, V109, P5364, DOI 10.1073/pnas.1201079109; Landsman L, 2011, P NATL ACAD SCI USA, V108, P17010, DOI 10.1073/pnas.1105404108; Lenoir O, 2011, DIABETES, V60, P2861, DOI 10.2337/db11-0440; Li WD, 2014, ELIFE, V3, DOI 10.7554/eLife.01846; Lin JW, 2004, DEV BIOL, V270, P474, DOI 10.1016/j.ydbio.2004.02.023; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Manfroid I, 2012, DEV BIOL, V366, P268, DOI 10.1016/j.ydbio.2012.04.002; Mansouri Ahmed, 2012, ISRN Endocrinol, V2012, P640956, DOI 10.5402/2012/640956; Mastracci TL, 2011, DEV BIOL, V359, P1, DOI 10.1016/j.ydbio.2011.08.001; Matthaei H, 2011, NAT REV GASTRO HEPAT, V8, P141, DOI 10.1038/nrgastro.2011.2; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Offield MF, 1996, DEVELOPMENT, V122, P983; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; Pierreux CE, 2006, GASTROENTEROLOGY, V130, P532, DOI 10.1053/j.gastro.2005.12.005; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Prevot PP, 2013, GASTROENTEROLOGY, V145, P668, DOI 10.1053/j.gastro.2013.05.016; Prevot PP, 2012, GUT, V61, P1723, DOI 10.1136/gutjnl-2011-300266; Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10; Puri S, 2013, GENE DEV, V27, P2563, DOI 10.1101/gad.227785.113; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Sancho R, 2014, CELL STEM CELL, V15, P139, DOI 10.1016/j.stem.2014.06.019; Schaffer AE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003274; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Seymour PA, 2008, DEV BIOL, V323, P19, DOI 10.1016/j.ydbio.2008.07.034; Shang LS, 2014, DIABETES, V63, P923, DOI 10.2337/db13-0717; Shi CJ, 2012, HUM PATHOL, V43, P1, DOI 10.1016/j.humpath.2011.04.003; Shi G, 2013, ONCOGENE, V32, P1950, DOI 10.1038/onc.2012.210; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Song SY, 1999, GASTROENTEROLOGY, V117, P1416, DOI 10.1016/S0016-5085(99)70292-1; Spijker HS, 2013, DIABETES, V62, P2471, DOI 10.2337/db12-1001; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Swales N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037055; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; von Figura G, 2014, GUT, V63, P656, DOI 10.1136/gutjnl-2012-304287; von Figura G, 2014, NAT CELL BIOL, V16, P255, DOI 10.1038/ncb2916; Vortmeyer AO, 2004, J CLIN ENDOCR METAB, V89, P1934, DOI 10.1210/jc.2003-031575; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Wilcox CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066214; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yang YP, 2011, GENE DEV, V25, P1680, DOI 10.1101/gad.16875711; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang HJ, 2009, MECH DEVELOP, V126, P958, DOI 10.1016/j.mod.2009.09.006; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	120	98	101	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2015	16	1					18	31		10.1016/j.stem.2014.11.001	http://dx.doi.org/10.1016/j.stem.2014.11.001			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AY6YK	25465113	Bronze, Green Accepted			2022-12-28	WOS:000347708400008
J	Cuiffo, BG; Campagne, A; Bell, GW; Lembo, A; Orso, F; Lien, EC; Bhasin, MK; Raimo, M; Hanson, SE; Marusyk, A; El-Ashry, D; Hematti, P; Polyak, K; Mechta-Grigoriou, F; Mariani, O; Volinia, S; Vincent-Salomon, A; Taverna, D; Kamoub, AE				Cuiffo, Benjamin G.; Campagne, Antoine; Bell, George W.; Lembo, Antonio; Orso, Francesca; Lien, Evan C.; Bhasin, Manoj K.; Raimo, Monica; Hanson, Summer E.; Marusyk, Andriy; El-Ashry, Dorraya; Hematti, Peiman; Polyak, Kornelia; Mechta-Grigoriou, Fatima; Mariani, Odette; Volinia, Stefano; Vincent-Salomon, Anne; Taverna, Daniela; Kamoub, Antoine E.			MSC-Regulated MicroRNAs Converge on the Transcription Factor FOXP2 and Promote Breast Cancer Metastasis	CELL STEM CELL			English	Article							MESENCHYMAL STEM-CELLS; HUMAN OVARIAN-CANCER; EXPRESSION SIGNATURE; TUMOR PROGRESSION; EMERGING ROLES; SURVIVAL; GROWTH; CARCINOGENESIS; TUMORIGENESIS; TRANSITION	Mesenchymal stem/stromal cells (MSCs) are progenitor cells shown to participate in breast tumor stroma formation and to promote metastasis. Despite expanding knowledge of their contributions to breast malignancy, the underlying molecular responses of breast cancer cells (BCCs) to MSC influences remain incompletely understood. Here, we show that MSCs cause aberrant expression of microRNAs, which, led by microRNA-199a, provide BCCs with enhanced cancer stem cell (CSC) properties. We demonstrate that such MSC-deregulated microRNAs constitute a network that converges on and represses the expression of FOXP2, a forkhead transcription factor tightly associated with speech and language development. FOXP2 knockdown in BCCs was sufficient in promoting CSC propagation, tumor initiation, and metastasis. Importantly, elevated microRNA-199a and depressed FOXP2 expression levels are prominent features of malignant clinical breast cancer and are associated significantly with poor survival. Our results identify molecular determinants of cancer progression of potential utility in the prognosis and therapy of breast cancer.	[Cuiffo, Benjamin G.; Campagne, Antoine; Lien, Evan C.; Kamoub, Antoine E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Campagne, Antoine; Mechta-Grigoriou, Fatima; Mariani, Odette; Vincent-Salomon, Anne] Inst Curie, F-75248 Paris 05, France; [Bell, George W.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lembo, Antonio; Orso, Francesca; Raimo, Monica; Taverna, Daniela] Univ Turin, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy; [Lembo, Antonio; Orso, Francesca; Raimo, Monica; Taverna, Daniela] MBC, I-10126 Turin, Italy; [Bhasin, Manoj K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Hanson, Summer E.; Hematti, Peiman] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI 53792 USA; [Marusyk, Andriy; Polyak, Kornelia] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Med Oncol, Boston, MA 02215 USA; [Marusyk, Andriy; Polyak, Kornelia] Harvard Univ, Dept Med, Sch Med, Boston, MA 02215 USA; [El-Ashry, Dorraya] Univ Miami, Miller Sch Med, Dept Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Volinia, Stefano] Univ Ferrara, Human Anat Branch, Dept Morphol Surg & Expt Med, I-44121 Ferrara, Italy; [Kamoub, Antoine E.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Kamoub, Antoine E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Turin; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Miami; University of Ferrara; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kamoub, AE (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA.	akarnoub@bidmc.harvard.edu	Volinia, Stefano/AAA-9264-2019; MECHTA-GRIGORIOU, Fatima/C-5253-2017; Volinia, Stefano/A-3029-2010; taverna, daniela/J-8358-2016; Orso, Francesca/B-1985-2014	Volinia, Stefano/0000-0003-0910-3893; MECHTA-GRIGORIOU, Fatima/0000-0002-3751-6989; Volinia, Stefano/0000-0003-0910-3893; taverna, daniela/0000-0002-6365-527X; Orso, Francesca/0000-0003-4706-6464; Bhasin, Manoj/0000-0001-5172-420X; Lien, Evan/0000-0001-7866-4761	BIDMC; Sidney Kimmel Cancer Research Foundation; Susan G. Komen For The Cure; AIRC [IG14201]; Compagnia di San Paolo [2008.1054]; Progetto Ricerca Ateneo Torino; BIDMC Prostate and Breast Cancer Research Program	BIDMC; Sidney Kimmel Cancer Research Foundation; Susan G. Komen For The Cure(Susan G. Komen Breast Cancer Foundation); AIRC(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo(Compagnia di San Paolo); Progetto Ricerca Ateneo Torino; BIDMC Prostate and Breast Cancer Research Program	We thank J. Love, J.-A. Kwon, and S. Gupta for miRNA profiling data analysis; A. Contreras for assistance in animal studies; K. Groglio and M. Fahlberg for FACS sorting assistance; D. Louvard for assistance in clinical specimen procurement; and P. Pandolfi and P. Provero for helpful discussions. This work was supported by start-up funds from BIDMC (A.E.K.), the Sidney Kimmel Cancer Research Foundation (A.E.K.), the Susan G. Komen For The Cure (A.E.K.), AIRC IG14201 (D.T.), Compagnia di San Paolo, 2008.1054 (D.T.), and Progetto Ricerca Ateneo Torino (D.T.). Human BM-MSCs were provided by the Texas A&M Health Science Center (CMI for Regenerative Medicine at Scott & White) through NIH P40RR017447. B.G.C. is a 2012 American Cancer Society Postdoctoral Fellow. F.O. is a recipient of FIRB giovani 2008 (RBFR08F2FS-276 002). A.E.K. is a 2010 Kimmel Scholar, a recipient of a Career Development Award from the BIDMC Prostate and Breast Cancer Research Program, and a recipient of a 2012 Career Catalyst Research Award from Susan G. Komen For The Cure.	Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Battula VL, 2012, J CLIN INVEST, V122, P2066, DOI 10.1172/JCI59735; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Brenner B, 2011, WORLD J GASTROENTERO, V17, P3976, DOI 10.3748/wjg.v17.i35.3976; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Cimino D, 2013, FASEB J, V27, P1223, DOI 10.1096/fj.12-214692; Cuiffo BG, 2012, CELL ADHES MIGR, V6, P220, DOI 10.4161/cam.20875; Dedeurwaerder S, 2011, EMBO MOL MED, V3, P726, DOI 10.1002/emmm.201100801; Dorado J, 2011, J GASTROENTEROL, V46, P966, DOI 10.1007/s00535-011-0422-x; Drews-Elger K, 2014, BREAST CANCER RES TR, V144, P503, DOI 10.1007/s10549-014-2887-9; El-Haibi CP, 2012, P NATL ACAD SCI USA, V109, P17460, DOI 10.1073/pnas.1206653109; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Feber A, 2011, ANN THORAC SURG, V91, P1523, DOI 10.1016/j.athoracsur.2011.01.056; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goldstein RH, 2010, CANCER RES, V70, P10044, DOI 10.1158/0008-5472.CAN-10-1254; Hanson SE, 2013, AESTHET SURG J, V33, P888, DOI 10.1177/1090820X13496115; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2766; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mascaux C, 2009, EUR RESPIR J, V33, P352, DOI 10.1183/09031936.00084108; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nair R, 2014, ONCOGENE, V33, P3992, DOI 10.1038/onc.2013.368; Okamoto OK, 2007, BBA-GENE STRUCT EXPR, V1769, P437, DOI 10.1016/j.bbaexp.2007.05.002; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prantl L, 2010, PROSTATE, V70, P1709, DOI 10.1002/pros.21206; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Sabatier R, 2011, BREAST CANCER RES TR, V126, P407, DOI 10.1007/s10549-010-0897-9; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Schwarzenbach H, 2012, BREAST CANCER RES TR, V134, P933, DOI 10.1007/s10549-012-1988-6; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Suzuki K, 2011, MOL MED, V17, P579, DOI 10.2119/molmed.2010.00157; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Toullec A, 2010, EMBO MOL MED, V2, P211, DOI 10.1002/emmm.201000073; Tsui D, 2013, J NEUROSCI, V33, P244, DOI 10.1523/JNEUROSCI.1665-12.2013; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wan DW, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0378-6; Yan XL, 2012, BREAST CANCER RES TR, V132, P153, DOI 10.1007/s10549-011-1577-0; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhang XJ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-46; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006	65	126	131	2	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					762	774		10.1016/j.stem.2014.10.001	http://dx.doi.org/10.1016/j.stem.2014.10.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25515522	Bronze, Green Submitted			2022-12-28	WOS:000347174300014
J	Varum, S; Sommer, L				Varum, Sandra; Sommer, Lukas			Reinventing the Neural Crest: Direct Reprogramming Makes iNCCs	CELL STEM CELL			English	Editorial Material							PATIENT-SPECIFIC IPSCS; STEM-CELLS; DISEASE	Aberrant neural crest (NC) development is at the origin of many congenital diseases. Given the limitations in human NC cell isolation and expansion, the development of new strategies for NC generation is crucial. In this issue of Cell Stem Cell, Kim et al. (2014) report the direct reprogramming of postnatal fibroblasts into multipotent NC cells.	[Varum, Sandra; Sommer, Lukas] Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland	University of Zurich	Sommer, L (corresponding author), Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland.	lukas.sommer@anatom.uzh.ch		Sommer, Lukas/0000-0002-1143-7908				Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035; Groves AK, 2014, DEV BIOL, V389, P2, DOI 10.1016/j.ydbio.2013.11.027; Kim YJ, 2014, CELL STEM CELL, V15, P497, DOI 10.1016/j.stem.2014.07.013; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Takahashi Y, 2013, SCIENCE, V341, P860, DOI 10.1126/science.1230717	8	0	0	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					397	399		10.1016/j.stem.2014.09.007	http://dx.doi.org/10.1016/j.stem.2014.09.007			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25280213	Bronze, Green Accepted			2022-12-28	WOS:000343235800003
J	Pellegrini, G; De Luca, M				Pellegrini, Graziella; De Luca, Michele			Eyes on the Prize: Limbal Stem Cells and Corneal Restoration	CELL STEM CELL			English	Editorial Material							OCULAR SURFACE; TRANSPLANTATION; KERATINOCYTE; EPITHELIUM; P63	Corneal diseases and blindness can result from deficiency in limbal stem cells, and autologous transplantation is often the only therapeutic option. Two recent studies in Nature have provided insights into regulation of limbal stem cell function and corneal regeneration and present new opportunities for clinical interventions in eye diseases.	[Pellegrini, Graziella; De Luca, Michele] Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, Modena, Italy	Universita di Modena e Reggio Emilia	Pellegrini, G (corresponding author), Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, Via G Gottardi 100, Modena, Italy.	graziella.pellegrini@unimore.it; michele.deluca@unimore.it	Pellegrini, Graziella/E-1189-2015; De Luca, Michele/N-5883-2014	Pellegrini, Graziella/0000-0001-9861-0736; De Luca, Michele/0000-0002-0850-8445				BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; Kenyon KR, 1989, OPHTHALMOLOGY, V96, P722; Ksander BR, 2014, NATURE, V511, P353, DOI 10.1038/nature13426; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Ouyang H, 2014, NATURE, V511, P358, DOI 10.1038/nature13465; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045	11	30	31	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					121	122		10.1016/j.stem.2014.07.011	http://dx.doi.org/10.1016/j.stem.2014.07.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	25105577	Bronze			2022-12-28	WOS:000340880100006
J	Seifert, BA; Xiong, Y				Seifert, Bryce A.; Xiong, Yue			Out of the F-box: Reawakening the Pancreas	CELL STEM CELL			English	Editorial Material							BETA-CELLS; DIFFERENTIATION; MECHANISMS	The adult pancreas lacks stem cells, and consequently, differentiation of pancreatic endocrine cells has been restricted to embryonic development or experimental manipulation. In this issue of Cell Stem Cell, Sancho et al. (2014) show that pancreas-specific loss of the ubiquitin ligase Fbxw7 stabilizes an endocrine-specific transcription factor, Ngn3, thus inducing in vivo beta cell neogenesis.	[Seifert, Bryce A.; Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Seifert, Bryce A.; Xiong, Yue] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Xiong, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	yxiong@email.unc.edu	Seifert, Bryce/R-6071-2019	Seifert, Bryce/0000-0001-7970-3611	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067113] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067113] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Pagliuca FW, 2013, DEVELOPMENT, V140, P2472, DOI 10.1242/dev.093187; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sancho R, 2014, CELL STEM CELL, V15, P139, DOI 10.1016/j.stem.2014.06.019; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	9	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					111	112		10.1016/j.stem.2014.07.006	http://dx.doi.org/10.1016/j.stem.2014.07.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	25105572	Green Accepted, Bronze			2022-12-28	WOS:000340880100001
J	Yoon, KJ; Nguyen, HN; Ursini, G; Zhang, FY; Kim, NS; Wen, ZX; Makri, G; Nauen, D; Shin, JH; Park, Y; Chung, R; Pekle, E; Zhang, C; Towe, M; Mohammed, S; Hussaini, Q; Lee, Y; Rujescu, D; St Clair, D; Kleinman, JE; Hyde, TM; Krauss, G; Christian, KM; Rapoport, JL; Weinberger, DR; Song, HJ; Ming, GL				Yoon, Ki-Jun; Ha Nam Nguyen; Ursini, Gianluca; Zhang, Fengyu; Kim, Nam-Shik; Wen, Zhexing; Makri, Georgia; Nauen, David; Shin, Joo Heon; Park, Youngbin; Chung, Raeeun; Pekle, Eva; Zhang, Ce; Towe, Maxwell; Mohammed, Syed; Hussaini, Qasim; Lee, Yohan; Rujescu, Dan; St Clair, David; Kleinman, Joel E.; Hyde, Thomas M.; Krauss, Gregory; Christian, Kimberly M.; Rapoport, Judith L.; Weinberger, Daniel R.; Song, Hongjun; Ming, Guo-li			Modeling a Genetic Risk for Schizophrenia in iPSCs and Mice Reveals Neural Stem Cell Deficits Associated with Adherens Junctions and Polarity	CELL STEM CELL			English	Article							COPY NUMBER VARIANTS; RECURRENT MICRODELETIONS; 15Q11.2; PROTEIN; WAVE2; PATHOGENESIS; MAINTENANCE; PRECURSORS; DROSOPHILA; MIGRATION	Defects in brain development are believed to contribute toward the onset of neuropsychiatric disorders, but identifying specific underlying mechanisms has proven difficult. Here, we took a multifaceted approach to investigate why 15q11.2 copy number variants are prominent risk factors for schizophrenia and autism. First, we show that human iPSC-derived neural progenitors carrying 15q11.2 microdeletion exhibit deficits in adherens junctions and apical polarity. This results from haploinsufficiency of CYFIP1, a gene within 15q11.2 that encodes a subunit of the WAVE complex, which regulates cytoskeletal dynamics. In developing mouse cortex, deficiency in CYFIP1 and WAVE signaling similarly affects radial glial cells, leading to their ectopic localization outside of the ventricular zone. Finally, targeted human genetic association analyses revealed an epistatic interaction between CYFIP1 and WAVE signaling mediator ACTR2 and risk for schizophrenia. Our findings provide insight into how CYFIP1 regulates neural stem cell function and may contribute to the susceptibility of neuropsychiatric disorders.	[Yoon, Ki-Jun; Ha Nam Nguyen; Kim, Nam-Shik; Wen, Zhexing; Makri, Georgia; Nauen, David; Park, Youngbin; Chung, Raeeun; Pekle, Eva; Zhang, Ce; Towe, Maxwell; Mohammed, Syed; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Yoon, Ki-Jun; Kim, Nam-Shik; Wen, Zhexing; Makri, Georgia; Zhang, Ce; Krauss, Gregory; Christian, Kimberly M.; Weinberger, Daniel R.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ha Nam Nguyen; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Ursini, Gianluca; Zhang, Fengyu; Shin, Joo Heon; Kleinman, Joel E.; Hyde, Thomas M.; Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Nauen, David] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Lee, Yohan; Rapoport, Judith L.] NIMH, Child Psychiat Branch, Bethesda, MD 20892 USA; [Rujescu, Dan] Univ Munich, Dept Psychiat, D-80336 Munich, Germany; [St Clair, David] Univ Aberdeen, Royal Cornhill Hosp, Aberdeen AB25 2ZD, Scotland; [Weinberger, Daniel R.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Munich; University of Aberdeen; Johns Hopkins University	Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	shongju1@jhmi.edu; gming1@jhmi.edu	Wen, Zhexing/B-9313-2014; Rujescu, Dan/GRS-3875-2022; St Clair, David/AAN-2412-2021; Zhang, Fengyu/M-1396-2019; Yoon, Ki-Jun/S-8170-2018; Ursini, Gianluca/AAA-8242-2019; Wen, Zhexing/L-1228-2018	Zhang, Fengyu/0000-0001-8504-0770; Wen, Zhexing/0000-0002-1518-3845; Hussaini, Syed/0000-0002-8006-5343; Ming, Guo-li/0000-0002-2517-6075; Park, Youngbin/0000-0003-1949-4568; Yoon, Ki-Jun/0000-0003-2985-2541; Ursini, Gianluca/0000-0002-4733-5196	NIH [NS048271, HD069184, NS047344, MH087874, F31MH102978]; Brain and Behavior Research Foundation (NARSAD); Maryland Stem Cell Research Fund (MSCRF); Simons Foundation Autism Research Initiative (SFARI); International Mental Health Research Organization (IMHRO); Lieber Institute for Brain Development; NARSAD; MSCRF; HFSP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH102978, R33MH087874, ZIAMH002581, R21MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344, R56NS047344, R01NS048271, R01NS047344] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation (NARSAD)(NARSAD); Maryland Stem Cell Research Fund (MSCRF); Simons Foundation Autism Research Initiative (SFARI); International Mental Health Research Organization (IMHRO); Lieber Institute for Brain Development; NARSAD(NARSAD); MSCRF; HFSP(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank members of G.-l.M. and H.S. laboratories for discussion, ICE stem cell core and H. Kim for generating some iPSC lines, K. Ahn, T. Andersen, V. Villagomez, L. Liu, and Y. Cai for technical support and help. This work was supported by NIH (NS048271, HD069184), the Brain and Behavior Research Foundation (NARSAD), and the Maryland Stem Cell Research Fund (MSCRF) (to G.-l. M.), the Simons Foundation Autism Research Initiative (SFARI), NIH (NS047344, MH087874), and the International Mental Health Research Organization (IMHRO) to H. S., the Lieber Institute for Brain Development to D.R.W., J.E.K., and T.M.H., NARSAD and MSCRF to K.M.C., by fellowships from HFSP to K-j.Y. and MSCRF to G.M., N.-S.K., and Z.W., and from NIH (F31MH102978) to H.N.N.	Arnold SE, 1999, DEV PSYCHOPATHOL, V11, P439, DOI 10.1017/S095457949900214X; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Bogdan S, 2004, DEVELOPMENT, V131, P3981, DOI 10.1242/dev.01274; Bozdagi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042422; Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; Chiang CH, 2011, MOL PSYCHIATR, V16, P358, DOI 10.1038/mp.2011.13; Christian Kimberly M, 2012, Front Biol (Beijing), V7, P179, DOI 10.1007/s11515-012-1216-0; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; De Wolf V, 2013, AM J MED GENET A, V161, P2846, DOI 10.1002/ajmg.a.36209; Dubielecka PM, 2011, P NATL ACAD SCI USA, V108, P7022, DOI 10.1073/pnas.1016811108; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Galy A, 2011, DEV BIOL, V359, P37, DOI 10.1016/j.ydbio.2011.08.009; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Itoh Y, 2013, NAT NEUROSCI, V16, P416, DOI 10.1038/nn.3336; Jahn JA, 2014, EPILEPSY RES, V108, P109, DOI 10.1016/j.eplepsyres.2013.10.001; Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Mattai AA, 2011, J AM ACAD CHILD PSY, V50, P697, DOI 10.1016/j.jaac.2011.03.016; Mullen SA, 2013, NEUROLOGY, V81, P1507, DOI 10.1212/WNL.0b013e3182a95829; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Rousso DL, 2012, NEURON, V74, P314, DOI 10.1016/j.neuron.2012.02.024; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Thomson Pippa A, 2013, Front Biol (Beijing), V8, P1; van der Zwaag B, 2010, AM J MED GENET B, V153B, P960, DOI 10.1002/ajmg.b.31055; Vauti F, 2007, FEBS LETT, V581, P5691, DOI 10.1016/j.febslet.2007.11.031; Wegiel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035414; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Zhang FY, 2011, BIOL PSYCHIAT, V69, P914, DOI 10.1016/j.biopsych.2011.01.003; Zhao L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003450; Zhao Q, 2013, SCHIZOPHRENIA BULL, V39, P712, DOI 10.1093/schbul/sbr197	53	170	175	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					79	91		10.1016/j.stem.2014.05.003	http://dx.doi.org/10.1016/j.stem.2014.05.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24996170	Bronze, Green Accepted			2022-12-28	WOS:000340878600013
J	Yeo, JC; Jiang, JM; Tan, ZY; Yim, GR; Ng, JH; Goke, J; Kraus, P; Liang, HQ; Gonzales, KAU; Chong, HC; Tan, CP; Lim, YS; Tan, NS; Lufkin, T; Ng, HH				Yeo, Jia-Chi; Jiang, Jianming; Tan, Zi-Ying; Yim, Guo-Rong; Ng, Jia-Hui; Goeke, Jonathan; Kraus, Petra; Liang, Hongqing; Gonzales, Kevin Andrew Uy; Chong, Han-Chung; Tan, Cheng-Peow; Lim, Yee-Siang; Tan, Nguan-Soon; Lufkin, Thomas; Ng, Huck-Hui			Klf2 Is an Essential Factor that Sustains Ground State Pluripotency	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; MOUSE; GENERATION; PROTEINS; LINEAGE; LIF; ES	The maintenance of mouse embryonic stem cells (mESCs) requires LIF and serum. However, a pluripotent "ground state," bearing resemblance to preimplantation mouse epiblasts, can be established through dual inhibition (2i) of both prodifferentiation Mek/Erk and Gsk3/Tcf3 pathways. While Gsk3 inhibition has been attributed to the transcriptional derepression of Esrrb, the molecular mechanism mediated by Mek inhibition remains unclear. In this study, we show that Kruppel-like factor 2 (Klf2) is phosphorylated by Erk2 and that phospho-Klf2 is proteosomally degraded. Mek inhibition hence prevents Klf2 protein phosphodegradation to sustain pluripotency. Indeed, while Klf2-null mESCs can survive under LIF/Serum, they are not viable under 2i, demonstrating that Klf2 is essential for ground state pluripotency. Importantly, we also show that ectopic Klf2 expression can replace Mek inhibition in mESCs, allowing the culture of Klf2-null mESCs under Gsk3 inhibition alone. Collectively, our study defines the Mek/Erk/Klf2 axis that cooperates with the Gsk3/Tcf3/Esrrb pathway in mediating ground state pluripotency.	[Yeo, Jia-Chi; Jiang, Jianming; Tan, Zi-Ying; Yim, Guo-Rong; Ng, Jia-Hui; Goeke, Jonathan; Kraus, Petra; Liang, Hongqing; Gonzales, Kevin Andrew Uy; Tan, Cheng-Peow; Lim, Yee-Siang; Lufkin, Thomas; Ng, Huck-Hui] Genome Inst Singapore, Singapore 138672, Singapore; [Yeo, Jia-Chi; Chong, Han-Chung; Tan, Nguan-Soon; Ng, Huck-Hui] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Tan, Zi-Ying; Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Gonzales, Kevin Andrew Uy; Ng, Huck-Hui] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Ctr Translat Med, Singapore 117599, Singapore; [Kraus, Petra; Lufkin, Thomas] Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA; [Tan, Nguan-Soon] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; National University of Singapore; Clarkson University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Ng, HH (corresponding author), Genome Inst Singapore, 60 Biopolis St,02-01 Genome Bldg, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg	Lufkin, Thomas/B-5352-2011; Tan, Nguan Soon/A-2220-2011; jiang, jianming/B-3421-2012; Kraus, Petra/I-5849-2014; Lufkin, Thomas/AAG-7476-2019; Ng, Huck Hui/A-1135-2009; Yim, Daniel/J-8834-2013	Lufkin, Thomas/0000-0002-7902-4771; Tan, Nguan Soon/0000-0003-0136-7341; jiang, jianming/0000-0003-3251-2716; Kraus, Petra/0000-0002-6716-5550; Lufkin, Thomas/0000-0002-7902-4771; Lim, Yee Siang/0000-0001-6522-7386; Goke, Jonathan/0000-0002-0825-4991; Gonzales, Kevin Andrew/0000-0001-7418-965X; Yim, Daniel/0000-0001-6153-4725	Biomedical Research Council (BMRC); Agency for Science, Technology and Research (A*STAR); NTU Research; SINGA; National University of Singapore; German Academic Exchange Service (DAAD)	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); NTU Research; SINGA; National University of Singapore(National University of Singapore); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	We are grateful to the Biomedical Research Council (BMRC) and Agency for Science, Technology and Research (A*STAR) for funding. J.Y., Z.T., and K. G. are supported by the NTU Research, SINGA, and National University of Singapore Scholarships, respectively. J.G. is supported by a fellowship within the Postdoctoral Programme of the German Academic Exchange Service (DAAD). We thank W. Yue and G. Feng for their assistance in autoradiographic experiments. We also thank members of the Ng laboratory for their support and comments on this manuscript.	Bagci H, 2013, CELL STEM CELL, V13, P265, DOI 10.1016/j.stem.2013.08.005; Blair K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002019; Bryja V, 2006, STEM CELLS, V24, P844, DOI 10.1634/stemcells.2005-0444; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gillich A, 2012, CELL STEM CELL, V10, P425, DOI 10.1016/j.stem.2012.01.020; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kraus P, 2010, GENESIS, V48, P394, DOI 10.1002/dvg.20627; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Li QR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001750; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1996, MECH DEVELOP, V57, P123, DOI 10.1016/0925-4773(96)00531-X; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	30	84	86	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					864	872		10.1016/j.stem.2014.04.015	http://dx.doi.org/10.1016/j.stem.2014.04.015			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905170	Bronze			2022-12-28	WOS:000341248500021
J	Soler, E; Grosveld, F				Soler, Eric; Grosveld, Frank			Targeting Epigenetics to Speed Up Repair	CELL STEM CELL			English	Editorial Material							CELLS; REVEALS; COMPLEX; GENES		[Soler, Eric] CEA, DSV, iRCM, INSERM UMR967, F-92265 Fontenay Aux Roses, France; [Grosveld, Frank] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Erasmus University Rotterdam; Erasmus MC	Soler, E (corresponding author), CEA, DSV, iRCM, INSERM UMR967, F-92265 Fontenay Aux Roses, France.	eric.soler@cea.fr; f.grosveld@erasmusmc.nl	Soler, Eric/ABE-9723-2021	Soler, Eric/0000-0003-0521-7463				Benslimane-Ahmim Z, 2011, J THROMB HAEMOST, V9, P834, DOI 10.1111/j.1538-7836.2011.04207.x; Mylona A, 2013, BLOOD, V121, P2902, DOI 10.1182/blood-2012-11-467654; Palii CG, 2014, CELL STEM CELL, V14, P644, DOI 10.1016/j.stem.2014.03.003; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Pelosi E, 2014, BLOOD CELL MOL DIS, V52, P186, DOI 10.1016/j.bcmd.2013.11.004; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Sugimoto K, 2014, TRANSPL INT, V27, P408, DOI 10.1111/tri.12265; van Riel B, 2012, MOL CELL BIOL, V32, P3814, DOI 10.1128/MCB.05938-11; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	10	0	0	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					553	554		10.1016/j.stem.2014.04.018	http://dx.doi.org/10.1016/j.stem.2014.04.018			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24792110	Bronze			2022-12-28	WOS:000335659900003
J	Chan, YS; Goke, J; Ng, JH; Lu, XY; Gonzales, KAU; Tan, CP; Tng, WQ; Hong, ZZ; Lim, YS; Ng, HH				Chan, Yun-Shen; Goeke, Jonathan; Ng, Jia-Hui; Lu, Xinyi; Gonzales, Kevin Andrew Uy; Tan, Cheng-Peow; Tng, Wei-Quan; Hong, Zhong-Zhi; Lim, Yee-Siang; Ng, Huck-Hui			Induction of a Human Pluripotent State with Distinct Regulatory Circuitry that Resembles Preimplantation Epiblast	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; EXPRESSION ANALYSIS; SIGNALING PATHWAYS; FATE DECISIONS; SOMATIC-CELLS; ACTIVATION; FGF; MAINTENANCE; DERIVATION	Human embryonic stem cells (hESCs) are derived from the inner cell mass of the blastocyst. Despite sharing the common property of pluripotency, hESCs are notably distinct from epiblast cells of the preimplantation blastocyst. Here we use a combination of three small-molecule inhibitors to sustain hESCs in a LIF signaling-dependent hESC state (3iL hESCs) with elevated expression of NANOG and epiblast-enriched genes such as KLF4, DPPA3, and TBX3. Genome-wide transcriptome analysis confirms that the expression signature of 3iL hESCs shares similarities with native preimplantation epiblast cells. We also show that 3iL hESCs have a distinct epigenetic landscape, characterized by derepression of preimplantation epiblast genes. Using genome-wide binding profiles of NANOG and OCT4, we identify enhancers that contribute to rewiring of the regulatory circuitry. In summary, our study identifies a distinct hESC state with defined regulatory circuitry that will facilitate future analysis of human preimplantation embryogenesis and pluripotency.	[Chan, Yun-Shen; Goeke, Jonathan; Ng, Jia-Hui; Lu, Xinyi; Gonzales, Kevin Andrew Uy; Tan, Cheng-Peow; Tng, Wei-Quan; Hong, Zhong-Zhi; Lim, Yee-Siang; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Gonzales, Kevin Andrew Uy; Tng, Wei-Quan; Ng, Huck-Hui] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Ng, Huck-Hui] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biochem, Singapore 117559, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Chan, YS (corresponding author), Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore.	chanysw@gis.a-star.edu.sg; nghh@gis.a-star.edu.sg	Chan, Yun-Shen/GWC-4616-2022; Ng, Huck Hui/A-1135-2009	Goke, Jonathan/0000-0002-0825-4991; LU, Xinyi/0000-0002-3885-3960; Gonzales, Kevin Andrew/0000-0001-7418-965X; Lim, Yee Siang/0000-0001-6522-7386	German Academic Exchange Service (DAAD)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	We are grateful to the Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A<SUP>star</SUP>STAR). Jonathan Goke is also supported by a fellowship within the Postdoctoral Programme of the German Academic Exchange Service (DAAD). We acknowledge Valere Cacheux-Rataboul for karyotype analysis and GTB group for sequencing. We would also like to acknowledge the support provided by Paul Robson and the GIS-Fluidigm Single-Cell Omics Center for the single-cell gene expression analysis.	Abe M, 2003, ARTERIOSCL THROM VAS, V23, P404, DOI 10.1161/01.ATV.0000059405.51042.A0; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Do DV, 2013, GENE DEV, V27, P1378, DOI 10.1101/gad.221176.113; Dunglison GF, 1996, HUM REPROD, V11, P191; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Gafni O, 2013, NATURE; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Kimber SJ, 2008, REPRODUCTION, V135, P635, DOI 10.1530/REP-07-0359; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WL, 2013, CELL STEM CELL, V13, P270, DOI 10.1016/j.stem.2013.08.002; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Neri F, 2013, CELL, V155, P121, DOI 10.1016/j.cell.2013.08.056; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Pera RAR, 2009, DIFFERENTIATION, V78, P18, DOI 10.1016/j.diff.2009.03.004; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2012, J CELL SCI, V125, P5609, DOI 10.1242/jcs.096032; Zhou HY, 2010, J BIOL CHEM, V285, P29676, DOI 10.1074/jbc.C110.150599	56	284	300	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					663	675		10.1016/j.stem.2013.11.015	http://dx.doi.org/10.1016/j.stem.2013.11.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24315441	Bronze			2022-12-28	WOS:000329571700010
J	Jaglin, XH; Fishell, G				Jaglin, Xavier H.; Fishell, Gord			A Foot in the Door: How the Chromatin Modifier Brg1 and Pax6 Jointly Potentiate Adult Neurogenesis	CELL STEM CELL			English	Editorial Material							OLFACTORY-BULB	Transcription factors and chromatin modifiers are known to contribute to cell specification. However, whether and how they jointly act is poorly understood. In this issue of Cell Stem Cell, Ninkovic et al. show that Pax6 and Brg1 cooperate to modulate gene expression in order to direct neurogenic fate in the olfactory bulb.	[Jaglin, Xavier H.; Fishell, Gord] NYU, Dept Neurosci & Physiol, Smilow Neurosci Program, Inst Neurosci, New York, NY 10016 USA	New York University	Fishell, G (corresponding author), NYU, Dept Neurosci & Physiol, Smilow Neurosci Program, Inst Neurosci, 550 1St Ave, New York, NY 10016 USA.	gordon.fishell@med.nyu.edu		Fishell, Gordon/0000-0002-9640-9278				Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Betarbet R, 1996, INT J DEV NEUROSCI, V14, P921, DOI 10.1016/S0736-5748(96)00066-4; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Ninkovic J, 2007, CURR OPIN NEUROBIOL, V17, P338, DOI 10.1016/j.conb.2007.04.006; Ninkovic J, 2013, CELL STEM CELL, V13, P403, DOI 10.1016/j.stem.2013.07.002; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Yu Y, 2013, CELL, V152, P248, DOI 10.1016/j.cell.2012.12.006	10	1	1	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					373	374		10.1016/j.stem.2013.09.013	http://dx.doi.org/10.1016/j.stem.2013.09.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094315	Bronze			2022-12-28	WOS:000329571100002
J	Bagci, H; Fisher, AG				Bagci, Hakan; Fisher, Amanda G.			DNA Demethylation in Pluripotency and Reprogramming: The Role of Tet Proteins and Cell Division	CELL STEM CELL			English	Review							EMBRYONIC STEM-CELLS; PRIMORDIAL GERM-CELLS; PREIMPLANTATION DEVELOPMENT; SELF-RENEWAL; METHYLATION; ERASURE; GENOME; 5-HYDROXYMETHYLCYTOSINE; REPLICATION; GENERATION	Cytosine methylation is found in the genomes of many plants and animals and has been associated with transcriptional silencing in mammals. At critical stages in embryo development, when cellular potential is reset, DNA methylation is lost in a series of "sequential waves." The mechanism underlying this is controversial and complex. Several new reports now suggest that TET enzymes and cell division are important for these in vivo transitions as well as for experimentally induced reprogramming.	[Bagci, Hakan; Fisher, Amanda G.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England	Imperial College London	Fisher, AG (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, Du Cane Rd, London W12 0NN, England.	amanda.fisher@imperial.ac.uk			Medical Research Council (MRC), UK; MRC [MC_U120027516] Funding Source: UKRI; Medical Research Council [MC_U120027516] Funding Source: researchfish	Medical Research Council (MRC), UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	H.B. and A.G.F. are funded by the Medical Research Council (MRC), UK.	Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Foshay KM, 2012, MOL CELL, V46, P159, DOI 10.1016/j.molcel.2012.02.013; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Sakaue M, 2010, CURR BIOL, V20, P1452, DOI 10.1016/j.cub.2010.06.050; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Schmidt CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052629; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadtfeld M., 2012, NAT GENET, V44, pS1, DOI DOI 10.1038/NG.1110; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Tsubouchi T, 2013, CELL, V152, P873, DOI 10.1016/j.cell.2013.01.012; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Vincent JJ, 2013, CELL STEM CELL, V12, P470, DOI 10.1016/j.stem.2013.01.016; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	43	53	56	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					265	269		10.1016/j.stem.2013.08.005	http://dx.doi.org/10.1016/j.stem.2013.08.005			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	24012367	Bronze			2022-12-28	WOS:000329570800005
J	Giani, FC; Fiorini, C; Wakabayashi, A; Ludwig, LS; Salem, RM; Jobaliya, CD; Regan, SN; Ulirsch, JC; Liang, G; Steinberg-Shemer, O; Guo, MH; Esko, T; Tong, W; Brugnara, C; Hirschhorn, JN; Weiss, MJ; Zon, LI; Chou, ST; French, DL; Musunuru, K; Sankaran, VG				Giani, Felix C.; Fiorini, Claudia; Wakabayashi, Aoi; Ludwig, Leif S.; Salem, Rany M.; Jobaliya, Chintan D.; Regan, Stephanie N.; Ulirsch, Jacob C.; Liang, Ge; Steinberg-Shemer, Orna; Guo, Michael H.; Esko, Tonu; Tong, Wei; Brugnara, Carlo; Hirschhorn, Joel N.; Weiss, Mitchell J.; Zon, Leonard I.; Chou, Stella T.; French, Deborah L.; Musunuru, Kiran; Sankaran, Vijay G.			Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells	CELL STEM CELL			English	Article							LNK; DIFFERENTIATION; MUTATIONS; SPECIFICATION; PROGENITORS; CHALLENGES; PROTEIN; VIVO	Multipotent and pluripotent stem cells are potential sources for cell and tissue replacement therapies. For example, stem cell-derived red blood cells (RBCs) are a potential alternative to donated blood, but yield and quality remain a challenge. Here, we show that application of insight from human population genetic studies can enhance RBC production from stem cells. The SH2B3 gene encodes a negative regulator of cytokine signaling and naturally occurring loss-of-function variants in this gene increase RBC counts in vivo. Targeted suppression of SH2B3 in primary human hematopoietic stem and progenitor cells enhanced the maturation and overall yield of in-vitro-derived RBCs. Moreover, inactivation of SH2B3 by CRISPR/Cas9 genome editing in human pluripotent stem cells allowed enhanced erythroid cell expansion with preserved differentiation. Our findings therefore highlight the potential for combining human genome variation studies with genome editing approaches to improve cell and tissue production for regenerative medicine.	[Giani, Felix C.; Fiorini, Claudia; Wakabayashi, Aoi; Ludwig, Leif S.; Ulirsch, Jacob C.; Zon, Leonard I.; Sankaran, Vijay G.] Harvard Univ, Sch Med, Div Hematol Oncol, Boston Childrens Hosp, Boston, MA 02115 USA; [Giani, Felix C.; Fiorini, Claudia; Wakabayashi, Aoi; Ludwig, Leif S.; Ulirsch, Jacob C.; Zon, Leonard I.; Sankaran, Vijay G.] Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Giani, Felix C.; Fiorini, Claudia; Wakabayashi, Aoi; Ludwig, Leif S.; Salem, Rany M.; Regan, Stephanie N.; Ulirsch, Jacob C.; Guo, Michael H.; Esko, Tonu; Hirschhorn, Joel N.; Zon, Leonard I.; Musunuru, Kiran; Sankaran, Vijay G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Jobaliya, Chintan D.; Liang, Ge; Steinberg-Shemer, Orna; Tong, Wei; Chou, Stella T.; French, Deborah L.] Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Jobaliya, Chintan D.; Liang, Ge; Steinberg-Shemer, Orna; Tong, Wei; Chou, Stella T.; French, Deborah L.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Regan, Stephanie N.; Zon, Leonard I.; Musunuru, Kiran] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Salem, Rany M.; Guo, Michael H.; Esko, Tonu; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Salem, Rany M.; Guo, Michael H.; Esko, Tonu; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Weiss, Mitchell J.] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Brugnara, Carlo] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; [Giani, Felix C.; Ludwig, Leif S.] Charite, Dept Neonatol, D-10117 Berlin, Germany; [Ludwig, Leif S.] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; St Jude Children's Research Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Sankaran, VG (corresponding author), Harvard Univ, Sch Med, Div Hematol Oncol, Boston Childrens Hosp, Boston, MA 02115 USA.; Sankaran, VG (corresponding author), Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.; Sankaran, VG (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	sankaran@broadinstitute.org	Brugnara, Carlo/A-8041-2010; Weiss, Mitchell J/W-9814-2018; Ludwig, Leif S./A-1913-2015	Brugnara, Carlo/0000-0001-8192-8713; Weiss, Mitchell J/0000-0003-2460-3036; Ludwig, Leif S./0000-0002-2916-2164; Ulirsch, Jacob/0000-0002-7947-0827; Tong, Wei/0000-0001-9951-2273; Fiorini, Claudia/0000-0003-4878-2438; Salem, Rany/0000-0001-8816-6862	National Institutes of Health (NIH) [R21 HL120791, R01 DK103794, K99 HL122515, R01 DK100854, R01 GM104464]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD086984] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095675, K99HL122515, R21HL120791, R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103794, U54DK110805, R01DK100854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104464] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Nathan, S. Orkin, L. Cheng, R. Kapur, D. Wojchowski, J. Flygare, H. Lodish, C. Dame, and members of the Sankaran laboratory for valuable comments on this work. We are grateful to L. Gaffney and T. Dicesare for help with illustrations. This work was supported by National Institutes of Health (NIH) grants R21 HL120791 and R01 DK103794 (V.G.S.), K99 HL122515 (R.M.S.), R01 DK100854 (S.T.C.), and R01 GM104464 (K.M.).	ABKOWITZ JL, 1991, BLOOD, V78, P2198; Bersenev A, 2008, J CLIN INVEST, V118, P2832, DOI 10.1172/JCI35808; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; DONOFRIO G, 1995, BLOOD, V85, P818, DOI 10.1182/blood.V85.3.818.bloodjournal853818; Fox IJ, 2014, SCIENCE, V345, P889, DOI 10.1126/science.1247391; Gery S, 2013, ONCOGENE, V32, P3111, DOI 10.1038/onc.2012.435; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Hirose S, 2013, STEM CELL REP, V1, P499, DOI 10.1016/j.stemcr.2013.10.010; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Huang XS, 2014, MOL THER, V22, P451, DOI 10.1038/mt.2013.201; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kobari L, 2012, HAEMATOL-HEMATOL J, V97, P1795, DOI 10.3324/haematol.2011.055566; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Lasho TL, 2010, NEW ENGL J MED, V363, P1189, DOI 10.1056/NEJMc1006966; Lee HY, 2015, NATURE, V522, P474, DOI 10.1038/nature14326; Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557; McMullin MF, 2011, AM J HEMATOL, V86, P962, DOI 10.1002/ajh.22154; Migliaccio AR, 2012, CELL STEM CELL, V10, P115, DOI 10.1016/j.stem.2012.01.001; Mills JA, 2014, METHODS MOL BIOL, V1185, P181, DOI 10.1007/978-1-4939-1133-2_12; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Perrotta S, 2008, LANCET, V372, P1411, DOI 10.1016/S0140-6736(08)61588-3; Rousseau GF, 2014, BIOTECHNOL J, V9, P28, DOI 10.1002/biot.201200368; Sankaran VG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011643; Sankaran VG, 2012, GENE DEV, V26, P2075, DOI 10.1101/gad.197020.112; Sankaran VG, 2011, P NATL ACAD SCI USA, V108, P1519, DOI 10.1073/pnas.1018384108; Slukvin II, 2013, BLOOD, V122, P4035, DOI 10.1182/blood-2013-07-474825; Spolverini A, 2013, HAEMATOLOGICA, V98, pE101, DOI [10.3324/haematol.2013.090175, 10.3324/haematol.2013.0904175]; Sturgeon CM, 2014, NAT BIOTECHNOL, V32, P554, DOI 10.1038/nbt.2915; Sturgeon CM, 2013, NAT BIOTECHNOL, V31, P416, DOI 10.1038/nbt.2571; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Williamson LM, 2013, LANCET, V381, P1866, DOI 10.1016/S0140-6736(13)60631-5	35	60	62	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					73	78		10.1016/j.stem.2015.09.015	http://dx.doi.org/10.1016/j.stem.2015.09.015			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26607381	Green Accepted, Bronze			2022-12-28	WOS:000372321300013
J	Krishnakumar, R; Chen, AF; Pantovich, MG; Danial, M; Parchem, RJ; Labosky, PA; Blelloch, R				Krishnakumar, Raga; Chen, Amy F.; Pantovich, Marisol G.; Danial, Muhammad; Parchem, Ronald J.; Labosky, Patricia A.; Blelloch, Robert			FOXD3 Regulates Pluripotent Stem Cell Potential by Simultaneously Initiating and Repressing Enhancer Activity	CELL STEM CELL			English	Article							CHROMATIN REMODELING COMPLEX; TISSUE-SPECIFIC ENHANCERS; FORKHEAD BOX PROTEINS; EARLY MOUSE EMBRYO; NEURAL CREST; TRANSCRIPTION FACTORS; UP-REGULATION; SELF-RENEWAL; ES CELLS; LINEAGE	Early development is governed by the ability of pluripotent cells to retain the full range of developmental potential and respond accurately to developmental cues. This property is achieved in large part by the temporal and contextual regulation of gene expression by enhancers. Here, we evaluated regulation of enhancer activity during differentiation of embryonic stem to epiblast cells and uncovered the forkhead transcription factor FOXD3 as a major regulator of the developmental potential of both pluripotent states. FOXD3 bound to distinct sites in the two cell types priming enhancers through a dual-functional mechanism. It recruited the SWI/SNF chromatin remodeling complex ATPase BRG1 to promote nucleosome removal while concurrently inhibiting maximal activation of the same enhancers by recruiting histone deacetylases1/2. Thus, FOXD3 prepares cognate genes for future maximal expression by establishing and simultaneously repressing enhancer activity. Through switching of target sites, FOXD3 modulates the developmental potential of pluripotent cells as they differentiate.	[Krishnakumar, Raga; Chen, Amy F.; Parchem, Ronald J.; Blelloch, Robert] Univ Calif San Francisco, Ctr Reprod Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Krishnakumar, Raga; Chen, Amy F.; Pantovich, Marisol G.; Danial, Muhammad; Parchem, Ronald J.; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Labosky, Patricia A.] NIH, Off Strateg Coordinat, Div Program Coordinat Planning & Strateg Initiat, Bethesda, MD 20892 USA; [Labosky, Patricia A.] NIH, Off Director, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA	Blelloch, R (corresponding author), Univ Calif San Francisco, Ctr Reprod Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Blelloch, R (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.	blellochr@stemcell.ucsf.edu		Krishnakumar, Raga/0000-0002-2479-754X; Labosky, Patricia/0000-0001-5880-2194	NIH [R01 GM101180, U54 HD055764]; CIRM [RN2-00906-1]; AP Gianinni Postdoctoral Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055764, P50HD055764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101180, T32GM008568] Funding Source: NIH RePORTER; Direct For Biological Sciences [1458641] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); AP Gianinni Postdoctoral Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Jennifer Plank and Scott Oakes for technical advice and Glencijoy David, Brandon Chu, Greg Bronevetsky, and Richard Lao for technical support. We acknowledge Indiana University for access to their Mason cluster of computers. We thank the following people for critical reading of the manuscript: Marco Conti, Diana Laird, Barbara Panning, Brian DeVeale, Jacob Freimer, Jennifer Plank, Archana Shenoy, Mayya Shveygert, John Vincent, and Julia Ye. This project was funded by NIH (R01 GM101180, U54 HD055764) and CIRM (RN2-00906-1) to R.B. and an AP Gianinni Postdoctoral Award to R.K.	Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Arduini BL, 2012, STEM CELLS, V30, P2188, DOI 10.1002/stem.1200; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Basile KJ, 2012, ONCOGENE, V31, P2471, DOI 10.1038/onc.2011.424; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chang LL, 2010, DEV BIOL, V342, P39, DOI 10.1016/j.ydbio.2010.03.017; Chenoweth JG, 2010, DEV GROWTH DIFFER, V52, P293, DOI 10.1111/j.1440-169X.2010.01171.x; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; Francetic T., 2012, J MOL BIOL; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hamed M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02390; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hochgreb-Hagele T, 2013, DEV BIOL, V374, P1, DOI 10.1016/j.ydbio.2012.11.035; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Jamaladdin S, 2014, P NATL ACAD SCI USA, V111, P9840, DOI 10.1073/pnas.1321330111; Jouneau A, 2012, RNA, V18, P253, DOI 10.1261/rna.028878.111; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lalmansingh AS, 2012, BBA-GENE REGUL MECH, V1819, P707, DOI 10.1016/j.bbagrm.2012.02.018; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Li ZY, 2012, CELL, V151, P1608, DOI 10.1016/j.cell.2012.11.018; Liber D, 2010, CELL STEM CELL, V7, P114, DOI 10.1016/j.stem.2010.05.020; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mundell NA, 2011, DEVELOPMENT, V138, P641, DOI 10.1242/dev.054718; Nagy G, 2013, IMMUNOBIOLOGY, V218, P1416, DOI 10.1016/j.imbio.2013.07.006; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nitzan E, 2013, P NATL ACAD SCI USA, V110, P12709, DOI 10.1073/pnas.1306287110; Parchem RJ, 2014, CELL STEM CELL, V14, P617, DOI 10.1016/j.stem.2014.01.021; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Plank JL, 2014, STEM CELL RES, V12, P233, DOI 10.1016/j.scr.2013.10.008; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Shim EY, 1998, GENE DEV, V12, P5, DOI 10.1101/gad.12.1.5; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Takebayashi S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-42; Teng L, 2008, DEVELOPMENT, V135, P1615, DOI 10.1242/dev.012179; Thomas AJ, 2009, DEVELOPMENT, V136, P1849, DOI 10.1242/dev.031989; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang WD, 2011, DEV BIOL, V360, P173, DOI 10.1016/j.ydbio.2011.09.019; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	68	53	55	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2016	18	1					104	117		10.1016/j.stem.2015.10.003	http://dx.doi.org/10.1016/j.stem.2015.10.003			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GP	26748757	Bronze, Green Accepted			2022-12-28	WOS:000372321300016
J	Studer, L; Vera, E; Cornacchia, D				Studer, Lorenz; Vera, Elsa; Cornacchia, Daniela			Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency	CELL STEM CELL			English	Review							EMBRYONIC STEM-CELLS; FUNCTIONAL-NEURONS; LIFE-SPAN; CALORIE RESTRICTION; PROGENITOR CELLS; MOUSE MODEL; T-CELLS; IPSCS; DIFFERENTIATION; TELOMERASE	The ability to reprogram adult somatic cells back to pluripotency presents a powerful tool for studying cell-fate identity and modeling human disease. However, the reversal of cellular age during reprogramming results in an embryonic-like state of induced pluripotent stem cells (iPSCs) and their derivatives, which presents specific challenges for modeling late onset disease. This age reset requires novel methods to mimic age-related changes but also offers opportunities for studying cellular rejuvenation in real time. Here, we discuss how iPSC research may transform studies of aging and enable the precise programming of cellular age in parallel to cell-fate specification.	[Studer, Lorenz; Vera, Elsa; Cornacchia, Daniela] Mem Sloan Kettering Canc Ctr, Dev Biol & Ctr Stem Cell Biol, New York, NY 10003 USA	Memorial Sloan Kettering Cancer Center	Studer, L (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol & Ctr Stem Cell Biol, New York, NY 10003 USA.	studerl@mskcc.org	Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987	NYSTEM postdoctoral fellowship; Starr Foundation; NYSTEM [C028503, C026447]; NINDS/NIH [NS072381]; NCI/NIH [P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072381, R21NS084334] Funding Source: NIH RePORTER	NYSTEM postdoctoral fellowship; Starr Foundation; NYSTEM; NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	E.V. was supported by a NYSTEM postdoctoral fellowship. The work of the authors described in this review was supported by grants from the Starr Foundation, NYSTEM (C028503 and C026447), NINDS/NIH (NS072381), and NCI/NIH (P30CA008748).	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; [Anonymous], 2015, SCIENCE; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bardy C., 2015, P NATL ACAD SCI US, V13, P2015; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Bert P, 1864, J LANATOMIE PHYSIOLO, V1, P69; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Byers B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026159; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy MJ, 2013, AGING CELL, V12, P525, DOI 10.1111/acel.12065; Cooper O, 2012, SCI TRANSL MED, V4, p41ra90; Andrade LND, 2012, HUM MOL GENET, V21, P3825, DOI 10.1093/hmg/dds211; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Harel I, 2015, CELL, V160, P1013, DOI 10.1016/j.cell.2015.01.038; Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Isacson O., 1997, AGING DIS, V1, P72; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kipling D, 2004, SCIENCE, V305, P1426, DOI 10.1126/science.1102587; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Lapasset L, 2011, GENE DEV, V25, P2248, DOI 10.1101/gad.173922.111; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Liu GH, 2012, CURR OPIN CELL BIOL, V24, P765, DOI 10.1016/j.ceb.2012.08.014; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; MANN DMA, 1974, BRAIN, V97, P489, DOI 10.1093/brain/97.1.489; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Prigione A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027352; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Srikanth P, 2014, J NEUROGENET, V28, P5, DOI 10.3109/01677063.2014.881358; Steinbeck JA, 2015, NEURON, V86, P187, DOI 10.1016/j.neuron.2015.03.002; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Themeli M, 2013, NAT BIOTECHNOL, V31, P928, DOI 10.1038/nbt.2678; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	90	109	112	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					591	600		10.1016/j.stem.2015.05.004	http://dx.doi.org/10.1016/j.stem.2015.05.004			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26046759	Green Accepted, Bronze			2022-12-28	WOS:000355932300009
J	Shi, Y; Ping, YF; Zhang, X; Bian, XW				Shi, Yu; Ping, Yi-fang; Zhang, Xia; Bian, Xiu-wu			Hostile Takeover: Glioma Stem Cells Recruit TAMs to Support Tumor Progression	CELL STEM CELL			English	Editorial Material							CANCER; MACROPHAGES; INVASION	The dynamic interaction between cancer cells and immune cells is a critical concern for developing effective tumor immunotherapies. In a recent issue of Nature Cell Biology, Zhou et al. (2015) report that glioma stem cells secrete Periostin (POSTN), which recruits tumor-associated macrophages (TAMs) and supports the tumor-promoting M2 subtype.	[Shi, Yu; Ping, Yi-fang; Zhang, Xia; Bian, Xiu-wu] Third Mil Med Univ, Inst Pathol, Southwest Hosp, Chongqing 400038, Peoples R China; [Shi, Yu; Ping, Yi-fang; Zhang, Xia; Bian, Xiu-wu] Third Mil Med Univ, Southwest Canc Ctr, Southwest Hosp, Chongqing 400038, Peoples R China; [Shi, Yu; Ping, Yi-fang; Zhang, Xia; Bian, Xiu-wu] Third Mil Med Univ, Minist Educ China, Key Lab Tumor Immunopathol, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Ministry of Education, China	Bian, XW (corresponding author), Third Mil Med Univ, Inst Pathol, Southwest Hosp, Chongqing 400038, Peoples R China.	bianxiuwu@263.net	Zhang, Xia/B-8152-2008; Bian, Xiu-Wu/D-4736-2017	Zhang, Xia/0000-0002-9040-1486; Bian, Xiu-Wu/0000-0003-4383-0197				Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Bruno A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju200; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090	10	20	23	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2015	16	3					219	220		10.1016/j.stem.2015.02.008	http://dx.doi.org/10.1016/j.stem.2015.02.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0GC	25748928	Bronze			2022-12-28	WOS:000350747700004
J	Grompe, M				Grompe, Markus			Liver Stem Cells, Where Art Thou?	CELL STEM CELL			English	Editorial Material							REGENERATION; RAT	Facultative liver stem cells have long been thought to be an important source of new hepatocytes during chronic liver injury. This longstanding paradigm is being challenged by two papers discussed herein (Schaub et al., 2014; Yanger et al., 2014).	Oregon Hlth & Sci Univ, Dept Pediat, Oregon Stem Cell Ctr, Pape Family Pediat Res Inst, Portland, OR 97239 USA	Oregon Health & Science University	Grompe, M (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, Oregon Stem Cell Ctr, Pape Family Pediat Res Inst, L 321, Portland, OR 97239 USA.	grompem@ohsu.edu		Grompe, Markus/0000-0002-6616-4345				Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737; FARBER E, 1956, CANCER RES, V16, P142; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; IRodrigo-Torres D., 2014, HEPATOLOGY IN PRESS; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Schaub J.R., 2014, CELL REPORT IN PRESS; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003	10	59	61	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					257	258		10.1016/j.stem.2014.08.004	http://dx.doi.org/10.1016/j.stem.2014.08.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25192457	Bronze			2022-12-28	WOS:000341441600002
J	Malam, Z; Cohn, RD				Malam, Zeenat; Cohn, Ronald D.			Stem Cells on Alert: Priming Quiescent Stem Cells after Remote Injury	CELL STEM CELL			English	Editorial Material							LIFE-SPAN; RENEWAL; MICE	A recent paper published by Rodgers et al. describes a novel phase of stem cell quiescence, termed G(Alert), that serves to prime cells in response to injury-induced signals. These stem cells are located distal to the site of injury and require mTORC1 activity to elicit the alert response.	[Malam, Zeenat; Cohn, Ronald D.] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Cohn, Ronald D.] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Cohn, Ronald D.] Univ Toronto, Dept Paediat & Mol Genet, Toronto, ON M5R 0A3, Canada; [Cohn, Ronald D.] Hosp Sick Children, Ctr Genet Med, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Cohn, RD (corresponding author), Hosp Sick Children, Res Inst, Program Genet & Genome Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ronald.cohn@sickkids.ca	Cohn, Ronald/AAC-5835-2021					Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hartman NW, 2013, CELL REP, V5, P433, DOI 10.1016/j.celrep.2013.09.017; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Rodgers J.T., 2014, NATURE IN PRESS; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006	8	9	9	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					8	9		10.1016/j.stem.2014.06.012	http://dx.doi.org/10.1016/j.stem.2014.06.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24996163	Bronze			2022-12-28	WOS:000340878600004
J	Rao, J; Pfeiffer, MJ; Frank, S; Adachi, K; Piccini, I; Quaranta, R; Arauzo-Bravo, M; Schwarz, J; Schade, D; Leidel, S; Scholer, HR; Seebohm, G; Greber, B				Rao, Jyoti; Pfeiffer, Martin J.; Frank, Stefan; Adachi, Kenjiro; Piccini, Ilaria; Quaranta, Roberto; Arauzo-Bravo, Marcos; Schwarz, Juliane; Schade, Dennis; Leidel, Sebastian; Schoeler, Hans R.; Seebohm, Guiscard; Greber, Boris			Stepwise Clearance of Repressive Roadblocks Drives Cardiac Induction in Human ESCs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; BETA-CATENIN; PROGENITOR CELLS; DIFFERENTIATION; SPECIFICATION; MESODERM; TRANSCRIPTION; GASTRULATION; PLURIPOTENCY; ACTIVATION	Cardiac induction requires stepwise integration of BMP and WNT pathway activity. Human embryonic stem cells (hESCs) are developmentally and clinically relevant for studying the poorly understood molecular mechanisms downstream of these cascades. We show that BMP and WNT signaling drive cardiac specification by removing sequential roadblocks that otherwise redirect hESC differentiation toward competing fates, rather than activating a cardiac program per se. First, BMP and WNT signals pattern mesendoderm through cooperative repression of SOX2, a potent mesoderm antagonist. BMP signaling promotes miRNA-877 maturation to induce SOX2 mRNA degradation, while WNT-driven EOMES induction transcriptionally represses SOX2. Following mesoderm formation, cardiac differentiation requires inhibition of WNT activity. We found that WNT inhibition serves to restrict expression of anti-cardiac regulators MSX1 and CDX2/1. Conversely, their simultaneous disruption partially abrogates the requirement for WNT inactivation. These results suggest that human cardiac induction depends on multi-stage repression of alternate lineages, with implications for deriving expandable cardiac stem cells.	[Rao, Jyoti; Pfeiffer, Martin J.; Frank, Stefan; Quaranta, Roberto; Greber, Boris] Max Planck Inst Mol Biomed, Human Stem Cell Pluripotency Lab, D-48149 Munster, Germany; [Rao, Jyoti; Pfeiffer, Martin J.; Frank, Stefan; Quaranta, Roberto; Greber, Boris] Max Planck Gesell, Chem Genom Ctr, D-44227 Dortmund, Germany; [Adachi, Kenjiro; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Piccini, Ilaria; Seebohm, Guiscard] Univ Hosp Munster, Dept Cardiovasc Med, Inst Genet Heart Dis IfGH, D-48149 Munster, Germany; [Arauzo-Bravo, Marcos] Biodonostia Hlth Res Inst, Grp Computat Biol & Syst Biomed, San Sebastian 20014, Spain; [Arauzo-Bravo, Marcos] Basque Fdn Sci, Ikerbasque, Bilbao 48009, Spain; [Schwarz, Juliane; Leidel, Sebastian] Max Planck Inst Mol Biomed, Max Planck Res Grp RNA Biol, D-48149 Munster, Germany; [Schwarz, Juliane; Leidel, Sebastian] Univ Munster, Fac Med, Cells In Mot Cluster Excellence, D-48149 Munster, Germany; [Schade, Dennis] Tech Univ Dortmund, D-44227 Dortmund, Germany; [Frank, Stefan] Ctr Mol Med Cologne ZMMK, Lab Dev & Regenerat RNA Biol, D-50931 Cologne, Germany	Max Planck Society; Max Planck Society; Max Planck Society; University of Munster; Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science; Max Planck Society; University of Munster; Dortmund University of Technology; University of Cologne	Greber, B (corresponding author), Max Planck Inst Mol Biomed, Human Stem Cell Pluripotency Lab, D-48149 Munster, Germany.; Greber, B (corresponding author), Max Planck Gesell, Chem Genom Ctr, D-44227 Dortmund, Germany.	boris.greber@mpi-muenster.mpg.de	Marcos, Arauzo-Bravo/A-1706-2011; Leidel, Sebastian/K-9507-2019; Schade, Dennis/AAH-4758-2019; , HS/AAB-4434-2019	Marcos, Arauzo-Bravo/0000-0002-3264-464X; Leidel, Sebastian/0000-0002-0523-6325; Schade, Dennis/0000-0002-5515-1821; , HS/0000-0003-2643-5136; Quaranta, Roberto/0000-0002-8365-4952; Greber, Boris/0000-0002-9404-7293; Rao, Jyoti/0000-0002-7624-930X	Chemical Genomics Centre of the Max Planck Society; CiM-IMPRS; CiM bridging fellowship	Chemical Genomics Centre of the Max Planck Society; CiM-IMPRS; CiM bridging fellowship	This work was supported by the Chemical Genomics Centre of the Max Planck Society. We thank Prof. Bernhard Herrmann for critical comments on the manuscript. J.R. thanks CiM-IMPRS for support. J.S. was supported by a CiM bridging fellowship.	Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Frank S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041958; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Funa NS, 2015, CELL STEM CELL, V16, P639, DOI 10.1016/j.stem.2015.03.008; Gertow K, 2013, STEM CELL REP, V1, P53, DOI 10.1016/j.stemcr.2013.04.002; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Lallemand Y, 2005, DEVELOPMENT, V132, P3003, DOI 10.1242/dev.01877; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Savory JGA, 2009, DEV BIOL, V330, P114, DOI 10.1016/j.ydbio.2009.03.016; Sherman L. S., 2001, HUMAN EMBRYOLOGY; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Yamauchi K, 2010, GENES CELLS, V15, P1216, DOI 10.1111/j.1365-2443.2010.01455.x; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang M, 2015, STEM CELLS, V33, P1456, DOI 10.1002/stem.1964	35	56	56	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 3	2016	18	3					341	353		10.1016/j.stem.2015.11.019	http://dx.doi.org/10.1016/j.stem.2015.11.019			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GX	26748419	Bronze			2022-12-28	WOS:000372322200011
J	Qian, PX; He, XC; Paulson, A; Li, ZR; Tao, F; Perry, JM; Guo, FL; Zhao, M; Zhi, L; Venkatraman, A; Haug, JS; Parmely, T; Li, H; Dobrowsky, RT; Ding, WX; Kono, T; Ferguson-Smith, AC; Li, LH				Qian, Pengxu; He, Xi C.; Paulson, Ariel; Li, Zhenrui; Tao, Fang; Perry, John M.; Guo, Fengli; Zhao, Meng; Zhi, Lei; Venkatraman, Aparna; Haug, Jeffrey S.; Parmely, Tari; Li, Hua; Dobrowsky, Rick T.; Ding, Wen-Xing; Kono, Tomohiro; Ferguson-Smith, Anne C.; Li, Linheng			The Dlk1-Gtl2 Locus Preserves LT-HSC Function by Inhibiting the PI3K-mTOR Pathway to Restrict Mitochondrial Metabolism	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; MTORC1 CONTROLS; HYPOXIC NICHE; SELF-RENEWAL; EXPRESSION; CLUSTER; DOMAIN; QUIESCENCE; DELETION; GENE	The mammalian imprinted Dlk1-Gtl2 locus produces multiple non-coding RNAs (ncRNAs) from the maternally inherited allele, including the largest miRNA cluster in the mammalian genome. This locus has characterized functions in some types of stem cell, but its role in hematopoietic stem cells (HSCs) is unknown. Here, we show that the Dlk1-Gtl2 locus plays a critical role in preserving long-term repopulating HSCs (LT-HSCs). Through transcriptome profiling in 17 hematopoietic cell types, we found that ncRNAs expressed from the Dlk1-Gtl2 locus are predominantly enriched in fetal liver HSCs and the adult LT-HSC population and sustain long-term HSC functionality. Mechanistically, the miRNA mega-cluster within the Dlk1-Gtl2 locus suppresses the entire PI3K-mTOR pathway. This regulation in turn inhibits mitochondrial biogenesis and metabolic activity and protects LT-HSCs from excessive reactive oxygen species (ROS) production. Our data therefore show that the imprinted Dlk1-Gtl2 locus preserves LT-HSC function by restricting mitochondrial metabolism.	[Qian, Pengxu; He, Xi C.; Paulson, Ariel; Li, Zhenrui; Tao, Fang; Perry, John M.; Guo, Fengli; Zhao, Meng; Haug, Jeffrey S.; Parmely, Tari; Li, Hua; Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Li, Zhenrui; Tao, Fang; Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Zhi, Lei] Tianjin Med Univ, Key Lab Immuno Microenvironm & Dis, Educ Minist, Dept Immunol,Tianjin Key Lab Cellular & Mol Immun, Tianjin, Peoples R China; [Venkatraman, Aparna] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore 632002, Tamil Nadu, India; [Dobrowsky, Rick T.] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA; [Ding, Wen-Xing] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Tokyo 1568502, Japan; [Ferguson-Smith, Anne C.] Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EG, England	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Tianjin Medical University; Christian Medical College & Hospital (CMCH) Vellore; University of Kansas; University of Kansas; University of Kansas Medical Center; Tokyo University of Agriculture; University of Cambridge	Li, LH (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.; Li, LH (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA.	lil@stowers.org	; Qian, Pengxu/B-9376-2016	Li, Linheng/0000-0001-9963-430X; Qian, Pengxu/0000-0001-5636-6704; Zhao, Meng/0000-0001-7909-7594; Ferguson-Smith, Anne/0000-0002-7608-5894; Li, Zhenrui/0000-0001-7172-7643	Stowers Institute for Medical Research; American Society of Hematology (ASH) Scholar Award; National Natural Science Foundation of China [31200575]; Natural Science Foundation of Tianjin [12JCQNJC07600]; Medical Research Council [MR/J001597/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075311] Funding Source: NIH RePORTER; MRC [MR/J001597/1] Funding Source: UKRI	Stowers Institute for Medical Research; American Society of Hematology (ASH) Scholar Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Miller for model image modification; K. Tannen for proofreading and editing; and M. Hembree, H. Marshall, K. Zapien, D. Dukes, C. Semerad, A. Box, J. Park, L. Blunk, A. Perera, and A. Peak for technical support. We are grateful to Linheng Li laboratory members for scientific discussion and critical reading of the manuscript. This work was funded by the Stowers Institute for Medical Research and the American Society of Hematology (ASH) Scholar Award. L.Z. was supported by the National Natural Science Foundation of China (31200575) and the Natural Science Foundation of Tianjin (12JCQNJC07600).	Alvarez-Dominguez JR, 2014, BLOOD, V123, P570, DOI 10.1182/blood-2013-10-530683; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Berg JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026410; Cavaille J, 1996, NATURE, V383, P732, DOI 10.1038/383732a0; Charalambous M, 2012, CELL METAB, V15, P209, DOI 10.1016/j.cmet.2012.01.006; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cullen SM, 2014, CURR TOP DEV BIOL, V107, P39, DOI 10.1016/B978-0-12-416022-4.00002-0; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Das PP, 2015, CELL REP, V12, P1456, DOI 10.1016/j.celrep.2015.07.053; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Hirao A, 2013, CANCER SCI, V104, P977, DOI 10.1111/cas.12189; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Labialle S, 2014, EMBO J, V33, P2216, DOI 10.15252/embj.201387038; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lin SP, 2007, DEVELOPMENT, V134, P417, DOI 10.1242/dev.02726; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Luo M, 2015, CELL STEM CELL, V16, P426, DOI 10.1016/j.stem.2015.02.002; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	43	107	109	2	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2016	18	2					214	228		10.1016/j.stem.2015.11.001	http://dx.doi.org/10.1016/j.stem.2015.11.001			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8GT	26627594	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000372321700012
J	Shin, J; Berg, DA; Zhu, YH; Shin, JY; Song, J; Bonaguidi, MA; Enikolopov, G; Nauen, DW; Christian, KM; Ming, GL; Song, HJ				Shin, Jaehoon; Berg, Daniel A.; Zhu, Yunhua; Shin, Joseph Y.; Song, Juan; Bonaguidi, Michael A.; Enikolopov, Grigori; Nauen, David W.; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun			Single-Cell RNA-Seq with Waterfall Reveals Molecular Cascades underlying Adult Neurogenesis	CELL STEM CELL			English	Article							NEURAL STEM-CELLS; PROGENITOR CELLS; QUIESCENT; QUANTIFICATION; DYNAMICS	Somatic stem cells contribute to tissue ontogenesis, homeostasis, and regeneration through sequential processes. Systematic molecular analysis of stem cell behavior is challenging because classic approaches cannot resolve cellular heterogeneity or capture developmental dynamics. Here we provide a comprehensive resource of single-cell transcriptomes of adult hippocampal quiescent neural stem cells (qNSCs) and their immediate progeny. We further developed Waterfall, a bioinformatic pipeline, to statistically quantify singe-cell gene expression along a de novo reconstructed continuous developmental trajectory. Our study reveals molecular signatures of adult qNSCs, characterized by active niche signaling integration and low protein translation capacity. Our analyses further delineate molecular cascades underlying qNSC activation and neurogenesis initiation, exemplified by decreased extrinsic signaling capacity, primed translational machinery, and regulatory switches in transcription factors, metabolism, and energy sources. Our study reveals the molecular continuum underlying adult neurogenesis and illustrates how Waterfall can be used for single-cell omics analyses of various continuous biological processes.	[Shin, Jaehoon; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Shin, Jaehoon; Berg, Daniel A.; Zhu, Yunhua; Song, Juan; Bonaguidi, Michael A.; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Berg, Daniel A.; Zhu, Yunhua; Song, Juan; Bonaguidi, Michael A.; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Shin, Joseph Y.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Nauen, David W.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Berg, Daniel A.] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17117 Stockholm, Sweden; [Enikolopov, Grigori] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Enikolopov, Grigori] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Enikolopov, Grigori] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Karolinska Institutet; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA.	shongju1@jhmi.edu	Berg, Daniel/DVZ-4324-2022; Enikolopov, Grigori/P-5731-2019	Enikolopov, Grigori/0000-0001-8178-8917; Berg, Daniel/0000-0001-9595-2052; Ming, Guo-li/0000-0002-2517-6075; nauen, david/0000-0002-2652-9944	MSCRF; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Samsung; EMBO long-term post-doctoral fellowship; Swedish Research Council	MSCRF; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Samsung(Samsung); EMBO long-term post-doctoral fellowship(European Molecular Biology Organization (EMBO)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank S.L. Salzberg, H.H. Kazazian, and B. Langmead for suggestions; members of Song and Ming laboratories for discussion; and Y. Cai and L. Liu for technical support. This work was supported by MSCRF to H.S. and G.L.M., the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation to G.L.M, a fellowship from Samsung to J. Shin, and an EMBO long-term post-doctoral fellowship and a grant from Swedish Research Council to D.A.B.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Berg Daniel A, 2015, [Frontiers in Biology, 生物学前沿], V10, P262; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hoppe PS, 2014, NAT CELL BIOL, V16, P919, DOI 10.1038/ncb3042; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Muramoto T, 2012, P NATL ACAD SCI USA, V109, P7350, DOI 10.1073/pnas.1117603109; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965	36	457	468	3	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					360	372		10.1016/j.stem.2015.07.013	http://dx.doi.org/10.1016/j.stem.2015.07.013			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26299571	Bronze, Green Accepted			2022-12-28	WOS:000364011000014
J	Dulken, B; Brunet, A				Dulken, Ben; Brunet, Anne			Stem Cell Aging and Sex: Are We Missing Something?	CELL STEM CELL			English	Editorial Material							LIFE-SPAN	Longevity differs between sexes, with females being longer-lived in most mammals, including humans. One hallmark of aging is the functional decline of stem cells. Thus, a key question is whether the aging of stem cells differs between males and females and whether this has consequences for disease and lifespan.	[Dulken, Ben] Stanford Univ, Med Scientist Training Program, Stanford, CA 94305 USA; [Dulken, Ben] Stanford Univ, Stem Cell Biol & Regenerat Med PhD Program, Stanford, CA 94305 USA; [Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Brunet, Anne] Stanford Univ, Glenn Labs Biol Aging, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Brunet, A (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	abrunet1@stanford.edu			NATIONAL INSTITUTE ON AGING [P01AG036695] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG036695] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bruderlein S, 2008, AGING CELL, V7, P663, DOI 10.1111/j.1474-9726.2008.00413.x; Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Kyo S, 1999, CANCER RES, V59, P5917; Min KJ, 2012, CURR BIOL, V22, pR792, DOI 10.1016/j.cub.2012.06.036; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Sisci D, 2013, CELL CYCLE, V12, P3405, DOI 10.4161/cc.26421; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013	10	16	16	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					588	590		10.1016/j.stem.2015.05.006	http://dx.doi.org/10.1016/j.stem.2015.05.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26046758	Bronze, Green Accepted			2022-12-28	WOS:000355932300008
J	Li, MM; Gou, HF; Tripathi, BK; Huang, J; Jiang, SL; Dubois, W; Waybright, T; Lei, M; Shi, JX; Zhou, M; Huang, J				Li, Mangmang; Gou, Hongfeng; Tripathi, Brajendra K.; Huang, Jing; Jiang, Shunlin; Dubois, Wendy; Waybright, Tim; Lei, Ming; Shi, Jianxin; Zhou, Ming; Huang, Jing			An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells	CELL STEM CELL			English	Article							LONG NONCODING RNA; DNA-DAMAGE; MDM2-DEFICIENT MICE; NANOG EXPRESSION; P53; LETHALITY; RESCUE; TARGET; TRANSCRIPTION; PROMOTERS	Maintaining genomic integrity is of paramount importance to embryonic stem cells (ESCs), as mutations are readily propagated to daughter cells. ESCs display hypersensitivity to DNA damage-induced apoptosis (DIA) to prevent such propagation, although the molecular mechanisms underlying this apoptotic response are unclear. Here, we report that the regulatory RNA Apela positively regulates p53-mediated DIA. Apela is highly expressed in mouse ESCs and is repressed by p53 activation, and Apela depletion compromises p53-dependent DIA. Although Apela contains a coding region, this coding ability is dispensable for Apela's role in p53-mediated DIA. Instead, Apela functions as a regulatory RNA and interacts with hnRNPL, which prevents the mitochondrial localization and activation of p53. Together, these results describe a tri-element negative feedback loop composed of p53, Apela, and hnRNPL that regulates p53-mediated DIA, and they further demonstrate that regulatory RNAs add a layer of complexity to the apoptotic response of ESCs after DNA damage.	[Li, Mangmang; Gou, Hongfeng; Jiang, Shunlin; Dubois, Wendy; Huang, Jing] NCI, Ctr Canc Res, Lab Canc Biol & Genet, Cancer & Stem Cell Epigenet, Bethesda, MD 20892 USA; [Tripathi, Brajendra K.] NCI, Ctr Canc Res, Cellular Oncol Lab, Signaling & Oncogenesis Sect, Bethesda, MD 20892 USA; [Huang, Jing; Lei, Ming] Univ Michigan, Howard Hughes Med Inst, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Waybright, Tim; Zhou, Ming] Frederick Natl Lab Canc Res, Canc Res Technol Program, Prot Characterizat Lab, Frederick, MD 21702 USA; [Shi, Jianxin] NCI, Div Canc Epidemiol & Genet, Biostat Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Huang, J (corresponding author), NCI, Ctr Canc Res, Lab Canc Biol & Genet, Cancer & Stem Cell Epigenet, Bethesda, MD 20892 USA.	huangj3@mail.nih.gov	LI, MANGMANG/J-1683-2015; Huang, Jing/A-2566-2009	Huang, Jing/0000-0002-7163-5156	Office of Science and Technology at the CCR; National Cancer Institute (NCI) at the National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE [ZIABC011158] Funding Source: NIH RePORTER	Office of Science and Technology at the CCR; National Cancer Institute (NCI) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Douglas Lowy for reading the manuscript. This study was funded by the intramural research program and partially funded by the Office of Science and Technology Partnerships at the CCR, the National Cancer Institute (NCI) at the National Institutes of Health (NIH). The computational analyses utilized the high-performance computational capabilities of the Helix Systems at NIH (http://helix.nih.gov).	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Cinghu S, 2014, P NATL ACAD SCI USA, V111, pE1581, DOI 10.1073/pnas.1318598111; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Goh AM, 2012, P NATL ACAD SCI USA, V109, P1685, DOI 10.1073/pnas.1114173109; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee DF, 2012, CELL STEM CELL, V11, P179, DOI 10.1016/j.stem.2012.05.020; Lee KH, 2010, P NATL ACAD SCI USA, V107, P69, DOI 10.1073/pnas.0909734107; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; LUNA RMD, 1995, NATURE, V378, P203; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang XY, 2013, CELL CYCLE, V12, P1279, DOI 10.4161/cc.24364	36	63	65	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					669	683		10.1016/j.stem.2015.04.002	http://dx.doi.org/10.1016/j.stem.2015.04.002			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	25936916	Green Accepted, Bronze			2022-12-28	WOS:000355932300015
J	Diez-Juan, A; Simon, C				Diez-Juan, Antonio; Simon, Carlos			Converting a Problem into an Opportunity: mtDNA Heteroplasmy Shift	CELL STEM CELL			English	Editorial Material							DNA COPY NUMBER; MITOCHONDRIAL-DNA; GENOMES	The transmission of mitochondrial DNA (mtDNA) disease from a mother with a heteroplasmic mtDNA mutation to her children is unpredictable. In a recent issue of Cell, Reddy et al. (2015) present the potential for mitochondrial-targeted nucleases to remove mutated mtDNA through the induction of heteroplasmy shift in oocytes and zygotes.	[Diez-Juan, Antonio; Simon, Carlos] Parc Cient Valencia Univ, Igenomix, Valencia 46980, Spain; [Simon, Carlos] Univ Valencia, Sch Med, Dept Obstet & Gynecol, FIVI, Valencia 46015, Spain; [Simon, Carlos] Inst Univ IVI INCLIVA, Valencia 46015, Spain; [Simon, Carlos] Stanford Univ, Dept Obstet & Gynecol, Palo Alto, CA 94304 USA	University of Valencia; Stanford University	Simon, C (corresponding author), Parc Cient Valencia Univ, Igenomix, Valencia 46980, Spain.	carlos.simon@uv.es	Simon, Carlos/G-2186-2014; Diez Juan, Antonio/D-3695-2018; Diez-Juan, Antonio/H-5464-2015	Simon, Carlos/0000-0003-0902-9531; Diez-Juan, Antonio/0000-0002-0166-1869				Bacman SR, 2014, METHOD ENZYMOL, V547, P373, DOI 10.1016/B978-0-12-801415-8.00018-7; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Callaway E, 2014, NATURE, V509, P414, DOI 10.1038/509414a; Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672; Monnot S, 2013, HUM MOL GENET, V22, P1867, DOI 10.1093/hmg/ddt040; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258	9	4	4	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					457	458		10.1016/j.stem.2015.04.012	http://dx.doi.org/10.1016/j.stem.2015.04.012			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25957899	Bronze			2022-12-28	WOS:000354188600005
J	Cho, KO; Hsieh, J				Cho, Kyung-Ok; Hsieh, Jenny			The IncRNA Pnky in the Brain	CELL STEM CELL			English	Editorial Material							LONG NONCODING RNAS; STEM-CELLS; DIFFERENTIATION; PLURIPOTENCY; DISEASE	Long noncoding RNAs (IncRNAs) influence diverse cellular processes and have been implicated in regulating stem cell properties. Now in Cell Stem Cell, Ramos et al. (2015) demonstrate that the neural-specific lncRNA Pnky regulates neuronal differentiation from neural stem cells and mediates RNA splicing through interactions with polypyrimidine tract-binding protein 1 (PTBP1).	[Cho, Kyung-Ok] Catholic Univ Korea, Dept Pharmacol, Seoul 137701, South Korea; [Cho, Kyung-Ok] Catholic Univ Korea, Catholic Neurosci Inst, Sch Med, Seoul 137701, South Korea; [Hsieh, Jenny] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; [Hsieh, Jenny] UT Southwestern Med Ctr, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	Catholic University of Korea; Catholic University of Korea; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hsieh, J (corresponding author), UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.	jenny.hsieh@utsouthwestern.edu	Cho, Kyungok/R-5359-2019	Cho, Kyungok/0000-0002-1314-7584				Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Jin W, 2000, CANCER RES, V60, P1221; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Ng SY, 2013, TRENDS GENET, V29, P461, DOI 10.1016/j.tig.2013.03.002; Ramos AD, 2015, CELL STEM CELL, V16, P439, DOI 10.1016/j.stem.2015.02.007; Ramos AD, 2013, CELL STEM CELL, V12, P616, DOI 10.1016/j.stem.2013.03.003	10	9	10	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					344	345		10.1016/j.stem.2015.03.015	http://dx.doi.org/10.1016/j.stem.2015.03.015			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25842971	Bronze			2022-12-28	WOS:000352228600003
J	Johannesson, B; Sagi, I; Gore, A; Paull, D; Yamada, M; Golan-Lev, T; Li, Z; LeDuc, C; Shen, YF; Stern, S; Xu, NF; Ma, H; Kang, EJ; Mitalipov, S; Sauer, MV; Zhang, K; Benvenisty, N; Egli, D				Johannesson, Bjarki; Sagi, Ido; Gore, Athurva; Paull, Daniel; Yamada, Mitsutoshi; Golan-Lev, Tamar; Li, Zhe; LeDuc, Charles; Shen, Yufeng; Stern, Samantha; Xu, Nanfang; Ma, Hong; Kang, Eunju; Mitalipov, Shoukhrat; Sauer, Mark V.; Zhang, Kun; Benvenisty, Nissim; Egli, Dieter			Comparable Frequencies of Coding Mutations and Loss of Imprinting in Human Pluripotent Cells Derived by Nuclear Transfer and Defined Factors	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; SOMATIC-CELLS; MOUSE; IDENTIFICATION; HOTSPOTS; MEMORY; GENE	The recent finding that reprogrammed human pluripotent stem cells can be derived by nuclear transfer into human oocytes as well as by induced expression of defined factors has revitalized the debate on whether one approach might be advantageous over the other. Here we compare the genetic and epigenetic integrity of human nuclear-transfer embryonic stem cell (NT-ESC) lines and isogenic induced pluripotent stem cell (iPSC) lines, derived from the same somatic cell cultures of fetal, neonatal, and adult origin. The two cell types showed similar genome-wide gene expression and DNA methylation profiles. Importantly, NT-ESCs and iPSCs had comparable numbers of de novo coding mutations, but significantly more than parthenogenetic ESCs. As iPSCs, NT-ESCs displayed clone- and gene-specific aberrations in DNA methylation and allele-specific expression of imprinted genes. The occurrence of these genetic and epigenetic defects in both NT-ESCs and iPSCs suggests that they are inherent to reprogramming, regardless of derivation approach.	[Johannesson, Bjarki; Paull, Daniel; Yamada, Mitsutoshi; Stern, Samantha; Egli, Dieter] New York Stem Cell Fdn Res Inst, New York, NY 10032 USA; [Sagi, Ido; Golan-Lev, Tamar; Benvenisty, Nissim] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Genet, Stem Cell Unit, IL-91904 Jerusalem, Israel; [Gore, Athurva; Li, Zhe; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [LeDuc, Charles; Egli, Dieter] Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [LeDuc, Charles; Egli, Dieter] Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Shen, Yufeng] Columbia Univ, Med Ctr, JP Sulzberger Columbia Genome Ctr, Dept Syst Biol, New York, NY 10032 USA; [Shen, Yufeng] Columbia Univ, Med Ctr, JP Sulzberger Columbia Genome Ctr, Dept Biomed Informat, New York, NY 10032 USA; [Xu, Nanfang] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10032 USA; [Ma, Hong; Kang, Eunju; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, Portland, OR 97239 USA; [Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Ctr Womens Reprod Care, New York, NY 10019 USA	Hebrew University of Jerusalem; University of California System; University of California San Diego; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Oregon Health & Science University; Columbia University	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Genet, Stem Cell Unit, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il; d.egli@nyscf.org	Zhang, Kun/ABE-6349-2020	Zhang, Kun/0000-0002-7596-5224; LeDuc, Charles/0000-0002-2073-5050	New York Stem Cell Foundation (NYSCF); New York State Stem Cell Science IIRP award [C026184]; Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation [269/12]	New York Stem Cell Foundation (NYSCF); New York State Stem Cell Science IIRP award; Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation	This work was supported by the New York Stem Cell Foundation (NYSCF), the New York State Stem Cell Science IIRP award no. C026184 (to D. E.), and the Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation (grant 269/12) (N.B.). B.J. is a NYSCF-Druckenmiller fellow, D. E. is a NYSCF-Robertson Investigator, and N.B. is the Herbert Cohn Chair in Cancer Research. The authors would like to thank Lauren Bauer Vensand, Carmen Dusenberry, and Travis Kroeker for expert laboratory support. Exome and RNA sequencing was performed at the Sulzberger Columbia Genome Center.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chan MM, 2012, NAT GENET, V44, P978, DOI 10.1038/ng.2382; Chung YG, 2014, CELL STEM CELL, V14, P777, DOI 10.1016/j.stem.2014.03.015; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Frost JM, 2011, EPIGENETICS-US, V6, P52, DOI 10.4161/epi.6.1.13361; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Jelinic P, 2007, J PATHOL, V211, P261, DOI 10.1002/path.2116; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Li Z, 2014, STEM CELL REP, V2, P399, DOI 10.1016/j.stemcr.2014.02.005; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Stelzer Y, 2011, NAT STRUCT MOL BIOL, V18, P735, DOI 10.1038/nsmb.2050; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Wang T, 2013, NAT CELL BIOL, V15, P700, DOI 10.1038/ncb2748; Yamada M, 2014, NATURE, V510, P533, DOI 10.1038/nature13287; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002	35	87	90	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					634	642		10.1016/j.stem.2014.10.002	http://dx.doi.org/10.1016/j.stem.2014.10.002			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517467	Bronze			2022-12-28	WOS:000345012700015
J	Kriegstein, AR				Kriegstein, Arnold R.			Yoshiki Sasai (1962-2014) Obituary	CELL STEM CELL			English	Biographical-Item									Univ Calif San Francisco, Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kriegstein, AR (corresponding author), Univ Calif San Francisco, Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, 35 Med Ctr Way, San Francisco, CA 94143 USA.	kriegsteina@stemcell.ucsf.edu			NINDS NIH HHS [R01 NS021223] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		SASAI Y, PUBLICATION LIST	1	0	0	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2014	15	3					265	266		10.1016/j.stem.2014.08.007	http://dx.doi.org/10.1016/j.stem.2014.08.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO6EF	25333080	Bronze			2022-12-28	WOS:000341441600006
J	Winzi, M; Paszkowski-Rogacz, M; Buchholz, F				Winzi, Maria; Paszkowski-Rogacz, Maciej; Buchholz, Frank			Another Brick in the Wall: RNAi Screens Identify New Barriers in iPSC Reprogramming	CELL STEM CELL			English	Editorial Material							PLURIPOTENCY; CELLS	Somatic cells can be reprogrammed to induced pluripotent stem cells via exogenous expression of a small set of transcription factors, but the regulatory mechanisms controlling this cell transition are poorly understood. Two recent reports demonstrate the value of RNAi screens as a tool to uncover roadblocks in this inefficient process.	[Winzi, Maria; Paszkowski-Rogacz, Maciej; Buchholz, Frank] Tech Univ Dresden, Univ Hosp, D-01307 Dresden, Germany; [Winzi, Maria; Paszkowski-Rogacz, Maciej; Buchholz, Frank] Tech Univ Dresden, UCC, Med Fac Carl Gustav Carus, D-01307 Dresden, Germany; [Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society	Buchholz, F (corresponding author), Tech Univ Dresden, Univ Hosp, D-01307 Dresden, Germany.	frank.buchholz@tu-dresden.de	Buchholz, Frank/B-4700-2017	Buchholz, Frank/0000-0002-4577-3344				dos Santos RL, 2014, CELL STEM CELL, V15, P102, DOI 10.1016/j.stem.2014.04.019; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Friedmann-Morvinski D, 2014, EMBO REP, V15, P244, DOI 10.1002/embr.201338254; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Qin H, 2014, CELL, V158, P449, DOI 10.1016/j.cell.2014.05.040; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Sakurai K, 2014, CELL STEM CELL, V14, P523, DOI 10.1016/j.stem.2014.03.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theunissen TW, 2014, CELL STEM CELL, V14, P720, DOI 10.1016/j.stem.2014.05.002; Yang C.-S., 2014, CELL REPORT IN PRESS	10	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2014	15	2					116	118		10.1016/j.stem.2014.07.008	http://dx.doi.org/10.1016/j.stem.2014.07.008			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8UK	25105575	Bronze			2022-12-28	WOS:000340880100004
J	Hine, C; Mitchell, JR				Hine, Christopher; Mitchell, James R.			Saying No to Drugs: Fasting Protects Hematopoietic Stem Cells from Chemotherapy and Aging	CELL STEM CELL			English	Editorial Material								Aging and chemotherapeutics damage hematopoietic stem cells (HSCs), leading to dysregulation of asymmetric division and subsequent immunosuppression and blood-related diseases. In this issue, Cheng et al. (2014) use prolonged fasting as a medical intervention to decrease IGF-1/PKA signaling and protect HSCs against chemotherapeutic toxicity and promote rejuvenation.	[Hine, Christopher; Mitchell, James R.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Mitchell, JR (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	jmitchel@hsph.harvard.edu		Hine, Christopher/0000-0003-1926-7939	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036712] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG036712] Funding Source: Medline; NIDDK NIH HHS [R01 DK090629] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bartucci M, 2011, CLIN CANCER RES, V17, P6185, DOI 10.1158/1078-0432.CCR-11-1232; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014; Ding Z.C., 2014, CANC RES; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; Mort D., 2008, BETTER WORSE REV CAR; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Robertson LT, 2013, EXP GERONTOL, V48, P1043, DOI 10.1016/j.exger.2013.01.009	10	4	6	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2014	14	6					704	705		10.1016/j.stem.2014.05.016	http://dx.doi.org/10.1016/j.stem.2014.05.016			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO3QK	24905161	Green Accepted, Bronze			2022-12-28	WOS:000341248500007
J	Fordham, RP; Yui, S; Hannan, NRF; Soendergaard, C; Madgwick, A; Schweiger, PJ; Nielsen, OH; Vallier, L; Pedersen, RA; Nakamura, T; Watanabe, M; Jensen, KB				Fordham, Robert P.; Yui, Shiro; Hannan, Nicholas R. F.; Soendergaard, Christoffer; Madgwick, Alison; Schweiger, Pawel J.; Nielsen, Ole H.; Vallier, Ludovic; Pedersen, Roger A.; Nakamura, Tetsuya; Watanabe, Mamoru; Jensen, Kim B.			Transplantation of Expanded Fetal Intestinal Progenitors Contributes to Colon Regeneration after Injury	CELL STEM CELL			English	Article							STEM-CELLS; IN-VITRO; HOMEOSTASIS; EXPANSION; MICE	Regeneration and homeostasis in the adult intestinal epithelium is driven by proliferative resident stem cells, whose functional properties during organismal development are largely unknown. Here, we show that human and mouse fetal intestine contains proliferative, immature progenitors, which can be expanded in vitro as Fetal Enterospheres (FEnS). A highly similar progenitor population can be established during intestinal differentiation of human induced pluripotent stem cells. Established cultures of mouse fetal intestinal progenitors express lower levels of Lgr5 than mature progenitors and propagate in the presence of the Wnt antagonist Dkk1, and new cultures can be induced to form mature intestinal organoids by exposure to Wnt3a. Following transplantation in a colonic injury model, FEnS contribute to regeneration of colonic epithelium by forming epithelial crypt-like structures expressing region-specific differentiation markers. This work provides insight into mechanisms underlying development of the mammalian intestine and points to future opportunities for patient-specific regeneration of the digestive tract.	[Fordham, Robert P.; Hannan, Nicholas R. F.; Madgwick, Alison; Vallier, Ludovic; Pedersen, Roger A.; Jensen, Kim B.] Univ Cambridge, Wellcome Trust, Cambridge CB2 1QR, England; [Fordham, Robert P.; Hannan, Nicholas R. F.; Madgwick, Alison; Vallier, Ludovic; Pedersen, Roger A.; Jensen, Kim B.] Univ Cambridge, MRC, Cambridge Stem Cell Inst, Cambridge CB2 1QR, England; [Fordham, Robert P.; Hannan, Nicholas R. F.; Vallier, Ludovic; Pedersen, Roger A.] Univ Cambridge, Dept Surg, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England; [Yui, Shiro; Schweiger, Pawel J.; Jensen, Kim B.] Univ Copenhagen, BRIC, DK-2200 Copenhagen N, Denmark; [Yui, Shiro; Nakamura, Tetsuya; Watanabe, Mamoru] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Bunkyo Ku, Tokyo 1138519, Japan; [Soendergaard, Christoffer; Nielsen, Ole H.] Univ Copenhagen, Herlev Hosp, Fac Hlth & Med Sci, Dept Gastroenterol,Med Sect, DK-2730 Herlev, Denmark	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Copenhagen; Tokyo Medical & Dental University (TMDU); University of Copenhagen; Herlev & Gentofte Hospital	Jensen, KB (corresponding author), Univ Cambridge, Wellcome Trust, Cambridge CB2 1QR, England.	kim.jensen@bric.ku.dk	Watanabe, Mamoru/AHE-0489-2022; Jensen, Kim/F-5333-2014; Nielsen, Ole Haagen/AAK-2482-2021; Hannan, Nicholas/ABG-6497-2020	Nielsen, Ole Haagen/0000-0003-4612-8635; Vallier, Ludovic/0000-0002-3848-2602; Yui, Shiro/0000-0003-4268-647X; Soendergaard, Christoffer/0000-0002-2943-6911; Jensen, Kim/0000-0001-6569-1664; Hannan, Nicholas/0000-0002-9843-1559	MRC; Evelyn Trust; EC FP7 ERC starting investigator research grant; Cambridge Hospitals National Institute for Health Research Biomedical Research Center; Regenerative Medicine Realization Base Network Program from Japan Science and Technology Agency (JST); MEXT/JSPS KAKENHI [22229005]; Ministry of Health, Labor and Welfare of Japan; Sidney Sussex College; Danish Cancer Society; Wellcome Trust; Lundbeck Foundation; MRC [G0701448, G0800784, G0600275, G1000847] Funding Source: UKRI; Lundbeck Foundation [R105-2011-9755] Funding Source: researchfish; Medical Research Council [G1000847, G0600275, G0800784, G0701448] Funding Source: researchfish; Grants-in-Aid for Scientific Research [24112508, 24390186] Funding Source: KAKEN	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Evelyn Trust; EC FP7 ERC starting investigator research grant; Cambridge Hospitals National Institute for Health Research Biomedical Research Center; Regenerative Medicine Realization Base Network Program from Japan Science and Technology Agency (JST); MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Sidney Sussex College; Danish Cancer Society(Danish Cancer Society); Wellcome Trust(Wellcome TrustEuropean Commission); Lundbeck Foundation(Lundbeckfonden); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank F. Watt for EGFP transgenic mice, SCI Core Facilities for their support, and R. Barker for facilitating access to human fetal tissue. We thank A. Martinez-Arias, B. Simons, M. Zilbauer, and the Jensen, Pedersen, and Watanabe labs for critical discussions. This work was supported by an MRC PhD Studentship and Centenary Awards (R. P. F.), the Evelyn Trust grant (N.R.F.H.), EC FP7 ERC starting investigator research grant (L. V.), the Cambridge Hospitals National Institute for Health Research Biomedical Research Center (L. V.), the Regenerative Medicine Realization Base Network Program from Japan Science and Technology Agency (JST) (T.N. and M. W.), the MEXT/JSPS KAKENHI (Grant Number 22229005 to T.N. and M. W.), a Health and Labor Sciences Research Grant for Research on rare and intractable diseases from the Ministry of Health, Labor and Welfare of Japan (M. W.), Sidney Sussex College (A. M.), The Danish Cancer Society (K.B.J.), a Wellcome Trust Career Development Fellowship (K.B.J.), and a Lundbeck Foundation Fellowship (K.B.J.). L. V. is a founder and shareholder of DefiniGEN.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Hannan NRF, 2013, STEM CELL REP, V1, P293, DOI 10.1016/j.stemcr.2013.09.003; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lin HT, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0334; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Montgomery RK, 1999, GASTROENTEROLOGY, V116, P702, DOI 10.1016/S0016-5085(99)70193-9; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Spence JR, 2011, DEV DYNAM, V240, P501, DOI 10.1002/dvdy.22540; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	26	237	250	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					734	744		10.1016/j.stem.2013.09.015	http://dx.doi.org/10.1016/j.stem.2013.09.015			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24139758	Green Published, hybrid			2022-12-28	WOS:000329571700015
J	Schwank, G; Koo, BK; Sasselli, V; Dekkers, JF; Heo, I; Demircan, T; Sasaki, N; Boymans, S; Cuppen, E; van der Ent, CK; Nieuwenhuis, EES; Beekman, JM; Clevers, H				Schwank, Gerald; Koo, Bon-Kyoung; Sasselli, Valentina; Dekkers, Johanna F.; Heo, Inha; Demircan, Turan; Sasaki, Nobuo; Boymans, Sander; Cuppen, Edwin; van der Ent, Cornelis K.; Nieuwenhuis, Edward E. S.; Beekman, Jeffrey M.; Clevers, Hans			Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients	CELL STEM CELL			English	Article							ZINC-FINGER NUCLEASES; IN-VITRO EXPANSION; RNA-GUIDED ENDONUCLEASE; HOMOLOGOUS RECOMBINATION; CAS9 NUCLEASE; WNT RECEPTORS; GENE; DNA; IDENTIFICATION; SPECIFICITY	Single murine and human intestinal stem cells can be expanded in culture over long time periods as genetically and phenotypically stable epithelial organoids. Increased cAMP levels induce rapid swelling of such organoids by opening the cystic fibrosis transmembrane conductor receptor (CFTR). This response is lost in organoids derived from cystic fibrosis (CF) patients. Here we use the CRISPR/Cas9 genome editing system to correct the CFTR locus by homologous recombination in cultured intestinal stem cells of CF patients. The corrected allele is expressed and fully functional as measured in clonally expanded organoids. This study provides proof of concept for gene correction by homologous recombination in primary adult stem cells derived from patients with a single-gene hereditary defect.	[Schwank, Gerald; Koo, Bon-Kyoung; Sasselli, Valentina; Heo, Inha; Demircan, Turan; Sasaki, Nobuo; Boymans, Sander; Cuppen, Edwin; Clevers, Hans] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Schwank, Gerald; Koo, Bon-Kyoung; Sasselli, Valentina; Heo, Inha; Sasaki, Nobuo; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Dekkers, Johanna F.; van der Ent, Cornelis K.] Wilhelmina Childrens Hosp, Univ Med Ctr, Dept Pediat Pulmonol, NL-3584 EA Utrecht, Netherlands; [Dekkers, Johanna F.] Wilhelmina Childrens Hosp, Univ Med Ctr, Dept Immunol, NL-3584 EA Utrecht, Netherlands; [Nieuwenhuis, Edward E. S.; Beekman, Jeffrey M.] Wilhelmina Childrens Hosp, Univ Med Ctr, Dept Pediat Gastroenterol, NL-3584 EA Utrecht, Netherlands; [Cuppen, Edwin; Beekman, Jeffrey M.] UMC Utrecht, Dept Med Genet, NL-3584 GG Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Schwank, Gerald/AAE-6640-2020; Schwank, Gerald/A-8586-2018; Demircan, Turan/AAB-7226-2021; Sasaki, Nobuo/HDO-8251-2022; Demircan, Turan/AAQ-1936-2020; Beekman, Jeffrey M/I-7781-2014; Koo, Bon-Kyoung/V-5219-2017; Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016	Schwank, Gerald/0000-0003-0767-2953; Schwank, Gerald/0000-0003-0767-2953; Sasaki, Nobuo/0000-0002-8798-7244; Beekman, Jeffrey M/0000-0003-4886-3756; Koo, Bon-Kyoung/0000-0002-4134-8033; Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Van der Ent, Cornelis/0000-0002-2501-4121; Sasselli, Valentina/0000-0002-7118-0067	European Research Council [EU/232814-StemCeLLMark]; KNAW/3V-fund; SNF [PA00P3 139732]; Human Frontiers in Science Program [LT000422/2012]; Wellcome Trust [097922/C/11/Z]; EU [EU/330571-FP7-IIF]; Astellas Foundation; JSPS	European Research Council(European Research Council (ERC)European Commission); KNAW/3V-fund; SNF; Human Frontiers in Science Program(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); Astellas Foundation(Astellas Pharmaceuticals); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank K. Tenbrock (Department of Pediatrics, the RWTH Aachen University, Germany) for providing intestinal rest-material and A. Smith (Wellcome Trust Centre for Stem Cell Research, University of Cambridge) for providing Rosa-CreERT2 mice. This work was funded by grants from the European Research Council (EU/232814-StemCeLLMark), the KNAW/3V-fund, the SNF fellowship for advanced researchers PA00P3 139732 (G. S.), the Human Frontiers in Science Program long-term fellowship LT000422/2012 (G. S.), the Wellcome Trust (097922/C/11/Z) (B.-K.K.), the EU Marie Curie Fellowship EU/330571-FP7-IIF (I. H.), the Astellas Foundation (N.S.), and JSPS (N.S.).	Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barnes DE, 2001, CURR BIOL, V11, pR455, DOI 10.1016/S0960-9822(01)00279-2; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, REGEN MED, V8, P385, DOI 10.2217/rme.13.39; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwank G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076871; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Thiagarajah JR, 2004, FASEB J, V18, P875, DOI 10.1096/fj.03-1248fje; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; van den Bosch M, 2002, BIOL CHEM, V383, P873; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	43	878	999	14	368	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					653	658		10.1016/j.stem.2013.11.002	http://dx.doi.org/10.1016/j.stem.2013.11.002			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24315439	Bronze			2022-12-28	WOS:000329571700008
J	Gunther, S; Kim, J; Kostin, S; Lepper, C; Fan, CM; Braun, T				Guenther, Stefan; Kim, Johnny; Kostin, Sawa; Lepper, Christoph; Fan, Chen-Ming; Braun, Thomas			Myf5-Positive Satellite Cells Contribute to Pax7-Dependent Long-Term Maintenance of Adult Muscle Stem Cells	CELL STEM CELL			English	Article							PAX7; DISTINCT; MYF5; SPECIFICATION; REGENERATION; POPULATION; EXPRESSION; EFFICIENT; RENEWAL; GENES	Skeletal muscle contains Pax7-expressing muscle stem or satellite cells, enabling muscle regeneration throughout most of adult life. Here, we demonstrate that induced inactivation of Pax7 in Pax7-expressing cells of adult mice leads to loss of muscle stem cells and reduced heterochromatin condensation in rare surviving satellite cells. Inactivation of Pax7 in Myf5-expressing cells revealed that the majority of adult muscle stem cells originate from myogenic lineages, which express the myogenic regulators Myf5 or MyoD. Likewise, the majority of muscle stem cells are replenished from Myf5-expressing myogenic cells during adult life, and inactivation of Pax7 in Myf5-expressing cells after muscle damage leads to a complete arrest of muscle regeneration. Finally, we demonstrate that a relatively small number of muscle stem cells are sufficient for efficient repair of skeletal muscles. We conclude that Pax7 acts at different levels in a nonhierarchical regulatory network controlling muscle-satellite-cell-mediated muscle regeneration.	[Guenther, Stefan; Kim, Johnny; Kostin, Sawa; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Lepper, Christoph; Fan, Chen-Ming] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA	Max Planck Society; Carnegie Institution for Science	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Ludwigstr 43, D-61231 Bad Nauheim, Germany.	thomas.braun@mpi-bn.mpg.de	Kim, Johnny/AAY-2149-2020; Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804; Kim, Johnny/0000-0002-5226-5460	DFG (Excellence Cluster Cardio-Pulmonary System [ECCPS] [Br1416, SFB TR81]; LOEWE Center for Cell and Gene Therapy; German Center for Cardiovascular Research; Universities of Giessen and Marburg Lung Center (UGMLC); NIH [RO1AR060042, R21AR063847];  [DP5OD009208]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063847, R01AR060042] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009208] Funding Source: NIH RePORTER	DFG (Excellence Cluster Cardio-Pulmonary System [ECCPS](German Research Foundation (DFG)); LOEWE Center for Cell and Gene Therapy; German Center for Cardiovascular Research; Universities of Giessen and Marburg Lung Center (UGMLC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are indebted to Dr. Frank Constanini, Dr. Charles Keller, and Dr. Phil Soriano for the contribution of mouse strains. T.B. was supported by the DFG (Excellence Cluster Cardio-Pulmonary System [ECCPS], Br1416, and SFB TR81), the LOEWE Center for Cell and Gene Therapy, the German Center for Cardiovascular Research, and the Universities of Giessen and Marburg Lung Center (UGMLC). C.-M.F. is supported by the NIH (RO1AR060042 and R21AR063847). C.L. is supported by DP5OD009208 and R21AR063847).	Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cooper RN, 1999, J CELL SCI, V112, P2895; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gensch N, 2008, DEVELOPMENT, V135, P1597, DOI 10.1242/dev.019331; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Krauss V, 2008, GENETICA, V133, P93, DOI 10.1007/s10709-007-9184-z; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Massuda ES, 1997, P NATL ACAD SCI USA, V94, P14701, DOI 10.1073/pnas.94.26.14701; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soleimani VD, 2012, DEV CELL, V22, P1208, DOI 10.1016/j.devcel.2012.03.014; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	33	167	176	4	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					590	601		10.1016/j.stem.2013.07.016	http://dx.doi.org/10.1016/j.stem.2013.07.016			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	23933088	Bronze, Green Accepted			2022-12-28	WOS:000329571500011
J	Hysolli, E; Park, IH				Hysolli, Eriona; Park, In-Hyun			Trivalent Chromatin Marks the Way iN	CELL STEM CELL			English	Editorial Material							FIBROBLASTS; CELLS	Recently in Cell, Wapinski et al. (2013) investigated the epigenetic mechanisms underlying the direct conversion of fibroblasts to induced neurons (iNs). They found that Ascl1 acts as a pioneer factor at neurogenic loci marked by a closed "trivalent" chromatin state in cells permissive to direct conversion, but not in restrictive cell types.	[Hysolli, Eriona; Park, In-Hyun] Yale Univ, Dept Genet, Yale Stem Cell Ctr, Sch Med, New Haven, CT 06520 USA	Yale University	Park, IH (corresponding author), Yale Univ, Dept Genet, Yale Stem Cell Ctr, Sch Med, 10 Amistad,201B, New Haven, CT 06520 USA.	inhyun.park@yale.edu			NIGMS NIH HHS [T32 GM007223] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Ladewig J, 2013, NAT REV MOL CELL BIO, V14, P225, DOI 10.1038/nrm3543; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	10	0	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					510	512		10.1016/j.stem.2013.10.007	http://dx.doi.org/10.1016/j.stem.2013.10.007			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24209756	Green Accepted, Bronze			2022-12-28	WOS:000329571500003
J	Kubaczka, C; Senner, CE; Cierlitza, M; Arauzo-Bravo, MJ; Kuckenberg, P; Peitz, M; Hemberger, M; Schorle, H				Kubaczka, Caroline; Senner, Claire E.; Cierlitza, Monika; Arauzo-Bravo, Marcos J.; Kuckenberg, Peter; Peitz, Michael; Hemberger, Myriam; Schorle, Hubert			Direct Induction of Trophoblast Stem Cells from Murine Fibroblasts	CELL STEM CELL			English	Article							EXTRAEMBRYONIC ECTODERM; EPIGENETIC MEMORY; SELF-RENEWAL; CDX2; TROPHECTODERM; FATE; LINEAGE; ETS2; DIFFERENTIATION; SPECIFICATION	Trophoblast stem cells (TSCs) arise from the first cell fate decision in the developing embryo and generate extra-embryonic lineages, giving rise to the fetal portion of the placenta. Mouse embryonic and extra-embryonic lineages are strictly separated by a distinct epigenetic barrier, which is not fully overcome following expression of TSC-determining factors in embryonic stem cells. Here, we show that transient expression of Tfap2c, Gata3, Eomes, and Ets2 is sufficient to reprogram mouse embryonic fibroblasts and post-natal tail-tip-derived fibroblasts into induced TSCs (iTSCs) and surmount the epigenetic barrier separating somatic from extra-embryonic lineages. iTSCs share nearly identical morphological characteristics, gene expression profiles, and DNA methylation patterns with blastocyst-derived TSCs. Furthermore, iTSCs display transgene-independent self-renewal, differentiate along extra-embryonic lineages, and chimerize host placentas following blastocyst injection. These findings provide insights into the transcription factor networks governing TSC identity and opportunities for studying the epigenetic barriers underlying embryonic and extra-embryonic lineage segregation.	[Kubaczka, Caroline; Cierlitza, Monika; Kuckenberg, Peter; Schorle, Hubert] Univ Bonn, Inst Pathol, Dept Dev Pathol, D-53127 Bonn, Germany; [Senner, Claire E.; Hemberger, Myriam] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Senner, Claire E.; Hemberger, Myriam] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Arauzo-Bravo, Marcos J.] Biodonostia Hlth Res Inst, Grp Computat Biol & Syst Biomed, San Sebastian 20014, Spain; [Arauzo-Bravo, Marcos J.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain; [Peitz, Michael] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany; [Peitz, Michael] German Ctr Neurodegenerat Dis DZNE, D-53127 Bonn, Germany	University of Bonn; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Schorle, H (corresponding author), Univ Bonn, Inst Pathol, Dept Dev Pathol, D-53127 Bonn, Germany.	hubert.schorle@ukb.uni-bonn.de	Peitz, Michael/AHB-0741-2022; Kubaczka, Caroline/AAA-5047-2022; Schorle, Hubert/M-5001-2016; Schorle, Hubert/S-1713-2019; Marcos, Arauzo-Bravo/A-1706-2011	Schorle, Hubert/0000-0001-8272-0076; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Senner, Claire/0000-0001-5237-3165; Kubaczka, Caroline/0000-0002-7783-6602; Hemberger, Myriam/0000-0003-3332-6958	DFG [Scho 503/10-1]; BBSRC [BB/I008764/1, BBS/E/B/000C0402, BBS/E/B/000C0403] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I008764/1, BBS/E/B/000C0402, BBS/E/B/000C0403] Funding Source: researchfish	DFG(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are extremely grateful to Angela Egert for blastocyst injections; Gaby Beine and Susanne Steiner for excellent technical assistance; and Alexander Murray, who generously provided primers for MassArray and RT-qPCR analysis. Additionally, we thank the Department of Genomics, Life and Brain Center, Bonn for performing Illumina expression arrays and Eva Riechert for generating the pLV-tetO-Eomes construct. This study was supported by DFG grant Scho 503/10-1.	Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Cambuli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6538; Chen Y, 2013, BIOCHEM BIOPH RES CO, V431, P197, DOI 10.1016/j.bbrc.2012.12.135; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; Donnison M, 2015, DEV BIOL, V397, P77, DOI 10.1016/j.ydbio.2014.10.011; Erlebacher A, 2004, DEV BIOL, V275, P158, DOI 10.1016/j.ydbio.2004.07.032; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Georgiades P, 2006, DEVELOPMENT, V133, P1059, DOI 10.1242/dev.02277; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hemberger M, 2010, HUM MOL GENET, V19, P2456, DOI 10.1093/hmg/ddq128; Islas JF, 2012, P NATL ACAD SCI USA, V109, P13016, DOI 10.1073/pnas.1120299109; Kidder BL, 2010, GENOME RES, V20, P458, DOI 10.1101/gr.101469.109; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kubaczka C, 2014, STEM CELL REP, V2, P232, DOI 10.1016/j.stemcr.2013.12.013; Kuckenberg P, 2011, MOL CELL BIOL, V31, P1748, DOI 10.1128/MCB.01047-10; Kuckenberg P, 2010, MOL CELL BIOL, V30, P3310, DOI 10.1128/MCB.01215-09; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Oda M, 2009, P NATL ACAD SCI USA, V106, P16293, DOI 10.1073/pnas.0908009106; Odiatis C, 2010, PLACENTA, V31, P630, DOI 10.1016/j.placenta.2010.05.001; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Quail MA, 2012, NAT METHODS, V9, P10, DOI 10.1038/nmeth.1814; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Rugg-Gunn PJ, 2012, DEV CELL, V22, P887, DOI 10.1016/j.devcel.2012.01.005; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Senner CE, 2012, STEM CELLS, V30, P2732, DOI 10.1002/stem.1249; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wen F, 2007, DEV BIOL, V312, P284, DOI 10.1016/j.ydbio.2007.09.024; Wu GM, 2010, DEVELOPMENT, V137, P4159, DOI 10.1242/dev.056630; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315	41	55	55	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2015	17	5					557	568		10.1016/j.stem.2015.08.005	http://dx.doi.org/10.1016/j.stem.2015.08.005			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4UB	26412560	Bronze			2022-12-28	WOS:000365694700009
J	Metcalfe, C; Siebel, CW				Metcalfe, Ciara; Siebel, Christian W.			The Hedgehog Hold on Homeostasis	CELL STEM CELL			English	Editorial Material							SONIC HEDGEHOG; PULMONARY-FIBROSIS; REPAIR	The adult lung is largely quiescent, with airway epithelia turning over slowly. Peng et al. (2015) describe a key role for the Hedgehog pathway in actively maintaining this quiescence, a surprising turn of events given the pathway's established mitogenic role, and they show that Hedgehog pathway attenuation is required for proliferative regeneration.	[Metcalfe, Ciara] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Siebel, Christian W.] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Siebel, CW (corresponding author), Genentech Inc, Dept Discovery Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	siebel.christian@gene.com						Bellusci S, 1997, DEVELOPMENT, V124, P53; Hu BA, 2015, AM J RESP CELL MOL, V52, P418, DOI 10.1165/rcmb.2014-0108OC; Kugler MC, 2015, AM J RESP CELL MOL, V52, P1, DOI 10.1165/rcmb.2014-0132TR; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Bolanos AL, 2012, AM J PHYSIOL-LUNG C, V303, pL978, DOI 10.1152/ajplung.00184.2012; Moshai EF, 2014, AM J RESP CELL MOL, V51, P11, DOI 10.1165/rcmb.2013-0154OC; Peng T, 2015, NATURE, V526, P578, DOI 10.1038/nature14984; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; van Dop WA, 2010, GASTROENTEROLOGY, V139, P1665, DOI 10.1053/j.gastro.2010.07.045; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608	10	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2015	17	5					505	506		10.1016/j.stem.2015.10.010	http://dx.doi.org/10.1016/j.stem.2015.10.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4UB	26544111	Bronze			2022-12-28	WOS:000365694700004
J	Ng, SY; Soh, BS; Rodriguez-Muela, N; Hendrickson, DG; Price, F; Rinn, JL; Rubin, LL				Ng, Shi-Yan; Soh, Boon Seng; Rodriguez-Muela, Natalia; Hendrickson, David G.; Price, Feodor; Rinn, John L.; Rubin, Lee L.			Genome-wide RNA-Seq of Human Motor Neurons Implicates Selective ER Stress Activation in Spinal Muscular Atrophy	CELL STEM CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; PLURIPOTENT STEM-CELLS; MOUSE MODEL; IN-VIVO; SMN; RESCUE; APOPTOSIS; DEATH; CASPASE-4	Spinal muscular atrophy (SMA) is caused by mutations in the SMN1 gene. Because this gene is expressed ubiquitously, it remains poorly understood why motor neurons (MNs) are one of the most affected cell types. To address this question, we carried out RNA sequencing studies using fixed, antibody-labeled, and purified MNs produced from control and SMA patient-derived induced pluripotent stem cells (iPSCs). We found SMA-specific changes in MNs, including hyper-activation of the ER stress pathway. Functional studies demonstrated that inhibition of ER stress improves MN survival in vitro even in MNs expressing low SMN. In SMA mice, systemic delivery of an ER stress inhibitor that crosses the blood-brain barrier led to the preservation of spinal cord MNs. Therefore, our study implies that selective activation of ER stress underlies MN death in SMA. Moreover, the approach we have taken would be broadly applicable to the study of disease-prone human cells in heterogeneous cultures.	[Ng, Shi-Yan; Soh, Boon Seng; Rodriguez-Muela, Natalia; Hendrickson, David G.; Price, Feodor; Rinn, John L.; Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ng, Shi-Yan; Soh, Boon Seng; Rodriguez-Muela, Natalia; Price, Feodor; Rinn, John L.; Rubin, Lee L.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Soh, Boon Seng] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Hendrickson, David G.; Rinn, John L.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA	Harvard University; Harvard University; Karolinska Institutet; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rubin, LL (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	lee_rubin@harvard.edu	Muela, Natalia Rodriguez/A-8098-2016	Muela, Natalia Rodriguez/0000-0003-1065-1870; Rubin, Lee/0000-0002-8658-841X; Ng, Shi-Yan/0000-0003-3418-2757	NINDS [1P01NS066888]; Spinal Muscular Atrophy Foundation; Harvard Stem Cell Institute; A*STAR International Fellowship (Singapore); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS066888] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Spinal Muscular Atrophy Foundation; Harvard Stem Cell Institute; A*STAR International Fellowship (Singapore)(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Catherine McGillivary for histology assistance and Erika Norabuena for genotyping of mice. This work is supported by grants from the NINDS (1P01NS066888), the Spinal Muscular Atrophy Foundation, and the Harvard Stem Cell Institute. S.Y.N. is a recipient of the A*STAR International Fellowship (Singapore).	Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; Andreassi C, 2004, EUR J HUM GENET, V12, P59, DOI 10.1038/sj.ejhg.5201102; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Corti S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004108; d'Errico P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082654; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hrvatin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089459; Hua YM, 2015, GENE DEV, V29, P288, DOI 10.1101/gad.256644.114; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; MEACHAM RH, 1981, DRUG METAB DISPOS, V9, P509; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Munoz-Lobato F, 2014, ANTIOXID REDOX SIGN, V20, P217, DOI 10.1089/ars.2012.5051; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Singhal N, 2011, DEV NEUROBIOL, V71, P982, DOI 10.1002/dneu.20953; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Ugolini G, 2003, J NEUROSCI, V23, P8526; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	33	82	83	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2015	17	5					569	584		10.1016/j.stem.2015.08.003	http://dx.doi.org/10.1016/j.stem.2015.08.003			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4UB	26321202	Green Accepted, Bronze			2022-12-28	WOS:000365694700010
J	Galonska, C; Ziller, MJ; Karnik, R; Meissner, A				Galonska, Christina; Ziller, Michael J.; Karnik, Rahul; Meissner, Alexander			Ground State Conditions Induce Rapid Reorganization of Core Pluripotency Factor Binding before Global Epigenetic Reprogramming	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; NAIVE PLURIPOTENCY; TRANSCRIPTIONAL NETWORK; PRIMED PLURIPOTENCY; SELF-RENEWAL; MOUSE; TRANSITION; GENOME; METHYLATION; ACTIVATION	Mouse embryonic stem cells (mESCs) cultured under serum/LIF conditions exhibit heterogeneous expression of pluripotency-associated factors that can be overcome by two inhibitors (2i) of the MEK and GSK3 pathways. Several studies have shown that the "ground state" induced by 2i is characterized by global hypomethylation and specific transcriptional profiles, but little is known about the contributing effectors. Here we show that 2i conditions rapidly alter the global binding landscape of OCT4, SOX2, and NANOG. The dynamic binding influences enhancer activity and shows enrichment for regulators linked to Wnt and Erk signaling. Epigenomic characterization provided limited insights to the immediate transcriptional dynamics, suggesting that these are likely more secondary effects. Likewise, loss of the PRC2 component EED to prevent H3K27me3 deposition had minimal effect on the transcriptome, implying that it is largely dispensable for continued repression of bivalent genes and de novo silencing in 2i.	[Galonska, Christina; Ziller, Michael J.; Karnik, Rahul; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Galonska, Christina; Ziller, Michael J.; Karnik, Rahul; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Galonska, Christina; Ziller, Michael J.; Karnik, Rahul; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu		Karnik, Rahul/0000-0002-0400-635X; Galonska, Christina/0000-0002-6920-5608	Human Frontiers Science Program, NIH [1P50HG006193, P01GM099117]; New York Stem Cell Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER	Human Frontiers Science Program, NIH; New York Stem Cell Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Robbyn Issner, Holly Whitton, and Hongcang Gu for their advice and support regarding the ChIP-seq library preparation. A.M. is a New York Stem Cell Foundation, Robertson Investigator. This work was funded by the Human Frontiers Science Program, NIH grants 1P50HG006193 and P01GM099117, and the New York Stem Cell Foundation.	Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cusanovich DA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004226; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Galonska C, 2014, STEM CELL REP, V2, P245, DOI 10.1016/j.stemcr.2014.01.007; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gregg Jennifer, 2011, Genes Cancer, V2, P900, DOI 10.1177/1947601911431885; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yang SH, 2014, CELL REP, V7, P1968, DOI 10.1016/j.celrep.2014.05.037; Yeo JC, 2014, CELL STEM CELL, V14, P864, DOI 10.1016/j.stem.2014.04.015; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	33	76	77	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 1	2015	17	4					462	470		10.1016/j.stem.2015.07.005	http://dx.doi.org/10.1016/j.stem.2015.07.005			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4TS	26235340	Bronze, Green Accepted			2022-12-28	WOS:000365693800012
J	Kikushige, Y; Miyamoto, T; Yuda, J; Jabbarzadeh-Tabrizi, S; Shima, T; Takayanagi, S; Niiro, H; Yurino, A; Miyawaki, K; Takenaka, K; Iwasaki, H; Akashi, K				Kikushige, Yoshikane; Miyamoto, Toshihiro; Yuda, Junichiro; Jabbarzadeh-Tabrizi, Siamak; Shima, Takahiro; Takayanagi, Shin-ichiro; Niiro, Hiroaki; Yurino, Ayano; Miyawaki, Kohta; Takenaka, Katsuto; Iwasaki, Hiromi; Akashi, Koichi			A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression	CELL STEM CELL			English	Article							NF-KAPPA-B; BETA-CATENIN; TIM-3; PROGENITORS; GALECTIN-9; RECEPTOR; PATHWAY; GROWTH; CANCER; AML	Signaling mechanisms underlying self-renewal of leukemic stem cells (LSCs) are poorly understood, and identifying pathways specifically active in LSCs could provide opportunities for therapeutic intervention. T-cell immunoglobin mucin-3 (TIM-3) is expressed on the surface of LSCs in many types of human acute myeloid leukemia (AML), but not on hematopoietic stem cells (HSCs). Here, we show that TIM-3 and its ligand, galectin-9 (Gal-9), constitute an autocrine loop critical for LSC self-renewal and development of human AML. Serum Gal-9 levels were significantly elevated in AML patients and in mice xenografted with primary human AML samples, and neutralization of Gal-9 inhibited xenogeneic reconstitution of human AML. Gal-9-mediated stimulation of TIM-3 co-activated NF-kappa B and beta-catenin signaling, pathways known to promote LSC self-renewal. These changes were further associated with leukemic transformation of a variety of pre-leukemic disorders and together highlight that targeting the TIM-3/Gal-9 autocrine loop could be a useful strategy for treating myeloid leukemias.	[Kikushige, Yoshikane; Miyamoto, Toshihiro; Yuda, Junichiro; Jabbarzadeh-Tabrizi, Siamak; Shima, Takahiro; Niiro, Hiroaki; Yurino, Ayano; Miyawaki, Kohta; Akashi, Koichi] Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan; [Kikushige, Yoshikane; Takenaka, Katsuto; Iwasaki, Hiromi; Akashi, Koichi] Kyushu Univ Hosp, Ctr Cellular & Mol Med, Fukuoka 8128582, Japan; [Kikushige, Yoshikane] Japan Soc Promot Sci, Tokyo 1020083, Japan; [Takayanagi, Shin-ichiro] Kyowa Hakko Kirin Co Ltd, R&D Div, Oncol R&D Unit, Oncol Res Labs, Tokyo 1948533, Japan	Kyushu University; Kyushu University; Japan Society for the Promotion of Science; Kyowa Kirin Ltd	Akashi, K (corresponding author), Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan.	akashi@med.kyushu-u.ac.jp			Japan intractable diseases research foundation [26713034, 22130001, 22130002, 25115002, 25253069, 23390254]; Chiyu-Kai; Kyowa Hakko Kirin Co., Ltd.	Japan intractable diseases research foundation; Chiyu-Kai; Kyowa Hakko Kirin Co., Ltd.(Kyowa Kirin Ltd)	This study was supported in part by a Grant-in-Aid for Young Scientists (A) (to Y.K., no. 26713034), a Grant-in-Aid for Scientific Research on Innovative Areas "Development of Novel Treatment Strategies Targeting Cancer Stem Cells'' (to K.A. no., 22130001 and 22130002) and "Stem Cell Aging and Disease'' (to T.M., no. 25115002), a Grant-in-Aid for JSPS fellows (to Y.K.), a Grant-in-Aid for Scientific Research (A) (to K.A., no. 25253069), a Grant-in-Aid for Scientific Research (B)(to T.M., no. 23390254), and a Grant-in-Aid from Japan intractable diseases research foundation (to Y.K.). This study was also supported in part by a contribution from Chiyu-Kai and by a grant from Kyowa Hakko Kirin Co., Ltd., and S.-i.T. is an employee of Kyowa Hakko Kirin Co., Ltd.	AKASHI K, 1991, J CLIN INVEST, V88, P223, DOI 10.1172/JCI115281; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Birkenkamp KU, 2004, LEUKEMIA, V18, P103, DOI 10.1038/sj.leu.2403145; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bouck DC, 2011, J BIOMOL SCREEN, V16, P394, DOI 10.1177/1087057110397889; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; de Weyer PSV, 2006, BIOCHEM BIOPH RES CO, V351, P571, DOI 10.1016/j.bbrc.2006.10.079; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Gleason MK, 2012, BLOOD, V119, P3064, DOI 10.1182/blood-2011-06-360321; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Heusschen R, 2013, BBA-REV CANCER, V1836, P177, DOI 10.1016/j.bbcan.2013.04.006; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Jan M, 2011, P NATL ACAD SCI USA, V108, P5009, DOI 10.1073/pnas.1100551108; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kuchroo VK, 2008, NAT REV IMMUNOL, V8, P577, DOI 10.1038/nri2366; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; MUROHASHI I, 1989, BLOOD, V74, P35; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Oomizu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048574; OSTER W, 1989, J CLIN INVEST, V84, P451, DOI 10.1172/JCI114186; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Sada-Ovalle I, 2012, J IMMUNOL, V189, P5896, DOI 10.4049/jimmunol.1200990; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Schmole AC, 2010, BIOORGAN MED CHEM, V18, P6785, DOI 10.1016/j.bmc.2010.07.045; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; van Rhenen A, 2007, BLOOD, V110, P2659, DOI 10.1182/blood-2007-03-083048; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wang J, 2005, EMBO J, V24, P368, DOI 10.1038/sj.emboj.7600521; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Yamaguchi H, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00015; Yamauchi T, 2013, BLOOD, V121, P1316, DOI 10.1182/blood-2012-06-440354; Yoshimoto G, 2009, BLOOD, V114, P5034, DOI 10.1182/blood-2008-12-196055; Ysebaert L, 2006, LEUKEMIA, V20, P1211, DOI 10.1038/sj.leu.2404239; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	57	139	147	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					341	352		10.1016/j.stem.2015.07.011	http://dx.doi.org/10.1016/j.stem.2015.07.011			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26279267	Bronze			2022-12-28	WOS:000364011000012
J	Li, X; Zuo, XH; Jing, JZ; Ma, YT; Wang, JM; Liu, DF; Zhu, JL; Du, XM; Xiong, L; Du, YY; Xu, J; Xiao, X; Wang, JL; Chai, Z; Zhao, Y; Deng, HK				Li, Xiang; Zuo, Xiaohan; Jing, Junzhan; Ma, Yantao; Wang, Jiaming; Liu, Defang; Zhu, Jialiang; Du, Xiaomin; Xiong, Liang; Du, Yuanyuan; Xu, Jun; Xiao, Xiong; Wang, Jinlin; Chai, Zhen; Zhao, Yang; Deng, Hongkui			Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons	CELL STEM CELL			English	Article							DOPAMINERGIC-NEURONS; CELL FATE; CONVERSION; PLURIPOTENCY; IDENTIFICATION; EXPRESSION; GENERATION; INHIBITORS; GENES	Recently, direct reprogramming between divergent lineages has been achieved by the introduction of regulatory transcription factors. This approach may provide alternative cell resources for drug discovery and regenerative medicine, but applications could be limited by the genetic manipulation involved. Here, we show that mouse fibroblasts can be directly converted into neuronal cells using only a cocktail of small molecules, with a yield of up to >90% being TUJ1-positive after 16 days of induction. After a further maturation stage, these chemically induced neurons (CiNs) possessed neuron-specific expression patterns, generated action potentials, and formed functional synapses. Mechanistically, we found that a BET family bromodomain inhibitor, I-BET151, disrupted the fibroblast-specific program, while the neurogenesis inducer ISX9 was necessary to activate neuron-specific genes. Overall, our findings provide a "proof of principle'' for chemically induced direct reprogramming of somatic cell fates across germ layers without genetic manipulation, through disruption of cell-specific programs and induction of an alternative fate.	[Li, Xiang; Ma, Yantao; Wang, Jiaming; Zhu, Jialiang; Du, Xiaomin; Xiong, Liang; Du, Yuanyuan; Xu, Jun; Zhao, Yang; Deng, Hongkui] Peking Univ, MOE Key Lab Cell Proliferat & Differentiat, Coll Life Sci, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Li, Xiang; Ma, Yantao; Wang, Jiaming; Zhu, Jialiang; Du, Xiaomin; Xiong, Liang; Du, Yuanyuan; Xu, Jun; Zhao, Yang; Deng, Hongkui] Peking Univ, Hlth Sci Ctr, Dept Cell Biol,State Key Lab Nat & Biomimet Drugs, Sch Basic Med Sci,Stem Cell Res Ctr,Ctr Mol & Tra, Beijing 100191, Peoples R China; [Zuo, Xiaohan; Liu, Defang; Xiao, Xiong; Wang, Jinlin; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Shenzhen Stem Cell Engn Lab, Key Lab Chem Genom, Shenzhen 518055, Guangdong, Peoples R China; [Jing, Junzhan; Chai, Zhen] Peking Univ, Coll Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China; [Ma, Yantao; Xiong, Liang] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; University Town of Shenzhen; Peking University; Peking University	Chai, Z (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China.	zhenchai@pku.edu.cn; yangzhao@pku.edu.cn; hongkui_deng@pku.edu.cn	Jing, Junzhan/AAE-1888-2020; du, xiaomin/GPW-7436-2022	Jing, Junzhan/0000-0003-4647-0932; 	National Basic Research Program of China (973 Program) [2012CB966401, 2015CB964501]; National Natural Science Foundation of China [91310305]; Ministry of Science and Technology [2013DFG30680]; Key New Drug Creation and Manufacturing Program [2011ZX09102-010-03]; Ministry of Education of China (111 Project)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Key New Drug Creation and Manufacturing Program; Ministry of Education of China (111 Project)	We would like to thank W.F. Yang, C.Y. Wang, Y. Shi, M. Yin, and F.C. Tang for suggestions, and we would also like to thank X.C. Li, X.M. Hao, L.J. Cheng, Z.C. Miao, S.G. Duo, Q.Z. Meng, Z.Y. Hou, and J.F. Liu for technical assistance. This work was supported by the National Basic Research Program of China (973 Program 2012CB966401 and 2015CB964501), the National Natural Science Foundation of China (91310305), Ministry of Science and Technology (2013DFG30680), Key New Drug Creation and Manufacturing Program (2011ZX09102-010-03), and the Ministry of Education of China (111 Project). We also wish to thank other members of our laboratories for their support.	Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Chiang CM, 2014, CHEM BIOL, V21, P804, DOI 10.1016/j.chembiol.2014.07.003; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Di Micco R, 2014, CELL REP, V9, P234, DOI 10.1016/j.celrep.2014.08.055; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Dworkin S, 2010, EXPERT OPIN THER TAR, V14, P869, DOI 10.1517/14728222.2010.501332; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; Seal J, 2012, BIOORG MED CHEM LETT, V22, P2968, DOI 10.1016/j.bmcl.2012.02.041; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wu T, 2015, STEM CELL REP, V4, P390, DOI 10.1016/j.stemcr.2015.01.012; Xu J, 2015, CELL STEM CELL, V16, P119, DOI 10.1016/j.stem.2015.01.013; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yu C, 2014, CURR OPIN GENET DEV, V28, P50, DOI 10.1016/j.gde.2014.09.006	28	273	298	5	108	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					195	203		10.1016/j.stem.2015.06.003	http://dx.doi.org/10.1016/j.stem.2015.06.003			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26253201	Bronze			2022-12-28	WOS:000361878500010
J	Miki, K; Endo, K; Takahashi, S; Funakoshi, S; Takei, I; Katayama, S; Toyoda, T; Kotaka, M; Takaki, T; Umeda, M; Okubo, C; Nishikawa, M; Oishi, A; Narita, M; Miyashita, I; Asano, K; Hayashi, K; Osafune, K; Yamanaka, S; Saito, H; Yoshida, Y				Miki, Kenji; Endo, Kei; Takahashi, Seiya; Funakoshi, Shunsuke; Takei, Ikue; Katayama, Shota; Toyoda, Taro; Kotaka, Maki; Takaki, Tadashi; Umeda, Masayuki; Okubo, Chikako; Nishikawa, Misato; Oishi, Akiko; Narita, Megumi; Miyashita, Ito; Asano, Kanako; Hayashi, Karin; Osafune, Kenji; Yamanaka, Shinya; Saito, Hirohide; Yoshida, Yoshinori			Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches	CELL STEM CELL			English	Article							EMBRYONIC-STEM-CELL; MODIFIED MESSENGER-RNA; PROGENITOR CELLS; CARDIOMYOCYTES; EXPRESSION; DIFFERENTIATION; TRANSPLANTATION; INTEGRATION; ENRICHMENT; SURVIVAL	Isolation of specific cell types, including pluripotent stem cell (PSC)-derived populations, is frequently accomplished using cell surface antigens expressed by the cells of interest. However, specific antigens for many cell types have not been identified, making their isolation difficult. Here, we describe an efficient method for purifying cells based on endogenous miRNA activity. We designed synthetic mRNAs encoding a fluorescent protein tagged with sequences targeted by miRNAs expressed by the cells of interest. These miRNA switches control their translation levels by sensing miRNA activities. Several miRNA switches (miR-1-, miR-208a-, and miR-499a-5p-switches) efficiently purified cardiomyocytes differentiated from human PSCs, and switches encoding the apoptosis inducer Bim enriched for cardiomyocytes without cell sorting. This approach is generally applicable, as miR-126-, miR-122-5p-, and miR-375-switches purified endothelial cells, hepatocytes, and insulin-producing cells differentiated from hPSCs, respectively. Thus, miRNA switches can purify cell populations for which other isolation strategies are unavailable.	[Miki, Kenji; Endo, Kei; Takahashi, Seiya; Funakoshi, Shunsuke; Takei, Ikue; Katayama, Shota; Toyoda, Taro; Kotaka, Maki; Takaki, Tadashi; Umeda, Masayuki; Okubo, Chikako; Nishikawa, Misato; Oishi, Akiko; Narita, Megumi; Miyashita, Ito; Asano, Kanako; Hayashi, Karin; Osafune, Kenji; Yamanaka, Shinya; Saito, Hirohide; Yoshida, Yoshinori] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Miki, Kenji; Yamanaka, Shinya] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6068507, Japan; [Endo, Kei] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan; [Funakoshi, Shunsuke] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Umeda, Masayuki] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; Kyoto University; University of Tokyo; Kyoto University; Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Saito, H (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan.	hirohide.saito@cira.kyoto-u.ac.jp; yoshinor@cira.kyoto-u.ac.jp	Endo, Kei/AAT-2169-2020; Yoshida, Yoshinori/AAY-6009-2020; Miki, Kenji/GSI-6891-2022; Endo, Kei/C-7325-2015	Endo, Kei/0000-0003-1020-7884; Yoshida, Yoshinori/0000-0001-5511-9090; Miki, Kenji/0000-0001-7901-6133; Endo, Kei/0000-0003-1020-7884; Katayama, Shota/0000-0002-0078-3207; Okubo, Chikako/0000-0001-5562-410X; Nakamura, Akiko/0000-0003-4331-6585	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)"; Council for Science and Technology Policy (CSTP); Balzan Prize; Health and Labour Sciences Research Grants from the Ministry of Health Labour and Welfare; Research Center Network for Realization of Regenerative Medicine; iPS Cell Research Fund; JSPS KAKENHI [24790277, 25870355, 23681042, 24104002]; Grants-in-Aid for Scientific Research [15H02774] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Balzan Prize; Health and Labour Sciences Research Grants from the Ministry of Health Labour and Welfare; Research Center Network for Realization of Regenerative Medicine; iPS Cell Research Fund; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are grateful to Gordon Keller and Mark Gagliardi (University Health Network) for providing valuable advice and support for the cardiomyocyte differentiation method. We thank Nanaka Nishimura and Shunnichi Kashida (Kyoto University) for preparing some of the materials and for critical comments on the project, respectively. We also thank Yasuhiro Yamada, Takuya Yamamoto, Callum Parr, and Peter Karagiannis (Kyoto University) for critical reading of the manuscript. We are grateful to Rie Kato, Sayaka Takeshima, Eri Nishikawa, Ryoko Fujiwara, Kyoko Nakahara, Yukiko Nakagawa, and Yoko Miyake for their administrative support. This research was funded by the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)" initiated by the Council for Science and Technology Policy (CSTP) (to S.Y.), the Balzan Prize assigned to S.Y. and H.S., Health and Labour Sciences Research Grants from the Ministry of Health Labour and Welfare (to Y.Y.), grants from the Research Center Network for Realization of Regenerative Medicine (to H.S., Y.Y., and S.Y.), and the iPS Cell Research Fund. A part of this study was supported by JSPS KAKENHI grant numbers 24790277 (to Y.Y.), 25870355 (to K.E.), and 23681042 and 24104002 (to H.S.). S.Y. is a scientific advisor of iPS Academia Japan without salary and K.O. is a member without salary of the scientific advisory boards of iPS Portal, Japan. Kyoto University has filed a patent application broadly relevant to this work. K.E., K.M., S.T., Y.Y., and H.S. are the investigators of record listed on the patent application.	Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303; Ban KW, 2013, CIRCULATION, V128, P1897, DOI 10.1161/CIRCULATIONAHA.113.004228; Bizy A, 2013, STEM CELL RES, V11, P1335, DOI 10.1016/j.scr.2013.09.003; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Endo K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt347; Francis Natalie, 2014, Microrna, V3, P54; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Gepstein L, 2010, STEM CELLS, V28, P2151, DOI 10.1002/stem.545; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Kawamura M, 2013, CIRCULATION, V128, pS87, DOI 10.1161/CIRCULATIONAHA.112.000366; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lahmy R, 2014, MOL BIOL REP, V41, P2055, DOI 10.1007/s11033-014-3054-4; Leisner M, 2010, NAT NANOTECHNOL, V5, P666, DOI [10.1038/NNANO.2010.135, 10.1038/nnano.2010.135]; Li ZJ, 2011, STEM CELLS DEV, V20, P1701, DOI 10.1089/scd.2010.0426; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]; Ozcan S, 2014, MOL ENDOCRINOL, V28, P1922, DOI 10.1210/me.2014-1306; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; White MP, 2013, STEM CELLS, V31, P92, DOI 10.1002/stem.1267; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Ye HF, 2013, CURR OPIN CHEM BIOL, V17, P910, DOI 10.1016/j.cbpa.2013.10.006; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682; Zhang DY, 2011, NAT CHEM, V3, P103, DOI 10.1038/NCHEM.957	35	126	137	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					699	711		10.1016/j.stem.2015.04.005	http://dx.doi.org/10.1016/j.stem.2015.04.005			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26004781	Bronze			2022-12-28	WOS:000355932300017
J	Goke, J; Lu, XY; Chan, YS; Ng, HH; Ly, LH; Sachs, F; Szczerbinska, I				Goeke, Jonathan; Lu, Xinyi; Chan, Yun-Shen; Ng, Huck-Hui; Ly, Lam-Ha; Sachs, Friedrich; Szczerbinska, Iwona			Dynamic Transcription of Distinct Classes of Endogenous Retroviral Elements Marks Specific Populations of Early Human Embryonic Cells	CELL STEM CELL			English	Article							TRANSPOSABLE ELEMENTS; REGULATORY NETWORK; STEM-CELLS; RNA; PLURIPOTENCY; EXPRESSION; RETROTRANSPOSONS; EVOLUTION; CIRCUITRY; ABUNDANT	About half of the human genome consists of highly repetitive elements, most of which are considered dispensable for human life. Here, we report that repetitive elements originating from endogenous retroviruses (ERVs) are systematically transcribed during human early embryogenesis in a stage-specific manner. Our analysis highlights that the long terminal repeats (LTRs) of ERVs provide the template for stage-specific transcription initiation, thereby generating hundreds of co-expressed, ERV-derived RNAs. Conversion of human embryonic stem cells (hESCs) to an epiblast-like state activates blastocyst-specific ERV elements, indicating that their activity dynamically reacts to changes in regulatory networks. In addition to initiating stage-specific transcription, many ERV families contain preserved splice sites that join the ERV segment with non-ERV exons in their genomic vicinity. In summary, we find that ERV expression is a hallmark of cellular identity and cell potency that characterizes the cell populations in early human embryos.	[Goeke, Jonathan; Ly, Lam-Ha] Genome Inst Singapore, Singapore 138672, Singapore; [Lu, Xinyi; Chan, Yun-Shen; Ng, Huck-Hui; Sachs, Friedrich; Szczerbinska, Iwona] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Ng, Huck-Hui; Sachs, Friedrich; Szczerbinska, Iwona] Natl Univ Singapore, Dept Biochem, Singapore 117559, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Ng, Huck-Hui] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Goke, J (corresponding author), Genome Inst Singapore, 60 Biopolis St, Singapore 138672, Singapore.	gokej@gis.a-star.edu.sg	Ng, Huck Hui/A-1135-2009; Chan, Yun-Shen/GWC-4616-2022	Goke, Jonathan/0000-0002-0825-4991; LU, Xinyi/0000-0002-3885-3960	Agency for Science, Technology and Research (A*STAR) of Singapore; Singapore International Graduate Award from A*STAR; Singapore International Pre-Graduate Award from A*STAR	Agency for Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore International Graduate Award from A*STAR(Agency for Science Technology & Research (A*STAR)); Singapore International Pre-Graduate Award from A*STAR(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (A*STAR) of Singapore. F.S. and I.S. are supported by the Singapore International Graduate Award from A*STAR. L.-H.L. is supported by the Singapore International Pre-Graduate Award from A*STAR. The authors would like to thank Weiwei Zhai for helpful discussion and comments on the manuscript and Andreas Wilm for suggestions about sequence alignments.	Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; del Rosario RCH, 2014, GENOME RES, V24, P1469, DOI 10.1101/gr.168963.113; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Fuchs NV, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-115; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Goke J, 2012, BIOINFORMATICS, V28, P656, DOI 10.1093/bioinformatics/bts028; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Jacques PE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003504; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Lu XY, 2013, NAT CELL BIOL, V15, P1141, DOI 10.1038/ncb2839; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macia A, 2011, MOL CELL BIOL, V31, P300, DOI 10.1128/MCB.00561-10; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tonjes RR, 1997, J VIROL, V71, P2747; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Weiss RA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-67; Werren JH, 2011, P NATL ACAD SCI USA, V108, P10863, DOI 10.1073/pnas.1102343108; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Young JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003947	37	178	186	4	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					135	141		10.1016/j.stem.2015.01.005	http://dx.doi.org/10.1016/j.stem.2015.01.005			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25658370	Bronze			2022-12-28	WOS:000349455000009
J	Kushner, JA; MacDonald, PE; Atkinson, MA				Kushner, Jake A.; MacDonald, Patrick E.; Atkinson, Mark A.			Stem Cells to Insulin Secreting Cells: Two Steps Forward and Now a Time to Pause?	CELL STEM CELL			English	Editorial Material							HUMAN PANCREATIC-ISLETS	Two groups recently reported the in vitro differentiation of human embryonic stem cells into insulin-secreting cells, achieving an elusive goal for regenerative medicine. Herein we provide a perspective regarding these developments, compare phenotypes of the insulin-containing cells to human beta cells, and discuss implications for type 1 diabetes research and clinical care.	[Kushner, Jake A.] Texas Childrens Hosp, Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA; [MacDonald, Patrick E.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2E1, Canada; [MacDonald, Patrick E.] Alberta Diabet Inst, Edmonton, AB T6G 2E1, Canada; [Atkinson, Mark A.] Univ Florida, Dept Pathol, Gainesville, FL 32610 USA; [Atkinson, Mark A.] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA	Baylor College of Medicine; University of Alberta; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kushner, JA (corresponding author), Texas Childrens Hosp, Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA.	kushner@bcm.edu	Kushner, Jake A/AAF-5049-2022; Kushner, Jake A/AFJ-8198-2022	Kushner, Jake A/0000-0002-3646-1744; Kushner, Jake A/0000-0002-3646-1744; MacDonald, Patrick/0000-0002-5439-6288				Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; KINDMARK H, 1991, FEBS LETT, V291, P310, DOI 10.1016/0014-5793(91)81309-V; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Ledford H, 2014, NATURE, V514, P281, DOI 10.1038/514281a; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Rezania A., 2014, NAT BIOTECH IN PRESS; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401	9	30	30	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					535	536		10.1016/j.stem.2014.10.012	http://dx.doi.org/10.1016/j.stem.2014.10.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517460	Bronze			2022-12-28	WOS:000345012700005
J	Cabezas-Wallscheid, N; Klimmeck, D; Hansson, J; Lipka, DB; Reyes, A; Wang, Q; Weichenhan, D; Lier, A; von Paleske, L; Renders, S; Wunsche, P; Zeisberger, P; Brocks, D; Gu, L; Herrmann, C; Haas, S; Essers, MAG; Brors, B; Eils, R; Huber, W; Milsom, MD; Plass, C; Krijgsveld, J; Trumpp, A				Cabezas-Wallscheid, Nina; Klimmeck, Daniel; Hansson, Jenny; Lipka, Daniel B.; Reyes, Alejandro; Wang, Qi; Weichenhan, Dieter; Lier, Amelie; von Paleske, Lisa; Renders, Simon; Wuensche, Peer; Zeisberger, Petra; Brocks, David; Gu, Lei; Herrmann, Carl; Haas, Simon; Essers, Marieke A. G.; Brors, Benedikt; Eils, Roland; Huber, Wolfgang; Milsom, Michael D.; Plass, Christoph; Krijgsveld, Jeroen; Trumpp, Andreas			Identification of Regulatory Networks in HSCs and Their Immediate Progeny via Integrated Proteome, Transcriptome, and DNA Methylome Analysis	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; SELF-RENEWAL; HOX GENES; MAP; RECONSTITUTION; QUIESCENCE; EXPRESSION; SEQUENCES; PARADIGM	In this study, we present integrated quantitative proteome, transcriptome, and methylome analyses of hematopoietic stem cells (HSCs) and four multipotent progenitor (MPP) populations. From the characterization of more than 6,000 proteins, 27,000 transcripts, and 15,000 differentially methylated regions (DMRs), we identified coordinated changes associated with early differentiation steps. DMRs show continuous gain or loss of methylation during differentiation, and the overall change in DNA methylation correlates inversely with gene expression at key loci. Our data reveal the differential expression landscape of 493 transcription factors and 682 lncRNAs and highlight specific expression clusters operating in HSCs. We also found an unexpectedly dynamic pattern of transcript isoform regulation, suggesting a critical regulatory role during HSC differentiation, and a cell cycle/DNA repair signature associated with multipotency in MPP2 cells. This study provides a comprehensive genome-wide resource for the functional exploration of molecular, cellular, and epigenetic regulation at the top of the hematopoietic hierarchy.	[Cabezas-Wallscheid, Nina; Klimmeck, Daniel; von Paleske, Lisa; Renders, Simon; Wuensche, Peer; Zeisberger, Petra; Trumpp, Andreas] Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Cabezas-Wallscheid, Nina; Klimmeck, Daniel; Lier, Amelie; von Paleske, Lisa; Renders, Simon; Wuensche, Peer; Zeisberger, Petra; Haas, Simon; Essers, Marieke A. G.; Milsom, Michael D.; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany; [Klimmeck, Daniel; Hansson, Jenny; Reyes, Alejandro; Huber, Wolfgang; Krijgsveld, Jeroen] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Lipka, Daniel B.; Weichenhan, Dieter; Brocks, David; Gu, Lei; Plass, Christoph] DKFZ, Div Epigen & Canc Risk Factors, D-69120 Heidelberg, Germany; [Wang, Qi; Gu, Lei; Herrmann, Carl; Brors, Benedikt; Eils, Roland] DKFZ, Dept Bioinformat & Funct Genom, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Lier, Amelie; Milsom, Michael D.] DKFZ, Div Stem Cells & Canc, Jr Res Grp Expt Hematol, D-69120 Heidelberg, Germany; [Haas, Simon; Essers, Marieke A. G.] DKFZ, Div Stem Cells & Canc, Jr Res Grp Stress Induced Activat Hematopoiet Ste, D-69120 Heidelberg, Germany; [Brors, Benedikt; Eils, Roland; Plass, Christoph; Trumpp, Andreas] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Wang, Qi; Gu, Lei; Herrmann, Carl; Brors, Benedikt; Eils, Roland] Heidelberg Univ, IPMB, D-69120 Heidelberg, Germany; [Wang, Qi; Gu, Lei; Herrmann, Carl; Brors, Benedikt; Eils, Roland] Heidelberg Univ, BioQuant, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Trumpp, A (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, D-69120 Heidelberg, Germany.	a.trumpp@dkfz.de	Reyes, Alejandro/D-8258-2017; Hansson, Jenny/J-5062-2014; Eils, Roland/B-6121-2009; Trumpp, Andreas/Z-2141-2019; Essers, Marieke A.G./B-7758-2017; Gu, Lei/GWQ-6785-2022; Brors, Benedikt/E-5620-2013; Herrmann, Carl/AAR-3167-2020; Milsom, Michael/AAK-4600-2020; Herrmann, Carl/H-5859-2011	Reyes, Alejandro/0000-0001-8717-6612; Hansson, Jenny/0000-0001-9174-8089; Eils, Roland/0000-0002-0034-4036; Trumpp, Andreas/0000-0002-6212-3466; Essers, Marieke A.G./0000-0003-3117-1809; Brors, Benedikt/0000-0001-5940-3101; Herrmann, Carl/0000-0003-4989-4722; Krijgsveld, Jeroen/0000-0001-7549-9326; Huber, Wolfgang/0000-0002-0474-2218; Wang, Qi/0000-0002-6420-1720; /0000-0002-3567-254X; Klimmeck, Daniel/0000-0001-5605-5762; Haas, Simon/0000-0001-9227-2051	BioRN Spitzencluster "Molecular and Cell Based Medicine"; German Bundesministerium fur Bildung und Forschung; EU; Dietmar Hopp Foundation; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich SFB 873]; Netherlands Organization for Scientific Research (NWO); DFG [SP1463]; DKFZ (Epigenetics@DKFZ); Humboldt research fellowship for postdoctoral researchers	BioRN Spitzencluster "Molecular and Cell Based Medicine"; German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Dietmar Hopp Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); DFG(German Research Foundation (DFG)); DKFZ (Epigenetics@DKFZ); Humboldt research fellowship for postdoctoral researchers	We thank A. Rathgeb from the Central Animal Laboratory; S. Schmidt, U. Ernst, A. Hotz-Wagenblatt, C. Previti, and S. Wolf from the Genomics and Proteomics Core Facility; S. Schmitt and G. de la Cruz from the Flow Cytometry Core Facility at the DKFZ; and the EMBL Proteomics Core Facility for expert assistance. We also thank M. Bahr and M. Helf for technical assistance. We further thank C. C. Oakes, A. M. Lindroth, and R. Claus for helpful discussions as well as P. Komardin for support in handling data submission to the GEO database. This work was supported by the BioRN Spitzencluster "Molecular and Cell Based Medicine" supported by the German Bundesministerium fur Bildung und Forschung (to A. T.), by the EU FP7 Programs "EuroSyStem" (to A. T.) and "Radiant" (to W. H. and A. R.), by the Dietmar Hopp Foundation (to A. T.), by the Sonderforschungsbereich SFB 873 funded by the Deutsche Forschungsgemeinschaft (to A. T.), by a Vidi grant from the Netherlands Organization for Scientific Research (NWO) (to J.K.), by the DFG Priority Program SP1463 (to D. B. L. and C. P.), by an intramural grant from the DKFZ (Epigenetics@DKFZ) (to D. B. L. and M. D. M.), and by a Humboldt research fellowship for postdoctoral researchers (to Q.W.).	Adey A, 2012, GENOME RES, V22, P1139, DOI 10.1101/gr.136242.111; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Alharbi RA, 2013, LEUKEMIA, V27, P1000, DOI 10.1038/leu.2012.356; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Arab K., 2014, MOL CELL IN PRESS; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Bakker ST, 2013, EXP HEMATOL, V41, P915, DOI 10.1016/j.exphem.2013.09.007; Battista S, 2003, FASEB J, V17, P1496, DOI 10.1096/fj.02-0977fje; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Berg JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026410; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bowman TV, 2006, STEM CELLS, V24, P662, DOI 10.1634/stemcells.2005-0552; Chanda B, 2013, CELL, V155, P215, DOI 10.1016/j.cell.2013.08.055; Cleynen I, 2007, MOL CANCER RES, V5, P363, DOI 10.1158/1541-7786.MCR-06-0331; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dumon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043300; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Gao X, 2013, J EXP MED, V210, P2833, DOI 10.1084/jem.20130733; Gazit R., 2013, STEM CELL REV, V1, P1; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Klimmeck D., 2012, MOL CELL PEOTEOMICS, V11, P1; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Lindsley RC, 2013, ANNU REV PATHOL-MECH, V8, P21, DOI 10.1146/annurev-pathol-011811-132436; Lopez AJ, 1995, DEV BIOL, V172, P396, DOI 10.1006/dbio.1995.8050; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luis TC, 2012, LEUKEMIA, V26, P414, DOI 10.1038/leu.2011.387; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Martin-Subero JI, 2013, CURR OPIN HEMATOL, V20, P362, DOI 10.1097/MOH.0b013e32836235dc; McKinney-Freeman S, 2012, CELL STEM CELL, V11, P701, DOI 10.1016/j.stem.2012.07.018; Medyouf H, 2014, CELL STEM CELL, V14, P824, DOI 10.1016/j.stem.2014.02.014; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Paralkar VR, 2013, BLOOD, V121, P4842, DOI 10.1182/blood-2013-03-456111; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Sebastian S, 2013, GENE DEV, V27, P1247, DOI 10.1101/gad.215400.113; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Shah SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063419; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Taneri B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r75; Tesio M, 2011, CELL STEM CELL, V9, P187, DOI 10.1016/j.stem.2011.08.005; Tew KD, 2012, ANTIOXID REDOX SIGN, V17, P1728, DOI 10.1089/ars.2012.4640; Tickenbrock L, 2008, INT J ONCOL, V33, P1215, DOI 10.3892/ijo_00000111; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang Q, 2013, NAT PROTOC, V8, P2022, DOI 10.1038/nprot.2013.118; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yaniv K, 2002, GENE, V287, P49, DOI 10.1016/S0378-1119(01)00866-6; Zhang Q, 2013, MBIO, V4, DOI 10.1128/mBio.00596-12; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	81	313	315	3	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					507	522		10.1016/j.stem.2014.07.005	http://dx.doi.org/10.1016/j.stem.2014.07.005			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25158935	Bronze, Green Published			2022-12-28	WOS:000343235800016
J	Shen, L; Inoue, A; He, J; Liu, YT; Lu, FL; Zhang, Y				Shen, Li; Inoue, Azusa; He, Jin; Liu, Yuting; Lu, Falong; Zhang, Yi			Tet3 and DNA Replication Mediate Demethylation of Both the Maternal and Paternal Genomes in Mouse Zygotes	CELL STEM CELL			English	Article							BASE EXCISION-REPAIR; PREIMPLANTATION DEVELOPMENT; ACTIVE-DEMETHYLATION; EARLY EMBRYOS; METHYLATION LANDSCAPE; GENE-EXPRESSION; MAMMALIAN DNA; 5-METHYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; 5-CARBOXYLCYTOSINE	With the exception of imprinted genes and certain repeats, DNA methylation is globally erased during preimplantation development. Recent studies have suggested that Tet3-mediated oxidation of 5-methylcytosine (5mC) and DNA replication-dependent dilution both contribute to global paternal DNA demethylation, but demethylation of the maternal genome occurs via replication. Here we present genome-scale DNA methylation maps for both the paternal and maternal genomes of Tet3-depleted and/or DNA replication-inhibited zygotes. In both genomes, we found that inhibition of DNA replication blocks DNA demethylation independently from Tet3 function and that Tet3 facilitates DNA demethylation largely by coupling with DNA replication. For both genomes, our data indicate that replication-dependent dilution is the major contributor to demethylation, but Tet3 plays an important role, particularly at certain loci. Our study thus defines the respective functions of Tet3 and DNA replication in paternal DNA demethylation and reveals an unexpected contribution of Tet3 to demethylation of the maternal genome.	[Shen, Li; Inoue, Azusa; He, Jin; Liu, Yuting; Lu, Falong; Zhang, Yi] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Shen, Li; Inoue, Azusa; He, Jin; Liu, Yuting; Lu, Falong; Zhang, Yi] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Shen, Li; Inoue, Azusa; He, Jin; Liu, Yuting; Lu, Falong; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zhang, Y (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, WAB 149G 200 Longwood Ave, Boston, MA 02115 USA.	yzhang@genetics.med.harvard.edu	Lu, Falong/Q-3013-2016	Lu, Falong/0000-0002-8321-4818; He, Jin/0000-0001-8283-7952	NIH [U01DK089565]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Hao Wu and Luis M. Tuesta for critical reading of the manuscript, Dr. Guoliang Xu for the Tet3 antibody. This project is supported by NIH grant U01DK089565. Y.Z. is an investigator of the Howard Hughes Medical Institute.	Bian CJ, 2014, NUCLEIC ACIDS RES, V42, P2893, DOI 10.1093/nar/gkt1261; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Guo HS, 2013, GENOME RES, V23, P2126, DOI 10.1101/gr.161679.113; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Inoue A, 2012, CELL RES, V22, P1640, DOI 10.1038/cr.2012.160; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kang EJ, 2014, NATURE, V509, P101, DOI 10.1038/nature13134; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Plongthongkum N, 2014, NAT REV GENET, V15, P647, DOI 10.1038/nrg3772; Santos F, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-39; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Weyrich A., 2012, CURR PROTOC MOL BIOL, V1- 3, P13; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019	38	163	171	1	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2014	15	4					459	470		10.1016/j.stem.2014.09.002	http://dx.doi.org/10.1016/j.stem.2014.09.002			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AR0DE	25280220	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000343235800012
J	Chen, KG; Mallon, BS; McKay, RDG; Robey, PG				Chen, Kevin G.; Mallon, Barbara S.; McKay, Ronald D. G.; Robey, Pamela G.			Human Pluripotent Stem Cell Culture: Considerations for Maintenance, Expansion, and Therapeutics	CELL STEM CELL			English	Review							TERM SELF-RENEWAL; SYNTHETIC SURFACES; SUSPENSION-CULTURE; DIFFERENTIATION; GROWTH; DERIVATION; LINES; PROPAGATION; GENERATION; INDUCTION	Human pluripotent stem cells (hPSCs) provide powerful resources for application in regenerative medicine and pharmaceutical development. In the past decade, various methods have been developed for large-scale hPSC culture that rely on combined use of multiple growth components, including media containing various growth factors, extracellular matrices, 3D environmental cues, and modes of multicellular association. In this Protocol Review, we dissect these growth components by comparing cell culture methods and identifying the benefits and pitfalls associated with each one. We further provide criteria, considerations, and suggestions to achieve optimal cell growth for hPSC expansion, differentiation, and use in future therapeutic applications.	[Chen, Kevin G.; Mallon, Barbara S.] Natl Inst Neurol Disorders & Stroke, NIH Stem Cell Unit, NIH, Bethesda, MD 20892 USA; [McKay, Ronald D. G.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Robey, Pamela G.] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Chen, KG (corresponding author), Natl Inst Neurol Disorders & Stroke, NIH Stem Cell Unit, NIH, Bethesda, MD 20892 USA.	cheng@mail.nih.gov	Robey, Pamela Gehron/H-1429-2011; Chen, Kevin/GYU-8963-2022; Chen, Kevin G/D-6769-2011	Robey, Pamela Gehron/0000-0002-5316-5576; Chen, Kevin G/0000-0003-2983-6330	Intramural Research Program of the National Institutes of Health (NIH) at the National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZICNS003008] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH) at the National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Institutes of Health (NIH) at the National Institute of Neurological Disorders and Stroke. We thank Dr. Peter Zandstra, Dr. Kyeyoon Park, Dr. Daniel Hoeppner, and Ms. Rebecca Hamilton for discussion and suggestions. We thank Mr. George Leiman for editorial assistance.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Amit M, 2010, STEM CELL REV REP, V6, P248, DOI 10.1007/s12015-010-9149-y; Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Banerjee I, 2011, J TISSUE ENG REGEN M, V5, P313, DOI 10.1002/term.317; Borstlap J, 2010, IN VITRO CELL DEV-AN, V46, P242, DOI 10.1007/s11626-010-9295-1; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Braam SR, 2008, NAT PROTOC, V3, P1435, DOI 10.1038/nprot.2008.140; Braam SR, 2008, NAT METHODS, V5, P389, DOI 10.1038/NMETH.1200; Cameron CM, 2006, BIOTECHNOL BIOENG, V94, P938, DOI 10.1002/bit.20919; Chaddah MR, 2011, AMYOTROPH LATERAL SC, V12, P315, DOI 10.3109/17482968.2011.590992; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen Allen K, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01c11s14; Chen AKL, 2011, STEM CELL RES, V7, P97, DOI 10.1016/j.scr.2011.04.007; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Chen KG, 2012, STEM CELL RES, V9, P237, DOI 10.1016/j.scr.2012.06.003; Chen VC, 2012, STEM CELL RES, V8, P388, DOI 10.1016/j.scr.2012.02.001; Cimetta E, 2009, METHODS, V47, P81, DOI 10.1016/j.ymeth.2008.10.015; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; Crook JM, 2010, IN VITRO CELL DEV-AN, V46, P169, DOI 10.1007/s11626-010-9301-7; Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Dang SM, 2004, STEM CELLS, V22, P275, DOI 10.1634/stemcells.22-3-275; DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039; Derda R, 2007, ACS CHEM BIOL, V2, P347, DOI 10.1021/cb700032u; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Engle SJ, 2013, CELL STEM CELL, V12, P669, DOI 10.1016/j.stem.2013.05.011; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fernandes AM, 2009, BRAZ J MED BIOL RES, V42, P515, DOI 10.1590/S0100-879X2009000600007; Fok EYL, 2005, STEM CELLS, V23, P1333, DOI 10.1634/stemcells.2005-0112; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Genbacev O, 2005, FERTIL STERIL, V83, P1517, DOI 10.1016/j.fertnstert.2005.01.086; Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V86, P493, DOI 10.1002/bit.20045; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Heng BC, 2012, STEM CELLS DEV, V21, P1701, DOI 10.1089/scd.2011.0509; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; KLEINMAN HK, 1983, BIOCHEMISTRY-US, V22, P4969, DOI 10.1021/bi00290a014; Kolhar P, 2010, J BIOTECHNOL, V146, P143, DOI 10.1016/j.jbiotec.2010.01.016; Krawetz R, 2010, TISSUE ENG PART C-ME, V16, P573, DOI [10.1089/ten.tec.2009.0228, 10.1089/ten.TEC.2009.0228]; Kunova M, 2013, STEM CELL TRANSL MED, V2, P246, DOI 10.5966/sctm.2012-0081; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lecina M, 2010, TISSUE ENG PART C-ME, V16, P1609, DOI [10.1089/ten.tec.2010.0104, 10.1089/ten.TEC.2010.0104]; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Leung HW, 2011, TISSUE ENG PART C-ME, V17, P165, DOI 10.1089/ten.TEC.2010.0320; Li LY, 2011, P NATL ACAD SCI USA, V108, P11745, DOI 10.1073/pnas.1101454108; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Lock LT, 2009, TISSUE ENG PT A, V15, P2051, DOI 10.1089/ten.tea.2008.0455; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; MACKAY AR, 1993, BIOTECHNIQUES, V15, P1048; Malchenko S, 2010, J CELL PHYSIOL, V225, P390, DOI 10.1002/jcp.22280; Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Moledina F, 2012, P NATL ACAD SCI USA, V109, P3264, DOI 10.1073/pnas.1111478109; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nie Y, 2009, BIOTECHNOL PROGR, V25, P20, DOI 10.1002/btpr.110; Niebruegge S, 2009, BIOTECHNOL BIOENG, V102, P493, DOI 10.1002/bit.22065; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Padmanabhan R, 2012, STEM CELLS, V30, P2175, DOI 10.1002/stem.1195; Panchision DM, 2013, STEM CELL TRANSL MED, V2, P217, DOI 10.5966/sctm.2012-0149; Phillips BW, 2008, J BIOTECHNOL, V138, P24, DOI 10.1016/j.jbiotec.2008.07.1997; Pistollato F, 2012, EXPERT OPIN DRUG MET, V8, P239, DOI 10.1517/17425255.2012.639763; Rao M, 2013, STEM CELL REP, V1, P281, DOI 10.1016/j.stemcr.2013.10.002; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Saha K, 2011, P NATL ACAD SCI USA, V108, P18714, DOI 10.1073/pnas.1114854108; Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009; Serra M, 2012, TRENDS BIOTECHNOL, V30, P350, DOI 10.1016/j.tibtech.2012.03.003; Serra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023212; Siti-Ismail N, 2008, BIOMATERIALS, V29, P3946, DOI 10.1016/j.biomaterials.2008.04.027; Stacey GN, 2013, CELL STEM CELL, V13, P385, DOI 10.1016/j.stem.2013.09.007; Steiner D, 2010, NAT BIOTECHNOL, V28, P361, DOI 10.1038/nbt.1616; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsutsui H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1165; Turner M, 2013, CELL STEM CELL, V13, P382, DOI 10.1016/j.stem.2013.08.003; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; van der Meer AD, 2013, LAB CHIP, V13, P3562, DOI 10.1039/c3lc50435b; Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631; Villa-Diaz LG, 2009, LAB CHIP, V9, P1749, DOI 10.1039/b820380f; VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q; Wang GW, 2005, BIOCHEM BIOPH RES CO, V330, P934, DOI 10.1016/j.bbrc.2005.03.058; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yirme G, 2008, STEM CELLS DEV, V17, P1227, DOI 10.1089/scd.2007.0272; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zweigerdt R, 2011, NAT PROTOC, V6, P689, DOI 10.1038/nprot.2011.318	104	233	242	0	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					13	26		10.1016/j.stem.2013.12.005	http://dx.doi.org/10.1016/j.stem.2013.12.005			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24388173	Green Accepted, Bronze			2022-12-28	WOS:000329571900006
J	Zheng, Y; Geiger, H				Zheng, Yi; Geiger, Hartmut			HSPCs Get Their Motors Running for Asymmetric Fate Choice	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM; CELL-DIVISION	Contractile forces are implicated in cell polarity and asymmetric division, but their contribution to cell fate is unclear. In this issue of Cell Stem Cell, Shin et al. (2014) show that myosin-II isoforms sense matrix stiffness in hematopoietic stem and progenitor cells, with polarized myosin-IIB promoting asymmetric self-renewal and constitutive myosin-IIA activation promoting cytokine-triggered differentiation.	[Zheng, Yi; Geiger, Hartmut] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Geiger, Hartmut] Univ Ulm, Inst Mol Med, D-89081 Ulm, Germany	Cincinnati Children's Hospital Medical Center; Ulm University	Zheng, Y (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	yi.zheng@cchmc.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074	NIA NIH HHS [R01 AG040118] Funding Source: Medline; NIDDK NIH HHS [P30 DK090971] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040118] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Holst J, 2010, NAT BIOTECHNOL, V28, P1123, DOI 10.1038/nbt.1687; Li R, 2013, DEV CELL, V25, P439, DOI 10.1016/j.devcel.2013.05.003; LICHTMAN MA, 1970, NEW ENGL J MED, V283, P943, DOI 10.1056/NEJM197010292831801; Ou GS, 2010, SCIENCE, V330, P677, DOI 10.1126/science.1196112; Schroeder T, 2007, CELL STEM CELL, V1, P479, DOI 10.1016/j.stem.2007.10.016; Shin J.-W., 2014, CELL STEM CELL; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007	10	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					1	2		10.1016/j.stem.2013.12.002	http://dx.doi.org/10.1016/j.stem.2013.12.002			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24388168	Bronze, Green Accepted			2022-12-28	WOS:000329571900001
J	Saini, A				Saini, Angela			International Stem Cell Networks: The Power of Contacts	CELL STEM CELL			English	News Item												angela.d.saini@gmail.com							0	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					644	646		10.1016/j.stem.2013.11.011	http://dx.doi.org/10.1016/j.stem.2013.11.011			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24475471	Bronze			2022-12-28	WOS:000329571700006
J	Wu, YX; Liang, D; Wang, YH; Bai, MZ; Tang, W; Bao, SM; Yan, ZQ; Li, DS; Li, JS				Wu, Yuxuan; Liang, Dan; Wang, Yinghua; Bai, Meizhu; Tang, Wei; Bao, Shiming; Yan, Zhiqiang; Li, Dangsheng; Li, Jinsong			Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9	CELL STEM CELL			English	Article							ONE-STEP GENERATION; CAS9 NUCLEASE; HUMAN-CELLS; GENOME; SYSTEM; MICE; SPECIFICITY; MUTATIONS; ELEGANS	The CRISPR-Cas9 system has been employed to generate mutant alleles in a range of different organisms. However, so far there have not been reports of use of this system for efficient correction of a genetic disease. Here we show that mice with a dominant mutation in Crygc gene that causes cataracts could be rescued by coinjection into zygotes of Cas9 mRNA and a single-guide RNA (sgRNA) targeting the mutant allele. Correction occurred via homology-directed repair (HDR) based on an exogenously supplied oligonucleotide or the endogenous WT allele, with only rare evidence of off-target modifications. The resulting mice were fertile and able to transmit the corrected allele to their progeny. Thus, our study provides proof of principle for use of the CRISPR-Cas9 system to correct genetic disease.	[Wu, Yuxuan; Liang, Dan; Wang, Yinghua; Bai, Meizhu; Li, Jinsong] Chinese Acad Sci, Shanghai Key Lab Mol Androl, Grp Epigenet Reprogramming,Shanghai Inst Biol Sci, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Liang, Dan; Wang, Yinghua] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Bai, Meizhu; Li, Jinsong] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Tang, Wei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Anim Core Facil, Shanghai 200031, Peoples R China; [Bao, Shiming; Yan, Zhiqiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Lab Anim Ctr, Shanghai 201615, Peoples R China; [Li, Dangsheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences	Li, JS (corresponding author), Chinese Acad Sci, Shanghai Key Lab Mol Androl, Grp Epigenet Reprogramming,Shanghai Inst Biol Sci, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	jsli@sibcb.ac.cn		Bai, Meizhu/0000-0001-8208-4073; Liang, Dan/0000-0003-2404-3075; li, jin song/0000-0003-3456-662X	Ministry of Science and Technology of China [2014CB964803]; National Natural Science Foundation of China [31225017, 91319310]; Chinese Academy of Sciences [XDA01010403]; Shanghai Municipal Commission for Science and Technology [12JC1409600, 13XD1404000]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Commission for Science and Technology	This study was supported by the Ministry of Science and Technology of China (2014CB964803), the National Natural Science Foundation of China (31225017 and 91319310), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01010403), and the Shanghai Municipal Commission for Science and Technology (12JC1409600 and 13XD1404000).	Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhao LY, 2010, MAMM GENOME, V21, P361, DOI 10.1007/s00335-010-9275-5	20	421	599	9	272	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					659	662		10.1016/j.stem.2013.10.016	http://dx.doi.org/10.1016/j.stem.2013.10.016			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24315440	Bronze			2022-12-28	WOS:000329571700009
J	Kozar, S; Morrissey, E; Nicholson, AM; van der Heijden, M; Zecchini, HI; Kemp, R; Tavare, S; Vermeulen, L; Winton, DJ				Kozar, Sarah; Morrissey, Edward; Nicholson, Anna M.; van der Heijden, Maartje; Zecchini, Heather I.; Kemp, Richard; Tavare, Simon; Vermeulen, Louis; Winton, Douglas J.			Continuous Clonal Labeling Reveals Small Numbers of Functional Stem Cells in Intestinal Crypts and Adenomas	CELL STEM CELL			English	Article							IN-VIVO; MOUSE; EXPRESSION; LGR5; PROLIFERATION; PATTERN; COLON; BMI1	Lineage-tracing approaches, widely used to characterize stem cell populations, rely on the specificity and stability of individual markers for accurate results. We present a method in which genetic labeling in the intestinal epithelium is acquired as a mutation-induced clonal mark during DNA replication. By determining the rate of mutation in vivo and combining this data with the known neutral-drift dynamics that describe intestinal stem cell replacement, we quantify the number of functional stem cells in crypts and adenomas. Contrary to previous reports, we find that significantly lower numbers of "working" stem cells are present in the intestinal epithelium (five to seven per crypt) and in adenomas (nine per gland), and that those stem cells are also replaced at a significantly lower rate. These findings suggest that the bulk of tumor stem cell divisions serve only to replace stem cell loss, with rare clonal victors driving gland repopulation and tumor growth.	[Kozar, Sarah; Morrissey, Edward; Nicholson, Anna M.; van der Heijden, Maartje; Zecchini, Heather I.; Kemp, Richard; Tavare, Simon; Vermeulen, Louis; Winton, Douglas J.] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [van der Heijden, Maartje; Vermeulen, Louis] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, NL-1105 AZ Amsterdam, Netherlands	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam	Winton, DJ (corresponding author), Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.	doug.winton@cruk.cam.ac.uk	Vermeulen, Louis/B-7488-2008	Vermeulen, Louis/0000-0002-6066-789X; Kemp, Richard/0000-0002-0121-7709; Morrissey, Edward/0000-0003-1021-5358	Cancer Research UK; KWF fellowship from the Dutch Cancer Society; Cancer Research UK [19556, 17044, 22310] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); KWF fellowship from the Dutch Cancer Society; Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK, and L.V. is the recipient of a KWF fellowship from the Dutch Cancer Society. We gratefully acknowledge the following core facilities at the Cancer Research UK Cambridge Institute: the Transgenic Laboratory, the Biological Resources Unit, and Histopathology.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Humphries A, 2013, P NATL ACAD SCI USA, V110, pE2490, DOI 10.1073/pnas.1220353110; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; McCutcheon SC, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-89; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Nygren JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003710; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Reizel Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002192; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wasan HS, 1998, J PATHOL, V185, P246; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Wong WM, 2002, GUT, V50, P212, DOI 10.1136/gut.50.2.212; Yamada NA, 2002, MUTAT RES-FUND MOL M, V499, P213, DOI 10.1016/S0027-5107(01)00282-2; Zhu YH, 2013, CELL STEM CELL, V12, P298, DOI 10.1016/j.stem.2013.01.003	29	151	155	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					626	633		10.1016/j.stem.2013.08.001	http://dx.doi.org/10.1016/j.stem.2013.08.001			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24035355	Bronze			2022-12-28	WOS:000329571500014
J	Phesse, TJ; Sansom, OJ				Phesse, Toby J.; Sansom, Owen J.			Responding to R-Spondin: Slit2 Potentiates Intestinal Regeneration	CELL STEM CELL			English	Editorial Material							STEM-CELL; BETA-CATENIN; ACTIVATION	Gastrointestinal toxicity of chemoradiotherapy treatment in late-stage cancer patients limits tolerable doses and effectiveness of treatments. Zhou and colleagues in Nature (Zhou et al., 2013) suggest that activating Robo/Slit signaling in concert with R-Spondin potentiates Wnt signaling in intestinal stem cells and drives successful intestinal regeneration and recovery.	[Phesse, Toby J.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Phesse, Toby J.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Walter & Eliza Hall Institute; University of Melbourne; Beatson Institute	Sansom, OJ (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk		Sansom, Owen J./0000-0001-9540-3010; Phesse, Toby/0000-0001-9568-4916	Cancer Research UK [12481] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Meniel V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003638; Myant KB, 2013, CELL STEM CELL, V12, P761, DOI 10.1016/j.stem.2013.04.006; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Tseng RC, 2010, CANCER RES, V70, P543, DOI 10.1158/0008-5472.CAN-09-2084; Zhou WJ, 2013, NATURE, V501, P107, DOI 10.1038/nature12416	10	4	4	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					512	514		10.1016/j.stem.2013.10.006	http://dx.doi.org/10.1016/j.stem.2013.10.006			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24209757	Bronze, Green Accepted			2022-12-28	WOS:000329571500004
J	Li, Y; Wang, HY; Muffat, J; Cheng, AW; Orlando, DA; Loven, J; Kwok, SM; Feldman, DA; Bateup, HS; Gao, Q; Hockemeyer, D; Mitalipova, M; Lewis, CA; Vander Heiden, MG; Sur, M; Young, RA; Jaenisch, R				Li, Yun; Wang, Haoyi; Muffat, Julien; Cheng, Albert W.; Orlando, David A.; Loven, Jakob; Kwok, Show-ming; Feldman, Danielle A.; Bateup, Helen S.; Gao, Qing; Hockemeyer, Dirk; Mitalipova, Maisam; Lewis, Caroline A.; Vander Heiden, Matthew G.; Sur, Mriganka; Young, Richard A.; Jaenisch, Rudolf			Global Transcriptional and Translational Repression in Human-Embryonic-Stem-Cell-Derived Rett Syndrome Neurons	CELL STEM CELL			English	Article							MOUSE MODEL; MITOCHONDRIAL ABNORMALITIES; NEURAL CONVERSION; MUTANT MICE; MECP2; DISEASE; EXPRESSION; GENES; DYSFUNCTION; DEFICIENCY	Rett syndrome (RTT) is caused by mutations of MECP2, a methyl CpG binding protein thought to act as a global transcriptional repressor. Here we show, using an isogenic human embryonic stem cell model of RTT, that MECP2 mutant neurons display key molecular and cellular features of this disorder. Unbiased global gene expression analyses demonstrate that MECP2 functions as a global activator in neurons but not in neural precursors. Decreased transcription in neurons was coupled with a significant reduction in nascent protein synthesis and lack of MECP2 was manifested as a severe defect in the activity of the AKT/mTOR pathway. Lack of MECP2 also leads to impaired mitochondrial function in mutant neurons. Activation of AKT/mTOR signaling by exogenous growth factors or by depletion of PTEN boosted protein synthesis and ameliorated disease phenotypes in mutant neurons. Our findings indicate a vital function for MECP2 in maintaining active gene transcription in human neuronal cells.	[Li, Yun; Wang, Haoyi; Muffat, Julien; Cheng, Albert W.; Orlando, David A.; Loven, Jakob; Gao, Qing; Hockemeyer, Dirk; Mitalipova, Maisam; Young, Richard A.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Cheng, Albert W.] MIT, Dept Computat & Syst Biol, Cambridge, MA 02139 USA; [Kwok, Show-ming; Feldman, Danielle A.; Sur, Mriganka] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Bateup, Helen S.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Lewis, Caroline A.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Young, Richard A.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Muffat, Julien/P-2298-2014; Li, Yun/C-3367-2011; Young, Richard A/F-6495-2012	Li, Yun/0000-0002-5849-5910; Young, Richard A/0000-0001-8855-8647; Muffat, Julien/0000-0003-1889-7023; Hockemeyer, Dirk/0000-0002-5598-5092; Cheng, Albert/0000-0003-2653-5743	NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation; IRSF; Croucher scholarship; Swedish Research Council [VR-B0086301]; NIH [R01-HG002668, HD 045022, R37-CA084198]; Koch Institute; Curt Marble Cancer Research Fund; SFARI; ELA foundation;  [P30-CA14051]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484] Funding Source: NIH RePORTER	NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation(NARSAD); IRSF; Croucher scholarship; Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koch Institute; Curt Marble Cancer Research Fund; SFARI; ELA foundation; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Ping Xu, Raaji Alagappan, Tenzin Lungjangwa, Dongdong Fu, Daniel B. Dadon, Kibibi Ganz, and Ruth Flannery for technical support; Drs. Bryan Luikart and David Sabatini for PTEN shRNA lentivirus constructs and access to Seahorse XF24; Dr. Carson Thoreen for advice on the protein synthesis assay; Drs. Peter Rahl, Bingbing Yuan, and Jeong-Ah Kwon for assistance with microarray; and members of the Jaenisch lab for helpful discussions. Y.L. was a Simons Postdoctoral Fellow. Y.L. was supported in part by a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation and the IRSF. A. W. C. was supported by a Croucher scholarship. J.L. was supported by a Swedish Research Council Postdoctoral Fellowship (VR-B0086301). D.O. and R.Y. were supported by NIH grant R01-HG002668. M. V. H and C. A. L. acknowledge support from P30-CA14051, the Koch Institute, and Curt Marble Cancer Research Fund. R.J. was supported by NIH grants HD 045022 and R37-CA084198, SFARI, and the ELA foundation.	Akbarian S, 2002, AM J PSYCHIAT, V159, P1103, DOI 10.1176/appi.ajp.159.7.1103; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255; Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; CORNFORD ME, 1994, J CHILD NEUROL, V9, P424, DOI 10.1177/088307389400900419; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Kline DD, 2010, J NEUROSCI, V30, P5303, DOI 10.1523/JNEUROSCI.5503-09.2010; Kriaucionis S, 2006, MOL CELL BIOL, V26, P5033, DOI 10.1128/MCB.01665-05; Kron M, 2012, J NEUROSCI, V32, P13860, DOI 10.1523/JNEUROSCI.2159-12.2012; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Li Y, 2012, P NATL ACAD SCI USA, V109, P15491, DOI 10.1073/pnas.1212899109; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Luikart BW, 2011, J NEUROSCI, V31, P4345, DOI 10.1523/JNEUROSCI.0061-11.2011; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pirooznia M, 2012, BIOINFORMATICS, V28, P897, DOI 10.1093/bioinformatics/bts040; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Scala E, 2007, AM J MED GENET A, V143A, P2775, DOI 10.1002/ajmg.a.32002; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Su D, 2012, EPIGENETICS-US, V7, P146, DOI 10.4161/epi.7.2.18907; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Urdinguio RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003669; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Yazdani M, 2012, STEM CELLS, V30, P2128, DOI 10.1002/stem.1180; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	59	208	213	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					446	458		10.1016/j.stem.2013.09.001	http://dx.doi.org/10.1016/j.stem.2013.09.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094325	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000329571100013
J	LaBarge, MA				LaBarge, Mark A.			Breaking the Canon: Indirect Regulation of Wnt Signaling in Mammary Stem Cells by MMP3	CELL STEM CELL			English	Editorial Material							GLAND	Matrix metalloproteases promote tumor cell invasion, epithelial-to-mesenchymal transitions, and metastases, but whether they directly regulate stem cells is unknown. In this issue of Cell Stem Cell, Kessenbrock et al. (2013) now show that MMP3, independent of its proteolytic activity, regulates murine mammary stem cells by sequestering noncanonical Wnt signaling ligands, which has implications for breast cancer pathogenesis.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	LaBarge, MA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA.	malabarge@lbl.gov	Kessenbrock, Kai/B-6936-2011	LaBarge, Mark/0000-0003-2405-4719				Alexander C.M., 2012, COLD SPRING HARB PER, V4, P4; Correia AL, 2013, GENE DEV, V27, P805, DOI 10.1101/gad.211383.112; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Kessenbrock K, 2013, CELL STEM CELL, V13, P300, DOI 10.1016/j.stem.2013.06.005; LaBarge MA, 2010, CLIN CANCER RES, V16, P3121, DOI 10.1158/1078-0432.CCR-09-2933; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Sorrell DA, 2005, J DAIRY RES, V72, P433, DOI 10.1017/S0022029905001202; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0	10	3	3	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					259	260		10.1016/j.stem.2013.08.008	http://dx.doi.org/10.1016/j.stem.2013.08.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	24012364	Bronze			2022-12-28	WOS:000329570800002
J	Qi, J; Singh, S; Hua, WK; Cai, Q; Chao, SW; Li, L; Liu, HJ; Ho, YW; McDonald, T; Lin, A; Marcucci, G; Bhatia, R; Huang, WJ; Chang, CI; Kuo, YH				Qi, Jing; Singh, Sandeep; Hua, Wei-Kai; Cai, Qi; Chao, Shi-Wei; Li, Ling; Liu, Hongjun; Ho, Yinwei; McDonald, Tinisha; Lin, Allen; Marcucci, Guido; Bhatia, Ravi; Huang, Wei-Jan; Chang, Chung-I; Kuo, Ya-Huei			HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation	CELL STEM CELL			English	Article							CBF-BETA-SMMHC; MYOSIN HEAVY-CHAIN; HISTONE DEACETYLASE 8; BINDING; FUSION; GENE; DIFFERENTIATION; T(8/21); RUNX1; LEUKEMOGENESIS	Acute myeloid leukemia (AML) is driven and sustained by leukemia stem cells (LSCs) with unlimited self-renewal capacity and resistance to chemotherapy. Mutation in the TP53 tumor suppressor is relatively rare in de novo AML; however, p53 can be regulated through post-translational mechanisms. Here, we show that p53 activity is inhibited in inv(16)(+) AML LSCs via interactions with the CBFb-SMMHC (CM) fusion protein and histone deacetylase 8 (HDAC8). HDAC8 aberrantly deacetylates p53 and promotes LSC transformation and maintenance. HDAC8 deficiency or inhibition using HDAC8-selective inhibitors (HDAC8i) effectively restores p53 acetylation and activity. Importantly, HDAC8 inhibition induces apoptosis in inv(16)+ AML CD34(+) cells, while sparing the normal hematopoietic stem cells. Furthermore, in vivo HDAC8i administration profoundly diminishes AML propagation and abrogates leukemia-initiating capacity of both murine and patient-derived LSCs. This study elucidates an HDAC8-mediated p53-inactivating mechanism promoting LSC activity and highlights HDAC8 inhibition as a promising approach to selectively target inv(16)(+) LSCs.	[Qi, Jing; Singh, Sandeep; Hua, Wei-Kai; Cai, Qi; Li, Ling; Liu, Hongjun; Ho, Yinwei; McDonald, Tinisha; Lin, Allen; Marcucci, Guido; Bhatia, Ravi; Kuo, Ya-Huei] City Hope Natl Med Ctr, Norbert Gehr & Family Leukemia Ctr, Beckman Res Inst, Div Hematopoiet Stem Cell & Leukemia Res, Duarte, CA 91010 USA; [Chang, Chung-I] Acad Sinica, Inst Biol Chem, Taipei 11574, Taiwan; [Chao, Shi-Wei; Huang, Wei-Jan] Taipei Med Univ, Taipei 11031, Taiwan	City of Hope; Beckman Research Institute of City of Hope; Academia Sinica - Taiwan; Taipei Medical University	Kuo, YH (corresponding author), City Hope Natl Med Ctr, Norbert Gehr & Family Leukemia Ctr, Beckman Res Inst, Div Hematopoiet Stem Cell & Leukemia Res, 1500 E Duarte Rd, Duarte, CA 91010 USA.	ykuo@coh.org	Singh, Sandeep/W-4239-2019; qi, jing/Q-1009-2015; singh, sandeep/W-4595-2019	qi, jing/0000-0003-3210-2784; singh, sandeep/0000-0001-8780-5124; Chang, Chung-I/0000-0003-0989-1228	V Foundation Scholar Award; American Cancer Society [123278-RSG-12-140-01-CSM]; National Cancer Institute [R01 CA178387, P30 CA033572]; California Institute of Regenerative Medicine [TG2-01150]; NATIONAL CANCER INSTITUTE [R01CA178387, R01CA095684, P30CA033572] Funding Source: NIH RePORTER	V Foundation Scholar Award; American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the V Foundation Scholar Award (to Y.-H.K.), the American Cancer Society grant 123278-RSG-12-140-01-CSM (to Y.-H.K.), and the National Cancer Institute grants R01 CA178387 (to Y.-H.K.) and P30 CA033572 (to COH). J.Q. was supported by the California Institute of Regenerative Medicine training grant TG2-01150 (to COH). We thank Dr. Pual Liu (NIH) for the generous gift of CM deletion plasmids; Dr. Gerard Evan (University of Cambridge) for the p53ER<SUP>TAM</SUP> KI mice; Dr. Mu-Shui Dai (Oregon Health & Sciences University) for the p53 reporter plasmid; Dr. Wei Gu (Columbia University) for the p53-WT and p53-8KR plasmids; and Dr. Sriram Balasubramanian (Pharmacyclics) for providing PCI-34051. We thank the excellent technical support of the Analytical Cytometry Core and Animal Resource Center at COH.	Adya N, 1998, MOL CELL BIOL, V18, P7432, DOI 10.1128/MCB.18.12.7432; Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Ben-Ami O, 2013, CELL REP, V4, P1131, DOI 10.1016/j.celrep.2013.08.020; Bots M, 2014, BLOOD, V123, P1341, DOI 10.1182/blood-2013-03-488114; Castilla LH, 1996, CELL, V87, P687, DOI 10.1016/S0092-8674(00)81388-4; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; Fu Y, 2014, INT J BIOCHEM CELL B, V54, P68, DOI 10.1016/j.biocel.2014.07.003; Goyama S, 2013, J CLIN INVEST, V123, P3876, DOI 10.1172/JCI68557; Haferlach C, 2008, LEUKEMIA, V22, P1539, DOI 10.1038/leu.2008.143; Huang WJ, 2012, CHEMMEDCHEM, V7, P1815, DOI 10.1002/cmdc.201200300; Hyde RK, 2015, LEUKEMIA, V29, P1771, DOI 10.1038/leu.2015.58; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kamikubo Y, 2013, BLOOD, V121, P638, DOI 10.1182/blood-2012-06-434688; Kamikubo Y, 2010, CANCER CELL, V17, P455, DOI 10.1016/j.ccr.2010.03.022; Kanno Y, 1998, MOL CELL BIOL, V18, P4252, DOI 10.1128/MCB.18.7.4252; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kuo YH, 2008, BLOOD, V111, P1543, DOI 10.1182/blood-2007-07-104422; Kuo YH, 2009, BLOOD, V113, P3323, DOI 10.1182/blood-2008-06-162248; Kuo YH, 2006, CANCER CELL, V9, P57, DOI 10.1016/j.ccr.2005.12.014; LIU P, 1993, SCIENCE, V261, P1041, DOI 10.1126/science.8351518; Liu PP, 1996, GENE CHROMOSOME CANC, V16, P77, DOI 10.1002/(SICI)1098-2264(199606)16:2<77::AID-GCC1>3.0.CO;2-#; Long JT, 2010, BLOOD, V116, P71, DOI 10.1182/blood-2010-01-261628; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lukasik SM, 2002, NAT STRUCT BIOL, V9, P674, DOI 10.1038/nsb831; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Lutterbach B, 1999, P NATL ACAD SCI USA, V96, P12822, DOI 10.1073/pnas.96.22.12822; Moreno DA, 2010, BRIT J HAEMATOL, V150, P665, DOI 10.1111/j.1365-2141.2010.08301.x; Odenike OM, 2008, CLIN CANCER RES, V14, P7095, DOI 10.1158/1078-0432.CCR-08-1007; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Prebet T, 2009, J CLIN ONCOL, V27, P4747, DOI 10.1200/JCO.2008.21.0674; Ruckner FG, 2012, BLOOD, V119, P2114, DOI 10.1182/blood-2011-08-375758; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Ustun C, 2015, CURR OPIN HEMATOL, V22, P85, DOI 10.1097/MOH.0000000000000124; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Yang G, 2007, ONCOGENE, V26, P91, DOI 10.1038/sj.onc.1209760; Zhao L, 2007, BLOOD, V109, P3432, DOI 10.1182/blood-2006-10-051508; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710	46	64	73	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2015	17	5					597	610		10.1016/j.stem.2015.08.004	http://dx.doi.org/10.1016/j.stem.2015.08.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX4UB	26387755	Green Accepted, Bronze			2022-12-28	WOS:000365694700012
J	Hyman, SE				Hyman, Steven E.			Enlisting hESCs to Interrogate Genetic Variants Associated with Neuropsychiatric Disorders	CELL STEM CELL			English	Editorial Material							SCHIZOPHRENIA	Connecting rare genetic variants to neuropsychiatric disease mechanisms remains a significant challenge. In this issue of Cell Stem Cell, Pak et al. (2015) combine gene targeting and stem cell technologies to identify a significant cellular effect of rare penetrant NRXN1 mutations in human neurons, which was found to cause a defect in neurotransmitter release.	[Hyman, Steven E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Hyman, Steven E.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Hyman, SE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	seh@harvard.edu						Asadollahi R, 2014, J MED GENET, V51, P677, DOI 10.1136/jmedgenet-2014-102588; Hoeffding LKE, 2014, AM J MED GENET B, V165, P52, DOI 10.1002/ajmg.b.32204; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; McCarroll SA, 2013, NEURON, V80, P578, DOI 10.1016/j.neuron.2013.10.046; Pak C, 2015, CELL STEM CELL, V17, P316, DOI 10.1016/j.stem.2015.07.017; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456	9	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					253	254		10.1016/j.stem.2015.08.013	http://dx.doi.org/10.1016/j.stem.2015.08.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26340523	Bronze			2022-12-28	WOS:000364011000003
J	Llorens-Bobadilla, E; Zhao, S; Baser, A; Saiz-Castro, G; Zwadlo, K; Martin-Villalba, A				Llorens-Bobadilla, Enric; Zhao, Sheng; Baser, Avni; Saiz-Castro, Gonzalo; Zwadlo, Klara; Martin-Villalba, Ana			Single-Cell Transcriptomics Reveals a Population of Dormant Neural Stem Cells that Become Activated upon Brain Injury	CELL STEM CELL			English	Article							RNA-SEQ; PROTEIN-SYNTHESIS; EXPRESSION ANALYSIS; NEUROGENESIS; GENERATION; RECONSTRUCTION; LINEAGE; NEURONS; NICHE	Heterogeneous pools of adult neural stem cells (NSCs) contribute to brain maintenance and regeneration after injury. The balance of NSC activation and quiescence, as well as the induction of lineage-specific transcription factors, may contribute to diversity of neuronal and glial fates. To identify molecular hallmarks governing these characteristics, we performed single-cell sequencing of an unbiased pool of adult subventricular zone NSCs. This analysis identified a discrete, dormant NSC subpopulation that already expresses distinct combinations of line age-specific transcription factors during homeostasis. Dormant NSCs enter a primed-quiescent state before activation, which is accompanied by downregulation of glycolytic metabolism, Notch, and BMP signaling and a concomitant upregulation of line age-specific transcription factors and protein synthesis. In response to brain ischemia, interferon gamma signaling induces dormant NSC subpopulations to enter the primed-quiescent state. This study unveils general principles underlying NSC activation and lineage priming and opens potential avenues for regenerative medicine in the brain.	[Llorens-Bobadilla, Enric; Zhao, Sheng; Baser, Avni; Saiz-Castro, Gonzalo; Zwadlo, Klara; Martin-Villalba, Ana] German Canc Res Ctr, Mol Neurobiol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Martin-Villalba, A (corresponding author), German Canc Res Ctr, Mol Neurobiol, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.	a.martin-villalba@dkfz.de		Llorens Bobadilla, Enric/0000-0002-7891-1272; Martin-Villalba, Ana/0000-0002-9405-8910	German Cancer Research Center (DKFZ), a DAAD-LaCaixa scholarship; German Research Foundation (DFG) [SFB-873]	German Cancer Research Center (DKFZ), a DAAD-LaCaixa scholarship; German Research Foundation (DFG)(German Research Foundation (DFG))	We thank S. Wolf from the DKFZ Genomics and Proteomics Core Facility; K. Borowski from the Heidelberg University Hospital FACS Core Facility; members of the DKFZ Flow Cytometry Core Facility; K. Busch and H.-R. Rodewald for pan-YFP mice; M. Essers for Ifngr1<SUP>-/-</SUP> and Ifnr<SUP>-/-</SUP> mice; A. Lutge for data analysis; S. Limpert for technical assistance; D. Krunic and the Light Microscopy Core Facility for support with image analysis; L. Buades for preparing the graphical abstract; and the members of the Martin-Villalba laboratory for critically reading the manuscript. This work was supported by the German Cancer Research Center (DKFZ), a DAAD-LaCaixa scholarship to E.L.-B., and the German Research Foundation (DFG; SFB-873).	Agoston Z, 2014, DEVELOPMENT, V141, P28, DOI 10.1242/dev.097295; Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; Amamoto R, 2014, SCIENCE, V343, P504, DOI 10.1126/science.1239882; Andersen J, 2014, NEURON, V83, P1085, DOI 10.1016/j.neuron.2014.08.004; Basak O, 2012, J NEUROSCI, V32, P5654, DOI 10.1523/JNEUROSCI.0455-12.2012; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Buszczak M, 2014, CELL, V159, P242, DOI 10.1016/j.cell.2014.09.016; Calzolari F, 2015, NAT NEUROSCI, V18, P490, DOI 10.1038/nn.3963; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durruthy-Durruthy R, 2014, CELL, V157, P964, DOI 10.1016/j.cell.2014.03.036; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Genander M, 2014, CELL STEM CELL, V15, P619, DOI 10.1016/j.stem.2014.09.009; Giachino C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00032; Giachino C, 2014, STEM CELLS, V32, P70, DOI 10.1002/stem.1520; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Kawaguchi D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2895; Kelsch W, 2007, PLOS BIOL, V5, P2501, DOI 10.1371/journal.pbio.0050300; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Lavado A, 2011, DEVELOPMENT, V138, P5291, DOI 10.1242/dev.067470; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Lopez-Juarez A, 2013, GENE DEV, V27, P1272, DOI 10.1101/gad.217539.113; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mich JK, 2014, ELIFE, V3, DOI 10.7554/eLife.02669; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mirzadeh Z, 2010, J VIS EXP, P39; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Nakafuku M, 2013, PATTERNING CELL TYPE; Ortega F, 2013, NAT CELL BIOL, V15, P602, DOI 10.1038/ncb2736; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Sequerra EB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00434; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Yoshioka H, 2011, J NEUROTRAUM, V28, P649, DOI 10.1089/neu.2010.1662; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965	58	392	403	5	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					329	340		10.1016/j.stem.2015.07.002	http://dx.doi.org/10.1016/j.stem.2015.07.002			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26235341	Bronze			2022-12-28	WOS:000364011000011
J	Kaestner, KH				Kaestner, Klaus H.			An Epigenomic Road Map for Endoderm Development	CELL STEM CELL			English	Editorial Material							TRANSCRIPTION FACTORS; FOXA2; CELL	While studies of organ development have traditionally relied on model organisms, recent advances in embryonic stem cell (ESC) culture allow investigation of organogenesis in human cells. Wang et al. (2015) employ this system to map the dynamic enhancer landscape during ESC differentiation to the endoderm derivatives pancreas and liver.	[Kaestner, Klaus H.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Kaestner, Klaus H.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Kaestner, KH (corresponding author), Univ Penn, Dept Genet, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	kaestner@mail.med.upenn.edu						D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Gao N, 2010, MOL ENDOCRINOL, V24, P1594, DOI 10.1210/me.2009-0513; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Li ZY, 2012, CELL, V151, P1608, DOI 10.1016/j.cell.2012.11.018; Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wang A, 2015, CELL STEM CELL, V16, P386, DOI 10.1016/j.stem.2015.02.013	10	5	5	2	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					343	344		10.1016/j.stem.2015.03.006	http://dx.doi.org/10.1016/j.stem.2015.03.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25842970	Bronze			2022-12-28	WOS:000352228600002
J	Kuo, YH; Bhatia, R				Kuo, Ya-Huei; Bhatia, Ravi			Pushing the Limits: Defeating Leukemia Stem Cells by Depleting Telomerase	CELL STEM CELL			English	Editorial Material								Leukemia stem cells (LSCs), featuring unlimited self-renewal capacity and chemoresistance, are critical cellular targets for new treatments to improve outcomes for acute myeloid leukemia (AML). In this issue of Cell Stem Cell, Bruedigam et al. (2014) demonstrate that inhibition of telomerase is damaging to LSCs and may represent a promising therapeutic approach in AML.	[Kuo, Ya-Huei; Bhatia, Ravi] City Hope Natl Med Ctr, Beckman Res Inst, Div Hematopoiet Stem Cell & Leukemia Res, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Kuo, YH (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Hematopoiet Stem Cell & Leukemia Res, Duarte, CA 91010 USA.	ykuo@coh.org; rbhatia@coh.org			NATIONAL CANCER INSTITUTE [R01CA095684, R01CA178387] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA095684, R01 CA178387] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bruedigam C, 2014, CELL STEM CELL, V15, P775, DOI 10.1016/j.stem.2014.11.010; Gessner A, 2010, LEUKEMIA, V24, P1751, DOI 10.1038/leu.2010.155; Gonzalez OG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5599; Herbert BS, 2005, ONCOGENE, V24, P5262, DOI 10.1038/sj.onc.1208760; Pucci F, 2013, CELL STEM CELL, V12, P479, DOI 10.1016/j.stem.2013.01.018; Townsley DM, 2014, BLOOD, V124, P2775, DOI 10.1182/blood-2014-05-526285; Vicente-Duenas C, 2012, ONCOTARGET, V3, P261, DOI 10.18632/oncotarget.461; Wang J., 2014, BLOOD IN PRESS; Ye J, 2014, NAT REV GENET, V15, P491, DOI 10.1038/nrg3743	9	3	5	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					673	675		10.1016/j.stem.2014.11.014	http://dx.doi.org/10.1016/j.stem.2014.11.014			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25479742	Bronze, Green Accepted			2022-12-28	WOS:000347174300003
J	Zeuner, A; Todaro, M; Stassi, G; De Maria, R				Zeuner, Ann; Todaro, Matilde; Stassi, Giorgio; De Maria, Ruggero			Colorectal Cancer Stem Cells: From the Crypt to the Clinic	CELL STEM CELL			English	Review							TUMOR-INITIATING CELLS; COLON-CANCER; SELF-RENEWAL; INTESTINAL CRYPT; IN-VITRO; PHENOTYPIC CHARACTERIZATION; LGR5; PROMOTE; METASTASIS; EXPANSION	Since their first discovery, investigations of colorectal cancer stem cells (CSCs) have revealed some unexpected properties, including a high degree of heterogeneity and plasticity. By exploiting a combination of genetic, epigenetic, and microenvironmental factors, colorectal CSCs metastasize, resist chemotherapy, and continually adapt to a changing microenvironment, representing a formidable challenge to cancer eradication. Here, we review the current understanding of colorectal CSCs, including their origin, relationship to stem cells of the intestine, phenotypic characterization, and underlying regulatory mechanisms. We also discuss limitations to current preclinical models of colorectal cancer and how understanding CSC plasticity can improve the development of clinical strategies.	[Zeuner, Ann] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Todaro, Matilde; Stassi, Giorgio] Univ Palermo, Dept Surg & Oncol Sci, I-90127 Palermo, Italy; [De Maria, Ruggero] Regina Elena Inst Canc Res, I-00144 Rome, Italy	Istituto Superiore di Sanita (ISS); University of Palermo; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Zeuner, A (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	a.zeuner@iss.it; demaria@ifo.it	Stassi, Giorgio/AAC-1175-2022; todaro, matilde/AAC-1003-2022; De Maria, Ruggero/S-6385-2019; Zeuner, Ann/K-8607-2016; Zeuner, Ann/A-8529-2010	todaro, matilde/0000-0001-8686-8043; De Maria, Ruggero/0000-0003-2255-0583; Zeuner, Ann/0000-0002-8295-3715	Italian Association for Cancer Research (AIRC)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Association for Cancer Research (AIRC) with a "5 per mille" grant to R.D.M. and G.S. The authors would like to thank the director and staff of the ISS library for logistic support; Mauro Di Giovanni for figures; and Federica Francescangeli, Paola Contavalli, and Marcello Maugeri-Sacca for helpful discussions. We extend our most sincere thanks to all the colleagues that, with their efforts, have brought to light the knowledge collected in this review.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; [Anonymous], NAT CELL BIOL, V16, P268; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Bartucci M., 2014, ONCOGENE IN PRESS; Basak O, 2014, EMBO J, V33, P2057, DOI 10.15252/embj.201488017; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Bu PC, 2013, CELL STEM CELL, V12, P602, DOI 10.1016/j.stem.2013.03.002; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056380; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Colak S, 2014, CELL DEATH DIFFER, V21, P1170, DOI 10.1038/cdd.2014.37; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Melo FDE, 2013, EMBO REP, V14, P686, DOI 10.1038/embor.2013.92; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Francescangeli F, 2012, STEM CELLS, V30, P1819, DOI 10.1002/stem.1163; Gao WC, 2013, GASTROENTEROLOGY, V145, P636, DOI 10.1053/j.gastro.2013.05.049; Gerger A, 2011, CLIN CANCER RES, V17, P6934, DOI 10.1158/1078-0432.CCR-11-1180; Giampieri R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072843; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Harless WW, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-1; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hirata A, 2013, DEVELOPMENT, V140, P66, DOI 10.1242/dev.084103; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Hu XW, 2012, CELL CYCLE, V11, P2691, DOI 10.4161/cc.21021; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Humphries A, 2013, P NATL ACAD SCI USA, V110, pE2490, DOI 10.1073/pnas.1220353110; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Janku F, 2014, CELL REP, V6, P377, DOI 10.1016/j.celrep.2013.12.035; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kemper K, 2012, STEM CELLS, V30, P2378, DOI 10.1002/stem.1233; Kemper K, 2012, CLIN CANCER RES, V18, P3132, DOI 10.1158/1078-0432.CCR-11-3066; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kobayashi S, 2012, STEM CELLS, V30, P2631, DOI 10.1002/stem.1257; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kozar S, 2013, CELL STEM CELL, V13, P626, DOI 10.1016/j.stem.2013.08.001; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Kryczek I, 2014, IMMUNITY, V40, P772, DOI 10.1016/j.immuni.2014.03.010; Kwon C, 2011, NAT CELL BIOL, V13, P1244, DOI 10.1038/ncb2313; Le P.N., 2014, PHARM THER IN PRESS; Lee GY, 2011, INT J HEMATOL, V93, P27, DOI 10.1007/s12185-010-0734-2; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Lotti F, 2013, J EXP MED, V210, P2851, DOI 10.1084/jem.20131195; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; MacArthur BD, 2014, P NATL ACAD SCI USA, V111, P3653, DOI 10.1073/pnas.1401030111; MacArthur BD, 2013, CELL, V154, P484, DOI 10.1016/j.cell.2013.07.024; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Moon BS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt373; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Myant KB, 2013, CELL STEM CELL, V12, P761, DOI 10.1016/j.stem.2013.04.006; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Ormanns S, 2014, ONCOTARGET, V5, P2999, DOI 10.18632/oncotarget.1626; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Puig I, 2013, CLIN CANCER RES, V19, P6787, DOI 10.1158/1078-0432.CCR-12-1740; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ragusa S, 2014, CELL REP, V8, P1957, DOI 10.1016/j.celrep.2014.08.041; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Rothenberg M.E., 2012, GASTROENTEROLOGY, V142; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Snippert HJ, 2014, EMBO REP, V15, P62, DOI 10.1002/embr.201337799; Song XY, 2014, IMMUNITY, V40, P140, DOI 10.1016/j.immuni.2013.11.018; Sottoriva A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001132; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Vermeulen L, 2014, NAT REV CANCER, V14, P468, DOI 10.1038/nrc3744; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Voorneveld PW, 2014, GASTROENTEROLOGY, V147, P196, DOI 10.1053/j.gastro.2014.03.052; WERSTO RP, 1991, CANCER, V67, P106, DOI 10.1002/1097-0142(19910101)67:1<106::AID-CNCR2820670120>3.0.CO;2-I; Westphalen CB, 2014, J CLIN INVEST, V124, P1283, DOI 10.1172/JCI73434; Whissell G, 2014, NAT CELL BIOL, V16, P695, DOI 10.1038/ncb2992; Wiener Z, 2014, CELL REP, V8, P1943, DOI 10.1016/j.celrep.2014.08.034; Wild C.P., 2014, WORLD CANC REPORT; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zhang B., 2010, GASTROENTEROLOGY, V138; Zhang XN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4295; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589; Zhu YH, 2013, CELL STEM CELL, V12, P298, DOI 10.1016/j.stem.2013.01.003; Ziskin JL, 2013, GUT, V62, P1012, DOI 10.1136/gutjnl-2011-301195	133	260	269	3	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					692	705		10.1016/j.stem.2014.11.012	http://dx.doi.org/10.1016/j.stem.2014.11.012			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25479747	Bronze, Green Submitted			2022-12-28	WOS:000347174300009
J	Maden, M				Maden, Malcolm			Who Needs Stem Cells if You Can Dedifferentiate?	CELL STEM CELL			English	Editorial Material							LIMB REGENERATION; ACTIVATION; BRAIN		[Maden, Malcolm] Univ Florida, Genet Inst, Dept Biol, Gainesville, FL 32611 USA; [Maden, Malcolm] Univ Florida, Genet Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Maden, M (corresponding author), Univ Florida, Genet Inst, Dept Biol, Gainesville, FL 32611 USA.	malcmaden@ufl.edu						Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541; HAY ED, 1959, DEV BIOL, V1, P555, DOI 10.1016/0012-1606(59)90018-1; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Maden M, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-1; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sandoval-Guzman T., 2013, CELL STEM C IN PRESS, V13; Tanaka EM, 1999, CURR BIOL, V9, P792, DOI 10.1016/S0960-9822(99)80362-5; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777	9	5	5	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					640	641		10.1016/j.stem.2013.11.020	http://dx.doi.org/10.1016/j.stem.2013.11.020			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24315436	Bronze			2022-12-28	WOS:000329571700004
J	Bruneau, BG; Tesar, P; Solomon, SL; Knoepfler, PS; Westin, E; Ellison, BM; Caulfield, T; Kho, J; Doherty, K; Kemp, E				Bruneau, Benoit G.; Tesar, Paul; Solomon, Susan L.; Knoepfler, Paul S.; Westin, Erik; Ellison, Brooke M.; Caulfield, Timothy; Kho, Jordan; Doherty, Kate; Kemp, Emma			#StemCells: Education, Innovation, and Outreach	CELL STEM CELL			English	Editorial Material									[Bruneau, Benoit G.] Gladstone Inst Cardiovasc Dis, Sch Med, San Francisco, CA USA; [Tesar, Paul] Case Western Reserve Univ, Cleveland, OH USA; [Solomon, Susan L.] New York Stem Cell Fdn, Sch Med, New York, NY USA; [Knoepfler, Paul S.] Univ Calif Davis, Tim Townes Lab, Davis, CA USA; [Westin, Erik] Univ Alabama Birmingham, Stem Cell Facil, Birmingham, AL USA; [Ellison, Brooke M.] SUNY Stony Brook, Health Law Inst, Stony Brook, NY USA; [Caulfield, Timothy] Univ Alberta, Edmonton, AB, Canada; [Kho, Jordan] Baylor Coll Med, Houston, TX USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Case Western Reserve University; The New York Stem Cell Foundation; University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Alberta; Baylor College of Medicine			Tesar, Paul J/C-9848-2014; Tesar, Paul/GPK-5942-2022	Tesar, Paul J/0000-0003-1532-3155; Tesar, Paul/0000-0003-1532-3155					0	0	0	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					517	519		10.1016/j.stem.2013.10.014	http://dx.doi.org/10.1016/j.stem.2013.10.014			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24367811	Bronze			2022-12-28	WOS:000329571500016
J	Doulatov, S; Vo, LT; Chou, SS; Kim, PG; Arora, N; Li, H; Hadland, BK; Bernstein, ID; Collins, JJ; Zon, LI; Daley, GQ				Doulatov, Sergei; Vo, Linda T.; Chou, Stephanie S.; Kim, Peter G.; Arora, Natasha; Li, Hu; Hadland, Brandon K.; Bernstein, Irwin D.; Collins, James J.; Zon, Leonard I.; Daley, George Q.			Induction of Multipotential Hematopoietic Progenitors from Human Pluripotent Stem Cells via Respecification of Lineage-Restricted Precursors	CELL STEM CELL			English	Article							RED-BLOOD-CELLS; REPOPULATING ABILITY; IN-VITRO; DIFFERENTIATION; GENERATION; EXPRESSION; MACROPHAGES; PATIENT	Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. However, the inability to derive engraftable human hematopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34(+)CD45(+) myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34(+)CD38(-) cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells.	[Doulatov, Sergei; Vo, Linda T.; Chou, Stephanie S.; Kim, Peter G.; Arora, Natasha; Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA; [Doulatov, Sergei; Vo, Linda T.; Chou, Stephanie S.; Kim, Peter G.; Arora, Natasha; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Doulatov, Sergei; Vo, Linda T.; Chou, Stephanie S.; Kim, Peter G.; Arora, Natasha; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Doulatov, Sergei; Vo, Linda T.; Chou, Stephanie S.; Kim, Peter G.; Arora, Natasha; Zon, Leonard I.; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Hu; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Hadland, Brandon K.; Bernstein, Irwin D.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Hadland, Brandon K.; Bernstein, Irwin D.] Univ Washington, Dept Pediat, Seattle, WA 98105 USA; [Zon, Leonard I.] Childrens Hosp, Howard Hughes Med Inst, Div Pediat Hematol Oncol, Stem Cell Program, Boston, MA 02115 USA; [Zon, Leonard I.; Daley, George Q.] Broad Inst, Cambridge, MA 02141 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston University; Howard Hughes Medical Institute; Boston University; Harvard University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Daley, GQ (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu		Hadland, Brandon/0000-0003-3999-9002	US National Institute of Diabetes and Digestive and Kidney Diseases [R24-DK092760]; National Heart, Lung, Blood Institute Progenitor Cell Biology Consortium [UO1-HL100001]; Alex's Lemonade Stand; Doris Duke Medical Foundation; Helen Hay Whitney Foundation; NSF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092760, P30DK049216] Funding Source: NIH RePORTER	US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, Blood Institute Progenitor Cell Biology Consortium; Alex's Lemonade Stand; Doris Duke Medical Foundation(Doris Duke Charitable Foundation (DDCF)); Helen Hay Whitney Foundation; NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank Thorsten Schlaeger and the BCH ESC core, Ronald Mathieu from the flow cytometry core, and Norman Gerry from the Coriell Genotyping and Microarray Center for assistance. Andrea Ditadi and Gordon Keller provided reagents and advice. Band3 antibody was a gift from the Narla Mohandas lab. This work is supported by grants from the US National Institute of Diabetes and Digestive and Kidney Diseases (R24-DK092760) and the National Heart, Lung, Blood Institute Progenitor Cell Biology Consortium (UO1-HL100001); Alex's Lemonade Stand; and the Doris Duke Medical Foundation. G. Q. D. is an associate member of the Broad Institute and an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research. S. D. is supported by a fellowship from the Helen Hay Whitney Foundation. L. T. V. is supported by the NSF Graduate Research Fellowship.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Anstee DJ, 2012, CURR OPIN HEMATOL, V19, P163, DOI 10.1097/MOH.0b013e328352240a; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chang KH, 2006, BLOOD, V108, P1515, DOI 10.1182/blood-2005-11-011874; Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354; Cherry ABC, 2013, ANNU REV MED, V64, P277, DOI 10.1146/annurev-med-050311-163324; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131; Di-Poi N, 2010, DEV BIOL, V341, P488, DOI 10.1016/j.ydbio.2010.03.006; Dias J, 2011, STEM CELLS DEV, V20, P1639, DOI 10.1089/scd.2011.0078; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Garcon L, 2013, BLOOD, V122, P912, DOI 10.1182/blood-2013-01-478321; Hu Z, 2011, BLOOD, V118, P5938, DOI 10.1182/blood-2010-11-321414; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kumano K, 2012, BLOOD, V119, P6234, DOI 10.1182/blood-2011-07-367441; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Lee GS, 2008, MOL CELLS, V25, P487; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Martin CH, 2008, BLOOD, V112, P2730, DOI 10.1182/blood-2008-01-133801; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; McKinney-Freeman S, 2012, CELL STEM CELL, V11, P701, DOI 10.1016/j.stem.2012.07.018; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Migliaccio AR, 2012, CELL STEM CELL, V10, P115, DOI 10.1016/j.stem.2012.01.001; Muller LUW, 2012, BLOOD, V119, P5449, DOI 10.1182/blood-2012-02-408674; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Sankaran VG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011643; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Tulpule A, 2013, CELL STEM CELL, V12, P727, DOI 10.1016/j.stem.2013.04.002; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554	47	183	189	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					459	470		10.1016/j.stem.2013.09.002	http://dx.doi.org/10.1016/j.stem.2013.09.002			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094326	Bronze, Green Accepted			2022-12-28	WOS:000329571100014
J	Deglincerti, A; Brivanlou, AH				Deglincerti, Alessia; Brivanlou, Ali H.			Human SCNT Gets a Boost from Histone Demethylation	CELL STEM CELL			English	Editorial Material							CELL NUCLEAR TRANSFER; STEM-CELLS	Human somatic cell nuclear transfer (SCNT) holds great potential in regenerative medicine; however, its applicability has been limited by great variability in reprogramming efficiencies. A new study in this issue of Cell Stem Cell reports a simple way to expand human SCNT to hard-to-reprogram oocytes (Chung et al., 2015).	[Deglincerti, Alessia; Brivanlou, Ali H.] Rockefeller Univ, Lab Stem Cell Biol & Mol Embryol, New York, NY 10065 USA	Rockefeller University	Brivanlou, AH (corresponding author), Rockefeller Univ, Lab Stem Cell Biol & Mol Embryol, New York, NY 10065 USA.	brvnlou@rockefeller.edu						Chung YG, 2014, CELL STEM CELL, V14, P777, DOI 10.1016/j.stem.2014.03.015; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Yamada M, 2014, NATURE, V510, P533, DOI 10.1038/nature13287	6	2	2	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					641	642		10.1016/j.stem.2015.11.014	http://dx.doi.org/10.1016/j.stem.2015.11.014			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26637938	Bronze			2022-12-28	WOS:000366139100003
J	Zhao, TB; Zhang, ZN; Westenskow, PD; Todorova, D; Hu, Z; Lin, TX; Rong, ZL; Kim, J; He, JJ; Wang, MY; Clegg, DO; Yang, YG; Zhang, K; Friedlander, M; Xu, Y				Zhao, Tongbiao; Zhang, Zhen-ning; Westenskow, Peter D.; Todorova, Dilyana; Hu, Zheng; Lin, Tongxiang; Rong, Zhili; Kim, Jinchul; He, Jingjin; Wang, Meiyan; Clegg, Dennis O.; Yang, Yong-guang; Zhang, Kun; Friedlander, Martin; Xu, Yang			Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							EPIGENETIC MEMORY; SOMATIC-CELLS	The breakthrough of induced pluripotent stem cell (iPSC) technology has raised the possibility that patient-specific iPSCs may become a renewable source of autologous cells for cell therapy without the concern of immune rejection. However, the immunogenicity of autologous humaniPSC(hiPSC)-derived cells is not well understood. Using a humanized mouse model (denoted Hu-mice) reconstituted with a functional human immune system, we demonstrate that most teratomas formed by autologous integration-free hiPSCs exhibit local infiltration of antigen-specific T cells and associated tissue necrosis, indicating immune rejection of certain hiPSC-derived cells. In this context, autologous hiPSC-derived smooth muscle cells (SMCs) appear to be highly immunogenic, while autologous hiPSC-derived retinal pigment epithelial (RPE) cells are immune tolerated even in non-ocular locations. This differential immunogenicity is due in part to abnormal expression of immunogenic antigens in hiPSC-derived SMCs, but not in hiPSC-derived RPEs. These findings support the feasibility of developing hiPSC-derived RPEs for treating macular degeneration.	[Zhao, Tongbiao; Zhang, Zhen-ning; Todorova, Dilyana; He, Jingjin; Wang, Meiyan; Xu, Yang] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Zhao, Tongbiao] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Westenskow, Peter D.; Friedlander, Martin] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Hu, Zheng; Yang, Yong-guang] Jilin Univ, Hosp 1, Changchun 130021, Jilin, Peoples R China; [Lin, Tongxiang] Guangzhou Univ Tradit Chinese Med, Clin Hosp 2, Guangzhou 510006, Guangdong, Peoples R China; [Rong, Zhili; Kim, Jinchul; He, Jingjin; Xu, Yang] Southern Med Univ, Canc Res Inst, Guangzhou 510515, Guangdong, Peoples R China; [Clegg, Dennis O.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Yang, Yong-guang] Columbia Univ, Med Ctr, Ctr Translat Immunol, New York, NY 10032 USA; [Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Chinese Academy of Sciences; Institute of Zoology, CAS; Scripps Research Institute; Jilin University; Guangzhou University of Chinese Medicine; Southern Medical University - China; University of California System; University of California Santa Barbara; Columbia University; University of California System; University of California San Diego	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu	Lin, Tongxiang/I-4695-2013; Zhang, Kun/ABE-6349-2020; Zhao, Tongbiao/C-5761-2011	Lin, Tongxiang/0000-0001-7033-6982; Zhang, Kun/0000-0002-7596-5224; Zhao, Tongbiao/0000-0003-1429-5818; Rong, Zhili/0000-0002-1699-7074; Westenskow, Peter/0000-0001-9841-6220; Zhang, Zhen-Ning/0000-0003-3798-7104; Xu, Yang/0000-0001-5574-921X; Yang, Yong-Guang/0000-0003-4985-1247; Wang, Meiyan/0000-0002-4838-7182	National Natural Science Foundation of China [81430032]; Chinese Ministry of Science and Technology [2013CB966900, 2013ZX10002008-002]; Strategic Priority Research Program of Chinese Academy of Sciences [XDA01040108]; NIH Ruth L. Kirschstein National Research Service Award [EY021416]; California Institute of Regenerative Medicine [TR1-01219]; National Eye Institute of National Institutes of Health [EY11254]; Early Translational Award from California Institute for Regenerative Medicine [TR1-01277]; NATIONAL EYE INSTITUTE [R01EY011254, F32EY021416] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); NIH Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Eye Institute of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Early Translational Award from California Institute for Regenerative Medicine; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank UCSD Cancer Center pathologic core for help with histologic analysis and Ms. Shengyun Zhu for technical support. This work was supported by a grant from National Natural Science Foundation of China (81430032), grants from Chinese Ministry of Science and Technology (2013CB966900 and 2013ZX10002008-002), the Strategic Priority Research Program of the Chinese Academy of Sciences to T.Z. (XDA01040108), an NIH Ruth L. Kirschstein National Research Service Award to P.D.W. (EY021416), grants to M.F. from the California Institute of Regenerative Medicine (TR1-01219) and the National Eye Institute of the National Institutes of Health (EY11254), and an Early Translational Award from California Institute for Regenerative Medicine to Y.X. (TR1-01277).	Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; de Almeida PE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4903; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Krohne TU, 2012, STEM CELL TRANSL MED, V1, P96, DOI 10.5966/sctm.2011-0057; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rong ZL, 2014, CELL STEM CELL, V14, P121, DOI 10.1016/j.stem.2013.11.014; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	19	141	145	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					353	359		10.1016/j.stem.2015.07.021	http://dx.doi.org/10.1016/j.stem.2015.07.021			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26299572	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000364011000013
J	Artandi, SE; Blau, HM; de Haan, G; Geiger, H; Goodell, MA; Jones, L; Levine, RL; Munoz-Canoves, P; Rodewald, HR; Wagers, A; Wang, ZQ; Yamashita, Y				Artandi, Steven E.; Blau, Helen M.; de Haan, Gerald; Geiger, Hartmut; Goodell, Margaret A.; Jones, Leanne; Levine, Ross L.; Munoz-Canoves, Pura; Rodewald, Hans-Reimer; Wagers, Amy; Wang, Zhao-Qi; Yamashita, Yukiko			Stem Cells and Aging: What's Next?	CELL STEM CELL			English	Editorial Material								We asked 12 leaders in the stem cell and aging fields to share their personal perspectives on the future of the field and the unanswered questions that drive them to work in this exciting area.	[Artandi, Steven E.; Blau, Helen M.] Stanford Univ, Stanford, CA USA; [de Haan, Gerald] European Res Inst Biol Ageing, Groningen, Netherlands; [Geiger, Hartmut] Univ Ulm, Ulm, Germany; [Geiger, Hartmut] CCHMC, Cincinnati, OH USA; [Goodell, Margaret A.] Baylor Coll Med, Houston, TX USA; [Jones, Leanne] Univ California, Los Angeles, CA USA; [Levine, Ross L.] Mem Sloan Kettering Canc Ctr, New York, NY USA; [Munoz-Canoves, Pura] Pompeu Fabra Univ, ICREA, Barcelona, Spain; [Rodewald, Hans-Reimer] German Canc Res Ctr, Heidelberg, Germany; [Wagers, Amy] Harvard Univ, Cambridge, MA USA; [Wang, Zhao-Qi] Leibniz Inst Age Res, FLI, Jena, Germany; [Yamashita, Yukiko] Univ Michigan, HHMI, Ann Arbor, MI USA	Stanford University; Ulm University; Baylor College of Medicine; University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center; ICREA; Pompeu Fabra University; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Artandi, SE (corresponding author), Stanford Univ, Stanford, CA USA.		de Haan, Gerald/D-2081-2015; de Haan, Gerald/AAF-8963-2019; levine, ross/AAE-7658-2019; Munoz-Canoves, Pura/B-3889-2015	de Haan, Gerald/0000-0001-9706-0138; de Haan, Gerald/0000-0001-9706-0138; Goodell, Margaret A./0000-0003-1111-2932; Yamashita, Yukiko/0000-0001-5541-0216	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICREA(ICREA)			0	7	8	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2015	16	6					578	581						4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CK0YR	26247067				2022-12-28	WOS:000355932300005
J	Kida, YS; Kawamura, T; Wei, Z; Sogo, T; Jacinto, S; Shigeno, A; Kushige, H; Yoshihara, E; Liddle, C; Ecker, JR; Yu, RT; Atkins, AR; Downes, M; Evans, RM				Kida, Yasuyuki S.; Kawamura, Teruhisa; Wei, Zong; Sogo, Takahiro; Jacinto, Sandra; Shigeno, Asako; Kushige, Hiroko; Yoshihara, Eiji; Liddle, Christopher; Ecker, Joseph R.; Yu, Ruth T.; Atkins, Annette R.; Downes, Michael; Evans, Ronald M.			ERRs Mediate a Metabolic Switch Required for Somatic Cell Reprogramming to Pluripotency	CELL STEM CELL			English	Article							STEM-CELLS; EXPRESSION; ESRRB; OCT4; FIBROBLASTS; INDUCTION; TARGET; ALPHA	Cell metabolism is adaptive to extrinsic demands; however, the intrinsic metabolic demands that drive the induced pluripotent stem cell (iPSC) program remain unclear. Although glycolysis increases throughout the reprogramming process, we show that the estrogen-related nuclear receptors (ERR alpha and ERR gamma) and their partnered co-factors PGC-1 alpha and PGC-1 beta are transiently induced at an early stage, resulting in a burst of oxidative phosphorylation (OXPHOS) activity. Upregulation of ERR alpha or ERR gamma is required for the OXPHOS burst in both human and mouse cells, respectively, as well as iPSC generation itself. Failure to induce this metabolic switch collapses the reprogramming process. Furthermore, we identify a rare pool of Sca1(-)/CD34(-) sortable cells that is highly enriched in bona fide reprogramming progenitors. Transcriptional profiling confirmed that these progenitors are ERR gamma and PGC-1 beta positive and have undergone extensive metabolic reprogramming. These studies characterize a previously unrecognized, ERR-dependent metabolic gate prior to establishment of induced pluripotency.	[Kida, Yasuyuki S.; Wei, Zong; Jacinto, Sandra; Yoshihara, Eiji; Yu, Ruth T.; Atkins, Annette R.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Kawamura, Teruhisa; Sogo, Takahiro; Shigeno, Asako] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Kyoto 6068501, Japan; [Liddle, Christopher] Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW 2145, Australia; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Kida, Yasuyuki S.; Kushige, Hiroko] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058562, Japan; [Kawamura, Teruhisa; Shigeno, Asako] Ritsumeikan Univ, Coll Life Sci, Dept Biomed Sci, Kusatsu, Shiga 5258577, Japan	Salk Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; Kyoto University; University of Sydney; Westmead Institute for Medical Research; University of Sydney; National Institute of Advanced Industrial Science & Technology (AIST); Ritsumeikan University	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	evans@salk.edu	kida, yasuyuki S/J-1718-2018; Ecker, Joseph R/B-9144-2008; Evans, Ronald/AAF-4001-2019	kida, yasuyuki S/0000-0002-9972-293X; Ecker, Joseph R/0000-0001-5799-5895; Evans, Ronald/0000-0002-9986-5965; Wei, Zong/0000-0002-4691-0101; Atkins, Annette/0000-0003-2558-7058; Yoshihara, Eiji/0000-0001-6324-6495; Yu, Ruth/0000-0002-9527-9627	Japan Society for the Promotion of Science; CIRM; NIH [HD105278, DK057978, DK062434, DK063491]; Leona M. and Harry B. Helmsley Charitable Trust; Howard Hughes Medical Institute; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, P30DK063491, R37DK057978] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. S. Fang, J. Jonker, and W. Fan for useful discussions and reagents and L. Ong and C. Brondos for administrative assistance. R.M.E. is an Investigator of the Howard Hughes Medical Institute at the Salk Institute and March of Dimes Chair in Molecular and Developmental Biology. Y.S.K. was supported by the Japan Society for the Promotion of Science. Z.W. is supported by a CIRM training grant. This work was supported by grants from CIRM; NIH grants HD105278, DK057978, DK062434, and DK063491; the Leona M. and Harry B. Helmsley Charitable Trust and the Howard Hughes Medical Institute (R.M.E.); and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Special Coordination Fund for Promoting Science and Technology of MEXT (T.K.). Y.S.K., T.K., Z.W., R.T.Y, A.R.A., M.D., and R.M.E are coinventors of a method of modulating somatic cell reprogramming and may be entitled to royalties.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Dufour CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002143; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Mathieu J, 2014, CELL STEM CELL, V14, P592, DOI 10.1016/j.stem.2014.02.012; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theunissen TW, 2014, CELL STEM CELL, V14, P720, DOI 10.1016/j.stem.2014.05.002; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	34	83	87	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2015	16	5					547	555		10.1016/j.stem.2015.03.001	http://dx.doi.org/10.1016/j.stem.2015.03.001			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH7AS	25865501	Bronze, Green Accepted			2022-12-28	WOS:000354188600014
J	Alberta, HB; Cheng, A; Jackson, EL; Pjecha, M; Levine, AD				Alberta, Hillary B.; Cheng, Albert; Jackson, Emily L.; Pjecha, Matthew; Levine, Aaron D.			Assessing State Stem Cell Programs in the United States: How Has State Funding Affected Publication Trends?	CELL STEM CELL			English	Editorial Material							POLICY	Several states responded to federal funding limitations placed on human embryonic stem cell research and the potential of the field by creating state stem cell funding programs, yet little is known about the impact of these programs. Here we examine how state programs have affected publication trends in four states.	[Alberta, Hillary B.; Pjecha, Matthew; Levine, Aaron D.] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA; [Cheng, Albert] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Jackson, Emily L.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Cheng, Albert; Levine, Aaron D.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Levine, AD (corresponding author), Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA.	aaron.levine@pubpolicy.gatech.edu			Division Of Research On Learning [1150114] Funding Source: National Science Foundation	Division Of Research On Learning(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))		Furman JL, 2012, J POLICY ANAL MANAG, V31, P661, DOI 10.1002/pam.21644; Gottweis H, 2010, CELL STEM CELL, V7, P555, DOI 10.1016/j.stem.2010.10.008; Guhr A, 2006, STEM CELLS, V24, P2187, DOI 10.1634/stemcells.2006-0053; Karmali RN, 2010, NAT BIOTECHNOL, V28, P1246, DOI 10.1038/nbt1210-1246; Levine Aaron, 2004, Politics Life Sci, V23, P40, DOI 10.2990/1471-5457(2004)23[40:TITGDO]2.0.CO;2; Levine AD, 2008, CELL STEM CELL, V2, P521, DOI 10.1016/j.stem.2008.05.008; Levine AD, 2013, SCI PUBL POLICY, V40, P544, DOI 10.1093/scipol/sct005; Levine AD, 2011, CELL STEM CELL, V8, P132, DOI 10.1016/j.stem.2011.01.002; Scott CT, 2011, CELL, V145, P820, DOI 10.1016/j.cell.2011.05.032; Smith JO, 2006, NAT BIOTECHNOL, V24, P391, DOI 10.1038/nbt0406-391	10	12	12	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					115	118		10.1016/j.stem.2015.01.007	http://dx.doi.org/10.1016/j.stem.2015.01.007			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25658368	Bronze			2022-12-28	WOS:000349455000007
J	Harrisingh, MC; Ffrench-Constant, C				Harrisingh, Marie C.; Ffrench-Constant, Charles			Can the Irradiated Brain Be Salvaged by Oligodendrocyte Precursor Transplantation?	CELL STEM CELL			English	Editorial Material							PROGENITOR CELLS; CNS	Radiotherapy is a mainstay of brain cancer treatment, but it causes significant complications. In this issue of Cell Stem Cell, Piao et al. (2015) derive oligodendrocyte precursors from human embryonic stem cells and show that engrafted cells replenish depleted precursor numbers, generate new myelin, and reverse behavioral defects in irradiated rats.	[Harrisingh, Marie C.; Ffrench-Constant, Charles] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland	University of Edinburgh	Ffrench-Constant, C (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, SCRM Bldg,Edinburgh bioQuarter,5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	cffc@ed.ac.uk						Chari DM, 2006, EXP NEUROL, V198, P145, DOI 10.1016/j.expneurol.2005.11.023; Franklin RJM, 1996, EXP NEUROL, V137, P263, DOI 10.1006/exnr.1996.0025; GANSMULLER A, 1986, DEV NEUROSCI-BASEL, V8, P197, DOI 10.1159/000112253; Goldman SA, 2012, SCIENCE, V338, P491, DOI 10.1126/science.1218071; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Najm FJ, 2011, NAT METHODS, V8, P957, DOI [10.1038/NMETH.1712, 10.1038/nmeth.1712]; Padovani L, 2012, NAT REV NEUROL, V8, P578, DOI 10.1038/nrneurol.2012.182; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Piao JH, 2015, CELL STEM CELL, V16, P198, DOI 10.1016/j.stem.2015.01.004; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002	10	2	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2015	16	2					113	114		10.1016/j.stem.2015.01.010	http://dx.doi.org/10.1016/j.stem.2015.01.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB2KC	25658367	Bronze			2022-12-28	WOS:000349455000006
J	Brenner, C; Franz, WM				Brenner, Christoph; Franz, Wolfgang-Michael			Pluripotent-Stem-Cell-Derived Epicardial Cells: A Step toward Artificial Cardiac Tissue	CELL STEM CELL			English	Editorial Material							HEART DEVELOPMENT; LINEAGE; PROGENITORS; MESP1	Epicardial cells are crucial for heart development, function, and regeneration, but methods to study them have been lacking. Using WNT and BMP signaling pathways, Witty et al. (2014) have now developed an elaborate method to generate fully functional epicardial cells from human pluripotent stem cells, allowing their in vitro investigation.	[Brenner, Christoph; Franz, Wolfgang-Michael] Med Univ Innsbruck, Dept Internal Med Cardiol & Angiol 3, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Brenner, C (corresponding author), Med Univ Innsbruck, Dept Internal Med Cardiol & Angiol 3, Anichstr 35, A-6020 Innsbruck, Austria.	mail@med.cbrenner.net; wolfgang-michael.franz@uki.at						Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Brenner C, 2011, EXPERT REV MED DEVIC, V8, P209, DOI 10.1586/ERD.10.78; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; David R, 2011, CARDIOVASC RES, V92, P115, DOI 10.1093/cvr/cvr158; David R, 2009, CARDIOVASC RES, V84, P263, DOI 10.1093/cvr/cvp211; Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024; Witty AD, 2014, NAT BIOTECHNOL, V32, P1026, DOI 10.1038/nbt.3002; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	9	1	2	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2014	15	5					533	534		10.1016/j.stem.2014.10.007	http://dx.doi.org/10.1016/j.stem.2014.10.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT5XH	25517459	Bronze			2022-12-28	WOS:000345012700004
J	Wang, L; Zhang, HJ; Rodriguez, S; Cao, LY; Parish, J; Mumaw, C; Zollman, A; Kamoka, MM; Mu, J; Chen, DZ; Srour, EF; Chitteti, BR; HogenEsch, H; Tu, XL; Bellido, TM; Boswell, HS; Manshouri, T; Verstovsek, S; Yoder, MC; Kapur, R; Cardoso, AA; Carlesso, N				Wang, Lin; Zhang, Huajia; Rodriguez, Sonia; Cao, Liyun; Parish, Jonathan; Mumaw, Christen; Zollman, Amy; Kamoka, Malgorzata M.; Mu, Jian; Chen, Danny Z.; Srour, Edward F.; Chitteti, Brahmananda R.; HogenEsch, Harm; Tu, Xiaolin; Bellido, Teresita M.; Boswell, H. Scott; Manshouri, Taghi; Verstovsek, Srdan; Yoder, Mervin C.; Kapur, Reuben; Cardoso, Angelo A.; Carlesso, Nadia			Notch-Dependent Repression of miR-155 in the Bone Marrow Niche Regulates Hematopoiesis in an NF-kappa B-Dependent Manner	CELL STEM CELL			English	Article							ENDOTHELIAL-CELLS; MYELOPROLIFERATIVE DISORDER; TARGET GENES; NITRIC-OXIDE; STEM-CELLS; INFLAMMATION; ACTIVATION; PATHWAY; BINDING; MICROENVIRONMENT	The microRNA miR-155 has been implicated in regulating inflammatory responses and tumorigenesis, but its precise role in linking inflammation and cancer has remained elusive. Here, we identify a connection between miR-155 and Notch signaling in this context. Loss of Notch signaling in the bone marrow (BM) niche alters hematopoietic homeostasis and leads to lethal myeloproliferative-like disease. Mechanistically, Notch signaling represses miR-155 expression by promoting binding of RBPJ to the miR-155 promoter. Loss of Notch/RBPJ signaling upregulates miR-155 in BM endothelial cells, leading to miR-155-mediated targeting of the nuclear factor kappa B (NF-kappa B) inhibitor kappa B-Ras1, NF-kappa B activation, and increased proinflammatory cytokine production. Deletion of miR-155 in the stroma of RBPJ(-/-) mice prevented the development of myeloproliferative-like disease and cytokine induction. Analysis of BM from patients carrying myeloproliferative neoplasia also revealed elevated expression of miR-155. Thus, the Notch/miR-155/kappa B-Ras1/NF-kappa B axis regulates the inflammatory state of the BM niche and affects the development of myeloproliferative disorders.	[Wang, Lin; Zhang, Huajia; Rodriguez, Sonia; Cao, Liyun; Parish, Jonathan; Mumaw, Christen; Zollman, Amy; Srour, Edward F.; Yoder, Mervin C.; Kapur, Reuben; Cardoso, Angelo A.; Carlesso, Nadia] Indiana Univ Sch Med, Dept Pediat, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Kamoka, Malgorzata M.; Srour, Edward F.; Chitteti, Brahmananda R.; Boswell, H. Scott] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mu, Jian; Chen, Danny Z.] Univ Notre Dame, Dept Comp Sci & Engn, South Bend, IN 46556 USA; [HogenEsch, Harm] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Tu, Xiaolin; Bellido, Teresita M.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Manshouri, Taghi; Verstovsek, Srdan] Univ Texas MD Anderson Canc Ctr, Leukemia Dept, Houston, TX 77030 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Notre Dame; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; University of Texas System; UTMD Anderson Cancer Center	Carlesso, N (corresponding author), Indiana Univ Sch Med, Dept Pediat, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	ncarless@iu.edu	ray, jay/GYV-3810-2022	Zhang, Huajia/0000-0002-8728-5242; Verstovsek, MD, PhD, Professor of Medicine, Srdan/0000-0002-6912-8569; HogenEsch, Harm/0000-0002-2738-9189; Yoder, Mervin/0000-0003-4354-7631	NHLBI [R01 HL068256, HL55716]; ITRAC program at Indiana University Simon Cancer Center; RSFG at IUPUI; Indiana Center for Excellence in Molecular Hematology [NIDDK P30 DK090948];  [R01 CA134777]; Direct For Computer & Info Scie & Enginr [1217906] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA134777, R01CA173852] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL110854, R01HL055716, R01HL068256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090948] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002104] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ITRAC program at Indiana University Simon Cancer Center; RSFG at IUPUI; Indiana Center for Excellence in Molecular Hematology; ; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grant NHLBI R01 HL068256 (N.C.), the ITRAC program at Indiana University Simon Cancer Center (N.C.), the RSFG at IUPUI (N.C.), the Indiana Center for Excellence in Molecular Hematology (NIDDK P30 DK090948), NHLBI HL55716 (E.F.S.) and R01 CA134777 (R.K.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Barbarulo A, 2011, J IMMUNOL, V186, P6199, DOI 10.4049/jimmunol.1002136; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Chang SH, 2011, NAT MED, V17, P1275, DOI 10.1038/nm.2459; Chen Y, 2004, MOL CELL BIOL, V24, P3048, DOI 10.1128/MCB.24.7.3048-3056.2004; Chitteti BR, 2010, J CELL BIOCHEM, V111, P284, DOI 10.1002/jcb.22694; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; De Strooper B, 2005, CELL, V122, P318, DOI 10.1016/j.cell.2005.07.021; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Faust N, 2000, BLOOD, V96, P719; Fenwick C, 2000, SCIENCE, V287, P869, DOI 10.1126/science.287.5454.869; Fernandez L, 2008, EXP HEMATOL, V36, P545, DOI 10.1016/j.exphem.2007.12.012; Forde A, 2002, GENESIS, V33, P191, DOI 10.1002/gene.10117; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kim MY, 2008, J CELL SCI, V121, P1466, DOI 10.1242/jcs.019018; Kim YW, 2008, BLOOD, V112, P4628, DOI 10.1182/blood-2008-03-148999; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Kuhlencordt PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1195, DOI 10.1152/ajpcell.00546.2002; Lobry C, 2013, J EXP MED, V210, P301, DOI 10.1084/jem.20121484; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Neelakantan S, 2009, BIOORG MED CHEM LETT, V19, P4346, DOI 10.1016/j.bmcl.2009.05.092; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Sakano D, 2010, DEV CELL, V18, P450, DOI 10.1016/j.devcel.2009.12.023; Schneider A, 2003, AM J PHYSIOL-RENAL, V284, pF411, DOI 10.1152/ajprenal.00235.2002; Tefferi A, 2011, J CLIN ONCOL, V29, P1356, DOI 10.1200/JCO.2010.32.9490; Tiberi L, 2012, NAT NEUROSCI, V15, P1627, DOI 10.1038/nn.3264; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Yao D, 2011, BLOOD, V117, P5652, DOI 10.1182/blood-2010-12-326074; Yoda M, 2011, BLOOD, V118, P6939, DOI 10.1182/blood-2011-06-357210	45	137	141	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					51	65		10.1016/j.stem.2014.04.021	http://dx.doi.org/10.1016/j.stem.2014.04.021			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24996169	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000340878600011
J	Schurch, CM; Riether, C; Ochsenbein, AF				Schuerch, Christian M.; Riether, Carsten; Ochsenbein, Adrian F.			Cytotoxic CD8(+) T Cells Stimulate Hematopoietic Progenitors by Promoting Cytokine Release from Bone Marrow Mesenchymal Stromal Cells	CELL STEM CELL			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NECROSIS FACTOR-ALPHA; INTERFERON-GAMMA; IFN-GAMMA; STEM-CELLS; GRANULOCYTE-MACROPHAGE; TOLERANCE INDUCTION; MYELOID-LEUKEMIA; SELF-RENEWAL; INFECTION	Cytotoxic CD8(+) T cells (CTLs) play a major role in host defense against intracellular pathogens, but a complete clearance of pathogens and return to homeostasis requires the regulated interplay of the innate and acquired immune systems. Here, we show that interferon gamma (IFN gamma) secreted by effector CTLs stimulates hematopoiesis at the level of early multipotent hematopoietic progenitor cells and induces myeloid differentiation. IFN gamma did not primarily affect hematopoietic stem or progenitor cells directly. Instead, it promoted the release of hematopoietic cytokines, including interleukin 6 from bone marrow mesenchymal stromal cells (MSCs) in the hematopoietic stem cell niche, which in turn reduced the expression of the transcription factors Runx-1 and Cebp alpha in early hematopoietic progenitor cells and increased myeloid differentiation. Therefore, our study indicates that, during an acute viral infection, CTLs indirectly modulate early multipotent hematopoietic progenitors via MSCs in order to trigger the temporary activation of emergency myelopoiesis and promote clearance of the infection.	[Schuerch, Christian M.; Riether, Carsten; Ochsenbein, Adrian F.] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Schuerch, Christian M.] Univ Bern, Inst Pathol, CH-3010 Bern, Switzerland; [Ochsenbein, Adrian F.] Univ Hosp Bern, Dept Med Oncol, Inselspital, CH-3010 Bern, Switzerland; [Ochsenbein, Adrian F.] Univ Bern, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern	Ochsenbein, AF (corresponding author), Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland.	adrian.ochsenbein@insel.ch	Riether, Carsten/ABC-7699-2021; Schürch, Christian/L-6188-2019; Riether, Carsten/K-8603-2013	Riether, Carsten/0000-0001-7512-513X; Schürch, Christian/0000-0002-1792-1768; Riether, Carsten/0000-0001-7512-513X; Ochsenbein, Adrian/0000-0003-1773-5436	Swiss National Science Foundation; Swiss Cancer League; Cancer League of the Canton of Bern; Werner und Hedy Berger-Janser-Stiftung; Swiss MD-PhD scholarship; Gertrud Hagmann-Stiftung fur Malignomforschung; SwissLife Jubilaumsstiftung; Fondazione Dr. Carlo Gianella; Hans Altschuler-Stiftung; Sassella Foundation; Fondation BIOS pour la recherche; Ehmann Stiftung; Fondazione per la Ricerca Sulla Trasfusione e Sui Trapianti; Olga Mayenfisch Stiftung; Novartis Stiftung fur Medizinisch-Biologische Forschung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Cancer League of the Canton of Bern; Werner und Hedy Berger-Janser-Stiftung; Swiss MD-PhD scholarship; Gertrud Hagmann-Stiftung fur Malignomforschung; SwissLife Jubilaumsstiftung; Fondazione Dr. Carlo Gianella; Hans Altschuler-Stiftung; Sassella Foundation; Fondation BIOS pour la recherche; Ehmann Stiftung; Fondazione per la Ricerca Sulla Trasfusione e Sui Trapianti; Olga Mayenfisch Stiftung; Novartis Stiftung fur Medizinisch-Biologische Forschung	This work was supported by grants from the Swiss National Science Foundation, the Swiss Cancer League, the Cancer League of the Canton of Bern, the Werner und Hedy Berger-Janser-Stiftung (A.F.O.), a Swiss MD-PhD scholarship, the Gertrud Hagmann-Stiftung fur Malignomforschung, the SwissLife Jubilaumsstiftung, the Fondazione Dr. Carlo Gianella, the Hans Altschuler-Stiftung (C. M. S.), the Sassella Foundation, the Fondation BIOS pour la recherche (C. R.), the Ehmann Stiftung, the Fondazione per la Ricerca Sulla Trasfusione e Sui Trapianti, the Olga Mayenfisch Stiftung (C. M. S. and C. R.), and the Novartis Stiftung fur Medizinisch-Biologische Forschung (A.F.O. and C. R.). We thank Kathleen D. McCoy, Rolf M. Zinkernagel, and Daniel D. Pinschewer for critically reading the manuscript and Anne-Laure Huguenin for excellent technical assistance.	Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Binder D, 1997, J EXP MED, V185, P517, DOI 10.1084/jem.185.3.517; Binder D, 1998, J EXP MED, V187, P1903, DOI 10.1084/jem.187.11.1903; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; BROXMEYER HE, 1983, J IMMUNOL, V131, P1300; BROXMEYER HE, 1985, J IMMUNOL, V135, P2502; BRUGGER W, 1993, BLOOD, V81, P2579; Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2; CAUX C, 1992, BLOOD, V79, P2628; Chen HC, 2003, CELL IMMUNOL, V225, P42, DOI 10.1016/j.cellimm.2003.09.006; Chen J, 2004, BLOOD, V104, P1671, DOI 10.1182/blood-2004-03-1115; Chou DB, 2012, J LEUKOCYTE BIOL, V92, P123, DOI 10.1189/jlb.1011527; Crane MJ, 2009, J IMMUNOL, V183, P2810, DOI 10.4049/jimmunol.0900205; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; de Bruin AM, 2012, BLOOD, V119, P1543, DOI 10.1182/blood-2011-07-367706; Demoulin JB, 1999, EUR CYTOKINE NETW, V10, P49; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Ehl S, 1998, J EXP MED, V187, P763, DOI 10.1084/jem.187.5.763; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; GEISSLER K, 1989, CANCER RES, V49, P3057; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; LU L, 1988, J IMMUNOL, V141, P201; MacNamara KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028669; MacNamara KC, 2011, J IMMUNOL, V186, P1032, DOI 10.4049/jimmunol.1001893; Matter M, 2006, J EXP MED, V203, P2145, DOI 10.1084/jem.20060651; MOSKOPHIDIS D, 1994, J VIROL, V68, P1951, DOI 10.1128/JVI.68.3.1951-1955.1994; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; MURPHY M, 1986, J EXP MED, V164, P263, DOI 10.1084/jem.164.1.263; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Parra B, 1999, J IMMUNOL, V162, P1641; PIACIBELLO W, 1986, BLOOD, V68, P1339; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Racine R, 2011, J IMMUNOL, V186, P1011, DOI 10.4049/jimmunol.1002836; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schepers K, 2012, BLOOD, V120, P3425, DOI 10.1182/blood-2011-11-395418; Schurch C, 2013, J EXP MED, V210, P605, DOI 10.1084/jem.20121229; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Shimozato O, 2002, J IMMUNOL, V168, P1746, DOI 10.4049/jimmunol.168.4.1746; SNAPPER CM, 1991, INT IMMUNOL, V3, P845, DOI 10.1093/intimm/3.9.845; Song JH, 2010, BLOOD, V115, P2592, DOI 10.1182/blood-2009-01-200071; Stagg J, 2006, BLOOD, V107, P2570, DOI 10.1182/blood-2005-07-2793; Stanford WL, 1997, J EXP MED, V186, P705, DOI 10.1084/jem.186.5.705; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Tate MD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-57; THOMSEN AR, 1983, SCAND J IMMUNOL, V17, P489, DOI 10.1111/j.1365-3083.1983.tb00816.x; THOMSEN AR, 1983, SCAND J IMMUNOL, V18, P271, DOI 10.1111/j.1365-3083.1983.tb01798.x; TISHON A, 1995, VIROLOGY, V212, P244, DOI 10.1006/viro.1995.1477; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Yadav A, 2009, J NEUROIMMUNE PHARM, V4, P430, DOI 10.1007/s11481-009-9174-2; Young HA, 1997, BLOOD, V89, P583, DOI 10.1182/blood.V89.2.583; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhao X, 2010, STEM CELLS, V28, P122, DOI 10.1002/stem.252	66	138	142	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2014	14	4					460	472		10.1016/j.stem.2014.01.002	http://dx.doi.org/10.1016/j.stem.2014.01.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AF5PW	24561082	Bronze			2022-12-28	WOS:000334766400010
J	Gouon-Evans, V				Gouon-Evans, Valerie			The Race for Regeneration: Pluripotent-Stem-Cell-Derived 3D Kidney Structures	CELL STEM CELL			English	Editorial Material								The kidney's complex spatial organization and poorly defined lineage specification programs have impeded derivation of kidney progenitors from pluripotent stem cells (PSCs). Now in Cell Stem Cell, Taguchi et al. (2014) redefine the identity of embryonic kidney progenitors in vivo to obtain PSC-derived kidney progenitors that can form nephrons in vivo.	Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, Black Family Stem Cell Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Gouon-Evans, V (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, Black Family Stem Cell Inst, New York, NY 10029 USA.	valerie.gouon-evans@mssm.edu		Gouon-Evans, Valerie/0000-0001-5424-6573	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087867] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK087867] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Harari-Steinberg O, 2013, EMBO MOL MED, V5, P1556, DOI 10.1002/emmm.201201584; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M., 2014, NAT CELL BI IN PRESS; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872	7	2	4	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 2	2014	14	1					5	6		10.1016/j.stem.2013.12.004	http://dx.doi.org/10.1016/j.stem.2013.12.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287WB	24388170	Green Accepted, Bronze			2022-12-28	WOS:000329571900003
J	May, G; Soneji, S; Tipping, AJ; Teles, J; McGowan, SJ; Wu, MC; Guo, YP; Fugazza, C; Brown, J; Karlsson, G; Pina, C; Olariu, V; Taylor, S; Tenen, DG; Peterson, C; Enver, T				May, Gillian; Soneji, Shamit; Tipping, Alex J.; Teles, Jose; McGowan, Simon J.; Wu, Mengchu; Guo, Yanping; Fugazza, Cristina; Brown, John; Karlsson, Goran; Pina, Cristina; Olariu, Victor; Taylor, Stephen; Tenen, Daniel G.; Peterson, Carsten; Enver, Tariq			Dynamic Analysis of Gene Expression and Genome-wide Transcription Factor Binding during Lineage Specification of Multipotent Progenitors	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; CHROMATIN OCCUPANCY ANALYSIS; CHIP-SEQ DATA; FACTOR GATA-1; DNA-BINDING; MEGAKARYOCYTE DEVELOPMENT; REGULATORY NETWORKS; HUMAN HEMATOPOIESIS; SELF-RENEWAL; DIFFERENTIATION	We used the paradigmatic GATA-PU.1 axis to explore, at the systems level, dynamic relationships between transcription factor (TF) binding and global gene expression programs as multipotent cells differentiate. We combined global ChIP-seq of GATA1, GATA2, and PU.1 with expression profiling during differentiation to erythroid and neutrophil lineages. Our analysis reveals (1) differential complexity of sequence motifs bound by GATA1, GATA2, and PU.1; (2) the scope and interplay of GATA1 and GATA2 programs within, and during transitions between, different cell compartments, and the extent of their hard-wiring by DNA motifs; (3) the potential to predict gene expression trajectories based on global associations between TF-binding data and target gene expression; and (4) how dynamic modeling of DNA-binding and gene expression data can be used to infer regulatory logic of TF circuitry. This rubric exemplifies the utility of this cross-platform resource for deconvoluting the complexity of transcriptional programs controlling stem/progenitor cell fate in hematopoiesis.	[May, Gillian; Soneji, Shamit; Tipping, Alex J.; Teles, Jose; Guo, Yanping; Fugazza, Cristina; Brown, John; Karlsson, Goran; Pina, Cristina; Enver, Tariq] UCL, UCL Canc Inst, Stem Cell Grp, London WC1E 6BT, England; [May, Gillian; Soneji, Shamit; Tipping, Alex J.; Guo, Yanping; Fugazza, Cristina; Brown, John; Pina, Cristina; Enver, Tariq] Univ Oxford, Weatherall Inst Mol Med, Mol Haematol Unit, Oxford OX3 9DS, England; [Teles, Jose; Olariu, Victor; Peterson, Carsten] Lund Univ, Dept Theoret Phys, S-22362 Lund, Sweden; [McGowan, Simon J.; Taylor, Stephen] Univ Oxford, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford OX3 9DS, England; [Wu, Mengchu; Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore; [Tenen, Daniel G.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA	University of London; University College London; University of Oxford; Lund University; University of Oxford; National University of Singapore; Harvard University; Harvard Medical School	Enver, T (corresponding author), UCL, UCL Canc Inst, Stem Cell Grp, Mortimer St, London WC1E 6BT, England.	t.enver@cancer.ucl.ac.uk		Fugazza, Cristina/0000-0003-4242-0540; McGowan, Simon/0000-0001-9720-1914; Pina, Cristina/0000-0002-2575-6301; Tenen, Daniel/0000-0002-6423-3888; Karlsson, Goran/0000-0001-8197-754X	FCT [SFRH/BD/33208/2007]; Swedish Research Council; Swedish Foundation for Strategic Research; National Medical Research Council [NMRC/STaR/0001/2008]; NIH [HL112719]; Medical Research Council UK; EuroSyStem; European Cancer Stem Cell Training, Leukaemia and Lymphoma Research; UCL Comprehensive Biomedical Research Centre; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112719] Funding Source: NIH RePORTER; Cancer Research UK [12796] Funding Source: researchfish; Medical Research Council [MC_U137973817] Funding Source: researchfish; MRC [MC_U137973817] Funding Source: UKRI	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EuroSyStem(European Commission); European Cancer Stem Cell Training, Leukaemia and Lymphoma Research; UCL Comprehensive Biomedical Research Centre; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Nicole Sparkes and Oxford Gene Technology for microarrays; Pawan Dhami, Dave Vetrie, and Sjaak Philipsen for initial help with ChIP; Jim Hughes, Zong-Pei Han, and Luqman Hakim B. Abdul Hadi for bioinformatic input and discussions; Alan Friedman for PU.1ERT DNA; Adrian Thrasher and Waseem Qasim for lentiviral components; and Richie Soong, the Cancer Science Institute Translational Interface, UCL Genomics, and Richard Jenner for ChIP-seq input and support. J.T. is part of the Ph.D. program in computational biology at Instituto Gulbenkian de Ciencia, FCT grant SFRH/BD/33208/2007. V.O. is funded by the Swedish Research Council. C. Peterson is supported by the Swedish Foundation for Strategic Research. D. G. T. is the recipient of a Singapore Translational Research Investigator (STaR) Award (NMRC/STaR/0001/2008) from the National Medical Research Council and NIH grant HL112719. This work was funded by the Medical Research Council UK (Transcriptional Programming in Normal and Leukaemic Stem Cells), EuroSyStem, European Cancer Stem Cell Training, Leukaemia and Lymphoma Research, and UCL Comprehensive Biomedical Research Centre.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Chou ST, 2009, BLOOD, V114, P983, DOI 10.1182/blood-2009-03-207944; Donaldson IJ, 2005, HUM MOL GENET, V14, P595, DOI 10.1093/hmg/ddi056; Dore LC, 2012, BLOOD, V119, P3724, DOI 10.1182/blood-2011-09-380634; Dore LC, 2011, BLOOD, V118, P231, DOI 10.1182/blood-2011-04-285981; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Feng X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-139; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gupta P, 2009, J CELL MOL MED, V13, P4349, DOI 10.1111/j.1582-4934.2009.00757.x; Hannah R, 2011, EXP HEMATOL, V39, P531, DOI 10.1016/j.exphem.2011.02.009; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heyworth C, 1999, GENE DEV, V13, P1847, DOI 10.1101/gad.13.14.1847; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang Z, 2009, MOL CELL BIOL, V29, P5168, DOI 10.1128/MCB.00482-09; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kaneko H, 2010, CURR OPIN HEMATOL, V17, P163, DOI 10.1097/MOH.0b013e32833800b8; Kassouf MT, 2008, BLOOD, V112, P1056, DOI 10.1182/blood-2007-12-128900; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kee BL, 2011, CELL STEM CELL, V8, P122, DOI 10.1016/j.stem.2011.01.006; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kitajima K, 2006, BLOOD, V107, P1857, DOI 10.1182/blood-2005-06-2527; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li LQ, 2011, NAT IMMUNOL, V12, P129, DOI 10.1038/ni.1978; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Narula J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000771; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; PEVNY L, 1995, DEVELOPMENT, V121, P163; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Porcher C, 1999, DEVELOPMENT, V126, P4603; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Rothenberg EV, 2002, DEV BIOL, V246, P29, DOI 10.1006/dbio.2002.0667; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; SPOONCER E, 1986, DIFFERENTIATION, V31, P111, DOI 10.1111/j.1432-0436.1986.tb00391.x; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Suzuki M, 2011, INT J HEMATOL, V93, P150, DOI 10.1007/s12185-011-0770-6; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Trainor CD, 2000, J BIOL CHEM, V275, P28157; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vyas P, 1999, DEVELOPMENT, V126, P2799; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wontakal SN, 2012, P NATL ACAD SCI USA, V109, P3832, DOI 10.1073/pnas.1121019109; Wontakal SN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001392; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	62	55	55	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					754	768		10.1016/j.stem.2013.09.003	http://dx.doi.org/10.1016/j.stem.2013.09.003			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24120743	hybrid, Green Published			2022-12-28	WOS:000329571700017
J	Miller, JD; Ganat, YM; Kishinevsky, S; Bowman, RL; Liu, B; Tu, EY; Mandal, PK; Vera, E; Shim, JW; Kriks, S; Taldone, T; Fusaki, N; Tomishima, MJ; Krainc, D; Milner, TA; Rossi, DJ; Studer, L				Miller, Justine D.; Ganat, Yosif M.; Kishinevsky, Sarah; Bowman, Robert L.; Liu, Becky; Tu, Edmund Y.; Mandal, Pankaj K.; Vera, Elsa; Shim, Jae-won; Kriks, Sonja; Taldone, Tony; Fusaki, Noemi; Tomishima, Mark J.; Krainc, Dimitri; Milner, Teresa A.; Rossi, Derrick J.; Studer, Lorenz			Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; LAMIN-A/C EXPRESSION; NEURONAL LOSS; NEURAL CELLS; RAT-BRAIN; MOUSE; DEGENERATION; PARKIN; PINK1; RNA	Reprogramming somatic cells to induced pluripotent stem cells (iPSCs) resets their identity back to an embryonic age and, thus, presents a significant hurdle for modeling late-onset disorders. In this study, we describe a strategy for inducing aging-related features in human iPSC-derived lineages and apply it to the modeling of Parkinson's disease (PD). Our approach involves expression of progerin, a truncated form of lamin A associated with premature aging. We found that expression of progerin in iPSC-derived fibroblasts and neurons induces multiple aging-related markers and characteristics, including dopamine-specific phenotypes such as neuromelanin accumulation. Induced aging in PD iPSC-derived dopamine neurons revealed disease phenotypes that require both aging and genetic susceptibility, such as pronounced dendrite degeneration, progressive loss of tyrosine hydroxylase (TH) expression, and enlarged mitochondria or Lewy-body-precursor inclusions. Thus, our study suggests that progerin-induced aging can be used to reveal late-onset age-related disease features in hiPSC-based disease models.	[Miller, Justine D.; Ganat, Yosif M.; Kishinevsky, Sarah; Liu, Becky; Tu, Edmund Y.; Vera, Elsa; Shim, Jae-won; Kriks, Sonja; Tomishima, Mark J.; Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA; [Miller, Justine D.; Ganat, Yosif M.; Kishinevsky, Sarah; Liu, Becky; Tu, Edmund Y.; Vera, Elsa; Shim, Jae-won; Kriks, Sonja; Tomishima, Mark J.; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY 10065 USA; [Miller, Justine D.; Bowman, Robert L.] Sloan Kettering Inst Canc Res, Gerstner Sloan Kettering Grad Sch, New York, NY 10065 USA; [Bowman, Robert L.] Sloan Kettering Inst Canc Res, Canc Biol & Genet Program, New York, NY 10065 USA; [Taldone, Tony] Sloan Kettering Inst Canc Res, New York, NY 10065 USA; [Mandal, Pankaj K.; Rossi, Derrick J.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Mandal, Pankaj K.; Rossi, Derrick J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Fusaki, Noemi] DNAVEC Corp, Tsukuba, Ibaraki 3002611, Japan; [Fusaki, Noemi] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo 1608582, Japan; [Krainc, Dimitri] Harvard Univ, Massachusetts Gen Inst Neurodegenerat Dis, Sch Med, Dept Neurol,Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Milner, Teresa A.] Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY 10065 USA; [Milner, Teresa A.] Rockefeller Univ, Harold & Margaret Milliken Hatch Lab Neuroendocri, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; DNAVEC Corporation; Keio University; Harvard University; Massachusetts General Hospital; Cornell University; Rockefeller University	Studer, L (corresponding author), Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, 1275 York Ave, New York, NY 10065 USA.	studerl@mskcc.org	Fusaki, Noemi/U-1628-2019; Bowman, Robert/ABF-1007-2021; Studer, Lorenz/ABH-1491-2021; mandal, pankaj/B-4885-2016	Studer, Lorenz/0000-0003-0741-7987; Mandal, Pankaj/0000-0003-1993-9918; Bowman, Robert/0000-0002-8294-8748	Phil and Marcia Rothblum foundation by NINDS [NS078338]; Tri-Institutional Stem Cell Initiative (Starr Foundation); NIH [DA08259, HL098351, NS076054]; NSF; NATIONAL CANCER INSTITUTE [P30CA008748, F31CA167863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076054, R01NS052671, U24NS078338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008259] Funding Source: NIH RePORTER	Phil and Marcia Rothblum foundation by NINDS; Tri-Institutional Stem Cell Initiative (Starr Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the K. Eggan lab for retroviral-derived control iPSCs, Philip Manos for modified-RNA technical advice, C. Klein for PD fibroblasts, Yvonne Mica and Elizabeth Calder for general technical advice and data interpretation, Andreina Gonzalez, Tracey Van Kempen, and Vladimir Mudragel for help in preparing electron microscopy samples, the MSKCC genomics core laboratory for RNA-seq, MSKCC Molecular Cytology Core facility for histology slices, and MSKCC Cytogenetics core facility for karyotyping. D.J.R. is a New York Stem Cell Foundation Robertson Investigator. The work was supported in part by Phil and Marcia Rothblum foundation by NINDS contract NS078338 and by a grant from the Tri-Institutional Stem Cell Initiative (Starr Foundation) to L. S., and NIH grants DA08259 and HL098351 to T. A. M. and NS076054 to D. K. J.D.M was supported by an NSF fellowship.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104; Cheng HC, 2011, J NEUROSCI, V31, P2125, DOI 10.1523/JNEUROSCI.5519-10.2011; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; Cooper O, 2012, SCI TRANSL MED, V4, p41ra90; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010; Fornai F, 2004, J NEUROCHEM, V88, P114, DOI 10.1046/j.1471-4159.2003.02137.x; Freije JMP, 2012, CURR OPIN CELL BIOL, V24, P757, DOI 10.1016/j.ceb.2012.08.009; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Isacson O, 1997, TRENDS NEUROSCI, V20, P477, DOI 10.1016/S0166-2236(97)01081-3; Jaworski T, 2011, AM J PATHOL, V179, P2001, DOI 10.1016/j.ajpath.2011.06.025; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Koch CM, 2011, AGING-US, V3, P1018, DOI 10.18632/aging.100395; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lapasset L, 2011, GENE DEV, V25, P2248, DOI 10.1101/gad.173922.111; Liu GH, 2012, CURR OPIN CELL BIOL, V24, P765, DOI 10.1016/j.ceb.2012.08.014; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Mahmoudi S, 2012, CURR OPIN CELL BIOL, V24, P744, DOI 10.1016/j.ceb.2012.10.004; Malagelada C, 2008, J NEUROSCI, V28, P14363, DOI 10.1523/JNEUROSCI.3928-08.2008; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; MANN DMA, 1974, BRAIN, V97, P489, DOI 10.1093/brain/97.1.489; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Milner TA, 2011, METHODS MOL BIOL, V793, P23, DOI 10.1007/978-1-61779-328-8_3; Nissan X, 2012, CELL REP, V2, P1, DOI 10.1016/j.celrep.2012.05.015; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Phillips SE, 2008, J NEUROSCI, V28, P6569, DOI 10.1523/JNEUROSCI.5529-07.2008; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; ROBER RA, 1989, DEVELOPMENT, V105, P365; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Sulzer D, 2008, J NEUROCHEM, V106, P24, DOI 10.1111/j.1471-4159.2008.05385.x; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Timmons S, 2009, NEUROSCI LETT, V467, P30, DOI 10.1016/j.neulet.2009.09.055; VERLINDEN J, 1981, FEBS LETT, V123, P287, DOI 10.1016/0014-5793(81)80310-9; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wood SH, 2013, AGE, V35, P763, DOI 10.1007/s11357-012-9410-1; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002	56	451	461	6	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 5	2013	13	6					691	705		10.1016/j.stem.2013.11.006	http://dx.doi.org/10.1016/j.stem.2013.11.006			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VZ	24315443	Bronze, Green Accepted			2022-12-28	WOS:000329571700012
J	Joseph, C; Quach, JM; Walkley, CR; Lane, SW; Lo Celso, C; Purton, LE				Joseph, Chacko; Quach, Julie M.; Walkley, Carl R.; Lane, Steven W.; Lo Celso, Cristina; Purton, Louise E.			Deciphering Hematopoietic Stem Cells in Their Niches: A Critical Appraisal of Genetic Models, Lineage Tracing, and Imaging Strategies	CELL STEM CELL			English	Review							LASER-SCANNING CYTOMETRY; SITE-SPECIFIC RECOMBINATION; DIPHTHERIA-TOXIN RECEPTOR; BONE-MARROW NICHE; IN-VIVO; TRANSGENIC MICE; CRE-RECOMBINASE; PROGENITOR CELLS; STEM/PROGENITOR CELLS; OSTEOBLAST LINEAGE	In recent years, technical developments in mouse genetics and imaging equipment have substantially advanced our understanding of hematopoietic stem cells (HSCs) and their niche. The availability of numerous Cre strains for targeting HSCs and microenvironmental cells provides extensive flexibility in experimental design, but it can also pose significant challenges due to strain-specific differences in cell specificity. Here we outline various genetic approaches for isolating, detecting, and ablating HSCs and niche components and provide a guide for advantages and caveats to consider. We also discuss opportunities and limitations presented by imaging technologies that allow investigation of HSC behavior in situ.	[Joseph, Chacko; Quach, Julie M.; Walkley, Carl R.; Purton, Louise E.] St Vincents Inst Med Res, Stem Cell Regulat Unit, Fitzroy, Vic 3065, Australia; [Joseph, Chacko; Walkley, Carl R.; Purton, Louise E.] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia; [Lane, Steven W.] Univ Queensland, QIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia; [Lo Celso, Cristina] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; QIMR Berghofer Medical Research Institute; University of Queensland; Imperial College London	Purton, LE (corresponding author), St Vincents Inst Med Res, Stem Cell Regulat Unit, 9 Princes St, Fitzroy, Vic 3065, Australia.	lpurton@svi.edu.au	Walkley, Carl/AAO-6021-2020; Purton, Louise/AAI-8956-2021; Lane, Steven/C-3215-2012	Walkley, Carl/0000-0002-4784-9031; Purton, Louise/0000-0001-6593-3168; Lane, Steven/0000-0002-8050-6209; Lo Celso, Cristina/0000-0002-1163-4207	National Health and Medical Research Council of Australia (NHMRC); Australian Cancer Research Foundation; NHMRC; Association for International Cancer Research; Cancer Research U.K.; Victorian State Government; Biotechnology and Biological Sciences Research Council [BB/K021168/1, BB/I004033/1] Funding Source: researchfish; Cancer Research UK [11831] Funding Source: researchfish; Worldwide Cancer Research [10-0715] Funding Source: researchfish; BBSRC [BB/I004033/1, BB/K021168/1] Funding Source: UKRI	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Association for International Cancer Research; Cancer Research U.K.(Cancer Research UK); Victorian State Government; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Dr. C. Maes for reading and commenting on the manuscript. This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC; to C.R.W., S.W.L., and L.E.P.); the Australian Cancer Research Foundation (to C.R.W. and L.E.P.); a NHMRC Senior Research Fellowship (L.E.P.); the Association for International Cancer Research (to L.E.P.); the Career Establishment Award from Cancer Research U.K. (to C.L.C.), and in part by the Victorian State Government Operational Infrastructure Support Program (to St. Vincent's Institute of Medical Research). C.R.W. is the Philip Desbrow Senior Research Fellow of the Leukaemia Foundation and S.W.L is a fellow of the Leukaemia Foundation.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Asada N, 2013, CELL STEM CELL, V12, P737, DOI 10.1016/j.stem.2013.05.001; Askmyr M, 2009, TRENDS ENDOCRIN MET, V20, P303, DOI 10.1016/j.tem.2009.03.004; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Blanpain C, 2013, NAT CELL BIOL, V15, P126, DOI 10.1038/ncb2657; Bradford GB, 1997, EXP HEMATOL, V25, P445; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Bromberg O, 2012, BLOOD, V120, P303, DOI 10.1182/blood-2011-09-377853; Cha JH, 2003, MOL MICROBIOL, V49, P235, DOI 10.1046/j.1365-2958.2003.03550.x; Chen J, 2009, GENESIS, V47, P122, DOI 10.1002/dvg.20465; Clatch RJ, 1996, AM J CLIN PATHOL, V105, P744; Clatch RJ, 1998, CYTOMETRY, V34, P36, DOI 10.1002/(SICI)1097-0320(19980215)34:1<36::AID-CYTO6>3.0.CO;2-C; Clatch RJ, 1998, CYTOMETRY, V34, P3, DOI 10.1002/(SICI)1097-0320(19980215)34:1<3::AID-CYTO2>3.0.CO;2-L; Cochrane RL, 2007, GENESIS, V45, P17, DOI 10.1002/dvg.20259; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; de Lange WJ, 2008, PHYSIOL GENOMICS, V35, P1, DOI 10.1152/physiolgenomics.90284.2008; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; DEXTER TM, 1973, J CELL PHYSIOL, V82, P461, DOI 10.1002/jcp.1040820315; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Dworkin S, 2009, STEM CELLS, V27, P1347, DOI 10.1002/stem.56; Elefteriou F, 2011, BONE, V49, P1242, DOI 10.1016/j.bone.2011.08.021; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Fuchs E, 2011, NAT CELL BIOL, V13, P513, DOI 10.1038/ncb0511-513; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Gerstner AOH, 2004, CYTOM PART A, V59A, P210, DOI 10.1002/cyto.a.20054; Gonzalez-Nieto D, 2012, BLOOD, V119, P5144, DOI 10.1182/blood-2011-07-368506; Gothert JR, 2004, BLOOD, V104, P1769, DOI 10.1182/blood-2003-11-3952; Gothert JR, 2005, BLOOD, V105, P2724, DOI 10.1182/blood-2004-08-3037; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Gottgens B, 2004, MOL CELL BIOL, V24, P1870, DOI 10.1128/MCB.24.5.1870-1883.2004; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Harnett MM, 2007, NAT REV IMMUNOL, V7, P897, DOI 10.1038/nri2188; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Henriksen M, 2011, METHOD CELL BIOL, V102, P161, DOI 10.1016/B978-0-12-374912-3.00007-9; HEYMAN RA, 1989, P NATL ACAD SCI USA, V86, P2698, DOI 10.1073/pnas.86.8.2698; Hirschi KK, 2012, BLOOD, V119, P4823, DOI 10.1182/blood-2011-12-353466; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Krause DS, 2013, CYTOM PART B-CLIN CY, V84B, P7, DOI 10.1002/cyto.b.21066; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kunisaki Y., 2013, NATURE IN PRESS; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Lewandowski D, 2010, BLOOD, V115, P443, DOI 10.1182/blood-2009-05-222711; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lo Celso C, 2011, NAT PROTOC, V6, P1, DOI 10.1038/nprot.2010.168; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maes C, 2007, ANN NY ACAD SCI, V1116, P149, DOI 10.1196/annals.1402.060; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; Martins RAP, 2008, GENE DEV, V22, P179, DOI 10.1101/gad.1608008; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Migliaccio AR, 1999, EXP HEMATOL, V27, P1655, DOI 10.1016/S0301-472X(99)00110-1; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakamura-Ishizu A, 2013, BBA-GEN SUBJECTS, V1830, P2404, DOI 10.1016/j.bbagen.2012.08.023; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Ogilvy S, 1999, BLOOD, V94, P1855; Ohishi M, 2012, AM J PATHOL, V180, P811, DOI 10.1016/j.ajpath.2011.10.028; Oswald J, 2004, CYTOM PART A, V57A, P100, DOI 10.1002/cyto.a.10118; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Plum L, 2007, CELL METAB, V6, P431, DOI 10.1016/j.cmet.2007.10.012; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; Progatzky F, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0001; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Scheller EL, 2010, STEM CELLS, V28, P1071, DOI 10.1002/stem.432; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; SCHNURCH H, 1993, DEVELOPMENT, V119, P957; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SORIANO P, 1991, J VIROL, V65, P2314, DOI 10.1128/JVI.65.5.2314-2319.1991; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Takaku T, 2010, BLOOD, V116, pE41, DOI 10.1182/blood-2010-02-268466; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Tang YF, 2010, GENESIS, V48, P563, DOI 10.1002/dvg.20654; Tarnok A, 2002, CYTOMETRY, V50, P133, DOI 10.1002/cyto.10099; Theis M, 2001, GENESIS, V29, P1, DOI 10.1002/1526-968X(200101)29:1<1::AID-GENE1000>3.0.CO;2-0; TRENTIN JJ, 1971, AM J PATHOL, V65, P621; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Trumpp A, 1999, GENE DEV, V13, P3136, DOI 10.1101/gad.13.23.3136; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Turan S, 2011, J MOL BIOL, V407, P193, DOI 10.1016/j.jmb.2011.01.004; Visnjic D, 2001, J BONE MINER RES, V16, P2222, DOI 10.1359/jbmr.2001.16.12.2222; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang L, 2013, EMBO J, V32, P219, DOI 10.1038/emboj.2012.308; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wojcik EM, 2001, DIAGN CYTOPATHOL, V24, P200, DOI 10.1002/1097-0339(200103)24:3<200::AID-DC1041>3.0.CO;2-1; WOLF NS, 1968, J EXP MED, V127, P205, DOI 10.1084/jem.127.1.205; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zabaglo L, 2003, CYTOM PART B-CLIN CY, V56B, P55, DOI 10.1002/cyto.b.10055; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao H, 2010, CYTOM PART A, V77A, P999, DOI 10.1002/cyto.a.20983; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	145	113	115	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					520	533		10.1016/j.stem.2013.10.010	http://dx.doi.org/10.1016/j.stem.2013.10.010			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24209759	Bronze			2022-12-28	WOS:000329571500006
J	Yoshioka, N; Gros, E; Li, HR; Kumar, S; Deacon, DC; Maron, C; Muotri, AR; Chi, NC; Fu, XD; Yu, BD; Dowdy, SF				Yoshioka, Naohisa; Gros, Edwige; Li, Hai-Ri; Kumar, Shantanu; Deacon, Dekker C.; Maron, Cornelia; Muotri, Alysson R.; Chi, Neil C.; Fu, Xiang-Dong; Yu, Benjamin D.; Dowdy, Steven F.			Efficient Generation of Human iPSCs by a Synthetic Self-Replicative RNA	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; EQUINE ENCEPHALITIS-VIRUS; SENDAI-VIRUS; INDUCTION	The generation of human induced pluripotent stem cells (iPSCs) holds great promise for the development of regenerative medicine therapies to treat a wide range of human diseases. However, the generation of iPSCs in the absence of integrative DNA vectors remains problematic. Here, we report a simple, highly reproducible RNA-based iPSC generation approach that utilizes a single, synthetic self-replicating VEE-RF RNA replicon that expresses four reprogramming factors (OCT4, KLF4, and SOX2, with c-MYC or GLIS1) at consistent high levels prior to regulated RNA degradation. A single VEE-RF RNA transfection into newborn or adult human fibroblasts resulted in efficient generation of iPSCs with all the hallmarks of stem cells, including cell surface markers, global gene expression profiles, and in vivo pluripotency, to differentiate into all three germ layers. The VEE-RF RNA-based approach has broad applicability for the generation of iPSCs for ultimate use in human stem cell therapies in regenerative medicine.	[Yoshioka, Naohisa; Gros, Edwige; Li, Hai-Ri; Maron, Cornelia; Muotri, Alysson R.; Fu, Xiang-Dong; Dowdy, Steven F.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kumar, Shantanu; Yu, Benjamin D.] Univ Calif San Diego, Sch Med, Dept Med, Div Dermatol, La Jolla, CA 92093 USA; [Deacon, Dekker C.; Chi, Neil C.] Univ Calif San Diego, Sch Med, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Muotri, Alysson R.; Yu, Benjamin D.] Univ Calif San Diego, Sch Med, Stem Cell Program, La Jolla, CA 92093 USA; [Chi, Neil C.; Fu, Xiang-Dong; Yu, Benjamin D.] Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dowdy, SF (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sdowdy@ucsd.edu		Yu, Benjamin/0000-0001-6663-6616	California Institute for Regenerative Medicine; National Institutes of Health [U01HL107442]; Department of Defense; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Frolov (UAB) for VEE vector and T. Kogiso for valuable input. This work was supported by grants from the California Institute for Regenerative Medicine (to A. R. M., B.D.Y., D. C. D., and S. F. D.), National Institutes of Health (# U01HL107442 to N.C.C.), Department of Defense (to X.-D.F.), and the Howard Hughes Medical Institute (to S. F. D.).	Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Angel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011756; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Davis NL, 2002, IUBMB LIFE, V53, P209, DOI 10.1080/15216540212657; Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10; Fox-Walsh K, 2011, GENOMICS, V98, P266, DOI 10.1016/j.ygeno.2011.04.003; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Geuking MB, 2009, SCIENCE, V323, P393, DOI 10.1126/science.1167375; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Hussein SMI, 2011, CLIN PHARMACOL THER, V89, P741, DOI 10.1038/clpt.2011.37; KINNEY RM, 1989, VIROLOGY, V170, P19, DOI 10.1016/0042-6822(89)90347-4; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Mochiduki Y, 2012, BIOTECHNOL J, V7, P789, DOI 10.1002/biot.201100356; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Petrakova O, 2005, J VIROL, V79, P7597, DOI 10.1128/JVI.79.12.7597-7608.2005; Schelle B., 2007, T7 RIBOMAX EXPRESS G; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	194	218	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					246	254		10.1016/j.stem.2013.06.001	http://dx.doi.org/10.1016/j.stem.2013.06.001			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910086	Bronze, Green Accepted			2022-12-28	WOS:000329570600017
J	Chung, YG; Matoba, S; Liu, YT; Eum, JH; Lu, FL; Jiang, W; Lee, JE; Sepilian, V; Cha, KY; Lee, DR; Zhang, Y				Chung, Young Gie; Matoba, Shogo; Liu, Yuting; Eum, Jin Hee; Lu, Falong; Jiang, Wei; Lee, Jeoung Eun; Sepilian, Vicken; Cha, Kwang Yul; Lee, Dong Ryul; Zhang, Yi			Histone Demethylase Expression Enhances Human Somatic Cell Nuclear Transfer Efficiency and Promotes Derivation of Pluripotent Stem Cells	CELL STEM CELL			English	Article							IMPLANTATION; PREGNANCY; EMBRYOS; RATES	The extremely low efficiency of human embryonic stem cell (hESC) derivation using somatic cell nuclear transfer (SCNT) limits its potential application. Blastocyst formation from human SCNT embryos occurs at a low rate and with only some oocyte donors. We previously showed in mice that reduction of histone H3 lysine 9 trimethylation (H3K9me3) through ectopic expression of the H3K9me3 demethylase Kdm4d greatly improves SCNT embryo development. Here we show that overexpression of a related H3K9me3 demethylase KDM4A improves human SCNT, and that, as in mice, H3K9me3 in the human somatic cell genome is an SCNT reprogramming barrier. Overexpression of KDM4A significantly improves the blastocyst formation rate in human SCNT embryos by facilitating transcriptional reprogramming, allowing efficient derivation of SCNT-derived ESCs using adult Age-related Macular Degeneration (AMD) patient somatic nuclei donors. This conserved mechanistic insight has potential applications for improving SCNT in a variety of contexts, including regenerative medicine.	[Chung, Young Gie; Sepilian, Vicken; Lee, Dong Ryul] CHA Hlth Syst, Res Inst Stem Cell Res, Los Angeles, CA 90036 USA; [Chung, Young Gie; Eum, Jin Hee; Lee, Jeoung Eun; Cha, Kwang Yul; Lee, Dong Ryul] CHA Univ, CHA Stem Cell Inst, Seoul 135081, South Korea; [Matoba, Shogo; Liu, Yuting; Lu, Falong; Jiang, Wei; Zhang, Yi] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Matoba, Shogo; Liu, Yuting; Lu, Falong; Jiang, Wei; Zhang, Yi] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Matoba, Shogo; Liu, Yuting; Lu, Falong; Jiang, Wei; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA	Pochon Cha University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lee, DR (corresponding author), CHA Hlth Syst, Res Inst Stem Cell Res, Los Angeles, CA 90036 USA.	drleedr@cha.ac.kr; yzhang@genetics.med.harvard.edu	Chung, Young Gie/AAC-8149-2020; Lu, Falong/Q-3013-2016; Jiang, Wei/J-7993-2012; MATOBA, Shogo/D-9995-2016	Jiang, Wei/0000-0002-6463-7356; MATOBA, Shogo/0000-0003-0474-232X; Lu, Falong/0000-0002-8321-4818	HHMI; Bio & Medical Technology Development Program of NRF and MSIP of Republic of Korea [2012M3A9C6049723, 2015M3A9C6028961]; Cha Medical Foundation in Republic of Korea; Japan Society for the Promotion of Science (JSPS); Juvenile Diabetes Research Foundation [3-2012-293]	HHMI(Howard Hughes Medical Institute); Bio & Medical Technology Development Program of NRF and MSIP of Republic of Korea; Cha Medical Foundation in Republic of Korea; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	We thank Dr. Luis Tuesta for critical reading of the manuscript; Drs. Sungwook Hong and Yumie Lee for oocyte preparations and donor recruitments, respectively; and Dr. Young Ho Choi for technical help in SCNT. This project is supported by HHMI (to Y.Z.) and the Bio & Medical Technology Development Program (2012M3A9C6049723 and 2015M3A9C6028961) of NRF and MSIP of Republic of Korea (to D.R.L). This project is also partially supported by Cha Medical Foundation in Republic of Korea (to D.R.L). S.M. is supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science (JSPS). W.J. is supported by a Juvenile Diabetes Research Foundation postdoctoral fellowship (3-2012-293). Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Chung YG, 2014, CELL STEM CELL, V14, P777, DOI 10.1016/j.stem.2014.03.015; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; French AJ, 2008, STEM CELLS, V26, P485, DOI 10.1634/stemcells.2007-0252; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Krishnan S, 2013, STRUCTURE, V21, P98, DOI 10.1016/j.str.2012.10.018; Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Rodriguez-Osorio N, 2012, THERIOGENOLOGY, V78, P1869, DOI 10.1016/j.theriogenology.2012.05.030; Shapiro BS, 2002, FERTIL STERIL, V77, P1296, DOI 10.1016/S0015-0282(02)03086-8; Simerly C, 2003, SCIENCE, V300, P297, DOI 10.1126/science.1082091; Stone BA, 2014, FERTIL STERIL, V102, P1055, DOI 10.1016/j.fertnstert.2014.06.049; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wang L, 2013, CELL STEM CELL, V13, P676, DOI 10.1016/j.stem.2013.10.008; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yamada M, 2014, NATURE, V510, P533, DOI 10.1038/nature13287; Yamada M, 2010, HUM MOL GENET, V19, P480, DOI 10.1093/hmg/ddp512; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	24	123	136	3	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2015	17	6					758	766		10.1016/j.stem.2015.10.001	http://dx.doi.org/10.1016/j.stem.2015.10.001			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY1AS	26526725	Bronze, Green Submitted			2022-12-28	WOS:000366139100016
J	Liu, YF; Xiao, A				Liu, Yifei; Xiao, Andrew			Adaption by Rewiring Epigenetic Landscapes	CELL STEM CELL			English	Editorial Material							STEM-CELLS; ELEMENTS	Embryonic stem cells (ESCs) generally rely on repressive histone modifications to silence retrotransposons, rather than DNA methylation as in differentiated cells. In this issue of Cell Stem Cell, He et al. (2015) show that Daxx/Atrx repress transposons in ESCs devoid of 5mC, demonstrating dynamic reorganization of epigenetic networks and crosstalk between distinct repressive mechanisms to maintain transposon silencing.	[Liu, Yifei; Xiao, Andrew] Yale Univ, Dept Genet, New Haven, CT 06519 USA; [Liu, Yifei; Xiao, Andrew] Yale Univ, Yale Stem Cell Ctr, New Haven, CT 06519 USA	Yale University; Yale University	Xiao, A (corresponding author), Yale Univ, Dept Genet, New Haven, CT 06519 USA.	andrew.xiao@yale.edu	Liu, Yifei/H-1730-2014		NIGMS NIH HHS [R01 GM114205, R01GM114205-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114205] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; He QY, 2015, CELL STEM CELL, V17, P273, DOI 10.1016/j.stem.2015.07.022; Hutnick LK, 2010, J BIOL CHEM, V285, P21082, DOI 10.1074/jbc.M110.125674; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Waddington C., 1957, STRATEGY GENES; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165	8	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2015	17	3					249	250		10.1016/j.stem.2015.08.015	http://dx.doi.org/10.1016/j.stem.2015.08.015			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV1JN	26340521	Green Accepted, Bronze			2022-12-28	WOS:000364011000001
J	Babos, K; Ichida, JK				Babos, Kimberley; Ichida, Justin K.			Small Molecules Take a Big Step by Converting Fibroblasts into Neurons	CELL STEM CELL			English	Editorial Material							DEFINED FACTORS; CONVERSION; MOUSE	Direct lineage conversion could provide a rich source of somatic cell types for translational medicine, but concerns over the use of transgenic reprogramming factors have limited its potential. In this issue of Cell Stem Cell, Li et al. (2015) and Hu et al. (2015) identify small-molecule cocktails that can convert fibroblasts into functional neurons without exogenous genetic factors.	[Babos, Kimberley; Ichida, Justin K.] Univ So Calif, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90033 USA; [Babos, Kimberley; Ichida, Justin K.] Univ So Calif, Eli & Edythe Broad CIRM Ctr Regenerat Med & Stem, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Ichida, JK (corresponding author), Univ So Calif, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90033 USA.	ichida@usc.edu						Cheng L, 2015, CELL RES, V25, P645, DOI 10.1038/cr.2015.55; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Xu J, 2015, CELL STEM CELL, V16, P119, DOI 10.1016/j.stem.2015.01.013	11	11	14	7	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2015	17	2					127	129		10.1016/j.stem.2015.07.018	http://dx.doi.org/10.1016/j.stem.2015.07.018			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS2DR	26253195	Bronze			2022-12-28	WOS:000361878500001
J	Themeli, M; Riviere, I; Sadelain, M				Themeli, Maria; Riviere, Isabelle; Sadelain, Michel			New Cell Sources for T Cell Engineering and Adoptive Immunotherapy	CELL STEM CELL			English	Review							CHIMERIC-ANTIGEN-RECEPTOR; PLURIPOTENT STEM-CELLS; ENHANCED ANTITUMOR-ACTIVITY; ZINC-FINGER NUCLEASES; HEMATOPOIETIC STEM; CANCER REGRESSION; RAPID EXPANSION; CLINICAL-TRIAL; HUMAN TUMOR; IN-VITRO	The promising clinical results obtained with engineered T cells, including chimeric antigen receptor (CAR) therapy, call for further advancements to facilitate and broaden their applicability. One potentially beneficial innovation is to exploit new T cell sources that reduce the need for autologous cell manufacturing and enable cell transfer across histocompatibility barriers. Here we review emerging T cell engineering approaches that utilize alternative T cell sources, which include virus-specific or T cell receptor-less allogeneic T cells, expanded lymphoid progenitors, and induced pluripotent stem cell (iPSC)-derived T lymphocytes. The latter offer the prospect for true off-the-shelf, genetically enhanced, histocompatible cell therapy products.	[Themeli, Maria; Riviere, Isabelle; Sadelain, Michel] Mem Sloan Kettering Canc, Immunol Programs, Ctr Cell Engn, New York, NY 10065 USA; [Themeli, Maria; Riviere, Isabelle; Sadelain, Michel] Mem Sloan Kettering Canc, Mol Pharmacol Programs, Ctr Cell Engn, New York, NY 10065 USA; [Themeli, Maria; Riviere, Isabelle; Sadelain, Michel] Mem Sloan Kettering Canc, Chem Programs, Ctr Cell Engn, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Sadelain, M (corresponding author), Mem Sloan Kettering Canc, Immunol Programs, Ctr Cell Engn, New York, NY 10065 USA.	m-sadelain@ski.mskcc.org		Themeli, Maria/0000-0003-0585-7786	NCI NIH HHS [P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afzali B, 2007, TISSUE ANTIGENS, V69, P545, DOI 10.1111/j.1399-0039.2007.00834.x; Awong G, 2007, SEMIN IMMUNOL, V19, P341, DOI 10.1016/j.smim.2007.10.005; Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; Berdien B, 2014, GENE THER, V21, P539, DOI 10.1038/gt.2014.26; Biasco L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010314; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Cohen CJ, 2005, J IMMUNOL, V175, P5799, DOI 10.4049/jimmunol.175.9.5799; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Cruz CRY, 2013, BLOOD, V122, P2965, DOI 10.1182/blood-2013-06-506741; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Davila ML, 2012, ONCOIMMUNOLOGY, V1, P1577, DOI 10.4161/onci.22524; DiGiusto D, 2007, CYTOTHERAPY, V9, P613, DOI 10.1080/14653240701650320; Doubrovina E, 2012, BLOOD, V119, P2644, DOI 10.1182/blood-2011-08-371971; Egawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001512; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; Flynn JK, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.16; Gallot G, 2014, J IMMUNOTHER, V37, P170, DOI 10.1097/CJI.0000000000000031; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gourraud PA, 2012, STEM CELLS, V30, P180, DOI 10.1002/stem.772; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Haque T, 2007, BLOOD, V110, P1123, DOI 10.1182/blood-2006-12-063008; Heathman TRJ, 2015, REGEN MED, V10, P49, DOI [10.2217/RME.14.73, 10.2217/rme.14.73]; HESLOP HE, 1994, NEW ENGL J MED, V331, P679; Heslop HE, 1996, NAT MED, V2, P551, DOI 10.1038/nm0596-551; Ho WY, 2003, CANCER CELL, V3, P431, DOI 10.1016/S1535-6108(03)00113-2; Hollyman D, 2009, J IMMUNOTHER, V32, P169, DOI 10.1097/CJI.0b013e318194a6e8; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Inoue H, 2014, EMBO J, V33, P409, DOI 10.1002/embj.201387098; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Klebanoff CA, 2012, J IMMUNOTHER, V35, P651, DOI 10.1097/CJI.0b013e31827806e6; Kochenderfer J.N., 2014, J CLIN ONCO IN PRESS; Kochenderfer JN, 2013, BLOOD, V122, P4129, DOI 10.1182/blood-2013-08-519413; Kochenderfer JN, 2013, NAT REV CLIN ONCOL, V10, P267, DOI 10.1038/nrclinonc.2013.46; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Kolb HJ, 2005, HEMATOLOGY, V10, P115, DOI 10.1080/10245330512331390122; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Laport GG, 2003, BLOOD, V102, P2004, DOI 10.1182/blood-2003-01-0095; Latouche JB, 2000, NAT BIOTECHNOL, V18, P405, DOI 10.1038/74455; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Leen AM, 2013, BLOOD, V121, P5113, DOI 10.1182/blood-2013-02-486324; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; PAPADOPOULOS EB, 1994, NEW ENGL J MED, V330, P1185, DOI 10.1056/NEJM199404283301703; Papanicolaou GA, 2003, BLOOD, V102, P2498, DOI 10.1182/blood-2003-02-0345; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Parkhurst MR, 2009, CLIN CANCER RES, V15, P169, DOI 10.1158/1078-0432.CCR-08-1638; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Pule MA, 2005, MOL THER, V12, P933, DOI 10.1016/j.ymthe.2005.04.016; Ramos CA, 2014, CANCER J, V20, P112, DOI 10.1097/PPO.0000000000000031; RIDDELL SR, 1995, ANNU REV IMMUNOL, V13, P545; Riddell SR, 2014, CANCER J, V20, P141, DOI 10.1097/PPO.0000000000000036; Riolobos L, 2013, MOL THER, V21, P1232, DOI 10.1038/mt.2013.59; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rothenberg EV, 2011, J IMMUNOL, V186, P6649, DOI 10.4049/jimmunol.1003703; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Shah DK, 2014, J IMMUNOL, V192, P4017, DOI 10.4049/jimmunol.1302259; Snauwaert S, 2014, LEUKEMIA, V28, P830, DOI 10.1038/leu.2013.285; Somerville RPT, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-69; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Stacey GN, 2013, CELL STEM CELL, V13, P385, DOI 10.1016/j.stem.2013.09.007; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; Themeli M, 2013, NAT BIOTECHNOL, V31, P928, DOI 10.1038/nbt.2678; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969; Timmermans F, 2009, J IMMUNOL, V182, P6879, DOI 10.4049/jimmunol.0803670; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Turner M, 2013, CELL STEM CELL, V13, P382, DOI 10.1016/j.stem.2013.08.003; Vacchelli E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24238; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Voss RH, 2008, J IMMUNOL, V180, P391, DOI 10.4049/jimmunol.180.1.391; Wakao H, 2013, CELL STEM CELL, V12, P546, DOI 10.1016/j.stem.2013.03.001; Wang X, 2015, CANCER GENE THER, V22, P85, DOI 10.1038/cgt.2014.81; Wang XL, 2012, J IMMUNOTHER, V35, P689, DOI 10.1097/CJI.0b013e318270dec7; Wu R, 2012, CANCER J, V18, P160, DOI 10.1097/PPO.0b013e31824d4465; Xu Y, 2014, BLOOD, V123, P3750, DOI 10.1182/blood-2014-01-552174; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zakrzewski JL, 2008, NAT BIOTECHNOL, V26, P453, DOI 10.1038/nbt1395; Zakrzewski JL, 2006, NAT MED, V12, P1039, DOI 10.1038/nm1463; Zhao YB, 2007, CANCER RES, V67, P2425, DOI 10.1158/0008-5472.CAN-06-3977; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210	112	105	123	2	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2015	16	4					357	366		10.1016/j.stem.2015.03.011	http://dx.doi.org/10.1016/j.stem.2015.03.011			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CF0JD	25842976	Bronze, Green Accepted			2022-12-28	WOS:000352228600008
J	Brown, S; Greco, V				Brown, Samara; Greco, Valentina			Stem Cells in the Wild: Understanding the World of Stem Cells through Intravital Imaging	CELL STEM CELL			English	Editorial Material							NICHE; BEHAVIOR	The limitations of canonical imaging techniques have hampered our abilities to study stem cells in their native environment. Here, we discuss some of the exciting ways stem cells are being visualized by intravital imaging, the intriguing discoveries that have resulted from these endeavors, and the future of this stimulating field.	[Brown, Samara; Greco, Valentina] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Greco, Valentina] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Greco, Valentina] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Greco, Valentina] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Greco, V (corresponding author), Yale Univ, Sch Med, Dept Genet, 315 Cedar St, New Haven, CT 06510 USA.	valentina.greco@yale.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR063663] Funding Source: Medline; NIGMS NIH HHS [T32 GM007223] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alt C., 2012, INTRAVITAL, V1, P132, DOI [10.4161/intv.23561, DOI 10.4161/INTV.23561]; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Deschene ER, 2014, SCIENCE, V343, P1353, DOI 10.1126/science.1248373; Hara K, 2014, CELL STEM CELL, V14, P658, DOI 10.1016/j.stem.2014.01.019; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Rashidi NM, 2014, BLOOD, V124, P79, DOI 10.1182/blood-2013-10-534859; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218	10	12	12	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2014	15	6					683	686		10.1016/j.stem.2014.11.006	http://dx.doi.org/10.1016/j.stem.2014.11.006			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX8QS	25479745	Green Accepted, Bronze			2022-12-28	WOS:000347174300007
J	Liu, Y; Yang, RL; Liu, XB; Zhou, Y; Qu, CY; Kikuiri, T; Wang, SL; Zandi, E; Du, JB; Ambudkar, IS; Shi, ST				Liu, Yi; Yang, Ruili; Liu, Xibao; Zhou, Yu; Qu, Cunye; Kikuiri, Takashi; Wang, Songlin; Zandi, Ebrahim; Du, Junbao; Ambudkar, Indu S.; Shi, Songtao			Hydrogen Sulfide Maintains Mesenchymal Stem Cell Function and Bone Homeostasis via Regulation of Ca2+ Channel Sulfhydration	CELL STEM CELL			English	Article							CYSTATHIONINE BETA-SYNTHASE; ESCHERICHIA-COLI; STROMAL CELLS; HIP FRACTURE; RAT-LIVER; HOMOCYSTEINE; CYSTEINE; VITAMIN-B-12; EXPRESSION; H2S	Gaseous signaling molecules such as hydrogen sulfide (H2S) are produced endogenously and mediate effects through diverse mechanisms. H2S is one such gasotransmitters that regulates multiple signaling pathways in mammalian cells, and abnormal H2S metabolism has been linked to defects in bone homeostasis. Here, we demonstrate that bone marrow mesenchymal stem cells (BMMSCs) produce H2S in order to regulate their self-renewal and osteogenic differentiation, and H2S deficiency results in defects in BMMSC differentiation. H2S deficiency causes aberrant intracellular Ca2+ influx because of reduced sulfhydration of cysteine residues on multiple Ca2+ TRP channels. This decreased Ca2+ flux downregulates PKC/Erk-mediated Wnt/beta-catenin signaling which controls osteogenic differentiation of BMMSCs. Consistently, H2S-deficient mice display an osteoporotic phenotype that can be rescued by small molecules that release H2S. These results demonstrate that H2S regulates BMMSCs and that restoring H2S levels via nontoxic donors may provide treatments for diseases such as osteoporosis that can arise from H2S deficiencies.	[Liu, Yi; Yang, Ruili; Qu, Cunye; Kikuiri, Takashi; Shi, Songtao] Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [Liu, Yi; Wang, Songlin] Capital Med Univ, Sch Stomatol, Dept Periodont, Beijing 100050, Peoples R China; [Liu, Xibao; Ambudkar, Indu S.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, Bethesda, MD 20892 USA; [Zhou, Yu; Zandi, Ebrahim] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Du, Junbao] Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China	University of Southern California; Capital Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Southern California; Peking University	Liu, Y (corresponding author), Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	liuyi@ccmu.edu.cn; songtaos@usc.edu	Zhou, Yu/M-7975-2014		National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services [R01DE017449, R01 DE019932]; National Natural Science Foundation of China [81222011]; Science and Technology Activities of Beijing Overseas Students Preferred Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017449, R01DE019932, ZIADE000438] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Activities of Beijing Overseas Students Preferred Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services (R01DE017449 and R01 DE019932 to S.S.), the National Natural Science Foundation of China (81222011 to Y.L), and Science and Technology Activities of Beijing Overseas Students Preferred Foundation (to Y.L.).	Abe K, 1996, J NEUROSCI, V16, P1066; Bao LM, 1998, ARCH BIOCHEM BIOPHYS, V350, P95, DOI 10.1006/abbi.1997.0486; BUKOVSKA G, 1994, PROTEIN EXPRES PURIF, V5, P442, DOI 10.1006/prep.1994.1063; CARMEL R, 1988, NEW ENGL J MED, V319, P70, DOI 10.1056/NEJM198807143190202; Chen SF, 1997, J MEMBRANE BIOL, V155, P11, DOI 10.1007/s002329900154; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Dhonukshe-Rutten RAM, 2005, J BONE MINER RES, V20, P921, DOI 10.1359/JBMR.050202; Distrutti Elenora, 2011, Inflammation & Allergy Drug Targets, V10, P123; Donovan LM, 2011, RESPIRATION, V82, P522, DOI 10.1159/000330722; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ERICKSON PF, 1990, BIOCHEM J, V269, P335, DOI 10.1042/bj2690335; Fiorucci S, 2005, HEPATOLOGY, V42, P539, DOI 10.1002/hep.20817; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Gaustadnes M, 2000, THROMB HAEMOSTASIS, V83, P554, DOI 10.1055/s-0037-1613862; Gil V, 2011, BRIT J PHARMACOL, V164, P485, DOI 10.1111/j.1476-5381.2011.01431.x; Gjesdal CG, 2007, J BONE MINER RES, V22, P747, DOI 10.1359/JBMR.070210; Herrmann M, 2005, CLIN CHEM, V51, P2348, DOI 10.1373/clinchem.2005.053363; Herrmann M, 2008, J CELL MOL MED, V12, P1205, DOI 10.1111/j.1582-4934.2008.00104.x; Herrmann M, 2007, CLIN CHIM ACTA, V384, P129, DOI 10.1016/j.cca.2007.06.016; Kelly PJ, 2003, NEUROLOGY, V60, P275, DOI 10.1212/01.WNL.0000042479.55406.B3; Kluijtmans LAJ, 1999, AM J HUM GENET, V65, P59, DOI 10.1086/302439; Koh JM, 2006, J BONE MINER RES, V21, P1003, DOI [10.1359/jbmr.060406, 10.1359/JBMR.060406]; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Li L, 2006, CURR OPIN PHARMACOL, V6, P125, DOI 10.1016/j.coph.2005.10.007; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Lof C, 2012, MOL ENDOCRINOL, V26, P2046, DOI 10.1210/me.2012-1171; Maclean KN, 2002, HUM MUTAT, V19, P641, DOI 10.1002/humu.10089; Mancardi D, 2009, BBA-BIOENERGETICS, V1787, P864, DOI 10.1016/j.bbabio.2009.03.005; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; Melton LJ, 2003, J BONE MINER RES, V18, P1139, DOI 10.1359/jbmr.2003.18.6.1139; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Ogawa H, 2012, NEUROSCIENCE, V218, P335, DOI 10.1016/j.neuroscience.2012.05.044; Olson KR, 2009, ACTA HISTOCHEM, V111, P244, DOI 10.1016/j.acthis.2008.11.004; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sakamoto W, 2005, BBA-MOL BASIS DIS, V1740, P12, DOI 10.1016/j.bbadis.2005.03.004; SIMPSON RC, 1976, J NUTR, V106, P1272, DOI 10.1093/jn/106.9.1272; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; SWAROOP M, 1992, J BIOL CHEM, V267, P11455; Tang Chaoshu, 2006, Current Vascular Pharmacology, V4, P17; Thaler R, 2010, BONE, V46, P703, DOI 10.1016/j.bone.2009.10.038; UREN JR, 1978, BIOCHEM PHARMACOL, V27, P2807, DOI 10.1016/0006-2952(78)90194-6; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Yusuf M, 2005, BIOCHEM BIOPH RES CO, V333, P1146, DOI 10.1016/j.bbrc.2005.06.021; Zhong GZ, 2003, J HYPERTENS, V21, P1879, DOI 10.1097/00004872-200310000-00015	50	163	177	5	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2014	15	1					66	78		10.1016/j.stem.2014.03.005	http://dx.doi.org/10.1016/j.stem.2014.03.005			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AN8TX	24726192	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000340878600012
J	Parchem, RJ; Ye, J; Judson, RL; LaRussa, MF; Krishnakumar, R; Blelloch, A; Oldham, MC; Blelloch, R				Parchem, Ronald J.; Ye, Julia; Judson, Robert L.; LaRussa, Marie F.; Krishnakumar, Raga; Blelloch, Amy; Oldham, Michael C.; Blelloch, Robert			Two miRNA Clusters Reveal Alternative Paths in Late-Stage Reprogramming	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; SELF-RENEWAL; DNA METHYLATION; IPS CELLS; EMBRYONIC-DEVELOPMENT; MOUSE EMBRYOS; GROUND-STATE; MICRORNAS; GENE	Ectopic expression of specific factors such as Oct4, Sox2, and Klf4 (OSK) is sufficient to reprogram somatic cells into induced pluripotent stem cells (iPSCs). In this study, we examine the paths taken by cells during the reprogramming process by following the transcriptional activation of two pluripotent miRNA clusters (mir-290 and mir-302) in individual cells in vivo and in vitro with knockin reporters. During embryonic development and embryonic stem cell differentiation, all cells sequentially expressed mir-290 and mir-302. In contrast, during OSK-induced reprogramming, cells activated the miRNA loci in a stochastic, nonordered manner. However, the addition of Sall4 to the OSK cocktail led to a consistent reverse sequence of locus activation (mir-302 then mir-290) and increased reprogramming efficiency. These results demonstrate that cells can follow multiple paths during the late stages of reprogramming, and that the trajectory of any individual cell is strongly influenced by the combination of factors introduced.	[Parchem, Ronald J.; Ye, Julia; Judson, Robert L.; LaRussa, Marie F.; Krishnakumar, Raga; Blelloch, Amy; Oldham, Michael C.; Blelloch, Robert] Univ Calif San Francisco, Ctr Reprod Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Parchem, Ronald J.; Ye, Julia; Judson, Robert L.; LaRussa, Marie F.; Krishnakumar, Raga; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Oldham, Michael C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blelloch, R (corresponding author), Univ Calif San Francisco, Ctr Reprod Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	blellochr@stemcell.ucsf.edu		Krishnakumar, Raga/0000-0002-2479-754X	National Institutes of Health [R01 GM101180]; Leona M. and Harry B. Helmsley Charitable Trust [09PG-T1D002]; California Institute of Regenerative Medicine [RN2-00906-1]; NIH [T32 HD 007263-27, F32 HD 070572 -01]; UCSF; A.P. Giannini Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007263, P50HD055764, U54HD055764, F32HD070572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF; A.P. Giannini Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Nicole Moore for technical support, Grace Wei for assistance with the BioStation CT, and Diana Laird for critical reading of the manuscript. This work was supported by funds to R. H. B from the National Institutes of Health (R01 GM101180), the Leona M. and Harry B. Helmsley Charitable Trust (09PG-T1D002), and the California Institute of Regenerative Medicine (New Faculty Award, RN2-00906-1). R.J.P. was supported by NIH postdoctoral fellowships (T32 HD 007263-27 and F32 HD 070572 -01), R.L.J. was supported by a UCSF Julius R. and Patricia A. Krevans Fellowship, and R. K. was supported by an A.P. Giannini Foundation postdoctoral fellowship.	Amano H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-11; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jouneau A, 2012, RNA, V18, P253, DOI 10.1261/rna.028878.111; Judson RL, 2013, NAT STRUCT MOL BIOL, V20, P1227, DOI 10.1038/nsmb.2665; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kim H, 2011, CELL STEM CELL, V8, P695, DOI 10.1016/j.stem.2011.04.002; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Madan B, 2009, MOL CELL BIOL, V29, P3186, DOI 10.1128/MCB.01970-08; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Moltzahn F, 2011, JOVE-J VIS EXP, DOI 10.3791/2552; Neri F, 2013, CELL, V155, P121, DOI 10.1016/j.cell.2013.08.056; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oldham MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-63; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tashiro F, 2010, GENES CELLS, V15, P813, DOI 10.1111/j.1365-2443.2010.01420.x; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	58	61	64	2	156	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 1	2014	14	5					617	631		10.1016/j.stem.2014.01.021	http://dx.doi.org/10.1016/j.stem.2014.01.021			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG8HR	24630794	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000335659900011
J	Schulz, EG; Meisig, J; Nakamura, T; Okamoto, I; Sieber, A; Picard, C; Borensztein, M; Saitou, M; Bluthgen, N; Heard, E				Schulz, Edda G.; Meisig, Johannes; Nakamura, Tomonori; Okamoto, Ikuhiro; Sieber, Anja; Picard, Christel; Borensztein, Maud; Saitou, Mitinori; Bluethgen, Nils; Heard, Edith			The Two Active X Chromosomes in Female ESCs Block Exit from the Pluripotent State by Modulating the ESC Signaling Network	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GROUND-STATE; NAIVE PLURIPOTENCY; SELF-RENEWAL; NEGATIVE FEEDBACK; MOUSE; INACTIVATION; GENOME; LOCALIZATION; MAINTENANCE	During early development of female mouse embryos, both X chromosomes are transiently active. X gene dosage is then equalized between the sexes through the process of X chromosome inactivation (XCI). Whether the double dose of X-linked genes in females compared with males leads to sex-specific developmental differences has remained unclear. Using embryonic stem cells with distinct sex chromosome compositions as a model system, we show that two X chromosomes stabilize the naive pluripotent state by inhibiting MAPK and Gsk3 signaling and stimulating the Akt pathway. Since MAPK signaling is required to exit the pluripotent state, differentiation is paused in female cells as long as both X chromosomes are active. By preventing XCI or triggering it precociously, we demonstrate that this differentiation block is released once XX cells have undergone X inactivation. We propose that double X dosage interferes with differentiation, thus ensuring a tight coupling between X chromosome dosage compensation and development.	[Schulz, Edda G.; Picard, Christel; Borensztein, Maud; Heard, Edith] Inst Curie, CNRS UMR 3215, INSERM U934, Mammalian Dev Epigenet Grp, F-75248 Paris, France; [Meisig, Johannes; Sieber, Anja; Bluethgen, Nils] Charite, Inst Pathol, D-10117 Berlin, Germany; [Meisig, Johannes; Sieber, Anja; Bluethgen, Nils] Humboldt Univ, Integrat Res Inst Life Sci, D-10115 Berlin, Germany; [Meisig, Johannes; Sieber, Anja; Bluethgen, Nils] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Nakamura, Tomonori; Okamoto, Ikuhiro; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Nakamura, Tomonori; Okamoto, Ikuhiro; Saitou, Mitinori] ERATO, JST, Sakyo Ku, Kyoto 6068501, Japan; [Saitou, Mitinori] Kyoto Univ, Ctr IPS Cell Res & Applicat, Sakyo Ku, Kyoto 6068507, Japan; [Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin; Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University	Schulz, EG (corresponding author), Inst Curie, CNRS UMR 3215, INSERM U934, Mammalian Dev Epigenet Grp, F-75248 Paris, France.	edda.schulz@curie.fr; edith.heard@curie.fr	Heard, Edith/D-7197-2017; Borensztein, Maud/AAR-9303-2021; Nakamura, Tomonori/V-8828-2019; Bluthgen, Nils/A-1711-2011	Heard, Edith/0000-0001-8052-7117; Borensztein, Maud/0000-0002-4378-5018; Nakamura, Tomonori/0000-0002-0173-0780; Bluthgen, Nils/0000-0002-0171-7447	EU FP7 SYBOSS [242129]; HFSP long-term fellowship [LT000597/2010-L]; EU EpiGeneSys FP7 Network of Excellence [257082]; BMBF (FORSYS)	EU FP7 SYBOSS; HFSP long-term fellowship; EU EpiGeneSys FP7 Network of Excellence; BMBF (FORSYS)(Federal Ministry of Education & Research (BMBF))	We thank A. Wutz for the TX R26<SUP>rtTA</SUP> mice, R. Jaenisch and J. Gribnau for the Xist<SUP>2lox</SUP> mice, N. Brockdorff and T. Nesterova for Pgk12.1 and Pgk12.-E8(XO) mESC lines, M. Okano for Dnmt-TKO and J1 cell lines, A. Jouneau for male and female EpiSC lines, D. Schubeler for a list of regions that gain DNA methylation during ESC differentiation, and S. Keyse for the Dusp9 antibody. We thank the staff of the imaging facility PICTIBiSA@BDD for technical assistance, D. Gentien and C. Hego from the Institut Curie for microarray hybridizations, and M. Walter, J. Iranzo, and D. Bourc'his for help with the LUMA assay, embryo studies, and fruitful discussions. We thank K. Bernhard, F. S. Stewart, and A. Smith, who in the context of the EU FP7 SYBOSS (grant No. 242129) provided protocols and material for 2i culture and EpiLC differentiation. We are grateful to members of E.H.'s laboratory for critical input, and we thank E. Blackburn for a critical reading of the manuscript. This work was funded by an HFSP long-term fellowship (LT000597/2010-L) to E. G. S. and grants from the EU EpiGeneSys FP7 Network of Excellence No. 257082. N. B. was supported by BMBF (FORSYS).	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Bruck T, 2013, CELL REP, V4, P262, DOI 10.1016/j.celrep.2013.06.026; Burgoyne PS, 1995, PHILOS T R SOC B, V350, P253, DOI 10.1098/rstb.1995.0159; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Grabole N, 2013, EMBO REP, V14, P629, DOI 10.1038/embor.2013.67; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Jamieson RV, 1998, DEV BIOL, V201, P13, DOI 10.1006/dbio.1998.8972; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; MITTWOCH U, 1993, HUM REPROD, V8, P1550, DOI 10.1093/oxfordjournals.humrep.a137889; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; O'Neill LP, 2003, HUM MOL GENET, V12, P1783, DOI 10.1093/hmg/ddg193; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Ooi SKT, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-17; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Savarese F, 2006, MOL CELL BIOL, V26, P7167, DOI 10.1128/MCB.00810-06; Schulz EG, 2013, CURR OPIN GENET DEV, V23, P109, DOI 10.1016/j.gde.2013.01.008; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAKAGI N, 1990, DEVELOPMENT, V109, P189; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; THORNHILL AR, 1993, DEVELOPMENT, V118, P171; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Welham MJ, 2011, BIOCHEM SOC T, V39, P674, DOI 10.1042/BST0390674; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	46	101	104	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					203	216		10.1016/j.stem.2013.11.022	http://dx.doi.org/10.1016/j.stem.2013.11.022			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24506884	Green Published, Bronze			2022-12-28	WOS:000330835800012
J	Zhao, H; Feng, JF; Seidel, K; Shi, ST; Klein, O; Sharpe, P; Chai, Y				Zhao, Hu; Feng, Jifan; Seidel, Kerstin; Shi, Songtao; Klein, Ophir; Sharpe, Paul; Chai, Yang			Secretion of Shh by a Neurovascular Bundle Niche Supports Mesenchymal Stem Cell Homeostasis in the Adult Mouse Incisor	CELL STEM CELL			English	Article							STROMAL CELLS; SONIC-HEDGEHOG; PROGENITOR CELLS; RAT INCISOR; ARTERIAL DIFFERENTIATION; PERIVASCULAR CELLS; BONE-MARROW; GROWTH; ORGAN; TOOTH	Mesenchymal stem cells (MSCs) are typically defined by their in vitro characteristics, and as a consequence the in vivo identity of MSCs and their niches are poorly understood. To address this issue, we used lineage tracing in a mouse incisor model and identified the neurovascular bundle (NVB) as an MSC niche. We found that NVB sensory nerves secrete Shh protein, which activates Gli1 expression in periarterial cells that contribute to all mesenchymal derivatives. These periarterial cells do not express classical MSC markers used to define MSCs in vitro. In contrast, NG2(+) pericytes represent an MSC subpopulation derived from Gli1+ cells; they express classical MSC markers and contribute little to homeostasis but are actively involved in injury repair. Likewise, incisor Gli1(+) cells, but not NG2(+) cells, exhibit typical MSC characteristics in vitro. Collectively, we demonstrate that MSCs originate from periarterial cells and are regulated by Shh secretion from an NVB.	[Zhao, Hu; Feng, Jifan; Shi, Songtao; Chai, Yang] Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [Seidel, Kerstin; Klein, Ophir] Univ Calif San Francisco, Dept Orofacial Sci & Pediat, San Francisco, CA 94143 USA; [Sharpe, Paul] Kings Coll London, Inst Dent, Dept Craniofacial Dev & Stem Cell Biol, London TN3 9TF, England	University of Southern California; University of California System; University of California San Francisco; University of London; King's College London	Chai, Y (corresponding author), Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St, Los Angeles, CA 90033 USA.	ychai@usc.edu	zhao, hu/K-3901-2012	Hu, Zhao/0000-0002-2961-0086; Klein, Ophir/0000-0002-6254-7082; Sharpe, Paul/0000-0003-2116-9561	National Institute of Dental and Craniofacial Research, National Insitutes of Health [R90 DE022528, DE022503, DE020065, DE012711]; Medical Research Council; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R90DE022528, R37DE012711, U01DE020065, R01DE022503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012711] Funding Source: NIH RePORTER; MRC [MR/K018035/1] Funding Source: UKRI; Medical Research Council [MR/J006742/1, MR/K018035/1] Funding Source: researchfish	National Institute of Dental and Craniofacial Research, National Insitutes of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Julie Mayo and Bridget Samuels for critical reading of the manuscript, Dr. Alexandra Joyner (Memorial Sloan-Kettering Cancer Center) for providing the Gli1-GFP mice, and Dr. Richard Pelikan for performing microarray analysis. H. Z. gratefully acknowledges training grant support from the National Institute of Dental and Craniofacial Research, National Insitutes of Health (R90 DE022528). P. S. acknowledges support from the Medical Research Council. This study was supported by grants from the National Institute of Dental and Craniofacial Research, National Insitutes of Health (DE022503, DE020065, and DE012711 to Y.C.).	Bai CB, 2002, DEVELOPMENT, V129, P4753; Balic A, 2010, J DENT RES, V89, P1287, DOI 10.1177/0022034510375828; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Chan-Ling TL, 2005, MICROCIRCULATION, V12, P539, DOI 10.1080/10739680500253287; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; CHIEGO DJ, 1983, CELL TISSUE RES, V230, P197; CHIEGO DJ, 1981, ARCH ORAL BIOL, V26, P83, DOI 10.1016/0003-9969(81)90075-3; Chung IH, 2009, STEM CELLS, V27, P866, DOI 10.1002/stem.2; Corselli M, 2012, STEM CELLS DEV, V21, P1299, DOI 10.1089/scd.2011.0200; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Savastano LE, 2010, J NEUROSCI METH, V192, P22, DOI 10.1016/j.jneumeth.2010.07.007; Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108; Fitch SR, 2012, CELL STEM CELL, V11, P554, DOI 10.1016/j.stem.2012.07.002; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Grompe M, 2012, CELL STEM CELL, V10, P685, DOI 10.1016/j.stem.2012.04.006; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Hashimoto E, 2008, ARCH HISTOL CYTOL, V71, P317, DOI 10.1679/aohc.71.317; ISHIZUKA H, 1992, ARCH HISTOL CYTOL, V55, P167, DOI 10.1679/aohc.55.167; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; JOHANSSON CS, 1992, ANAT RECORD, V234, P144, DOI 10.1002/ar.1092340116; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; KEREZOUDIS NP, 1995, ARCH ORAL BIOL, V40, P815, DOI 10.1016/0003-9969(95)00048-T; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Knox SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2493; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; KUBOTA K, 1985, ANAT ANZEIGER, V158, P323; Ladizesky MG, 2001, AUTON NEUROSCI-BASIC, V93, P65, DOI 10.1016/S1566-0702(01)00337-X; Lapthanasupkul P, 2012, DEV BIOL, V367, P140, DOI 10.1016/j.ydbio.2012.04.029; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Li WL, 2013, DEV CELL, V24, P359, DOI 10.1016/j.devcel.2013.01.009; Majesky MW, 2012, CELLS TISSUES ORGANS, V195, P73, DOI 10.1159/000331413; Mao JJ, 2012, CELL STEM CELL, V11, P291, DOI 10.1016/j.stem.2012.08.010; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Murfee WL, 2005, MICROCIRCULATION, V12, P151, DOI 10.1080/10739680590904955; Olgart L, 1996, CRIT REV ORAL BIOL M, V7, P159, DOI 10.1177/10454411960070020401; Parsa S, 2010, DEVELOPMENT, V137, P3743, DOI 10.1242/dev.051672; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sasano T, 1995, J DENT RES, V74, P1665, DOI 10.1177/00220345950740100701; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Senzaki K, 2010, MOL CELL NEUROSCI, V43, P296, DOI 10.1016/j.mcn.2009.12.003; SMITH CE, 1975, ANAT RECORD, V183, P523, DOI 10.1002/ar.1091830405; Tabata S, 1998, ANAT RECORD, V251, P384, DOI 10.1002/(SICI)1097-0185(199807)251:3<384::AID-AR14>3.0.CO;2-K; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Zhang JQ, 1998, ANAT REC, V251, P214, DOI 10.1002/(SICI)1097-0185(199806)251:2<214::AID-AR9>3.0.CO;2-Y; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	66	284	292	5	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2014	14	2					160	173		10.1016/j.stem.2013.12.013	http://dx.doi.org/10.1016/j.stem.2013.12.013			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA1DF	24506883	Green Accepted, Bronze			2022-12-28	WOS:000330835800009
J	Sun, XN; Xu, J; Lu, HX; Liu, W; Miao, ZC; Sui, X; Liu, HS; Su, L; Du, WC; He, QH; Chen, FY; Shi, Y; Deng, HK				Sun, Xiaoning; Xu, Jun; Lu, Hongxia; Liu, Wang; Miao, Zhenchuan; Sui, Xin; Liu, Haisong; Su, Li; Du, Weichao; He, Qihua; Chen, Fangyuan; Shi, Yan; Deng, Hongkui			Directed Differentiation of Human Embryonic Stem Cells into Thymic Epithelial Progenitor-like Cells Reconstitutes the Thymic Microenvironment In Vivo	CELL STEM CELL			English	Article							ENDODERM; MICE; ORGANOGENESIS; GENERATION; LUNG; IDENTIFICATION; INHIBITION; MECHANISMS; EXPRESSION; TISSUE	Thymus transplantation has great clinical potential for treating immunological disorders, but the shortage of transplant donors limits the progress of this therapy. Human embryonic stem cells (hESCs) are promising cell sources for generating thymic epithelial cells. Here, we report a stepwise protocol to direct the differentiation of hESCs into thymic epithelial progenitor-like cells (TEPLCs) by mimicking thymus organogenesis with sequential regulation of Activin, retinoic acid, BMP, and WNT signals. The hESC-derived TEPLCs expressed the key thymic marker gene FOXN1 and could further develop in vivo into thymic epithelium expressing the functional thymic markers MHC II and AIRE upon transplantation. Moreover, the TEPLC-derived thymic epithelium could supportmouse thymopoiesis in T-cell-deficient mice and promote human T cell generation in NOD/SCID mice engrafted with human hematopoietic stem cells (hHSCs). These findings could facilitate hESC-based replacement therapy and provide a valuable in vitro platform for studying human thymus organogenesis and regeneration.	[Sun, Xiaoning; Sui, Xin; Liu, Haisong; Shi, Yan; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Key Lab Chem Genom, Shenzhen 518055, Peoples R China; [Xu, Jun; Lu, Hongxia; Liu, Wang; Miao, Zhenchuan; Sui, Xin; Du, Weichao; Chen, Fangyuan; Deng, Hongkui] Peking Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Deng, Hongkui] Peking Univ, Ctr Life Sci, Beijing 100871, Peoples R China; [Su, Li; He, Qihua] Peking Univ, Ctr Med & Hlth Anal, Beijing 100191, Peoples R China	Peking University; University Town of Shenzhen; Peking University; Peking University; Peking University	Shi, Y (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Key Lab Chem Genom, Shenzhen 518055, Peoples R China.	shiyan@pkusz.edu.cn; hongkui_deng@pku.edu.cn		liu, Haisong/0000-0002-7645-0855	National Basic Research Program of China (973 program) [2012CB966401]; Key New Drug Creation and Manufacturing Program [2011ZX09102-010-03]; National Science and Technology Major Project [2012ZX10001-008, 2013ZX10001003]; Ministry of Science and Technology [2011DFA30730, 2013DFG30680]; 111 project; Bill & Melinda Gates Foundation [37871]; National Natural Science Foundation of China [30900855]; China Postdoctoral Science Foundation [20080440269]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Key New Drug Creation and Manufacturing Program; National Science and Technology Major Project; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 111 project(Ministry of Education, China - 111 Project); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank Dr. D. S. Li for critical reading of the manuscript and Dr. Y. Zhao for advice on experimental design. We also thank Y.Z. Zhang, T. Yang, and W.F. Lai for the Q-PCR analysis; S. G. Duo, M. Liu, and D. C. Zhu for the animal experiments; and Y.X. Liu, C.Y. Wang, D. X. Zhao, S. Chen, H. F. Xie, and Y. Liu for discussion in the preparation of this manuscript. H. D. conceived the project and X. Sun, H. Lu, and J.X. designed the experiments. X. Sun performed the in vitro experiments with the technical help and advice of J.X, W. L., H. Liu, L. S., Q. H., and W. D.; X. Sun, J.X.; and H. Lu performed the in vivo experiments in the help of Z.M., W. L., X. Sui, and F. C.; X. Sun and J.X. analyzed the data and wrote the manuscript with the assistance and advice of H. D., H. Lu, Y. S., and Z.M.; X. Sun, J.X., and H. Lu contributed equally to this work. This work was supported by the National Basic Research Program of China (973 program 2012CB966401), the Key New Drug Creation and Manufacturing Program (2011ZX09102-010-03), the National Science and Technology Major Project (2012ZX10001-008, 2013ZX10001003), the Ministry of Science and Technology (2011DFA30730, 2013DFG30680) and 111 project, Bill & Melinda Gates Foundation Grant (37871), the National Natural Science Foundation of China (30900855), and the China Postdoctoral Science Foundation (20080440269).	Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chinn IK, 2011, J ALLERGY CLIN IMMUN, V127, P1351, DOI 10.1016/j.jaci.2011.03.033; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Graham A, 2005, J ANAT, V207, P479, DOI 10.1111/j.1469-7580.2005.00472.x; Green MD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-51; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Markert ML, 1999, NEW ENGL J MED, V341, P1180, DOI 10.1056/NEJM199910143411603; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nowell Craig S, 2007, Methods Mol Biol, V380, P125; ROCHA B, 1990, EUR J IMMUNOL, V20, P919, DOI 10.1002/eji.1830200430; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Tomaru U, 2009, BLOOD, V113, P5186, DOI 10.1182/blood-2008-11-187633; Tsai PT, 2003, BLOOD, V102, P3947, DOI 10.1182/blood-2003-05-1657; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Zhao Y, 1997, J IMMUNOL, V158, P1641; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	32	78	86	0	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					230	236		10.1016/j.stem.2013.06.014	http://dx.doi.org/10.1016/j.stem.2013.06.014			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910085	Bronze			2022-12-28	WOS:000329570600015
